PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kumar, V; Hallstrom, BM; Janke, A				Kumar, Vikas; Hallstroem, Bjoern M.; Janke, Axel			Coalescent-Based Genome Analyses Resolve the Early Branches of the Euarchontoglires	PLOS ONE			English	Article							PLACENTAL MAMMAL PHYLOGENY; COMPLETE MITOCHONDRIAL GENOME; SPECIES-TREE ANALYSIS; AMINO-ACID; MITOGENOMIC RELATIONSHIPS; LIKELIHOOD APPROACH; GENE TREES; SEQUENCES; EVOLUTIONARY; NUCLEOTIDE	Despite numerous large-scale phylogenomic studies, certain parts of the mammalian tree are extraordinarily difficult to resolve. We used the coding regions from 19 completely sequenced genomes to study the relationships within the super-clade Euarchontoglires (Primates, Rodentia, Lagomorpha, Dermoptera and Scandentia) because the placement of Scandentia within this clade is controversial. The difficulty in resolving this issue is due to the short time spans between the early divergences of Euarchontoglires, which may cause incongruent gene trees. The conflict in the data can be depicted by network analyses and the contentious relationships are best reconstructed by coalescent-based analyses. This method is expected to be superior to analyses of concatenated data in reconstructing a species tree from numerous gene trees. The total concatenated dataset used to study the relationships in this group comprises 5,875 protein-coding genes (9,799,170 nucleotides) from all orders except Dermoptera (flying lemurs). Reconstruction of the species tree from 1,006 gene trees using coalescent models placed Scandentia as sister group to the primates, which is in agreement with maximum likelihood analyses of concatenated nucleotide sequence data. Additionally, both analytical approaches favoured the Tarsier to be sister taxon to Anthropoidea, thus belonging to the Haplorrhine clade. When divergence times are short such as in radiations over periods of a few million years, even genome scale analyses struggle to resolve phylogenetic relationships. On these short branches processes such as incomplete lineage sorting and possibly hybridization occur and make it preferable to base phylogenomic analyses on coalescent methods.	[Kumar, Vikas; Hallstroem, Bjoern M.; Janke, Axel] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Kumar, Vikas; Hallstroem, Bjoern M.; Janke, Axel] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Germany; [Hallstroem, Bjoern M.] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Royal Institute of Technology	Janke, A (corresponding author), Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany.	axel.janke@senckenberg.de	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904; Kumar, Vikas/0000-0002-5263-9303	Hesse's Ministry of Higher Education, Research, and the Arts	Hesse's Ministry of Higher Education, Research, and the Arts	The present study was supported by the research funding program LOEWE: "Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-102; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Curnoe D, 2006, J EVOLUTION BIOL, V19, P59, DOI 10.1111/j.1420-9101.2005.00989.x; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Gregory WK, 1910, B AM MUSEUM NATURAL, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hallstrom BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028199; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson HD, 2010, PHYLOGENETIC NETWORK; Jameson NM, 2011, J HUM EVOL, V61, P295, DOI 10.1016/j.jhevol.2011.04.004; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; McKenna MC, 1975, PHYLOGENY CLASSIFICA, P21; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Pumo DE, 1998, J MOL EVOL, V47, P709, DOI 10.1007/PL00006430; Rannala B, 2003, GENETICS, V164, P1645; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Schmitz J, 2000, MOL BIOL EVOL, V17, P1334, DOI 10.1093/oxfordjournals.molbev.a026417; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simmons MP, 2004, MOL PHYLOGENET EVOL, V32, P913, DOI 10.1016/j.ympev.2004.04.011; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; Waddell PJ, 2003, MOL PHYLOGENET EVOL, V28, P197, DOI 10.1016/S1055-7903(03)00115-5; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104	53	31	31	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60019	10.1371/journal.pone.0060019	http://dx.doi.org/10.1371/journal.pone.0060019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560065	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900041
J	Tolg, C; Ahsan, A; Dworski, S; Kirwan, T; Yu, J; Aitken, K; Bagli, DJ				Tolg, Cornelia; Ahsan, Alya; Dworski, Shaalee; Kirwan, Tyler; Yu, Jeffery; Aitken, Karen; Baegli, Darius Jehan			Pathologic Bladder Microenvironment Attenuates Smooth Muscle Differentiation of Skin Derived Precursor Cells: Implications for Tissue Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACTIVATED PROTEIN-KINASE; NEUROPATHIC BLADDER; GROWTH-FACTOR; IN-VITRO; AUGMENTATION CYSTOPLASTY; DIRECTED DIFFERENTIATION; EXTRACELLULAR-MATRIX; OUTLET OBSTRUCTION; EXPRESSION	Smooth muscle cell containing organs (bladder, heart, blood vessels) are damaged by a variety of pathological conditions necessitating surgery or organ replacement. Currently, regeneration of contractile tissues is hampered by lack of functional smooth muscle cells. Multipotent skin derived progenitor cells (SKPs) can easily be isolated from adult skin and can be differentiated in vitro into contractile smooth muscle cells by exposure to FBS. Here we demonstrate an inhibitory effect of a pathologic contractile organ microenvironment on smooth muscle cell differentiation of SKPs. In vivo, urinary bladder strain induces microenvironmental changes leading to de-differentiation of fully differentiated bladder smooth muscle cells. Coculture of SKPs with organoids isolated from ex vivo stretched bladders or exposure of SKPs to diffusible factors released by stretched bladders (e. g. bFGF) suppresses expression of smooth muscle markers (alpha SMactin, calponin, myocardin, myosin heavy chain) as demonstrated by qPCR and immunofluorescent staining. Rapamycin, an inhibitor of mTOR signalling, previously observed to prevent bladder strain induced de-differentiation of fully differentiated smooth muscle cells in vitro, inhibits FBS-induced smooth muscle cell differentiation of undifferentiated SKPs. These results suggest that intended precursor cell differentiation may be paradoxically suppressed by the disease context for which regeneration may be required. Organ-specific microenvironment contexts, particularly prevailing disease, may play a significant role in modulating or attenuating an intended stem cell phenotypic fate, possibly explaining the variable and inefficient differentiation of stem cell constructs in in vivo settings. These observations must be considered in drafting any regeneration strategies.	[Tolg, Cornelia; Ahsan, Alya; Dworski, Shaalee; Kirwan, Tyler; Yu, Jeffery; Aitken, Karen; Baegli, Darius Jehan] Res Inst, Toronto, ON, Canada; [Aitken, Karen; Baegli, Darius Jehan] Hosp Sick Children, Res Inst, Div Urol, Toronto, ON M5G 1X8, Canada; [Dworski, Shaalee; Baegli, Darius Jehan] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Baegli, Darius Jehan] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Baegli, Darius Jehan] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Bagli, DJ (corresponding author), Res Inst, Toronto, ON, Canada.	darius.bagli@sickkids.ca	Aitken, KJ/AAC-5383-2019		CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	Funding was provided by the CIHR operating grant "Novel Therapeutic Strategies for Obstructive Bladder Disease." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Aitken KJ, 2010, AM J PATHOL, V176, P304, DOI 10.2353/ajpath.2010.080834; Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201; Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230; Anumanthan G, 2008, J UROLOGY, V180, P1778, DOI 10.1016/j.juro.2008.04.076; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Bagli DJ, 1999, J UROLOGY, V162, P832, DOI 10.1097/00005392-199909010-00071; Beqaj SH, 2005, J UROLOGY, V174, P1699, DOI 10.1097/01.ju.0000176633.92150.4e; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Biernaskie J, 2010, CAN J NEUROL SCI, V37, pS34, DOI 10.1017/S0317167100022411; Biernaskie J, 2010, J INVEST DERMATOL, V130, P1202, DOI 10.1038/jid.2009.449; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Borer JG, 1999, LAB INVEST, V79, P1335; Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55; Duel BP, 1998, J UROLOGY, V159, P998, DOI 10.1016/S0022-5347(01)63820-5; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes Karl J. L., 2009, V482, P159, DOI 10.1007/978-1-59745-060-7_10; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FLOOD HD, 1995, NEUROUROL URODYNAM, V14, P297, DOI 10.1002/nau.1930140402; Golub L M, 1998, Adv Dent Res, V12, P12; Hanemaaijer R, 1998, Adv Dent Res, V12, P114; Hegner B, 2009, ARTERIOSCL THROM VAS, V29, P232, DOI 10.1161/ATVBAHA.108.179457; Herz DB, 2003, J UROLOGY, V170, P2072, DOI 10.1097/01.ju.0000091810.33953.13; Imamura M, 2007, AM J; Kim JC, 2001, UROLOGY, V57, P371, DOI 10.1016/S0090-4295(00)00886-4; Kramer J, 2001, J VASC RES, V38, P120, DOI 10.1159/000051039; Kramer J, 1999, J MOL MED-JMM, V77, P294, DOI 10.1007/s001090050352; Lavoie JF, 2009, STEM CELLS DEV, V18, P893, DOI 10.1089/scd.2008.0260; Lin Ching-Shwun, 2010, World J Stem Cells, V2, P1, DOI 10.4252/wjsc.v2.i1.1; Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; Rensen SSM, 2002, CARDIOVASC RES, V55, P850, DOI 10.1016/S0008-6363(02)00491-1; Sabha N, 2006, IN VITRO CELL DEV-AN, V42, P124; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sharma AK, 2009, J UROLOGY, V182, P1898, DOI 10.1016/j.juro.2009.03.014; Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y; Smith GN, 1999, ARTHRITIS RHEUM, V42, P1140, DOI 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7; Steinbach SK, 2011, ARTERIOSCL THROM VAS, V31, P2938, DOI 10.1161/ATVBAHA.111.232975; Takeuchi K, 2003, ANAT REC PART A, V274A, P883, DOI 10.1002/ar.a.10111; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; vanEys GJJM, 1997, CELL STRUCT FUNCT, V22, P65, DOI 10.1247/csf.22.65; Yu RN, UROLOGY, V75, P664; Zhao LM, 2011, VITAM HORM, V87, P127, DOI 10.1016/B978-0-12-386015-6.00042-1; Zhou J, METHODS MOL BIOL, V821, P361; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8; Zhu YF, 2008, UROL INT, V81, P222, DOI 10.1159/000144066	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59413	10.1371/journal.pone.0059413	http://dx.doi.org/10.1371/journal.pone.0059413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560047	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900015
J	Oliveira, PH; da Silva, CL; Cabral, JMS				Oliveira, Pedro H.; da Silva, Claudia Lobato; Cabral, Joaquim M. S.			An Appraisal of Human Mitochondrial DNA Instability: New Insights into the Role of Non-Canonical DNA Structures and Sequence Motifs	PLOS ONE			English	Article							RECOMBINATION HOT-SPOTS; INTRINSICALLY BENT DNA; LARGE-SCALE DELETIONS; HUMAN GENOME; HUMAN-CELLS; B-DNA; TRANSCRIPTION; REPLICATION; MUTATIONS; REGIONS	Mitochondrial DNA (mtDNA) deletion mutations are frequently observed in aged postmitotic tissues and are the cause of a wide range of human disorders. Presently, the molecular bases underlying mtDNA deletion formation remain a matter of intense debate, and it is commonly accepted that several mechanisms contribute to the spectra of mutations in the mitochondrial genome. In this work we performed an extensive screening of human mtDNA deletions and evaluated the association between breakpoint density and presence of non-canonical DNA elements and over-represented sequence motifs. Our observations support the involvement of helix-distorting intrinsically curved regions and long G-tetrads in eliciting instability events. In addition, higher breakpoint densities were consistently observed within GC-skewed regions and in the close vicinity of the degenerate sequence motif YMMYMNNMMHM. A parallelism is also established with hot spot motifs previously identified in the nuclear genome, as well as with the minimal binding site for the mitochondrial transcription termination factor mTERF. This study extends the current knowledge on the mechanisms driving mitochondrial rearrangements and opens up exciting avenues for further research.	[Oliveira, Pedro H.] Inst Super Tecn, Dept Bioengn, Lisbon, Portugal; Inst Super Tecn, Inst Biotechnol & Bioengn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Oliveira, PH (corresponding author), Inst Super Tecn, Dept Bioengn, Lisbon, Portugal.	pcphco@gmail.com	Cabral, Joaquim M S/G-2052-2010; da Silva, Claudia L./K-6104-2012; Oliveira, Pedro H./E-4818-2011	Cabral, Joaquim M S/0000-0002-2405-5845; da Silva, Claudia L./0000-0002-1091-7651; Oliveira, Pedro H./0000-0003-3161-8367	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/EQU-EQU/114231/2009, BPD/64652/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through the MIT-Portugal Program, Bioengineering Focus Area and Project PTDC/EQU-EQU/114231/2009. PHO acknowledges FCT for the Post-Doctoral Grant BPD/64652/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; Boan F, 2010, CHEMBIOCHEM, V11, P331, DOI 10.1002/cbic.200900612; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97; Cress WD, 1996, MOL CELL BIOL, V16, P2119; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gimenes F, 2008, GENET MOL RES, V7, P549, DOI 10.4238/vol7-2gmr461; GOODSELL DS, 1994, NUCLEIC ACIDS RES, V22, P5497, DOI 10.1093/nar/22.24.5497; Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006; Hou JH, 1998, MUTAT RES-FUND MOL M, V403, P75, DOI 10.1016/S0027-5107(98)00054-2; Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Katzman S, 2011, GENOME BIOL EVOL, V3, P614, DOI 10.1093/gbe/evr058; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Kusakabe T, 2001, GENE, V274, P271, DOI 10.1016/S0378-1119(01)00631-X; Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Maliarchuk B A, 2002, Mol Biol (Mosk), V36, P418; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; McIvor EI, 2010, RNA BIOL, V7, P551, DOI 10.4161/rna.7.5.12745; MILOT E, 1992, EMBO J, V11, P5063, DOI 10.1002/j.1460-2075.1992.tb05613.x; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; PerezMartin J, 1997, ANNU REV MICROBIOL, V51, P593, DOI 10.1146/annurev.micro.51.1.593; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocher C, 2002, MOL GENET METAB, V76, P123, DOI 10.1016/S1096-7192(02)00024-0; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	41	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59907	10.1371/journal.pone.0059907	http://dx.doi.org/10.1371/journal.pone.0059907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555828	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900040
J	Rawat, M; Vijay, S; Gupta, Y; Tiwari, PK; Sharma, A				Rawat, Manmeet; Vijay, Sonam; Gupta, Yash; Tiwari, Pramod Kumar; Sharma, Arun			Imperfect Duplicate Insertions Type of Mutations in Plasmepsin V Modulates Binding Properties of PEXEL Motifs of Export Proteins in Indian Plasmodium vivax	PLOS ONE			English	Article							MALARIA PARASITES; HOST ERYTHROCYTE; MOLECULAR DOCKING; WEB SERVER; PREDICTION; FALCIPARUM; INTERPROSCAN; REFINEMENT; VIRULENCE; PROTEASES	Introduction: Plasmepsin V (PM-V) have functionally conserved orthologues across the Plasmodium genus who's binding and antigenic processing at the PEXEL motifs for export about 200-300 essential proteins is important for the virulence and viability of the causative Plasmodium species. This study was undertaken to determine P. vivax plasmepsin-V-Ind (PvPM-V-Ind) PEXEL motif export pathway for pathogenicity-related proteins/antigens export thereby altering plasmodium exportome during erythrocytic stages. Method: We identify and characterize Plasmodium vivax plasmepsin-V-Ind (mutant) gene by cloning, sequence analysis, in silico bioinformatic protocols and structural modeling predictions based on docking studies on binding capacity with PEXEL motifs processing in terms of binding and accessibility of export proteins. Results: Cloning and sequence analysis for genetic diversity demonstrates PvPM-V-Ind (mutant) gene is highly conserved among all isolates from different geographical regions of India. Imperfect duplicate insertion types of mutations (SVSE from 246-249 AA and SLSE from 266-269 AA) were identified among all Indian isolates in comparison to P. vivax Sal-1 (PvPM-V-Sal-1) isolate. In silico bioinformatics interaction studies of PEXEL peptide and active enzyme reveal that PvPM-V-Ind (mutant) is only active in endoplasmic reticulum lumen and membrane embedding is essential for activation of plasmepsin V. Structural modeling predictions based on docking studies with PEXEL motif show significant variation in substrate protein binding of these imperfect mutations with data mined PEXEL sequences. The predicted variation in the docking score and interacting amino acids of PvPM-V-Ind (mutant) proteins with PEXEL and lopinavir suggests a modulation in the activity of PvPM-V in terms of binding and accessibility at these sites. Conclusion/Significance: Our functional modeled validation of PvPM-V-Ind (mutant) imperfect duplicate insertions with data mined PEXEL sequences leading to altered binding and substrate accessibility of the enzyme makes it a plausible target to investigate export mechanisms for in silico virtual screening and novel pharmacophore designing.	[Rawat, Manmeet; Vijay, Sonam; Sharma, Arun] Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Div, New Delhi, India; [Gupta, Yash] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Microbiol & Mol Biol, Agra, Uttar Pradesh, India; [Tiwari, Pramod Kumar] Jiwaji Univ, Ctr Genom Mol & Human Genet, Gwalior, Madhya Pradesh, India; [Rawat, Manmeet] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Jiwaji University Gwalior; University of New Mexico	Sharma, A (corresponding author), Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Div, New Delhi, India.	arushar@gmail.com	Gupta, Yash/AAG-4189-2021; Manmeet, Rawat/AAE-5057-2021	Gupta, Yash/0000-0003-3002-1315; Rawat, Manmeet/0000-0002-8325-3390	Department of Biotechnology, New Delhi Government of India	Department of Biotechnology, New Delhi Government of India(Department of Biotechnology (DBT) India)	This work has been financially supported by the Department of Biotechnology, New Delhi Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilio MS, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.268; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Carlton J, 2003, TRENDS PARASITOL, V19, P227, DOI 10.1016/S1471-4922(03)00066-7; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Haase S, 2010, CELL MICROBIOL, V12, P580, DOI 10.1111/j.1462-5822.2010.01455.x; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Lin YC, 2006, NUCLEIC ACIDS RES, V34, pW696, DOI 10.1093/nar/gkl169; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mashiach E, 2010, NUCLEIC ACIDS RES, V38, pW457, DOI 10.1093/nar/gkq373; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mulder Nicola, 2007, V396, P59; Na Byoung-Kuk, 2004, Korean Journal of Parasitology, V42, P61, DOI 10.3347/kjp.2004.42.2.61; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Rawat M, 2011, INFECT GENET EVOL, V11, P924, DOI 10.1016/j.meegid.2011.02.024; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Seiler M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-144; Sharma A, 2007, CURR OPIN INVEST DR, V8, P642; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 1996, WHOMAL961077; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60077	10.1371/journal.pone.0060077	http://dx.doi.org/10.1371/journal.pone.0060077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555891	Green Submitted, gold, Green Published			2022-12-27	WOS:000317263900056
J	Trindade, AJ; Medvetz, DA; Neuman, NA; Myachina, F; Yu, J; Priolo, C; Henske, EP				Trindade, Anil J.; Medvetz, Douglas A.; Neuman, Nicole A.; Myachina, Faina; Yu, Jane; Priolo, Carmen; Henske, Elizabeth P.			MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)	PLOS ONE			English	Article							TUMOR-SUPPRESSOR TSC2; GENE TSC2; PATHWAY; CELL; EXPRESSION; COMPLEX; MTOR; MUTATIONS; GROWTH; ANGIOMYOLIPOMA	Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of smooth muscle-like cells in the lung resulting in cystic lung destruction. Women with LAM can also develop renal angiomyolipomas. LAM is caused by mutations in the tuberous sclerosis complex genes (TSC1 or TSC2), resulting in hyperactive mammalian Target of Rapamycin (mTOR) signaling. The mTOR inhibitor, Rapamycin, stabilizes lung function in LAM and decreases the volume of renal angiomyolipomas, but lung function declines and angiomyolipomas regrow when treatment is discontinued, suggesting that factors induced by mTORC1 inhibition may promote the survival of TSC2-deficient cells. Whether microRNA (miRNA, miR) signaling is involved in the response of LAM to mTORC1 inhibition is unknown. We identified Rapamycin-dependent miRNA in LAM patient angiomyolipoma-derived cells using two separate screens. First, we assayed 132 miRNA of known significance to tumor biology. Using a cut-off of > 1.5-fold change, 48 microRNA were Rapamycin-induced, while 4 miRs were downregulated. In a second screen encompassing 946 miRNA, 18 miRs were upregulated by Rapamycin, while eight were downregulated. Dysregulation of miRs 29b, 21, 24, 221, 106a and 199a were common to both platforms and were classified as candidate "RapamiRs.'' Validation by qRT-PCR confirmed that these microRNA were increased. miR-21, a pro-survival miR, was the most significantly increased by mTOR-inhibition (p < 0.01). The regulation of miR-21 by Rapamycin is cell type independent. mTOR inhibition promotes the processing of the miR-21 transcript (pri-miR-21) to a premature form (pre-miR-21). In conclusion, our findings demonstrate that Rapamycin upregulates multiple miRs, including pro-survival miRs, in TSC2-deficient patient-derived cells. The induction of miRs may contribute to the response of LAM and TSC patients to Rapamycin therapy.	[Henske, Elizabeth P.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Henske, EP (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	ehenske@partners.org			LAM Foundation;  [NIH-T32 HL007633-27]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER	LAM Foundation; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this project came from NIH-T32 HL007633-27 (AJT) and the LAM Foundation (EPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Astrinidis A, 2000, J MED GENET, V37, P55, DOI 10.1136/jmg.37.1.55; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; El-Hashemite N, 2005, AM J RESP CELL MOL, V33, P227, DOI 10.1165/rcmb.2005-0152RC; EVERITT JI, 1995, AM J PATHOL, V146, P1556; Fasanaro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044651; Finlay G, 2004, AM J PHYSIOL-LUNG C, V286, pL690, DOI 10.1152/ajplung.00311.2003; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P561, DOI 10.1165/rcmb.2005-0300OC; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Harari S, 2011, EUR RESPIR REV, V20, P34, DOI 10.1183/09059180.00011010; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Koerner C, 2013, J BIOL CHEM; Kwiatkowski DJ, 2010, LYMPHAT RES BIOL, V8, P51, DOI 10.1089/lrb.2009.0013; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Milosevic J, 2012, AM J RESP CELL MOL B; Pacheco-Rodriguez G, 2009, J IMMUNOL, V182, P1270, DOI 10.4049/jimmunol.182.3.1270; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Scott CL, 2010, AM J PHYSIOL-LUNG C, V299, pL455, DOI 10.1152/ajplung.00348.2009; Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Wang M, 2011, ARTERIOSCL THROM VAS, V31, P2046, DOI 10.1161/ATVBAHA.111.229559; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	51	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60014	10.1371/journal.pone.0060014	http://dx.doi.org/10.1371/journal.pone.0060014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555865	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900051
J	Sun, LD; Yang, WR; Zhang, QX; Cheng, TR; Pan, HT; Xu, ZD; Zhang, J; Chen, CG				Sun, Lidan; Yang, Weiru; Zhang, Qixiang; Cheng, Tangren; Pan, Huitang; Xu, Zongda; Zhang, Jie; Chen, Chuguang			Genome-Wide Characterization and Linkage Mapping of Simple Sequence Repeats in Mei (Prunus mume Sieb. et Zucc.)	PLOS ONE			English	Article							SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; MICROSATELLITE POLYMORPHISM; MAP; DNA; MARKERS; RECOMBINATION; CONSTRUCTION; SELECTION; METHYLATION	Because of its popularity as an ornamental plant in East Asia, mei (Prunus mume Sieb. et Zucc.) has received increasing attention in genetic and genomic research with the recent shotgun sequencing of its genome. Here, we performed the genome-wide characterization of simple sequence repeats (SSRs) in the mei genome and detected a total of 188,149 SSRs occurring at a frequency of 794 SSR/Mb. Mononucleotide repeats were the most common type of SSR in genomic regions, followed by di- and tetranucleotide repeats. Most of the SSRs in coding sequences (CDS) were composed of tri- or hexanucleotide repeat motifs, but mononucleotide repeats were always the most common in intergenic regions. Genome-wide comparison of SSR patterns among the mei, strawberry (Fragaria vesca), and apple (Malusxdomestica) genomes showed mei to have the highest density of SSRs, slightly higher than that of strawberry (608 SSR/Mb) and almost twice as high as that of apple (398 SSR/Mb). Mononucleotide repeats were the dominant SSR motifs in the three Rosaceae species. Using 144 SSR markers, we constructed a 670 cM-long linkage map of mei delimited into eight linkage groups (LGs), with an average marker distance of 5 cM. Seventy one scaffolds covering about 27.9% of the assembled mei genome were anchored to the genetic map, depending on which the macro-colinearity between the mei genome and Prunus TxE reference map was identified. The framework map of mei constructed provides a first step into subsequent high-resolution genetic mapping and marker-assisted selection for this ornamental species.	[Sun, Lidan; Yang, Weiru; Zhang, Qixiang; Cheng, Tangren; Pan, Huitang; Xu, Zongda; Zhang, Jie] Beijing Forestry Univ, Natl Engn Res Ctr Floriculture, Coll Landscape Architecture, Beijing, Peoples R China; [Chen, Chuguang] Beijing Microread Genet Co Ltd, Beijing, Peoples R China	Beijing Forestry University	Zhang, QX (corresponding author), Beijing Forestry Univ, Natl Engn Res Ctr Floriculture, Coll Landscape Architecture, Beijing, Peoples R China.	zqx@bjfu.edu.cn	Cheng, Tangren/HDM-6455-2022		State Forestry Administration of China [201004012]; Ministry of Science and Technology [2011AA100207]	State Forestry Administration of China; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The work was supported by the State Forestry Administration of China (201004012), and Ministry of Science and Technology (2011AA100207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; CAUSSE MA, 1994, GENETICS, V138, P1251; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen JY, 1996, CHINESE MEI FLOWERS, P14; Chu MY, 1999, CHINA FRUIT RECORDS, P12; Dettori MT, 2001, GENOME, V44, P783, DOI 10.1139/g01-065; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Fahima T, 2002, THEOR APPL GENET, V104, P17, DOI 10.1007/s001220200002; Fang JG, 2006, GENOME, V49, P1256, DOI 10.1139/G06-097; GACY AM, 1995, CELL, V81, P533; Gao LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-521; Gaspari Z, 2007, FEBS LETT, V581, P2523, DOI 10.1016/j.febslet.2007.04.073; Gautami B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041213; Hurtado MA, 2002, THEOR APPL GENET, V105, P182, DOI 10.1007/s00122-002-0936-y; Jauregui B, 2001, THEOR APPL GENET, V102, P1169, DOI 10.1007/s001220000511; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koilkonda P, 2012, MOL BREEDING, V30, P125, DOI 10.1007/s11032-011-9604-8; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lambert P, 2004, THEOR APPL GENET, V108, P1120, DOI 10.1007/s00122-003-1526-3; Li XY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-66; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Meglecz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040861; Messier W, 1996, NATURE, V381, P483, DOI 10.1038/381483a0; Metzgar D, 2000, GENOME RES, V10, P72; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; MITAS M, 1995, NUCLEIC ACIDS RES, V23, P1050, DOI 10.1093/nar/23.6.1050; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Ooijen JV, 2006, JOINMAP 4 SOFTWARE C, P1; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029453; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Shokeen B, 2011, ANN BOT-LONDON, V108, P321, DOI 10.1093/aob/mcr162; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Testolin R, 2000, GENOME, V43, P512, DOI 10.1139/gen-43-3-512; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vilanova S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-67; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015952; Yang CD, 2008, TREE GENET GENOMES, V4, P255, DOI 10.1007/s11295-007-0106-0; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-371; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005	65	41	45	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59562	10.1371/journal.pone.0059562	http://dx.doi.org/10.1371/journal.pone.0059562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555708	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200028
J	Tschinkel, WR				Tschinkel, Walter R.			Florida Harvester Ant Nest Architecture, Nest Relocation and Soil Carbon Dioxide Gradients	PLOS ONE			English	Article							POGONOMYRMEX-BADIUS; INTERNAL STRUCTURE; CO2 CONCENTRATIONS; HYMENOPTERA; VENTILATION; EXCAVATION; DYNAMICS; EFFLUX; FOREST; SIZE	Colonies of the Florida harvester ant, Pogonomyrmex badius, excavate species-typical subterranean nests up the 3 m deep with characteristic vertical distribution of chamber area/shape, spacing between levels and vertical arrangement of the ants by age and brood stage. Colonies excavate and occupy a new nest about once a year, and doing so requires that they have information about the depth below ground. Careful excavation and mapping of vacated and new nests revealed that there was no significant difference between the old and new nests in any measure of nest size, shape or arrangement. Colonies essentially built a replicate of the just-vacated nest (although details differed), and they did so in less than a week. The reason for nest relocation is not apparent. Tschinkel noted that the vertical distribution of chamber area, worker age and brood type was strongly correlated to the soil carbon dioxide gradient, and proposed that this gradient serves as a template for nest excavation and vertical distribution. To test this hypothesis, the carbon dioxide gradient of colonies that were just beginning to excavate a new nest was eliminated by boring 6 vent holes around the forming nest, allowing the soil CO2 to diffuse into the atmosphere and eliminating the gradient. Sadly, neither the nest architecture nor the vertical ant distribution of vented nests differed from either unvented control or from their own vacated nest. In a stronger test, workers excavated a new nest under a reversed carbon dioxide gradient (high concentration near the surface, low below). Even under these conditions, the new and old nests did not differ significantly, showing that the soil carbon dioxide gradient does not serve as a template for nest construction or vertical worker distribution. The possible importance of soil CO2 gradients for soil-dwelling animals is discussed.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation [IOS-1021632]	National Science Foundation(National Science Foundation (NSF))	This work was carried out in part with the support of National Science Foundation grant number IOS-1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Remaining funding was personal, and no additional external funding was received for this study.	Bekele A, 2007, FOREST ECOL MANAG, V242, P587, DOI 10.1016/j.foreco.2007.01.088; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Cerquera LM, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6401; Cox MD, 2000, J THEOR BIOL, V204, P223, DOI 10.1006/jtbi.2000.2010; Duval M., 1929, C R SOC BIOL PARIS, V3, P906; Edwards C. A., 1977, BIOL ECOLOGY EARTHWO; Halley JD, 2005, INSECT SOC, V52, P350, DOI 10.1007/s00040-005-0818-9; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; Holmes JW, 1992, ENCY EARTH SYSTEMS S, V4, P241; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 1996, NATURWISSENSCHAFTEN, V83, P566; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; LACHER V, 1964, Z VERGL PHYSIOL, V48, P587, DOI 10.1007/BF00333743; Lipson DA, 2006, MICROB ECOL, V51, P302, DOI 10.1007/s00248-006-9032-1; Maier M, 2010, EUR J SOIL SCI, V61, P877, DOI 10.1111/j.1365-2389.2010.01287.x; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Minter NJ, 2012, J R SOC INTERFACE, V9, P586, DOI 10.1098/rsif.2011.0377; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Raffy A, 1929, C R SOC BIOL PARIS, V3, P908; Rasse P, 2001, J INSECT BEHAV, V14, P433, DOI 10.1023/A:1011163804217; Risk D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014002; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Scholes SR, 2006, BEHAV ECOL SOCIOBIOL, V59, P531, DOI 10.1007/s00265-005-0078-8; SCHWARTZ DM, 1973, OECOLOGIA, V12, P161, DOI 10.1007/BF00345515; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; Shiraishi K, 1954, SCI REP TOHOHU U, V20, P256; Smith CR, 2005, J INSECT BEHAV, V18, P859, DOI 10.1007/s10905-005-8745-1; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; Theraulaz G, 1999, INFORM PROCESSING SO; Tschinkel WR, 2010, J INSECT SCI, V10, DOI [10.1673/031.010.8801, 10.1673/031.010.6501]; Tschinkel WR, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.11401; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Tschinkel WR, 2011, J INSECT SCI; WILSON EDWARD O., 1962, ANIMAL BEHAVIOUR, V10, P159, DOI 10.1016/0003-3472(62)90143-4	42	10	10	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59911	10.1371/journal.pone.0059911	http://dx.doi.org/10.1371/journal.pone.0059911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555829	Green Published, gold			2022-12-27	WOS:000317262200057
J	Bethell, D; Saunders, D; Jongkaewwattana, A; Kramyu, J; Thitithayanont, A; Wiboon-ut, S; Yongvanitchit, K; Limsalakpetch, A; Kum-Arb, U; Uthaimongkol, N; Garcia, JM; Timmermans, AE; Peiris, M; Thomas, S; Engering, A; Jarman, RG; Mongkolsirichaikul, D; Mason, C; Khemnu, N; Tyner, SD; Fukuda, MM; Walsh, DS; Pichyangkul, S				Bethell, Delia; Saunders, David; Jongkaewwattana, Anan; Kramyu, Jarin; Thitithayanont, Arunee; Wiboon-ut, Suwimon; Yongvanitchit, Kosol; Limsalakpetch, Amporn; Kum-Arb, Utaiwan; Uthaimongkol, Nichapat; Garcia, Jean Michel; Timmermans, Ans E.; Peiris, Malik; Thomas, Stephen; Engering, Anneke; Jarman, Richard G.; Mongkolsirichaikul, Duangrat; Mason, Carl; Khemnu, Nuanpan; Tyner, Stuart D.; Fukuda, Mark M.; Walsh, Douglas S.; Pichyangkul, Sathit			Evaluation of In Vitro Cross-Reactivity to Avian H5N1 and Pandemic H1N1 2009 Influenza Following Prime Boost Regimens of Seasonal Influenza Vaccination in Healthy Human Subjects: A Randomised Trial	PLOS ONE			English	Article							T-CELLS; NEURAMINIDASE ANTIBODY; MF59-ADJUVANTED INFLUENZA; VIRUS; VACCINES; LIVE; PROTECTION; RESPONSES; IMMUNITY; IMMUNOGENICITY	Introduction: Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit production of heterosubtypic antibodies, which can neutralize avian H5N1 virus in a small proportion of subjects. We hypothesized that prime boost regimens of live and inactivated trivalent seasonal influenza vaccines (LAIV and IIV) would enhance production of heterosubtypic immunity and provide evidence of cross-protection against other influenza viruses. Methods: In an open-label study, 26 adult volunteers were randomized to receive one of four vaccine regimens containing two doses of 2009-10 seasonal influenza vaccines administered 8 (61) weeks apart: 2 doses of LAIV; 2 doses of IIV; LAIV then IIV; IIV then LAIV. Humoral immunity assays for avian H5N1, 2009 pandemic H1N1 (pH1N1), and seasonal vaccine strains were performed on blood collected pre-vaccine and 2 and 4 weeks later. The percentage of cytokine-producing T-cells was compared with baseline 14 days after each dose. Results: Subjects receiving IIV had prompt serological responses to vaccine strains. Two subjects receiving heterologous prime boost regimens had enhanced haemagglutination inhibition (HI) and neutralization (NT) titres against pH1N1, and one subject against avian H5N1; all three had pre-existing cross-reactive antibodies detected at baseline. Significantly elevated titres to H5N1 and pH1N1 by neuraminidase inhibition (NI) assay were observed following LAIV-IIV administration. Both vaccines elicited cross-reactive CD4+ T-cell responses to nucleoprotein of avian H5N1 and pH1N1. All regimens were safe and well tolerated. Conclusion: Neither homologous nor heterologous prime boost immunization enhanced serum HI and NT titres to 2009 pH1N1 or avian H5N1 compared to single dose vaccine. However heterologous prime-boost vaccination did lead to in vitro evidence of cross-reactivity by NI; the significance of this finding is unclear. These data support the strategy of administering single dose trivalent seasonal influenza vaccine at the outset of an influenza pandemic while a specific vaccine is being developed.	[Bethell, Delia; Saunders, David; Yongvanitchit, Kosol; Limsalakpetch, Amporn; Kum-Arb, Utaiwan; Uthaimongkol, Nichapat; Timmermans, Ans E.; Engering, Anneke; Tyner, Stuart D.; Fukuda, Mark M.; Walsh, Douglas S.; Pichyangkul, Sathit] Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand; [Jongkaewwattana, Anan; Kramyu, Jarin] Natl Ctr Genet Engn & Biotechnol, Virol & Cell Technol Lab, Bangkok, Thailand; [Thitithayanont, Arunee; Wiboon-ut, Suwimon] Mahidol Univ, Fac Sci, Bangkok 10400, Thailand; [Garcia, Jean Michel; Peiris, Malik] Univ Hong Kong Pasteur Res Ctr, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Thomas, Stephen; Jarman, Richard G.; Mongkolsirichaikul, Duangrat] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Mason, Carl; Khemnu, Nuanpan] Armed Forces Res Inst Med Sci, Dept Enter Dis, Bangkok 10400, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; University of Hong Kong; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Bethell, D (corresponding author), Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand.	delia.bethell@afrims.org	Garcia, Jean-Michel/J-7166-2013; Mason, Carl/ABH-3298-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Garcia, Jean-Michel/0000-0002-6005-9982; Mason, Carl/0000-0002-3676-2811; Thomas, Stephen/0000-0002-8368-7682; Manopwisedjaroen, Suwimon/0000-0002-7571-8733; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	MedImmune	MedImmune(AstraZenecaMedimmune)	This study was funded by a MedImmune Investigator-Initiated Research Program grant from MedImmune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Christopher S, 2006, Semin Pediatr Infect Dis, V17, P206, DOI 10.1053/j.spid.2006.08.007; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Garcia JM, 2010, J CLIN VIROL, V47, P29, DOI 10.1016/j.jcv.2009.10.009; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; MONTO AS, 1973, LANCET, V1, P623, DOI 10.1016/S0140-6736(73)92196-X; MURPHY BR, 1972, NEW ENGL J MED, V286, P1329, DOI 10.1056/NEJM197206222862502; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Verrier F, 2000, J VIROL, V74, P10025, DOI 10.1128/JVI.74.21.10025-10033.2000; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2013, CUM NUMB CONF HUM CA; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YAP KL, 1978, SCAND J IMMUNOL, V7, P73, DOI 10.1111/j.1365-3083.1978.tb00428.x; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	35	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59674	10.1371/journal.pone.0059674	http://dx.doi.org/10.1371/journal.pone.0059674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555741	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500072
J	Ma, F; Zhang, P; Lin, DX; Yu, DK; Yuan, P; Wang, JY; Fan, Y; Xu, BH				Ma, Fei; Zhang, Ping; Lin, Dongxin; Yu, Dianke; Yuan, Peng; Wang, Jiayu; Fan, Yin; Xu, Binghe			There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; AFRICAN-AMERICAN; EXPRESSION; TARGET; MIR-34A; SITES; AMPLIFICATION; MIR-17-92; VARIANTS; C13ORF25	Triple-negative breast cancer (TNBC) is defined by the lack of the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). It is characterized by aggressive behavior, poor prognosis and lack of targeted therapies. MicroRNA (miRNA) as a novel modulator of gene expression has played an important regulatory role in the malignancy. Dysregulation and/or mutation of the miRNAs may also contribute to the TNBC susceptibility since it is associated with the expression of ER, PR and HER2. Single nucleotide polymorphisms (SNPs) in miRNAs may be extremely relevant for TNBC. We tried to validate the hypothesis that genetic variations in miRNA are associated with TNBC development, and identify candidate biomarkers for TNBC susceptibility and clinical treatment. We screened the genetic variants in all miRNA genes listed in the public database miRBase and NCBI. A total of 23 common SNPs in 22 miRNAs, which tagged the known common variants in the Chinese Han people with a minor allele frequency greater than 0.05, were genotyped. This case-control study involved 191 patients with TNBC and 192 healthy female controls. Frequencies of SNPs were compared between cases and controls to identify the SNPs associated with TNBC susceptibility. No significant association was found between TNBC risk and the SNPs in the miRNA genes in the Chinese Han people (P>0.05), but this warrants further studies.	[Ma, Fei; Zhang, Ping; Yuan, Peng; Wang, Jiayu; Fan, Yin; Xu, Binghe] Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing 100730, Peoples R China; [Ma, Fei; Zhang, Ping; Lin, Dongxin; Yu, Dianke; Yuan, Peng; Wang, Jiayu; Fan, Yin; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lin, Dongxin; Yu, Dianke] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Xu, BH (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing 100730, Peoples R China.	xubinghe@medmail.com.cn		Lin, Dongxin/0000-0002-8723-8868; Ma, Fei/0000-0001-9432-1902	National Natural Scientific Foundation of China [30972934, 81000991]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Scientific Foundation of China, grants nos. 30972934 (BX) and 81000991 (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Ma KK, 2012, ASIAN PAC J CANCER P, V13, P2109, DOI 10.7314/APJCP.2012.13.5.2109; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Perez EA, 2010, BREAST CANCER RES TR, V120, P285, DOI 10.1007/s10549-010-0736-z; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rinaldi A, 2007, LEUKEMIA LYMPHOMA, V48, P410, DOI 10.1080/10428190601059738; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Wang Tian-Yu, 2010, Yichuan, V32, P874, DOI 10.3724/SP.J.1005.2010.00874; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	37	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60195	10.1371/journal.pone.0060195	http://dx.doi.org/10.1371/journal.pone.0060195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555923	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500122
J	Macfadyen, S; Muller, W				Macfadyen, Sarina; Muller, Warren			Edges in Agricultural Landscapes: Species Interactions and Movement of Natural Enemies	PLOS ONE			English	Article							PATCH SHAPE; PEST; HETEROGENEITY; BIODIVERSITY; PERMEABILITY; DISPERSAL; SPILLOVER; RESPONSES; DYNAMICS	Agricultural landscapes can be characterized as a mosaic of habitat patches interspersed with hostile matrix, or as a gradient of patches ranging from suitable to unsuitable for different species. Arthropods moving through these landscapes encounter a range of edges, with different permeability. Patches of native vegetation in these landscapes may support natural enemies of crop pests by providing alternate hosts for parasitic wasps and/or acting as a source for predatory insects. We test this by quantifying species interactions and measuring movement across different edge-types. A high diversity of parasitoid species used hosts in the native vegetation patches, however we recorded few instances of the same parasitoid species using hosts in both the native vegetation and the crop (canola). However, we did find overall greater densities of parasitoids moving from native vegetation into the crop. Of the parasitoid groups examined, parasitoids of aphids (Braconidae: Aphidiinae) frequently moved from native vegetation into canola. In contrast, parasitoids of caterpillars (Braconidae: Microgastrinae) moved commonly from cereal fields into canola. Late season samples showed both aphids and parasitoids moving frequently out of native vegetation, in contrast predators moved less commonly from native vegetation (across the whole season). The season-long net advantage or disadvantage of native vegetation for pest control services is therefore difficult to evaluate. It appears that the different edge-types alter movement patterns of natural enemies more so than herbivorous pest species, and this may impact pest control services.	[Macfadyen, Sarina] CSIRO Ecosyst Sci & Sustainable Agr Flagship, Canberra, ACT, Australia; [Muller, Warren] CSIRO Math Informat & Stat, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Macfadyen, S (corresponding author), CSIRO Ecosyst Sci & Sustainable Agr Flagship, Canberra, ACT, Australia.	sarina.macfadyen@csiro.au	Muller, Warren J/C-8648-2009; Macfadyen, Sarina/C-1511-2008	Macfadyen, Sarina/0000-0003-3553-4910; Muller, Warren/0000-0001-5910-3600	Grains Research and Development Corporation; National Invertebrate Pest Initiative	Grains Research and Development Corporation(Grains R&D Corp); National Invertebrate Pest Initiative	SM's research is supported by the Grains Research and Development Corporation and is part of the National Invertebrate Pest Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Brady MJ, 2011, AUSTRAL ECOL, V36, P35, DOI 10.1111/j.1442-9993.2010.02110.x; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Corbett A, 1996, ECOL ENTOMOL, V21, P155, DOI 10.1111/j.1365-2311.1996.tb01182.x; Cosentino BJ, 2011, LANDSCAPE ECOL, V26, P371, DOI 10.1007/s10980-010-9563-1; Cunningham SA, 2013, AUSTRAL ECOL, V38, P456, DOI 10.1111/j.1442-9993.2012.02432.x; Dangerfield PC, 1999, INVERTEBR TAXON, V13, P917, DOI 10.1071/IT98020; DUELLI P, 1990, BIOL CONSERV, V54, P193, DOI 10.1016/0006-3207(90)90051-P; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fitton M.G., 1984, INTRO ICHNEUMONIDAE, P353; Furlong MJ, 2010, ENTOMOL EXP APPL, V135, P225, DOI 10.1111/j.1570-7458.2010.00988.x; GenStat, 2011, GENSTAT WINDOWS; Gorley C.K., 2006, GETTING STARTED PRIM; Grez AA, 2000, ENVIRON ENTOMOL, V29, P1244, DOI 10.1603/0046-225X-29.6.1244; Hinde J, 1998, COMPUT STAT DATA AN, V27, P151, DOI 10.1016/S0167-9473(98)00007-3; Kent JK, 1996, TAXONOMY HYMENOPTERA; Leidner AK, 2011, CONSERV BIOL, V25, P1022, DOI 10.1111/j.1523-1739.2011.01720.x; Macfadyen S, 2011, ECOL APPL, V21, P516, DOI 10.1890/09-2111.1; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Menalled FD, 1999, ECOL APPL, V9, P634, DOI 10.1890/1051-0761(1999)009[0634:DALSAP]2.0.CO;2; Nams VO, 2012, ECOL APPL, V22, P1827, DOI 10.1890/11-1034.1; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Thorbek P, 2005, BIOCONTROL, V50, P1, DOI 10.1007/s10526-004-1114-8; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Vandermeer J, 2010, LANDSCAPE ECOL, V25, P509, DOI 10.1007/s10980-010-9449-2; Wimp GM, 2011, ECOL LETT, V14, P863, DOI 10.1111/j.1461-0248.2011.01656.x	31	64	66	1	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59659	10.1371/journal.pone.0059659	http://dx.doi.org/10.1371/journal.pone.0059659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555737	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500069
J	Righi, M; Giacomini, A; Cleris, L; Carlo-Stella, C				Righi, Marco; Giacomini, Arianna; Cleris, Loredana; Carlo-Stella, Carmelo			D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; COMBRETASTATIN A-4; ANGIOGENESIS; SU11248; POTENT; NORMALIZATION; VISUALIZATION; MECHANISMS; SORAFENIB	Quantitative characterization of the in vivo effects of vascular-targeted therapies on tumor vessels is hampered by the absence of useful 3D vascular network descriptors aside from microvessel density. In this study, we extended the quantification of planar vessel distribution to the analysis of vascular volumes by studying the effects of antiangiogenic (sorafenib and sunitinib) or antivascular (combretastatin A4 phosphate) treatments on the quantity and spatial distributions of thin microvessels. These observations were restricted to perinecrotic areas of treated human multiple myeloma tumors xenografted in immunodeficient mice and to microvessels with an approximate cross-sectional area lower than 75 mu m(2). Finally, vessel skeletonization minimized artifacts due to possible differential wall staining and allowed a comparison of the various treatment effects. Antiangiogenic drug treatment reduced the number of vessels of every caliber (at least 2-fold fewer vessels vs. controls; p<0.001, n = 8) and caused a heterogeneous distribution of the remaining vessels. In contrast, the effects of combretastatin A4 phosphate mainly appeared to be restricted to a homogeneous reduction in the number of thin microvessels (not more than 2-fold less vs. controls; p<0.001, n = 8) with marginal effects on spatial distribution. Unexpectedly, these results also highlighted a strict relationship between microvessel quantity, distribution and cross-sectional area. Treatment-specific changes in the curves describing this relationship were consistent with the effects ascribed to the different drugs. This finding suggests that our results can highlight differences among vascular-targeted therapies, providing hints on the processes underlying sample vascularization together with the detailed characterization of a pathological vascular tree.	[Righi, Marco] CNR, Inst Neurosci, Milan, Italy; [Righi, Marco; Carlo-Stella, Carmelo] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Giacomini, Arianna; Carlo-Stella, Carmelo] Humanitas Clin & Res Ctr, Dept Hematol & Oncol, Milan, Italy; [Cleris, Loredana] Fdn IRCCS Ist Nazl Tumori, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Righi, M (corresponding author), CNR, Inst Neurosci, Milan, Italy.	m.righi@in.cnr.it	Righi, Marco Giovanni Enea/M-9003-2019; Carlo-Stella, Carmelo/B-3805-2010; Righi, Marco Giovanni Enea/G-5171-2011; Righi, Marco/P-4332-2019; Giacomini, Arianna/K-4437-2016; Giacomini, Arianna/U-6854-2019; Cleris, Loredana/T-3144-2018	Righi, Marco Giovanni Enea/0000-0003-1181-0327; Carlo-Stella, Carmelo/0000-0003-3144-0124; Righi, Marco Giovanni Enea/0000-0003-1181-0327; Giacomini, Arianna/0000-0002-9984-9033; Cleris, Loredana/0000-0001-8778-7931	Italian Consiglio Nazionale delle Ricerche (PNR-CNR Aging Program); Ministero dell'struzione, dellUniversita e della Ricerca (MIUR, Rome, Italy); Ministero della Salute (Rome, Italy); Regione Lombardia [SAL - 50 - 16983 TERDISMENTAL]	Italian Consiglio Nazionale delle Ricerche (PNR-CNR Aging Program); Ministero dell'struzione, dellUniversita e della Ricerca (MIUR, Rome, Italy)(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute (Rome, Italy)(Ministry of Health, Italy); Regione Lombardia(Regione Lombardia)	This work was funded by grants from the Italian Consiglio Nazionale delle Ricerche (PNR-CNR Aging Program 2012-2014), URL http://www.cnr.it; Ministero dell'struzione, dellUniversita e della Ricerca (MIUR, Rome, Italy), URL http://www.istruzione.it; Ministero della Salute (Rome, Italy), URL http://www.salute.gov.it; and Regione Lombardia (Project number SAL - 50 - 16983 TERDISMENTAL), URL http://www.regione.lombardia.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; CUNNINGHAM IA, 1987, MED PHYS, V14, P533, DOI 10.1118/1.596064; Dark GG, 1997, CANCER RES, V57, P1829; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Folkman J, 2003, CANC MED, P161; Hill SA, 2002, INT J CANCER, V102, P70, DOI 10.1002/ijc.10655; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kocinski M, 2012, COMPUT METH PROG BIO, V107, P140, DOI 10.1016/j.cmpb.2011.06.004; Lang S, 2012, MICROVASC RES, V84, P314, DOI 10.1016/j.mvr.2012.07.002; Lavazza C, 2010, BLOOD, V115, P2231, DOI 10.1182/blood-2009-08-239632; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Meijering EHW, 2001, MED IMAGE ANAL, V5, P111, DOI 10.1016/S1361-8415(00)00040-2; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Muller B, 2006, NUCL INSTRUM METH B, V246, P254, DOI 10.1016/j.nimb.2005.12.048; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Plouraboue F, 2004, J MICROSC-OXFORD, V215, P139, DOI 10.1111/j.0022-2720.2004.01362.x; Prise VE, 2002, INT J ONCOL, V21, P717; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reyes-Aldasoro CC, 2011, J MICROSC-OXFORD, V242, P262, DOI 10.1111/j.1365-2818.2010.03464.x; Righi M, 2009, LAB INVEST, V89, P1063, DOI 10.1038/labinvest.2009.76; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Seaman ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020807; Serra J., 1983, IMAGE ANAL MATH MORP; Siemann DW, 2005, CLIN CANCER RES, V11, P416; Soltanian-Zadeh H, 2005, COMPUT BIOL MED, V35, P791, DOI 10.1016/j.compbiomed.2004.06.009; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tozer GM, 2001, CANCER RES, V61, P6413; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Zhang C, 2011, CANCER LETT, V302, P11, DOI 10.1016/j.canlet.2010.12.001; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59691	10.1371/journal.pone.0059691	http://dx.doi.org/10.1371/journal.pone.0059691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555747	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500077
J	Soland, MA; Bego, M; Colletti, E; Zanjani, ED; St Jeor, S; Porada, CD; Almeida-Porada, G				Soland, Melisa A.; Bego, Mariana; Colletti, Evan; Zanjani, Esmail D.; St Jeor, Stephen; Porada, Christopher D.; Almeida-Porada, Graca			Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; GRAFT-REJECTION; DOWN-REGULATION; STROMAL CELLS; EXPRESSION; HOST; CD59; PHOSPHORYLATION; CYTOTOXICITY; ACTIVATION	Mesenchymal stem cells (MSC) preferentially migrate to damaged tissues and, due to their immunomodulatory and trophic properties, contribute to tissue repair. Although MSC express molecules, such as membrane cofactor protein (CD46), complement decay-accelerating factor (CD55), and protectin (CD59), which confer protection from complement-mediated lysis, MSC are recruited and activated by anaphylatoxins after transplantation, potentially causing MSC death and limiting therapeutic benefit. We have previously demonstrated that transduction of MSC with a retrovirus encoding HCMV-US proteins resulted in higher levels of MSC engraftment due to decreased HLA-I expression. Here, we investigate whether engineering MSC to express US2 (MSC-US2), US3 (MSC-US3), US6 (MSC-US6), or US11 (MSC-US11) HCMV proteins can alter complement recognition, thereby better protecting MSC from complement attack and lysis. HCMV-US proteins increased MSC CD59 expression at different levels as determined by flow cytometric evaluation of the median fluorescence intensity ratio (MFI). A significant increase in CD59 expression was seen in MSC-US2, MSC-US3, and MSC-US6, but not in MSC-US11. Only MSC-US2 displayed increased expression of CD46, while US2 and US3 proteins were both able to augment the percentage of MSC expressing this molecule. Regardless of the HCMV protein expressed, none changed CD55 MFI; however, expression of US6, US11, and US2 each increased the percentage of MSC that were positive for this molecule. Because US2 protein was the most efficient in up-regulating all three complement regulatory proteins, we used a functional complement-mediated cytotoxicity assay to investigate whether MSC-US2 were protected from complement-mediated lysis. We demonstrated that over-expression of the US2 protein reduced complement lysis by 59.10 +/- 12.89% when compared to untransduced MSC. This is the first report, to our knowledge, describing a role of HCMV-US proteins in complement evasion, and our data shows that over-expression of US2 protein on MSC could serve as a strategy to protect these cells from complement lysis.	[Soland, Melisa A.; Porada, Christopher D.; Almeida-Porada, Graca] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; [Bego, Mariana] Inst Rech Clin Montreal, Lab Human Retrovirol, Montreal, PQ H2W 1R7, Canada; [Colletti, Evan; Zanjani, Esmail D.] Univ Nevada Reno, Dept Anim Biotechnol, Reno, NV USA; [St Jeor, Stephen] Univ Nevada Reno, Dept Microbiol & Immunol, Sch Med, Reno, NV USA	Wake Forest University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Almeida-Porada, G (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.	galmeida@wakehealth.edu		soland, Melisa/0000-0001-8217-9734; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	National Institutes of Health (Bethesda, MD, USA) [HL73737, HL97623]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097623, R01HL073737] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (Bethesda, MD, USA) grants HL73737 and HL97623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Colletti EJ, 2009, STEM CELL RES, V2, P125, DOI 10.1016/j.scr.2008.08.002; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; de la Garza-Rodea AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014493; Diaz TM, 2004, CYTOM PART A, V62A, P54, DOI 10.1002/cyto.a.20076; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; FINBERG RW, 1992, J IMMUNOL, V149, P2055; Ignatius A, J CELLULAR BIOCH, V112, P2594; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kim JY, 2005, INT J BIOCHEM CELL B, V37, P69, DOI 10.1016/j.biocel.2004.04.024; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Lee EM, 2005, BIOCHEM BIOPH RES CO, V326, P825, DOI 10.1016/j.bbrc.2004.11.106; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MERI S, 1990, J EXP MED, V172, P367, DOI 10.1084/jem.172.1.367; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; NICHOLSONWELLER A, 1994, J LAB CLIN MED, V123, P485; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Sacks SH, 2005, SPRINGER SEMIN IMMUN, V27, P332, DOI 10.1007/s00281-005-0005-0; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Soland MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036163; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Spiller OB, 1996, EUR J IMMUNOL, V26, P1532, DOI 10.1002/eji.1830260719; Tu ZD, 2010, STEM CELLS DEV, V19, P1803, DOI 10.1089/scd.2009.0418; Wasowska BA, 2007, CELL IMMUNOL, V248, P18, DOI 10.1016/j.cellimm.2007.04.009	32	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60461	10.1371/journal.pone.0060461	http://dx.doi.org/10.1371/journal.pone.0060461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555976	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500136
J	Szewczyk, KA; Fuller, K; Chambers, TJ				Szewczyk, Kinga A.; Fuller, Karen; Chambers, Tim J.			Distinctive Subdomains in the Resorbing Surface of Osteoclasts	PLOS ONE			English	Article							BONE-RESORPTION; RUFFLED BORDER; OSTEOPETROSIS; SUBUNIT; MICE; DIFFERENTIATION; FIBROBLASTS; INHIBITION; MEMBRANE; PROTEIN	We employed a novel technique to inspect the substrate-apposed surface of activated osteoclasts, the cells that resorb bone, in the scanning electron microscope. The surface revealed unexpected complexity. At the periphery of the cells were circles and crescents of individual or confluent nodules. These corresponded to the podosomes and actin rings that form a 'sealing zone', encircling the resorptive hemivacuole into which protons and enzymes are secreted. Inside these rings and crescents the osteoclast surface was covered with strips and patches of membrane folds, which were flattened against the substrate surface and surrounded by fold-free membrane in which many orifices could be seen. Corresponding regions of folded and fold-free membrane were found by transmission electron microscopy in osteoclasts incubated on bone. We correlated these patterns with the distribution of several proteins crucial to resorption. The strips and patches of membrane folds corresponded in distribution to vacuolar H+-ATPase, and frequently co-localized with F-actin. Cathepsin K localized to F-actin-free foci towards the center of cells with circular actin rings, and at the retreating pole of cells with actin crescents. The chloride/ proton antiporter ClC-7 formed a sharply-defined band immediately inside the actin ring, peripheral to vacuolar H+-ATPase. The sealing zone of osteoclasts is permeable to molecules with molecular mass up to 10,000. Therefore, ClC-7 might be distributed at the periphery of the resorptive hemivacuole in order to prevent protons from escaping laterally from the hemivacuole into the sealing zone, where they would dissolve the bone mineral. Since the activation of resorption is attributable to recognition of the alpha V beta 3 ligands bound to bone mineral, such leakage would, by dissolving bone mineral, release the ligands and so terminate resorption. Therefore, ClC-7 might serve not only to provide the counterions that enable proton pumping, but also to facilitate resorption by acting as a 'functional sealing zone'.	[Szewczyk, Kinga A.; Fuller, Karen; Chambers, Tim J.] Univ London, Div Basic Med Sci, London, England	University of London	Chambers, TJ (corresponding author), Univ London, Div Basic Med Sci, Cranmer Terrace, London, England.	tchamber@sgul.ac.uk			Pathology Research Committee of St George's, University of London	Pathology Research Committee of St George's, University of London	This work was funded by the Pathology Research Committee of St George's, University of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisaka T, 2006, J ELECTRON MICROSC, V55, P53, DOI 10.1093/jmicro/dfl012; Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Chambers TJ, 2000, J PATHOL, V192, P4; CHAMBERS TJ, 1985, J CLIN PATHOL, V38, P241, DOI 10.1136/jcp.38.3.241; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Fuller K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012837; Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; HOLTROP ME, 1977, CLIN ORTHOP RELAT R, P177; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; LAITALA T, 1994, J CLIN INVEST, V93, P2311, DOI 10.1172/JCI117235; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MCSHEEHY PMJ, 1986, ENDOCRINOLOGY, V118, P824, DOI 10.1210/endo-118-2-824; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Stenbeck G, 2002, SEMIN CELL DEV BIOL, V13, P285, DOI 10.1016/S1084952102000587; Stenbeck G, 2000, J CELL SCI, V113, P1577; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Vaananen HK, 2000, J CELL SCI, V113, P377; van Meel E, 2011, TRAFFIC, V12, P912, DOI 10.1111/j.1600-0854.2011.01203.x; VANNOORDEN CJF, 1991, BIOCHEM BIOPH RES CO, V178, P178, DOI 10.1016/0006-291X(91)91796-F; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60285	10.1371/journal.pone.0060285	http://dx.doi.org/10.1371/journal.pone.0060285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555944	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400087
J	Claassens, M; van Schalkwyk, C; den Haan, L; Floyd, S; Dunbar, R; van Helden, P; Godfrey-Faussett, P; Ayles, H; Borgdorff, M; Enarson, D; Beyers, N				Claassens, Mareli; van Schalkwyk, Cari; den Haan, Leonie; Floyd, Sian; Dunbar, Rory; van Helden, Paul; Godfrey-Faussett, Peter; Ayles, Helen; Borgdorff, Martien; Enarson, Donald; Beyers, Nulda			High Prevalence of Tuberculosis and Insufficient Case Detection in Two Communities in the Western Cape, South Africa	PLOS ONE			English	Article							HIV PREVALENCE; DESIGN	Background: In South Africa the estimated incidence of all forms of tuberculosis (TB) for 2008 was 960/100000. It was reported that all South Africans lived in districts with Directly Observed Therapy, Short-course. However, the 2011 WHO report indicated South Africa as the only country in the world where the TB incidence is still rising. Aims: To report the results of a TB prevalence survey and to determine the speed of TB case detection in the study communities. Methods: In 2005 a TB prevalence survey was done to inform the sample size calculation for the ZAMSTAR (Zambia South Africa TB and AIDS Reduction) trial. It was a cluster survey with clustering by enumeration area; all households were visited within enumeration areas and informed consent obtained from eligible adults. A questionnaire was completed and a sputum sample collected from each adult. Samples were inoculated on both liquid mycobacterium growth indicator tube (MGIT) and Lowenstein-Jensen media. A follow-up HIV prevalence survey was done in 2007. Results: In Community A, the adjusted prevalence of culture positive TB was 32/1000 (95%CI 25-41/1000) and of smear positive TB 8/1000 (95% CI 5-13/1000). In Community B, the adjusted prevalence of culture positive TB was 24/1000 (95% CI 17-32/1000) and of smear positive TB 9/1000 (95% CI 6-15/1000). In Community A the patient diagnostic rate was 0.38/person-year while in community B it was 0.30/person-year. In both communities the adjusted HIV prevalence was 25% (19-30%). Discussion: In both communities a higher TB prevalence than national estimates and a low patient diagnostic rate was calculated, suggesting that cases are not detected at a sufficient rate to interrupt transmission. These findings may contribute to the rising TB incidence in South Africa. The TB epidemic should therefore be addressed rapidly and effectively, especially in the presence of the concurrently high HIV prevalence.	[Claassens, Mareli; den Haan, Leonie; Dunbar, Rory; Enarson, Donald; Beyers, Nulda] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa; [van Schalkwyk, Cari] Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn, Ctr Excellence Epidemiol Modelling & Anal, ZA-7505 Tygerberg, South Africa; [Floyd, Sian; Godfrey-Faussett, Peter; Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [van Helden, Paul] Univ Stellenbosch, Ctr Mol & Cellular Biol, Ctr Excellence Biomed TB Res, Natl Res Fdn,Med Res Council,Div Mol Biol & Human, ZA-7505 Tygerberg, South Africa; [Ayles, Helen] Univ Zambia, Zambia AIDS Related TB Project, Lusaka, Zambia; [Enarson, Donald] Int Union TB & Lung Dis, Paris, France; [Borgdorff, Martien] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; National Research Foundation - South Africa; South African Medical Research Council; Stellenbosch University; University of Zambia; University of Amsterdam	Claassens, M (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa.	mcla@sun.ac.za	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; Ayles, Helen/0000-0003-4108-2842; van Schalkwyk, Cari/0000-0001-5154-1390	Johns Hopkins University; Bill and Melinda Gates Foundation [19790.01]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Johns Hopkins University(Johns Hopkins University); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a subcontract from Johns Hopkins University with funds provided by grant number 19790.01 from the Bill and Melinda Gates Foundation. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GLOB TUB CONTR SURV; [Anonymous], 2011, GLOB TUB CONTR 2011; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Broekmans J, 2011, TUBERCULOSIS PREVALE; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Draper B, 2007, RECOMMENDATIONS POLI; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Medicins Sans Frontieres, 2007, REP INT TB HIV SERV; Shaikh N, 2006, SAMJ S AFR MED J, V96, P538; WHO, 2020, WHO REPORT; Williams B, 2008, INT J TUBERC LUNG D, V12, P1110; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organisation, 2006, GLOB TUB CONTR SURV, P147	18	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58689	10.1371/journal.pone.0058689	http://dx.doi.org/10.1371/journal.pone.0058689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560039	Green Published, Green Accepted, gold			2022-12-27	WOS:000316930900007
J	Pan, XD; Chen, ZP; Huang, R; Yao, YY; Ma, GS				Pan, Xiaodong; Chen, Zhongpu; Huang, Rong; Yao, Yuyu; Ma, Genshan			Transforming Growth Factor beta(1) Induces the Expression of Collagen Type I by DNA Methylation in Cardiac Fibroblasts	PLOS ONE			English	Article							EPIGENETIC REGULATION; GENE-EXPRESSION; LUNG FIBROSIS; PROMOTER; ALPHA-1(I); COL1A1; HYPERMETHYLATION; BINDING; METHYLTRANSFERASES; DIFFERENTIATION	Transforming growth factor-beta (TGF-beta), a key mediator of cardiac fibroblast activation, has a major influence on collagen type I production. However, the epigenetic mechanisms by which TGF-beta induces collagen type I alpha 1 (COL1A1) expression are not fully understood. This study was designed to examine whether or not DNA methylation is involved in TGF-beta-induced COL1A1 expression in cardiac fibroblasts. Cells isolated from neonatal Sprague-Dawley rats were cultured and stimulated with TGF-beta(1). The mRNA levels of COL1A1 and DNA methyltransferases (DNMTs) were determined via quantitative polymerase chain reaction and the protein levels of collagen type I were determined via Western blot as well as enzyme-linked immunosorbent assay. The quantitative methylation of the COL1A1 promoter region was analyzed using the MassARRAY platform of Sequenom. Results showed that TGF-beta(1) upregulated the mRNA expression of COL1A1 and induced the synthesis of cell-associated and secreted collagen type I in cardiac fibroblasts. DNMT1 and DNMT3a expressions were significantly downregulated and the global DNMT activity was inhibited when treated with 10 ng/mL of TGF-beta(1) for 48 h. TGF-beta(1) treatment resulted in a significant reduction of the DNA methylation percentage across multiple CpG sites in the rat COL1A1 promoter. Thus, TGF-beta(1) can induce collagen type I expression through the inhibition of DNMT1 and DNMT3a expressions as well as global DNMT activity, thereby resulting in DNA demethylation of the COL1A1 promoter. These findings suggested that the DNMT-mediated DNA methylation is an important mechanism in regulating the TGF-beta(1)-induced COL1A1 gene expression.	[Pan, Xiaodong; Chen, Zhongpu; Huang, Rong; Yao, Yuyu; Ma, Genshan] Southeast Univ, Dept Cardiol, Zhongda Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Ma, GS (corresponding author), Southeast Univ, Dept Cardiol, Zhongda Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	magenshan@hotmail.com			National Natural Science Foundation of China [81270204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81270204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Herman JG, 2000, CURR TOP MICROBIOL, V249, P35; Hoyles RK, 2008, ARTHRITIS RHEUM-US, V58, P1175, DOI 10.1002/art.23379; Hu B, 2010, AM J PATHOL, V177, P21, DOI 10.2353/ajpath.2010.090999; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; KOMURA J, 1995, BBA-GENE STRUCT EXPR, V1260, P73, DOI 10.1016/0167-4781(94)00180-B; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MICHALOWSKY LA, 1987, MOL CELL BIOL, V7, P3076, DOI 10.1128/MCB.7.9.3076; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Nagase H, 2008, FEBS J, V275, P1617, DOI 10.1111/j.1742-4658.2008.06330.x; Ohi T, 2006, J DENT RES, V85, P245, DOI 10.1177/154405910608500308; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PARKER MI, 1982, NUCLEIC ACIDS RES, V10, P5879, DOI 10.1093/nar/10.19.5879; Plachot C, 2004, EXP CELL RES, V298, P122, DOI 10.1016/j.yexcr.2004.04.024; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Prokhortchouk E, 2008, BBA-MOL CELL RES, V1783, P2167, DOI 10.1016/j.bbamcr.2008.07.015; RHODES K, 1994, MOL CELL BIOL, V14, P5950, DOI 10.1128/MCB.14.9.5950; Rhodes Katherine, 1992, Gene Expression, V2, P59; RITZENTHALER JD, 1991, BIOCHEM J, V280, P157, DOI 10.1042/bj2800157; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Rosensteel SM, 2010, EXP MOL PATHOL, V89, P307, DOI 10.1016/j.yexmp.2010.07.003; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Stoddart JH, 2000, J CELL BIOCHEM, V77, P135, DOI 10.1002/(SICI)1097-4644(20000401)77:1<135::AID-JCB14>3.0.CO;2-X; VILLARREAL FJ, 1993, CIRCULATION, V88, P2849, DOI 10.1161/01.CIR.88.6.2849; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Zhang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025168; Zhou XT, 2012, MOL VIS, V18, P1312	43	93	98	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60335	10.1371/journal.pone.0060335	http://dx.doi.org/10.1371/journal.pone.0060335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560091	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900066
J	Shen, H; Perez, RE; Davaadelger, B; Maki, CG				Shen, Hong; Perez, Ricardo E.; Davaadelger, Batzaya; Maki, Carl G.			Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance	PLOS ONE			English	Article							CHECKPOINT KINASE-1; P53; UCN-01; P21; PHOSPHORYLATION; INHIBITION; ADAPTATION; ACTIVATION; PROMOTES; CHK1	Cisplatin is a platinum-based drug that is used for the treatment of a wide-variety of primary human cancers. However, the therapeutic efficacy of cisplatin is often limited by intrinsic or acquired drug resistance. An important goal, therefore, is to identify mechanisms that lead to cisplatin resistance in cancer, and then use this information to more effectively target resistant cells. Cisplatin-resistant clones of the HCT116 cell line underwent a prolonged G2 arrest after cisplatin treatment while sensitive clones did not. The staurosporine analog UCN-01 abrogated this G2 arrest and sensitized the resistant clones to cisplatin. At later time points, 4N arrested cells assumed a tetraploid G1 state that was characterized by depletion of Cyclin A, Cyclin B, and CDC2, and increased expression of p53 and p21, in 4N cells. siRNA-mediated knockdown of p21 abrogated the tetraploid G1 arrest and induced killing that was dependent on p53. The results identify two targetable 4N arrests that can contribute to cisplatin resistance: First, a prolonged G2 arrest that can be targeted by UCN-01, and second, a tetraploid G1 arrest that can be targeted by siRNA against p21.	[Shen, Hong; Perez, Ricardo E.; Davaadelger, Batzaya; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Institutes of Health from the National Cancer Institute (NCI) [1RO1CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant 1RO1CA137598-01A1 from the National Cancer Institute (NCI) (to C. G. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fuse E, 2005, J CLIN PHARMACOL, V45, P394, DOI 10.1177/0091270005274549; Geyer RK, 2000, CELL GROWTH DIFFER, V11, P149; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He GG, 2011, GYNECOL ONCOL, V122, P402, DOI 10.1016/j.ygyno.2011.04.034; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawakami K, 1996, BIOCHEM BIOPH RES CO, V219, P778, DOI 10.1006/bbrc.1996.0310; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sato S, 2002, ONCOGENE, V21, P1727, DOI 10.1038/sj.onc.1205225; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Shen H, 2010, J BIOL CHEM, V285, P23103, DOI 10.1074/jbc.M110.124990; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Vitale I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001337; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Yu Q, 2002, CANCER RES, V62, P5743; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	34	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59848	10.1371/journal.pone.0059848	http://dx.doi.org/10.1371/journal.pone.0059848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560058	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900030
J	Wheeler, I; Price, C; Sitch, A; Banda, P; Kellett, J; Nyirenda, M; Rylance, J				Wheeler, India; Price, Charlotte; Sitch, Alice; Banda, Peter; Kellett, John; Nyirenda, Mulinda; Rylance, Jamie			Early Warning Scores Generated in Developed Healthcare Settings Are Not Sufficient at Predicting Early Mortality in Blantyre, Malawi: A Prospective Cohort Study	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; EMERGENCY-DEPARTMENT; MEDICAL PATIENTS; HEART-DISEASE; COUNTRIES; VALIDATION; ADMISSION; AFRICA; TRIAGE; DETERIORATION	Aim: Early warning scores (EWS) are widely used in well-resourced healthcare settings to identify patients at risk of mortality. The Modified Early Warning Score (MEWS) is a well-known EWS used comprehensively in the United Kingdom. The HOTEL score (Hypotension, Oxygen saturation, Temperature, ECG abnormality, Loss of independence) was developed and tested in a European cohort; however, its validity is unknown in resource limited settings. This study compared the performance of both scores and suggested modifications to enhance accuracy. Methods: A prospective cohort study of adults (>= 18 yrs) admitted to medical wards at a Malawian hospital. Primary outcome was mortality within three days. Performance of MEWS and HOTEL were assessed using ROC analysis. Logistic regression analysis identified important predictors of mortality and from this a new score was defined. Results: Three-hundred-and-two patients were included. Fifty-one (16.9%) died within three days of admission. With a cut-point >= 2, the HOTEL score had sensitivity 70.6% (95% CI: 56.2 to 82.5) and specificity 59.4% (95% CI: 53.0 to 65.5), and was superior to MEWS (cut-point >= 5); sensitivity: 58.8% (95% CI: 44.2 to 72.4), specificity: 56.2% (95% CI: 49.8 to 62.4). The new score, dubbed TOTAL (Tachypnoea, Oxygen saturation, Temperature, Alert, Loss of independence), showed slight improvement with a cut-point >= 2; sensitivity 76.5% (95% CI: 62.5 to 87.2) and specificity 67.3% (95% CI: 61.1 to 73.1). Conclusion: Using an EWS generated in developed healthcare systems in resource limited settings results in loss of sensitivity and specificity. A score based on predictors of mortality specific to the Malawian population showed enhanced accuracy but not enough to warrant clinical use. Despite an assumption of common physiological responses, disease and population differences seem to strongly determine the performance of EWS. Local validation and impact assessment of these scores should precede their adoption in resource limited settings.	[Wheeler, India] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Price, Charlotte; Sitch, Alice] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Banda, Peter; Nyirenda, Mulinda] Univ Malawi, Coll Med, Blantyre, Malawi; [Kellett, John] Nenagh Hosp, Dept Med, Nenagh, County Tipperar, Ireland; [Rylance, Jamie] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Birmingham; University of Birmingham; University of Malawi; University of Limerick; Liverpool School of Tropical Medicine; University of Liverpool	Wheeler, I (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	indi_wheeler@hotmail.com	Rylance, Jamie/ABD-9314-2021; Sitch, Alice/L-9121-2019	Sitch, Alice/0000-0001-7727-4497; Nyirenda, Mulinda/0000-0003-2037-7449; Rylance, Jamie/0000-0002-2323-3611; Price, Charlotte/0000-0003-0190-3300	University of Birmingham	University of Birmingham	Funding for the research was granted by the University of Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker T, 2009, TROP MED INT HEALTH, V14, P143, DOI 10.1111/j.1365-3156.2008.02202.x; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Burch VC, 2008, EMERG MED J, V25, P674, DOI 10.1136/emj.2007.057661; Cei M, 2009, INT J CLIN PRACT, V63, P591, DOI 10.1111/j.1742-1241.2008.01986.x; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Goldhill R, 2001, QJM, V94, P507; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Harrison GA, 2005, RESUSCITATION, V65, P149, DOI 10.1016/j.resuscitation.2004.11.017; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Kellett J, 2008, RESUSCITATION, V78, P52, DOI 10.1016/j.resuscitation.2008.02.011; Kennedy M, 2010, ACAD EMERG MED, V17, P1080, DOI 10.1111/j.1553-2712.2010.00872.x; Mabiala-Babela J R, 2009, Med Trop (Mars), V69, P281; Mensah GA, 2008, HEART, V94, P836, DOI 10.1136/hrt.2007.136523; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Robertson MA, 2001, ARCH DIS CHILD, V85, P208, DOI 10.1136/adc.85.3.208; Royal College of Physicians. National Early Warning Score, 2012, NAT EARL WARN SCOR S; Rylance J, 2009, T ROY SOC TROP MED H, V103, P790, DOI 10.1016/j.trstmh.2009.05.004; Sowden E, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-42; Stewart S, 2006, INT J CARDIOL, V108, P101, DOI 10.1016/j.ijcard.2006.01.001; Steyerberg E., 2009, CLIN PREDICTION MODE; Subbe CP, 2006, EMERG MED J, V23, P841, DOI 10.1136/emj.2006.035816; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Subbe CP, 2002, INTENS CARE MED, V28, pS21; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; Wallis LA, 2006, SAMJ S AFR MED J, V96, P53; Wujtewicz Magdalena A, 2011, Anestezjol Intens Ter, V43, P230; Yeguiayan JM, 2011, CRIT CARE, V15, DOI 10.1186/cc9982	30	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59830	10.1371/journal.pone.0059830	http://dx.doi.org/10.1371/journal.pone.0059830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555796	Green Accepted, Green Published, gold			2022-12-27	WOS:000317263900031
J	Deo, M; Huang, JLY; Van Raamsdonk, CD				Deo, Mugdha; Huang, Jenny Li-Ying; Van Raamsdonk, Catherine D.			Genetic Interactions between Neurofibromin and Endothelin Receptor B in Mice	PLOS ONE			English	Article							UVEAL MALIGNANT-MELANOMA; NEURAL CREST; MOUSE EMBRYOS; MELANOCYTES; MUTATIONS; SKIN; DIFFERENTIATION; PIGMENTATION; PRECURSORS; PROGENITOR	When mutations in two different genes produce the same mutant phenotype, it suggests that the encoded proteins either interact with each other, or act in parallel to fulfill a similar purpose. Haploinsufficiency of Neurofibromin and over-expression of Endothelin 3 both cause increased numbers of melanocytes to populate the dermis during mouse development, and thus we are interested in how these two signaling pathways might intersect. Neurofibromin is mutated in the human genetic disease, neurofibromatosis type 1, which is characterized by the development of Schwann cell based tumors and skin hyper-pigmentation. Neurofibromin is a GTPase activating protein, while the Endothelin 3 ligand activates Endothelin receptor B, a G protein coupled receptor. In order to study the genetic interactions between endothelin and neurofibromin, we defined the deletion breakpoints of the classical Ednrb piebald lethal allele (Ednrb(s-l)) and crossed these mice to mice with a loss-of-function mutation in neurofibromin, Dark skin 9 (Dsk9). We found that Neurofibromin haploinsufficiency requires Endothelin receptor B to darken the tail dermis. In contrast, Neurofibromin haploinsufficiency increases the area of the coat that is pigmented in Endothelin receptor B null mice. We also found an oncogenic mutation in the G protein alpha subunit, GNAQ, which couples to Endothelin receptor B, in a uveal melanoma from a patient with neurofibromatosis type 1. Thus, this data suggests that there is a complex relationship between Neurofibromin and Endothelin receptor B.	[Deo, Mugdha; Huang, Jenny Li-Ying; Van Raamsdonk, Catherine D.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia	Van Raamsdonk, CD (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	cvr@mail.ubc.ca	Van Raamsdonk, Catherine D./B-6207-2017	Van Raamsdonk, Catherine D./0000-0002-4309-3513	Canadian Institutes of Health Research [MOP-79511]; Canadian Cancer Society [019055]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research Skin Research Training Centre scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research Skin Research Training Centre scholarship(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Canadian Institutes of Health Research (MOP-79511), the Canadian Cancer Society (019055) and the Michael Smith Foundation for Health Research (to C.D.V.R.), and a Canadian Institutes of Health Research Skin Research Training Centre scholarship (to M.D.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; ANTLE CM, 1990, BRIT J OPHTHALMOL, V74, P502, DOI 10.1136/bjo.74.8.502; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; CROXATTO JO, 1981, AM J OPHTHALMOL, V92, P578, DOI 10.1016/0002-9394(81)90655-3; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Deo M, 2012, J INVEST DERMATOL; Diwakar G, 2008, J CELL SCI, V121, P167, DOI 10.1242/jcs.013912; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; Garcia RJ, 2008, J INVEST DERMATOL, V128, P131, DOI 10.1038/sj.jid.5700948; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; Ivey K, 2003, DEV BIOL, V255, P230, DOI 10.1016/S0012-1606(02)00097-0; Kang HY, 1998, PFLUG ARCH EUR J PHY, V435, P350, DOI 10.1007/s004240050522; Kunisada T, 1996, DEV GROWTH DIFFER, V38, P87; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Lau N, 2000, J NEUROPATH EXP NEUR, V59, P759, DOI 10.1093/jnen/59.9.759; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Reid K, 1996, DEVELOPMENT, V122, P3911; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Singh AD, 1998, OPHTHALMOLOGY, V105, P195, DOI 10.1016/S0161-6420(98)92205-9; SPECHT CS, 1988, CANCER-AM CANCER SOC, V62, P812, DOI 10.1002/1097-0142(19880815)62:4<812::AID-CNCR2820620429>3.0.CO;2-C; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Wehrle-Haller B, 2001, DEV BIOL, V232, P471, DOI 10.1006/dbio.2001.0167; WIZNIA RA, 1978, AM J OPHTHALMOL, V86, P684, DOI 10.1016/0002-9394(78)90191-5; Yokoyama S, 2006, FEBS J, V273, P1805, DOI 10.1111/j.1742-4658.2006.05200.x; Yoshida H, 1996, DEVELOPMENT, V122, P1207	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59931	10.1371/journal.pone.0059931	http://dx.doi.org/10.1371/journal.pone.0059931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555837	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200059
J	Lo, C; Chin, LT; Chu, CS; Wang, YT; Chan, KW; Yang, WC				Lo, Chieh; Chin, Li-Te; Chu, Chi-Shih; Wang, Yu-Ting; Chan, Kun-Wei; Yang, Wei-Cheng			Rapid Immune Colloidal Gold Strip for Cetacean Meat Restraining Illegal Trade and Consumption: Implications for Conservation and Public Health	PLOS ONE			English	Article							MYOGLOBIN; IDENTIFICATION; ANTIBODY; MERCURY; PROTEIN; WHALES	The consumption of cetacean meat is geographically common and often of undetermined sustainability. Besides, it can expose humans to contaminants and zoonotic pathogens. The illegality of possessing cetacean meat was likely under-reported in some countries due to lack of attention paid by the officials although DNA analysis of market products helped to show such practices. We developed two monoclonal antibodies against synthetic peptides of myoglobin (Mb) for constructing a rapid immune colloidal gold strip. Only cetacean Mb is capable of binding to both antibodies and presents positive signal while the Mb from other animals can bind only 1 of the antibodies and presents negative result. The strip for cetacean meat would be an applicable and cost-effective test for field inspectors and even the general public. It contributes to increase the reporting capacity and coverage of illegal cetacean meat possession, which has implications for global cetacean conservation and public health.	[Lo, Chieh; Wang, Yu-Ting; Chan, Kun-Wei; Yang, Wei-Cheng] Natl Chiayi Univ, Dept Vet Med, Chiayi, Taiwan; [Chin, Li-Te; Chu, Chi-Shih] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan	National Chiayi University; National Chiayi University	Yang, WC (corresponding author), Natl Chiayi Univ, Dept Vet Med, Chiayi, Taiwan.	jackywc@gmail.com			Council of Agriculture of Taiwan [100AS-02.1-FB99]	Council of Agriculture of Taiwan	This manuscript was funded through the Council of Agriculture of Taiwan (100AS-02.1-FB99). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATASSI MZ, 1975, IMMUNOCHEMISTRY, V12, P423, DOI 10.1016/0019-2791(75)90010-5; Booth S, 2005, ENVIRON HEALTH PERSP, V113, P521, DOI 10.1289/ehp.7603; Clapham P, 2007, MOL ECOL, V16, P2607, DOI 10.1111/j.1365-294X.2007.03378.x; Cowan DF, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P767; Dolar MLL, 1999, J EXP BIOL, V202, P227; Endo T, 2005, ENVIRON SCI TECHNOL, V39, P5703, DOI 10.1021/es050215e; Hsieh Y-HP, 1999, QUALITY ATTRIBUTES M, P287; Hsieh YHP, 2009, J FOOD SCI, V74, pC602, DOI 10.1111/j.1750-3841.2009.01315.x; Hunter BT, 2007, WHOLE FOODS PRIMER C, P119; Iwanami K, 2006, COMP BIOCHEM PHYS B, V145, P249, DOI 10.1016/j.cbpb.2006.08.002; JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2003, 61 M JOINT FAO WHO E, P18; Kao DJ, 2009, CHEM BIOL DRUG DES, V74, P33, DOI 10.1111/j.1747-0285.2009.00825.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kooyman GL, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P327; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRIE RA, 1950, J AGR SCI-CAMBRIDGE, V40, P356, DOI 10.1017/S0021859600046116; Lehninger AL, 1993, LEHNINGER PRINCIPLES, P111; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; Polasek LK, 2001, J EXP BIOL, V204, P209; Rao QC, 2007, MEAT SCI, V76, P489, DOI 10.1016/j.meatsci.2006.12.011; Reynolds JE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P682, DOI 10.1016/B978-0-12-373553-9.00159-0; Robards MD, 2011, BIOL CONSERV, V144, P2770, DOI 10.1016/j.biocon.2011.07.034; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiansilakul Y, 2011, FOOD CHEM, V124, P254, DOI 10.1016/j.foodchem.2010.06.028; Tryland M, 2011, 08108FINAL VKM NORW; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van Bressem MF, 2001, VET REC, V148, P657, DOI 10.1136/vr.148.21.657; Van Bressem MF, 1993, J WILDLIFE DIS, V129, P66; Wang YT, 2013, PAK J ZOOL, V45, P273	31	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60704	10.1371/journal.pone.0060704	http://dx.doi.org/10.1371/journal.pone.0060704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23556001	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200129
J	Nakasugi, K; Crowhurst, RN; Bally, J; Wood, CC; Hellens, RP; Waterhouse, PM				Nakasugi, Kenlee; Crowhurst, Ross N.; Bally, Julia; Wood, Craig C.; Hellens, Roger P.; Waterhouse, Peter M.			De Novo Transcriptome Sequence Assembly and Analysis of RNA Silencing Genes of Nicotiana benthamiana	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; DICER-LIKE; SEQ DATA; VIRAL-INFECTION; PLANTS; POLYMERASE; PROTEIN; GENOME; QUANTIFICATION; NORMALIZATION	Background: Nicotiana benthamiana has been widely used for transient gene expression assays and as a model plant in the study of plant-microbe interactions, lipid engineering and RNA silencing pathways. Assembling the sequence of its transcriptome provides information that, in conjunction with the genome sequence, will facilitate gaining insight into the plant's capacity for high-level transient transgene expression, generation of mobile gene silencing signals, and hypersusceptibility to viral infection. Methodology/Results: RNA-seq libraries from 9 different tissues were deep sequenced and assembled, de novo, into a representation of the transcriptome. The assembly, of 16GB of sequence, yielded 237,340 contigs, clustering into 119,014 transcripts (unigenes). Between 80 and 85% of reads from all tissues could be mapped back to the full transcriptome. Approximately 63% of the unigenes exhibited a match to the Solgenomics tomato predicted proteins database. Approximately 94% of the Solgenomics N. benthamiana unigene set (16,024 sequences) matched our unigene set (119,014 sequences). Using homology searches we identified 31 homologues that are involved in RNAi-associated pathways in Arabidopsis thaliana, and show that they possess the domains characteristic of these proteins. Of these genes, the RNA dependent RNA polymerase gene, Rdr1, is transcribed but has a 72 nt insertion in exon1 that would cause premature termination of translation. Dicer-like 3 (DCL3) appears to lack both the DEAD helicase motif and second dsRNA binding motif, and DCL2 and AGO4b have unexpectedly high levels of transcription. Conclusions: The assembled and annotated representation of the transcriptome and list of RNAi-associated sequences are accessible at www.benthgenome.com alongside a draft genome assembly. These genomic resources will be very useful for further study of the developmental, metabolic and defense pathways of N. benthamiana and in understanding the mechanisms behind the features which have made it such a well-used model plant.	[Nakasugi, Kenlee; Bally, Julia; Waterhouse, Peter M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Crowhurst, Ross N.; Hellens, Roger P.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Wood, Craig C.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia	University of Sydney; New Zealand Institute for Plant & Food Research Ltd; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nakasugi, K (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	kenlee.nakasugi@sydney.edu.au; peter.waterhouse@sydney.edu.au	Wood, Craig C/B-5792-2009; Crowhurst, Ross N/N-8892-2017	Crowhurst, Ross N/0000-0003-0608-2134; Waterhouse, Peter/0000-0002-2812-3753; Hellens, Roger/0000-0003-2094-0887; Bally, Julia/0000-0003-0692-280X	University of Sydney; Commonwealth Scientific and Industrial Research Organisation; New Zealand Institute for Plant and Food Research; Australian Research Council Federation Fellowship [FF0776510]	University of Sydney(University of Sydney); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); New Zealand Institute for Plant and Food Research; Australian Research Council Federation Fellowship(Australian Research Council)	This work was funded collaboratively by the University of Sydney, the Commonwealth Scientific and Industrial Research Organisation, and The New Zealand Institute for Plant and Food Research. PMW is funded by the Australian Research Council Federation Fellowship FF0776510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bombarely A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-406; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Clemente T, 2006, METH MOL B, V343, P143; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Dadami E, 2013, MOL PLANT, V6, P232, DOI 10.1093/mp/sss118; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Faino L, 2012, PLANT SIGNAL BEHAV, V7, P1065, DOI 10.4161/psb.21014; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Kozik A, 2010, PLANT AN GEN 18 C SA; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li W, 2012, BIOINFORMATICS; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Z, 2011, BRIEF FUNCT GENOMICS; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Marks CE, 2011, AUST SYST BOT, V24, P61, DOI 10.1071/SB11006; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulder N., 2007, COMP GENOMICS, P59; Naim F, 2012, PLOS ONE IN PRESS; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Purkayastha A, 2009, PLANT PHYSIOL BIOCH, V47, P967, DOI 10.1016/j.plaphy.2009.09.001; Rensink WA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-124; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Team RC, 2012, R LANG ENV STAT COMP; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhou Y, 2010, PLANT CELL, V22, P703, DOI 10.1105/tpc.109.071407	65	130	136	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59534	10.1371/journal.pone.0059534	http://dx.doi.org/10.1371/journal.pone.0059534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555698	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200025
J	Sthoeger, Z; Zinger, H; Sharabi, A; Asher, I; Mozes, E				Sthoeger, Zev; Zinger, Heidy; Sharabi, Amir; Asher, Ilan; Mozes, Edna			The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-alpha in Murine and Human Systemic Lupus Erythematosus	PLOS ONE			English	Article							COMPLEMENTARITY-DETERMINING REGION-1; PERIPHERAL-BLOOD LYMPHOCYTES; ANTI-DNA AUTOANTIBODY; T-CELL RESPONSES; AMELIORATES LUPUS; TGF-BETA; DISEASE-ACTIVITY; DENDRITIC CELLS; I INTERFERON; APOPTOSIS	Background: The tolerogenic peptide, hCDR1, ameliorated manifestations of systemic lupus erythematosus (SLE) via the immunomodulation of pro-inflammatory and immunosuppressive cytokines and the induction of regulatory T cells. Because type I interferon (IFN-alpha) has been implicated to play a role in SLE pathogenesis, we investigated the effects of hCDR1 on IFN-alpha in a murine model of SLE and in human lupus. Methodology/Principal Findings: (NZBxNZW) F1 mice with established SLE were treated with hCDR1 (10 weekly injections). Splenocytes were obtained for gene expression studies by real-time RT-PCR. hCDR1 down-regulated significantly IFN-alpha gene expression (73% inhibition compared to vehicle treated mice, p = 0.002) in association with diminished clinical manifestations. Further, hCDR1 reduced, in vitro, IFN-alpha gene expression in peripheral blood mononuclear cells (PBMC) of 10 lupus patients (74% inhibition compared to medium, p = 0.002) but had no significant effects on the expression levels of IFN-alpha in PBMC of primary anti-phospholipid syndrome patients or of healthy controls. Lupus patients were treated for 24 weeks with hCDR1 (5) or placebo (4) by weekly subcutaneous injections. Blood samples collected, before and after treatment, were frozen until mRNA isolation. A significant reduction in IFN-alpha was determined in hCDR1 treated patients (64.4% inhibition compared to pretreatment expression levels, p = 0.015). No inhibition was observed in the placebo treated patients. In agreement, treatment with hCDR1 resulted in a significant decrease of disease activity. IFN-alpha appears to play a role in the mechanism of action of hCDR1 since recombinant IFN-alpha diminished the immunomodulating effects of hCDR1 on IL-1 beta, TGF beta and FoxP3 gene expression. Conclusions/Significance: We reported previously that hCDR1 affected various cell types and immune pathways in correlation to disease amelioration. The present studies demonstrate that hCDR1 is also capable of down-regulating significantly (and specifically to lupus) IFN-alpha gene expression. Thus, hCDR1 has a potential role as a novel, disease specific treatment for lupus.	[Sthoeger, Zev; Zinger, Heidy; Sharabi, Amir; Mozes, Edna] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Sthoeger, Zev; Asher, Ilan] Kaplan Med Ctr, Dept Internal Med & Clin Immunol B, Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center	Sthoeger, Z (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	sthoeger@gmail.com; edna.mozes@weizmann.ac.il	Sharabi, Amir/I-1742-2019	Sharabi, Amir/0000-0002-6242-6774				Arazi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008447; Badr G, 2010, CELL IMMUNOL, V263, P31, DOI 10.1016/j.cellimm.2010.02.012; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Ben-David H, 2009, IMMUNOLOGY, V128, P245, DOI 10.1111/j.1365-2567.2009.03109.x; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b; EMLEN W, 1994, J IMMUNOL, V152, P3685; Farkas A, 2008, BRIT J DERMATOL, V158, P921, DOI 10.1111/j.1365-2133.2008.08508.x; Gigante M, 2008, J IMMUNOTHER, V31, P254, DOI 10.1097/CJI.0b013e318167b023; Gladman DD, 2002, J RHEUMATOL, V29, P288; HORWITZ DA, 1994, SPRINGER SEMIN IMMUN, V16, P181; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Lapter S, 2011, IMMUNOLOGY, V132, P87, DOI 10.1111/j.1365-2567.2010.03342.x; Lee P. Y., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P323; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Luger D, 2004, J CLIN IMMUNOL, V24, P579, DOI 10.1007/s10875-004-6245-2; Mauermann N, 2004, CLIN EXP IMMUNOL, V137, P513, DOI 10.1111/j.1365-2249.2004.02559.x; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Mozes E, 2010, AUTOIMMUN REV, V10, P22, DOI 10.1016/j.autrev.2010.07.004; Parameswaran R, 2009, CLIN IMMUNOL, V131, P223, DOI 10.1016/j.clim.2008.12.009; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Rapoport MJ, 2005, CLIN IMMUNOL, V117, P262, DOI 10.1016/j.clim.2005.09.003; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Segal R, 1997, J IMMUNOL, V158, P3009; Sela U, 2005, J IMMUNOL, V175, P7255, DOI 10.4049/jimmunol.175.11.7255; Sela U, 2005, J IMMUNOL, V174, P302, DOI 10.4049/jimmunol.174.1.302; Sela U, 2008, J IMMUNOL, V180, P1584, DOI 10.4049/jimmunol.180.3.1584; Sela U, 2006, EUR J IMMUNOL, V36, P2971, DOI 10.1002/eji.200636137; Sela U, 2009, IMMUNOLOGY, V128, pe395, DOI 10.1111/j.1365-2567.2008.02988.x; Shahin D, 2011, EGYPT J MED HUM GENE, V12, P139; Sharabi A, 2006, CLIN IMMUNOL, V119, P146, DOI 10.1016/j.clim.2006.01.007; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Sharabi A, 2007, J IMMUNOL, V179, P4979, DOI 10.4049/jimmunol.179.8.4979; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Sharabi A, 2010, J AUTOIMMUN, V34, P87, DOI 10.1016/j.jaut.2009.06.002; Sharabi A, 2009, CLIN IMMUNOL, V133, P61, DOI 10.1016/j.clim.2009.06.010; Sthoeger ZM, 2009, J AUTOIMMUN, V33, P77, DOI 10.1016/j.jaut.2009.03.009; Sthoeger ZM, 2009, HUM IMMUNOL, V70, P139, DOI 10.1016/j.humimm.2009.01.018; Sthoeger ZM, 2003, CLIN EXP IMMUNOL, V131, P385, DOI 10.1046/j.1365-2249.2003.02058.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Trebeden-Negre H, 2003, EUR J IMMUNOL, V33, P1603, DOI 10.1002/eji.200323665; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; WAISMAN A, 1995, INT IMMUNOL, V7, P689, DOI 10.1093/intimm/7.4.689; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Yee CS, 2008, ANN RHEUM DIS, V67, P873, DOI 10.1136/ard.2007.070847; YTTERBERG SR, 1982, ARTHRITIS RHEUM, V25, P401, DOI 10.1002/art.1780250407; Zagury D, 2009, P NATL ACAD SCI USA, V106, P5294, DOI 10.1073/pnas.0900615106	49	24	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60394	10.1371/journal.pone.0060394	http://dx.doi.org/10.1371/journal.pone.0060394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555966	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200114
J	Yin, JH; Sun, LL; Dong, YY; Chi, X; Zhu, WM; Qi, SH; Gao, HC				Yin, Jianhua; Sun, Linlin; Dong, Yangyang; Chi, Xun; Zhu, Weiming; Qi, Shu-hua; Gao, Haichun			Expression of blaA Underlies Unexpected Ampicillin-Induced Cell Lysis of Shewanella oneidensis	PLOS ONE			English	Article							D BETA-LACTAMASE; CARBAPENEM-HYDROLYZING OXACILLINASE; PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; MR-1; PBP5; ANTIBIOTICS; RESISTANCE	Shewanella oneidensis is a facultative anaerobic gamma-proteobacterium possessing remarkably diverse respiratory capacities for reducing various organic and inorganic substrates. As a veteran research model for investigating redox transformations of environmental contaminants the bacterium is well known to be a naturally ampicillin-resistant microorganism. However, in this study we discovered that ampicillin has a significant impact on growth of S. oneidensis. Particularly, cell lysis occurred only with ampicillin at levels ranging from 0.49 to 6.25 mu g/ml but not at 50 mu g/ml. This phenotype is attributable to insufficient expression of the beta-lactamase BlaA. The subsequent analysis revealed that the blaA gene is strongly induced by ampicillin at high (50 mu g/ml), but not at low levels (2.5 mu g/ml). In addition, we demonstrated that penicillin binding protein 5 (PBP5), the most abundant low molecular weight PBP (LMW PBP), is the only one relevant to beta-lactam resistance under the tested conditions. This nonessential PBP, largely resembling its Escherichia coli counterpart in functionality, mediates expression of the blaA gene.	[Yin, Jianhua; Sun, Linlin; Dong, Yangyang; Chi, Xun; Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Yin, Jianhua; Sun, Linlin; Dong, Yangyang; Chi, Xun; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Weiming] Ocean Univ China, Sch Med & Pharm, Qingdao, Shandong, Peoples R China; [Qi, Shu-hua] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Zhejiang University; Ocean University of China; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/AFU-4588-2022; Gao, Haichun/A-2160-2014	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [31270097]; Natural Science Foundation of Zhejiang province [R3110096]; Major Program of Science and Technology Department of Zhejiang [2009C12061]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Major Program of Science and Technology Department of Zhejiang	This research was supported by Major State Basic Research Development Program (973 Program: 2010CB833803), National Natural Science Foundation of China (31270097), and Natural Science Foundation of Zhejiang province (R3110096) and Major Program of Science and Technology Department of Zhejiang (2009C12061) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002571; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Biffinger JC, 2008, BIOSENS BIOELECTRON, V23, P820, DOI 10.1016/j.bios.2007.08.021; CATLIN BW, 1975, ANTIMICROB AGENTS CH, V7, P265, DOI 10.1128/AAC.7.3.265; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Cruz-Garcia C, 2007, J BACTERIOL, V189, P656, DOI 10.1128/JB.01194-06; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Girlich D, 2004, ANTIMICROB AGENTS CH, V48, P4217, DOI 10.1128/AAC.48.11.4217-4225.2004; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Heritier C, 2004, ANTIMICROB AGENTS CH, V48, P1670, DOI 10.1128/AAC.48.5.1670-1675.2004; Kishida H, 2006, BIOCHEMISTRY-US, V45, P783, DOI 10.1021/bi051533t; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; McWhinney BC, 2010, J CHROMATOGR B, V878, P2039, DOI 10.1016/j.jchromb.2010.05.027; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Poirel L, 2005, J ANTIMICROB CHEMOTH, V55, P680, DOI 10.1093/jac/dki065; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P348, DOI 10.1128/AAC.48.1.348-351.2004; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Potluri L, 2010, MOL MICROBIOL, V77, P300, DOI 10.1111/j.1365-2958.2010.07205.x; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Raskin C, 2003, CELL MOL LIFE SCI, V60, P1460, DOI 10.1007/s00018-003-3008-9; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x; Sarkar SK, 2010, INT J ANTIMICROB AG, V35, P244, DOI 10.1016/j.ijantimicag.2009.11.004; Sarkar SK, 2011, MICROBIOL-SGM, V157, P2702, DOI 10.1099/mic.0.046227-0; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yin Jianhua, 2011, Int J Microbiol, V2011, P863623, DOI 10.1155/2011/863623; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; ZYK N, 1972, ANTIMICROB AGENTS CH, V22, P356, DOI 10.1128/AAC.2.5.356	46	19	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60460	10.1371/journal.pone.0060460	http://dx.doi.org/10.1371/journal.pone.0060460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555975	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200117
J	Carrero, JA; Calderon, B; Towfic, F; Artyomov, MN; Unanue, ER				Carrero, Javier A.; Calderon, Boris; Towfic, Fadi; Artyomov, Maxim N.; Unanue, Emil R.			Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse	PLOS ONE			English	Article							DIABETOGENIC T-CELLS; INTERFERON-ALPHA; GENE-EXPRESSION; DENDRITIC CELLS; IFN-GAMMA; INDUCTION; ISLETS; AMPLIFICATION; PROGRESSION; LANGERHANS	Our ability to successfully intervene in disease processes is dependent on definitive diagnosis. In the case of autoimmune disease, this is particularly challenging because progression of disease is lengthy and multifactorial. Here we show the first chronological compendium of transcriptional and cellular signatures of diabetes in the non-obese diabetic mouse. Our data relates the immunological environment of the islets of Langerhans with the transcriptional profile at discrete times. Based on these data, we have parsed diabetes into several discrete phases. First, there is a type I interferon signature that precedes T cell activation. Second, there is synchronous infiltration of all immunological cellular subsets and a period of control. Finally, there is the killing phase of the diabetogenic process that is correlated with an NF-kB signature. Our data provides a framework for future examination of autoimmune diabetes and its disease progression markers.	[Carrero, Javier A.; Calderon, Boris; Artyomov, Maxim N.; Unanue, Emil R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Towfic, Fadi] Immuneering Corp, Cambridge, MA USA	Washington University (WUSTL)	Carrero, JA (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jacarrer@wustl.edu		Calderon, Boris/0000-0003-1575-0739	National Institutes of Health (NIH) [AI024742, DK058177, DK20579]; Juvenile Diabetes Research Foundation [1-2010-263, 17-2012-141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024742, R37AI024742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK058177, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by grants AI024742, DK058177 and DK20579 from the National Institutes of Health (NIH) and grants 1-2010-263 and 17-2012-141 from the Juvenile Diabetes Research Foundation (ERU). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Calderon B, 2008, J IMMUNOL, V181, P6964, DOI 10.4049/jimmunol.181.10.6964; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Calderon B, 2012, CURR OPIN IMMUNOL, V24, P119, DOI 10.1016/j.coi.2011.11.005; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1567, DOI 10.1073/pnas.1018975108; Chakrabarti D, 1996, J IMMUNOL, V157, P522; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Fujioka T, 2010, INTERNAL MED, V49, P1987, DOI 10.2169/internalmedicine.49.3831; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; HUANG XJ, 1994, IMMUNITY, V1, P469, DOI 10.1016/1074-7613(94)90089-2; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Juhl K, 2008, DIABETES, V57, P2755, DOI 10.2337/db07-1126; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matos M, 2004, DIABETES, V53, P2310, DOI 10.2337/diabetes.53.9.2310; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; Mori Y, 2009, INT IMMUNOL, V21, P1291, DOI 10.1093/intimm/dxp097; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Santamaria P, 2010, IMMUNITY, V32, P437, DOI 10.1016/j.immuni.2010.04.003; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; Tabas-Madrid D, 2012, NUCL ACIDS RES; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yin N, 2012, J IMMUNOL, V188, P4921, DOI 10.4049/jimmunol.1103725; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	60	83	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59701	10.1371/journal.pone.0059701	http://dx.doi.org/10.1371/journal.pone.0059701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555752	Green Published, gold			2022-12-27	WOS:000317418500081
J	Chen, G; Umelo, IA; Lv, SS; Teugels, E; Fostier, K; Kronenberger, P; Dewaele, A; Sadones, J; Geers, C; De Greve, J				Chen, Gang; Umelo, Ijeoma Adaku; Lv, Shasha; Teugels, Erik; Fostier, Karel; Kronenberger, Peter; Dewaele, Alex; Sadones, Jan; Geers, Caroline; De Greve, Jacques			miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; CERVICAL-CANCER; FACTOR RECEPTOR; EXPRESSION; MICRORNAS; INTERFERENCE; CONTRIBUTES; ONCOGENESIS; SUPPRESSOR; RNA	Aberrant expression of microRNA-146a (miR-146a) has been reported to be involved in the development and progression of various types of cancers. However, its role in non-small cell lung cancer (NSCLC) has not been elucidated. The aim of this study was to investigate the contribution of miR-146a to various aspects of the malignant phenotype of human NSCLCs. In functional experiments, miR-146a suppressed cell growth, induced cellular apoptosis and inhibited EGFR downstream signaling in five NSCLC cell lines (H358, H1650, H1975, HCC827 and H292). miR-146a also inhibited the migratory capacity of these NSCLC cells. On the other hand, miR-146a enhanced the inhibition of cell proliferation by drugs targeting EGFR, including both TKIs (gefitinib, erlotinib, and afatinib) and a monoclonal antibody (cetuximab). These effects were independent of the EGFR mutation status (wild type, sensitizing mutation or resistance mutation), but were less potent compared to the effects of siRNA targeting of EGFR. Our results suggest that these effects of miR-146a are due to its targeting of EGFR and NF-kappa B signaling. We also found, in clinical formalin fixed paraffin embedded (FFPE) lung cancer samples, that low expression of miR-146a was correlated with advanced clinical TNM stages and distant metastasis in NSCLC (P<0.05). The patients with high miR-146a expression in their tumors showed longer progression-free survival (25.6 weeks in miR-146a high patients vs. 4.8 weeks in miR-146a low patients, P<0.05). miR-146a is therefore a strong candidate prognostic biomarker in NSCLC. Thus inducing miR-146a might be a therapeutic strategy for NSCLC.	[Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi, Peoples R China; [Chen, Gang; Umelo, Ijeoma Adaku; Lv, Shasha; Teugels, Erik; Kronenberger, Peter; Dewaele, Alex; De Greve, Jacques] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Oncol, Lab Med & Mol Oncol,Dept Med Oncol, Brussels, Belgium; [Fostier, Karel] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Brussels, Belgium; [Kronenberger, Peter] Erasmushgsk Brussel, Dept Gezondheidszorg, Biotechnol Lab, Brussels, Belgium; [Sadones, Jan; Geers, Caroline] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Pathol, Brussels, Belgium	Guangxi Medical University; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University Hospital Brussels; Vrije Universiteit Brussel	De Greve, J (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Oncol, Lab Med & Mol Oncol,Dept Med Oncol, Brussels, Belgium.	Jacques.Degreve@uzbrussel.be	De Greve, Jacques/J-4939-2012	De Greve, Jacques/0000-0002-2389-0742; Geers, Caroline/0000-0002-9389-8803; Umelo, Ijeoma/0000-0001-9841-2705; Teugels, Erik/0000-0002-7828-4555	Boehringer Ingelheim GmbH	Boehringer Ingelheim GmbH(Boehringer Ingelheim)	This study was partly supported by the research fund of Boehringer Ingelheim GmbH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Chen G, 2012, BIOCH BIOPHYS RES CO; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Chen G, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-1; Chen G, 2010, ANAL BIOCHEM, V398, P266, DOI 10.1016/j.ab.2009.11.034; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Custodio A, 2011, CANC TREAT REV; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hou Z, 2011, MED ONCOL; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Jung JH, 2009, PATHOL RES PRACT, V205, P409, DOI 10.1016/j.prp.2008.12.015; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Koivusalo R, 2005, MOL PHARMACOL, V68, P372, DOI 10.1124/mol.105.011189; Larner-Svensson HM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-68; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Papagiannakopoulos T, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-15; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Post SM, 2010, EXPERT REV ANTICANC, V10, P655, DOI 10.1586/ERA.10.44; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Somaiah N, 2010, J THORAC ONCOL, V5, pS434, DOI 10.1097/01.JTO.0000391362.10517.1f; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Suhnel J, 1996, FOOD CHEM TOXICOL, V34, P1151, DOI 10.1016/S0278-6915(97)00087-2; Thu KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033003; Umelo IA, 2010, EJC SUPPL, V8, P68; Vinci S, 2011, CLIN CHEM LAB MED; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Yilmaz A, 2008, UPSALA J MED SCI, V113, P287, DOI 10.3109/2000-1967-236; Zhang ZF, 2010, ONCOTARGET, V1, P497	44	215	225	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60317	10.1371/journal.pone.0060317	http://dx.doi.org/10.1371/journal.pone.0060317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555954	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500129
J	Hashimoto, K; Ogawa, W; Nishioka, T; Tsuchiya, T; Kuroda, T				Hashimoto, Kohei; Ogawa, Wakano; Nishioka, Toshihiro; Tsuchiya, Tomofusa; Kuroda, Teruo			Functionally Cloned pdrM from Streptococcus pneumoniae Encodes a Na+ Coupled Multidrug Efflux Pump	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MELIBIOSE TRANSPORT-SYSTEM; BACILLUS-SUBTILIS; FLUOROQUINOLONE RESISTANCE; INCREASING PREVALENCE; MACROLIDE RESISTANCE; MOLECULAR-CLONING; ESCHERICHIA-COLI; ADULT PATIENTS; MATE FAMILY	Multidrug efflux pumps play an important role as a self-defense system in bacteria. Bacterial multidrug efflux pumps are classified into five families based on structure and coupling energy: resistance-nodulation-cell division (RND), small multidrug resistance (SMR), major facilitator (MF), ATP binding cassette (ABC), and multidrug and toxic compounds extrusion (MATE). We cloned a gene encoding a MATE-type multidrug efflux pump from Streptococcus pneumoniae R6, and designated it pdrM. PdrM showed sequence similarity with NorM from Vibrio parahaemolyticus, YdhE from Escherichia coli, and other bacterial MATE-type multidrug efflux pumps. Heterologous expression of PdrM let to elevated resistance to several antibacterial agents, norfloxacin, acriflavine, and 4',6-diamidino-2-phenylindole (DAPI) in E. coli KAM32 cells. PdrM effluxes acriflavine and DAPI in a Na+- or Li+-dependent manner. Moreover, Na+ efflux via PdrM was observed when acriflavine was added to Na+-loaded cells expressing pdrM. Therefore, we conclude that PdrM is a Na+/drug antiporter in S. pneumoniae. In addition to pdrM, we found another two genes, spr1756 and spr1877, that met the criteria of MATE-type by searching the S. pneumoniae genome database. However, cloned spr1756 and spr1877 did not elevate the MIC of any of the investigated drugs. mRNA expression of spr1756, spr1877, and pdrM was detected in S. pneumoniae R6 under laboratory growth conditions. Therefore, spr1756 and spr1877 are supposed to play physiological roles in this growth condition, but they may be unrelated to drug resistance.	[Hashimoto, Kohei; Ogawa, Wakano; Nishioka, Toshihiro; Tsuchiya, Tomofusa; Kuroda, Teruo] Okayama Univ, Dept Mol Microbiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University	Ogawa, W (corresponding author), Okayama Univ, Dept Mol Microbiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	wogawa@pharm.okayama-u.ac.jp	Ogawa, Wakano/AAI-2887-2020; KURODA, Teruo/B-2028-2011; OGAWA, Wakano/B-1997-2011		Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; Bamba Masahiro, 2006, Journal of Infection and Chemotherapy, V12, P36, DOI 10.1007/s10156-005-0422-y; BERNS KI, 1965, J MOL BIOL, V11, P476, DOI 10.1016/S0022-2836(65)80004-3; Boncoeur E, 2012, BIOCHEMISTRY-US, V51, P7755, DOI 10.1021/bi300762p; Brown DG, 2007, APPL ENVIRON MICROB, V73, P2777, DOI 10.1128/AEM.00984-06; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; COLLINS JF, 1993, P NATL ACAD SCI USA, V90, P3938, DOI 10.1073/pnas.90.9.3938; Diaz A, 2007, CHEST, V131, P779, DOI 10.1378/chest.06-1800; Gentile A, 2012, INT J INFECT DIS, V16, pE5, DOI 10.1016/j.ijid.2011.09.013; Gill MJ, 1999, ANTIMICROB AGENTS CH, V43, P187, DOI 10.1128/AAC.43.1.187; He X, NATURE, V467, P991; Hiramatsu T, 1998, J BACTERIOL, V180, P6642, DOI 10.1128/JB.180.24.6642-6648.1998; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hotomi M, 2008, J CLIN MICROBIOL, V46, P3808, DOI 10.1128/JCM.01782-08; Hsieh PC, 1998, P NATL ACAD SCI USA, V95, P6602, DOI 10.1073/pnas.95.12.6602; Huang M, 1999, J BACTERIOL, V181, P3837, DOI 10.1128/JB.181.12.3837-3841.1999; Huda MN, 2003, MICROBIOL IMMUNOL, V47, P419, DOI 10.1111/j.1348-0421.2003.tb03379.x; Huda MN, 2001, FEMS MICROBIOL LETT, V203, P235, DOI 10.1111/j.1574-6968.2001.tb10847.x; Imai S, 2009, CLIN MICROBIOL INFEC, V15, P1039, DOI 10.1111/j.1469-0691.2009.02935.x; Ishida T, 2008, RESPIROLOGY, V13, P240, DOI 10.1111/j.1440-1843.2007.01214.x; Jenkins SG, 2009, EMERG INFECT DIS, V15, P1260, DOI 10.3201/eid1508.081187; KAKINUMA Y, 1987, J BACTERIOL, V169, P3886, DOI 10.1128/jb.169.9.3886-3890.1987; KURODA T, 1994, J BIOCHEM-TOKYO, V116, P1030, DOI 10.1093/oxfordjournals.jbchem.a124624; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lagos R, 2008, J INFECT DIS, V198, P1809, DOI 10.1086/593334; Lee EW, 2003, BIOL PHARM BULL, V26, P266, DOI 10.1248/bpb.26.266; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; LOPILATO J, 1978, J BACTERIOL, V134, P147, DOI 10.1128/JB.134.1.147-156.1978; MACLEOD PR, 1992, MOL MICROBIOL, V6, P2673, DOI 10.1111/j.1365-2958.1992.tb01444.x; Maekawa Masako, 2003, Japanese Journal of Antibiotics, V56, P27; Marrer E, 2006, ANTIMICROB AGENTS CH, V50, P685, DOI 10.1128/AAC.50.2.685-693.2006; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Mera RM, 2005, DIAGN MICR INFEC DIS, V51, P195, DOI 10.1016/j.diagmicrobio.2004.10.009; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Morita Y, 2001, FEMS MICROBIOL LETT, V202, P139, DOI 10.1111/j.1574-6968.2001.tb10794.x; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; NEYFAKH AA, 1992, ANTIMICROB AGENTS CH, V36, P484, DOI 10.1128/AAC.36.2.484; Ochi K, 2009, ANTIMICROB AGENTS CH, V53, P193, DOI 10.1128/AAC.00873-08; Ogawa W, 1998, J BACTERIOL, V180, P6749, DOI 10.1128/JB.180.24.6749-6752.1998; Ohki R, 1997, J BACTERIOL, V179, P1423, DOI 10.1128/jb.179.4.1423-1427.1997; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Piddock LJV, 2000, ANTIMICROB AGENTS CH, V44, P3118, DOI 10.1128/AAC.44.11.3118-3121.2000; PINNER E, 1992, J BIOL CHEM, V267, P11064; Rantala M, 2005, ANTIMICROB AGENTS CH, V49, P4180, DOI 10.1128/AAC.49.10.4180-4184.2005; RUSSELL JB, 1988, J BACTERIOL, V170, P3531, DOI 10.1128/jb.170.8.3531-3536.1988; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Sousa D, 2013, CLIN MICROBIOL INFEC, V19, P187, DOI 10.1111/j.1469-0691.2012.03765.x; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; TaitKamradt A, 1997, ANTIMICROB AGENTS CH, V41, P2251, DOI 10.1128/AAC.41.10.2251; Tajima Takeshi, 2006, Journal of Infection and Chemotherapy, V12, P372, DOI 10.1007/s10156-006-0476-5; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Tocci N, 2013, ANTIMICROB AGENTS CH, V57, P248, DOI 10.1128/AAC.01298-12; TSUCHIYA T, 1978, MEMBRANE BIOCHEM, V2, P63, DOI 10.3109/09687687809063858; TSUCHIYA T, 1977, BIOCHEM BIOPH RES CO, V76, P26, DOI 10.1016/0006-291X(77)91663-1; Tsuge K, 2001, ANTIMICROB AGENTS CH, V45, P3566, DOI 10.1128/AAC.45.12.3566-3573.2001; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Umeki K, 2011, RESPIROLOGY, V16, P856, DOI 10.1111/j.1440-1843.2011.01983.x; Utsugi J, 1998, BBA-GENE STRUCT EXPR, V1398, P330, DOI 10.1016/S0167-4781(98)00058-X; Vainio A, 2009, APMIS, V117, P488, DOI 10.1111/j.1600-0463.2009.02463.x; Xu XJ, 2003, MICROBIOL IMMUNOL, V47, P937, DOI 10.1111/j.1348-0421.2003.tb03467.x; Yanagihara K, 2009, INTERNAL MED, V48, P527, DOI 10.2169/internalmedicine.48.1482	70	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59525	10.1371/journal.pone.0059525	http://dx.doi.org/10.1371/journal.pone.0059525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555691	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500044
J	Hollborn, M; Chen, R; Wiedemann, P; Reichenbach, A; Bringmann, A; Kohen, L				Hollborn, Margrit; Chen, Rui; Wiedemann, Peter; Reichenbach, Andreas; Bringmann, Andreas; Kohen, Leon			Cytotoxic Effects of Curcumin in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATITIS-B-VIRUS; LUNG-CANCER CELLS; HUMAN RPE CELLS; OXIDATIVE STRESS; IN-VITRO; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; DOWN-REGULATION; FACTOR RECEPTORS	Backround: Curcumin from turmeric is an ingredient in curry powders. Due to its antiinflammatory, antioxidant and anticarcinogenic effects, curcumin is a promising drug for the treatment of cancer and retinal diseases. We investigated whether curcumin alters the viability and physiological properties of human retinal pigment epithelial (RPE) cells in vitro. Methodology/Principal Findings: Cellular proliferation was investigated with a bromodeoxy-uridine immunoassay, and chemotaxis was investigated with a Boyden chamber assay. Cell viability was determined by trypan blue exclusion. Apoptosis and necrosis rates were determined with a DNA fragmentation ELISA. Gene expression was determined by real-time PCR, and secretion of VEGF and bFGF was examined with ELISA. The phosphorylation level of proteins was revealed by Western blotting. The proliferation of RPE cells was slightly increased by curcumin at 10 mu M and strongly reduced by curcumin above 50 mu M. Curcumin at 50 mu M increased slightly the chemotaxis of the cells. Curcumin reduced the expression and secretion of VEGF under control conditions and abolished the VEGF secretion induced by PDGF and chemical hypoxia. Whereas low concentrations of curcumin stimulated the expression of bFGF and HGF, high concentrations caused downregulation of both factors. Curcumin decreased dose-dependently the viability of RPE cells via induction of early necrosis (above 10 mu M) and delayed apoptosis (above 1 mu M). The cytotoxic effect of curcumin involved activation of caspase-3 and calpain, intracellular calcium signaling, mitochondrial permeability, oxidative stress, increased phosphorylation of p38 MAPK and decreased phosphorylation of Akt protein. Conclusion: It is concluded that curcumin at concentrations described to be effective in the treatment of tumor cells and in inhibiting death of retinal neurons (similar to 10 mM) has adverse effects on RPE cells. It is suggested that, during the intake of curcumin as concomitant therapy of cancer or in the treatment of eye diseases, retinal function should be monitored carefully.	[Hollborn, Margrit; Chen, Rui; Wiedemann, Peter; Bringmann, Andreas; Kohen, Leon] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Hollborn, Margrit; Chen, Rui; Wiedemann, Peter; Bringmann, Andreas; Kohen, Leon] Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany; [Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kohen, Leon] Helios Klinikum Aue, Aue, Germany	Leipzig University; Leipzig University; Leipzig University; Helios Kliniken	Hollborn, M (corresponding author), Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany.	hollbm@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017		Deutsche Forschungsgemeinschaft [KO 1547/7-1]; Geschwister Freter Stiftung (Hannover, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Geschwister Freter Stiftung (Hannover, Germany)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 1547/7-1) and the Geschwister Freter Stiftung (Hannover, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Alex AF, 2010, CURR EYE RES, V35, P1021, DOI 10.3109/02713683.2010.506970; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bharti AC, 2010, EXP CLIN TRANSPLANT, V8, P161; Bhaumik S, 1999, FEBS LETT, V456, P311, DOI 10.1016/S0014-5793(99)00969-2; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Briggs MC, 2000, INVEST OPHTH VIS SCI, V41, P3085; Burgos-Moron E, 2010, INT J CANCER, V126, P1771, DOI 10.1002/ijc.24967; Burugula B, 2011, INVEST OPHTH VIS SCI, V52, P4263, DOI 10.1167/iovs.10-7103; Chen J, 2005, PHARMAZIE, V60, P57; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; CROMPTON M, 1988, BIOCHEM J, V255, P357; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fraser-Bell S, 2008, CURR OPIN OPHTHALMOL, V19, P185, DOI 10.1097/ICU.0b013e3282fb7c45; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gao XH, 2005, J EXP THER ONCOL, V5, P39; Gupta SK, 2011, J OCUL PHARMACOL TH, V27, P123, DOI 10.1089/jop.2010.0123; Hadi SM, 2000, IUBMB LIFE, V50, P167, DOI 10.1080/152165400300001471; Halapin NA, 2010, NEUROCHEM RES, V35, P1944, DOI 10.1007/s11064-010-0351-8; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Hollborn M, 2006, BIOCHEM BIOPH RES CO, V344, P912, DOI 10.1016/j.bbrc.2006.03.185; Hollborn M, 2009, INVEST OPHTH VIS SCI, V50, P4452, DOI 10.1167/iovs.08-3194; Hung CM, 2012, J AGR FOOD CHEM, V60, P8427, DOI 10.1021/jf302754w; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kaarniranta K, 2005, MOL BRAIN RES, V137, P126, DOI 10.1016/j.molbrainres.2005.02.027; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kim HJ, 2009, J ETHNOPHARMACOL, V124, P189, DOI 10.1016/j.jep.2009.04.046; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; LI CJ, 1993, P NATL ACAD SCI USA, V90, P1839, DOI 10.1073/pnas.90.5.1839; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Mancuso C, 2009, TRENDS PHARMACOL SCI, V30, P333, DOI 10.1016/j.tips.2009.04.004; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Marathe S, 2009, VACCINE, V28, P291, DOI 10.1016/j.vaccine.2009.10.056; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; MILLER JW, 1994, AM J PATHOL, V145, P574; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Nowak JZ, 2006, PHARMACOL REP, V58, P353; O'Driscoll C, 2007, J NEUROCHEM, V103, P860, DOI 10.1111/j.1471-4159.2007.04827.x; Pazdro R, 2010, MECH AGEING DEV, V131, P276, DOI 10.1016/j.mad.2010.03.005; Peer J, 1996, BRIT J OPHTHALMOL, V80, P241, DOI 10.1136/bjo.80.3.241; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Premanand C, 2006, INVEST OPHTH VIS SCI, V47, P2179, DOI 10.1167/iovs.05-0580; Puliyappadamba VT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-220; Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067; Richer Stuart, 2004, Optometry, V75, P216, DOI 10.1016/S1529-1839(04)70049-4; Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x; Saha A, 2010, BIOL PHARM BULL, V33, P1291, DOI 10.1248/bpb.33.1291; Singh M, 2011, MOL CELL BIOCHEM, V347, P1, DOI 10.1007/s11010-010-0606-3; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI [10.2735/3505, 10.2741/3505]	68	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59603	10.1371/journal.pone.0059603	http://dx.doi.org/10.1371/journal.pone.0059603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555722	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500062
J	Lipsanen, A; Flunkert, S; Kuptsova, K; Hiltunen, M; Windisch, M; Hutter-Paier, B; Jolkkonen, J				Lipsanen, Anu; Flunkert, Stefanie; Kuptsova, Kristina; Hiltunen, Mikko; Windisch, Manfred; Hutter-Paier, Birgit; Jolkkonen, Jukka			Non-Selective Calcium Channel Blocker Bepridil Decreases Secondary Pathology in Mice after Photothrombotic Cortical Lesion	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MIDDLE CEREBRAL-ARTERY; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; TAU PHOSPHORYLATION; HYPERTENSIVE-RATS; FOCAL ISCHEMIA; SECRETED FORMS; MESSENGER-RNA	Experimental studies have identified a complex link between neurodegeneration, beta-amyloid (A beta) and calcium homeostasis. Here we asked whether early phase beta-amyloid pathology in transgenic hAPP(SL) mice exaggerates the ischemic lesion and remote secondary pathology in the thalamus, and whether a non-selective calcium channel blocker reduces these pathologies. Transgenic hAPP(SL) (n = 33) and non-transgenic (n = 30) male mice (4-5 months) were subjected to unilateral cortical photothrombosis and treated with the non-selective calcium channel blocker bepridil (50 mg/kg, p.o., once a day) or vehicle for 28 days, starting administration 2 days after the operation. Animals were then perfused for histological analysis of infarct size, A beta and calcium accumulation in the thalamus. Cortical photothrombosis resulted in a small infarct, which was associated with atypical A beta and calcium accumulation in the ipsilateral thalamus. Transgenic mice had significantly smaller infarct volumes than non-transgenic littermates (P<0.05) and ischemia-induced rodent A beta accumulation in the thalamus was lower in transgenic mice compared to non-transgenic mice (P<0.01). Bepridil decreased calcium load in the thalamus (P<0.01). The present data suggest less pronounced primary and secondary pathology in hAPP(SL) transgenic mice after ischemic cortical injury. Bepridil particularly decreased calcium pathology in the thalamus following ischemia.	[Lipsanen, Anu; Kuptsova, Kristina; Hiltunen, Mikko; Jolkkonen, Jukka] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Flunkert, Stefanie; Windisch, Manfred; Hutter-Paier, Birgit] QPS Austria GmbH, Grambach, Austria	University of Eastern Finland	Jolkkonen, J (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	jukka.jolkkonen@uef.fi	Lipsanen, Anu/C-7206-2014	Lipsanen, Anu/0000-0003-1696-224X; Flunkert, Stefanie/0000-0003-3806-3907	European Regional Development Fund (ERDF) from Tekes - the Finnish Funding Agency for Technology and Innovation [70050/10]; Health Research Council of the Academy of Finland; University of Eastern Finland; Sigrid Juselius Foundation; QPS Austria GmbH	European Regional Development Fund (ERDF) from Tekes - the Finnish Funding Agency for Technology and Innovation; Health Research Council of the Academy of Finland(Academy of Finland); University of Eastern Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); QPS Austria GmbH	This study was supported by European Regional Development Fund (ERDF) grant 70050/10 from Tekes - the Finnish Funding Agency for Technology and Innovation, the Health Research Council of the Academy of Finland, the strategic funding of the University of Eastern Finland and the Sigrid Juselius Foundation and QPS Austria GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; Aho L, 2006, STROKE, V37, P2940, DOI 10.1161/01.STR.0000248777.44128.93; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052347; Clarke J, 2007, EUR J NEUROSCI, V26, P1845, DOI 10.1111/j.1460-9568.2007.05807.x; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Havas D, 2011, J ALZHEIMERS DIS, V25, P231, DOI 10.3233/JAD-2011-101866; Hiltunen M, 2011, THALAMUS ANATOMY FUN, P83; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Huttunen HJ, 2010, J NEUROPATH EXP NEUR, V69, P777, DOI 10.1097/NEN.0b013e3181e77ed9; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Koistinaho J, 1996, NEUROREPORT, V7, P2727, DOI 10.1097/00001756-199611040-00064; Koistinaho M, 2005, BRAIN RES REV, V48, P240, DOI 10.1016/j.brainresrev.2004.12.014; Koistinaho M, 2002, P NATL ACAD SCI USA, V99, P1610, DOI 10.1073/pnas.032670899; Lipsanen A, 2011, PHARMACOL BIOCHEM BE, V99, P468, DOI 10.1016/j.pbb.2011.04.019; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Paylor R, 1998, LEARN MEMORY, V5, P302; Peers C, 2007, ESSAYS BIOCHEM, V43, P153, DOI 10.1042/bse0430153; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Riascos D, 2011, ACTA NEUROPATHOL, V122, P565, DOI 10.1007/s00401-011-0865-4; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Sarajarvi T, 2012, J CELL MOL MED, V16, P2754, DOI 10.1111/j.1582-4934.2012.01599.x; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Stys PK, 1998, NEUROSCIENCE, V82, P21; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; Watanabe H, 1998, J CEREBR BLOOD F MET, V18, P686, DOI 10.1097/00004647-199806000-00011; Whitehead SN, 2007, STROKE, V38, P3245, DOI 10.1161/STROKEAHA.107.492660; Whitehead SN, 2010, BRAIN RES, V1366, P246, DOI 10.1016/j.brainres.2010.10.008; Whitehead SN, 2005, STROKE, V36, P107, DOI 10.1161/01.STR.0000149627.30763.f9; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; Zhang J, 2012, J NEUROCHEM, V120, P564, DOI 10.1111/j.1471-4159.2011.07496.x	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60235	10.1371/journal.pone.0060235	http://dx.doi.org/10.1371/journal.pone.0060235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555933	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500126
J	Markelc, B; Sersa, G; Cemazar, M				Markelc, Bostjan; Sersa, Gregor; Cemazar, Maja			Differential Mechanisms Associated with Vascular Disrupting Action of Electrochemotherapy: Intravital Microscopy on the Level of Single Normal and Tumor Blood Vessels	PLOS ONE			English	Article							DORSAL WINDOW CHAMBER; IN-VIVO; IRREVERSIBLE ELECTROPORATION; CANCER; CELLS; FLOW; BLEOMYCIN; DELIVERY; DRUG; ELECTROTRANSFER	Electropermeabilization/electroporation (EP) provides a tool for the introduction of molecules into cells and tissues. In electrochemotherapy (ECT), cytotoxic drugs are introduced into cells in tumors, and nucleic acids are introduced into cells in gene electrotransfer. The normal and tumor tissue blood flow modifying effects of EP and the vascular disrupting effect of ECT in tumors have already been determined. However, differential effects between normal vs. tumor vessels, to ensure safety in the clinical application of ECT, have not been determined yet. Therefore, the aim of our study was to determine the effects of EP and ECT with bleomycin on the HT-29 human colon carcinoma tumor model and its surrounding blood vessels. The response of blood vessels to EP and ECT was monitored in real time, directly at the single blood vessel level, by in vivo optical imaging in a dorsal window chamber in SCID mice with 70 kDa fluorescently labeled dextrans. The response of tumor blood vessels to EP and ECT started to differ within the first hour. Both therapies induced a vascular lock, decreased functional vascular density (FVD) and increased the diameter of functional blood vessels within the tumor. The effects were more pronounced for ECT, which destroyed the tumor blood vessels within 24 h. Although the vasculature surrounding the tumor was affected by EP and ECT, it remained functional. The study confirms the current model of tumor blood flow modifying effects of EP and provides conclusive evidence that ECT is a vascular disrupting therapy with a specific effect on the tumor blood vessels.	[Markelc, Bostjan; Sersa, Gregor; Cemazar, Maja] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia	Institute of Oncology - Slovenia; University of Primorska	Cemazar, M (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.	mcemazar@onko-i.si	Markelc, Bostjan/AAC-2968-2022; Cemazar, Maja/K-6182-2013	Markelc, Bostjan/0000-0002-8674-702X; Cemazar, Maja/0000-0002-1418-1928	Slovenian Research Agency [P3-003, J3-4211, J3-4259]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	All three authors were financed by the Slovenian Research Agency through grants P3-003, J3-4211 and J3-4259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2011, CANCER RES, V71, P3753, DOI 10.1158/0008-5472.CAN-11-0451; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Bellard E, 2012, J CONTROL RELEASE, V163, P396, DOI 10.1016/j.jconrel.2012.09.010; Cemazar M, 2006, CURR PHARM DESIGN, V12, P3817, DOI 10.2174/138161206778559740; Cemazar M, 2001, BRIT J CANCER, V84, P565, DOI 10.1054/bjoc.2000.1625; Cemazar M, 2010, CURR GENE THER, V10, P300, DOI 10.2174/156652310791823425; Chiarella P, 2010, CURR GENE THER, V10, P281, DOI 10.2174/156652310791823506; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Frost Gregory I, 2003, Methods Mol Med, V85, P65; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Gehl J, 2000, MELANOMA RES, V10, P585, DOI 10.1097/00008390-200012000-00011; Heller LC, 2010, CURR GENE THER, V10, P312; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Jaroszeski MJ, 2000, ANTI-CANCER DRUG, V11, P201, DOI 10.1097/00001813-200003000-00008; Kanthou C, 2006, MOL CANCER THER, V5, P3145, DOI 10.1158/1535-7163.MCT-06-0410; Linnert M, 2012, RADIOL ONCOL, V46, P271, DOI 10.2478/v10019-012-0042-y; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Markelc B, 2012, J MEMBRANE BIOL, V245, P545, DOI 10.1007/s00232-012-9435-5; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Matthiessen LW, 2012, ACTA ONCOL, V51, P713, DOI 10.3109/0284186X.2012.685524; Meulenberg CJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052713; Miklavcic D, 2010, RADIOL ONCOL, V44, P34, DOI 10.2478/v10019-010-0002-3; Mir LM, 2009, MOL BIOTECHNOL, V43, P167, DOI 10.1007/s12033-009-9192-6; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; MIR LM, 1988, EXP CELL RES, V175, P15, DOI 10.1016/0014-4827(88)90251-0; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Patel RB, 2012, TOXICOL MECH METHOD, V22, P383, DOI 10.3109/15376516.2012.673089; Ramirez LH, 1998, BRIT J CANCER, V77, P2104, DOI 10.1038/bjc.1998.354; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Sedlar A, 2012, RADIOL ONCOL, V46, P302, DOI 10.2478/v10019-012-0044-9; Sentjurc M, 2004, SPECTROCHIM ACTA A, V60, P1379, DOI 10.1016/j.saa.2003.10.036; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Sersa G, 1999, ANTICANCER RES, V19, P4017; SERSA G, 1994, BIOELECTROCH BIOENER, V35, P23, DOI 10.1016/0302-4598(94)87006-3; Sersa G, 1999, EUR J CANCER, V35, P672, DOI 10.1016/S0959-8049(98)00426-2; Sersa G, 1998, ELECTRO MAGNETOBIOL, V17, P299; Sersa G, 2002, BRIT J CANCER, V87, P1047, DOI 10.1038/sj.bjc.6600606; Sersa G, 2001, CANCER RES, V61, P4266; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Snoj M, 2009, TUMORI J, V95, P398; Teissie J, 2012, INT J PHARMACEUT, V423, P3, DOI 10.1016/j.ijpharm.2011.09.038; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628	54	59	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59557	10.1371/journal.pone.0059557	http://dx.doi.org/10.1371/journal.pone.0059557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555705	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500052
J	Takagi, Y; Toriihara, A; Nakahara, Y; Yomota, M; Okuma, Y; Hosomi, Y; Shibuya, M; Okamura, T				Takagi, Yusuke; Toriihara, Akira; Nakahara, Yoshiro; Yomota, Makiko; Okuma, Yusuke; Hosomi, Yukio; Shibuya, Masahiko; Okamura, Tatsuru			Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study	PLOS ONE			English	Article							PACLITAXEL PLUS CARBOPLATIN; CHEMOTHERAPY-NAIVE PATIENTS; RANDOMIZED PHASE-II; DISEASE PROGRESSION; CLINICAL-TRIALS; SURVIVAL; GEMCITABINE; CISPLATIN; THERAPY; GEFITINIB	Background: Bevacizumab requires some unique eligibility criteria, such as absence of hemoptysis and major blood vessel invasion by the tumor. The prognostic impact of these bevacizumab-specific criteria has not been evaluated. Methods: Patients with stage IIIB/IV, non-squamous non-small cell lung cancer who started chemotherapy before the approval of bevacizumab were reviewed. Patients with impaired organ function, poor performance status or untreated/symptomatic brain metastasis were excluded before the evaluation of bevacizumab eligibility. We compared overall survival and time to treatment failure among patients who were eligible (Group A) or ineligible (Group B) to receive bevacizumab. Results: Among 283 patients with stage IIIB/IV non-squamous non-small cell lung cancer, eligibility for bevacizumab was evaluated in 154 patients. Fifty-seven patients were considered ineligible (Group B) based on one or more of a history of hemoptysis (n = 20), major blood vessel invasion (n = 43) and cardiovascular disease (n = 8). The remaining 97 patients were classified into Group A. Overall survival was significantly better in Group A (median, 14.6 months) than in Group B (median, 7.1 months; p<0.0001). Time to treatment failure was also significantly longer in Group A (median, 6.9 months) than in Group B (median, 3.0 months; p<0.0001). Adjusted hazard ratios of bevacizumab eligibility for overall survival and time to treatment failure were 0.48 and 0.38 (95% confidence intervals, 0.33-0.70 and 0.25-0.58), respectively. Conclusion: Eligibility for bevacizumab itself represents a powerful prognostic factor for patients with non-squamous nonsmall cell lung cancer. The proportion of patients who underwent first-line chemotherapy without disease progression or unacceptable toxicity can also be biased by bevacizumab eligibility. Selection bias can be large in clinical trials of bevacizumab, so findings from such trials should be interpreted with extreme caution.	[Takagi, Yusuke; Nakahara, Yoshiro; Yomota, Makiko; Okuma, Yusuke; Hosomi, Yukio; Shibuya, Masahiko; Okamura, Tatsuru] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Thorac Oncol & Resp Med, Tokyo, Japan; [Toriihara, Akira] Tokyo Med & Dent Univ, Dept Diagnost Radiol & Oncol, Tokyo, Japan	Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Tokyo Medical & Dental University (TMDU)	Takagi, Y (corresponding author), Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Thorac Oncol & Resp Med, Tokyo, Japan.	ytakagi-tmd@umin.net	Okuma, Yusuke/AAF-7326-2019	Okuma, Yusuke/0000-0001-5743-0149; Takagi, Yusuke/0000-0002-0305-1597				ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; ALBERTI W, 1995, BRIT MED J, V311, P899; Barlesi F, 2011, EUR J CANCER, V47, P16, DOI 10.1016/S0959-8049(11)70133-2; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Clarey J, 2012, ANN ONCOL, V23, P1229, DOI 10.1093/annonc/mdr443; Lima ABC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022681; Des Guetz G, 2012, CRIT REV ONCOL HEMAT, V84, P340, DOI 10.1016/j.critrevonc.2012.03.007; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; FINKELSTEIN DM, 1986, J CLIN ONCOL, V4, P702, DOI 10.1200/JCO.1986.4.5.702; Gridelli C, 2011, CLIN LUNG CANCER, V12, P407, DOI 10.1016/j.cllc.2011.05.002; Hartmann H, 2012, J CLIN ONCOL, V30, P3317, DOI 10.1200/JCO.2012.43.3409; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Okamoto I, 2010, J CLIN ONCOL, V28, P5240, DOI 10.1200/JCO.2010.31.0326; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Qi YW, 2012, CANCER-AM CANCER SOC, V118, P5358, DOI 10.1002/cncr.27528; Reck M, 2012, ANN ONCOL, V23, P1111, DOI 10.1093/annonc/mdr463; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Hoang T, 2012, J THORAC ONCOL, V7, P1361, DOI 10.1097/JTO.0b013e318260e106; Treat JA, 2010, ANN ONCOL, V21, P540, DOI 10.1093/annonc/mdp352; Zhu JY, 2012, JAMA-J AM MED ASSOC, V307, P1593, DOI 10.1001/jama.2012.454	26	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59700	10.1371/journal.pone.0059700	http://dx.doi.org/10.1371/journal.pone.0059700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555751	gold, Green Submitted, Green Published			2022-12-27	WOS:000317418500080
J	Koreishi, M; Gniadek, TJ; Yu, S; Masuda, J; Honjo, Y; Satoh, A				Koreishi, Mayuko; Gniadek, Thomas J.; Yu, Sidney; Masuda, Junko; Honjo, Yasuko; Satoh, Ayano			The Golgin Tether Giantin Regulates the Secretory Pathway by Controlling Stack Organization within Golgi Apparatus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRYPANOSOMA-BRUCEI; TRANSPORT-VESICLE; PROTEIN GIANTIN; COPI VESICLES; MEMBRANE; ARCHITECTURE; INTERACTS; P115; DYNAMICS	Golgins are coiled-coil proteins that play a key role in the regulation of Golgi architecture and function. Giantin, the largest golgin in mammals, forms a complex with p115, rab1, GM130, and soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), thereby facilitating vesicle tethering and fusion processes around the Golgi apparatus. Treatment with the microtubule destabilizing drug nocodazole transforms the Golgi ribbon into individual Golgi stacks. Here we show that siRNA-mediated depletion of giantin resulted in more dispersed Golgi stacks after nocodazole treatment than by control treatment, without changing the average cisternal length. Furthermore, depletion of giantin caused an increase in cargo transport that was associated with altered cell surface protein glycosylation. Drosophila S2 cells are known to have dispersed Golgi stacks and no giantin homolog. The exogenous expression of mammalian giantin cDNA in S2 cells resulted in clustered Golgi stacks, similar to the Golgi ribbon in mammalian cells. These results suggest that the spatial organization of the Golgi ribbon is mediated by giantin, which also plays a role in cargo transport and sugar modifications.	[Koreishi, Mayuko; Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Gniadek, Thomas J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Masuda, Junko] NIAID, Mucosal Immun Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Honjo, Yasuko] Okayama Univ, RCIS, Okayama, Japan	Okayama University; Johns Hopkins University; Chinese University of Hong Kong; Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Okayama University	Satoh, A (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.	ayano113@cc.okayama-u.ac.jp	Satoh, Ayano/B-2423-2011; Bin Sidney Yu, Siu/R-4936-2018	Satoh, Ayano/0000-0003-3736-1283; Bin Sidney Yu, Siu/0000-0001-9643-2729	Kurata Memorial Hitachi Science and Technology Foundation; special Coordination Fund for Promoting Science and Technology; JSPS KAKENHI of MEXT (Ministry of Education, Sport, Culture, Science and Technology in Japan) [23570167]; Hayashi Memorial Foundation for Female Natural Scientists; Ryobi Teien Memorial Foundation; Naito Foundation; Uehara Memorial Foundation; National Institutes of Health, USA [AG030101, GM060919]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG030101] Funding Source: NIH RePORTER	Kurata Memorial Hitachi Science and Technology Foundation; special Coordination Fund for Promoting Science and Technology; JSPS KAKENHI of MEXT (Ministry of Education, Sport, Culture, Science and Technology in Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Ryobi Teien Memorial Foundation(Ryobi Teien Memory Foundation); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding sources The Kurata Memorial Hitachi Science and Technology Foundation, the special Coordination Fund for Promoting Science and Technology, and JSPS KAKENHI Grant Number23570167 of MEXT (Ministry of Education, Sport, Culture, Science and Technology in Japan), Hayashi Memorial Foundation for Female Natural Scientists, Ryobi Teien Memorial Foundation, the Naito Foundation, the Uehara Memorial Foundation, and the National Institutes of Health (AG030101 and GM060919, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Gniadek TJ, 2007, TRAFFIC, V8, P339, DOI 10.1111/j.1600-0854.2007.00538.x; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Lee SW, 2005, J HISTOCHEM CYTOCHEM, V53, P249, DOI 10.1369/jhc.3B6194.2005; Lesa GM, 2000, J BIOL CHEM, V275, P2831, DOI 10.1074/jbc.275.4.2831; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Ramirez IBR, 2008, J CELL SCI, V121, P1538, DOI 10.1242/jcs.014324; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Rothman JE, 1996, PROTEIN SCI, V5, P185; Satoh A, 1997, FEBS LETT, V405, P107, DOI 10.1016/S0014-5793(97)00161-0; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Vivero-Salmeron G, 2008, HISTOCHEM CELL BIOL, V130, P709, DOI 10.1007/s00418-008-0471-2; Whyte JRC, 2002, J CELL SCI, V115, P2627; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387	32	48	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59821	10.1371/journal.pone.0059821	http://dx.doi.org/10.1371/journal.pone.0059821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555793	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400065
J	Simanski, M; Rademacher, F; Schroder, L; Schumacher, HM; Glaser, R; Harder, J				Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Schumacher, Hanna Maria; Glaeser, Regine; Harder, Juergen			IL-17A and IFN-gamma Synergistically Induce RNase 7 Expression via STAT3 in Primary Keratinocytes	PLOS ONE			English	Article							INVASIVE BACTERIAL-INFECTION; HYPER-IGE SYNDROME; ANTIMICROBIAL PEPTIDES; HUMAN SKIN; ATOPIC-DERMATITIS; IMMUNE DEFENSE; PSORIASIS; PROTECTS; PROTEINS; MECHANISMS	Human keratinocytes produce several antimicrobial peptides and proteins (AMP) which contribute to the protection of human skin against infection. RNase 7 is a major AMP involved in cutaneous defense with a high expression in keratinocytes and a broad spectrum of antimicrobial activity. The cytokine IL-17A has been recently identified as a potent inducer of several AMP in keratinocytes. Since the role of IL-17A to induce RNase 7 expression is unknown we analyzed IL-17A alone and in combination with other cytokines to induce RNase 7 expression in keratinocytes. Whereas IL-17A alone only weakly induced RNase 7 expression, the synergistic combination of IL-17A and IFN-gamma (IL-17A/IFN-gamma) was identified as a potent inducer of RNase 7 expression. This combination was more effective in inducing RNase 7 than the combination of IL-17A/TNF-alpha, a combination previously identified as a strong inducer of psoriasis-related immune response genes including several AMP. IFN-gamma and IL-17A both have been reported to activate the transcription factor STAT3 (Signal transducer and activator of transcription 3). Therefore we investigated the influence of STAT3 on the IL-17A/IFN-gamma -mediated RNase 7 induction. The use of a STAT3 inhibitor as well as siRNA-mediated downregulation of STAT3 resulted in a diminished IL-17A/IFN-gamma mediated RNase 7 induction in keratinocytes indicating that STAT3 is involved in this process. Similarly as seen with RNase 7, treatment of keratinocytes with IL-17A/IFN-c revealed also a synergistic induction of gene expression of the AMP human beta-defensin (hBD)-2 and -3 as well as the S100 protein psoriasin (S100A7) indicating that the combination of IL-17A/IFN-gamma is a potent inducer of various AMP classes in general. This was also reflected by an increase of the Staphylococcus aureus-killing activity of IL-17A/IFN-gamma -treated keratinocytes.	[Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Schumacher, Hanna Maria; Glaeser, Regine; Harder, Juergen] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Harder, J (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	jharder@dermatology.uni-kiel.de	Harder, Jürgen/B-3162-2010; Gläser, Regine/B-3168-2010	Harder, Jurgen/0000-0002-4075-4603	Deutsche Forschungsgemeinschaft [HA 3386/6-1]; Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by Deutsche Forschungsgemeinschaft (HA 3386/6-1), a grant of the Federal Ministry of Education and Research (BMBF, SkinStaph) given to R. Glaser and J. Harder and a Heisenberg program of the Deutsche Forschungsgemeinschaft given to J. Harder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI 10.1016/j.jaci.2008.10.031; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Guilloteau K, 2010, J IMMUNOL; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Koten B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006424; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Minegishi Y, 2012, ALLERGOL INT, V61, P191, DOI 10.2332/allergolint.12-RAI-0423; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; Simanski M, 2010, J INVEST DERMATOL, V130, P2836, DOI 10.1038/jid.2010.217; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zanger P, 2009, J INFECT DIS, V200, P1907, DOI 10.1086/648408	41	38	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59531	10.1371/journal.pone.0059531	http://dx.doi.org/10.1371/journal.pone.0059531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555696	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400048
J	Sachs, S; Hornung, JJ				Sachs, Sven; Hornung, Jahn J.			Ankylosaur Remains from the Early Cretaceous (Valanginian) of Northwestern Germany	PLOS ONE			English	Article							POLACANTHUS; SYSTEMATICS; HISTOLOGY	A fragmentary cervico-pectoral lateral spine and partial humerus of an ankylosaur from the Early Cretaceous (early Valanginian) of Gronau in Westfalen, northwestern Germany, are described. The spine shows closest morphological similarities to the characteristic cervical and pectoral spines of Hylaeosaurus armatus from the late Valanginian of England. An extensive comparison of distal humeri among thyreophoran dinosaurs supports systematic differences in the morphology of the distal condyli between Ankylosauria and Stegosauria and a referral of the Gronau specimen to the former. The humerus fragment indicates a rather small individual, probably in the size range of H. armatus, and both specimens are determined herein as ? Hylaeosaurus sp.. A short overview of other purported ankylosaur material from the Berriasian-Valanginian of northwest Germany shows that, aside from the material described herein, only tracks can be attributed to this clade with confidence at present.	[Hornung, Jahn J.] Univ Gottingen, Geowissensch Zentrum, D-37073 Gottingen, Germany			Sachs.Pal@gmx.de		Hornung, Jahn/0000-0002-4929-5490				[Anonymous], 1865, ILLUSTRATED LONDON N, V47, P270; [Anonymous], 1923, FORTSCHRITTE GEOLOGI; Ballerstedt M., 1922, KOSMOS, V19, P77; Barrett Paul M., 2011, Palaeontological Association Field Guides to Fossils, V14, P391; Blows WT, 2001, LIFE O PAST, P363; BLOWS WT, 1987, PALAEONTOLOGY, V30, P557; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; Carpenter Kenneth, 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P249; Company J, 2010, J IBER GEOL, V36, P243, DOI 10.5209/rev_JIGE.2010.v36.n2.10; Eaton T. H. Jr., 1960, Paleontological Contributions University Kansas Vertebrata, V8, P1; Ford Tracy L., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P157; Hayashi S, 2012, PALAEONTOLOGY, V55, P145, DOI 10.1111/j.1475-4983.2011.01122.x; Hennig E., 1915, SITZUNGSBERICHTE NAT, V1915, P219; Hennig E, 1925, PALAEONTOGRAPHICA S, V7, P103; Hornung J.J., 2007, FOSS OK 77 JAHR PAL, V36, P59; Kemper E., 1973, GEOLOGISCHES JB A, V9, P47; Kemper E, 1976, HEIMATVEREIN GRAFSCH, P1; Kilbourne B, 2005, NEUES JAHRB GEOL P-A, V237, P111, DOI 10.1127/njgpa/237/2005/111; Koken E., 1887, GEOLOGISCHE PALAEONT, V3, P311; Mallison H, 2011, PALAEONTOL ELECTRON, V14, P1; Mantell GA, 1833, P GEOLOGICAL SOC LON, V1, P410; Mutterlose J, 2000, CRETACEOUS RES, V21, P733, DOI 10.1006/cres.2000.0232; Mutterlose J., 2000, COURIER FORSCHUNGSIN, V226, P79; Mutterlose J, 1995, BOCHUMER GEOLOGISCHE, V45, P1; Mutterlose J., 1997, BOCHUMER GEOLOGISCHE, V46, P7; Naish Darren, 2001, Palaeontological Association Field Guides to Fossils, V10, P147; Nopesa F., 1915, Jahrb Kgl Ungar Geol Reich Budapest, V23, P1; Nyhuis C., 2009, 79 JAHR PAL GES KURZ, V2009, P85; Osborn H. F., 1923, American Museum Novitates, V95, P1; Owen R., 1858, PALAEONTOGRAPHICAL S, V10, DOI [10.1080/02693445.1858.12027916, DOI 10.1080/02693445.1858.12027916]; Pereda Suberbiola X., 2005, Geogaceta, V38, P35; PEREDASUBERBIOLA J, 1993, GEOL MAG, V130, P767, DOI 10.1017/S0016756800023141; Sachs Sven, 1996, Bericht des Naturwissenschaftlichen Vereins fuer Bielefeld und Umgegend E V, V37, P237; Sachs Sven, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1, P56; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Seeley H.G., 1888, REPORT BRIT ASS ADV, V57, P698; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Wegner T.H., 1914, FESTSCHRIFT WILHELM, P235; Wegner Th., 1911, Palaeontographica Stuttgart, V58; Windolf R., 1998, ARBEITSKREIS PAL ONT, V26, P1	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60571	10.1371/journal.pone.0060571	http://dx.doi.org/10.1371/journal.pone.0060571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560099	Green Published, gold			2022-12-27	WOS:000318840100087
J	An, JN; Ahn, SY; Yoon, CH; Youn, TJ; Han, MK; Kim, S; Chin, HJ; Na, KY; Chae, DW				An, Jung Nam; Ahn, Shin Young; Yoon, Chang-Hwan; Youn, Tae-Jin; Han, Moon-Ku; Kim, Sejoong; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan			The Occurrence of Warfarin-Related Nephropathy and Effects on Renal and Patient Outcomes in Korean Patients	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ALBUMIN; THERAPY; CALCIUM; DISEASE; DEATH	Background: Warfarin-related nephropathy (WRN) is a recently described disease entity, in which excessive warfarinization (international normalized ratio (INR) >3.0) causes acute kidney injury. Previous reports regarding WRN included few Asian patients who might have differed from the western WRN patients in terms of genetic and environmental factors. Methods: During the period of March 2003 to December 2011, the data about a total of 1297 patients who had serum creatinine (sCr) level measured within 1 week after INR >3.0 and within 6 months before INR >3.0 was analyzed through the retrospective review of electronic medical records of a single tertiary hospital in Korea. Result: WRN developed in 19.3% of patients having excessive warfarinization. The incidence was higher in the chronic kidney disease (CKD) group than the non-CKD group. The risk of WRN increased as the basal serum albumin level decreased and was strongly associated with highest quartile serum AST level at post INR elevation and the presence of congestive heart failure. But the presence of atrial fibrillation was protective against the development of WRN. Neither the presence of CKD nor basal estimated glomerular filtration rate (eGFR) was an independent risk factor for WRN. Despite no difference in the basal sCr level, the sCr level was higher in patients with WRN than those without WRN after follow-up. The mortality rates were also higher in patients with WRN. Conclusions: WRN developed in 19.3% of patients having excessive warfarinization. A lower basal serum albumin, highest quartile serum AST level at post INR elevation, and congestive heart failure were associated with the occurrence of WRN. The development of WRN adversely affected renal and patient outcomes.	[An, Jung Nam] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Ahn, Shin Young; Kim, Sejoong; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Songnam, Gyeonggi Do, South Korea; [Yoon, Chang-Hwan; Youn, Tae-Jin] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Cardiol, Songnam, Gyeonggi Do, South Korea; [Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Stroke Ctr,Neurosci Ctr, Songnam, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chae, DW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Songnam, Gyeonggi Do, South Korea.	cdw1302@snubh.org	Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962; HAN, MOON-KU/0000-0003-0166-387X; Yoon, Chang-Hwan/0000-0001-6305-4442				Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Brodsky SV, 2012, NEPHROL DIAL TRANSPL, V27, P475, DOI 10.1093/ndt/gfr559; Brodsky SV, 2011, KIDNEY INT, V80, P182, DOI 10.1038/ki.2011.44; Brodsky SV, 2010, NEPHRON CLIN PRACT, V115, pC142, DOI 10.1159/000312877; Brodsky SV, 2009, AM J KIDNEY DIS, V54, P1121, DOI 10.1053/j.ajkd.2009.04.024; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Demirkan K, 2000, SOUTH MED J, V93, P448; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Jaffer A, 2003, CLEV CLIN J MED, V70, P361, DOI 10.3949/ccjm.70.4.361; Kabir A, 2004, AM J KIDNEY DIS, V43, P757, DOI 10.1053/j.ajkd.2003.08.050; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Limdi NA, 2010, AM J KIDNEY DIS, V56, P823, DOI 10.1053/j.ajkd.2010.05.023; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; TARNOKY AL, 1982, BRIT MED J, V285, P812, DOI 10.1136/bmj.285.6344.812-a; TSAO SC, 1986, J PHARMACOKINET BIOP, V14, P51, DOI 10.1007/BF01059283; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WILTING J, 1980, J BIOL CHEM, V255, P3032	20	39	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e57661	10.1371/journal.pone.0057661	http://dx.doi.org/10.1371/journal.pone.0057661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560034	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900002
J	Chen, XM; Gan, T; Liao, ZQ; Chen, SQ; Xiao, JH				Chen, Ximing; Gan, Ting; Liao, Zhiqiong; Chen, Shengqiang; Xiao, Jianhua			Foxp3 (-/ATT) Polymorphism Contributes to the Susceptibility of Preeclampsia	PLOS ONE			English	Article							T-CELLS; GENE; TRANSCRIPTION; RS3761548	Objective: To evaluate the potential influence of Foxp3 polymorphism on preeclampsia (PE) susceptibility, we conducted a case-control study in Han Chinese women. Methods: Foxp3 genotyping was determined by polymerase chain reaction with sequence-specific primers (PCR-SSP) in 156 PE patients and 252 age-frequency matched controls. Immunohistochemical staining was used to detect the expression of Foxp3 specific transcription factor in 30 PE and 30 normal pregnant women. Results: The positive rate of Foxp3 expression in PE (26.67%) was significant difference from that in normal control (63.33%, P<0.05). The frequency of Foxp3-6054 TT genotype was significantly lower in PE patient than that in control. No significant difference was found in Foxp3-3279 genotypes between PE and control, as well as for the variant allele. The frequency of Foxp3-6054A/-3279C haplotype in PE was significantly higher than that in control (P<0.01), while the frequency of Foxp3 6054T/-3279C haplotype was significantly lower in PE patient than that in control (P<0.01). Conclusion: Our findings suggest that the immune suppression function in PE patients is weakened, which may result in the occurrence of PE. Foxp3 polymorphism (rs5902434) may be a potential contributor for the development of PE in Han Chinese women.	[Chen, Ximing; Xiao, Jianhua] Univ South, Coll Med, Guangzhou, Guangdong, Peoples R China; [Chen, Ximing; Gan, Ting] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Liao, Zhiqiong; Chen, Shengqiang] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Chen, XM (corresponding author), Univ South, Coll Med, Guangzhou, Guangdong, Peoples R China.	Chen_ximing@hotmail.com						Andre GM, 2011, FERTIL STERIL, V95, P2223, DOI 10.1016/j.fertnstert.2011.03.033; Cao WP, 2010, PATHOPHYSIOLOGY, V26, P1425; Fodor E, 2011, HUM IMMUNOL, V72, P926, DOI 10.1016/j.humimm.2011.06.011; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hassannia H, 2011, IRAN J IMMUNOL, V8, P218; Irani RA, 2010, HYPERTENSION, V55, P1246, DOI 10.1161/HYPERTENSIONAHA.110.150540; Jahan P, 2013, SCAND J IMMUNOL, V77, P104, DOI 10.1111/j.1365-3083.2012.02760.x; Lin YC, 2011, LUPUS, V20, P137, DOI 10.1177/0961203310382428; Metz TD, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.005; Park O, 2005, ANN NY ACAD SCI, V1051, P218, DOI 10.1196/annals.1361.125; Quinn KH, 2011, J REPROD IMMUNOL, V91, P76, DOI 10.1016/j.jri.2011.05.006; Ramma W, 2011, BIOCHEM SOC T, V39, P1619, DOI 10.1042/BST20110672; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Shen Z, 2010, J CELL MOL MED, V14, P226, DOI 10.1111/j.1582-4934.2008.00370.x; Toldi G, 2008, ACTA OBSTET GYN SCAN, V87, P1229, DOI 10.1080/00016340802389470; Vitoratos N, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/145487; Wang LiJun, 2010, Shandong Medical Journal, V50, P10; Wu ZG, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/896458; Yang SY, 2010, J IMMUNOL, V26, P320	19	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59696	10.1371/journal.pone.0059696	http://dx.doi.org/10.1371/journal.pone.0059696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560055	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900023
J	Zheng, D; Sun, Q; Su, ZL; Kong, FZ; Shi, XJ; Tong, J; Shen, P; Peng, TQ; Wang, SJ; Xu, HX				Zheng, Dong; Sun, Qiang; Su, Zhaoliang; Kong, Fanzhi; Shi, Xiaoju; Tong, Jia; Shen, Pei; Peng, Tianqing; Wang, Shengjun; Xu, Huaxi			Enhancing Specific-Antibody Production to the ragB Vaccine with GITRL That Expand Tfh, IFN-gamma(+) T Cells and Attenuates Porphyromonas gingivalis Infection in Mice	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; B-CELLS; PERIODONTAL-DISEASE; TISSUE DESTRUCTION; NASAL IMMUNIZATION; VIRULENCE FACTORS; GENE-TRANSFER; MURINE MODEL; RESPONSES; IMMUNITY	The outer membrane protein RagB is one of the major virulence factors of the periodontal pathogen Porphyromonas gingivalis (P. gingivalis). In order to induce protective immune response against P. gingivalis infection, an mGITRL gene-linked ragB DNA vaccine (pIRES-ragB-mGITRL) was constructed. Six-week-old female BALB/c mice were immunized with pIRES-ragB-mGITRL through intramuscular injection and then challenged by subcutaneous injection in the abdomen with P. gingivalis. RagB-specific antibody-forming cells were evaluated by an Enzyme-linked immunosorbent spot, and specific antibody was determined by enzyme-linked immunosorbent assay. In addition, the frequencies of Tfh and IFN-gamma(+) T cells in spleen were measured using flow cytometer, and the levels of IL-21 and IFN-gamma mRNA or proteins were detected by real time RT-PCR or ELISA. The data showed that the mGITRL-linked ragB DNA vaccine induced higher levels of RagB-specific IgG in serum and RagB-specific antibody-forming cells in spleen. The frequencies of Tfh and IFN-gamma(+) T cells were obviously expanded in mice immunized by pIRES-ragB-mGITRL compared with other groups (pIRES or pIRES-ragB). The levels of Tfh and IFN-gamma(+) T cells associated cytokines were also significantly increased in pIRES-ragB-mGITRL group. Therefore, the mice immunized with ragB plus mGITRL showed the stronger resistant to P. gingivalis infection and a significant reduction of the lesion size caused by P. gingivalis infection comparing with other groups. Taken together, our findings demonstrated that intramuscular injection of DNA vaccine ragB together with mGITRL induced protective immune response dramatically by increasing Tfh and IFN-gamma(+) T cells and antibody production to P. gingivalis.	[Zheng, Dong; Sun, Qiang; Su, Zhaoliang; Tong, Jia; Shen, Pei; Wang, Shengjun; Xu, Huaxi] Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Peoples R China; [Kong, Fanzhi] Jiangsu Univ, Affiliated Peoples Hosp, Zhenjiang, Peoples R China; [Shi, Xiaoju] Univ Kent, Medway Sch Pharm, Dept Microbiol, Canterbury CT2 7NZ, Kent, England; [Peng, Tianqing] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada	Jiangsu University; Jiangsu University; University of Kent; Western University (University of Western Ontario)	Wang, SJ (corresponding author), Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Peoples R China.	sjwjsu@yahoo.com.cn; xuhx@ujs.edu.cn	Peng, Tianqing/G-3340-2011	Wang, Shengjun/0000-0001-6584-1183	National Natural Science Foundation of China [31270947, 30972748, 31170849]; Innovation Fund for candidate of doctor in Jiangsu Province [CXZZ11_0593]; Postdoctoral Foundation of China [2012M511705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Fund for candidate of doctor in Jiangsu Province; Postdoctoral Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31270947, 30972748, 31170849), the Innovation Fund for candidate of doctor in Jiangsu Province (grant CXZZ11_0593) and Postdoctoral Foundation of China (2012M511705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Bradney CP, 2002, J VIROL, V76, P517, DOI 10.1128/JVI.76.2.517-524.2002; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Curtis MA, 1999, J PERIODONTAL RES, V34, P400, DOI 10.1111/j.1600-0765.1999.tb02273.x; DAVIS HL, 1993, HUM GENE THER, V4, P733, DOI 10.1089/hum.1993.4.6-733; Devi Prapulla, 2009, N Y State Dent J, V75, P30; Diaz-Romero RM, 2007, FACTA U SERIES MED B, V14, P6; Du XG, 2007, J GENE MED, V9, P136, DOI 10.1002/jgm.1004; Ebersole J L, 1995, Oral Dis, V1, P115; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fisher MA, 2011, KIDNEY INT, V79, P347, DOI 10.1038/ki.2010.384; Guo HM, 2006, IMMUNOL LETT, V107, P71, DOI 10.1016/j.imlet.2006.07.008; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Hall LMC, 2005, INFECT IMMUN, V73, P4253, DOI 10.1128/IAI.73.7.4253-4262.2005; Hanley SA, 1999, INFECT IMMUN, V67, P1157, DOI 10.1128/IAI.67.3.1157-1171.1999; Hokamura K, 2010, J PHARMACOL SCI, V113, P110, DOI 10.1254/jphs.09R26FM; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; JACKSON RJ, 1993, INFECT IMMUN, V61, P4272, DOI 10.1128/IAI.61.10.4272-4279.1993; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King C, 2011, IMMUNITY, V34, P827, DOI 10.1016/j.immuni.2011.06.007; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; Lee SH, 2009, J IMMUNOL, V182, P5823, DOI 10.4049/jimmunol.0802765; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; O'Brien-Simpson NM, 2000, INFECT IMMUN, V68, P4055, DOI 10.1128/IAI.68.7.4055-4063.2000; OGAWA T, 1992, INT IMMUNOL, V4, P1003, DOI 10.1093/intimm/4.9.1003; Pachuk CJ, 2000, BBA-BIOMEMBRANES, V1468, P20, DOI 10.1016/S0005-2736(00)00242-X; Shi XJ, 2007, INFECT IMMUN, V75, P2071, DOI 10.1128/IAI.01785-06; SLOTS J, 1984, J DENT RES, V63, P412, DOI 10.1177/00220345840630031101; Terpenning M S, 2001, Ann Periodontol, V6, P66, DOI 10.1902/annals.2001.6.1.66; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wang S, 2004, J JIANGSU U MED EDIT, V14, P97; Yonezawa H, 2001, INFECT IMMUN, V69, P2858, DOI 10.1128/IAI.69.5.2858-2864.2001; Zheng Dong, 2010, XI BAO YU FEN ZI MIA, V26, P572	46	10	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59604	10.1371/journal.pone.0059604	http://dx.doi.org/10.1371/journal.pone.0059604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560053	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900021
J	Crepeau, TN; Healy, SP; Bartlett-Healy, K; Unlu, I; Farajollahi, A; Fonseca, DM				Crepeau, Taryn N.; Healy, Sean P.; Bartlett-Healy, Kristen; Unlu, Isik; Farajollahi, Ary; Fonseca, Dina M.			Effects of Biogents Sentinel Trap Field Placement on Capture Rates of Adult Asian Tiger Mosquitoes, Aedes albopictus	PLOS ONE			English	Article							DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; DISPERSAL; SURVIVAL; INVASION	The Biogents (R) Sentinel (BGS) trap is the standard tool to monitor adult Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae), the Asian tiger mosquito. BGS traps are commonly placed in residential properties during surveillance operations, but locations within properties may have significant differences in ambient light, temperature, and humidity (e.g. between a sunlit lawn and shady underbrush). We examined the effect of BGS trap placement on Ae. albopictus capture rates in three residential properties in Monmouth County, New Jersey, USA. In each property we visually selected locations as shade, partial shade, and sun. Traps in "partial shade" locations were under vegetation and were exposed to filtered sunlight during some parts of the day while "shaded" locations were never exposed to direct sunlight. Locations defined as "sun" were exposed to direct sunlight for large parts of the day. We placed a BGS trap in each of the three location types and used small data loggers to measure temperature, relative humidity, and light exposure at each trap during a 24-hour deployment. To address temporal variability, we made seven separate measurements from 31 August to 22 September 2010. We found that "partial shade" and "full shade" locations did not differ but that "full sun" locations had significantly higher light exposure, higher temperature, and lower humidity. Importantly, Ae. albopictus catches (males, females, or both) were consistently and significantly over 3 times higher in traps located in shaded locations. To further investigate the effects of local temperature and humidity on surveillance we examined Ae. albopictus collections from 37 BGS traps fitted with data loggers and deployed weekly from August through mid October, during the 2009 season, in three urban sites in Mercer County, NJ. We confirmed that local climate influences capture rates and that Ae. albopictus surveillance projects need to monitor trap placement carefully for maximum efficiency.	[Crepeau, Taryn N.; Healy, Sean P.] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Bartlett-Healy, Kristen; Unlu, Isik; Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Unlu, Isik; Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA	Rutgers State University New Brunswick	Fonseca, DM (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	dinafons@rci.rutgers.edu	Fonseca, Dina Madeira/B-9951-2011; Fonseca, Dina/HHS-1320-2022	Fonseca, Dina Madeira/0000-0003-4726-7100; Healy, Kristen/0000-0002-3208-6537	USDA-ARS (US Department of Agriculture, Agricultural Research Service) [USDA-ARS-58-6615-8-14-105]; Rutgers University (PI at Rutgers) [USDA-ARS-58-6615-8-14-105]	USDA-ARS (US Department of Agriculture, Agricultural Research Service); Rutgers University (PI at Rutgers)	This work was funded by Cooperative Agreement USDA-ARS-58-6615-8-14-105 between USDA-ARS (US Department of Agriculture, Agricultural Research Service) and Rutgers University (PI at Rutgers: DMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett-Healy K, 2012, J MED ENTOMOLOGY, V49; Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P178; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crepeau TN, 2013, J AM MOSQUI IN PRESS; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Estrada-Franco J. G., 1995, Technical Paper - Pan American Health Organization; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Fonseca DM, 2013, PEST MANAGE IN PRESS; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Kawada H, 2007, J MED ENTOMOL, V44, P427, DOI 10.1603/0022-2585(2007)44[427:CLSOTR]2.0.CO;2; Keselman HJ, 2001, BRIT J MATH STAT PSY, V54, P1, DOI 10.1348/000711001159357; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Linthicum KJ, 2003, J AM MOSQUITO CONTR, V19, P301; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140	30	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60524	10.1371/journal.pone.0060524	http://dx.doi.org/10.1371/journal.pone.0060524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555987	gold, Green Published			2022-12-27	WOS:000317263900076
J	Mullaly, SC; Oudhoff, MJ; Min, PH; Burrows, K; Antignano, F; Rattray, DG; Chenery, A; McNagny, KM; Ziltener, HJ; Zaph, C				Mullaly, Sarah C.; Oudhoff, Menno J.; Min, Paul H.; Burrows, Kyle; Antignano, Frann; Rattray, David G.; Chenery, Alistair; McNagny, Kelly M.; Ziltener, Hermann J.; Zaph, Colby			Requirement for Core 2 O-Glycans for Optimal Resistance to Helminth Infection	PLOS ONE			English	Article							SELECTIN LIGAND FORMATION; CD34; CD43; BIOSYNTHESIS; INFLAMMATION; RECRUITMENT; CHEMOKINES; IMMUNITY; CELLS; MICE	The migration of lymphocytes to the small intestine is controlled by expression of the integrin alpha 4 beta 7 and the chemokine receptor CCR9. However, the molecules that specifically regulate migration to the large intestine remain unclear. Immunity to infection with the large intestinal helminth parasite Trichuris muris is dependent upon CD4(+) T cells that migrate to the large intestine. We examine the role of specific chemokine receptors, adhesion molecules and glycosyltransferases in the development of protective immunity to Trichuris. Mice deficient in expression of the chemokine receptors CCR2 or CCR6 were resistant to infection with Trichuris. Similarly, loss of CD34, CD43, CD44 or PSGL-1 had no effect on resistance to infection. In contrast, simultaneous deletion of the Core2 beta 1,6-N-acetylglucosaminyltransferase (C2GnT) enzymes C2GnT1 and C2Gnt2 resulted in delayed expulsion of worms. These results suggest that C2GnT-dependent modifications may play a role in migration of protective immune cells to the large intestine.	[Mullaly, Sarah C.; Oudhoff, Menno J.; Min, Paul H.; Burrows, Kyle; Antignano, Frann; Rattray, David G.; Chenery, Alistair; McNagny, Kelly M.; Ziltener, Hermann J.; Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [McNagny, Kelly M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Ziltener, Hermann J.; Zaph, Colby] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Zaph, C (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	colby@brc.ubc.ca	McNagny, Kelly/P-5239-2014	McNagny, Kelly/0000-0003-4737-3499; Oudhoff, Menno/0000-0002-1180-8975; Rattray, David/0000-0002-2444-0663; Burrows, Kyle/0000-0001-5371-3512; Antignano, Frann/0000-0003-0502-5330; Zaph, Colby/0000-0002-9889-9848; Chenery, Alistair/0000-0001-8755-461X	Canadian Institutes of Health [MOP-93580, MOP-111051, MSH-95368, MOP-89773, MOP-106623]; Canada Foundation for Innovation grant; CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada; CIHR/CAG/Janssen Inc.; Janssen Inc.	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation grant(Canada Foundation for Innovation); CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada(Canadian Institutes of Health Research (CIHR)); CIHR/CAG/Janssen Inc.(Canadian Institutes of Health Research (CIHR)); Janssen Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by the Canadian Institutes of Health Research grants (www.cihr.ca) (MOP-93580 to K.M.M, MOP-111051 to H.Z. and MSH-95368, MOP-89773, MOP-106623 to C.Z.,) and a Canada Foundation for Innovation grant (to C.Z.). S.C.M.F.A. is the recipient of a CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada postdoctoral fellowship. M.J.O. is the recipient of a CIHR/CAG/Janssen Inc. postdoctoral fellowship. KMM is a Michael Smith Foundation for Health Research (www.msfhr.ca) Senior Scholar. C.Z. is a CIHR New Investigator and an MSFHR Career Investigator. Dr Menno Oudhoff is supported by a fellowship sponsored in part by Janssen Inc. The funders had no role in the study design, data collection, data analysis, decision to publish or preparation of the manuscript. Further, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Antignano F, 2011, JOVE-J VIS EXP, DOI 10.3791/2774; Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; Artis DR, 2000, BIOORG MED CHEM LETT, V10, P2421, DOI 10.1016/S0960-894X(00)00482-0; Blanchet MR, 2007, BLOOD, V110, P2005, DOI 10.1182/blood-2006-12-062448; Blanchet MR, 2011, AM J RESP CRIT CARE, V184, P687, DOI 10.1164/rccm.201011-1764OC; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Carlow DA, 2001, J IMMUNOL, V167, P6841, DOI 10.4049/jimmunol.167.12.6841; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; deSchoolmeester ML, 2003, J IMMUNOL, V170, P4693, DOI 10.4049/jimmunol.170.9.4693; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Grassl GA, 2010, CELL MICROBIOL, V12, P1562, DOI 10.1111/j.1462-5822.2010.01488.x; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; Merzaban JS, 2005, J IMMUNOL, V174, P4051, DOI 10.4049/jimmunol.174.7.4051; Mody PD, 2007, BLOOD, V110, P2974, DOI 10.1182/blood-2007-01-065276; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rosenstein Y, 1999, IMMUNOL RES, V20, P89, DOI 10.1007/BF02786465; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Svensson M, 2010, IMMUNOLOGY, V129, P257, DOI 10.1111/j.1365-2567.2009.03178.x; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60124	10.1371/journal.pone.0060124	http://dx.doi.org/10.1371/journal.pone.0060124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555902	Green Published, gold			2022-12-27	WOS:000317263900059
J	Kulkarni, V; Rosati, M; Valentin, A; Ganneru, B; Singh, AK; Yan, J; Rolland, M; Alicea, C; Beach, RK; Zhang, GM; Le Gall, S; Broderick, KE; Sardesai, NY; Heckerman, D; Mothe, B; Brander, C; Weiner, DB; Mullins, JI; Pavlakis, GN; Felber, BK				Kulkarni, Viraj; Rosati, Margherita; Valentin, Antonio; Ganneru, Brunda; Singh, Ashish K.; Yan, Jian; Rolland, Morgane; Alicea, Candido; Beach, Rachel Kelly; Zhang, Gen-Mu; Le Gall, Sylvie; Broderick, Kate E.; Sardesai, Niranjan Y.; Heckerman, David; Mothe, Beatriz; Brander, Christian; Weiner, David B.; Mullins, James I.; Pavlakis, George N.; Felber, Barbara K.			HIV-1 p24(gag) Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; VIRAL REPLICATION CAPACITY; LYMPHOCYTE RESPONSES; EPITOPE PRESENTATION; MEMBRANE PROTEIN-1; ESCAPE MUTATIONS; II COMPARTMENT; BOOST VACCINE; TYPE-1	Viral diversity is considered a major impediment to the development of an effective HIV-1 vaccine. Despite this diversity, certain protein segments are nearly invariant across the known HIV-1 Group M sequences. We developed immunogens based on the highly conserved elements from the p24(gag) region according to two principles: the immunogen must (i) include strictly conserved elements of the virus that cannot mutate readily, and (ii) exclude both HIV regions capable of mutating without limiting virus viability, and also immunodominant epitopes located in variable regions. We engineered two HIV-1 p24(gag) DNA immunogens that express 7 highly Conserved Elements (CE) of 12-24 amino acids in length and differ by only 1 amino acid in each CE ('toggle site'), together covering >99% of the HIV-1 Group M sequences. Altering intracellular trafficking of the immunogens changed protein localization, stability, and also the nature of elicited immune responses. Immunization of C57BL/6 mice with p55(gag) DNA induced poor, CD4(+) mediated cellular responses, to only 2 of the 7 CE; in contrast, vaccination with p24CE DNA induced cross-clade reactive, robust T cell responses to 4 of the 7 CE. The responses were multifunctional and composed of both CD4(+) and CD8(+) T cells with mature cytotoxic phenotype. These findings provide a method to increase immune response to universally conserved Gag epitopes, using the p24CE immunogen. p24CE DNA vaccination induced humoral immune responses similar in magnitude to those induced by p55(gag), which recognize the virus encoded p24(gag) protein. The inclusion of DNA immunogens composed of conserved elements is a promising vaccine strategy to induce broader immunity by CD4(+) and CD8(+) T cells to additional regions of Gag compared to vaccination with p55(gag) DNA, achieving maximal cross-clade reactive cellular and humoral responses.	[Kulkarni, Viraj; Alicea, Candido; Beach, Rachel Kelly; Zhang, Gen-Mu; Felber, Barbara K.] Frederick Natl Lab Canc Res, Human Retrovirus Pathogenesis Sect, Ctr Canc Res, Frederick, MD USA; [Rosati, Margherita; Valentin, Antonio; Ganneru, Brunda; Singh, Ashish K.; Beach, Rachel Kelly; Zhang, Gen-Mu; Pavlakis, George N.] Frederick Natl Lab Canc Res, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD USA; [Yan, Jian; Weiner, David B.] Univ Penn, Philadelphia, PA 19104 USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Med, Seattle, WA USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Le Gall, Sylvie] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Broderick, Kate E.; Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA USA; [Heckerman, David] Microsoft Res, Redmond, WA USA; [Mothe, Beatriz; Brander, Christian] Autonomous Univ Barcelona, IrsiCaixa AIDS Res Inst HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Microsoft; Autonomous University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Pavlakis, GN (corresponding author), Frederick Natl Lab Canc Res, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD USA.	pavlakig@mail.nih.gov; felberb@mail.nih.gov	Weiner, David B/H-8579-2014	Sardesai, Niranjan/0000-0001-6920-1167; Brander, Christian/0000-0002-0548-5778; Mothe, Beatriz/0000-0001-9975-407X; Le Gall, Sylvie/0000-0003-0385-926X	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); Bill and Melinda Gates Foundation; Red de Investigacion de Sida (RIS) [RD06/04]; Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Spanish FIPSE [36-0737-09]; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [P30CA016520, ZIABC010749, ZIABC010350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Red de Investigacion de Sida (RIS); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III); Spanish FIPSE; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH). This work was funded by Bill and Melinda Gates Foundation and was supported in part by the Red de Investigacion de Sida (RIS) (RD06/04), Instituto de Salud Carlos III (ISCIII), Madrid, Spain and the Spanish FIPSE 36-0737-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045267; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Bockl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034723; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Christie NM, 2009, VIROLOGY, V388, P137, DOI 10.1016/j.virol.2009.03.003; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; De Groot AS, 2008, VACCINE, V26, P3059, DOI 10.1016/j.vaccine.2007.12.004; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Duda A, 2009, J VIROL, V83, P1228, DOI 10.1128/JVI.01545-08; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040015; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2008, AIDS, V22, P447, DOI 10.1097/QAD.0b013e3282f42412; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Hanke T, 1999, IMMUNOL LETT, V66, P177, DOI 10.1016/S0165-2478(98)00164-3; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Kaufman DR, 2012, VACCINE, V30, P506, DOI 10.1016/j.vaccine.2011.11.079; Kent SJ, 2005, TRENDS MICROBIOL, V13, P243, DOI 10.1016/j.tim.2005.03.011; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Lazaro E, 2011, J CLIN INVEST, V121, P2480, DOI 10.1172/JCI44932; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]; Mullins James I, 2004, Expert Rev Vaccines, V3, pS151, DOI 10.1586/14760584.3.4.S151; NASIOULAS G, 1994, J VIROL, V68, P2986, DOI 10.1128/JVI.68.5.2986-2993.1994; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Nickle DC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040025; Nickle DC, 2003, SCIENCE, V299, P1515; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Peyerl FW, 2004, J VIROL, V78, P13901, DOI 10.1128/JVI.78.24.13901-13910.2004; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Qiu JT, 1999, J VIROL, V73, P9145, DOI 10.1128/JVI.73.11.9145-9152.1999; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Valentin A, 2009, VACCINE, V27, P4840, DOI 10.1016/j.vaccine.2009.05.093; von Gegerfelt A, 2010, J IMMUNOL, V185, P3348, DOI 10.4049/jimmunol.1000572; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002; Zhang SC, 2012, J IMMUNOL, V188, P5924, DOI 10.4049/jimmunol.1200219; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	76	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60245	10.1371/journal.pone.0060245	http://dx.doi.org/10.1371/journal.pone.0060245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555935	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200102
J	Lempka, SF; McIntyre, CC				Lempka, Scott F.; McIntyre, Cameron C.			Theoretical Analysis of the Local Field Potential in Deep Brain Stimulation Applications	PLOS ONE			English	Article							HUMAN SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; PATHOLOGICAL SYNCHRONIZATION; FUNCTIONAL-SIGNIFICANCE; BETA; RECORDINGS; ELECTRODE; OSCILLATIONS; FREQUENCY; ACTIVATION	Deep brain stimulation (DBS) is a common therapy for treating movement disorders, such as Parkinson's disease (PD), and provides a unique opportunity to study the neural activity of various subcortical structures in human patients. Local field potential (LFP) recordings are often performed with either intraoperative microelectrodes or DBS leads and reflect oscillatory activity within nuclei of the basal ganglia. These LFP recordings have numerous clinical implications and might someday be used to optimize DBS outcomes in closed-loop systems. However, the origin of the recorded LFP is poorly understood. Therefore, the goal of this study was to theoretically analyze LFP recordings within the context of clinical DBS applications. This goal was achieved with a detailed recording model of beta oscillations (similar to 20 Hz) in the subthalamic nucleus. The recording model consisted of finite element models of intraoperative microelectrodes and DBS macroelectrodes implanted in the brain along with multi-compartment cable models of STN projection neurons. Model analysis permitted systematic investigation into a number of variables that can affect the composition of the recorded LFP (e. g. electrode size, electrode impedance, recording configuration, and filtering effects of the brain, electrode-electrolyte interface, and recording electronics). The results of the study suggest that the spatial reach of the LFP can extend several millimeters. Model analysis also showed that variables such as electrode geometry and recording configuration can have a significant effect on LFP amplitude and spatial reach, while the effects of other variables, such as electrode impedance, are often negligible. The results of this study provide insight into the origin of the LFP and identify variables that need to be considered when analyzing LFP recordings in clinical DBS applications.	[Lempka, Scott F.; McIntyre, Cameron C.] Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	McIntyre, CC (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	ccm4@case.edu			National Institutes of Health [R01 NS047388]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (R01 NS047388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2012, NEUROSURGERY, V71, P804, DOI 10.1227/NEU.0b013e3182676b91; Bedard C, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P136; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chen CC, 2006, EXP NEUROL, V198, P214, DOI 10.1016/j.expneurol.2005.11.019; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Foffani G, 2006, BRAIN RES BULL, V69, P123, DOI 10.1016/j.brainresbull.2005.11.012; Giannicola G, 2012, EXP NEUROL, V237, P312, DOI 10.1016/j.expneurol.2012.06.012; Gillies A, 2006, J NEUROPHYSIOL, V95, P2352, DOI 10.1152/jn.00525.2005; Gross RE, 2006, MOVEMENT DISORD, V21, pS259, DOI 10.1002/mds.20960; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; Ince NF, 2010, NEUROSURGERY, V67, P390, DOI 10.1227/01.NEU.0000372091.64824.63; Jenkinson N, 2013, EXP NEUROL, V245, P72, DOI 10.1016/j.expneurol.2012.07.005; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Kuhn AA, 2005, EXP NEUROL, V194, P212, DOI 10.1016/j.expneurol.2005.02.010; Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106; Lempka S. F., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Lempka SF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045006; Lempka SF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046001; Levesque JC, 2005, MOVEMENT DISORD, V20, P574, DOI 10.1002/mds.20374; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Linden H, 2010, J COMPUT NEUROSCI, V29, P423, DOI 10.1007/s10827-010-0245-4; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; MCADAMS ET, 1995, BIOSENS BIOELECTRON, V10, P67, DOI 10.1016/0956-5663(95)96795-Z; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Miyagi Y, 2009, STEREOT FUNCT NEUROS, V87, P211, DOI 10.1159/000225974; Moffitt MA, 2005, CLIN NEUROPHYSIOL, V116, P2240, DOI 10.1016/j.clinph.2005.05.018; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nelson MJ, 2008, J NEUROSCI METH, V169, P141, DOI 10.1016/j.jneumeth.2007.12.010; Pettersen KH, 2008, J COMPUT NEUROSCI, V24, P291, DOI 10.1007/s10827-007-0056-4; Pettersen KH, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P92; Pogosyan A, 2010, NEUROSCIENCE, V171, P245, DOI 10.1016/j.neuroscience.2010.08.068; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Priori A, 2013, EXP NEUROL, V245, P77, DOI 10.1016/j.expneurol.2012.09.013; Rosa M, 2010, EXP NEUROL, V222, P184, DOI 10.1016/j.expneurol.2009.12.013; Rossi L, 2008, BRAIN RES BULL, V76, P512, DOI 10.1016/j.brainresbull.2008.01.023; Santaniello S, 2011, IEEE T NEUR SYS REH, V19, P15, DOI 10.1109/TNSRE.2010.2081377; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Smith Y, 1998, NEUROSCIENCE, V86, P353; Stacey WC, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056007; Wei XF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046008; Weinberger M, 2006, J NEUROPHYSIOL, V96, P3248, DOI 10.1152/jn.00697.2006; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Yoshida F, 2010, J NEUROL NEUROSUR PS, V81, P885, DOI 10.1136/jnnp.2009.190918; Zaidel A, 2010, BRAIN, V133, P2007, DOI 10.1093/brain/awq144	59	60	63	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59839	10.1371/journal.pone.0059839	http://dx.doi.org/10.1371/journal.pone.0059839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555799	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200044
J	Qu, LS; Kuai, XL; Liu, TT; Chen, TY; Ni, ZP; Shen, XZ				Qu, Lishuai; Kuai, Xiaoling; Liu, Taotao; Chen, Taoyang; Ni, Zhengpin; Shen, Xizhong			Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Young Age Hepatocellular Carcinoma in Qidong, China	PLOS ONE			English	Article							HIGH VIRAL LOAD; CORE PROMOTER; RISK; LIVER; GENOTYPE; PREVALENCE; FEATURES; MUTANTS; SERUM	Background/Aim: To investigate the roles of biomedical factors, hepatitis B virus (HBV) DNA levels, genotypes, and specific viral mutation patterns on the progression of hepatocellular carcinoma (HCC) patients below 40 years of age in Qidong, China. Methods: We conducted a case-control study within a cohort of 2387 male HBV carriers who were recruited from August, 1996. The HBV DNA sequence was determined in 49 HCC and 90 chronic hepatitis (CH) patients below 40 years of age. Mutation exchanges during follow-up in 32 cases were compared with 65 controls with paired serum samples. In addition, a consecutive series of samples from 14 HCC cases were employed to compare the sequences before and after the occurrence of HCC. Results: After adjustment for age, history of cigarette smoking and alcohol consumption, HBeAg positive, HBV DNA levels >= 4.00 log(10) copies/mL, pre-S deletion, T1762/A1764 double mutations, and T1766 and/or A1768 mutations were associated with risk of young age HCC. Moreover, the presence of an increasing number of HCC-related mutations (pre-S deletion, T1762/A1764, and T1766 and/or A1768 mutations) was associated with an increased risk of young age HCC. Paired samples analysis indicated that the increased HCC risk for at-risk sequence mutations were attributable to the persistence of these mutations, but not a single time point mutation. The longitudinal observation demonstrated a gradual combination of pre-S deletion, T1762/A1764 double mutations, and T1766 and/or A1768 mutations during the development of HCC. Conclusion: High HBV DNA levels and pre-S deletion were independent risk factors of young age HCC. Combination of preS deletion and core promoter mutations increased the risk and persistence of at-risk sequence mutations is critical for HCC development.	[Qu, Lishuai; Kuai, Xiaoling] Nantong Univ, Affiliated Hosp, Dept Gastroenterol, Nantong, Jiangsu, Peoples R China; [Liu, Taotao; Shen, Xizhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Chen, Taoyang; Ni, Zhengpin] Qidong Liver Canc Inst, Dept Hepatol, Qidong, Jiangsu, Peoples R China	Nantong University; Fudan University	Shen, XZ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	shenxizhong@126.com	liu, taotao/GSI-7460-2022		China Ministry of Health [W201202]; Natural Science Foundation of Jiangsu Province [BK2012225]	China Ministry of Health; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The study was financially supported by China Ministry of Health (W201202), Natural Science Foundation of Jiangsu Province (BK2012225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumert TF, 1996, J CLIN INVEST, V98, P2268, DOI 10.1172/JCI119037; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; FERRARI C, 1992, GASTROENTEROLOGY, V103, P255, DOI 10.1016/0016-5085(92)91121-J; Gao ZY, 2007, J GASTROENTEROL, V42, P761, DOI 10.1007/s00535-007-2085-1; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Ito K, 2006, CLIN INFECT DIS, V42, P1, DOI 10.1086/498522; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kidd AH, 1996, NUCLEIC ACIDS RES, V24, P3295, DOI 10.1093/nar/24.17.3295; Kim JH, 2006, J GASTROEN HEPATOL, V21, P588, DOI 10.1111/j.1440-1746.2005.04127.x; Lam CM, 2004, ALIMENT PHARM THER, V19, P771, DOI 10.1111/j.1365-2036.2004.01912.x; Li J, 1999, J VIROL, V73, P1239, DOI 10.1128/JVI.73.2.1239-1244.1999; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; NAMIENO T, 1995, ANN SURG, V221, P308, DOI 10.1097/00000658-199503000-00014; Ohata K, 2004, J GASTROEN HEPATOL, V19, P670, DOI 10.1111/j.1440-1746.2004.03360.x; Qu LS, 2011, HEPATOL RES, V41, P54, DOI 10.1111/j.1872-034X.2010.00732.x; Sezaki H, 2004, J GASTROENTEROL, V39, P550, DOI 10.1007/s00535-003-1341-2; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023	32	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59583	10.1371/journal.pone.0059583	http://dx.doi.org/10.1371/journal.pone.0059583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555717	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200030
J	Shimao, H; Nakamaru, M				Shimao, Hajime; Nakamaru, Mayuko			Strict or Graduated Punishment? Effect of Punishment Strictness on the Evolution of Cooperation in Continuous Public Goods Games	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; ANTISOCIAL PUNISHMENT; COSTLY PUNISHMENT; COEVOLUTION; RECIPROCITY; ECONOMICS; EMERGENCE; DYNAMICS	Whether costly punishment encourages cooperation is one of the principal questions in studies on the evolution of cooperation and social sciences. In society, punishment helps deter people from flouting rules in institutions. Specifically, graduated punishment is a design principle for long-enduring common-pool resource institutions. In this study, we investigate whether graduated punishment can promote a higher cooperation level when each individual plays the public goods game and has the opportunity to punish others whose cooperation levels fall below the punisher's threshold. We then examine how spatial structure affects evolutionary dynamics when each individual dies inversely proportional to the game score resulting from the social interaction and another player is randomly chosen from the population to produce offspring to fill the empty site created after a player's death. Our evolutionary simulation outcomes demonstrate that stricter punishment promotes increased cooperation more than graduated punishment in a spatially structured population, whereas graduated punishment increases cooperation more than strict punishment when players interact with randomly chosen opponents from the population. The mathematical analysis also supports the results.	[Shimao, Hajime; Nakamaru, Mayuko] Tokyo Inst Technol, Dept Value & Decis Sci, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology	Nakamaru, M (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Meguro Ku, Tokyo 152, Japan.	nakamaru@valdes.titech.ac.jp	Nakamaru, Mayuko/N-9127-2013	Nakamaru, Mayuko/0000-0003-2116-1711	Japan Society for the Promotion of Science JSPS KAKENHI [21770016, 19046006]	Japan Society for the Promotion of Science JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research of MN has been supported by Japan Society for the Promotion of Science JSPS KAKENHI Grant Number 21770016, 19046006 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Chen XJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066133; Chu CYC, 2000, INT REV LAW ECON, V20, P127, DOI 10.1016/S0144-8188(00)00024-7; Connor RC, 2010, PHILOS T R SOC B, V365, P2687, DOI 10.1098/rstb.2010.0150; Cox M, 2010, ECOL SOC, V15; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Eldakar OT, 2007, J THEOR BIOL, V249, P198, DOI 10.1016/j.jtbi.2007.07.024; Emons W, 2003, INT REV LAW ECON, V23, P253, DOI 10.1016/j.irle.2003.09.002; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Frank B, 2000, J ECON BEHAV ORGAN, V43, P101, DOI 10.1016/S0167-2681(00)00111-6; Gao J, 2012, PHYSICA A, V391, P4111, DOI 10.1016/j.physa.2012.03.027; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hastings A, 2012, ENCY THEORETICAL ECO, P7; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert Christoph, 2008, Biology Theory, V3, P114, DOI 10.1162/biot.2008.3.2.114; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hilbe C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00458; Iglesias JR, 2012, PHYSICA A, V391, P3942, DOI 10.1016/j.physa.2012.03.001; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Mungan MC, 2010, INT REV LAW ECON, V30, P173, DOI 10.1016/j.irle.2009.11.002; Nakamaru M, 2005, EVOL ECOL RES, V7, P853; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Nakamaru M, 1998, J THEOR BIOL, V194, P101, DOI 10.1006/jtbi.1998.0750; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; Nakamaru M, 2009, J THEOR BIOL, V257, P1, DOI 10.1016/j.jtbi.2008.09.004; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Ostrom E., 1990, GOVERNING COMMONS EV; Perc M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043013; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Sekiguchi T, 2009, J THEOR BIOL, V256, P297, DOI 10.1016/j.jtbi.2008.09.025; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sober E., 1999, OTHERS EVOLUTION PSY; Szolnoki A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093016; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	56	16	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59894	10.1371/journal.pone.0059894	http://dx.doi.org/10.1371/journal.pone.0059894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555826	Green Published, gold			2022-12-27	WOS:000317262200056
J	Aryan, A; Anderson, MAE; Myles, KM; Adelman, ZN				Aryan, Azadeh; Anderson, Michelle A. E.; Myles, Kevin M.; Adelman, Zach N.			TALEN-Based Gene Disruption in the Dengue Vector Aedes aegypti	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; WHITE EYE; GENOME; DNA; EFFICIENT; TRANSFORMATION; STRAIN; MUTANT	In addition to its role as the primary vector for dengue viruses, Aedes aegypti has a long history as a genetic model organism for other bloodfeeding mosquitoes, due to its ease of colonization, maintenance and reproductive productivity. Though its genome has been sequenced, functional characterization of many Ae. aegypti genes, pathways and behaviors has been slow. TALE nucleases (TALENs) have been used with great success in a number of organisms to generate site-specific DNA lesions. We evaluated the ability of a TALEN pair to target the Ae. aegypti kmo gene, whose protein product is essential in the production of eye pigmentation. Following injection into pre-blastoderm embryos, 20-40% of fertile survivors produced kmo alleles that failed to complement an existing kh(w) mutation. Most of these individuals produced more than 20% white-eyed progeny, with some producing up to 75%. Mutant alleles were associated with lesions of 1-7 bp specifically at the selected target site. White-eyed individuals could also be recovered following a blind intercross of G(1) progeny, yielding several new white-eyed strains in the genetic background of the sequenced Liverpool strain. We conclude that TALENs are highly active in the Ae. aegypti germline, and have the potential to transform how reverse genetic experiments are performed in this important disease vector.	[Adelman, Zach N.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; Virginia Tech, Dept Entomol, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Adelman, ZN (corresponding author), Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	zachadel@vt.edu		Anderson, Michelle/0000-0003-1510-2942; Adelman, Zach/0000-0001-5901-7171	National Institutes of Health [AI085091, AI099843]; Fralin Life Science Institute at Virginia Tech.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085091, R21AI099843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fralin Life Science Institute at Virginia Tech.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (grants AI085091 and AI099843) as well as by the Fralin Life Science Institute at Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002; Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; BHALLA SC, 1968, MOSQ NEWS, V28, P380; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Cornel AJ, 1997, INSECT BIOCHEM MOLEC, V27, P993, DOI 10.1016/S0965-1748(97)00084-2; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Han Q, 2003, INSECT MOL BIOL, V12, P483, DOI 10.1046/j.1365-2583.2003.00433.x; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Pal GB, 1967, GENETICS INSECT VECT, P67; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Sezutsu H, 2012, INSECT BIOCHEM MOLEC, V1, P17; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Watanabe T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2020; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	34	77	80	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60082	10.1371/journal.pone.0060082	http://dx.doi.org/10.1371/journal.pone.0060082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555893	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400079
J	Hectors, TLM; Vanparys, C; Pereira-Fernandes, A; Martens, GA; Blust, R				Hectors, Tine L. M.; Vanparys, Caroline; Pereira-Fernandes, Anna; Martens, Geert A.; Blust, Ronny			Evaluation of the INS-1 832/13 Cell Line as a Beta-Cell Based Screening System to Assess Pollutant Effects on Beta-Cell Function	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; ENDOCRINE-DISRUPTING CHEMICALS; PANCREATIC-ISLETS; BISPHENOL-A; IN-VITRO; ENVIRONMENTAL CONTAMINANTS; PROINSULIN BIOSYNTHESIS; ESTROGEN-RECEPTORS; TOXCAST PROGRAM; RODENT ISLETS	Environmental pollutants have recently emerged as potential risk factors for metabolic diseases, urging systematic investigation of pollutant effects on metabolic disease processes. To enable risk assessment of these so-called metabolic disruptors the use of stable, robust and well-defined cell based screening systems has recently been encouraged. Since beta-cell (dys)functionality is central in diabetes pathophysiology, the need to develop beta-cell based pollutant screening systems is evident. In this context, the present research evaluated the strengths and weaknesses of the INS-1 832/13 pancreatic beta-cell line as diabetogenic pollutant screening system with a focus on beta-cell function. After optimization of exposure conditions, positive (exendin-4, glibenclamide) and negative (diazoxide) control compounds for acute insulin secretion responses were tested and those with the most profound effects were selected to allow potency estimations and ranking of pollutants. This was followed by a first explorative screening of acute bisphenol A and bis(2-ethylhexyl)phthalate effects. The same approach was applied for chronic exposures, focusing primarily on evaluation of acknowledged chronic stimulators (diazoxide, T0901317, exendin-4) or inhibitors (glibenclamide) of insulin secretion responses to select the most responsive ones for use as control compounds in a chronic pollutant testing framework. Our results showed that INS-1 832/13 cells responded conform previous observations regarding acute effects of control compounds on insulin secretion, while bisphenol A and bis(2-ethylhexyl)phthalate had limited acute effects. Furthermore, chronic exposure to known beta-cell reactive compounds resulted in deviating insulin secretion and insulin content profiles compared to previous reports. In conclusion, this INS-1 subclone appears to lack certain characteristics needed to respond appropriately to acute pollutant exposure or long term exposure to known beta-cell reactive compounds and thus seems to be, in our setting, inadequate as a diabetogenic pollutant screening system.	[Hectors, Tine L. M.; Vanparys, Caroline; Pereira-Fernandes, Anna; Blust, Ronny] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Martens, Geert A.] Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium	University of Antwerp; Vrije Universiteit Brussel	Hectors, TLM (corresponding author), Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium.	tine.hectors@ua.ac.be	Martens, Geert A./F-6920-2015; Martens, Geert/ABA-6297-2020	Martens, Geert A./0000-0003-1208-6289; Martens, Geert/0000-0003-1208-6289	GOA of the University of Antwerp [FA020000/2/3565]; 'Fund for Scientific Research (FWO)' Flanders (Belgium); 'Institute for the promotion of innovation by science and technology (IWT)' TM in Flanders (Belgium)	GOA of the University of Antwerp; 'Fund for Scientific Research (FWO)' Flanders (Belgium)(FWO); 'Institute for the promotion of innovation by science and technology (IWT)' TM in Flanders (Belgium)	This study was supported by a GOA project (Endocrine disrupting environmental chemicals: From accumulation to their role in the global "neuro-endocrine" epidemic of obesity and its metabolic consequences; FA020000/2/3565) of the University of Antwerp. Tine Hectors acknowledges financial support from the 'Fund for Scientific Research (FWO)' Flanders (Belgium). Anna Pereira-Fernandes is financially supported by the 'Institute for the promotion of innovation by science and technology (IWT)' TM in Flanders (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2005, FOOD CHEM TOXICOL, V43, P713, DOI 10.1016/j.fct.2005.01.009; Akintomide O.A., 2012, GRADUATE THESES DISS, V446; Alarcon C, 2006, DIABETOLOGIA, V49, P2920, DOI 10.1007/s00125-006-0433-y; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, HORM-INT J ENDOCRINO, V9, P118, DOI 10.1007/BF03401277; Anello M, 1999, BRIT J PHARMACOL, V127, P1883, DOI 10.1038/sj.bjp.0702731; Ball AJ, 2004, PHARMACOL RES, V50, P41, DOI 10.1016/j.phrs.2003.12.001; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Chen JG, 2006, METABOLISM, V55, P1674, DOI 10.1016/j.metabol.2006.08.009; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; DAMBRA R, 1990, ENDOCRINOLOGY, V126, P2815, DOI 10.1210/endo-126-6-2815; Del Guerra S, 2005, J DIABETES COMPLICAT, V19, P60, DOI 10.1016/j.jdiacomp.2004.05.001; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; GOKE R, 1993, J BIOL CHEM, V268, P19650; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horn PA, 2000, EUR J ENDOCRINOL, V142, P84, DOI 10.1530/eje.0.1420084; ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods), 2001, ICCVAM GUID DOC US V; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Lin Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE527, DOI 10.1152/ajpendo.00233.2011; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Longnecker MP, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454649; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Makaji E, 2011, INT J TOXICOL, V30, P410, DOI 10.1177/1091581811405544; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Ohtani M, 2006, MOL PHARMACOL, V69, P899, DOI 10.1124/mol.105.014902; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ropero AB, 2009, J ENDOCRINOL, V200, P127, DOI 10.1677/JOE-08-0397; Ruzzin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-298; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251; Song LQ, 2012, J ENDOCRINOL, V215, P303, DOI 10.1530/JOE-12-0219; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Tang-Peronard JL, 2011, OBES REV, V12, P622, DOI 10.1111/j.1467-789X.2011.00871.x; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yoshikawa H, 2004, AM J PHYSIOL-ENDOC M, V287, pE1202, DOI 10.1152/ajpendo.00255.2004; Zawalich WS, 2008, METABOLISM, V57, P30, DOI 10.1016/j.metabol.2007.07.020; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	58	26	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60030	10.1371/journal.pone.0060030	http://dx.doi.org/10.1371/journal.pone.0060030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555872	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400075
J	Koch, J; Hau, J; Christensen, JP; Jensen, HE; Hansen, MB; Rieneck, K				Koch, Janne; Hau, Jann; Christensen, Jan Pravsgaard; Jensen, Henrik Elvang; Hansen, Morten Bagge; Rieneck, Klaus			Immune Cells from SR/CR Mice Induce the Regression of Established Tumors in BALB/c and C57BL/6 Mice	PLOS ONE			English	Article							RESISTANCE; CANCER	Few experimental models are available for the study of natural resistance to cancer. One of them is the SR/CR (spontaneous regression/complete resistance) mouse model in which natural resistance to a variety of cancer types appeared to be inherited in SR/CR strains of BALB/c and C57BL/6 mice. The genetic, cellular, and molecular effector mechanisms in this model are largely unknown, but cells from the innate immune system may play a significant role. In contrast to previous observations, the cancer resistance was limited to S180 sarcoma cancer cells. We were unable to confirm previous observations of resistance to EL-4 lymphoma cells and J774A.1 monocyte-macrophage cancer cells. The cancer resistance against S180 sarcoma cells could be transferred to susceptible non-resistant BALB/c mice as well as C57BL/6 mice after depletion of both CD4+/CD8+ leukocytes and B-cells from SR/CR mice. In the responding recipient mice, the cancer disappeared gradually following infiltration of a large number of polymorphonuclear granulocytes and remarkably few lymphocytes in the remaining tumor tissues. This study confirmed that the in vivo growth and spread of cancer cells depend on a complex interplay between the cancer cells and the host organism. Here, hereditary components of the immune system, most likely the innate part, played a crucial role in this interplay and lead to resistance to a single experimental cancer type. The fact that leukocytes depleted of both CD4+/CD8+ and B cells from the cancer resistant donor mice could be transferred to inhibit S180 cancer cell growth in susceptible recipient mice support the vision of an efficient and adverse event free immunotherapy in future selected cancer types.	[Koch, Janne; Hau, Jann] Univ Copenhagen, Fac Hlth Sci, Dept Expt Med, Copenhagen, Denmark; [Christensen, Jan Pravsgaard] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Koch, Janne; Jensen, Henrik Elvang] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Hansen, Morten Bagge; Rieneck, Klaus] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Koch, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Expt Med, Copenhagen, Denmark.	jako@sund.ku.dk	Christensen, Jan Pravsgaard/I-4782-2017; Hau, Jann/C-8692-2012	Christensen, Jan Pravsgaard/0000-0002-4299-9479; Hau, Jann/0000-0001-8586-5705; Jensen, Henrik Elvang/0000-0001-7277-7829	A. P. Moller Foundation; Beckett Foundation; Dagmar Marshalls Foundation; Kleinsmed Svend Helge Arvid Schroders Foundation; Fabrikant Einar Willumsens Mindelegat Foundation; Brodrene Hartmann Foundation	A. P. Moller Foundation; Beckett Foundation; Dagmar Marshalls Foundation; Kleinsmed Svend Helge Arvid Schroders Foundation; Fabrikant Einar Willumsens Mindelegat Foundation; Brodrene Hartmann Foundation	This study has been financed by grants from the following funds: The A. P. Moller Foundation, The Beckett Foundation, the Dagmar Marshalls Foundation, the Kleinsmed Svend Helge Arvid Schroders Foundation, the Fabrikant Einar Willumsens Mindelegat Foundation and the Brodrene Hartmann Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFARO G, 1992, VET IMMUNOL IMMUNOP, V30, P385, DOI 10.1016/0165-2427(92)90107-2; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; COBBOLD SP, 1990, EUR J IMMUNOL, V20, P2747, DOI 10.1002/eji.1830201232; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; Cui Z, 2003, P NATL ACAD SCI USA, V100, P6682, DOI 10.1073/pnas.1031601100; EGOROV OS, 1992, IMMUNOGENETICS, V36, P219, DOI 10.1007/BF00215051; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hicks Amy M, 2006, Cancer Immun, V6, P11; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Koch J, 2008, IN VIVO, V22, P565; Koch J, 2012, APMIS, V120, P974, DOI 10.1111/j.1600-0463.2012.02925.x; Li JH, 2009, VACCINE, V27, P558, DOI 10.1016/j.vaccine.2008.11.014; Riedlinger G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-179	14	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59995	10.1371/journal.pone.0059995	http://dx.doi.org/10.1371/journal.pone.0059995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555858	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400074
J	Motta, MCM; Martins, ACD; de Souza, SS; Catta-Preta, CMC; Silva, R; Klein, CC; de Almeida, LGP; Cunha, OD; Ciapina, LP; Brocchi, M; Colabardini, AC; Lima, BD; Machado, CR; Soares, CMD; Probst, CM; de Menezes, CBA; Thompson, CE; Bartholomeu, DC; Gradia, DF; Pavoni, DP; Grisard, EC; Fantinatti-Garboggini, F; Marchini, FK; Rodrigues-Luiz, GF; Wagner, G; Goldman, GH; Fietto, JLR; Elias, MC; Goldman, MHS; Sagot, MF; Pereira, M; Stoco, PH; de Mendonca-Neto, RP; Teixeira, SMR; Maciel, TEF; Mendes, TAD; Urmenyi, TP; de Souza, W; Schenkman, S; de Vasconcelos, ATR				Machado Motta, Maria Cristina; de Azevedo Martins, Allan Cezar; de Souza, Silvana Sant'Anna; Costa Catta-Preta, Carolina Moura; Silva, Rosane; Klein, Cecilia Coimbra; Paula de Almeida, Luiz Gonzaga; Cunha, Oberdan de Lima; Ciapina, Luciane Prioli; Brocchi, Marcelo; Colabardini, Ana Cristina; Lima, Bruna de Araujo; Machado, Carlos Renato; de Almeida Soares, Celia Maria; Probst, Christian Macagnan; Afonso de Menezes, Claudia Beatriz; Thompson, Claudia Elizabeth; Bartholomeu, Daniella Castanheira; Gradia, Daniela Fiori; Pavoni, Daniela Parada; Grisard, Edmundo C.; Fantinatti-Garboggini, Fabiana; Marchini, Fabricio Klerynton; Rodrigues-Luiz, Gabriela Flaia; Wagner, Glauber; Goldman, Gustavo Henrique; Rangel Fietto, Juliana Lopes; Elias, Maria Carolina; Goldman, Maria Helena S.; Sagot, Marie-France; Pereira, Maristela; Stoco, Patricia H.; de Mendonca-Neto, Rondon Pessoa; Ribeiro Teixeira, Santuza Maria; Ferreira Maciel, Talles Eduardo; de Oliveira Mendes, Tiago Antonio; Uermenyi, Turan P.; de Souza, Wanderley; Schenkman, Sergio; Ribeiro de Vasconcelos, Ana Tereza			Predicting the Proteins of Angomonas deanei, Strigomonas culicis and Their Respective Endosymbionts Reveals New Aspects of the Trypanosomatidae Family	PLOS ONE			English	Article							MANNOSE-TYPE OLIGOSACCHARIDES; CELL-DIVISION PROTEIN; CRITHIDIA-DEANEI; PROTEOBACTERIAL ENDOSYMBIONTS; KINETOPLASTID PARASITES; BLASTOCRITHIDIA-CULICIS; INSECT TRYPANOSOMATIDS; PARAFLAGELLAR ROD; PURINE METABOLISM; TERMINAL OXIDASES	Endosymbiont-bearing trypanosomatids have been considered excellent models for the study of cell evolution because the host protozoan co-evolves with an intracellular bacterium in a mutualistic relationship. Such protozoa inhabit a single invertebrate host during their entire life cycle and exhibit special characteristics that group them in a particular phylogenetic cluster of the Trypanosomatidae family, thus classified as monoxenics. In an effort to better understand such symbiotic association, we used DNA pyrosequencing and a reference-guided assembly to generate reads that predicted 16,960 and 12,162 open reading frames (ORFs) in two symbiont-bearing trypanosomatids, Angomonas deanei (previously named as Crithidia deanei) and Strigomonas culicis (first known as Blastocrithidia culicis), respectively. Identification of each ORF was based primarily on TriTrypDB using tblastn, and each ORF was confirmed by employing getorf from EMBOSS and Newbler 2.6 when necessary. The monoxenic organisms revealed conserved housekeeping functions when compared to other trypanosomatids, especially compared with Leishmania major. However, major differences were found in ORFs corresponding to the cytoskeleton, the kinetoplast, and the paraflagellar structure. The monoxenic organisms also contain a large number of genes for cytosolic calpain-like and surface gp63 metalloproteases and a reduced number of compartmentalized cysteine proteases in comparison to other TriTryp organisms, reflecting adaptations to the presence of the symbiont. The assembled bacterial endosymbiont sequences exhibit a high A+T content with a total of 787 and 769 ORFs for the Angomonas deanei and Strigomonas culicis endosymbionts, respectively, and indicate that these organisms hold a common ancestor related to the Alcaligenaceae family. Importantly, both symbionts contain enzymes that complement essential host cell biosynthetic pathways, such as those for amino acid, lipid and purine/pyrimidine metabolism. These findings increase our understanding of the intricate symbiotic relationship between the bacterium and the trypanosomatid host and provide clues to better understand eukaryotic cell evolution.	[Machado Motta, Maria Cristina; de Azevedo Martins, Allan Cezar; de Souza, Silvana Sant'Anna; Costa Catta-Preta, Carolina Moura; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [de Souza, Silvana Sant'Anna; Silva, Rosane; Uermenyi, Turan P.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Metab Macromol Firmino Torres de Castro, BR-21941 Rio De Janeiro, Brazil; [Klein, Cecilia Coimbra; Paula de Almeida, Luiz Gonzaga; Cunha, Oberdan de Lima; Ciapina, Luciane Prioli; Thompson, Claudia Elizabeth; Ribeiro de Vasconcelos, Ana Tereza] Lab Bioinformat, Lab Nacl Computacao Cient, Rio De Janeiro, Brazil; [Klein, Cecilia Coimbra; Sagot, Marie-France] INRIA Grenoble Rhone Alpes, BAMBOO Team, Villeurbanne, France; [Klein, Cecilia Coimbra; Sagot, Marie-France] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Brocchi, Marcelo; Lima, Bruna de Araujo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Colabardini, Ana Cristina; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, Sao Paulo, Brazil; Lab Nacl Ciencia & Tecnol Bioetano, Sao Paulo, Brazil; [Machado, Carlos Renato; de Mendonca-Neto, Rondon Pessoa; Ribeiro Teixeira, Santuza Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [de Almeida Soares, Celia Maria; Pereira, Maristela] Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil; [Probst, Christian Macagnan; Gradia, Daniela Fiori] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Biol Mol Tripanossomatideos, Curitiba, Parana, Brazil; [Probst, Christian Macagnan; Pavoni, Daniela Parada; Marchini, Fabricio Klerynton] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Genom Func, Curitiba, Parana, Brazil; [Afonso de Menezes, Claudia Beatriz; Fantinatti-Garboggini, Fabiana] Univ Estadual Campinas, Ctr Pluridisciplinar Pesquisas Quim Biol & Agr, Sao Paulo, Brazil; [Bartholomeu, Daniella Castanheira; Rodrigues-Luiz, Gabriela Flaia; de Oliveira Mendes, Tiago Antonio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Grisard, Edmundo C.; Wagner, Glauber; Stoco, Patricia H.] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Ctr Ciencias Biol, Lab Protozool & Bioinformat, Florianopolis, SC, Brazil; [Rangel Fietto, Juliana Lopes; Ferreira Maciel, Talles Eduardo] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Ctr Ciencias Biol & Saude, Vicosa, MG, Brazil; [Elias, Maria Carolina] Inst Butantan, Lab Especial Ciclo Celular, Sao Paulo, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Schenkman, Sergio] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Laboratorio Nacional de Computacao Cientifica (LNCC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Goias; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Estadual de Campinas; Universidade Federal de Minas Gerais; Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Vicosa; Instituto Butantan; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Schenkman, S (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	sschenkman@unifesp.br; atrv@lncc.br	Azevedo-Martins, Allan Cézar de/M-9298-2015; Soares, Celia/N-6395-2014; Wagner, Glauber GW/B-2369-2013; Schenkman, Sergio/A-9227-2013; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Elias, Maria QB/AAW-9284-2021; Bartholomeu, Daniella C./J-4714-2015; Pavoni, Daniela P/L-3302-2014; Motta, Maria Cristina M/I-3140-2014; Fietto, Juliana Lopes Rangel/AAY-3153-2020; Gradia, Daniela Fiori/I-8068-2012; Goldman, Gustavo Henrique/F-1848-2013; Marchini, Fabricio/ABE-4613-2020; Marchini, Fabricio/AAA-1027-2019; Vasconcelos, Ana Tereza R/I-1011-2012; Thompson, Claudia/C-3203-2014; Goldman, Maria Helena S./D-1424-2012; Menezes, Claudia Beatriz A/M-9304-2018; Fantinatti-Garboggini, Fabiana/F-3991-2012; Silva, Rosane/U-6913-2019; de Araujo Lima, Bruna/A-5961-2013; Machado, Carlos Renato/H-1043-2015; Azevedo-Martins, Allan Cézar de/AAC-6883-2022; Almeida, Luiz GP/G-5829-2012; Catta Preta, Carolina/J-2505-2014; Rodrigues-Luiz, Gabriela Flavia/AAE-4937-2020; Probst, Christian/B-8678-2009; Grisard, Edmundo C/A-7338-2015; Mendes, Tiago/AAG-1709-2021; Marchini, Fabricio K/A-4775-2009; Elias, Maria Carolina/E-9197-2015; Pereira, Maristela/AAT-5765-2021; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; MACHADO, CARLOS/AAW-1492-2020; Klein, Cecilia C/H-7019-2015; Brocchi, Marcelo/E-3723-2012; Colabardini, Ana/P-1791-2015	Azevedo-Martins, Allan Cézar de/0000-0002-9798-0636; Wagner, Glauber GW/0000-0001-5003-6595; Schenkman, Sergio/0000-0001-9353-8480; Bartholomeu, Daniella C./0000-0003-0974-7357; Pavoni, Daniela P/0000-0001-6776-4345; Fietto, Juliana Lopes Rangel/0000-0001-6122-1710; Gradia, Daniela Fiori/0000-0002-1452-5807; Goldman, Gustavo Henrique/0000-0002-2986-350X; Marchini, Fabricio/0000-0001-5695-2746; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Thompson, Claudia/0000-0003-3639-1851; Goldman, Maria Helena S./0000-0002-6786-9320; Menezes, Claudia Beatriz A/0000-0002-2595-5140; Silva, Rosane/0000-0002-2998-6999; Machado, Carlos Renato/0000-0002-8724-3165; Azevedo-Martins, Allan Cézar de/0000-0002-9798-0636; Almeida, Luiz GP/0000-0002-7124-2715; Rodrigues-Luiz, Gabriela Flavia/0000-0003-3838-1008; Probst, Christian/0000-0001-9993-6375; Grisard, Edmundo C/0000-0001-8916-8296; Mendes, Tiago/0000-0002-5569-4893; Marchini, Fabricio K/0000-0001-5695-2746; Elias, Maria Carolina/0000-0002-0501-8280; Klein, Cecilia C/0000-0001-9736-5994; Colabardini, Ana/0000-0002-2131-7969; De Araujo Lima Lagos, Bruna/0000-0003-4359-9845; Catta-Preta, Carolina/0000-0001-8983-3487; Fantinatti-Garboggini, Fabiana/0000-0002-0096-047X; Prioli Ciapina, Luciane/0000-0003-1894-3923; /0000-0002-5933-9960; Motta, Maria Cristina/0000-0002-0947-4830; Brocchi, Marcelo/0000-0002-3020-531X	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); ERC AdG SISYPHE	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ERC AdG SISYPHE	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The work of CCK as part of her PhD is funded by the ERC AdG SISYPHE coordinated by MFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Atayde VD, 2011, TRENDS PARASITOL, V27, P321, DOI 10.1016/j.pt.2011.03.002; Augusto-Pinto L, 2003, GENETICS, V164, P117; Avliyakulov NK, 2004, EUKARYOT CELL, V3, P518, DOI 10.1128/EC.3.2.518-526.2004; Barnes RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002678; BEECH PL, 1991, PROTOPLASMA, V164, P23, DOI 10.1007/BF01320812; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Brenchley R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-434; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Caffrey CR, 2011, ADV EXP MED BIOL, V712, P84, DOI 10.1007/978-1-4419-8414-2_6; CAMARGO EP, 1978, EXP PARASITOL, V46, P141, DOI 10.1016/0014-4894(78)90125-X; CAMARGO EP, 1977, NATURE, V270, P52, DOI 10.1038/270052a0; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Cavalcanti DP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-120; Cavalcanti DP, 2008, HISTOCHEM CELL BIOL, V130, P1177, DOI 10.1007/s00418-008-0450-7; Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995; CERON CR, 1979, J PROTOZOOL, V26, P479, DOI 10.1111/j.1550-7408.1979.tb04657.x; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Chen JC, 1999, J BACTERIOL, V181, P521, DOI 10.1128/JB.181.2.521-530.1999; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Correa-Da-Silva MS, 2006, PARASITOL RES, V99, P384, DOI 10.1007/s00436-006-0154-7; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; d'Avila-Levy CM, 2008, EXP PARASITOL, V118, P345, DOI 10.1016/j.exppara.2007.09.007; d'Avila-Levy CM, 2005, FEMS MICROBIOL LETT, V252, P279, DOI 10.1016/j.femsle.2005.09.012; da Silva CM, 2008, IMMUNOBIOLOGY, V213, P481, DOI 10.1016/j.imbio.2007.11.006; de Azevedo-Martins AC, 2007, FEMS MICROBIOL LETT, V275, P229, DOI 10.1111/j.1574-6968.2007.00892.x; DELEDERKREMER RM, 1995, GLYCOBIOLOGY, V5, P547, DOI 10.1093/glycob/5.6.547; Drummond AJ, 2011, GENEIOUS V5 5; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; DU YB, 1994, J BACTERIOL, V176, P3081, DOI 10.1128/JB.176.10.3081-3084.1994; DWYER DM, 1976, P NATL ACAD SCI USA, V73, P852, DOI 10.1073/pnas.73.3.852; EDWARDS C, 1984, FEMS MICROBIOL LETT, V21, P319, DOI 10.1111/j.1574-6968.1984.tb00329.x; EDWARDS C, 1982, J GEN MICROBIOL, V128, P1409; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; Fampa P, 2003, INT J PARASITOL, V33, P1019, DOI 10.1016/S0020-7519(03)00124-3; FREYMULLER E, 1981, J PROTOZOOL, V28, P175, DOI 10.1111/j.1550-7408.1981.tb02829.x; Frossard ML, 2006, BIOCHEM BIOPH RES CO, V343, P443, DOI 10.1016/j.bbrc.2006.02.168; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; Gadelha C, 2007, CELL MOTIL CYTOSKEL, V64, P629, DOI 10.1002/cm.20210; Galetovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027634; GALINARI S, 1978, EXP PARASITOL, V46, P277, DOI 10.1016/0014-4894(78)90141-8; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; GILL JW, 1963, J PROTOZOOL, V10, P148, DOI 10.1111/j.1550-7408.1963.tb01653.x; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Glover L, 2012, MOL BIOCHEM PARASIT, V183, P78, DOI 10.1016/j.molbiopara.2012.01.008; Grandgenett PM, 2007, PLOS PATHOG, V3, P1432, DOI 10.1371/journal.ppat.0030150; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Hebert L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029953; Hebert L, 2011, J BACTERIOL, V193, P1785, DOI 10.1128/JB.01547-10; Hollar L, 1998, J EUKARYOT MICROBIOL, V45, P293, DOI 10.1111/j.1550-7408.1998.tb04539.x; Huang H, 2011, ADV PARASIT, V75, P325, DOI 10.1016/B978-0-12-385863-4.00015-0; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Kim YR, 2010, ACTA ONCOL, V49, P859, DOI 10.3109/02841861003767513; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lange BMH, 1996, TRENDS CELL BIOL, V6, P348, DOI 10.1016/0962-8924(96)10033-7; Machado CR, 2006, MUTAT RES-REV MUTAT, V612, P40, DOI 10.1016/j.mrrev.2005.05.001; Motta MCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012415; Maioli TU, 2004, PARASITOL RES, V94, P207, DOI 10.1007/s00436-004-1193-6; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; MENDELZON DH, 1986, MOL BIOCHEM PARASIT, V18, P355, DOI 10.1016/0166-6851(86)90092-7; MENDELZON DH, 1986, J BIOL CHEM, V261, P2129; Mengeling BJ, 1998, CURR OPIN STRUC BIOL, V8, P572, DOI 10.1016/S0959-440X(98)80146-2; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mingorance J, 2004, J MOL RECOGNIT, V17, P481, DOI 10.1002/jmr.718; MORAES CT, 1988, BIOCHEMISTRY-US, V27, P1543, DOI 10.1021/bi00405a022; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Motta Maria Cristina M., 2010, Open Parasitology Journal, V4, P139; Motta MCM, 1997, J EUKARYOT MICROBIOL, V44, P492, DOI 10.1111/j.1550-7408.1997.tb05729.x; Motta MCM, 2004, J EUKARYOT MICROBIOL, V51, P394, DOI 10.1111/j.1550-7408.2004.tb00386.x; Motta MCM, 1997, EUR J CELL BIOL, V72, P370; MUNDIM MH, 1974, J PROTOZOOL, V21, P518, DOI 10.1111/j.1550-7408.1974.tb03691.x; Nascimento MTC, 2010, ACTA TROP, V113, P269, DOI 10.1016/j.actatropica.2009.11.010; NEWTON BA, 1956, NATURE, V177, P279, DOI 10.1038/177279b0; NEWTON BA, 1957, J GEN MICROBIOL, V17, P708, DOI 10.1099/00221287-17-3-708; Ni Y, 2007, BIOTECHNOL BIOENG, V97, P1347, DOI 10.1002/bit.21375; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; de Melo AC, 2006, INT J PARASITOL, V36, P415, DOI 10.1016/j.ijpara.2005.12.006; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; ODA LM, 1984, J PROTOZOOL, V31, P131, DOI 10.1111/j.1550-7408.1984.tb04301.x; Oppenheimer M, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/415976; Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013; Palmie-Peixoto IV, 2006, FEMS MICROBIOL LETT, V255, P33, DOI 10.1111/j.1574-6968.2005.00056.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; PLESNER L, 1995, INT REV CYTOL, V158, P141; Podlipaev SA, 2000, MEM I OSWALDO CRUZ, V95, P517, DOI 10.1590/S0074-02762000000400013; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Pyke KA, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq016; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; SALZMAN TA, 1985, INT J BIOCHEM, V17, P1343, DOI 10.1016/0020-711X(85)90058-8; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Schenkman S, 2011, ADV PARASIT, V75, P251, DOI 10.1016/B978-0-12-385863-4.00012-5; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SUGIMOTO C, 1983, CURR MICROBIOL, V9, P155, DOI 10.1007/BF01567289; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wu Y, 2001, GASTROENTEROLOGY, V120, P1580, DOI 10.1053/gast.2001.25117; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; XU CX, 1993, P NATL ACAD SCI USA, V90, P1786, DOI 10.1073/pnas.90.5.1786; Yao CQ, 2010, PROTEOM CLIN APPL, V4, P4, DOI 10.1002/prca.200900050; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	122	48	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60209	10.1371/journal.pone.0060209	http://dx.doi.org/10.1371/journal.pone.0060209			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560078	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100054
J	Kase, ET; Nikolic, N; Bakke, SS; Bogen, KK; Aas, V; Thoresen, GH; Rustan, AC				Kase, Eili Tranheim; Nikolic, Natasa; Bakke, Siril Skaret; Bogen, Kaja Kamilla; Aas, Vigdis; Thoresen, G. Hege; Rustan, Arild Christian			Remodeling of Oxidative Energy Metabolism by Galactose Improves Glucose Handling and Metabolic Switching in Human Skeletal Muscle Cells	PLOS ONE			English	Article							DIABETIC SUBJECTS; FAT OXIDATION; TRANSPORT; MYOTUBES; ORIGIN; ACID	Cultured human myotubes have a low mitochondrial oxidative potential. This study aims to remodel energy metabolism in myotubes by replacing glucose with galactose during growth and differentiation to ultimately examine the consequences for fatty acid and glucose metabolism. Exposure to galactose showed an increased [C-14] oleic acid oxidation, whereas cellular uptake of oleic acid uptake was unchanged. On the other hand, both cellular uptake and oxidation of [C-14] glucose increased in myotubes exposed to galactose. In the presence of the mitochondrial uncoupler carbonylcyanide p-trifluormethoxy-phenylhydrazone (FCCP) the reserve capacity for glucose oxidation was increased in cells grown with galactose. Staining and live imaging of the cells showed that myotubes exposed to galactose had a significant increase in mitochondrial and neutral lipid content. Suppressibility of fatty acid oxidation by acute addition of glucose was increased compared to cells grown in presence of glucose. In summary, we show that cells grown in galactose were more oxidative, had increased oxidative capacity and higher mitochondrial content, and showed an increased glucose handling. Interestingly, cells exposed to galactose showed an increased suppressibility of fatty acid metabolism. Thus, galactose improved glucose metabolism and metabolic switching of myotubes, representing a cell model that may be valuable for metabolic studies related to insulin resistance and disorders involving mitochondrial impairments.	[Kase, Eili Tranheim; Nikolic, Natasa; Bakke, Siril Skaret; Bogen, Kaja Kamilla; Thoresen, G. Hege; Rustan, Arild Christian] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Aas, Vigdis] Oslo & Akershus Univ Coll Appl Sci, Inst Pharm & Biomed Lab Sci, Oslo, Norway; [Thoresen, G. Hege] Univ Oslo, Fac Med, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Thoresen, G. Hege] Oslo Univ Hosp, Oslo, Norway	University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Kase, ET (corresponding author), Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway.	e.t.kase@farmasi.uio.no	, Natasa/X-3265-2019	, Natasa/0000-0001-9614-9050	University of Oslo from the Norwegian Research Council; Norwegian Diabetes Foundation; Freia Chocolate Factory Medical Foundation; Anders Jahre's Foundation	University of Oslo from the Norwegian Research Council; Norwegian Diabetes Foundation; Freia Chocolate Factory Medical Foundation; Anders Jahre's Foundation	This work was supported by University of Oslo and grants from the Norwegian Research Council, the Norwegian Diabetes Foundation, Freia Chocolate Factory Medical Foundation and the Anders Jahre's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Bosma M, 2012, PROG LIPID RES, V51, P36, DOI 10.1016/j.plipres.2011.11.003; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandra D, 1807, BIOCH BIOPHYS ACTA, P620; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Hessvik NP, 2012, J STEROID BIOCHEM, V128, P154, DOI 10.1016/j.jsbmb.2011.10.006; Hessvik NP, AM J PHYSL ENDOCRINO, V298, pE602; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kitzmann M, 2011, BBA-MOL BASIS DIS, V1812, P423, DOI 10.1016/j.bbadis.2010.12.007; Mantzaris MD, 2011, FEBS J, V278, P519, DOI 10.1111/j.1742-4658.2010.07972.x; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Martineau LC, 2012, BBA-GEN SUBJECTS, V1820, P133, DOI 10.1016/j.bbagen.2011.11.012; Nikolic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033203; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; SHINBUEHRING YS, 1977, PEDIATR RES, V11, P1045, DOI 10.1203/00006450-197710000-00004; Sparks LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021068; Thoresen GH, 2011, PROSTAG LEUKOTR ESS, V85, P227, DOI 10.1016/j.plefa.2011.04.017; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Voet D., 1995, BIOCHEMISTRY; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; ZUURVELD JGEM, 1985, BIOCHIM BIOPHYS ACTA, V844, P1, DOI 10.1016/0167-4889(85)90226-5	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59972	10.1371/journal.pone.0059972	http://dx.doi.org/10.1371/journal.pone.0059972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560061	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900037
J	Greulich, S; Chen, WJY; Maxhera, B; Rijzewijk, LJ; van der Meer, RW; Jonker, JT; Mueller, H; de Wiza, DH; Floerke, RR; Smiris, K; Lamb, HJ; de Roos, A; Bax, JJ; Romijn, JA; Smit, JWA; Akhyari, P; Lichtenberg, A; Eckel, J; Diamant, M; Ouwens, DM				Greulich, Sabrina; Chen, Weena J. Y.; Maxhera, Bujar; Rijzewijk, Luuk J.; van der Meer, Rutger W.; Jonker, Jacqueline T.; Mueller, Heidi; de Wiza, Daniella Herzfeld; Floerke, Ralf-Ruediger; Smiris, Konstantinos; Lamb, Hildo J.; de Roos, Albert; Bax, Jeroen J.; Romijn, Johannes A.; Smit, Jan W. A.; Akhyari, Payam; Lichtenberg, Artur; Eckel, Juergen; Diamant, Michaela; Ouwens, D. Margriet			Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies	PLOS ONE			English	Article							MYOCARDIAL SUBSTRATE METABOLISM; ADIPOSE-TISSUE; CARDIAC-FUNCTION; CIRCULATING OMENTIN; INSULIN-RESISTANCE; GENE-EXPRESSION; PIOGLITAZONE; ADIPOKINES; FAT; IDENTIFICATION	Context: Adipokines are linked to the development of cardiovascular dysfunction in type 2 diabetes (DM2). In DM2-patients, circulating levels of omentin-1, an adipokine preferentially expressed in epicardial adipose tissue, are decreased. This study investigated whether omentin-1 has a cardioprotective function. Methods: Omentin-1 levels in plasma and cardiac fat depots were determined in DM2-patients versus controls. Moreover, the relation between omentin-1 levels and cardiac function was examined in men with uncomplicated DM2. Finally, we determined whether omentin-1 could reverse the induction of cardiomyocyte dysfunction by conditioned media derived from epicardial adipose tissue from patients with DM2. Results: Omentin-1 was highly expressed and secreted by epicardial adipose tissue, and reduced in DM2. Circulating omentin-1 levels were lower in DM2 versus controls, and positively correlated with the diastolic parameters early peak filling rate, early deceleration peak and early deceleration mean (all P<0.05). The improved diastolic function following pioglitazone treatment associated with increases in omentin-1 levels (P<0.05). In vitro, exposure of cardiomyocytes to conditioned media derived from epicardial adipose tissue from patients with DM2 induced contractile dysfunction and insulin resistance, which was prevented by the addition of recombinant omentin. Conclusion: These data identify omentin-1 as a cardioprotective adipokine, and indicate that decreases in omentin-1 levels could contribute to the induction of cardiovascular dysfunction in DM2.	[Greulich, Sabrina; Mueller, Heidi; de Wiza, Daniella Herzfeld; Floerke, Ralf-Ruediger; Ouwens, D. Margriet] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [Chen, Weena J. Y.; Rijzewijk, Luuk J.; Diamant, Michaela] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Ctr Diabet, Amsterdam, Netherlands; [Maxhera, Bujar; Smiris, Konstantinos; Akhyari, Payam; Lichtenberg, Artur] Heinrich Heine Univ, Fac Med, Dept Cardiovasc Surg, Dusseldorf, Germany; [van der Meer, Rutger W.; Lamb, Hildo J.; de Roos, Albert] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Jonker, Jacqueline T.; Smit, Jan W. A.] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Bax, Jeroen J.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1012 WX Amsterdam, Netherlands; [Eckel, Juergen] German Diabet Ctr, Paul Langerhans Grp, Dusseldorf, Germany; [Ouwens, D. Margriet] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium	Deutsches Diabetes-Zentrum (DDZ); Vrije Universiteit Amsterdam; Heinrich Heine University Dusseldorf; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Deutsches Diabetes-Zentrum (DDZ); Ghent University; Ghent University Hospital	Ouwens, DM (corresponding author), German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany.	margriet.ouwens@ddz.uni-duesseldorf.de	Ouwens, Margriet/H-2442-2013; Smit, J.W.A./H-8091-2014; Lamb, Hildo/ABE-1171-2021; Akhyari, Payam/AAK-8866-2020	Ouwens, Margriet/0000-0001-6709-2702; Smit, J.W.A./0000-0003-1052-9314; Lamb, Hildo/0000-0002-6969-2418; Akhyari, Payam/0000-0002-6452-8678; Eckel, Juergen/0000-0003-3645-5288	Federal Ministry of Health; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine Westphalia; Commission of the European Communities [HEALTH F2-2008-201100]; German Centre for Diabetes Research (Deutsches Zentrum fur Diabetesforschung, DZD); Eli Lilly, The Netherlands; Medtronic; Boston Scientific; Biotronik; St. Jude Medicial; BMS Medical Imaging; Edwards Lifesciences; GE Healthcare; Amylin Pharmaceuticals Inc; Novo Nordisk; Merck; Sharp; Dohme; Sanofi	Federal Ministry of Health; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine Westphalia; Commission of the European Communities(European Commission); German Centre for Diabetes Research (Deutsches Zentrum fur Diabetesforschung, DZD); Eli Lilly, The Netherlands(Eli LillyNetherlands Government); Medtronic(Medtronic); Boston Scientific(Boston Scientific); Biotronik; St. Jude Medicial; BMS Medical Imaging; Edwards Lifesciences; GE Healthcare(General ElectricGE Healthcare); Amylin Pharmaceuticals Inc(Bristol-Myers Squibb); Novo Nordisk(Novo Nordisk); Merck(Merck & Company); Sharp; Dohme; Sanofi	This work was supported by the Federal Ministry of Health, the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine Westphalia, the Commission of the European Communities (Collaborative Project ADAPT, contract no. HEALTH F2-2008-201100), and the German Centre for Diabetes Research (Deutsches Zentrum fur Diabetesforschung, DZD). The PIRAMID study (an investigator-initiated study) was supported by Eli Lilly and Company, The Netherlands. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; JJB received grants from Medtronic, Boston Scientific, Biotronik, St. Jude Medicial, BMS Medical Imaging, Edwards Lifesciences and GE Healthcare. MD is a consultant and speaker for Eli Lilly and Company, Novo Nordisk and Merck, Sharp and Dohme and Sanofi, and a consultant for Astra-Zeneca/BMS. Through MD the VU University Medical Center in Amsterdam has received research grants from Amylin Pharmaceuticals Inc, Eli Lilly and Company, Novo Nordisk, Merck, Sharp and Dohme and Sanofi. MD receives no personal payments in connection to the above-mentioned activities, but all payments are directly transferred to the Institutional Research Foundation. The other authors have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akbarzadeh S, 2012, CYTOKINE, V58, P295, DOI 10.1016/j.cyto.2012.02.005; Auguet T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-60; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Chen WJY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-67; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Duan XY, 2011, AMINO ACIDS, V41, P1223, DOI 10.1007/s00726-010-0800-3; El-Mesallamy HO, 2011, DIABETIC MED, V28, P1194, DOI 10.1111/j.1464-5491.2011.03353.x; Esteghamati A, 2013, REGUL PEPT; Fain JN, 2008, INT J OBESITY, V32, P810, DOI 10.1038/sj.ijo.0803790; Fioravanti A, 2011, RHEUMATOL INT; Greulich S, 2012, CIRCULATION IN PRESS; Greulich S, 2011, J CELL MOL MED, V15, P2399, DOI 10.1111/j.1582-4934.2010.01232.x; Iacobellis G, 2009, J AM SOC ECHOCARDIOG, V22, P1311, DOI 10.1016/j.echo.2009.10.013; Iozzo P, 2010, NUTR METAB CARDIOVAS, V20, P147, DOI 10.1016/j.numecd.2009.08.011; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; Jonker JT, 2010, J CLIN ENDOCR METAB, V95, P456, DOI 10.1210/jc.2009-1441; Kazama K, 2012, EUR J PHARMACOL, V686, P116, DOI 10.1016/j.ejphar.2012.04.033; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Liu R, 2011, DIABETES RES CLIN PR, V93, P21, DOI 10.1016/j.diabres.2011.03.001; Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; Moro C, 2007, DIABETOLOGIA, V50, P1038, DOI 10.1007/s00125-007-0614-3; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouwens D. M., 2007, Archives of Physiology and Biochemistry, V113, P76, DOI 10.1080/13813450701422633; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Rijzewijk LJ, 2010, DIABETES, V59, P2747, DOI 10.2337/db09-1201; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; Smith U, 2001, INT J CLIN PRACT, P13; Tan BK, 2008, DIABETES, V57, P801, DOI 10.2337/db07-0990; Tan BK, 2010, DIABETES, V59, P3023, DOI 10.2337/db10-0124; Thalmann Sebastien, 2008, V456, P195, DOI 10.1007/978-1-59745-245-8_14; van der Meer RW, 2007, J CARDIOVASC MAGN R, V9, P645, DOI 10.1080/10976640601093703; van der Meer RW, 2009, CIRCULATION, V119, P2069, DOI 10.1161/CIRCULATIONAHA.108.803916; Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053; Yan P, 2011, EXP CLIN ENDOCR DIAB, V119, P257, DOI 10.1055/s-0030-1269912; Yan PJ, 2011, DIABETES RES CLIN PR, V92, P368, DOI 10.1016/j.diabres.2011.02.030; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004	38	72	78	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59697	10.1371/journal.pone.0059697	http://dx.doi.org/10.1371/journal.pone.0059697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555749	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900023
J	Bervoets, L; Knapen, D; De Jonge, M; Van Campenhout, K; Blust, R				Bervoets, Lieven; Knapen, Dries; De Jonge, Maarten; Van Campenhout, Karen; Blust, Ronny			Differential Hepatic Metal and Metallothionein Levels in Three Feral Fish Species along a Metal Pollution Gradient	PLOS ONE			English	Article							GUDGEON GOBIO-GOBIO; CARP CYPRINUS-CARPIO; FRESH-WATER; RAINBOW-TROUT; HEAVY-METALS; CONTAMINATED SEDIMENTS; CADMIUM ACCUMULATION; DIETARY-CADMIUM; TRACE-METALS; RIVER SEINE	The accumulation of cadmium, copper and zinc and the induction of metallothioneins (MT) in liver of three freshwater fish species was studied. Gudgeon (Gobio gobio), roach (Rutilus rutilus) and perch (Perca fluviatilis) were captured at 6 sampling sites along a cadmium and zinc gradient and one reference site in a tributary of the Scheldt River in Flanders (Belgium). At each site up to 10 individuals per species were collected and analyzed on their general condition factor (K), hepatosomatic index (HSI) and gonadosomatic index (GSI). From each individual fish the liver was dissected and analyzed on Cd, Cu and Zn and MT-content. Although not all species were present at each site, hepatic Cd and Zn levels generally followed the pollution gradient and highest levels were measured in perch, followed by roach and gudgeon. Nevertheless also an effect of site was observed on this order. MT-levels appeared to be the highest in gudgeon although differences with the other species were not very pronounced and depended on the site. Significant relationships were found between hepatic zinc accumulation and MT levels. For each species the ratio MTtheoretical/MTmeasured was calculated, which gives an indication of the relative capacity to induce MTs and thus immobilize the metals. Perch had the lowest capacity in inducing MTs (highest ratio). Relationships between hepatic metal levels and fish condition indices were absent or very weak.	[Bervoets, Lieven; Knapen, Dries; De Jonge, Maarten; Blust, Ronny] Univ Antwerp, Dept Biol Syst Physiol & Ecotoxicol Res, B-2020 Antwerp, Belgium; [Knapen, Dries] Univ Antwerp, Dept Vet Sci, Vet Physiol Lab, B-2020 Antwerp, Belgium; [Van Campenhout, Karen] Flemish Govt, Dept Environm & Hlth, Brussels, Belgium	University of Antwerp; University of Antwerp; Siemens AG	Bervoets, L (corresponding author), Univ Antwerp, Dept Biol Syst Physiol & Ecotoxicol Res, B-2020 Antwerp, Belgium.	lieven.bervoets@ua.ac.be	Bervoets, Lieven/E-5012-2015	Knapen, Dries/0000-0003-0472-8114	Flemish Government [VLINA/9903, VLINA/0004]; Agency for Innovation by Science and Technology	Flemish Government(European Commission); Agency for Innovation by Science and Technology	This work was sponsored by two projects of the Flemish Government (VLINA/9903 and VLINA/0004). MDJ is supported by the Agency for Innovation by Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksander-Kwaterczak U, 2009, J SOIL SEDIMENT, V9, P13, DOI 10.1007/s11368-008-0051-z; ALLENGIL SM, 1995, SCI TOTAL ENVIRON, V160-61, P653, DOI 10.1016/0048-9697(95)93634-T; Altug G, 2008, FRESEN ENVIRON BULL, V17, P24; Andres S, 2000, SCI TOTAL ENVIRON, V248, P11, DOI 10.1016/S0048-9697(99)00477-5; [Anonymous], 1999, ENV PROTECTION AGENC; Bervoets L, 2005, ENVIRON POLLUT, V138, P338, DOI 10.1016/j.envpol.2005.03.005; Bervoets L, 2003, ENVIRON POLLUT, V126, P9, DOI 10.1016/S0269-7491(03)00173-8; Bervoets L, 1998, ECOTOX ENVIRON SAFE, V41, P275, DOI 10.1006/eesa.1998.1707; Bervoets L, 2009, ECOTOX ENVIRON SAFE, V72, P720, DOI 10.1016/j.ecoenv.2008.10.008; BIENENGRABER M, 1995, ANAL BIOCHEM, V228, P69, DOI 10.1006/abio.1995.1316; Bird DJ, 2008, ENVIRON POLLUT, V151, P641, DOI 10.1016/j.envpol.2007.03.018; Blanchard M, 1999, HYDROBIOLOGIA, V400, P149, DOI 10.1023/A:1003715131607; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Canadian Council of Ministers of the Environment, 1999, CAN ENV QUAL GUID; Chowdhury MJ, 2008, ENVIRON SCI TECHNOL, V42, P1359, DOI 10.1021/es071889n; Chowdhury MJ, 2005, ARCH ENVIRON CON TOX, V48, P381, DOI 10.1007/s00244-004-0068-2; Clements WH, 1997, T AM FISH SOC, V126, P774, DOI 10.1577/1548-8659(1997)126&lt;0774:EOHMOP&gt;2.3.CO;2; Cooley HM, 2002, ARCH ENVIRON CON TOX, V43, P418, DOI 10.1007/s00244-002-1251-y; COSSON RP, 1994, BIOMETALS, V7, P9; Costa PM, 2008, ECOTOX ENVIRON SAFE, V71, P117, DOI 10.1016/j.ecoenv.2007.05.012; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; DALLINGER R, 1985, OECOLOGIA, V67, P82, DOI 10.1007/BF00378455; Dallinger R, 1997, AQUAT TOXICOL, V38, P47, DOI 10.1016/S0166-445X(96)00840-5; De Boeck G, 2003, AQUAT TOXICOL, V65, P413, DOI 10.1016/S0166-445X(03)00178-4; De Jonge M, 2011, ENVIRON SCI TECHNOL, V45, P3131, DOI 10.1021/es1037595; De Jonge M, 2010, ENVIRON POLLUT, V158, P1381, DOI 10.1016/j.envpol.2010.01.001; de la Torre FR, 2000, WATER AIR SOIL POLL, V121, P205, DOI 10.1023/A:1005243521758; De Wit M, 1998, J ANAL ATOM SPECTROM, V13, P515; DeCooman W, 1995, SOIL ENVIRONM, V5, P191; Dethloff GM, 2001, ARCH ENVIRON CON TOX, V40, P371, DOI 10.1007/s002440010185; Fabrik I, 2008, J APPL ICHTHYOL, V24, P522, DOI 10.1111/j.1439-0426.2008.01132.x; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Fernandes C, 2008, ENVIRON MONIT ASSESS, V145, P315, DOI 10.1007/s10661-007-0041-4; Flemish Government, 2000, BELGISCH STAATS 0805; Gray JS, 2002, MAR POLLUT BULL, V45, P46, DOI 10.1016/S0025-326X(01)00323-X; HOGSTRAND C, 1989, MAR ENVIRON RES, V28, P179, DOI 10.1016/0141-1136(89)90220-1; Hutchinson SM, 2008, ENVIRON POLLUT, V155, P61, DOI 10.1016/j.envpol.2007.10.033; KITO H, 1982, COMP BIOCHEM PHYS C, V73, P121, DOI 10.1016/0306-4492(82)90178-2; KLEIN D, 1994, ANAL BIOCHEM, V221, P405, DOI 10.1006/abio.1994.1434; Knapen D, 2004, AQUAT TOXICOL, V67, P155, DOI 10.1016/j.aquatox.2003.12.001; Knapen D, 2007, AQUAT TOXICOL, V82, P163, DOI 10.1016/j.aquatox.2007.02.008; Knapen D, 2009, AQUAT TOXICOL, V95, P17, DOI 10.1016/j.aquatox.2009.07.022; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; LOBONCERVIA J, 1991, J FISH BIOL, V39, P285, DOI 10.1111/j.1095-8649.1991.tb04363.x; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; Maceda-Veiga A, 2012, ECOTOX ENVIRON SAFE, V76, P93, DOI 10.1016/j.ecoenv.2011.09.013; Mieiro CL, 2011, CHEMOSPHERE, V85, P114, DOI 10.1016/j.chemosphere.2011.05.034; Nguyen HL, 2009, WATER AIR SOIL POLL, V200, P119, DOI 10.1007/s11270-008-9898-2; Olsson PE, 1997, BBA-GENE STRUCT EXPR, V1350, P325, DOI 10.1016/S0167-4781(96)00173-X; Olsvik PA, 2001, BIOMARKERS, V6, P274, DOI 10.1080/13547500010014522; Ozmen M, 2006, ECOTOXICOLOGY, V15, P157, DOI 10.1007/s10646-005-0045-1; Paris-Palacios S, 2000, COMP BIOCHEM PHYS C, V126, P113, DOI 10.1016/S0742-8413(00)00103-1; Paris-Palacios S, 2003, BIOMARKERS, V8, P128, DOI 10.1080/1354750021000050511; PEREIRA JJ, 1993, ARCH ENVIRON CON TOX, V24, P427, DOI 10.1007/BF01146157; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Reynders H, 2008, SCI TOTAL ENVIRON, V391, P82, DOI 10.1016/j.scitotenv.2007.10.056; Szarek-Gwiazda E, 2006, AQUAT ECOL, V40, P221, DOI 10.1007/s10452-004-7341-3; Teil MJ, 1996, SCI TOTAL ENVIRON, V181, P111, DOI 10.1016/0048-9697(95)04950-9; Terra BF, 2008, WATER AIR SOIL POLL, V187, P275, DOI 10.1007/s11270-007-9515-9; TESSIER A, 1984, CAN J FISH AQUAT SCI, V41, P1463, DOI 10.1139/f84-180; Van Campenhout K, 2003, ENVIRON TOXICOL CHEM, V22, P1548, DOI [10.1002/etc.5620220717, 10.1897/1551-5028(2003)22&lt;1548:MCINPO&gt;2.0.CO;2]; Van Campenhout K, 2008, SCI TOTAL ENVIRON, V394, P379, DOI 10.1016/j.scitotenv.2008.01.026; Van Campenhout K, 2010, ECOTOX ENVIRON SAFE, V73, P296, DOI 10.1016/j.ecoenv.2009.10.007; Van Campenhout K, 2009, ENVIRON TOXICOL CHEM, V28, P209, DOI 10.1897/08-136.1; Wang YM, 2010, ENVIRON MONIT ASSESS, V165, P97, DOI 10.1007/s10661-009-0929-2; Weis P, 2007, ARCH ENVIRON CON TOX, V52, P80, DOI 10.1007/s00244-006-0093-4	66	40	41	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60805	10.1371/journal.pone.0060805	http://dx.doi.org/10.1371/journal.pone.0060805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23556004	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200131
J	Gilbert, SJ; Hadjipavlou, N; Raoelison, M				Gilbert, Sam J.; Hadjipavlou, Nicola; Raoelison, Matthieu			Automaticity and Control in Prospective Memory: A Computational Model	PLOS ONE			English	Article							SPONTANEOUS RETRIEVAL; COST; REALIZATION; INTENTIONS; SWITCH; TASK	Prospective memory (PM) refers to our ability to realize delayed intentions. In event-based PM paradigms, participants must act on an intention when they detect the occurrence of a pre-established cue. Some theorists propose that in such paradigms PM responding can only occur when participants deliberately initiate processes for monitoring their environment for appropriate cues. Others propose that perceptual processing of PM cues can directly trigger PM responding in the absence of strategic monitoring, at least under some circumstances. In order to address this debate, we present a computational model implementing the latter account, using a parallel distributed processing (interactive activation) framework. In this model PM responses can be triggered directly as a result of spreading activation from units representing perceptual inputs. PM responding can also be promoted by top-down monitoring for PM targets. The model fits a wide variety of empirical findings from PM paradigms, including the effect of maintaining PM intentions on ongoing response time and the intention superiority effect. The model also makes novel predictions concerning the effect of stimulus degradation on PM performance, the shape of response time distributions on ongoing and prospective memory trials, and the effects of instructing participants to make PM responses instead of ongoing responses or alongside them. These predictions were confirmed in two empirical experiments. We therefore suggest that PM should be considered to result from the interplay between bottom-up triggering of PM responses by perceptual input, and top-down monitoring for appropriate cues. We also show how the model can be extended to simulate encoding new intentions and subsequently deactivating them, and consider links between the model's performance and results from neuroimaging.	[Gilbert, Sam J.; Hadjipavlou, Nicola; Raoelison, Matthieu] UCL, Inst Cognit Neurosci, London, England	University of London; University College London	Gilbert, SJ (corresponding author), UCL, Inst Cognit Neurosci, London, England.	sam.gilbert@ucl.ac.uk	Gilbert, Sam J./C-1909-2008; Gilbert, Sam/V-2503-2019	Gilbert, Sam J./0000-0002-3839-7045; Gilbert, Sam/0000-0002-3839-7045	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	SJG is supported by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Cohen AL, 2008, MEM COGNITION, V36, P149, DOI 10.3758/MC.36.1.149; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Freeman JE, 2003, J EXP PSYCHOL LEARN, V29, P976, DOI 10.1037/0278-7393.29.5.976; Gilbert SJ, 2012, J COGNITIVE NEUROSCI, V24, P93, DOI 10.1162/jocn_a_00094; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gilbert SJ, 2002, COGNITIVE PSYCHOL, V44, P297, DOI 10.1006/cogp.2001.0770; Goschke T, 1993, J EXP PSYCHOL LEARN, V24, P336; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Horn SS, 2011, CAN J EXP PSYCHOL, V65, P69, DOI 10.1037/a0022808; Knight JB, 2011, J EXP PSYCHOL LEARN, V37, P298, DOI 10.1037/a0021969; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Luce R. D., 1986, RESPONSE TIMES; Marsh R. L., 2008, PROSPECTIVE MEMORY C, P77; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P350, DOI 10.1037/0278-7393.24.2.350; Marsh RL, 2002, J EXP PSYCHOL LEARN, V28, P652, DOI 10.1037//0278-7393.28.4.652; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; McDaniel MA, 1998, MEM COGNITION, V26, P121, DOI 10.3758/BF03211375; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McGann D, 2003, EUR J COGN PSYCHOL, V15, P19, DOI 10.1080/09541440303598; McNerney MW, 2007, MEM COGNITION, V35, P275; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2011, NEUROPSYCHOLOGIA, V49, P2258, DOI 10.1016/j.neuropsychologia.2011.02.005; Pitt MA, 2006, PSYCHOL REV, V113, P57, DOI 10.1037/0033-295X.113.1.57; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rummel J, 2011, Q J EXP PSYCHOL, V64, P2194, DOI 10.1080/17470218.2011.586708; Scullin MK, 2012, PSYCHOL AGING, V27, P46, DOI 10.1037/a0026112; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Scullin MK, 2009, MEM COGNITION, V37, P425, DOI 10.3758/MC.37.4.425; Segalowitz N, 1999, BRAIN COGNITION, V40, P255; SEGALOWITZ NS, 1993, APPL PSYCHOLINGUIST, V14, P369, DOI 10.1017/S0142716400010845; Shallice T., 2011, ORG MIND; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2006, J EXP PSYCHOL LEARN, V32, P623, DOI 10.1037/0278-7393.32.3.623; Walser M, 2012, J EXP PSYCHOL LEARN, V38, P1030, DOI 10.1037/a0027000; West R, 2005, PSYCHON B REV, V12, P502, DOI 10.3758/BF03193795; West R, 2002, COGN AFFECT BEHAV NE, V2, P162, DOI 10.3758/CABN.2.2.162	49	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59852	10.1371/journal.pone.0059852	http://dx.doi.org/10.1371/journal.pone.0059852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555807	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200049
J	Guerrero-Bosagna, C; Savenkova, M; Haque, MM; Nilsson, E; Skinner, MK				Guerrero-Bosagna, Carlos; Savenkova, Marina; Haque, Md. Muksitul; Nilsson, Eric; Skinner, Michael K.			Environmentally Induced Epigenetic Transgenerational Inheritance of Altered Sertoli Cell Transcriptome and Epigenome: Molecular Etiology of Male Infertility	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; APOPTOSIS; BIOLOGY; NUTRITION; LACTATE; HEALTH; DIET	Environmental toxicants have been shown to induce the epigenetic transgenerational inheritance of adult onset disease, including testis disease and male infertility. The current study was designed to determine the impact of an altered sperm epigenome on the subsequent development of an adult somatic cell (Sertoli cell) that influences the onset of a specific disease (male infertility). A gestating female rat (F0 generation) was exposed to the agriculture fungicide vinclozolin during gonadal sex determination and then the subsequent F3 generation progeny used for the isolation of Sertoli cells and assessment of testis disease. As previously observed, enhanced spermatogenic cell apoptosis was observed. The Sertoli cells provide the physical and nutritional support for the spermatogenic cells. Over 400 genes were differentially expressed in the F3 generation control versus vinclozolin lineage Sertoli cells. A number of specific cellular pathways were identified to be transgenerationally altered. One of the key metabolic processes affected was pyruvate/lactate production that is directly linked to spermatogenic cell viability. The Sertoli cell epigenome was also altered with over 100 promoter differential DNA methylation regions (DMR) modified. The genomic features and overlap with the sperm DMR were investigated. Observations demonstrate that the transgenerational sperm epigenetic alterations subsequently alters the development of a specific somatic cell (Sertoli cell) epigenome and transcriptome that correlates with adult onset disease (male infertility). The environmentally induced epigenetic transgenerational inheritance of testis disease appears to be a component of the molecular etiology of male infertility.	[Guerrero-Bosagna, Carlos; Savenkova, Marina; Haque, Md. Muksitul; Nilsson, Eric; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Washington, DC USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Washington, DC USA.	skinner@wsu.edu	Savenkova, Marina/AAN-9927-2021; Nilsson, Eric/AAR-5021-2020; Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	National Institute of Health (NIH) NIEHS	National Institute of Health (NIH) NIEHS	The research was supported by a grant from the National Institute of Health (NIH) NIEHS to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bay K, 2006, BEST PRACT RES CL EN, V20, P77, DOI 10.1016/j.beem.2005.09.004; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dunkel L, 1997, CELL DEATH DIFFER, V4, P171, DOI 10.1038/sj.cdd.4400234; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Erkkila K, 2002, MOL HUM REPROD, V8, P109, DOI 10.1093/molehr/8.2.109; Esteves SC, 2012, UROLOGY, V79, P16, DOI 10.1016/j.urology.2011.08.003; Falconnet M, 2012, J COMPUT BIOL, V19, P519, DOI 10.1089/cmb.2011.0135; FAWCETT DW, 1979, PERSPECT BIOL MED, V22, pS56; Giwercman A, 2007, REPROD BIOMED ONLINE, V15, P633, DOI 10.1016/S1472-6483(10)60530-5; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; GROOTEGOED JA, 1984, BIOCHIM BIOPHYS ACTA, V767, P248, DOI 10.1016/0005-2728(84)90194-4; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hirai K, 2004, EXP CELL RES, V294, P77, DOI 10.1016/j.yexcr.2003.11.012; Holeski LM, 2012, TRENDS ECOL EVOL; Hutson JC, 2006, EXP BIOL MED, V231, P1; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Lillycrop KA, 2011, P NUTR SOC, V70, P64, DOI 10.1017/S0029665110004027; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pastuszak AW, 2012, J ANDROL; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; Raychoudhury SS, 2003, ENVIRON HEALTH PERSP, V111, P33, DOI 10.1289/ehp.5458; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Saradha B, 2006, ENVIRON TOXICOL PHAR, V21, P34, DOI 10.1016/j.etap.2005.06.004; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Thorup J, 2010, J PEDIATR SURG, V45, P2074, DOI 10.1016/j.jpedsurg.2010.07.030; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Wolstenholme JT, 2012, ENDOCRINOLOGY; Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001; Xing YL, 2007, PLOS GENET, V3, P1598, DOI 10.1371/journal.pgen.0030151; Zirkin BR, 2012, J ANDROL, V33, P1111, DOI 10.2164/jandrol.112.017160	60	88	91	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59922	10.1371/journal.pone.0059922	http://dx.doi.org/10.1371/journal.pone.0059922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555832	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200058
J	Turktas, M; Inal, B; Okay, S; Erkilic, EG; Dundar, E; Hernandez, P; Dorado, G; Unver, T				Turktas, Mine; Inal, Behcet; Okay, Sezer; Erkilic, Emine Gulden; Dundar, Ekrem; Hernandez, Pilar; Dorado, Gabriel; Unver, Turgay			Nutrition Metabolism Plays an Important Role in the Alternate Bearing of the Olive Tree (Olea europaea L.)	PLOS ONE			English	Article							MICROARRAY ANALYSIS; GENE-EXPRESSION; SEASONAL-CHANGES; BUD GROWTH; FRUIT; TRANSCRIPTOMES; NORMALIZATION; PHOSPHORUS; INDUCTION; RESPONSES	The olive tree (Olea europaea L.) is widely known for its strong tendency for alternate bearing, which severely affects the fruit yield from year to year. Microarray based gene expression analysis using RNA from olive samples (on-off years leaves and ripe-unripe fruits) are particularly useful to understand the molecular mechanisms influencing the periodicity in the olive tree. Thus, we carried out genome wide transcriptome analyses involving different organs and temporal stages of the olive tree using the NimbleGen Array containing 136,628 oligonucleotide probe sets. Cluster analyses of the genes showed that cDNAs originated from different organs could be sorted into separate groups. The nutritional control had a particularly remarkable impact on the alternate bearing of olive, as shown by the differential expression of transcripts under different temporal phases and organs. Additionally, hormonal control and flowering processes also played important roles in this phenomenon. Our analyses provide further insights into the transcript changes between ''on year'' and "off year'' leaves along with the changes from unrpipe to ripe fruits, which shed light on the molecular mechanisms underlying the olive tree alternate bearing. These findings have important implications for the breeding and agriculture of the olive tree and other crops showing periodicity. To our knowledge, this is the first study reporting the development and use of an olive array to document the gene expression profiling associated with the alternate bearing in olive tree.	[Turktas, Mine; Inal, Behcet; Okay, Sezer; Erkilic, Emine Gulden; Unver, Turgay] Cankiri Karatekin Univ, Dept Biol, Fac Sci, Cankiri, Turkey; [Dundar, Ekrem] Balikesir Univ, Dept Biol, Fac Art & Sci, Balikesir, Turkey; [Hernandez, Pilar] CSIC, IAS, Cordoba, Spain; [Dorado, Gabriel] Univ Cordoba, Dep Bioquim & Biol Mol, Cordoba, Spain	Cankiri Karatekin University; Balikesir University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Cordoba	Unver, T (corresponding author), Cankiri Karatekin Univ, Dept Biol, Fac Sci, Cankiri, Turkey.	turgayunver@gmail.com	Hernandez, Pilar/B-5996-2016; OKAY, Sezer/AAF-4394-2019; inal, Behcet/V-2583-2017; Unver, Turgay/B-4819-2009	Hernandez, Pilar/0000-0001-5166-4454; OKAY, Sezer/0000-0003-0355-6672; inal, Behcet/0000-0003-2215-2710; Unver, Turgay/0000-0001-6760-443X	TUBITAK [1090661]; MINECO (Spain) [AGL2010-17316]	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); MINECO (Spain)	TUBITAK with grant no: 1090661 and the MINECO (Spain, project number AGL2010-17316) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shdiefat SM, 2008, JORDAN J AGR SCI, V4, P12; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Baktir I, 2004, HORTSCIENCE, V39, P987, DOI 10.21273/HORTSCI.39.5.987; Ben-Gal A, 2011, IRRIGATION SCI, V29, P253, DOI 10.1007/s00271-010-0237-1; Besnard G, 2007, HEREDITY, V99, P608, DOI 10.1038/sj.hdy.6801037; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonghi C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-107; BONZON M, 1983, PLANTA, V159, P254, DOI 10.1007/BF00397533; Bouranis DL, 1999, J PLANT NUTR, V22, P245, DOI 10.1080/01904169909365623; Bustan A, 2011, TREE PHYSIOL, V31, P519, DOI 10.1093/treephys/tpr036; Dag A, 2010, SCI HORTIC-AMSTERDAM, V123, P469, DOI 10.1016/j.scienta.2009.11.014; Davey MW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-436; De la Rosa R, 2000, HORTSCIENCE, V35, P1223, DOI 10.21273/HORTSCI.35.7.1223; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Erel R, 2008, J AM SOC HORTIC SCI, V133, P639, DOI 10.21273/JASHS.133.5.639; Fenart S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-592; Fernandez-Escobar R, 1999, SCI HORTIC-AMSTERDAM, V82, P25, DOI 10.1016/S0304-4238(99)00045-X; Fernandez-Ocana A, 2010, TREE GENET GENOMES, V6, P891, DOI 10.1007/s11295-010-0299-5; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Goldschmidt E. E., 2005, Italus Hortus, V12, P11; GOLDSCHMIDT EE, 1982, J AM SOC HORTIC SCI, V107, P206; Goldschmidt EE, 1999, HORTSCIENCE, V34, P1020, DOI 10.21273/HORTSCI.34.6.1020; Grace SC, 2000, PHILOS T R SOC B, V355, P1499, DOI 10.1098/rstb.2000.0710; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES WW, 1976, PLANT PHYSIOL, V58, P681, DOI 10.1104/pp.58.5.681; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Lavee S, 1996, SCI HORTIC-AMSTERDAM, V66, P149, DOI 10.1016/S0304-4238(96)00941-7; Lavee S., 1986, HDB FRUIT SET DEV, P261; Lavee Shimon, 2007, Annales Series Historia Naturalis, V17, P101; Martin-Vertedor AI, 2011, AGR WATER MANAGE, V98, P941, DOI 10.1016/j.agwat.2011.01.002; Monselise S. P., 1984, Horticultural Reviews, V4, P128, DOI 10.1002/9781118060773.ch5; Moore S, 2005, J EXP BOT, V56, P2885, DOI 10.1093/jxb/eri283; Munoz-Fambuena N, 2011, ANN BOT-LONDON, V108, P511, DOI 10.1093/aob/mcr164; Naor A, 2013, IRRIGATION SCI, V31, P781, DOI 10.1007/s00271-012-0363-z; Ozgenturk NO, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/757512; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Pignocchi C, 2006, PLANT PHYSIOL, V141, P423, DOI 10.1104/pp.106.078469; Ramel F, 2009, ANN BOT-LONDON, V104, P1323, DOI 10.1093/aob/mcp243; Roach MJ, 2007, MOL GENET GENOMICS, V278, P149, DOI 10.1007/s00438-007-0241-1; Rosecrance RC, 1998, ANN BOT-LONDON, V82, P463, DOI 10.1006/anbo.1998.0696; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Shalom L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046930; Spann TM, 2008, TREE PHYSIOL, V28, P207, DOI 10.1093/treephys/28.2.207; STUTTE GW, 1986, J AM SOC HORTIC SCI, V111, P27; Ulger S., 1999, Turkish Journal of Agriculture & Forestry, V23, P619; Ulger S, 2004, PLANT GROWTH REGUL, V42, P89, DOI 10.1023/B:GROW.0000014897.22172.7d; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10	57	34	34	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59876	10.1371/journal.pone.0059876	http://dx.doi.org/10.1371/journal.pone.0059876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555820	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200054
J	Wigman, JTW; van Os, J; Thiery, E; Derom, C; Collip, D; Jacobs, N; Wichers, M				Wigman, Johanna T. W.; van Os, Jim; Thiery, Evert; Derom, Catherine; Collip, Dina; Jacobs, Nele; Wichers, Marieke			Psychiatric Diagnosis Revisited: Towards a System of Staging and Profiling Combining Nomothetic and Idiographic Parameters of Momentary Mental States	PLOS ONE			English	Article							ATTENUATED PSYCHOSIS SYNDROME; DAILY-LIFE STRESS; EMOTIONAL REACTIVITY; DISORDERS; DEPRESSION; RISK; PSYCHOPATHOLOGY; SCHIZOPHRENIA; DIMENSIONS; COMMUNITY	Background: Mental disorders may be reducible to sets of symptoms, connected through systems of causal relations. A clinical staging model predicts that in earlier stages of illness, symptom expression is both non-specific and diffuse. With illness progression, more specific syndromes emerge. This paper addressed the hypothesis that connection strength and connection variability between mental states differ in the hypothesized direction across different stages of psychopathology. Methods: In a general population sample of female siblings (mostly twins), the Experience Sampling Method was used to collect repeated measures of three momentary mental states (positive affect, negative affect and paranoia). Staging was operationalized across four levels of increasing severity of psychopathology, based on the total score of the Symptom Check List. Multilevel random regression was used to calculate inter-and intra-mental state connection strength and connection variability over time by modelling each momentary mental state at t as a function of the three momentary states at t-1, and by examining moderation by SCL-severity. Results: Mental states impacted dynamically on each other over time, in interaction with SCL-severity groups. Thus, SCL-90 severity groups were characterized by progressively greater inter-and intra-mental state connection strength, and greater inter-and intra-mental state connection variability. Conclusion: Diagnosis in psychiatry can be described as stages of growing dynamic causal impact of mental states over time. This system achieves a mode of psychiatric diagnosis that combines nomothetic (group-based classification across stages) and idiographic (individual-specific psychopathological profiles) components of psychopathology at the level of momentary mental states impacting on each other over time.	[Wigman, Johanna T. W.; van Os, Jim; Collip, Dina; Jacobs, Nele; Wichers, Marieke] Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands; [Wigman, Johanna T. W.] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Thiery, Evert] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium; [Derom, Catherine] Univ Hosp Leuven, Ctr Human Genet, Louvain, Belgium; [Derom, Catherine] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Jacobs, Nele] Open Univ Netherlands, Fac Psychol, Heerlen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; University of London; King's College London; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; KU Leuven; Open University Netherlands	Wigman, JTW (corresponding author), Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands.	hanneke.wigman@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Wigman, Johanna/Y-8874-2019; van Os, Jim/C-2113-2014; Wichers, Marieke/N-6667-2014	van Os, Jim/0000-0002-7245-1586; Wigman, Johanna/0000-0001-9504-4564; Wichers, Marieke/0000-0001-5024-9064; Derom, Catherine/0000-0001-5574-796X	Fund for Scientific Research, Flanders and Twins; Dutch Medical Council (VENI) [916.76.147]; European Community [HEALTH-F2-2009-241909]	Fund for Scientific Research, Flanders and Twins(FWO); Dutch Medical Council (VENI)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This research was supported by the Fund for Scientific Research, Flanders and Twins, a non-profit association for scientific research in multiple births (Belgium) (to the East Flanders Prospective Survey), the Dutch Medical Council (VENI grant number 916.76.147) (to Dr M. Wichers) and by the European Community's Seventh Framework Programme under grant agreement number HEALTH-F2-2009-241909 (Project EU-GEI). The authors thank all participants for their cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J, 1993, PSYCHOL MED, V23, P475, DOI 10.1017/S0033291700028567; Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1; Binbay T, 2012, SCHIZOPHRENIA BULL, V38, P992, DOI 10.1093/schbul/sbr003; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Carpenter WT, 2011, AM J PSYCHIAT, V168, P460, DOI 10.1176/appi.ajp.2011.10121816; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Derom CA, 2006, TWIN RES HUM GENET, V9, P733, DOI 10.1375/183242706779462723; FAVA GA, 1990, J AFFECT DISORDERS, V19, P149, DOI 10.1016/0165-0327(90)90020-9; First MB., 1997, USERS GUIDE STRUCTUR; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Fusar-Poli P, 2012, LANCET, V379, P591, DOI 10.1016/S0140-6736(11)61507-9; Goldberg D, 2000, COMPR PSYCHIAT, V41, P8, DOI 10.1016/S0010-440X(00)80002-4; Green C, 2006, BRIT J CLIN PSYCHOL, V45, P561, DOI 10.1348/014466506X98768; Haslam N, 2011, PSYCHOL MED, V1, P1; Jackson A, 2003, J AFFECT DISORDERS, V74, P209, DOI 10.1016/S0165-0327(02)00266-5; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Kendler KS, 2011, PSYCHOL MED, V41, P1143, DOI 10.1017/S0033291710001844; Kendler KS, 2005, AM J PSYCHIAT, V162, P433, DOI 10.1176/appi.ajp.162.3.433; Kendler KS, 1998, AM J PSYCHIAT, V155, P172; Kramer IMA, 2012, PSYCHOL MED, V42, P283, DOI 10.1017/S0033291711001474; Kravariti E, 2012, SCHIZOPHR RES, V140, P221, DOI 10.1016/j.schres.2012.06.008; Krueger RF, 2002, BEHAV RES THER, V40, P485, DOI 10.1016/S0005-7967(02)00016-5; Maric N, 2004, SOC PSYCH PSYCH EPID, V39, P600, DOI 10.1007/s00127-004-0803-z; McGorry P, 2013, LANCET, V381, P343, DOI 10.1016/S0140-6736(12)61268-9; McGorry PD, 2007, MED J AUSTRALIA, V187, pS8, DOI 10.5694/j.1326-5377.2007.tb01327.x; McGorry PD, 2007, AM J PSYCHIAT, V164, P859, DOI 10.1176/appi.ajp.164.6.859; McGorry PD, 2006, AUST NZ J PSYCHIAT, V40, P616, DOI 10.1111/j.1440-1614.2006.01860.x; Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Regeer EJ, 2006, PSYCHOL MED, V36, P619, DOI 10.1017/S0033291705006823; Regeer EJ, 2009, INT J METH PSYCH RES, V18, P279, DOI 10.1002/mpr.290; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Tijssen MJA, 2010, PSYCHOL MED, V40, P289, DOI 10.1017/S0033291709006138; van Os J, 2012, SCHIZOPHRENIA BULL, V38, P227, DOI 10.1093/schbul/sbr188; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; Wardenaar KJ, 2011, BIOL PSYCHIAT, V69, P366, DOI 10.1016/j.biopsych.2010.09.005; Whittington JE, 1996, PSYCHOL MED, V26, P1253, DOI 10.1017/S0033291700035972; Wichers M, 2007, BRIT J PSYCHIAT, V191, P218, DOI 10.1192/bjp.bp.106.032201; Wichers M, 2012, BRIT J CLIN PSYCHOL, V51, P206, DOI 10.1111/j.2044-8260.2011.02021.x; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	44	59	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59559	10.1371/journal.pone.0059559	http://dx.doi.org/10.1371/journal.pone.0059559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555706	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200027
J	Yague, P; Rodriguez-Garcia, A; Lopez-Garcia, MT; Martin, JF; Rioseras, B; Sanchez, J; Manteca, A				Yaguee, Paula; Rodriguez-Garcia, Antonio; Lopez-Garcia, Maria T.; Martin, Juan F.; Rioseras, Beatriz; Sanchez, Jesus; Manteca, Angel			Transcriptomic Analysis of Streptomyces coelicolor Differentiation in Solid Sporulating Cultures: First Compartmentalized and Second Multinucleated Mycelia Have Different and Distinctive Transcriptomes	PLOS ONE			English	Article							CPK GENE-CLUSTER; ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; SPORE GERMINATION; RNA; BIOSYNTHESIS; EXPRESSION; A3(2)	Streptomycetes are very important industrial bacteria, which produce two thirds of all clinically relevant secondary metabolites. They have a complex developmental-cycle in which an early compartmentalized mycelium (MI) differentiates to a multinucleated mycelium (MII) that grows inside the culture medium (substrate mycelium) until it starts to growth into the air (aerial mycelium) and ends up forming spores. Streptomyces developmental studies have focused mainly on the later stages of MII differentiation (aerial mycelium and sporulation), with regulation of pre-sporulation stages (MI/MII transition) essentially unknown. This work represents the first study of the Streptomyces MI transcriptome, analyzing how it differs from the MII transcriptome. We have used a very conservative experimental approach to fractionate MI from MII and quantify gene expressions. The expression of well characterized key developmental/metabolic genes involved in bioactive compound production (actinorhodin, undecylprodigiosin, calcium-dependent antibiotic, cpk, geosmin) or hydrophobic cover formation-sporulation (bld, whi, wbl, rdl, chp, ram) was correlated with MII differentiation. Additionally, 122 genes conserved in the Streptomyces genus, whose biological function had not been previously characterized, were found to be differentially expressed (more than 4-fold) in MI or MII. These genes encoded for putative regulatory proteins (transcriptional regulators, kinases), as well as hypothetical proteins. Knowledge about differences between the MI (vegetative) and MII (reproductive) transcriptomes represents a huge advance in Streptomyces biology that will make future experiments possible aimed at characterizing the biochemical pathways controlling pre-sporulation developmental stages and activation of secondary metabolism in Streptomyces.	[Yaguee, Paula; Lopez-Garcia, Maria T.; Rioseras, Beatriz; Sanchez, Jesus; Manteca, Angel] Univ Oviedo, Dept Biol Func, Area Microbiol, Oviedo, Spain; [Yaguee, Paula; Lopez-Garcia, Maria T.; Rioseras, Beatriz; Sanchez, Jesus; Manteca, Angel] Univ Oviedo, IUBA, Oviedo, Spain; [Rodriguez-Garcia, Antonio; Martin, Juan F.] Inst Biotecnol Leon INBIOTEC, Leon, Spain	University of Oviedo; University of Oviedo	Manteca, A (corresponding author), Univ Oviedo, Dept Biol Func, Area Microbiol, Oviedo, Spain.	mantecaangel@uniovi.es	Rioseras de Bustos, Beatriz/H-1522-2015; Manteca-Fernandez, Angel/L-9699-2018; Yagüe, Paula/AAT-3011-2020; Menéndez, Paula Yagüe/H-1496-2015; López, Maite/G-9944-2015; Rodríguez-García, Antonio/A-9461-2011	Manteca-Fernandez, Angel/0000-0001-8001-8988; Yagüe, Paula/0000-0003-1526-3121; Menéndez, Paula Yagüe/0000-0003-1526-3121; López, Maite/0000-0001-8170-1316; Rodríguez-García, Antonio/0000-0001-8118-9762	Subdireccion General de Proyectos de Investigacion, (DGI), Ministry of Science and Innovation (MICINN), Spain [BIO2010-16303]; ERC [280304]	Subdireccion General de Proyectos de Investigacion, (DGI), Ministry of Science and Innovation (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)); ERC(European Research Council (ERC)European Commission)	This research was funded by grant BIO2010-16303 from the Subdireccion General de Proyectos de Investigacion, (DGI), Ministry of Science and Innovation (MICINN), Spain; and by an ERC Starting Grant (Strp-differentiation 280304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa JA, 2010, ANTON LEEUW INT J G, V98, P225, DOI 10.1007/s10482-010-9443-3; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bucca G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r5; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; de Jong W, 2009, MOL MICROBIOL, V71, P1591, DOI 10.1111/j.1365-2958.2009.06633.x; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Gatewood ML, 2012, J BACTERIOL, V194, P2228, DOI 10.1128/JB.06541-11; Gomez-Escribano JP, 2012, CHEM SCI, V3, P2716, DOI 10.1039/c2sc20410j; Gottelt M, 2010, MICROBIOL-SGM, V156, P2343, DOI 10.1099/mic.0.038281-0; GRUND AD, 1985, J GEN MICROBIOL, V131, P833; GUIJARRO J A, 1983, Canadian Journal of Microbiology, V29, P637; HARDISSON C, 1978, J GEN MICROBIOL, V105, P203, DOI 10.1099/00221287-105-2-203; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hesketh A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-261; HIRSCH CF, 1976, J BACTERIOL, V126, P13, DOI 10.1128/JB.126.1.13-23.1976; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manteca A, 2006, RES MICROBIOL, V157, P143, DOI 10.1016/j.resmic.2005.07.003; Manteca A, 2008, APPL ENVIRON MICROB, V74, P3877, DOI 10.1128/AEM.02715-07; Manteca A, 2010, J PROTEOME RES, V9, P4801, DOI 10.1021/pr100513p; Manteca A, 2010, MOL CELL PROTEOMICS, V9, P1423, DOI 10.1074/mcp.M900449-MCP200; Manteca A, 2009, APPL ENVIRON MICROB, V75, P2920, DOI 10.1128/AEM.02288-08; MIKULIK K, 1984, EUR J BIOCHEM, V145, P381, DOI 10.1111/j.1432-1033.1984.tb08565.x; Nieselt K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-10; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; NOVELLA IS, 1992, CAN J MICROBIOL, V38, P769, DOI 10.1139/m92-125; Ou XJ, 2008, ACTA BIOCH BIOPH SIN, V40, P877, DOI 10.1111/j.1745-7270.2008.00466.x; Pawlik K, 2010, J MOL MICROB BIOTECH, V19, P147, DOI 10.1159/000321501; Piette A, 2005, J PROTEOME RES, V4, P1699, DOI 10.1021/pr050155b; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Strakova E, 2013, J PROTEOME RES, V12, P525, DOI 10.1021/pr300980v	32	33	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60665	10.1371/journal.pone.0060665	http://dx.doi.org/10.1371/journal.pone.0060665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555999	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200127
J	He, W; Wang, W; Han, HM; Wang, L; Zhang, G; Gao, B				He, Wen; Wang, Wei; Han, Huamin; Wang, Lei; Zhang, Ge; Gao, Bin			Molecular Basis of Live-Attenuated Influenza Virus	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; PROTECTIVE IMMUNITY; VACCINE STRAINS; REPLICATION; INFECTION; GENERATION; MUTATIONS; STABILITY; RESPONSES; CHILDREN	Human influenza is a seasonal disease associated with significant morbidity and mortality. The most effective means for controlling infection and thereby reducing morbidity and mortality is vaccination with a three inactivated influenza virus strains mixture, or by intranasal administration of a group of three different live attenuated influenza vaccine strains. Comparing to the inactivated vaccine, the attenuated live viruses allow better elicitation of a long-lasting and broader immune (humoral and cellular) response that represents a naturally occurring transient infection. The cold-adapted (ca) influenza A/AA/6/60 (H2N2) (AA ca) virus is the backbone for the live attenuated trivalent seasonal influenza vaccine licensed in the United States. Similarly, the influenza A components of live-attenuated vaccines used in Russia have been prepared as reassortants of the cold-adapted (ca) H2N2 viruses, A/Leningrad/134/17/57-ca (Len/17) and A/Leningrad/134/47/57-ca (Len/47) along with virulent epidemic strains. However, the mechanism of temperature-sensitive attenuation is largely elusive. To understand how modification at genetic level of influenza virus would result in attenuation of human influenza virus A/PR/8/34 (H1N1,A/PR8), we investigated the involvement of key mutations in the PB1 and/or PB2 genes in attenuation of influenza virus in vitro and in vivo. We have demonstrated that a few of residues in PB1 and PB2 are critical for the phenotypes of live attenuated, temperature sensitive influenza viruses by minigenome assay and real-time PCR. The information of these mutation loci could be used for elucidation of mechanism of temperature-sensitive attenuation and as a new strategy for influenza vaccine development.	[He, Wen; Wang, Wei; Han, Huamin; Wang, Lei; Zhang, Ge; Gao, Bin] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [He, Wen] Hebei Key Lab Med Biotechnol, Shijiazhuang, Peoples R China; [Wang, Wei; Wang, Lei; Zhang, Ge] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China; [Gao, Bin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gao, B (corresponding author), Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	bgao2004@gmail.com			National Science and Technology Major Project [2008ZX10003-012, 2009ZX 1004-305]; National Natural Science Foundation of China (NSFC) [81021003]; NSFC [31070783]	National Science and Technology Major Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Science and Technology Major Project (grant No. 2008ZX10003-012), National Natural Science Foundation of China (NSFC, grant No. 81021003), National Science and Technology Major Project (grant No. 2009ZX 1004-305) and NSFC (grant No. 31070783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Cha TA, 2000, J CLIN MICROBIOL, V38, P839, DOI 10.1128/JCM.38.2.839-845.2000; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; FLEISCHER B, 1985, J IMMUNOL, V135, P2800; Gendon Yu. Z., 2001, Voprosy Virusologii, V46, P5; GHENDON YZ, 1984, INFECT IMMUN, V44, P730, DOI 10.1128/IAI.44.3.730-733.1984; He W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-538; Isakova-Sivak I, 2011, VIROLOGY, V412, P297, DOI 10.1016/j.virol.2011.01.004; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kendal AP, 1997, EUR J EPIDEMIOL, V13, P591, DOI 10.1023/A:1007327505862; Klimov AI, 2001, INT CONGR SER, V1219, P955, DOI 10.1016/S0531-5131(01)00369-7; KLIMOV AI, 1995, J GEN VIROL, V76, P1521, DOI 10.1099/0022-1317-76-6-1521; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lau YF, 2011, J VIROL, V85, P76, DOI 10.1128/JVI.01564-10; Leroux-Roels I, 2009, EXPERT REV VACCINES, V8, P401, DOI 10.1586/ERV.09.15; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; Mendelman PM, 2004, PEDIATR INFECT DIS J, V23, P1053, DOI 10.1097/01.inf.0000143643.44463.b1; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Neumann G, 2004, CURR TOP MICROBIOL, V283, P43; Nguyen HH, 1999, VIROLOGY, V254, P50, DOI 10.1006/viro.1998.9521; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; Palese Peter, 1997, Journal of Infectious Diseases, V176, pS45, DOI 10.1086/514175; SUBBARAO EK, 1995, J VIROL, V69, P5969, DOI 10.1128/JVI.69.10.5969-5977.1995; TANNOCK GA, 1984, INFECT IMMUN, V43, P457, DOI 10.1128/IAI.43.2.457-462.1984; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Zakay-Rones Z, 2010, EXPERT REV VACCINES, V9, P1423, DOI 10.1586/ERV.10.144	31	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60413	10.1371/journal.pone.0060413	http://dx.doi.org/10.1371/journal.pone.0060413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555969	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500133
J	Oikawa, T; Okamura, H; Dietrich, F; Senju, Y; Takenawa, T; Suetsugu, S				Oikawa, Tsukasa; Okamura, Hitomi; Dietrich, Franziska; Senju, Yosuke; Takenawa, Tadaomi; Suetsugu, Shiro			IRSp53 Mediates Podosome Formation via VASP in NIH-Src Cells	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; HUMAN BREAST-CANCER; STRUCTURAL BASIS; POSITIVE REGULATION; HOMOLOGY DOMAIN; ACTIN; MEMBRANE; MIGRATION; CDC42; FILOPODIA	Podosomes are cellular "`feet," characterized by F-actin-rich membrane protrusions, which drive cell migration and invasion into the extracellular matrix. Small GTPases that regulate the actin cytoskeleton, such as Cdc42 and Rac are central regulators of podosome formation. The adaptor protein IRSp53 contains an I-BAR domain that deforms membranes into protrusions and binds to Rac, a CRIB motif that interacts with Cdc42, an SH3 domain that binds to many actin cytoskeletal regulators with proline-rich peptides including VASP, and the C-terminal variable region by splicing. However, the role of IRSp53 and VASP in podosome formation had been unclear. Here we found that the knockdown of IRSp53 by RNAi attenuates podosome formation and migration in Src-transformed NIH3T3 ( NIH-Src) cells. Importantly, the differences in the IRSp53 C-terminal splicing isoforms did not affect podosome formation. Overexpression of IRSp53 deletion mutants suggested the importance of linking small GTPases to SH3 binding partners. Interestingly, VASP physically interacted with IRSp53 in NIH-Src cells and was essential for podosome formation. These data highlight the role of IRSp53 as a linker of small GTPases to VASP for podosome formation.	[Oikawa, Tsukasa] Keio Univ, Sch Med, Lab Cell & Tissue Biol, Sinju Ku, Tokyo, Japan; [Okamura, Hitomi; Dietrich, Franziska; Senju, Yosuke; Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Dietrich, Franziska] Univ Duisburg Essen, Essen, Germany; [Takenawa, Tadaomi] Kobe Univ, Sch Med, Kobe, Hyogo 650, Japan	Keio University; University of Tokyo; University of Duisburg Essen; Kobe University	Suetsugu, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan.	suetsugu@iam.u-tokyo.ac.jp	Suetsugu, Shiro/AAF-4427-2019; Senju, Yosuke/O-7813-2015; Suetsugu, Shiro/ABB-6033-2020; Oikawa, Tsukasa/B-7718-2013; Suetsugu, Shiro/B-3300-2010	Suetsugu, Shiro/0000-0002-4612-0628; Senju, Yosuke/0000-0002-9606-3270; Oikawa, Tsukasa/0000-0003-2694-2699; Suetsugu, Shiro/0000-0002-4612-0628	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Astellas Foundation for Research on Metabolic Disorders	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders	This work was supported by grants from the Funding Program for Next Generation World-Leading Researchers (NEXT Program) and the Astellas Foundation for Research on Metabolic Disorders to S. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Crespi A, 2012, J CELL SCI, V125, P4543, DOI 10.1242/jcs.106484; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; de Groot JC, 2011, STRUCTURE, V19, P1294, DOI 10.1016/j.str.2011.06.015; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Hu LD, 2008, ONCOL REP, V19, P1015; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Mizutani K, 2002, CANCER RES, V62, P669; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Morita T, 2007, J BIOL CHEM, V282, P8454, DOI 10.1074/jbc.M609983200; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Suetsugu S, 2012, TRENDS CELL BIOL, V22, P141, DOI 10.1016/j.tcb.2012.01.001; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Vaggi F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002088; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002	43	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60528	10.1371/journal.pone.0060528	http://dx.doi.org/10.1371/journal.pone.0060528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555988	gold, Green Submitted, Green Published			2022-12-27	WOS:000317418500139
J	Pan, W; Zhou, HJ; Shen, YJ; Wang, Y; Xu, YX; Hu, Y; Jiang, YY; Yuan, ZY; Ugwu, CE; Cao, JP				Pan, Wei; Zhou, He-Jun; Shen, Yu-Juan; Wang, Ying; Xu, Yu-Xin; Hu, Yuan; Jiang, Yan-Yan; Yuan, Zhong-Ying; Ugwu, Chidiebere E.; Cao, Jian-Ping			Surveillance on the Status of Immune Cells after Echinnococcus granulosus Protoscoleces Infection in Balb/c Mice	PLOS ONE			English	Article							IMMATURE MYELOID CELLS; ECHINOCOCCUS-GRANULOSUS; SUPPRESSOR-CELLS; BONE-MARROW; T-CELLS; MECHANISMS; PROLIFERATION; HYDATIDOSIS; POPULATION; TOLERANCE	Background: Cystic echinococcosis is a global parasitic disease caused by infection with Echinococcus granulosus larvae with potentially life-threatening complications in humans. To date, the status of the immune cells believed to be associated with the pathogenicity of E. granulosus infection has not been demonstrated clearly. Methodology/Principal Findings: In this study, we developed a multiplex flow cytometry assay to investigate the systemic immune status of innate and adaptive immunity at 30, 180, 360 days post-infection (dpi) in mice infected with E. granulousus. At 30 dpi, an increase in the number of CD11b(+) and CD11c(+) antigen-presenting cells (APCs) was observed. This was accompanied by the slight down-regulated expression of the co-stimulatory molecule MHC-II, indicating the impairment of APCs in early infection through the release of secretory-excretory products. In all infected groups, we observed a significant increase in innate immune cells, including APCs and GR-1(+) cells, and a dramatic increase in the myeloid-derived suppressor cells (MDSC) expressing CD11b(+)/GR-1(+). Moreover, the upregulation of the activated markers CD69, CD44, CD40L, and the downregulation of CD62L were observed in the CD4(+) and CD8(+) T cells following infection. Regulatory T cells expressing CD4(+)/CD25(+)/FoxP(3)(+) increased significantly over the course of infection. Conclusions: Our findings demonstrate that the microenvironment in the peripheral immune system after E. granulosus infection changes in subtle but detectably ways, especially during the persistent period of infection. We found that T cells were activated following infection, but observed that the significant increase of immunosuppressive cells such as MDSC and Treg cells could inhibit T cell response to E. granulosus antigens. We suggest these cells may play a neglected but key role in the downregulation of the immune response in long-term parasitic infection. Understanding the basic functions and temporal interactions of these immunosuppressive cells will pave the way for new strategies of parasite vaccine design.	[Pan, Wei; Zhou, He-Jun; Shen, Yu-Juan; Wang, Ying; Xu, Yu-Xin; Hu, Yuan; Jiang, Yan-Yan; Yuan, Zhong-Ying; Ugwu, Chidiebere E.; Cao, Jian-Ping] World Hlth Org Collaborating Ctr Malaria Schistos, Minstry Hlth, Key Lab Parasite & Vector Biol, Chinese Ctr Dis Control & Prevent,Natl Inst Paras, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; World Health Organization	Cao, JP (corresponding author), World Hlth Org Collaborating Ctr Malaria Schistos, Minstry Hlth, Key Lab Parasite & Vector Biol, Chinese Ctr Dis Control & Prevent,Natl Inst Paras, Shanghai, Peoples R China.	caojp@yahoo.com	Cao, Jianping/AFL-5468-2022	Cao, Jianping/0000-0002-1974-0047	National Natural Science Foundation [30872212, 30901354]; National S & T Major Program [2012ZX10004-201, 2009ZX10004-201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National S & T Major Program	The study was supported by grants from the National Natural Science Foundation No. 30872212 (JC), 30901354(HZ), the National S & T Major Program No. 2012ZX10004-201 and 2009ZX10004-201(JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZSILVA M, 1993, J CELL SCI, V104, P477; Amri M, 2009, EUR CYTOKINE NETW, V20, P63, DOI 10.1684/ecn.2009.0154; ARAJ GF, 1977, Z PARASITENKD, V52, P23, DOI 10.1007/BF00380555; Battelli G, 2009, VET RES COMMUN, V33, pS47, DOI 10.1007/s11259-009-9247-y; BAZ A, 1995, IMMUNOLOGY, V84, P350; Carmena D, 2008, ZOONOSES PUBLIC HLTH, V55, P156, DOI 10.1111/j.1863-2378.2007.01100.x; Colebrook AL, 2002, PARASITOLOGY, V125, P485, DOI 10.1017/S0031182002002330; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Cotterell SEJ, 2000, BLOOD, V95, P1642, DOI 10.1182/blood.V95.5.1642.005k10_1642_1651; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dutra HS, 1998, PARASITOL RES, V84, P668, DOI 10.1007/s004360050467; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Guilliams M, 2009, J IMMUNOL, V182, P1107, DOI 10.4049/jimmunol.182.2.1107; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Justin KN, 2012, PLOS NEGLECT TROP D, V6, pe1516; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Macintyre AR, 2001, EXP PARASITOL, V99, P198, DOI 10.1006/expr.2001.4662; Mezioug D, 2009, PARASITE, V16, P57, DOI 10.1051/parasite/2009161057; Ortona E, 2003, PARASITE IMMUNOL, V25, P119, DOI 10.1046/j.1365-3024.2003.00617.x; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Rigano R, 2007, INFECT IMMUN, V75, P1667, DOI 10.1128/IAI.01156-06; ROBINSON RD, 1985, ANN TROP MED PARASIT, V79, P117, DOI 10.1080/00034983.1985.11811897; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rogan MT, 1998, PARASITE IMMUNOL, V20, P527, DOI 10.1046/j.1365-3024.1998.00180.x; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tuxun T, 2012, PARASITE IMMUNOL, V34, P520, DOI 10.1111/j.1365-3024.2012.01383.x; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Vuitton DA, 2004, GASTROEN CLIN BIOL, V28, P1122, DOI 10.1016/S0399-8320(04)95191-3; Vuitton DA, 2004, CLIN REV ALLERG IMMU, V26, P93, DOI 10.1007/s12016-004-0004-2; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	40	41	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59746	10.1371/journal.pone.0059746	http://dx.doi.org/10.1371/journal.pone.0059746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555767	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500086
J	Thiebaud, N; Da Silva, SV; Jakob, I; Sicard, G; Chevalier, J; Menetrier, F; Berdeaux, O; Artur, Y; Heydel, JM; Le Bon, AM				Thiebaud, Nicolas; Da Silva, Stephanie Veloso; Jakob, Ingrid; Sicard, Gilles; Chevalier, Joelle; Menetrier, Franck; Berdeaux, Olivier; Artur, Yves; Heydel, Jean-Marie; Le Bon, Anne-Marie			Odorant Metabolism Catalyzed by Olfactory Mucosal Enzymes Influences Peripheral Olfactory Responses in Rats	PLOS ONE			English	Article							PHEROMONE-DEGRADING ENZYME; NASAL-MUCOSA; MAMMALIAN CARBOXYLESTERASES; VERTEBRATE OLFACTION; PERIRECEPTOR EVENTS; SENSORY CILIA; RECEPTOR; TRANSPORT; LOCALIZATION; INHIBITION	A large set of xenobiotic-metabolizing enzymes (XMEs), such as the cytochrome P450 monooxygenases (CYPs), esterases and transferases, are highly expressed in mammalian olfactory mucosa (OM). These enzymes are known to catalyze the biotransformation of exogenous compounds to facilitate elimination. However, the functions of these enzymes in the olfactory epithelium are not clearly understood. In addition to protecting against inhaled toxic compounds, these enzymes could also metabolize odorant molecules, and thus modify their stimulating properties or inactivate them. In the present study, we investigated the in vitro biotransformation of odorant molecules in the rat OM and assessed the impact of this metabolism on peripheral olfactory responses. Rat OM was found to efficiently metabolize quinoline, coumarin and isoamyl acetate. Quinoline and coumarin are metabolized by CYPs whereas isoamyl acetate is hydrolyzed by carboxylesterases. Electro-olfactogram (EOG) recordings revealed that the hydroxylated metabolites derived from these odorants elicited lower olfactory response amplitudes than the parent molecules. We also observed that glucurono-conjugated derivatives induced no olfactory signal. Furthermore, we demonstrated that the local application of a CYP inhibitor on rat olfactory epithelium increased EOG responses elicited by quinoline and coumarin. Similarly, the application of a carboxylesterase inhibitor increased the EOG response elicited by isoamyl acetate. This increase in EOG amplitude provoked by XME inhibitors is likely due to enhanced olfactory sensory neuron activation in response to odorant accumulation. Taken together, these findings strongly suggest that biotransformation of odorant molecules by enzymes localized to the olfactory mucosa may change the odorant's stimulating properties and may facilitate the clearance of odorants to avoid receptor saturation.	[Thiebaud, Nicolas; Da Silva, Stephanie Veloso; Jakob, Ingrid; Chevalier, Joelle; Menetrier, Franck; Berdeaux, Olivier; Artur, Yves; Heydel, Jean-Marie; Le Bon, Anne-Marie] CNRS, UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Thiebaud, Nicolas; Da Silva, Stephanie Veloso; Jakob, Ingrid; Chevalier, Joelle; Menetrier, Franck; Berdeaux, Olivier; Artur, Yves; Heydel, Jean-Marie; Le Bon, Anne-Marie] INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France; [Thiebaud, Nicolas; Da Silva, Stephanie Veloso; Jakob, Ingrid; Chevalier, Joelle; Menetrier, Franck; Berdeaux, Olivier; Artur, Yves; Heydel, Jean-Marie; Le Bon, Anne-Marie] Univ Bourgogne, Ctr Sci Gout & Alimentat, Dijon, France; [Sicard, Gilles] Univ Aix Marseille 2, Neurobiol Interact Cellulaires & Neurophysiopatho, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; UDICE-French Research Universities; Aix-Marseille Universite	Le Bon, AM (corresponding author), CNRS, UMR6265, Ctr Sci Gout & Alimentat, Dijon, France.	lebon@dijon.inra.fr	Heydel, jean-Marie/E-5379-2017; ARTUR, Yves E/A-8504-2019; Thiebaud, Nicolas/U-5317-2017	Heydel, jean-Marie/0000-0002-6089-9922; Thiebaud, Nicolas/0000-0002-4354-7423; Le Bon, Anne Marie/0000-0001-8770-2862	Agence Nationale de la Recherche [ANR-05-PNRA-1.E7-Aromalim]; Burgundy Regional Council; French Research Ministry	Agence Nationale de la Recherche(French National Research Agency (ANR)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); French Research Ministry(Ministry of Research, France)	This work was supported by grants from the Agence Nationale de la Recherche (ANR-05-PNRA-1.E7-Aromalim) and the Burgundy Regional Council and by fellowships from the French Research Ministry (N. Thiebaud and S. Veloso Da Silva). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; BANGER KK, 1993, BIOCHEM J, V290, P199, DOI 10.1042/bj2900199; BOGDANFFY MS, 1987, TOXICOL APPL PHARM, V88, P183, DOI 10.1016/0041-008X(87)90004-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARR WES, 1990, TRENDS NEUROSCI, V13, P212, DOI 10.1016/0166-2236(90)90162-4; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; DAHL AR, 1987, TOXICOL LETT, V36, P129, DOI 10.1016/0378-4274(87)90176-7; DING X, 2003, HDB OLFACTION GUSTAT, P51; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; HABER D, 1994, XENOBIOTICA, V24, P169, DOI 10.3109/00498259409043230; Heydel JM, 2001, MOL BRAIN RES, V90, P83, DOI 10.1016/S0169-328X(01)00080-8; Hirano Y, 2003, J PHARM PHARMACOL, V55, P1667, DOI 10.1211/0022357022278; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Iyanagi T, 2007, INT REV CYTOL, V260, P35, DOI 10.1016/S0074-7696(06)60002-8; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Larsson P, 2000, TOXICOL SCI, V55, P383, DOI 10.1093/toxsci/55.2.383; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Leclerc S, 2002, MOL BRAIN RES, V107, P201, DOI 10.1016/S0169-328X(02)00455-2; LONGO V, 1988, TOXICOL LETT, V44, P289, DOI 10.1016/0378-4274(88)90168-3; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; MICO BA, 1987, DRUG METAB DISPOS, V15, P274; Minn A, 2002, J DRUG TARGET, V10, P285, DOI 10.1080/713714452; Minn AL, 2005, DRUG METAB DISPOS, V33, P1229, DOI 10.1124/dmd.105.004085; Mori I, 2005, J NEUROVIROL, V11, P129, DOI 10.1080/13550280590922793; Nagashima A, 2010, J NEUROSCI, V30, P16391, DOI 10.1523/JNEUROSCI.2527-10.2010; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; OLSON MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P307, DOI 10.1177/41.2.8419465; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; SAEKI K, 1993, BIOL PHARM BULL, V16, P232; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Schilling B, 2010, CHEMOECOLOGY, V20, P135, DOI 10.1007/s00049-009-0035-5; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Thiebaud N, 2010, DRUG METAB DISPOS, V38, P1865, DOI 10.1124/dmd.110.035014; ThorntonManning JR, 1997, MUTAT RES-FUND MOL M, V380, P43, DOI 10.1016/S0027-5107(97)00126-7; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Vassallo JD, 2003, J CHROMATOGR B, V794, P257, DOI 10.1016/S1570-0232(03)00473-2; von Weymarn LB, 2001, CHEM RES TOXICOL, V14, P1386, DOI 10.1021/tx010065v; Wadkins RM, 2005, J MED CHEM, V48, P2906, DOI 10.1021/jm049011j; Zhuo XL, 1999, J PHARMACOL EXP THER, V288, P463; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	51	50	52	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59547	10.1371/journal.pone.0059547	http://dx.doi.org/10.1371/journal.pone.0059547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555703	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500050
J	Qasim, M; Khan, I; Shafie, S				Qasim, Muhammad; Khan, Ilyas; Shafie, Sharidan			Heat Transfer in a Micropolar Fluid over a Stretching Sheet with Newtonian Heating	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MHD FLOW; MAGNETOHYDRODYNAMIC FLOW; THERMAL-RADIATION; CHEMICAL-REACTION; STAGNATION POINT; VERTICAL SURFACE; CONVECTION; DRIVEN	This article looks at the steady flow of Micropolar fluid over a stretching surface with heat transfer in the presence of Newtonian heating. The relevant partial differential equations have been reduced to ordinary differential equations. The reduced ordinary differential equation system has been numerically solved by Runge-Kutta-Fehlberg fourth-fifth order method. Influence of different involved parameters on dimensionless velocity, microrotation and temperature is examined. An excellent agreement is found between the present and previous limiting results.	[Khan, Ilyas; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia; [Qasim, Muhammad] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan	Universiti Teknologi Malaysia; COMSATS University Islamabad (CUI)	Khan, I (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia.	ilyaskhanqau@yahoo.com	SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019	SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371	Ministry of Higher Education, Research Management Center Universiti Teknologi Malaysia [4F109]	Ministry of Higher Education, Research Management Center Universiti Teknologi Malaysia	The authors would like to acknowledge the financial support received from the Ministry of Higher Education, Research Management Center Universiti Teknologi Malaysia (4F109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, INT J NONLIN MECH, V39, P1067, DOI 10.1016/S0020-7462(03)00097-0; Arifin N.M., 2007, MALAYSIAN J MATH SCI, V2, P217; Bhargava R, 2003, INT J ENG SCI, V41, P2161, DOI 10.1016/S0020-7225(03)00209-X; Chaudhary RC, 2007, J ENG PHYS THERMOPH+, V80, P954, DOI 10.1007/s10891-007-0127-4; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Desseaux A., 2000, J ANZIAM, V42, P536, DOI DOI 10.21914/ANZIAMJ.V42I0.612; Eringen A. C., 1964, INT J ENG SCI, V2, P205; ERINGEN AC, 1966, J MATH MECH, V16, P1; Eringen AC, 2001, MICROCONTINUUM FIELD; Hayat T, 2010, Z NATURFORSCH A, V65, P950, DOI 10.1515/zna-2010-1107; Ishak A, 2008, PHYS LETT A, V372, P559, DOI 10.1016/j.physleta.2007.08.003; Ishak A, 2008, COMPUT MATH APPL, V56, P3188, DOI 10.1016/j.camwa.2008.09.013; Ishak A, 2010, PHYSICA A, V389, P40, DOI 10.1016/j.physa.2009.09.008; Kandasamy R, 2005, INT J HEAT MASS TRAN, V48, P4557, DOI 10.1016/j.ijheatmasstransfer.2005.05.006; Kandasamy R., 2005, J COMPUT APPL MECH, V6, P27; Kelson NA, 2001, INT J ENG SCI, V39, P1881, DOI 10.1016/S0020-7225(01)00026-X; Lesnic D, 1999, INT J HEAT MASS TRAN, V42, P2621, DOI 10.1016/S0017-9310(98)00251-8; Lukaszewicz G., 1999, MICROPOLAR FLUIDS TH; Mahmoud MAA, 2007, PHYSICA A, V375, P401, DOI 10.1016/j.physa.2006.09.010; Makinde OD, 2012, BRAZ J CHEM ENG, V29, P159, DOI 10.1590/S0104-66322012000100017; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Nazar R, 2004, INT J NONLIN MECH, V39, P1227, DOI [10.1016/j.ijnonlinmec.2003.08.007, 10.1016/j.ijnonlinemec.2003.08.007]; Peddieson J., 1970, RECENT ADV ENGNG SCI, V5, P405; Salleh MZ, 2010, J TAIWAN INST CHEM E, V41, P651, DOI 10.1016/j.jtice.2010.01.013; Siddheshwar PG, 1998, INT J ENG SCI, V36, P1183, DOI 10.1016/S0020-7225(98)00015-9; Siddheshwar PG, 2005, INT J NONLIN MECH, V40, P807, DOI 10.1016/j.ijnonlinmec.2004.04.006; Siddheshwar PG, 2000, INT J ENG SCI, V38, P765, DOI 10.1016/S0020-7225(99)00040-3; Siddheshwar PG, 2002, AEROSP SCI TECHNOL, V6, P105, DOI 10.1016/S1270-9638(01)01144-0; Takhar HS, 2000, INT J ENG SCI, V38, P1907, DOI 10.1016/S0020-7225(00)00019-7; WILLSON AJ, 1970, PROC CAMB PHILOS S-M, V67, P469	30	87	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59393	10.1371/journal.pone.0059393	http://dx.doi.org/10.1371/journal.pone.0059393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565151	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300018
J	Nan, HM; Giovannucci, EL; Wu, KN; Selhub, J; Paul, L; Rosner, B; Fuchs, CS; Cho, E				Nan, Hongmei; Giovannucci, Edward L.; Wu, Kana; Selhub, Jacob; Paul, Ligi; Rosner, Bernard; Fuchs, Charles S.; Cho, Eunyoung			Pre-Diagnostic Leukocyte Genomic DNA Methylation and the Risk of Colorectal Cancer in Women	PLOS ONE			English	Article							ONE-CARBON METABOLISM; METHYLENETETRAHYDROFOLATE-REDUCTASE; LIQUID-CHROMATOGRAPHY; COMMON MUTATION; FOLATE STATUS; ADENOMA; HYPOMETHYLATION; POLYMORPHISM; ALCOHOL; PLASMA	Background: Abnormal one-carbon metabolism may lead to general genomic (global) hypomethylation, which may predispose an individual to the development of colorectal neoplasia. Methods: We evaluated the association between pre-diagnostic leukocyte genomic DNA methylation level and the risk of colorectal cancer in a nested case-control study of 358 colorectal cancer cases and 661 matched controls within the all-female cohort of the Nurses' Health Study (NHS). Among control subjects, we further examined major plasma components in the one-carbon metabolism pathway in relation to genomic DNA methylation level. Liquid chromatography/tandem mass spectrometry was used to examine leukocyte genomic DNA methylation level. We calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) using logistic regression. Results: Overall genomic DNA methylation level was not associated with the risk of colorectal cancer (p for trend, 0.45). Compared with women in the lowest quintile of methylation, the multivariate OR of colorectal cancer risk was 1.32 (95% CI, 0.82-2.13) for those in the highest quintile. We did not find significant associations between major plasma components of one-carbon metabolism or risk factors for colorectal cancer and genomic DNA methylation level (all p for trend >0.05). Also, neither one-carbon metabolism-related plasma components nor well-known risk factors for colorectal cancer modified the association between genomic DNA methylation level and the risk of colorectal cancer (all p for interaction >0.05). Conclusions: We found no evidence that hypomethylation of leukocyte genomic DNA increases risk of colorectal cancer among women. Additional studies are needed to investigate the association between pre-diagnostic genomic DNA methylation level and colorectal cancer risk among diverse populations.	[Nan, Hongmei] Univ Maryland, Sch Med, Div Canc Epidemiol, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Nan, Hongmei; Giovannucci, Edward L.; Rosner, Bernard; Fuchs, Charles S.; Cho, Eunyoung] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Nan, Hongmei; Giovannucci, Edward L.; Rosner, Bernard; Fuchs, Charles S.; Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Giovannucci, Edward L.; Wu, Kana] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Selhub, Jacob; Paul, Ligi] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Tufts University; United States Department of Agriculture (USDA); Harvard University; Harvard T.H. Chan School of Public Health	Cho, E (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	eunyoung.cho@channing.harvard.edu	Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582	United States National Institutes of Health [CA136950, CA55075]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA136950] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants CA136950 and CA55075 from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, MODERN PATHOL, V20, P711, DOI 10.1038/modpathol.3800822; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Breslow NE, 1987, DESIGN ANAL COHORT S, P1; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Choi SW, 1999, J NUTR, V129, P1945, DOI 10.1093/jn/129.11.1945; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Friso S, 2005, CANCER EPIDEM BIOMAR, V14, P938, DOI 10.1158/1055-9965.EPI-04-0601; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; Huang WY, 2012, PROSPECTIVE STUDY GE; Kim MS, 2008, BIOCHEM BIOPH RES CO, V370, P38, DOI 10.1016/j.bbrc.2008.03.026; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Koushik A, 2006, CANCER EPIDEM BIOMAR, V15, P2408, DOI 10.1158/1055-9965.EPI-06-0624; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Levine AJ, 2000, CANCER EPIDEM BIOMAR, V9, P657; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Lucock M, 2005, NAT REV GENET, V6, P235, DOI 10.1038/nrg1558; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Pufulete M, 2005, BRIT J CANCER, V92, P838, DOI 10.1038/sj.bjc.6602439; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; SHIN YS, 1983, CLIN CHIM ACTA, V127, P77, DOI 10.1016/0009-8981(83)90077-3; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; *USDA, 1999, USDA NUTR DAT STAND; van Bemmel D, 2012, CANCER EPIDEM BIOMAR, V21, P1143, DOI 10.1158/1055-9965.EPI-11-1030; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; van Engeland M, 2011, J CLIN ONCOL, V29, P1382, DOI 10.1200/JCO.2010.28.2319; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	42	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59455	10.1371/journal.pone.0059455	http://dx.doi.org/10.1371/journal.pone.0059455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560049	gold, Green Published			2022-12-27	WOS:000316930900017
J	Persu, A; Lambert, M; Deinum, J; Cossu, M; de Visscher, N; Irenge, L; Ambroise, J; Minon, JM; Nesterovitch, AB; Churbanov, A; Popova, IA; Danilov, SM; Danser, AHJ; Gala, JL				Persu, Alexandre; Lambert, Michel; Deinum, Jaap; Cossu, Marta; de Visscher, Nathalie; Irenge, Leonid; Ambroise, Jerome; Minon, Jean-Marc; Nesterovitch, Andrew B.; Churbanov, Alexander; Popova, Isolda A.; Danilov, Sergei M.; Danser, A. H. Jan; Gala, Jean-Luc			A Novel Splice-Site Mutation in Angiotensin I-Converting Enzyme (ACE) Gene, c.3691+1G > A (IVS25+1G > A), Causes a Dramatic Increase in Circulating ACE through Deletion of the Transmembrane Anchor	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; FAMILIAL ELEVATION; MOLECULAR-CLONING; SERUM; SARCOIDOSIS; CELLS; LOCALIZATION; STALK; DIAGNOSIS; MEMBRANE	Background: Angiotensin-converting enzyme (ACE) (EC 4.15.1) metabolizes many biologically active peptides and plays a key role in blood pressure regulation and vascular remodeling. Elevated ACE levels are associated with different cardiovascular and respiratory diseases. Methods and Results: Two Belgian families with a 8-16-fold increase in blood ACE level were incidentally identified. A novel heterozygous splice site mutation of intron 25 - IVS25+1G>A (c.3691+1G>A) - cosegregating with elevated plasma ACE was identified in both pedigrees. Messenger RNA analysis revealed that the mutation led to the retention of intron 25 and Premature Termination Codon generation. Subjects harboring the mutation were mostly normotensive, had no left ventricular hypertrophy or cardiovascular disease. The levels of renin-angiotensin-aldosterone system components in the mutated cases and wild-type controls were similar, both at baseline and after 50 mg captopril. Compared with non-affected members, quantification of ACE surface expression and shedding using flow cytometry assay of dendritic cells derived from peripheral blood monocytes of affected members, demonstrated a 50% decrease and 3-fold increase, respectively. Together with a dramatic increase in circulating ACE levels, these findings argue in favor of deletion of transmembrane anchor, leading to direct secretion of ACE out of cells. Conclusions: We describe a novel mutation of the ACE gene associated with a major familial elevation of circulating ACE, without evidence of activation of the renin-angiotensin system, target organ damage or cardiovascular complications. These data are consistent with the hypothesis that membrane-bound ACE, rather than circulating ACE, is responsible for Angiotensin II generation and its cardiovascular consequences.	[Persu, Alexandre] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Persu, Alexandre] Catholic Univ Louvain, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium; [Lambert, Michel; de Visscher, Nathalie] Catholic Univ Louvain, Clin Univ St Luc, Div Internal Med, B-1200 Brussels, Belgium; [Deinum, Jaap] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Cossu, Marta] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Cossu, Marta] Univ Med Ctr, Dept Rheumatol, Utrecht, Netherlands; [Irenge, Leonid; Ambroise, Jerome; Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Appl Mol Technol, B-1200 Brussels, Belgium; [Minon, Jean-Marc] CHR Citadelle, Dept Lab Med, Transfus & Thrombosis Haemostasis Unit, Liege, Belgium; [Nesterovitch, Andrew B.] Rush Univ, Dept Dermatol, Chicago, IL 60612 USA; [Churbanov, Alexander] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Popova, Isolda A.] Northwestern Univ, Inst Chem Life, Evanston, IL USA; [Danilov, Sergei M.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Danser, A. H. Jan] Erasmus Univ, Dept Internal Med, Div Pharmacol & Vasc Med, Rotterdam, Netherlands	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Universite Catholique Louvain; Rush University; New Mexico State University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Erasmus University Rotterdam	Persu, A (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	alexandre.persu@uclouvain.be	Danser, Jan/GLR-1479-2022; Deinum, J./L-4261-2015	Deinum, J./0000-0003-2465-1986; Nesterovitch, Andrew/0000-0002-9508-5363; Persu, Alexandre/0000-0002-4007-9695	Fonds de la Recherche Scientifique Medicale (F.R.S.M.) [3.4.587.08 F]	Fonds de la Recherche Scientifique Medicale (F.R.S.M.)(Fonds de la Recherche Scientifique - FNRS)	These studies were partially supported by the Fonds de la Recherche Scientifique Medicale (F.R.S.M.) convention number 3.4.587.08 F (to A.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; BELDENT V, 1993, J BIOL CHEM, V268, P26428; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; Churbanov A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-22; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danilov SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025952; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; Divina P, 2009, EUR J HUM GENET, V17, P759, DOI 10.1038/ejhg.2008.257; Ehlers MR, 1989, BIOCHEMISTRY-US, V8, P5311; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; ELDORRY HA, 1983, BIOCHEM BIOPH RES CO, V115, P1096, DOI 10.1016/S0006-291X(83)80048-5; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; HUBERT C, 1991, J BIOL CHEM, V266, P15377; KASAHARA Y, 1981, CLIN CHEM, V27, P1922; Klotz S, 2009, EUR HEART J, V30, P805, DOI 10.1093/eurheartj/ehp012; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Kramers C, 2003, Ned Tijdschr Geneeskd, V147, P473; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; LUISETTI M, 1990, EUR RESPIR J, V3, P441; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; OKABE T, 1985, Q J MED, V55, P55; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RYAN JW, 1975, BIOCHEM J, V146, P497, DOI 10.1042/bj1460497; Sakharov I Iu, 1991, Biokhimiia, V56, P55; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SILVERSTEIN E, 1976, ANN NY ACAD SCI, V278, P498, DOI 10.1111/j.1749-6632.1976.tb47062.x; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Sturrock ED, 2012, HDB PROTEOLYTIC ENZY, P332; Tom B, 2003, ARTERIOSCL THROM VAS, V23, P251, DOI 10.1161/01.ATV.0000051875.41849.25; von Kodolitsch Y, 1999, CIRCULATION, V100, P693, DOI 10.1161/01.CIR.100.7.693; WEI L, 1991, J BIOL CHEM, V266, P5540; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59537	10.1371/journal.pone.0059537	http://dx.doi.org/10.1371/journal.pone.0059537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560051	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900019
J	Schul, D; Schmitt, A; Regneri, J; Schartl, M; Wagner, TU				Schul, Daniela; Schmitt, Alexandra; Regneri, Janine; Schartl, Manfred; Wagner, Toni Ulrich			Bursted BMP Triggered Receptor Kinase Activity Drives Smad1 Mediated Long-Term Target Gene Oscillation in c2c12 Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; TGF-BETA; NUCLEAR EXPORT; GROWTH; SIGNAL; ACTIVATION; SPECIFICITY; MECHANISM	Bone Morphogenetic Proteins (BMPs) are important growth factors that regulate many cellular processes. During embryogenesis they act as morphogens and play a critical role during organ development. They influence cell fates via concentration-gradients in the embryos where cells transduce this extracellular information into gene expression profiles and cell fate decisions. How receiving cells decode and quantify BMP2/4 signals is hardly understood. There is little data on the quantitative relationships between signal input, transducing molecules, their states and location, and ultimately their ability to integrate graded systemic inputs and generate qualitative responses. Understanding this signaling network on a quantitative level should be considered a prerequisite for efficient pathway modulation, as the BMP pathway is a prime target for therapeutic invention. Hence, we quantified the spatial distribution of the main signal transducer of the BMP2/4 pathway in response to different types and levels of stimuli in c2c12 cells. We found that the subcellular localization of Smad1 is independent of ligand concentration. In contrast, Smad1 phosphorylation levels relate proportionally to BMP2 ligand concentrations and they are entirely located in the nucleus. Interestingly, we found that BMP2 stimulates target gene expression in non-linear, wave-like forms. Amplitudes showed a clear concentration-dependency, for sustained and transient stimulation. We found that even burst-stimulation triggers gene-expression wave-like modulations that are detectable for at least 30 h. Finally, we show here that target gene expression oscillations depend on receptor kinase activity, as the kinase drives further expression pulses without receptor reactivation and the target gene expression breaks off after inhibitor treatment in c2c12 cells.	[Schul, Daniela; Schmitt, Alexandra; Regneri, Janine; Schartl, Manfred; Wagner, Toni Ulrich] Univ Wurzburg, Wurzburg, Germany	University of Wurzburg	Wagner, TU (corresponding author), Univ Wurzburg, Wurzburg, Germany.	toni.wagner@viserion.com		Schartl, Manfred/0000-0001-9882-5948	German Research Foundation (DFG);  [GK 1048]	German Research Foundation (DFG)(German Research Foundation (DFG)); 	Funding was provided by the German Research Foundation (DFG; www.dfg.de), and GK 1048 (www.gk-1048.uni-wuerzburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Bachmann J, 2012, J INTERN MED, V271, P155, DOI 10.1111/j.1365-2796.2011.02492.x; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; CONNOR JM, 1982, J MED GENET, V19, P35, DOI 10.1136/jmg.19.1.35; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jiang S, 2010, J CELL BIOCHEM, V110, P509, DOI 10.1002/jcb.22567; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Munoz O, 2004, LEUKEMIA, V18, P2015, DOI 10.1038/sj.leu.2403485; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Peiffer DA, 2005, DEV DYNAM, V232, P445, DOI 10.1002/dvdy.20230; RAPP PE, 1981, J THEOR BIOL, V90, P531, DOI 10.1016/0022-5193(81)90304-0; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; Warmflash A, 2012, P NATL ACAD SCI USA, P1; Xiao Z, 2003, J BIOL CHEM, V278, P34245, DOI 10.1074/jbc.M301596200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22	45	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59442	10.1371/journal.pone.0059442	http://dx.doi.org/10.1371/journal.pone.0059442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560048	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900016
J	Espedido, BA; Steen, JA; Ziochos, H; Grimmond, SM; Cooper, MA; Gosbell, IB; van Hal, SJ; Jensen, SO				Espedido, Bjoern A.; Steen, Jason A.; Ziochos, Helen; Grimmond, Sean M.; Cooper, Matthew A.; Gosbell, Iain B.; van Hal, Sebastiaan J.; Jensen, Slade O.			Whole Genome Sequence Analysis of the First Australian OXA-48-Producing Outbreak-Associated Klebsiella pneumoniae Isolates: The Resistome and In Vivo Evolution	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; ANTIMICROBIAL SUSCEPTIBILITY; TRANSCRIPTIONAL REGULATOR; INTRAABDOMINAL INFECTIONS; SLYA PROTEIN; RESISTANCE; PLASMID; GENE; ENTEROBACTERIACEAE	Whole genome sequencing was used to characterize the resistome of intensive care unit (ICU) outbreak-associated carbapenem-resistant K. pneumoniae isolates. Importantly, and of particular concern, the carbapenem-hydrolyzing beta-lactamase gene bla(OXA-48) and the extended-spectrum beta-lactamase gene bla(CTX-M-14), were identified on a single broad host-range conjugative plasmid. This represents the first report of bla(OXA-48) in Australia and highlights the importance of resistance gene surveillance, as such plasmids can silently spread amongst enterobacterial populations and have the potential to drastically limit treatment options. Furthermore, the in vivo evolution of these isolates was also examined after 18 months of intra-abdominal carriage in a patient that transited through the ICU during the outbreak period. Reflecting the clonality of K. pneumoniae, only 11 single nucleotide polymorphisms (SNPs) were accumulated during this time-period and many of these were associated with genes involved in tolerance/resistance to antibiotics, metals or organic solvents, and transcriptional regulation. Collectively, these SNPs are likely to be associated with changes in virulence (at least to some extent) that have refined the in vivo colonization capacity of the original outbreak isolate.	[Espedido, Bjoern A.; Gosbell, Iain B.; van Hal, Sebastiaan J.; Jensen, Slade O.] Univ Western Sydney, Antibiot Resistance & Mobile Elements Grp, Sch Med, Penrith, NSW 1797, Australia; [Steen, Jason A.; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Steen, Jason A.; Grimmond, Sean M.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ziochos, Helen; Gosbell, Iain B.] NSW Pathol, Sydney South Western Pathol Serv, Sydney, NSW, Australia; [van Hal, Sebastiaan J.] Royal Prince Alfred Hosp, Dept Microbiol & Infect Dis, Sydney, NSW, Australia	Western Sydney University; University of Queensland; University of Queensland; University of Sydney	van Hal, SJ (corresponding author), Univ Western Sydney, Antibiot Resistance & Mobile Elements Grp, Sch Med, Penrith, NSW 1797, Australia.	sebastian.vanHal@sswahs.nsw.gov.au; s.jensen@uws.edu.au	Grimmond, Sean/K-3246-2019; Cooper, Matthew A./C-7988-2009; Grimmond, Sean M/J-5304-2016	Grimmond, Sean/0000-0002-8102-7998; Cooper, Matthew A./0000-0003-3147-3460; Grimmond, Sean M/0000-0002-8102-7998; van Hal, Sebastiaan/0000-0001-5852-4155; Jensen, Slade/0000-0003-4489-589X; Steen, Jason/0000-0003-1351-5815; Gosbell, Iain/0000-0001-5245-5152	National Health and Medical Research Council (NHMRC) Australia Fellowship [AF511105]	National Health and Medical Research Council (NHMRC) Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MAC acknowledges the support of a National Health and Medical Research Council (NHMRC) Australia Fellowship (AF511105). SMG is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2011, J ANTIMICROB CHEMOTH, V66, P2763, DOI 10.1093/jac/dkr382; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Carrer A, 2010, ANTIMICROB AGENTS CH, V54, P1369, DOI 10.1128/AAC.01312-09; Chatterji M, 2003, ARCH MICROBIOL, V180, P339, DOI 10.1007/s00203-003-0598-4; Coatsworth NR, 2012, PATHOLOGY, V44, P42, DOI 10.1097/PAT.0b013e32834e4228; Cornaglia G., 2011, Lancet Infectious Diseases, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Dutzler R, 1999, STRUCT FOLD DES, V7, P425, DOI 10.1016/S0969-2126(99)80055-0; Espedido BA, 2008, ANTIMICROB AGENTS CH, V52, P2984, DOI 10.1128/AAC.01634-07; Fritsche TR, 2008, ANTIMICROB AGENTS CH, V52, P1843, DOI 10.1128/AAC.01477-07; Hammerum AM, 2012, INT J ANTIMICROB AG, V40, P191, DOI 10.1016/j.ijantimicag.2012.05.003; Hawser SP, 2010, ANTIMICROB AGENTS CH, V54, P3043, DOI 10.1128/AAC.00265-10; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879, DOI 10.1128/AAC.40.4.879; Ho PL, 2010, J MED MICROBIOL, V59, P702, DOI 10.1099/jmm.0.015032-0; Hsueah PR, 2010, INT J ANTIMICROB AG, V36, P408, DOI 10.1016/j.ijantimicag.2010.07.002; Huang CC, 2012, INT J ANTIMICROB AG, V40, pS4, DOI 10.1016/S0924-8579(12)70003-1; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Ktari S, 2011, J ANTIMICROB CHEMOTH, V66, P1644, DOI 10.1093/jac/dkr181; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McVicker G, 2011, J BIOL CHEM, V286, P32026, DOI 10.1074/jbc.M111.266619; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P5933, DOI 10.1128/AAC.00639-11; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Philippon LN, 1997, ANTIMICROB AGENTS CH, V41, P2188, DOI 10.1128/AAC.41.10.2188; Pitart C, 2011, ANTIMICROB AGENTS CH, V55, P4398, DOI 10.1128/AAC.00329-11; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Potron A, 2012, J ANTIMICROB CHEMOTH; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; SANSCHAGRIN F, 1995, ANTIMICROB AGENTS CH, V39, P887, DOI 10.1128/AAC.39.4.887; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Sidjabat H, 2011, CLIN INFECT DIS, V52, P481, DOI 10.1093/cid/ciq178; Sidjabat HE, 2013, INT J ANTIMICROB AG, V41, P294, DOI 10.1016/j.ijantimicag.2012.11.003; Valenzuela JK, 2007, J CLIN MICROBIOL, V45, P453, DOI 10.1128/JCM.01971-06; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	41	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59920	10.1371/journal.pone.0059920	http://dx.doi.org/10.1371/journal.pone.0059920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555831	Green Published, gold			2022-12-27	WOS:000317263900041
J	Peacock, JP; Cole, JK; Murugapiran, SK; Dodsworth, JA; Fisher, JC; Moser, DP; Hedlund, BP				Peacock, Joseph P.; Cole, Jessica K.; Murugapiran, Senthil K.; Dodsworth, Jeremy A.; Fisher, Jenny C.; Moser, Duane P.; Hedlund, Brian P.			Pyrosequencing Reveals High-Temperature Cellulolytic Microbial Consortia in Great Boiling Spring after In Situ Lignocellulose Enrichment	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE ACTIVITIES; THERMOTOGA-MARITIMA; SP-NOV; THERMOSTABLE ENZYMES; GENOME SEQUENCE; HOT-SPRINGS; SWITCHGRASS; GENUS; EXPRESSION; DIVERSITY	To characterize high-temperature cellulolytic microbial communities, two lignocellulosic substrates, ammonia fiber-explosion- treated corn stover and aspen shavings, were incubated at average temperatures of 77 and 85 degrees C in the sediment and water column of Great Boiling Spring, Nevada. Comparison of 109,941 quality-filtered 16S rRNA gene pyrosequences (pyrotags) from eight enrichments to 37,057 quality-filtered pyrotags from corresponding natural samples revealed distinct enriched communities dominated by phylotypes related to cellulolytic and hemicellulolytic Thermotoga and Dictyoglomus, cellulolytic and sugar-fermenting Desulfurococcales, and sugar-fermenting and hydrogenotrophic Archaeoglobales. Minor enriched populations included close relatives of hydrogenotrophic Thermodesulfobacteria, the candidate bacterial phylum OP9, and candidate archaeal groups C2 and DHVE3. Enrichment temperature was the major factor influencing community composition, with a negative correlation between temperature and richness, followed by lignocellulosic substrate composition. This study establishes the importance of these groups in the natural degradation of lignocellulose at high temperatures and suggests that a substantial portion of the diversity of thermophiles contributing to consortial cellulolysis may be contained within lineages that have representatives in pure culture.	[Peacock, Joseph P.; Cole, Jessica K.; Murugapiran, Senthil K.; Dodsworth, Jeremy A.; Moser, Duane P.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Peacock, Joseph P.; Fisher, Jenny C.; Moser, Duane P.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Hedlund, BP (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	brian.hedlund@unlv.edu		Murugapiran, Senthil/0000-0002-6952-4713; Hedlund, Brian/0000-0001-8530-0448; Dodsworth, Jeremy/0000-0003-2014-5488	United States National Science Foundation [MCB 0546865, DBI REU 1005223]; United States Department of Energy [DE-EE-0000716]; Nevada Renewable Energy Consortium; DOE; Joint Genome Institute at the DOE [CSP-182]; Greg Fullmer through the UNLV Foundation; Div Of Biological Infrastructure [1005223] Funding Source: National Science Foundation; Office Of The Director [0968421] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Nevada Renewable Energy Consortium; DOE(United States Department of Energy (DOE)); Joint Genome Institute at the DOE; Greg Fullmer through the UNLV Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by the United States National Science Foundation grants, MCB 0546865 and DBI REU 1005223; United States Department of Energy grant DE-EE-0000716; the Nevada Renewable Energy Consortium, funded by the DOE; and the Joint Genome Institute at the DOE (CSP-182). The authors are grateful for support from Greg Fullmer through the UNLV Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh H, 2005, APPL BIOCHEM BIOTECH, V121, P1133, DOI 10.1385/ABAB:124:1-3:1133; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Anderson I, 2008, J BACTERIOL, V190, P2957, DOI 10.1128/JB.01949-07; Anderson J. P., 1978, COLO SCH MINES Q, V73, P15; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2008, 1 2 GEN BIOF TECHN O; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bringezu S, 2009, SUSTAINABLE PRODUCTI; BRONNENMEIER K, 1995, APPL ENVIRON MICROB, V61, P1399, DOI 10.1128/AEM.61.4.1399-1407.1995; Brumm P, 2011, APPL BIOCHEM BIOTECH, V163, P205, DOI 10.1007/s12010-010-9029-6; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Cole JK, 2013, ISME J, V7, P718, DOI 10.1038/ismej.2012.157; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Delucchi MA, 2010, ANN NY ACAD SCI, V1195, P28, DOI 10.1111/j.1749-6632.2010.05457.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dodsworth JA, 2011, ENVIRON MICROBIOL, V13, P2371, DOI 10.1111/j.1462-2920.2011.02508.x; Dodsworth JA, 2011, METHOD ENZYMOL, V486, P171, DOI [10.1016/S0076-6879(11)86008-8, 10.1016/B978-0-12-381294-0.00008-0]; Frock AD, 2012, APPL ENVIRON MICROB, V78, P1978, DOI 10.1128/AEM.07069-11; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hamilton-Brehm SD, 2010, APPL ENVIRON MICROB, V76, P1014, DOI 10.1128/AEM.01903-09; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hedlund BP, 2011, GEOBIOLOGY, V9, P471, DOI 10.1111/j.1472-4669.2011.00295.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Kluskens LD, 2005, FEBS J, V272, P5464, DOI 10.1111/j.1742-4658.2005.04935.x; Kluskens LD, 2003, BIOCHEM J, V370, P651, DOI 10.1042/BJ20021595; Kozubal MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00109; LAL R, 2010, SOIL QUALITY BIOFUEL; Lefevre CT, 2010, APPL ENVIRON MICROB, V76, P3740, DOI 10.1128/AEM.03018-09; Liebl W, 2001, METHOD ENZYMOL, V330, P290; Miller-Coleman RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035964; MOZHAEV VV, 1993, TRENDS BIOTECHNOL, V11, P88, DOI 10.1016/0167-7799(93)90057-G; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Oracle Corporation, 2012, MYSQL COMM ED; Patel BKC, 2010, BERGEYS MANUAL SYSTE, P775; Perevalova AA, 2005, INT J SYST EVOL MICR, V55, P995, DOI 10.1099/ijs.0.63378-0; Pysz MA, 2004, APPL ENVIRON MICROB, V70, P6098, DOI 10.1128/AEM.70.10.6098-6112.2004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; SAIKI T, 1985, INT J SYST BACTERIOL, V35, P253, DOI 10.1099/00207713-35-3-253; SCHONHEIT P, 1995, WORLD J MICROB BIOT, V11, P26, DOI 10.1007/BF00339135; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Svetlichnii V, 1988, MIKROBIOLOGIYA, P364; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; WASDE, 2012, WORLD AGR SUPPL DEM; WINDBERGER E, 1989, ARCH MICROBIOL, V151, P506, DOI 10.1007/BF00454866; Xue YM, 2006, BIOTECHNOL LETT, V28, P351, DOI 10.1007/s10529-005-5934-0; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; ZEIKUS JG, 1983, J GEN MICROBIOL, V129, P1159; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	66	31	32	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59927	10.1371/journal.pone.0059927	http://dx.doi.org/10.1371/journal.pone.0059927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555835	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900043
J	Duan, M; Yao, HH; Hu, GK; Chen, XM; Lund, AK; Buch, S				Duan, Ming; Yao, Honghong; Hu, Guoku; Chen, XianMing; Lund, Amie K.; Buch, Shilpa			HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERCELLULAR-ADHESION MOLECULE-1; NF-KAPPA-B; PROTEIN; CELLS; INVOLVEMENT; INFECTION; MICRORNAS; DISEASE; MAPK	Cardiac involvement is a well-documented complication of human immunodeficiency virus-1 (HIV-1) infection. Previous studies have demonstrated increased adhesion of monocytes to human vascular endothelial cells in HIV-infected individuals. HIV Tat protein, which is the transactivator of transcription (Tat), plays a key role in activating endothelial cells. In the present study, we demonstrated that exposure of HUVECs to HIV Tat protein resulted in induced expression of cell adhesion molecules specifically ICAM-1, leading to increased adhesion of monocytes to the endothelium. This effect of Tat was mediated through activation of mitogen-activated protein kinases and downstream transcription factor NF-kappa B. Increased expression of ICAM-1 was regulated by microRNA (miRNA) miR-221 and to some extent by miR-222, both of which are known to target ICAM-1. Functional inhibition of the respective miRNAs with anti-miR oligonucleotides resulted in induction of ICAM-1 protein in HUVECs. Furthermore, Tat-stimulated regulation of ICAM-1 via miR-221/-222 involved the NF-kappa B-dependent pathway. Functional implication and specificity of up-regulated ICAM-1 was confirmed using the ICAM-1 neutralizing antibody in the in vitro cell adhesion assays. These findings were further confirmed in vivo using the HIV transgenic (Tg) rats. These animals not only demonstrated increased expression of ICAM-1 mRNA, with a concomitant reduction in the expression of miR-221 in the aorta and heart, but also had increased expression of the ICAM-1 protein that was predominantly in the endothelial cell layer. Taken together, these findings implicate that Tat-mediated induction of ICAM-1 expression plays a critical role in monocyte adhesion observed in HIV-1-associated cardiomyopathies.	[Duan, Ming; Yao, Honghong; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Duan, Ming] Jilin Univ, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Hu, Guoku; Chen, XianMing] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Lund, Amie K.] Lovelace Resp Res Inst, Cardiopulm & Environm Toxicol Dept, Albuquerque, NM USA	University of Nebraska System; University of Nebraska Medical Center; Jilin University; Creighton University; Lovelace Respiratory Research Institute	Buch, S (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	sbuch@unmc.edu	Hu, Guoku/AAG-7233-2019; duan, ming/M-9892-2016; Lund, Amie K/L-4355-2017	Hu, Guoku/0000-0002-4792-0416; Lund, Amie K/0000-0002-0878-751X; Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA023397, DA024442, R00ES016586]; Clinical Research Center of the Mount Sinai School of Medicine [M01-RR-00071]; Lovelace Respiratory Research Institute; Nebraska Tobacco Settlement Biomedical Research; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023397, R01DA024442, R01DA020392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Research Center of the Mount Sinai School of Medicine; Lovelace Respiratory Research Institute; Nebraska Tobacco Settlement Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants MH-068212, DA020392, DA023397, DA024442 (SB) and R00ES016586 (AL) from the National Institutes of Health and by grant M01-RR-00071 from the Clinical Research Center of the Mount Sinai School of Medicine (SM) in addition to Nebraska Tobacco Settlement Biomedical Research (SB), and also Lovelace Respiratory Research Institute internal funding (AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Barbaro G, 2001, ANN NY ACAD SCI, V946, P57, DOI 10.1111/j.1749-6632.2001.tb03903.x; Barbaro G, 1998, NEW ENGL J MED, V339, P1093, DOI 10.1056/NEJM199810153391601; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; CARLOS TM, 1994, BLOOD, V84, P2068; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; CONALDI PG, 1995, J MED VIROL, V47, P355, DOI 10.1002/jmv.1890470411; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; Dhawan S, 1997, BLOOD, V90, P1535; DHAWAN S, 1995, J IMMUNOL, V154, P422; Fiala Milan, 2004, Cardiovasc Toxicol, V4, P97, DOI 10.1385/CT:4:2:097; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Ho AWY, 2008, IMMUNOBIOLOGY, V213, P533, DOI 10.1016/j.imbio.2008.01.003; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Hope SA, 2003, INTERN MED J, V33, P380, DOI 10.1046/j.1444-0903.2003.00378.x; Hu GK, 2010, AM J PHYSIOL-GASTR L, V298, pG542, DOI 10.1152/ajpgi.00490.2009; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; JANG YS, 1994, J AM COLL CARDIOL, V24, P1591, DOI 10.1016/0735-1097(94)90162-7; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Lafrenie RM, 1996, J IMMUNOL, V157, P974; Lin FS, 2005, J CELL PHYSIOL, V202, P464, DOI 10.1002/jcp.20142; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; Lund AK, 2011, AM J PHYSIOL-LUNG C, V301, pL315, DOI 10.1152/ajplung.00045.2011; Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107; Luo SF, 2010, ARTHRITIS RHEUM-US, V62, P105, DOI 10.1002/art.25060; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; Prendergast MA, 2002, BRAIN RES, V954, P300, DOI 10.1016/S0006-8993(02)03360-7; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Ren ZG, 2002, LAB INVEST, V82, P245, DOI 10.1038/labinvest.3780418; Starc TJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e14; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Vittecoq D, 2003, ADV CARDIOL, V40, P151; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xia M, 2009, ATHEROSCLEROSIS, V202, P41, DOI 10.1016/j.atherosclerosis.2008.04.005; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yunis NA, 1998, J ACQ IMMUN DEF SYND, V18, P145, DOI 10.1097/00042560-199806010-00006; Zietz C, 1996, AM J PATHOL, V149, P1887	49	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60170	10.1371/journal.pone.0060170	http://dx.doi.org/10.1371/journal.pone.0060170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555914	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200091
J	Fischer, M; Dietmann, A; Beer, R; Broessner, G; Helbok, R; Pfausler, B; Schmutzhard, E; Lackner, P				Fischer, Marlene; Dietmann, Anelia; Beer, Ronny; Broessner, Gregor; Helbok, Raimund; Pfausler, Bettina; Schmutzhard, Erich; Lackner, Peter			Differential Regulation of Matrix-Metalloproteinases and Their Tissue Inhibitors in Patients with Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							EARLY BRAIN-INJURY; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; FOCAL ISCHEMIA; BLOOD; CELL; MATRIX-METALLOPROTEINASE-9; ACTIVATION; MEDIATORS; MMP-9	Background: Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are involved in vascular remodeling, (neuro) inflammation, blood-brain barrier breakdown and neuronal apoptosis. Proinflammatory mechanisms are suggested to play an important role during early brain injury and cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH). This study aimed to analyze MMP-3, MMP-9, TIMP-1 and TIMP-3 in patients with SAH and their respective association with cerebral vasospasm (CVS). Methods: Blood samples were collected in 20 SAH patients on days 1 to 7, 9, 11, 13 and 15 and 20 healthy age and gender matched volunteers. Serum MMPs and TIMPs were analyzed using enzyme-linked immunosorbent assay. Doppler sonographic CVS was defined as a mean blood flow velocity above 120 cm/sec in the middle cerebral artery. When discharged from hospital and at 6 month follow-up neurological outcome was evaluated using the Glasgow Outcome Score and the modified Rankin Scale. Results: MMP-9 was higher in SAH patients compared to healthy controls (p<0.001). Patients with CVS (n = 11) had elevated MMP-9 serum levels compared to patients without CVS (n = 9, p<0.05). Higher MMP-9 was observed in the presence of cerebral ischemia associated with cerebral vasospasm (p<0.05). TIMP-1 was increased in patients with SAH on day 4 (p<0.05). There was an imbalance of the MMP-9/TIMP-1 ratio in favor of MMP-9 in SAH patients, in particular those with CVS (p<0.001). MMP-3 and TIMP-3 were significantly lower in SAH patients throughout day 4 and day 7, respectively (p<0.05). We did not find an association between MMP-, TIMP levels and neurological outcome after 6 months. Conclusions: MMP-3 and -9 are differentially regulated in SAH patients with both enzymes showing peak levels correlating with the development of CVS. The inhibitors TIMP-1 and -3 were low during the acute phase after SAH and increased later on which might suggest a preponderance of pro-inflammatory mechanisms.	[Fischer, Marlene; Dietmann, Anelia; Beer, Ronny; Broessner, Gregor; Helbok, Raimund; Pfausler, Bettina; Schmutzhard, Erich; Lackner, Peter] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Fischer, M (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	marlene.fischer@i-med.ac.at	Helbok, Raimund/AAA-8361-2021	Schmutzhard, Erich/0000-0003-3295-7491; Dietmann, Anelia/0000-0002-8949-0645	Medical University Innsbruck for young scientists MUI-START [2010012006]	Medical University Innsbruck for young scientists MUI-START	This work was supported by the intramural funding program of the Medical University Innsbruck for young scientists MUI-START, Project 2010012006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Broessner G, 2009, CRIT CARE MED, V37, P1886, DOI 10.1097/CCM.0b013e31819ffd7f; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Candelario-Jalil E, 2011, STROKE, V42, P1345, DOI 10.1161/STROKEAHA.110.600825; Chen KM, 2005, INT J EXP PATHOL, V86, P81, DOI 10.1111/j.0959-9673.2005.00413.x; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Chou SHY, 2011, STROKE, V42, P3624, DOI 10.1161/STROKEAHA.111.631135; Crocker SJ, 2006, J NEUROCHEM, V98, P812, DOI 10.1111/j.1471-4159.2006.03927.x; Cuzner ML, 1999, J NEUROIMMUNOL, V94, P1, DOI 10.1016/S0165-5728(98)00241-0; DORSCH NWC, 1995, BRIT J NEUROSURG, V9, P403, DOI 10.1080/02688699550041403; Fernandez-Patron C, 2001, FASEB J, V15, P2230, DOI 10.1096/fj.01-0178com; Friedrich V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-103; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Guo ZD, 2011, ACTA NEUROCHIR SUPPL, V110, P71, DOI 10.1007/978-3-7091-0353-1_13; Hansen-Schwartz J, 2007, TRENDS PHARMACOL SCI, V28, P252, DOI 10.1016/j.tips.2007.04.002; Horstmann S, 2006, J NEUROL SCI, V251, P82, DOI 10.1016/j.jns.2006.09.005; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Keyrouz SG, 2007, CRIT CARE, V11, DOI 10.1186/cc5958; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Koyama Y, 2008, BIOCHEM BIOPH RES CO, V371, P659, DOI 10.1016/j.bbrc.2008.04.064; Lee CI, 2012, MOL MED REP, V5, P118, DOI 10.3892/mmr.2011.614; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Luckman SP, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/151258; Maddahi A, 2011, J CEREBR BLOOD F MET, V31, P144, DOI 10.1038/jcbfm.2010.62; Mahmoodi M, 2005, AM J PATHOL, V166, P1733, DOI 10.1016/S0002-9440(10)62483-2; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Park SM, 2006, PROTEOMICS, V6, P1192, DOI 10.1002/pmic.200500402; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Romi F, 2012, EUR NEUROL, V67, P121, DOI 10.1159/000334862; Rosell A, 2005, STROKE, V36, P1415, DOI 10.1161/01.STR.0000170641.01047.cc; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Sherchan P, 2011, J NEUROTRAUM, V28, P2503, DOI 10.1089/neu.2011.1864; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Wang Z, 2012, J MOL NEUROSCI; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Worthmann H, 2010, CEREBROVASC DIS, V30, P85, DOI 10.1159/000314624; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	46	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59952	10.1371/journal.pone.0059952	http://dx.doi.org/10.1371/journal.pone.0059952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555845	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200061
J	Miura, K; Diakite, M; Diouf, A; Doumbia, S; Konate, D; Keita, AS; Moretz, SE; Tullo, G; Zhou, H; Lopera-Mesa, TM; Anderson, JM; Fairhurst, RM; Long, CA				Miura, Kazutoyo; Diakite, Mahamadou; Diouf, Ababacar; Doumbia, Saibou; Konate, Drissa; Keita, Abdoul S.; Moretz, Samuel E.; Tullo, Gregory; Zhou, Hong; Lopera-Mesa, Tatiana M.; Anderson, Jennifer M.; Fairhurst, Rick M.; Long, Carole A.			Relationship between Malaria Incidence and IgG Levels to Plasmodium falciparum Merozoite Antigens in Malian Children: Impact of Hemoglobins S and C	PLOS ONE			English	Article							SICKLE-CELL TRAIT; APICAL MEMBRANE ANTIGEN-1; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; IMMUNOGLOBULIN-G; IN-VITRO; INFECTED ERYTHROCYTES; ACQUIRED-IMMUNITY; SURFACE PROTEIN-1; VACCINE	Heterozygous hemoglobin (Hb) AS (sickle-cell trait) and HbAC are hypothesized to protect against Plasmodium falciparum malaria in part by enhancing naturally-acquired immunity to this disease. To investigate this hypothesis, we compared antibody levels to four merozoite antigens from the P. falciparum 3D7 clone (apical membrane antigen 1, AMA1-3D7; merozoite surface protein 1, MSP1-3D7; 175 kDa erythrocyte-binding antigen, EBA175-3D7; and merozoite surface protein 2, MSP2-3D7) in a cohort of 103 HbAA, 73 HbAS and 30 HbAC children aged 3 to 11 years in a malaria-endemic area of Mali. In the 2009 transmission season we found that HbAS, but not HbAC, significantly reduced the risk of malaria compared to HbAA. IgG levels to MSP1 and MSP2 at the start of this transmission season inversely correlated with malaria incidence after adjusting for age and Hb type. However, HbAS children had significantly lower IgG levels to EBA175 and MSP2 compared to HbAA children. On the other hand, HbAC children had similar IgG levels to all four antigens. The parasite growth-inhibitory activity of purified IgG samples did not differ significantly by Hb type. Changes in antigen-specific IgG levels during the 2009 transmission and 2010 dry seasons also did not differ by Hb type, and none of these IgG levels dropped significantly during the dry season. These data suggest that sickle-cell trait does not reduce the risk of malaria by enhancing the acquisition of IgG responses to merozoite antigens.	[Miura, Kazutoyo; Diouf, Ababacar; Moretz, Samuel E.; Tullo, Gregory; Zhou, Hong; Lopera-Mesa, Tatiana M.; Anderson, Jennifer M.; Fairhurst, Rick M.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Diakite, Mahamadou; Doumbia, Saibou; Konate, Drissa; Keita, Abdoul S.] Univ Bamako, Fac Med Pharm & Odontostomatol, Bamako, Mali	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako	Miura, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	kmiura@niaid.nih.gov; clong@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	Intramural Research Program of the National Institute of Allergy and Infectious Diseases/NIH; PATH/Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, ZIAAI001062, ZIAAI001000] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH/Malaria Vaccine Initiative(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases/NIH. The GIA Reference Center was supported by the PATH/Malaria Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; BAYOUMI RA, 1990, IMMUNOL LETT, V25, P243, DOI 10.1016/0165-2478(90)90122-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Boutlis CS, 2003, J INFECT DIS, V187, P862, DOI 10.1086/367897; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Courtin D, 2011, INFECT GENET EVOL, V11, P1287, DOI 10.1016/j.meegid.2011.04.016; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Diatta AM, 2004, CLIN DIAGN LAB IMMUN, V11, P6, DOI 10.1128/CDLI.11.1.6-11.2004; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; GILLES HM, 1967, LANCET, V1, P138; Gong L, 2012, BLOOD, V119, P3808, DOI 10.1182/blood-2011-08-371062; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Guinet F, 1997, ACTA TROP, V68, P175, DOI 10.1016/S0001-706X(97)00089-2; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kreuels B, 2010, BLOOD, V115, P4551, DOI 10.1182/blood-2009-09-241844; Le Hesran JY, 1999, INT J EPIDEMIOL, V28, P793, DOI 10.1093/ije/28.4.793; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Lopera-Mesa TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046424; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Maya DWM, 2006, EXP PARASITOL, V112, P92, DOI 10.1016/j.exppara.2005.09.014; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; Paul W, 2008, FUNDAMENTAL IMMUNOLO, P862; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; RILEY EM, 1993, PARASITE IMMUNOL, V15, P513, DOI 10.1111/j.1365-3024.1993.tb00639.x; Sarr JB, 2006, MICROBES INFECT, V8, P1260, DOI 10.1016/j.micinf.2005.12.005; Tan XL, 2011, J INFECT DIS, V204, P1750, DOI 10.1093/infdis/jir638; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Verra F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000978; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60182	10.1371/journal.pone.0060182	http://dx.doi.org/10.1371/journal.pone.0060182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555917	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200093
J	Scorzoni, L; de Lucas, MP; Mesa-Arango, AC; Fusco-Almeida, AM; Lozano, E; Cuenca-Estrella, M; Mendes-Giannini, MJ; Zaragoza, O				Scorzoni, Liliana; Pilar de Lucas, Maria; Cecilia Mesa-Arango, Ana; Fusco-Almeida, Ana Marisa; Lozano, Encarnacion; Cuenca-Estrella, Manuel; Mendes-Giannini, Maria Jose; Zaragoza, Oscar			Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile	PLOS ONE			English	Article							GALLERIA-MELLONELLA; CRYPTOCOCCUS-NEOFORMANS; CAENORHABDITIS-ELEGANS; VIVO PATHOGENICITY; IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; INVASIVE CANDIDIASIS; FUNGAL-INFECTIONS; EPIDEMIOLOGY; AGENTS	The incidence of opportunistic fungal infections has increased in recent decades due to the growing proportion of immunocompromised patients in our society. Candida krusei has been described as a causative agent of disseminated fungal infections in susceptible patients. Although its prevalence remains low among yeast infections (2-5%), its intrinsic resistance to fluconazole makes this yeast important from epidemiologic aspects. Non mammalian organisms are feasible models to study fungal virulence and drug efficacy. In this work we have used the lepidopteran Galleria mellonella and the nematode Caenorhabditis elegans as models to assess antifungal efficacy during infection by C. krusei. This yeast killed G. mellonella at 25, 30 and 37 degrees C and reduced haemocytic density. Infected larvae melanized in a dose-dependent manner. Fluconazole did not protect against C. krusei infection, in contrast to amphotericin B, voriconazole or caspofungin. However, the doses of these antifungals required to obtain larvae protection were always higher during C. krusei infection than during C. albicans infection. Similar results were found in the model host C. elegans. Our work demonstrates that non mammalian models are useful tools to investigate in vivo antifungal efficacy and virulence of C. krusei.	[Scorzoni, Liliana; Cecilia Mesa-Arango, Ana; Cuenca-Estrella, Manuel; Zaragoza, Oscar] Inst Salud Carlos III, Mycol Reference Lab, Natl Ctr Microbiol, Madrid, Spain; [Scorzoni, Liliana; Fusco-Almeida, Ana Marisa; Mendes-Giannini, Maria Jose] Univ Estadual Paulista Sao Paulo, Fac Ciencias Farmaceut, Lab Micol Clin, Araraquara, Brazil; [Pilar de Lucas, Maria; Lozano, Encarnacion] Inst Salud Carlos III, Natl Ctr Microbiol, Dept Cellular Biol, Madrid, Spain; [Cecilia Mesa-Arango, Ana] Univ Antioquia, Grp Invest Dermatol, Medellin, Colombia	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad de Antioquia	Mendes-Giannini, MJ (corresponding author), Univ Estadual Paulista Sao Paulo, Fac Ciencias Farmaceut, Lab Micol Clin, Araraquara, Brazil.	giannini@fcfar.unesp.br; ozaragoza@isciii.es	Scorzoni, Liliana/E-2661-2013; Lozano, Encarnacion/C-5161-2008; Giannini, Maria José Soares Mendes/C-5387-2012; Scorzoni, Liliana/V-2553-2019; FUSCO-ALMEIDA, ANA/G-1507-2013; de Lucas, María Pilar/F-2272-2016	Scorzoni, Liliana/0000-0002-0178-6653; Giannini, Maria José Soares Mendes/0000-0002-8059-0826; Scorzoni, Liliana/0000-0002-0178-6653; FUSCO-ALMEIDA, ANA/0000-0002-5399-8527; de Lucas, María Pilar/0000-0001-9516-2157; Zaragoza, Oscar/0000-0002-1581-0845; Lozano, Encarnacion/0000-0003-0254-0935	Spanish Ministry for Economics and Competitiveness [SAF2011-25140]; Agencia Espanola para la Cooperacion Internacional y Desarrollo; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Astellas Pharma; bioMerieux; Gilead Sciences; Merck Sharp and Dohme; Pfizer; Schering Plough; Soria Melguizo SA; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Spanish Ministry for Economics and Competitiveness; Agencia Espanola para la Cooperacion Internacional y Desarrollo; National Institutes of Health Office of Research Infrastructure Programs; Astellas Pharma(Astellas Pharmaceuticals); bioMerieux; Gilead Sciences(Gilead Sciences); Merck Sharp and Dohme(Merck & Company); Pfizer(Pfizer); Schering Plough(Merck & CompanySchering Plough Corporation); Soria Melguizo SA; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	O.Z. is funded by grant SAF2011-25140 from the Spanish Ministry for Economics and Competitiveness. L. S. is funded by a fellowship from the Agencia Espanola para la Cooperacion Internacional y Desarrollo. C. elegans strain AU37 was provided by the CGC (Caenorhabditis Genetics Center), which is funded by National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The authors have the following interests: In the past 5 years, M. C. E. has received grant support from Astellas Pharma, bioMerieux, Gilead Sciences, Merck Sharp and Dohme, Pfizer, Schering Plough and Soria Melguizo SA. He has been an advisor/consultant to Gilead Sciences, Merck Sharp and Dohme, Pfizer, and Schering Plough. He has been paid for talks on behalf of Gilead Sciences, Merck Sharp and Dohme, Pfizer, and Schering Plough. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abbas J, 2000, ARCH INTERN MED, V160, P2659, DOI 10.1001/archinte.160.17.2659; Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622; Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Alvarado-Ramirez E, 2008, REV IBEROAM MICOL, V25, P150, DOI 10.1016/S1130-1406(08)70035-4; ANAISSIE EJ, 1994, J INFECT DIS, V170, P384, DOI 10.1093/infdis/170.2.384; Arendrup M, 2002, INFECTION, V30, P286, DOI 10.1007/s15010-002-2131-0; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Ben-Ami R, 2008, CLIN INFECT DIS, V47, P226, DOI 10.1086/589290; Bergin D, 2003, MICROBES INFECT, V5, P1389, DOI 10.1016/j.micinf.2003.09.019; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Chen S, 2006, EMERG INFECT DIS, V12, P1508, DOI 10.3201/eid1210.060389; Coleman JJ, 2011, FUNGAL BIOL-UK, V115, P1279, DOI 10.1016/j.funbio.2011.09.005; Coleman JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025321; Coleman JJ, 2010, ACS CHEM BIOL, V5, P321, DOI 10.1021/cb900243b; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2010, ANTIMICROB AGENTS CH, V54, P1864, DOI 10.1128/AAC.00911-09; Colombo AL, 2011, MED MYCOL, V49, P785, DOI 10.3109/13693786.2011.577821; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Desalermos A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002451; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Drago M, 2004, EUR J CLIN MICROBIOL, V23, P619, DOI 10.1007/s10096-004-1174-9; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Fuchs BB, 2011, MYCOPATHOLOGIA, V171, P273, DOI 10.1007/s11046-010-9368-4; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Fukuoka T, 2003, ANTIMICROB AGENTS CH, V47, P1213, DOI 10.1128/AAC.47.4.1213-1219.2003; Garcia-Rodas R, 2012, FEMS IMMUNOL MED MIC, V64, P147, DOI 10.1111/j.1574-695X.2011.00871.x; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; KARYOTAKIS NC, 1993, J INFECT DIS, V168, P1311, DOI 10.1093/infdis/168.5.1311; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kelly J, 2011, J MED MICROBIOL, V60, P189, DOI 10.1099/jmm.0.025494-0; Labelle AJ, 2008, CRIT CARE MED, V36, P2967, DOI 10.1097/CCM.0b013e31818b3477; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Majithiya J, 2009, J ANTIMICROB CHEMOTH, V63, P161, DOI 10.1093/jac/dkn431; Mesa-Arango AC, 2012, MED MYCOL; Mesa-Arango Ana C, 2012, Front Microbiol, V3, P286; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Muhammed M, 2012, MED MYCOL, V50, P488, DOI 10.3109/13693786.2011.648217; Munoz P, 2005, J ANTIMICROB CHEMOTH, V55, P188, DOI 10.1093/jac/dkh532; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Orozco AS, 1998, ANTIMICROB AGENTS CH, V42, P2645, DOI 10.1128/AAC.42.10.2645; Ostrosky-Zeichner L, 2009, ANTIMICROB AGENTS CH, V53, P1639, DOI 10.1128/AAC.00955-08; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Peman J, 2012, ENFERM INFEC MICR CL, V30, P90, DOI 10.1016/j.eimc.2011.09.004; Peman Javier, 2002, Rev Iberoam Micol, V19, P30; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P515, DOI 10.1128/JCM.01915-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pukkila-Worley R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002074; Rodriguez-Tudela JL, 2008, CLIN MICROBIOL INFEC, V14, P398, DOI 10.1111/j.1469-0691.2007.01935.x; Rodriguez-Tudela JL, 2010, DRUG NEWS PERSPECT, V23, P93, DOI 10.1358/dnp.2010.23.2.1400855; Rodriguez-Tudela JL, 2008, INT J ANTIMICROB AG, V32, pS111, DOI 10.1016/S0924-8579(08)70010-4; Rogers TR, 2006, INT J ANTIMICROB AG, V27, pS7, DOI 10.1016/j.ijantimicag.2006.03.012; Rowan R, 2009, BIOMETALS, V22, P461, DOI 10.1007/s10534-008-9182-3; Shao PL, 2007, INT J ANTIMICROB AG, V30, P487, DOI 10.1016/j.ijantimicag.2007.07.019; Shorr AF, 2009, CRIT CARE MED, V37, P2519, DOI 10.1097/CCM.0b013e3181a0f95d; Spanakis EK, 2006, CLIN INFECT DIS, V43, P1060, DOI 10.1086/507891; Steenbergen JN, 2003, INFECT IMMUN, V71, P4862, DOI 10.1128/IAI.71.9.4862-4872.2003; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tampakakis E, 2008, NAT PROTOC, V3, P1925, DOI 10.1038/nprot.2008.193; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; Venkateswarlu K, 1996, ANTIMICROB AGENTS CH, V40, P2443, DOI 10.1128/AAC.40.11.2443; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994	79	107	109	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60047	10.1371/journal.pone.0060047	http://dx.doi.org/10.1371/journal.pone.0060047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555877	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200072
J	Yue, XY; Zheng, Y; Cai, YH; Yin, NN; Zhou, JX				Yue, Xiao-Yan; Zheng, Yi; Cai, Ye-Hua; Yin, Ning-Ning; Zhou, Jian-Xin			Real-Time Continuous Glucose Monitoring Shows High Accuracy within 6 Hours after Sensor Calibration: A Prospective Study	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; POINT-OF-CARE; BLOOD-GLUCOSE; HYPERGLYCEMIA; HYPOGLYCEMIA; FEASIBILITY; CHILDREN; SAFETY; ADULTS	Accurate and timely glucose monitoring is essential in intensive care units. Real-time continuous glucose monitoring system (CGMS) has been advocated for many years to improve glycemic management in critically ill patients. In order to determine the effect of calibration time on the accuracy of CGMS, real-time subcutaneous CGMS was used in 18 critically ill patients. CGMS sensor was calibrated with blood glucose measurements by blood gas/glucose analyzer every 12 hours. Venous blood was sampled every 2 to 4 hours, and glucose concentration was measured by standard central laboratory device (CLD) and by blood gas/glucose analyzer. With CLD measurement as reference, relative absolute difference (mean +/- SD) in CGMS and blood gas/glucose analyzer were 14.4% +/- 12.2% and 6.5% +/- 6.2%, respectively. The percentage of matched points in Clarke error grid zone A was 74.8% in CGMS, and 98.4% in blood gas/glucose analyzer. The relative absolute difference of CGMS obtained within 6 hours after sensor calibration (8.8% +/- 67.2%) was significantly less than that between 6 to 12 hours after calibration (20.1% +/- 13.5%, p < 0.0001). The percentage of matched points in Clarke error grid zone A was also significantly higher in data sets within 6 hours after calibration (92.4% versus 57.1%, p < 0.0001). In conclusion, real-time subcutaneous CGMS is accurate in glucose monitoring in critically ill patients. CGMS sensor should be calibrated less than 6 hours, no matter what time interval recommended by manufacturer.	[Yue, Xiao-Yan; Zheng, Yi; Cai, Ye-Hua; Yin, Ning-Ning; Zhou, Jian-Xin] Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China	Capital Medical University	Zhou, JX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China.	zhoujx.cn@gmail.com			Beijing Municipal Health Bureau [2009-3-28]	Beijing Municipal Health Bureau	The study was funded by Beijing Municipal Health Bureau (Grant Number: 2009-3-28. Website: http://english.bjhb.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasanthiran A, 2012, CLIN MED, V12, P272; Bilotta F, 2012, WORLD J DIABETES, V3, P130, DOI 10.4239/wjd.v3.i7.130; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Branco RG, 2010, PEDIATR CRIT CARE ME, V11, P415, DOI 10.1097/PCC.0b013e3181c59144; Bridges BC, 2010, CRIT CARE, V14, DOI 10.1186/cc9280; Brunner R, 2011, CRIT CARE MED, V39, P659, DOI 10.1097/CCM.0b013e318206bf2e; CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc5048; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2008, JAMA-J AM MED ASSOC, V300, P963, DOI 10.1001/jama.300.8.963; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Goldberg Philip A, 2004, Diabetes Technol Ther, V6, P339, DOI 10.1089/152091504774198034; Holzinger U, 2009, INTENS CARE MED, V35, P1383, DOI 10.1007/s00134-009-1471-y; Jacobs Brooke, 2010, J Diabetes Sci Technol, V4, P636; Joseph Jeffrey I, 2009, J Diabetes Sci Technol, V3, P1309; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Khan AI, 2006, ARCH PATHOL LAB MED, V130, P1527; Klonoff David C, 2011, J Diabetes Sci Technol, V5, P755; Lee JH, 2012, J EMERG MED, V43, P251, DOI 10.1016/j.jemermed.2011.06.037; Logtenberg SJ, 2009, DIABETES TECHNOL THE, V11, P31, DOI 10.1089/dia.2008.0028; Lorencio C, 2012, DIABETES TECHNOL THE, V14, P568, DOI 10.1089/dia.2012.0008; Piper HG, 2006, PEDIATRICS, V118, P1176, DOI 10.1542/peds.2006-0347; Pitkin Andrew D, 2009, J Diabetes Sci Technol, V3, P1270; Price Grant C, 2008, Crit Care Resusc, V10, P209; Rabiee Atoosa, 2009, J Diabetes Sci Technol, V3, P951; Reach G, 2008, CURR DIABETES REV, V4, P175, DOI 10.2174/157339908785294488; Society of Critical Care Medicine Chinese Medical Association, 2006, Zhonghua Wai Ke Za Zhi, V44, P1156; Tiemessen CAM, 2011, J NEUROSURG ANESTH, V23, P206, DOI 10.1097/ANA.0b013e31821aa6f2; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vriesendorp T M, 2005, Diabetes Technol Ther, V7, P315, DOI 10.1089/dia.2005.7.315	34	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60070	10.1371/journal.pone.0060070	http://dx.doi.org/10.1371/journal.pone.0060070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555886	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200077
J	Melo, RCN; Paganoti, GF; Dvorak, AM; Weller, PF				Melo, Rossana C. N.; Paganoti, Guillherme F.; Dvorak, Ann M.; Weller, Peter F.			The Internal Architecture of Leukocyte Lipid Body Organelles Captured by Three-Dimensional Electron Microscopy Tomography	PLOS ONE			English	Article							ENDOPEROXIDE SYNTHASE CYCLOOXYGENASE; TRYPANOSOMA-CRUZI INFECTION; ULTRASTRUCTURAL-LOCALIZATION; HUMAN EOSINOPHILS; IN-VIVO; INTRACELLULAR DOMAINS; EICOSANOID FORMATION; INFLAMMATORY CELLS; DROPLET PROTEINS; BODIES	Lipid bodies (LBs), also known as lipid droplets, are complex organelles of all eukaryotic cells linked to a variety of biological functions as well as to the development of human diseases. In cells from the immune system, such as eosinophils, neutrophils and macrophages, LBs are rapidly formed in the cytoplasm in response to inflammatory and infectious diseases and are sites of synthesis of eicosanoid lipid mediators. However, little is known about the structural organization of these organelles. It is unclear whether leukocyte LBs contain a hydrophobic core of neutral lipids as found in lipid droplets from adipocytes and how diverse proteins, including enzymes involved in eicosanoid formation, incorporate into LBs. Here, leukocyte LB ultrastructure was studied in detail by conventional transmission electron microscopy (TEM), immunogold EM and electron tomography. By careful analysis of the two-dimensional ultrastructure of LBs from human blood eosinophils under different conditions, we identified membranous structures within LBs in both resting and activated cells. Cyclooxygenase, a membrane inserted protein that catalyzes the first step in prostaglandin synthesis, was localized throughout the internum of LBs. We used fully automated dual-axis electron tomography to study the three-dimensional architecture of LBs in high resolution. By tracking 4 nm-thick serial digital sections we found that leukocyte LBs enclose an intricate system of membranes within their "cores". After computational reconstruction, we showed that these membranes are organized as a network of tubules which resemble the endoplasmic reticulum (ER). Our findings explain how membrane-bound proteins interact and are spatially arranged within LB "cores" and support a model for LB formation by incorporating cytoplasmic membranes of the ER, instead of the conventional view that LBs emerge from the ER leaflets. This is important to understand the functional capabilities of leukocyte LBs in health and during diverse diseases in which these organelles are functionally involved.	[Melo, Rossana C. N.; Paganoti, Guillherme F.] Univ Fed Juiz de Fora, UFJF, Lab Cellular Biol, Dept Biol, Juiz De Fora, MG, Brazil; [Melo, Rossana C. N.; Weller, Peter F.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Dvorak, Ann M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Pathol, Sch Med, Boston, MA 02215 USA	Universidade Federal de Juiz de Fora; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Weller, PF (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA.	pweller@bidmc.harvard.edu	Melo, Rossana C. N./B-8248-2013	Melo, Rossana C. N./0000-0003-1736-0806	National Institutes of Health (NIH) [USA- AI033372, AI020241, AI022571]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [481970/2010-0, 305983/2011-3]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil) [APQ-04129-10, CBB PPM 00456/12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020241, R01AI020241, R01AI033372, R01AI022571] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH grants, USA- AI033372, AI020241, AI022571) and by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil- 481970/2010-0, 305983/2011-3) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil- APQ-04129-10, CBB PPM 00456/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2007, IMMUNOL ALLERGY CLIN, V27, P357, DOI 10.1016/j.iac.2007.07.004; Bandeira-Melo C, 2000, J IMMUNOL METHODS, V244, P105, DOI 10.1016/S0022-1759(00)00264-7; Bandeira-Melo C, 2001, J BIOL CHEM, V276, P22779, DOI 10.1074/jbc.M101436200; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; BENDAYAN M, 1983, J HISTOCHEM CYTOCHEM, V31, P101, DOI 10.1177/31.1.6187796; Bozza PT, 1997, J EXP MED, V186, P909, DOI 10.1084/jem.186.6.909; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Charron AJ, 2002, J CELL SCI, V115, P3049; Chen XB, 2008, J NEUROSCI, V28, P9321, DOI 10.1523/JNEUROSCI.2992-08.2008; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; D'Avila H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/478601; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; DVORAK AM, 1994, INT ARCH ALLERGY IMM, V105, P245; DVORAK AM, 1992, J HISTOCHEM CYTOCHEM, V40, P759, DOI 10.1177/40.6.1316915; DVORAK AM, 1993, INT ARCH ALLERGY IMM, V101, P136, DOI 10.1159/000236511; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Kondo H, 2008, TOHOKU J EXP MED, V214, P167, DOI 10.1620/tjem.214.167; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meadows JW, 2005, J CLIN ENDOCR METAB, V90, P2344, DOI 10.1210/jc.2004-1199; Melo RCN, 2006, INFLAMM RES, V55, P342, DOI 10.1007/s00011-006-5205-0; Melo RCN, 2005, TRAFFIC, V6, P1047, DOI 10.1111/j.1600-0854.2005.00344.x; Melo RCN, 2005, TRAFFIC, V6, P866, DOI 10.1111/j.1600-0854.2005.00322.x; Melo RCN, 2003, TISSUE CELL, V35, P59, DOI 10.1016/S0040-8166(02)00105-2; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Melo RCN, 2009, J CELL MOL MED, V13, P279, DOI 10.1111/j.1582-4934.2008.00388.x; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pulido-Mendez M., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P143; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Robenek H, 2009, BBA-MOL CELL BIOL L, V1791, P408, DOI 10.1016/j.bbalip.2008.12.001; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schmitz G, 2008, REV PHYSIOL BIOCH P, V160, P93, DOI 10.1007/112_2008_802; Shamri R, 2011, CELL TISSUE RES, V343, P57, DOI 10.1007/s00441-010-1049-6; Staehelin LA, 2008, PLANT PHYSIOL, V147, P1454, DOI 10.1104/pp.108.120618; Sun J, 2013, ALLERGY; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; TRIGGIANI M, 1995, J EXP MED, V182, P1181, DOI 10.1084/jem.182.5.1181; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Vieira-De-Abreu A, 2005, AM J RESP CELL MOL, V33, P254, DOI 10.1165/rcmb.2005-0145OC; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004	59	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59578	10.1371/journal.pone.0059578	http://dx.doi.org/10.1371/journal.pone.0059578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555714	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500057
J	Kowalski, WJ; Dur, O; Wang, YJ; Patrick, MJ; Tinney, JP; Keller, BB; Pekkan, K				Kowalski, William J.; Dur, Onur; Wang, Yajuan; Patrick, Michael J.; Tinney, Joseph P.; Keller, Bradley B.; Pekkan, Kerem			Critical Transitions in Early Embryonic Aortic Arch Patterning and Hemodynamics	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; WALL SHEAR-STRESS; CHICK-EMBRYO; OUTFLOW TRACT; ADAPTIVE REGULATION; CARDIAC DEVELOPMENT; EPIGENETIC FACTOR; VASCULAR SYSTEM; LEFT-VENTRICLE; BLOOD-FLOW	Transformation from the bilaterally symmetric embryonic aortic arches to the mature great vessels is a complex morphogenetic process, requiring both vasculogenic and angiogenic mechanisms. Early aortic arch development occurs simultaneously with rapid changes in pulsatile blood flow, ventricular function, and downstream impedance in both invertebrate and vertebrate species. These dynamic biomechanical environmental landscapes provide critical epigenetic cues for vascular growth and remodeling. In our previous work, we examined hemodynamic loading and aortic arch growth in the chick embryo at Hamburger-Hamilton stages 18 and 24. We provided the first quantitative correlation between wall shear stress (WSS) and aortic arch diameter in the developing embryo, and observed that these two stages contained different aortic arch patterns with no inter-embryo variation. In the present study, we investigate these biomechanical events in the intermediate stage 21 to determine insights into this critical transition. We performed fluorescent dye microinjections to identify aortic arch patterns and measured diameters using both injection recordings and high-resolution optical coherence tomography. Flow and WSS were quantified with 3D computational fluid dynamics (CFD). Dye injections revealed that the transition in aortic arch pattern is not a uniform process and multiple configurations were documented at stage 21. CFD analysis showed that WSS is substantially elevated compared to both the previous (stage 18) and subsequent (stage 24) developmental time-points. These results demonstrate that acute increases in WSS are followed by a period of vascular remodeling to restore normative hemodynamic loading. Fluctuations in blood flow are one possible mechanism that impacts the timing of events such as aortic arch regression and generation, leading to the variable configurations at stage 21. Aortic arch variations noted during normal rapid vascular remodeling at stage 21 identify a temporal window of increased vulnerability to aberrant aortic arch morphogenesis with the potential for profound effects on subsequent cardiovascular morphogenesis.	[Kowalski, William J.; Dur, Onur; Wang, Yajuan; Keller, Bradley B.; Pekkan, Kerem] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Patrick, Michael J.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Tinney, Joseph P.; Keller, Bradley B.] Univ Louisville, Dept Pediat, Cardiovasc Innovat Inst, Louisville, KY 40292 USA	Carnegie Mellon University; Carnegie Mellon University; University of Louisville	Pekkan, K (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	kpekkan@andrew.cmu.edu	Kowalski, William/D-1298-2017; Pekkan, Kerem/P-5038-2019	Kowalski, William/0000-0003-2343-2706; Pekkan, Kerem/0000-0001-7637-4445	American Heart Association [0765284U]; NSF CAREER Award [0954465]; Pittsburgh Supercomputing Center [CCR080013]; Kosair Charities Pediatric Heart Research Program	American Heart Association(American Heart Association); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Pittsburgh Supercomputing Center; Kosair Charities Pediatric Heart Research Program	This research was supported by American Heart Association Beginning Grant in Aid 0765284U (KP), NSF CAREER Award 0954465 (KP), Pittsburgh Supercomputing Center Grant CCR080013 (KP), and the Kosair Charities Pediatric Heart Research Program (BBK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Roubaie S, 2011, AM J PHYSIOL-HEART C, V301, pH2473, DOI 10.1152/ajpheart.00475.2011; Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Bayer IM, 1999, ARTERIOSCL THROM VAS, V19, P1499, DOI 10.1161/01.ATV.19.6.1499; Beloussov LV, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOULNOIS J-L, 1986, Lasers in Medical Science, V1, P47, DOI 10.1007/BF02030737; BROEKHUIZEN MLA, 1993, PEDIATR RES, V34, P44, DOI 10.1203/00006450-199307000-00011; Broekhuizen MLA, 1999, ULTRASOUND OBST GYN, V13, P437, DOI 10.1046/j.1469-0705.1999.13060437.x; Burggren W. W., 1998, DEV CARDIOVASCULAR S; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; CLARK EB, 1982, CIRC RES, V51, P810, DOI 10.1161/01.RES.51.6.810; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Culver JC, 2010, MICROCIRCULATION, V17, P164, DOI 10.1111/j.1549-8719.2010.00025.x; Dealmeida A, 2007, CIRC RES, V100, P1363, DOI 10.1161/01.RES.0000266606.88463.cb; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; Dur O, 2011, CARDIOVASC ENG TECHN, V2, P35, DOI DOI 10.1007/S13239-010-0029-Z; Egorova AD, 2011, DEV DYNAM, V240, P1670, DOI 10.1002/dvdy.22660; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; GESSNER IH, 1966, CIRC RES, V18, P625, DOI 10.1161/01.RES.18.6.625; Girerd X, 1996, HYPERTENSION, V27, P799, DOI 10.1161/01.HYP.27.3.799; Groenendijk BCW, 2004, DEV DYNAM, V230, P57, DOI 10.1002/dvdy.20029; Hacking WJG, 1996, AM J PHYSIOL-HEART C, V270, pH364, DOI 10.1152/ajpheart.1996.270.1.H364; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Henning AL, 2011, DEV DYNAM, V240, P1949, DOI 10.1002/dvdy.22694; HIRUMA T, 1995, ANAT EMBRYOL, V191, P415, DOI 10.1007/BF00304427; Hogers B, 1999, CARDIOVASC RES, V41, P87, DOI 10.1016/S0008-6363(98)00218-1; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665; Hu N, 2009, ANAT REC, V292, P652, DOI 10.1002/ar.20885; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; HUDETZ AG, 1992, ADV EXP MED BIOL, V316, P31; Hughes AFW, 1934, PHILOS T ROY SOC B, V224, P75, DOI 10.1098/rstb.1934.0016; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Kardong KV, 2009, VERTEBRATES COMP ANA; Kastschenko N., 1887, Archiv fuer Anatomie und Physiologie (Anat), P258; KEENAN RL, 1973, CARDIOVASC RES, V7, P670, DOI 10.1093/cvr/7.5.670; Kowalski WJ, 2012, BIOMECH MODEL MECHAN, V11, P1057, DOI 10.1007/s10237-012-0373-z; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Lu X, 2001, AM J PHYSIOL-HEART C, V280, pH1547, DOI 10.1152/ajpheart.2001.280.4.H1547; Lucitti JL, 2006, AM J PHYSIOL-HEART C, V291, pH1919, DOI 10.1152/ajpheart.01061.2005; Lucitti JL, 2005, J EXP BIOL, V208, P1877, DOI 10.1242/jeb.01574; Manner J, 2000, ANAT RECORD, V259, P248, DOI 10.1002/1097-0185(20000701)259:3<248::AID-AR30>3.0.CO;2-K; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; McElhinney DB, 2010, CIRCULATION, V121, P1256, DOI 10.1161/CIRCULATIONAHA.109.870246; Milnor W.R., 1989, HEMODYNAMICS, V2nd Edn; Molin DGM, 2004, CIRC RES, V95, P1109, DOI 10.1161/01.RES.0000150047.16909.ab; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Muller Berlien, 1997, ANGEW LASERMEDIZIN E; PARRISH JA, 1981, J INVEST DERMATOL, V77, P45, DOI 10.1111/1523-1747.ep12479235; Patten B. M., 1920, EARLY EMBRYOLOGY CHI; PEXIEDER T, 1969, Folia Morphologica (Prague), V17, P102; PEXIEDER T, 1986, TERATOLOGY, V33, pC91; Poelmann RE, 2008, MED BIOL ENG COMPUT, V46, P479, DOI 10.1007/s11517-008-0304-4; Reckova M, 2003, CIRC RES, V93, P77, DOI 10.1161/01.RES.0000079488.91342.B7; RODBARD S, 1975, CARDIOLOGY, V60, P4, DOI 10.1159/000169701; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; RYCHTER Z., 1962, ADVANCES MORPHOGENESIS, V2, P333; Rychter Z, 1965, Fed Proc Transl Suppl, V24, P815; Sabin FR, 1917, CONTRIB EMBRYOL, V6, P63; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; SMITH BR, 1992, JMRI-J MAGN RESON IM, V2, P237, DOI 10.1002/jmri.1880020220; STEWART DE, 1986, CIRC RES, V59, P545, DOI 10.1161/01.RES.59.5.545; Taber LA, 2001, J BIOMECH, V34, P121, DOI 10.1016/S0021-9290(00)00173-1; Taber LA, 1996, J THEOR BIOL, V180, P343, DOI 10.1006/jtbi.1996.0107; Taber LA, 2009, PHILOS T R SOC A, V367, P3555, DOI 10.1098/rsta.2009.0100; Tobita K, 2005, ANAT REC PART A, V283A, P193, DOI 10.1002/ar.a.20133; Ursem NTC, 2001, ULTRASOUND MED BIOL, V27, P919, DOI 10.1016/S0301-5629(01)00393-3; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; Watanabe M, 1998, DEVELOPMENT, V125, P3809; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Yelbuz TM, 2002, CIRCULATION, V106, P2771, DOI 10.1161/01.CIR.0000042672.51054.7B; Yoshigi M, 2000, COMPUT METH PROG BIO, V63, P29, DOI 10.1016/S0169-2607(00)00061-4	75	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60271	10.1371/journal.pone.0060271	http://dx.doi.org/10.1371/journal.pone.0060271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555940	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400086
J	Roher, AE; Cribbs, DH; Kim, RC; Maarouf, CL; Whiteside, CM; Kokjohn, TA; Daugs, ID; Head, E; Liebsack, C; Serrano, G; Belden, C; Sabbagh, MN; Beach, TG				Roher, Alex E.; Cribbs, David H.; Kim, Ronald C.; Maarouf, Chera L.; Whiteside, Charisse M.; Kokjohn, Tyler A.; Daugs, Ian D.; Head, Elizabeth; Liebsack, Carolyn; Serrano, Geidy; Belden, Christine; Sabbagh, Marwan N.; Beach, Thomas G.			Bapineuzumab Alters A beta Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy	PLOS ONE			English	Article							BRAIN-BARRIER BREAKDOWN; ALZHEIMERS-DISEASE; CHEMICAL-CHARACTERIZATION; IMAGING ABNORMALITIES; PASSIVE IMMUNOTHERAPY; PEPTIDE REMNANTS; RISK-FACTORS; IMMUNIZATION; PATHOLOGY; DEPOSITS	The characteristic neuropathological changes associated with Alzheimer's disease (AD) and other lines of evidence support the amyloid cascade hypothesis. Viewing amyloid deposits as the prime instigator of dementia has now led to clinical trials of multiple strategies to remove or prevent their formation. We performed neuropathological and biochemical assessments of 3 subjects treated with bapineuzumab infusions. Histological analyses were conducted to quantify amyloid plaque densities, Braak stages and the extent of cerebral amyloid angiopathy (CAA). Amyloid-beta (A beta) species in frontal and temporal lobe samples were quantified by ELISA. Western blots of amyloid-beta precursor protein (A beta PP) and its C-terminal (CT) fragments as well as tau species were performed. Bapineuzumab-treated (Bapi-AD) subjects were compared to non-immunized age-matched subjects with AD (NI-AD) and non-demented control (NDC) cases. Our study revealed that Bapi-AD subjects exhibited overall amyloid plaque densities similar to those of NI-AD cases. In addition, CAA was moderate to severe in NI-AD and Bapi-AD patients. Although histologically-demonstrable leptomeningeal, cerebrovascular and neuroparenchymal-amyloid densities all appeared unaffected by treatment, A beta peptide profiles were significantly altered in Bapi-AD subjects. There was a trend for reduction in total A beta(42) levels as well as an increase in A beta(40) which led to a corresponding significant decrease in A beta(42):A beta(40) ratio in comparison to NI-AD subjects. There were no differences in the levels of A beta PP, CT99 and CT83 or tau species between Bapi-AD and NI-AD subjects. The remarkable alteration in A beta profiles reveals a dynamic amyloid production in which removal and depositional processes were apparently perturbed by bapineuzumab therapy. Despite the alteration in biochemical composition, all 3 immunized subjects exhibited continued cognitive decline.	[Roher, Alex E.; Maarouf, Chera L.; Whiteside, Charisse M.; Kokjohn, Tyler A.; Daugs, Ian D.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA; [Cribbs, David H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Cribbs, David H.] Univ Calif Irvine, UCI MIND, Irvine, CA 92717 USA; [Kim, Ronald C.] Univ Calif Irivine, Dept Pathol, Irivine, CA USA; [Kokjohn, Tyler A.] Midwestern Univ, Sch Med, Dept Microbiol, Glendale, AZ USA; [Head, Elizabeth] Univ Kentucky, Sanders Brown Ctr Aging, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Liebsack, Carolyn; Belden, Christine; Sabbagh, Marwan N.] Banner Sun Hlth Res Inst, Roberts Clin Ctr, Sun City, AZ USA; [Serrano, Geidy; Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; University of California System; University of California Irvine; University of California System; University of California Irvine; Midwestern University; University of Kentucky; Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute	Roher, AE (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA.	alex.roher@bannerhealth.com			National Institute on Aging (NIA) [R01 AG-19795]; NIA Arizona Alzheimer's Disease Core Center [P30 AG-19610]; State of Arizona Alzheimer's Research Consortium; University of California (Irvine) - ADRC NIH/NIA [P50 AG-16573]; National Institute of Neurological Disorders and Stroke [U24 NS072026]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; Celgene; Quintiles/Genentech; AVID; Lilly; GE; Wyeth; Bayer; Pfizer; BMS; Baxter; Janssen; Medivation; Amerisciences; Wiley; AVID-Radiopharmaceuticals; Schering-Bayer Pharmaceuticals; GE Healthcare; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019795, P50AG016573, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA Arizona Alzheimer's Disease Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); State of Arizona Alzheimer's Research Consortium; University of California (Irvine) - ADRC NIH/NIA; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; Celgene(Bristol-Myers SquibbCelgene Corporation); Quintiles/Genentech; AVID; Lilly(Eli Lilly); GE; Wyeth(Wyeth); Bayer(Bayer AG); Pfizer(Pfizer); BMS(Bristol-Myers Squibb); Baxter; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medivation; Amerisciences; Wiley; AVID-Radiopharmaceuticals; Schering-Bayer Pharmaceuticals; GE Healthcare(General ElectricGE Healthcare); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging (NIA) grant R01 AG-19795, the NIA Arizona Alzheimer's Disease Core Center P30 AG-19610, the State of Arizona Alzheimer's Research Consortium and by the University of California (Irvine) - ADRC NIH/NIA Grant P50 AG-16573. The Brain Donation Program at Banner Sun Health Research Institute is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; CB's salary is supported, in part, by Celgene, Quintiles/Genentech, AVID, Lilly, GE, Wyeth, Bayer, and Pfizer. MNS receives grant support from BMS, Avid, GE, Bayer, Baxter, Wyeth, Janssen, Lilly and Medivation, and is in the consultant/advisory board for Janssen/Pfizer, Amerisciences, Eisai and GSK, and receives royalties from Amerisciences and Wiley. TGB receives funding from AVID-Radiopharmaceuticals, Schering-Bayer Pharmaceuticals and GE Healthcare. None of the above funding was for this specific study. The bapineuzumab used in this study is a Pfizer/Johnson & Johnson/Elan product. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abraham CR, 2000, ANN NY ACAD SCI, V920, P245; ABRAHAM CR, 1989, ANN MED, V21, P77, DOI 10.3109/07853898909149188; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Atwood CS, 2003, BRAIN RES REV, V43, P164, DOI 10.1016/S0165-0173(03)00206-6; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Black RS, 2010, ALZ DIS ASSOC DIS, V24, P198, DOI 10.1097/WAD.0b013e3181c53b00; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Cheng-te Chou P, 2012, ALZHEIMERS DEMENT, V8, pP11, DOI DOI 10.1016/J.JALZ.2012.05.035; Chuang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033120; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; de la Torre JC, 2012, J ALZHEIMERS DIS; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Fagan T, 2012, CLIN TRIALS INTRAVEN; Fagan T, 2011, PFIZER HALTS DEV ASS; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Giulian D, 1996, J NEUROSCI, V16, P6021; Goodman J, 2012, ALZHEIMERS DEMENT, V8, pP153; GOWING E, 1994, J BIOL CHEM, V269, P10987; Grammas P, 2004, J ALZHEIMERS DIS, V6, P275; Hachinski V, 2012, NEUROLOGY, V79, P107, DOI 10.1212/01.wnl.0000416262.36658.49; Head E, 2001, NEUROBIOL DIS, V8, P252, DOI 10.1006/nbdi.2000.0380; Head E, 2006, ACTA NEUROPATHOL, V112, P217, DOI 10.1007/s00401-006-0098-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kenche VB, 2011, BRIT J PHARMACOL, V163, P211, DOI 10.1111/j.1476-5381.2011.01221.x; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Kokjohn TA, 2012, ALZHEIMERS DEMENT, V8, P574, DOI 10.1016/j.jalz.2011.05.2429; Kokjohn TA, 2009, CNS NEUROL DISORD-DR, V8, P88, DOI 10.2174/187152709787847315; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 2000, BIOCHEM BIOPH RES CO, V268, P750, DOI 10.1006/bbrc.2000.2222; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lin PY, 2012, ALZHEIMERS DEMENT, V8, pP651; Lleo A, 2004, AM J GERIAT PSYCHIAT, V12, P146, DOI 10.1176/appi.ajgp.12.2.146; Luo F, 2010, J PHARMACOL EXP THER, V335, P580, DOI 10.1124/jpet.110.172932; Lyubchenko Y, 2012, ALZHEIMERS DEMENT, V8, pP659; Lyubchenko YL, 2010, WIRES NANOMED NANOBI, V2, P526, DOI 10.1002/wnan.102; Maarouf CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027291; Maarouf CL, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-39; Maarouf CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-20; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Matsuoka H, 2002, CNS DRUGS, V16, P509, DOI 10.2165/00023210-200216080-00001; Melchor JP, 2003, J NEUROSCI, V23, P8867; Melchor JP, 2003, J MOL NEUROSCI, V20, P287, DOI 10.1385/JMN:20:3:287; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Pul R, 2011, EXPERT OPIN BIOL TH, V11, P343, DOI 10.1517/14712598.2011.552884; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Roher AE, 2011, J ALZHEIMERS DIS, V24, P315, DOI 10.3233/JAD-2011-101809; Sabbagh MN, 2010, CURR ALZHEIMER RES, V7, P280, DOI 10.2174/156720510791162340; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Strobel G, 2012, EXPANDING NETWORK DI; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Van Vickle GD, 2008, MOL MED, V14, P184, DOI [10.2119/2007-00094.VanVickle, 10.2119/2007-00094.Van Vickle]; VANNOSTRAND WE, 1991, ANN NY ACAD SCI, V640, P140; VANNOSTRAND WE, 1992, ANN NY ACAD SCI, V674, P243; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; Zakaib GD, 2012, PHASE 3 SOLANEZUMAB; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	98	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59735	10.1371/journal.pone.0059735	http://dx.doi.org/10.1371/journal.pone.0059735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555764	Green Published, gold			2022-12-27	WOS:000316546400059
J	Seyer, A; Cantiello, M; Bertrand-Michel, J; Roques, V; Nauze, M; Bezirard, V; Collet, X; Touboul, D; Brunelle, A; Comera, C				Seyer, Alexandre; Cantiello, Michela; Bertrand-Michel, Justine; Roques, Veronique; Nauze, Michel; Bezirard, Valerie; Collet, Xavier; Touboul, David; Brunelle, Alain; Comera, Christine			Lipidomic and Spatio-Temporal Imaging of Fat by Mass Spectrometry in Mice Duodenum during Lipid Digestion	PLOS ONE			English	Article							TOF-SIMS; PHYSIOLOGICAL REGULATION; CHOLESTEROL ABSORPTION; ENDOPLASMIC-RETICULUM; HUMAN PLASMA; LIPOPROTEINS; ENTEROCYTES; SECRETION; TRANSPORT; PROTEIN	Intestinal absorption of dietary fat is a complex process mediated by enterocytes leading to lipid assembly and secretion of circulating lipoproteins as chylomicrons, vLDL and intestinal HDL (iHDL). Understanding lipid digestion is of importance knowing the correlation between excessive fat absorption and atherosclerosis. By using time-of-flight secondary ion mass spectrometry (TOF-SIMS), we illustrated a spatio-temporal localization of fat in mice duodenum, at different times of digestion after a lipid gavage, for the first time. Fatty acids progressively increased in enterocytes as well as taurocholic acid, secreted by bile and engaged in the entero-hepatic re-absorption cycle. Cytosolic lipid droplets (CLD) from enterocytes were originally purified separating chylomicron-like, intermediate droplets and smaller HDL-like. A lipidomic quantification revealed their contents in triglycerides, free and esterified cholesterol, phosphatidylcholine, sphingomyelin and ceramides but also in free fatty acids, mono- and di-acylglycerols. An acyl-transferase activity was identified and the enzyme monoacylglycerol acyl transferase 2 (MGAT2) was immunodetected in all CLD. The largest droplets was also shown to contain the microsomal triglyceride transfer protein (MTTP), the acyl-coenzyme A-cholesterol acyltransferases (ACAT) 1 and 2, hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL). This highlights the fact that during the digestion of fats, enterocyte CLD contain some enzymes involved in the different stages of the metabolism of diet fatty acids and cholesterol, in anticipation of the crucial work of endoplasmic reticulum in the process. The data further underlines the dual role of chylomicrons and iHDL in fat digestion which should help to efficiently complement lipid-lowering therapy.	[Seyer, Alexandre; Touboul, David; Brunelle, Alain] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, Gif Sur Yvette, France; [Cantiello, Michela; Comera, Christine] Hop Purpan, INSERM, U563, Toulouse, France; [Bertrand-Michel, Justine; Roques, Veronique; Nauze, Michel; Collet, Xavier] Hop Rangueil, INSERM, U1048, Toulouse, France; [Bezirard, Valerie; Comera, Christine] TOXALIM, INRA, UMR 1331, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Comera, C (corresponding author), Hop Purpan, INSERM, U563, Toulouse, France.	Christine.Comera@toulouse.inra.fr	Seyer, Alexandre/N-2315-2019; Collet, Xavier/M-6938-2017; Brunelle, Alain/L-3889-2013; Seyer, Alexandre/I-3514-2012	Brunelle, Alain/0000-0001-6526-6481; Touboul, David/0000-0003-2751-774X	ANR/PNRA (National program for diet and nutrition research) [5.34]; Institut de Chimie des Substances Naturelles (CNRS); PNRA [5.34]	ANR/PNRA (National program for diet and nutrition research)(French National Research Agency (ANR)); Institut de Chimie des Substances Naturelles (CNRS)(Centre National de la Recherche Scientifique (CNRS)); PNRA	This study was funded by the ANR/PNRA (National program for diet and nutrition research) project #5.34 ABSINTE. AS was supported by a Ph.D. research fellowship from the Institut de Chimie des Substances Naturelles (CNRS) and MC received a post-doctoral fellowship from PNRA #5.34 'ABSINTE'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Atshaves BP, 2001, J BIOL CHEM, V276, P25324, DOI 10.1074/jbc.M100560200; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Benabdellah F, 2010, ANAL BIOANAL CHEM, V396, P151, DOI 10.1007/s00216-009-3031-2; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P496; Beuling E, 2010, GUT, V59, P888, DOI 10.1136/gut.2009.204990; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Black DD, 2007, AM J PHYSIOL-GASTR L, V293, pG519, DOI 10.1152/ajpgi.00189.2007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; BROUSSEAU T, 1993, CLIN CHEM, V39, P960; Brulet M, 2010, J LIPID RES, V51, P3034, DOI 10.1194/jlr.M008870; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; BUSCHMANN RJ, 1981, J ULTRA MOL STRUCT R, V76, P15, DOI 10.1016/S0022-5320(81)80047-0; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Chang CC, 2007, J BIOL CHEM, V273, P35132; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Debois D, 2009, ANAL CHEM, V81, P2823, DOI 10.1021/ac900045m; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; ERNSTER L, 1962, J CELL BIOL, V15, P541, DOI 10.1083/jcb.15.3.541; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Fullekrug J, 2010, FEBS LETT, V584, P2168; Gilmore IS, 2000, INT J MASS SPECTROM, V202, P217, DOI 10.1016/S1387-3806(00)00245-1; Gilmore IS, 2002, APPL SURF SCI, V187, P89, DOI 10.1016/S0169-4332(01)00787-5; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Hamilton RL, 1998, J LIPID RES, V39, P1543; Hui DY, 2008, AM J PHYSIOL-GASTR L, V294, pG839, DOI 10.1152/ajpgi.00061.2008; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lagakos WS, 2001, AM J PHYSL GASTROINT, V300, pG803; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; NEVIN P, 1995, J LIPID RES, V36, P2405; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Nguyen DV, 2009, J LIPID RES, V50, P2235, DOI 10.1194/jlr.M900036-JLR200; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Pfleiderer G, 1970, METHOD ENZYMOL, V19, P514; Reboul E, 2011, BR J NUTR, V20, P1; RUDEL LL, 1972, J CLIN INVEST, V51, P2686, DOI 10.1172/JCI107087; SABESIN SM, 1977, J LIPID RES, V18, P496; Sodhi RNS, 2004, ANALYST, V129, P483, DOI 10.1039/b402607c; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Touboul D, 2005, J AM SOC MASS SPECTR, V16, P1608, DOI 10.1016/j.jasms.2005.06.005; Touboul D, 2004, ANAL CHEM, V76, P1550, DOI 10.1021/ac035243z; Touboul D, 2007, INT J MASS SPECTROM, V260, P158, DOI 10.1016/j.ijms.2006.09.027; Touboul D, 2011, CURR OPIN CHEM BIOL, V15, P725, DOI 10.1016/j.cbpa.2011.04.017; Touboul D, 2011, BIOCHIMIE, V93, P113, DOI 10.1016/j.biochi.2010.05.013; Vickerman JC, 2010, SURFACE SPECTRA IM P, P1; Wagner KH, 2001, EUR J NUTR, V40, P161, DOI 10.1007/s003940170004; Warnakula S, 2011, CAN J CARDIOL, V27, P183, DOI 10.1016/j.cjca.2010.12.020; Weingartner O, 2010, ATHEROSCLEROSIS, V210, P362, DOI 10.1016/j.atherosclerosis.2010.01.003; WOOD P, 1964, J LIPID RES, V5, P225; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	67	33	33	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58224	10.1371/journal.pone.0058224	http://dx.doi.org/10.1371/journal.pone.0058224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560035	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100007
J	Yu, S; Liang, YD; Sun, SJ; Zhang, K; Zhang, J; Fang, J				Yu, Shuang; Liang, Yongdong; Sun, Shujun; Zhang, Kai; Zhang, Jue; Fang, Jing			Vehicle Exhaust Gas Clearance by Low Temperature Plasma-Driven Nano-Titanium Dioxide Film Prepared by Radiofrequency Magnetron Sputtering	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; NONTHERMAL PLASMA; CATALYTIC-OXIDATION; DECOMPOSITION; DISCHARGE; REMOVAL; BENZENE; REACTOR; DESTRUCTION; REDUCTION	A novel plasma-driven catalysis (PDC) reactor with special structure was proposed to remove vehicle exhaust gas. The PDC reactor which consisted of three quartz tubes and two copper electrodes was a coaxial dielectric barrier discharge (DBD) reactor. The inner and outer electrodes firmly surrounded the outer surface of the corresponding dielectric barrier layer in a spiral way, respectively. Nano-titanium dioxide (TiO2) film prepared by radiofrequency (RF) magnetron sputtering was coated on the outer wall of the middle quartz tube, separating the catalyst from the high voltage electrode. The spiral electrodes were designed to avoid overheating of microdischarges inside the PDC reactor. Continuous operation tests indicated that stable performance without deterioration of catalytic activity could last for more than 25 h. To verify the effectiveness of the PDC reactor, a non-thermal plasma(NTP) reactor was employed, which has the same structure as the PDC reactor but without the catalyst. The real vehicle exhaust gas was introduced into the PDC reactor and NTP reactor, respectively. After the treatment, compared with the result from NTP, the concentration of HC in the vehicle exhaust gas treated by PDC reactor reduced far more obviously while that of NO decreased only a little. Moreover, this result was explained through optical emission spectrum. The O emission lines can be observed between 870 nm and 960 nm for wavelength in PDC reactor. Together with previous studies, it could be hypothesized that O derived from catalytically O-3 destruction by catalyst might make a significant contribution to the much higher HC removal efficiency by PDC reactor. A series of complex chemical reactions caused by the multi-components mixture in real vehicle exhaust reduced NO removal efficiency. A controllable system with a real-time feedback module for the PDC reactor was proposed to further improve the ability of removing real vehicle exhaust gas.	[Yu, Shuang; Sun, Shujun; Zhang, Kai; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Liang, Yongdong; Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, J (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	zhangjue@pku.edu.cn	Zhang, Jue/E-2067-2014; Zhang, Jue/N-7594-2013		Bioelectrics Inc., United States of America	Bioelectrics Inc., United States of America	This study is supported by the Bioelectrics Inc., United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the Bioelectrics Inc., United States of America. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Chen HL, 2008, APPL CATAL B-ENVIRON, V85, P1, DOI 10.1016/j.apcatb.2008.06.021; Chen HL, 2009, ENVIRON SCI TECHNOL, V43, P2216, DOI 10.1021/es802679b; Chen Z, 2003, IND ENG CHEM RES, V42, P6682, DOI 10.1021/ie030096g; Ding HX, 2006, J PHYS D APPL PHYS, V39, P3603, DOI 10.1088/0022-3727/39/16/012; Fan HY, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/225105; Fan X, 2009, CHEMOSPHERE, V75, P1301, DOI 10.1016/j.chemosphere.2009.03.029; Fantz U, 2006, PLASMA SOURCES SCI T, V15, pS137, DOI 10.1088/0963-0252/15/4/S01; Francke KP, 2000, CATAL TODAY, V59, P411, DOI 10.1016/S0920-5861(00)00306-0; Futamura S, 2004, CATAL TODAY, V89, P89, DOI 10.1016/j.cattod.2003.11.014; Futamura S, 2002, CATAL TODAY, V72, P259, DOI 10.1016/S0920-5861(01)00503-X; Guo YF, 2006, J MOL CATAL A-CHEM, V245, P93, DOI 10.1016/j.molcata.2005.09.013; Guo YF, 2007, CATALYSIS; Harling AM, 2008, APPL CATAL B-ENVIRON, V82, P180, DOI 10.1016/j.apcatb.2008.01.017; Harling AM, 2007, J PHYS CHEM C, V111, P5090, DOI 10.1021/jp067821w; Holzer F, 2002, APPL CATAL B-ENVIRON, V38, P163, DOI 10.1016/S0926-3373(02)00040-1; Huang HB, 2011, IEEE T PLASMA SCI, V39, P877, DOI 10.1109/TPS.2010.2103403; Huang HB, 2011, IEEE T PLASMA SCI, V39, P576, DOI 10.1109/TPS.2010.2086498; Kim HH, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100444; Kim HH, 2005, APPL CATAL B-ENVIRON, V56, P213, DOI 10.1016/j.apcatb.2004.09.008; Kim HH, 2004, CATALYSIS LETT, V96; Kim HH, 2006, IEEE T PLASMA SCI, V34, P984, DOI 10.1109/TPS.2006.875728; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Lee YH, 2001, SURF COAT TECH, V146, P474, DOI 10.1016/S0257-8972(01)01459-1; Lin H, 2007, P COMBUST INST, V31, P3335, DOI 10.1016/j.proci.2006.07.075; LOFTHUS A, 1977, J PHYS CHEM REF DATA, V6, P113, DOI 10.1063/1.555546; Lu B, 2006, J HAZARD MATER, V137, P633, DOI 10.1016/j.jhazmat.2006.02.012; Maciuca A, 2008, APPL CATAL B-ENVIRON, V125, P432; Malik MA, 2011, J HAZARD MATER, V197, P220, DOI 10.1016/j.jhazmat.2011.09.079; MASUDA S, 1993, IEEE T IND APPL, V29, P781, DOI 10.1109/28.231994; Mista W, 2008, CATAL TODAY, V137, P345, DOI 10.1016/j.cattod.2008.02.009; Mok YS, 2003, IND ENG CHEM RES, V42, P2960, DOI 10.1021/ie0208873; Oh SM, 2006, THIN SOLID FILMS, V506, P418, DOI 10.1016/j.tsf.2005.08.105; Rappe KG, 2004, CATAL TODAY, V89, P143, DOI 10.1016/j.cattod.2003.11.020; Song CL, 2009, J HAZARD MATER, V166, P523, DOI 10.1016/j.jhazmat.2008.11.068; Staack D, 2006, PLASMA SOURCES SCI T, V15, P818, DOI 10.1088/0963-0252/15/4/027; Tu X, 2012, APPL CATAL B-ENVIRON, V125, P439, DOI 10.1016/j.apcatb.2012.06.006; Van Durme J, 2008, APPL CATAL B-ENVIRON, V78, P324, DOI 10.1016/j.apcatb.2007.09.035; Vandenbroucke AM, 2011, J HAZARD MATER, V195, P30, DOI 10.1016/j.jhazmat.2011.08.060; Walsh JL, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982497; Xu L, 2007, J PHYS D APPL PHYS, V40, P803, DOI 10.1088/0022-3727/40/3/017; Yan K, 1999, PLASMA CHEM PLASMA P, V19, P421, DOI 10.1023/A:1021824504271; Zhang PY, 2003, J PHOTOCH PHOTOBIO A, V156, P189, DOI 10.1016/S1010-6030(02)00432-X; Zhang YP, 2004, CATAL COMMUN, V5, P35, DOI 10.1016/j.catcom.2003.11.006; Zhu XM, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/40/403001	44	5	5	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59974	10.1371/journal.pone.0059974	http://dx.doi.org/10.1371/journal.pone.0059974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560062	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100037
J	Jowsey, T; McRae, IS; Valderas, JM; Dugdale, P; Phillips, R; Bunton, R; Gillespie, J; Banfield, M; Jones, L; Kljakovic, M; Yen, L				Jowsey, Tanisha; McRae, Ian S.; Valderas, Jose M.; Dugdale, Paul; Phillips, Rebecca; Bunton, Robin; Gillespie, James; Banfield, Michelle; Jones, Lesley; Kljakovic, Marjan; Yen, Laurann			Time's Up. Descriptive Epidemiology of Multi-Morbidity and Time Spent on Health Related Activity by Older Australians: A Time Use Survey	PLOS ONE			English	Article							SELF-MANAGEMENT; CHRONIC DISEASE; PRIMARY-CARE; MULTIMORBIDITY; COMORBIDITY; PEOPLE	Most Western health systems remain single illness orientated despite the growing prevalence of multi-morbidity. Identifying how much time people with multiple chronic conditions spend managing their health will help policy makers and health service providers make decisions about areas of patient need for support. This article presents findings from an Australian study concerning the time spent on health related activity by older adults (aged 50 years and over), most of whom had multiple chronic conditions. A recall questionnaire was developed, piloted, and adjusted. Sampling was undertaken through three bodies; the Lung Foundation Australia (COPD sub-sample), National Diabetes Services Scheme (Diabetes sub-sample) and National Seniors Australia (Seniors sub-sample). Questionnaires were mailed out during 2011 to 10,600 older adults living in Australia. 2540 survey responses were received and analysed. Descriptive analyses were completed to obtain median values for the hours spent on each activity per month. The mean number of chronic conditions was 3.7 in the COPD sub-sample, 3.4 in the Diabetes sub-sample and 2.0 in the NSA sub-sample. The study identified a clear trend of increased time use associated with increased number of chronic conditions. Median monthly time use was 5-16 hours per month overall for our three sub-samples. For respondents in the top decile with five or more chronic conditions the median time use was equivalent to two to three hours per day, and if exercise is included in the calculations, respondents spent from between five and eight hours per day: an amount similar to full-time work. Multi-morbidity imposes considerable time burdens on patients. Ageing is associated with increasing rates of multi-morbidity. Many older adults are facing high demands on their time to manage their health in the face of decreasing energy and mobility. Their time use must be considered in health service delivery and health system reform.	[Jowsey, Tanisha; McRae, Ian S.; Banfield, Michelle; Yen, Laurann] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia; [Valderas, Jose M.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Dugdale, Paul] Australian Natl Univ, Ctr Hlth Stewardship, ANU Med Sch, Canberra, ACT, Australia; [Phillips, Rebecca] Australian Natl Univ, Sch Sociol, Canberra, ACT, Australia; [Bunton, Robin; Jones, Lesley] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Gillespie, James] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia; [Gillespie, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia; [Kljakovic, Marjan] Australian Natl Univ, Acad Unit Gen Practice, ANU Med Sch, Canberra, ACT, Australia	Australian National University; University of Oxford; Australian National University; Australian National University; University of Hull; University of York - UK; University of Sydney; University of Sydney; Australian National University	Jowsey, T (corresponding author), Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia.	tanisha.jowsey@anu.edu.au	Dugdale, Paul/GYJ-7351-2022; Valderas, Jose M/Y-9814-2019; Valderas, Jose M/G-7967-2014; Gillespie, James/P-4007-2019	Valderas, Jose M/0000-0002-9299-1555; Gillespie, James/0000-0002-0355-4178; Jowsey, Tanisha/0000-0003-1499-9225; Phillips, Rebecca/0000-0002-7015-1934; Dugdale, Paul/0000-0002-2315-5051	National Health and Medical Research Council [402793]; National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the National Health and Medical Research Council ID (402793, 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B., 1995, TIMEWATCH SOCIAL ANA; Anstey MHR, 2012, AUST HEALTH REV, V36, P244, DOI 10.1071/AH11063; Barlow JH, 2005, J HEALTH PSYCHOL, V10, P863, DOI 10.1177/1359105305057320; Battersby M, 2007, MILBANK Q, V85, P37, DOI 10.1111/j.1468-0009.2007.00476.x; Bittman M, 2005, INT J TIME USE RES, V2, P54, DOI DOI 10.13085/eIJTUR.2.1.54-66; Black DA, 2012, AUSTR J PRIMARY HLTH, P1, DOI DOI 10.1071/PY11071.ACCESSED; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bower P, 2011, FAM PRACT, V28, P579, DOI 10.1093/fampra/cmr018; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Caughey GE, 2010, DIABETES RES CLIN PR, V87, P385, DOI 10.1016/j.diabres.2009.10.019; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; Caughey GE, 2010, AGE AGEING, V39, P488, DOI 10.1093/ageing/afq055; Cheffins TE, 2012, AUST J PRIM HEALTH, V18, P112, DOI 10.1071/PY11021; Corbin J. M., 1988, UNENDING WORK CARE M; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dixon A, 2009, PATIENT, V2, P257, DOI 10.2165/11313790-000000000-00000; Dumont S, 2010, SOC SCI MED, V71, P1890, DOI 10.1016/j.socscimed.2010.08.003; Gilbert AL, 2011, AUSTRALAS J AGEING, V30, P32, DOI 10.1111/j.1741-6612.2011.00530.x; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Harrison M, 2012, PATIENT EDUC COUNS, V87, P67, DOI 10.1016/j.pec.2011.06.007; Healthier Hospitals Tools, 2015, HLTH HOSP PRACT GREE; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Iversen MD, 2010, ANN RHEUM DIS, V69, P955, DOI 10.1136/ard.2010.129270; Jeon YH, 2010, AUST J PRIM HEALTH, V16, P66, DOI 10.1071/PY09039; Jonas DE, 2011, J AM BOARD FAM MED, V24, P380, DOI 10.3122/jabfm.2011.04.100260; Jowsey T, 2009, AUSTR NZ HLTH POLICY, V6, P1; Jowsey T, 2012, BMC PUBLIC HEALTH, V12, P1; Jowsey T, 2010, AUSTR J PRIMARY HLTH, V17, P162; Krueger AB, 2009, NY TIMES; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Morris RL, 2011, CHRONIC ILLN, V7, P147, DOI 10.1177/1742395310393365; Noffsinger EB, 2009, COOPERATIVE HEALTHCA, P99; Roughead EE., 2011, AGING HLTH, V7, P695, DOI [10.2217/ahe.11.64, DOI 10.2217/AHE.11.64, DOI 10.2217/ahe.11.64]; Russell LB, 2009, PATIENTS TIME MED CA, V47, P89; Russell LB, 2007, MED CARE, V45, P680, DOI 10.1097/MLR.0b013e3180455782; Russell LB, 2008, PATIENT, V1, P211, DOI 10.2165/1312067-200801030-00008; Safford MM, 2005, J AM BOARD FAM PRACT, V18, P262, DOI 10.3122/jabfm.18.4.262; Safford MM, 2005, J FAM PRACTICE, V54, P455; Soubhi H, 2010, ANN FAM MED, V8, P170, DOI 10.1370/afm.1056; Stata Corp L P, 2009, STAT 11; Strazdins L, 2011, ENVIRON PLANN A, V43, P545, DOI 10.1068/a4360; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Zwar N, 2006, SYSTEMATIC REV CHRON	44	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59379	10.1371/journal.pone.0059379	http://dx.doi.org/10.1371/journal.pone.0059379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117CY	23560046	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900014
J	Kidane, D; Sakkas, D; Nottoli, T; McGrath, J; Sweasy, JB				Kidane, Dawit; Sakkas, Denny; Nottoli, Timothy; McGrath, James; Sweasy, Joann B.			Kinesin 5B (KIF5B) Is Required for Progression through Female Meiosis and Proper Chromosomal Segregation in Mitotic Cells	PLOS ONE			English	Article							PROTEIN KLP3A; SPINDLE; MOUSE; CYTOKINESIS; MITOSIS; CHROMOKINESIN; INSTABILITY; CHECKPOINT; TRANSPORTS; CENTRIOLES	The fidelity of chromosomal segregation during cell division is important to maintain chromosomal stability in order to prevent cancer and birth defects. Although several spindle-associated molecular motors have been shown to be essential for cell division, only a few chromosome arm-associated motors have been described. Here, we investigated the role of Kinesin 5b (Kif5b) during female mouse meiotic cell development and mitotic cell division. RNA interference (RNAi)-mediated silencing of Kif5b in mouse oocytes induced significant delay in germinal vesicle breakdown (GVBD) and failure in extrusion of the first polar body (PBE). In mitotic cells, knockdown of Kif5b leads to centrosome amplification and a chromosomal segregation defect. These data suggest that KIF5B is critical in suppressing chromosomal instability at the early stages of female meiotic cell development and mitotic cell division.	[Kidane, Dawit; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Kidane, Dawit; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Kidane, Dawit; Sweasy, Joann B.] Yale Univ, Ctr Comprehens Canc, New Haven, CT USA; [McGrath, James] Yale Univ, Sch Med, Comparat Med Fac, Yale Anim Genom Serv, New Haven, CT USA; [Sakkas, Denny; Nottoli, Timothy] Yale Univ, Sch Med, Dept Obstet, New Haven, CT USA; [Sakkas, Denny; Nottoli, Timothy] Yale Univ, Sch Med, Dept Gynecol, New Haven, CT USA; [Sakkas, Denny; Nottoli, Timothy] Yale Univ, Sch Med, Dept Reprod Sci, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	joann.sweasy@yale.edu	Kidane, Dawit/AAQ-7109-2020		United States National Institutes of Health (NIH) [NIH/NCI 1 K01 CA15485401]; Anna Fuller Fund Postdoctoral Fellowship;  [CA 116753]; NATIONAL CANCER INSTITUTE [K01CA154854, R01CA116753] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund Postdoctoral Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DK was supported by United States National Institutes of Health (NIH) NIH/NCI 1 K01 CA15485401 and the Anna Fuller Fund Postdoctoral Fellowship. The work was also supported by CA 116753 (to J.B.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Carleton M, 2006, MOL CELL BIOL, V26, P3853, DOI 10.1128/MCB.26.10.3853-3863.2006; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Marshall Wallace F, 2002, Trends Cell Biol, V12, P9, DOI 10.1016/S0962-8924(01)02212-7; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Phelps MA, 2003, DRUG DISCOV TODAY, V8, P494, DOI 10.1016/S1359-6446(03)02707-7; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Vallente RU, 2006, CHROMOSOMA, V115, P241, DOI 10.1007/s00412-006-0058-4; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; West RR, 2002, J CELL SCI, V115, P931; Williams BC, 1997, DEVELOPMENT, V124, P2365; WILLIAMS BC, 1995, J CELL BIOL, V129, P709, DOI 10.1083/jcb.129.3.709; Wise DA, 1997, CELL MOTIL CYTOSKEL, V36, P291	40	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58585	10.1371/journal.pone.0058585	http://dx.doi.org/10.1371/journal.pone.0058585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560038	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900006
J	Oliveira, L; Ladouceur, CD; Phillips, ML; Brammer, M; Mourao-Miranda, J				Oliveira, Leticia; Ladouceur, Cecile D.; Phillips, Mary L.; Brammer, Michael; Mourao-Miranda, Janaina			What Does Brain Response to Neutral Faces Tell Us about Major Depression? Evidence from Machine Learning and fMRI	PLOS ONE			English	Article							HAPPY FACIAL EXPRESSIONS; NEUROBIOLOGICAL MARKERS; BIPOLAR DISORDER; NEURAL RESPONSES; EMOTION; PATTERN; SAD; CLASSIFICATION; RECOGNITION; UNIPOLAR	Introduction: A considerable number of previous studies have shown abnormalities in the processing of emotional faces in major depression. Fewer studies, however, have focused specifically on abnormal processing of neutral faces despite evidence that depressed patients are slow and less accurate at recognizing neutral expressions in comparison with healthy controls. The current study aimed to investigate whether this misclassification described behaviourally for neutral faces also occurred when classifying patterns of brain activation to neutral faces for these patients. Methods: Two independent depressed samples: (1) Nineteen medication-free patients with depression and 19 healthy volunteers and (2) Eighteen depressed individuals and 18 age and gender-ratio-matched healthy volunteers viewed emotional faces (sad/neutral; happy/neutral) during an fMRI experiment. We used a new pattern recognition framework: first, we trained the classifier to discriminate between two brain states (e. g. viewing happy faces vs. viewing neutral faces) using data only from healthy controls (HC). Second, we tested the classifier using patterns of brain activation of a patient and a healthy control for the same stimuli. Finally, we tested if the classifier's predictions (predictive probabilities) for emotional and neutral face classification were different for healthy controls and depressed patients. Results: Predictive probabilities to patterns of brain activation to neutral faces in both groups of patients were significantly lower in comparison to the healthy controls. This difference was specific to neutral faces. There were no significant differences in predictive probabilities to patterns of brain activation to sad faces (sample 1) and happy faces (samples 2) between depressed patients and healthy controls. Conclusions: Our results suggest that the pattern of brain activation to neutral faces in depressed patients is not consistent with the pattern observed in healthy controls subject to the same stimuli. This difference in brain activation might underlie the behavioural misinterpretation of the neutral faces content by the depressed patients.	[Oliveira, Leticia; Brammer, Michael; Mourao-Miranda, Janaina] Kings Coll London, Dept Neuroimaging, London WC2R 2LS, England; [Oliveira, Leticia] Univ Fed Fluminense, Inst Biomed, Niteroi, RJ, Brazil; [Ladouceur, Cecile D.; Phillips, Mary L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Phillips, Mary L.] Cardiff Univ, Dept Psychol Med, Cardiff CF10 3AX, S Glam, Wales; [Mourao-Miranda, Janaina] UCL, Dept Comp Sci, London, England	University of London; King's College London; Universidade Federal Fluminense; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cardiff University; University of London; University College London	Oliveira, L (corresponding author), Kings Coll London, Dept Neuroimaging, London WC2R 2LS, England.	ldol@vm.uff.br	Oliveira, Leticia/P-1159-2019; Mourao-Miranda, Janaina/AAS-2072-2021; Mourao-Miranda, Janaina/AAT-2985-2021; Ladouceur, Cecile D/H-3124-2016	Oliveira, Leticia/0000-0002-8450-2264; Mourao-Miranda, Janaina/0000-0002-3309-8441; 	National Institute of Mental Health [R01MH076971, R01MH073953, K01MH083001]; Wellcome Trust Career Development Fellowship [WT086565/Z/08/Z]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073953, K01MH083001, R01MH076971, R01MH073801] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust Career Development Fellowship(Wellcome Trust); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institute of Mental Health (MLP:R01MH076971, R01MH073953, CD:K01MH083001); NARSAD (CDL, MLP), Wellcome Trust Career Development Fellowship under grant no. WT086565/Z/08/Z (JMM), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil (LO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Ekman P., 1976, PICTURES FACIAL AFFE; First M.B., 2016, STRUCTURED CLIN INTE; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Fu CHY, 2007, AM J PSYCHIAT, V164, P599, DOI 10.1176/appi.ajp.164.4.599; Gilbert AR, 2008, J AFFECT DISORDERS, V109, P117, DOI 10.1016/j.jad.2007.12.223; Gollan JK, 2008, PSYCHIAT RES, V159, P18, DOI 10.1016/j.psychres.2007.06.011; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Lishman WA, 1994, DIAGNOSTIC STAT MANU; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Suslow T, 2004, J AFFECT DISORDERS, V83, P59, DOI 10.1016/j.jad.2004.03.003; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041	34	26	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60121	10.1371/journal.pone.0060121	http://dx.doi.org/10.1371/journal.pone.0060121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560073	gold, Green Published, Green Accepted			2022-12-27	WOS:000316930900048
J	Kacprzyk, LA; Laible, M; Andrasiuk, T; Brase, JC; Borno, ST; Falth, M; Kuner, R; Lehrach, H; Schweiger, MR; Sultmann, H				Kacprzyk, Lukasz A.; Laible, Mark; Andrasiuk, Tatjana; Brase, Jan C.; Boerno, Stefan T.; Faelth, Maria; Kuner, Ruprecht; Lehrach, Hans; Schweiger, Michal R.; Sueltmann, Holger			ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer	PLOS ONE			English	Article							EWINGS-SARCOMA TRANSLOCATION; TRANSCRIPTION FACTOR ERG; GENE-EXPRESSION; TMPRSS2-ERG FUSION; PIWI PROTEINS; SMALL RNAS; EWS GENE; GERMLINE; CELLS; FAMILY	Background: Overexpression of ERG transcription factor due to genomic ERG-rearrangements defines a separate molecular subtype of prostate tumors. One of the consequences of ERG accumulation is modulation of the cell's gene expression profile. Tudor domain-containing protein 1 gene (TDRD1) was reported to be differentially expressed between TMPRSS2:ERG-negative and TMPRSS2: ERG-positive prostate cancer. The aim of our study was to provide a mechanistic explanation for the transcriptional activation of TDRD1 in ERG rearrangement-positive prostate tumors. Methodology/Principal Findings: Gene expression measurements by real-time quantitative PCR revealed a remarkable co-expression of TDRD1 and ERG (r(2) = 0.77) but not ETV1 (r(2)< 0.01) in human prostate cancer in vivo. DNA methylation analysis by MeDIP-Seq and bisulfite sequencing showed that TDRD1 expression is inversely correlated with DNA methylation at the TDRD1 promoter in vitro and in vivo (p = -0.57). Accordingly, demethylation of the TDRD1 promoter in TMPRSS2:ERG-negative prostate cancer cells by DNA methyltransferase inhibitors resulted in TDRD1 induction. By manipulation of ERG dosage through gene silencing and forced expression we show that ERG governs loss of DNA methylation at the TDRD1 promoter-associated CpG island, leading to TDRD1 overexpression. Conclusions/Significance: We demonstrate that ERG is capable of disrupting a tissue-specific DNA methylation pattern at the TDRD1 promoter. As a result, TDRD1 becomes transcriptionally activated in TMPRSS2: ERG-positive prostate cancer. Given the prevalence of ERG fusions, TDRD1 overexpression is a common alteration in human prostate cancer which may be exploited for diagnostic or therapeutic procedures.	[Kacprzyk, Lukasz A.; Laible, Mark; Andrasiuk, Tatjana; Brase, Jan C.; Faelth, Maria; Kuner, Ruprecht; Sueltmann, Holger] Natl Ctr Tumor Dis NCT, Unit Canc Genome Res, Div Mol Genet, Heidelberg, Germany; [Kacprzyk, Lukasz A.; Laible, Mark; Andrasiuk, Tatjana; Brase, Jan C.; Faelth, Maria; Kuner, Ruprecht; Sueltmann, Holger] German Canc Res Ctr, Heidelberg, Germany; [Boerno, Stefan T.; Lehrach, Hans; Schweiger, Michal R.] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Boerno, Stefan T.] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Free University of Berlin	Kacprzyk, LA (corresponding author), UGA Biopharma GmbH, Hennigsdorf, Germany.	kacprzyk@ugabiopharma.com	Sültmann, Holger/E-4534-2013; Schweiger, Michal R/H-5270-2015	Sültmann, Holger/0000-0002-5257-8600; Schweiger, Michal R/0000-0002-4672-0623; Brase, Jan Christoph/0000-0002-1325-2528	German Federal Ministry of Education and Research [01GS0890, 01GS0891, 01GS08107, 01GS08111]; Helmholtz International Graduate School for Cancer Research of the DKFZ	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz International Graduate School for Cancer Research of the DKFZ	This work was supported by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/) in the framework of the Program for Medical Genome Research (NGFNplus; IG-Prostate Cancer, 01GS0890 and 01GS0891; IG-Mutanom, 01GS08107; Intestinal Modifier, 01GS08111) as well as the Helmholtz International Graduate School for Cancer Research of the DKFZ ((www.dkfz.de/phd/)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Baldus CD, 2004, P NATL ACAD SCI USA, V101, P3915, DOI 10.1073/pnas.0400272101; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Cooper A, 2011, CLIN CANCER RES, V17, P56, DOI 10.1158/1078-0432.CCR-10-1417; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; HART AH, 1995, ONCOGENE, V10, P1423; Heyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047892; Huang HY, 2011, EMBO J, V30, P3298, DOI 10.1038/emboj.2011.228; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; JEON IS, 1995, ONCOGENE, V10, P1229; Jhavar S, 2008, J MOL DIAGN, V10, P50, DOI 10.2353/jmoldx.2008.070085; Jhavar S, 2009, BJU INT, V103, P1256, DOI 10.1111/j.1464-410X.2008.08200.x; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Minner S, 2012, HISTOPATHOLOGY, V61, P445, DOI 10.1111/j.1365-2559.2012.04240.x; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Paulo P, 2012, NEOPLASIA, V14, P600, DOI 10.1593/neo.12600; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Singal R, 2001, CANCER RES, V61, P4820; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsuzuki S, 2011, BLOOD, V117, P3858, DOI 10.1182/blood-2010-11-320515; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wittig-Blaich SM, 2011, NEOPLASIA, V13, P579, DOI 10.1593/neo.11294; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	64	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59976	10.1371/journal.pone.0059976	http://dx.doi.org/10.1371/journal.pone.0059976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555854	Green Published, gold			2022-12-27	WOS:000317263900047
J	Raddum, AM; Evensen, L; Hollas, H; Grindheim, AK; Lorens, JB; Vedeler, A				Raddum, Aase M.; Evensen, Lasse; Hollas, Hanne; Grindheim, Ann Kari; Lorens, James B.; Vedeler, Anni			Domains I and IV of Annexin A2 Affect the Formation and Integrity of In Vitro Capillary-Like Networks	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ENDOTHELIAL-CELL RECEPTOR; ANGIOGENIC DRUG DISCOVERY; VE-CADHERIN; F-ACTIN; ADHERENS JUNCTIONS; ADHESION MOLECULE; BINDING PROTEINS; VESSEL FORMATION; MESSENGER-RNA	Annexin A2 (AnxA2) is a widely expressed multifunctional protein found in different cellular compartments. In spite of lacking a hydrophobic signal peptide, AnxA2 is found at the cell surface of endothelial cells, indicative of a role in angiogenesis. Increased extracellular levels of AnxA2 in tumours correlate with neoangiogenesis, metastasis and poor prognosis. We hypothesised that extracellular AnxA2 may contribute to angiogenesis by affecting endothelial cell-cell interactions and motility. To address this question, we studied the effect of heterotetrameric and monomeric forms of AnxA2, as well as its two soluble domains on the formation and maintenance of capillary-like structures by using an in vitro co-culture system consisting of endothelial and smooth muscle cells. In particular, addition of purified domains I and IV of AnxA2 potently inhibited the vascular endothelial growth factor (VEGF)-dependent formation of the capillary-like networks in a dose-dependent manner. In addition, these AnxA2 domains disrupted endothelial cell-cell contacts in preformed capillary-like networks, resulting in the internalisation of vascular endothelial (VE)-cadherin and the formation of VE-cadherin-containing filopodia-like structures between the endothelial cells, suggesting increased cell motility. Addition of monoclonal AnxA2 antibodies, in particular against Tyr23 phosphorylated AnxA2, also strongly inhibited network formation in the co-culture system. These results suggest that extracellular AnxA2, most likely in its Tyr phosphorylated form, plays a pivotal role in angiogenesis. The exogenously added AnxA2 domains most likely mediate their effects by competing with endogenous AnxA2 for extracellular factors necessary for the initiation and maintenance of angiogenesis, such as those involved in the formation/integrity of cell-cell contacts.	[Raddum, Aase M.; Evensen, Lasse; Hollas, Hanne; Grindheim, Ann Kari; Lorens, James B.; Vedeler, Anni] Univ Bergen, Dept Biomed, Bergen, Norway; [Raddum, Aase M.] Univ Bergen, Ctr Pharm, Bergen, Norway; [Grindheim, Ann Kari] Univ Bergen, MIC, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Vedeler, A (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Anni.Vedeler@biomed.uib.no	Lorens, James/B-9737-2017	Lorens, James/0000-0002-6782-3349	University of Bergen; Western Norway Regional Health Authority [911499]	University of Bergen; Western Norway Regional Health Authority	The study was supported financially by the University of Bergen and the Western Norway Regional Health Authority (grant no 911499)(http://www.helse-vest.no/fagfolk/forskning/det-regionale-samarbeidsorganet/Sider/side.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Aukrust I, 2007, J MOL BIOL, V368, P1367, DOI 10.1016/j.jmb.2007.02.094; Aukrust I, 2006, J MOL BIOL, V363, P469, DOI 10.1016/j.jmb.2006.08.042; Babiychuk EB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0070com; Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844; Bartoli M, 2000, J BIOL CHEM, V275, P33189, DOI 10.1074/jbc.C000318200; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Cordier-Ochsenbein F, 1998, J MOL BIOL, V279, P1163, DOI 10.1006/jmbi.1998.1829; Das S, 2010, BIOCHEMISTRY-US, V49, P2216, DOI 10.1021/bi9013038; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Drevs J, 2002, CANCER RES, V62, P4015; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Evensen L, 2010, CURR PHARM DESIGN, V16, P3958, DOI 10.2174/138161210794455030; Evensen L, 2010, CYTOM PART A, V77A, P41, DOI 10.1002/cyto.a.20808; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Flood EC, 2011, VASC PHARMACOL, V54, P59, DOI 10.1016/j.vph.2011.03.003; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1997, ANN NY ACAD SCI, V811, P337, DOI 10.1111/j.1749-6632.1997.tb52013.x; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Heyraud S, 2008, MOL CELL BIOL, V28, P1657, DOI 10.1128/MCB.00695-07; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Hollas H, 2006, BBA-MOL CELL RES, V1763, P1325, DOI 10.1016/j.bbamcr.2006.08.043; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JONES PG, 1992, J BIOL CHEM, V267, P13993; Jost M, 1997, J CELL SCI, V110, P221; Kang HM, 1999, TRENDS CARDIOVAS MED, V9, P92, DOI 10.1016/S1050-1738(99)00012-2; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Kirshner J, 2003, J BIOL CHEM, V278, P50338, DOI 10.1074/jbc.M309115200; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Ozorowski G, 2012, BIOL CHEM, V393, P1151, DOI 10.1515/hsz-2012-0184; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Roda O, 2003, J BIOL CHEM, V278, P5702, DOI 10.1074/jbc.M207605200; Rosengarth A., 2004, ANNEXINS, V1, P129; Sarkar S, 2012, AM J PHYSIOL-GASTR L, V302, pG712, DOI 10.1152/ajpgi.00406.2011; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Sharma M, 2010, EXP MOL PATHOL; Sharma M, 2012, EXP MOL PATHOL, V92, P175, DOI 10.1016/j.yexmp.2011.10.003; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; TRESSLER RJ, 1993, J CELL BIOCHEM, V53, P265, DOI 10.1002/jcb.240530311; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Valapala M, 2011, J CELL SCI, V124, P1453, DOI 10.1242/jcs.079236; Vedeler A, 2000, BIOCHEM J, V348, P565, DOI 10.1042/0264-6021:3480565; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zhao SH, 2009, MOL VIS, V15, P1231; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390; Zhou S, 2012, PROTEOMICS, V11; Zobiack N, 2002, J CELL SCI, V115, P91	81	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60281	10.1371/journal.pone.0060281	http://dx.doi.org/10.1371/journal.pone.0060281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555942	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900066
J	Collard, JM; Sanda, AKA; Jusot, JF				Collard, Jean-Marc; Sanda, Abdel-kader Alio; Jusot, Jean-Francois			Determination of Pneumococcal Serotypes in Meningitis Cases in Niger, 2003-2011	PLOS ONE			English	Article							SEQUENTIAL MULTIPLEX PCR; DETERMINING CAPSULAR SEROTYPES; STREPTOCOCCUS-PNEUMONIAE SEROTYPES; BACTERIAL-MENINGITIS; ASSAY; SURVEILLANCE; CHILDREN; VACCINE; BELT; NEED	Background: The epidemiology of pneumococcal meningitis in the African 'meningitis belt' is poorly studied. In order to ensure an effective vaccination strategy and post-vaccination surveillance, we examined the serotype distribution patterns of pneumococcal meningitis in Niger over the period 2003-2011. Methods: Cerebrospinal fluid (CSF) samples were collected from different health facilities throughout Niger in the frame of the national microbiological surveillance of meningitis. Determination of the serotype of CSF positive for pneumococci was performed using a sequential multiplex PCR method (SM-PCR) adapted with a national algorithm in which 32 different serotypes were covered and grouped into eight consecutive PCR. Results: The SM-PCR assay could predict the Sp serotype for 779 CSF (88.7%), 98 CSF (11.3%) were not-typeable in our national-adapted algorithm. In total, 26 different serotypes were identified. Serotype 1 (n = 393) was the most prevalent and accounted for 45.3% of infections, followed by serogroups/serotypes 12F/(12A)/(44)/(46) (7.3%), 6/(6A/6B/6C/6D) (5.4%), 14 (5.2%), 5 (4.6%), 23F (4.2%), 45 (3.6%), 2 (3.1%), 18/(18A/18B/18C/18F) (2.9%) and 17 others serotypes with a prevalence of less than 2%. The proportion of serotype 1 in infants(<2 years old) represented only 4.3% of the cases affected by this serotype. In contrast, serotypes 5, 6, 14, 19A and 23F were only detected in very young children. Conclusions: The proportion of serotype 1 in the pneumococcal meningitis cases and the theoretical vaccine coverage across all age groups advocates for the introduction of a conjugate vaccine (PCV10 or 13) into the Expanded Programme on Immunization (EPI) in Niger. Post-vaccine introduction surveillance supported by molecular approaches will be essential to provide a comprehensive picture of the impact of the vaccine on the burden reduction of pneumococcal meningitis and on pneumococcal serotype distribution.	[Collard, Jean-Marc; Sanda, Abdel-kader Alio; Jusot, Jean-Francois] Ctr Rech Med & Sanit CERMES, Niamey, Niger		Collard, JM (corresponding author), Ctr Rech Med & Sanit CERMES, Niamey, Niger.	jmcollard@cermes.org	Collard, Jean-Marc/Q-2342-2019	Collard, Jean-Marc/0000-0002-1490-3978	Sanofi Pasteur [Men07]; French Ministry of Foreign Affairs [2005-174]	Sanofi Pasteur; French Ministry of Foreign Affairs	This work was financially supported by Sanofi Pasteur (contract Men07) and by the French Ministry of Foreign Affairs (FSP No. 2005-174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisier P, 2007, VACCINE, V25, pA24, DOI 10.1016/j.vaccine.2007.04.036; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Centers for Disease Control and Prevention, 2012, STREPT LAB PCR DED P; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Collard JM, 2010, EMERG INFECT DIS, V16, P1496, DOI 10.3201/eid1609.100510; Cornick JE, 2011, EMERG INFECT DIS, V17, P1107, DOI [10.3201/eid1706.101404, 10.3201/eid/1706.101404]; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; DENIS FA, 1983, B WORLD HEALTH ORGAN, V61, P661; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; GAVI Alliance, 2011, PNEUM VACC SUPP GAVI; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Iraurgui P, 2010, CLIN MICROBIOL INFEC, V16, P1504, DOI 10.1111/j.1469-0691.2009.03129.x; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Jourdain S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-100; Kong F, 2007, Patent Application Publication, Patent No. [US20070020631A1, 20070020631]; Lafourcade BMN, 2010, J CLIN MICROBIOL, V48, P612, DOI 10.1128/JCM.01402-09; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Lin JS, 2006, J CLIN MICROBIOL, V44, P383, DOI 10.1128/JCM.44.2.383-388.2006; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Pneumococcal Global Serotype Project, 2007, SAGE M; Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Sidikou F, 2003, EMERG INFECT DIS, V9, P1486, DOI 10.3201/eid0911.030462; Tali-Maamar H, 2012, MED MALADIES INFECT, V42, P59, DOI 10.1016/j.medmal.2011.12.001; Wang QA, 2007, J MICROBIOL METH, V68, P128, DOI 10.1016/j.mimet.2006.07.001; World Health Organisation, 2011, REG OFF AFR MEN WEEK; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60432	10.1371/journal.pone.0060432	http://dx.doi.org/10.1371/journal.pone.0060432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555971	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200115
J	Estrada, F; Perron, P; Gay-Garcia, C; Martinez-Lopez, B				Estrada, Francisco; Perron, Pierre; Gay-Garcia, Carlos; Martinez-Lopez, Benjamin			A Time-Series Analysis of the 20th Century Climate Simulations Produced for the IPCC's Fourth Assessment Report	PLOS ONE			English	Article							TEMPERATURE CONTAIN; TREND; MODELS; BREAK	In this paper evidence of anthropogenic influence over the warming of the 20th century is presented and the debate regarding the time-series properties of global temperatures is addressed in depth. The 20th century global temperature simulations produced for the Intergovernmental Panel on Climate Change's Fourth Assessment Report and a set of the radiative forcing series used to drive them are analyzed using modern econometric techniques. Results show that both temperatures and radiative forcing series share similar time-series properties and a common nonlinear secular movement. This long-term co-movement is characterized by the existence of time-ordered breaks in the slope of their trend functions. The evidence presented in this paper suggests that while natural forcing factors may help explain the warming of the first part of the century, anthropogenic forcing has been its main driver since the 1970's. In terms of Article 2 of the United Nations Framework Convention on Climate Change, significant anthropogenic interference with the climate system has already occurred and the current climate models are capable of accurately simulating the response of the climate system, even if it consists in a rapid or abrupt change, to changes in external forcing factors. This paper presents a new methodological approach for conducting time-series based attribution studies.	[Estrada, Francisco; Gay-Garcia, Carlos; Martinez-Lopez, Benjamin] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Dept Atmospher Sci, Mexico City 04510, DF, Mexico; [Estrada, Francisco] Vrije Univ Amsterdam, Inst Environm Studies, Dept Environm Econ, Amsterdam, Netherlands; [Perron, Pierre] Boston Univ, Dept Econ, Boston, MA 02215 USA	Universidad Nacional Autonoma de Mexico; Vrije Universiteit Amsterdam; Boston University	Estrada, F (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Dept Atmospher Sci, Mexico City 04510, DF, Mexico.	feporrua@atmosfera.unam.mx	Estrada, Francisco/H-1104-2015	Martinez Lopez, Benjamin/0000-0003-0803-3854; Estrada Porrua, Francisco/0000-0002-1403-2180	Consejo Nacional de Ciencia y Tecnologia [CONACYT-310026]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	FE acknowledges financial support for this work from the Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.gob.mx) under grant CONACYT-310026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierens HJ, 2000, J BUS ECON STAT, V18, P323, DOI 10.2307/1392265; Broccoli AJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003812; Delworth TL, 2000, SCIENCE, V287, P2246, DOI 10.1126/science.287.5461.2246; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; ENGLE RF, 1993, J BUS ECON STAT, V11, P369, DOI 10.2307/1391623; Estrada F, 2010, CLIMATIC CHANGE, V101, P407, DOI 10.1007/s10584-010-9928-0; GALBRAITH JW, 1992, CLIMATIC CHANGE, V22, P209, DOI 10.1007/BF00143028; Gay-Garcia C, 2009, CLIMATIC CHANGE, V94, P333, DOI 10.1007/s10584-008-9524-8; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hegerl G, 2003, CLIVAR EXCH, V26, pS3; Intergovernmental Panel on Climate Change. & Intergovernmental Panel on Climate Change. Working Group I, 2007, CLIMATE CHANGE 2007; Ivanov MA, 2010, INT J CLIMATOL, V30, P1738, DOI 10.1002/joc.2002; Kaufmann RK, 1997, NATURE, V388, P39, DOI 10.1038/40332; Kaufmann RK, 2006, CLIMATIC CHANGE, V77, P249, DOI 10.1007/s10584-006-9062-1; Kaufmann RK, 2010, CLIMATIC CHANGE, V101, P395, DOI 10.1007/s10584-009-9711-2; Kerr RA, 2007, SCIENCE, V317, P28; Kiehl JT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031383; Kim D, 2009, J ECONOMETRICS, V148, P1, DOI 10.1016/j.jeconom.2008.08.019; Kravtsov S, 2008, J CLIMATE, V21, P1104, DOI 10.1175/2007JCLI1874.1; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Metz B, 2007, CLIMATE CHANGE 2007; Mills T. C., 2010, J COSMOL, V8, P1947; Mills TC, 2010, CLIMATIC CHANGE, V101, P415, DOI 10.1007/s10584-010-9801-1; PERRON P, 1993, ECONOMETRICA, V61, P248; Perron P, 2005, J ECONOMETRICS, V129, P65, DOI 10.1016/j.jeconom.2004.09.004; PERRON P, 1989, ECONOMETRICA, V57, P1361, DOI 10.2307/1913712; Perron P, 2009, J BUS ECON STAT, V27, P369, DOI 10.1198/jbes.2009.07268; Perron P, 2009, J ECONOMETRICS, V151, P56, DOI 10.1016/j.jeconom.2009.03.011; Raupach MR, 2010, CURR OPIN ENV SUST, V2, P210, DOI 10.1016/j.cosust.2010.04.003; Ruggieri E, 2012, INT J CLIMA IN PRESS; SAID SE, 1984, BIOMETRIKA, V71, P599; Seidel DJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004414; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Wang XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022740; WOODWARD WA, 1993, J CLIMATE, V6, P953, DOI 10.1175/1520-0442(1993)006&lt;0953:GWATPO&gt;2.0.CO;2; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683; Zheng XG, 1999, J CLIMATE, V12, P2347, DOI 10.1175/1520-0442(1999)012<2347:STSMAT>2.0.CO;2	39	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60017	10.1371/journal.pone.0060017	http://dx.doi.org/10.1371/journal.pone.0060017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555866	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200069
J	Lee, HW; Cheng, J; Kovbasnjuk, O; Donowitz, M; Guggino, WB				Lee, Ha Won; Cheng, Jie; Kovbasnjuk, Olga; Donowitz, Mark; Guggino, William B.			Insulin-Like Growth Factor 1 (IGF-1) Enhances the Protein Expression of CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PDZ-INTERACTING DOMAIN; CYSTIC-FIBROSIS GENE; PLASMA-MEMBRANE; FACTOR-I; DEPENDENT ACTIVATION; EXOCYST COMPLEX; TRAFFICKING; ASSOCIATION; GOLGI	Low levels of insulin-like growth factor 1 (IGF-1) have been observed in the serum of cystic fibrosis (CF) patients. However, the effects of low serum IGF-1 on the cystic fibrosis transmembrane conductance regulator (CFTR), whose defective function is the primary cause of cystic fibrosis, have not been studied. Here, we show in human cells that IGF-1 increases the steady-state levels of mature wildtype CFTR in a CFTR-associated ligand (CAL)- and TC10-dependent manner; moreover, IGF-1 increases CFTR-mediated chloride transport. Using an acceptor photobleaching fluorescence resonance energy transfer (FRET) assay, we have confirmed the binding of CAL and CFTR in the Golgi. We also show that CAL overexpression inhibits forskolin-induced increases in the cell-surface expression of CFTR. We found that IGF-1 activates TC10, and active TC10 alters the functional association between CAL and CFTR. Furthermore, IGF-1 and active TC10 can reverse the CAL-mediated reduction in the cell-surface expression of CFTR. IGF-1 does not increase the expression of Delta F508 CFTR, whose processing is arrested in the ER. This finding is consistent with our observation that IGF-1 alters the functional interaction of CAL and CFTR in the Golgi. However, when Delta F508 CFTR is rescued with low temperature or the corrector VRT-325 and proceeds to the Golgi, IGF-1 can increase the expression of the rescued DF508 CFTR. Our data support a model indicating that CAL-CFTR binding in the Golgi inhibits CFTR trafficking to the cell surface, leading CFTR to the degradation pathway instead. IGF-1-activated TC10 changes the interaction of CFTR and CAL, allowing CFTR to progress to the plasma membrane. These findings offer a potential strategy using a combinational treatment of IGF-1 and correctors to increase the post-Golgi expression of CFTR in cystic fibrosis patients bearing the Delta F508 mutation.	[Lee, Ha Won; Cheng, Jie; Donowitz, Mark; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kovbasnjuk, Olga] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu	Lee, Hawon/ABQ-4063-2022	Lee, Hawon/0000-0001-5382-9646	Cystic Fibrosis Foundation [GUGGINO5X0]; Korea Science and Engineering Foundation (KOSEF); National Institutes of Health [NHLBI PO1 HL51811, NIDDK PO1 DK072084, RO1 DK 58928]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026523, P30DK089502, R01DK061765, R01DK058928, P01DK072084] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cystic Fibrosis Foundation GUGGINO5X0, Korea Science and Engineering Foundation (KOSEF), and the National Institutes of Health (NHLBI PO1 HL51811 to WBG, NIDDK PO1 DK072084 to WBG, MD, OK; and RO1 DK 58928 to OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Bucuvalas JC, 2001, J PEDIATR GASTR NUTR, V33, P576, DOI 10.1097/00005176-200111000-00012; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dupraz S, 2009, J NEUROSCI, V29, P13292, DOI 10.1523/JNEUROSCI.3907-09.2009; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; GIBSON LE, 1959, PEDIATRICS, V23, P545; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hardin DS, 2005, CLIN ENDOCRINOL, V62, P560, DOI 10.1111/j.1365-2265.2005.02259.x; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KEREM BS, 1989, AM J HUM GENET, V44, P827; Kim WY, 2009, CANCER RES, V69, P7439, DOI 10.1158/0008-5472.CAN-08-3792; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Neudauer CL, 2001, BIOCHEM BIOPH RES CO, V280, P541, DOI 10.1006/bbrc.2000.4160; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SHOJI S, 1990, AM J RESP CELL MOL, V2, P553, DOI 10.1165/ajrcmb/2.6.553; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Taylor AM, 1997, ARCH DIS CHILD, V76, P304, DOI 10.1136/adc.76.4.304; Taylor AM, 1999, CLIN ENDOCRINOL, V51, P659, DOI 10.1046/j.1365-2265.1999.00858.x; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, PEDIATR PULM, P154; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80; Yu GJ, 2008, J MED CHEM, V51, P6044, DOI 10.1021/jm800533c	62	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59992	10.1371/journal.pone.0059992	http://dx.doi.org/10.1371/journal.pone.0059992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555857	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200066
J	Paul, K; Wang, ML; Mladenov, E; Bencsik-Theilen, A; Bednar, T; Wu, WQ; Arakawa, H; Iliakis, G				Paul, Katja; Wang, Minli; Mladenov, Emil; Bencsik-Theilen, Alena; Bednar, Theresa; Wu, Wenqi; Arakawa, Hiroshi; Iliakis, George			DNA Ligases I and III Cooperate in Alternative Non-Homologous End-Joining in Vertebrates	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BACKUP PATHWAYS; MAMMALIAN-CELLS; REPAIR; RADIATION; NHEJ; INVOLVEMENT; GAMMA-H2AX; DEFECTS; ABSENCE	Biochemical and genetic studies suggest that vertebrates remove double-strand breaks (DSBs) from their genomes predominantly by two non-homologous end joining (NHEJ) pathways. While canonical NHEJ depends on the well characterized activities of DNA-dependent protein kinase (DNA-PK) and LIG4/XRCC4/XLF complexes, the activities and the mechanisms of the alternative, backup NHEJ are less well characterized. Notably, the contribution of LIG1 to alternative NHEJ remains conjectural and although biochemical, cytogenetic and genetic experiments implicate LIG3, this contribution has not been formally demonstrated. Here, we take advantage of the powerful genetics of the DT40 chicken B-cell system to delineate the roles of LIG1 and LIG3 in alternative NHEJ. Our results expand the functions of LIG1 to alternative NHEJ and demonstrate a remarkable ability for LIG3 to backup DSB repair by NHEJ in addition to its essential function in the mitochondria. Together with results on DNA replication, these observations uncover a remarkable and previously unappreciated functional flexibility and interchangeability between LIG1 and LIG3.	[Paul, Katja; Wang, Minli; Mladenov, Emil; Bencsik-Theilen, Alena; Bednar, Theresa; Wu, Wenqi; Iliakis, George] Univ Duisburg Essen Med Sch, Inst Med Radiat Biol, Essen, Germany; [Arakawa, Hiroshi] German Res Ctr Environm Hlth, Inst Radiocytogenet, Helmholtz Zentrum Munchen, Neuherberg, Germany	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Iliakis, G (corresponding author), Univ Duisburg Essen Med Sch, Inst Med Radiat Biol, Essen, Germany.	Georg.Iliakis@uk-essen.de			Bundesministerium fur Bildung und Forschung of Germany [02NUK001B, 02NUK005C]	Bundesministerium fur Bildung und Forschung of Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Bundesministerium fur Bildung und Forschung of Germany, grant numbers: 02NUK001B and 02NUK005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Arakawa H, 2012, NUCLEIC ACIDS RES, V40, P2599, DOI 10.1093/nar/gkr1024; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Boboila C, 2012, P NATL ACAD SCI USA, V109, P2473, DOI 10.1073/pnas.1121470109; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chernikova SB, 1999, RADIAT RES, V151, P159, DOI 10.2307/3579766; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Dibiase SJ, 2000, CANCER RES, V60, P1245; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Iliakis George, 2007, P67, DOI 10.1007/978-3-540-71414-9_5; Iliakis G, 2009, RADIOTHER ONCOL, V92, P310, DOI 10.1016/j.radonc.2009.06.024; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; LASKO DD, 1990, J BIOL CHEM, V265, P12618; Lee K, 2007, GENETICS, V176, P2003, DOI 10.1534/genetics.107.076539; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; METZGER L, 1991, INT J RADIAT BIOL, V59, P1325, DOI 10.1080/09553009114551201; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Perrault R, 2004, J CELL BIOCHEM, V92, P781, DOI 10.1002/jcb.20104; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rosidi B, 2008, NUCLEIC ACIDS RES, V36, P1610, DOI 10.1093/nar/gkn013; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Simsek D, 2011, CELL CYCLE, V10, P3636, DOI 10.4161/cc.10.21.18094; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang HC, 2001, NUCLEIC ACIDS RES, V29, P1653, DOI 10.1093/nar/29.8.1653; Wang HC, 2001, ONCOGENE, V20, P2212, DOI 10.1038/sj.onc.1204350; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; Windhofer F, 2007, INT J RADIAT ONCOL, V68, P1462, DOI 10.1016/j.ijrobp.2007.04.038; Wu WQ, 2008, RADIAT RES, V170, P512, DOI 10.1667/RR1456.1; Wu W, 2008, DNA REPAIR, V7, P329, DOI 10.1016/j.dnarep.2007.11.008; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940	46	61	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59505	10.1371/journal.pone.0059505	http://dx.doi.org/10.1371/journal.pone.0059505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555685	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200023
J	Amato, F; Seia, M; Giordano, S; Elce, A; Zarrilli, F; Castaldo, G; Tomaiuolo, R				Amato, Felice; Seia, Manuela; Giordano, Sonia; Elce, Ausilia; Zarrilli, Federica; Castaldo, Giuseppe; Tomaiuolo, Rossella			Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis?	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPIDEMIOLOGY	Cystic fibrosis (CF) is the most frequent lethal genetic disorder among Caucasians. It depends on alterations of a chloride channel expressed by most epithelial cells and encoded by CFTR gene. Also using scanning techniques to analyze the whole coding regions of CFTR gene, mutations are not identified in up to 10% of CF alleles, and such figure increases in CFTR-related disorders (CFTR-RD). Other gene regions may be the site of causing-disease mutations. We searched for genetic variants in the 1500 bp of CFTR 39 untranslated region, typical target of microRNA (miRNA) posttranscriptional gene regulation, in either CF patients with the F508del homozygous genotype and different clinical expression (n = 20), CF (n = 32) and CFTR-RD (n = 43) patients with one or none mutation after CFTR scanning and in controls (n = 50). We identified three SNPs, one of which, the c.*1043A>C, was located in a region predicted to bind miR-433 and miR-509-3p. Such mutation was peculiar of a CFTR-RD patient that had Congenital Bilateral Absence of Vas Deferens (CBAVD), diffuse bronchiectasis, a borderline sweat chloride test and the heterozygous severe F508del mutation on the other allele. The expression analysis demonstrated that the c.*1043A>C increases the affinity for miR-509-3p and slightly decreases that for the miR-433. Both miRNAs cause in vitro a reduced expression of CFTR protein. Thus, the c.*1043A>C may act as a mild CFTR mutation enhancing the affinity for inhibitory miRNAs as a novel pathogenetic mechanism in CF.	[Amato, Felice; Giordano, Sonia; Elce, Ausilia; Zarrilli, Federica; Castaldo, Giuseppe; Tomaiuolo, Rossella] CEINGE Biotecnol Avanzate, Naples, Italy; [Amato, Felice; Giordano, Sonia; Elce, Ausilia; Zarrilli, Federica; Castaldo, Giuseppe; Tomaiuolo, Rossella] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Seia, Manuela] Fdn IRCCS Ca Granda Osped Maggiore Policlin Mangi, Med Genet Lab, Milan, Italy; [Zarrilli, Federica] Univ Molise, Dipartimento Biosci & Terr, Isernia, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Molise	Castaldo, G (corresponding author), CEINGE Biotecnol Avanzate, Naples, Italy.	giuseppe.castaldo@unina.it	Amato, Felice/AAC-6805-2022; Tomaiuolo, Rossella/AAY-9485-2020; Castaldo, Giuseppe/AAC-6782-2022; Tomaiuolo, Rossella/W-9946-2019	Castaldo, Giuseppe/0000-0002-4036-0874; Amato, Felice/0000-0002-0596-2933; Elce, Ausilia/0000-0002-7421-6176; Zarrilli, Federica/0000-0003-1614-6816; Tomaiuolo, Rossella/0000-0002-2828-782X; Giordano, Sonia/0000-0003-0608-9467	Ministero della Salute [Legge 548/93, Legge 548/07, Legge 548/08, Legge 548/12]; F.A.R.O.	Ministero della Salute(Ministry of Health, Italy); F.A.R.O.	Grants from Ministero della Salute (Legge 548/93, 2007, 2008 and 2012) and from F.A.R.O. 2010 project supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato F, 2012, J MOL DIAGN, V14, P81, DOI 10.1016/j.jmoldx.2011.09.001; Castaldo G, 2005, ANN HUM GENET, V69, P15, DOI 10.1046/j.1529-8817.2004.00130.x; Castaldo G, 2010, CLIN CHEM LAB MED, V48, P973, DOI 10.1515/CCLM.2010.182; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; MCINTOSH I, 1992, FASEB J, V6, P2775, DOI 10.1096/fasebj.6.10.1378801; Megiorni Francesca, 2011, PLoS One, V6, pe26601, DOI 10.1371/journal.pone.0026601; Salvatore F, 2002, AM J MED GENET, V111, P88, DOI 10.1002/ajmg.10461; Singh SK, 2008, FEBS J, V275, P4929, DOI 10.1111/j.1742-4658.2008.06624.x; Tomaiuolo R, 2008, J CYST FIBROS, V7, P347, DOI 10.1016/j.jcf.2007.12.004; Wirsing A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027438	13	68	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60448	10.1371/journal.pone.0060448	http://dx.doi.org/10.1371/journal.pone.0060448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555973	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500135
J	Wan, X; Chen, X; Liu, L; Zhao, Y; Huang, WJ; Zhang, Q; Miao, GG; Chen, W; Xie, HG; Cao, CC				Wan, Xin; Chen, Xin; Liu, Lin; Zhao, Ye; Huang, Wen-Juan; Zhang, Qian; Miao, Gang-Gang; Chen, Wen; Xie, Hong-Guang; Cao, Chang-Chun			Berberine Ameliorates Chronic Kidney Injury Caused by Atherosclerotic Renovascular Disease through the Suppression of NF kappa B Signaling Pathway in Rats	PLOS ONE			English	Article							RENAL-ARTERY STENOSIS; OXIDATIVE STRESS; INFLAMMATION; HYPERTENSION; MECHANISMS; MACROPHAGES; DAMAGE; NEPHROPATHY; FIBROSIS; DISTINCT	Background and objectives: Impaired renal function in atherosclerotic renovascular disease (ARD) may be the result of crosstalk between atherosclerotic renovascular stenosis and amplified oxidative stress, inflammation and fibrosis. Berberine (BBR) regulates cholesterol metabolism and exerts antioxidant effects. Accordingly, we hypothesized that BBR treatment may ameliorate ARD-induced kidney injury through its cholesterol-lowering effect and also suppression of the pathways involved in oxidative stress, inflammation and NF kappa B activation. Methods: Male rats were subjected to unilateral renal artery stenosis with silver-irritant coil, and then fed with 12-week hypercholesterolemic diet. Rats with renal artery stenosis were randomly assigned to two groups (n = 6 each) - ARD, or ARD+BBR - according to diet alone or in combination with BBR. Similarly, age-matched rats underwent sham operation and were also fed with hypercholesterolemic diet alone or in combination with BBR as two corresponding controls. Single-kidney hemodynamic metrics were measured in vivo with Doppler ultrasound to determine renal artery flow. The metrics reflecting hyperlipidemia, oxidative stress, renal structure and function, inflammation and NF kappa B activation were measured, respectively. Results: Compared with control rats, ARD rats had a significant increase in urinary albumin, plasma cholesterol, LDL and thiobarbituric acid reactive substances (TBARS) and a significant decrease in SOD activity. When exposed to 12-week BBR, ARD rats had significantly lower levels in blood pressure, LDL, urinary albumin, and TBARS. In addition, there were significantly lower expression levels of iNOS and TGF-beta in the ARD+BBR group than in the ARD group, with attenuated NF kappa B-DNA binding activity and down-regulated protein levels of subunits p65 and p50 as well as IKK beta. Conclusions: We conclude that BBR can improve hypercholesterolemia and redox status in the kidney, eventually ameliorating chronic renal injury in rats with ARD, and that BBR can act against proinflammatory and profibrotic responses through suppression of the NF kappa B signaling pathway.	[Wan, Xin; Zhao, Ye; Zhang, Qian; Cao, Chang-Chun] Nanjing Med Univ, Nanjing Hosp 1, Dept Med, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Chen, Xin; Miao, Gang-Gang; Chen, Wen] Nanjing Med Univ, Nanjing Hosp 1, Dept Surg, Div Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Liu, Lin; Huang, Wen-Juan] Xuzhou Med Coll, Dept Med, Div Nephrol, Xuzhou, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Dept Pharmacol, Sch Pharm, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University; Nanjing Medical University	Xie, HG (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing, Jiangsu, Peoples R China.	hongg.xie@gmail.com; caochangchun@njmu.edu.cn			Chinese Medical Association [09010290184]	Chinese Medical Association	This work was supported by grants from clinical research and special project funds of the Chinese Medical Association (09010290184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; An WS, 2009, AM J PHYSIOL-RENAL, V297, pF895, DOI 10.1152/ajprenal.00217.2009; Cao CC, 2004, KIDNEY INT, V65, P834, DOI 10.1111/j.1523-1755.2004.00463.x; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Chade AR, 2004, J AM SOC NEPHROL, V15, P958, DOI 10.1097/01.ASN.0000117774.83396.E9; Chade AR, 2002, CIRCULATION, V106, P1165, DOI 10.1161/01.CIR.0000027105.02327.48; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Guzik TJ, 2007, CIRC RES, V101, P227, DOI 10.1161/CIRCRESAHA.107.158295; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Iacobini C, 2009, J PATHOL, V218, P360, DOI 10.1002/path.2536; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Keddis MT, 2010, NEPHROL DIAL TRANSPL, V25, P3615, DOI 10.1093/ndt/gfq269; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Lee TS, 2010, J CELL BIOCHEM, V111, P104, DOI 10.1002/jcb.22667; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lerman LO, 2009, PROG CARDIOVASC DIS, V52, P196, DOI 10.1016/j.pcad.2009.09.002; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Nakanishi K, 2005, METABOLISM, V54, P788, DOI 10.1016/j.metabol.2005.01.023; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarna LK, 2010, CAN J PHYSIOL PHARM, V88, P369, DOI 10.1139/Y09-136; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Urbieta-Caceres VH, 2010, AM J PHYSIOL-RENAL, V299, pF135, DOI 10.1152/ajprenal.00159.2010; Vaziri ND, 2006, NAT CLIN PRACT NEPHR, V2, P582, DOI 10.1038/ncpneph0283; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; Wu CC, 2011, HYPERTENSION, V57, P788, DOI 10.1161/HYPERTENSIONAHA.110.161570; Wu N, 2011, AM J PHYSIOL-REG I, V300, pR635, DOI 10.1152/ajpregu.00441.2010	35	31	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59794	10.1371/journal.pone.0059794	http://dx.doi.org/10.1371/journal.pone.0059794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555784	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500092
J	Li, H; Liu, Q; Hou, SP; Du, LP; Zhou, QY; Zhou, Y; Kijlstra, A; Yang, PZ				Li, Hong; Liu, Qing; Hou, Shengping; Du, Liping; Zhou, Qingyun; Zhou, Yan; Kijlstra, Aize; Yang, Peizeng			TNFAIP3 Gene Polymorphisms in a Chinese Han Population with Vogt-Koyanagi-Harada Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NF-KAPPA-B; MULTIPLE AUTOIMMUNE-DISEASES; RHEUMATOID-ARTHRITIS; MONOZYGOTIC TWINS; BEHCETS-DISEASE; CELL LYMPHOMA; ASSOCIATION; VARIANTS; LOCI	Background: This study was performed to evaluate the potential association of TNFAIP3 polymorphisms with Vogt-Koyanagi-Harada (VKH) disease in a Chinese Han population. Methodology/Principal Findings: Five single-nucleotide polymorphisms (SNPs), rs10499194, rs610604, rs7753873, rs5029928 and rs9494885 of TNFAIP3 were genotyped in 834 VKH disease patients and 1415 healthy controls using a PCR-restriction fragment length polymorphism assay. An increased frequency of the C allele and CT genotype for rs9494885 were found in VKH patients in the Guangzhou and Chongqing cohorts (pc = 0.015, OR = 1.6, pc = 0.036, OR = 1.7; pc = 2.36 x 10-4, OR = 1.5, pc = 0.012, OR = 1.5, respectively). Meanwhile, a decreased frequency of the TT genotype for rs9494885 was observed in VKH patients in the Guangzhou and Chongqing cohorts (pc = 0.026, OR = 0.6, pc = 0.0074, OR = 0.7, respectively). The combined analysis showed that a significantly increased prevalence of the rs9494885 TC genotype and C allele were found in VKH disease patients compared with controls (pc = 2.26 x 10-5, OR = 1.7; pc = 1.09 x 10-5, OR = 1.6, respectively). The frequency of the TT genotype of rs9494885 was markedly lower in VKH disease patients as compared with that in controls (pc = 1.12 x 10-5, OR = 0.6; p(c) = 1.09 x 10(-5), OR = 0.6, respectively). No association was found between rs10499194, rs610604, rs7753873 and rs5029928 polymorphisms and VKH disease. To our knowledge this is the first report describing the association of a TNFAIP3 gene polymorphism with VKH disease in a Chinese Han population. Conclusions/Significance: The results suggest that the rs9494885 TC genotype and C allele may be predisposing factors to VKH disease, whereas the rs9494885 TT genotype and T allele may provide protection against this disease.	[Li, Hong; Liu, Qing; Hou, Shengping; Du, Liping; Zhou, Qingyun; Zhou, Yan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Liu, Q (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.	qingliu5566@163.com; peizengycmu@126.com	Du, Liping/M-9495-2019; Hou, Shengping/E-5250-2013		Natural Science Foundation Major International (Regional) Joint Research Project [30910103912]; National Basic Research Program of China (973 Program) [2011CB510200]; Key Project of Natural Science Foundation [81130019]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and Fund for PAR-EU Scholars Program, Key Project of Health Bureau of Chongqing [2012-1-003]	Natural Science Foundation Major International (Regional) Joint Research Project; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Project of Natural Science Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and Fund for PAR-EU Scholars Program, Key Project of Health Bureau of Chongqing	This work was supported by the Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), National Basic Research Program of China (973 Program) (2011CB510200), Key Project of Natural Science Foundation (81130019), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and Fund for PAR-EU Scholars Program, Key Project of Health Bureau of Chongqing (2012-1-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Bowes J, 2011, ANN RHEUM DIS, V70, P1641, DOI 10.1136/ard.2011.150102; Bowes J, 2010, HUM GENET, V128, P627, DOI 10.1007/s00439-010-0889-1; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Du LP, 2008, CLIN IMMUNOL, V127, P43, DOI 10.1016/j.clim.2008.01.004; FORSTER DJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P1421, DOI 10.1001/archopht.1990.01070120069031; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hou SP, 2008, MOL VIS, V14, P2597; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; ISHIKAWA A, 1994, RETINA-J RET VIT DIS, V14, P435, DOI 10.1097/00006982-199414050-00008; ITHO S, 1992, INT OPHTHALMOL, V16, P49, DOI 10.1007/BF00917073; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; OHNO S, 1981, T OPHTHAL SOC UK, V101, P335; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Prahalad S, 2009, ARTHRITIS RHEUM-US, V60, P2124, DOI 10.1002/art.24618; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; RUTZEN AR, 1995, AM J OPHTHALMOL, V119, P239, DOI 10.1016/S0002-9394(14)73884-X; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sheu SJ, 2005, CURR OPIN NEUROL, V18, P323, DOI 10.1097/01.wco.0000169753.31321.4e; Shimane K, 2010, ARTHRITIS RHEUM-US, V62, P574, DOI 10.1002/art.27190; Shindo Y, 1996, TISSUE ANTIGENS, V47, P344, DOI 10.1111/j.1399-0039.1996.tb02565.x; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; ZHAO M, 1991, ARCH OPHTHALMOL-CHIC, V109, P368, DOI 10.1001/archopht.1991.01080030070041; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zhou Q, 2013, HUM GENET	37	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59515	10.1371/journal.pone.0059515	http://dx.doi.org/10.1371/journal.pone.0059515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555688	Green Submitted, gold, Green Published			2022-12-27	WOS:000316546400047
J	Liu, JH; Yin, CH; Xia, SG; Jia, LF; Guo, YQ; Zhao, ZL; Li, XB; Han, Y; Jia, JP				Liu, Jianghong; Yin, Changhao; Xia, Shugao; Jia, Longfei; Guo, Yanqin; Zhao, Zhilian; Li, Xiaobo; Han, Ying; Jia, Jianping			White Matter Changes in Patients with Amnestic Mild Cognitive Impairment Detected by Diffusion Tensor Imaging	PLOS ONE			English	Article							ASSOCIATION FIBER TRACTS; ALZHEIMERS-DISEASE; POSTERIOR CINGULATE; CORPUS-CALLOSUM; HIPPOCAMPAL VOLUME; ABNORMAL INTEGRITY; BRAIN; PROGRESSION; SUBTYPES; DEMENTIA	Compared to normal aging adults, individuals with amnestic mild cognitive impairment (aMCI) have significantly increased risk for progressing into Alzheimer's disease (AD). Autopsy studies found that most of the brains of aMCI cases showed anatomical features associated with AD pathology. The recent development of non-invasive neuroimaging technique, such as diffusion tensor imaging (DTI), makes it possible to investigate the microstructures of the cerebral white matter in vivo. We hypothesized that disrupted white matter (WM) integrity existed in aMCI. So we used DTI technique, by measuring fractional anisotropy (FA) and mean diffusivity (MD), to test the brain structures involved in patients with aMCI. DTI scans were collected from 40 patients with aMCI, and 28 normal controls (NC). Tract-based spatial statistics (TBSS) analyses of whole-brain FA and MD images in each individual and group comparisons were carried out. Compared to NC, aMCI patients showed significant FA reduction bilaterally, in the association and projection fibers of frontal, parietal, and temporal lobes, corpus callosum, bilateral corona radiation, right posterior thalamic radiation and right sagittal stratum. aMCI patients also showed significantly increased MD widespreadly in the association and projection fibers of frontal, parietal and temporal lobes, and corpus callosum. Assessment of the WM integrity of the frontal, parietal, temporal lobes, and corpus callosum by using DTI measures may aid early diagnosis of aMCI.	[Liu, Jianghong; Han, Ying; Jia, Jianping] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Liu, Jianghong; Han, Ying; Jia, Jianping] Minist Educ Peoples Republ China, Key Neurodegenerat Lab, Beijing, Peoples R China; [Yin, Changhao; Guo, Yanqin] Hongqi Hosp, Dept Neurol, Mudanjiang Med Coll, Mudangjiang, Peoples R China; [Xia, Shugao; Li, Xiaobo] Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, Bronx, NY USA; [Xia, Shugao; Li, Xiaobo] Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Neurosci, Bronx, NY USA; [Xia, Shugao; Li, Xiaobo] Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Psychiat, Bronx, NY USA; [Xia, Shugao; Li, Xiaobo] Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Behav Sci, Bronx, NY USA; [Jia, Longfei] Capital Med Univ, Tongren Hosp, Dept Neurol, Beijing, Peoples R China; [Zhao, Zhilian] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Ministry of Education, China; Mudanjiang Medical University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Capital Medical University; Capital Medical University	Li, XB (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, Bronx, NY USA.	xli.aecom@gmail.com; sophiehany@hotmail.com	Han, Ying/H-7111-2017; Jia, Longfei/B-9842-2014; Xia, Shugao/F-6845-2013	Xia, Shugao/0000-0002-2960-3468; Jia, Jianping/0000-0003-4624-0336	National Natural Science Foundation of China [30970823]; key project of the National Natural Science Foundation of China [30830045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30970823) and the key project of the National Natural Science Foundation of China (30830045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Bai F, 2009, NEUROSCI LETT, V462, P147, DOI 10.1016/j.neulet.2009.07.009; Bai F, 2009, J NEUROL SCI, V278, P102, DOI 10.1016/j.jns.2008.12.009; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Cacciari C, 2010, J ALZHEIMERS DIS, V20, P501, DOI 10.3233/JAD-2010-1384; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Delano-Wood L, 2012, J ALZHEIMERS DIS, V29, P589, DOI 10.3233/JAD-2012-102103; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Ding B, 2008, DEMENT GERIATR COGN, V25, P218, DOI 10.1159/000113948; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Fouquet M, 2012, NEUROIMAGE, V59, P3309, DOI 10.1016/j.neuroimage.2011.11.036; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; He J, 2009, ARCH NEUROL-CHICAGO, V66, P1393, DOI 10.1001/archneurol.2009.252; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Knopman DS, 2003, MAYO CLIN PROC, V78, P1290, DOI 10.4065/78.10.1290; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Lee KS, 2011, ARCH GERONTOL GERIAT; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Rogalski EJ, 2009, BEHAV NEUROL, V21, P51, DOI [10.3233/BEN-2009-0235, 10.1155/2009/408037]; Rose SE, 2006, J NEUROL NEUROSUR PS, V77, P1122, DOI 10.1136/jnnp.2005.074336; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Saito Y, 2007, NEUROPATHOLOGY, V27, P578, DOI 10.1111/j.1440-1789.2007.00806.x; Shim YS, 2008, CLIN NEUROL NEUROSUR, V110, P552, DOI 10.1016/j.clineuro.2008.02.021; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Teipel SJ, 2009, HUM BRAIN MAPP, V30, P2098, DOI 10.1002/hbm.20652; Thillainadesan S, 2012, INT PSYCHOGERIATR, V24, P1483, DOI 10.1017/S1041610212000270; van de Pol LA, 2009, J NEUROL NEUROSUR PS, V80, P1069, DOI 10.1136/jnnp.2008.158881; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P1130, DOI 10.1001/archneur.64.8.1130; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Xie YF, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-44; Xie Yu-Feng, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P95; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01	67	25	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59440	10.1371/journal.pone.0059440	http://dx.doi.org/10.1371/journal.pone.0059440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555673	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400040
J	Chou, CY; Huang, CK; Lu, KW; Horng, TL; Lin, WL				Chou, Cheng-Ying; Huang, Chih-Kang; Lu, Kuo-Wei; Horng, Tzyy-Leng; Lin, Win-Li			Investigation of the Spatiotemporal Responses of Nanoparticles in Tumor Tissues with a Small-Scale Mathematical Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-KILLING ACTION; VASCULAR-PERMEABILITY; EXTRACELLULAR-MATRIX; MACROMOLECULAR THERAPEUTICS; INTERSTITIAL PRESSURE; SUBCUTANEOUS TUMORS; SOLID TUMORS; TRANSPORT; DELIVERY	The transport and accumulation of anticancer nanodrugs in tumor tissues are affected by many factors including particle properties, vascular density and leakiness, and interstitial diffusivity. It is important to understand the effects of these factors on the detailed drug distribution in the entire tumor for an effective treatment. In this study, we developed a small-scale mathematical model to systematically study the spatiotemporal responses and accumulative exposures of macromolecular carriers in localized tumor tissues. We chose various dextrans as model carriers and studied the effects of vascular density, permeability, diffusivity, and half-life of dextrans on their spatiotemporal concentration responses and accumulative exposure distribution to tumor cells. The relevant biological parameters were obtained from experimental results previously reported by the Dreher group. The area under concentration-time response curve (AUC) quantified the extent of tissue exposure to a drug and therefore was considered more reliable in assessing the extent of the overall drug exposure than individual concentrations. The results showed that 1) a small macromolecule can penetrate deep into the tumor interstitium and produce a uniform but low spatial distribution of AUC; 2) large macromolecules produce high AUC in the perivascular region, but low AUC in the distal region away from vessels; 3) medium-sized macromolecules produce a relatively uniform and high AUC in the tumor interstitium between two vessels; 4) enhancement of permeability can elevate the level of AUC, but have little effect on its uniformity while enhancement of diffusivity is able to raise the level of AUC and improve its uniformity; 5) a longer half-life can produce a deeper penetration and a higher level of AUC distribution. The numerical results indicate that a long half-life carrier in plasma and a high interstitial diffusivity are the key factors to produce a high and relatively uniform spatial AUC distribution in the interstitium.	[Chou, Cheng-Ying; Huang, Chih-Kang] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Lu, Kuo-Wei; Lin, Win-Li] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Kuo-Wei; Lin, Win-Li] Natl Hlth Res Inst, Med Engn Res Div, Miaoli, Taiwan; [Horng, Tzyy-Leng] Feng Chia Univ, Dept Appl Math, Taichung 40724, Taiwan	National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan; Feng Chia University	Horng, TL (corresponding author), Feng Chia Univ, Dept Appl Math, Taichung 40724, Taiwan.	tlhorng@math.fcu.edu.tw; winli@ntu.edu.tw		CHOU, CHENG-YING/0000-0002-5737-6960	National Science Council [NSC 99-2221-E-002-043-MY3, NSC 98-2115-M-035-001-MY2, NSC 99-2120-M-002-003, NSC 100-2632-E-035 -001-MY3, NSC 101-2115-M-035-001]; National Health Research Institutes [NHRI-MP-100-PP-13]; Taida Institute for Mathematical Science (TIMS); National Center for Theoretical Sciences (NCTS)	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Taida Institute for Mathematical Science (TIMS); National Center for Theoretical Sciences (NCTS)	This work was supported in part by: National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp = 7) under grant Nos. NSC 99-2221-E-002-043-MY3, NSC 98-2115-M-035-001-MY2, NSC 99-2120-M-002-003, NSC 100-2632-E-035 -001-MY3, and NSC 101-2115-M-035-001; and National Health Research Institutes (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do) under grant No. NHRI-MP-100-PP-13. Author TLH also acknowledges the support from Taida Institute for Mathematical Science (TIMS) (http://www.tims.ntu.edu.tw/) and the National Center for Theoretical Sciences (NCTS) (http://www.cts.nthu.edu.tw/main.php). All the funders mentioned above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGIRE GH, 1945, J NATL CANCER I, V6, P73, DOI 10.1093/jnci/6.1.73; Banerjee RK, 2001, J CONTROL RELEASE, V74, P193, DOI 10.1016/S0168-3659(01)00317-0; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BOUCHER Y, 1990, CANCER RES, V50, P4478; Campbell RB, 2002, CANCER RES, V62, P6831; Dellian M, 2000, BRIT J CANCER, V82, P1513; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Duffull SB, 1997, CLIN PHARMACOKINET, V33, P161, DOI 10.2165/00003088-199733030-00002; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Gasselhuber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047453; GERLOWSKI LE, 1986, MICROVASC RES, V31, P288, DOI 10.1016/0026-2862(86)90018-X; Goodman TT, 2008, BIOTECHNOL BIOENG, V101, P388, DOI 10.1002/bit.21910; Graff CP, 2003, CANCER RES, V63, P1288; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; JAIN RK, 1987, CANCER RES, V47, P3039; Jones D, 2002, PHARM STAT, P30; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Koning GA, 2010, PHARM RES-DORDR, V27, P1750, DOI 10.1007/s11095-010-0154-2; Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8; Kuszyk BS, 2001, AM J ROENTGENOL, V177, P747, DOI 10.2214/ajr.177.4.1770747; Kwon Y, 2001, HDB ESSENTIAL PHARMA, P19; Lewis WH, 1927, B JOHNS HOPKINS HOSP, V41, P156; Lin CY, 2010, J CONTROL RELEASE, V146, P291, DOI 10.1016/j.jconrel.2010.05.033; Lin YC, 1997, MOL BIOL CELL, V8, P59, DOI 10.1091/mbc.8.1.59; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Magzoub M, 2008, FASEB J, V22, P276, DOI 10.1096/fj.07-9150com; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Nagai N, 1997, CANCER CHEMOTH PHARM, V40, P11, DOI 10.1007/s002800050618; Netti PA, 2000, CANCER RES, V60, P2497; Okamoto H, 1999, J CLIN ONCOL, V17, P3540, DOI 10.1200/JCO.1999.17.11.3540; OZAWA S, 1988, CANCER CHEMOTH PHARM, V21, P185; OZAWA S, 1989, CANCER CHEMOTH PHARM, V23, P279, DOI 10.1007/BF00292404; Peiris PM, 2012, ACS NANO, V6, P4157, DOI 10.1021/nn300652p; Pellegrin P, 2002, MOL BIOL CELL, V13, P570, DOI 10.1091/mbc.01-06-0280; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602; Sandison JC, 1928, AM J ANAT, V41, P475, DOI 10.1002/aja.1000410304; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Stylianopoulos T, 2010, BIOPHYS J, V99, P1342, DOI 10.1016/j.bpj.2010.06.016; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Watson KD, 2012, CANCER RES, V72, P1485, DOI 10.1158/0008-5472.CAN-11-3232; Wong C, 2011, P NATL ACAD SCI USA, V108, P2426, DOI 10.1073/pnas.1018382108; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	47	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59135	10.1371/journal.pone.0059135	http://dx.doi.org/10.1371/journal.pone.0059135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565142	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300009
J	Pezeshkian, B; Donnelly, C; Tamburo, K; Geddes, T; Madlambayan, GJ				Pezeshkian, Bahareh; Donnelly, Christopher; Tamburo, Kelley; Geddes, Timothy; Madlambayan, Gerard J.			Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MARROW VASCULAR NICHE; SELECTIN LIGANDS; PROGENITOR CELLS; SOLUBLE FACTORS; GROWTH-FACTOR; IN-VITRO; PROLIFERATION; EXPRESSION; VIVO	In acute myeloid leukemia (AML), the chances of achieving disease-free survival are low. Studies have demonstrated a supportive role of endothelial cells (ECs) in normal hematopoiesis. Here we show that similar intercellular relationships exist in leukemia. We demonstrate that leukemia cells themselves initiate these interactions by directly modulating the behavior of resting ECs through the induction of EC activation. In this inflammatory state, activated ECs induce the adhesion of a subset of leukemia cells through the cell adhesion molecule E-selectin. These adherent leukemia cells are sequestered in a quiescent state and are unaffected by chemotherapy. The ability of adherent cells to later detach and again become proliferative following exposure to chemotherapy suggests a role of this process in relapse. Interestingly, differing leukemia subtypes modulate this process to varying degrees, which may explain the varied response of AML patients to chemotherapy and relapse rates. Finally, because leukemia cells themselves induce EC activation, we postulate a positive-feedback loop in leukemia that exists to support the growth and relapse of the disease. Together, the data defines a new mechanism describing how ECs and leukemia cells interact during leukemogenesis, which could be used to develop novel treatments for those with AML.	[Pezeshkian, Bahareh; Donnelly, Christopher; Tamburo, Kelley; Madlambayan, Gerard J.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA; [Geddes, Timothy] William Beaumont Hlth Syst, Radiat Oncol, Royal Oak, MI USA	Oakland University; Beaumont Health	Madlambayan, GJ (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.	madlamba@oakland.edu		Madlambayan, Gerard/0000-0003-1471-5915	Oakland University	Oakland University	Funds used to carry out these studies were from Oakland University start-up funds provided to Dr. Madlambayan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2006, CIRC RES, V98, P159, DOI 10.1161/01.RES.0000204553.32549.a7; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Barbaric D, 2007, BLOOD, V109, P2314, DOI 10.1182/blood-2005-11-025536; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; CAVENAGH JD, 1993, BRIT J HAEMATOL, V85, P285, DOI 10.1111/j.1365-2141.1993.tb03168.x; Chase SD, 2012, ANN BIOMED ENG, V40, P849, DOI 10.1007/s10439-011-0507-y; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Chute JP, 2005, BLOOD, V105, P576, DOI 10.1182/blood-2004-04-1467; Chute JP, 2004, EXP HEMATOL, V32, P308, DOI 10.1016/j.exphem.2003.12.002; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Fiedler W, 1997, BLOOD, V89, P1870, DOI 10.1182/blood.V89.6.1870; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Hatfield K, 2006, INT J CANCER, V119, P2313, DOI 10.1002/ijc.22180; Hatfield K, 2009, BRIT J HAEMATOL, V144, P53, DOI 10.1111/j.1365-2141.2008.07411.x; Hu SY, 2011, J NATL CANCER I, V103, P893, DOI 10.1093/jnci/djr107; Hussong JW, 2000, BLOOD, V95, P309; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kerr SC, 2008, J IMMUNOL, V181, P1480, DOI 10.4049/jimmunol.181.2.1480; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kuldo Joanna M., 2005, Current Vascular Pharmacology, V3, P11, DOI 10.2174/1570161052773898; Lengfelder E, 2009, LEUKEMIA, V23, P2248, DOI 10.1038/leu.2009.183; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Madlambayan GJ, 2010, BLOOD, V116, P1539, DOI 10.1182/blood-2009-06-230474; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Muramoto GG, 2006, BIOL BLOOD MARROW TR, V12, P530, DOI 10.1016/j.bbmt.2005.12.039; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Petit I, 2008, BLOOD, V111, P1951, DOI 10.1182/blood-2007-05-089219; REUSSBORST MA, 1995, LEUKEMIA, V9, P869; Ribatti D, 2010, LEUKEMIA, V24, P1247, DOI 10.1038/leu.2010.103; Rigolin GM, 2007, EUR J HAEMATOL, V78, P365, DOI 10.1111/j.1600-0609.2007.00839.x; Rizzi M, 2007, J LEUKOCYTE BIOL, V81, P1599, DOI 10.1189/jlb.0606400; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Schliemann C, 2006, HAEMATOLOGICA, V91, P1203; SEMPERE A, 1993, LEUKEMIA LYMPHOMA, V12, P103, DOI 10.3109/10428199309059577; Shu Q, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3812; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; STASI R, 1994, BLOOD, V83, P1619, DOI 10.1182/blood.V83.6.1619.bloodjournal8361619; Stucki A, 2001, BLOOD, V97, P2121, DOI 10.1182/blood.V97.7.2121; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tu LL, 1996, J IMMUNOL, V157, P3995; Wang L, 2007, BLOOD, V110, P3334, DOI 10.1182/blood-2007-01-068122; Watarai M, 2002, LEUKEMIA, V16, P112, DOI 10.1038/sj.leu.2402326; WILLMSKR.K, 1967, LAB INVEST, V17, P334; Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang J, 2010, TOXICOL PATHOL, V38, P856, DOI 10.1177/0192623310378866	54	43	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60823	10.1371/journal.pone.0060823	http://dx.doi.org/10.1371/journal.pone.0060823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560111	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900081
J	Hashizume, M; Chaves, LF; Faruque, ASG; Yunus, M; Streatfield, K; Moji, K				Hashizume, Masahiro; Fernando Chaves, Luis; Faruque, A. S. G.; Yunus, Md; Streatfield, Kim; Moji, Kazuhiko			A Differential Effect of Indian Ocean Dipole and El Nino on Cholera Dynamics in Bangladesh	PLOS ONE			English	Article							VIBRIO-CHOLERAE; INFECTIOUS-DISEASE; CLIMATE-VARIABILITY; MALARIA EPIDEMICS; WAVELET ANALYSIS; ENDEMIC CHOLERA; GLOBAL CLIMATE; ENSO; RAINFALL; MODE	Background: A stationary (i.e., constant through time) association between El Nino Southern Oscillation (ENSO), the Indian Ocean Dipole (IOD) and epidemics of cholera in Bangladesh has been widely assumed. However, whether or not elements of the local climate that are relevant for cholera transmission have stationary signatures of the IOD on their dynamics over different time scales is still not clear. Here we report results on the time-varying relationships between the various remote and local environmental drivers and cholera incidence in Bangladesh. Methodology/Principal Findings: We performed a cross wavelet coherency analysis to examine patterns of association between monthly cholera cases in the hospitals in Dhaka and Matlab (1983-2008) and indices for both IOD and ENSO. Our results showed that the strength of both the IOD and ENSO associations with cholera hospitalizations changed across time scales during the study period. In Dhaka, 4-year long coherent cycles were observed between cholera and the index of IOD in 1988-1997. In Matlab, the effect of ENSO was more dominant while there was no evidence for an IOD effect on cholera hospitalizations. Conclusions/Significance: Our results call for the consideration of non-stationary, possibly non-linear, patterns of association between cholera hospitalizations and climatic factors in cholera epidemic early warning systems.	[Hashizume, Masahiro; Fernando Chaves, Luis] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Hashizume, Masahiro; Fernando Chaves, Luis] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Fernando Chaves, Luis] Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica; [Faruque, A. S. G.; Yunus, Md; Streatfield, Kim] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Moji, Kazuhiko] Res Inst Humanity & Nat, Kyoto, Japan	Nagasaki University; Nagasaki University; Universidad Nacional Costa Rica; International Centre for Diarrhoeal Disease Research (ICDDR); Research Institute for Humanity & Nature (RIHN)	Hashizume, M (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	hashizum@nagasaki-u.ac.jp	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Hashizume, Masahiro/0000-0003-4720-1750	EcoHealth Project, Research Institute for Humanity and Nature, Kyoto, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [20790441]; Nagasaki University; Japan Society for the Promotion of Science	EcoHealth Project, Research Institute for Humanity and Nature, Kyoto, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagasaki University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the EcoHealth Project, Research Institute for Humanity and Nature, Kyoto, Japan and by Grants-in-Aid for Scientific Research (20790441) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. LFC is funded by a Nagasaki University Cooperative grant and Japan Society for the Promotion of Science. The International Centre for Diarrhoeal Disease Research, Bangladesh acknowledges with gratitude the commitment of the Research Institute for Humanity and Nature, Japan to its research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Ajayamohan RS, 2008, J METEOROL SOC JPN, V86, P245, DOI 10.2151/jmsj.86.245; Akanda AS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009914; Akanda AS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039312; Annamalai H, 2003, DEEP-SEA RES PT II, V50, P2305, DOI 10.1016/S0967-0645(03)00058-4; Ashok K, 2004, J CLIMATE, V17, P3141, DOI 10.1175/1520-0442(2004)017&lt;3141:IACIOE&gt;2.0.CO;2; Ashok K, 2001, GEOPHYS RES LETT, V28, P4499, DOI 10.1029/2001GL013294; Behera SK, 2006, J CLIMATE, V19, P1688, DOI 10.1175/JCLI3797.1; Bolker B, 2008, ECOLOGICAL MODELS DA; Bouma MJ, 2001, HYDROBIOLOGIA, V460, P147, DOI 10.1023/A:1013165215074; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Chaves LF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000033; COCKBURN TA, 1960, PUBLIC HEALTH REP, V75, P791, DOI 10.2307/4590925; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; de Magny GC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-20; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Fischer AS, 2005, J CLIMATE, V18, P3428, DOI 10.1175/JCLI3478.1; Han WQ, 2002, J PHYS OCEANOGR, V32, P216, DOI 10.1175/1520-0485(2002)032<0216:FMOSLI>2.0.CO;2; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00269; Hashizume M, 2011, ENVIRON HEALTH PERSP, V119, P239, DOI 10.1289/ehp.1002302; Hashizume M, 2010, EPIDEMIOLOGY, V21, P706, DOI 10.1097/EDE.0b013e3181e5b053; Hay SI, 2003, LANCET, V361, P1705, DOI 10.1016/S0140-6736(03)13366-1; Hong CC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009151; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; *ICDDRB, 2006, HLTH DEM SURV SYST M, V35; ISLAM MS, 1994, J DIARRHOEAL DIS RES, V12, P87; ISLAM MS, 1989, J TROP MED HYG, V92, P396; Jensen TG, 2007, J CLIMATE, V20, P2869, DOI 10.1175/JCLI4286.1; Jutla AS, 2011, AM J TROP MED HYG, V85, P303, DOI 10.4269/ajtmh.2011.11-0181; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Luo JJ, 2007, J CLIMATE, V20, P2178, DOI 10.1175/JCLI4132.1; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; SHUMWAY RH, 2000, TIME SERIES ANAL ITS; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; World Health Organization, 2005, US CLIM PRED INF DIS; YAMAGATA T, 2004, EARTH CLIMATE OCEAN	54	16	18	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60001	10.1371/journal.pone.0060001	http://dx.doi.org/10.1371/journal.pone.0060001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555861	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900050
J	McNabb-Baltar, J; Trinh, QD; Barkun, AN				McNabb-Baltar, Julia; Quoc-Dien Trinh; Barkun, Alan N.			Disparities in Outcomes following Admission for Cholangitis	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; LENGTH-OF-STAY; RACIAL DISPARITIES; COLORECTAL-CARCINOMA; PORTAL-HYPERTENSION; COMORBIDITY INDEX; INSURANCE STATUS; HEALTH-CARE; WEEKEND; QUALITY	Introduction: Few have examined determinants of adverse outcomes in patients presenting with ascending cholangitis. The objective of this study was to examine factors associated with in-hospital mortality, prolonged length of stay (LOS) and increased hospital charges (HC) in patients presenting with acute cholangitis. Methods: Within the Health Care Utilization Project Nationwide Inpatient Sample (NIS), we focused on patients, 18 years and older, admitted to the emergency department with cholangitis as primary diagnosis (1998-2009). Models were fitted to predict likelihood of in-hospital mortality, prolonged LOS and increased HC. Covariates included race, day of admission, insurance status, socio-economical status and other patient and hospital characteristics. Results: Overall, weighted estimates of 248,942 patients were admitted with acute cholangitis between 1998 and 2009, of which 13,534 (5.4%) died during the admission. Multivariable analyses revealed that relative to Caucasian patients, African American, Hispanic and Asian and Pacific Islander patients were more likely to die (OR = 1.61, p<0.001, OR = 1.20, p = 0.01 and OR = 1.26, p = 0.008), to experience a prolonged LOS (OR = 1.77, p<0.001, OR = 1.30, p<0.001, 1.34, p<0.001), and to incur high HC (OR = 1.83, p<0.001, OR = 1.51, p<0.001, OR = 1.56, p<0.001). Moreover, Medicaid and Medicare patients were more likely to die (OR = 1.64, p<0.001, OR = 1.24, p<0.001), to experience a prolonged LOS (1.74, p<0.001, OR = 1.25, p<0.001) and to incur high HC (OR = 1.23, p = 0.002, OR = 1.12, p = 0.002) compared to privately insured patients. In subgroup analysis, there were no differences for Medicare patients age 65 years and over. However, those under 65, most of whom have disability or end stage renal disease, were more likely to experience the negative outcomes. Conclusion: Race and insurance status represent independent predictors of in-hospital mortality and adverse outcomes in patients presenting with cholangitis. Whether these disparities are due to biological predisposition or unequal quality of care requires further investigation. Regardless, efforts should be made to reduce these outcome disparities.	[McNabb-Baltar, Julia; Barkun, Alan N.] McGill Univ, Div Gastroenterol, Montreal, PQ, Canada; [Quoc-Dien Trinh] Henry Ford Hlth Syst, Dept Surg, Detroit, MI USA; [Quoc-Dien Trinh] Univ Montreal, Canc Prognost & Hlth Outcomes Unit, Ctr Hlth, Montreal, PQ, Canada	McGill University; Henry Ford Health System; Henry Ford Hospital; Universite de Montreal	McNabb-Baltar, J (corresponding author), McGill Univ, Div Gastroenterol, Montreal, PQ, Canada.	julia.mcnabb-baltar@mail.mcgill.ca						Ananthakrishnan AN, 2009, CLIN GASTROENTEROL H, V7, P296, DOI 10.1016/j.cgh.2008.08.013; Anger JT, 2007, J UROLOGY, V177, P1846, DOI 10.1016/j.juro.2007.01.035; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; BOEY JH, 1980, ANN SURG, V191, P264, DOI 10.1097/00000658-198003000-00002; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; DARLING DA, 1957, ANN MATH STAT, V28, P823, DOI 10.1214/aoms/1177706788; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Downing SR, 2010, ARCH SURG-CHICAGO, V145, P785, DOI 10.1001/archsurg.2010.131; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Glenn LL, 1999, J RURAL HEALTH, V15, P94, DOI 10.1111/j.1748-0361.1999.tb00603.x; Halpern MT, 2008, LANCET ONCOL, V9, P222, DOI 10.1016/S1470-2045(08)70032-9; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Janssen-Heijnen MLG, 2007, EUR J CANCER, V43, P2179, DOI 10.1016/j.ejca.2007.06.008; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Khuri SF, 2001, ANN SURG, V234, P370, DOI 10.1097/00000658-200109000-00011; Lee CC, 2007, AM J GASTROENTEROL, V102, P563, DOI 10.1111/j.1572-0241.2007.01095.x; Luyt CE, 2007, CRIT CARE MED, V35, P3, DOI 10.1097/01.CCM.0000249832.36518.11; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; Mayumi T, 2007, J HEPATO-BILIARY-PAN, V14, P114, DOI 10.1007/s00534-006-1163-8; Nathan H, 2008, J AM COLL SURGEONS, V207, P312, DOI 10.1016/j.jamcollsurg.2008.04.015; Nguyen GC, 2008, CLIN GASTROENTEROL H, V6, P1146, DOI 10.1016/j.cgh.2008.05.024; Nguyen GC, 2007, HEPATOLOGY, V45, P1282, DOI 10.1002/hep.21580; Ouellette JR, 2004, J GASTROINTEST SURG, V8, P1061, DOI 10.1016/j.gassur.2004.09.045; Perelman J, 2008, SOC SCI MED, V66, P88, DOI 10.1016/j.socscimed.2007.07.013; Ren Z, 2011, HEPATOGASTROENTEROLO, V59; REYNOLDS BM, 1959, ANN SURG, V150, P299, DOI 10.1097/00000658-195908000-00013; Saha S, 2003, AM J PUBLIC HEALTH, V93, P1713, DOI 10.2105/AJPH.93.10.1713; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Schyve PM, 2007, J GEN INTERN MED, V22, P360, DOI 10.1007/s11606-007-0365-3; Shao YH, 2009, JNCI-J NATL CANCER I, V101, P1280, DOI 10.1093/jnci/djp262; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; WELCH HG, 1993, HEALTH SERV RES, V28, P441	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59487	10.1371/journal.pone.0059487	http://dx.doi.org/10.1371/journal.pone.0059487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555680	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900013
J	Wang, JH; Dong, YH; Zhou, TL; Liu, XL; Deng, YY; Wang, C; Lee, J; Zhang, LH				Wang, Jianhe; Dong, Yihu; Zhou, Tielin; Liu, Xiaoling; Deng, Yinyue; Wang, Chao; Lee, Jasmine; Zhang, Lian-Hui			Pseudomonas aeruginosa Cytotoxicity Is Attenuated at High Cell Density and Associated with the Accumulation of Phenylacetic Acid	PLOS ONE			English	Article							III SECRETION SYSTEM; BACTERIAL PATHOGENS; GENE-EXPRESSION; VIRULENCE; PROTEIN; PERSISTENCE; INFECTIONS; REGULON; ACTIN; RNA	Background: p.aeruginosa is known to cause acute cytotoxicity against various human and animal cells and tissues. Methodology/Findings: Intriguingly, however, in this study we noticed that while a low cell density inoculum of P. aeruginosa caused severe cytotoxicity against human lung tissue cell line A549, increasing the cell density of bacterial inoculum led to decreased cytotoxicity. Addition of the supernatants from high density bacterial culture to low cell density inoculum protected the human cells from bacterial cytotoxic damage, suggesting that P. aeruginosa may produce and accumulate an inhibitory molecule(s) counteracting its pathogenic infection. The inhibitor was purified from the stationary-phase culture supernatants of P. aeruginosa strain PAO1 using bioassay-guided high performance liquid chromatography (HPLC), and characterized to be phenylacetic acid (PAA) by mass spectrometry and nuclear magnetic resonance spectroscopy. Microarray analysis revealed that treatment of P. aeruginosa with PAA down-regulated the transcriptional expression of Type III secretion system (T3SS) genes and related regulatory genes including rsmA and vfr, which were confirmed by transcriptional and translational analysis. Conclusions: Identification of bacterial metabolite PAA as a T3SS-specific inhibitor explains this intriguing inverse celldensity-dependent- cytotoxicity phenomenon as T3SS is known to be a key virulence factor associated with cytotoxicity and acute infection. The findings may provide useful clues for design and development of new strategies to combat this formidable bacterial pathogen.	[Wang, Jianhe; Dong, Yihu; Zhou, Tielin; Liu, Xiaoling; Deng, Yinyue; Wang, Chao; Lee, Jasmine; Zhang, Lian-Hui] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Zhang, Lian-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Zhang, LH (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	lianhui@imcb.a-star.edu.sg	Liu, Xiaoling/HGD-3566-2022		Biomedical Research Council; Agency of Science , Technology and Research (A*Star), Singapore	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency of Science , Technology and Research (A*Star), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council, the Agency of Science, Technology and Research (A*Star), Singapore (http://www.a-star.edu.sg/tabid/64/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BODEY GP, 1983, REV INFECT DIS, V5, P279; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; Diaz MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00089; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hiromi S, 2011, PLOS ONE, V6; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mulcahy H, 2008, INFECT IMMUN, V76, P632, DOI 10.1128/IAI.01132-07; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Sambrook J, 1987, MOL CLONING LAB MANU; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291; Zolfaghar I, 2005, MICROBES INFECT, V7, P1305, DOI 10.1016/j.micinf.2005.04.017	30	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60187	10.1371/journal.pone.0060187	http://dx.doi.org/10.1371/journal.pone.0060187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555919	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900061
J	Metzler-Baddeley, C; Baddeley, RJ; Jones, DK; Aggleton, JP; O'Sullivan, MJ				Metzler-Baddeley, Claudia; Baddeley, Roland J.; Jones, Derek K.; Aggleton, John P.; O'Sullivan, Michael J.			Individual Differences in Fornix Microstructure and Body Mass Index	PLOS ONE			English	Article							EFFERENT PROJECTIONS; ORBITOFRONTAL CORTEX; EPISODIC MEMORY; DIFFUSION; MRI; HIPPOCAMPUS; BRAIN; ORIENTATION; AMYGDALA; SYSTEM	The prevalence of obesity and associated health conditions is increasing in the developed world. Obesity is related to atrophy and dysfunction of the hippocampus and hippocampal lesions may lead to increased appetite and weight gain. The hippocampus is connected via the fornix tract to the hypothalamus, orbitofrontal cortex, and the nucleus accumbens, all key structures for homeostatic and reward related control of food intake. The present study employed diffusion MRI tractography to investigate the relationship between microstructural properties of the fornix and variation in Body Mass Index (BMI), within normal and overweight ranges, in a group of community-dwelling older adults (53-93 years old). Larger BMI was associated with larger axial and mean diffusivity in the fornix (r = 0.64 and r = 0.55 respectively), relationships that were most pronounced in overweight individuals. Moreover, controlling for age, education, cognitive performance, blood pressure and global brain volume increased these correlations. Similar associations were not found in the parahippocampal cingulum, a comparison temporal association pathway. Thus, microstructural changes in fornix white matter were observed in older adults with increasing BMI levels from within normal to overweight ranges, so are not exclusively related to obesity. We propose that hippocampal-hypothalamic-prefrontal interactions, mediated by the fornix, contribute to the healthy functioning of networks involved in food intake control. The fornix, in turn, may display alterations in microstructure that reflect weight gain.	[Metzler-Baddeley, Claudia; Jones, Derek K.; Aggleton, John P.; O'Sullivan, Michael J.] Cardiff Univ, CUBRIC, Sch Psychol & Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Metzler-Baddeley, Claudia; Jones, Derek K.; Aggleton, John P.; O'Sullivan, Michael J.] Cardiff Univ, Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Baddeley, Roland J.] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [O'Sullivan, Michael J.] Kings Coll London, Dept Clin Neurosci, Inst Psychiat, London WC2R 2LS, England	Cardiff University; Cardiff University; University of Bristol; University of London; King's College London	Metzler-Baddeley, C (corresponding author), Cardiff Univ, CUBRIC, Sch Psychol & Neurosci, Cardiff CF10 3AX, S Glam, Wales.	Metzler-baddeleyc@cardiff.ac.uk	Metzler-Baddeley, Claudia/A-1595-2010; Metzler-Baddeley, Claudia/ABG-2313-2020; O'Sullivan, Michael/A-1796-2010	Metzler-Baddeley, Claudia/0000-0002-8646-1144; Metzler-Baddeley, Claudia/0000-0002-8646-1144; Aggleton, John/0000-0002-5573-1308; Jones, Derek K/0000-0003-4409-8049; O'Sullivan, Michael/0000-0002-2869-4580	Medical Research Council, UK, via a Clinician Scientist Fellowship [G0701912]; MRC [G0701912] Funding Source: UKRI; Medical Research Council [G0701912] Funding Source: researchfish	Medical Research Council, UK, via a Clinician Scientist Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Medical Research Council, UK, via a Clinician Scientist Fellowship to MOS (G0701912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BELAROUSSI B, 2008, 16 SCI M EXH INT SOC; Benoit SC, 2010, BRAIN RES, V1350, P71, DOI 10.1016/j.brainres.2010.06.009; Blatt GJ, 1998, J COMP NEUROL, V392, P92, DOI 10.1002/(SICI)1096-9861(19980302)392:1<92::AID-CNE7>3.0.CO;2-K; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Chudasama Y, 2012, J NEUROSCI, V32, P10915, DOI 10.1523/JNEUROSCI.1463-12.2012; Davidson TL, 2007, CURR OPIN PHARMACOL, V7, P613, DOI 10.1016/j.coph.2007.10.008; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; DelParigi A, 2004, INT J OBESITY, V28, P370, DOI 10.1038/sj.ijo.0802558; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; IBM SPSS Inc, 2011, PASW STAT 18 0 COMM; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Kim Dong-Hoon, 2012, Front Biosci (Schol Ed), V4, P953; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Leemans AJ., 2009, P INT SOC MAG RESON; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Nelson H., 1991, NATL ADULT READING T; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; POLETTI CE, 1977, J COMP NEUROL, V175, P101, DOI 10.1002/cne.901750107; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Roesch MR, 2012, J NEUROSCI, V32, P5525, DOI 10.1523/JNEUROSCI.0586-12.2012; Saunders RC, 2007, HIPPOCAMPUS, V17, P396, DOI 10.1002/hipo.20276; Schoenbaum G, 2010, CURR OPIN NEUROBIOL, V20, P205, DOI 10.1016/j.conb.2010.01.009; Sergi G, 2012, P NUTR SOC, V31, P1; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640	48	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59849	10.1371/journal.pone.0059849	http://dx.doi.org/10.1371/journal.pone.0059849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555805	Green Published, Green Accepted, gold			2022-12-27	WOS:000317262200048
J	Okamoto, S; Jiang, YY; Kawamura, K; Shingyoji, M; Fukamachi, T; Tada, Y; Takiguchi, Y; Tatsumi, K; Shimada, H; Hiroshima, K; Kobayashi, H; Tagawa, M				Okamoto, Shinya; Jiang, Yuanyuan; Kawamura, Kiyoko; Shingyoji, Masato; Fukamachi, Toshihiko; Tada, Yuji; Takiguchi, Yuichi; Tatsumi, Koichiro; Shimada, Hideaki; Hiroshima, Kenzo; Kobayashi, Hiroshi; Tagawa, Masatoshi			Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels	PLOS ONE			English	Article							CELL LUNG-CANCER; GENE-THERAPY; BISPHOSPHONATES; CHEMOTHERAPY; PATIENT; MODEL	We examined anti-tumor effects of zoledronic acid (ZOL), one of the bisphosphonates agents clinically used for preventing loss of bone mass, on human mesothelioma cells bearing the wild-type p53 gene. ZOL-treated cells showed activation of caspase-3/7, -8 and -9, and increased sub-G1 phase fractions. A combinatory use of ZOL and cisplatin (CDDP), one of the first-line anti-cancer agents for mesothelioma, synergistically or additively produced the cytotoxicity on mesothelioma cells. Moreover, the combination achieved greater anti-tumor effects on mesothelioma developed in the pleural cavity than administration of either ZOL or CDDP alone. ZOL-treated cells as well as CDDP-treated cells induced p53 phosphorylation at Ser 15, a marker of p53 activation, and up-regulated p53 protein expression levels. Down-regulation of p53 levels with siRNA however did not influence the ZOL-mediated cytotoxicity but negated the combinatory effects by ZOL and CDDP. In addition, ZOL treatments augmented cytotoxicity of adenoviruses expressing the p53 gene on mesothelioma. These data demonstrated that ZOL-mediated augmentation of p53, which was not linked with ZOL-induced cytotoxicity, played a role in the combinatory effects with a p53 up-regulating agent, and suggests a possible clinical use of ZOL to mesothelioma with anti-cancer agents.	[Okamoto, Shinya; Fukamachi, Toshihiko; Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Chiba, Japan; [Jiang, Yuanyuan; Kawamura, Kiyoko; Tagawa, Masatoshi] Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, Chiba 2608717, Japan; [Jiang, Yuanyuan; Tagawa, Masatoshi] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan; [Shingyoji, Masato] Chiba Canc Ctr, Dept Thorac Dis, Chiba 2608717, Japan; [Tada, Yuji; Tatsumi, Koichiro] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Japan; [Takiguchi, Yuichi] Chiba Univ, Dept Med Oncol, Grad Sch Med, Chiba, Japan; [Shimada, Hideaki] Toho Univ, Sch Med, Dept Surg, Tokyo, Japan; [Hiroshima, Kenzo] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Yachiyo, Japan	Chiba University; Chiba Cancer Center; Chiba University; Chiba Cancer Center; Chiba University; Chiba University; Toho University; Tokyo Women's Medical University	Tagawa, M (corresponding author), Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, 666-2 Nitonacho, Chiba 2608717, Japan.	mtagawa@chiba-cc.jp	jiang, anyi/GPT-0379-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Nichias Corporation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Nichias Corporation	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan, and a Grant-in-Aid from the Nichias Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018828; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Benassi MS, 2007, CANCER LETT, V250, P194, DOI 10.1016/j.canlet.2006.10.004; Clezardin P, 2011, BONE, V48, P71, DOI 10.1016/j.bone.2010.07.016; Green JR, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-90004-3; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Hopkins-Donaldson S, 2006, NEOPLASIA, V8, P551, DOI 10.1593/neo.06148; Horie N, 2007, BRIT J CANCER, V96, P255, DOI 10.1038/sj.bjc.6603548; Horio Y, 2000, CANCER GENE THER, V7, P537, DOI 10.1038/sj.cgt.7700148; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuroda J, 2004, CANCER SCI, V95, P186, DOI 10.1111/j.1349-7006.2004.tb03202.x; Kuroda J, 2003, BLOOD, V102, P2229, DOI 10.1182/blood-2003-01-0305; Li Q, 2012, CANCER GENE THER, V19, P218, DOI 10.1038/cgt.2011.86; Liu DH, 2006, CHIN J CANC PREV TRE, V13, P1108; Nakataki E, 2006, CANCER SCI, V97, P183, DOI 10.1111/j.1349-7006.2006.00163.x; Ory B, 2007, MOL PHARMACOL, V71, P333, DOI 10.1124/mol.106.028837; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Prins JB, 1998, INT J CANCER, V75, P649, DOI 10.1002/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.3.CO;2-L; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Rossi A, 2012, J CLIN ONCOL, V30, P1692, DOI 10.1200/JCO.2011.40.4905; Senzer N, 2007, MOL CANCER THER, V6, P1478, DOI 10.1158/1535-7163.MCT-07-0125; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Skerjanec A, 2003, J CLIN PHARMACOL, V43, P154, DOI 10.1177/0091270002239824; Tada Y, 2008, ONCOL RES, V17, P239, DOI 10.3727/096504008786991602; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weinrib L, 2001, CANCER GENE THER, V8, P352, DOI 10.1038/sj.cgt.7700319; Yang CT, 2000, J NATL CANCER I, V92, P636, DOI 10.1093/jnci/92.8.636; Yuasa T, 2007, CURR MED CHEM, V14, P2126	31	9	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60297	10.1371/journal.pone.0060297	http://dx.doi.org/10.1371/journal.pone.0060297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555949	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200106
J	Stamer, UM; Zhang, L; Book, M; Lehmann, LE; Stuber, F; Musshoff, F				Stamer, Ulrike M.; Zhang, Lan; Book, Malte; Lehmann, Lutz E.; Stuber, Frank; Musshoff, Frank			CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients	PLOS ONE			English	Article							ORAL OXYCODONE; GENETIC POLYMORPHISMS; INTRAVENOUS OXYCODONE; PLASMA-CONCENTRATIONS; ANALGESIC EFFICACY; CYP3A ACTIVITIES; PALLIATIVE CARE; MORPHINE; PHARMACOKINETICS; PHARMACODYNAMICS	Background: The impact of polymorphic cytochrome P450 CYP2D6 enzyme on oxycodone's metabolism and clinical efficacy is currently being discussed. However, there are only spare data from postoperative settings. The hypothesis of this study is that genotype dependent CYP2D6 activity influences plasma concentrations of oxycodone and its metabolites and impacts analgesic consumption. Methods: Patients received oxycodone 0.05 mg/kg before emerging from anesthesia and patient-controlled analgesia (PCA) for the subsequent 48 postoperative hours. Blood samples were drawn at 30, 90 and 180 minutes after the initial oxycodone dose. Plasma concentrations of oxycodone and its metabolites oxymorphone, noroxycodone and noroxymorphone were analyzed by liquid chromatography-mass spectrometry with electrospray ionization. CYP2D6 genotyping was performed and 121 patients were allocated to the following genotype groups: PM (poor metabolizer: no functionally active CYP2D6 allele), HZ/IM (heterozygous subjects, intermediate metabolizers with decreased CYP2D6 activity), EM (extensive metabolizers, normal CYP2D6 activity) and UM (ultrarapid metabolizers, increased CYP2D6 activity). Primary endpoint was the genotype dependent metabolite ratio of plasma concentrations oxymorphone/oxycodone. Secondary endpoint was the genotype dependent analgesic consumption with calculation of equianalgesic doses compared to the standard non-CYP dependent opioid piritramide. Results: Metabolism differed between CYP2D6 genotypes. Mean (95%-CI) oxymophone/oxycodone ratios were 0.10 (0.02/0.19), 0.13 (0.11/0.16), 0.18 (0.16/0.20) and 0.28 (0.07/0.49) in PM, HZ/IM, EM and UM, respectively (p = 0.005). Oxycodone consumption up to the 12 th hour was highest in PM (p = 0.005), resulting in lowest equianalgesic doses of piritramide versus oxycodone for PM (1.6 (1.4/1.8); EM and UM 2.2 (2.1/2.3); p<0.001). Pain scores did not differ between genotypes. Conclusions: In this postoperative setting, the number of functionally active CYP2D6 alleles had an impact on oxycodone metabolism. The genotype also impacted analgesic consumption, thereby causing variation of equianalgesic doses piritramide : oxycodone. Different analgesic needs by genotypes were met by PCA technology in this postoperative cohort.	[Stamer, Ulrike M.; Zhang, Lan] Univ Bern, Inselspital, Dept Anaesthesiol & Pain Med, CH-3010 Bern, Switzerland; [Stamer, Ulrike M.; Zhang, Lan; Book, Malte; Lehmann, Lutz E.; Stuber, Frank] Univ Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany; [Musshoff, Frank] Univ Bonn, Dept Forens Med, Bonn, Germany	University of Bern; University Hospital of Bern; University of Bonn; University of Bonn	Stamer, UM (corresponding author), Univ Bern, Inselspital, Dept Anaesthesiol & Pain Med, CH-3010 Bern, Switzerland.	ulrike.stamer@dkf.unibe.ch						[Anonymous], 2012, NCBI SNP DAT; Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659; Bouillon T, 1999, ANESTHESIOLOGY, V90, P7, DOI 10.1097/00000542-199901000-00004; Crettol S, 2008, THER DRUG MONIT, V30, P689, DOI 10.1097/FTD.0b013e31818a2a60; de Leon J, 2003, J CLIN PSYCHOPHARM, V23, P420, DOI 10.1097/01.jcp.0000085421.74359.60; Foster Adriana, 2007, Pain Pract, V7, P352, DOI 10.1111/j.1533-2500.2007.00153.x; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Gronlund J, 2011, CLIN DRUG INVEST, V31, P143, DOI 10.2165/11539950-000000000-00000; Gronlund J, 2010, J CLIN PHARMACOL, V50, P101, DOI 10.1177/0091270009336444; Hagelberg N, 2009, EUR J CLIN PHARMACOL, V65, P263, DOI 10.1007/s00228-008-0568-5; Heiskanen T, 1998, CLIN PHARMACOL THER, V64, P603, DOI 10.1016/S0009-9236(98)90051-0; Hesselink DA, 2003, CLIN PHARMACOL THER, V74, P245, DOI 10.1016/S0009-9236(03)00168-1; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; KALSO E, 1991, ACTA ANAESTH SCAND, V35, P642, DOI 10.1111/j.1399-6576.1991.tb03364.x; Kalso E, 2007, PAIN, V132, P227, DOI 10.1016/j.pain.2007.09.027; Kharasch ED, 2011, CLIN PHARMACOL THER, V89, P562, DOI 10.1038/clpt.2010.313; Kumar N, 1999, BRIT J ANAESTH, V82, P3, DOI 10.1093/bja/82.1.3; Lalovic B, 2006, CLIN PHARMACOL THER, V79, P461, DOI 10.1016/j.clpt.2006.01.009; Lemberg KK, 2010, SCAND J PAIN, V1, P24, DOI 10.1016/j.sjpain.2009.09.003; Lemberg KK, 2006, ANESTHESIOLOGY, V105, P801, DOI 10.1097/00000542-200610000-00027; Lemberg KK, 2009, SCAND J PAIN, V1, pS18, DOI 10.1016/S1877-8860(09)70005-9; Lenz H, 2009, ANESTH ANALG, V109, P1279, DOI 10.1213/ane.0b013e3181b0f0bb; LEOW KP, 1994, LIFE SCI, V54, P1229; Maddocks I, 1996, J PAIN SYMPTOM MANAG, V12, P182, DOI 10.1016/0885-3924(96)00050-4; Musshoff F, 2006, J MASS SPECTROM, V41, P633, DOI 10.1002/jms.1021; Naito T, 2011, J CLIN PHARMACOL, V51, P1529, DOI 10.1177/0091270010388033; Nieminen TH, 2009, ANESTHESIOLOGY, V110, P1371, DOI 10.1097/ALN.0b013e31819faa54; Peckham EM, 2006, J PHARMACOL EXP THER, V316, P1195, DOI 10.1124/jpet.105.094276; Saari TI, 2010, EUR J CLIN PHARMACOL, V66, P387, DOI 10.1007/s00228-009-0775-8; Samer CF, 2010, BRIT J PHARMACOL, V160, P919, DOI 10.1111/j.1476-5381.2010.00709.x; Samer CF, 2010, BRIT J PHARMACOL, V160, P907, DOI 10.1111/j.1476-5381.2010.00673.x; Silvasti M, 1998, ACTA ANAESTH SCAND, V42, P576, DOI 10.1111/j.1399-6576.1998.tb05169.x; Society of Toxicological and Forensic Chemistry, 2012, REQ VAL AN METH; Stamer UM, 2007, CLIN PHARMACOL THER, V82, P41, DOI 10.1038/sj.clpt.6100152; Stamer UM, 2011, ANESTH ANALG, V113, P48, DOI 10.1213/ANE.0b013e31821d01bc; STUBHAUG A, 1995, PAIN, V62, P111, DOI 10.1016/0304-3959(95)00056-X; Susce MT, 2006, PROG NEURO-PSYCHOPH, V30, P1356, DOI 10.1016/j.pnpbp.2006.03.018; Thompson CM, 2004, J PHARMACOL EXP THER, V308, P547, DOI 10.1124/jpet.103.058602; WEINSTEIN SH, 1979, J PHARM SCI, V68, P527, DOI 10.1002/jps.2600680441; Wojnowski L, 2006, EXPERT OPIN DRUG MET, V2, P171, DOI 10.1517/17425255.2.2.171; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000; Zwisler ST, 2010, ACTA ANAESTH SCAND, V54, P232, DOI 10.1111/j.1399-6576.2009.02104.x; Zwisler ST, 2009, BASIC CLIN PHARMACOL, V104, P335, DOI 10.1111/j.1742-7843.2009.00378.x	43	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60239	10.1371/journal.pone.0060239	http://dx.doi.org/10.1371/journal.pone.0060239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555934	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200101
J	Bellei, B; Pitisci, A; Ottaviani, M; Ludovici, M; Cota, C; Luzi, F; Dell'Anna, ML; Picardo, M				Bellei, Barbara; Pitisci, Angela; Ottaviani, Monica; Ludovici, Matteo; Cota, Carlo; Luzi, Fabiola; Dell'Anna, Maria Lucia; Picardo, Mauro			Vitiligo: A Possible Model of Degenerative Diseases	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; BLOOD MONONUCLEAR-CELLS; HYDROGEN-PEROXIDE H2O2; LESIONAL SKIN; OXIDATIVE STRESS; CYCLE ARREST; TNF-ALPHA; SENESCENCE; MELANOCYTES; EPIDERMIS	Vitiligo is characterized by the progressive disappearance of pigment cells from skin and hair follicle. Several in vitro and in vivo studies show evidence of an altered redox status, suggesting that loss of cellular redox equilibrium might be the pathogenic mechanism in vitiligo. However, despite the numerous data supporting a pathogenic role of oxidative stress, there is still no consensus explanation underlying the oxidative stress-driven disappear of melanocytes from the epidermis. In this study, in vitro characterization of melanocytes cultures from non-lesional vitiligo skin revealed at the cellular level aberrant function of signal transduction pathways common with neurodegenerative diseases including modification of lipid metabolism, hyperactivation of mitogen-activated protein kinase (MAPK) and cAMP response element-binding protein (CREB), constitutive p53-dependent stress signal transduction cascades, and enhanced sensibility to pro-apoptotic stimuli. Notably, these long-term effects of subcytotoxic oxidative stress are also biomarkers of pre-senescent cellular phenotype. Consistent with this, vitiligo cells showed a significant increase in p16 that did not correlate with the chronological age of the donor. Moreover, vitiligo melanocytes produced many biologically active proteins among the senescence-associated secretory phenotype (SAPS), such as interleukin-6 (IL-6), matrix metallo proteinase-3 (MMP3), cyclooxygenase-2 (Cox-2), insulin-like growth factor-binding protein-3 and 7 (IGFBP3, IGFBP7). Together, these data argue for a complicated pathophysiologic puzzle underlying melanocytes degeneration resembling, from the biological point of view, neurodegenerative diseases. Our results suggest new possible targets for intervention that in combination with current therapies could correct melanocytes intrinsic defects.	[Bellei, Barbara; Pitisci, Angela; Ottaviani, Monica; Ludovici, Matteo; Dell'Anna, Maria Lucia; Picardo, Mauro] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy; [Cota, Carlo] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Dermatopathol Unit, Rome, Italy; [Luzi, Fabiola] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Bellei, B (corresponding author), Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy.	bellei@ifo.it	Pitisci, Angela/AAH-9415-2019; Ottaviani, Monica/J-3183-2016; Bellei, Barbara/K-5288-2016; Luzi, Fabiola/AAC-2394-2019; Ludovici, Matteo/H-2159-2016; Picardo, Mauro/A-6978-2011	Ottaviani, Monica/0000-0002-6613-2570; Bellei, Barbara/0000-0002-3883-5500; Ludovici, Matteo/0000-0001-7517-2315; Cota, Carlo/0000-0001-6335-8649; Maria Lucia, Dell'Anna/0000-0001-5196-7017; Picardo, Mauro/0000-0003-4899-6639	Ministry of Health, Italy	Ministry of Health, Italy(Ministry of Health, Italy)	The study was partially supported by Ministry of Health, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Birol A, 2006, INT J DERMATOL, V45, P992, DOI 10.1111/j.1365-4632.2006.02744.x; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Boissy RE, 2004, PIGM CELL RES, V17, P208, DOI 10.1111/j.1600-0749.2004.00130.x; Bondanza S, 2007, PIGM CELL RES, V20, P288, DOI 10.1111/j.1600-0749.2007.00385.x; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005; Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dell'Anna ML, 2007, J INVEST DERMATOL, V127, P1226, DOI 10.1038/sj.jid.5700700; Dell'Anna ML, 2012, EXP DERMATOL, V21, P490, DOI 10.1111/j.1600-0625.2012.01506.x; Dell'Anna ML, 2003, PIGM CELL RES, V16, P553, DOI 10.1034/j.1600-0749.2003.00087.x; Dumont P, 2000, J ANAT, V197, P529, DOI 10.1046/j.1469-7580.2000.19740529.x; Eising R, 2003, PLANT PHYSIOL, V97, P1422; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Feily A, 2011, ARCH DERMATOL RES, V303, P623, DOI 10.1007/s00403-011-1165-5; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Gatza C, 2007, CELL CYCLE, V6, P52, DOI 10.4161/cc.6.1.3667; Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x; Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x; Giovannelli L, 2004, MUTAT RES-FUND MOL M, V556, P101, DOI 10.1016/j.mrfmmm.2004.07.005; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; JIMBOW K, 1975, J CELL BIOL, V66, P663, DOI 10.1083/jcb.66.3.663; Kauser S, 2011, J INVEST DERMATOL, V131, P979, DOI 10.1038/jid.2010.397; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Kostyuk VA, 2010, ANTIOXID REDOX SIGN, V13, P607, DOI 10.1089/ars.2009.2976; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485; Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172; Malik B, 2008, CELL CYCLE, V7, P637, DOI 10.4161/cc.7.5.5427; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; MEDRANO EE, 1990, J INVEST DERMATOL, V95, P441; Mendonsa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004655; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Nakamura M, 2003, EXP CELL RES, V290, P381, DOI 10.1016/S0014-4827(03)00343-4; Natarajan VT, 2010, J INVEST DERMATOL, V130, P2781, DOI 10.1038/jid.2010.201; Ohno-Iwashita Y, 2010, GERIATR GERONTOL INT, V10, pS41, DOI 10.1111/j.1447-0594.2010.00600.x; Pani A, 2009, J ALZHEIMERS DIS, V18, P829, DOI 10.3233/JAD-2009-1193; Pani A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-66; Ruzankina Y, 2008, MECH AGEING DEV, V129, P460, DOI 10.1016/j.mad.2008.03.009; Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schallreuter KU, 2003, EXP DERMATOL, V12, P268, DOI 10.1034/j.1600-0625.2003.00084.x; Schallreuter KU, 2002, DERMATOLOGY, V204, P194, DOI 10.1159/000057881; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Taieb A, 2012, PIGM CELL MELANOMA R, V25, P9, DOI 10.1111/j.1755-148X.2011.00939.x; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Tobin DJ, 2000, J PATHOL, V191, P407; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Yaar M, 2001, CLIN EXP DERMATOL, V26, P583, DOI 10.1046/j.1365-2230.2001.00895.x; Yaar M, 2012, J INVEST DERMATOL, V132, P835, DOI 10.1038/jid.2011.386; Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033	63	63	67	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59782	10.1371/journal.pone.0059782	http://dx.doi.org/10.1371/journal.pone.0059782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555779	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500088
J	Cohen, R; Elhadad, M; Birk, O				Cohen, Raphael; Elhadad, Michael; Birk, Ohad			Analysis of Free Online Physician Advice Services	PLOS ONE			English	Article							HEALTH INFORMATION; INTERNET; UMLS	Background: Online Consumer Health websites are a major source of information for patients worldwide. We focus on another modality, online physician advice. We aim to evaluate and compare the freely available online expert physicians' advice in different countries, its scope and the type of content provided. Setting: Using automated methods for information retrieval and analysis, we compared consumer health portals from the US, Canada, the UK and Israel (WebMD, NetDoctor, AskTheDoctor and BeOK). The evaluated content was generated between 2002 and 2011. Results: We analyzed the different sites, looking at the distribution of questions in the various health topics, answer lengths and content type. Answers could be categorized into longer broad-educational answers versus shorter patient-specific ones, with different physicians having personal preferences as to answer type. The Israeli website BeOK, providing 10 times the number of answers than in the other three health portals, supplied answers that are shorter on average than in the other websites. Response times in these sites may be rapid with 32% of the WebMD answers and 64% of the BeOK answers provided in less than 24 hours. The voluntary contribution model used by BeOK and WebMD enables generation of large numbers of physician expert answers at low cost, providing 50,000 and 3,500 answers per year, respectively. Conclusions: Unlike health information in online databases or advice and support in patient-forums, online physician advice provides qualified specialists' responses directly relevant to the questions asked. Our analysis showed that high numbers of expert answers could be generated in a timely fashion using a voluntary model. The length of answers varied significantly between the internet sites. Longer answers were associated with educational content while short answers were associated with patient-specific content. Standard site-specific guidelines for expert answers will allow for more desirable content (educational content) or better throughput (patient-specific content).	[Cohen, Raphael; Elhadad, Michael] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Birk, Ohad] Ben Gurion Univ Negev, Genet Inst, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Birk, Ohad] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, NIBN, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Cohen, R (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel.	cohenrap@bgu.ac.il; obirk@bgu.ac.il	ELHADAD, MICHAEL/AIB-3614-2022	ELHADAD, MICHAEL/0000-0002-5629-2351; Birk, Ohad/0000-0003-1430-1296				Agency CS, 2010, IND INT US E COMM; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Baker L, 2003, JAMA-J AM MED ASSOC, V289, P2400, DOI 10.1001/jama.289.18.2400; Bauer MA, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-17; Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Choi E, 2012, DEV TYPOLOGY ONLINE; Cline RJW, 2001, HEALTH EDUC RES, V16, P671, DOI 10.1093/her/16.6.671; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen R, 2012, UNDERSTANDING MED TE; Esquivel A, 2006, BMJ-BRIT MED J, V332, P939, DOI 10.1136/bmj.38753.524201.7C; Geifman N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-229; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Holstein RC, 2003, JAMA-J AM MED ASSOC, V290, P2255, DOI 10.1001/jama.290.17.2255-a; Inniss Tasha R., 2006, P 1 INT WORKSH TEXT, P7; Kummervold PE, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1583; Lipsky-Gorman S, 2011, CLINNOTE HEALTHTERMF; Neter E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1619; Rhebergen MDF, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1886; Rice RE, 2006, INT J MED INFORM, V75, P8, DOI 10.1016/j.ijmedinf.2005.07.032; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Weitzman ER, 2011, J AM MED INFORM ASSN, V18, P292, DOI [10.1136/jamia.2010.009712, 10.1136/amiajnl-2010.009712]	22	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59963	10.1371/journal.pone.0059963	http://dx.doi.org/10.1371/journal.pone.0059963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555848	gold, Green Published			2022-12-27	WOS:000317418500109
J	Wojciechowicz, K; Gledhill, K; Ambler, CA; Manning, CB; Jahoda, CAB				Wojciechowicz, Kamila; Gledhill, Karl; Ambler, Carrie A.; Manning, Craig B.; Jahoda, Colin A. B.			Development of the Mouse Dermal Adipose Layer Occurs Independently of Subcutaneous Adipose Tissue and Is Marked by Restricted Early Expression of FABP4	PLOS ONE			English	Article							HAIR FOLLICLE; BETA-CATENIN; STEM-CELLS; ADIPOCYTES; WHITE; SKIN; FAT; MICE; ADIPOGENESIS; FETAL	The laboratory mouse is a key animal model for studies of adipose biology, metabolism and disease, yet the developmental changes that occur in tissues and cells that become the adipose layer in mouse skin have received little attention. Moreover, the terminology around this adipose body is often confusing, as frequently no distinction is made between adipose tissue within the skin, and so called subcutaneous fat. Here adipocyte development in mouse dorsal skin was investigated from before birth to the end of the first hair follicle growth cycle. Using Oil Red O staining, immunohistochemistry, quantitative RT-PCR and TUNEL staining we confirmed previous observations of a close spatio-temporal link between hair follicle development and the process of adipogenesis. However, unlike previous studies, we observed that the skin adipose layer was created from cells within the lower dermis. By day 16 of embryonic development (e16) the lower dermis was demarcated from the upper dermal layer, and commitment to adipogenesis in the lower dermis was signalled by expression of FABP4, a marker of adipocyte differentiation. In mature mice the skin adipose layer is separated from underlying subcutaneous adipose tissue by the panniculus carnosus. We observed that the skin adipose tissue did not combine or intermix with subcutaneous adipose tissue at any developmental time point. By transplanting skin isolated from e14.5 mice (prior to the start of adipogenesis), under the kidney capsule of adult mice, we showed that skin adipose tissue develops independently and without influence from subcutaneous depots. This study has reinforced the developmental link between hair follicles and skin adipocyte biology. We argue that because skin adipocytes develop from cells within the dermis and independently from subcutaneous adipose tissue, that it is accurately termed dermal adipose tissue and that, in laboratory mice at least, it represents a separate adipose depot.	[Wojciechowicz, Kamila; Gledhill, Karl; Ambler, Carrie A.; Manning, Craig B.; Jahoda, Colin A. B.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Wojciechowicz, Kamila] Netherlands Canc Inst, Amsterdam, North Holland, Netherlands	Durham University; Netherlands Cancer Institute	Gledhill, K (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	karl.gledhill@durham.ac.uk		Jahoda, Colin/0000-0002-1762-1220; Ambler, Carrie/0000-0002-2697-7376	Diabetes UK [09\0003857]; EMBO; Biotechnology and Biological Sciences Research Council [BB/H02431X/1] Funding Source: researchfish; BBSRC [BB/H02431X/1] Funding Source: UKRI	Diabetes UK(Diabetes UK); EMBO(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are extremely grateful to the Diabetes UK (http://www.diabetes.org.uk/) for grant funding (GRANT NUMBER 09\0003857) to CABJ for this work, and to EMBO for a travelling fellowship for KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DB, 1972, J LIPID RES, V13, P593; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Billon N, 2012, STEM CELL REV REP, V8, P55, DOI 10.1007/s12015-011-9242-x; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Borodach GN, 1955, J INVEST DERMATOL, V26, P229; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; CHASE HB, 1953, ANAT REC, V116, P75, DOI 10.1002/ar.1091160107; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Cinti S, 2007, ADIPOSE TISSUE ADIPO, P3, DOI [10.1007/978-1-59745-370-7_1, DOI 10.1007/978-1-59745-370-7_1]; CINTI S, 2001, ADIPOSE TISSUES, P11; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Fantauzzo KA, 2008, GENE EXPR PATTERNS, V8, P51, DOI 10.1016/j.modgep.2007.10.006; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gipbs HF, 1941, ANAT REC, V80, P61, DOI 10.1002/ar.1090800108; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; HAUSMAN GJ, 1985, J ANIM SCI, V60, P1539, DOI 10.2527/jas1985.6061539x; HAUSMAN GJ, 1982, J ANIM SCI, V54, P1286, DOI 10.2527/jas1982.5461286x; HAUSMAN GJ, 1981, J ANIM SCI, V52, P1442, DOI 10.2527/jas1981.5261442x; HAUSMAN GJ, 1981, AM J ANAT, V161, P85, DOI 10.1002/aja.1001610107; Hausman GJ, 2004, J ANIM SCI, V82, P925; HAUSMAN GJ, 1986, J ANIM SCI, V63, P642, DOI 10.2527/jas1986.632642x; HAUSMAN GJ, 1984, J ANIM SCI, V58, P1550, DOI 10.2527/jas1984.5861550x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hong KM, 2005, FASEB J, V19, P2029, DOI 10.1096/fj.05-4295fje; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Klein J, 2007, EXP DERMATOL, V16, P45, DOI 10.1111/j.1600-0625.2006.00519.x; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Majka SM, 2011, STEM CELLS, V29, P1034, DOI 10.1002/stem.653; MOFFAT GH, 1968, J ANAT, V102, P527; Ohtola J, 2008, DEVELOPMENT, V135, P2321, DOI 10.1242/dev.021170; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P107, DOI 10.1387/ijdb.15272376; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; POISSONNET CM, 1984, EARLY HUM DEV, V10, P1, DOI 10.1016/0378-3782(84)90106-3; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Richardson GD, 2009, DEVELOPMENT, V136, P2153, DOI 10.1242/dev.031427; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Sugawara K, 2010, J DERMATOL SCI, V57, P155, DOI 10.1016/j.jdermsci.2009.12.004; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tran TH, 2010, DEVELOPMENT, V137, P3973, DOI 10.1242/dev.056473; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wojciechowicz K, 2008, EXP DERMATOL, V17, P675, DOI 10.1111/j.1600-0625.2007.00689.x; Wolnicka-Glubisz A, 2005, J INVEST DERMATOL, V125, P383, DOI 10.1111/j.0022-202X.2005.23781.x; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014	53	57	57	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59811	10.1371/journal.pone.0059811	http://dx.doi.org/10.1371/journal.pone.0059811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555789	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000317418500093
J	Tattersall, MC; Gangnon, RE; Karmali, KN; Cullen, MW; Stein, JH; Keevil, JG				Tattersall, Matthew C.; Gangnon, Ronald E.; Karmali, Kunal N.; Cullen, Michael W.; Stein, James H.; Keevil, Jon G.			Trends in Low-Density Lipoprotein Cholesterol Goal Achievement in High Risk United States Adults: Longitudinal Findings from the 1999-2008 National Health and Nutrition Examination Surveys	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; US ADULTS; PRIMARY-PREVENTION; CARDIOVASCULAR EVENTS; STROKE PREVENTION; LIPID-LEVELS; NHANES-III; PREVALENCE; MANAGEMENT; CARE	Background: Previous studies have demonstrated gaps in achievement of low-density lipoprotein-cholesterol (LDL-C) goals among U. S. individuals at high cardiovascular disease risk; however, recent studies in selected populations indicate improvements. Objective: We sought to define the longitudinal trends in achieving LDL-C goals among high-risk United States adults from 1999-2008. Methods We analyzed five sequential population-based cross-sectional National Health and Nutrition Examination Surveys 1999-2008, which included 18,656 participants aged 20-79 years. We calculated rates of LDL-C goal achievement and treatment in the high-risk population. Results: The prevalence of high-risk individuals increased from 13% to 15.5% (p = 0.046). Achievement of LDL-C <100 mg/dL increased from 24% to 50.4% (p<0.0001) in the high-risk population with similar findings in subgroups with (27% to 64.8% p<0.0001) and without (21.8% to 43.7%, p<0.0001) coronary heart disease (CHD). Achievement of LDL-C <70 mg/dL improved from 2.4% to 17% (p<0.0001) in high-risk individuals and subgroups with (3.4% to 21.4%, p<0.0001) and without (1.7% to 14.9%, p<0.0001) CHD. The proportion with LDL-C >= 130 mg/dL and not on lipid medications decreased from 29.4% to 18% (p = 0.0002), with similar findings among CHD (25% to 11.9% p = 0.0013) and non-CHD (35.8% to 20.8% p<0.0001) subgroups. Conclusion: The proportions of the U. S. high-risk population achieving LDL-C <100 mg/dL and <70 mg/dL increased over the last decade. With 65% of the CHD subpopulation achieving an LDL-C <100 mg/dL in the most recent survey, U. S. LDL-C goal achievement exceeds previous reports and approximates rates achieved in highly selected patient cohorts.	[Tattersall, Matthew C.; Karmali, Kunal N.; Stein, James H.; Keevil, Jon G.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Gangnon, Ronald E.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Cullen, Michael W.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic	Keevil, JG (corresponding author), Univ Wisconsin, Dept Med, Div Cardiovasc Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jgk@medicine.wisc.edu		Gangnon, Ronald/0000-0003-2587-6714; Stein, James/0000-0002-2770-8223	National Institutes of Health, under Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute [T32 HL 07936]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER	National Institutes of Health, under Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This investigation was supported by the National Institutes of Health, under Ruth L. Kirschstein National Research Service Award T32 HL 07936 from the National Heart Lung and Blood Institute to the University of Wisconsin-Madison Cardiovascular Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Beaton SJ, 2004, DIABETES CARE, V27, P694, DOI 10.2337/diacare.27.3.694; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Case CC, 2003, AM J CARDIOL, V91, P1134, DOI 10.1016/S0002-9149(03)00167-X; Centers for Disease Control and Prevention, 2005, NAT HLTH NUTR EX SUR; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; Cullen MW, 2008, AM HEART J, V156, P284, DOI 10.1016/j.ahj.2008.03.004; Davidson MH, 2005, AM J CARDIOL, V96, P556, DOI 10.1016/j.amjcard.2005.04.019; Eaton CB, 2006, J AM BOARD FAM MED, V19, P46, DOI 10.3122/jabfm.19.1.46; Fedder DO, 2002, CIRCULATION, V105, P152, DOI 10.1161/hc0202.101971; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghandehari H, 2008, AM HEART J, V156, P112, DOI 10.1016/j.ahj.2008.03.005; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hoerger TJ, 1998, AM J CARDIOL, V82, P61, DOI 10.1016/S0002-9149(98)00227-6; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Jacobson TA, 2000, ARCH INTERN MED, V160, P1361, DOI 10.1001/archinte.160.9.1361; Kennedy AG, 2005, DIABETES CARE, V28, P1029, DOI 10.2337/diacare.28.5.1029; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; McBride P, 1998, ARCH INTERN MED, V158, P1238, DOI 10.1001/archinte.158.11.1238; Michos ED, 2009, J AM COLL CARDIOL, V53, P931, DOI 10.1016/j.jacc.2008.12.010; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; PEDERSEN TR, 1994, LANCET, V344, P1383; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Sundquist J, 2001, J AM GERIATR SOC, V49, P109, DOI 10.1046/j.1532-5415.2001.49030.x; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Waters DD, 2004, AM J CARDIOL, V93, P154, DOI 10.1016/j.amjcard.2003.09.031; Wilper AP, 2008, ANN INTERN MED, V149, P170, DOI 10.7326/0003-4819-149-3-200808050-00006	42	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59309	10.1371/journal.pone.0059309	http://dx.doi.org/10.1371/journal.pone.0059309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565146	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300013
J	Chowdhury, S; Ongchin, M; Sharratt, E; Dominguez, I; Wang, J; Brattain, MG; Rajput, A				Chowdhury, Sanjib; Ongchin, Melanie; Sharratt, Elizabeth; Dominguez, Ivan; Wang, Jing; Brattain, Michael G.; Rajput, Ashwani			Intra-Tumoral Heterogeneity in Metastatic Potential and Survival Signaling between Iso-Clonal HCT116 and HCT116b Human Colon Carcinoma Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; COLORECTAL-CANCER; PROGRESSION; ACTIVATION; RESISTANCE; DIVERSITY; KINASE	Background: Colorectal cancer (CRC) metastasis is a leading cause of cancer-related deaths in the United States. The molecular mechanisms underlying this complex, multi-step pathway are yet to be completely elucidated. Recent reports have stressed the importance of intra-tumoral heterogeneity in the development of a metastatic phenotype. The purpose of this study was to characterize the intra-tumoral phenotypic heterogeneity between two iso-clonal human colon cancer sublines HCT116 and HCT116b on their ability to undergo metastatic colonization and survive under growth factor deprivation stress (GFDS). Materials and Methods: HCT116 and HCT116b cells were transfected with green fluorescence protein and subcutaneously injected into BALB/c nude male mice. Once xenografts were established, they were excised and orthotopically implanted into other male BALB/c nude mice using microsurgical techniques. Animal tissues were studied for metastases using histochemical techniques. Microarray analysis was performed to generate gene signatures associated with each subline. In vitro assessment of growth factor signaling pathway was performed under GFDS for 3 and 5 days. Results: Both HCT116 and HCT116b iso-clonal variants demonstrated 100% primary tumor growth, invasion and peritoneal spread. However, HCT116 was highly metastatic with 68% metastasis observed in liver and/or lungs compared to 4% in HCT116b. Microarray analysis revealed an upregulation of survival and metastatic genes in HCT116 cells compared to HCT116b cells. In vitro analysis showed that HCT116 upregulated survival and migratory signaling proteins and downregulated apoptotic agents under GFDS. However, HCT116b cells effectively showed the opposite response under stress inducing cell death. Conclusions: We demonstrate the importance of clonal variation in determining metastatic potential of colorectal cancer cells using the HCT116/HCT116b iso-clonal variants in an orthotopic metastatic mouse model. Determination of clonal heterogeneity in patient tumors can serve as useful tools to identify clinically relevant biomarkers for diagnostic and therapeutic assessment of metastatic colorectal cancer.	[Chowdhury, Sanjib; Wang, Jing; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE USA; [Ongchin, Melanie; Dominguez, Ivan] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA; [Sharratt, Elizabeth] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Rajput, Ashwani] Univ New Mexico, Div Surg Oncol, Dept Surg, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of Nebraska System; University of Nebraska Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; University of New Mexico; University of New Mexico's Health Sciences Center	Chowdhury, S (corresponding author), Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE USA.	schowdhury@unmc.edu; arajput@salud.unm.edu			National Cancer Institute (NCI) [CA054807, CA034432, CA038173, CA072001]; NATIONAL CANCER INSTITUTE [R01CA140988, R01CA034432, R01CA072001, R37CA038173, R01CA038173, R01CA054807] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the work came from National Cancer Institute (NCI) grants to MGB (CA054807, CA034432, CA038173 and CA072001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awwad RA, 2003, CANCER RES, V63, P4731; BOYD DD, 1988, CANCER RES, V48, P2469; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; BRATTAIN MG, 1983, BRIT J CANCER, V47, P373, DOI 10.1038/bjc.1983.56; Chowdhury S, 2011, J BIOL CHEM, V286, P30937, DOI 10.1074/jbc.M110.212035; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Crowe DL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-18; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Jiang DH, 1998, J BIOL CHEM, V273, P31471, DOI 10.1074/jbc.273.47.31471; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NOH DY, 1994, CANCER, V73, P36, DOI 10.1002/1097-0142(19940101)73:1<36::AID-CNCR2820730108>3.0.CO;2-5; Ongchin M, 2009, J SURG RES, V156, P250, DOI 10.1016/j.jss.2009.02.002; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rajput A, 2007, CANCER RES, V67, P665, DOI 10.1158/0008-5472.CAN-06-2773; Wang DG, 2002, ONCOGENE, V21, P2785, DOI 10.1038/sj.onc.1205375; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200	25	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60299	10.1371/journal.pone.0060299	http://dx.doi.org/10.1371/journal.pone.0060299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560089	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900064
J	Fan, HK; Xiao, Y; Yang, YD; Xia, W; Mason, AS; Xia, ZH; Qiao, F; Zhao, SL; Tang, HR				Fan, Haikuo; Xiao, Yong; Yang, Yaodong; Xia, Wei; Mason, Annaliese S.; Xia, Zhihui; Qiao, Fei; Zhao, Songlin; Tang, Haoru			RNA-Seq Analysis of Cocos nucifera: Transcriptome Sequencing and De Novo for Subsequent Functional Genomics Approaches	PLOS ONE			English	Article							KYOTO ENCYCLOPEDIA; TOOL; GENES; EXPRESSION; KEGG	Background: Cocos nucifera (coconut), a member of the Arecaceae family, is an economically important woody palm grown in tropical regions. Despite its agronomic importance, previous germplasm assessment studies have relied solely on morphological and agronomical traits. Molecular biology techniques have been scarcely used in assessment of genetic resources and for improvement of important agronomic and quality traits in Cocos nucifera, mostly due to the absence of available sequence information. Methodology/Principal Findings: To provide basic information for molecular breeding and further molecular biological analysis in Cocos nucifera, we applied RNA-seq technology and de novo assembly to gain a global overview of the Cocos nucifera transcriptome from mixed tissue samples. Using Illumina sequencing, we obtained 54.9 million short reads and conducted de novo assembly to obtain 57,304 unigenes with an average length of 752 base pairs. Sequence comparison between assembled unigenes and released cDNA sequences of Cocos nucifera and Elaeis guineensis indicated that the assembled sequences were of high quality. Approximately 99.9% of unigenes were novel compared to the released coconut EST sequences. Using BLASTX, 68.2% of unigenes were successfully annotated based on the Genbank non-redundant (Nr) protein database. The annotated unigenes were then further classified using the Gene Ontology (GO), Clusters of Orthologous Groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Conclusions/Significance: Our study provides a large quantity of novel genetic information for Cocos nucifera. This information will act as a valuable resource for further molecular genetic studies and breeding in coconut, as well as for isolation and characterization of functional genes involved in different biochemical pathways in this important tropical crop species.	[Fan, Haikuo; Tang, Haoru] Sichuan Agr Univ, Coll Hort, Yaan, Sichuang Provin, Peoples R China; [Fan, Haikuo; Xiao, Yong; Yang, Yaodong; Xia, Wei; Zhao, Songlin] Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconut Res Inst, Wenchang, Hainan, Peoples R China; [Qiao, Fei] Chinese Acad Trop Agr Sci, Trop Corps Genet Resources Inst, Key Lab Crop Gene Resources & Germplasm Enhanceme, Danzhou, Hainan Province, Peoples R China; [Mason, Annaliese S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Mason, Annaliese S.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia; [Xia, Zhihui] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Inst BioSci & Technol, Haikou, Hainan Province, Peoples R China	Sichuan Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences; University of Queensland; University of Queensland; Hainan University	Yang, YD (corresponding author), Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconut Res Inst, Wenchang, Hainan, Peoples R China.	yangyd@tocri.com; htang@sicau.edu.cn	Yang, Yaodong/L-8445-2019; Mason, Annaliese S/B-8809-2011	Yang, Yaodong/0000-0002-6599-5665; Mason, Annaliese S/0000-0003-2701-7964	National Natural Science Foundation of China [31101179]; Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute Research Grant of CATAS [1630032012044, 1630032012028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute Research Grant of CATAS	The research works were funded by the National Natural Science Foundation of China (No. 31101179), the Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China (2011), and the National Nonprofit Institute Research Grant of CATAS-No. 1630032012044 and 1630032012028, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; BABAYAN VK, 1987, LIPIDS, V22, P417, DOI 10.1007/BF02537271; Bilgin DD, 2009, NAT PROTOC, V4, P333, DOI 10.1038/nprot.2008.249; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Santos GA, 1996, MANUAL STANDARDIZED; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036940; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xiao Y, 2012, PLANT OMICS, V5, P584; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; YAU JC, 1991, POULTRY SCI, V70, P167, DOI 10.3382/ps.0700167; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	38	46	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59997	10.1371/journal.pone.0059997	http://dx.doi.org/10.1371/journal.pone.0059997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555859	Green Submitted, gold, Green Published			2022-12-27	WOS:000317263900048
J	Osterndorff-Kahanek, E; Ponomarev, I; Blednov, YA; Harris, RA				Osterndorff-Kahanek, Elizabeth; Ponomarev, Igor; Blednov, Yuri A.; Harris, R. Adron			Gene Expression in Brain and Liver Produced by Three Different Regimens of Alcohol Consumption in Mice: Comparison with Immune Activation	PLOS ONE			English	Article							ETHANOL-CONSUMPTION; C57BL/6J MICE; WITHDRAWAL EXPERIENCE; ILLUMINA MICROARRAY; NUCLEUS-ACCUMBENS; ADDICTION; DRINKING; TRANSCRIPTOME; MODEL; DEPENDENCE	Chronically available alcohol escalates drinking in mice and a single injection of the immune activator lipopolysaccharide can mimic this effect and result in a persistent increase in alcohol consumption. We hypothesized that chronic alcohol drinking and lipopolysaccharide injections will produce some similar molecular changes that play a role in regulation of alcohol intake. We investigated the molecular mechanisms of chronic alcohol consumption or lipopolysaccharide insult by gene expression profiling in prefrontal cortex and liver of C57BL/6J mice. We identified similar patterns of transcriptional changes among four groups of animals, three consuming alcohol (vs water) in different consumption tests and one injected with lipopolysaccharide (vs. vehicle). The three tests of alcohol consumption are the continuous chronic two bottle choice (Chronic), two bottle choice available every other day (Chronic Intermittent) and limited access to one bottle of ethanol (Drinking in the Dark). Gene expression changes were more numerous and marked in liver than in prefrontal cortex for the alcohol treatments and similar in the two tissues for lipopolysaccharide. Many of the changes were unique to each treatment, but there was significant overlap in prefrontal cortex for Chronic-Chronic Intermittent and for Chronic Intermittent-lipopolysaccharide and in liver all pairs showed overlap. In silico cell-type analysis indicated that lipopolysaccharide had strongest effects on brain microglia and liver Kupffer cells. Pathway analysis detected a prefrontal cortex-based dopamine-related (PPP1R1B, DRD1, DRD2, FOSB, PDNY) network that was highly over-represented in the Chronic Intermittent group, with several genes from the network being also regulated in the Chronic and lipopolysaccharide (but not Drinking in the Dark) groups. Liver showed a CYP and GST centered metabolic network shared in part by all four treatments. We demonstrate common consequences of chronic alcohol consumption and immune activation in both liver and brain and show distinct genomic consequences of different types of alcohol consumption.	[Harris, R. Adron] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Coll Nat Sci, Austin, TX 78712 USA; Univ Texas Austin, Coll Pharm, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Harris, RA (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Coll Nat Sci, Austin, TX 78712 USA.	harris@austin.utexas.edu			National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) Integrated Neuroscience Initiative on Alcoholism (INIA-West) [AA13520]; NIH [AA017234, AA013518]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA017234, U01AA013520, R01AA012404, U01AA013518] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) Integrated Neuroscience Initiative on Alcoholism (INIA-West); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) Integrated Neuroscience Initiative on Alcoholism (INIA-West, http://www.scripps.edu/california/research/inia/; AA13520), NIH K award to IP (AA017234), and NIH grant AA013518 to RAH (NIH, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Bazov I, 2013, ADDICT BIOL, V18, P161, DOI 10.1111/j.1369-1600.2011.00366.x; Becker HC, 1997, PHARMACOL BIOCHEM BE, V57, P179, DOI 10.1016/S0091-3057(96)00303-6; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Bell RL, 2009, PHARMACOL BIOCHEM BE, V94, P131, DOI 10.1016/j.pbb.2009.07.019; Blanco AM, 2007, FRONT BIOSCI-LANDMRK, V12, P2616, DOI 10.2741/2259; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2006, ALCOHOL, V40, P73, DOI 10.1016/j.alcohol.2006.12.002; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Clarke TK, 2012, GENES BRAIN BEHAV, V11, P415, DOI 10.1111/j.1601-183X.2012.00785.x; Contet C, 2011, ADDICT BIOL, V16, P615, DOI 10.1111/j.1369-1600.2010.00304.x; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Crews FT, 2012, BIOL PSYCHIAT, DOI [10.1016/j.biopsych.2012.09.030, DOI 10.1016/J.BIOP-SYCH.2012.09.030]; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Deaciuc IV, 2004, J HEPATOL, V40, P219, DOI 10.1016/j.jhep.2003.10.021; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Femenia T, 2012, ADDICT BIOL, V17, P322, DOI 10.1111/j.1369-1600.2011.00378.x; Harris RA, 2011, NEUROSCI LETT, V488, P31, DOI 10.1016/j.neulet.2010.10.075; Hopf FW, 2011, BIOL PSYCHIAT, V69, P618, DOI 10.1016/j.biopsych.2010.11.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Leeman RF, 2010, ADDICT BIOL, V15, P109, DOI 10.1111/j.1369-1600.2009.00192.x; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Logrip ML, 2012, ADDICT BIOL, V17, P920, DOI 10.1111/j.1369-1600.2012.00460.x; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; McBride WJ, 2010, ALCOHOL, V44, P171, DOI 10.1016/j.alcohol.2009.12.001; Melendez RI, 2012, ADDICT BIOL, V17, P351, DOI 10.1111/j.1369-1600.2011.00357.x; MELISKA CJ, 1995, PHARMACOL BIOCHEM BE, V50, P619, DOI 10.1016/0091-3057(94)00354-8; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Nocjar C, 1999, ALCOHOL CLIN EXP RES, V23, P683, DOI 10.1111/j.1530-0277.1999.tb04170.x; Nuutinen S, 2011, NEUROSCI LETT, V503, P31, DOI 10.1016/j.neulet.2011.08.002; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Ponomarev I, 2010, NEUROPSYCHOPHARMACOL, V35, P1402, DOI 10.1038/npp.2010.10; R-Development TC, 2011, R LANG ENV STAT COMP; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodd ZA, 2008, PHARMACOL BIOCHEM BE, V89, P481, DOI 10.1016/j.pbb.2008.01.023; Rosenwasser AM, 2013, ADDICT BIOL, V18, P496, DOI 10.1111/j.1369-1600.2012.00481.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Szabo G, 2011, ALCOHOL CLIN EXP RES, V35, P782, DOI 10.1111/j.1530-0277.2010.01398.x; Takahara Y, 2006, WORLD J GASTROENTERO, V12, P6473, DOI 10.3748/wjg.v12.i40.6473; Taqi MM, 2011, ADDICT BIOL, V16, P499, DOI 10.1111/j.1369-1600.2011.00323.x; Vetreno PV, 2013, NEURAL IMMUNE INTERA, P251; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021100; Yin HQ, 2009, TOXICOL APPL PHARM, V235, P312, DOI 10.1016/j.taap.2008.12.018; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x	68	70	71	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59870	10.1371/journal.pone.0059870	http://dx.doi.org/10.1371/journal.pone.0059870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555817	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900038
J	Zhou, Y; Hong, WJ; Lu, L				Zhou, Yan; Hong, Wanjin; Lu, Lei			Imaging Beads-Retained Prey Assay for Rapid and Quantitative Protein-Protein Interaction	PLOS ONE			English	Article							TAIL SORTING SIGNALS; FURIN; GOLGI; NETWORK; ARL1	Conventional Western blot based pull-down methods involve lengthy and laborious work and the results are generally not quantitative. Here, we report the imaging beads-retained prey (IBRP) assay that is rapid and quantitative in studying protein-protein interactions. In this assay, the bait is immobilized onto beads and the prey is fused with a fluorescence protein. The assay takes advantage of the fluorescence of prey and directly quantifies the amount of prey binding to the immobilized bait under a microscope. We validated the assay using previously well studied interactions and found that the amount of prey retained on beads could have a relative linear relationship to both the inputs of bait and prey. IBRP assay provides a universal, fast, quantitative and economical method to study protein interactions and it could be developed to a medium- or high-throughput compatible method. With the availability of fluorescence tagged whole genome ORFs in several organisms, we predict IBRP assay should have wide applications.	[Zhou, Yan; Lu, Lei] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Hong, Wanjin] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lu, L (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	lulei@ntu.edu.sg	Lu, Lei/A-2225-2011; Zhou, Yan/D-7731-2014	Lu, Lei/0000-0002-8192-1471; Zhou, Yan/0000-0002-0677-5195	Nanyang Technological University (SUG); Ministry of Education [RG18/11]; Ministry of Health [NMRC/CBRG/0007/2012]	Nanyang Technological University (SUG)(Nanyang Technological University); Ministry of Education; Ministry of Health	This work is supported by the following grants to LL: Nanyang Technological University (SUG), Ministry of Education (RG18/11) and Ministry of Health (NMRC/CBRG/0007/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Kang J, 2005, ANAL BIOCHEM, V345, P66, DOI 10.1016/j.ab.2005.07.008; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2001, J CELL SCI, V114, P4543; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Schulte R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002061; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714	12	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59727	10.1371/journal.pone.0059727	http://dx.doi.org/10.1371/journal.pone.0059727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555762	Green Published, gold			2022-12-27	WOS:000317263900024
J	Cassimeris, L; Guglielmi, L; Denis, V; Larroque, C; Martineau, P				Cassimeris, Lynne; Guglielmi, Laurence; Denis, Vincent; Larroque, Christian; Martineau, Pierre			Specific In Vivo Labeling of Tyrosinated alpha-Tubulin and Measurement of Microtubule Dynamics Using a GFP Tagged, Cytoplasmically Expressed Recombinant Antibody	PLOS ONE			English	Article							PLUS ENDS; MAMMALIAN-CELLS; INSTABILITY; BINDING; STABILIZATION; ORGANIZATION; ACETYLATION; MECHANISMS; STABILITY; REVEALS	GFP-tagged proteins are used extensively as biosensors for protein localization and function, but the GFP moiety can interfere with protein properties. An alternative is to indirectly label proteins using intracellular recombinant antibodies (scFvs), but most antibody fragments are insoluble in the reducing environment of the cytosol. From a synthetic hyperstable human scFv library we isolated an anti-tubulin scFv, 2G4, which is soluble in mammalian cells when expressed as a GFP-fusion protein. Here we report the use of this GFP-tagged scFv to label microtubules in fixed and living cells. We found that 2G4-GFP localized uniformly along microtubules and did not disrupt binding of EB1, a protein that binds microtubule ends and serves as a platform for binding by a complex of proteins regulating MT polymerization. TOGp and CLIP-170 also bound microtubule ends in cells expressing 2G4-GFP. Microtubule dynamic instability, measured by tracking 2G4-GFP labeled microtubules, was nearly identical to that measured in cells expressing GFP-alpha-tubulin. Fluorescence recovery after photobleaching demonstrated that 2G4-GFP turns over rapidly on microtubules, similar to the turnover rates of fluorescently tagged microtubule-associated proteins. These data indicate that 2G4-GFP binds relatively weakly to microtubules, and this conclusion was confirmed in vitro. Purified 2G4 partially co-pelleted with microtubules, but a significant fraction remained in the soluble fraction, while a second anti-tubulin scFv, 2F12, was almost completely co-pelleted with microtubules. In cells, 2G4-GFP localized to most microtubules, but did not co-localize with those composed of detyrosinated alpha-tubulin, a post-translational modification associated with non-dynamic, more stable microtubules. Immunoblots probing bacterially expressed tubulins confirmed that 2G4 recognized a-tubulin and required tubulin's C-terminal tyrosine residue for binding. Thus, a recombinant antibody with weak affinity for its substrate can be used as a specific intracellular biosensor that can differentiate between unmodified and post-translationally modified forms of a protein.	[Cassimeris, Lynne] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Guglielmi, Laurence; Denis, Vincent; Larroque, Christian; Martineau, Pierre] IRCM, Montpellier, France; [Guglielmi, Laurence; Denis, Vincent; Larroque, Christian; Martineau, Pierre] INSERM, U896, Montpellier, France; [Guglielmi, Laurence; Denis, Vincent; Larroque, Christian; Martineau, Pierre] Univ Montpellier I, Montpellier, France; [Guglielmi, Laurence; Denis, Vincent; Larroque, Christian; Martineau, Pierre] CRLC Val dAurelle Paul Lamarque, Montpellier, France	Lehigh University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Cassimeris, L (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	lc07@lehigh.edu	Martineau, Pierre/N-4386-2017	Martineau, Pierre/0000-0002-7993-7183; Cassimeris, Lynne/0000-0003-1058-0734; Guglielmi, Laurence/0000-0003-2517-4616	Pennsylvania (USA) Dept. of Health grant; Institut National de la Sante et de la Recherche Medicale; University of Montpellier 1	Pennsylvania (USA) Dept. of Health grant; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 1	Pennsylvania (USA) Dept. of Health grant to LC. Institut National de la Sante et de la Recherche Medicale and the University of Montpellier 1 to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bonfils C, 2007, J BIOL CHEM, V282, P5570, DOI 10.1074/jbc.M605641200; Bulinski JC, 2001, J CELL SCI, V114, P3885; Burbank KS, 2006, CURR BIOL, V16, pR516, DOI 10.1016/j.cub.2006.06.044; Cassimeris L, 2001, J CELL SCI, V114, P3025; Cassimeris L, 2009, CELL MOTIL CYTOSKEL, V66, P535, DOI 10.1002/cm.20359; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; Guglielmi L, 2011, PROTEIN ENG DES SEL, V24, P873, DOI 10.1093/protein/gzr049; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Matrone MA, 2010, ONCOGENE, V29, P3217, DOI 10.1038/onc.2010.68; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051442; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Philibert P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-81; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Quinones GB, 2011, MOL BIOL CELL, V22, P1045, DOI 10.1091/mbc.E10-06-0519; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Warren JC, 2006, MOL BIOL CELL, V17, P3557, DOI 10.1091/mbc.E05-09-0850; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795	41	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59812	10.1371/journal.pone.0059812	http://dx.doi.org/10.1371/journal.pone.0059812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555790	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200042
J	Madeira, FB; Silva, AA; Veloso, HF; Goldani, MZ; Kac, G; Cardoso, VC; Bettiol, H; Barbieri, MA				Madeira, Francilene B.; Silva, Antonio A.; Veloso, Helma F.; Goldani, Marcelo Z.; Kac, Gilberto; Cardoso, Viviane C.; Bettiol, Heloisa; Barbieri, Marco A.			Normal Weight Obesity Is Associated with Metabolic Syndrome and Insulin Resistance in Young Adults from a Middle-Income Country	PLOS ONE			English	Article							BODY-MASS INDEX; RIBEIRAO-PRETO; GENERALIZED EQUATIONS; RISK-FACTOR; TRENDS; PREVALENCE; SENSITIVITY; DEFINITION; OVERWEIGHT; MORTALITY	Objective: This population-based birth cohort study examined whether normal weight obesity is associated with metabolic disorders in young adults in a middle-income country undergoing rapid nutrition transition. Design and Methods: The sample involved 1,222 males and females from the 1978/79 Ribeirao Preto birth cohort, Brazil, aged 23-25 years. NWO was defined as body mass index (BMI) within the normal range (18.5-24.9 kg/m(2)) and the sum of subscapular and triceps skinfolds above the sex-specific 90th percentiles of the study sample. It was also defined as normal BMI and % BF (body fat) >23% in men and >30% in women. Insulin resistance (IR), insulin sensitivity and secretion were based on the Homeostasis Model Assessment (HOMA) model. Results: In logistic models, after adjusting for age, sex and skin colour, NWO was significantly associated with Metabolic Syndrome (MS) according to the Joint Interim Statement (JIS) definition (Odds Ratio OR = 6.83; 95% Confidence Interval CI 2.84-16.47). NWO was also associated with HOMA2-IR (OR = 3.81; 95% CI 1.57-9.28), low insulin sensitivity (OR = 3.89; 95% CI 2.39-6.33), and high insulin secretion (OR = 2.17; 95% CI 1.24-3.80). Significant associations between NWO and some components of the MS were also detected: high waist circumference (OR = 8.46; 95% CI 5.09-14.04), low High Density Lipoprotein cholesterol (OR = 1.65; 95% CI 1.11-2.47) and high triglyceride levels (OR = 1.93; 95% CI 1.02-3.64). Most estimates changed little after further adjustment for early and adult life variables. Conclusions: NWO was associated with MS and IR, suggesting that clinical assessment of excess body fat in normal-BMI individuals should begin early in life even in middle-income countries.	[Madeira, Francilene B.] Univ Estadual Piaui, Phys Educ Undergrad Course, Teresina, Brazil; [Silva, Antonio A.; Veloso, Helma F.] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Brazil; [Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Fac Med, Dept Pediat & Puericulture, Porto Alegre, RS, Brazil; [Kac, Gilberto] Univ Fed Rio de Janeiro, Josue de Castro Nutr Inst, Dept Social & Appl Nutr, Rio De Janeiro, Brazil; [Cardoso, Viviane C.; Bettiol, Heloisa; Barbieri, Marco A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Puericulture & Pediat, BR-14049 Ribeirao Preto, Brazil	Universidade Estadual do Piaui (UESPI); Universidade Federal do Maranhao; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Silva, AA (corresponding author), Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Brazil.	aasilva@ufma.br	Kac, Gilberto/H-6862-2012; Barbieri, Marco/J-2597-2014; Goldani, Marcelo Zubaran/U-8596-2019; Bettiol, Heloisa/B-4190-2013; Silva, Antonio A M/B-5410-2009; Cardoso, Viviane/D-6254-2012	Kac, Gilberto/0000-0001-8603-9077; Bettiol, Heloisa/0000-0001-8744-4373; Silva, Antonio A M/0000-0003-4968-5138; Cardoso, Viviane/0000-0002-2677-5600	Brazilian Research Council (CNPq); University of Sao Paulo; Sao Paulo Research Foundation (FAPESP) [00/09508-7]	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Sao Paulo; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Brazilian Research Council (CNPq, Brazilian acronym), the University of Sao Paulo and the Sao Paulo Research Foundation (FAPESP, Brazilian acronym) grant number 00/09508-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 1991, ANTHROPOMETRIC STAND; Barbieri MA, 2006, BRAZ J MED BIOL RES, V39, P1041, DOI 10.1590/S0100-879X2006000800007; Bustos P, 2007, NUTR METAB CARDIOVAS, V17, P581, DOI 10.1016/j.numecd.2006.06.001; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cardoso VC, 2007, BRAZ J MED BIOL RES, V40, P1165, DOI 10.1590/S0100-879X2006005000148; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Lorenzo A, 2006, NUTR METAB CARDIOVAS, V16, P513, DOI 10.1016/j.numecd.2005.10.010; De Lorenzo A, 2011, INT J CARDIOL; De Lorenzo A, 2007, AM J CLIN NUTR, V85, P40, DOI 10.1093/ajcn/85.1.40; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Di Renzo L, 2010, OBESITY, V18, P2125, DOI 10.1038/oby.2010.50; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Hosseinpanah F, 2011, ANN NUTR METAB, V58, P126, DOI 10.1159/000327147; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, PESQ ORC FAM 2008 20; IPAQ, 2004, GUID DAT PROC AN INT; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kim LJ, 2011, OBESITY, V19, P1265, DOI 10.1038/oby.2010.291; Kosmala W, 2012, CIRC-CARDIOVASC IMAG, V5, P349, DOI 10.1161/CIRCIMAGING.111.969956; Marques-Vidal P, 2010, NUTR METAB CARDIOVAS, V20, P669, DOI 10.1016/j.numecd.2009.06.001; Marques-Vidal P, 2008, EUR J NUTR, V47, P251, DOI 10.1007/s00394-008-0719-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Molina MC, 2007, BRAZ J MED BIOL RES, V40, P1257, DOI 10.1590/S0100-879X2006005000168; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Olds TS, 2009, EUR J CLIN NUTR, V63, P934, DOI 10.1038/ejcn.2009.7; Popkin BM, 1998, NUTR REV, V56, P106; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Silva AAM, 2012, NUTR METAB CARDIOVAS, V22, P533, DOI 10.1016/j.numecd.2010.09.012; Silva AA, 2011, NUTR METAB CARDIOVAS; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Tsai CH, 2009, CHINESE MED J-PEKING, V122, P2534, DOI 10.3760/cma.j.issn.0366-6999.2009.21.003; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, 1995, PHYS STAT US INT ANT; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	50	98	109	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60673	10.1371/journal.pone.0060673	http://dx.doi.org/10.1371/journal.pone.0060673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23556000	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200128
J	Zala, D; Hinckelmann, MV; Saudou, F				Zala, Diana; Hinckelmann, Maria-Victoria; Saudou, Frederic			Huntingtin's Function in Axonal Transport Is Conserved in Drosophila melanogaster	PLOS ONE			English	Article							MUTANT HUNTINGTIN; VESICLE TRANSPORT; DISEASE; NEURONS; NEURODEGENERATION; PROTEIN; DYNACTIN; MODEL; BRAIN; MICE	Huntington's disease (HD) is a devastating dominantly inherited neurodegenerative disorder caused by an abnormal polyglutamine expansion in the N-terminal part of the huntingtin (HTT) protein. HTT is a large scaffold protein that interacts with more than a hundred proteins and is probably involved in several cellular functions. The mutation is dominant, and is thought to confer new and toxic functions to the protein. However, there is emerging evidence that the mutation also alters HTT's normal functions. Therefore, HD models need to recapitulate this duality if they are to be relevant. Drosophila melanogaster is a useful in vivo model, widely used to study HD through the overexpression of full-length or N-terminal fragments of mutant human HTT. However, it is unclear whether Drosophila huntingtin (DmHTT) shares functions similar to the mammalian HTT. Here, we used various complementary approaches to analyze the function of DmHTT in fast axonal transport. We show that DmHTT interacts with the molecular motor dynein, associates with vesicles and co-sediments with microtubules. DmHTT co-localizes with Brain-derived neurotrophic factor (BDNF)-containing vesicles in rat cortical neurons and partially replaces mammalian HTT in a fast axonal transport assay. DmHTT-KO flies show a reduced fast axonal transport of synaptotagmin vesicles in motoneurons in vivo. These results suggest that the function of HTT in axonal transport is conserved between flies and mammals. Our study therefore validates Drosophila melanogaster as a model to study HTT function, and its dysfunction associated with HD.	[Zala, Diana; Hinckelmann, Maria-Victoria; Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Zala, Diana; Hinckelmann, Maria-Victoria; Saudou, Frederic] CNRS, UMR 3306, F-91405 Orsay, France; [Zala, Diana; Hinckelmann, Maria-Victoria; Saudou, Frederic] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay	Zala, D (corresponding author), Inst Curie, F-91405 Orsay, France.	diana.zala@curie.fr; frederic.saudou@curie.fr	ZALA, Diana/L-4651-2017; Zala, Diana/R-8196-2019; SAUDOU, Frédéric/L-3454-2014	ZALA, Diana/0000-0002-0052-8011; Zala, Diana/0000-0002-0052-8011; SAUDOU, Frédéric/0000-0001-6107-1046	Agence Nationale pour la Recherche [ANR-08-MNP-039]; Fondation pour la Recherche Medicale (FRM); CNRS; INSERM; Institut Curie; Association Huntington France; Fondation Pierre-Gilles de Gennes pour la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie; Association Huntington France; Fondation Pierre-Gilles de Gennes pour la Recherche	This work was supported by grants from Agence Nationale pour la Recherche (ANR-08-MNP-039, FS), Fondation pour la Recherche Medicale (FRM, equipe labellisee) (FS), CNRS, INSERM and the Institut Curie (FS). We thank for fellowship support: Association Huntington France (MVH), Institut Curie (DZ) and Fondation Pierre-Gilles de Gennes pour la Recherche (DZ); FS and DZ are INSERM investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Branco J, 2008, HUM MOL GENET, V17, P376, DOI 10.1093/hmg/ddm315; Caviston JP, 2009, TRENDS CELL BIOL, P1; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Kuznicki ML, 2010, JOVE-J VIS EXP, V44; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Liot G, 2013, J NEUROSCI IN PRESS; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marsh JL, 2003, HUM MOL GENET, V12, pR187, DOI 10.1093/hmg/ddg271; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Pardo R, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-17; Pineda JR, 2009, MOL BRAIN, V11, P1; Power D, 2012, NEUROREPORT, V23, P970, DOI 10.1097/WNR.0b013e328359d990; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Schulte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023841; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Van Raamsdonk JM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-80; Vecchi M, 2005, J CELL BIOL, V170, P169, DOI 10.1083/jcb.200506039; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	55	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60162	10.1371/journal.pone.0060162	http://dx.doi.org/10.1371/journal.pone.0060162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555909	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200088
J	Bavinger, C; Bendavid, E; Niehaus, K; Olshen, RA; Olkin, I; Sundaram, V; Wein, N; Holodniy, M; Hou, NJ; Owens, DK; Desai, M				Bavinger, Clay; Bendavid, Eran; Niehaus, Katherine; Olshen, Richard A.; Olkin, Ingram; Sundaram, Vandana; Wein, Nicole; Holodniy, Mark; Hou, Nanjiang; Owens, Douglas K.; Desai, Manisha			Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review	PLOS ONE			English	Review							MARGINAL STRUCTURAL MODELS; REVERSE-TRANSCRIPTASE INHIBITORS; MYOCARDIAL-INFARCTION; CEREBROVASCULAR EVENTS; PROTEASE INHIBITORS; CAUSAL INFERENCE; CLINICAL-TRIALS; ABACAVIR; DRUGS; ZIDOVUDINE	Background: Recent studies suggest certain antiretroviral therapy (ART) drugs are associated with increases in cardiovascular disease. Purpose: We performed a systematic review and meta-analysis to summarize the available evidence, with the goal of elucidating whether specific ART drugs are associated with an increased risk of myocardial infarction (MI). Data Sources: We searched Medline, Web of Science, the Cochrane Library, and abstract archives from the Conference on Retroviruses and Opportunistic Infections and International AIDS Society up to June 2011 to identify published articles and abstracts. Study Selection: Eligible studies were comparative and included MI, strokes, or other cardiovascular events as outcomes. Data Extraction: Eligibility screening, data extraction, and quality assessment were performed independently by two investigators. Data Synthesis: Random effects methods and Fisher's combined probability test were used to summarize evidence. Findings: Twenty-seven studies met inclusion criteria, with 8 contributing to a formal meta-analysis. Findings based on two observational studies indicated an increase in risk of MI for patients recently exposed (usually defined as within last 6 months) to abacavir (RR 1.92, 95% CI 1.51-2.42) and protease inhibitors (PI) (RR 2.13, 95% CI 1.06-4.28). Our analysis also suggested an increased risk associated with each additional year of exposure to indinavir (RR 1.11, 95% CI 1.05-1.17) and lopinavir (RR 1.22, 95% CI 1.01-1.47). Our findings of increased cardiovascular risk from abacavir and PIs were in contrast to four published meta-analyses based on secondary analyses of randomized controlled trials, which found no increased risk from cardiovascular disease. Conclusion: Although observational studies implicated specific drugs, the evidence is mixed. Further, meta-analyses of randomized trials did not find increased risk from abacavir and PIs. Our findings that implicate specific ARTs in the observational setting provide sufficient evidence to warrant further investigation of this relationship in studies designed for that purpose.	[Bavinger, Clay; Bendavid, Eran; Niehaus, Katherine; Sundaram, Vandana; Wein, Nicole; Hou, Nanjiang; Owens, Douglas K.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Bavinger, Clay; Bendavid, Eran; Niehaus, Katherine; Sundaram, Vandana; Wein, Nicole; Hou, Nanjiang; Owens, Douglas K.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ Med Ctr, Div Gen Internal Med, Stanford, CA USA; [Holodniy, Mark; Hou, Nanjiang; Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Olshen, Richard A.] Stanford Univ Med Ctr, Div Biostat, Stanford, CA USA; [Olkin, Ingram] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Desai, Manisha] Stanford Univ Med Ctr, Dept Med, Quantitat Sci Unit, Stanford, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University	Bavinger, C (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA.	claybavinger@gmail.com		Holodniy, Mark/0000-0002-6655-7982	United States National Institutes of Health [1RC1AI086927-01, 2 R01 DA15612-016]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the United States National Institutes of Health 1RC1AI086927-01 and 2 R01 DA15612-016. Dr. Owens and Dr. Holodniy are supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; Barbaro G, 2003, CLIN THER, V25, P2405, DOI 10.1016/S0149-2918(03)80283-7; Bedimo R, 2009, 5 IAS C HIV PATH TRE; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Braga LH, 2011, J UROLOGY, V186, P266, DOI 10.1016/j.juro.2011.03.044; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Coplan PM, 2003, AIDS RES HUM RETROV, V19, P449, DOI 10.1089/088922203766774487; Corral I, 2009, CEREBROVASC DIS, V27, P559, DOI 10.1159/000214219; Daftary M, 2004, 15 INT AIDS C; David MH, 2002, CLIN INFECT DIS, V34, P98, DOI 10.1086/324745; Ding X, 2012, JAIDS; Ding X, 2011, C RETR OPP INF BOST; Durand M, 2009, 5 IAS C HIV PATH TRE; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Hernan MA, 2002, STAT MED, V21, P1689, DOI 10.1002/sim.1144; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holmberg SD, 2002, 14 INT AIDS C; Iloeje UH, 2005, HIV MED, V6, P37, DOI 10.1111/j.1468-1293.2005.00265.x; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Kwong GPS, 2006, AIDS, V20, P1941, DOI 10.1097/01.aids.0000247115.81832.a1; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Levy AR, 2003, 2 IAS C HIV PATH TRE; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Monforte AD, 2004, AIDS, V18, P1811, DOI 10.1097/00002030-200409030-00010; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Quiros-Roldan E, 2005, INT J STD AIDS, V16, P14, DOI 10.1258/0956462052932665; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Rickerts V, 2000, Eur J Med Res, V5, P329; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Sturmer T, 2007, AM J EPIDEMIOL, V165, P1110, DOI 10.1093/aje/kwm074; Triant V, 2010, INT AIDS C VIENN; Vaughn G, 2007, AIDS CARE, V19, P492, DOI 10.1080/09540120701203329; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	53	140	148	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59551	10.1371/journal.pone.0059551	http://dx.doi.org/10.1371/journal.pone.0059551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555704	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500051
J	Chen, M; Yang, L; Ma, YL; Su, YZ; Yang, CJ; Luo, HB; Chen, HC; Chen, L; Yan, WY; Shi, YH; Jia, MH; Lu, L				Chen, Min; Yang, Li; Ma, Yanling; Su, Yingzhen; Yang, Chaojun; Luo, Hongbing; Chen, Huichao; Chen, Ling; Yan, Wenyun; Shi, Yuhua; Jia, Manhong; Lu, Lin			Emerging Variability in HIV-1 Genetics among Recently Infected Individuals in Yunnan, China	PLOS ONE			English	Article							INJECTION-DRUG USERS; CIRCULATING RECOMBINANT FORMS; MOLECULAR EPIDEMIOLOGY; TYPE-1 GENOME; VIRUS; PROVINCE; SUBTYPES; TRANSMISSION; STRAIN; CRF07-BC	Background: Yunnan has the longest endured Human Immunodeficiency Virus-1 (HIV-1) epidemic in China, and the genetic diversity of HIV-1 constitutes an essential characteristic of molecular epidemiology in this region. To obtain a more comprehensive picture of the dynamic changes in Yunnan's HIV-1 epidemic, a cross-sectional molecular epidemiological investigation was carried out among recently infected individuals. Methodology/Principal Findings: We sequenced partial gag (HXB2:781-1861) and env (HXB2:7002-7541) genes from 308 plasma samples of recently infected patients. With phylogenetic analysis, 130 specimens generated interpretable genotyping data. We found that the circulating genotypes included: CRF08_BC (40.8%), unique recombinant forms (URFs, 27.7%), CRF01_AE (18.5%), CRF07_BC (9.2%), subtype B (2.3%) and C (1.5%). CRF08_BC was the most common genotype, and was predominant in both intravenous drug users (IDUs) and heterosexually transmitted populations. CRF08_BC and CRF07_BC still predominated in eastern Yunnan, but CRF08_BC showed increasing prevalence in western Yunnan. Strikingly, the URFs raised dramatically in most regions of Yunnan. Seven different types of URFs were detected from 12 prefectures, suggesting that complicated and frequent recombination is a salient feature of Yunnan's HIV-1 epidemic. Among URFs, two BC clusters with distinctive recombination patterns might be potential new CRF_BCs. CRF01_AE was no longer confined to the prefectures bordering Myanmar, and had spread to the eastern part of Yunnan, especially the capital city of Kunming, with a large number of infections in the transient population. The ratios of the main genotypes showed no statistical differences between infected IDUs and heterosexually transmitted infections. Conclusions/Significance: The changing patterns of the dominant HIV-1 genotypes in Yunnan indicate the complex evolving dynamic nature of the epidemic. Understanding new trends in molecular epidemiology of HIV-1 infection is critical for adjusting current prevention strategies and vaccine development in Yunnan.	[Chen, Min; Yang, Li; Ma, Yanling; Su, Yingzhen; Yang, Chaojun; Luo, Hongbing; Chen, Huichao; Chen, Ling; Yan, Wenyun; Shi, Yuhua; Jia, Manhong; Lu, Lin] Yunnan Ctr Dis Control & Prevent, Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China; [Lu, Lin] Kunming Med Univ, Coll Publ Hlth, Kunming, Yunnan, Peoples R China	Kunming Medical University	Jia, MH (corresponding author), Yunnan Ctr Dis Control & Prevent, Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China.	jmanhong@yahoo.com.cn; lulin@yncdc.cn	MA, YAN/HHN-2912-2022		Major Project of China's "Eleventh Five-Years Plan'' for Science and Technology Development [2009ZX10004-902]; ''Twelfth Five-Years Plan'' for Science and Technology Development [2011ZX10004-903]; China Postdoctoral Science Foundation [200902022]	Major Project of China's "Eleventh Five-Years Plan'' for Science and Technology Development; ''Twelfth Five-Years Plan'' for Science and Technology Development; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Major Project of China's "Eleventh Five-Years Plan'' for Science and Technology Development (2009ZX10004-902),''Twelfth Five-Years Plan'' for Science and Technology Development (2011ZX10004-903) and the special grade of financial support from the China Postdoctoral Science Foundation (200902022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Chen LL, 2011, AIDS RES HUM RETROV, V27, P693, DOI [10.1089/aid.2010.0264, 10.1089/AID.2010.0264]; CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jiang Y, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000304696.62508.8a; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Li L, 2010, AIDS RES HUM RETROV, V26, P1255, DOI 10.1089/aid.2010.0116; Li XJ, 2005, AIDS RES HUM RETROV, V21, P977, DOI 10.1089/aid.2005.21.977; Li Z, 2012, AIDS; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Liu YJ, 2011, AIDS RES HUM RETROV, V27, P445, DOI 10.1089/aid.2010.0212; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Ma Yan-ling, 2008, Zhonghua Yufang Yixue Zazhi, V42, P892; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meng ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052373; Pang W, 2012, AIDS; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Shao YM, 1994, CHINESE J VIROL, V4, P291; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; WENIGER BG, 1994, AIDS, V8, pS13; Wolf H, 1996, CHINESE J VIROL, V12, P9; Yang RG, 2003, J VIROL, V77, P685, DOI 10.1128/JVI.77.1.685-695.2003; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zeng HY, 2012, AIDS RES HUM RETROV, V28, P1352, DOI 10.1089/aid.2011.0364; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	38	37	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60101	10.1371/journal.pone.0060101	http://dx.doi.org/10.1371/journal.pone.0060101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555898	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500117
J	Chung, BH; Lim, SW; Doh, KC; Piao, SG; Heo, SB; Yang, CW				Chung, Byung Ha; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Heo, Seong Beom; Yang, Chul Woo			Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress	PLOS ONE			English	Article							PROTECT; EXPRESSION; MODEL; TRANSPLANTATION; MECHANISMS; APOPTOSIS; FIBROSIS; KIDNEYS; KLOTHO; INJURY	The aim of this study was to investigate whether hATMSCs protect against cyclosporine (CsA)-induced renal injury. CsA (7.5 mg/kg) and hATMSCs (3x10(6)/5 mL) were administered alone and together to rats for 4 weeks. The effect of hATMSCs on CsA-induced renal injury was evaluated by assessing renal function, interstitial fibrosis, infiltration of inflammatory cells, and apoptotic cell death. Four weeks of CsA-treatment produced typical chronic CsA-nephropathy. Combined treatment with CsA and hATMSCs did not prevent these effects and showed a trend toward further renal deterioration. To evaluate why hATMSCs aggravated CsA-induced renal injury, we measured oxidative stress, a major mechanism of CsA-induced renal injury. Both urine and serum 8-hydroxydeoxyguanosine(8-OHdG) levels were higher in the CsA+hATMSCs group than in the CsA group (P<0.05). An in vitro study showed similar results. Although the rate of apoptosis did not differ significantly between HK-2 cells cultured in hATMSCs-conditioned medium and those cultured in DMEM, addition of CsA resulted in greater apoptosis in HK-2 cells cultured in hATMSCs-conditioned medium. Addition of CsA increased oxidative stress in the hATMSCs-conditioned medium. The results of our study suggest that treatment with hATMSCs may aggravate CsA-induced renal injury because hATMSCs cause oxidative stress in the presence of CsA.	[Chung, Byung Ha; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Heo, Seong Beom; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Chung, Byung Ha; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Heo, Seong Beom; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Heo, Seong Beom; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Korea Healthcare Technology R&D Project , Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]	Korea Healthcare Technology R&D Project , Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant (A092258) from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KO, 2008, TRANSPLANTATION, V86, P571, DOI 10.1097/TP.0b013e3181820470; Bennett WM, 1996, KIDNEY INT, V50, P1089, DOI 10.1038/ki.1996.415; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Choi HJ, 2011, J KOREAN MED SCI, V26, P482, DOI 10.3346/jkms.2011.26.4.482; Crop MJ, 2009, TRANSPLANTATION, V87, P896, DOI 10.1097/TP.0b013e31819b3d72; Dekel B, 2006, STEM CELLS, V24, P1185, DOI 10.1634/stemcells.2005-0265; Deters M, 1997, TOXICOLOGY, V123, P197, DOI 10.1016/S0300-483X(97)00123-6; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Ghee JY, 2008, NEPHROL DIAL TRANSPL, V23, P4061, DOI 10.1093/ndt/gfn388; Han DH, 2010, TRANSPLANTATION, V90, P135, DOI 10.1097/TP.0b013e3181e117b4; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hoogduijn MJ, 2008, TRANSPLANTATION, V86, P1283, DOI 10.1097/TP.0b013e31818aa536; Horn AP, 2011, STEM CELLS DEV, V20, P1171, DOI 10.1089/scd.2010.0157; Horn AP, 2009, NEUROSCI RES, V63, P35, DOI 10.1016/j.neures.2008.10.001; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Kim JH, 2012, AM J PHYSIOL-RENAL, V302, pF1141, DOI 10.1152/ajprenal.00060.2011; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mohammadzadeh M, 2012, CELL STRESS CHAPERON, V17, P553, DOI 10.1007/s12192-012-0331-9; Muller MH, 2006, MOL ECOL, V15, P1589, DOI 10.1111/j.1365-294X.2006.02851.x; MYERS BD, 1984, NEW ENGL J MED, V311, P699, DOI 10.1056/NEJM198409133111103; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; OWUNWANNE A, 1993, J HEART LUNG TRANSPL, V12, P199; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Redondo-Horcajo M, 2005, J NEPHROL, V18, P453; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Sun CK, 2012, CRIT CARE MED, V40, P1279, DOI 10.1097/CCM.0b013e31823dae23; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; WANG CY, 1995, KIDNEY INT, V47, P927, DOI 10.1038/ki.1995.138; Whone AL, 2012, BRAIN RES, V1431, P86, DOI 10.1016/j.brainres.2011.10.038; Yang CW, 2002, AM J TRANSPLANT, V2, P391, DOI 10.1034/j.1600-6143.2002.20501.x; Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zhang W, 2007, TRANSPL P, V39, P3404, DOI 10.1016/j.transproceed.2007.06.092; Zhou HP, 2006, TRANSPL P, V38, P3046, DOI 10.1016/j.transproceed.2006.10.002	43	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59693	10.1371/journal.pone.0059693	http://dx.doi.org/10.1371/journal.pone.0059693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555748	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500078
J	Kim, SI; Tai, TH				Kim, Sang-Ic; Tai, Thomas H.			Identification of SNPs in Closely Related Temperate Japonica Rice Cultivars Using Restriction Enzyme-Phased Sequencing	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISCOVERY; REGISTRATION; IMPUTATION; INFERENCE; REVEALS; TRAITS; LINES; MAP	Very low polymorphism in the germplasm typically used by breeding programs poses a significant bottleneck with regards to molecular breeding and the exploitation of breeding materials for quantitative trait analyses. California rice cultivars, derived from a very small base of temperate japonica germplasm and having a relatively brief breeding history, are a good example. In this study, we employed a reduced representation sequencing approach called Restriction Enzyme Site Comparative Analysis (RESCAN) to simultaneously identify and genotype single nucleotide polymorphisms (SNPs) in forty-five rice cultivars representing the majority of the 100 year-old breeding history in California. Over 20,000 putative SNPs were detected relative to the Nipponbare reference genome which enabled the identification and analysis of inheritance of pedigree haplotypes. Haplotype blocks distinguishing modern California cultivars from each other and from the ancestral short grain temperate japonica cultivars were easily identified. Reduced representation sequencing methods such as RESCAN are a valuable alternative to SNP chip genotyping and low coverage whole genome sequencing.	[Kim, Sang-Ic; Tai, Thomas H.] Univ Calif Davis, USDA ARS Crops Pathol & Genet Res Unit, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Tai, TH (corresponding author), Univ Calif Davis, USDA ARS Crops Pathol & Genet Res Unit, Dept Plant Sci, Davis, CA 95616 USA.	Thomas.Tai@ars.usda.gov			USDA-ARS CRIS Project [5306-21000-017-00D]; California Rice Research Board Project [RB-3]; California Rice Research Board	USDA-ARS CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); California Rice Research Board Project; California Rice Research Board	This work was supported by USDA-ARS CRIS Project 5306-21000-017-00D (www.ars.usda.gov) and California Rice Research Board Project RB-3 (www.carrb.com). The California Rice Research Board is a non-profit, California rice grower-funded body which awards grants primarily to public research institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR CR, 1972, CROP SCI, V12, P256, DOI 10.2135/cropsci1972.0011183X001200020042x; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; CARNAHAN HL, 1978, CROP SCI, V18, P357, DOI 10.2135/cropsci1978.0011183X001800020055x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Deschamps Stephane, 2012, Biology (Basel), V1, P460, DOI 10.3390/biology1030460; DILDAY RH, 1990, CROP SCI, V30, P905, DOI 10.2135/cropsci1990.0011183X003000040030x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falush D, 2003, GENETICS, V164, P1567; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kim SI, 2009, SABRAO J BREED GENET, V41, P25; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; MASTENBROEK J. J., 1970, Crop science, V10, pp, DOI 10.2135/cropsci1970.0011183X001000060054x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MCKENZIE KS, 1994, AUST J EXP AGR, V34, P897, DOI 10.1071/EA9940897; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Monson-Miller J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-72; Poland JA, 2012, PLANT GENOME-US, V5, P92, DOI 10.3835/plantgenome2012.05.0005; Pritchard JK, 2000, GENETICS, V155, P945; RUTGER JN, 1977, CROP SCI, V17, P978, DOI 10.2135/cropsci1977.0011183X001700060047x; Seymour DK, 2012, P NATL ACAD SCI USA, V109, P4227, DOI 10.1073/pnas.1117277109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TSENG ST, 1984, CROP SCI, V24, P1213, DOI 10.2135/cropsci1984.0011183X002400060055x; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	37	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60176	10.1371/journal.pone.0060176	http://dx.doi.org/10.1371/journal.pone.0060176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555916	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500120
J	Nomura, S; Gilmour, S; Tsubokura, M; Yoneoka, D; Sugimoto, A; Oikawa, T; Kami, M; Shibuya, K				Nomura, Shuhei; Gilmour, Stuart; Tsubokura, Masaharu; Yoneoka, Daisuke; Sugimoto, Amina; Oikawa, Tomoyoshi; Kami, Masahiro; Shibuya, Kenji			Mortality Risk amongst Nursing Home Residents Evacuated after the Fukushima Nuclear Accident: A Retrospective Cohort Study	PLOS ONE			English	Article							RADIATION-EXPOSURE; DISASTER; EARTHQUAKE; JAPAN; CARE	Background: Safety of evacuation is of paramount importance in disaster planning for elderly people; however, little effort has been made to investigate evacuation-related mortality risks. After the Fukushima Daiichi Nuclear Plant accident we conducted a retrospective cohort survival survey of elderly evacuees. Methods: A total of 715 residents admitted to five nursing homes in Minamisoma city, Fukushima Prefecture in the five years before 11th March 2011 joined this retrospective cohort study. Demographic and clinical characteristics were drawn from facility medical records. Evacuation histories were tracked until the end of 2011. The evacuation's impact on mortality was assessed using mortality incidence density and hazard ratios in Cox proportional hazards regression. Results: Overall relative mortality risk before and after the earthquake was 2.68 (95% CI: 2.04-3.49). There was a substantial variation in mortality risks across the facilities ranging from 0.77 (95% CI: 0.34-1.76) to 2.88 (95% CI: 1.74-4.76). No meaningful influence of evacuation distance on mortality was observed although the first evacuation from the original facility caused significantly higher mortality than subsequent evacuations, with a hazard ratio of 1.94 (95% CI: 1.07-3.49). Conclusion: High mortality, due to initial evacuation, suggests that evacuation of the elderly was not the best life-saving strategy for the Fukushima nuclear disaster. Careful consideration of the relative risks of radiation exposure and the risks and benefits of evacuation is essential. Facility-specific disaster response strategies, including in-site relief and care, may have a strong influence on survival. Where evacuation is necessary, careful planning and coordination with other nursing homes, evacuation sites and government disaster agencies is essential to reduce the risk of mortality.	[Nomura, Shuhei; Gilmour, Stuart; Yoneoka, Daisuke; Sugimoto, Amina; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Tsubokura, Masaharu; Oikawa, Tomoyoshi] Minamisoma City Gen Hosp, Dept Internal Med, Haramachi Ku, Fukushima, Japan	University of Tokyo; University of Tokyo	Shibuya, K (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	shibuyak@m.u-tokyo.ac.jp	Tsubokura, Masaharu/AAV-4364-2021; Tsubokura, Masaharu/D-7300-2017; Nomura, Shuhei/HCH-5356-2022; Yoneoka, Daisuke/A-9336-2016	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X; Yoneoka, Daisuke/0000-0002-3525-5092; Nomura, Shuhei/0000-0002-2963-7297; Shibuya, Kenji/0000-0003-2528-7530	Toyota Foundation; Ministry of Health Labour and Welfare of Japan [H22-seisaku-shitei-033, 24030401]	Toyota Foundation; Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Toyota Foundation (http://www.toyotafound.or.jp/) and the Ministry of Health Labour and Welfare of Japan (grant type: H22-seisaku-shitei-033, grant number: 24030401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Red Cross, 2011, SOC MED DIS EM; Bailey JH, 2008, AM J MED SCI, V336, P124, DOI 10.1097/MAJ.0b013e318180f19f; Blanchard G, 2009, J AM MED DIR ASSOC, V10, P639, DOI 10.1016/j.jamda.2009.06.010; BOLIN R, 1983, INT J AGING HUM DEV, V16, P283, DOI 10.2190/MQEG-YN39-8D5V-WKMP; Brumfiel G, 2011, NATURE, V471, P273, DOI 10.1038/471273a; Castle NG, 2008, AM J PUBLIC HEALTH, V98, P1235, DOI 10.2105/AJPH.2006.107532; Dosa D, 2012, J AM MED DIR ASSOC, V13; Dosa DM, 2008, J AM MED DIR ASSOC, V9, P599, DOI 10.1016/j.jamda.2008.05.007; Dosa DM, 2007, J AM MED DIR ASSOC, V8, P142, DOI 10.1016/j.jamda.2006.11.004; Fitzgerald J, 2012, BIOSECUR BIOTERROR, V10, P228, DOI 10.1089/bsp.2012.0021; Gautam S, 2009, DISASTER MED PUBLIC, V3, P144, DOI 10.1097/DMP.0b013e3181b9db91; Gladwin H., 1997, HURRICANE ANDREW ETH, P52; Harasawa K, 2012, LANCET, V379, P2240, DOI 10.1016/S0140-6736(12)60978-7; Irisawa A, 2012, DIGEST ENDOSC, V24, P3, DOI 10.1111/j.1443-1661.2012.01280.x; Levinson DR, 2006, NURSING HOME EMERGEN; McCurry J, 2011, LANCET, V378, P1061, DOI 10.1016/S0140-6736(11)61466-9; Ministry of Health Labour and Welfare, 2012, LAWS CERT LONG TERM; Ministry of Internal Affairs and Communications, 2011, RES RES CURR SIT PRE; Ministry of Internal Affairs and Communications, 2010, RES RES CURR SIT PRE; Ministry of Internal Affairs and Communications, 2006, EV GUID DIS MAN; MV Z, 1997, AGE AGEING, V28, P153; Nakagawa I, 2009, HEART, V95, P2009, DOI 10.1136/hrt.2009.174201; Ogawa K, 2000, INT J EPIDEMIOL, V29, P449, DOI 10.1093/ije/29.3.449; Ruder Shirley, 2012, Home Healthc Nurse, V30, P355, DOI 10.1097/NHH.0b013e3182348a37; SILVERMAN MA, 1995, SOUTHERN MED J, V88, P603, DOI 10.1097/00007611-199506000-00001; Tanida N, 1996, BRIT MED J, V313, P1133, DOI 10.1136/bmj.313.7065.1133; Tanigawa K, 2012, LANCET, V379, P889, DOI 10.1016/S0140-6736(12)60384-5; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839	28	73	73	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60192	10.1371/journal.pone.0060192	http://dx.doi.org/10.1371/journal.pone.0060192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555921	Green Published, gold			2022-12-27	WOS:000317418500121
J	Ozhuner, E; Eldem, V; Ipek, A; Okay, S; Sakcali, S; Zhang, BH; Boke, H; Unver, T				Ozhuner, Esma; Eldem, Vahap; Ipek, Arif; Okay, Sezer; Sakcali, Serdal; Zhang, Baohong; Boke, Hatice; Unver, Turgay			Boron Stress Responsive MicroRNAs and Their Targets in Barley	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; SMALL RNAS; CONSERVED MICRORNAS; REGULATORY ROLES; GENE-EXPRESSION; PLANT MICRORNA; MIRNAS; TOXICITY; PLAYERS	Boron stress is an environmental factor affecting plant development and production. Recently, microRNAs (miRNAs) have been found to be involved in several plant processes such as growth regulation and stress responses. In this study, miRNAs associated with boron stress were identified and characterized in barley. miRNA profiles were also comparatively analyzed between root and leave samples. A total of 31 known and 3 new miRNAs were identified in barley; 25 of them were found to respond to boron treatment. Several miRNAs were expressed in a tissue specific manner; for example, miR156d, miR171a, miR397, and miR444a were only detected in leaves. Additionally, a total of 934 barley transcripts were found to be specifically targeted and degraded by miRNAs. In silico analysis of miRNA target genes demonstrated that many miRNA targets are conserved transcription factors such as Squamosa promoter-binding protein, Auxin response factor (ARF), and the MYB transcription factor family. A majority of these targets were responsible for plant growth and response to environmental changes. We also propose that some of the miRNAs in barley such as miRNA408 might play critical roles against boron exposure. In conclusion, barley may use several pathways and cellular processes targeted by miRNAs to cope with boron stress.	[Ozhuner, Esma; Eldem, Vahap; Ipek, Arif; Okay, Sezer; Boke, Hatice; Unver, Turgay] Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey; [Eldem, Vahap] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey; [Sakcali, Serdal] Suleyman Demirel Univ, Fac Arts & Sci, Dept Biol, TR-32200 Isparta, Turkey; [Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC USA	Cankiri Karatekin University; Istanbul University; Suleyman Demirel University; University of North Carolina; East Carolina University	Unver, T (corresponding author), Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey.	turgayunver@gmail.com	OKAY, Sezer/AAF-4394-2019; Unver, Turgay/B-4819-2009; sakcali, serdal/J-5337-2014; Eldem, Vahap/A-9160-2018	OKAY, Sezer/0000-0003-0355-6672; Unver, Turgay/0000-0001-6760-443X; Eldem, Vahap/0000-0003-3767-5661; OZHUNER, ESMA/0000-0002-5456-3496	Scientific and Technological Research Coucil of Turkey (TUBITAK) [109O661, 111O036]; Ministry of Development of Turkish Republic [DPT2010K120720]	Scientific and Technological Research Coucil of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Ministry of Development of Turkish Republic(Turkiye Cumhuriyeti Kalkinma Bakanligi)	The authors gratefully acknowledge the support of the Scientific and Technological Research Coucil of Turkey (TUBITAK) with grant numbers 109O661 and 111O036 and Ministry of Development of Turkish Republic with grant number DPT2010K120720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2000, GENES GENET SYST, V75, P211, DOI 10.1266/ggs.75.211; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Bussemer J, 2009, FEBS J, V276, P4294, DOI 10.1111/j.1742-4658.2009.07102.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi X, 2011, PLOS ONE, V6, P11; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fujisawa Y, 1999, P NATL ACAD SCI USA, V96, P7575, DOI 10.1073/pnas.96.13.7575; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Ma Lina, 2012, Genomics Proteomics & Bioinformatics, V10, P326, DOI 10.1016/j.gpb.2012.11.001; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Mendoza-Soto AB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00105; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Schulte D, 2009, PLANT PHYSIOL, V149, P142, DOI 10.1104/pp.108.128967; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sreenivasulu N., 2008, INT J PLANT GENOMICS, DOI [10.1155/2008/486258, DOI 10.1155/2008/486258]; Stangoulis JCR, 2002, BORON IN PLANT AND ANIMAL NUTRITION, P227; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; UNVER T, 2009, INT J PLANT GENOMICS; Unver T, 2008, PLANT CELL REP, V27, P1411, DOI 10.1007/s00299-008-0560-7; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	57	64	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59543	10.1371/journal.pone.0059543	http://dx.doi.org/10.1371/journal.pone.0059543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555702	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500049
J	Kim, JH; Lee, MJ; Hwang, I; Hwang, HJ				Kim, Jeong Hee; Lee, Min Jun; Hwang, Inhwan; Hwang, Hyun Jin			In-Cell Protease Assay Systems Based on Trans-Localizing Molecular Beacon Proteins Using HCV Protease as a Model System	PLOS ONE			English	Article							HEPATITIS-C; PHOSPHORYLATION; BOCEPREVIR; INHIBITORS; DIVERSITY; APOPTOSIS; BETA	This study describes a sensitive in-cell protease detection system that enables direct fluorescence detection of a target protease and its inhibition inside living cells. This live-cell imaging system provides a fluorescent molecular beacon protein comprised of an intracellular translocation signal sequence, a protease-specific cleavage sequence, and a fluorescent tag sequence(s). The molecular beacon protein is designed to change its intracellular localization upon cleavage by a target protease, i.e., from the cytosol to a subcellular organelle or from a subcellular organelle to the cytosol. Protease activity can be monitored at the single cell level, and accordingly the entire cell population expressing the protease can be accurately enumerated. The clear cellular change in fluorescence pattern makes this system an ideal tool for various life science and drug discovery research, including high throughput and high content screening applications.	[Kim, Jeong Hee; Lee, Min Jun] Kyung Hee Univ, Sch Dent, Dept Biochem & Mol Biol, Seoul, South Korea; [Hwang, Inhwan] POSTECH, Dept Life Sci, Pohang, South Korea; [Lee, Min Jun; Hwang, Hyun Jin] Ahram Biosyst Inc, R&D Ctr, Seoul, South Korea	Kyung Hee University; Pohang University of Science & Technology (POSTECH)	Kim, JH (corresponding author), Kyung Hee Univ, Sch Dent, Dept Biochem & Mol Biol, Seoul, South Korea.	jhkimh@khu.ac.kr; ahrambio@gmail.com		Kim, Jeong Hee/0000-0002-3884-4503	Ministry of Health and Welfare [03-PJ1-PG11-VN01-SV02-0019]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant from the Ministry of Health and Welfare (03-PJ1-PG11-VN01-SV02-0019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C.S., 2012, MOL BIOL INT, V2012; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Emery A, 2011, J BIOMOL SCREEN, V16, P925, DOI 10.1177/1087057111413923; Fang Y, 2008, COMB CHEM HIGH T SCR, V11, P357, DOI 10.2174/138620708784534789; Forestier N, 2012, EXPERT OPIN PHARMACO, V13, P593, DOI 10.1517/14656566.2012.660524; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Ghosh AK, 2012, J NEUROCHEM, V120, P71, DOI 10.1111/j.1471-4159.2011.07476.x; Guan LZ, 2013, TRANSGENIC RES, V22, P805, DOI 10.1007/s11248-012-9682-3; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Kuschel L, 1999, FEBS LETT, V456, P17, DOI 10.1016/S0014-5793(99)00917-5; Nimmanapalli Ramadevi, 2003, Methods Mol Biol, V223, P465; Paecharoenchai O, 2012, J DRUG TARGET, V20, P783, DOI 10.3109/1061186X.2012.716846; Piao W, 2001, BIOCHEM PHARMACOL, V62, P1439, DOI 10.1016/S0006-2952(01)00796-1; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Roohvand F, 2012, TSITOL GENET+, V46, P19; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Smotrov N, 2009, J BIOMOL SCREEN, V14, P404, DOI 10.1177/1087057109331803; Tan S-L, 2006, HORIZON BIOSCIENCE; Watson P, 2009, DRUG NEWS PERSPECT, V22, P69, DOI 10.1358/dnp.2009.22.2.1334450; Welsch C, 2012, GASTROENTEROLOGY, V142, P654, DOI 10.1053/j.gastro.2011.11.035; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677	29	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59710	10.1371/journal.pone.0059710	http://dx.doi.org/10.1371/journal.pone.0059710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555756	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400055
J	Kumoi, K; Satoh, T; Murata, K; Hiromoto, T; Mizushima, T; Kamiya, Y; Noda, M; Uchiyama, S; Yagi, H; Kato, K				Kumoi, Kentaro; Satoh, Tadashi; Murata, Kazuyoshi; Hiromoto, Takeshi; Mizushima, Tsunehiro; Kamiya, Yukiko; Noda, Masanori; Uchiyama, Susumu; Yagi, Hirokazu; Kato, Koichi			An Archaeal Homolog of Proteasome Assembly Factor Functions as a Proteasome Activator	PLOS ONE			English	Article							20S PROTEASOME; REGULATORY PARTICLE; COMPLEX; GATE; BINDING; PAN; IDENTIFICATION; VISUALIZATION; TRANSLOCATION; MECHANISMS	Assembly of the eukaryotic 20S proteasome is an ordered process involving several proteins operating as proteasome assembly factors including PAC1-PAC2 but archaeal 20S proteasome subunits can spontaneously assemble into an active cylindrical architecture. Recent bioinformatic analysis identified archaeal PAC1-PAC2 homologs PbaA and PbaB. However, it remains unclear whether such assembly factor-like proteins play an indispensable role in orchestration of proteasome subunits in archaea. We revealed that PbaB forms a homotetramer and exerts a dual function as an ATP-independent proteasome activator and a molecular chaperone through its tentacle-like C-terminal segments. Our findings provide insights into molecular evolution relationships between proteasome activators and assembly factors.	[Kumoi, Kentaro; Satoh, Tadashi; Hiromoto, Takeshi; Mizushima, Tsunehiro; Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Murata, Kazuyoshi] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Mizushima, Tsunehiro] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Picobiol Inst, Kamigori, Hyogo, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Noda, Masanori; Uchiyama, Susumu] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan	Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Hyogo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Osaka University	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi, Japan.	kkatonmr@ims.ac.jp	Satoh, Tadashi/M-5157-2017; UCHIYAMA, Susumu/F-9590-2017; Yagi, Hirokazu/ABH-6151-2020	UCHIYAMA, Susumu/0000-0002-5181-179X; Mizushima, Tsunehiro/0000-0002-6631-2889; Satoh, Tadashi/0000-0002-4493-4978; Yagi, Hirokazu/0000-0001-9296-0225; Murata, Kazuyoshi/0000-0001-9446-3652; Kato, Koichi/0000-0001-7187-9612	Ministry of Education, Culture, Sports, Science and Technology, Japan; Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); Grants-in-Aid for Scientific Research [24770102] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Targeted Proteins Research Program (to TM and K. Kato) and Grants-in-Aid for Scientific Research (to TS, TM, YK, SU and K. Kato) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Diffraction datasets were collected at Osaka University using beamline BL44XU at SPring-8 equipped with MX225-HE (Rayonix), which is financially supported by Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MA CP, 1992, J BIOL CHEM, V267, P10515; Madding LS, 2007, J BACTERIOL, V189, P583, DOI 10.1128/JB.01382-06; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Menon AL, 2009, MOL CELL PROTEOMICS, V8, P735, DOI 10.1074/mcp.M800246-MCP200; Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006; Murata K, 2010, J ELECTRON MICROSC, V59, P215, DOI 10.1093/jmicro/dfp059; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	46	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60294	10.1371/journal.pone.0060294	http://dx.doi.org/10.1371/journal.pone.0060294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555947	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400089
J	Pearson, CAB; Zeng, C; Simha, R				Pearson, Carl A. B.; Zeng, Chen; Simha, Rahul			Network Class Superposition Analyses	PLOS ONE			English	Article							BOOLEAN NETWORK; ROBUSTNESS; MODELS; FRAGILITY; BIOLOGY	Networks are often used to understand a whole system by modeling the interactions among its pieces. Examples include biomolecules in a cell interacting to provide some primary function, or species in an environment forming a stable community. However, these interactions are often unknown; instead, the pieces' dynamic states are known, and network structure must be inferred. Because observed function may be explained by many different networks (e. g., approximate to 10(30) for the yeast cell cycle process [1]), considering dynamics beyond this primary function means picking a single network or suitable sample: measuring over all networks exhibiting the primary function is computationally infeasible. We circumvent that obstacle by calculating the network class ensemble. We represent the ensemble by a stochastic matrix T, which is a transition-by-transition superposition of the system dynamics for each member of the class. We present concrete results for T derived from Boolean time series dynamics on networks obeying the Strong Inhibition rule, by applying T to several traditional questions about network dynamics. We show that the distribution of the number of point attractors can be accurately estimated with T. We show how to generate Derrida plots based on T. We show that T-based Shannon entropy outperforms other methods at selecting experiments to further narrow the network structure. We also outline an experimental test of predictions based on T. We motivate all of these results in terms of a popular molecular biology Boolean network model for the yeast cell cycle, but the methods and analyses we introduce are general. We conclude with open questions for T, for example, application to other models, computational considerations when scaling up to larger systems, and other potential analyses.	[Pearson, Carl A. B.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Pearson, Carl A. B.; Zeng, Chen; Simha, Rahul] George Washington Univ, Washington, DC USA; [Zeng, Chen] Huazhong Univ Sci & Technol, Wuhan 430074, Peoples R China	State University System of Florida; University of Florida; George Washington University; Huazhong University of Science & Technology	Pearson, CAB (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	cap10@ufl.edu	Pearson, Carl/AAH-8892-2019	Pearson, Carl/0000-0003-0701-7860	NSF [0941228]; Army Research Office Award [W911NF-11-1-0036Z]	NSF(National Science Foundation (NSF)); Army Research Office Award	This work was supported under NSF grant 0941228 and Army Research Office Award W911NF-11-1-0036Z. NSF link: http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 0941228. ARO link: http://www.arl.army.mil/www/default.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bayardo RJ, 2000, SEVENTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-2001) / TWELFTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-2000), P157; Bornholdt S, 1998, PHYS REV LETT, V81, P236, DOI 10.1103/PhysRevLett.81.236; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Darwiche A, 2004, FRONT ARTIF INTEL AP, V110, P328; DERRIDA B, 1986, EUROPHYS LETT, V2, P739, DOI 10.1209/0295-5075/2/10/001; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ideker T E, 2000, Pac Symp Biocomput, P305; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kroc L, 2008, LECT NOTES COMPUT SC, V5015, P127, DOI 10.1007/978-3-540-68155-7_12; Lau KY, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051907; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; METZ CE, 1973, RADIOLOGY, V109, P297, DOI 10.1148/109.2.297; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pearson C, 2012, PLOS ONE; Proulx S, 2005, TRENDS ECOLOGY EVOLU, P20; Samuelsson B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.098701; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stephens M., 1993, 467 STANF U DEP STAT; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Wei W., 2005, THEORY APPL SATISFIA, P96; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442	37	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59046	10.1371/journal.pone.0059046	http://dx.doi.org/10.1371/journal.pone.0059046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565141	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300008
J	Zhao, XY; Ze, YG; Gao, GD; Sang, XZ; Li, B; Gui, SX; Sheng, L; Sun, QQ; Cheng, J; Cheng, Z; Hu, RP; Wang, L; Hong, FS				Zhao, Xiaoyang; Ze, Yuguan; Gao, Guodong; Sang, Xuezi; Li, Bing; Gui, Suxin; Sheng, Lei; Sun, Qingqing; Cheng, Jie; Cheng, Zhe; Hu, Renping; Wang, Ling; Hong, Fashui			Nanosized TiO2-Induced Reproductive System Dysfunction and Its Mechanism in Female Mice	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; LONG-TERM EXPOSURE; MOLECULAR-MECHANISM; QUANTITATIVE PCR; OXIDATIVE DAMAGE; GENE-EXPRESSION; ACUTE TOXICITY; LH RECEPTOR; FOLLICLE; APOPTOSIS	Recent studies have demonstrated nanosized titanium dioxide (nano-TiO2)-induced fertility reduction and ovary injury in animals. To better understand how nano-TiO2 act in mice, female mice were exposed to 2.5, 5, and 10 mg/kg nano-TiO2 by intragastric administration for 90 consecutive days; the ovary injuries, fertility, hormone levels, and inflammation-related or follicular atresia-related cytokine expression were investigated. The results showed that nano-TiO2 was deposited in the ovary, resulting in significant reduction of body weight, relative weight of ovary and fertility, alterations of hematological and serum parameters and sex hormone levels, atretic follicle increases, inflammation, and necrosis. Furthermore, nano-TiO2 exposure resulted in marked increases of insulin-like growth factor-binding protein 2, epidermal growth factor, tumor necrosis factor-alpha, tissue plasminogen activator, interleukin-1 beta, interleukin -6, Fas, and FasL expression, and significant decreases of insulin-like growth factor-1, luteinizing hormone receptor, inhibin alpha, and growth differentiation factor 9 expression in mouse ovary. These findings implied that fertility reduction and ovary injury of mice following exposure to nano-TiO2 may be associated with alteration of inflammation-related or follicular atresia-related cytokine expressions, and humans should take great caution when handling nano-TiO2.	[Zhao, Xiaoyang; Ze, Yuguan; Gao, Guodong; Sang, Xuezi; Li, Bing; Gui, Suxin; Sheng, Lei; Sun, Qingqing; Cheng, Jie; Cheng, Zhe; Hu, Renping; Wang, Ling; Hong, Fashui] Soochow Univ, Coll Med, Suzhou, Peoples R China	Soochow University - China	Hong, FS (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	Hongfsh_cn@sina.com	li, bing/GWQ-9617-2022		National Natural Science Foundation of China [81273036, 30901218]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National New Ideas Foundation of Student of China [11028534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; National New Ideas Foundation of Student of China	This work was supported by the National Natural Science Foundation of China (grant No. 81273036, 30901218), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, National New Ideas Foundation of Student of China (grant No. 11028534). The authors acknowledged in the manuscript all financial support for the work and confirmed that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra CV, 2000, CAN J PHYSIOL PHARM, V78, P1003, DOI 10.1139/cjpp-78-12-1003; Auger AP, 2000, P NATL ACAD SCI USA, V97, P7551, DOI 10.1073/pnas.97.13.7551; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; Choi H, 2006, APPL CATAL B-ENVIRON, V63, P60, DOI 10.1016/j.apcatb.2005.09.012; CHUN SY, 1994, ENDOCRINOLOGY, V135, P1845, DOI 10.1210/en.135.5.1845; Cui YL, 2012, TOXICOL SCI, V128, P171, DOI 10.1093/toxsci/kfs153; Cui YL, 2011, J BIOMED MATER RES A, V96A, P221, DOI 10.1002/jbm.a.32976; Cui YL, 2010, J HAZARD MATER, V183, P874, DOI 10.1016/j.jhazmat.2010.07.109; Di Virgilio AL, 2010, J HAZARD MATER, V177, P711, DOI 10.1016/j.jhazmat.2009.12.089; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Esterkin CR, 2005, AICHE J, V51, P2298, DOI 10.1002/aic.10472; FINDLAY JK, 1993, BIOL REPROD, V48, P15, DOI 10.1095/biolreprod48.1.15; Fisher J., 2001, KIRK OTHMER ENCY CHE; Gui SX, 2011, J HAZARD MATER, V195, P365, DOI 10.1016/j.jhazmat.2011.08.055; Guo Li-li, 2009, Zhonghua Nan Ke Xue, V15, P517; GUO MW, 1994, BIOCHEM BIOPH RES CO, V203, P1438, DOI 10.1006/bbrc.1994.2346; Guo MW, 1997, AM J REPROD IMMUNOL, V37, P391; Hou Juan, 2009, Academic Journal of Second Military Medical University, V30, P869; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Hu RP, 2010, BIOMATERIALS, V31, P8043, DOI 10.1016/j.biomaterials.2010.07.011; Jackson P, 2013, NANOTOXICOLOGY, V7, P85, DOI 10.3109/17435390.2011.633715; Kaida Takahiro, 2004, J Cosmet Sci, V55, P219; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Ke LD, 2000, MOL CELL PROBE, V14, P127, DOI 10.1006/mcpr.2000.0288; Kim JM, 1999, ENDOCRINOLOGY, V140, P2307, DOI 10.1210/en.140.5.2307; Li N, 2010, TOXICOL LETT, V195, P161, DOI 10.1016/j.toxlet.2010.03.1116; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo WX, 2000, SCI CHINA SER C, V43, P272, DOI 10.1007/BF02879286; Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028; Ma LL, 2009, NANOSCALE RES LETT, V4, P1275, DOI 10.1007/s11671-009-9393-8; Manikkam M, 1997, BIOL REPROD, V57, P580, DOI 10.1095/biolreprod57.3.580; Murdoch WJ, 1997, J ANIM SCI, V75, P1601; Pu YP, 2009, CH J PUBLIC HLTH, V25, P310; Sang XZ, 2012, J BIOMED MATER RES A, V100A, P894, DOI 10.1002/jbm.a.34024; Scown TM, 2009, TOXICOL SCI, V109, P372, DOI 10.1093/toxsci/kfp064; Shin JA, 2010, NEUROSCIENCE, V165, P445, DOI 10.1016/j.neuroscience.2009.10.057; Sun QQ, 2012, J HAZARD MATER, V235, P47, DOI 10.1016/j.jhazmat.2012.05.072; Sun QQ, 2012, J BIOMED MATER RES A, V100A, P2554, DOI 10.1002/jbm.a.34190; Takeda K, 2009, J HEALTH SCI, V55, P95, DOI 10.1248/jhs.55.95; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; Wang JX, 2011, CHEMOSPHERE, V83, P461, DOI 10.1016/j.chemosphere.2010.12.069; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang J, 2011, BIOL TRACE ELEM RES, V140, P186, DOI 10.1007/s12011-010-8687-0; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Yan JL, 1999, SCI CHINA SER C, V42, P583, DOI 10.1007/BF02881575; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3; Yu Y, 2008, NEUROL RES, DOI [10.1179/174313208X305391, DOI 10.1179/174313208X305391]; Zhao JF, 2010, J EXP NANOSCI, V5, P447, DOI 10.1080/17458081003628931	53	69	74	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59378	10.1371/journal.pone.0059378	http://dx.doi.org/10.1371/journal.pone.0059378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565150	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300017
J	Khalid, R; Nawawi, MKM; Kawsar, LA; Ghani, NA; Kamil, AA; Mustafa, A				Khalid, Ruzelan; Nawawi, Mohd Kamal M.; Kawsar, Luthful A.; Ghani, Noraida A.; Kamil, Anton A.; Mustafa, Adli			A Discrete Event Simulation Model for Evaluating the Performances of an M/G/C/C State Dependent Queuing System	PLOS ONE			English	Article								M/G/C/C state dependent queuing networks consider service rates as a function of the number of residing entities (e. g., pedestrians, vehicles, and products). However, modeling such dynamic rates is not supported in modern Discrete Simulation System (DES) software. We designed an approach to cater this limitation and used it to construct the M/G/C/C state-dependent queuing model in Arena software. Using the model, we have evaluated and analyzed the impacts of various arrival rates to the throughput, the blocking probability, the expected service time and the expected number of entities in a complex network topology. Results indicated that there is a range of arrival rates for each network where the simulation results fluctuate drastically across replications and this causes the simulation results and analytical results exhibit discrepancies. Detail results that show how tally the simulation results and the analytical results in both abstract and graphical forms and some scientific justifications for these have been documented and discussed.	[Khalid, Ruzelan; Nawawi, Mohd Kamal M.] Univ Utara Malaysia, Sch Quantitat Sci, Sintok, Kedah, Malaysia; [Kawsar, Luthful A.; Ghani, Noraida A.; Kamil, Anton A.] Univ Sains Malaysia, Sch Distance Educ, George Town, Malaysia; [Mustafa, Adli] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Kawsar, Luthful A.] Shahjalal Univ Sci & Technol, Sch Phys Sci, Dept Stat, Sylhet, Bangladesh	Universiti Utara Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Shahjalal University of Science & Technology (SUST)	Nawawi, MKM (corresponding author), Univ Utara Malaysia, Sch Quantitat Sci, Sintok, Kedah, Malaysia.	mdkamal@uum.edu.my	Mohd Nawawi, Mohd Kamal/B-7061-2011; Khalid, Ruzelan/O-7188-2019; Khalid, Ruzelan/N-4642-2013; Kamil, Anton Abdulbasah/A-9795-2011	Mohd Nawawi, Mohd Kamal/0000-0003-4447-9941; Khalid, Ruzelan/0000-0002-4283-0737; Kamil, Anton Abdulbasah/0000-0001-5410-812X; Mustafa, Adli/0000-0003-0989-674X; Kawsar, Luthful Alahi/0000-0002-8010-6379; Nawawi, M Ikhsan/0000-0002-1372-453X	Universiti Sains Malaysia [1001/PJJAUH/811097]	Universiti Sains Malaysia(Universiti Sains Malaysia)	This study was supported by the Research University (RU) Grant Scheme, [account number 1001/PJJAUH/811097], Universiti Sains Malaysia. L. A. Kawsar wishes to thank Universiti Sains Malaysia for the financial support (USM Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok T, 2007, SIMULATION MODELING AND ANALYSIS WITH ARENA, P1; Banks J., 2010, DISCRETE EVENT SYSTE, V5th ed., International version ed.; Bedell P, 2012, COMPUT OPER RES, V39, P2800, DOI 10.1016/j.cor.2012.02.009; Cheah J, 1990, STATE DEPENDENT QUEU; Concannon K., 2007, SIMULATION MODELING; Cruz FRB, 2005, COMPUT OPER RES, V32, P919, DOI 10.1016/j.cor.2003.09.006; Garrido J. M., 1998, PRACTICAL PROCESS SI; Garrido JM, 2001, SER COM SYS; Kawsar LA, 2012, WORLD ACAD SCI ENG T, P399; Kelton W., 2009, SIMULATION ARENA; Prata S., 2011, C PRIMER PLUS, V6th; Rossetti M.D., 2009, SIMULATION MODELING; Smith JM, 2012, INT J PROD RES, V50, P461, DOI 10.1080/00207543.2010.535041; Strickland J, 2011, DISCRETE EVENT SIMUL; Tregenza P., 1976, DESIGN INTERIOR CIRC; Wainer GA, 2010, THEORY APPL; Watkins K, 1993, DISCRETE EVENT SIMUL; Yuhaski S. J.  Jr., 1989, Queueing Systems Theory and Applications, V4, P319, DOI 10.1007/BF01159471	18	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58402	10.1371/journal.pone.0058402	http://dx.doi.org/10.1371/journal.pone.0058402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560037	Green Accepted, Green Published, gold			2022-12-27	WOS:000316930900005
J	Liu, JJ; Yin, TM; Ye, N; Chen, YN; Yin, TT; Liu, M; Hassani, D				Liu, Jingjing; Yin, Tongming; Ye, Ning; Chen, Yingnan; Yin, Tingting; Liu, Min; Hassani, Danial			Transcriptome Analysis of the Differentially Expressed Genes in the Male and Female Shrub Willows (Salix suchowensis)	PLOS ONE			English	Article							SEX DETERMINATION; WHITE CAMPION; EVOLUTION; GENOME; MARKER; ANNOTATION; CHROMOSOME; SEQUENCE; POPULUS; FLOWERS	Background: The dioecious system is relatively rare in plants. Shrub willow is an annual flowering dioecious woody plant, and possesses many characteristics that lend it as a great model for tracking the missing pieces of sex determination evolution. To gain a global view of the genes differentially expressed in the male and female shrub willows and to develop a database for further studies, we performed a large-scale transcriptome sequencing of flower buds which were separately collected from two types of sexes. Results: Totally, 1,201,931 high quality reads were obtained, with an average length of 389 bp and a total length of 467.96 Mb. The ESTs were assembled into 29,048 contigs, and 132,709 singletons. These unigenes were further functionally annotated by comparing their sequences to different proteins and functional domain databases and assigned with Gene Ontology (GO) terms. A biochemical pathway database containing 291 predicted pathways was also created based on the annotations of the unigenes. Digital expression analysis identified 806 differentially expressed genes between the male and female flower buds. And 33 of them located on the incipient sex chromosome of Salicaceae, among which, 12 genes might involve in plant sex determination empirically. These genes were worthy of special notification in future studies. Conclusions: In this study, a large number of EST sequences were generated from the flower buds of a male and a female shrub willow. We also reported the differentially expressed genes between the two sex-type flowers. This work provides valuable information and sequence resources for uncovering the sex determining genes and for future functional genomics analysis of Salicaceae spp.	[Liu, Jingjing; Yin, Tongming; Ye, Ning; Chen, Yingnan; Yin, Tingting; Liu, Min; Hassani, Danial] Nanjing Forestry Univ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn	Hassani, Danial/AGZ-8246-2022; Ye, Ning/O-3246-2015	Hassani, Danial/0000-0001-8024-0837; Ye, Ning/0000-0001-7249-8352	Natural Science Foundation of China [31125008]; 973 project [2012CB114505]; PCSIRT program; Educational Department of China; Educational Department of Jiangsu Province; Doctorate Fellowship Foundation; PAPD (Priority Academic Program Development) program at Nanjing Forestry University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China); PCSIRT program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Educational Department of China; Educational Department of Jiangsu Province; Doctorate Fellowship Foundation; PAPD (Priority Academic Program Development) program at Nanjing Forestry University	Funding for this work is provided by the Natural Science Foundation of China (31125008), the 973 project (2012CB114505) and the PCSIRT program funded by the Educational Department of China and Jiangsu Province. It is also funded by the Doctorate Fellowship Foundation and PAPD (Priority Academic Program Development) program at Nanjing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH C, 1995, PLANT CELL, V7, P1583, DOI 10.1105/tpc.7.10.1583; Alstrom-Rapaport C, 1998, J HERED, V89, P44, DOI 10.1093/jhered/89.1.44; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Barbacar N, 1997, PLANT J, V12, P805, DOI 10.1046/j.1365-313X.1997.12040805.x; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Berlin S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-129; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Farbos I, 1999, GENETICS, V151, P1187; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; GRANT S, 1994, DEV GENET, V15, P214, DOI 10.1002/dvg.1020150304; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hanley SJ, 2007, TREE GENET GENOMES, V3, P35, DOI 10.1007/s11295-006-0049-x; HARDENACK S, 1994, PLANT CELL, V6, P1775, DOI 10.1105/tpc.6.12.1775; IRISH EE, 1989, PLANT CELL, V1, P737, DOI 10.1105/tpc.1.8.737; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Lardon A, 1999, GENETICS, V151, P1173; Lloyd D.G., 1984, PERSPECTIVES PLANT P, P277; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Markussen T, 2007, SILVAE GENET, V56, P180, DOI 10.1515/sg-2007-0027; Matsunaga S, 1996, PLANT J, V10, P679, DOI 10.1046/j.1365-313X.1996.10040679.x; Meyer E, 2012, PLANT J, V70, P879, DOI 10.1111/j.1365-313X.2012.04938.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pazos-Navarro M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-104; PETO F. H., 1938, CANADIAN JOUR RES SECT C BOT SCI, V16, P445; POETHIG RS, 1986, DEV BIOL, V117, P392, DOI 10.1016/0012-1606(86)90308-8; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-57; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smith E. Chalmers, 1943, JOUR ARNOLD ARBORETUM, V24, P275; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2012, TREE GENET GENOMES, V8, P559, DOI 10.1007/s11295-012-0495-6; VAN BUUTENEN J. P., 1959, BOT GAZETTE, V121, P60, DOI 10.1086/336044; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Walbot V, 2003, NAT REV GENET, V4, P369, DOI 10.1038/nrg1064; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Ye J, 2005, NUCLEIC ACIDS RES, V34, P293; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379	56	31	35	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60181	10.1371/journal.pone.0060181	http://dx.doi.org/10.1371/journal.pone.0060181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560075	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900052
J	Smucny, J; Rojas, DC; Eichman, LC; Tregellas, JR				Smucny, Jason; Rojas, Donald C.; Eichman, Lindsay C.; Tregellas, Jason R.			Neural Effects of Auditory Distraction on Visual Attention in Schizophrenia	PLOS ONE			English	Article							FUSIFORM FACE AREA; DORSOLATERAL PREFRONTAL CORTEX; WORD FORM AREA; BOTTOM-UP; HEMODYNAMIC-RESPONSE; NEURONAL MECHANISMS; NEGATIVE SYMPTOMS; ODDBALL TASK; FMRI; MEMORY	Sensory flooding, particularly during auditory stimulation, is a common problem for patients with schizophrenia. The functional consequences of this impairment during cross-modal attention tasks, however, are unclear. The purpose of this study was to examine how auditory distraction differentially affects task-associated response during visual attention in patients and healthy controls. To that end, 21 outpatients with schizophrenia and 23 healthy comparison subjects performed a visual attention task in the presence or absence of distracting, environmentally relevant "urban'' noise while undergoing functional magnetic resonance imaging at 3T. The task had two conditions (difficult and easy); task-related neural activity was defined as difficult - easy. During task performance, a significant distraction (noise or silence) by group (patient or control) interaction was observed in the left dorsolateral prefrontal cortex, right hippocampus, left temporoparietal junction, and right fusiform gyrus, with patients showing relative hypoactivation during noise compared to controls. In patients, the ability to recruit the dorsolateral prefrontal cortex during the task in noise was negatively correlated with the effect of noise on reaction time. Clinically, the ability to recruit the fusiform gyrus during the task in noise was negatively correlated with SANS affective flattening score, and hippocampal recruitment during the task in noise was positively correlated with global functioning. In conclusion, schizophrenia may be associated with abnormalities in neural response during visual attention tasks in the presence of cross-modal noise distraction. These response differences may predict global functioning in the illness, and may serve as a biomarker for therapeutic development.	[Smucny, Jason; Rojas, Donald C.; Tregellas, Jason R.] Univ Colorado, Neurosci Program, Aurora, CO 80045 USA; [Smucny, Jason; Rojas, Donald C.; Eichman, Lindsay C.; Tregellas, Jason R.] Univ Colorado, Dept Psychiat, Aurora, CO USA; [Rojas, Donald C.; Eichman, Lindsay C.; Tregellas, Jason R.] Denver VA Med Ctr, Res Serv, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Tregellas, JR (corresponding author), Univ Colorado, Neurosci Program, Anschutz Med Campus, Aurora, CO 80045 USA.	Jason.Tregellas@ucdenver.edu	Rojas, Don/AAX-6678-2020; Tregellas, Jason/J-3637-2015	Rojas, Don/0000-0001-6560-9616; Smucny, Jason/0000-0001-5656-7987	National Institute of Mental Health [MH-061412]; NIMH [MH-086383]; Brain & Behavior Research Foundation; United States Department of Veterans Affairs; Blowitz-Ridgeway Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061412, P50MH086383] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain & Behavior Research Foundation(NARSAD); United States Department of Veterans Affairs(US Department of Veterans Affairs); Blowitz-Ridgeway Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding came from National Institute of Mental Health Grant MH-061412 (http://www.nimh.nih.gov/index.shtml); NIMH Grant MH-086383; National Alliance for Research on Schizophrenia and Depression, now Brain & Behavior Research Foundation (No Grant Number) (bbrfoundation.org); United States Department of Veterans Affairs (No Grant Number) (www.va.gov); and Blowitz-Ridgeway Foundation (No Grant Number) (http://www.blowitzridgeway.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ASARNOW RF, 1978, J ABNORM PSYCHOL, V87, P597, DOI 10.1037/0021-843X.87.6.597; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bak N, 2011, NEUROIMAGE, V54, P2711, DOI 10.1016/j.neuroimage.2010.11.039; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Blanchard JJ, 2006, SCHIZOPHRENIA BULL, V32, P238, DOI 10.1093/schbul/sbj013; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Chang CF, 2012, HUM BRAIN MAPP; Choi JW, 2008, PSYCHIAT INVEST, V5, P52, DOI 10.4306/pi.2008.5.1.52; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dien J, 2009, NEUROPSYCHOLOGIA, V47, P1, DOI 10.1016/j.neuropsychologia.2008.08.024; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Geng JJ, 2011, NEUROIMAGE, V54, P594, DOI 10.1016/j.neuroimage.2010.08.025; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Gur RE, 2007, AM J PSYCHIAT, V164, P442, DOI 10.1176/appi.ajp.164.3.442; Habel U, 2010, SCHIZOPHR RES, V122, P113, DOI 10.1016/j.schres.2010.06.009; Holt DJ, 2005, BIOL PSYCHIAT, V57, P1011, DOI 10.1016/j.biopsych.2005.01.033; Hong LE, 2005, BIOL PSYCHIAT, V57, P726, DOI 10.1016/j.biopsych.2004.12.015; Javitt DC, 2009, SCHIZOPHRENIA BULL, V35, P1059, DOI 10.1093/schbul/sbp110; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiehl KA, 2005, BIOL PSYCHIAT, V57, P1029, DOI 10.1016/j.biopsych.2005.01.035; Kiehl KA, 2001, SCHIZOPHR RES, V48, P159, DOI 10.1016/S0920-9964(00)00117-1; Kroes MCW, 2012, NEUROSCI BIOBEHAV R, V36, P1646, DOI 10.1016/j.neubiorev.2012.02.014; Laurens KR, 2005, SCHIZOPHR RES, V75, P159, DOI 10.1016/j.schres.2004.12.010; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Santos JL, 2010, SCHIZOPHR RES, V119, P183, DOI 10.1016/j.schres.2010.01.010; Malaspina D, 1999, BIOL PSYCHIAT, V46, P89, DOI 10.1016/S0006-3223(98)00306-0; Malaspina D, 2004, BIOL PSYCHIAT, V56, P931, DOI 10.1016/j.biopsych.2004.09.013; Mathiak K, 2011, PSYCHIAT RES-NEUROIM, V194, P95, DOI 10.1016/j.pscychresns.2011.01.001; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Onitsuka T, 2005, AM J PSYCHIAT, V162, P599, DOI 10.1176/appi.ajp.162.3.599; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Park J, 2012, J COGNITIVE NEUROSCI, V24, P39, DOI 10.1162/jocn_a_00085; PAYNE RW, 1967, J ABNORM PSYCHOL, V72, P112, DOI 10.1037/h0020086; Popov T, 2011, BIOL PSYCHIAT, V69, P465, DOI 10.1016/j.biopsych.2010.09.028; Potkin SG, 2002, AM J PSYCHIAT, V159, P227, DOI 10.1176/appi.ajp.159.2.227; Rametti G, 2009, EUR ARCH PSY CLIN N, V259, P203, DOI 10.1007/s00406-008-0852-5; Ravizza SM, 2011, NEUROIMAGE, V55, P1836, DOI 10.1016/j.neuroimage.2010.12.021; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Silverstein SM, 2010, PSYCHOL MED, V40, P1159, DOI 10.1017/S0033291709991735; Smucny J, 2013, BRAIN COGNI IN PRESS; Stella F, 2012, NEUROSCI BIOBEHAV R, V36, P1609, DOI 10.1016/j.neubiorev.2011.12.002; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Tregellas JR, 2007, SCHIZOPHR RES, V92, P262, DOI 10.1016/j.schres.2006.12.033; Tregellas JR, 2012, SCHIZOPHR RES, V142, P230, DOI 10.1016/j.schres.2012.09.008; Tregellas JR, 2009, AM J PSYCHIAT, V166, P354, DOI 10.1176/appi.ajp.2008.08030411; Tregellas JR, 2004, AM J PSYCHIAT, V161, P315, DOI 10.1176/appi.ajp.161.2.315; Tregellas JR, 2012, SCHIZOPHR RES; Uncapher MR, 2009, J NEUROSCI, V29, P8270, DOI 10.1523/JNEUROSCI.1043-09.2009; Walther S, 2009, PSYCHIAT RES-NEUROIM, V172, P184, DOI 10.1016/j.pscychresns.2008.07.009; Weidner R, 2009, J COGNITIVE NEUROSCI, V21, P2100, DOI 10.1162/jocn.2008.21173; Williams TJ, 2011, PSYCHOPHYSIOLOGY, V48, P470, DOI 10.1111/j.1469-8986.2010.01119.x; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009	66	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60606	10.1371/journal.pone.0060606	http://dx.doi.org/10.1371/journal.pone.0060606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560100	Green Published, gold			2022-12-27	WOS:000316930900071
J	Vlieghe, ER; Phe, T; De Smet, B; Veng, HC; Kham, C; Lim, K; Koole, O; Lynen, L; Peetermans, WE; Jacobs, JA				Vlieghe, Erika R.; Phe, Thong; De Smet, Birgit; Veng, Heng Chhun; Kham, Chun; Lim, Kruy; Koole, Olivier; Lynen, Lut; Peetermans, Willy E.; Jacobs, Jan A.			Bloodstream Infection among Adults in Phnom Penh, Cambodia: Key Pathogens and Resistance Patterns	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ACQUIRED BACTEREMIA; BETA-LACTAMASES; HEALTH-CARE; AUREUS; SUSCEPTIBILITY; AZITHROMYCIN; PREVALENCE; DISEASE; ASIA	Background: Bloodstream infections (BSI) cause important morbidity and mortality worldwide. In Cambodia, no surveillance data on BSI are available so far. Methods: From all adults presenting with SIRS at Sihanouk Hospital Centre of HOPE (July 2007-December 2010), 20 ml blood was cultured. Isolates were identified using standard microbiological techniques; antibiotic susceptibilities were assessed using disk diffusion and MicroScan (R), with additional E-test, D-test and double disk test where applicable, according to CLSI guidelines. Results: A total of 5714 samples from 4833 adult patients yielded 501 clinically significant organisms (8.8%) of which 445 available for further analysis. The patients' median age was 45 years (range 15-99 y), 52.7% were women. HIV-infection and diabetes were present in 15.6% and 8.8% of patients respectively. The overall mortality was 22.5%. Key pathogens included Escherichia coli (n = 132; 29.7%), Salmonella spp. (n = 64; 14.4%), Burkholderia pseudomallei (n = 56; 12.6%) and Staphylococcus aureus (n = 53; 11.9%). Methicillin resistance was seen in 10/46 (21.7%) S. aureus; 4 of them were co-resistant to erythromycin, clindamycin, moxifloxacin and sulphamethoxazole-trimethoprim (SMX-TMP). We noted combined resistance to amoxicillin, SMX-TMP and ciprofloxacin in 81 E. coli isolates (62.3%); 62 isolates (47.7%) were confirmed as producers of extended spectrum beta-lactamase. Salmonella isolates displayed high rates of multidrug resistance (71.2%) with high rates of decreased ciprofloxacin susceptibility (90.0%) in Salmonella Typhi while carbapenem resistance was observed in 5.0% of 20 Acinetobacter sp. isolates. Conclusions: BSI in Cambodian adults is mainly caused by difficult-to-treat pathogens. These data urge for microbiological capacity building, nationwide surveillance and solid interventions to contain antibiotic resistance.	[Vlieghe, Erika R.; De Smet, Birgit; Koole, Olivier; Lynen, Lut; Jacobs, Jan A.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Phe, Thong; Veng, Heng Chhun; Kham, Chun; Lim, Kruy] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Peetermans, Willy E.] Univ Hosp, Dept Internal Med, Louvain, Belgium	Institute of Tropical Medicine (ITM)	Vlieghe, ER (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	evlieghe@itg.be; jjacobs@itg.be	De Smet, Birgit/F-4638-2014; Lynen, Lutgarde/AAT-9180-2020; Jacobs, Jan/GRX-7316-2022; Lynen, Lutgarde/A-1212-2014	De Smet, Birgit/0000-0002-1790-1900; Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Koole, Olivier/0000-0002-1122-5382	Belgian Directorate General of Development Cooperation [2.08]; Institute of Tropical Medicine, Antwerp (Belgium) [2.08]; 'Secundaire OnderzoeksFinanciering ITG type A' (SOFI-A) grant of the Institute of Tropical Medicine, Antwerp (Belgium)	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp (Belgium); 'Secundaire OnderzoeksFinanciering ITG type A' (SOFI-A) grant of the Institute of Tropical Medicine, Antwerp (Belgium)	This work was supported by Project 2.08 of the third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine, Antwerp (Belgium). EV was supported by the 'Secundaire OnderzoeksFinanciering ITG type A' (SOFI-A) grant of the Institute of Tropical Medicine, Antwerp (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Chareonkul Chanin, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P418; Chen YH, 2011, J INFECTION, V62, P280, DOI 10.1016/j.jinf.2011.02.009; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; CLSI, 2012, M100S22 CLSI; Cornaglia G, 2004, CLIN MICROBIOL INFEC, V10, P349, DOI 10.1111/j.1198-743X.2004.00887.x; Grimont PA, 2007, ANTIGENIC FORMULAE S, V9th; Hancart-Petitet P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-83; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; JARLIER V, 1988, REV INFECT DIS, V10, P867; Jean SS, 2011, INT J ANTIMICROB AG, V37, P291, DOI 10.1016/j.ijantimicag.2011.01.009; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lay KS, 2011, J VET MED SCI, V73, P325, DOI 10.1292/jvms.10-0373; Leelarasamee Amorn, 2004, Journal of the Medical Association of Thailand, V87, P464; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Ministry of Health Cambodia Department of drugs food and cosmetics, 2010, MED POL KINGD CAMB; Ministry of Health Cambodia Department of drugs food and cosmetics, 2010, ESS MED LIST; Ministry of Health Cambodia Department of Hospital Services, 2012, INF PREV CONTR GUID; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Ong CWM, 2009, RESPIROLOGY, V14, P1200, DOI 10.1111/j.1440-1843.2009.01630.x; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; Ruppe E, 2009, EMERG INFECT DIS, V15, P741, DOI 10.3201/eid1505.071299; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; Srifuengfung Somporn, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P347; Tran VTN, 2012, T ROY SOC TROP MED H, V106, P26, DOI 10.1016/j.trstmh.2011.10.004; Vlieghe E, 2011, EMERG INFECT DIS, V17, P1289, DOI 10.3201/eid1707.101069; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; WEISBLUM B, 1969, J BACTERIOL, V98, P447, DOI 10.1128/JB.98.2.447-452.1969; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WHO, 2012, EDM RES SER, V037	37	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59775	10.1371/journal.pone.0059775	http://dx.doi.org/10.1371/journal.pone.0059775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555777	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900028
J	Melis, M; Aragoni, MC; Arca, M; Cabras, T; Caltagirone, C; Castagnola, M; Crnjar, R; Messana, I; Tepper, BJ; Barbarossa, IT				Melis, Melania; Aragoni, Maria Carla; Arca, Massimiliano; Cabras, Tiziana; Caltagirone, Claudia; Castagnola, Massimo; Crnjar, Roberto; Messana, Irene; Tepper, Beverly J.; Barbarossa, Iole Tomassini			Marked Increase in PROP Taste Responsiveness Following Oral Supplementation with Selected Salivary Proteins or Their Related Free Amino Acids	PLOS ONE			English	Article							RECEPTOR GENE TAS2R38; BODY-MASS INDEX; BITTER-TASTE; 6-N-PROPYLTHIOURACIL PROP; DIETARY RESTRAINT; VEGETABLE INTAKE; SENSITIVITY; PERCEPTION; PHENYLTHIOCARBAMIDE; PTC	The genetic predisposition to taste 6-n-propylthiouracil (PROP) varies among individuals and is associated with salivary levels of Ps-1 and II-2 peptides, belonging to the basic proline-rich protein family (bPRP). We evaluated the role of these proteins and free amino acids that selectively interact with the PROP molecule, in modulating bitter taste responsiveness. Subjects were classified by their PROP taster status based on ratings of perceived taste intensity for PROP and NaCl solutions. Quantitative and qualitative determinations of Ps-1 and II-2 proteins in unstimulated saliva were performed by HPLC-ESI-MS analysis. Subjects rated PROP bitterness after supplementation with Ps-1 and II-2, and two amino acids (L-Arg and L-Lys) whose interaction with PROP was demonstrated by H-1-NMR spectroscopy. ANOVA showed that salivary levels of II-2 and Ps-1 proteins were higher in unstimulated saliva of PROP super-tasters and medium tasters than in non-tasters. Supplementation of Ps-1 protein in individuals lacking it in saliva enhanced their PROP bitter taste responsiveness, and this effect was specific to the non-taster group. H-1-NMR results showed that the interaction between PROP and L-Arg is stronger than that involving L-Lys, and taste experiments confirmed that oral supplementation with these two amino acids increased PROP bitterness intensity, more for L-Arg than for L-Lys. These data suggest that Ps-1 protein facilitates PROP bitter taste perception and identifies a role for free L-Arg and L-Lys in PROP tasting.	[Melis, Melania; Crnjar, Roberto; Barbarossa, Iole Tomassini] Univ Cagliari, Physiol Sect, Dept Biomed Sci, Monserrato, Italy; [Aragoni, Maria Carla; Arca, Massimiliano; Caltagirone, Claudia] Univ Cagliari, Dipartimento Sci Chim & Geol, Monserrato, Italy; [Cabras, Tiziana; Messana, Irene] Univ Cagliari, Dept Life & Environm Sci, Macrosect Biomed, Monserrato, Italy; [Castagnola, Massimo] Catholic Univ, Inst Biochem & Clin Biochem, Rome, Italy; [Tepper, Beverly J.] Rutgers State Univ, Dept Food Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	University of Cagliari; University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Rutgers State University New Brunswick	Barbarossa, IT (corresponding author), Univ Cagliari, Physiol Sect, Dept Biomed Sci, Monserrato, Italy.	tomassin@unica.it	Castagnola, Massimo/AAB-2825-2019; Messana, Irene/L-2478-2019; Castagnola, Massimo/AAM-6355-2021; ARAGONI, Maria Carla/AAG-1802-2019; Arca, Massimiliano/L-6902-2017; Cabras, Tiziana/AAF-6231-2020	Castagnola, Massimo/0000-0002-0959-7259; Messana, Irene/0000-0002-1436-6105; ARAGONI, Maria Carla/0000-0002-5010-7370; Arca, Massimiliano/0000-0002-0058-6406; TOMASSINI BARBAROSSA, IOLE/0000-0002-2849-4052; MELIS, MELANIA/0000-0003-3410-3158	Italian Ministry of University and Research; Fondazione Banco di Sardegna; Sardinia Regional Government	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Sardinia Regional Government(Regione Sardegna)	This work was supported by the Italian Ministry of University and Research and "Fondazione Banco di Sardegna''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Authors thank the volunteers, without whose contributions this study would not be possible. We also thank Dr. Caterina Chillotti for running clinical trials. Melania Melis gratefully acknowledges Sardinia Regional Government for the financial support of her PhD scholarship (P.O.R. Sardegna F. S. E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013 - Axis IV Human Resources, Objective L 3, Line of Activity L3.1.).	Bajec MR, 2008, PHYSIOL BEHAV, V95, P581, DOI 10.1016/j.physbeh.2008.08.009; Bartoshuk LM, 1998, ANN NY ACAD SCI, V855, P793, DOI 10.1111/j.1749-6632.1998.tb10660.x; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Behrens M, 2009, ANN NY ACAD SCI, V1170, P111, DOI 10.1111/j.1749-6632.2009.03897.x; Bell KI, 2006, AM J CLIN NUTR, V84, P245, DOI 10.1093/ajcn/84.1.245; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Blakeslee AF, 1932, P NATL ACAD SCI USA, V18, P120, DOI 10.1073/pnas.18.1.120; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030962; Calo C, 2011, PHYSIOL BEHAV, V104, P1065, DOI 10.1016/j.physbeh.2011.06.013; Charlton AJ, 1996, FEBS LETT, V382, P289, DOI 10.1016/0014-5793(96)00186-X; COHEN J, 1949, SCIENCE, V110, P532, DOI 10.1126/science.110.2864.532; des Gachons CP, 2009, ANN NY ACAD SCI, V1170, P140, DOI 10.1111/j.1749-6632.2009.04594.x; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Dinnella C, 2011, APPETITE, V56, P633, DOI 10.1016/j.appet.2011.02.017; Dinnella C, 2010, CHEM SENSES, V35, P75, DOI 10.1093/chemse/bjp084; Dinnella C, 2009, CHEM SENSES, V34, P295, DOI 10.1093/chemse/bjp003; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Duffy VB, 2010, CHEMOSENS PERCEPT, V3, P137, DOI 10.1007/s12078-010-9079-8; Duffy VB, 2000, J AM DIET ASSOC, V100, P647, DOI 10.1016/S0002-8223(00)00191-7; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; FISCHER R, 1964, Arzneimittelforschung, V14, P673; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; GLANVILL.EV, 1965, NATURE, V205, P930, DOI 10.1038/205930a0; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Guo SW, 2001, ANN HUM BIOL, V28, P111; HARRIS H, 1949, ANN EUGENIC, V14, P309, DOI 10.1111/j.1469-1809.1949.tb02420.x; Hartmann G, 1939, ANN EUGENIC, V9, P123, DOI 10.1111/j.1469-1809.1939.tb02202.x; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2007, CHEM SENSES, V32, P225, DOI 10.1093/chemse/bjl050; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Henkin RI, 1999, AM J MED SCI, V318, P392, DOI 10.1097/00000441-199912000-00006; Kawai M, 2012, AMINO ACIDS, V43, P2349, DOI 10.1007/s00726-012-1315-x; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Mennella JA, 2011, CHEM SENSES, V36, P161, DOI 10.1093/chemse/bjq106; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Padiglia A, 2010, AM J CLIN NUTR, V92, P539, DOI 10.3945/ajcn.2010.29418; Prodi DA, 2004, CHEM SENSES, V29, P697, DOI 10.1093/chemse/bjh074; Rankin KM, 2004, GENETIC VARIATION TA, P63, DOI DOI 10.1201/9780203023433.CH3; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Soares S, 2011, J AGR FOOD CHEM, V59, P5535, DOI 10.1021/jf104975d; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tan J, 2012, J CHEM INF MODEL, V52, P1875, DOI 10.1021/ci300133a; Tandra P, 1989, J EXP BIOL, V27, P695; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2009, ANN NY ACAD SCI, V1170, P126, DOI 10.1111/j.1749-6632.2009.03916.x; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Tepper BJ, 2002, PHYSIOL BEHAV, V75, P305, DOI 10.1016/S0031-9384(01)00664-3; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Tsuji M, 2012, EUR J CLIN NUTR, V66, P47, DOI 10.1038/ejcn.2011.127; Ullrich NV, 2004, J AM DIET ASSOC, V104, P543, DOI 10.1016/j.jada.2004.01.011; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yeomans MR, 2009, Q J EXP PSYCHOL, V62, P1648, DOI 10.1080/17470210802557793; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	63	54	54	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59810	10.1371/journal.pone.0059810	http://dx.doi.org/10.1371/journal.pone.0059810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555788	gold, Green Published			2022-12-27	WOS:000317262200041
J	Pinder, JB; McQuaid, ME; Dobson, MJ				Pinder, Jordan B.; McQuaid, Mary E.; Dobson, Melanie J.			Deficient Sumoylation of Yeast 2-Micron Plasmid Proteins Rep1 and Rep2 Associated with Their Loss from the Plasmid-Partitioning Locus and Impaired Plasmid Inheritance	PLOS ONE			English	Article							2-MU-M CIRCLE PLASMID; NUCLEOSOME-REMODELING COMPLEX; 2 MICRON PLASMID; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; SUMO MODIFICATION; COPY NUMBER; DNA PLASMID; LOCALIZATION; SYSTEM	The 2-micron plasmid of the budding yeast Saccharomyces cerevisiae encodes copy-number amplification and partitioning systems that enable the plasmid to persist despite conferring no advantage to its host. Plasmid partitioning requires interaction of the plasmid Rep1 and Rep2 proteins with each other and with the plasmid-partitioning locus STB. Here we demonstrate that Rep1 stability is reduced in the absence of Rep2, and that both Rep proteins are sumoylated. Lysine-to-arginine substitutions in Rep1 and Rep2 that inhibited their sumoylation perturbed plasmid inheritance without affecting Rep protein stability or two-hybrid interaction between Rep1 and Rep2. One-hybrid and chromatin immunoprecipitation assays revealed that Rep1 was required for efficient retention of Rep2 at STB and that sumoylation-deficient mutants of Rep1 and Rep2 were impaired for association with STB. The normal co-localization of both Rep proteins with the punctate nuclear plasmid foci was also lost when Rep1 was sumoylation-deficient. The correlation of Rep protein sumoylation status with plasmid-partitioning locus association suggests a theme common to eukaryotic chromosome segregation proteins, sumoylated forms of which are found enriched at centromeres, and between the yeast 2-micron plasmid and viral episomes that depend on sumoylation of their maintenance proteins for persistence in their hosts.	[Pinder, Jordan B.; McQuaid, Mary E.; Dobson, Melanie J.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University	Dobson, MJ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	dobson@dal.ca		Dobson, Melanie/0000-0001-9291-7200; McQuaid, Mary E/0000-0002-0491-127X	NSERC Discovery [155268]; Killam predoctoral scholarship; Killam predoctoral; NSERC CGSM; PGSD scholarships	NSERC Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam predoctoral scholarship; Killam predoctoral; NSERC CGSM(Natural Sciences and Engineering Research Council of Canada (NSERC)); PGSD scholarships	This research was supported by an NSERC Discovery grant 155268 to MJD, NSERC CGSD and Killam predoctoral scholarship to JBP, and Killam predoctoral and NSERC CGSM and PGSD scholarships to MEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YT, 1997, J BACTERIOL, V179, P7497, DOI 10.1128/jb.179.23.7497-7506.1997; Bartel P, 1993, ANONYMOUS CELLULAR I, P153; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; BROACH JR, 1991, MOL CELLULAR BIOL YE, V1, P297; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Burke D., 2000, METHODS YEAST GENETI; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; CASHMORE AM, 1986, MOL GEN GENET, V203, P154, DOI 10.1007/BF00330397; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cui H, 2009, J CELL BIOL, V185, P251, DOI 10.1083/jcb.200810130; Dobson MJ, 2005, MOL CELL BIOL, V25, P4299, DOI 10.1128/MCB.25.10.4299-4310.2005; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FUTCHER AB, 1983, J BACTERIOL, V154, P612, DOI 10.1128/JB.154.2.612-622.1983; FUTCHER AB, 1986, J THEOR BIOL, V119, P197, DOI 10.1016/S0022-5193(86)80074-1; FUTCHER AB, 1988, YEAST, V4, P27, DOI 10.1002/yea.320040104; Ghosh SK, 2006, ANNU REV BIOCHEM, V75, P211, DOI 10.1146/annurev.biochem.75.101304.124037; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HADFIELD C, 1995, NUCLEIC ACIDS RES, V23, P995, DOI 10.1093/nar/23.6.995; Hajra S, 2006, J CELL BIOL, V174, P779, DOI 10.1083/jcb.200603042; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Jakobs A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm617; JAYARAM M, 1983, CELL, V34, P95, DOI 10.1016/0092-8674(83)90139-3; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; KIKUCHI Y, 1983, CELL, V35, P487, DOI 10.1016/0092-8674(83)90182-4; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; LIVINGSTON DM, 1977, GENETICS, V86, P73; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Mehta S, 2005, MOL CELL BIOL, V25, P4283, DOI 10.1128/MCB.25.10.4283-4298.2005; Mehta S, 2002, J CELL BIOL, V158, P625, DOI 10.1083/jcb.200204136; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Niedenthal R, 2007, BIOCHEM SOC T, V35, P1430, DOI 10.1042/BST0351430; Niedenthal Rainer, 2009, V497, P63, DOI 10.1007/978-1-59745-566-4_5; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ryu H, 2010, J BIOL CHEM, V285, P32576, DOI 10.1074/jbc.M110.153817; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott-Drew S, 1998, J CELL SCI, V111, P1779; Scott-Drew S, 2002, CELL BIOL INT, V26, P393, DOI 10.1006/cbir.2002.0867; Sengupta A, 2001, J BACTERIOL, V183, P2306, DOI 10.1128/JB.183.7.2306-2315.2001; SIKORSKI RS, 1989, GENETICS, V122, P19; SOM T, 1988, CELL, V52, P27, DOI 10.1016/0092-8674(88)90528-4; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Tsalik EL, 1998, YEAST, V14, P847, DOI 10.1002/(SICI)1097-0061(19980630)14:9<847::AID-YEA285>3.0.CO;2-9; VEIT BE, 1988, MOL CELL BIOL, V8, P4949, DOI 10.1128/MCB.8.11.4949; VEIT BE, 1985, MOL CELL BIOL, V5, P2190, DOI 10.1128/MCB.5.9.2190; Velmurugan S, 1998, MOL CELL BIOL, V18, P7466, DOI 10.1128/MCB.18.12.7466; Velmurugan S, 2000, J CELL BIOL, V149, P553, DOI 10.1083/jcb.149.3.553; VOLKERT FC, 1986, CELL, V46, P541, DOI 10.1016/0092-8674(86)90879-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wong MCVL, 2002, MOL CELL BIOL, V22, P4218, DOI 10.1128/MCB.22.12.4218-4229.2002; Wu YC, 2008, VIROLOGY, V378, P329, DOI 10.1016/j.virol.2008.06.008; XIAO W, 1991, GENE, V101, P75, DOI 10.1016/0378-1119(91)90226-2; XIAO W, 1991, J MOL EVOL, V32, P145, DOI 10.1007/BF02515386; Xiong L, 2009, MOL BIOL CELL, V20, P1241, DOI 10.1091/mbc.E08-06-0659; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yang XM, 2004, MOL CELL BIOL, V24, P5290, DOI 10.1128/MCB.24.12.5290-5303.2004; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	81	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60384	10.1371/journal.pone.0060384	http://dx.doi.org/10.1371/journal.pone.0060384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555963	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200112
J	Shi, JQ; Huang, SM; Fu, DH; Yu, JY; Wang, XF; Hua, W; Liu, SY; Liu, GH; Wang, HZ				Shi, Jiaqin; Huang, Shunmou; Fu, Donghui; Yu, Jinyin; Wang, Xinfa; Hua, Wei; Liu, Shengyi; Liu, Guihua; Wang, Hanzhong			Evolutionary Dynamics of Microsatellite Distribution in Plants: Insight from the Comparison of Sequenced Brassica, Arabidopsis and Other Angiosperm Species	PLOS ONE			English	Article							COMPARATIVE GENOMICS; TANDEM REPEATS; TRANSPOSABLE ELEMENTS; MUTATION-RATES; SSR-MARKERS; DNA; DIVERSITY; THALIANA; REGIONS; DIPLOIDIZATION	Despite their ubiquity and functional importance, microsatellites have been largely ignored in comparative genomics, mostly due to the lack of genomic information. In the current study, microsatellite distribution was characterized and compared in the whole genomes and both the coding and non-coding DNA sequences of the sequenced Brassica, Arabidopsis and other angiosperm species to investigate their evolutionary dynamics in plants. The variation in the microsatellite frequencies of these angiosperm species was much smaller than those for their microsatellite numbers and genome sizes, suggesting that microsatellite frequency may be relatively stable in plants. The microsatellite frequencies of these angiosperm species were significantly negatively correlated with both their genome sizes and transposable elements contents. The pattern of microsatellite distribution may differ according to the different genomic regions (such as coding and non-coding sequences). The observed differences in many important microsatellite characteristics (especially the distribution with respect to motif length, type and repeat number) of these angiosperm species were generally accordant with their phylogenetic distance, which suggested that the evolutionary dynamics of microsatellite distribution may be generally consistent with plant divergence/evolution. Importantly, by comparing these microsatellite characteristics (especially the distribution with respect to motif type) the angiosperm species (aside from a few species) all clustered into two obviously different groups that were largely represented by monocots and dicots, suggesting a complex and generally dichotomous evolutionary pattern of microsatellite distribution in angiosperms. Polyploidy may lead to a slight increase in microsatellite frequency in the coding sequences and a significant decrease in microsatellite frequency in the whole genome/non-coding sequences, but have little effect on the microsatellite distribution with respect to motif length, type and repeat number. Interestingly, several microsatellite characteristics seemed to be constant in plant evolution, which can be well explained by the general biological rules.	[Shi, Jiaqin; Huang, Shunmou; Yu, Jinyin; Wang, Xinfa; Hua, Wei; Liu, Shengyi; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol, Wuhan, Peoples R China; [Fu, Donghui] Jiangxi Agr Univ, Agron Coll, Minist Educ, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Jiangxi Agricultural University	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol, Wuhan, Peoples R China.	wanghz@oilcrops.cn	Liu, Shengyi/S-6772-2016	Liu, Shengyi/0000-0002-4955-4763	National Basic Research and Development Program [2011CB109305]; National Science and Technology Supporting Program [2010BAD01B02]; National High Technology Research and Development Program of China [2012AA101107]	National Basic Research and Development Program(National Basic Research Program of China); National Science and Technology Supporting Program; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Basic Research and Development Program (2011CB109305), National Science and Technology Supporting Program (2010BAD01B02) and National High Technology Research and Development Program (2012AA101107) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2001, MOL GENET GENOMICS, V266, P471, DOI 10.1007/s004380100563; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chen LZ, 2007, PLANTA, V225, P603, DOI 10.1007/s00425-006-0381-2; Cieslarova J, 2011, J APPL GENET, V52, P391, DOI 10.1007/s13353-011-0058-9; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fidalgo M, 2006, P NATL ACAD SCI USA, V103, P11228, DOI 10.1073/pnas.0601713103; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gao CH, 2011, MOL GENET GENOMICS, V286, P161, DOI 10.1007/s00438-011-0636-x; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Guo WJ, 2009, GENOMICS, V93, P323, DOI 10.1016/j.ygeno.2008.12.009; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hazzouri RM, 2008, GENETICS, V179, P581, DOI 10.1534/genetics.107.085761; Hefferon TW, 2004, P NATL ACAD SCI USA, V101, P3504, DOI 10.1073/pnas.0400182101; Ijaz S, 2011, AFR J BIOTECHNOL, V10, P7723; Jiang BA, 2011, PLANT MOL BIOL, V77, P225, DOI 10.1007/s11103-011-9804-y; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Merkel A, 2008, BRIEF BIOINFORM, V9, P355, DOI 10.1093/bib/bbn028; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r94; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Ott A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022306; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; SAS INSTITUTE, 2000, SAS STAT US GUID VER; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Schranz ME, 2007, CURR OPIN PLANT BIOL, V10, P168, DOI 10.1016/j.pbi.2007.01.014; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schug MD, 1998, MOL BIOL EVOL, V15, P1751, DOI 10.1093/oxfordjournals.molbev.a025901; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Tomas D, 2012, INT J MOL SCI, V13, P8549, DOI 10.3390/ijms13078549; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; U. N., 1935, Japanese Journal of Botany, V7, P389; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wierdl M, 1997, GENETICS, V146, P769; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wren JD, 2000, AM J HUM GENET, V67, P345, DOI 10.1086/303013; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005	62	40	42	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59988	10.1371/journal.pone.0059988	http://dx.doi.org/10.1371/journal.pone.0059988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555856	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200065
J	Simini, F; Maritan, A; Neda, Z				Simini, Filippo; Maritan, Amos; Neda, Zoltan			Human Mobility in a Continuum Approach	PLOS ONE			English	Article							INTERVENING OPPORTUNITIES; GRAVITY; MODEL; MIGRATION	Human mobility is investigated using a continuum approach that allows to calculate the probability to observe a trip to any arbitrary region, and the fluxes between any two regions. The considered description offers a general and unified framework, in which previously proposed mobility models like the gravity model, the intervening opportunities model, and the recently introduced radiation model are naturally resulting as special cases. A new form of radiation model is derived and its validity is investigated using observational data offered by commuting trips obtained from the United States census data set, and the mobility fluxes extracted from mobile phone data collected in a western European country. The new modeling paradigm offered by this description suggests that the complex topological features observed in large mobility and transportation networks may be the result of a simple stochastic process taking place on an inhomogeneous landscape.	[Simini, Filippo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Simini, Filippo] Northeastern Univ, Dept Phys Biol & Comp Sci, Boston, MA 02115 USA; [Simini, Filippo] Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary; [Maritan, Amos] Univ Padua, CNISM, Dipartimento Fis & Astron G Galilei, Padua, Italy; [Maritan, Amos] Ist Nazl Fis Nucl, Padua, Italy; [Neda, Zoltan] Univ Babes Bolyai, Dept Phys, R-3400 Cluj Napoca, Romania	Northeastern University; Northeastern University; Budapest University of Technology & Economics; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Babes Bolyai University from Cluj	Simini, F (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	f.simini@neu.edu	Néda, Zoltán/C-3754-2011	Maritan, Amos/0000-0002-3535-7873	Cariparo Foundation; European Union [270833]; PRIN (Progetti di Ricerca di Interesse Nazionale);  [PN-II-ID-PCE-2011-3-0348]	Cariparo Foundation(Fondazione Cariparo); European Union(European Commission); PRIN (Progetti di Ricerca di Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); 	The present work was supported by research grant PN-II-ID-PCE-2011-3-0348. AM research is supported by the Cariparo Foundation and PRIN (Progetti di Ricerca di Interesse Nazionale). The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 270833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 1956, PAPERS REGIONAL SCI, V2, P175, DOI DOI 10.1111/J.1435-5597.1956.TB01563.X; [Anonymous], 1960, CONTRIBUTIONS PROBAB; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bohn S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088702; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Caldarelli G., 2007, SCALE FREE NETWORKS; Cohen JE, 2008, P NATL ACAD SCI USA, V105, P15269, DOI 10.1073/pnas.0808185105; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Durand M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088701; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hu YQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.108701; Jung WS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48005; Kaluza P., 2010, J ROYAL SOC INTERFAC; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; LUKERMANN F, 1960, ANN ASSOC AM GEOGR, V50, P493, DOI 10.1111/j.1467-8306.1960.tb00364.x; Masucci A, 2012, ARXIV12065735; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; POYHONEN P, 1963, WELTWIRTSCH ARCH, V90, P93; RITCHEY PN, 1976, ANNU REV SOCIOL, V2, P363, DOI 10.1146/annurev.so.02.080176.002051; SCHMITT RR, 1978, GEOGR ANAL, V10, P73; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	32	61	61	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60069	10.1371/journal.pone.0060069	http://dx.doi.org/10.1371/journal.pone.0060069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555885	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200076
J	Bobek, G; Stait-Gardner, T; Surmon, L; Makris, A; Lind, JM; Price, WS; Hennessy, A				Bobek, Gabriele; Stait-Gardner, Tim; Surmon, Laura; Makris, Angela; Lind, Joanne M.; Price, William S.; Hennessy, Annemarie			Magnetic Resonance Imaging Detects Placental Hypoxia and Acidosis in Mouse Models of Perturbed Pregnancies	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIAC MYOCYTE DEATH; IN-VIVO; RELAXATION; HYPERTENSION; CONTRAST; PREECLAMPSIA; PERFUSION; MUSCLE; SFLT-1	Endothelial dysfunction as a result of dysregulation of anti-angiogenic molecules secreted by the placenta leads to the maternal hypertensive response characteristic of the pregnancy complication of preeclampsia. Structural abnormalities in the placenta have been proposed to result in altered placental perfusion, placental oxidative stress, cellular damage and inflammation and the release of anti-angiogenic compounds into the maternal circulation. The exact link between these factors is unclear. Here we show, using Magnetic Resonance Imaging as a tool to examine placental changes in mouse models of perturbed pregnancies, that T-2 contrast between distinct regions of the placenta is abolished at complete loss of blood flow. Alterations in T-2 (spin-spin or transverse) relaxation times are explained as a consequence of hypoxia and acidosis within the tissue. Similar changes are observed in perturbed pregnancies, indicating that acidosis as well as hypoxia may be a feature of pregnancy complications such as preeclampsia and may play a prominent role in the signalling pathways that lead to the increased secretion of anti-angiogenic compounds.	[Bobek, Gabriele; Stait-Gardner, Tim; Surmon, Laura; Makris, Angela; Lind, Joanne M.; Price, William S.; Hennessy, Annemarie] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia; [Stait-Gardner, Tim; Price, William S.; Hennessy, Annemarie] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Makris, Angela; Hennessy, Annemarie] Univ Sydney, Heart Res Inst, Sydney, NSW 2006, Australia; [Makris, Angela] Liverpool Hosp, Renal Unit Liverpool, Liverpool, NSW, Australia	Western Sydney University; Western Sydney University; University of Sydney; Heart Research Institute; Liverpool Hospital	Bobek, G (corresponding author), Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.	g.bobek@uws.edu.au	Hennessy, Annemarie/HGB-5049-2022; Price, William S/D-8619-2011	Price, William S/0000-0002-8549-4665; Stait-Gardner, Timothy/0000-0002-7898-8202; Hennessy, Annemarie/0000-0002-5975-2843	National Health and Medical Research Council (NHMRC) [102528]; Australian National Imaging Facility; NHMRC Australian Biomedical Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian National Imaging Facility; NHMRC Australian Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a grant from the National Health and Medical Research Council (NHMRC) # 102528. Support from the Australian National Imaging Facility is also acknowledged. JML is supported by an NHMRC Australian Biomedical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2002, AM J HYPERTENS, V15, P170, DOI 10.1016/S0895-7061(01)02255-5; Alexander BT, 2001, HYPERTENSION, V37, P1191, DOI 10.1161/01.HYP.37.4.1191; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Boedtkjer E, 2011, CIRCULATION, V124, P1819, DOI 10.1161/CIRCULATIONAHA.110.015974; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Chalouhi GE, 2011, SEMIN FETAL NEONAT M, V16, P22, DOI 10.1016/j.siny.2010.09.001; Damodaram M, 2010, PLACENTA, V31, P491, DOI 10.1016/j.placenta.2010.03.001; Duncan KR, 1998, PLACENTA, V19, P539, DOI 10.1016/S0143-4004(98)91048-7; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Girsh E, 2007, NMR BIOMED, V20, P28, DOI 10.1002/nbm.1087; Gowland P, 2005, SEMIN FETAL NEONAT M, V10, P485, DOI 10.1016/j.siny.2005.05.001; Gowland PA, 1998, MAGNET RESON MED, V40, P467, DOI 10.1002/mrm.1910400318; Graham RA, 2004, J EXP BIOL, V207, P3189, DOI 10.1242/jeb.01109; JEHENSON P, 1993, AM J ROENTGENOL, V161, P347, DOI 10.2214/ajr.161.2.8333376; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Louie EA, 2009, MAGN RESON MED, V61, P560, DOI 10.1002/mrm.21847; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; MEYER ME, 1995, MAGNET RESON MED, V34, P234, DOI 10.1002/mrm.1910340215; Moore RJ, 2000, MAGNET RESON MED, V43, P295, DOI 10.1002/(SICI)1522-2594(200002)43:2<295::AID-MRM18>3.0.CO;2-2; Moore RJ, 2000, PLACENTA, V21, P726, DOI 10.1053/plac.2000.0567; Nakada E, 2009, PLACENTA, V30, P774, DOI 10.1016/j.placenta.2009.07.001; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Plaks V, 2011, MOL IMAGING BIOL, V13, P481, DOI 10.1007/s11307-010-0390-1; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Salomon LJ, 2006, PLACENTA, V27, P1007, DOI 10.1016/j.placenta.2005.10.007; Sasaki S, 2004, CARDIOVASC RES, V62, P578, DOI 10.1016/j.cardiores.2004.01.031; Scheffler K, 2001, MAGNET RESON MED, V45, P720, DOI 10.1002/mrm.1097; Sunderland NS, 2011, CYTOKINE, V56, P192, DOI 10.1016/j.cyto.2011.06.003; Taillieu F, 2006, RADIOLOGY, V241, P737, DOI 10.1148/radiol.2413051168; Tomlinson TM, 2010, AM J PHYSL REGULATOR, V298; Wright C, 2011, PLACENTA, V32, P1010, DOI 10.1016/j.placenta.2011.07.008; Zenclussen AC, 2012, AM J REPROD IMMUNOL; Zheng M, 2004, FASEB J, V18, P109, DOI 10.1096/fj.04-2604fje	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59971	10.1371/journal.pone.0059971	http://dx.doi.org/10.1371/journal.pone.0059971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555853	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500110
J	Kacerovsky, M; Celec, P; Vlkova, B; Skogstrand, K; Hougaard, DM; Cobo, T; Jacobsson, B				Kacerovsky, Marian; Celec, Peter; Vlkova, Barbora; Skogstrand, Kristin; Hougaard, David M.; Cobo, Teresa; Jacobsson, Bo			Amniotic Fluid Protein Profiles of Intraamniotic Inflammatory Response to Ureaplasma spp. and Other Bacteria	PLOS ONE			English	Article							PRETERM LABOR ANALYSIS; MICROBIAL INVASION; SWEDISH POPULATION; CYTOKINE RESPONSE; MULTIPLE-PROTEINS; FECAL MICROBIOTA; TNF-ALPHA; WOMEN; SECRETION; INFECTION	This study aimed to evaluate the amniotic fluid protein profiles and the intensity of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria, using the multiplex xMAP technology. Methods: A retrospective cohort study was undertaken in the Department of Obstetrics and Gynecology, University Hospital Hradec Kralove, Czech Republic. A total of 145 pregnant women with preterm prelabor rupture of membranes between gestational age 24+0 and 36+6 weeks were included in the study. Amniocenteses were performed. The presence of Ureaplasma spp. and other bacteria was evaluated using 16S rRNA gene sequencing. The levels of specific proteins were determined using multiplex xMAP technology. Results: The presence of Ureaplasma spp. and other bacteria in the amniotic fluid was associated with increased levels of interleukin (IL)-6, IL-8, IL-10, brain-derived neurotropic factor, granulocyte macrophage colony stimulating factor, monocyte chemotactic protein-1, macrophage inflammatory protein-1, and matrix metalloproteinasis-9. Ureaplasma spp. were also associated with increased levels of neurotropin-3 and triggering receptor expressed on myeloid cells-1. Conclusions: The presence of Ureaplasma spp. in the amniotic fluid is associated with a slightly different protein profile of inflammatory response, but the intensity of inflammatory response to Ureaplasma spp. is comparable with the inflammatory response to other bacteria.	[Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Kacerovsky, Marian] Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Celec, Peter; Vlkova, Barbora] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Skogstrand, Kristin; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Cobo, Teresa] Hosp Clin Barcelona, IDIBAPS, Maternal Fetal Med Dept, Barcelona, Spain; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Oslo, Norway	University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Comenius University Bratislava; Statens Serum Institut; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Sahlgrenska University Hospital	Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Celec, Peter/I-7103-2012; Hougaard, David/AAD-6368-2019; Kacerovsky, Marian/ABE-3437-2020; Vlkova, Barbora/I-5014-2014; Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/A-7586-2011; Cobo, Teresa/K-2770-2017	Celec, Peter/0000-0001-5883-3580; Vlkova, Barbora/0000-0003-3907-5432; Jacobsson, Bo/0000-0001-5079-2374; Kacerovsky, Marian/0000-0001-9858-7900; Skogstrand, Kristin/0000-0002-0026-3711; Cobo, Teresa/0000-0003-3130-1829	Ministry of Health, Czech Republic [NT13461-4/2012]; REVOGENE project [ITMS 6240220067]; Research & Development Operational Programme; ERDF; Swedish government [ALFGBG-136431]; Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg, Sweden; Swedish Medical Society, Stockholm, Sweden [2008-21198]; Jane and Dan Olsson Research Foundation, Gothenburg, Sweden	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); REVOGENE project; Research & Development Operational Programme; ERDF(European Commission); Swedish government; Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg, Sweden; Swedish Medical Society, Stockholm, Sweden; Jane and Dan Olsson Research Foundation, Gothenburg, Sweden	This work was supported by a grant from the Ministry of Health, Czech Republic (NT13461-4/2012) and by REVOGENE project, ITMS 6240220067, supported by the Research & Development Operational Programme funded by ERDF. Additional support came from Swedish government grants to researchers in the public health service (ALF) (ALFGBG-136431), Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg, Sweden, the Swedish Medical Society, Stockholm, Sweden (2008-21198) and the Jane and Dan Olsson Research Foundation, Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2007, BJOG-INT J OBSTET GY, V114, P1432, DOI 10.1111/j.1471-0528.2007.01410.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Cobo T, 2012, ACTA OBSTET GYN SCAN, V91, P930, DOI 10.1111/j.1600-0412.2012.01427.x; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; He X, 2011, MOL ORAL MICROBIOL, V26, P337, DOI 10.1111/j.2041-1014.2011.00622.x; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Kacerovsky M, 2012, J MATERN-FETAL NEO M, V25, P2014, DOI 10.3109/14767058.2012.671873; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Lemon KP, 2010, J MOL BIOL, V215, P403; Maldonado-Contreras A, 2011, ISME J, V5, P574, DOI 10.1038/ismej.2010.149; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Nemoto H, 2012, DIGEST DIS SCI, V57, P2955, DOI 10.1007/s10620-012-2236-y; Oh KJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.035; Polgarova K, 2010, NEW MICROBIOL, V33, P373; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; Sakamoto M, 2003, J MED MICROBIOL, V52, P79, DOI 10.1099/jmm.0.04991-0; Shiga H, 2012, DIGEST LIVER DIS, V44, P736, DOI 10.1016/j.dld.2012.04.014; Tashima LS, 1999, OBSTET GYNECOL, V94, P441, DOI 10.1016/S0029-7844(99)00339-7; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vogel I, 2007, J REPROD IMMUNOL, V75, P133, DOI 10.1016/j.jri.2007.02.008; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Zaga-Clavellina V, 2012, J MATERN-FETAL NEO M, V25, P358, DOI 10.3109/14767058.2011.578695; Zaga-Clavellina V, 2012, AM J REPROD IMMUNOL, V67, P34, DOI 10.1111/j.1600-0897.2011.01054.x; Zaga-Clavellina V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-46	31	72	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60399	10.1371/journal.pone.0060399	http://dx.doi.org/10.1371/journal.pone.0060399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555967	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500131
J	Mi, JX; Liu, JX				Mi, Jian-Xun; Liu, Jin-Xing			Face Recognition Using Sparse Representation-Based Classification on K-Nearest Subspace	PLOS ONE			English	Article							ITERATIVE THRESHOLDING ALGORITHM; LINEAR INVERSE PROBLEMS	The sparse representation-based classification (SRC) has been proven to be a robust face recognition method. However, its computational complexity is very high due to solving a complex l1-minimization problem. To improve the calculation efficiency, we propose a novel face recognition method, called sparse representation-based classification on k-nearest subspace (SRC-KNS). Our method first exploits the distance between the test image and the subspace of each individual class to determine the k nearest subspaces and then performs SRC on the k selected classes. Actually, SRC-KNS is able to reduce the scale of the sparse representation problem greatly and the computation to determine the k nearest subspaces is quite simple. Therefore, SRC-KNS has a much lower computational complexity than the original SRC. In order to well recognize the occluded face images, we propose the modular SRC-KNS. For this modular method, face images are partitioned into a number of blocks first and then we propose an indicator to remove the contaminated blocks and choose the k nearest subspaces. Finally, SRC is used to classify the occluded test sample in the new feature space. Compared to the approach used in the original SRC work, our modular SRC-KNS can greatly reduce the computational load. A number of face recognition experiments show that our methods have five times speed-up at least compared to the original SRC, while achieving comparable or even better recognition rates.	[Mi, Jian-Xun] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China; [Mi, Jian-Xun] Key Lab Network Oriented Intelligent Computat, Shenzhen, Guangdong, Peoples R China; [Liu, Jin-Xing] Qufu Normal Univ, Coll Informat & Commun Technol, Rizhao, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; Qufu Normal University	Liu, JX (corresponding author), Qufu Normal Univ, Coll Informat & Commun Technol, Rizhao, Peoples R China.	sdcavell@126.com	Liu, Jin-Xing/AAU-7257-2020; Mi, Jianxun/U-3642-2019; Mi, Jianxun/J-9670-2014	Mi, Jianxun/0000-0002-7531-4341	National Nature Science Committee of China [61071179, 61203376, 61263032, 61202276, 61272292]	National Nature Science Committee of China	This work was supported by the National Nature Science Committee of China under Grant Nos. 61071179, 61203376, 61263032, 61202276 and 61272292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Basri R, 2003, IEEE T PATTERN ANAL, V25, P218, DOI 10.1109/TPAMI.2003.1177153; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; Chien JT, 2002, IEEE T PATTERN ANAL, V24, P1644, DOI 10.1109/TPAMI.2002.1114855; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; Debruyne M, 2010, ADV DATA ANAL CLASSI, V4, P151, DOI 10.1007/s11634-010-0068-1; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Khoramian S, 2012, APPL COMPUT HARMON A, V32, P109, DOI 10.1016/j.acha.2011.03.004; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Lei Z, 2011, SPARSE REPRESENTATIO, P471; Li SZ, 2005, IEEE T IMAGE PROCESS, V14, P705, DOI 10.1109/TIP.2005.847295; Liu CJ, 2003, IEEE T NEURAL NETWOR, V14, P919, DOI 10.1109/TNN.2003.813829; Malioutov DM, 2005, INT CONF ACOUST SPEE, P733; Martinez A., 1998, AR FACE DATABASE CVC; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; PENTLAND A, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P84, DOI 10.1109/CVPR.1994.323814; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Tsaig Y, 2006, SIGNAL PROCESS, V86, P549, DOI 10.1016/j.sigpro.2005.05.028; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang AY, 2010, IEEE IMAGE PROC, P1849, DOI 10.1109/ICIP.2010.5651522; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097	30	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59430	10.1371/journal.pone.0059430	http://dx.doi.org/10.1371/journal.pone.0059430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555671	Green Published, gold			2022-12-27	WOS:000317418500038
J	Phe, T; Thai, S; Veng, C; Sok, S; Lynen, L; van Griensven, J				Phe, Thong; Sopheak Thai; Veng, Chhunheng; Sok, Sopheak; Lynen, Lutgarde; van Griensven, Johan			Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment	PLOS ONE			English	Article							THERAPY; NEVIRAPINE; HAART	Background: Anemia is the main concern among patients using a zidovudine (AZT)-based antiretroviral treatment (ART). Some studies suggested weight-adjusted AZT dosing as a way to reduce toxicity. We analyzed the risk factors associated with AZT-induced anemia in a cohort using AZT as substitution for stavudine (D4T). Methods: We retrospectively studied HIV-infected patients in a referral hospital in Phnom Penh, Cambodia between 2003 and 2011. Factors associated with AZT-related anemia requiring AZT-discontinuation within the first year after AZT initiation were analyzed using Cox regression. Results: Overall, 1180 patients, 60.5% female, were included. At AZT initiation, the median hemoglobin was 12.7 g/dL (IQR 11.7-13.9), the median weight: 51 kg (IQR 45-58) and the median time on ART prior to AZT substitution: 1.4 years (IQR 1.0-2.0). Within one year follow-up, 139 patients (11.8%) developed anemia requiring AZT discontinuation. Overall, there was no independent association of body weight with AZT discontinuation. AZT discontinuation was associated with lower hemoglobin level when starting AZT; older age and taking D4T-based ART less than one year prior to AZT. In exploratory analysis, a linear increase in risk of grade 2-4 anemia with lower body weight was seen if starting AZT substitution within less than one year of D4T-based ART. Conclusion: Our findings argue against the need of weight-based dosing of AZT to reduce anemia among patients using AZT as substitution for D4T. Whether this also applies to ART-naive individuals remains to be assessed. Future studies with AZT dose reduction should assess efficacy and overall tolerance of AZT.	[Phe, Thong; Sopheak Thai; Veng, Chhunheng; Sok, Sopheak; van Griensven, Johan] Sihanouk Hosp Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia; [Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Phe, T (corresponding author), Sihanouk Hosp Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia.	thongphe@sihosp.org	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine; Antwerp; Global Fund to fight AIDS; Tuberculosis and Malaria; Hope World Wide; InBev-Baillet Latour Fund	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine; Antwerp; Global Fund to fight AIDS; Tuberculosis and Malaria; Hope World Wide; InBev-Baillet Latour Fund	The HIV program was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. JvG is supported by the InBev-Baillet Latour Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2010, INDIAN J MED RES, V132, P386; Bastard JP, 2012, ANTIVIR THER, V17, P915, DOI 10.3851/IMP2093; Cambodian Ministry of Health, 2005, NAT GUID US ANT THER; Cambodian Ministry of Health, 2012, NAT GUID US ANT THER; Cressey TR, 2006, JAIDS-J ACQ IMM DEF, V42, P387, DOI 10.1097/01.qai.0000221685.90681.1b; Huffam SE, 2007, HIV MED, V8, P465, DOI 10.1111/j.1468-1293.2007.00498.x; Isaakidis P, 2008, JAIDS-J ACQ IMM DEF, V49, P48, DOI 10.1097/QAI.0b013e31817bec19; Kesselring AM, 2009, AIDS, V23, P1689, DOI 10.1097/QAD.0b013e32832d3b54; Kumarasamy N, 2009, INT J INFECT DIS, V13, pE360, DOI 10.1016/j.ijid.2008.11.030; Lichtfuss GF, 2012, J IMMUNOL, V189, P1491, DOI 10.4049/jimmunol.1200458; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Mathieu R, 2012, COMP STANDARD DOSE A; Moh R, 2005, ANTIVIR THER, V10, P615; NORRBY SR, 1992, BRIT MED J, V304, P13; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Sok S, 2009, 5 IAS C HIV PATH TRE; Ssali F, 2006, ANTIVIR THER, V11, P741; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Toeung PD, 2007, 4 IAS C HIV PATH TRE; van Griensven J, 2009, AIDS, V23, P2374, DOI 10.1097/QAD.0b013e328331900c; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V53, P215, DOI 10.1097/QAI.0b013e3181bc0f10; World Health Organization, 2004, SCAL ANT THER RES LT; Zhou JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-5	25	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60206	10.1371/journal.pone.0060206	http://dx.doi.org/10.1371/journal.pone.0060206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555926	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500123
J	Fazal, F; Bijli, KM; Murrill, M; Leonard, A; Minhajuddin, M; Anwar, KN; Finkelstein, JN; Watterson, DM; Rahman, A				Fazal, Fabeha; Bijli, Kaiser M.; Murrill, Matthew; Leonard, Antony; Minhajuddin, Mohammad; Anwar, Khandaker N.; Finkelstein, Jacob N.; Watterson, D. Martin; Rahman, Arshad			Critical Role of Non-Muscle Myosin Light Chain Kinase in Thrombin-Induced Endothelial Cell Inflammation and Lung PMN Infiltration	PLOS ONE			English	Article							NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; RESPIRATORY-DISTRESS-SYNDROME; RELA/P65 NUCLEAR TRANSLOCATION; NEUTROPHIL ADHESION; ACTIN CYTOSKELETON; ICAM-1 EXPRESSION; VASCULAR INJURY; TISSUE-FACTOR; COAGULATION	The pathogenesis of acute lung injury (ALI) involves bidirectional cooperation and close interaction between inflammatory and coagulation pathways. A key molecule linking coagulation and inflammation is the procoagulant thrombin, a serine protease whose concentration is elevated in plasma and lavage fluids of patients with ALI and acute respiratory distress syndrome (ARDS). However, little is known about the mechanism by which thrombin contributes to lung inflammatory response. In this study, we developed a new mouse model that permits investigation of lung inflammation associated with intravascular coagulation. Using this mouse model and in vitro approaches, we addressed the role of non-muscle myosin light chain kinase (nmMLCK) in thrombin-induced endothelial cell (EC) inflammation and lung neutrophil (PMN) infiltration. Our in vitro experiments revealed a key role of nmMLCK in ICAM-1 expression by its ability to control nuclear translocation and transcriptional capacity of RelA/p65 in EC. When subjected to intraperitoneal thrombin challenge, wild type mice showed a marked increase in lung PMN infiltration via expression of ICAM-1. However, these responses were markedly attenuated in mice deficient in nmMLCK. These results provide mechanistic insight into lung inflammatory response associated with intravascular coagulation and identify nmMLCK as a critical target for modulation of lung inflammation.	[Fazal, Fabeha; Bijli, Kaiser M.; Murrill, Matthew; Leonard, Antony; Minhajuddin, Mohammad; Finkelstein, Jacob N.; Rahman, Arshad] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Anwar, Khandaker N.] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA; [Watterson, D. Martin] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA	University of Rochester; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Fazal, F (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA.	Fabeha_Fazal@URMC.Rochester.edu	Minhajuddin, Mohammad/AAC-9227-2022	Watterson, Daniel/0000-0001-7605-5866; Murrill, Matthew/0000-0001-7567-7727	National Heart, Lung, and Blood Institute [HL67424, HL096907]; National Institute of Environmental Health Sciences Center (EHSC) [ES-01247]; Biomedical Research Grant from American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067424, R01HL096907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences Center (EHSC); Biomedical Research Grant from American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Heart, Lung, and Blood Institute Grants HL67424 and HL096907. This study was also supported in part by National Institute of Environmental Health Sciences Center (EHSC) Grant ES-01247, and a Biomedical Research Grant from American Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1983, J CLIN INVEST, V72, P1863, DOI 10.1172/JCI111148; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Cirino G, 2006, CURR OPIN PHARMACOL, V6, P428, DOI 10.1016/j.coph.2006.05.001; COLOTTA F, 1994, AM J PATHOL, V144, P975; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; COOPER JA, 1984, J APPL PHYSIOL, V57, P826, DOI 10.1152/jappl.1984.57.3.826; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Knezevic N, 2012, J EXP MED; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Levitt JE, 2006, SEMIN RESP CRIT CARE, V27, P426, DOI 10.1055/s-2006-948296; Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; MALIK AB, 1987, AM REV RESPIR DIS, V136, P467, DOI 10.1164/ajrccm/136.2.467; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Niessen F, 2009, BLOOD, V113, P2859, DOI 10.1182/blood-2008-12-192385; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2012, AM J RESP CELL MOL B; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Ranaivo HR, 2007, AM J PATHOL, V170, P439, DOI 10.2353/ajpath.2007.060219; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van der Poll T, 2008, CRIT CARE, V12, DOI 10.1186/cc7026; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu Z, 2012, BLOOD, V119, P2422, DOI 10.1182/blood-2011-04-350413; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Xu N, 2002, AM J PHYSIOL-LUNG C, V282, pL796, DOI 10.1152/ajplung.00298.2001; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393	53	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59965	10.1371/journal.pone.0059965	http://dx.doi.org/10.1371/journal.pone.0059965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555849	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400072
J	Sheehan-Rooney, K; Swartz, ME; Ben Lovely, C; Dixon, MJ; Eberhart, JK				Sheehan-Rooney, Kelly; Swartz, Mary E.; Ben Lovely, C.; Dixon, Michael J.; Eberhart, Johann K.			Bmp and Shh Signaling Mediate the Expression of satb2 in the Pharyngeal Arches	PLOS ONE			English	Article							NEURAL CREST CELLS; EPITHELIAL-MESENCHYMAL INTERACTIONS; RECEPTOR-DEFICIENT MICE; SONIC-HEDGEHOG; CRANIOFACIAL DEVELOPMENT; GENE-EXPRESSION; CLEFT-PALATE; ENDODERM FORMATION; FACIAL ECTODERM; JAW JOINT	In human, mutation of the transcription factor SATB2 causes severe defects to the palate and jaw. The expression and sequence of SATB2 is highly conserved across vertebrate species, including zebrafish. We sought to understand the regulation of satb2 using the zebrafish model system. Due to the normal expression domains of satb2, we analyzed satb2 expression in mutants with disrupted Hh signaling or defective ventral patterning. While satb2 expression appears independent of Edn1 signaling, appropriate expression requires Shha, Smo, Smad5 and Hand2 function. Transplantation experiments show that neural crest cells receive both Bmp and Hh signaling to induce satb2 expression. Dorsomorphin- and cyclopamine-mediated inhibition of Bmp and Hh signaling, respectively, suggests that proper satb2 expression requires a relatively earlier Bmp signal and a later Hh signal. We propose that Bmp signaling establishes competence for the neural crest to respond to Hh signaling, thus inducing satb2 expression.	[Sheehan-Rooney, Kelly; Swartz, Mary E.; Ben Lovely, C.; Eberhart, Johann K.] Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Dixon, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Life Sci, Manchester, Lancs, England; [Dixon, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England	University of Texas System; University of Texas Austin; University of Manchester; University of Manchester	Eberhart, JK (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	eberhart@austin.utexas.edu	Swartz, Mary/AAO-4293-2020; Eberhart, Johann/AAO-4241-2020	Lovely, Charles/0000-0002-7838-5823	United States National Institutes of Health [DE018088, DE020884]; MRC [G1001601]; Healing Foundation; Medical Research Council [G1001601] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018088] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Healing Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by United States National Institutes of Health grants DE018088 and DE020884 to J.K.E. and MRC grant (G1001601) and support from the Healing Foundation to M.J.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2007, INT J DEV BIOL, V51, P97, DOI 10.1387/ijdb.062237ma; Abzhanov A, 2004, DEV BIOL, V273, P134, DOI 10.1016/j.ydbio.2004.05.028; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Baek JA, 2011, DEV BIOL, V350, P520, DOI 10.1016/j.ydbio.2010.12.028; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Collery RF, 2011, DEV DYNAM, V240, P712, DOI 10.1002/dvdy.22567; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Duench K, 2012, DEV BIOL, V365, P251, DOI 10.1016/j.ydbio.2012.02.016; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Fish JL, 2011, EVOL DEV, V13, P549, DOI 10.1111/j.1525-142X.2011.00511.x; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Foppiano S, 2007, DEV BIOL IN PRESS; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Holzschuh J, 2005, DEVELOPMENT, V132, P3731, DOI 10.1242/dev.01936; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Kimmel CB, 2008, INTEGR COMP BIOL, V48, P668, DOI 10.1093/icb/icn048; Ko SO, 2007, DEV BIOL, V312, P435, DOI 10.1016/j.ydbio.2007.09.050; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kuratani S, 2005, ZOOLOGY, V108, P13, DOI 10.1016/j.zool.2004.12.001; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Miller CT, 2007, DEV BIOL, V308, P144, DOI 10.1016/j.ydbio.2007.05.018; Miller CT, 2000, DEVELOPMENT, V127, P3815; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; NODEN DM, 1991, J CRAN GENET DEV BIO, V11, P192; Osborne N, 2011, DEV BIOL; Ozeki H, 2004, MECH DEVELOP, V121, P387, DOI 10.1016/j.mod.2004.02.002; Sato T, 2008, P NATL ACAD SCI USA, V105, P18806, DOI 10.1073/pnas.0807345105; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sheehan-Rooney K, 2010, DEV DYNAM, V239, P3481, DOI 10.1002/dvdy.22483; Stanier P, 2004, HUM MOL GENET, V13, pR73, DOI 10.1093/hmg/ddh052; Swartz ME, 2012, DEV BIOL, V369, P65, DOI 10.1016/j.ydbio.2012.05.032; Swartz ME, 2011, DEV DYNAM, V240, P2204, DOI 10.1002/dvdy.22713; Thomas T, 1998, DEVELOPMENT, V125, P3005; Trainor PA, 2003, INT J DEV BIOL, V47, P541; Tucker AS, 1998, DEV DYNAM, V212, P533, DOI 10.1002/(SICI)1097-0177(199808)212:4<533::AID-AJA6>3.3.CO;2-I; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Vieux-Rochas M, 2010, GENESIS, V48, P362, DOI 10.1002/dvg.20625; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Walker MB, 2007, DEV BIOL, V304, P194, DOI 10.1016/j.ydbio.2006.12.027; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilson J, 2004, DEV BIOL, V266, P138, DOI 10.1016/j.ydbio.2003.10.012; WOO K, 1995, DEVELOPMENT, V121, P2595; Yanagisawa H, 2003, DEVELOPMENT, V130, P1069, DOI 10.1242/dev.00337; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zuniga E, 2011, DEVELOPMENT, V138, P5147, DOI 10.1242/dev.067785; Zuniga E, 2010, DEVELOPMENT, V137, P1843, DOI 10.1242/dev.049056	70	15	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59533	10.1371/journal.pone.0059533	http://dx.doi.org/10.1371/journal.pone.0059533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555697	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400049
J	Tang, MK; Liang, YJ; Chan, JYH; Wong, SW; Chen, E; Yao, Y; Gan, JY; Xiao, LH; Leung, HC; Kung, HF; Wang, H; Lee, KKH				Tang, Mei Kuen; Liang, Yong Jia; Chan, John Yeuk Hon; Wong, Sing Wan; Chen, Elve; Yao, Yao; Gan, Jingyi; Xiao, Lihai; Leung, Hin Cheung; Kung, Hsiang Fu; Wang, Hua; Lee, Kenneth Ka Ho			Promyelocytic Leukemia (PML) Protein Plays Important Roles in Regulating Cell Adhesion, Morphology, Proliferation and Migration	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; ANNEXIN-IV; OSTEOGENIC DIFFERENTIATION; PROTEOMIC ANALYSIS; GENE-EXPRESSION; NUCLEAR-BODIES; HEAT-SHOCK; RECEPTOR; CANCER; STRESS	PML protein plays important roles in regulating cellular homeostasis. It forms PML nuclear bodies (PML-NBs) that act like nuclear relay stations and participate in many cellular functions. In this study, we have examined the proteome of mouse embryonic fibroblasts (MEFs) derived from normal (PML+/+) and PML knockout (PML-/-) mice. The aim was to identify proteins that were differentially expressed when MEFs were incapable of producing PML. Using comparative proteomics, total protein were extracted from PML-/- and PML+/+ MEFs, resolved by two dimensional electrophoresis (2-DE) gels and the differentially expressed proteins identified by LC-ESI-MS/MS. Nine proteins (PML, NDRG1, CACYBP, CFL1, RSU1, TRIO, CTRO, ANXA4 and UBE2M) were determined to be down-regulated in PML-/- MEFs. In contrast, ten proteins (CIAPIN1, FAM50A, SUMO2 HSPB1 NSFL1C, PCBP2, YWHAG, STMN1, TPD52L2 and PDAP1) were found up-regulated. Many of these differentially expressed proteins play crucial roles in cell adhesion, migration, morphology and cytokinesis. The protein profiles explain why PML-/- and PML+/+ MEFs were morphologically different. In addition, we demonstrated PML-/- MEFs were less adhesive, proliferated more extensively and migrated significantly slower than PML+/+ MEFs. NDRG1, a protein that was down-regulated in PML-/- MEFs, was selected for further investigation. We determined that silencing NDRG1expression in PML+/+ MEFs increased cell proliferation and inhibited PML expression. Since NDRG expression was suppressed in PML-/- MEFs, this may explain why these cells proliferate more extensively than PML+/+ MEFs. Furthermore, silencing NDRG1expression also impaired TGF-beta 1 signaling by inhibiting SMAD3 phosphorylation.	[Tang, Mei Kuen; Wong, Sing Wan; Chen, Elve; Yao, Yao; Gan, Jingyi; Xiao, Lihai; Leung, Hin Cheung; Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China; [Liang, Yong Jia; Chan, John Yeuk Hon; Lee, Kenneth Ka Ho] JiNan Univ, Minist Educ, Joint JNU CUHK Key Labs Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Kung, Hsiang Fu; Wang, Hua] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Jinan University; Chinese University of Hong Kong	Tang, MK (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China.	florencetang@cuhk.edu.hk; kaholee@cuhk.edu.hk	Lee, Kenneth Ka Ho/H-6698-2013; Tang, Florence/AAW-4103-2021	Lee, Kenneth Ka Ho/0000-0002-6520-304X; Tang, Mei Kuen/0000-0002-5077-0682; Wong, Sing-Wan/0000-0002-7518-6474	Hong Kong Cancer Fund [6903321]	Hong Kong Cancer Fund	This project was supported by the Hong Kong Cancer Fund, project no.: 6903321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Borden KLB, 2009, FRONT BIOSCI-LANDMRK, V14, P497, DOI 10.2741/3258; Bourdeau V, 2009, FRONT BIOSCI-LANDMRK, V14, P475, DOI 10.2741/3256; Butler RN, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a399; Capobianco V, 2012, J PROTEOME RES, V11, P3358, DOI 10.1021/pr300152z; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Fabunmi RP, 2001, J CELL SCI, V114, P29; Geng YY, 2012, J BIOL CHEM, V287, P30729, DOI 10.1074/jbc.M112.374769; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; JUNKER M, 1994, BIOCHEMISTRY-US, V33, P8930, DOI 10.1021/bi00196a010; Kaetzel MA, 2001, BIOCHEMISTRY-US, V40, P4192, DOI 10.1021/bi002507s; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kim A, 2010, EXPERT OPIN THER TAR, V14, P963, DOI 10.1517/14728222.2010.511180; Kitowska A, 2010, ACTA BIOCHIM POL, V57, P15; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Le Goff P, 2004, EXP CELL RES, V294, P480, DOI 10.1016/j.yexcr.2003.11.031; Lerner A, 2012, J BIOMED BIOTECHNOL, V2012, P2561; Li WJ, 2009, CELL CYCLE, V8, P2711, DOI 10.4161/cc.8.17.9462; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015331; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Liu LY, 2010, BIOMECH MODEL MECHAN, V9, P659, DOI 10.1007/s10237-010-0206-x; Lunardi Andrea, 2011, Genes Cancer, V2, P10, DOI 10.1177/1947601911402682; Masuishi Y, 2011, FEBS J, V278, P1470, DOI 10.1111/j.1742-4658.2011.08059.x; Moller A, 2003, ARCH IMMUNOL THER EX, V51, P295; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; Piljic A, 2006, MOL BIOL CELL, V17, P3318, DOI 10.1091/mbc.E06-01-0041; Rana S, 2008, EXPERT REV ANTICANC, V8, P1461, DOI 10.1586/14737140.8.9.1461; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Reineke EL, 2009, INT J BIOL SCI, V5, P366; ROWLEY JD, 1977, LANCET, V1, P549; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Sang J, 2011, BIOCHEM J, V435, P489, DOI 10.1042/BJ20101474; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Schreck KC, 2009, NAT NEUROSCI, V12, P108, DOI 10.1038/nn0209-108; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Sun HJ, 2006, J ORTHOP RES, V24, P2059, DOI 10.1002/jor.20273; Sung KS, 2011, EXP CELL RES, V317, P1060, DOI 10.1016/j.yexcr.2010.12.016; Tang MK, 2009, PROTEOM CLIN APPL, V3, P1362, DOI 10.1002/prca.200900097; Tang MK, 2006, PROTEOMICS, V6, P2376, DOI 10.1002/pmic.200500603; Tian XX, 1999, BRIT J CANCER, V81, P994, DOI 10.1038/sj.bjc.6690798; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; van Rijssel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029912; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang R, 2011, BIOCHEM BIOPH RES CO, V415, P702, DOI 10.1016/j.bbrc.2011.10.146; Wang ZG, 1998, SCIENCE, V279, P1547; Webb SE, 1997, DEV DYNAM, V209, P206, DOI 10.1002/(SICI)1097-0177(199706)209:2<206::AID-AJA6>3.0.CO;2-M; Yang Q, 2013, ONCOGENE, V32, P3156, DOI 10.1038/onc.2012.332; Yau WWY, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-3; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhang L, 2011, CURR DRUG METAB, V12, P455, DOI 10.2174/138920011795495303	58	17	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59477	10.1371/journal.pone.0059477	http://dx.doi.org/10.1371/journal.pone.0059477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555679	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400044
J	Thayer, ZM; Dobson, SD				Thayer, Zaneta M.; Dobson, Seth D.			Geographic Variation in Chin Shape Challenges the Universal Facial Attractiveness Hypothesis	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; PHYSICAL ATTRACTIVENESS; HUMAN FACES; SELECTION; BEAUTY; PERCEPTION; SYMMETRY; AVERAGENESS; PREFERENCES; JUDGMENTS	The universal facial attractiveness (UFA) hypothesis proposes that some facial features are universally preferred because they are reliable signals of mate quality. The primary evidence for this hypothesis comes from cross-cultural studies of perceived attractiveness. However, these studies do not directly address patterns of morphological variation at the population level. An unanswered question is therefore: Are universally preferred facial phenotypes geographically invariant, as the UFA hypothesis implies? The purpose of our study is to evaluate this often overlooked aspect of the UFA hypothesis by examining patterns of geographic variation in chin shape. We collected symphyseal outlines from 180 recent human mandibles (90 male, 90 female) representing nine geographic regions. Elliptical Fourier functions analysis was used to quantify chin shape, and principle components analysis was used to compute shape descriptors. In contrast to the expectations of the UFA hypothesis, we found significant geographic differences in male and female chin shape. These findings are consistent with region-specific sexual selection and/or random genetic drift, but not universal sexual selection. We recommend that future studies of facial attractiveness take into consideration patterns of morphological variation within and between diverse human populations.	[Thayer, Zaneta M.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Dobson, Seth D.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA	Northwestern University; Dartmouth College	Thayer, ZM (corresponding author), Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA.	zane@u.northwestern.edu	Thayer, Zaneta/AAU-3274-2020	Thayer, Zaneta/0000-0001-8028-942X	Goodman Grant for Anthropological Research at Dartmouth College; NSF Graduate Research Fellowship; Northwestern University Presidential Fellowship	Goodman Grant for Anthropological Research at Dartmouth College; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Northwestern University Presidential Fellowship	This research was supported by a Goodman Grant for Anthropological Research at Dartmouth College. ZMT was supported by a NSF Graduate Research Fellowship and Northwestern University Presidential Fellowship during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 1877, DIFFERENT FORMS FLOW; Athreya S, 2006, J HUM EVOL, V50, P627, DOI 10.1016/j.jhevol.2005.11.005; BATESON P, 1980, Z TIERPSYCHOL, V53, P231; Byers S.N., 2002, INTRO FORENSIC ANTHR; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; CUNNINGHAM MR, 1986, J PERS SOC PSYCHOL, V50, P925, DOI 10.1037/0022-3514.50.5.925; Curnoe D., 2011, INT J EVOLUTIONARY B, V2011; Daegling, 1993, EVOL ANTHROPOL, V1, P170; Daegling DJ, 2000, J HUM EVOL, V39, P107, DOI 10.1006/jhev.2000.0402; Darwin C, 1871, DESCENT MAN RELATION; Dobson SD, 2002, J HUM EVOL, V43, P67, DOI 10.1006/jhev.2002.0563; Enlow D.H., 1982, HDB FACIAL GROWTH; Fukase H, 2008, AM J PHYS ANTHROPOL, V136, P441, DOI 10.1002/ajpa.20828; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Garvin HM, 2012, AM J PHYS ANTHROPOL, V147, P661, DOI 10.1002/ajpa.22036; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; Hawks J, 2000, MOL BIOL EVOL, V17, P2, DOI 10.1093/oxfordjournals.molbev.a026233; Ichim I, 2006, J BIOMECH, V39, P1903, DOI 10.1016/j.jbiomech.2005.05.022; Ichim I, 2006, J DENT RES, V85, P638, DOI 10.1177/154405910608500711; JOHNSTON VS, 1993, ETHOL SOCIOBIOL, V14, P183, DOI 10.1016/0162-3095(93)90005-3; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; KEATING CF, 1981, ETHOL SOCIOBIOL, V2, P41, DOI 10.1016/0162-3095(81)90021-2; Kendrick KM, 1998, NATURE, V395, P229, DOI 10.1038/26129; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; LALAND KN, 1994, THEOR POPUL BIOL, V45, P1, DOI 10.1006/tpbi.1994.1001; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lestrel PE, 1997, FOURIER DESCRIPTORS, P3; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2006, ANIM BEHAV, V72, P981, DOI 10.1016/j.anbehav.2006.01.026; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; MAZUR A, 1984, AM J SOCIOL, V90, P125, DOI 10.1086/228050; Mueller U, 1997, BEHAV ECOL, V8, P569; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; O'Toole AJ, 1998, MEM COGNITION, V26, P146, DOI 10.3758/BF03211378; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2001, PERCEPTION, V30, P611, DOI 10.1068/p3123; Schwartz J.H., 2007, SKELETON KEYS INTRO; Thayer ZM, 2010, AM J PHYS ANTHROPOL, V143, P417, DOI 10.1002/ajpa.21330; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; WINKLER EM, 1994, AM J HUM BIOL, V6, P203, DOI 10.1002/ajhb.1310060208; Yu DW, 1998, NATURE, V396, P321, DOI 10.1038/24512; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	52	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60681	10.1371/journal.pone.0060681	http://dx.doi.org/10.1371/journal.pone.0060681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23560102	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100094
J	Eitel, M; Osigus, HJ; DeSalle, R; Schierwater, B				Eitel, Michael; Osigus, Hans-Juergen; DeSalle, Rob; Schierwater, Bernd			Global Diversity of the Placozoa	PLOS ONE			English	Review							ADHAERENS SCHULZE,F.E. PLACOZOA; TRICHOPLAX-ADHAERENS; FIBER CELLS; MITOCHONDRIAL GENOME; PHYLUM; EVOLUTION; SUPPORTS; METAZOA; RECORD; FIELD	The enigmatic animal phylum Placozoa holds a key position in the metazoan Tree of Life. A simple bauplan makes it appear to be the most basal metazoan known and genetic evidence also points to a position close to the last common metazoan ancestor. Trichoplax adhaerens is the only formally described species in the phylum to date, making the Placozoa the only monotypic phylum in the animal kingdom. However, recent molecular genetic as well as morphological studies have identified a high level of diversity, and hence a potential high level of taxonomic diversity, within this phylum. Different taxa, possibly at different taxonomic levels, are awaiting description. In this review we firstly summarize knowledge on the morphology, phylogenetic position and ecology of the Placozoa. Secondly, we give an overview of placozoan morphological and genetic diversity and finally present an updated distribution of placozoan populations. We conclude that there is great potential and need to erect new taxa and to establish a firm system for this taxonomic tabula rasa.	[Eitel, Michael; Osigus, Hans-Juergen; Schierwater, Bernd] Univ Vet Med Hannover, Inst Tierokol & Zellbiol Ecol & Evolut, Hannover, Germany; [Eitel, Michael] Univ Hong Kong, Sch Biol Sci, Fac Sci, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [DeSalle, Rob; Schierwater, Bernd] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [DeSalle, Rob; Schierwater, Bernd] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Schierwater, Bernd] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of Veterinary Medicine Hannover, Foundation; University of Hong Kong; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Yale University	Eitel, M (corresponding author), Univ Vet Med Hannover, Inst Tierokol & Zellbiol Ecol & Evolut, Hannover, Germany.	meitel@hku.hk		Eitel, Michael/0000-0002-0531-0732	German Research Foundation [Schi-227/20-2, Schi-227/26-1]; Evangelisches Studienwerk e.V. Villigst; Stiftung Tierarztliche Hochschule Hannover; German Academic Exchange service; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Evangelisches Studienwerk e.V. Villigst; Stiftung Tierarztliche Hochschule Hannover; German Academic Exchange service(Deutscher Akademischer Austausch Dienst (DAAD)); Studienstiftung des deutschen Volkes	The study was supported by German Research Foundation grants Schi-227/20-2 and Schi-227/26-1 to BS. ME was kindly supported by a doctoral fellowship of the Evangelisches Studienwerk e.V. Villigst, by an "Otto Butschli" fellowship of the Stiftung Tierarztliche Hochschule Hannover, and by a fellowship within the Postdoc-Programme of the German Academic Exchange service. HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. RD acknowledges the kind support of the Lewis and Dorothy Cullman Foundation and the Korein Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleoshin VV, 2004, RUSS J GENET+, V40, P1423, DOI 10.1007/s11177-005-0015-y; Appeltans W, 2011, WORLD REGISTER MARIN; BEHRENDT G, 1986, ZOOMORPHOLOGY, V106, P123, DOI 10.1007/BF00312114; BUCHHOLZ K, 1995, Z NATURFORSCH C, V50, P282; Burger G, 2009, TRENDS GENETICS; Butschli O, 1884, BEMERKUNGEN GASTRAEA; COLEMAN BD, 1982, ECOLOGY, V63, P1121, DOI 10.2307/1937249; COLEMAN BD, 1981, MATH BIOSCI, V54, P191, DOI 10.1016/0025-5564(81)90086-9; de Jong D, 2009, MOL BIOL EVOL, V26, P1333, DOI 10.1093/molbev/msp042; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2008, BIOESSAYS, V30, P1043, DOI 10.1002/bies.20842; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Eitel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019639; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; GRELL K G, 1971, Mikrokosmos, V60, P97; Grell K.G., 1984, Advances in Invertebrate Reproduction, V3, P541; Grell K.G., 1982, P639; GRELL K G, 1971, Naturwissenschaftliche Rundschau, V24, P160; Grell K.G., 1991, P13; GRELL K G, 1971, Cytobiologie, V4, P216; Grell K.G., 1981, TRICHOPLAX ADHAERENS, P107; GRELL KG, 1981, ZOOMORPHOLOGY, V98, P47, DOI 10.1007/BF00310320; GRELL KG, 1971, NATURWISSENSCHAFTEN, V58, P570, DOI 10.1007/BF00598728; GRELL KG, 1972, Z MORPHOL TIERE, V73, P297, DOI 10.1007/BF00391925; GRELL KG, 1974, Z MORPHOL TIERE, V79, P295; GRELL KG, 1974, Z NATURFORSCH C, VC 29, P790; Grell KG, 1980, LEHRB SPEZIELLE, P247; GRELL KG, 1988, ANALES I CIENCIAS MA, V14, P255; Grell KG, 1973, TRICHOPLAX ADHAERENS; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; IVANOV DL, 1980, ZOOL ZH, V59, P1735; IVANOV DL, 1980, ZOOLOGICHESKY ZH, V59, P1734; Jackson DJ, 2010, DEV GENES EVOL, V220, P221, DOI 10.1007/s00427-010-0343-3; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLAUSER MD, 1982, THESIS CLEMSON U CLE; Maruyama YK, 2004, BIOL BULL-US, V206, P55, DOI 10.2307/1543198; Miller RL, 1971, BIOL BULL, V19, P373; Miyazawa H, 2012, ZOOL SCI, V29, P223, DOI 10.2108/zsj.29.223; Monticelli F.S., 1893, ATTI ACAD LINCEI REN, V5, P39; Morandini AC, 2006, ZOOL ANZ, V245, P127, DOI 10.1016/j.jcz.2006.05.006; Ocana A, 2006, BELG J ZOOL, V136, P255; Osigus HJ, 2012, MOL PHYLOGENET EVOL; PEARSE V, 1989, AM ZOOL 1989 CENT M, P772; PEARSE V B, 1989, Pacific Science, V43, P117; Pearse V. B., 1988, FIELD BIOL PLA UNPUB; PEARSE VB, 1994, T AM MICROSC SOC, V113, P385, DOI 10.2307/3226631; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pearse VB, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P259; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; RASSAT J, 1979, ZOOMORPHOLOGIE, V93, P59, DOI 10.1007/BF02568675; RUTHMANN A, 1981, Z NATURFORSCH C, V36, P564; RUTHMANN A, 1979, DIFFERENTIATION, V13, P185, DOI 10.1111/j.1432-0436.1979.tb01581.x; RUTHMANN A, 1975, CYTOBIOLOGIE, V10, P421; RUTHMANN A, 1986, ZOOMORPHOLOGY, V106, P115, DOI 10.1007/BF00312113; RUTHMANN A, 1977, CYTOBIOLOGIE, V15, P58; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; SCHIERWATER B, 2009, COMMUNICATIVE INTEGR, V2, P1; Schierwater B, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P289; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schierwater B, 2009, INT J BIOCHEM CELL B, V41, P370, DOI 10.1016/j.biocel.2008.09.023; SCHULSINGER F, 1991, Acta Psychiatrica Scandinavica Supplementum, P1; Schulze FE, 1883, ZOOL ANZ, V6, P92; SCHWARTZ V, 1984, Z NATURFORSCH C, V39, P818; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Signorovitch AY, 2006, BIOL BULL-US, V211, P149, DOI 10.2307/4134589; Signorovitch AY, 2005, P NATL ACAD SCI USA, V102, P15518, DOI 10.1073/pnas.0504031102; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stiasny G, 1903, Z WISS ZOOL ABT A, V75, P430; Sudzuki M., 1977, Proceedings of the Japanese Society for Systematic Zoology, VNo. 13, P1; Syed T, 2002, VIE MILIEU, V52, P177; THIEMANN M, 1988, Z NATURFORSCH C, V43, P955; THIEMANN M, 1989, ZOOMORPHOLOGY, V109, P89, DOI 10.1007/BF00312314; THIEMANN M, 1990, ZOOMORPHOLOGY, V110, P37, DOI 10.1007/BF01632810; THIEMANN M, 1991, ZOOMORPHOLOGY, V110, P165, DOI 10.1007/BF01632872; Tomassetti Paolo, 2005, Meiofauna Marina, V14, P5; Ueda T, 1999, BIOSYSTEMS, V54, P65, DOI 10.1016/S0303-2647(99)00066-0; Uehara T., 1989, ABSTR ZOOL SCI, V6, P1209; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; von der Chevallerie K., 2010, CAH BIOL MAR, V51, P212; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	87	49	51	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e57131	10.1371/journal.pone.0057131	http://dx.doi.org/10.1371/journal.pone.0057131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565136	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300003
J	Wang, YD; Wu, BR; Chamberlain, AA; Lui, W; Koirala, P; Susztak, K; Klein, D; Taylor, V; Zhou, B				Wang, Yidong; Wu, Bingruo; Chamberlain, Alyssa A.; Lui, Wendy; Koirala, Pratistha; Susztak, Katalin; Klein, Diana; Taylor, Verdon; Zhou, Bin			Endocardial to Myocardial Notch-Wnt-Bmp Axis Regulates Early Heart Valve Development	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; GROWTH-FACTOR; NF-ATC; CUSHION; CELLS; TRANSFORMATION; SLUG; EXPRESSION	Endocardial to mesenchymal transformation (EMT) is a fundamental cellular process required for heart valve formation. Notch, Wnt and Bmp pathways are known to regulate this process. To further address how these pathways coordinate in the process, we specifically disrupted Notch1 or Jagged1 in the endocardium of mouse embryonic hearts and showed that Jagged1-Notch1 signaling in the endocardium is essential for EMT and early valvular cushion formation. qPCR and RNA in situ hybridization assays reveal that endocardial Jagged1-Notch1 signaling regulates Wnt4 expression in the atrioventricular canal (AVC) endocardium and Bmp2 in the AVC myocardium. Whole embryo cultures treated with Wnt4 or Wnt inhibitory factor 1 (Wif1) show that Bmp2 expression in the AVC myocardium is dependent on Wnt activity; Wnt4 also reinstates Bmp2 expression in the AVC myocardium of endocardial Notch1 null embryos. Furthermore, while both Wnt4 and Bmp2 rescue the defective EMT resulting from Notch inhibition, Wnt4 requires Bmp for its action. These results demonstrate that Jagged1-Notch1 signaling in endocardial cells induces the expression of Wnt4, which subsequently acts as a paracrine factor to upregulate Bmp2 expression in the adjacent AVC myocardium to signal EMT.	[Wang, Yidong] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Wang, Yidong] Sichuan Univ, Ctr Canc, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Wang, Yidong; Wu, Bingruo; Chamberlain, Alyssa A.; Lui, Wendy; Koirala, Pratistha; Zhou, Bin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Susztak, Katalin] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Klein, Diana] Univ Hosp Essen, Inst Anat, Essen, North Rhine Wes, Germany; [Taylor, Verdon] Univ Basel, Dept Biomed, Basel, Switzerland; [Zhou, Bin] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Pediat, Bronx, NY 10467 USA; [Zhou, Bin] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, Bronx, NY 10467 USA; [Zhou, Bin] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhou, Bin] Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China	Sichuan University; Sichuan University; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University of Duisburg Essen; University of Basel; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Nanjing Medical University; Nanjing Medical University	Zhou, B (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	bin.zhou@einstein.yu.edu	Klein, Diana/AAB-5251-2020; Klein, Diana/ABC-7916-2020; Susztak, Katalin/ABE-7474-2021	Klein, Diana/0000-0002-1770-443X; Klein, Diana/0000-0002-1770-443X; Susztak, Katalin/0000-0002-1005-3726; Taylor, Verdon/0000-0003-3497-5976	National Institute of Health [R01HL078881, R01HL111770, R01DK076077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111770, R01HL078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health (R01HL078881 and R01HL111770) to BZ and R01DK076077 to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri CM, 2010, DEV BIOL, V338, P127, DOI 10.1016/j.ydbio.2009.11.030; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Baldwin H. Scott, 1999, Current Opinion in Pediatrics, V11, P413, DOI 10.1097/00008480-199910000-00008; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen YH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-75; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hang CT, 2012, METHODS MOL BIOL, V843, P3, DOI 10.1007/978-1-61779-523-7_1; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Krebs LT, 2000, GENE DEV, V14, P1343; Lencinas A, 2011, BIRTH DEFECTS RES C, V93, P298, DOI 10.1002/bdrc.20222; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; de la Pompa JL, 2009, PEDIATR CARDIOL, V30, P643, DOI 10.1007/s00246-008-9368-z; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Romano LA, 1999, DEV BIOL, V212, P243, DOI 10.1006/dbio.1999.9339; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	51	49	54	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60244	10.1371/journal.pone.0060244	http://dx.doi.org/10.1371/journal.pone.0060244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560082	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900057
J	Barajas-Lopez, JD; Kremnev, D; Shaikhali, J; Pinas-Fernandez, A; Strand, A				Barajas-Lopez, Juan de Dios; Kremnev, Dmitry; Shaikhali, Jehad; Pinas-Fernandez, Aurora; Strand, Asa			PAPP5 Is Involved in the Tetrapyrrole Mediated Plastid Signalling during Chloroplast Development	PLOS ONE			English	Article							MG-PROTOPORPHYRIN-IX; GENE-EXPRESSION; NUCLEAR GENES; CHLOROPHYLL PRECURSORS; PROTEIN PHOSPHATASE-5; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; LIGHT INDUCTION; HIGHER-PLANTS; ACCUMULATION	The initiation of chloroplast development in the light is dependent on nuclear encoded components. The nuclear genes encoding key components in the photosynthetic machinery are regulated by signals originating in the plastids. These plastid signals play an essential role in the regulation of photosynthesis associated nuclear genes (PhANGs) when proplastids develop into chloroplasts. One of the plastid signals is linked to the tetrapyrrole biosynthesis and accumulation of the intermediates the Mg-ProtoIX and its methyl ester Mg-ProtoIX-ME. Phytochrome-Associated Protein Phosphatase 5 (PAPP5) was isolated in a previous study as a putative Mg-ProtoIX interacting protein. In order to elucidate if there is a biological link between PAPP5 and the tetrapyrrole mediated signal we generated double mutants between the Arabidopsis papp5 and the crd mutants. The crd mutant over-accumulates Mg-ProtoIX and Mg-ProtoIX-ME and the tetrapyrrole accumulation triggers retrograde signalling. The crd mutant exhibits repression of PhANG expression, altered chloroplast morphology and a pale phenotype. However, in the papp5crd double mutant, the crd phenotype is restored and papp5crd accumulated wild type levels of chlorophyll, developed proper chloroplasts and showed normal induction of PhANG expression in response to light. Tetrapyrrole feeding experiments showed that PAPP5 is required to respond correctly to accumulation of tetrapyrroles in the cell and that PAPP5 is most likely a component in the plastid signalling pathway down stream of the tetrapyrrole Mg-ProtoIX/Mg-ProtoIX-ME. Inhibition of phosphatase activity phenocopied the papp5crd phenotype in the crd single mutant demonstrating that PAPP5 phosphatase activity is essential to mediate the retrograde signal and to suppress PhANG expression in the crd mutant. Thus, our results suggest that PAPP5 receives an inbalance in the tetrapyrrole biosynthesis through the accumulation of Mg-ProtoIX and acts as a negative regulator of PhANG expression during chloroplast biogenesis and development.	[Barajas-Lopez, Juan de Dios; Kremnev, Dmitry; Shaikhali, Jehad; Pinas-Fernandez, Aurora; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Strand, A (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	Asa.Strand@plantphys.umu.se		Barajas Lopez, Juan de Dios/0000-0003-1515-5059	Swedish research foundation, VR; Swedish research foundation; Knut and Alice Wallenberg Foundation	Swedish research foundation, VR(Swedish Research Council); Swedish research foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by a grant from the Swedish research foundation, VR (to AS). from the Swedish research foundation is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarti PD, 2006, PHYSIOL PLANTARUM, V128, P186, DOI 10.1111/j.1399-3054.2006.00720.x; Ankele E, 2007, PLANT CELL, V19, P1964, DOI 10.1105/tpc.106.048744; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Bang WY, 2008, PLANT CELL PHYSIOL, V49, P1350, DOI 10.1093/pcp/pcn111; Barajas-Lopez JD, 2013, BBA-MOL CELL RES, V1833, P425, DOI 10.1016/j.bbamcr.2012.06.020; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRADBEER JW, 1979, NATURE, V279, P816, DOI 10.1038/279816a0; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Galvez-Valdivieso G, 2010, PHYSIOL PLANTARUM, V138, P430, DOI 10.1111/j.1399-3054.2009.01331.x; Hall M, 2011, METHODS MOL BIOL, V775, P207, DOI 10.1007/978-1-61779-237-3_11; HESS WR, 1994, MOL GEN GENET, V242, P305, DOI 10.1007/BF00280420; JACOBS JM, 1993, PLANT PHYSIOL, V101, P1181, DOI 10.1104/pp.101.4.1181; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kindgren P, 2011, PHYSIOL PLANTARUM, V141, P310, DOI 10.1111/j.1399-3054.2010.01440.x; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; Kropat J, 2000, PLANT J, V24, P523, DOI 10.1046/j.1365-313x.2000.00898.x; Leon P, 1998, ANNU REV PLANT PHYS, V49, P453, DOI 10.1146/annurev.arplant.49.1.453; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; MATILE P, 1992, PLANTA, V187, P230, DOI 10.1007/BF00201944; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogson BJ, 2011, PLANT PHYSIOL, V155, P1545, DOI 10.1104/pp.110.170365; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RAPP JC, 1991, PLANT MOL BIOL, V17, P813, DOI 10.1007/BF00037063; Ruckle ME, 2007, PLANT CELL, V19, P3944, DOI 10.1105/tpc.107.054312; Ruckle ME, 2009, NEW PHYTOL, V182, P367, DOI 10.1111/j.1469-8137.2008.02729.x; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Sullivan JA, 1999, PLANT CELL, V11, P901, DOI 10.1105/tpc.11.5.901; Sullivan JA, 2000, PLANT CELL, V12, P1927, DOI 10.1105/tpc.12.10.1927; THOMAS J, 1990, PLANT PHYSIOL, V94, P1414, DOI 10.1104/pp.94.3.1414; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; van Bentem SDF, 2005, PLANT J, V43, P284, DOI 10.1111/j.1365-313X.2005.02450.x; Voigt C, 2010, PHYSIOL PLANTARUM, V138, P503, DOI 10.1111/j.1399-3054.2009.01343.x; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Wilson KE, 2003, PHYSIOL PLANTARUM, V119, P126, DOI 10.1034/j.1399-3054.2003.00153.x; Zhang ZW, 2011, J PLANT PHYSIOL, V168, P714, DOI 10.1016/j.jplph.2010.10.016; Zubko MK, 1998, PLANT J, V15, P265, DOI 10.1046/j.1365-313X.1998.00195.x	52	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60305	10.1371/journal.pone.0060305	http://dx.doi.org/10.1371/journal.pone.0060305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555952	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900068
J	Wilkie, R; Tajar, A; McBeth, J				Wilkie, Ross; Tajar, Abdelouahid; McBeth, John			The Onset of Widespread Musculoskeletal Pain Is Associated with a Decrease in Healthy Ageing in Older People: A Population-Based Prospective Study	PLOS ONE			English	Article							GENERAL-POPULATION; FOLLOW-UP; OSTEOARTHRITIS; ADULTS; AGE; PREVALENCE; MORTALITY; FRAILTY; MODEL	Objective: Chronic musculoskeletal pain is common in older adults but the nature of its relationship with ageing is unclear. The objective for this study was to test the hypothesis that the onset of widespread pain would be associated with a decrease in healthy ageing. Methods: Population-based prospective cohort study. A "healthy ageing" index was constructed across biomedical, physical, psychosocial and lay components. Analysis was performed with 2949 adults aged 50 years and over who had complete index scores at baseline, 3 and 6-year follow-ups. Results: At three and six year follow-up, 365 (16.8%) and 259 (14.3%) experienced the onset of widespread pain. The onset of widespread pain during the six-year period was associated with a 25% and a 46% decrease in healthy ageing index scores; this decrease was independent of age, sex, education, social networks, smoking status, alcohol consumption and physical inactivity. The decrease in healthy ageing attenuated to 20% and 39% following adjustment for diagnosed musculoskeletal conditions and analgesic and non-steroidal use. Conclusions: The onset of widespread pain was associated with a decrease in healthy ageing throughout the six-year period. When pain increased over time, the markers of unhealthy ageing increased also. Strong analgesia was associated with unhealthy ageing. Research could now usefully test whether early identification, improved treatment and prevention of pain prior to old age may facilitate healthy ageing.	[Wilkie, Ross; McBeth, John] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Tajar, Abdelouahid] Univ Oxford, Ctr Stat Med, Oxford, England	Keele University; University of Oxford	Wilkie, R (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	r.wilkie@keele.ac.uk	McBeth, John/AAG-1954-2019	McBeth, John/0000-0001-7047-2183	Medical Research Council, UK [G9900220]; North Staffordshire Primary Care RD Consortium	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North Staffordshire Primary Care RD Consortium	This study is supported financially by the Medical Research Council, UK (grant code: G9900220) and by the North Staffordshire Primary Care R&D Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedson J, 2010, RHEUMATOLOGY, V49, pI148; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Blyth FM, 2007, EUR J PAIN, V11, P564, DOI 10.1016/j.ejpain.2006.08.001; Bowling A, 2005, BRIT MED J, V331, P1548, DOI 10.1136/bmj.331.7531.1548; Bowling A, 2006, AGE AGEING, V35, P607, DOI 10.1093/ageing/afl100; Candore G, 2010, CURR PHARM DESIGN, V16, P584, DOI 10.2174/138161210790883868; Castro-Lionard K, 2011, AGE AGEING, V40, P259, DOI 10.1093/ageing/afq174; Doyle YG, 2012, EUR J PUBLIC HEALTH, V22, P71, DOI 10.1093/eurpub/ckq132; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Ebrahim S, 1999, LANCET, V353, P1990, DOI 10.1016/S0140-6736(99)00195-6; Griep EN, 1998, J RHEUMATOL, V25, P1374; Lee DM, 2010, PAIN, V151, P30, DOI 10.1016/j.pain.2010.04.024; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Maier SF, 1998, PSYCHOL REV, V105, P83, DOI 10.1037/0033-295X.105.1.83; MARGOLIS RB, 1988, PAIN, V33, P49, DOI 10.1016/0304-3959(88)90202-3; McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424; McLaughlin SJ, 2010, J GERONTOL B-PSYCHOL, V65, P216, DOI 10.1093/geronb/gbp101; Neogi T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2844; NHS Information Authority, 2000, CLIN TERMS VERS 3 RE; Nicholl BI, 2009, PAIN, V141, P119, DOI 10.1016/j.pain.2008.10.022; Nosraty Lily, 2012, J Aging Res, V2012, P868797, DOI 10.1155/2012/868797; Porcheret M, 2004, J AM MED INFORM ASSN, V11, P78, DOI 10.1197/jamia.M1362; Pruchno RA, 2010, GERONTOLOGIST, V50, P821, DOI 10.1093/geront/gnq041; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2010, J AM GERIATR SOC, V58, P318, DOI 10.1111/j.1532-5415.2009.02667.x; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Tajar A, 2011, J RHEUMATOL, V38, P370, DOI 10.3899/jrheum.100604; Thielke Stephen, 2012, J Aging Res, V2012, P243263, DOI 10.1155/2012/243263; Thinggaard M, 2010, J GERONTOL A-BIOL, V65, P526, DOI 10.1093/gerona/glp214; Thomas E, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-2; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; University of Michigan, HLTH RET SURV SIT DO; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilkie R, 2005, QUAL LIFE RES, V14, P1889, DOI 10.1007/s11136-005-4325-2; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; World Health Organisation, 2003, WHO TECHN REP SER, V919; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59858	10.1371/journal.pone.0059858	http://dx.doi.org/10.1371/journal.pone.0059858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121SG	23555810	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000317263900035
J	Belavy, DL; Gast, U; Daumer, M; Fomina, E; Rawer, R; Schiessl, H; Schneider, S; Schubert, H; Soaz, C; Felsenberg, D				Belavy, Daniel L.; Gast, Ulf; Daumer, Martin; Fomina, Elena; Rawer, Rainer; Schiessl, Hans; Schneider, Stefan; Schubert, Harald; Soaz, Cristina; Felsenberg, Dieter			Progressive Adaptation in Physical Activity and Neuromuscular Performance during 520d Confinement	PLOS ONE			English	Article							OXIDATIVE STRESS; JUMPING POWER; MUSCLE; BONE; DECLINE; MEN; AGE	To understand whether prolonged confinement results in reductions in physical activity and adaptation in the musculoskeletal system, six subjects were measured during 520 d isolation in the Mars500 study. We tested the hypothesis that physical activity reduces in prolonged confinement and that this would be associated with decrements of neuromuscular performance. Physical activity, as measured by average acceleration of the body's center of mass ("activity temperature") using the actibelt (R) device, decreased progressively over the course of isolation (p<0.00001). Concurrently, countermovement jump power and single-leg hop force decreased during isolation (p<0.001) whilst grip force did not change (p >= 0.14). Similar to other models of inactivity, greater decrements of neuromuscular performance occurred in the lower-limb than in the upper-limb. Subject motivational state increased non-significantly (p = 0.20) during isolation, suggesting reductions in lower-limb neuromuscular performance were unrelated to motivation. Overall, we conclude that prolonged confinement is a form of physical inactivity and is associated with adaptation in the neuromuscular system.	[Belavy, Daniel L.; Gast, Ulf; Felsenberg, Dieter] Charite, Ctr Muscle & Bone Res, D-13353 Berlin, Germany; [Daumer, Martin; Soaz, Cristina] Sylvia Lawry Ctr Multiple Sclerosis Res eV, Human Mot Inst, Munich, Germany; [Fomina, Elena] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia; [Rawer, Rainer; Schiessl, Hans; Schubert, Harald] Novotec Med Gesell Beschrankter Haftung, Pforzheim, Germany; [Schneider, Stefan] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany; [Soaz, Cristina] Tech Univ Munich, Inst Data Proc, D-80290 Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; German Sport University Cologne; Technical University of Munich	Belavy, DL (corresponding author), Charite, Ctr Muscle & Bone Res, D-13353 Berlin, Germany.	belavy@gmail.com	Schneider, Stefan/AAH-7418-2020; Fomina, Elena/AAC-1778-2020; Belavy, Daniel/P-4947-2016	Schneider, Stefan/0000-0002-4563-9890; Fomina, Elena/0000-0003-4664-4752; Belavy, Daniel/0000-0002-9307-832X	space agency of the German Aerospace Center [50WB0720]; German Federal Ministry for Economics and Technology	space agency of the German Aerospace Center; German Federal Ministry for Economics and Technology	This study was supported by grant number 50WB0720 from space agency of the German Aerospace Center with funds of the German Federal Ministry for Economics and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams OS, 1961, HUMAN PERFORMANCE FU; Brunner E, 2002, NONPARAMETRIC ANAL L; Farley CT, 1999, J BIOMECH, V32, P267, DOI 10.1016/S0021-9290(98)00170-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fox KM, 2000, OSTEOPOROSIS INT, V11, P31, DOI 10.1007/s001980050003; Giangregorio LM, 2005, SPINAL CORD, V43, P649, DOI 10.1038/sj.sc.3101774; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Incel Nurgul Arinci, 2002, SMJ Singapore Medical Journal, V43, P234; Izquierdo M, 1999, EUR J APPL PHYSIOL, V79, P260, DOI 10.1007/s004210050504; Jorgensen L, 2000, BONE, V27, P701, DOI 10.1016/S8756-3282(00)00374-4; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; Luria T, 2010, CALCIFIED TISSUE INT, V86, P8, DOI 10.1007/s00223-009-9308-9; Michaelis I., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P64; Palinkas LA, 2000, ENVIRON BEHAV, V32, P128, DOI 10.1177/00139160021972469; Palinkas LA, 2011, PSYCHOL CHARACTERIST; Pallafacchina G, 2013, NUTR METAB CARDIOVAS, V23, pS12, DOI 10.1016/j.numecd.2012.02.002; Pinheiro J, 2001, MIXED EFFECTS MODELS; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Runge M, 2004, CLIN PHYSIOL FUNCT I, V24, P335, DOI 10.1111/j.1475-097X.2004.00567.x; Sauer J, 1996, ACTA ASTRONAUT, V39, P579, DOI 10.1016/S0094-5765(97)00006-4; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023080; Schneider S, 2009, STRESS, V12, P336, DOI 10.1080/10253890802499175; Shimamiya T, 2004, J APPL PHYSIOL, V97, P920, DOI 10.1152/japplphysiol.00043.2004; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z	26	16	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60090	10.1371/journal.pone.0060090	http://dx.doi.org/10.1371/journal.pone.0060090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555896	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200082
J	Forsman, H; Onnheim, K; Andreasson, E; Christenson, K; Karlsson, A; Bylund, J; Dahlgren, C				Forsman, Huamei; Onnheim, Karin; Andreasson, Emil; Christenson, Karin; Karlsson, Anna; Bylund, Johan; Dahlgren, Claes			Reactivation of Desensitized Formyl Peptide Receptors by Platelet Activating Factor: A Novel Receptor Cross Talk Mechanism Regulating Neutrophil Superoxide Anion Production	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; C5A CHEMOATTRACTANT RECEPTORS; NADPH-OXIDASE RESPONSE; INTRACELLULAR CALCIUM; LIGAND RECOGNITION; N-FORMYLPEPTIDE; BETA-ARRESTINS; PHOSPHORYLATION; CYTOSKELETON; LEUKOCYTES	Neutrophils express different chemoattractant receptors of importance for guiding the cells from the blood stream to sites of inflammation. These receptors communicate with one another, a cross talk manifested as hierarchical, heterologous receptor desensitization. We describe a new receptor cross talk mechanism, by which desensitized formyl peptide receptors (FPRdes) can be reactivated. FPR desensitization is induced through binding of specific FPR agonists and is reached after a short period of active signaling. The mechanism that transfers the receptor to a non-signaling desensitized state is not known, and a signaling pathway has so far not been described, that transfers FPRdes back to an active signaling state. The reactivation signal was generated by PAF stimulation of its receptor (PAFR) and the cross talk was uni-directional. LatrunculinA, an inhibitor of actin polymerization, induced a similar reactivation of FPRdes as PAF while the phosphatase inhibitor CalyculinA inhibited reactivation, suggesting a role for the actin cytoskeleton in receptor desensitization and reactivation. The activated PAFR could, however, reactivate FPRdes also when the cytoskeleton was disrupted prior to activation. The receptor cross talk model presented prophesies that the contact on the inner leaflet of the plasma membrane that blocks signaling between the G-protein and the FPR is not a point of no return; the receptor cross-talk from the PAFRs to the FPRdes initiates an actin-independent signaling pathway that turns desensitized receptors back to a signaling state. This represents a novel mechanism for amplification of neutrophil production of reactive oxygen species.	[Forsman, Huamei; Onnheim, Karin; Andreasson, Emil; Christenson, Karin; Karlsson, Anna; Bylund, Johan; Dahlgren, Claes] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Gothenburg	Dahlgren, C (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	Claes.Dahlgren@microbio.gu.se	Karlsson, Anna/A-4130-2012	Karlsson, Anna/0000-0001-6796-1154; Granhagen Onnheim, Karin/0000-0001-5415-6842	Swedish Medical Research Council; King Gustaf V 80-Year Foundation; Goteborg Rheumatism Association; Swedish state under the ALF-agreement	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Gustaf V 80-Year Foundation; Goteborg Rheumatism Association; Swedish state under the ALF-agreement	The work was supported by the Swedish Medical Research Council, the King Gustaf V 80-Year Foundation, the Goteborg Rheumatism Association, and the Swedish state under the ALF-agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; ALI H, 1993, J BIOL CHEM, V268, P24247; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2003, J BIOL CHEM, V278, P30578, DOI 10.1074/jbc.M209202200; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; Forsman H, 2011, SCAND J IMMUNOL; Fu HM, 2004, IMMUNOLOGY, V112, P201, DOI 10.1111/j.1365-2567.2004.01884.x; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; GARCIA RC, 1992, BIOCHEM J, V286, P687, DOI 10.1042/bj2860687; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Harbecke O, 1997, J LEUKOCYTE BIOL, V61, P753, DOI 10.1002/jlb.61.6.753; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; JESAITIS AJ, 1993, EUR J HAEMATOL, V51, P288; JESAITIS AJ, 1986, J BIOL CHEM, V261, P3662; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Karlsson J, 2010, J IMMUNOL METHODS, V352, P45, DOI 10.1016/j.jim.2009.10.011; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; Liu L, 1998, J IMMUNOL, V160, P2463; LUNDQVIST H, 1994, BBA-MOL CELL RES, V1224, P43, DOI 10.1016/0167-4889(94)90111-2; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Luttrell Louis M., 2006, V332, P3; Magalhaes AC, 2011, BRIT J PHARM; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Min JA, 2011, MOL PHARMACOL, V80, P760, DOI 10.1124/mol.111.072470; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; OMANN GM, 1987, J IMMUNOL, V139, P3447; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; Segal BH, 2012, FREE RADICAL BIO MED, V53, P72, DOI 10.1016/j.freeradbiomed.2012.04.022; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Shenoy SK, 2011, TRENDS PHARM SCI; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; TARDIF M, 1993, J IMMUNOL, V150, P3534; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Vazquez-Prado J, 2003, CELL SIGNAL, V15, P549, DOI 10.1016/S0898-6568(02)00151-1; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Welch EJ, 2009, MOL PHARMACOL, V75, P227, DOI 10.1124/mol.108.051003; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	51	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60169	10.1371/journal.pone.0060169	http://dx.doi.org/10.1371/journal.pone.0060169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555913	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200090
J	Lee, H; Alpi, AF; Park, MS; Rose, A; Koo, HS				Lee, Hyojin; Alpi, Arno F.; Park, Mi So; Rose, Ann; Koo, Hyeon-Sook			C-elegans Ring Finger Protein RNF-113 Is Involved in Interstrand DNA Crosslink Repair and Interacts with a RAD51C Homolog	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; REPLICATION STRESS; DAMAGE; ROLES; SLX4; GENE; IDENTIFICATION; ACTIVATION; MUTATIONS; NUCLEASE	The Fanconi anemia (FA) pathway recognizes interstrand DNA crosslinks (ICLs) and contributes to their conversion into double-strand DNA breaks, which can be repaired by homologous recombination. Seven orthologs of the 15 proteins associated with Fanconi anemia are functionally conserved in the model organism C. elegans. Here we report that RNF-113, a ubiquitin ligase, is required for RAD-51 focus formation after inducing ICLs in C. elegans. However, the formation of foci of RPA-1 or FCD-2/FANCD2 in the FA pathway was not affected by depletion of RNF-113. Nevertheless, the RPA-1 foci formed did not disappear with time in the depleted worms, implying serious defects in ICL repair. As a result, RNF-113 depletion increased embryonic lethality after ICL treatment in wild-type worms, but it did not increase the ICL-induced lethality of rfs-1/rad51C mutants. In addition, the persistence of RPA-1 foci was suppressed in doubly-deficient rnf-113;rfs-1 worms, suggesting that there is an epistatic interaction between the two genes. These results lead us to suggest that RNF-113 and RFS-1 interact to promote the displacement of RPA-1 by RAD-51 on single-stranded DNA derived from ICLs.	[Lee, Hyojin; Park, Mi So; Koo, Hyeon-Sook] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Alpi, Arno F.] Univ Dundee, Scottish Inst Cell Signaling, Dundee, Scotland; [Rose, Ann] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	Yonsei University; University of Dundee; University of British Columbia	Koo, HS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	kooh@yonsei.ac.kr		Koo, Hyeon-Sook/0000-0002-5712-3875; Alpi, Arno/0000-0002-9572-7266	National Research Foundation of Korea; Korean government (MEST) [2009-0080247]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	Our work was supported by a National Research Foundation of Korea (http://www.nrf.re.kr/) grant funded by the Korean government (MEST) (No. 2009-0080247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dequen F, 2005, COMP BIOCHEM PHYS B, V141, P453, DOI 10.1016/j.cbpc.2005.05.010; Digweed M, 2002, CARCINOGENESIS, V23, P1121, DOI 10.1093/carcin/23.7.1121; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Godthelp BC, 2006, MUTAT RES-FUND MOL M, V594, P39, DOI 10.1016/j.mrfmmm.2005.07.008; Goldfeder MB, 2008, J BIOL CHEM, V283, P2644, DOI 10.1074/jbc.M707885200; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Huang M, 2010, MOL CELL, V39, P259, DOI 10.1016/j.molcel.2010.07.005; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Jones M, 2012, ANEMIA, V2012, DOI 10.1155/2012/323721; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kerins JA, 2010, DEV DYNAM, V239, P1555, DOI 10.1002/dvdy.22274; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Lee KY, 2007, BIOCHEM BIOPH RES CO, V352, P479, DOI 10.1016/j.bbrc.2006.11.039; Lee KY, 2010, DNA REPAIR, V9, P374, DOI 10.1016/j.dnarep.2009.12.018; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2002, CHARACTERIZATION INT; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Saito TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000735; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Ward JD, 2007, EMBO J, V26, P3384, DOI 10.1038/sj.emboj.7601766; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2009, MUTAT RES-FUND MOL M, V668, P103, DOI 10.1016/j.mrfmmm.2008.11.007; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	56	6	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e600701	10.1371/journal.pone.0060071	http://dx.doi.org/10.1371/journal.pone.0060071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555887	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200078
J	Brizendine, KD; Baddley, JW; Pappas, PG				Brizendine, Kyle D.; Baddley, John W.; Pappas, Peter G.			Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; VIRUS-NEGATIVE PATIENTS; AMPHOTERICIN-B; PULMONARY CRYPTOCOCCOSIS; NEOFORMANS INFECTION; RANDOMIZED-TRIAL; MENINGITIS; FLUCYTOSINE; FLUCONAZOLE; DISEASE	Introduction: Cryptococcosis is an invasive fungal infection causing substantial morbidity and mortality. Prognostic factors are largely derived from trials conducted prior to the modern era of antifungal and potent combination antiretroviral therapies, immunosuppression, and transplantation. Data describing the clinical features and predictors of mortality in a modern cohort are needed. Methods: We conducted a retrospective cohort study of patients at our institution diagnosed with cryptococcosis from 1996 through 2010. Data included demographics, clinical features, diagnostics, treatment, and outcomes. Results: We identified 302 individuals: 108 (36%) human immunodeficiency virus (HIV)-positive, 84 (28%) organ transplant recipients (OTRs), and 110 (36%) non-HIV, non-transplant (NHNT) patients including 39 with no identifiable immunodeficiency. Mean age was 49 years, 203 (67%) were male and 170 (56%) were white. All-cause mortality at 90 days was 21%. In multivariable logistic regression analyses, cryptococcemia (OR 5.09, 95% CI 2.54-10.22) and baseline opening pressure >25 cmH(2)O (OR 2.93, 95% CI 1.25-6.88) were associated with increased odds of mortality; HIV-positive patients (OR 0.46, 95% CI 0.19-1.16) and OTRs (OR 0.46, 95% CI 0.21-1.05) had lower odds of death compared to NHNT patients. Conclusions: Predictors of mortality from cryptococcosis in the modern period include cryptococcemia, high intracranial pressure, and NHNT status while drug(s) used for induction and historical prognostic factors including organ failure syndromes and hematologic malignancy were not associated with mortality.	[Brizendine, Kyle D.] Cleveland Clin, Dept Infect Dis, Cleveland, OH 44106 USA; [Baddley, John W.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Baddley, John W.; Pappas, Peter G.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA	Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham	Brizendine, KD (corresponding author), Cleveland Clin, Dept Infect Dis, Cleveland, OH 44106 USA.	brizenk@ccf.org; pappas@uab.edu			National Institutes of Health [T32AI520699]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	KDB acknowledges National Institutes of Health mentored training grant, T32AI520699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 1999, CHEST, V115, P734, DOI 10.1378/chest.115.3.734; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Chang WC, 2006, CHEST, V129, P333, DOI 10.1378/chest.129.2.333; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Davis JA, 2009, TRANSPL INFECT DIS, V11, P432, DOI 10.1111/j.1399-3062.2009.00424.x; DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602; Dromer F, 1996, CLIN INFECT DIS, V22, pS154, DOI 10.1093/clinids/22.Supplement_2.S154; Dromer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002870; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Hage CA, 2003, CHEST, V124, P2395, DOI 10.1378/chest.124.6.2395; Husain S, 2001, EMERG INFECT DIS, V7, P375; Jean SS, 2002, QJM-INT J MED, V95, P511, DOI 10.1093/qjmed/95.8.511; Jongwutiwes U, 2008, JPN J INFECT DIS, V61, P111; Liao CH, J MICROBIOL IMMUNOL, V45, P296; Liliang PC, 2003, CLIN INFECT DIS, V37, P673, DOI 10.1086/377208; Lin TY, 2009, J MICROBIOL IMMUNOL, V42, P220; Milefchik E, 2008, MED MYCOL, V46, P393, DOI 10.1080/13693780701851695; Nguyen MH, 2010, J INFECTION, V61, P419, DOI 10.1016/j.jinf.2010.08.004; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Singh N, 2005, TRANSPLANTATION, V80, P1033, DOI 10.1097/01.tp.0000173774.74388.49; Singh N, 2007, J INFECT DIS, V195, P756, DOI 10.1086/511438; Sun HY, 2009, CLIN INFECT DIS, V49, P1721, DOI 10.1086/647948; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Vilchez RA, 2001, MEDICINE, V80, P308, DOI 10.1097/00005792-200109000-00004	31	138	145	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60431	10.1371/journal.pone.0060431	http://dx.doi.org/10.1371/journal.pone.0060431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555970	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500134
J	Kammel, C; Thomaier, M; Sorensen, BB; Schubert, T; Langst, G; Grasser, M; Grasser, KD				Kammel, Christine; Thomaier, Maren; Sorensen, Brian B.; Schubert, Thomas; Laengst, Gernot; Grasser, Marion; Grasser, Klaus D.			Arabidopsis DEAD-Box RNA Helicase UAP56 Interacts with Both RNA and DNA as well as with mRNA Export Factors	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; BINDING PROTEINS; STRUCTURAL BASIS; YEAST HOMOLOG; TRANSCRIPTION; RESPONSES; TREX; ATP; NUCLEOLUS; HEL/UAP56	The DEAD-box protein UAP56 (U2AF65-associcated protein) is an RNA helicase that in yeast and metazoa is critically involved in mRNA splicing and export. In Arabidopsis, two adjacent genes code for an identical UAP56 protein, and both genes are expressed. In case one of the genes is inactivated by a T-DNA insertion, wild type transcript level is maintained by the other intact gene. In contrast to other organisms that are severely affected by elevated UAP56 levels, Arabidopsis plants that overexpress UAP56 have wild type appearance. UAP56 localises predominantly to euchromatic regions of Arabidopsis nuclei, and associates with genes transcribed by RNA polymerase II independently from the presence of introns, while it is not detected at non-transcribed loci. Biochemical characterisation revealed that in addition to ssRNA and dsRNA, UAP56 interacts with dsDNA, but not with ssDNA. Moreover, the enzyme displays ATPase activity that is stimulated by RNA and dsDNA and it has ATP-dependent RNA helicase activity unwinding dsRNA, whereas it does not unwind dsDNA. Protein interaction studies showed that UAP56 directly interacts with the mRNA export factors ALY2 and MOS11, suggesting that it is involved in mRNA export from plant cell nuclei.	[Kammel, Christine; Thomaier, Maren; Sorensen, Brian B.; Grasser, Marion; Grasser, Klaus D.] Univ Regensburg, Dept Cell Biol & Plant Biochem, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany; [Schubert, Thomas; Laengst, Gernot] Univ Regensburg, Inst Biochem 3, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Grasser, M (corresponding author), Univ Regensburg, Dept Cell Biol & Plant Biochem, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany.	Marion.Grasser@biologie.uni-regensburg.de; Klaus.Grasser@biologie.uni-regensburg.de	Längst, Gernot/G-5287-2015	Längst, Gernot/0000-0002-8232-1179; Schubert, Thomas/0000-0002-9709-3287	German Research Foundation (DFG) [SFB960]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) through grant SFB960 to MG and KDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; FRIED MG, 1989, ELECTROPHORESIS, V10, P366, DOI 10.1002/elps.1150100515; Garbelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019810; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Germain H, 2011, PLOS GENET, V6; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Grasser KD, 1996, J BIOL CHEM, V271, P32900, DOI 10.1074/jbc.271.51.32900; Grasser M, 2006, J MOL BIOL, V358, P654, DOI 10.1016/j.jmb.2006.02.068; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Kiesler E, 2002, CURR BIOL, V12, P859, DOI 10.1016/S0960-9822(02)00840-0; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Launholt D, 2006, PLANT CELL, V18, P2904, DOI 10.1105/tpc.106.047274; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Li XW, 2011, PLANT CELL, V23, P1416, DOI 10.1105/tpc.110.082636; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Lolas IB, 2010, PLANT J, V61, P686, DOI 10.1111/j.1365-313X.2009.04096.x; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Nicol SM, 2000, EXP CELL RES, V257, P272, DOI 10.1006/excr.2000.4886; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; OWTTRIM GW, 1994, PLANT MOL BIOL, V26, P1747, DOI 10.1007/BF00019489; OWTTRIM GW, 1991, NUCLEIC ACIDS RES, V19, P5491, DOI 10.1093/nar/19.20.5491; Pedersen DS, 2011, NEW PHYTOL, V192, P577, DOI 10.1111/j.1469-8137.2011.03828.x; Pedersen DS, 2010, PLANT PHYSIOL, V154, P1831, DOI 10.1104/pp.110.163055; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Rottgers K, 2000, PLANT J, V23, P395, DOI 10.1046/j.1365-313x.2000.00801.x; Schmidt A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001155; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shen HH, 2008, GENE DEV, V22, P1796, DOI 10.1101/gad.1657308; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Shen JP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702304200; Stemmer C, 1997, EUR J BIOCHEM, V250, P646, DOI 10.1111/j.1432-1033.1997.00646.x; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taniguchi I, 2008, MOL CELL BIOL, V28, P601, DOI 10.1128/MCB.01341-07; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022671; Uhrig JF, 2004, PLANT PHYSIOL, V135, P2411, DOI 10.1104/pp.104.046086; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Vain P, 2011, PLANT J, V66, P929, DOI 10.1111/j.1365-313X.2011.04555.x; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	63	46	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60644	10.1371/journal.pone.0060644	http://dx.doi.org/10.1371/journal.pone.0060644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555998	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500142
J	Pereira, CBL; Leal, MF; de Souza, CRT; Montenegro, RC; Rey, JA; Carvalho, AA; Assumpcao, PP; Khayat, AS; Pinto, GR; Demachki, S; Smith, MDC; Burbano, RR				Lins Pereira, Cynthia Brito; Leal, Mariana Ferreira; Teixeira de Souza, Carolina Rosal; Montenegro, Raquel Carvalho; Rey, Juan Antonio; Carvalho, Antonio Alberto; Assumpcao, Paulo Pimentel; Khayat, Andre Salim; Pinto, Giovanny Reboucas; Demachki, Samia; Cardoso Smith, Marilia de Arruda; Burbano, Rommel Rodriguez			Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy	PLOS ONE			English	Article							C-MYC; GROWTH ARREST; TUMOR CELLS; AMPLIFICATION; EXPRESSION; GENE; ASSOCIATION; CARCINOMAS; MUTATIONS; ONCOGENE	Breast cancer is a complex disease, with heterogeneous clinical evolution. Several analyses have been performed to identify the risk factors for breast cancer progression and the patients who respond best to a specific treatment. We aimed to evaluate whether the hormone receptor expression, HER2 and MYC genes and their protein status, and KRAS codon 12 mutations may be prognostic or predictive biomarkers of breast cancer. Protein, gene and mutation status were concomitantly evaluated in 116 breast tumors from women who underwent neoadjuvant chemotherapy with doxorubicin plus cyclophosphamide. We observed that MYC expression was associated with luminal B and HER2 overexpression phenotypes compared to luminal A (p<0.05). The presence of MYC duplication or polysomy 8, as well as KRAS mutation, were also associated with the HER2 overexpression subtype (p<0.05). MYC expression and MYC gain were more frequently observed in early-onset compared to late-onset tumors (p<0.05). KRAS mutation was a risk factor of grade 3 tumors (p<0.05). A multivariate logistic regression demonstrated that MYC amplification defined as MYC/nucleus ratio of >= 2.5 was a protective factor for chemotherapy resistance. On the other hand, age and grade 2 tumors were a risk factor. Additionally, luminal B, HER2 overexpression, and triple-negative tumors presented increased odds of being resistant to chemotherapy relative to luminal A tumors. Thus, breast tumors with KRAS codon 12 mutations seem to present a worse prognosis. Additionally, MYC amplification may help in the identification of tumors that are sensitive to doxorubicin plus cyclophosphamide treatment. If confirmed in a large set of samples, these markers may be useful for clinical stratification and prognosis.	[Lins Pereira, Cynthia Brito] Ophir Loyola Hosp, Mastol Unit, Belem, PA, Brazil; [Leal, Mariana Ferreira] Univ Fed Sao Paulo, Dept Orthopaed & Traumatol, Sao Paulo, Brazil; [Teixeira de Souza, Carolina Rosal; Montenegro, Raquel Carvalho; Carvalho, Antonio Alberto; Burbano, Rommel Rodriguez] Fed Univ Para, Inst Biol Sci, Human Cytogenet Lab, BR-66059 Belem, PA, Brazil; [Rey, Juan Antonio] Hosp Univ La Paz, Res Unit Unidad Invest, Madrid, Spain; [Assumpcao, Paulo Pimentel; Khayat, Andre Salim; Demachki, Samia] Fed Univ Para, Nucleu Res Oncol, Joao de Barros Barreto Univ Hosp, BR-66059 Belem, PA, Brazil; [Pinto, Giovanny Reboucas] Univ Fed Piaui, Dept Biomed, Parnaiba, PI, Brazil; [Cardoso Smith, Marilia de Arruda] Univ Fed Sao Paulo, Div Genet, Dept Morphol & Genet, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Hospital Universitario La Paz; Universidade Federal do Para; Universidade Federal do Piaui; Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Orthopaed & Traumatol, Sao Paulo, Brazil.	mariana.morf@epm.br	Leal, Mariana/C-4010-2012; Pinto, Giovanny R/G-9852-2012; Rey, Juan A/H-5026-2013; Khayat, Andre/AAF-2415-2019; Montenegro, Raquel/I-1260-2013; de A. C. Smith, Marilia/C-4397-2012; Pinto, Giovanny Rebouças/AAB-9308-2020; Burbano, Rommel R/C-4149-2012; Souza, Carolina Rosal Teixeira/ABF-8886-2021	Leal, Mariana/0000-0003-4375-2563; Pinto, Giovanny R/0000-0001-9110-1840; Montenegro, Raquel/0000-0002-3861-293X; de A. C. Smith, Marilia/0000-0002-1441-1033; Burbano, Rommel R/0000-0002-4872-234X; Souza, Carolina Rosal Teixeira/0000-0002-5123-9025	Fundacao Amazonia Paraense de Amparo a Pesquisa [FAPESPA/PPSUS 247/2009, 300240/2009]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao Amazonia Paraense de Amparo a Pesquisa(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding for this study was provided as grants and fellowships from the Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA/PPSUS 247/2009, #300240/2009), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to RRB and MACS) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to MFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Barinoff J, 2013, EUR J CANCER, V49, P305, DOI 10.1016/j.ejca.2012.07.027; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Chunder N, 2004, ANN SURG ONCOL, V11, P1045, DOI 10.1245/ASO.2004.02.022; Cleator S, 2002, ENDOCR-RELAT CANCER, V9, P183, DOI 10.1677/erc.0.0090183; Crown J, 2002, LANCET ONCOL, V3, P719, DOI 10.1016/S1470-2045(02)00927-0; Dechaphunkul A, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/290854; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Dobrzycka B, 2009, FOLIA HISTOCHEM CYTO, V47, P65, DOI 10.2478/v10042-009-0014-2; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; da Costa JDFB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021988; FORNARI FA, 1994, CELL GROWTH DIFFER, V5, P723; Fornari FA, 1996, BIOCHEM PHARMACOL, V51, P931, DOI 10.1016/0006-2952(96)00050-0; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Martin Vittoria, 2012, Patholog Res Int, V2012, P261857, DOI 10.1155/2012/261857; Martin V, 2012, HISTOL HISTOPATHOL, V27, P785, DOI 10.14670/HH-27.785; Moon HG, 2013, ANN SURG, V257, P133, DOI 10.1097/SLA.0b013e3182686bd9; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Olah E, 1996, ANTICANCER RES, V16, P2469; Park K, 2005, HUM PATHOL, V36, P634, DOI 10.1016/j.humpath.2005.04.016; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Perez EA, 2011, J CLIN ONCOL, V29, P651, DOI 10.1200/JCO.2010.30.2125; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Silva TCR, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-85; Saltzman BS, 2012, BREAST CANCER RES TR, V135, P849, DOI 10.1007/s10549-012-2183-5; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Singhi AD, 2012, MODERN PATHOL, V25, P378, DOI 10.1038/modpathol.2011.171; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sobin LH, 2004, TNM CLASSIFICATION M; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Todorovic-Rakovic N, 2012, CLIN EXP MED, V12, P217, DOI 10.1007/s10238-011-0169-y; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Yasojima H, 2011, EUR J CANCER, V47, P1779, DOI 10.1016/j.ejca.2011.06.017	41	42	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60576	10.1371/journal.pone.0060576	http://dx.doi.org/10.1371/journal.pone.0060576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555992	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500140
J	Mul, JD; O'Duibhir, E; Shrestha, YB; Koppen, A; Vargovic, P; Toonen, PW; Zarebidaki, E; Kvetnansky, R; Kalkhoven, E; Cuppen, E; Bartness, TJ				Mul, Joram D.; O'Duibhir, Eoghan; Shrestha, Yogendra B.; Koppen, Arjen; Vargovic, Peter; Toonen, Pim W.; Zarebidaki, Eleen; Kvetnansky, Richard; Kalkhoven, Eric; Cuppen, Edwin; Bartness, Timothy J.			Pmch-Deficiency in Rats Is Associated with Normal Adipocyte Differentiation and Lower Sympathetic Adipose Drive	PLOS ONE			English	Article							MELANIN-CONCENTRATING-HORMONE; PROTEIN-COUPLED RECEPTOR; NEUROCHEMICAL CHARACTERIZATION; NEUROPEPTIDE-Y; TISSUE; INNERVATION; METABOLISM; FAT; EXPRESSION; PATHWAYS	The orexigenic neuropeptide melanin-concentrating hormone (MCH), a product of Pmch, is an important mediator of energy homeostasis. Pmch-deficient rodents are lean and smaller, characterized by lower food intake, body-, and fat mass. Pmch is expressed in hypothalamic neurons that ultimately are components in the sympathetic nervous system (SNS) drive to white and interscapular brown adipose tissue (WAT, iBAT, respectively). MCH binds to MCH receptor 1 (MCH1R), which is present on adipocytes. Currently it is unknown if Pmch-ablation changes adipocyte differentiation or sympathetic adipose drive. Using Pmch-deficient and wild-type rats on a standard low-fat diet, we analyzed dorsal subcutaneous and perirenal WAT mass and adipocyte morphology (size and number) throughout development, and indices of sympathetic activation in WAT and iBAT during adulthood. Moreover, using an in vitro approach we investigated the ability of MCH to modulate 3T3-L1 adipocyte differentiation. Pmch-deficiency decreased dorsal subcutaneous and perirenal WAT mass by reducing adipocyte size, but not number. In line with this, in vitro 3T3-L1 adipocyte differentiation was unaffected by MCH. Finally, adult Pmch-deficient rats had lower norepinephrine turnover (an index of sympathetic adipose drive) in WAT and iBAT than wild-type rats. Collectively, our data indicate that MCH/MCH1R-pathway does not modify adipocyte differentiation, whereas Pmch-deficiency in laboratory rats lowers adiposity throughout development and sympathetic adipose drive during adulthood.	[Mul, Joram D.; O'Duibhir, Eoghan; Toonen, Pim W.; Cuppen, Edwin] Hubrecht Inst KNAW, Utrecht, Netherlands; [Mul, Joram D.; O'Duibhir, Eoghan; Toonen, Pim W.; Cuppen, Edwin] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Shrestha, Yogendra B.; Zarebidaki, Eleen; Bartness, Timothy J.] Georgia State Univ, Dept Biol, Neurobiol & Behav Program, Atlanta, GA 30303 USA; [Shrestha, Yogendra B.; Zarebidaki, Eleen; Bartness, Timothy J.] Georgia State Univ, Exploring & Testing Strategies Obes Reversal Ctr, Atlanta, GA USA; [Koppen, Arjen; Kalkhoven, Eric] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vargovic, Peter; Kvetnansky, Richard] Slovak Acad Sci, Inst Expt Endocrinol, Lab Stress Res, Bratislava, Slovakia; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Utrecht University; Utrecht University Medical Center; Slovak Academy of Sciences; Utrecht University; Utrecht University Medical Center	Bartness, TJ (corresponding author), Georgia State Univ, Dept Biol, Neurobiol & Behav Program, Atlanta, GA 30303 USA.	bartness@gsu.edu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; Vargovič, Peter/E-8660-2018; Koppen, Arjen/GLV-6743-2022; Mul, Joram/C-3125-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Vargovič, Peter/0000-0003-0417-8984; Mul, Joram/0000-0003-0453-2568	National Institutes of Health [R37 Dk35254]; European Science Foundation EURYI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Science Foundation EURYI(European Science Foundation (ESF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R37 Dk35254 to TJB and by the European Science Foundation EURYI to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler ES, 2012, J NEUROSCI, V32, P15913, DOI 10.1523/JNEUROSCI.2591-12.2012; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bradley RL, 2000, DIABETES, V49, P1073, DOI 10.2337/diabetes.49.7.1073; Bradley RL, 2005, OBES RES, V13, P653, DOI 10.1038/oby.2005.73; Bradley RL, 2002, AM J PHYSIOL-ENDOC M, V283, pE584, DOI 10.1152/ajpendo.00161.2002; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Cook LB, 2010, MOL CELL ENDOCRINOL, V320, P45, DOI 10.1016/j.mce.2010.02.009; FREDHOLM BB, 1970, ACTA PHYSIOL SCAND, V79, P564, DOI 10.1111/j.1748-1716.1970.tb04759.x; Guesdon B, 2009, AM J PHYSIOL-REG I, V296, pR469, DOI 10.1152/ajpregu.90556.2008; Handlon AL, 2006, J MED CHEM, V49, P4017, DOI 10.1021/jm058239j; Hill J, 2001, J BIOL CHEM, V276, P20125, DOI 10.1074/jbc.M102068200; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Imbernon M, 2013, GASTROENTEROLOGY, V144, P636, DOI 10.1053/j.gastro.2012.10.051; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Lembo PMC, 1999, NAT CELL BIOL, V1, P267, DOI 10.1038/12978; Mul JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019600; Mul JD, 2010, AM J PHYSIOL-ENDOC M, V298, pE477, DOI 10.1152/ajpendo.00154.2009; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; ONAI T, 1995, AM J PHYSIOL-REG I, V269, pR519, DOI 10.1152/ajpregu.1995.269.3.R519; Pissios P, 2006, ENDOCR REV, V27, P606, DOI 10.1210/er.2006-0021; Pissios P, 2009, PEPTIDES, V30, P2040, DOI 10.1016/j.peptides.2009.05.002; Richard D, 2007, Minerva Endocrinol, V32, P173; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; SPECTOR S, 1965, J PHARMACOL EXP THER, V147, P86; Stanley S, 2010, P NATL ACAD SCI US; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; WIRSEN C, 1967, NATURE, V214, P625, DOI 10.1038/214625a0; Yang JX, 2009, MOL CELL ENDOCRINOL, V311, P11, DOI 10.1016/j.mce.2009.03.023; ZARJEVSKI N, 1994, DIABETES, V43, P764, DOI 10.2337/diabetes.43.6.764	39	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60214	10.1371/journal.pone.0060214	http://dx.doi.org/10.1371/journal.pone.0060214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555928	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500124
J	Castillero, E; Alamdari, N; Aversa, Z; Gurav, A; Hasselgren, PO				Castillero, Estibaliz; Alamdari, Nima; Aversa, Zaira; Gurav, Aniket; Hasselgren, Per-Olof			PPAR beta/delta Regulates Glucocorticoid- and Sepsis-Induced FOXO1 Activation and Muscle Wasting	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; RECEPTOR-ALPHA GENE; SKELETAL-MUSCLE; TRANSCRIPTION FACTORS; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; FORKHEAD TRANSCRIPTION; GLUCOSE-TRANSPORT; MITOCHONDRIAL-FUNCTION; INSULIN-RESISTANCE	FOXO1 is involved in glucocorticoid- and sepsis-induced muscle wasting, in part reflecting regulation of atrogin-1 and MuRF1. Mechanisms influencing FOXO1 expression in muscle wasting are poorly understood. We hypothesized that the transcription factor peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) upregulates muscle FOXO1 expression and activity with a downstream upregulation of atrogin-1 and MuRF1 expression during sepsis and glucocorticoid treatment and that inhibition of PPAR beta/delta activity can prevent muscle wasting. We found that activation of PPAR beta/delta in cultured myotubes increased FOXO1 activity, atrogin-1 and MuRF1 expression, protein degradation and myotube atrophy. Treatment of myotubes with dexamethasone increased PPAR beta/delta expression and activity. Dexamethasone-induced FOXO1 activation and atrogin-1 and MuRF1 expression, protein degradation, and myotube atrophy were inhibited by PPAR beta/delta blocker or siRNA. Importantly, muscle wasting induced in rats by dexamethasone or sepsis was prevented by treatment with a PPAR beta/delta inhibitor. The present results suggest that PPAR beta/delta regulates FOXO1 activation in glucocorticoid-and sepsis-induced muscle wasting and that treatment with a PPAR beta/delta inhibitor may ameliorate loss of muscle mass in these conditions.	[Castillero, Estibaliz; Alamdari, Nima; Aversa, Zaira; Gurav, Aniket; Hasselgren, Per-Olof] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hasselgren, PO (corresponding author), Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	phasselg@bidmc.harvard.edu	Castillero, Estibaliz/ABI-4921-2020	Castillero, Estibaliz/0000-0002-2213-5809	National Institutes of Health [R01 DK37908]; Gobierno Vasco, Spain [BFI2010-240]; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gobierno Vasco, Spain(Basque Government); Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported in part by National Institutes of Health grant R01 DK37908 (POH). EC was supported in part by Gobierno Vasco, Spain (BFI2010-240). ZA was supported in part by the Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari N, 2012, BIOCHEM BIOPH RES CO, V417, P528, DOI 10.1016/j.bbrc.2011.11.154; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Aversa Z, 2011, CRIT REV CL LAB SCI, V48, P71, DOI 10.3109/10408363.2011.591365; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Brunmair B, 2006, DIABETOLOGIA, V49, P2713, DOI 10.1007/s00125-006-0357-6; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chamberlain W, 2012, BIOCHEM CELL BIOL, V90, P200, DOI [10.1139/O11-082, 10.1139/o11-082]; Chambers Melissa A, 2009, Crit Care Med, V37, pS337, DOI 10.1097/CCM.0b013e3181b6e974; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; Constantin D, 2007, J PHYSIOL-LONDON, V583, P381, DOI 10.1113/jphysiol.2007.135459; Cresser J, 2010, AM J PHYSIOL-REG I, V299, pR470, DOI 10.1152/ajpregu.00431.2009; De Jonghe B, 2004, INTENS CARE MED, V30, P1117, DOI 10.1007/s00134-004-2174-z; Debard C, 2006, J MOL MED-JMM, V84, P747, DOI 10.1007/s00109-006-0077-x; Dhar A, 2011, CURR OPIN PEDIATR, V23, P269, DOI 10.1097/MOP.0b013e3283464b3e; Dimopoulos N, 2007, FEBS LETT, V581, P4743, DOI 10.1016/j.febslet.2007.08.072; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Fredriksson K, 2007, CRIT CARE MED, V35, pS449, DOI 10.1097/01.CCM.0000278048.00896.4B; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Fuster G, 2007, CANCER RES, V67, P6512, DOI 10.1158/0008-5472.CAN-07-0231; Girroir EE, 2008, BIOCHEM BIOPH RES CO, V371, P456, DOI 10.1016/j.bbrc.2008.04.086; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gonnella P, 2011, J CELL BIOCHEM, V112, P1737, DOI 10.1002/jcb.23093; HALLANGERAS M, 1991, SURGERY, V109, P468; Hasselgren PO, 2007, J CELL PHYSIOL, V213, P679, DOI 10.1002/jcp.21190; Hasselgren PO, 2010, CURR OPIN CLIN NUTR, V13, P423, DOI 10.1097/MCO.0b013e32833a5107; Herridge Margaret S, 2009, Crit Care Med, V37, pS457, DOI 10.1097/CCM.0b013e3181b6f35c; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Johnson TE, 1999, ENDOCRINOLOGY, V140, P3245, DOI 10.1210/en.140.7.3245; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Katoh M, 2004, INT J ONCOL, V25, P1495; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Menconi MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE533, DOI 10.1152/ajpendo.00596.2009; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Naruhn S, 2011, MOL PHARMACOL, V80, P828, DOI 10.1124/mol.111.074039; Needham M, 2000, J STEROID BIOCHEM, V72, P35, DOI 10.1016/S0960-0760(00)00027-3; Nie M, 2005, J BIOL CHEM, V280, P2550, DOI 10.1074/jbc.M410616200; Penner CG, 2001, BIOCHEM BIOPH RES CO, V281, P1331, DOI 10.1006/bbrc.2001.4497; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Philibert D, 1984, RU38486 ORIGINAL MUL; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Sanchez-Siles AA, 2011, J CLIN BIOCHEM NUTR, V49, P42, DOI 10.3164/jcbn.10-139; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Smith IJ, 2010, J CELL BIOCHEM, V111, P1059, DOI 10.1002/jcb.22796; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Sun XY, 2002, AM J PHYSIOL-REG I, V282, pR509, DOI 10.1152/ajpregu.00509.2001; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Terada S, 2006, AM J PHYSIOL-ENDOC M, V290, pE607, DOI 10.1152/ajpendo.00430.2005; Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Tiao G, 1996, J CLIN INVEST, V97, P339, DOI 10.1172/JCI118421; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Vanasco V, 2008, FREE RADICAL RES, V42, P815, DOI 10.1080/10715760802438709; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang L, 1998, SHOCK, V10, P298, DOI 10.1097/00024382-199810000-00011; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Williams AB, 1999, FASEB J, V13, P1435, DOI 10.1096/fasebj.13.11.1435; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; ZAMIR O, 1992, J PEDIATR SURG, V27, P1399, DOI 10.1016/0022-3468(92)90185-A; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	86	27	31	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59726	10.1371/journal.pone.0059726	http://dx.doi.org/10.1371/journal.pone.0059726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555761	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400057
J	Kalish, BT; Le, HD; Gura, KM; Bistrian, BR; Puder, M				Kalish, Brian T.; Le, Hau D.; Gura, Kathleen M.; Bistrian, Bruce R.; Puder, Mark			A Metabolomic Analysis of Two Intravenous Lipid Emulsions in a Murine Model	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TOTAL PARENTERAL-NUTRITION; ALPHA-LINOLENIC ACID; HEPATIC STEATOSIS; LIVER COMPLICATIONS; INFLAMMATION; ANTIOXIDANT; INJURY; OMEGA-3-FATTY-ACIDS; PATHOGENESIS	Background: Parenteral nutrition (PN), including intravenous lipid administration, is a life-saving therapy but can be complicated by cholestasis and liver disease. The administration of intravenous soy bean oil (SO) has been associated with the development of liver disease, while the administration of intravenous fish oil (FO) has been associated with the resolution of liver disease. The biochemical mechanism of this differential effect is unclear. This study compares SO and FO lipid emulsions in a murine model of hepatic steatosis, one of the first hits in PN-associated liver disease. Methods: We established a murine model of hepatic steatosis in which liver injury is induced by orally feeding mice a PN solution. C57BL/6J mice were randomized to receive PN alone (a high carbohydrate diet (HCD)), PN plus intravenous FO (Omegaven (R); Fresenius Kabi AG, Bad Homburg VDH, Germany), PN plus intravenous SO (Intralipid (R); Fresenius Kabi AG, Bad Homburg v.d.H., Germany, for Baxter Healthcare, Deerfield, IL), or a chow diet. After 19 days, liver tissue was harvested from all animals and subjected to metabolomic profiling. Results: The administration of an oral HCD without lipid induced profound hepatic steatosis. SO was associated with macro- and microvesicular hepatic steatosis, while FO largely prevented the development of steatosis. 321 detectable compounds were identified in the metabolomic analysis. HCD induced de novo fatty acid synthesis and oxidative stress. Both FO and SO relieved some of the metabolic shift towards de novo lipogenesis, but FO offered additional advantages in terms of lipid peroxidation and the generation of inflammatory precursors. Conclusions: Improved lipid metabolism combined with reduced oxidative stress may explain the protective effect offered by intravenous FO in vivo.	[Kalish, Brian T.; Le, Hau D.; Puder, Mark] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Kalish, Brian T.; Le, Hau D.; Puder, Mark] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Gura, Kathleen M.] Boston Childrens Hosp, Dept Pharm, Boston, MA USA; [Bistrian, Bruce R.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Le, Hau D.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Puder, M (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA USA.	mark.puder@childrens.harvard.edu		Le, Hau/0000-0003-0514-3513	Howard Hughes Medical Institute Research Fellowship; Children's Hospital Surgical Foundation (Boston, Massachusetts)	Howard Hughes Medical Institute Research Fellowship; Children's Hospital Surgical Foundation (Boston, Massachusetts)	BTK was funded by a Howard Hughes Medical Institute Research Fellowship. HDL and MP were funded by the Children's Hospital Surgical Foundation (Boston, Massachusetts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwayn IPJ, 2005, PEDIATR RES, V57, P445, DOI 10.1203/01.PDR.0000153672.43030.75; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Clayton PT, 1998, NUTRITION, V14, P158, DOI 10.1016/S0899-9007(97)00233-5; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; HALL RI, 1984, J CLIN INVEST, V74, P1658, DOI 10.1172/JCI111582; Hao W, 2010, J PEDIATR SURG, V45, P2412, DOI 10.1016/j.jpedsurg.2010.08.044; Hasanoglu A, 2005, PROSTAG LEUKOTR ESS, V73, P99, DOI 10.1016/j.plefa.2005.04.015; Hong L, 2007, JPEN-PARENTER ENTER, V31, P199, DOI 10.1177/0148607107031003199; Hong L, 2009, J PEDIATR SURG, V44, P1712, DOI 10.1016/j.jpedsurg.2009.04.002; Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200; IRITANI N, 1980, LIPIDS, V15, P371, DOI 10.1007/BF02533553; Javid PJ, 2005, J PEDIATR SURG, V40, P1446, DOI 10.1016/j.jpedsurg.2005.05.045; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kajikawa S, 2009, PROSTAG LEUKOTR ESS, V80, P229, DOI 10.1016/j.plefa.2009.02.004; Kelly DA, 1998, NUTRITION, V14, P153, DOI 10.1016/S0899-9007(97)00232-3; Kosters A, 2010, SEMIN LIVER DIS, V30, P186, DOI 10.1055/s-0030-1253227; Lespine A, 2001, JPEN-PARENTER ENTER, V25, P52, DOI 10.1177/014860710102500252; Meisel JA, 2011, J PEDIATR SURG, V46, P666, DOI 10.1016/j.jpedsurg.2010.08.018; Miloudi K, 2012, CLIN NUTR, V31, P526, DOI 10.1016/j.clnu.2011.12.012; NASSAR BA, 1986, LIPIDS, V21, P652, DOI 10.1007/BF02537216; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Puder M, 2009, ANN SURG, V250, P395, DOI 10.1097/SLA.0b013e3181b36657; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Squires RH, 2012, J PEDIATR-US, V161, P723, DOI 10.1016/j.jpeds.2012.03.062; Stoll B, 2010, J NUTR, V140, P2193, DOI 10.3945/jn.110.125799; WONG S, 1985, METABOLISM, V34, P900, DOI 10.1016/0026-0495(85)90135-0; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yeh SL, 1997, NUTRITION, V13, P32, DOI 10.1016/S0899-9007(97)90876-5	33	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59653	10.1371/journal.pone.0059653	http://dx.doi.org/10.1371/journal.pone.0059653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565157	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300026
J	Roncero, I; Alvarez, E; Acosta, C; Sanz, C; Barrio, P; Hurtado-Carneiro, V; Burks, D; Blazquez, E				Roncero, Isabel; Alvarez, Elvira; Acosta, Carlos; Sanz, Carmen; Barrio, Pedro; Hurtado-Carneiro, Veronica; Burks, Deborah; Blazquez, Enrique			Insulin-Receptor Substrate-2 (IRS-2) Is Required for Maintaining Glucokinase and Glucokinase Regulatory Protein Expression in Mouse Liver	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GENE-EXPRESSION; RAT-BRAIN; GLUCOSE-METABOLISM; HEPATOCYTES; RESISTANCE; MICE; ACTIVATORS; PHOSPHORYLATION; TRANSCRIPTION	Insulin receptor substrate (IRS) proteins play important roles in hepatic nutrient homeostasis. Since glucokinase (GK) and glucokinase regulatory protein (GKRP) function as key glucose sensors, we have investigated the expression of GK and GKRP in liver of Irs-2 deficient mice and Irs2(-/-) mice where Irs2 was reintroduced specifically into pancreatic beta-cells [RIP-Irs-2/IRS-2(-/-)]. We observed that liver GK activity was significantly lower (p<0.0001) in IRS-2(-/-) mice. However, in RIP-Irs-2/IRS-2(-/-) mice, GK activity was similar to the values observed in wild-type animals. GK activity in hypothalamus was not altered in IRS-2(-/-) mice. GK and GKRP mRNA levels in liver of IRS-2(-/-) were significantly lower, whereas in RIP-Irs-2/IRS-2(-/-) mice, both GK and GKRP mRNAs levels were comparable to wild-type animals. At the protein level, the liver content of GK was reduced in IRS-2(-/-) mice as compared with controls, although GKRP levels were similar between these experimental models. Both GK and GKRP levels were lower in RIP-Irs-2/IRS-2(-/-) mice. These results suggest that IRS-2 signalling is important for maintaining the activity of liver GK. Moreover, the differences between liver and brain GK may be explained by the fact that expression of hepatic, but not brain, GK is controlled by insulin. GK activity was restored by the beta-cell compensation in the RIP-Irs-2/IRS-2 mice. Interestingly, GK and GKRP protein expression remained low in RIP-Irs-2/IRS-2(-/-) mice, perhaps reflecting different mRNA half-lives or alterations in the process of translation and post-translational regulation.	[Roncero, Isabel; Alvarez, Elvira; Acosta, Carlos; Sanz, Carmen; Barrio, Pedro; Hurtado-Carneiro, Veronica; Burks, Deborah; Blazquez, Enrique] Ctr Biomed Res Diabet & Associated Metab Disorder, Madrid, Spain; [Roncero, Isabel; Alvarez, Elvira; Sanz, Carmen; Barrio, Pedro; Hurtado-Carneiro, Veronica; Blazquez, Enrique] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Madrid, Spain; [Acosta, Carlos; Burks, Deborah] Ctr Invest Principe Felipe, Valencia, Spain; [Sanz, Carmen] Univ Complutense Madrid, Fac Med, Dept Biol Celular, Madrid, Spain	Complutense University of Madrid; Prince Felipe Research Center; Complutense University of Madrid	Blazquez, E (corresponding author), Ctr Biomed Res Diabet & Associated Metab Disorder, Madrid, Spain.	eblazquez@med.ucm.es	SANZ, CARMEN/L-7266-2014; Barrio, Pedro/O-1464-2018; ALVAREZ, ELVIRA/S-8977-2019; ALVAREZ, ELVIRA/F-2994-2017; BLAZQUEZ, ENRIQUE/G-9019-2017	SANZ, CARMEN/0000-0001-7025-6667; Barrio, Pedro/0000-0002-9308-7701; ALVAREZ, ELVIRA/0000-0002-9074-3857; BLAZQUEZ, ENRIQUE/0000-0003-3611-0087; HURTADO-CARNEIRO, VERONICA/0000-0003-2517-8895	MICINN [SAF2006-0475, SAF2009-11297]; Ayudas del Programa de Creacion y Consolidacion de Grupos de Investigacion UCM-Banco Santander [GR58/08, GR35/10A, GR35/10B, GR42/10]; Fundacion de Investigacion Medica Mutua Madrilena; IODURE project, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an initiative of ISCIII (Ministerio de Ciencia e Innovacion)	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Ayudas del Programa de Creacion y Consolidacion de Grupos de Investigacion UCM-Banco Santander; Fundacion de Investigacion Medica Mutua Madrilena; IODURE project, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an initiative of ISCIII (Ministerio de Ciencia e Innovacion)	This work was supported by grants from MICINN (SAF2006-0475 and SAF2009-11297), Ayudas del Programa de Creacion y Consolidacion de Grupos de Investigacion UCM-Banco Santander (GR58/08, GR35/10A, GR35/10B and GR42/10), Fundacion de Investigacion Medica Mutua Madrilena and IODURE project, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an initiative of ISCIII (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x; Alvarez E, 1996, J NEUROCHEM, V66, P920; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; BEDOYA FJ, 1986, J BIOL CHEM, V261, P760; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Guertin KR, 2006, CURR MED CHEM, V13, P1839, DOI 10.2174/092986706777452551; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Garcia-Barrado MJ, 2011, BIOCHEM PHARMACOL, V81, P279, DOI 10.1016/j.bcp.2010.10.008; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Navarro M, 1996, J NEUROCHEM, V67, P1982; Roncero I, 2000, J NEUROCHEM, V74, P1848, DOI 10.1046/j.1471-4159.2000.0741848.x; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Sanz C, 2007, J ENDOCRINOL, V193, P259, DOI 10.1677/JOE-06-0146; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Torres TP, 2009, DIABETES, V58, P78, DOI 10.2337/db08-1119; Tripathy D, 2004, DIABETOLOGIA, V47, P782, DOI 10.1007/s00125-004-1393-8; Valverde AM, 2004, HEPATOLOGY, V40, P1285, DOI 10.1002/hep.20485; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VINUELA E, 1963, J BIOL CHEM, V238, P1175; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	43	10	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58797	10.1371/journal.pone.0058797	http://dx.doi.org/10.1371/journal.pone.0058797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560040	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900008
J	Fu, AL; Zhang, MM; Gao, FY; Xu, XR; Chen, ZB				Fu, Ailing; Zhang, Miaomiao; Gao, Feiyan; Xu, Xingran; Chen, Zhangbao			A Novel Peptide Delivers Plasmids across Blood-Brain Barrier into Neuronal Cells as a Single-Component Transfer Vector	PLOS ONE			English	Article							EXPERIMENTAL PARKINSONS-DISEASE; CENTRAL-NERVOUS-SYSTEM; GENE-THERAPY; NEUROLOGICAL DISEASES; PENETRATING PEPTIDE; INTERFERING RNA; CELLULAR-UPTAKE; DNA; GLYCOPROTEIN; BDNF	There is no data up to now to show that peptide can deliver plasmid into brain as a single-component transfer vector. Here we show that a novel peptide, RDP (consisted of 39 amino acids), can be exploited as an efficient plasmid vector for brain-targeting delivery. The plasmids containing Lac Z reporter gene (pVAX-Lac Z) and BDNF gene (pVAX-BDNF) are complexed with RDP and intravenously injected into mice. The results of gel retardation assay show that RDP enables to bind DNA in a dose-dependent manner, and the X-Gal staining identity that Lac Z is specifically expressed in the brain. Also, the results of Western blot and immunofluorescence staining of BDNF indicate that pVAX-BDNF complexed with RDP can be delivered into brain, and show neuroprotective properties in experimental Parkinson's disease (PD) model. The results demonstrate that RDP enables to bind and deliver DNA into the brain, resulting in specific gene expression in the neuronal cells. This strategy provides a novel, simple and effective approach for non-viral gene therapy of brain diseases.	[Fu, Ailing; Zhang, Miaomiao; Gao, Feiyan; Xu, Xingran; Chen, Zhangbao] Southwest Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China	Southwest University - China	Fu, AL (corresponding author), Southwest Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China.	Fuailing1008@yahoo.com.cn			Natural Science Foundation of China [31072098, 81273416]; Natural Science Foundation of Chongqing [CSTC 2011BB5011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work is supported by the grants from the Natural Science Foundation of China (31072098 and 81273416) and the Natural Science Foundation of Chongqing (CSTC 2011BB5011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami RC, 1999, J PHARM SCI, V88, P739, DOI 10.1021/js990042p; Adami RC, 1998, J PHARM SCI, V87, P678, DOI 10.1021/js9800477; Allen C, 2013, GENE THER, V20, P444, DOI 10.1038/gt.2012.62; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; de Silva S, 2011, CURR GENE THER, V11, P332; Du LT, 2011, HUM MOL GENET, V20, P3151, DOI 10.1093/hmg/ddr217; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Fu AL, 2007, NEUROSCI LETT, V428, P77, DOI 10.1016/j.neulet.2007.09.040; Fu AL, 2010, BIOCHEM BIOPH RES CO, V397, P257, DOI 10.1016/j.bbrc.2010.05.095; Fu AL, 2010, NEUROPHARMACOLOGY, V58, P722, DOI 10.1016/j.neuropharm.2009.12.020; Fu AL, 2012, PHARM RES-DORDR, V29, P1562, DOI 10.1007/s11095-012-0667-y; Fu AL, 2010, BRAIN RES, V1352, P208, DOI 10.1016/j.brainres.2010.06.059; Fu AL, 2008, J PSYCHIATR RES, V43, P55, DOI 10.1016/j.jpsychires.2008.01.018; Fu AL, 2005, BIOCHEM BIOPH RES CO, V328, P901, DOI 10.1016/j.bbrc.2004.12.194; Hwang DW, 2011, BIOMATERIALS, V32, P4968, DOI 10.1016/j.biomaterials.2011.03.047; Klein RL, 1999, BRAIN RES, V847, P314, DOI 10.1016/S0006-8993(99)02116-2; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Masahira N, 2005, NEUROSCI LETT, V374, P17, DOI 10.1016/j.neulet.2004.10.023; Meade BR, 2007, ADV DRUG DELIVER REV, V59, P134, DOI 10.1016/j.addr.2007.03.004; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nagykery N, 2013, J NEUROSCI METH, V212, P106, DOI 10.1016/j.jneumeth.2012.09.021; Oehlke J, 1997, FEBS LETT, V415, P196, DOI 10.1016/S0014-5793(97)01123-X; Pardridge WM, 2007, J CONTROL RELEASE, V122, P345, DOI 10.1016/j.jconrel.2007.04.001; Plenat T, 2005, BIOPHYS J, V89, P4300, DOI 10.1529/biophysj.105.061697; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Rodger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031061; Rogers ML, 2012, J CONTROL RELEASE, V157, P183, DOI 10.1016/j.jconrel.2011.08.026; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Schlachetzki F, 2004, NEUROLOGY, V62, P1275, DOI 10.1212/01.WNL.0000120551.38463.D9; Shimamura M, 2011, CURR GENE THER, V11, P491, DOI 10.2174/156652311798192833; Singh Shalini, 2006, Indian Journal of Experimental Biology, V44, P699; Tang Qing, 2000, Virologica Sinica, V15, P22; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; TUFFEREAU C, 1989, VIROLOGY, V172, P206, DOI 10.1016/0042-6822(89)90122-0; Tuffereau C, 1998, J VIROL, V72, P1085, DOI 10.1128/JVI.72.2.1085-1091.1998; Xiang L, J DRUG TARGET, V19, P632; Zhang Y, 2009, PHARM RES-DORDR, V26, P1059, DOI 10.1007/s11095-008-9815-9	41	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59642	10.1371/journal.pone.0059642	http://dx.doi.org/10.1371/journal.pone.0059642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555734	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900020
J	Kaul, H; Cui, ZF; Ventikos, Y				Kaul, Himanshu; Cui, Zhanfeng; Ventikos, Yiannis			A Multi-Paradigm Modeling Framework to Simulate Dynamic Reciprocity in a Bioreactor	PLOS ONE			English	Article							CELL-POPULATION DYNAMICS; LIQUID-SOLID-FLOWS; NUMERICAL-SIMULATION; EXTRACELLULAR-MATRIX; FLUID-DYNAMICS; TISSUE-GROWTH; TRANSPORT; PERFORMANCE; DIFFUSION; MIGRATION	Despite numerous technology advances, bioreactors are still mostly utilized as functional black-boxes where trial and error eventually leads to the desirable cellular outcome. Investigators have applied various computational approaches to understand the impact the internal dynamics of such devices has on overall cell growth, but such models cannot provide a comprehensive perspective regarding the system dynamics, due to limitations inherent to the underlying approaches. In this study, a novel multi-paradigm modeling platform capable of simulating the dynamic bidirectional relationship between cells and their microenvironment is presented. Designing the modeling platform entailed combining and coupling fully an agent-based modeling platform with a transport phenomena computational modeling framework. To demonstrate capability, the platform was used to study the impact of bioreactor parameters on the overall cell population behavior and vice versa. In order to achieve this, virtual bioreactors were constructed and seeded. The virtual cells, guided by a set of rules involving the simulated mass transport inside the bioreactor, as well as cell-related probabilistic parameters, were capable of displaying an array of behaviors such as proliferation, migration, chemotaxis and apoptosis. In this way the platform was shown to capture not only the impact of bioreactor transport processes on cellular behavior but also the influence that cellular activity wields on that very same local mass transport, thereby influencing overall cell growth. The platform was validated by simulating cellular chemotaxis in a virtual direct visualization chamber and comparing the simulation with its experimental analogue. The results presented in this paper are in agreement with published models of similar flavor. The modeling platform can be used as a concept selection tool to optimize bioreactor design specifications.	[Ventikos, Yiannis] Univ Oxford, Inst Biomed Engn, Oxford, England; Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England	University of Oxford; University of Oxford	Ventikos, Y (corresponding author), Univ Oxford, Inst Biomed Engn, Oxford, England.	yiannis.ventikos@eng.ox.ac.uk	Kaul, Himanshu/AAY-1146-2020	Kaul, Himanshu/0000-0003-1586-7486; Ventikos, Yiannis/0000-0002-8589-8117; Cui, Zhanfeng/0000-0002-9251-9752	BBSRC [BB/L003961/1, BB/D525772/1, BB/H008608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L003961/1, BB/D525772/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/H008608/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008511; Amaziane B, 2008, COMPUTAT GEOSCI, V12, P437, DOI 10.1007/s10596-008-9083-0; Annaland MS, 2005, CHEM ENG SCI, V60, P6188, DOI 10.1016/j.ces.2005.04.038; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bourloutski E, 2004, HEAT MASS TRANSF, P243; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Burgess BT, 2000, ANN BIOMED ENG, V28, P110, DOI 10.1114/1.259; Chavali AK, 2008, TRENDS IMMUNOL, V29, P589, DOI 10.1016/j.it.2008.08.006; Cheng G, 2006, BIOPHYS J, V90, P713, DOI 10.1529/biophysj.105.063701; Cheng G, 2009, BIOPHYS J, V97, P401, DOI 10.1016/j.bpj.2009.03.067; Chung CA, 2006, BIOTECHNOL BIOENG, V94, P1138, DOI 10.1002/bit.20944; Chung CA, 2010, J THEOR BIOL, V262, P267, DOI 10.1016/j.jtbi.2009.09.031; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; De Santis V, 2008, COMPEL, V27, P1307, DOI 10.1108/03321640810905783; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Farnoosh N, 2011, IEEE T DIELECT EL IN, V18, P211, DOI 10.1109/TDEI.2011.5704512; Ferziger J.H., 2002, COMPUTATIONAL METHOD; Flaibani M, 2010, IND ENG CHEM RES, V49, P859, DOI 10.1021/ie900418g; Freshney RI, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P155, DOI 10.1016/B978-012370615-7/50016-0; Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X; Galban CJ, 1999, BIOTECHNOL BIOENG, V64, P633, DOI 10.1002/(SICI)1097-0290(19990920)64:6<633::AID-BIT1>3.0.CO;2-6; Galban CJ, 1999, BIOTECHNOL BIOENG, V65, P121, DOI 10.1002/(SICI)1097-0290(19991020)65:2<121::AID-BIT1>3.0.CO;2-6; Galbusera F., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P279, DOI 10.1080/10255840701318404; Galbusera F, 2008, BIOMED MICRODEVICES, V10, P547, DOI 10.1007/s10544-008-9164-9; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Jennings NR, 2000, ARTIF INTELL, V117, P277, DOI 10.1016/S0004-3702(99)00107-1; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Kiran M, 2010, FLEXIBLE LARGE SCALE; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lapin A, 2004, IND ENG CHEM RES, V43, P4647, DOI 10.1021/ie030786k; Lapin A, 2002, CHEM ENG SCI, V57, P1419, DOI 10.1016/S0009-2509(01)00348-7; Lapin A, 2006, CHEM ENG SCI, V61, P4783, DOI 10.1016/j.ces.2006.03.003; Lapin A, 2010, ADV BIOCHEM ENG BIOT, V121, P23, DOI 10.1007/10_2009_53; LEE Y, 1995, BIOPHYS J, V69, P1284, DOI 10.1016/S0006-3495(95)79996-9; Lee Y, 1994, COMPUTER ASSISTED AN; Lemon G, 2007, MATH MED BIOL, V24, P57, DOI 10.1093/imammb/dql020; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Lonsdale RD, 1993, INT J NUMER METHOD H, V3, P3, DOI 10.1108/eb017512; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mertsching H, 2009, ADV BIOCHEM ENG BIOT, V112, P29, DOI [10.1007/10_2008_11, 10.1007/978-3-540-69357-4_2]; Muinonen-Martin A, 2012, E COMMUNICATION 1120; Muinonen-Martin A, 2012, E COMMUNICATION 1121; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Patankar S.V., 2018, NUMERICAL HEAT TRANS; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Portillo PM, 2007, AICHE J, V53, P119, DOI 10.1002/aic.11054; Richmond P, 2010, BRIEF BIOINFORM, V11, P334, DOI 10.1093/bib/bbp073; Selivanova OM, 2003, J BIOL CHEM, V278, P36311, DOI 10.1074/jbc.M304713200; Singh H, 2009, ADV BIOCHEM ENG BIOT, V112, P231, DOI [10.1007/10_2008_6, 10.1007/978-3-540-69357-4_10]; Smallwood R, 2006, I S BIOMED IMAGING, P816; Stathopoulos GT, 2008, MOL CANCER RES, V6, P364, DOI 10.1158/1541-7786.MCR-07-0309; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Sun T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008515; Thorne BC, 2007, BRIEF BIOINFORM, V8, P245, DOI 10.1093/bib/bbm024; Tsompanopoulou PE, 2008, J COMPUT INF SCI ENG, V8, DOI 10.1115/1.2966384; VANDOORMAAL JP, 1984, NUMER HEAT TRANSFER, V7, P147, DOI 10.1080/01495728408961817; Viswanathan S, 2003, CYTOTECHNOLOGY, V41, P75, DOI 10.1023/A:1024866504538; Wang WG, 2002, CANCER RES, V62, P6278; Weidt C, 2004, STEM CELLS, V22, P890, DOI 10.1634/stemcells.22-6-890; Wells A, 2000, ADV CANCER RES, V78, P31; Wendt D, 2009, ADV BIOCHEM ENG BIOT, V112, P1, DOI [10.1007/978-3-540-69357-4_1, 10.1007/10_2008_1]; Weyand B, 2009, ADV BIOCHEM ENG BIOT, V112, P251, DOI [10.1007/10_2008_13, 10.1007/978-3-540-69357-4_11]; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	67	21	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59671	10.1371/journal.pone.0059671	http://dx.doi.org/10.1371/journal.pone.0059671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555740	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900022
J	Tang, LY; An, JJ; Xie, ZD; Dehghan, S; Seto, D; Xu, WB; Ji, YX				Tang, Liuying; An, Junjing; Xie, Zhengde; Dehghan, Shoaleh; Seto, Donald; Xu, Wenbo; Ji, Yixin			Genome and Bioinformatic Analysis of a HAdV-B14p1 Virus Isolated from a Baby with Pneumonia in Beijing, China	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; HUMAN ADENOVIRUS; EPIDEMIC KERATOCONJUNCTIVITIS; COMPUTATIONAL ANALYSIS; FATAL PNEUMONIA; SEQUENCE; OUTBREAK; SEROTYPE; GENE	The genome of HAdV-B14p1 strain BJ430, isolated from a six-month-old baby diagnosed with bronchial pneumonia at the Beijing Children's Hospital in December 2010, was sequenced, analyzed, and compared with reference adenovirus genome sequences archived in GenBank. This genome is 34,762 bp in length, remarkably presenting 99.9% identity with the genome from HAdV14p1 strain 303600, which was isolated in the USA (2006). Even more remarkable, it is 99.7% identical with the HAdV-B14p (prototype "de Wit'' strain) genome, isolated from The Netherlands in 1955. The patient and its parents presumably had no or limited contact with persons from the USA and Ireland, both of which reported outbreaks of the re-emergent virus HAdV-14p1 recently. These genome data, its analysis, and this report provide a reference for any additional HAdV-B14 outbreak in China and provide the basis for the development of adenovirus vaccines and molecular pathogen surveillance protocols in high-risk areas.	[Tang, Liuying; Xu, Wenbo; Ji, Yixin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [An, Junjing] Fengtai Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Xie, Zhengde] Capital Med Univ, Affiliated Beijing Childrens Hosp, Beijing Inst Pediat Res, Beijing, Peoples R China; [Dehghan, Shoaleh; Seto, Donald] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Dehghan, Shoaleh] American Univ, Dept Chem, Washington, DC 20016 USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; George Mason University; American University	Tang, LY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	tangly812@hotmail.com	Tang, Liuying/GXF-3556-2022		"China Mega-Project for Infectious Disease" from the People's Republic of China [2011ZX10004-001]	"China Mega-Project for Infectious Disease" from the People's Republic of China	This work was supported by grants from the "China Mega-Project for Infectious Disease (2011ZX10004-001)'' from the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr MJ, 2011, EMERG INFECT DIS, V17, P1402, DOI [10.3201/eid1708.101760, 10.3201/1708.101760]; Dehghan S, 2011, J VIROL, V85, P11540, DOI 10.1128/JVI.06051-11; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; GUO DF, 1988, MICROBIOL IMMUNOL, V32, P1107, DOI 10.1111/j.1348-0421.1988.tb01475.x; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Houng HSH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-116; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; Kajon AE, 2010, J INFECT DIS, V202, P93, DOI 10.1086/653083; Liu EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024491; Matsushima Y, 2012, EMERG INFECT DIS, V18, P846, DOI 10.3201/eid1805.111584; Mei YF, 1996, J VIROL, V70, P3688, DOI 10.1128/JVI.70.6.3688-3697.1996; MEVZOS L. M., 1966, VOP VIRUSOL, V11, P426; O'Flanagan D, 2011, EUROSURVEILLANCE, V16; Ou ZY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-122; Purkayastha A, 2005, J VIROL, V79, P2559, DOI 10.1128/JVI.79.4.2559-2572.2005; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Robinson CM, 2009, J VIROL, V83, P8980, DOI 10.1128/JVI.00786-09; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Seto J, 2009, VIRUS RES, V143, P94, DOI 10.1016/j.virusres.2009.03.011; Singh G, 2012, J VIROL, V86, P4693, DOI 10.1128/JVI.06969-11; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; VANDERVEEN J, 1957, AM J HYG, V65, P119; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Yang ZH, 2009, J CLIN MICROBIOL, V47, P3082, DOI 10.1128/JCM.00282-09; Zhang QW, 2012, J VIROL, V86, P7019, DOI 10.1128/JVI.00814-12; Zhou XH, 2012, INVEST OPHTH VIS SCI, V53, P2804, DOI 10.1167/iovs.12-9656; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	29	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60345	10.1371/journal.pone.0060345	http://dx.doi.org/10.1371/journal.pone.0060345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555956	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900070
J	Bhowmik, A; Das, N; Pal, U; Mandal, M; Bhattacharya, S; Sarkar, M; Jaisankar, P; Maiti, NC; Ghosh, MK				Bhowmik, Arijit; Das, Nilanjana; Pal, Uttam; Mandal, Madhumita; Bhattacharya, Seemana; Sarkar, Moumita; Jaisankar, Parasuraman; Maiti, Nakul C.; Ghosh, Mrinal K.			2,2 '-Diphenyl-3,3 '-Diindolylmethane: A Potent Compound Induces Apoptosis in Breast Cancer Cells by Inhibiting EGFR Pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BAX-ALPHA; DEATH; EXPRESSION; PROTEIN; ACTIVATION; DOCKING; STAT3; FAMILY; DIINDOLYLMETHANE	Despite recent advances in medicine, 30-40% of patients with breast cancer show recurrence underscoring the need for improved effective therapy. In this study, by in vitro screening we have selected a novel synthetic indole derivative 2,2'-diphenyl-3,3'-diindolylmethane (DPDIM) as a potential anti- breast cancer agent. DPDIM induces apoptosis both in vitro in breast cancer cells MCF7, MDA-MB 231 and MDA-MB 468 and in vivo in 7,12-dimethylbenz[alpha]anthracene (DMBA) induced Sprague-Dawley (SD) rat mammary tumor. Our in vitro studies show that DPDIM exerts apoptotic effect by negatively regulating the activity of EGFR and its downstream molecules like STAT3, AKT and ERK1/2 which are involved in the proliferation and survival of these cancer cells. In silico predictions also suggest that DPDIM may bind to EGFR at its ATP binding site. DPDIM furthermore inhibits EGF induced increased cell viability. We have also shown decreased expression of pro-survival factor Bcl-XL as well as increase in the level of pro-apoptotic proteins like Bax, Bad, Bim in DPDIM treated cells in vitro and in vivo. Our results further indicate that the DPDIM induced apoptosis is mediated through mitochondrial apoptotic pathway involving the caspase-cascade. To the best of our knowledge this is the first report of DPDIM for its anticancer activity. Altogether this report suggests that DPDIM could be an effective therapeutic agent for breast cancer.	[Bhowmik, Arijit; Das, Nilanjana; Bhattacharya, Seemana; Sarkar, Moumita; Ghosh, Mrinal K.] IICB, CSIR, Signal Transduct Canc & Stem Cells Lab, Div Canc Biol & Inflammatory Disorder, Kolkata, W Bengal, India; [Pal, Uttam; Maiti, Nakul C.] IICB, CSIR, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India; [Mandal, Madhumita; Jaisankar, Parasuraman] IICB, CSIR, Div Chem, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ghosh, MK (corresponding author), IICB, CSIR, Signal Transduct Canc & Stem Cells Lab, Div Canc Biol & Inflammatory Disorder, Kolkata, W Bengal, India.	mrinal.res@gmail.com	Maiti, Nakul/GLR-3207-2022; Jaisankar, Parasuraman/C-1553-2009; Pal, Uttam/A-8544-2013	Maiti, Nakul/0000-0002-8498-6502; Jaisankar, Parasuraman/0000-0003-0583-4920; Pal, Uttam/0000-0003-2110-4610; Sarkar, Dr Moumita/0000-0002-7437-5353	Council of Scientific and Industrial Research, CSIR [EMPOWER: OLP-002]; DST [SR/SO/HS- 0150/2010]	Council of Scientific and Industrial Research, CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by grants provided by Council of Scientific and Industrial Research, CSIR (EMPOWER: OLP-002) and DST (SR/SO/HS- 0150/2010) to Dr. Mrinal K. Ghosh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Alam A, 2012, J BIOL CHEM, V287, P24844, DOI 10.1074/jbc.M112.341321; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Bajt ML, 2001, TOXICOL APPL PHARM, V175, P243, DOI 10.1006/taap.2001.9242; Bargou RC, 1996, J CLIN INVEST, V97, P2651, DOI 10.1172/JCI118715; BARGOU RC, 1995, INT J CANCER, V60, P854, DOI 10.1002/ijc.2910600622; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J; Chen JH, 1998, P NATL ACAD SCI USA, V95, P2648, DOI 10.1073/pnas.95.5.2648; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Contractor R, 2005, CANCER RES, V65, P2890, DOI 10.1158/0008-5472.CAN-04-3781; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; GODDEN J, 1992, ANTICANCER RES, V12, P1683; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Guturi KKN, 2012, J BIOL CHEM, V287, P18287, DOI 10.1074/jbc.M111.324798; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Laskin JJ, 2004, CANCER TREAT REV, V30, P1, DOI 10.1016/j.ctrv.2003.10.002; Le Gall M, 2000, MOL BIOL CELL, V11, P1103, DOI 10.1091/mbc.11.3.1103; Liao QH, 2011, MED CHEM, V7, P24, DOI 10.2174/157340611794072698; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Lubet RA, 2011, ONCOL REP, V26, P731, DOI 10.3892/or.2011.1316; Maldonado-Rojas W, 2012, MOLECULES, V17, P8118, DOI 10.3390/molecules17078118; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Moiseeva EP, 2006, APOPTOSIS, V11, P799, DOI 10.1007/s10495-006-5877-5; Moiseeva EP, 2007, CARCINOGENESIS, V28, P435, DOI 10.1093/carcin/bgl171; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murray SA, 2005, J CELL BIOCHEM, V95, P875, DOI 10.1002/jcb.20414; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Pal C, 2007, BIOORG MED CHEM LETT, V17, P4924, DOI 10.1016/j.bmcl.2007.06.025; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; PAVELIC ZP, 1980, CANCER RES, V40, P2160; Pradhan PK, 2005, SYNTHESIS-STUTTGART, P1779, DOI 10.1055/s-2005-869897; Roy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028493; Rudra DS, 2012, J PINEAL RE IN PRESS; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Selvendiran K, 2008, CELL CYCLE, V7, P81, DOI 10.4161/cc.7.1.5103; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Wang ZW, 2008, MOL CANCER THER, V7, P341, DOI 10.1158/1535-7163.MCT-07-0476; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077; Zhu CY, 2003, FOOD CHEM TOXICOL, V41, P455, DOI 10.1016/S0278-6915(02)00278-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	62	31	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59798	10.1371/journal.pone.0059798	http://dx.doi.org/10.1371/journal.pone.0059798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555785	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200039
J	Daftary, GS; Zheng, Y; Tabbaa, ZM; Schoolmeester, JK; Gada, RP; Grzenda, AL; Mathison, AJ; Keeney, GL; Lomberk, GA; Urrutia, R				Daftary, Gaurang S.; Zheng, Ye; Tabbaa, Zaid M.; Schoolmeester, John K.; Gada, Ravi P.; Grzenda, Adrienne L.; Mathison, Angela J.; Keeney, Gary L.; Lomberk, Gwen A.; Urrutia, Raul			A Novel Role of the Sp/KLF Transcription Factor KLF11 in Arresting Progression of Endometriosis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; PERITONEAL-FLUID; MOUSE MODEL; CELL-LINE; MICE; ESTABLISHMENT; PROTEIN	Endometriosis affects approximately 10% of young, reproductive-aged women. Disease associated pelvic pain; infertility and sexual dysfunction have a significant adverse clinical, social and financial impact. As precise disease etiology has remained elusive, current therapeutic strategies are empiric, unfocused and often unsatisfactory. Lack of a suitable genetic model has impaired further translational research in the field. In this study, we evaluated the role of the Sp/KLF transcription factor KLF11/Klf11 in the pathogenesis of endometriosis. KLF11, a human disease-associated gene is etiologically implicated in diabetes, uterine fibroids and cancer. We found that KLF11 expression was diminished in human endometriosis implants and further investigated its pathogenic role in Klf11-/- knockout mice with surgically induced endometriotic lesions. Lesions in Klf11-/- animals were large and associated with prolific fibrotic adhesions resembling advanced human disease in contrast to wildtype controls. To determine phenotype-specificity, endometriosis was also generated in Klf9-/- animals. Unlike in Klf11-/- mice, lesions in Klf9-/- animals were neither large, nor associated with a significant fibrotic response. KLF11 also bound to specific elements located in the promoter regions of key fibrosis-related genes from the Collagen, MMP and TGF-beta families in endometrial stromal cells. KLF11 binding resulted in transcriptional repression of these genes. In summary, we identify a novel pathogenic role for KLF11 in preventing de novo disease-associated fibrosis in endometriosis. Our model validates in vivo the phenotypic consequences of dysregulated Klf11 signaling. Additionally, it provides a robust means not only for further detailed mechanistic investigation but also the ability to test any emergent translational ramifications thereof, so as to expand the scope and capability for treatment of endometriosis.	[Daftary, Gaurang S.; Zheng, Ye; Tabbaa, Zaid M.; Gada, Ravi P.] Mayo Clin, Dept Obstet & Gynecol, Lab Translat Epigenet Reprod, Rochester, MN 55905 USA; [Schoolmeester, John K.; Keeney, Gary L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Grzenda, Adrienne L.; Mathison, Angela J.; Lomberk, Gwen A.; Urrutia, Raul] Mayo Clin, Epigen Translat Program, Ctr Individualized Med, Epigenet & Chromatin Dynam Lab,Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Daftary, GS (corresponding author), Mayo Clin, Dept Obstet & Gynecol, Lab Translat Epigenet Reprod, Rochester, MN 55905 USA.	daftary.gaurang@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Grzenda, Adrienne L/K-4421-2019	Lomberk, Gwen/0000-0001-5463-789X; Grzenda, Adrienne L/0000-0001-5952-6953; Mathison, Angela/0000-0002-6763-2710	Mayo Clinic Institutional Funds; NIH [DK52913]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913] Funding Source: NIH RePORTER	Mayo Clinic Institutional Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Mayo Clinic Institutional Funds to GSD and NIH Grant DK52913 to RU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, Fertil Steril, V43, P351; Balasch J, 1996, HUM REPROD, V11, P387, DOI 10.1093/HUMREP/11.2.387; Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Bruner-Tran KL, 2002, ANN NY ACAD SCI, V955, P328, DOI 10.1111/j.1749-6632.2002.tb02793.x; Bruner-Tran KL, 2002, J CLIN ENDOCR METAB, V87, P4782, DOI 10.1210/jc.2002-020418; Burns KA, 2012, ENDOCRINOLOGY, V153, P3960, DOI 10.1210/en.2012-1294; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Carter, 1994, J Am Assoc Gynecol Laparosc, V1, pS6; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Daftary GS, 2012, J BIOL CHEM, V287, P7010, DOI 10.1074/jbc.M111.266007; Daftary GS, 2011, MOL ENDOCRINOL, V25, P1539, DOI 10.1210/me.2011-0001; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Du HL, 2005, MOL ENDOCRINOL, V19, P2222, DOI 10.1210/me.2004-0336; Ellenrieder V, 2004, GASTROENTEROLOGY, V127, P607, DOI 10.1053/j.gastro.2004.05.018; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fortin M, 2003, FERTIL STERIL, V80, P832, DOI 10.1016/S0015-0282(03)00986-5; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Griffiths EA, 2008, SEMIN HEMATOL, V45, P23, DOI 10.1053/j.seminhematol.2007.11.007; Guan YM, 2003, GYNECOL OBSTET INVES, V55, P7, DOI 10.1159/000068950; GUIGO R, 1995, J MOL BIOL, V253, P51, DOI 10.1006/jmbi.1995.0535; GUZICK DS, 1982, FERTIL STERIL, V38, P171; HIDEIKU S, 1995, EXP TOXICOL PATHOL, V47, P287, DOI 10.1016/S0940-2993(11)80261-7; Hirata T, 2005, HUM REPROD, V20, P2092, DOI 10.1093/humrep/dei012; Hoeger KM, 1999, CLIN OBSTET GYNECOL, V42, P611, DOI 10.1097/00003081-199909000-00015; HUANG JC, 1994, J CLIN ENDOCR METAB, V79, P1097, DOI 10.1210/jc.79.4.1097; Huang JC, 1996, FERTIL STERIL, V65, P931, DOI 10.1016/S0015-0282(16)58263-6; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Johnson KL, 1997, ENVIRON HEALTH PERSP, V105, P750, DOI 10.1289/ehp.97105750; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee B, 2009, BIOL REPROD, V80, P79, DOI 10.1095/biolreprod.108.070391; Lessey BA, 1996, J STEROID BIOCHEM, V59, P31, DOI 10.1016/S0960-0760(96)00103-3; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Niu X, 2007, DIABETOLOGIA, V50, P1433, DOI 10.1007/s00125-007-0667-3; Olive DL, 2001, NEW ENGL J MED, V345, P266, DOI 10.1056/NEJM200107263450407; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; OOSTERLYNCK DJ, 1994, OBSTET GYNECOL, V83, P287; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rossi G, 2000, ARCH GYNECOL OBSTET, V263, P102, DOI 10.1007/s004040050005; Simmen FA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-41; Simmen RCM, 2004, J BIOL CHEM, V279, P29286, DOI 10.1074/jbc.M403139200; SIMMS JS, 1991, OBSTET GYNECOL, V78, P850; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Styer AK, 2008, ENDOCRINOLOGY, V149, P506, DOI 10.1210/en.2007-1225; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Uchida H, 2005, ENDOCRINOLOGY, V146, P5365, DOI 10.1210/en.2005-0359; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Yin P, 2011, FERTIL STERIL, V96, P439, DOI 10.1016/j.fertnstert.2011.05.062; Zhang DY, 2002, ENDOCRINOLOGY, V143, P62, DOI 10.1210/en.143.1.62; Zhang XL, 2003, J BIOL CHEM, V278, P21474, DOI 10.1074/jbc.M212098200	58	29	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60165	10.1371/journal.pone.0060165	http://dx.doi.org/10.1371/journal.pone.0060165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555910	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200089
J	Darlow, HM; Dylman, AS; Gheorghiu, AI; Matthews, WJ				Darlow, Hannah M.; Dylman, Alexandra S.; Gheorghiu, Ana I.; Matthews, William J.			Do Changes in the Pace of Events Affect One-Off Judgments of Duration?	PLOS ONE			English	Article							TEMPORAL DISCRIMINATION; TIME PERCEPTION; INTERNAL CLOCK; CLICK TRAINS; INTERVAL; MODEL; PREDICTABILITY; PSYCHOPHYSICS; SEGMENTATION; INTERFERENCE	Five experiments examined whether changes in the pace of external events influence people's judgments of duration. In Experiments 1a-1c, participants heard pieces of music whose tempo accelerated, decelerated, or remained constant. In Experiment 2, participants completed a visuo-motor task in which the rate of stimulus presentation accelerated, decelerated, or remained constant. In Experiment 3, participants completed a reading task in which facts appeared onscreen at accelerating, decelerating, or constant rates. In all experiments, the physical duration of the to-be-judged interval was the same across conditions. We found no significant effects of temporal structure on duration judgments in any of the experiments, either when participants knew that a time estimate would be required (prospective judgments) or when they did not (retrospective judgments). These results provide a starting point for the investigation of how temporal structure affects one-off judgments of duration like those typically made in natural settings.	[Darlow, Hannah M.; Dylman, Alexandra S.; Gheorghiu, Ana I.; Matthews, William J.] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England	University of Essex	Matthews, WJ (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.	will@essex.ac.uk		Gheorghiu, Ana Ioana/0000-0001-9102-4312	British Academy	British Academy	This research was funded by the British Academy (http://www.britac.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1977, PERCEPT PSYCHOPHYS, V21, P527, DOI 10.3758/BF03198733; Allan K., 1984, ANN NEW YORK ACAD SC, V423; [Anonymous], 1969, EXPERIENCE TIME; Beckmann JS, 2009, J EXP PSYCHOL ANIM B, V35, P525, DOI 10.1037/a0015891; Bisson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033049; BLOCK RA, 1978, J EXP PSYCHOL-HUM L, V4, P656, DOI 10.1037/0278-7393.4.6.656; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Boltz MG, 1998, J EXP PSYCHOL HUMAN, V24, P1087, DOI 10.1037/0096-1523.24.4.1087; Boltz MG, 1998, PERCEPT PSYCHOPHYS, V60, P768, DOI 10.3758/BF03206062; Brown GDA, 2005, J EXP PSYCHOL HUMAN, V31, P919, DOI 10.1037/0096-1523.31.5.919; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; BROWN SW, 1992, PERCEPTION, V21, P545, DOI 10.1068/p210545; BUFFARDI L, 1971, PERCEPT PSYCHOPHYS, V10, P292, DOI 10.3758/BF03212828; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Droit-Volet S, 2010, ACTA PSYCHOL, V135, P226, DOI 10.1016/j.actpsy.2010.07.003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forster KI, 2003, BEHAV RES METHODS IN, P35; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Hedges LV, 2014, STAT METHODS META AN; Israeli N, 1930, ARCH PSYCHOL, V19, P5; Jones LA, 2011, Q J EXP PSYCHOL, V64, P363, DOI 10.1080/17470218.2010.502580; Jones LA, 2009, Q J EXP PSYCHOL, V62, P2171, DOI 10.1080/17470210902782200; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KILLEEN PR, 1988, PSYCHOL REV, V95, P274, DOI 10.1037/0033-295X.95.2.274; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Makin ADJ, 2012, ACTA PSYCHOL, V139, P524, DOI 10.1016/j.actpsy.2012.01.013; Matthews WJ, 2013, COGNITIVE PSYCHOL, V66, P259, DOI 10.1016/j.cogpsych.2013.01.001; Matthews WJ, 2011, JUDGM DECIS MAK, V6, P843; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P1617, DOI 10.1037/a0022193; Matthews WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019815; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Matthews WJ, 2011, BEHAV PROCESS, V86, P68, DOI 10.1016/j.beproc.2010.09.006; Matthews WJ, 2009, Q J EXP PSYCHOL, V62, P2014, DOI 10.1080/17470210802649285; Matthews WJ, 2009, JUDGM DECIS MAK, V4, P64; NAKAJIMA Y, 1987, PERCEPTION, V16, P485, DOI 10.1068/p160485; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pariyadath V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049362; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Poynter D., 1989, ADV PSYCHOL, VVol. 59, P305, DOI [10.1016/S0166-4115(08)61045-6, DOI 10.1016/S0166-4115(08)61045-6, 10.1016/s0166-4115(08)61045-6]; POYNTER WD, 1983, MEM COGNITION, V11, P77, DOI 10.3758/BF03197664; R Core Team, 2012, R LANG ENV STAT COMP; Rammsayer T, 2001, PSYCHON B REV, V8, P270, DOI 10.3758/BF03196161; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; THOMAS EAC, 1974, PERCEPT PSYCHOPHYS, V16, P449, DOI 10.3758/BF03198571; Tobin S, 2012, MEM COGNITION, V40, P1339, DOI 10.3758/s13421-012-0231-3; Tobin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009271; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; WARD LM, 1970, J EXP PSYCHOL, V84, P27, DOI 10.1037/h0028949; WEARDEN JH, 1992, J EXP PSYCHOL ANIM B, V18, P134, DOI 10.1037/0097-7403.18.2.134; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P289; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wetzels R, 2012, AM STAT, V66, P104, DOI 10.1080/00031305.2012.695956; ZAKAY D, 1994, MEM COGNITION, V22, P344, DOI 10.3758/BF03200861; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zauberman G, 2010, PSYCHOL SCI, V21, P133, DOI 10.1177/0956797609356420; Zellner A., 1980, BAYESIAN STAT, V31, P585, DOI [10.1007/BF02888369, DOI 10.1007/BF02888369]	64	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59847	10.1371/journal.pone.0059847	http://dx.doi.org/10.1371/journal.pone.0059847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555804	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000317262200047
J	Ghamlouch, H; Ouled-Haddou, H; Damaj, G; Royer, B; Gubler, B; Marolleau, JP				Ghamlouch, Hussein; Ouled-Haddou, Hakim; Damaj, Gandhi; Royer, Bruno; Gubler, Brigitte; Marolleau, Jean-Pierre			A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis In Vitro	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BONE-MARROW; SURVIVAL CAPACITY; CD38 EXPRESSION; 1ST TREATMENT; LYMPH-NODE; STIMULATION; RESISTANCE; BLOOD; APRIL	B-chronic lymphocytic leukemia (B-CLL), the most common human leukemia, is characterized by predominantly nondividing malignant mature CD5+ B lymphocytes with an apoptosis defect. Various microenvironmental stimuli confer a growth advantage on these leukemic cells and extend their survival in vivo. Nevertheless, when cultured in vitro, CLL B-cells rapidly die from apoptosis. Certain cytokines may extend the survival capacity of CLL B-cells in vitro and individual antiapoptotic effects of several cytokines have been reported. The potential cumulative effect of such cytokines has not been studied. We therefore investigated the effects on CLL B-cells survival in vitro of humoral factors, polyclonal lymphocyte activators and a combination of cytokines known for their anti-apoptotic effects. Purified CLL B-cells were cultured in the presence or absence of various soluble molecules and the leukemic cell response was assessed in terms of viability. Apoptotic cell death was detected by flow cytometry using annexinV and 7-amino-actinomycin. The survival of CLL B-cells in vitro was highly variable. When tested separately, cytokines (IL-2, -6, -10, -12, -15, -21, BAFF and APRIL) improved CLL B cell survival moderately; in combination, they significantly enhanced survival of these cells, even up to 7 days of culture. We also report that humoral factors from autologous serum are important for survival of these malignant cells. Our findings support the concept that the CLL microenvironment is critical and suggest that soluble factors may contribute directly to the prolonged survival of CLL B-cells. Therefore, the combination of cytokines we describe as providing strong resistance to apoptosis in vitro might be used to improve the treatment of CLL.	[Ghamlouch, Hussein; Ouled-Haddou, Hakim; Damaj, Gandhi; Royer, Bruno; Gubler, Brigitte; Marolleau, Jean-Pierre] Univ Picardie Jules Verne, UFR Med, EA4666, Immunol Lab, Amiens, France; [Gubler, Brigitte] CHU Amiens, Lab Oncobiol Mol, Amiens, France; [Damaj, Gandhi; Royer, Bruno; Marolleau, Jean-Pierre] CHU Amiens, Serv Hematol Clin & Therapie Cellulaire, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Ghamlouch, H (corresponding author), Univ Picardie Jules Verne, UFR Med, EA4666, Immunol Lab, Amiens, France.	hussein.ghamlouch@hotmail.com; marolleau.jean-pierre@chu-amiens.fr	Gubler, Brigitte/D-9479-2018	Ghamlouch, Hussein/0000-0002-2932-1081	Centre Hospitalo-Universitaire d'Amiens (CHU d'Amiens); Conseil Regional de Picardie	Centre Hospitalo-Universitaire d'Amiens (CHU d'Amiens); Conseil Regional de Picardie(Region Hauts-de-France)	This work was supported by Centre Hospitalo-Universitaire d'Amiens (CHU d'Amiens: www.chu-amiens.fr) and Conseil Regional de Picardie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Barragan M, 2003, LEUKEMIA LYMPHOMA, V44, P1865, DOI 10.1080/1042819031000110964; Barragan M, 2002, BLOOD, V99, P2969, DOI 10.1182/blood.V99.8.2969; Bomstein Y, 2003, EUR J HAEMATOL, V70, P290, DOI 10.1034/j.1600-0609.2003.00063.x; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2010, SEMIN CANCER BIOL, V20, P424, DOI 10.1016/j.semcancer.2010.09.005; Caligaris-Cappio F, 2007, BEST PRACT RES CL HA, V20, P385, DOI 10.1016/j.beha.2007.02.005; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; Decker T, 2010, ANN HEMATOL, V89, P1125, DOI 10.1007/s00277-010-0994-1; FLUCKIGER AC, 1993, J EXP MED, V178, P1473, DOI 10.1084/jem.178.5.1473; Gamberale R, 2001, LEUKEMIA, V15, P1860, DOI 10.1038/sj.leu.2402288; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Huh YO, 2001, AM J CLIN PATHOL, V116, P437, DOI 10.1309/438N-E0FH-A5PR-XCAC; Kamdje AHN, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.17; Kater AP, 2007, BLOOD, V110, P2811, DOI 10.1182/blood-2007-01-068932; Kay NE, 2007, LEUKEMIA RES, V31, P899, DOI 10.1016/j.leukres.2006.11.024; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Krysov S, 2012, BLOOD, V119, P170, DOI 10.1182/blood-2011-07-370403; Levesque MC, 2006, LEUKEMIA RES, V30, P24, DOI 10.1016/j.leukres.2005.05.022; Ma JJ, 2011, CYTOKINE, V56, P133, DOI 10.1016/j.cyto.2011.07.011; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI200523409; Molica S, 2010, EUR J HAEMATOL, V85, P314, DOI 10.1111/j.1600-0609.2010.01482.x; Nadkarni JJ, 1998, CANCER BIOTHER RADIO, V13, P269, DOI 10.1089/cbr.1998.13.269; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Ostanin AA, 2011, B EXP BIOL MED+, V151, P133, DOI 10.1007/s10517-011-1275-2; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pedersen IM, 2002, BLOOD, V100, P1795, DOI 10.1182/blood.V100.5.1795.h81702001795_1795_1801; Plander M, 2009, LEUKEMIA, V23, P2118, DOI 10.1038/leu.2009.145; Schuhknecht S, 2002, CANCER BIOTHER RADIO, V17, P495, DOI 10.1089/108497802760804718; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Tecchio C, 2011, EUR J HAEMATOL, V87, P228, DOI 10.1111/j.1600-0609.2011.01650.x; Trentin L, 1996, BLOOD, V87, P3327, DOI 10.1182/blood.V87.8.3327.bloodjournal8783327; Wickremasinghe RG, 2001, BRIT J HAEMATOL, V114, P608, DOI 10.1046/j.1365-2141.2001.02978.x; Yan XJ, 2011, BLOOD, V118, P5201, DOI 10.1182/blood-2011-03-342436; Zolnierczyk JD, 2011, MED ONCOL	40	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60370	10.1371/journal.pone.0060370	http://dx.doi.org/10.1371/journal.pone.0060370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555960	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500130
J	Hiremath, S; Akbari, A; Shabana, W; Fergusson, DA; Knoll, GA				Hiremath, Swapnil; Akbari, Ayub; Shabana, Wael; Fergusson, Dean A.; Knoll, Greg A.			Prevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar To Intravenous? A Systematic Review of the Evidence	PLOS ONE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; ACUTE-RENAL-FAILURE; INDUCED NEPHROPATHY; SODIUM-BICARBONATE; CARDIAC-CATHETERIZATION; INDUCED NEPHROTOXICITY; SALINE HYDRATION; RANDOMIZED-TRIAL; RISK; ANGIOGRAPHY	Background: Pre-procedural intravenous fluid administration is an effective prophylaxis measure for contrast-induced acute kidney injury. For logistical ease, the oral route is an alternative to the intravenous. The objective of this study was to compare the efficacy of the oral to the intravenous route in prevention of contrast-induced acute kidney injury. Study Design: A systematic review and meta-analysis of randomised trials with a stratified analysis and metaregression. Databases included MEDLINE (1950 to November 23 2011), EMBASE (1947 to week 47 2011), Cochrane CENTRAL (3rd quarter 2011). Two reviewers identified relevant trials and abstracted data. Settings and Population: Trials including patients undergoing a contrast enhanced procedure. Selection Criteria: Randomised controlled trial; adult (. 18 years) population; comparison of oral versus intravenous volume expansion. Intervention: Oral route of volume expansion compared to the intravenous route. Outcomes: Any measure of acute kidney injury, need for renal replacement therapy, hospitalization and death. Results: Six trials including 513 patients met inclusion criteria. The summary odds ratio was 1.19 (95% CI 0.46, 3.10, p = 0.73) suggesting no difference between the two routes of volume expansion. There was significant heterogeneity (Cochran's Q = 11.65, p = 0.04; I-2 = 57). In the stratified analysis, inclusion of the five studies with a prespecified oral volume expansion protocol resulted in a shift towards oral volume expansion (OR 0.75, 95% CI 0.37, 1.50, p = 0.42) and also resolved the heterogeneity (Q = 3.19, P = 0.53; I-2 = 0). Limitations: Small number of studies identified; lack of hard clinical outcomes. Conclusion: The oral route may be as effective as the intravenous route for volume expansion for contrast-induced acute kidney injury prevention. Adequately powered trials with hard endpoints should be done given the potential advantages of oral (e. g. reduced patient burden and cost) over intravenous volume expansion.	[Hiremath, Swapnil; Akbari, Ayub; Knoll, Greg A.] Univ Ottawa, Fac Med, Div Nephrol, Ottawa, ON, Canada; [Hiremath, Swapnil; Akbari, Ayub; Fergusson, Dean A.; Knoll, Greg A.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Shabana, Wael] Univ Ottawa, Fac Med, Dept Med Imaging, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Hiremath, S (corresponding author), Univ Ottawa, Fac Med, Div Nephrol, Ottawa, ON, Canada.	shiremath@toh.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416; Fergusson, Dean/0000-0002-3389-2485; Knoll, Greg/0000-0001-5442-9310	Department of Medicine; Ottawa Hospital; University of Ottawa; University of Ottawa Chair in Clinical Transplantation Research	Department of Medicine; Ottawa Hospital; University of Ottawa; University of Ottawa Chair in Clinical Transplantation Research	This study was not directly funded by any source. However, SH and AA are supported by research salary awards from the Department of Medicine, The Ottawa Hospital and the University of Ottawa. GK is supported by a University of Ottawa Chair in Clinical Transplantation Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Radiology A, 2010, ACR MAN CONTR MED, P25; Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038; Brar SS, 2009, CLIN J AM SOC NEPHRO, V4, P1584, DOI 10.2215/CJN.03120509; Cho R, 2010, J INTERV CARDIOL, V23, P460, DOI 10.1111/j.1540-8183.2010.00585.x; CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dial J, 2012, LOCATION CT SCAN CTR; Duggan C, 1992, MMWR Recomm Rep, V41, P1; Dussol B, 2006, NEPHROL DIAL TRANSPL, V21, P2120, DOI 10.1093/ndt/gfl133; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 1997, SYSTEMATIC REV HLTH; Endre ZH, 2010, NEPHROL DIAL TRANSPL, V25, P107, DOI 10.1093/ndt/gfp501; Gruberg L, 2001, CATHETER CARDIO INTE, V52, P409, DOI 10.1002/ccd.1093; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Ishikawa T, 2010, J OCCUP HEALTH, V52, P209, DOI 10.1539/joh.L9156; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Katzberg RW, 2010, RADIOLOGY, V256, P21, DOI 10.1148/radiol.10092000; Katzberg RW, 2006, KIDNEY INT, V69, pS3, DOI 10.1038/sj.ki.5000366; Kim SM, 2010, AM J KIDNEY DIS, V55, P1018, DOI 10.1053/j.ajkd.2009.10.057; Klein LW, 2009, CATHETER CARDIO INTE, V74, P728, DOI 10.1002/ccd.22113; Lawlor DK, 2007, ANN VASC SURG, V21, P593, DOI 10.1016/j.avsg.2007.07.006; Marenzi G, 2009, ANN INTERN MED, V150, P170, DOI 10.7326/0003-4819-150-3-200902030-00006; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2006, REV CARDIOVASC MED, V7, P177; McCullough PA, 2006, AM J CARDIOL, V98, p27K, DOI 10.1016/amjcard.2006.01.022; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Persson PB, 2005, KIDNEY INT, V68, P14, DOI 10.1111/j.1523-1755.2005.00377.x; Reade MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6941; Sheldon WC, 2001, CATHETER CARDIO INTE, V53, P40, DOI 10.1002/ccd.1127; SMITH GD, 1994, BMJ-BRIT MED J, V308, P72, DOI 10.1136/bmj.308.6921.72; Stacul F, 2006, AM J CARDIOL, V98, p59K, DOI 10.1016/j.amjcard.2006.01.024; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Taylor AJ, 1998, CHEST, V114, P1570, DOI 10.1378/chest.114.6.1570; The Royal Australian and New Zealand College of Radiologists R, 2009, GUID IOD CONTR ADM, P14; To P, 2011, NEPHROLOGY, V16, P57; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Weisbord SD, 2008, CLIN J AM SOC NEPHRO, V3, P1274, DOI 10.2215/CJN.01260308; Weisbord SD, 2009, J GEN INTERN MED, V24, P289, DOI 10.1007/s11606-008-0894-4; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009; Wrobel W, 2010, KARDIOL POL, V68, P1015	48	58	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60009	10.1371/journal.pone.0060009	http://dx.doi.org/10.1371/journal.pone.0060009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555863	gold, Green Published			2022-12-27	WOS:000317418500111
J	Liu, C; Pham, K; Luo, DF; Reynolds, BA; Hothi, P; Foltz, G; Harrison, JK				Liu, Che; Kien Pham; Luo, Defang; Reynolds, Brent A.; Hothi, Parvinder; Foltz, Gregory; Harrison, Jeffrey K.			Expression and Functional Heterogeneity of Chemokine Receptors CXCR4 and CXCR7 in Primary Patient-Derived Glioblastoma Cells	PLOS ONE			English	Article							TUMOR-GROWTH; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BETA-ARRESTIN; IN-VIVO; BREAST; CXCL12; ACTIVATION; PROMOTES; CANCER	Glioblastoma (GBM) is the most common primary brain tumor in adults. The poor prognosis and minimally successful treatments of these tumors indicates a need to identify new therapeutic targets. Therapy resistance of GBMs is attributed to heterogeneity of the glioblastoma due to genetic alterations and functional subpopulations. Chemokine receptors CXCR4 and CXCR7 play important roles in progression of various cancers although the specific functions of the CXCL12-CXCR4-CXCR7 axis in GBM are less characterized. In this study we examined the expression and function of CXCR4 and CXCR7 in four primary patient-derived GBM cell lines of the proliferative subclass, investigating their roles in in vitro growth, migration, sphere and tube formation. CXCR4 and CXCR7 cell surface expression was heterogeneous both between and within each cell line examined, which was not reflected by RT-PCR analysis. Variable percentages of CXCR4+CXCR7- (CXCR4 single positive), CXCR4-CXCR7+ (CXCR7 single positive), CXCR4+CXCR7+ (double positive), and CXCR4-CXCR7- (double negative) subpopulations were evident across the lines examined. A subpopulation of slow cell cycling cells was enriched in CXCR4 and CXCR7. CXCR4+, CXCR7+, and CXCR4+/CXCR7+ subpopulations were able to initiate intracranial tumors in vivo. CXCL12 stimulated in vitro cell growth, migration, sphere formation and tube formation in some lines and, depending on the response, the effects were mediated by either CXCR4 or CXCR7. Collectively, our results indicate a high level of heterogeneity in both the surface expression and functions of CXCR4 and CXCR7 in primary human GBM cells of the proliferative subclass. Should targeting of CXCR4 and CXCR7 provide clinical benefits to GBM patients, a personalized treatment approach should be considered given the differential expression and functions of these receptors in GBM.	[Liu, Che; Kien Pham; Luo, Defang; Harrison, Jeffrey K.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Reynolds, Brent A.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL 32610 USA; [Hothi, Parvinder; Foltz, Gregory] Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Swedish Medical Center	Harrison, JK (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	jharriso@ufl.edu			United States National Institutes of Health, NIAID [AI058256]; Florida Center for Brain Tumor Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058256] Funding Source: NIH RePORTER	United States National Institutes of Health, NIAID; Florida Center for Brain Tumor Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the United States National Institutes of Health, NIAID, AI058256, and the Florida Center for Brain Tumor Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Barbero S, 2003, CANCER RES, V63, P1969; Bertolini F, 2002, CANCER RES, V62, P3106; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calatozzolo C, 2011, CANCER BIOL THER, V11, P242, DOI 10.4161/cbt.11.2.13951; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Deleyrolle LP, 2011, BRAIN, V134, P1331, DOI 10.1093/brain/awr081; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hothi P, 2012, ONCOTARGET, V3, P1124; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Kanda S, 2003, J BIOL CHEM, V278, P257, DOI 10.1074/jbc.M204771200; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Luker KE, 2012, ONCOGENE; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neuhaus T, 2003, CELL PROLIFERAT, V36, P75, DOI 10.1046/j.1365-2184.2003.00262.x; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Schuller U, 2005, INT J CANCER, V117, P82, DOI 10.1002/ijc.21116; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stevenson CB, 2008, NEUROSURGERY, V63, P560, DOI 10.1227/01.NEU.0000324896.26088.EF; Tadagaki K, 2012, BLOOD, V119, P4908, DOI 10.1182/blood-2011-08-372516; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Zeelenberg IS, 2003, CANCER RES, V63, P3833	47	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59750	10.1371/journal.pone.0059750	http://dx.doi.org/10.1371/journal.pone.0059750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555768	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400062
J	Nunes, FP; Merker, VL; Jennings, D; Caruso, PA; di Tomaso, E; Muzikansky, A; Barker, FG; Stemmer-Rachamimov, A; Plotkin, SR				Nunes, Fabio P.; Merker, Vanessa L.; Jennings, Dominique; Caruso, Paul A.; di Tomaso, Emmanuelle; Muzikansky, Alona; Barker, Fred G., II; Stemmer-Rachamimov, Anat; Plotkin, Scott R.			Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients	PLOS ONE			English	Article							PHASE-II; NEUROFIBROMATOSIS TYPE-2; RECURRENT MENINGIOMAS; HYDROXYUREA; REGRESSION; THERAPY; ADULTS	Bevacizumab treatment can result in tumor shrinkage of progressive vestibular schwannomas in some neurofibromatosis 2 (NF2) patients but its effect on meningiomas has not been defined. To determine the clinical activity of bevacizumab against NF2-related meningiomas, we measured changes in volume of meningiomas in NF2 patients who received bevacizumab for treatment of progressive vestibular schwannomas. A radiographic response was defined as a 20% decrease in tumor size by volumetric MRI analysis. In addition, we determined the expression pattern of growth factors associated with tumor angiogenesis in paraffin-embedded tissues from 26 unrelated meningiomas. A total of 48 meningiomas in 15 NF2 patients were included in this study with a median follow up time of 18 months. A volumetric radiographic response was seen in 29% of the meningiomas (14/48). Tumor shrinkage was not durable: the median duration of response was 3.7 months and the median time to progression was 15 months. There was no significant correlation between pre-treatment growth rate and meningioma response in regression models. Tissue analysis showed no correlation between tumor microvascular density and expression of VEGF pathway components. This data suggests that, in contrast to schwannomas, activation of VEGF pathway is not the primary driver of angiogenesis in meningiomas. Our results suggest that a minority of NF2-associated meningiomas shrink during bevacizumab therapy and that these responses were of short duration. These results are comparable to previous studies of bevacizumab in sporadic meningiomas.	[Nunes, Fabio P.; Merker, Vanessa L.; Plotkin, Scott R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Nunes, Fabio P.] Massachusetts Gen Hosp, Dept Genet, Boston, MA 02114 USA; [Merker, Vanessa L.; Plotkin, Scott R.] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Boston, MA 02114 USA; [Jennings, Dominique] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Caruso, Paul A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [di Tomaso, Emmanuelle; Stemmer-Rachamimov, Anat] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Muzikansky, Alona] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Barker, Fred G., II] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Plotkin, SR (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	splotkin@partners.org	Merker, Vanessa/AAM-7250-2020	Merker, Vanessa/0000-0002-4542-5227; Plotkin, Scott/0000-0002-6109-6419	United States National Institutes of Heath [5-T32-GM007748-32]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER	United States National Institutes of Heath; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a United States National Institutes of Heath grant (5-T32-GM007748-32) to FPN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baser ME, 2002, AM J HUM GENET, V71, P715, DOI 10.1086/342716; Bria C, 2011, J CANCER RES THER, V7, P52, DOI 10.4103/0973-1482.80462; CBTRUS, 2012, CBTRUS STAT REP PRIM; Chamberlain MC, 2008, CANCER-AM CANCER SOC, V113, P2146, DOI 10.1002/cncr.23803; Chamberlain MC, 2006, J NEURO-ONCOL, V78, P271, DOI 10.1007/s11060-005-9093-x; Chamberlain MC, 2004, NEUROLOGY, V62, P1210, DOI 10.1212/01.WNL.0000118300.82017.F4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; GOODWIN JW, 1993, J NEURO-ONCOL, V15, P75, DOI 10.1007/BF01050266; Goutagny S, 2011, ANN ONCOL, V22, P990, DOI 10.1093/annonc/mdr012; Grunberg SM, 2006, CANCER INVEST, V24, P727, DOI 10.1080/07357900601062339; Johnson DR, 2011, NEURO-ONCOLOGY, V13, P530, DOI 10.1093/neuonc/nor044; Kaba SE, 1997, NEUROSURGERY, V40, P271, DOI 10.1097/00006123-199702000-00007; Lou E, 2012, J NEURO-ONCOL, V109, P63, DOI 10.1007/s11060-012-0861-0; Loven D, 2004, J NEURO-ONCOL, V67, P221, DOI 10.1023/B:NEON.0000021827.85754.8e; Mason WP, 2002, J NEUROSURG, V97, P341, DOI 10.3171/jns.2002.97.2.0341; Nayak L, 2012, J NEURO-ONCOL, V109, P187, DOI 10.1007/s11060-012-0886-4; Norden AD, 2009, J NEUROONCOL; Norden AD, 2009, CURR NEUROL NEUROSCI, V9, P231, DOI 10.1007/s11910-009-0034-5; Nunes F, 2003, J CHILD NEUROL, V18, P718, DOI 10.1177/08830738030180101301; Plotkin SR, 2012, OTOL NEUROTOL, V33, P1046, DOI 10.1097/MAO.0b013e31825e73f5; Plotkin SR, 2009, NEW ENGL J MED, V361, P358, DOI 10.1056/NEJMoa0902579; Puchner MJA, 2010, ANN ONCOL, V21, P2445, DOI 10.1093/annonc/mdq634; Rosen Lee S, 2002, Cancer Control, V9, P36; Schrell UMH, 1997, J NEUROSURG, V86, P840, DOI 10.3171/jns.1997.86.5.0840; Schulz C, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS111; Smith MJ, 2011, J MED GENET, V48, P261, DOI 10.1136/jmg.2010.085241; Wen PY, 2009, NEURO-ONCOLOGY, V11, P853, DOI 10.1215/15228517-2009-010	28	64	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59941	10.1371/journal.pone.0059941	http://dx.doi.org/10.1371/journal.pone.0059941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555840	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400070
J	Kyaw, T; Cui, P; Tay, C; Kanellakis, P; Hosseini, H; Liu, E; Rolink, AG; Tipping, P; Bobik, A; Toh, BH				Kyaw, Tin; Cui, Peng; Tay, Christopher; Kanellakis, Peter; Hosseini, Hamid; Liu, Edgar; Rolink, Antonius G.; Tipping, Peter; Bobik, Alex; Toh, Ban-Hock			BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE(-/-) Mice	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; E KNOCKOUT MICE; CD4(+) T-CELLS; B-CELLS; AGGRAVATES ATHEROSCLEROSIS; NATURAL IGM; CYTOKINES; INFLAMMATION; SURVIVAL; DISEASE	Aims: Option to attenuate atherosclerosis by depleting B2 cells is currently limited to anti-CD20 antibodies which deplete all B-cell subtypes. In the present study we evaluated the capacity of a monoclonal antibody to B cell activating factor-receptor (BAFFR) to selectively deplete atherogenic B2 cells to prevent both development and progression of atherosclerosis in the ApoE(-/-) mouse. Methods and Results: To determine whether the BAFFR antibody prevents atherosclerosis development, we treated ApoE(-/-) mice with the antibody while feeding them a high fat diet (HFD) for 8 weeks. Mature CD93(-) CD19(+) B2 cells were reduced by treatment, spleen B-cell zones disrupted and spleen CD20 mRNA expression decreased while B1a cells and non-B cells were spared. Atherosclerosis was ameliorated in the hyperlipidemic mice and CD19(+) B cells, CD4(+) and CD8(+) T cells were reduced in atherosclerotic lesions. Expressions of proinflammatory cytokines, IL1 beta, TNF alpha, and IFN gamma in the lesions were also reduced, while MCP1, MIF and VCAM-1 expressions were unaffected. Plasma immunoglobulins were reduced, but MDA-oxLDL specific antibodies were unaffected. To determine whether anti-BAFFR antibody ameliorates progression of atherosclerosis, we first fed ApoE(-/-) mice a HFD for 6 weeks, and then instigated anti-BAFFR antibody treatment for a further 6 week-HFD. CD93(-) CD19(+) B2 cells were selectively decreased and atherosclerotic lesions were reduced by this treatment. Conclusion: Anti-BAFFR monoclonal antibody selectively depletes mature B2 cells while sparing B1a cells, disrupts spleen B-cell zones and ameliorates atherosclerosis development and progression in hyperlipidemic ApoE(-/-) mice. Our findings have potential for clinical translation to manage atherosclerosis-based cardiovascular diseases.	[Kyaw, Tin; Cui, Peng; Tay, Christopher; Kanellakis, Peter; Hosseini, Hamid; Liu, Edgar; Bobik, Alex] Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Clayton, Vic, Australia; [Kyaw, Tin; Cui, Peng; Tay, Christopher; Hosseini, Hamid; Tipping, Peter; Toh, Ban-Hock] Monash Univ, Ctr Inflammatory Dis, Dept Med, Southern Clin Sch,Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia; [Rolink, Antonius G.] Univ Basel, Dept Biomed, Basel, Switzerland	Baker Heart and Diabetes Institute; Monash University; University of Basel	Kyaw, T (corresponding author), Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Clayton, Vic, Australia.	tinsoe.kyaw@bakeridi.edu.au	Kyaw, Tin/F-7712-2013	Kyaw, Tin/0000-0003-4003-7433	National Health and Medical Research Council of Australia [1025211]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This study is supported by the National Health and Medical Research Council of Australia (ID 1025211) and supported in part by the Victorian Government's Operational Infrastructure Support Program. (NHMRC -http://www.nhmrc.gov.au/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Brink R, 2006, SEMIN IMMUNOL, V18, P276, DOI 10.1016/j.smim.2006.04.003; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Chan T, 2011, CELL IMMUNOL, V266, P180, DOI 10.1016/j.cellimm.2010.10.002; de Wit J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013016; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Keystone EC, 2012, J RHEUMATOLOGY; Kim SJ, 2012, LEUKEMIA LYMPHOMA, V53, P19, DOI 10.3109/10428194.2011.603448; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Kreuzaler M, 2012, J IMMUNOL, V188, P497, DOI 10.4049/jimmunol.1102321; Kyaw T, 2012, TRENDS CARDIOVAS MED, V22, P48, DOI 10.1016/j.tcm.2012.06.011; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Kyaw T, 2011, CURR OPIN LIPIDOL, V22, P373, DOI 10.1097/MOL.0b013e32834adaf3; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lavie F, 2007, ANN RHEUM DIS, V66, P700, DOI 10.1136/ard.2006.060772; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Maurer MA, 2012, J CLIN INVEST, V122, P1393, DOI 10.1172/JCI58743; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Persson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-70; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Pollard RP, 2012, ANN RHEUM DIS; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Rosenfeld ME, 2002, ARTERIOSCL THROM VAS, V22, P361, DOI 10.1161/hq0302.104847; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sakurai D, 2007, EUR J IMMUNOL, V37, P110, DOI 10.1002/eji.200636623; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Tussiwand R, 2012, EUR J IMMUNOL, V42, P206, DOI 10.1002/eji.201141957; Vincent FB, 2012, IMMUNOL CELL BIOL, V90, P293, DOI 10.1038/icb.2011.111; Yu SG, 2008, J IMMUNOL, V180, P7706, DOI 10.4049/jimmunol.180.11.7706; Zhou XH, 2000, CIRCULATION, V102, P2919	43	68	68	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60430	10.1371/journal.pone.0060430	http://dx.doi.org/10.1371/journal.pone.0060430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560095	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100070
J	He, QQ; Zhang, Z; Zhang, JX; Wang, ZG; Tu, Y; Ji, T; Tao, Y				He, Qiao-Qiao; Zhang, Zhen; Zhang, Jian-Xin; Wang, Zhi-Guo; Tu, Ying; Ji, Ting; Tao, Yi			Potentials-Attract or Likes-Attract in Human Mate Choice in China	PLOS ONE			English	Article							MARITAL SUCCESS; FEMALE CHOICE; PREFERENCES; STRATEGIES; SELECTION; WOMEN	To explain how individuals' self-perceived long-term mate value influences their mate preference and mate choice, two hypotheses have been presented, which are "potentials-attract" and "likes-attract", respectively. The potentials-attract means that people choose mates matched with their sex-specific traits indicating reproductive potentials; and the likes-attract means that people choose mates matched with their own conditions. However, the debate about these two hypotheses still remains unsolved. In this paper, we tested these two hypotheses using a human's actual mate choice data from a Chinese online dating system (called the Baihe website), where 27,183 users of Baihe website are included, in which there are 590 paired couples (1180 individuals) who met each other via the website. Our main results show that not only the relationship between individuals' own attributes and their self-stated mate preference but also that between individuals' own attributes and their actual mate choice are more consistent with the likes-attract hypothesis, i.e., people tend to choose mates who are similar to themselves in a variety of attributes.	[He, Qiao-Qiao; Ji, Ting; Tao, Yi] Chinese Acad Sci, Inst Zool, Ctr Computat & Evolutionary Biol, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Zhen; Zhang, Jian-Xin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Grp Psychol Assessment & Psychol Intervent, Beijing 100101, Peoples R China; [Wang, Zhi-Guo; Tu, Ying] Beijing Baihe Online Technol Co Ltd, Res Planning, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Ji, T (corresponding author), Chinese Acad Sci, Inst Zool, Ctr Computat & Evolutionary Biol, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiting@ioz.ac.cn		Tao, Yi/0000-0002-0749-6614; He, Qiaoqiao/0000-0002-9381-7444	"Hundred Talents Program" of Chinese Academy of Sciences [NSFC31270439]; The Science Development Foundation of Institute of Psychology, Chinese Academy of Science [Y0CX441S01]	"Hundred Talents Program" of Chinese Academy of Sciences(Chinese Academy of Sciences); The Science Development Foundation of Institute of Psychology, Chinese Academy of Science	This research was supported by "Hundred Talents Program" of Chinese Academy of Sciences, Grant of NSFC31270439 and "The Science Development Foundation of Institute of Psychology, Chinese Academy of Science (Y0CX441S01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Bereczkei T, 1997, ETHOLOGY, V103, P681; Bereczkei T, 1996, ETHOL SOCIOBIOL, V17, P17, DOI 10.1016/0162-3095(95)00104-2; Bittles AH, 2002, ANN HUM BIOL, V29, P111, DOI 10.1080/03014460110075657; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; BUSS DM, 1994, AM SCI, V82, P238; BUSS DM, 1985, AM SCI, V73, P47; Buston PM, 2003, P NATL ACAD SCI USA, V100, P8805, DOI 10.1073/pnas.1533220100; CATTELL RB, 1967, J PERS SOC PSYCHOL, V7, P351, DOI 10.1037/h0025248; CLARK P. J., 1959, HUMAN BIOL, V31, P121; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; EPSTEIN E, 1984, SOC BIOL, V31, P243; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; FEINGOLD A, 1992, PSYCHOL BULL, V112, P125, DOI 10.1037/0033-2909.112.1.125; GARRISON RJ, 1968, EUGEN QUART, V15, P113, DOI 10.1080/19485565.1968.9987762; Godoy R, 2008, EVOL HUM BEHAV, V29, P201, DOI 10.1016/j.evolhumbehav.2007.12.003; Huber S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022330; Keller MC, 1996, PERS INDIV DIFFER, V21, P217, DOI 10.1016/0191-8869(96)00066-9; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Little AC, 2006, PERS INDIV DIFFER, V40, P973, DOI 10.1016/j.paid.2005.09.016; Luo SH, 2005, J PERS SOC PSYCHOL, V88, P304, DOI 10.1037/0022-3514.88.2.304; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Montoya RM, 2008, J SOC PERS RELAT, V25, P889, DOI 10.1177/0265407508096700; MULDER MB, 1990, BEHAV ECOL SOCIOBIOL, V27, P255; MULDER MB, 1989, BEHAV ECOL SOCIOBIOL, V24, P145, DOI 10.1007/BF00292097; Pawlowski B, 1999, P ROY SOC B-BIOL SCI, V266, P281, DOI 10.1098/rspb.1999.0634; Silventoinen K, 2003, AM J HUM BIOL, V15, P620, DOI 10.1002/ajhb.10183; Skopek J, 2011, EUR SOCIOL REV, V27, P180, DOI 10.1093/esr/jcp068; Symons D, 1979, EVOLUTION HUMAN SEXU; Taylor LS, 2011, PERS SOC PSYCHOL B, V37, P942, DOI 10.1177/0146167211409947; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Todd PM, 2007, P NATL ACAD SCI USA, V104, P15011, DOI 10.1073/pnas.0705290104; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tsou MW, 2011, BIOL LETTERS, V7, P562, DOI 10.1098/rsbl.2010.1208; VOLAND E, 1990, ETHOLOGY, V84, P144; Watson D, 2004, J PERS, V72, P1029, DOI 10.1111/j.0022-3506.2004.00289.x; WAYNFORTH D, 1995, BEHAVIOUR, V132, P755, DOI 10.1163/156853995X00135; Weeden J, 2007, ARCH SEX BEHAV, V36, P79, DOI 10.1007/s10508-006-9075-x; WEISFELD GE, 1992, ETHOL SOCIOBIOL, V13, P125, DOI 10.1016/0162-3095(92)90022-V; Xu XH, 2000, J FAM ISSUES, V21, P47, DOI 10.1177/019251300021001003	43	4	5	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59457	10.1371/journal.pone.0059457	http://dx.doi.org/10.1371/journal.pone.0059457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565153	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300020
J	Nivon, LG; Moretti, R; Baker, D				Nivon, Lucas Gregorio; Moretti, Rocco; Baker, David			A Pareto-Optimal Refinement Method for Protein Design Scaffolds	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; OPTIMIZATION	Computational design of protein function involves a search for amino acids with the lowest energy subject to a set of constraints specifying function. In many cases a set of natural protein backbone structures, or "scaffolds", are searched to find regions where functional sites (an enzyme active site, ligand binding pocket, protein - protein interaction region, etc.) can be placed, and the identities of the surrounding amino acids are optimized to satisfy functional constraints. Input native protein structures almost invariably have regions that score very poorly with the design force field, and any design based on these unmodified structures may result in mutations away from the native sequence solely as a result of the energetic strain. Because the input structure is already a stable protein, it is desirable to keep the total number of mutations to a minimum and to avoid mutations resulting from poorly-scoring input structures. Here we describe a protocol using cycles of minimization with combined backbone/sidechain restraints that is Pareto-optimal with respect to RMSD to the native structure and energetic strain reduction. The protocol should be broadly useful in the preparation of scaffold libraries for functional site design.	[Nivon, Lucas Gregorio; Moretti, Rocco; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	Defense Advanced Research Projects Agency/Defense Threat Reduction Agency grant, Protein Design Processes; National Science Foundation Minority Postdoctoral Fellowship	Defense Advanced Research Projects Agency/Defense Threat Reduction Agency grant, Protein Design Processes; National Science Foundation Minority Postdoctoral Fellowship(National Science Foundation (NSF))	DB and RM were supported by a Defense Advanced Research Projects Agency/Defense Threat Reduction Agency grant, Protein Design Processes. LGN was supported by a National Science Foundation Minority Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leach AR, 2001, MOL MODELLING PRINCI, P367; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Richter F., 2011, PLOS ONE, V6; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Song YF, 2011, PROTEINS, V79, P1898, DOI 10.1002/prot.23013; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	15	126	127	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59004	10.1371/journal.pone.0059004	http://dx.doi.org/10.1371/journal.pone.0059004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565140	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300007
J	Pede, V; Rombout, A; Vermeire, J; Naessens, E; Mestdagh, P; Robberecht, N; Vanderstraeten, H; Van Roy, N; Vandesompele, J; Speleman, F; Philippe, J; Verhasselt, B				Pede, Valerie; Rombout, Ans; Vermeire, Jolien; Naessens, Evelien; Mestdagh, Pieter; Robberecht, Nore; Vanderstraeten, Hanne; Van Roy, Nadine; Vandesompele, Jo; Speleman, Frank; Philippe, Jan; Verhasselt, Bruno			CLL Cells Respond to B-Cell Receptor Stimulation with a MicroRNA/mRNA Signature Associated with MYC Activation and Cell Cycle Progression	PLOS ONE			English	Article							CHRONIC-LYMPHOCYTIC-LEUKEMIA; GENE-EXPRESSION; ZAP-70 EXPRESSION; SURFACE IGM; SURVIVAL; LIGATION; REVEALS; ENGAGEMENT; INHIBITOR; PHENOTYPE	Chronic lymphocytic leukemia (CLL) is a disease with variable clinical outcome. Several prognostic factors such as the immunoglobulin heavy chain variable genes (IGHV) mutation status are linked to the B-cell receptor (BCR) complex, supporting a role for triggering the BCR in vivo in the pathogenesis. The miRNA profile upon stimulation and correlation with IGHV mutation status is however unknown. To evaluate the transcriptional response of peripheral blood CLL cells upon BCR stimulation in vitro, miRNA and mRNA expression was measured using hybridization arrays and qPCR. We found both IGHV mutated and unmutated CLL cells to respond with increased expression of MYC and other genes associated with BCR activation, and a phenotype of cell cycle progression. Genome-wide expression studies showed hsa-miR-132-3p/hsa-miR-212 miRNA cluster induction associated with a set of downregulated genes, enriched for genes modulated by BCR activation and amplified by Myc. We conclude that BCR triggering of CLL cells induces a transcriptional response of genes associated with BCR activation, enhanced cell cycle entry and progression and suggest that part of the transcriptional profiles linked to IGHV mutation status observed in isolated peripheral blood are not cell intrinsic but rather secondary to in vivo BCR stimulation.	[Pede, Valerie; Rombout, Ans; Vermeire, Jolien; Naessens, Evelien; Robberecht, Nore; Vanderstraeten, Hanne; Philippe, Jan; Verhasselt, Bruno] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Mestdagh, Pieter; Van Roy, Nadine; Vandesompele, Jo; Speleman, Frank] Univ Ghent, Dept Med Genet, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University	Verhasselt, B (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	Bruno.Verhasselt@UGent.be	philippé, jan/AAG-8964-2019; speleman, frank/AAR-5184-2020; Vandesompele, Jo/W-3411-2018	philippé, jan/0000-0003-4857-5746; speleman, frank/0000-0002-6628-8559; Vandesompele, Jo/0000-0001-6274-0184; Mestdagh, Pieter/0000-0001-7821-9684; Verhasselt, Bruno/0000-0002-4645-1144	Research Foundation - Flanders (FWO)	Research Foundation - Flanders (FWO)(FWO)	This work was supported by grants from the Research Foundation - Flanders (FWO) to JP and BV. VP is a Ph. D. fellow of the Agency for Innovation by Science and Technology (IWT); AR and JVe are Ph. D. fellows, PM is a Postdoctoral Fellows and BV is a Senior Clinical Investigator of the FWO. Support: This work was supported by grants from the Research Foundation - Flanders (FWO) to JP and BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen L, 2007, BLOOD; Chen LG, 2005, BLOOD, V105, P2036, DOI 10.1182/blood-2004-05-1715; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Deglesne PA, 2006, CANCER RES, V66, P7158, DOI 10.1158/0008-5472.CAN-06-0085; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Efremov DG, 2007, AUTOIMMUN REV, V7, P102, DOI 10.1016/j.autrev.2007.02.021; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Guarini A, 2008, BLOOD, V112, P782, DOI 10.1182/blood-2007-12-127688; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kofler DM, 2004, GENE THER, V11, P1416, DOI 10.1038/sj.gt.3302279; Koh DI, 2009, J BIOL CHEM, V284, P19856, DOI 10.1074/jbc.M109.025817; Krysov S, 2012, BLOOD, V119, P170, DOI 10.1182/blood-2011-07-370403; Lanham S, 2003, BLOOD, V101, P1087, DOI 10.1182/blood-2002-06-1822; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Menten B, 2005, EUR J MED GENET, V48, P301, DOI 10.1016/j.ejmg.2005.04.014; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, P8; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mockridge CI, 2007, BLOOD, V109, P4424, DOI 10.1182/blood-2006-11-056648; Nicoloso MS, 2007, BRIT J HAEMATOL, V139, P709, DOI 10.1111/j.1365-2141.2007.06868.x; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Park JK, 2011, BIOCHEM BIOPH RES CO, V406, P518, DOI 10.1016/j.bbrc.2011.02.065; Perrot A, 2011, BLOOD; Petlickovski A, 2005, BLOOD, V105, P4820, DOI 10.1182/blood-2004-07-2669; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Rodriguez A, 2007, LEUKEMIA, V21, P1984, DOI 10.1038/sj.leu.2404831; Rosen A, 2010, SEMIN CANCER BIOL, V20, P400, DOI 10.1016/j.semcancer.2010.09.004; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Stamatopoulos B, 2009, HAEMATOL-HEMATOL J, V94, P790, DOI 10.3324/haematol.2008.002626; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Vallat L, 2003, BLOOD, V101, P4598, DOI 10.1182/blood-2002-06-1743; Van Bockstaele F, 2008, LEUKEMIA, V22, P323, DOI 10.1038/sj.leu.2405007; Van Bockstaele F, 2007, CLIN CHEM, V53, P204, DOI 10.1373/clinchem.2006.076331; Van Bockstaele F, 2006, CYTOM PART B-CLIN CY, V70B, P302, DOI 10.1002/cyto.b.20122; Van Bockstaele F, 2009, BLOOD REV, V23, P25, DOI 10.1016/j.blre.2008.05.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; Vlad A, 2009, CANCER RES, V69, P6387, DOI 10.1158/0008-5472.CAN-08-4750; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	59	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60275	10.1371/journal.pone.0060275	http://dx.doi.org/10.1371/journal.pone.0060275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560086	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900061
J	Viart, V; Varilh, J; Lopez, E; Rene, C; Claustres, M; Taulan-Cadars, M				Viart, Victoria; Varilh, Jessica; Lopez, Estelle; Rene, Celine; Claustres, Mireille; Taulan-Cadars, Magali			Phosphorylated C/EBP beta Influences a Complex Network Involving YY1 and USF2 in Lung Epithelial Cells	PLOS ONE			English	Article							CONDUCTANCE REGULATOR GENE; TRANSCRIPTIONAL REPRESSION; BINDING PROTEINS; EXPRESSION; CFTR; PROMOTER; ELEMENT; DIFFERENTIATION; DIMERIZATION; ACETYLATION	The promoter of the cystic fibrosis transmembrane conductance regulator gene CFTR is tightly controlled by regulators including CCAAT/enhancer binding proteins (C/EBPs). We previously reported that the transcription factors YY1 and USF2 affect CFTR expression. We can now demonstrate that C/EBP beta, a member of the CCAAT family, binds to the CFTR promoter and contributes to its transcriptional activity. Our data reveal that C/EBP beta cooperates with USF2 and acts antagonistically to YY1 in the control of CFTR expression. Interestingly, YY1, a strong repressor, fails to repress the CFTR activation induced by USF2 through DNA binding competition. Collectively, the data strongly suggest a model by which USF2 functionally interacts with YY1 blocking its inhibitory activity, in favour of C/EBP beta transactivation. Further investigation into the interactions between these three proteins revealed that phosphorylation of C/EBP beta influences the DNA occupancy of YY1 and favours the interaction between USF2 and YY1. This phosphorylation process has several implications in the CFTR transcriptional process, thus evoking an additional layer of complexity to the mechanisms influencing CFTR gene regulation.	[Viart, Victoria; Lopez, Estelle; Rene, Celine; Claustres, Mireille; Taulan-Cadars, Magali] Univ Montpellier I, UFR Med, Montpellier, France; [Viart, Victoria; Varilh, Jessica; Lopez, Estelle; Rene, Celine; Claustres, Mireille; Taulan-Cadars, Magali] INSERM, U827, Lab Genet Malad Rares, Montpellier, France; [Varilh, Jessica; Rene, Celine; Claustres, Mireille] CHU Montpellier, Lab Genet Mol, Hop Arnaud de Villeneuve, Montpellier, France	Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Taulan-Cadars, M (corresponding author), Univ Montpellier I, UFR Med, Montpellier, France.	magali.taulan@inserm.fr		TAULAN, MAGALI/0000-0003-0059-9394	Vaincre la Mucoviscidose; Universite Montpellier 1; Hopital Arnaud de Villeneuve/CHU Montpellier; Inserm Institute	Vaincre la Mucoviscidose; Universite Montpellier 1; Hopital Arnaud de Villeneuve/CHU Montpellier; Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from Vaincre la Mucoviscidose, Universite Montpellier 1, Hopital Arnaud de Villeneuve/CHU Montpellier, and the Inserm Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoubi TAY, 2007, NATURE PRECEDINGS, DOI 10.1038; Baudouin-Legros M, 2008, CELL PHYSIOL BIOCHEM, V21, P75, DOI 10.1159/000113749; Bauknecht T, 1996, J VIROL, V70, P7695, DOI 10.1128/JVI.70.11.7695-7705.1996; Berg T, 2005, BIOCHEM BIOPH RES CO, V334, P638, DOI 10.1016/j.bbrc.2005.06.146; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; CHOU JL, 1991, J BIOL CHEM, V266, P24471; Crawford EL, 2007, CARCINOGENESIS, V28, P2552, DOI 10.1093/carcin/bgm214; Dahle MK, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-10; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dhar M, 2001, ONCOGENE, V20, P4750, DOI 10.1038/sj.onc.1204637; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matlapudi A, 2002, BBA-GENE STRUCT EXPR, V1575, P91, DOI 10.1016/S0167-4781(02)00288-9; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Nuthall HN, 1999, BIOCHEM J, V341, P601, DOI 10.1042/0264-6021:3410601; Pilipuk GP, 2003, J BIOL CHEM, V278, P35668, DOI 10.1074/jbc.M305182200; PITTMAN N, 1995, J BIOL CHEM, V270, P28848, DOI 10.1074/jbc.270.48.28848; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Rene C, 2010, CELL MOL LIFE SCI, V67, P2297, DOI 10.1007/s00018-010-0336-4; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Romey MC, 2000, J BIOL CHEM, V275, P3561, DOI 10.1074/jbc.275.5.3561; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shi W, 2007, CHEST, V132, P651, DOI 10.1378/chest.06-2663; Taulan M, 2007, BIOCHEM BIOPH RES CO, V361, P775, DOI 10.1016/j.bbrc.2007.07.091; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200	39	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60211	10.1371/journal.pone.0060211	http://dx.doi.org/10.1371/journal.pone.0060211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560079	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900055
J	Goldmacher, GV; Nasser, R; Lee, DY; Yigit, S; Rosenwasser, R; Iacovitti, L				Goldmacher, Gregory V.; Nasser, Rena; Lee, Daniel Y.; Yigit, Sargon; Rosenwasser, Robert; Iacovitti, Lorraine			Tracking Transplanted Bone Marrow Stem Cells and Their Effects in the Rat MCAO Stroke Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; FUNCTIONAL RECOVERY; ANGIOGENESIS; INJURY; MOUSE; INFLAMMATION; DYSFUNCTION; MECHANISMS; PLASTICITY; ABLATION	In this study, rat bone marrow stromal stem cells (BMSCs) were tracked after IV administration to rats with experimental stroke caused by middle cerebral artery occlusion (MCAO). In addition, the effects of BMSC treatment on blood cell composition, brain glia and sensorimotor behavior was studied and compared to that which occurred spontaneously during the normal recovery process after stroke. We found that the vast majority of radiolabeled or fluorescently labeled BMSCs traveled to and remained in peripheral organs (lungs, spleen, liver) 3 days after IV injection in the MCAO rat. Once in the circulation, BMSCs also produced rapid alterations in host blood cell composition, increasing both neutrophil and total white blood cell count by 6 hours post-injection. In contrast, few injected BMSCs traveled to the brain and almost none endured there long term. Nonetheless, BMSC treatment produced dramatic changes in the number and activation of brain astroglia and microglia, particularly in the region of the infarct. These cellular changes were correlated with a marked improvement in performance on tests of sensory and motor function as compared to the partial recovery of function seen in PBS-injected control rats. We conclude that the notable recovery in function observed after systemic administration of BMSCs to MCAO rats is likely due to the cellular changes in blood and/or brain cell number, activation state and their cytokine/growth factor products.	[Goldmacher, Gregory V.; Nasser, Rena; Lee, Daniel Y.; Yigit, Sargon; Iacovitti, Lorraine] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Nasser, Rena; Yigit, Sargon; Iacovitti, Lorraine] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [Rosenwasser, Robert; Iacovitti, Lorraine] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Iacovitti, L (corresponding author), Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA.	lorraine.iacovittti@jefferson.edu	ROSENWASSER, ROBERT H/L-2482-2014	Goldmacher, Gregory/0000-0001-7310-6146				ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Aulesa C, 2003, Lab Hematol, V9, P214; Bin Deng Y, 2010, NEUROL RES, V32, P148, DOI 10.1179/174313209X414434; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Eissa A, 2012, J CLIN PHARM THER, V37, P620, DOI 10.1111/j.1365-2710.2012.01366.x; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; HEISS WD, 1992, STROKE, V23, P1668, DOI 10.1161/01.STR.23.11.1668; Hess David C, 2008, Expert Rev Neurother, V8, P1193, DOI 10.1586/14737175.8.8.1193; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kriz Jasna, 2006, Critical Reviews in Neurobiology, V18, P145; Kriz J, 2009, ACTA NEUROPATHOL, V117, P497, DOI 10.1007/s00401-009-0496-1; Lalancette-Hebert M, 2009, BRAIN, V132, P940, DOI 10.1093/brain/awn345; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Miller DW, 1999, J NEUROVIROL, V5, P570, DOI 10.3109/13550289909021286; Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018; Miyamoto M, 2012, J NUCL MED OFFICIAL; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Steiner B, 2012, NEUROSCI LETT, V513, P25, DOI 10.1016/j.neulet.2012.01.078; Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023; Symon L, 2007, ISCHEMIC PENUMBRA; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang L, 2012, BRAIN RES, V1489, P104, DOI 10.1016/j.brainres.2012.10.017; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao YJ, 2010, NEUROL RES, V32, P748, DOI 10.1179/016164109X12445616596562	42	36	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60049	10.1371/journal.pone.0060049	http://dx.doi.org/10.1371/journal.pone.0060049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555879	Green Published, gold			2022-12-27	WOS:000317263900055
J	Agarwal, C; Wadhwa, R; Deep, G; Biedermann, D; Gazak, R; Kren, V; Agarwal, R				Agarwal, Chapla; Wadhwa, Ritambhara; Deep, Gagan; Biedermann, David; Gazak, Radek; Kren, Vladimir; Agarwal, Rajesh			Anti-Cancer Efficacy of Silybin Derivatives - A Structure-Activity Relationship	PLOS ONE			English	Article							INDUCED GROWTH-INHIBITION; CARCINOMA DU145 CELLS; PROSTATE-CANCER; MILK THISTLE; MOLECULAR-MECHANISMS; ORAL SILIBININ; IN-VIVO; SILYMARIN; 2,3-DEHYDROSILYBIN; ANTIOXIDANT	Silybin or silibinin, a flavonolignan isolated from Milk thistle seeds, is one of the popular dietary supplements and has been extensively studied for its antioxidant, hepatoprotective and anti-cancer properties. We have envisioned that potency of silybin could be further enhanced through suitable modification/s in its chemical structure. Accordingly, here, we synthesized and characterized a series of silybin derivatives namely 2,3-dehydrosilybin (DHS), 7-O-methylsilybin (7OM), 7-Ogalloylsilybin (7OG), 7,23-disulphatesilybin (DSS), 7-O-palmitoylsilybin (7OP), and 23-O-palmitoylsilybin (23OP); and compared their anti-cancer efficacy using human bladder cancer HTB9, colon cancer HCT116 and prostate carcinoma PC3 cells. In all the 3 cell lines, DHS, 7OM and 7OG demonstrated better growth inhibitory effects and compared to silybin, while other silybin derivatives showed lesser or no efficacy. Next, we prepared the optical isomers (A and B) of silybin, DHS, 7OM and 7OG, and compared their anti-cancer efficacy. Isomers of these three silybin derivatives also showed better efficacy compared with respective silybin isomers, but in each, there was no clear cut silybin A versus B isomer activity preference. Further studies in HTB cells found that DHS, 7OM and 7OG exert better apoptotic activity than silibinin. Clonogenic assays in HTB9 cells further confirmed that both the racemic mixtures as well as pure optical isomers of DHS, 7OM and 7OG were more effective than silybin. Overall, these results clearly suggest that the anti-cancer efficacy of silybin could be significantly enhanced through structural modifications, and identify strong anti-cancer efficacy of silybin derivatives, namely DHS, 7OM, and 7OG, signifying that their efficacy and toxicity should be evaluated in relevant preclinical cancer models in rodents.	[Agarwal, Chapla; Wadhwa, Ritambhara; Deep, Gagan; Agarwal, Rajesh] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, La Jolla, CA 92093 USA; [Agarwal, Chapla; Deep, Gagan; Agarwal, Rajesh] Univ Colorado, Ctr Canc, Aurora, CO USA; [Biedermann, David; Gazak, Radek; Kren, Vladimir] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Agarwal, R (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, La Jolla, CA 92093 USA.	Rajesh.Agarwal@UCDenver.edu	Gažák, Radek/H-2443-2014; Biedermann, David/AAZ-3010-2021; Deep, Gagan/H-1853-2012; Kren, Vladimir/H-8461-2014	Gažák, Radek/0000-0003-3881-0327; Biedermann, David/0000-0001-6726-9301; 	NCI [CA102514, CA112304]; Ministry of Education of the Czech Republic [ME10027]; Institutional Concept of the Institute of Microbiology, Prague [RVO61388971]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA102514, R01CA112304] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Concept of the Institute of Microbiology, Prague; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI RO1 grants CA102514 and CA112304, AMVIS CZ-US collaborative project ME10027 from Ministry of Education of the Czech Republic (V. K. and R. A.), and RVO61388971 (Institutional Concept of the Institute of Microbiology, Prague). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, ANTICANCER RES, V26, P4457; Basaga H, 1997, CELL BIOCHEM FUNCT, V15, P27; Davis-Searles PR, 2005, CANCER RES, V65, P4448, DOI 10.1158/0008-5472.CAN-04-4662; Deep G, 2012, CURRENT CAN IN PRESS; Deep G, 2008, CURR OPIN INVEST DR, V9, P591; Deep G, 2007, CARCINOGENESIS, V28, P1533, DOI 10.1093/carcin/bgm069; Deep G, 2007, INTEGR CANCER THER, V6, P130, DOI 10.1177/1534735407301441; Deep G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034630; Deep G, 2010, CANCER METAST REV, V29, P447, DOI 10.1007/s10555-010-9237-0; Dhanalakshmi S, 2003, INT J CANCER, V106, P699, DOI 10.1002/ijc.11299; Dzubak P, 2006, BIOORGAN MED CHEM, V14, P3793, DOI 10.1016/j.bmc.2006.01.035; Flaig TW, 2007, INVEST NEW DRUG, V25, P139, DOI 10.1007/s10637-006-9019-2; Flaig TW, 2007, INT J CANCER, V120, P2028, DOI 10.1002/ijc.22465; Flaig TW, 2010, PROSTATE, V70, P848, DOI 10.1002/pros.21118; Gazak R, 2004, BIOORGAN MED CHEM, V12, P5677, DOI 10.1016/j.bmc.2004.07.064; Gazak R, 2007, CURR MED CHEM, V14, P315, DOI 10.2174/092986707779941159; Gazak R, 2013, TETRAHEDRON LETT, V54, P315, DOI 10.1016/j.tetlet.2012.11.049; Gazak R, 2011, J MED CHEM, V54, P7397, DOI 10.1021/jm201034h; Gazak R, 2010, PROCESS BIOCHEM, V45, P1657, DOI 10.1016/j.procbio.2010.06.019; Gazak R, 2010, EUR J MED CHEM, V45, P1059, DOI 10.1016/j.ejmech.2009.11.056; Gazak R, 2009, FREE RADICAL BIO MED, V46, P745, DOI 10.1016/j.freeradbiomed.2008.11.016; Giacomelli S, 2002, LIFE SCI, V70, P1447, DOI 10.1016/S0024-3205(01)01511-9; Graf TN, 2007, PLANTA MED, V73, P1495, DOI 10.1055/s-2007-990239; GYORGY I, 1992, INT J RADIAT BIOL, V61, P603, DOI 10.1080/09553009214551411; Hoh C, 2006, CLIN CANCER RES, V12, P2944, DOI 10.1158/1078-0432.CCR-05-2724; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Monti D, 2010, J NAT PROD, V73, P613, DOI 10.1021/np900758d; Pradhan SC, 2006, INDIAN J MED RES, V124, P491; Rainone F, 2005, AM FAM PHYSICIAN, V72, P1285; Scambia G, 1996, EUR J CANCER, V32A, P877, DOI 10.1016/0959-8049(96)00011-1; Sharma G, 2003, ANTICANCER RES, V23, P2649; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh RP, 2004, CLIN CANCER RES, V10, P8641, DOI 10.1158/1078-0432.CCR-04-1435; Trouillas P, 2008, J PHYS CHEM A, V112, P1054, DOI 10.1021/jp075814h; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; Tyagi AK, 2004, ONCOL REP, V11, P493	36	42	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e00074	10.1371/journal.pone.0060074	http://dx.doi.org/10.1371/journal.pone.0060074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555889	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200079
J	Borness, C; Proudfoot, J; Crawford, J; Valenzuela, M				Borness, Catherine; Proudfoot, Judith; Crawford, John; Valenzuela, Michael			Putting Brain Training to the Test in the Workplace: A Randomized, Blinded, Multisite, Active-Controlled Trial	PLOS ONE			English	Article							COGNITIVE REMEDIATION; METAANALYSIS; PERFORMANCE; DEPRESSION; RECOVERY; MEMORY; ONSET	Background: Cognitive training (CT) is effective at improving cognitive outcomes in children with and without clinical impairment as well as older individuals. Yet whether CT is of any preventative health benefit to working age adults is controversial. Our objective was therefore to investigate the real-world efficacy of CT in the workplace, involving employees from across the working-age spectrum and addressing many of the design issues that have limited trials to date. Methods and Findings: 135 white collar employees of a large Australian public sector organization were randomised to either 16 weeks (20 minutes three times per week) of online CT or an active control (AC) program of equal length and structure. Cognitive, wellbeing and productivity outcome measures were analysed across three timepoints: baseline, immediately after training and 6 months post-training. CT effects on cognitive outcomes were limited, even after planned subgroup analyses of cognitive capacity and age. Unexpectedly, we found that our AC condition, which comprised viewing short documentaries about the natural world, had more impact. Compared to the CT group, 6 months after the end of training, those in the AC group experienced a significant increase in their self-reported Quality of Life (Effect Size g =.34 vs -.15; TIMExGROUP p =.003), decrease in stress levels (g =.22 vs -.19; TIMExGROUP p =.03), and overall improvement in Psychological Wellbeing (g =.32 vs -.06; TIMExGROUP p =.02). Conclusions: CT does not appear to positively impact cognition or wellbeing amongst white collar office workers; however, short time-out respite activities may have value in the promotion of psychological wellbeing. Given looming challenges to workplace productivity, further work-based interventional research targeting employee mental health is recommended.	[Borness, Catherine; Proudfoot, Judith; Crawford, John; Valenzuela, Michael] Univ New S Wales, Fac Med, Sch Psychiat, Sydney, NSW, Australia; [Proudfoot, Judith] Univ New S Wales, Black Dog Inst, Sydney, NSW, Australia; [Borness, Catherine; Valenzuela, Michael] Univ New S Wales, Fac Med, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Valenzuela, Michael] Univ Sydney, Brain & Mind Res Inst, Regenerat Neurosci Grp, Sydney, NSW 2006, Australia	University of New South Wales Sydney; Black Dog Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Borness, C (corresponding author), Univ New S Wales, Fac Med, Sch Psychiat, Sydney, NSW, Australia.	z8701822@student.unsw.edu.au		Valenzuela, Michael/0000-0001-7162-6607	Brain Department Pty Ltd (Sydney, Australia); Australian Postgraduate Award scholarship	Brain Department Pty Ltd (Sydney, Australia); Australian Postgraduate Award scholarship	While this study was sponsored by The Brain Department Pty Ltd (Sydney, Australia) through their provision of the intervention, CB, the primary researcher, was independently supported by an Australian Postgraduate Award scholarship. This arrangement did not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Becker WJ, 2010, J ORGAN BEHAV, V31; Beddington J, 2008, MENTAL CAPITAL WELLB, P1; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Croisile B, 2000, SPARK BRAINS WORK; Elgamal S, 2007, PSYCHOL MED, V37, P1229, DOI 10.1017/S0033291707001110; Gates N, 2011, BMC GERIATR, V11; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaques E, 1994, HUMAN CAPABILITY STU; Katsnelson A, 2010, NATURE, V464, P1111, DOI 10.1038/4641111a; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; KNEGTERING H, 1994, DRUG AGING, V5, P192, DOI 10.2165/00002512-199405030-00005; Laplagne P., 2007, EFFECTS HLTH ED LABO; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P401, DOI 10.1097/JOM.0b013e31816bae50; Lindenmayer JP, 2008, PSYCHIAT SERV, V59, P241, DOI 10.1176/appi.ps.59.3.241; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Miller R.G., 1981, SIMULTANEOUS STAT IN, Ved 2nd, DOI DOI 10.1007/s11263-015-0816-y; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sitzer DI, 2006, ACTA PSYCHIAT SCAND, V114, P75, DOI 10.1111/j.1600-0447.2006.00789.x; Spreen O., 1991, PROFILE TEST RESULTS; Trougakos JP, 2009, RES OCCUP STRESS WEL, V7, P37, DOI 10.1108/S1479-3555(2009)0000007005; Tucker P, 2003, WORK STRESS, V17, P123, DOI 10.1080/0267837031000155949; Valenzuela M, 2009, AM J GERIAT PSYCHIAT, V17, P179, DOI 10.1097/JGP.0b013e3181953b57; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wolinsky FD, 2009, J GERONTOL B-PSYCHOL, V64, P577, DOI 10.1093/geronb/gbp061; Zelinski E., 2010, SCI CRITIQUE BBC NAT	36	26	26	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59982	10.1371/journal.pone.0059982	http://dx.doi.org/10.1371/journal.pone.0059982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555855	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200064
J	Ju, HL; Ahn, SH; Kim, DY; Baek, S; Chung, SI; Seong, J; Han, KH; Ro, SW				Ju, Hye-Lim; Ahn, Sang Hoon; Kim, Do Young; Baek, Sinhwa; Chung, Sook In; Seong, Jinsil; Han, Kwang-Hyub; Ro, Simon Weonsang			Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging	PLOS ONE			English	Article							SLEEPING-BEAUTY-TRANSPOSON; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; PLASMID DNA; HUMAN-CELLS; MICE; CARCINOGENESIS; DELIVERY; SYSTEM; IDENTIFICATION	Liver cancer is a complex multistep process requiring genetic alterations in multiple proto-oncogenes and tumor suppressor genes. Although hundreds of genes are known to play roles in hepatocarcinogenesis, oncogenic collaboration among these genes is still largely unknown. Here, we report a simple methodology by which oncogenic cooperation between cancer-related genes can be efficiently investigated in the liver. We developed various non-germline transgenic mouse models using hydrodynamics-based transfection which express HrasG12V, SmoM2, and a short-hairpin RNA down- regulating p53 (shp53) individually or in combination in the liver. In this transgenic system, firefly luciferase was co-expressed with the oncogenes as a reporter, allowing tumor growth in the liver to be monitored over time without an invasive procedure. Very strong bioluminescence imaging (BLI) signals were observed at 4 weeks post-hydrodynamic injection (PHI) in mice co-expressing HrasG12V and shp53, while only background signals were detected in other double or single transgenic groups until 30 weeks PHI. Consistent with the BLI data, tumors were observed in the HrasG12V plus shp53 group at 4 weeks PHI, while other transgenic groups failed to exhibit a hyperplastic nodule at 30 weeks PHI. In the HrasG12V plus shp53 transgenic group, BLI signals were well-correlated with actual tumor growth in the liver, confirming the versatility of BLI-based monitoring of tumor growth in this organ. The methodology described here is expected to accelerate and facilitate in vivo studies of the hepatocarcinogenic potential of cancer-related genes by means of oncogenic cooperation.	[Ju, Hye-Lim; Ahn, Sang Hoon; Kim, Do Young; Baek, Sinhwa; Chung, Sook In; Han, Kwang-Hyub; Ro, Simon Weonsang] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ju, Hye-Lim; Baek, Sinhwa; Chung, Sook In] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Ahn, Sang Hoon; Kim, Do Young; Han, Kwang-Hyub; Ro, Simon Weonsang] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Seong, Jinsil] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ro, SW (corresponding author), Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea.	simonr@yuhs.ac	Ro, Simon Weonsang/AAK-7198-2020	Ro, Simon Weonsang/0000-0003-2187-3698; CHUNG, SOOK IN/0000-0002-7915-9203; Ahn, Sang Hoon/0000-0002-3629-4624; Han, Kwang-Hyub/0000-0003-3960-6539	Nuclear RD program [2010-0018539]; National Research Foundation of Korea [2010-0024939, 2010-0025261, 2011-0021830]; Ministry of Education, Science and Technology	Nuclear RD program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Nuclear R&D program (grant no. 2010-0018539 to JS) and the Basic Science Research Program (grant nos. 2010-0024939 to SHA, 2010-0025261 to DYK, and 2011-0021830 to SWR) through the National Research Foundation of Korea, which is funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Hackett PB, 2005, ADV GENET, V54, P189, DOI 10.1016/S0065-2660(05)54009-4; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2002, LANCET ONCOL, V3, P546, DOI 10.1016/S1470-2045(02)00848-3; Hueper K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030432; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Podetz-Pedersen KM, 2010, HUM GENE THER, V21, P210, DOI 10.1089/hum.2009.128; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Wiesner SM, 2009, CANCER RES, V69, P431, DOI 10.1158/0008-5472.CAN-08-1800; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	31	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59869	10.1371/journal.pone.0059869	http://dx.doi.org/10.1371/journal.pone.0059869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555816	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200052
J	Lin, SH; Liao, YC				Lin, Shin-Hung; Liao, Yu-Chieh			CISA: Contig Integrator for Sequence Assembly of Bacterial Genomes	PLOS ONE			English	Article							ALGORITHMS; READS	A plethora of algorithmic assemblers have been proposed for the de novo assembly of genomes, however, no individual assembler guarantees the optimal assembly for diverse species. Optimizing various parameters in an assembler is often performed in order to generate the most optimal assembly. However, few efforts have been pursued to take advantage of multiple assemblies to yield an assembly of high accuracy. In this study, we employ various state-of-the-art assemblers to generate different sets of contigs for bacterial genomes. A tool, named CISA, has been developed to integrate the assemblies into a hybrid set of contigs, resulting in assemblies of superior contiguity and accuracy, compared with the assemblies generated by the state-of-the-art assemblers and the hybrid assemblies merged by existing tools. This tool is implemented in Python and requires MUMmer and BLAST+ to be installed on the local machine. The source code of CISA and examples of its use are available at http://sb.nhri.org.tw/CISA/.	[Lin, Shin-Hung; Liao, Yu-Chieh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan	National Health Research Institutes - Taiwan	Liao, YC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan.	jade@nhri.org.tw	Liao, Yu-Chieh/E-5031-2011; Liao, Yu-Chieh/L-5113-2019	Liao, Yu-Chieh/0000-0002-4360-7932	National Health Research Institutes [PH-101-PP-45]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes intramural funding (PH-101-PP-45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2011, PLOS ONE, V6; Casagrande A, 2009, IEEE INT C BIOINFORM, P321, DOI 10.1109/BIBM.2009.28; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Kislyuk AO, 2010, BIOINFORMATICS, V26, P1819, DOI 10.1093/bioinformatics/btq284; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Nijkamp J, 2010, BIOINFORMATICS, V26, pi433, DOI 10.1093/bioinformatics/btq366; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yao GH, 2012, BIOINFORMATICS, V28, P13, DOI 10.1093/bioinformatics/btr588; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimin AV, 2008, BIOINFORMATICS, V24, P42, DOI 10.1093/bioinformatics/btm542	16	129	131	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60843	10.1371/journal.pone.0060843	http://dx.doi.org/10.1371/journal.pone.0060843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23556006	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200132
J	Trzcinski, K; Bogaert, D; Wyllie, A; Chu, MLJN; van der Ende, A; Bruin, JP; van den Dobbelsteen, G; Veenhoven, RH; Sanders, EAM				Trzcinski, Krzysztof; Bogaert, Debby; Wyllie, Anne; Chu, Mei Ling J. N.; van der Ende, Arie; Bruin, Jacob P.; van den Dobbelsteen, Germie; Veenhoven, Reinier H.; Sanders, Elisabeth A. M.			Superiority of Trans-Oral over Trans-Nasal Sampling in Detecting Streptococcus pneumoniae Colonization in Adults	PLOS ONE			English	Article							CAPSULAR ANTIGEN-DETECTION; UPPER RESPIRATORY-TRACT; PNEUMOCOCCAL CARRIAGE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; BACTERIAL-FLORA; CHILDREN; FAMILIES; SEQUENCE; CULTURE	The human nasopharynx is the main reservoir for Streptococcus pneumoniae. We applied conventional and molecular methods to determine the prevalence of S. pneumoniae nasopharyngeal colonization in adults. Paired trans-orally and trans-nasally obtained nasopharyngeal samples from 268 parents of 24-month-old children were assessed for pneumococcal presence. Parents were classified as colonized when live pneumococci were recovered from either sample cultured on medium selective for S. pneumoniae. Of the 52 (19%) colonized parents 49 (18%) were culture-positive in trans-nasal and 10 (4%) in trans-oral samples. Bacterial growth was harvested from these cultures, DNA isolated and tested by quantitative-PCR (qPCR) targeting lytA and piaA genes specific for S. pneumoniae. A sample was considered positive if signals for both genes were detected. Altogether 105 (39%) individuals were classified as positive for pneumococcus by qPCR including 50 (19%) in trans-nasal and 94 (35%) in trans-oral settings. Although significantly more trans-nasal compared to trans-oral samples were culture-positive for S. pneumoniae at the primary diagnostic step (p<0.001) the opposite was observed in qPCR results (p<0.001). To confirm the presence of live pneumococcus in samples positive by qPCR but negative at the initial diagnostic step, we serially-diluted cell harvests, re-cultured and carefully examined for S. pneumoniae presence. Live pneumococci were recovered from an additional 43 parents including 42 positive in trans-oral and 4 in trans-nasal samples increasing the number of individuals culture-and qPCR-positive to 93 (35%) and positive by either of two methods to 107 (40%). There were significantly more trans-oral than trans-nasal samples positive for pneumococcus by both culture and qPCR (n = 71; 27%; vs. n = 50; 19%; p<0.05). Our data suggest that pneumococcal colonization is more common in adults than previously estimated and point towards the superiority of a trans-oral over a trans-nasal approach when testing adults for colonization with S. pneumoniae.	[Trzcinski, Krzysztof; Bogaert, Debby; Wyllie, Anne; Chu, Mei Ling J. N.; Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Wilhelminas Children Hosp, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands; [van den Dobbelsteen, Germie] Netherlands Vaccine Inst, Ctr Infect Dis Control, Unit Vaccinol, Bilthoven, Netherlands; [Veenhoven, Reinier H.] Spaarne Hosp, Linnaeus Inst, Hoofddorp, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Spaarne Hospital	Trzcinski, K (corresponding author), Univ Med Ctr Utrecht, Wilhelminas Children Hosp, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands.	K.Trzcinski@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; van der Ende, Arie/0000-0003-1298-3086; Wyllie, Anne/0000-0001-6015-0279; Bogaert, Debby/0000-0003-2651-7000	Wilhelmina Children's Hospital of the University Medical Centre Utrecht; Pfizer; GlaxoSmithKline; Baxter	Wilhelmina Children's Hospital of the University Medical Centre Utrecht; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Baxter	This work was supported by internal funds from Wilhelmina Children's Hospital of the University Medical Centre Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In response to the journal request to disclose potential conflict of interests, the authors would like to state that K. Trzcinski and D. Bogaert are receiving consulting fees from Pfizer. A. van der Ende and R. H. Veenhoven report receiving consulting fees from Pfizer and GlaxoSmithKline and grant support from Pfizer and GlaxoSmithKline for vaccine studies. E. A. M. Sanders reports receiving unrestricted grants from Pfizer and Baxter for research, consulting fees from Pfizer and GlaxoSmithKline, lecturing fees from Pfizer and grant support from Pfizer and GlaxoSmithKline for vaccine studies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; BOERSMA WG, 1993, SCAND J INFECT DIS, V25, P51, DOI 10.3109/00365549309169669; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Erasto P, 2010, EPIDEMIOL INFECT, V138, P861, DOI 10.1017/S0950268809991415; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Heffron R, 1939, HLTH CARRIERS NOT HA, P343; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Hoti F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-102; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Konno Masatoshi, 2007, Journal of Infection and Chemotherapy, V13, P235, DOI 10.1007/s10156-007-0533-8; Lankinen KS, 1997, AM J TROP MED HYG, V56, P211, DOI 10.4269/ajtmh.1997.56.211; Leino T, 2001, PEDIATR INFECT DIS J, V20, P1022, DOI 10.1097/00006454-200111000-00004; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; MASTERS PL, 1958, BMJ-BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.5081.1200; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Porat N, 2006, J INFECT DIS, V194, P689, DOI 10.1086/506453; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; Simoes AS, 2010, J CLIN MICROBIOL, V48, P238, DOI 10.1128/JCM.01313-09; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Versalovic J, 2011, MANUAL CLIN MICROBIO; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Whalan RH, 2006, J BACTERIOL, V188, P1031, DOI 10.1128/JB.188.3.1031-1038.2006; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000	40	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60520	10.1371/journal.pone.0060520	http://dx.doi.org/10.1371/journal.pone.0060520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555985	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200122
J	Bernal-Quiros, M; Wu, YY; Alarcon-Riquelme, ME; Castillejo-Lopez, C				Bernal-Quiros, Manuel; Wu, Ying-Yu; Alarcon-Riquelme, Marta E.; Castillejo-Lopez, Casimiro			BANK1 and BLK Act through Phospholipase C Gamma 2 in B-Cell Signaling	PLOS ONE			English	Article							TYROSINE KINASES; SCAVENGER RECEPTOR; SOLUBLE CD163; CUTTING EDGE; C-GAMMA-2; LYN; SRC; PHOSPHORYLATION; ACTIVATION; PROTEIN	The B cell adaptor protein with ankyrin repeats (BANK1) and the B lymphoid tyrosine kinase (BLK) have been genetically associated with autoimmunity. The proteins of these genes interact physically and work in concert during B-cell signaling. Little is know about their interactions with other B-cell signaling molecules or their role in the process. Using yeast two hybrid (Y2H) we sought for factors that interact with BANK1. We found that the molecular switch PLCg2 interacts with BANK1 and that the interaction is promoted by B-cell receptor (BCR) stimulation. We found further that the kinase activity of BLK enhanced BANK1-PLCg2 binding and that the interaction was suppressed upon BLK depletion. Immunoprecipitation and mutational analysis demonstrated that the interaction between BANK1 and PLCg2 was dependent on specific tyrosine and proline residues on the adaptor protein. Our results provide new information important to understand the role of these two genes in basic B-cell physiology and immune-related diseases.	[Bernal-Quiros, Manuel; Alarcon-Riquelme, Marta E.; Castillejo-Lopez, Casimiro] Pfizer Univ Granada Junta de Andalucia, Ctr Genom & Invest Oncol, Granada, Spain; [Wu, Ying-Yu; Alarcon-Riquelme, Marta E.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA	Pfizer; University of Granada; Oklahoma Medical Research Foundation	Alarcon-Riquelme, ME (corresponding author), Pfizer Univ Granada Junta de Andalucia, Ctr Genom & Invest Oncol, Granada, Spain.	marta.alarcon@genyo.es; casimiro.castillejo@genyo.es	Alarcón-Riquelme, Marta E./ABF-8163-2020	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Bernal-Quiros, Manuel/0000-0002-7511-2774	Swedish Research Council of Medicine; Instituto de Salud Carlos III [PI09/0129]; European Union FEDER funds; Alliance for Lupus Research; National Institutes of Health Centers of Biomedical Research Excellence [P20 GM103456-09]; Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	Swedish Research Council of Medicine; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union FEDER funds(European Commission); Alliance for Lupus Research; National Institutes of Health Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Swedish Research Council of Medicine, the Instituto de Salud Carlos III (PI09/0129), partly financed by the European Union FEDER funds, the Alliance for Lupus Research, the National Institutes of Health Centers of Biomedical Research Excellence (P20 GM103456-09), and the Oklahoma Center for the Advancement of Science and Technology to MEAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Battersby A, 2003, J MOL BIOL, V329, P479, DOI 10.1016/S0022-2836(03)00489-3; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Castillejo-Lopez C, 2012, ANN RHEUM DIS, V71, P136, DOI 10.1136/annrheumdis-2011-200085; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Darmoise A, 2010, ADV IMMUNOL, V105, P25, DOI 10.1016/S0065-2776(10)05002-9; Everett KL, 2011, MOL CELL BIOL, V31, P1240, DOI 10.1128/MCB.01408-10; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Ishiai M, 1999, J IMMUNOL, V163, P1746; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kozyrev SV, 2012, GENES IMMUN, V13, P129, DOI 10.1038/gene.2011.62; Kozyrev SV, 2008, NAT GENET; Kozyrev SV, 2011, GENES IMMUN; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; PLEIMAN CM, 1993, MOL CELL BIOL, V13, P5877, DOI 10.1128/MCB.13.9.5877; REEVES WH, 1989, J CLIN INVEST, V84, P562, DOI 10.1172/JCI114199; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rueda B, 2010, ANN RHEUM DIS, V69, P700, DOI 10.1136/ard.2009.118174; Samuelson EM, 2012, IMMUNOL CELL BIOL, V90, P620, DOI 10.1038/icb.2011.76; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Sato S, 2000, J IMMUNOL, V165, P6635, DOI 10.4049/jimmunol.165.11.6635; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	43	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59842	10.1371/journal.pone.0059842	http://dx.doi.org/10.1371/journal.pone.0059842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555801	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500099
J	Hermoso, V; Kennard, MJ; Linke, S				Hermoso, Virgilio; Kennard, Mark J.; Linke, Simon			Data Acquisition for Conservation Assessments: Is the Effort Worth It?	PLOS ONE			English	Article							BIODIVERSITY SURVEYS; RESERVE SELECTION; REGIONAL-SCALE; UNCERTAINTY; DISTRIBUTIONS; SENSITIVITY; SURROGATES; MODELS	When identifying conservation priorities, the accuracy of conservation assessments is constrained by the quality of data available. Despite previous efforts exploring how to deal with imperfect datasets, little is known about how data uncertainty translates into errors in conservation planning outcomes. Here, we evaluate the magnitude of commission and omission error, effectiveness and efficiency of conservation planning outcomes derived from three datasets with increasing data quality. We demonstrate that investing in data acquisition might not always be the best strategy as the magnitude of errors introduced by new sites/species can exceed the benefits gained. There was a trade-off between effectiveness and efficiency due to poorly sampled rare species. Given that data acquisition is limited by the high cost and time required, we recommend focusing on improving the quality of data for those species with the highest level of uncertainty (rare species) when acquiring new data.	[Hermoso, Virgilio] Griffith Univ, Natl Environm Res Program Northern Australia Hub, Australian Rivers Inst, Nathan, Qld 4111, Australia; Griffith Univ, Natl Environm Res Program Northern Australia Hub, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Hermoso, V (corresponding author), Griffith Univ, Natl Environm Res Program Northern Australia Hub, Australian Rivers Inst, Nathan, Qld 4111, Australia.	virgilio.hermoso@gmail.com	Kennard, Mark James/C-3425-2008; Lopez, Virgilio Hermoso/H-8276-2015	Kennard, Mark James/0000-0003-4383-4999; Lopez, Virgilio Hermoso/0000-0003-3205-5033; Linke, Simon/0000-0002-1797-3947; Hermoso, Virgilio/0000-0002-8089-3448	Australian Research Council [DP120103353]; Australian Government Department of Sustainability, Environment, Water, Population and Communities; National Water Commission; Tropical Rivers and Coastal Knowledge (TRaCK) Research Hub; National Environmental Research Program Northern Australia Hub; Australian Rivers Institute, Griffith University	Australian Research Council(Australian Research Council); Australian Government Department of Sustainability, Environment, Water, Population and Communities(Australian Government); National Water Commission; Tropical Rivers and Coastal Knowledge (TRaCK) Research Hub; National Environmental Research Program Northern Australia Hub; Australian Rivers Institute, Griffith University(Griffith University)	The authors acknowledge the Australian Research Council (Discovery Grant No. DP120103353), Australian Government Department of Sustainability, Environment, Water, Population and Communities, the National Water Commission, the Tropical Rivers and Coastal Knowledge (TRaCK) Research Hub, the National Environmental Research Program Northern Australia Hub, and the Australian Rivers Institute, Griffith University, for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Balmford A, 1999, NATURE, V398, P204, DOI 10.1038/18339; Ben-Haim Y., 2006, INFO GAP DECISION TH, V33, P368; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; ESRI, 2002, ARCGIS; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freeman E., 2007, PRESENCEABSENCE R PA; Freitag S, 1998, P ROY SOC B-BIOL SCI, V265, P1475, DOI 10.1098/rspb.1998.0460; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston KJ, 2003, CONSERV BIOL, V17, P188, DOI 10.1046/j.1523-1739.2003.01268.x; Geoscience Australia, 2011, ENV ATTR DAT; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Guisan A, 1998, J VEG SCI, V9, P65, DOI 10.2307/3237224; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2013, BIOL CONSERV, V159, P197, DOI 10.1016/j.biocon.2012.11.026; Hermoso V, 2012, BIOL CONSERV, V147, P52, DOI 10.1016/j.biocon.2012.01.020; Hirzel A, 2002, ECOL MODEL, V157, P331, DOI 10.1016/S0304-3800(02)00203-X; Januchowski-Hartley SR, 2011, BIOL CONSERV, V144, P2499, DOI 10.1016/j.biocon.2011.07.004; Kennard MJ, 2010, IDENTIFYING HIGH CON; Langford WT, 2011, TRENDS ECOL EVOL, V26, P634, DOI 10.1016/j.tree.2011.08.001; Langford WT, 2009, ECOL INFORM, V4, P123, DOI 10.1016/j.ecoinf.2009.04.002; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Maidment D.R., 2002, ARC HYDRO GIS WATER; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moilanen A, 2005, CONSERV BIOL, V19, P1663, DOI 10.1111/j.1523-1739.2005.00203.x; Moilanen A, 2006, CONSERV BIOL, V20, P1688, DOI 10.1111/j.1523-1739.2006.00560.x; Possingham HP, 2007, J BIOGEOGR, V34, P758, DOI 10.1111/j.1365-2699.2007.01717.x; Pressey RL, 1999, J BIOGEOGR, V26, P179, DOI 10.1046/j.1365-2699.1999.00258.x; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Wessels KJ, 1998, BIODIVERS CONSERV, V7, P1093, DOI 10.1023/A:1008899802456; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004	41	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59662	10.1371/journal.pone.0059662	http://dx.doi.org/10.1371/journal.pone.0059662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555738	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500070
J	Kumar, A; Cocco, E; Atzori, L; Marrosu, MG; Pieroni, E				Kumar, Amit; Cocco, Eleonora; Atzori, Luigi; Marrosu, Maria Giovanna; Pieroni, Enrico			Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							RECEPTOR CROSS-REACTIVITY; SOLVATED INTERACTION ENERGY; MHC PROTEIN HLA-DR1; PEPTIDE-BINDING; HLA-DR; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; CLASS-I; FLEXIBILITY; RECOGNITION	Sardinia is a major Island in the Mediterranean with a high incidence of multiple sclerosis, a chronic autoimmune inflammatory disease of the central nervous system. Disease susceptibility in Sardinian population has been associated with five alleles of major histocompatibility complex (MHC) class II DRB1 gene. We performed 120 ns of molecular dynamics simulation on one predisposing and one protective alleles, unbound and in complex with the two relevant peptides: Myelin Basic Protein and Epstein Barr Virus derived peptide. In particular we focused on the MHC peptide binding groove dynamics. The predisposing allele was found to form a stable complex with both the peptides, while the protective allele displayed stability only when bound with myelin peptide. The local flexibility of the MHC was probed dividing the binding groove into four compartments covering the well known peptide anchoring pockets. The predisposing allele in the first half cleft exhibits a narrower and more rigid groove conformation in the presence of myelin peptide. The protective allele shows a similar behavior, while in the second half cleft it displays a narrower and more flexible groove conformation in the presence of viral peptide. We further characterized these dynamical differences by evaluating H-bonds, hydrophobic and stacking interaction networks, finding striking similarities with super-type patterns emerging in other autoimmune diseases. The protective allele shows a defined preferential binding to myelin peptide, as confirmed by binding free energy calculations. All together, we believe the presented molecular analysis could help to design experimental assays, supports the molecular mimicry hypothesis and suggests that propensity to multiple sclerosis in Sardinia could be partly linked to distinct peptide-MHC interaction and binding characteristics of the antigen presentation mechanism.	[Kumar, Amit; Cocco, Eleonora; Marrosu, Maria Giovanna] Univ Cagliari, Multiple Sclerosis Ctr, Dept Publ Hlth & Clin & Mol Med, Cagliari, Italy; [Kumar, Amit; Pieroni, Enrico] CRS4 Sci & Technol Pk Polaris, Bioengn Grp, Pula, CA, Italy; [Kumar, Amit; Atzori, Luigi] Univ Cagliari, Dept Biomed Sci, Oncol & Mol Pathol Unit, Cagliari, Italy	University of Cagliari; University of Cagliari	Kumar, A (corresponding author), Univ Cagliari, Multiple Sclerosis Ctr, Dept Publ Hlth & Clin & Mol Med, Cagliari, Italy.	amit369@gmail.com; ep@crs4.it	Cocco, Eleonora/G-5064-2012; Kumar, Amit/F-5259-2012; Atzori, Luigi/A-6169-2016; Kumar, Amit/F-5259-2012	Cocco, Eleonora/0000-0002-3878-8820; Kumar, Amit/0000-0002-2547-0071; Atzori, Luigi/0000-0002-0606-4959; Kumar, Amit/0000-0003-1589-6391; pieroni, enrico/0000-0002-4246-6963; Marrosu, Maria Giovanna/0000-0003-2334-2081	MIUR Italy; Fondazione Banco di Sardegna grant; Sardegna Ricerche	MIUR Italy(Ministry of Education, Universities and Research (MIUR)); Fondazione Banco di Sardegna grant(Fondazione Banco di Sardegna); Sardegna Ricerche(Regione Sardegna)	This work was supported by grant project PRIN 2008 call by MIUR Italy, Fondazione Banco di Sardegna grant 2009, Sardegna Ricerche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004164; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balaraju T, 2012, STRUCTURAL CHEM; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Fenwick RB, 2011, EUR BIOPHYS J BIOPHY, V40, P1339, DOI 10.1007/s00249-011-0754-8; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Call MJ, 2011, MOL IMMUNOL, V48, P1735, DOI 10.1016/j.molimm.2011.05.022; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Cocco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033972; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fugger L, 2009, NAT REV IMMUNOL, V9, P408, DOI 10.1038/nri2554; Gagnon SJ, 2006, MOL IMMUNOL, V43, P346, DOI 10.1016/j.molimm.2005.02.011; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Hansen BE, 2007, TISSUE ANTIGENS, V70, P42, DOI 10.1111/j.1399-0039.2007.00849.x; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hov JR, 2011, HEPATOLOGY, V53, P1967, DOI 10.1002/hep.24299; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; James EA, 2009, J IMMUNOL, V183, P3249, DOI 10.4049/jimmunol.0802228; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaas Quentin, 2005, In Silico Biology, V5, P505; Kakalacheva K, 2011, FEBS LETT, V585, P3724, DOI 10.1016/j.febslet.2011.04.006; Katsara M, 2009, IMMUNOLOGY, V128, P521, DOI 10.1111/j.1365-2567.2009.03137.x; Knapp B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011653; Kumar A, 2010, J PHYS CHEM B, V114, P9608, DOI 10.1021/jp9110579; Kumar N, 2007, NUCLEIC ACIDS RES, V35, pW549, DOI 10.1093/nar/gkm266; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Mechelli R, 2011, MULT SCLER J, V17, P1290, DOI 10.1177/1352458511410515; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Ou DW, 1998, HUM IMMUNOL, V59, P665, DOI 10.1016/S0198-8859(98)00067-6; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002404; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; ROTHBARD JB, 1991, ANNU REV IMMUNOL, V9, P527, DOI 10.1146/annurev.iy.09.040191.002523; Rupp B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018662; Sadegh-Nasseri S, 2010, IMMUNOL RES, V47, P56, DOI 10.1007/s12026-009-8138-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Southwood S, 1998, J IMMUNOL, V160, P3363; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Tsoulos IG, 2011, COMPUT PHYS COMMUN, V182, P834, DOI 10.1016/j.cpc.2010.11.032; van den Berg HA, 2007, IMMUNOL REV, V216, P81; Virtanen JO, 2012, CNS NEUROL DISORD-DR, V11, P528; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wucherpfennig KW, 2011, SEMIN IMMUNOL, V23, P84, DOI 10.1016/j.smim.2011.01.007; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Yaneva R, 2010, MOL IMMUNOL, V47, P649, DOI 10.1016/j.molimm.2009.10.008; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Zavattari P, 2001, HUM MOL GENET, V10, P881, DOI 10.1093/hmg/10.8.881; Zipp F, 2000, HUM IMMUNOL, V61, P1021, DOI 10.1016/S0198-8859(00)00173-7	80	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59711	10.1371/journal.pone.0059711	http://dx.doi.org/10.1371/journal.pone.0059711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555757	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500083
J	Sato, T; Kotake, D; Hiratsuka, M; Hirasawa, N				Sato, Taiki; Kotake, Daisuke; Hiratsuka, Masahiro; Hirasawa, Noriyasu			Enhancement of Inflammatory Protein Expression and Nuclear Factor Kb (NF-Kb) Activity by Trichostatin A (TSA) in OP9 Preadipocytes	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HEPATIC INSULIN-RESISTANCE; EMBRYONIC STEM-CELLS; KAPPA-B; ADIPOSE-TISSUE; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; FATTY-ACID; INTERLEUKIN-6; ACETYLATION	The production of inflammatory proteins such as interleukin-6 (IL-6) by preadipocytes and mature adipocytes is closely associated with the impairment of systemic glucose homeostasis. However, precisely how the production is regulated and the roles of histone deacetylases (HDACs) remain largely unknown. The aim of this study was to establish whether HDAC inhibitors affect the expression of inflammatory proteins in pre/mature adipocytes, and, if so, to determine the mechanism involved. Trichostatin A (TSA), an HDAC inhibitor, enhanced lipopolysaccharide (LPS)-induced production of IL-6 in OP9 preadipocytes but not the mature adipocytes. Moreover, TSA also enhanced palmitic acid-induced IL-6 production and the expression of inflammatory genes induced by LPS in preadipocytes. Although TSA did not affect TLR4 mRNA expression or the activation of MAPKs, a reporter gene assay revealed that the LPS-induced increase in nuclear factor kappa B (NF-kappa B) activity was enhanced by TSA. Moreover, TSA increased the level of NF-kappa B p65 acetylation at lysine 310 and duration of its translocation into the nucleus, which leads to enhancement of NF-kappa B activity and subsequently expression of inflammatory genes. These findings shed new light on the regulatory roles of HDACs in preadipocytes in the production of inflammatory proteins.	[Sato, Taiki; Kotake, Daisuke; Hiratsuka, Masahiro; Hirasawa, Noriyasu] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan	Tohoku University	Hirasawa, N (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	hirasawa@m.tohoku.ac.jp	Hiratsuka, Masahiro/AAO-8082-2020	Hiratsuka, Masahiro/0000-0002-3767-7686; Hirasawa, Noriyasu/0000-0002-8062-4838	Tohuku University	Tohuku University	Management Expenses Grants from Tohuku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen Q, 2011, J IMMUNOTOXICOL, V8, P210, DOI 10.3109/1547691X.2011.568979; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Davies JM, 2010, IMMUNOLOGY, V131, P438, DOI 10.1111/j.1365-2567.2010.03317.x; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Furumai R, 2011, CANCER SCI, V102, P1081, DOI 10.1111/j.1349-7006.2011.01904.x; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Grabiec AM, 2012, ANN RHEUM DIS, V71, P424, DOI 10.1136/ard.2011.154211; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hirasawa N, 2009, LIFE SCI, V85, P578, DOI 10.1016/j.lfs.2009.08.012; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Ping DS, 1999, J IMMUNOL, V162, P727; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rosen ED, 2000, GENE DEV, V14, P1293; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SOUTHERN C, 1990, BIOCHEM J, V272, P243, DOI 10.1042/bj2720243; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suuronen T, 2003, J NEUROCHEM, V87, P407, DOI 10.1046/j.1471-4159.2003.02004.x; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tao JY, 2009, J ETHNOPHARMACOL, V123, P97, DOI 10.1016/j.jep.2009.02.024; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Xie NC, 2010, NEUROSCI LETT, V482, P51, DOI 10.1016/j.neulet.2010.07.004; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	59	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59702	10.1371/journal.pone.0059702	http://dx.doi.org/10.1371/journal.pone.0059702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555753	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500082
J	Yu, RJ; Liu, B; Wang, LL; Chen, J; Liu, X				Yu, Rongjun; Liu, Bo; Wang, Lingling; Chen, Jun; Liu, Xian			Enhanced Functional Connectivity between Putamen and Supplementary Motor Area in Parkinson's Disease Patients	PLOS ONE			English	Article							UNILATERAL PALLIDOTOMY; BASAL GANGLIA; RESTING STATE; STRIATUM; COACTIVATION; EXECUTION; MOVEMENTS; DIRECTION; LEVODOPA; CORTEX	Parkinson's disease (PD) is a surprisingly heterogeneous disorder with symptoms including resting tremor, bradykinesia and rigidity. PD has been associated with abnormal task related brain activation in sensory and motor regions as well as reward related network. Although corticostriatal skeletomotor circuit dysfunction is implicated in the neurobiology of Parkinson's disease, the functional connectivity within this circuit at the resting state is still unclear for PD. Here we utilized resting state functional magnetic resonance imaging to measure the functional connectivity of striatum and motor cortex in 19 patients with PD and 20 healthy controls. We found that the putamen, but not the caudate, exhibited enhanced connectivity with supplementary motor area (SMA), using either the putamen or the SMA as the "seed region". Enhanced SMA-amygdala functional connectivity was also found in the PD group, compared with normal controls. Our findings highlight the key role of hyper-connected putamen-SMC circuit in the pathophysiology of PD.	[Yu, Rongjun; Wang, Lingling] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun; Wang, Lingling] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Liu, Bo; Chen, Jun; Liu, Xian] Guangdong Prov Hosp Tradit Chinese Med, Dept Image, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; Guangzhou University of Chinese Medicine	Yu, RJ (corresponding author), S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.	rongjun.yu@gmail.com; lbgdhtcm@163.com	Yu, Rongjun/AAV-2615-2020; Chen, Jun/AAD-7667-2020	Yu, Rongjun/0000-0003-0123-1524; CHEN, JUN/0000-0001-5049-5759				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; de Bie RMA, 2001, J NEUROL NEUROSUR PS, V71, P375, DOI 10.1136/jnnp.71.3.375; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Eckert T, 2005, NEUROIMAGE, V26, P912, DOI 10.1016/j.neuroimage.2005.03.012; Eickhoff SB, 2011, NEUROIMAGE, V57, P938, DOI 10.1016/j.neuroimage.2011.05.021; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; JAEGER D, 1995, BRAIN RES, V694, P111, DOI 10.1016/0006-8993(95)00780-T; Kas A, 2009, J CEREBR BLOOD F MET, V29, P1601, DOI 10.1038/jcbfm.2009.74; Kwak Y, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00143; Lee JN, 2010, NEUROIMAGE, V49, P1282, DOI 10.1016/j.neuroimage.2009.09.072; Marchand WR, 2008, NEUROREPORT, V19, P957, DOI 10.1097/WNR.0b013e328302c873; Morrish PK, 1996, BRAIN, V119, P2097, DOI 10.1093/brain/119.6.2097; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Smeding HMM, 2005, J NEUROL, V252, P176, DOI 10.1007/s00415-005-0628-z; Taniwaki T, 2003, J NEUROSCI, V23, P3432; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ueda Y, 2003, EUR J NEUROSCI, V18, P980, DOI 10.1046/j.1460-9568.2003.02814.x; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Wu T, 2011, NEUROIMAGE, V55, P204, DOI 10.1016/j.neuroimage.2010.11.074; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	32	58	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59717	10.1371/journal.pone.0059717	http://dx.doi.org/10.1371/journal.pone.0059717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555758	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500084
J	Andries, AM; Capraru, B				Andries, Alin Marius; Capraru, Bogdan			Impact of Financial Liberalization on Banking Sectors Performance from Central and Eastern European Countries	PLOS ONE			English	Article							PRODUCTIVITY GROWTH; EFFICIENCY; TRANSITION; INSTITUTIONS; DEREGULATION; REGULATIONS; COST; DETERMINANTS; SUPERVISION; OWNERSHIP	In this paper we analyse the impact of financial liberalization and reforms on the banking performance in 17 countries from CEE for the period 2004-2008 using a two-stage empirical model that involves estimating bank performance in the first stage and assessing its determinants in the second one. From our analysis it results that banks from CEE countries with higher level of liberalization and openness are able to increase cost efficiency and eventually to offer cheaper services to clients. Banks from non-member EU countries are less cost efficient but experienced much higher total productivity growth level, and large sized banks are much more cost efficient than medium and small banks, while small sized banks show the highest growth in terms of productivity.	[Andries, Alin Marius; Capraru, Bogdan] Alexandru Ioan Cuza Univ, Fac Econ & Business Adm, Iasi, Romania	Alexandru Ioan Cuza University	Andries, AM (corresponding author), Alexandru Ioan Cuza Univ, Fac Econ & Business Adm, Iasi, Romania.	alin.andries@uaic.ro	Capraru, Bogdan/H-6235-2015; Andries, Alin Marius/B-5980-2011	Capraru, Bogdan/0000-0003-4261-5268; Andries, Alin Marius/0000-0002-4415-4197	European Social Fund through Sectoral Operational Programme Human Resources Development [POSDRU/89/1.5/S/59184]	European Social Fund through Sectoral Operational Programme Human Resources Development	This work was financed from the European Social Fund through Sectoral Operational Programme Human Resources Development 2007-2013 project number POSDRU/89/1.5/S/59184 "Performance and excellence in postdoctoral research in Romanian economics science domain". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries AM, 2011, EASTERN EUR ECON, V49, P38, DOI 10.2753/EEE0012-8775490603; Asaftei G, 2008, J REGUL ECON, V33, P253, DOI 10.1007/s11149-007-9041-0; Athanasoglou P. P., 2008, J INT FINANC MARK I, V18, P121, DOI [10.1016/j.intfin.2006.07.001, DOI 10.1016/J.INTFIN.2006.07.001]; Barisitz Stephan, 2009, S E EUR J EC, V7, P161; Barth JR, 2004, J FINANC INTERMED, V13, P205, DOI 10.1016/j.jfi.2003.06.002; Battese GE., 1992, J PROD ANAL, V3, P153, DOI DOI 10.1007/BF00158774; BERG SA, 1992, SCAND J ECON, V94, pS211, DOI 10.2307/3440261; Berger AN, 1997, EUR J OPER RES, V98, P175, DOI 10.1016/S0377-2217(96)00342-6; BERGER AN, 1993, J BANK FINANC, V17, P221, DOI 10.1016/0378-4266(93)90030-H; Berger AN, 2003, J FINANC INTERMED, V12, P57, DOI 10.1016/S1042-9573(02)00006-2; Berger AN, 1997, J BANK FINANC, V21, P895, DOI 10.1016/S0378-4266(97)00010-1; BERGER AN, 1992, STUD INCOME, V56, P245; Berger AN., 2000, BROOKINGS WHARTON PA, V2000, P23, DOI DOI 10.1353/PFS.2000.0001; Bonin JP, 2005, J BANK FINANC, V29, P31, DOI 10.1016/j.jbankfin.2004.06.015; Brissimis SN, 2008, J BANK FINANC, V32, P2674, DOI 10.1016/j.jbankfin.2008.07.002; Casu B, 2004, J BANK FINANC, V28, P2521, DOI 10.1016/j.jbankfin.2003.10.014; Chinn MD., 2008, J COMP POLICY ANAL, V10, P309, DOI [10.1080/13876980802231123, DOI 10.1080/13876980802231123]; Daniel BC, 2007, J INT ECON, V72, P202, DOI 10.1016/j.jinteco.2006.07.009; Delis MD, 2011, J MONEY CREDIT BANK, V43, P735, DOI 10.1111/j.1538-4616.2011.00393.x; Demirguc-Kunt A, 2004, J MONEY CREDIT BANK, V36, P593, DOI 10.1353/mcb.2004.0045; Demirguc-Kunt A, 2011, J FINANC STABIL, V7, P179, DOI 10.1016/j.jfs.2010.03.003; Dietsch M, 2000, J BANK FINANC, V24, P985, DOI 10.1016/S0378-4266(99)00115-6; Fang YW, 2011, ECON TRANSIT, V19, P495, DOI 10.1111/j.1468-0351.2011.00420.x; Fare R., 1992, J PROD ANAL, V3, P85, DOI [10.1007/BF00158770, DOI 10.1007/BF00158770]; Festic M, 2011, J BANK FINANC, V35, P310, DOI 10.1016/j.jbankfin.2010.08.007; Fiordelisi F, 2011, J BANK FINANC, V35, P1315, DOI 10.1016/j.jbankfin.2010.10.005; Fried HO., 2008, MEASUREMENT PRODUCTI, DOI DOI 10.1093/ACPROF:OSO/9780195183528.003.0001; Fries S, 2005, J BANK FINANC, V29, P55, DOI 10.1016/j.jbankfin.2004.06.016; Fries S., 2001, 71 EUR BANK REC DEV; Gilbert RA, 1998, J ECON BUS, V50, P133, DOI [10.1016/S0148-6195(97)00074-X, DOI 10.1016/S0148-6195(97)00074-X]; GrifellTatje E, 1996, EUR ECON REV, V40, P1281, DOI 10.1016/0014-2921(95)00024-0; Grigorian D, 2002, 2850 WORLD BANK; Hasan I, 2003, J BANK FINANC, V27, P2249, DOI 10.1016/S0378-4266(02)00328-X; Havrylchyk O, 2006, J BANK FINANC, V30, P1975, DOI 10.1016/j.jbankfin.2005.07.009; Isik I, 2003, J BANK FINANC, V27, P1455, DOI 10.1016/S0378-4266(02)00288-1; Kasman A, 2006, APPL ECON, V38, P1079, DOI 10.1080/00036840600639022; Kaufmann D., 2006, GOVERNANCE MATTERS 5; Kosak M, 2011, ECON TRANSIT, V19, P473, DOI 10.1111/j.1468-0351.2011.00419.x; Koutsomanoli-Filippaki A, 2009, J BANK FINANC, V33, P557, DOI 10.1016/j.jbankfin.2008.09.009; Kumbhakar SC, 2001, J MONEY CREDIT BANK, V33, P101, DOI 10.2307/2673874; Leightner J. E., 1998, J EC BUSINESS, V50, P115, DOI DOI 10.1016/S0148-6195(97)00073-8; Louzis DP, 2012, J BANK FINANC, V36, P1012, DOI 10.1016/j.jbankfin.2011.10.012; Maudos J., 2002, J INT FINANC MARK I, V12, P33, DOI DOI 10.1016/S1042-4431(01)00051-8; Mukherjee K, 2001, J BANK FINANC, V25, P913, DOI 10.1016/S0378-4266(00)00103-5; Pasiouras F., 2009, INT REV FINANC ANAL, V18, P294, DOI DOI 10.1016/J.IRFA.2009.07.003; Pasiouras F, 2008, REV QUANT FINANC ACC, V30, P187, DOI 10.1007/s11156-007-0046-7; Shyu J., 1998, J EMERGING MARKETS, V3, P27; Weill L, 2003, ECON TRANSIT, V11, P569, DOI 10.1111/1468-0351.00155; Wheelock DC, 1999, J MONEY CREDIT BANK, V31, P212, DOI 10.2307/2601230; Winkler G, 2005, 96 OEST NAT; Yildirim H., 2007, EUR J FINANC, V13, P123, DOI DOI 10.1080/13518470600763687; Zaim O., 1995, APPL FINANCIAL EC, V5, P257, DOI DOI 10.1080/758536876; Zhao TS, 2010, J BANK FINANC, V34, P246, DOI 10.1016/j.jbankfin.2009.07.022	53	18	18	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59686	10.1371/journal.pone.0059686	http://dx.doi.org/10.1371/journal.pone.0059686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555745	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400053
J	Merler, S; Jurman, G				Merler, Stefano; Jurman, Giuseppe			A Combinatorial Model of Malware Diffusion via Bluetooth Connections	PLOS ONE			English	Article								We outline here the mathematical expression of a diffusion model for cellphones malware transmitted through Bluetooth channels. In particular, we provide the deterministic formula underlying the proposed infection model, in its equivalent recursive (simple but computationally heavy) and closed form (more complex but efficiently computable) expression.	[Merler, Stefano; Jurman, Giuseppe] Fdn Bruno Kessler, Trento, Italy	Fondazione Bruno Kessler	Jurman, G (corresponding author), Fdn Bruno Kessler, Trento, Italy.	jurman@fbk.eu	merler, stefano/I-3557-2017; Jurman, Giuseppe/GRS-8221-2022	merler, stefano/0000-0002-5117-0611; Jurman, Giuseppe/0000-0002-2705-5728	EU	EU(European Commission)	The authors acknowledge funding by the EU FP7 Project EPIWORK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ghallali M, 2012, INT J ENCOTE, V1, P1; Ghallali Mohamed, 2011, P 9 INT C ADV MOB CO, P256; Jian-Feng M, 2009, P WICOM 09, P1; Khouzani M, 2011, THESIS U PENNSYLVANI; La Polla M, 2013, IEEE COMMUN SURV TUT, V15, P446, DOI 10.1109/SURV.2012.013012.00028; Van HN, 2009, CLOUD: 2009 ICSE WORKSHOP ON SOFTWARE ENGINEERING CHALLENGES OF CLOUD COMPUTING, P1, DOI 10.1109/CLOUD.2009.5071526; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Yan GH, 2009, IEEE T MOBILE COMPUT, V8, P353, DOI 10.1109/TMC.2008.129; Zanero S, 2009, IEEE SECUR PRIV, V7, P70, DOI 10.1109/MSP.2009.142	9	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59468	10.1371/journal.pone.0059468	http://dx.doi.org/10.1371/journal.pone.0059468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555677	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400042
J	Jia, JM; Xu, XL; Liu, F; Guo, XK; Zhang, MY; Lu, MC; Xu, LL; Wei, JL; Zhu, J; Zhang, SL; Zhang, SM; Sun, HP; You, QD				Jia, JianMin; Xu, XiaoLi; Liu, Fang; Guo, XiaoKe; Zhang, MingYe; Lu, MengChen; Xu, LiLi; Wei, JinLian; Zhu, Jia; Zhang, ShengLie; Zhang, ShengMiao; Sun, HaoPeng; You, QiDong			Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; PHASE-II TRIAL; BIOLOGICAL EVALUATION; CHAPERONE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; TARGET; POTENT; DERIVATIVES	Heat shock protein 90 (Hsp90), whose inhibitors have shown promising activity in clinical trials, is an attractive anticancer target. In this work, we first explored the significant pharmacophore features needed for Hsp90 inhibitors by generating a 3D-QSAR pharmacophore model. It was then used to virtually screen the SPECS databases, identifying 17 hits. Compound S1 and S13 exhibited the most potent inhibitory activity against Hsp90, with IC50 value 1.61 +/- 0.28 mu M and 2.83 +/- 0.67 mu M, respectively. Binding patterns analysis of the two compounds with Hsp90 revealed reasonable interaction modes. Further evaluation showed that the compounds exhibited good anti-proliferative effects against a series of cancer cell lines with high expression level of Hsp90. Meanwhile, S13 induced cell apoptosis in a dose-dependent manner in different cell lines. Based on the consideration of binding affinities, physicochemical properties and toxicities, 24 derivatives of S13 were designed, leading to the more promising compound S40, which deserves further optimization.	[Jia, JianMin; Xu, XiaoLi; Liu, Fang; Guo, XiaoKe; Zhang, MingYe; Lu, MengChen; Xu, LiLi; Wei, JinLian; Zhu, Jia; Zhang, ShengLie; Zhang, ShengMiao; Sun, HaoPeng; You, QiDong] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Jia, JianMin; Xu, XiaoLi; Liu, Fang; Guo, XiaoKe; Zhang, MingYe; Lu, MengChen; Xu, LiLi; Wei, JinLian; Zhu, Jia; Zhang, ShengLie; Zhang, ShengMiao; Sun, HaoPeng; You, QiDong] China Pharmaceut Univ, Jiang Su Key Lab Drug Design & Optimizat, Nanjing, Jiangsu, Peoples R China; [Sun, HaoPeng] China Pharmaceut Univ, Dept Med Chem, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University	Sun, HP (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	sunhaopeng@163.com; youqidong@gmail.com	wei, jinlian/AHE-8538-2022; Sun, Haopeng/M-3063-2018	wei, jinlian/0000-0002-2628-342X; Sun, Haopeng/0000-0002-5109-0304	National Natural Science Foundation of China [91129732, 81230078]; 863 of the State Key Program; Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University [JKGQ201103]; National Major Science and Technology Project of China (Innovation and Development of New Drugs) [2008ZX09401-001, 2009ZX09501-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 of the State Key Program(National High Technology Research and Development Program of China); Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University; National Major Science and Technology Project of China (Innovation and Development of New Drugs)	This work is supported by the project 81230078 (key program), 81202463 (youth foundation) and 91129732 of National Natural Science Foundation of China, 863 of the State Key Program, Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (JKGQ201103), 2008ZX09401-001 and 2009ZX09501-003 of National Major Science and Technology Project of China (Innovation and Development of New Drugs). The authors declare no other conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Brough PA, 2005, BIOORG MED CHEM LETT, V15, P5197, DOI 10.1016/j.bmcl.2005.08.091; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Brough PA, 2009, J MED CHEM, V52, P4794, DOI 10.1021/jm900357y; Chen YD, 2008, J MOL GRAPH MODEL, V26, P1160, DOI 10.1016/j.jmgm.2007.10.007; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Eiseman JL, 2005, CANCER CHEMOTH PHARM, V55, P21, DOI 10.1007/s00280-004-0865-3; Gaya L.M., 2009, CURR CHEM BIOL, V3, P330; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Glaze ER, 2005, CANCER CHEMOTH PHARM, V56, P637, DOI 10.1007/s00280-005-1000-9; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Huang DN, 2012, J CHEM INF MODEL, V52, P1356, DOI 10.1021/ci300067q; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lee HS, 2009, J CHEM INF MODEL, V49, P2419, DOI 10.1021/ci9002365; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Massey AJ, 2010, J MED CHEM, V53, P7280, DOI 10.1021/jm100342z; Messaoudi S, 2008, ANTI-CANCER AGENT ME, V8, P761, DOI 10.2174/187152008785914824; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; SCHNUR RC, 1995, J MED CHEM, V38, P3813, DOI 10.1021/jm00019a011; Shi JD, 2012, J MED CHEM, V55, P7786, DOI 10.1021/jm300810x; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Tse AN, 2008, CLIN CANCER RES, V14, P6704, DOI 10.1158/1078-0432.CCR-08-1006; Verheij MHP, 2012, J MED CHEM, V55, P8603, DOI 10.1021/jm300801u; Wang JX, 2012, J MED CHEM, V55, P7978, DOI 10.1021/jm300521m; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	36	17	25	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59315	10.1371/journal.pone.0059315	http://dx.doi.org/10.1371/journal.pone.0059315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565147	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300014
J	Peng, RQ; Sridhar, S; Tyagi, G; Phillips, JE; Garrido, R; Harris, P; Burns, L; Renteria, L; Woods, J; Chen, L; Allard, J; Ravindran, P; Bitter, H; Liang, ZM; Hogaboam, CM; Kitson, C; Budd, DC; Fine, JS; Bauer, CMT; Stevenson, CS				Peng, Ruoqi; Sridhar, Sriram; Tyagi, Gaurav; Phillips, Jonathan E.; Garrido, Rosario; Harris, Paul; Burns, Lisa; Renteria, Lorena; Woods, John; Chen, Leena; Allard, John; Ravindran, Palanikumar; Bitter, Hans; Liang, Zhenmin; Hogaboam, Cory M.; Kitson, Chris; Budd, David C.; Fine, Jay S.; Bauer, Carla M. T.; Stevenson, Christopher S.			Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for "Active" Disease	PLOS ONE			English	Article							INDUCED LUNG FIBROSIS; GROWTH-FACTOR-BETA; EXPRESSION PROFILES; MYOFIBROBLAST; INHIBITION; MICE	The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms related to idiopathic pulmonary fibrosis (IPF), has incorrectly predicted efficacy for several candidate compounds suggesting that it may be of limited value. As an attempt to improve the predictive nature of this model, integrative bioinformatic approaches were used to compare molecular alterations in the lungs of bleomycin-treated mice and patients with IPF. Using gene set enrichment analysis we show for the first time that genes differentially expressed during the fibrotic phase of the single challenge bleomycin model were significantly enriched in the expression profiles of IPF patients. The genes that contributed most to the enrichment were largely involved in mitosis, growth factor, and matrix signaling. Interestingly, these same mitotic processes were increased in the expression profiles of fibroblasts isolated from rapidly progressing, but not slowly progressing, IPF patients relative to control subjects. The data also indicated that TGF beta was not the sole mediator responsible for the changes observed in this model since the ALK-5 inhibitor SB525334 effectively attenuated some but not all of the fibrosis associated with this model. Although some would suggest that repetitive bleomycin injuries may more effectively model IPF-like changes, our data do not support this conclusion. Together, these data highlight that a single bleomycin instillation effectively replicates several of the specific pathogenic molecular changes associated with IPF, and may be best used as a model for patients with active disease.	[Peng, Ruoqi; Phillips, Jonathan E.; Harris, Paul; Burns, Lisa; Renteria, Lorena; Woods, John; Chen, Leena; Kitson, Chris; Budd, David C.; Fine, Jay S.; Bauer, Carla M. T.; Stevenson, Christopher S.] Hoffmann La Roche Inc, DTA Inflammat, pRED, Nutley, NJ 07110 USA; [Sridhar, Sriram; Allard, John; Ravindran, Palanikumar; Bitter, Hans] Hoffmann La Roche Inc, Translat Res Sci, pRED, Nutley, NJ 07110 USA; [Tyagi, Gaurav; Garrido, Rosario; Liang, Zhenmin] Hoffmann La Roche Inc, Nonclin Safety, pRED, Nutley, NJ 07110 USA; [Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Stevenson, Christopher S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Resp Infect, Pharmacol & Toxicol Sect,Resp Pharmacol Grp, London, England	Roche Holding; Roche Holding; Roche Holding; University of Michigan System; University of Michigan; Imperial College London	Stevenson, CS (corresponding author), Hoffmann La Roche Inc, DTA Inflammat, pRED, 340 Kingsland St, Nutley, NJ 07110 USA.	stevenson.cs@gmail.com	Hogaboam, Cory M./AAI-1433-2021; Phillips, Jonathan E/C-3763-2009; hogaboam, cory/M-3578-2014	Hogaboam, Cory M./0000-0003-3366-4850; Phillips, Jonathan E/0000-0002-9036-649X; 	Hoffmann-La Roche Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Hoffmann-La Roche Inc.(Hoffmann-La Roche); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Authors RP, SS, GT, JEP, RG, PH, LB, LR, JW, LC, JA, PR, HB, ZL, CK, DCB, JSF, CMTB and CSS are all affiliated to Hoffmann-La Roche Inc. and the work presented in this manuscript was funded by Hoffmann-La Roche Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chung MP, 2003, AM J RESP CELL MOL, V29, P375, DOI 10.1165/rcmb.2003-0029OC; Coker RK, 1997, AM J PATHOL, V150, P981; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; du Bois RM, 2012, AM J RESP CRITICAL C; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Harris P, 2012, MUCOSAL IMMUNOLOGY; Higashiyama H, 2007, EXP MOL PATHOL, V83, P39, DOI 10.1016/j.yexmp.2006.12.003; Hogaboam CM, 2005, METH MOLEC MED, V117, P209; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Phillips JE, 2012, PULM PHARMACOL THER, V25, P281, DOI 10.1016/j.pupt.2011.10.001; Qunn L, 2002, VIRCHOWS ARCH, V441, P271, DOI 10.1007/s00428-002-0618-9; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiderski RE, 1998, AM J PATHOL, V152, P821; Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	31	127	134	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59348	10.1371/journal.pone.0059348	http://dx.doi.org/10.1371/journal.pone.0059348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565148	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300015
J	Nordsborg, RB; Meliker, JR; Ersboll, AK; Jacquez, GM; Raaschou-Nielsen, O				Nordsborg, Rikke Baastrup; Meliker, Jaymie R.; Ersboll, Annette Kjaer; Jacquez, Geoffrey M.; Raaschou-Nielsen, Ole			Space-Time Clustering of Non-Hodgkin Lymphoma Using Residential Histories in a Danish Case-Control Study	PLOS ONE			English	Article							LEUKEMIAS; EPIDEMIOLOGY	Non-Hodgkin lymphoma (NHL) is a frequent cancer and incidence rates have increased markedly during the second half of the 20th century; however, the few established risk factors cannot explain this rise and still little is known about the aetiology of NHL. Spatial analyses have been applied in an attempt to identify environmental risk factors, but most studies do not take human mobility into account. The aim of this study was to identify clustering of NHL in space and time in Denmark, using 33 years of residential addresses. We utilised the nation-wide Danish registers and unique personal identification number that all Danish citizens have to conduct a register-based case-control study of 3210 NHL cases and two independent control groups of 3210 each. Cases were identified in the Danish Cancer Registry and controls were matched by age and sex and randomly selected from the Civil Registration System. Residential addresses of cases and controls from 1971 to 2003 were collected from the Civil Registration System and geocoded. Data on pervious hospital diagnoses and operations were obtained from the National Patient Register. We applied the methods of the newly developed Q-statistics to identify space-time clustering of NHL. All analyses were conducted with each of the two control groups, and we adjusted for previous history of autoimmune disease, HIV/AIDS or organ transplantation. Some areas with statistically significant clustering were identified; however, results were not consistent across the two control groups; thus we interpret the results as chance findings. We found no evidence for clustering of NHL in space and time using 33 years of residential histories, suggesting that if the rise in incidence of NHL is a result of risk factors that vary across space and time, the spatio-temporal variation of such factors in Denmark is too small to be detected with the applied method.	[Nordsborg, Rikke Baastrup; Raaschou-Nielsen, Ole] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Nordsborg, Rikke Baastrup; Ersboll, Annette Kjaer] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Grad Program Publ Hlth, Stony Brook, NY 11794 USA; [Jacquez, Geoffrey M.] BioMedware Inc, Ann Arbor, MI USA; [Jacquez, Geoffrey M.] SUNY Buffalo, Buffalo, NY 14260 USA	Danish Cancer Society; University of Southern Denmark; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Nordsborg, RB (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	baastrup@cancer.dk	Raaschou-Nielsen, Ole/GOK-0338-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Meliker, Jaymie/0000-0002-6408-8596; Baastrup Nordsborg, Rikke/0000-0003-4374-8230	Danish Cancer Society [DP08090]; Danish Agency for Science, Technology and Innovation [08-032484]; National Institutes of Health (National Institutes of Health); BioMedware	Danish Cancer Society(Danish Cancer Society); Danish Agency for Science, Technology and Innovation; National Institutes of Health (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMedware	The research was funded by the Danish Cancer Society (grant number DP08090) and the Danish Agency for Science, Technology and Innovation (reference number 08-032484). National Institutes of Health (National Institutes of Health) grants to BioMedware funded methods development. http://www.cancer.dk/research/Funding/http://en.fi.dk/funding/funding-opportunities/industrial-phd-programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; ALEXANDER FE, 1992, BRIT J CANCER, V65, P583, DOI 10.1038/bjc.1992.118; Andersen TF, 1999, DAN MED BULL, V46, P263; Birch JM, 2000, BRIT J CANCER, V82, P1571, DOI 10.1054/bjoc.1999.1072; BITHELL JF, 1994, BRIT MED J, V309, P501, DOI 10.1136/bmj.309.6953.501; Dreiher J, 2005, HAEMATOLOGICA, V90, P1709; Ekstrom-Smedby K, 2006, ACTA ONCOL, V45, P258, DOI 10.1080/02841860500531682; Engholm G, NORDCAN CANC INCIDEN; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goovaerts P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-32; Gustafsson B, 2000, EUR J EPIDEMIOL, V16, P1111, DOI 10.1023/A:1010953713048; Jacquez Geoffrey M, 2005, Environ Health, V4, P4, DOI 10.1186/1476-069X-4-4; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Masala G, 1996, INT J CANCER, V68, P156, DOI 10.1002/(SICI)1097-0215(19961009)68:2<156::AID-IJC2>3.3.CO;2-4; Meliker JR, 2007, STOCH ENV RES RISK A, V21, P625, DOI 10.1007/s00477-007-0140-3; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Raaschou-Nielsen O, 2003, AM J EPIDEMIOL, V158, P1182, DOI 10.1093/aje/kwg282; Sandin S, 2006, CANCER EPIDEM BIOMAR, V15, P1295, DOI 10.1158/1055-9965.EPI-05-0958; Sloan CD, 2012, SPAT SPATIO-TEMPORAL, V3, P297, DOI 10.1016/j.sste.2012.09.002; Storm HH, 1997, DAN MED BULL, V44, P535; Viel JF, 2000, AM J EPIDEMIOL, V152, P13, DOI 10.1093/aje/152.1.13; Wheeler DC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-63	27	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60800	10.1371/journal.pone.0060800	http://dx.doi.org/10.1371/journal.pone.0060800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560108	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900078
J	Panas, D; Malinowska, U; Piotrowski, T; Zygierewicz, J; Suffczynski, P				Panas, Dagmara; Malinowska, Urszula; Piotrowski, Tadeusz; Zygierewicz, Jaroslaw; Suffczynski, Piotr			Statistical Analysis of Sleep Spindle Occurrences	PLOS ONE			English	Article							CONSOLIDATION; NEURONS; INPUTS; EEG	Spindles - a hallmark of stage II sleep - are a transient oscillatory phenomenon in the EEG believed to reflect thalamocortical activity contributing to unresponsiveness during sleep. Currently spindles are often classified into two classes: fast spindles, with a frequency of around 14 Hz, occurring in the centro-parietal region; and slow spindles, with a frequency of around 12 Hz, prevalent in the frontal region. Here we aim to establish whether the spindle generation process also exhibits spatial heterogeneity. Electroencephalographic recordings from 20 subjects were automatically scanned to detect spindles and the time occurrences of spindles were used for statistical analysis. Gamma distribution parameters were fit to each inter-spindle interval distribution, and a modified Wald-Wolfowitz lag-1 correlation test was applied. Results indicate that not all spindles are generated by the same statistical process, but this dissociation is not spindle-type specific. Although this dissociation is not topographically specific, a single generator for all spindle types appears unlikely.	[Panas, Dagmara] Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Malinowska, Urszula] Johns Hopkins Univ, Sch Med, Dept Neurol, Epilepsy Res Lab, Baltimore, MD 21205 USA; [Piotrowski, Tadeusz] Warsaw Med Univ, Dept Psychiat, Warsaw, Poland; [Zygierewicz, Jaroslaw; Suffczynski, Piotr] Univ Warsaw, Inst Expt Phys, Lab Biomed Phys, Fac Phys, Warsaw, Poland	University of Edinburgh; Johns Hopkins University; Medical University of Warsaw; University of Warsaw	Panas, D (corresponding author), Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	D.Panas@sms.ed.ac.uk	Suffczynski, Piotr/ABG-5183-2020	Suffczynski, Piotr/0000-0002-2300-1415; Zygierewicz, Jaroslaw/0000-0002-7536-0735; Malinowska, Urszula/0000-0001-8358-6024	Life Sciences Interface programme of the EPSRC (Engineering and Physical Sciences Research Council); MRC; BBSRC (Biotechnology and Biological Sciences Research Council); Polish Funds for Science	Life Sciences Interface programme of the EPSRC (Engineering and Physical Sciences Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Polish Funds for Science	DP was funded by the Life Sciences Interface programme of the EPSRC (Engineering and Physical Sciences Research Council) and cofunded by MRC and BBSRC (Biotechnology and Biological Sciences Research Council). Presented research also received funding from Polish Funds for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WS, 2012, EPILEPSY RES, V99, P202, DOI 10.1016/j.eplepsyres.2011.11.006; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Brown EN, 2004, MATH COMP BIOL SER, P253; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; De Gennaro L, 2005, NEUROIMAGE, V26, P114, DOI 10.1016/j.neuroimage.2005.01.020; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Dehghani N, 2011, HUM BRAIN MAPP, V32, P2217, DOI 10.1002/hbm.21183; Durka PJ, 2001, IEEE T SIGNAL PROCES, V49, P507, DOI 10.1109/78.905866; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Frank MG, 2006, NEUROSCIENTIST, V12, P477, DOI 10.1177/1073858406293552; Gibbs F., 1950, ATLAS ELECTROENCEPHA; JOBERT M, 1992, NEUROPSYCHOBIOLOGY, V26, P210, DOI 10.1159/000118923; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Malinowska U, 2006, IEEE ENG MED BIOL, V25, P26, DOI 10.1109/MEMB.2006.1657784; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Miura K, 2007, J NEUROSCI, V27, P13802, DOI 10.1523/JNEUROSCI.2452-07.2007; PARE D, 1987, J NEUROPHYSIOL, V57, P1669, DOI 10.1152/jn.1987.57.6.1669; Rechtschaffen A, 1968, NIH PUBLICATIONS; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; SMITH Y, 1987, NEUROSCIENCE, V22, P579, DOI 10.1016/0306-4522(87)90355-1; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3; Zygierewicz J, 2001, NEUROCOMPUTING, V38, P1619, DOI 10.1016/S0925-2312(01)00516-1	31	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59318	10.1371/journal.pone.0059318	http://dx.doi.org/10.1371/journal.pone.0059318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560045	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900013
J	Yuan, YK; Zhao, YW; Xin, SC; Wu, N; Wen, JL; Li, S; Chen, LJ; Wei, YQ; Yang, HS; Lin, S				Yuan, Yike; Zhao, Yuwei; Xin, Shengchang; Wu, Ni; Wen, Jiaolin; Li, Song; Chen, Lijuan; Wei, Yuquan; Yang, Hanshuo; Lin, Shuo			A Novel PEGylated Liposome-Encapsulated SANT75 Suppresses Tumor Growth through Inhibiting Hedgehog Signaling Pathway	PLOS ONE			English	Article							BREAST-CANCER; SMOOTHENED ACTIVITY; OVARIAN CANCERS; DRUG-DELIVERY; PHASE-I; THERAPY; ACTIVATION; CARCINOMA; CELLS; THERAPEUTICS	The Hedgehog (Hh) pathway inhibitors have shown great promise in cancer therapeutics. SANT75, a novel compound we previously designed to specially inhibit the Smoothened (SMO) protein in the Hh pathway, has greater inhibitory potency than many of commonly used Hh inhibitors. However, preclinical studies of SANT75 revealed water insolubility and acute toxicity. To overcome these limitations, we developed a liposomal formulation of SANT75 and investigated its antitumor efficacy in vitro and in vivo. We encapsulated SANT75 into PEGylated liposome and the mean particle size distribution and zeta-potential (ZP) of liposomes were optimized. Using the Shh-light2 cell and Gli-GFP or Flk-GFP transgenic reporter zebrafish, we confirmed that liposome-encapsulated SANT75 inhibited Hh activity with similar potency as the original SANT75. SANT75 encapsulated into liposome exerted strong tumor growth-inhibiting effects in vitro and in vivo. In addition, the liposomal SANT75 therapy efficiently improved the survival time of tumor-bearing mice without obvious systemic toxicity. The pathological morphology and immunohistochemistry staining revealed that liposomal SANT75 induced tumor cell apoptosis, inhibited tumor angiogenesis as assessed by CD31 and down-regulated the expression of Hh target protein Gli-1 in tumor tissues. Our findings suggest that liposomal formulated SANT75 has improved solubility and bioavailability and should be further developed as a drug candidate for treating tumors with abnormally high Hh activity.	[Yuan, Yike; Zhao, Yuwei; Wu, Ni; Wen, Jiaolin; Chen, Lijuan; Wei, Yuquan; Yang, Hanshuo; Lin, Shuo] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Yuan, Yike; Zhao, Yuwei; Wu, Ni; Wen, Jiaolin; Chen, Lijuan; Wei, Yuquan; Yang, Hanshuo; Lin, Shuo] Sichuan Univ, Ctr Canc, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Xin, Shengchang; Li, Song] Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Sichuan University; Sichuan University; Peking University; University Town of Shenzhen; University of California System; University of California Los Angeles	Yang, HS (corresponding author), Sichuan Univ, State Key Lab Biotherapy, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China.	yhansh@scu.edu.cn; shuolin@ucla.edu	Wen, Jiaolin/GZL-0162-2022		National ST Major project [2012ZX09501001-003]	National ST Major project	This work was supported by the National S&T Major project(2012ZX09501001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Cukierman E, 2010, BIOCHEM PHARMACOL, V80, P762, DOI 10.1016/j.bcp.2010.04.020; Dlugosz A, 2012, NAT REV DRUG DISCOV, V11, P437, DOI 10.1038/nrd3753; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Dritschilo A, 2006, CLIN CANCER RES, V12, P1251, DOI 10.1158/1078-0432.CCR-05-1260; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Ferrandina G, 2010, THER CLIN RISK MANAG, V6, P463, DOI 10.2147/TCRM.S3348; Fetterly GJ, 2008, CLIN CANCER RES, V14, P5856, DOI 10.1158/1078-0432.CCR-08-1046; Harris L, 2002, CANCER, V94, P25, DOI 10.1002/cncr.10201; Hioki A, 2010, BIOL PHARM BULL, V33, P1466, DOI 10.1248/bpb.33.1466; Kameda C, 2009, ANTICANCER RES, V29, P871; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Kim JY, 2009, BIOMATERIALS, V30, P5751, DOI 10.1016/j.biomaterials.2009.07.021; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Markman Maurie, 2011, Cancer Manag Res, V3, P219, DOI 10.2147/CMR.S15558; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Ruel L, 2009, GENE DEV, V23, P1843, DOI 10.1101/gad.1838109; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Sun DS, 2006, WORLD J GASTROENTERO, V12, P4741, DOI 10.3748/wjg.v12.i29.4741; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Torchilin V, 2012, ADV DEL SCI TECHNOL, P289, DOI 10.1007/978-1-4614-0881-9_11; Torchilin VP, 2005, ADV DRUG DELIVER REV, V57, P95, DOI 10.1016/j.addr.2004.06.002; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Xie JW, 2008, ACTA BIOCH BIOPH SIN, V40, P670, DOI 10.1111/j.1745-7270.2008.00431.x; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Yang HB, 2009, J BIOL CHEM, V284, P20876, DOI 10.1074/jbc.M807648200; Yang L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-112; Yoshimoto AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045332; You SH, 2010, UPSALA J MED SCI, V115, P169, DOI 10.3109/03009731003668316; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Yuan ZP, 2006, CLIN CANCER RES, V12, P3193, DOI 10.1158/1078-0432.CCR-05-2365; Zhang JA, 2005, EUR J PHARM BIOPHARM, V59, P177, DOI 10.1016/j.ejpb.2004.06.009	38	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60266	10.1371/journal.pone.0060266	http://dx.doi.org/10.1371/journal.pone.0060266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560085	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900060
J	Zhao, JL; Zhang, L; Dayanandan, S; Nagaraju, S; Liu, DM; Li, QM				Zhao, Jian-Li; Zhang, Lu; Dayanandan, Selvadurai; Nagaraju, Shivaprakash; Liu, Dong-Mei; Li, Qiao-Ming			Tertiary Origin and Pleistocene Diversification of Dragon Blood Tree (Dracaena cambodiana-Asparagaceae) Populations in the Asian Tropical Forests	PLOS ONE			English	Article							NEOTROPICAL RAIN-FOREST; ALLELE FREQUENCY; GENETIC DIFFERENTIATION; ENVIRONMENTAL-CHANGE; MIGRATION CAPACITY; UNIVERSAL PRIMERS; COMPUTER-PROGRAM; CHLOROPLAST DNA; CLIMATE-CHANGE; F-STATISTICS	Background: The origin of extraordinarily rich biodiversity in tropical forests is often attributed to evolution under stable climatic conditions over a long period or to climatic fluctuations during the recent Quaternary period. Here, we test these two hypotheses using Dracaena cambodiana, a plant species distributed in paleotropical forests. Methods: We analyzed nucleotide sequence data of two chloroplast DNA (cpDNA: atpB-rbcL and trnD-trnT) regions and genotype data of six nuclear microsatellites from 15 populations (140 and 363 individuals, respectively) distributed in Indochina Peninsular and Hainan Island to infer the patterns of genetic diversity and phylogeographic structure. The population bottleneck and genetic drift were estimated based upon nuclear microsatellites data using the software programs BOTTLENECK and 2MOD. The lineage divergence times and past population dynamics based on cpDNA data were estimated using coalescent-based isolation-with-migration (IMa) and BEAST software programs. Results: A significant phylogeographic structure (N-ST = 0.876, G(ST) = 0.796, FST-SSR = 0.329, R-ST = 0.449; N-ST>G(ST), R-ST>FST-SSR, P<0.05) and genetic differentiation among populations were detected. Bottleneck analyses and Bayesian skyline plot suggested recent population reduction. The cpDNA haplotype network revealed the ancestral populations from the southern Indochina region expanded to northward. The most recent ancestor divergence time of D. cambodiana dated back to the Tertiary era and rapid diversification of terminal lineages corresponded to the Quaternary period. Conclusions: The results indicated that the present distribution of genetic diversity in D. cambodiana was an outcome of Tertiary dispersal and rapid divergence during the Quaternary period under limited gene flow influenced by the uplift of Himalayan-Tibetan Plateau and Quaternary climatic fluctuations respectively. Evolutionary processes, such as extinction-recolonization during the Pleistocene may have contributed to the fast diversification in D. cambodiana.	[Zhao, Jian-Li; Zhang, Lu; Liu, Dong-Mei; Li, Qiao-Ming] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Lab Plant Phylogenet & Conservat, Kunming, Yunnan, Peoples R China; [Zhao, Jian-Li; Zhang, Lu; Liu, Dong-Mei; Li, Qiao-Ming] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China; [Zhao, Jian-Li; Zhang, Lu; Dayanandan, Selvadurai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Nagaraju, Shivaprakash] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Concordia University - Canada	Li, QM (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Lab Plant Phylogenet & Conservat, Kunming, Yunnan, Peoples R China.	lqm@xtbg.ac.cn	Zhao, Jianli/AAJ-5256-2020; Nagaraju, Shivaprakash/O-7654-2014	Zhao, Jianli/0000-0002-5137-7735; Nagaraju, Shivaprakash/0000-0002-5135-8737	Chinese Academy of Sciences (CAS) for Key Topics in Innovation Engineering [KSCX2-YW-Z-002]; CAS 135 program [XTBG-T01]	Chinese Academy of Sciences (CAS) for Key Topics in Innovation Engineering; CAS 135 program	This study was supported by the funds from the Chinese Academy of Sciences (CAS) for Key Topics in Innovation Engineering (grant number KSCX2-YW-Z-002) and from the CAS 135 program (XTBG-T01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bogler DJ, 1996, AM J BOT, V83, P1225, DOI 10.2307/2446206; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Cannon CH, 2003, J BIOGEOGR, V30, P211, DOI 10.1046/j.1365-2699.2003.00829.x; CHEN X Q, 2000, FLORA CHINA, V24, P215; Chiang TY, 1998, BOT BULL ACAD SINICA, V39, P245; Clift PD, 2008, NAT GEOSCI, V1, P875, DOI 10.1038/ngeo351; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cornuet JM, 1996, GENETICS, V144, P2001; CRANDALL KA, 1993, GENETICS, V134, P959; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ducrocq S, 1995, J SOUTHE ASIAN EARTH, V12, P65, DOI 10.1016/0743-9547(95)00021-6; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hall Robert, 1998, P99; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hooghiemstra H, 1998, EARTH-SCI REV, V44, P147, DOI 10.1016/S0012-8252(98)00027-0; HUCHON P, 1994, GEOLOGY, V22, P27, DOI 10.1130/0091-7613(1994)022<0027:IPATCO>2.3.CO;2; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; LACASSIN R, 1993, J STRUCT GEOL, V15, P677, DOI 10.1016/0191-8141(93)90055-F; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Marrero A, 1998, BOT J LINN SOC, V128, P291; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; NEI M, 1978, GENETICS, V89, P583; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Rambaut A., 2007, TRACER V1 4; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Riddle BR, 1996, TRENDS ECOL EVOL, V11, P207, DOI 10.1016/0169-5347(96)10032-X; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohlf FJ, 2000, NTSYS PC V2 10E NUME; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rowley D.B., 2001, EARTH PLANET SC LETT, V5836, P1; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Searle MP, 2006, J GEOL SOC LONDON, V163, P1025, DOI 10.1144/0016-76492005-144; Shepherd LD, 2011, MOL ECOL, V20, P1389, DOI 10.1111/j.1365-294X.2011.05017.x; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1995, GENETICS, V139, P457; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAPPONNIER P, 1990, NATURE, V343, P431, DOI 10.1038/343431a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willis KJ, 2004, PHILOS T R SOC B, V359, P159, DOI 10.1098/rstb.2003.1387; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211; Zhang L, 2010, AM J BOT, V97, pE91, DOI 10.3732/ajb.1000245	94	9	13	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60102	10.1371/journal.pone.0060102	http://dx.doi.org/10.1371/journal.pone.0060102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560070	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000316930900045
J	Kumar, S; Frank, M; Schwartz-Albiez, R				Kumar, Sonu; Frank, Martin; Schwartz-Albiez, Reinhard			Understanding the Specificity of Human Galectin-8C Domain Interactions with Its Glycan Ligands Based on Molecular Dynamics Simulations	PLOS ONE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; RAY CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; BINDING; AFFINITY; OLIGOSACCHARIDE; GLYCOPROTEINS; CONFORMATION; COMPLEXES; ALIGNMENT	Human Galectin-8 (Gal-8) is a member of the galectin family which shares an affinity for beta-galactosides. The tandem-repeat Gal-8 consists of a N- and a C-terminal carbohydrate recognition domain (N- and C-CRD) joined by a linker peptide of various length. Despite their structural similarity both CRDs recognize different oligosaccharides. While the molecular requirements of the N-CRD for high binding affinity to sulfated and sialylated glycans have recently been elucidated by crystallographic studies of complexes with several oligosaccharides, the binding specificities of the C-CRD for a different set of oligosaccharides, as derived from experimental data, has only been explained in terms of the three-dimensional structure for the complex C-CRD with lactose. In this study we performed molecular dynamics (MD) simulations using the recently released crystal structure of the Gal-8C-CRD to analyse the three-dimensional conditions for its specific binding to a variety of oligosaccharides as previously defined by glycan-microarray analysis. The terminal beta-galactose of disaccharides (LacNAc, lacto-N-biose and lactose) and the internal beta-galactose moiety of blood group antigens A and B (BGA, BGB) as well as of longer linear oligosaccharide chains (di-LacNAc and lacto-N-neotetraose) are interacting favorably with conserved amino acids (H53, R57, N66, W73, E76). Lacto-N-neotetraose and di-LacNAc as well as BGA and BGB are well accommodated. BGA and BGB showed higher affinity than LacNAc and lactose due to generally stronger hydrogen bond interactions and water mediated hydrogen bonds with alpha 1-2 fucose respectively. Our results derived from molecular dynamics simulations are able to explain the glycan binding specificities of the Gal-8C-CRD in comparison to those of the Gal-8N-CRD.	[Kumar, Sonu; Schwartz-Albiez, Reinhard] German Canc Res Ctr, Heidelberg, Germany; [Frank, Martin] Biognos AB, Gothenburg, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ)	Schwartz-Albiez, R (corresponding author), German Canc Res Ctr, D015,Neuenheimer Feld 280, Heidelberg, Germany.	r.s-albiez@dkfz.de	Kumar, Sonu/AAA-1746-2019; Kumar, Sonu/GZA-9110-2022; Kumar, Sonu/AAH-2962-2019; Kumar, Sonu/C-8268-2014; wu, zhongwei/G-2509-2011	Kumar, Sonu/0000-0003-0423-2880; Frank, Martin/0000-0002-1006-6746	European Commission [215536]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by European Commission's 7th Framework Programme FP7/2007-2013 (grant number 215536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bush CA, 1999, ANNU REV BIOPH BIOM, V28, P269, DOI 10.1146/annurev.biophys.28.1.269; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; CASE DA, 2004, AMBER, V8; Cattaneo V, 2011, BIOCHEM J, V434, P153, DOI 10.1042/BJ20101691; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Di Lella S, 2007, J PHYS CHEM B, V111, P7360, DOI 10.1021/jp068989k; Echeverria I, 2011, BIOPHYS J, V100, P2283, DOI 10.1016/j.bpj.2011.03.032; Ford MG, 2003, PROTEINS, V53, P229, DOI 10.1002/prot.10428; Frank M, 2007, NUCLEIC ACIDS RES, V35, pD287, DOI 10.1093/nar/gkl907; Frank M, 2010, CELL MOL LIFE SCI, V67, P2749, DOI 10.1007/s00018-010-0352-4; GABIUS HJ, 1990, ANAL BIOCHEM, V189, P91, DOI 10.1016/0003-2697(90)90050-J; Guardia CMA, 2011, J CHEM INF MODEL, V51, P1918, DOI 10.1021/ci200180h; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Imberty A, 2003, ADV MACROMOL CARB R, V2, P67; Kaltner H, 2012, HISTOL HISTOPATHOL, V27, P397, DOI 10.14670/HH-27.397; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krzeminski M, 2011, BBA-GEN SUBJECTS, V1810, P150, DOI 10.1016/j.bbagen.2010.11.001; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Levy Y, 2006, GLYCOBIOLOGY, V16, P463, DOI 10.1093/glycob/cwj097; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Meynier C, 2009, J BIOMOL STRUCT DYN, V27, P49, DOI 10.1080/07391102.2009.10507295; Miller MC, 2011, GLYCOBIOLOGY, V21, P1627, DOI 10.1093/glycob/cwr083; Nagae M, 2009, GLYCOBIOLOGY, V19, P112, DOI 10.1093/glycob/cwn121; Ponder J. W., 2010, TINKER SOFTWARE TOOL; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saraboji K, 2012, BIOCHEMISTRY-US, V51, P296, DOI 10.1021/bi201459p; Schwartz-Albiez R., 2009, SUGAR CODE FUNDAMENT, P447; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Vokhmyanina OA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1185, DOI 10.1134/S0006297911100130; Vokhmyanina OA, 2012, GLYCOBIOLOGY, V22, P1207, DOI 10.1093/glycob/cws079; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Yongye AB, 2012, BIOCHEMISTRY-US, V51, P7278, DOI 10.1021/bi300761s; Yoshida H, 2012, FEBS J, V279, P3937, DOI 10.1111/j.1742-4658.2012.08753.x; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	47	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59761	10.1371/journal.pone.0059761	http://dx.doi.org/10.1371/journal.pone.0059761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555773	gold, Green Submitted, Green Published			2022-12-27	WOS:000317263900025
J	Liu, ML; Wang, H; Wang, ZR; Zhang, YF; Chen, YQ; Zhu, FH; Zhang, YQ; Ma, J; Li, Z				Liu, Man-Li; Wang, Huan; Wang, Zong-Ren; Zhang, Yu-Fen; Chen, Yan-Qiu; Zhu, Fang-Hong; Zhang, Yuan-Qiang; Ma, Jing; Li, Zhen			TGF-beta 1 Regulation of Estrogen Production in Mature Rat Leydig Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; AROMATASE GENE-EXPRESSION; LIVER RECEPTOR HOMOLOG-1; TRANSFORMING GROWTH-FACTOR-BETA-1; DIFFERENTIAL EXPRESSION; STEROIDOGENIC FACTOR-1; POTENTIAL REGULATOR; RESPONSE ELEMENT; CONNEXIN43; TRANSCRIPTION	Background: Besides androgens, estrogens produced in Leydig cells are also crucial for mammalian germ cell differentiation. Transforming growth factor-beta 1 (TGF-beta 1) is now known to have multiple effects on regulation of Leydig cell function. The objective of the present study is to determine whether TGF-b1 regulates estradiol (E-2) synthesis in adult rat Leydig cells and then to assess the impact of TGF-beta 1 on Cx43-based gap junctional intercellular communication (GJIC) between Leydig cells. Methodology/Principal Findings: Primary cultured Leydig cells were incubated in the presence of recombinant TGF-beta 1 and the production of E-2 as well as testosterone (T) were measured by RIA. The activity of P450arom was addressed by the tritiated water release assay and the expression of Cyp19 gene was evaluated by Western blotting and real time RT-PCR. The expression of Cx43 and GJIC were investigated with immunofluorescence and fluorescence recovery after photo-bleaching (FRAP), respectively. Results from this study show that TGF-beta 1 down-regulates the level of E-2 secretion and the activity of P450arom in a dose-dependent manner in adult Leydig cells. In addition, the expression of Cx43 and GJIC was closely related to the regulation of E-2 and TGF-beta 1, and E-2 treatment in turn restored the inhibition of TGF-beta 1 on GJIC. Conclusions: Our results indicate, for the first time in adult rat Leydig cells, that TGF-beta 1 suppresses P450arom activity, as well as the expression of the Cyp19 gene, and that depression of E-2 secretion leads to down-regulation of Cx43-based GJIC between Leydig cells.	[Liu, Man-Li; Wang, Zong-Ren; Zhang, Yu-Fen; Chen, Yan-Qiu; Zhu, Fang-Hong; Ma, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Tradit Chinese Med, Xian 710032, Peoples R China; [Liu, Man-Li; Zhang, Yuan-Qiang; Li, Zhen] Fourth Mil Med Univ, Dept Human Anat & Histol & Embryol, Xian 710032, Peoples R China; [Wang, Huan] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Ma, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Tradit Chinese Med, Xian 710032, Peoples R China.	jingma@fmmu.edu.cn; lizhenhe@fmmu.edu.cn			Natural Science Foundation of China (NSFC) [3087326, 2008]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (NSFC) (3087326, 2008). The web site is http://isis.nsfc.gov.cn/portal/proj_search.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney TO, 1999, STEROIDS, V64, P610, DOI 10.1016/S0039-128X(99)00041-0; Bourguiba S, 2003, J STEROID BIOCHEM, V86, P335, DOI 10.1016/S0960-0760(03)00343-1; Bourguiba S, 2003, BIOL REPROD, V69, P592, DOI 10.1095/biolreprod.102.013961; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Carreau S, 2001, J STEROID BIOCHEM, V79, P203, DOI 10.1016/S0960-0760(01)00137-6; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; Chung TH, 2004, J MOL CELL CARDIOL, V37, P1013, DOI 10.1016/j.yjmcc.2004.08.003; Chung TH, 2009, INT J BIOCHEM CELL B, V41, P2323, DOI 10.1016/j.biocel.2009.06.001; Decrouy X, 2004, J CELL PHYSIOL, V200, P146, DOI 10.1002/jcp.10473; Derebecka-Holysz N, 2008, MOL CELL BIOCHEM, V307, P65, DOI 10.1007/s11010-007-9585-4; Di WL, 2001, MOL HUM REPROD, V7, P671, DOI 10.1093/molehr/7.7.671; Dickson C, 2002, MOL CELL ENDOCRINOL, V195, P65, DOI 10.1016/S0303-7207(02)00216-2; DOLL R, 1968, GUT, V9, P42, DOI 10.1136/gut.9.1.42; DOUALLABELL F, 1995, ENDOCRINOLOGY, V136, P5322, DOI 10.1210/en.136.12.5322; EMOTO N, 1991, P SOC EXP BIOL MED, V196, P351; Fiorelli G, 1998, J STEROID BIOCHEM, V66, P105, DOI 10.1016/S0960-0760(98)00050-8; Genissel C, 2001, MOL CELL ENDOCRINOL, V178, P141, DOI 10.1016/S0303-7207(01)00409-9; Gilleron J, 2009, INT J BIOCHEM CELL B, V41, P1381, DOI 10.1016/j.biocel.2008.12.008; Gonzalez CR, 2010, J REPROD DEVELOP, V56, P400, DOI 10.1262/jrd.09-167N; Grummer R, 2004, BIOL REPROD, V71, P273, DOI 10.1095/biolreprod.103.024067; Habermann H, 2001, ENDOCRINOLOGY, V142, P359, DOI 10.1210/en.142.1.359; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; Khan SA, 1999, MOL CELL ENDOCRINOL, V148, P21, DOI 10.1016/S0303-7207(98)00244-5; Lanzino M, 2001, BIOL REPROD, V64, P1439, DOI 10.1095/biolreprod64.5.1439; Le Roy C, 1999, J STEROID BIOCHEM, V69, P379, DOI 10.1016/S0960-0760(99)00075-8; Lehmann TP, 2005, ENDOCR RES, V31, P71, DOI 10.1080/07435800500229110; Li XM, 2002, GENE, V294, P279, DOI 10.1016/S0378-1119(02)00803-X; Liu MY, 2002, J CARDIOVASC PHARM, V40, P938, DOI 10.1097/00005344-200212000-00016; Loras B, 1999, HUM REPROD, V14, P1534, DOI 10.1093/humrep/14.6.1534; Luo S, 2002, MOL HUM REPROD, V8, P318, DOI 10.1093/molehr/8.4.318; MORERA AM, 1988, J STEROID BIOCHEM, V30, P443, DOI 10.1016/0022-4731(88)90139-2; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; O'Shaughnessy PJ, 2006, INT J ANDROL, V29, P90, DOI 10.1111/j.1365-2605.2005.00555.x; Pezzi V, 2004, ENDOCRINOLOGY, V145, P2186, DOI 10.1210/en.2003-1366; Pointis G, 2005, TRENDS ENDOCRIN MET, V16, P300, DOI 10.1016/j.tem.2005.07.001; RAINEY WE, 1992, J ENDOCRINOL, V133, P311, DOI 10.1677/joe.0.1330311; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Shozu M, 1998, MOL CELL ENDOCRINOL, V139, P117, DOI 10.1016/S0303-7207(98)00069-0; Shozu M, 2000, MOL CELL ENDOCRINOL, V160, P123, DOI 10.1016/S0303-7207(99)00233-6; Sierens J, 2010, MOL CELL ENDOCRINOL, V323, P307, DOI 10.1016/j.mce.2010.03.001; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Straume AH, 2012, EUR J ENDOCRINOL, V166, P941, DOI 10.1530/EJE-11-0849; Walker VR, 2004, ILAR J, V45, P455, DOI 10.1093/ilar.45.4.455; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; You S, 2000, J ENDOCRINOL, V166, P447, DOI 10.1677/joe.0.1660447; YU W, 1994, P ROY SOC B-BIOL SCI, V255, P125, DOI 10.1098/rspb.1994.0018; Yun SP, 2012, BIOL CELL, V104, P378, DOI 10.1111/boc.201100032; Zhao Y, 2008, CELL TISSUE RES, V334, P283, DOI 10.1007/s00441-008-0680-y; Zheng XF, 2008, REPRODUCTION, V136, P447, DOI 10.1530/REP-07-0316; Zhou H, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-146; Zirilli L, 2008, J STEROID BIOCHEM, V109, P212, DOI 10.1016/j.jsbmb.2008.03.026	53	8	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60197	10.1371/journal.pone.0060197	http://dx.doi.org/10.1371/journal.pone.0060197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555924	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900063
J	Arbelaez, AM; Su, Y; Thomas, JB; Hauch, AC; Hershey, T; Ances, BM				Arbelaez, Ana Maria; Su, Yi; Thomas, Jewell B.; Hauch, Amy C.; Hershey, Tamara; Ances, Beau M.			Comparison of Regional Cerebral Blood Flow Responses to Hypoglycemia Using Pulsed Arterial Spin Labeling and Positron Emission Tomography	PLOS ONE			English	Article							ROUTINE CLINICAL-PRACTICE; MEDIAL PREFRONTAL CORTEX; RECURRENT HYPOGLYCEMIA; INTRAVENOUS (H2O)-O-15; BRAIN; ACTIVATION; INCREASES; REGISTRATION; MECHANISM; NETWORKS	Different brain regions sense and modulate the counterregulatory responses that can occur in response to declining plasma glucose levels. The aim of this study was to determine if changes in regional cerebral blood flow (rCBF) during hypoglycemia relative to euglycemia are similar for two imaging modalities-pulsed arterial spin labeling magnetic resonance imaging (PASL-MRI) and positron emission tomography (PET). Nine healthy non-diabetic participants underwent a hyperinsulinemic euglycemic (92 +/- 3 mg/dL) - hypoglycemic (53 +/- 1 mg/dL) clamp. Counterregulatory hormone levels were collected at each of these glycemic levels and rCBF measurements within the previously described network of hypoglycemia-responsive regions (thalamus, medial prefrontal cortex and globus pallidum) were obtained using PASL-MRI and [O-15]water PET. In response to hypoglycemia, rCBF was significantly increased in the thalamus, medial prefrontal cortex, and globus pallidum compared to euglycemia for both PASL-MRI and PET methodologies. Both imaging techniques found similar increases in rCBF in the thalamus, medial prefrontal cortex, and globus pallidum in response to hypoglycemia. These brain regions may be involved in the physiologic and symptom responses to hypoglycemia. Compared to PET, PASL-MRI may provide a less invasive, less expensive method for assessing changes in rCBF during hypoglycemia without radiation exposure.	[Arbelaez, Ana Maria; Hauch, Amy C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Su, Yi; Hershey, Tamara] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Thomas, Jewell B.; Hershey, Tamara; Ances, Beau M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hershey, Tamara] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Arbelaez, AM (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	arbelaez_a@kids.wustl.edu		Hershey, Tamara/0000-0001-7549-0698; Su, Yi/0000-0002-1946-8063; Ances, Beau/0000-0003-3862-7397	Children's Discovery Institute; Mallinckrodt Institute at Washington University in St. Louis; National Institutes of Health (NIH) [UL1RR024992]; Harold Amos Medical Faculty Development Program; National Institute of Mental Health (NIMH) [K23MH081786]; National Institute of Nursing Research (NINR) [R01NR012907, R01NR012657]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH081786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012657, R01NR012907] Funding Source: NIH RePORTER	Children's Discovery Institute; Mallinckrodt Institute at Washington University in St. Louis; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold Amos Medical Faculty Development Program; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported in part by the Children's Discovery Institute (http://www.childrensdiscovery.org) and the Mallinckrodt Institute at Washington University in St. Louis (http://www.mir.wustl.edu). AMA was supported in part by National Institutes of Health (NIH) (http://www.nih.gov) grant UL1RR024992 and the Harold Amos Medical Faculty Development Program (http://www.amfdp.org). BMA was supported from the National Institute of Mental Health (NIMH) (www.nimh.nih.gov) (K23MH081786), National Institute of Nursing Research (NINR) (www.ninr.nih.gov) (R01NR012907 and R01NR012657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbelaez AM, 2008, DIABETES, V57, P470, DOI 10.2337/db07-1329; Arbelaez AM, 2012, DIABETES CARE, V35, P2570, DOI 10.2337/dc12-0297; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; BOLLI GB, 1984, DIABETES, V33, P732, DOI 10.2337/diabetes.33.8.732; Chen JJ, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/516359; Cherry S.R., 2006, PET PHYS INSTRUMENTA; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Deibler AR, 2008, AM J NEURORADIOL, V29, P1428, DOI 10.3174/ajnr.A1034; Deibler AR, 2008, AM J NEURORADIOL, V29, P1235, DOI 10.3174/ajnr.A1033; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P289, DOI 10.1097/00004728-199503000-00022; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; Hurst P, 2012, ENDOCRINOLOGY, V153, P1908, DOI 10.1210/en.2011-1827; INGVAR M, 1994, J CEREBR BLOOD F MET, V14, P628, DOI 10.1038/jcbfm.1994.78; Mangia S, 2012, J CEREBR BLOOD F MET, V32, P2084, DOI 10.1038/jcbfm.2012.117; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; McCrimmon R, 2009, DIABETES CARE, V32, P1357, DOI 10.2337/dc09-0123; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Page KA, 2009, DIABETES, V58, P448, DOI 10.2337/db08-1224; Pollock JM, 2009, MAGN RESON IMAGING C, V17, P315, DOI 10.1016/j.mric.2009.01.008; Powers WJ, 1996, AM J PHYSIOL-HEART C, V270, pH554, DOI 10.1152/ajpheart.1996.270.2.H554; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; RAICHLE ME, 1983, J NUCL MED, V24, P790; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; SCHWARTZ WJ, 1979, SCIENCE, V205, P723, DOI 10.1126/science.462184; SHAH SD, 1985, J LAB CLIN MED, V106, P624; Talairach J., 1988, COPLANAR STEREOTAXIC; Teh MM, 2010, NEUROIMAGE, V53, P584, DOI 10.1016/j.neuroimage.2010.06.033; Teves D, 2004, P NATL ACAD SCI USA, V101, P6217, DOI 10.1073/pnas.0307048101; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; TOWLER DA, 1993, DIABETES, V42, P1791, DOI 10.2337/diabetes.42.12.1791; VIDEEN TO, 1987, J CEREBR BLOOD F MET, V7, P513, DOI 10.1038/jcbfm.1987.97; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; WHITE NH, 1983, NEW ENGL J MED, V308, P485, DOI 10.1056/NEJM198303033080903; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	43	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60085	10.1371/journal.pone.0060085	http://dx.doi.org/10.1371/journal.pone.0060085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555895	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200081
J	Carty, N; Nash, KR; Brownlow, M; Cruite, D; Wilcock, D; Selenica, MLB; Lee, DC; Gordon, MN; Morgan, D				Carty, Nikisha; Nash, Kevin R.; Brownlow, Milene; Cruite, Dana; Wilcock, Donna; Selenica, Maj-Linda B.; Lee, Daniel C.; Gordon, Marcia N.; Morgan, Dave			Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; ENDOTHELIN-CONVERTING ENZYME; NEPRILYSIN GENE-TRANSFER; A-BETA; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; IN-VIVO; PEPTIDE; BRAIN; DEGRADATION	The accumulation of beta-amyloid peptides in the brain has been recognized as an essential factor in Alzheimer's disease pathology. Several proteases, including Neprilysin (NEP), endothelin converting enzyme (ECE), and insulin degrading enzyme (IDE), have been shown to cleave beta-amyloid peptides (A beta). We have previously reported reductions in amyloid in APP+PS1 mice with increased expression of ECE. In this study we compared the vector-induced increased expression of NEP and IDE. We used recombinant adeno-associated viral vectors expressing either native forms of NEP (NEP-n) or IDE (IDE-n), or engineered secreted forms of NEP (NEP-s) or IDE (IDE-s). In a six-week study, immunohistochemistry staining for total A beta was significantly decreased in animals receiving the NEP-n and NEP-s but not for IDE-n or IDE-s in either the hippocampus or cortex. Congo red staining followed a similar trend revealing significant decreases in the hippocampus and the cortex for NEP-n and NEP-s treatment groups. Our results indicate that while rAAV-IDE does not have the same therapeutic potential as rAAV-NEP, rAAV-NEP-s and NEP-n are effective at reducing amyloid loads, and both of these vectors continue to have significant effects nine months post-injection. As such, they may be considered reasonable candidates for gene therapy trials in AD.	[Carty, Nikisha; Nash, Kevin R.; Brownlow, Milene; Cruite, Dana; Gordon, Marcia N.; Morgan, Dave] Univ S Florida, Coll Med, Byrd Alzheimers Inst, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Wilcock, Donna] Univ Kentucky, Sanders Brown Ctr Aging, Dept Physiol, Lexington, KY 40536 USA; [Selenica, Maj-Linda B.; Lee, Daniel C.] Univ S Florida, Coll Pharm, Byrd Alzheimer Inst, Dept Pharmaceut Sci, Tampa, FL USA	State University System of Florida; University of South Florida; University of Kentucky; State University System of Florida; University of South Florida	Morgan, D (corresponding author), Univ S Florida, Coll Med, Byrd Alzheimers Inst, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	scientist.dave@gmail.com	Morgan, David G/J-5989-2012; Nash, Kevin R/B-4567-2009; Brownlow, Milene/ABC-1063-2020	Nash, Kevin R/0000-0002-8607-1832; Brownlow, Milene/0000-0002-5804-6445; Carty, Nikisha/0000-0002-0824-3897	National Institutes of Health (NIH) National Institute on Aging (NIA) [R01 AG025509]; NATIONAL INSTITUTE ON AGING [R01AG025509] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health (NIH) National Institute on Aging (NIA) grant R01 AG025509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Hauck B, 2003, MOL THERAPEUTICS, V7; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Herber DL, 2007, J NEUROIMMUNE PHARM, V2, P222, DOI 10.1007/s11481-007-9069-z; Holcomb L, 1998, NAT MED, V4, P4, DOI [10.1038/nm0198-097, DOI 10.1038/NM0198-097]; Hong CS, 2006, GENE THER, V13, P1068, DOI 10.1038/sj.gt.3302719; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Marr RA, 2003, J NEUROSCI, V23, P1992; McDermott JR, 1997, NEUROCHEM RES, V22, P8; Miners J, 2008, BRAIN PATHOL, V18, P13; Nalivaeva N, 2008, CURRENT ALZHEIMER RE, V5, P14; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Selkoe D, 1993, TRENDS NEUROSCI, V16, P7; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Zhao Z, 2007, NEUROBIOL AGING, V28, P7; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	32	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59626	10.1371/journal.pone.0059626	http://dx.doi.org/10.1371/journal.pone.0059626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555730	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200033
J	Huang, SC; Do, J; Mahalanabis, M; Fan, A; Zhao, L; Jepeal, L; Singh, SK; Klapperich, CM				Huang, Shichu; Do, Jaephil; Mahalanabis, Madhumita; Fan, Andy; Zhao, Lei; Jepeal, Lisa; Singh, Satish K.; Klapperich, Catherine M.			Low Cost Extraction and Isothermal Amplification of DNA for Infectious Diarrhea Diagnosis	PLOS ONE			English	Article							IMMUNOCHROMATOGRAPHIC STRIP TEST; REAL-TIME PCR; IDENTIFICATION; MICROFLUIDICS; TECHNOLOGIES; DEVICES; SYSTEMS; HEALTH; TOXIN	In order to counter the common perception that molecular diagnostics are too complicated to work in low resource settings, we have performed a difficult sample preparation and DNA amplification protocol using instrumentation designed to be operated without wall or battery power. In this work we have combined a nearly electricity-free nucleic acid extraction process with an electricity-free isothermal amplification assay to detect the presence of Clostridium difficile (C. difficile) DNA in the stool of infected patients. We used helicase-dependent isothermal amplification (HDA) to amplify the DNA in a low-cost, thermoplastic reaction chip heated with a pair of commercially available toe warmers, while using a simple Styrofoam insulator. DNA was extracted from known positive and negative stool samples. The DNA extraction protocol utilized an air pressure driven solid phase extraction device run using a standard bicycle pump. The simple heater setup required no electricity or battery and was capable of maintaining the temperature at 65 degrees C +/- 62 degrees C for 55 min, suitable for repeatable HDA amplification. Experiments were performed to explore the adaptability of the system for use in a range of ambient conditions. When compared to a traditional centrifuge extraction protocol and a laboratory thermocycler, this disposable, no power platform achieved approximately the same lower limit of detection (1.25 x 10(-2) pg of C. difficile DNA) while requiring much less raw material and a fraction of the lab infrastructure and cost. This proof of concept study could greatly impact the accessibility of molecular assays for applications in global health.	[Huang, Shichu; Do, Jaephil; Mahalanabis, Madhumita; Fan, Andy; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zhao, Lei] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Jepeal, Lisa; Singh, Satish K.] Boston Univ, Dept Gastroenterol, Boston, MA 02215 USA; [Singh, Satish K.] VA Boston Hlth Care Syst, Dept Med, Boston, MA USA; [Klapperich, Catherine M.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Klapperich, CM (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	catherin@bu.edu		Klapperich, Catherine/0000-0001-6103-849X; Singh, Satish/0000-0002-7664-3155	NIH [R21 AI71261]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH Grant R21 AI71261 to CMK and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, ANAL CHEM, V80, P6928, DOI 10.1021/ac800604v; [Anonymous], 2004, WORLD HLTH REP; Bartholomeusz DA, 2005, J MICROELECTROMECH S, V14, P1364, DOI 10.1109/JMEMS.2005.859087; Boel CHE, 2005, J CLIN MICROBIOL, V43, P2231, DOI 10.1128/JCM.43.5.2231-2235.2005; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brinkmann B, 1998, Methods Mol Biol, V98, P105; BURGESS DCH, 2006, IMPROVED DIAGNOSTIC; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033176; Chan CPY, 2008, ADV BIOCHEM ENG BIOT, V109, P123, DOI 10.1007/10_2007_075; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Chow WHA, 2008, J MOL DIAGN, V10, P452, DOI 10.2353/jmoldx.2008.080008; Christensen DR, 2006, CLIN CHEM, V52, P141, DOI 10.1373/clinchem.2005.052522; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229; Dupuy AM, 2005, CLIN CHEM LAB MED, V43, P1291, DOI 10.1515/CCL,.2005.223; Engler KH, 2002, J CLIN MICROBIOL, V40, P80, DOI 10.1128/JCM.40.1.80-83.2002; Gillers S, 2009, J MICROBIOL METH, V78, P203, DOI 10.1016/j.mimet.2009.05.020; Goldmeyer J, 2008, J CLIN MICROBIOL, V46, P1534, DOI 10.1128/JCM.02234-07; Gruentzig AW, 2011, ANAL METHODS-UK, V3, P1507, DOI 10.1039/c0ay00701c; Ivnitski D, 2003, BIOTECHNIQUES, V35, P862, DOI 10.2144/03354ss03; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kricka LJ, 1999, CLIN CHEM, V45, P453; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; Liu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042222; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Mahalanabis M, 2010, BIOMEDICAL MICRODEVI, P1; Mahalanabis M, 2009, LAB CHIP, V9, P2811, DOI 10.1039/b905065p; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Motre A, 2011, J MICROBIOL METH, V84, P343, DOI 10.1016/j.mimet.2010.12.002; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Patterson K, 2002, J CLIN MICROBIOL, V40, P3694, DOI 10.1128/JCM.40.10.3694-3702.2002; Qiu XB, 2011, SENSOR ACTUAT B-CHEM, V160, P1529, DOI 10.1016/j.snb.2011.08.012; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; Sia SK, 2008, LAB CHIP, V8, P1982, DOI 10.1039/b817915h; Sidransky D, 1997, SCIENCE, V278, P1054, DOI 10.1126/science.278.5340.1054; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Weigl B, 2008, LAB CHIP, V8, P1999, DOI 10.1039/b811314a; Wong AP, 2008, LAB CHIP, V8, P2032, DOI 10.1039/b809830c; Wong R, 2009, HANDHELD PORTABLE RE, P1; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yu C, 2000, ELECTROPHORESIS, V21, P120, DOI 10.1002/(SICI)1522-2683(20000101)21:1<120::AID-ELPS120>3.0.CO;2-H; Yun SS, 2010, LAB CHIP, V10, P1442, DOI 10.1039/b925244d; Zarakolu P, 2002, J CLIN MICROBIOL, V40, P3064, DOI 10.1128/JCM.40.8.3064-3065.2002	48	36	38	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60059	10.1371/journal.pone.0060059	http://dx.doi.org/10.1371/journal.pone.0060059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555883	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200075
J	Wu, JX; Li, Q; Wang, XY; Yu, SS; Li, L; Wu, XM; Chen, YL; Zhao, J; Zhao, Y				Wu, Jingxian; Li, Qiong; Wang, Xiaoyan; Yu, Shanshan; Li, Lan; Wu, Xuemei; Chen, Yanlin; Zhao, Jing; Zhao, Yong			Neuroprotection by Curcumin in Ischemic Brain Injury Involves the Akt/Nrf2 Pathway	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GLUTATHIONE-S-TRANSFERASE; HEME OXYGENASE-1 GENE; CORTICAL-NEURONS; ANTIOXIDANT; EXPRESSION; NRF2; PROTECTION; ELEVATION; REDUCTASE	Oxidative damage plays a critical role in many diseases of the central nervous system. This study was conducted to determine the molecular mechanisms involved in the putative anti-oxidative effects of curcumin against experimental stroke. Oxygen and glucose deprivation/reoxygenation (OGD/R) was used to mimic ischemic insult in primary cultured cortical neurons. A rapid increase in the intracellular expression of NAD(P) H: quinone oxidoreductase1 (NQO1) induced by OGD was counteracted by curcumin post-treatment, which paralleled attenuated cell injury. The reduction of phosphorylation Akt induced by OGD was restored by curcumin. Consequently, NQO1 expression and the binding activity of nuclear factor-erythroid 2-related factor 2 (Nrf2) to antioxidant response element (ARE) were increased. LY294002 blocked the increase in phospho-Akt evoked by curcumin and abolished the associated protective effect. Adult male Sprague-Dawley rats were subjected to transient middle cerebral artery occlusion for 60 minutes. Curcumin administration significantly reduced infarct size. Curcumin also markedly reduced oxidative stress levels in middle cerebral artery occlusion (MCAO) rats; hence, these effects were all suppressed by LY294002. Taken together, these findings provide evidence that curcumin protects neurons against ischemic injury, and this neuroprotective effect involves the Akt/Nrf2 pathway. In addition, Nrf2 is involved in the neuroprotective effects of curcumin against oxidative damage.	[Wu, Jingxian; Li, Qiong; Wang, Xiaoyan; Yu, Shanshan; Wu, Xuemei; Chen, Yanlin; Zhao, Yong] Chongqing Med Univ, Dept Pathol, Chongqing, Peoples R China; [Li, Lan; Zhao, Jing] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhao, J (corresponding author), Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China.	yangyang741022@sina.com; zhaoy2018@163.com			National Natural Science Foundation of China [81171090, 81271460, 81070917]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China, No. 81171090, No. 81271460 and No. 81070917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; ALAM J, 1995, J BIOL CHEM, V270, P11977, DOI 10.1074/jbc.270.20.11977; Balamurugan AN, 2009, PANCREAS, V38, P454, DOI 10.1097/MPA.0b013e318196c3e7; BENSON AM, 1979, CANCER RES, V39, P2971; BENSON AM, 1978, CANCER RES, V38, P4486; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dutta S, 2005, BIOORG MED CHEM LETT, V15, P2738, DOI 10.1016/j.bmcl.2005.04.001; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Ghoneim AI, 2002, PHARMACOL RES, V46, P273, DOI 10.1016/S1043-6618(02)00123-8; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Kalpana C., 2007, SMJ Singapore Medical Journal, V48, P124; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kilic EO, 2005, TURK PSIKIYATR DERG, V16, P1; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; LIND C, 1990, METHOD ENZYMOL, V186, P287; Lodha R., 2000, Annals Academy of Medicine Singapore, V29, P37; Ming YL, 2006, J NEUROCHEM, V98, P1316, DOI 10.1111/j.1471-4159.2006.03961.x; Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Van Erk Marjan J, 2004, J Carcinog, V3, P8, DOI 10.1186/1477-3163-3-8; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wei XB, 2005, NEUROSCI LETT, V386, P58, DOI 10.1016/j.neulet.2005.05.069; Williams EJ, 1999, MOL CELL NEUROSCI, V13, P272, DOI 10.1006/mcne.1999.0750; Wu XM, 2012, NEUROSCI BULL, V28, P509, DOI 10.1007/s12264-012-1273-z; Yang FY, 2012, EUR J CANC PREV; Yu SS, 2010, BRAIN RES, V1308, P167, DOI 10.1016/j.brainres.2009.10.037; Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	40	111	116	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59843	10.1371/journal.pone.0059843	http://dx.doi.org/10.1371/journal.pone.0059843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555802	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200045
J	Cubillo, E; Diaz-Lopez, A; Cuevas, EP; Moreno-Bueno, G; Peinado, H; Montes, A; Santos, V; Portillo, F; Cano, A				Cubillo, Eva; Diaz-Lopez, Antonio; Cuevas, Eva P.; Moreno-Bueno, Gema; Peinado, Hector; Montes, Amalia; Santos, Vanesa; Portillo, Francisco; Cano, Amparo			E47 and Id1 Interplay in Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; REPRESSES E-CADHERIN; LOOP-HELIX PROTEINS; BREAST-CANCER; GENE-EXPRESSION; CELL POLARITY; BHLH FACTORS; SIGNATURE; PROSTATE	E12/E47 proteins (encoded by E2A gene) are members of the class I basic helix-loop-helix (bHLH) transcription factors (also known as E proteins). E47 has been described as repressor of E-cadherin and inducer of epithelial-mesenchymal transition (EMT). We reported previously that EMT mediated by E47 in MDCK cells occurs with a concomitant overexpression of Id1 and Id3 proteins. Id proteins belong to class V of HLH factors that lack the basic domain; they dimerise with E proteins and prevent their DNA interaction, thus, acting as dominant negative of E proteins. Here, we show that E47 interacts with Id1 in E47 overexpressing MDCK cells that underwent a full EMT as well as in mesenchymal breast carcinoma and melanoma cell lines. By conducting chromatin immunoprecipitation assays we demonstrate that E47 binds directly to the endogenous E-cadherin promoter of mesenchymal MDCK-E47 cells in a complex devoid of Id1. Importantly, our data suggest that both E47 and Id1 are required to maintain the mesenchymal phenotype of MDCK-E47 cells. These data support the collaboration between E47 and Id1 in the maintenance of EMT by mechanisms independent of the dominant negative action of Id1 on E47 binding to E-cadherin promoter. Finally, the analysis of several N0 breast tumour series indicates that the expression of E47 and ID1 is significantly associated with the basal-like phenotype supporting the biological significance of the present findings.	[Cubillo, Eva; Diaz-Lopez, Antonio; Cuevas, Eva P.; Moreno-Bueno, Gema; Peinado, Hector; Montes, Amalia; Santos, Vanesa; Portillo, Francisco; Cano, Amparo] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM,IdiPAZ, Madrid, Spain; [Moreno-Bueno, Gema] MD Anderson Canc Ctr Madrid, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center	Cano, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM,IdiPAZ, Madrid, Spain.	acano@iib.uam.es	Moreno-Bueno, Gema/K-9354-2016; Cuevas, Eva P./P-4533-2019; Peinado, Hector/A-6417-2013; Diaz Lopez, Antonio/G-1402-2015	Moreno-Bueno, Gema/0000-0002-5030-6687; Cuevas, Eva P./0000-0001-6477-1283; Peinado, Hector/0000-0002-4256-3413; Diaz Lopez, Antonio/0000-0003-0103-3296; Portillo Perez, Francisco/0000-0003-4922-346X	Spanish Ministry of Education and Science [SAF2007-63051, SAF2010-21143, CDS07/00017, SAF2007-63075, SAF2010-20175]; Comunidad de Madrid [S2010/BMD-2303]	Spanish Ministry of Education and Science(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Spanish Ministry of Education and Science (SAF2007-63051; SAF2010-21143; Consolider Ingenio 2010 CDS07/00017) to A. C.; (SAF2007-63075 and SAF2010-20175) to G. M. B.; Comunidad de Madrid (S2010/BMD-2303) to A. C and G. M. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bergamaschi A, 2008, MOL ONCOL, V2, P327, DOI 10.1016/j.molonc.2008.09.004; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cano A, 2010, CELL ADHES MIGR, V4, P56, DOI 10.4161/cam.4.1.9995; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; de Candia P, 2003, P NATL ACAD SCI USA, V100, P12337, DOI 10.1073/pnas.2031337100; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gyorffy A, 2006, ANTICANCER RES, V26, P2971; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim J, 2010, CANCER SCI, V101, P1521, DOI 10.1111/j.1349-7006.2010.01536.x; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Molina-Ortiz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036132; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0; Yang HY, 2010, ONCOL REP, V23, P321, DOI 10.3892/or_00000639; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200	67	41	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59948	10.1371/journal.pone.0059948	http://dx.doi.org/10.1371/journal.pone.0059948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555842	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500107
J	Dabrowski, PW; Schroder, K; Nitsche, A				Dabrowski, Piotr Wojtek; Schroeder, Kati; Nitsche, Andreas			MultiPSQ: A Software Solution for the Analysis of Diagnostic n-Plexed Pyrosequencing Reactions	PLOS ONE			English	Article								Background: Pyrosequencing can be applied for Single-Nucleotide-Polymorphism (SNP)-based pathogen typing or for providing sequence information of short DNA stretches. However, for some pathogens molecular typing cannot be performed relying on a single SNP or short sequence stretch, necessitating the consideration of several genomic regions. A promising rapid approach is the simultaneous application of multiple sequencing primers, called multiplex pyrosequencing. These primers generate a fingerprint-pyrogram which is constituted by the sum of all individual pyrograms originating from each primer used. Methods: To improve pyrosequencing-based pathogen typing, we have developed the software tool MultiPSQ that expedites the analysis and evaluation of multiplex-pyrograms. As a proof of concept, a multiplex pyrosequencing assay for the typing of orthopoxviruses was developed to analyse clinical samples diagnosed in the German Consultant Laboratory for Poxviruses. Results: The software tool MultiPSQ enabled the analysis of multiplex-pyrograms originating from various pyrosequencing primers. Thus several target regions can be used for pathogen typing based on pyrosequencing. As shown with a proof of concept assay, SNPs present in different orthopoxvirus strains could be identified correctly with two primers by MultiPSQ. Conclusions: Software currently available is restricted to a fixed number of SNPs and sequencing primers, severely limiting the usefulness of this technique. In contrast, our novel software MultiPSQ allows analysis of data from multiplex pyrosequencing assays that contain any number of sequencing primers covering any number of polymorphisms.	[Dabrowski, Piotr Wojtek] Robert Koch Inst, Cent Adm IT 4, Berlin, Germany; [Dabrowski, Piotr Wojtek; Schroeder, Kati; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens 1, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Dabrowski, PW (corresponding author), Robert Koch Inst, Cent Adm IT 4, Berlin, Germany.	DabrowskiW@rki.de	Dabrowski, Piotr Wojtek/L-1423-2015	Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Nitsche, Andreas/0000-0001-8185-3176	Federal Ministry of Education and Research (BMBF) under the research programme for civil security of the German Federal Government as part of the high-tech strategy for Germany: Potential release-oriented biothreat emergency diagnostics (P.R.O.B.E.)	Federal Ministry of Education and Research (BMBF) under the research programme for civil security of the German Federal Government as part of the high-tech strategy for Germany: Potential release-oriented biothreat emergency diagnostics (P.R.O.B.E.)	This work was partly supported by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) funded project under the research programme for civil security of the German Federal Government as part of the high-tech strategy for Germany: Potential release-oriented biothreat emergency diagnostics (P.R.O.B.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Dabrowski PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038140; Doostzadeh J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002693; Elahi Elahe, 2004, Methods Mol Biol, V255, P211; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Gharizadeh B, 2005, J MOL DIAGN, V7, P198, DOI 10.1016/S1525-1578(10)60546-6; Gharizadeh B, 2003, ELECTROPHORESIS, V24, P1145, DOI 10.1002/elps.200390147; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Patel Pritesh, 2007, V373, P75; Pourmand N, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e31; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Slawski M., 2011, ADV NEURAL INFORM PR, V24, P1926	14	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60055	10.1371/journal.pone.0060055	http://dx.doi.org/10.1371/journal.pone.0060055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555882	Green Published, gold			2022-12-27	WOS:000317418500115
J	Endoh, T; Sugimoto, N				Endoh, Tamaki; Sugimoto, Naoki			Selection of RNAs for Constructing "Lighting-UP'' Biomolecular Switches in Response to Specific Small Molecules	PLOS ONE			English	Article							RIBOSWITCHES; BINDING; EXPRESSION; LIGANDS; PEPTIDE; VIRUS; RECOGNITION; APTAMERS; COMPLEX; SYSTEM	RNA and protein are potential molecules that can be used to construct functional nanobiomaterials. Recent findings on riboswitches emphasize on the dominative function of RNAs in regulating protein functions through allosteric interactions between RNA and protein. In this study, we demonstrate a simple strategy to obtain RNAs that have a switching ability with respect to protein function in response to specific target molecules. RNA aptamers specific for small ligands and a trans-activation-responsive (TAR)-RNA were connected by random RNA sequences. RNAs that were allosterically bound to a transactivator of transcription (Tat)-peptide in response to ligands were selected by repeated negative and positive selection in the absence and presence of the ligands, respectively. The selected RNAs interacted with artificially engineered Renilla Luciferase, in which the Tat-peptide was inserted within the Luciferase, in the presence of the specific ligand and triggered the "Lighting-UP'' switch of the engineered Luciferase.	[Endoh, Tamaki; Sugimoto, Naoki] Konan Univ, FIBER, Kobe, Hyogo, Japan; [Sugimoto, Naoki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Kobe, Hyogo, Japan	Konan University; Konan University	Sugimoto, N (corresponding author), Konan Univ, FIBER, Kobe, Hyogo, Japan.	sugimoto@konan-u.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities, Japan	MEXT-Supported Program for the Strategic Research Foundation at Private Universities, Japan	This work was supported in part by Grants-in-Aid for Scientific Research (http://www.jsps.go.jp/english/e-grants/index.html) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2009-2014) (http://www.mext.go.jp/english/), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andou T, 2011, ANALYST, V136, P2446, DOI 10.1039/c1an15130d; Andou T, 2009, ANAL BIOANAL CHEM, V393, P661, DOI 10.1007/s00216-008-2473-2; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3; Blouin S, 2009, CHEMBIOCHEM, V10, P400, DOI 10.1002/cbic.200800593; Campisi DM, 2001, EMBO J, V20, P178, DOI 10.1093/emboj/20.1.178; CHEN L, 1994, BIOCHEMISTRY-US, V33, P2708, DOI 10.1021/bi00175a046; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Endoh T, 2007, BIOCONJUGATE CHEM, V18, P956, DOI 10.1021/bc060351o; Endoh T, 2011, CHEMBIOCHEM, V12, P1174, DOI 10.1002/cbic.201100093; Endoh T, 2009, BIOCONJUGATE CHEM, V20, P2242, DOI 10.1021/bc9002184; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Miyazaki Y, 2010, J MOL BIOL, V396, P141, DOI 10.1016/j.jmb.2009.11.033; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Ogawa A, 2007, BIOORG MED CHEM LETT, V17, P3156, DOI 10.1016/j.bmcl.2007.03.033; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rentmeister A, 2007, NUCLEIC ACIDS RES, V35, P3713, DOI 10.1093/nar/gkm300; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Serganov A, 2012, CURR OPIN STRUC BIOL, V22, P279, DOI 10.1016/j.sbi.2012.04.005; Soukup GA, 2000, J MOL BIOL, V298, P623, DOI 10.1006/jmbi.2000.3704; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Tok JBH, 2004, BIOORG MED CHEM LETT, V14, P6101, DOI 10.1016/j.bmcl.2004.09.075; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/NCHEMBIO.609, 10.1038/nchembio.609]; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zimmermann GR, 2000, RNA, V6, P659, DOI 10.1017/S1355838200000169	33	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60222	10.1371/journal.pone.0060222	http://dx.doi.org/10.1371/journal.pone.0060222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555931	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500125
J	Mou, SL; Liu, ZQ; Guan, DY; Qiu, AL; Lai, Y; He, SL				Mou, Shaoliang; Liu, Zhiqin; Guan, Deyi; Qiu, Ailian; Lai, Yan; He, Shuilin			Functional Analysis and Expressional Characterization of Rice Ankyrin Repeat-Containing Protein, OsPIANK1, in Basal Defense against Magnaporthe oryzae Attack	PLOS ONE			English	Article							ESSENTIAL MOLECULAR CHAPERONE; OUTER-MEMBRANE PROTEINS; DISEASE RESISTANCE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; UBIQUITIN LIGASE; SALICYLIC-ACID; BINDING PROTEIN; LRR PROTEIN; ARABIDOPSIS	The ankyrin repeat-containing protein gene OsPIANK1 (AK068021) in rice (Oryza sativa L.) was previously shown to be upregulated following infection with the rice leaf blight pathogen Xanthomonas oryzae pv oryzae (Xoo). In this study, we further characterized the role of OsPIANK1 in basal defense against Magnaporthe oryzae (M. oryzae) by 59 deletion analysis of its promoter and overexpression of the gene. The promoter of OsPIANK1 with 1,985 bps in length was sufficient to induce the OsPIANK1 response to inoculation with M. oryzae and to exogenous application of methyl jasmonate (MeJA) or salicylic acid (SA), but not to exogenous application of abscisic acid (ABA). A TCA-element present in the region between 2563 bp and 2249 bp may be responsible for the OsPIANK1 response to both M. oryzae infection and exogenous SA application. The JERE box, CGTCA-box, and two MYB binding sites locating in the region between 21985 bp and 2907 bp may be responsible for the response of OsPIANK1 to exogenous MeJA. OsPIANK1 expression was upregulated after inoculation with M. oryzae and after treatment with exogenous SA and MeJA. Overexpression of OsPIANK1 enhanced resistance of rice to M. oryzae, although it did not confer complete resistance. The enhanced resistance to M. oryzae was accompanied by enhanced transcriptional expression of SA-and JA-dependent genes such as NH1, WKRY13, PAL, AOS2, PR1b, and PR5. This evidence suggests that OsPIANK1 acted as a positive regulator in rice basal defense mediated by SA-and JA-signaling pathways.	[Mou, Shaoliang; Liu, Zhiqin; Qiu, Ailian; Lai, Yan; He, Shuilin] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Mou, Shaoliang; Liu, Zhiqin; Guan, Deyi; Qiu, Ailian; Lai, Yan; He, Shuilin] Fujian Agr & Forestry Univ, Natl Educ Minster Key Lab Plant Genet Improvement, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	He, SL (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	shlhe2007@yahoo.com.cn			National Natural Science Foundation of China [30971718]; Research Fund for the Doctoral Program of Higher Education of China [20093535110004]; Transgenic Major Program [2009ZX08001-015B]; Natural Science Foundation of Fujian Province, China [2008J049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Transgenic Major Program; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	This work was supported by grants from National Natural Science Foundation of China (30971718), Research Fund for the Doctoral Program of Higher Education of China (20093535110004), the Transgenic Major Program (2009ZX08001-015B), and Natural Science Foundation of Fujian Province, China (2008J049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Bae W, 2008, NAT CELL BIOL, V10, P220, DOI 10.1038/ncb1683; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Blilou I, 2000, J EXP BOT, V51, P1969, DOI 10.1093/jexbot/51.353.1969; Bottner S, 2009, PLANT J, V58, P914, DOI 10.1111/j.1365-313X.2009.03829.x; Carvalho SD, 2012, MOL PLANT, V5, P1295, DOI 10.1093/mp/sss048; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Cui YL, 2011, PLANT PHYSIOL, V155, P130, DOI 10.1104/pp.110.165589; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dong Xinnian, 2004, Sci STKE, V2004, ppe6, DOI 10.1126/stke.2212004pe6; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Fridborg I, 2003, MOL PLANT MICROBE IN, V16, P132, DOI 10.1094/MPMI.2003.16.2.132; Ganesan V, 2001, PLANT SCI, V160, P1095, DOI 10.1016/S0168-9452(01)00327-2; Gao W, 2010, PLANT SIGNAL BEHAV, V5, P1025, DOI 10.4161/psb.5.8.12294; Garcion C, 2006, PLANT J, V48, P895, DOI 10.1111/j.1365-313X.2006.02922.x; Glinwood R, 2007, PLANT SIGNAL BEHAV, V2, P321, DOI 10.4161/psb.2.5.4494; Gu YN, 2011, PLANT PHYSIOL, V155, P1827, DOI 10.1104/pp.110.171785; Ha CM, 2004, PLANT CELL PHYSIOL, V45, P1361, DOI 10.1093/pcp/pch201; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Huang J, 2006, PLANT PHYSIOL, V140, P1374, DOI 10.1104/pp.105.074922; Huang JY, 2009, PLANT MOL BIOL, V71, P207, DOI 10.1007/s11103-009-9518-6; ITZHAKI H, 1994, P NATL ACAD SCI USA, V91, P8925, DOI 10.1073/pnas.91.19.8925; Jacques A, 2006, MOL PLANT MICROBE IN, V19, P747, DOI 10.1094/MPMI-19-0747; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jung HW, 2007, MOL PLANT PATHOL, V8, P503, DOI 10.1111/J.1364-3703.2007.00410.X; Katagiri F, 2004, CURR OPIN PLANT BIOL, V7, P506, DOI 10.1016/j.pbi.2004.07.013; Kim DH, 2011, PLANT PHYSIOL, V157, P132, DOI 10.1104/pp.111.178681; Knoth C, 2007, MOL PLANT MICROBE IN, V20, P120, DOI 10.1094/MPMI-20-2-0120; Knoth C, 2009, PLANT PHYSIOL, V150, P333, DOI 10.1104/pp.108.133678; Kottapalli KR, 2007, PLANT PHYSIOL BIOCH, V45, P834, DOI 10.1016/j.plaphy.2007.07.013; Kumagai H, 2007, PLANT PHYSIOL, V143, P1293, DOI 10.1104/pp.106.095356; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Li HY, 2004, PLANT MOL BIOL, V54, P233, DOI 10.1023/B:PLAN.0000028790.75090.ab; Li SF, 1995, PLANT J, V8, P963, DOI 10.1046/j.1365-313X.1995.8060963.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Maucher H, 2000, PLANT J, V21, P199, DOI 10.1046/j.1365-313x.2000.00669.x; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Norberg M, 2005, DEVELOPMENT, V132, P2203, DOI 10.1242/dev.01815; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Pumplin N, 2010, PLANT J, V61, P482, DOI 10.1111/j.1365-313X.2009.04072.x; Qi M, 2002, PHYTOPATHOLOGY, V92, P870, DOI 10.1094/PHYTO.2002.92.8.870; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Sacco MA, 2007, PLANT J, V52, P82, DOI 10.1111/j.1365-313X.2007.03213.x; Salazar M, 2007, PLANT CELL REP, V26, P1861, DOI 10.1007/s00299-007-0375-y; SCHARF KD, 1990, EMBO J, V9, P4495, DOI 10.1002/j.1460-2075.1990.tb07900.x; Seong ES, 2007, BIOCHEM BIOPH RES CO, V363, P983, DOI 10.1016/j.bbrc.2007.09.104; Shen GX, 2010, PLANT CELL, V22, P811, DOI 10.1105/tpc.109.065979; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; van der Fits L, 2001, PLANT J, V25, P43, DOI 10.1046/j.1365-313x.2001.00932.x; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang Q, 2010, PLANT CELL REP, V29, P185, DOI 10.1007/s00299-009-0811-2; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wu T, 2009, BIOCHEM GENET, V47, P439, DOI 10.1007/s10528-009-9238-2; Xie CG, 2010, J GENET GENOMICS, V37, P359, DOI 10.1016/S1673-8527(09)60054-0; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; Yang YA, 2012, PLANT PHYSIOL, V159, P1857, DOI 10.1104/pp.112.197152; Yoo J, 2011, PHYSIOL PLANTARUM, V142, P314, DOI 10.1111/j.1399-3054.2011.01468.x; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Yu F, 2010, P NATL ACAD SCI USA, V107, P22332, DOI 10.1073/pnas.1015911107; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; ZHANG H, 1992, PLANT CELL, V4, P1575, DOI 10.1105/tpc.4.12.1575; Zhang H, 2010, PLANT SIGNAL BEHAV, V5, P1520, DOI [10.1105/tpc.109.065979, 10.4161/psb.5.11.13714]; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zhang XC, 2010, MOL BIOL REP, V37, P653, DOI 10.1007/s11033-009-9507-5	75	40	41	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59699	10.1371/journal.pone.0059699	http://dx.doi.org/10.1371/journal.pone.0059699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555750	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500079
J	Mugge, W; van der Helm, FCT; Schouten, AC				Mugge, Winfred; van der Helm, Frans C. T.; Schouten, Alfred C.			Integration of Sensory Force Feedback Is Disturbed in CRPS-Related Dystonia	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; SENSORIMOTOR INTEGRATION; OBJECTIVE EVALUATION; PRECISION GRIP; DISORDERS; BEHAVIOR; MODEL	Complex regional pain syndrome (CRPS) is characterized by pain and disturbed blood flow, temperature regulation and motor control. Approximately 25% of cases develop fixed dystonia. The origin of this movement disorder is poorly understood, although recent insights suggest involvement of disturbed force feedback. Assessment of sensorimotor integration may provide insight into the pathophysiology of fixed dystonia. Sensory weighting is the process of integrating and weighting sensory feedback channels in the central nervous system to improve the state estimate. It was hypothesized that patients with CRPS-related dystonia bias sensory weighting of force and position toward position due to the unreliability of force feedback. The current study provides experimental evidence for dysfunctional sensory integration in fixed dystonia, showing that CRPS-patients with fixed dystonia weight force and position feedback differently than controls do. The study shows reduced force feedback weights in CRPS-patients with fixed dystonia, making it the first to demonstrate disturbed integration of force feedback in fixed dystonia, an important step towards understanding the pathophysiology of fixed dystonia.	[Mugge, Winfred; van der Helm, Frans C. T.; Schouten, Alfred C.] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands; [van der Helm, Frans C. T.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Schouten, Alfred C.] Univ Twente, Lab Biomech Engn, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Delft University of Technology; Northwestern University; University of Twente	Mugge, W (corresponding author), Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands.	w.mugge@tudelft.nl	Schouten, Alfred C./AAH-3560-2019	Schouten, Alfred C./0000-0003-3149-6726	Dutch Government [BSIK03016]	Dutch Government	The work was funded by Dutch Government grant BSIK03016 (http://www.agentschapnl.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; Chu WTV, 2009, MOVEMENT DISORD, V24, P1299, DOI 10.1002/mds.22573; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Helbig HB, 2008, J VISION, V8, DOI 10.1167/8.1.21; Hermsdorfer J, 2004, HUM MOVEMENT SCI, V23, P627; Johansson Roland S., 1996, P381, DOI 10.1016/B978-012759440-8/50025-6; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, J NEUROPHYSIOL, V92, P3161, DOI 10.1152/jn.00275.2004; Mahboobin A, 2005, EXP BRAIN RES, V167, P260, DOI 10.1007/s00221-005-0053-7; Merskey H., 1994, CLASSIFICATION CHRON, P40; Mugge W, 2012, J BIOMECH, V45, P90, DOI 10.1016/j.jbiomech.2011.09.024; Mugge W, 2009, J NEUROSCI, V29, P5476, DOI 10.1523/JNEUROSCI.0116-09.2009; Munts AG, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-53; Nowak DA, 2005, J NEUROL NEUROSUR PS, V76, P953, DOI 10.1136/jnnp.2004.043943; Nowak DA, 2005, MOVEMENT DISORD, V20, P11, DOI 10.1002/mds.20299; Nowak DA, 2006, BRAIN RES REV, V51, P108, DOI 10.1016/j.brainresrev.2005.10.003; Odergren T, 1996, BRAIN, V119, P569, DOI 10.1093/brain/119.2.569; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Prodoehl J, 2006, J NEUROL NEUROSUR PS, V77, P909, DOI 10.1136/jnnp.2006.091363; Prodoehl J, 2006, PARKINSONISM RELAT D, V12, P363, DOI 10.1016/j.parkreldis.2006.01.008; Schenk T, 2001, EXP BRAIN RES, V136, P321, DOI 10.1007/s002210000599; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Serrien DJ, 2000, MOVEMENT DISORD, V15, P965, DOI 10.1002/1531-8257(200009)15:5<965::AID-MDS1030>3.0.CO;2-0; Tinazzi M, 2003, MOVEMENT DISORD, V18, P605, DOI 10.1002/mds.10398; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; van Hilten JJ, 2007, PARKINSONISM RELAT D, V13, pS395, DOI 10.1016/S1353-8020(08)70037-3; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	31	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60293	10.1371/journal.pone.0060293	http://dx.doi.org/10.1371/journal.pone.0060293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555946	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500127
J	Schock, TB; Duke, J; Goodson, A; Weldon, D; Brunson, J; Leffler, JW; Bearden, DW				Schock, Tracey B.; Duke, Jessica; Goodson, Abby; Weldon, Daryl; Brunson, Jeff; Leffler, John W.; Bearden, Daniel W.			Evaluation of Pacific White Shrimp (Litopenaeus vannamei) Health during a Superintensive Aquaculture Growout Using NMR-Based Metabolomics	PLOS ONE			English	Article							ELEVATED AMBIENT AMMONIA; AMINO-ACID LEVELS; OXIDATIVE PYRIMIDINE METABOLISM; PAULENSIS PEREZ-FARFANTE; SALMON SALMO-SALAR; MAGNETIC-RESONANCE; CULTURE-SYSTEMS; ENVIRONMENTAL METABOLOMICS; PENAEUS-VANNAMEI; IMMUNE-RESPONSES	Success of the shrimp aquaculture industry requires technological advances that increase production and environmental sustainability. Indoor, superintensive, aquaculture systems are being developed that permit year-round production of farmed shrimp at high densities. These systems are intended to overcome problems of disease susceptibility and of water quality issues from waste products, by operating as essentially closed systems that promote beneficial microbial communities (biofloc). The resulting biofloc can assimilate and detoxify wastes, may provide nutrition for the farmed organisms resulting in improved growth, and may aid in reducing disease initiated from external sources. Nuclear magnetic resonance (NMR)-based metabolomic techniques were used to assess shrimp health during a full growout cycle from the nursery phase through harvest in a minimal-exchange, superintensive, biofloc system. Aberrant shrimp metabolomes were detected from a spike in total ammonia nitrogen in the nursery, from a reduced feeding period that was a consequence of surface scum build-up in the raceway, and from the stocking transition from the nursery to the growout raceway. The biochemical changes in the shrimp that were induced by the stressors were essential for survival and included nitrogen detoxification and energy conservation mechanisms. Inosine and trehalose may be general biomarkers of stress in Litopenaeus vannamei. This study demonstrates one aspect of the practicality of using NMR-based metabolomics to enhance the aquaculture industry by providing physiological insight into common environmental stresses that may limit growth or better explain reduced survival and production.	[Schock, Tracey B.; Duke, Jessica; Goodson, Abby; Bearden, Daniel W.] Natl Inst Stand & Technol, Hollings Marine Lab, Div Chem Sci, Charleston, SC USA; [Weldon, Daryl; Brunson, Jeff; Leffler, John W.] South Carolina Dept Nat Resources, Marine Resources Res Inst, Charleston, SC USA	National Institute of Standards & Technology (NIST) - USA	Schock, TB (corresponding author), Natl Inst Stand & Technol, Hollings Marine Lab, Div Chem Sci, Charleston, SC USA.	tracey.schock@nist.gov		Schock, Tracey/0000-0002-1808-7816; Bearden, Daniel/0000-0003-0330-8513	Hollings Marine Laboratory NMR Facility; Waddell Mariculture Center; USDA National Institute of Food and Agriculture (NIFA) US Marine Shrimp Farming Program [USMSFP2010-21115-SCDNR]	Hollings Marine Laboratory NMR Facility; Waddell Mariculture Center; USDA National Institute of Food and Agriculture (NIFA) US Marine Shrimp Farming Program	We are grateful for the assistance of Arezue Boroujerdi during the planning of this study and of Edward DuRant during the husbandry of the shrimp. We acknowledge the support of the Hollings Marine Laboratory NMR Facility and the Waddell Mariculture Center. Commercial equipment or materials are identified in this paper to specify adequately the experimental procedure. Such identification does not imply recommendation or endorsement by NIST, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. This is contribution number 695 from the South Carolina Department of Natural Resources Marine Resources Research Institute.; Major financial support for this project came from the USDA National Institute of Food and Agriculture (NIFA) US Marine Shrimp Farming Program, grant #USMSFP2010-21115-SCDNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz G, 1999, J WORLD AQUACULT SOC, V30, P90, DOI 10.1111/j.1749-7345.1999.tb00321.x; Arar E. J., 1997, 4460 USEPA; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Browdy CL, 2009, BASICS, P1010, DOI 10.1533/9781845696474.6.1010; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Burford MA, 2004, AQUACULTURE, V232, P525, DOI 10.1016/S0044-8486(03)00541-6; CHEN J-C, 1990, Journal of the World Aquaculture Society, V21, P300, DOI 10.1111/j.1749-7345.1990.tb00543.x; CHEN JC, 1992, AQUACULTURE, V104, P249, DOI 10.1016/0044-8486(92)90207-2; CHEN JC, 1994, COMP BIOCHEM PHYS A, V109, P339, DOI 10.1016/0300-9629(94)90137-6; CHEN JC, 1992, COMP BIOCHEM PHYS C, V102, P129, DOI 10.1016/0742-8413(92)90054-B; Chen JC, 1997, MAR ECOL PROG SER, V153, P197, DOI 10.3354/meps153197; Chen Jiann-Chu, 1993, Aquaculture, V109, P177, DOI 10.1016/0044-8486(93)90214-J; Chen JM, 2000, AQUAT TOXICOL, V50, P27, DOI 10.1016/S0166-445X(99)00095-8; CLAYBROOK DL, 1983, BIOL CRUSTACEA, V5, P163; Crab R, 2010, J APPL MICROBIOL, V109, P1643, DOI 10.1111/j.1365-2672.2010.04791.x; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dall W, 1990, BIOL PENACIDAE; DANIELLO A, 1980, EXPERIENTIA, V36, P392, DOI 10.1007/BF01975105; De Schryver P, 2008, AQUACULTURE, V277, P125, DOI 10.1016/j.aquaculture.2008.02.019; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Durand F, 1999, J EXP BIOL, V202, P2191; Eaton A. D., 2005, STANDARD METHODS EXA; Ekman DR, 2008, ENVIRON SCI TECHNOL, V42, P4188, DOI 10.1021/es8000618; Fisheries Statistics Division NMFS, 2011, SUPPL FISH PROD; GLOVER HE, 1979, LIMNOL OCEANOGR, V24, P510, DOI 10.4319/lo.1979.24.3.0510; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; Hari B, 2006, AQUACULTURE, V252, P248, DOI 10.1016/j.aquaculture.2005.06.044; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; HAYAISHI O, 1952, J BIOL CHEM, V197, P717; Hong ML, 2007, COMP BIOCHEM PHYS C, V145, P363, DOI 10.1016/j.cbpc.2007.01.003; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Karakach TK, 2009, METABOLOMICS, V5, P123, DOI 10.1007/s11306-008-0144-0; Krummenauer D, 2011, J WORLD AQUACULT SOC, V42, P726, DOI 10.1111/j.1749-7345.2011.00507.x; Kullgren A, 2013, COMP BIOCHEM PHYS A, V164, P44, DOI 10.1016/j.cbpa.2012.10.005; Kullgren A, 2010, AM J PHYSIOL-REG I, V299, pR1440, DOI 10.1152/ajpregu.00281.2010; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Mannina L, 2008, TALANTA, V77, P433, DOI 10.1016/j.talanta.2008.07.006; Martin FPJ, 2011, MAGN RESON CHEM, V49, pS47, DOI 10.1002/mrc.2810; Mercier L, 2006, AQUACULTURE, V258, P633, DOI 10.1016/j.aquaculture.2006.04.036; Mercier L, 2009, AQUAC RES, V40, P1849, DOI 10.1111/j.1365-2109.2009.02291.x; Miranda KC, 2009, COMP BIOCHEM PHYS C, V150, P377, DOI 10.1016/j.cbpc.2009.06.001; Moss SM, 2006, AQUACULTURE, V258, P388, DOI 10.1016/j.aquaculture.2006.04.008; MOSS SM, 1995, J EXP MAR BIOL ECOL, V187, P175, DOI 10.1016/0022-0981(94)00179-H; MOSS SM, 1995, AQUACULTURE, V132, P253, DOI 10.1016/0044-8486(94)00350-W; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; OSTRENSKY A, 1995, AQUACULTURE, V132, P339, DOI 10.1016/0044-8486(94)00343-M; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Pascual C, 2006, AQUACULTURE, V251, P416, DOI 10.1016/j.aquaculture.2005.06.001; Pellegrino R, 2008, J EXP MAR BIOL ECOL, V358, P144, DOI 10.1016/j.jembe.2008.02.005; Picone G, 2011, NUTRIENTS, V3, P212, DOI 10.3390/nu3020212; Racotta IS, 1998, J WORLD AQUACULT SOC, V29, P351, DOI 10.1111/j.1749-7345.1998.tb00658.x; Ray A.J., 2009, RISING TIDE, P255; Ray AJ, 2011, GLOBAL AQUACULTURE A, P14; Ray AJ, 2011, AQUACULT ENG, V45, P127, DOI 10.1016/j.aquaeng.2011.09.001; Ray AJ, 2010, AQUACULTURE, V310, P130, DOI 10.1016/j.aquaculture.2010.10.019; Ray AJ, 2010, AQUACULTURE, V299, P89, DOI 10.1016/j.aquaculture.2009.11.021; REGNAULT M, 1987, BIOL REV, V62, P1, DOI 10.1111/j.1469-185X.1987.tb00623.x; Rezzi S, 2007, J AGR FOOD CHEM, V55, P9963, DOI 10.1021/jf070736g; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; Rosas C, 2002, J EXP MAR BIOL ECOL, V268, P47, DOI 10.1016/S0022-0981(01)00370-7; Savorani F, 2010, FOOD CHEM, V120, P907, DOI 10.1016/j.foodchem.2009.10.071; Schmitt ASC, 1999, AQUAC RES, V30, P1, DOI 10.1046/j.1365-2109.1999.00268.x; Schock TB, 2012, FOOD CHEM, V133, P90, DOI 10.1016/j.foodchem.2011.12.077; Solanky KS, 2005, DIS AQUAT ORGAN, V65, P107, DOI 10.3354/dao065107; Soong CL, 2002, J BIOL CHEM, V277, P7051, DOI 10.1074/jbc.M110784200; Soong CL, 2001, BIOCHEM BIOPH RES CO, V286, P222, DOI 10.1006/bbrc.2001.5356; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; [USDA ERS], 2012, AQ DAT; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Viant MR, 2003, ENVIRON SCI TECHNOL, V37, P4982, DOI 10.1021/es034281x; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Walsh B., 2011, TIME MAGAZINE; Wasielesky W, 2006, AQUACULTURE, V258, P396, DOI 10.1016/j.aquaculture.2006.04.030; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Wu LX, 2002, AQUACULTURE, V210, P343, DOI 10.1016/S0044-8486(01)00860-2; Zhang PD, 2010, AQUACULT INT, V18, P1191, DOI 10.1007/s10499-010-9333-8; Zhou QL, 2009, BIORESOURCE TECHNOL, V100, P3780, DOI 10.1016/j.biortech.2008.12.037	80	48	49	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59521	10.1371/journal.pone.0059521	http://dx.doi.org/10.1371/journal.pone.0059521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555690	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500043
J	Ahlgrim, C; Pottgiesser, T; Sander, T; Schumacher, YO; Baumstark, MW				Ahlgrim, Christoph; Pottgiesser, Torben; Sander, Thomas; Schumacher, Yorck Olaf; Baumstark, Manfred W.			Flow Cytometric Assessment of Erythrocyte Shape through Analysis of FSC Histograms: Use of Kurtosis and Implications for Longitudinal Evaluation	PLOS ONE			English	Article								Sphericity of erythrocytes can be estimated from analysis of FSC signal distribution in flow cytometry. Previously, Pearson's coefficient of dissymmetry (PCD) and spherical index (SphI) were applied to determine erythrocyte sphericity from the FSC histogram. The aim of the present study is to illustrate the application of kurtosis as an indicator of erythrocyte sphericity in flow cytometry in a broad range of FSC distributions. Moreover, the possibility of longitudinal evaluation of erythrocyte sphericity is studied. Change of erythrocyte sphericity of 10 healthy subjects was induced by variation of buffer osmolarity to validate applicability of sphericity measures. Agreement between the sphericity indicators was then studied in samples from 20 healthy donors taken at three time points, which were processed through density gradient centrifugation and incubated with FITC-labelled antibodies to induce a broad variation of erythrocyte form (1086 samples). SphI, PCD and kurtosis of FSC distribution were calculated. Correlation of the respective measures, standard error of measurement (SEM) and r ratio (intra- to interindividual variance) were determined to illustrate agreement between the sphericity indicators. In the first study part, all sphericity indicators illustrated change of erythrocyte shape as induced by osmolarity variation. In the second part, correlation between kurtosis and SphI was -0.97 and correlation between kurtosis and PCD was 0.58 (p<0.05). In isotype control samples, correlation between kurtosis and SphI was -0.98 and correlation between kurtosis and PCD was 0.48 (p<0.05). In these samples, mean kurtosis was -0.80 (SEM 0.03), mean SphI was 2.19 (SEM 0.04) and mean PCD was -0.31 (SEM 0.02). r ratios of all measures of sphericity were <0.6. Our results show that kurtosis is closely correlated with SphI in a broad range of erythrocyte FSC distributions. Moreover, all measures of sphericity feature r ratios <0.6, highlighting that erythrocyte sphericity appears as a feasible parameter for individual longitudinal data monitoring.	[Ahlgrim, Christoph; Pottgiesser, Torben; Sander, Thomas; Baumstark, Manfred W.] Univ Freiburg, Med Ctr, Dept Rehabilitat & Prevent Sports Med, Freiburg, Germany; [Schumacher, Yorck Olaf] Aspetar Orthoped & Sports Med Hosp, Doha, Qatar	University of Freiburg; Aspetar Orthopaedic & Sports Medicine Hospital	Ahlgrim, C (corresponding author), Univ Freiburg, Med Ctr, Dept Rehabilitat & Prevent Sports Med, Freiburg, Germany.	christoph.ahlgrim@uniklinik-freiburg.de	Ahlgrim, Christoph/J-6431-2012; Baumstark, Manfred W/F-8432-2012	Ahlgrim, Christoph/0000-0003-3143-5659; Baumstark, Manfred W/0000-0002-5442-1586; Pottgiesser, Torben/0000-0003-4925-8478	German Institute of Sports Science (BISP) [BISP 070303/10-11]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Institute of Sports Science (BISP); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This project was supported with research funds of the German Institute of Sports Science (BISP) on behalf of "Deutscher Bundestag" (Dr. T. Pottgiesser, grant BISP 070303/10-11, www.bisp.de). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing (www.dfg.de, www.uni-freiburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRATOSIN D, 1995, GLYCOCONJUGATE J, V12, P258, DOI 10.1007/BF00731328; DARLINGT.RB, 1970, AM STAT, V24, P19, DOI 10.2307/2681925; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Dimitriadou E, 2008, MISC FUNCTIONS DEPAR; HARRIS EK, 1974, CLIN CHEM, V20, P1535; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; LEGGE DG, 1968, BRIT J HAEMATOL, V14, P323, DOI 10.1111/j.1365-2141.1968.tb01503.x; LINDERKAMP O, 1982, BLOOD, V59, P1121; MATHIEU O, 1978, J ULTRA MOL STRUCT R, V63, P20, DOI 10.1016/S0022-5320(78)80041-0; MULLANEY PF, 1969, REV SCI INSTRUM, V40, P1029, DOI 10.1063/1.1684143; Pearson K, 1905, BIOMETRIKA, V4, P169, DOI 10.1093/biomet/4.1-2.169; Pearson K, 1894, PHILOS T R SOC A, V186, P343, DOI DOI 10.1098/RSTA.1895.0010; Piagnerelli M, 2007, J CLIN PATHOL, V60, P549, DOI 10.1136/jcp.2006.037523; Piagnerelli M, 2003, CRIT CARE MED, V31, P2156, DOI 10.1097/01.CCM.0000079608.00875.14; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pottgiesser T, 2008, TRANSFUSION, V48, P1390, DOI 10.1111/j.1537-2995.2008.01719.x; ROLFESCURL A, 1991, EXP GERONTOL, V26, P327, DOI 10.1016/0531-5565(91)90045-N; Sottas PE, 2011, CLIN CHEM, V57, P969, DOI 10.1373/clinchem.2011.162271; VANDILLA M A, 1964, LA Rep, V127, P197; Yule G., 1950, INTRO THEORY STAT	20	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59862	10.1371/journal.pone.0059862	http://dx.doi.org/10.1371/journal.pone.0059862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555811	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400066
J	Apolinario, D; Brucki, SMD; Ferretti, RED; Farfel, JM; Magaldi, RM; Busse, AL; Jacob, W				Apolinario, Daniel; Dozzi Brucki, Sonia Maria; de Lucena Ferretti, Renata Eloah; Farfel, Jose Marcelo; Magaldi, Regina Miksian; Busse, Alexandre Leopold; Jacob-Filho, Wilson			Estimating Premorbid Cognitive Abilities in Low-Educated Populations	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTELLIGENCE LEVELS; READING-ABILITY; DECLINE; DEMENTIA; RESERVE; NORMS; SCALE; OLDER; PARTICIPATION	Objective: To develop an informant-based instrument that would provide a valid estimate of premorbid cognitive abilities in low-educated populations. Methods: A questionnaire was drafted by focusing on the premorbid period with a 10-year time frame. The initial pool of items was submitted to classical test theory and a factorial analysis. The resulting instrument, named the Premorbid Cognitive Abilities Scale (PCAS), is composed of questions addressing educational attainment, major lifetime occupation, reading abilities, reading habits, writing abilities, calculation abilities, use of widely available technology, and the ability to search for specific information. The validation sample was composed of 132 older Brazilian adults from the following three demographically matched groups: normal cognitive aging (n = 72), mild cognitive impairment (n = 33), and mild dementia (n = 27). The scores of a reading test and a neuropsychological battery were adopted as construct criteria. Post-mortem inter-informant reliability was tested in a sub-study with two relatives from each deceased individual. Results: All items presented good discriminative power, with corrected item-total correlation varying from 0.35 to 0.74. The summed score of the instrument presented high correlation coefficients with global cognitive function (r = 0.73) and reading skills (r = 0.82). Cronbach's alpha was 0.90, showing optimal internal consistency without redundancy. The scores did not decrease across the progressive levels of cognitive impairment, suggesting that the goal of evaluating the premorbid state was achieved. The intraclass correlation coefficient was 0.96, indicating excellent inter-informant reliability. Conclusion: The instrument developed in this study has shown good properties and can be used as a valid estimate of premorbid cognitive abilities in low-educated populations. The applicability of the PCAS, both as an estimate of premorbid intelligence and cognitive reserve, is discussed.	[Apolinario, Daniel; Farfel, Jose Marcelo; Magaldi, Regina Miksian; Busse, Alexandre Leopold; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Dept Internal Med, Div Geriatr, Sao Paulo, Brazil; [Dozzi Brucki, Sonia Maria] Univ Sao Paulo, Sch Med, Dept Neurol, Behav & Cognit Neurol Unit, Sao Paulo, Brazil; [de Lucena Ferretti, Renata Eloah] Univ Sao Paulo, Sch Nursing, Med Surg Nursing Dept, Sao Paulo, Brazil; [de Lucena Ferretti, Renata Eloah; Farfel, Jose Marcelo; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Brazilian Brain Bank Aging Brain Study Grp, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Apolinario, D (corresponding author), Univ Sao Paulo, Sch Med, Dept Internal Med, Div Geriatr, Sao Paulo, Brazil.	daniel.apolinario@usp.br	Busse, Alexandre Leopold/Q-1593-2016; Busse, Alexandre/AAA-3755-2021; Apolinario, Daniel/B-3533-2015; Jacob-Filho, Wilson WJF/H-5837-2012; de Lucena Ferretti-Rebustini, Renata Eloah/C-8126-2012; Apolinario, Daniel/D-2816-2014; Farfel, Jose/C-8936-2012; Brucki, Sonia MD/B-5736-2014; de Lucena Ferretti-Rebustini, Renata Eloah/ABF-5144-2020; Brucki, Sonia/L-4201-2019	de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Apolinario, Daniel/0000-0002-0261-129X; Farfel, Jose/0000-0003-2057-3669; Brucki, Sonia MD/0000-0002-8303-6732; de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Brucki, Sonia/0000-0002-8303-6732				Abrisqueta-Gomez J, 2008, ALZ DIS ASSOC DIS, V22, P72, DOI 10.1097/WAD.0b013e3181665397; Alves L, 2012, ARCH CLIN NEUROPSYCH, V27, P58, DOI 10.1093/arclin/acr103; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Apolinario D, 2012, REV SAUDE PUBL, V46, P702, DOI 10.1590/S0034-89102012005000047; Ardila A, 1998, Appl Neuropsychol, V5, P51; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Barnes DE, 2004, J GERONTOL A-BIOL, V59, P390; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beardsall L, 1997, BRIT J CLIN PSYCHOL, V36, P619, DOI 10.1111/j.2044-8260.1997.tb01266.x; Bielak AAM, 2010, GERONTOLOGY, V56, P507, DOI 10.1159/000264918; Brazilian Association of Research Companies, 2008, BRAZ EC CLASS CRIT; Brucki Sonia Maria Dozzi, 2011, Dement. neuropsychol., V5, P26, DOI 10.1590/S1980-57642011DN05010005; Carlson MC, 2012, J INT NEUROPSYCH SOC, V18, P286, DOI 10.1017/S135561771100169X; Chaves ML, 2009, J GERONTOL B-PSYCHOL, V64, P597, DOI 10.1093/geronb/gbp059; Cockburn J, 2000, J CLIN EXP NEUROPSYC, V22, P508, DOI 10.1076/1380-3395(200008)22:4;1-0;FT508; DeVellis RF, 2006, MED CARE, V44, pS50, DOI 10.1097/01.mlr.0000245426.10853.30; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Farias ST, 2008, NEUROPSYCHOLOGY, V22, P531, DOI 10.1037/0894-4105.22.4.531; Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jefferson AL, 2011, J AM GERIATR SOC, V59, P1403, DOI 10.1111/j.1532-5415.2011.03499.x; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Law R, 1998, INT J GERIATR PSYCH, V13, P727, DOI 10.1002/(SICI)1099-1166(1998100)13:10<727::AID-GPS851>3.0.CO;2-2; Leon I, 2011, REV NEUROLOGIA, V52, P653, DOI 10.33588/rn.5211.2010704; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nucci M, 2012, AGING CLIN EXP RES, V24, P218, DOI 10.3275/7800; OCARROLL RE, 1995, BRIT J PSYCHIAT, V167, P659, DOI 10.1192/bjp.167.5.659; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Rami L, 2011, REV NEUROLOGIA, V52, P195, DOI 10.33588/rn.5204.2010478; Rentz DM, 2004, NEUROPSYCHOLOGY, V18, P38, DOI 10.1037/0894-4105.18.1.38; Schinka JA, 2005, J INT NEUROPSYCH SOC, V11, P108, DOI 10.1017/S1355617705050125; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Teng EL, 2005, ALZ DIS ASSOC DIS, V19, P267, DOI 10.1097/01.wad.0000190805.13126.8e; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yeo RA, 2011, CURR ALZHEIMER RES, V8, P345	39	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60084	10.1371/journal.pone.0060084	http://dx.doi.org/10.1371/journal.pone.0060084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555894	gold, Green Submitted, Green Published			2022-12-27	WOS:000316546400080
J	Bonomi, AG; Soenen, S; Goris, AHC; Westerterp, KR				Bonomi, Alberto G.; Soenen, Stijn; Goris, Annelies H. C.; Westerterp, Klaas R.			Weight-Loss Induced Changes in Physical Activity and Activity Energy Expenditure in Overweight and Obese Subjects before and after Energy Restriction	PLOS ONE			English	Article							DOUBLY-LABELED WATER; RESTING METABOLIC-RATE; BODY-WEIGHT; POSTURE ALLOCATION; PIMA-INDIANS; MOVEMENT; WOMEN; ADOLESCENTS; ACCELEROMETERS; WALKING	Activity energy expenditure (AEE) is the component of daily energy expenditure that is mainly influenced by the amount of physical activity (PA) and by the weight of the body displaced. This study aimed at analyzing the effect of weight loss on PA and AEE. The body weight and PA of 66 overweight and obese subjects were measured at baseline and after 12 weeks of 67% energy restriction. PA was measured using a tri-axial accelerometer for movement registration (Tracmor) and quantified in activity counts. Tracmor recordings were also processed using a classification algorithm to recognize 6 common activity types engaged in during the day. A doubly-labeled water validated equation based on Tracmor output was used to estimate AEE. After weight loss, body weight decreased by 13 +/- 4%, daily activity counts augmented by 9% (95% CI: +2%, +15%), and this increase was weakly associated with the decrease in body weight (R-2=7%; P<0.05). After weight loss subjects were significantly (P<0.05) less sedentary (-26 min/d), and increased the time spent walking (+11 min/d) and bicycling (+4 min/d). However, AEE decreased by 0.6 +/- 0.4 MJ/d after weight loss. On average, a 2-hour/day reduction of sedentary time by increasing ambulatory and generic activities was required to restore baseline levels of AEE. In conclusion, after weight loss PA increased but the related metabolic demand did not offset the reduction in AEE due to the lower body weight. Promoting physical activity according to the extent of weight loss might increase successfulness of weight maintenance.	[Bonomi, Alberto G.; Soenen, Stijn; Westerterp, Klaas R.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Bonomi, Alberto G.] Philips Res, Personal Hlth Solut, Eindhoven, Netherlands; [Goris, Annelies H. C.] Philips Consumer Lifestyle, DirectLife, Amsterdam, Netherlands	Maastricht University; Philips; Philips Research; Philips	Bonomi, AG (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	a.bonomi@maastrichtuniversity.nl		Soenen, Stijn/0000-0002-0196-128X				Assah FK, 2009, OBESITY, V17, P1588, DOI 10.1038/oby.2009.39; Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; Bonomi AG, 2012, INT J OBESITY, V36, P167, DOI 10.1038/ijo.2011.99; Bonomi AG, 2009, J APPL PHYSIOL, V107, P655, DOI 10.1152/japplphysiol.00150.2009; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; Bouten CVC, 1996, J APPL PHYSIOL, V81, P1019, DOI 10.1152/jappl.1996.81.2.1019; CHONG PKK, 1993, DIABETIC MED, V10, P729, DOI 10.1111/j.1464-5491.1993.tb00156.x; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Ekelund U, 2004, AM J CLIN NUTR, V79, P851; Ekelund U, 2002, AM J CLIN NUTR, V76, P935, DOI 10.1093/ajcn/76.5.935; Esparza J, 2000, INT J OBESITY, V24, P55, DOI 10.1038/sj.ijo.0801085; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Harris AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1207, DOI 10.1152/ajpendo.00509.2006; Johannsen DL, 2008, OBESITY, V16, P34, DOI 10.1038/oby.2007.15; Leenders NY, 2006, MED SCI SPORT EXER, V38, P2165, DOI 10.1249/01.mss.0000235883.94357.95; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2000, AM J CLIN NUTR, V72, P1451; Levine JA, 2008, DIABETES, V57, P548, DOI 10.2337/db07-0815; Luke A, 2009, AM J CLIN NUTR, V89, P169, DOI 10.3945/ajcn.2008.26630; Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354; Martinez JA, 1999, PUBLIC HEALTH NUTR, V2, P125, DOI 10.1017/S1368980099000178; MEIJER GAL, 1992, EUR J APPL PHYSIOL O, V65, P525, DOI 10.1007/BF00602359; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Prentice AM, 1996, EUR J CLIN NUTR, V50, P93; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Prentice AM, 1996, INT J OBESITY, V20, P688; RAVUSSIN E, 1985, AM J CLIN NUTR, V41, P753, DOI 10.1093/ajcn/41.4.753; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; Schoeller DA, 2002, INT J OBESITY, V26, P97, DOI 10.1038/sj.ijo.0801851; TAYLOR HL, 1950, SCIENCE, V112, P215, DOI 10.1126/science.112.2904.215; Wang XW, 2008, MED SCI SPORT EXER, V40, P1781, DOI 10.1249/MSS.0b013e31817d8176; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Weinsier RL, 2002, AM J CLIN NUTR, V75, P499, DOI 10.1093/ajcn/75.3.499; Weinsier RL, 1998, AM J MED, V105, P145, DOI 10.1016/S0002-9343(98)00190-9; Westerterp MR, 2008, PHYSIOL BEHAV, V93, P1039, DOI 10.1016/j.physbeh.2008.01.021; ZURLO F, 1992, AM J PHYSIOL, V263, pE296, DOI 10.1152/ajpendo.1992.263.2.E296	41	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59641	10.1371/journal.pone.0059641	http://dx.doi.org/10.1371/journal.pone.0059641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555733	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400052
J	Jiang, XJ; Castelao, JE; Vandenberg, D; Carracedo, A; Redondo, CM; Conti, DV; Cotore, JPP; Potter, JD; Newcomb, PA; Passarelli, MN; Jenkins, MA; Hopper, JL; Gallinger, S; Le Marchand, L; Martinez, ME; Ahnen, DJ; Baron, JA; Lindor, NM; Haile, RW; Gago-Dominguez, M				Jiang, Xuejuan; Esteban Castelao, J.; Vandenberg, David; Carracedo, Angel; Redondo, Carmen M.; Conti, David V.; Paredes Cotore, Jesus P.; Potter, John D.; Newcomb, Polly A.; Passarelli, Michael N.; Jenkins, Mark A.; Hopper, John L.; Gallinger, Steven; Le Marchand, Loic; Martinez, Maria E.; Ahnen, Dennis J.; Baron, John A.; Lindor, Noralane M.; Haile, Robert W.; Gago-Dominguez, Manuela			Genetic Variations in SMAD7 Are Associated with Colorectal Cancer Risk in the Colon Cancer Family Registry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-BETA; TGF-BETA; CANDIDATE GENES; SUSCEPTIBILITY; EXPRESSION; VARIANTS; CELLS; 18Q21; EPIDEMIOLOGY	Background: Recent genome-wide studies identified a risk locus for colorectal cancer at 18q21, which maps to the SMAD7 gene. Our objective was to confirm the association between SMAD7 SNPs and colorectal cancer risk in the multi-center Colon Cancer Family Registry. Materials and Methods: 23 tagging SNPs in the SMAD7 gene were genotyped among 1,592 population-based and 253 clinic-based families. The SNP-colorectal cancer associations were assessed in multivariable conditional logistic regression. Results: Among the population-based families, both SNPs rs12953717 (odds ratio, 1.29; 95% confidence interval, 1.12-1.49), and rs11874392 (odds ratio, 0.80; 95% confidence interval, 0.70-0.92) were associated with risk of colorectal cancer. These associations were similar among the population-and the clinic-based families, though they were significant only among the former. Marginally significant differences in the SNP-colorectal cancer associations were observed by use of nonsteroidal anti-inflammatory drugs, cigarette smoking, body mass index, and history of polyps. Conclusions: SMAD7 SNPs were associated with colorectal cancer risk in the Colon Cancer Family Registry. There was evidence suggesting that the association between rs12953717 and colorectal cancer risk may be modified by factors such as smoking and use of nonsteroidal anti-inflammatory drugs.	[Jiang, Xuejuan; Vandenberg, David; Conti, David V.; Haile, Robert W.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Esteban Castelao, J.; Redondo, Carmen M.] Complejo Hosp Univ Vigo, Oncol & Genet Unit, Serv Galego Saude SERGAS, Vigo, Spain; [Carracedo, Angel; Gago-Dominguez, Manuela] Complejo Hosp Univ Santiago, Genom Med Grp, Galician Fdn Genom Med, Serv Galego Saude SERGAS,Inst Invest Sanitaria Sa, Santiago De Compostela, Spain; [Paredes Cotore, Jesus P.] Univ Hosp Santiago de Compostela, Dept Surg, Santiago De Compostela, Spain; [Potter, John D.; Newcomb, Polly A.; Passarelli, Michael N.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jenkins, Mark A.; Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Gallinger, Steven] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; [Martinez, Maria E.] Univ Calif San Diego, San Diego Moores Canc Ctr, San Diego, CA 92103 USA; [Ahnen, Dennis J.] Denver VA Med Ctr, Denver, CO USA; [Ahnen, Dennis J.] Univ Colorado, Denver, CO 80202 USA; [Baron, John A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA	University of Southern California; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Fred Hutchinson Cancer Center; University of Melbourne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Denver; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Mayo Clinic; Mayo Clinic Phoenix	Gago-Dominguez, M (corresponding author), Complejo Hosp Univ Santiago, Genom Med Grp, Galician Fdn Genom Med, Serv Galego Saude SERGAS,Inst Invest Sanitaria Sa, Santiago De Compostela, Spain.	manuela.gago.dominguez@sergas.es	Gallinger, Steven/E-4575-2013; Jenkins, Mark/P-7803-2015; Gago-Dominguez, Manuela/AAP-6611-2021; Van Den Berg, David J/G-8598-2017; Carracedo, Angel/D-4257-2012	Jenkins, Mark/0000-0002-8964-6160; Van Den Berg, David J/0000-0002-5404-5218; Carracedo, Angel/0000-0003-1085-8986; Castelao, Jose E/0000-0001-7110-1376; Gago, Manuela/0000-0001-6713-4351; Potter, John/0000-0001-5439-1500; Redondo, Carmen M./0000-0003-4971-2861	National Cancer Institute, National Institutes of Health [5R01CA114472-02, RFA CA-95-011]; Australasian Colorectal Cancer Family Registry [U01 CA097735]; University of Southern California Familial Colorectal Neoplasia Collaborative Group [U01 CA074799]; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01 CA074800]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; Seattle Colorectal Cancer Family Registry [U01 CA074794]; University of Hawaii Colorectal Cancer Family Registry [U01 CA074806]; University of California, Irvine Informatics Center [U01 CA078296]; Accion Estrategica de Salud del Instituto de Salud Carlos III [FIS PI12/02125]; FIS Intrasalud [PS09/02368]; Botin Foundation; NATIONAL CANCER INSTITUTE [K05CA152715, U24CA074799, U24CA074794, U24CA074800, U01CA078296, U01CA074783, T32CA009168, U01CA074806, U01CA097735, U01CA074800, U24CA097735, U01CA074799, U01CA074794, K22CA095011, R01CA114472, U24CA074783] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australasian Colorectal Cancer Family Registry; University of Southern California Familial Colorectal Neoplasia Collaborative Group; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies; Ontario Registry for Studies of Familial Colorectal Cancer; Seattle Colorectal Cancer Family Registry; University of Hawaii Colorectal Cancer Family Registry; University of California, Irvine Informatics Center(University of California System); Accion Estrategica de Salud del Instituto de Salud Carlos III; FIS Intrasalud; Botin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health, grant # 5R01CA114472-02 and RFA # CA-95-011 and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s: the Australasian Colorectal Cancer Family Registry (U01 CA097735); the University of Southern California Familial Colorectal Neoplasia Collaborative Group (U01 CA074799); the Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01 CA074800); the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); the Seattle Colorectal Cancer Family Registry (U01 CA074794); the University of Hawaii Colorectal Cancer Family Registry (U01 CA074806); the University of California, Irvine Informatics Center (U01 CA078296); FIS PI12/02125 Accion Estrategica de Salud del Instituto de Salud Carlos III; FIS Intrasalud (PS09/02368); and the Botin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Boulay JL, 2003, INT J CANCER, V104, P446, DOI 10.1002/ijc.10908; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P616, DOI 10.1158/1055-9965.EPI-08-0690; Dixon A, 2007, AM J PHYSIOL-RENAL, V293, pF1678, DOI 10.1152/ajprenal.00079.2007; Edlund CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-174; Ekman M, 2012, MOL BIOL CELL, V23, P2109, DOI 10.1091/mbc.E10-12-1000; Grau AM, 2006, CELL SIGNAL, V18, P1041, DOI 10.1016/j.cellsig.2005.08.021; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Gutierrez-Aguilar R, 2007, DIABETES METAB, V33, P372, DOI 10.1016/j.diabet.2007.06.002; Halder SK, 2005, EXP CELL RES, V307, P231, DOI 10.1016/j.yexcr.2005.03.009; Hill-Kapturczak N, 2000, J BIOL CHEM, V275, P40904, DOI 10.1074/jbc.M006621200; Korchynskyi O, 1999, INT J CANCER, V82, P197, DOI 10.1002/(SICI)1097-0215(19990719)82:2<197::AID-IJC8>3.0.CO;2-V; Lakatos PL, 2007, WORLD J GASTROENTERO, V13, P6134, DOI 10.3748/wjg.13.6134; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P89, DOI 10.1158/1055-9965.EPI-09-0727; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Loh YH, 2011, CANCER EPIDEMIOL, V35, P369, DOI 10.1016/j.canep.2010.09.011; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Niittymaki I, 2010, CANCER EPIDEM BIOMAR, V19, P1478, DOI 10.1158/1055-9965.EPI-09-1320; Passarelli MN, 2011, GENE CHROMOSOME CANC, V50, P875, DOI 10.1002/gcc.20913; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Slattery ML, 2010, CANCER RES, V70, P1479, DOI 10.1158/0008-5472.CAN-08-1792; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Song QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033318; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Thompson CL, 2009, CARCINOGENESIS, V30, P982, DOI 10.1093/carcin/bgp086; Witte JS, 1999, AM J EPIDEMIOL, V149, P693	34	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60464	10.1371/journal.pone.0060464	http://dx.doi.org/10.1371/journal.pone.0060464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560096	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100075
J	Li, X; Yang, GY; Li, XX; Zhang, Y; Yang, JL; Chang, J; Sun, XX; Zhou, XY; Guo, Y; Xu, Y; Liu, JP; Bensoussan, A				Li, Xun; Yang, Guoyan; Li, Xinxue; Zhang, Yan; Yang, Jingli; Chang, Jiu; Sun, Xiaoxuan; Zhou, Xiaoyun; Guo, Yu; Xu, Yue; Liu, Jianping; Bensoussan, Alan			Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese	PLOS ONE			English	Article								Background: Traditional Chinese medicine (TCM) has been widely applied for cancer care in China. There have been a large number of controlled clinical studies published in Chinese literature, yet no systematic searching and analysis has been done. This study summarizes the current evidence of controlled clinical studies of TCM for cancer. Methods: We searched all the controlled clinical studies of TCM therapies for all kinds of cancers published in Chinese in four main Chinese electronic databases from their inception to November 2011. We bibliometrically analyzed the included studies and assessed the reporting quality. Results: A total of 2964 reports (involving 253,434 cancer patients) including 2385 randomized controlled trials and 579 non-randomized controlled studies were included. The top seven cancer types treated were lung cancer, liver cancer, stomach cancer, breast cancer, esophagus cancer, colorectal cancer and nasopharyngeal cancer by both study numbers and case numbers. The majority of studies (72%) applied TCM therapy combined with conventional treatment, whilst fewer (28%) applied only TCM therapy in the experimental groups. Herbal medicine was the most frequently applied TCM therapy (2677 studies, 90.32%). The most frequently reported outcome was clinical symptom improvement (1667 studies, 56.24%) followed by biomarker indices (1270 studies, 42.85%), quality of life (1129 studies, 38.09%), chemo/radiotherapy induced side effects (1094 studies, 36.91%), tumor size (869 studies, 29.32%) and safety (547 studies, 18.45%). Completeness and adequacy of reporting appeared to improve with time. Conclusions: Data from controlled clinical studies of TCM therapies in cancer treatment is substantial, and different therapies are applied either as monotherapy or in combination with conventional medicine. Reporting of controlled clinical studies should be improved based on the CONSORT and TREND Statements in future. Further studies should address the most frequently used TCM therapy for common cancers and outcome measures should address survival, relapse/metastasis and quality of life.	[Li, Xun; Yang, Guoyan; Li, Xinxue; Liu, Jianping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Li, Xun; Bensoussan, Alan] Univ Western Sydney, Ctr Complementary Med Res CompleMED, Sydney, NSW, Australia; [Zhang, Yan; Chang, Jiu; Sun, Xiaoxuan] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China; [Yang, Jingli] Beijing Univ Chinese Med, Sch Management, Beijing, Peoples R China; [Zhou, Xiaoyun; Guo, Yu] Beijing Univ Chinese Med, Sch Acupuncture & Moxibust, Beijing, Peoples R China; [Xu, Yue] Beijing Univ Chinese Med, Sch Humanities, Beijing, Peoples R China	Beijing University of Chinese Medicine; Western Sydney University; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	jianping_l@hotmail.com; a.bensoussan@uws.edu.au	Yang, Guoyan/AAG-7873-2021	Yang, Guoyan/0000-0002-8012-2379; Liu, Jianping/0000-0002-0320-061X; Li, Xun/0000-0002-3513-5904; Bensoussan, Alan/0000-0002-7433-667X	Program for Innovative Research Team of Beijing University of Chinese Medicine [2011-CXTD-09]; Ministry of Science and Technology of China [2011ZX09302-006]; State Administration of Traditional Chinese Medicine [101207007]	Program for Innovative Research Team of Beijing University of Chinese Medicine; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Administration of Traditional Chinese Medicine	This work was supported by Program for Innovative Research Team of Beijing University of Chinese Medicine (No.2011-CXTD-09), and grant number 2011ZX09302-006 from the Ministry of Science and Technology of China and 101207007 from the State Administration of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], ICD 10 VERS 2010; Bao Y H, 1984, Zhong Xi Yi Jie He Za Zhi, V4, P16; Boon Heather S, 2007, BMC Womens Health, V7, P4, DOI 10.1186/1472-6874-7-4; Carmady B, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-22; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Ernst E, 2009, INT J SURG, V7, P499, DOI 10.1016/j.ijsu.2009.08.005; Guo Z, 2012, COCHRANE DATABASE SY; Huang S, 2011, THESIS BEIJING U CHI; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia LB, 2012, CHIN J INTEGR MED, V18, P325, DOI 10.1007/s11655-011-0950-5; Jiang M, 2012, PLANTA MED, V76, P2048; Li LN, 2003, SHANXI CANC ED, V11, P44; Li PW, 2003, MANAGEMENT CANC CHIN; Liu HT, 2009, ZHONG WAI YI XUE WEN, V8, P26; Liu JP, 2011, FORSCH KOMPLEMENTMED, V18, P257, DOI 10.1159/000333065; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Ni YH, 2012, COCHRANE DATABASE SY; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Tang X, 2008, COCHRANE DATABASE SY; Wang LF, 2010, SHANGHAI J TRADITION, V6, P41; Wang TX, 1985, CHINESE J CLIN ONCOL, V2, P144; Wei J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004560.pub2; World Health Organization, 2012, CANC FACT SHEETS; Xie BH, 1985, CHINESE J INTEGRATED, V10, P586; Xu Zhen-ye, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P874; Yang GY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/751046; Yoder Linda H, 2005, Medsurg Nurs, V14, P195; Zhang M, 2007, COCHRANE DATABASE SY; 吴涛, 2004, [中华流行病学杂志, Chinese Journal of Epidemiology], V25, P633	31	138	148	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60338	10.1371/journal.pone.0060338	http://dx.doi.org/10.1371/journal.pone.0060338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560092	gold, Green Published			2022-12-27	WOS:000318840100061
J	Chhabra, S; Barlow, N; Dolezal, O; Hattarki, MK; Newman, J; Peat, TS; Graham, B; Swarbrick, JD				Chhabra, Sandeep; Barlow, Nicholas; Dolezal, Olan; Hattarki, Meghan K.; Newman, Janet; Peat, Thomas S.; Graham, Bim; Swarbrick, James D.			Exploring the Chemical Space around 8-Mercaptoguanine as a Route to New Inhibitors of the Folate Biosynthesis Enzyme HPPK	PLOS ONE			English	Article							COLI 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE; BISUBSTRATE ANALOG INHIBITORS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CONFORMATIONAL TRANSITIONS; DIHYDROPTEROATE SYNTHASE; STAPHYLOCOCCUS-AUREUS; TERNARY COMPLEX; BINDING; TARGET	As the second essential enzyme of the folate biosynthetic pathway, the potential antimicrobial target, HPPK (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase), catalyzes the Mg2+-dependant transfer of pyrophosphate from the cofactor (ATP) to the substrate, 6-hydroxymethyl-7,8-dihydropterin. Recently, we showed that 8-mercaptoguanine (8-MG) bound at the substrate site (K-D similar to 13 mu M), inhibited the S. aureus enzyme (SaHPPK) (IC50 similar to 41 mu M), and determined the structure of the SaHPPK/8-MG complex. Here we present the synthesis of a series of guanine derivatives, together with their HPPK binding affinities, as determined by SPR and ITC analysis. The binding mode of the most potent was investigated using 2D NMR spectroscopy and X-ray crystallography. The results indicate, firstly, that the SH group of 8-MG makes a significant contribution to the free energy of binding. Secondly, direct N-9 substitution, or tautomerization arising from N-7 substitution in some cases, leads to a dramatic reduction in affinity due to loss of a critical N-9-H center dot center dot center dot Val46 hydrogen bond, combined with the limited space available around the N-9 position. The water-filled pocket under the N-7 position is significantly more tolerant of substitution, with a hydroxyl ethyl 8-MG derivative attached to N-7 (compound 21a) exhibiting an affinity for the apo enzyme comparable to the parent compound (K-D similar to 12 mu M). In contrast to 8-MG, however, 21a displays competitive binding with the ATP cofactor, as judged by NMR and SPR analysis. The 1.85 angstrom X-ray structure of the SaHPPK/21a complex confirms that extension from the N-7 position towards the Mg2+-binding site, which affords the only tractable route out from the pterin-binding pocket. Promising strategies for the creation of more potent binders might therefore include the introduction of groups capable of interacting with the Mg2+ centres or Mg2+-binding residues, as well as the development of bitopic inhibitors featuring 8-MG linked to a moiety targeting the ATP cofactor binding site.	[Chhabra, Sandeep; Barlow, Nicholas; Graham, Bim; Swarbrick, James D.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Chhabra, Sandeep; Dolezal, Olan; Hattarki, Meghan K.; Newman, Janet; Peat, Thomas S.] CSIRO, Div Mat Sci & Engn, Parkville, Vic, Australia	Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Swarbrick, JD (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	james.swarbrick@monash.edu	Barlow, Nicholas/W-8442-2019; Chhabra, Sandeep/T-5468-2018; chhabra, sandeep/R-9942-2017; Newman, Janet M/D-1857-2011; Dolezal, Olan/E-1691-2015; Peat, Thomas S/F-9817-2010	Chhabra, Sandeep/0000-0002-5225-1333; Newman, Janet M/0000-0003-2666-3219; Peat, Thomas S/0000-0002-6488-0831; Graham, Bim/0000-0002-1160-7751; DOLEZAL, OLAN/0000-0002-5823-6978; Barlow, Nicholas/0000-0002-5749-3542				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bermingham A, 2000, J BIOL CHEM, V275, P17962, DOI 10.1074/jbc.M000331200; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; Chhabra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029444; Chhabra S, 2010, ACTA CRYSTALLOGR F, V66, P575, DOI 10.1107/S1744309110010857; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Daeyaert F.F.D., 2005, Patent No. [2005028479, WO 2005028479 A3]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcon A, 2006, J MOL BIOL, V360, P644, DOI 10.1016/j.jmb.2006.05.038; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hennig M, 1999, J MOL BIOL, V287, P211, DOI 10.1006/jmbi.1999.2623; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Innovative Medicines Initiative, 2013, antimicrobial resistance programme, Patent No. [156559, EP 156559 A2]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Lescop E, 2009, BIOCHEMISTRY-US, V48, P302, DOI 10.1021/bi8016262; Li GY, 2006, BIOCHEMISTRY-US, V45, P12573, DOI 10.1021/bi061057m; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Li Y, 2002, BIOCHEMISTRY-US, V41, P8777, DOI 10.1021/bi025968h; LONG RA, 1967, J ORG CHEM, V32, P2751, DOI 10.1021/jo01284a024; Madre M, 1999, SYNTHESIS-STUTTGART, P775; Madre M, J CHEM RES S, P226; MICHAEL MA, 1993, J MED CHEM, V36, P3431, DOI 10.1021/jm00074a025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schwender CF, 1985, Eur Pat Appl, Patent No. [WO 2011/035009, 2011035009, EP 156559 A2]; Shi GB, 2000, BBA-PROTEIN STRUCT M, V1478, P289, DOI 10.1016/S0167-4838(00)00043-1; Shi GB, 2001, J MED CHEM, V44, P1364, DOI 10.1021/jm0004493; Shi GB, 2012, BIOORGAN MED CHEM, V20, P4303, DOI 10.1016/j.bmc.2012.05.060; Shi GB, 2012, BIOORGAN MED CHEM, V20, P47, DOI 10.1016/j.bmc.2011.11.032; SRIVASTA.PC, 1970, EXPERIENTIA, V26, P220, DOI 10.1007/BF01895597; Stammers DK, 1999, FEBS LETT, V456, P49, DOI 10.1016/S0014-5793(99)00860-1; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szczepankiewicz BG, 2003, J AM CHEM SOC, V125, P4087, DOI 10.1021/ja0296733; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029434; Wood HCS, 1975, CHEM BIOL PTERIDINES; Xiao B, 1999, STRUCTURE, V7, P489, DOI 10.1016/S0969-2126(99)80065-3; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109; Zhao Y, 2012, CHEMMEDCHEM, V7, P861, DOI 10.1002/cmdc.201200049	41	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59535	10.1371/journal.pone.0059535	http://dx.doi.org/10.1371/journal.pone.0059535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565155	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300023
J	de Magalhaes, MTQ; Barbosa, EA; Prates, MV; Verly, RM; Munhoz, VHO; de Araujo, IE; Bloch, C				de Magalhaes, Mariana T. Q.; Barbosa, Eder A.; Prates, Maura V.; Verly, Rodrigo M.; Munhoz, Victor Hugo O.; de Araujo, Ivan E.; Bloch, Carlos, Jr.			Conformational and Functional Effects Induced by D- and L-Amino Acid Epimerization on a Single Gene Encoded Peptide from the Skin Secretion of Hypsiboas punctatus	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; AMPHIBIAN SKIN; ACHATIN-I; PROTEIN; FROG; BINDING; DERMASEPTINS; UNPALATABILITY; SELECTIVITY; DELTORPHIN	Skin secretion of Hypsiboas punctatus is the source of a complex mixture of bioactive compounds where peptides and small proteins prevail, similarly to many other amphibians. Among dozens of molecules isolated from H. punctatus in a proteomic based approach, we report here the structural and functional studies of a novel peptide named Phenylseptin (FFFDTLKNLAGKVIGALT-NH2) that was purified as two naturally occurring D-and L-Phes configurations. The amino acid epimerization and C-terminal amidation for both molecules were confirmed by a combination of techniques including reverse-phase UFLC, ion mobility mass spectrometry, high resolution MS/MS experiments, Edman degradation, cDNA sequencing and solid-phase peptide synthesis. RMSD analysis of the twenty lowest-energy H-1 NMR structures of each peptide revealed a major 90 degrees difference between the two backbones at the first four N-terminal residues and substantial orientation changes of their respective side chains. These structural divergences were considered to be the primary cause of the in vitro quantitative differences in antimicrobial activities between the two molecules. Finally, both molecules elicited equally aversive reactions in mice when delivered orally, an effect that depended entirely on peripheral gustatory pathways.	[de Magalhaes, Mariana T. Q.; Barbosa, Eder A.; Prates, Maura V.; Bloch, Carlos, Jr.] Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [de Magalhaes, Mariana T. Q.; Barbosa, Eder A.] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Verly, Rodrigo M.; Munhoz, Victor Hugo O.] Univ Fed Minas Gerais, Inst Quim, Belo Horizonte, MG, Brazil; [de Magalhaes, Mariana T. Q.; de Araujo, Ivan E.] John B Pierce Lab, New Haven, CT USA; [de Araujo, Ivan E.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Verly, Rodrigo M.] Univ Fed Vales Jequitinhonha & Mucuri, Dept Quim, Diamantina, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal de Minas Gerais; Yale University; The John B Pierce Laboratory, Inc; Yale University; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Bloch, C (corresponding author), Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil.	cbloch@cenargen.embrapa.br	Barbosa, Eder/AAU-6959-2021; Prates, Maura/S-8399-2019; Bloch, Carlos/S-8375-2019; Verly, Rodrigo/E-7493-2015	Prates, Maura/0000-0002-0206-5890; De Araujo, Ivan/0000-0003-3081-3339; Torquato Quezado de Magalhaes, Mariana/0000-0003-4912-0233; Verly, Rodrigo/0000-0003-0356-6862; Bloch Jr, Carlos/0000-0003-2799-6883; Alves Barbosa, Eder/0000-0002-7613-4414	J.B. Pierce Foundation scholarship; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)	J.B. Pierce Foundation scholarship; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The J.B. Pierce Foundation scholarship and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Amiche M., 1998, EXS, V85, P57; ANDREWS EJ, 1993, J AM VET MED ASSOC, V202, P230; Apponyi MA, 2004, PEPTIDES, V25, P1035, DOI 10.1016/j.peptides.2004.03.006; Auvynet C, 2006, EUR J CELL BIOL, V85, P25, DOI 10.1016/j.ejcb.2005.09.022; BARRA D, 1994, PEPTIDES, V15, P199, DOI 10.1016/0196-9781(94)90002-7; Brand GD, 2006, PEPTIDES, V27, P2137, DOI 10.1016/j.peptides.2006.04.020; Brand GD, 2002, J BIOL CHEM, V277, P49332, DOI 10.1074/jbc.M209289200; Brand GD, 2006, BIOCHEM BIOPH RES CO, V347, P739, DOI 10.1016/j.bbrc.2006.06.168; Brandenburg LO, 2012, POLYMERS-BASEL, V4, P539, DOI 10.3390/polym4010539; Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042; D'Heursel A, 1999, ETHOL ECOL EVOL, V11, P339, DOI 10.1080/08927014.1999.9522818; Darst CR, 2006, NATURE, V440, P208, DOI 10.1038/nature04297; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; DUELLMAN W.E., 1986, BIOL AMPHIBIAN; ERSPAMER V, 1951, NATURE, V167, P1033, DOI 10.1038/1671033a0; ERSPAMER V, 1993, TOXICON, V31, P1099, DOI 10.1016/0041-0101(93)90125-3; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; EVANS G, 1968, J EXP MED, V128, P877, DOI 10.1084/jem.128.5.877; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; GARRETT R, 1995, BIOCHEMISTRY; Gunzburger MS, 2005, J HERPETOL, V39, P547, DOI 10.1670/1-05A.1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; Hicks R. D., 1907, ANIMA; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; ISHIDA T, 1992, INT J PEPT PROT RES, V39, P258; Iwasaki Y, 1981, Kaku Igaku, V18, P601; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; Kim HO, 2006, J AGR FOOD CHEM, V54, P10102, DOI 10.1021/jf062422j; KREIL G, 1989, EUR J PHARMACOL, V162, P123, DOI 10.1016/0014-2999(89)90611-0; KREIL G, 1994, CIBA F SYMP, V186, P77; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Leite JRSA, 2005, PEPTIDES, V26, P565, DOI 10.1016/j.peptides.2004.11.002; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Mangoni ML, 2006, BIOCHEMISTRY-US, V45, P4266, DOI 10.1021/bi052150y; Manteifel YB, 2002, AVOIDANCE NOXIOUS TA; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Min BS, 2006, J VIROL METHODS, V137, P280, DOI 10.1016/j.jviromet.2006.06.028; Minnerup J, 2009, NEUROTHERAPEUTICS, V6, P43, DOI 10.1016/j.nurt.2008.10.032; MONI RW, 1995, CELL MOL NEUROBIOL, V15, P465, DOI 10.1007/BF02071881; MOR A, 1994, J BIOL CHEM, V269, P31635; MORIKAWA N, 1992, BIOCHEM BIOPH RES CO, V189, P184, DOI 10.1016/0006-291X(92)91542-X; Poyurovsky M, 2011, CNS SPECTRUMS, V16, P63, DOI 10.1017/S1092852912000181; Prates MV, 2004, J BIOL CHEM, V279, P13018, DOI 10.1074/jbc.M310838200; ROPER TJ, 1987, ANIM BEHAV, V35, P739, DOI 10.1016/S0003-3472(87)80110-0; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Ruotolo BT, 2005, J AM SOC MASS SPECTR, V16, P158, DOI 10.1016/j.jasms.2004.10.006; Sandercock P, 1997, LANCET, V349, P1569; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Skelhorn J, 2005, BIOL LETT-UK, V1, P500, DOI 10.1098/rsbl.2005.0359; Sneader W, 2000, BRIT MED J, V321, P1591, DOI 10.1136/bmj.321.7276.1591; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	60	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59255	10.1371/journal.pone.0059255	http://dx.doi.org/10.1371/journal.pone.0059255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565145	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300012
J	Vassilev, I; Rogers, A; Blickem, C; Brooks, H; Kapadia, D; Kennedy, A; Sanders, C; Kirk, S; Reeves, D				Vassilev, Ivaylo; Rogers, Anne; Blickem, Christian; Brooks, Helen; Kapadia, Dharmi; Kennedy, Anne; Sanders, Caroline; Kirk, Sue; Reeves, David			Social Networks, the 'Work' and Work Force of Chronic Illness Self-Management: A Survey Analysis of Personal Communities	PLOS ONE			English	Article							LONG-TERM CONDITIONS; BEHAVIOR-CHANGE; EXPERT PATIENTS; CARE; DYNAMICS; SUPPORT; ENGLAND; SPREAD; LIFE; TIES	Self-management support forms a central aspect of chronic Illness management nationally and globally. Evidence for the success of self-management support has mainly focussed on individually-centred outcomes of behavioural change. While it is recognised that social network members play an important role there is currently a gap in knowledge regarding who provides what type of support and under what circumstances. This is relevant for understanding the division of labour and the meeting of needs for those living with a long-term condition. We therefore took a network approach to explore self-management support conceptualising it as types of illness 'work' undertaken within peoples' social networks. 300 people from deprived areas and with chronic illnesses took part in a survey conducted in 2010 in the North West of England. A concentric circles diagram was used as a research tool with which participants identified 2,544 network members who contributed to illness management. The results provide an articulation of how social network members are substantially involved in illness management. Whilst partners and close family make the highest contributions there is evidence of inputs from a wide range of relationships. Network member characteristics (type of relationship, proximity, frequency of contact) impact on the amount of illness work undertaken in peoples' networks. In networks with 'no partner' other people tend to contribute more in the way of illness related work than in networks with a partner. This indicates a degree of substitutability between differently constituted networks, and that the level and type of input by different members of a network might change according to circumstances. A network perspective offers an opportunity to redress the balance of an exclusively individual focus on self-management because it addresses the broader set of contributions and resources available to people in need of chronic illness management and support.	[Vassilev, Ivaylo; Rogers, Anne; Blickem, Christian; Brooks, Helen; Kapadia, Dharmi; Sanders, Caroline; Kirk, Sue; Reeves, David] Univ Manchester, Ctr Primary Care, Inst Populat Hlth, Collaborat Leadership Appl Hlth Res CLAHRC, Manchester, Lancs, England; [Rogers, Anne; Kennedy, Anne] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Kirk, Sue] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England	University of Manchester; University of Southampton; University of Manchester	Vassilev, I (corresponding author), Univ Manchester, Ctr Primary Care, Inst Populat Hlth, Collaborat Leadership Appl Hlth Res CLAHRC, Manchester, Lancs, England.	Ivaylo.vassilev@manchester.ac.uk	Sanders, Caroline/G-8021-2014; Brooks, Helen/N-3849-2018; Reeves, David/H-6203-2014; Brooks, Helen/O-4307-2014	Sanders, Caroline/0000-0002-0539-928X; Brooks, Helen/0000-0002-2157-0200; Reeves, David/0000-0001-6377-6859; Brooks, Helen/0000-0002-2157-0200; Vassilev, Ivaylo/0000-0002-2206-8247; Kirk, Susan/0000-0002-1485-8804	Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Greater Manchester	Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Greater Manchester	This research has been funded by the Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Greater Manchester. CLAHRC Greater Manchester is a partnership between the Greater Manchester NHS Trusts and the University of Manchester and is part of the National Institute for Health Research. The authors are members of the Patient Theme of CLAHRC for Greater Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Altschuler J, 2004, J WOMEN AGING, V16, P143, DOI 10.1300/J074v16n01_10; Bott E., 2014, FAM SOC NETWORK; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Christakis NA., 2010, CONNECTED AMAZING PO; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Conner M., 2005, PREDICTING HLTH BEHA, P1; Corbin J., 1985, QUALITATIVE SOCIOLOG, V8, P224, DOI [10.1007/BF00989485, DOI 10.1007/BF00989485]; Department of Health, 2005, SELF CAR REAL CHOIC; Department of Health, 2009, YOUR HLTH YOUR WAY G; Elder JP, 1999, AM J PREV MED, V17, P275, DOI 10.1016/S0749-3797(99)00094-X; Fiori KL, 2007, J GERONTOL B-PSYCHOL, V62, pP322, DOI 10.1093/geronb/62.6.P322; Flori KL, 2006, J GERONTOL B-PSYCHOL, V61, pP25, DOI 10.1093/geronb/61.1.P25; Gallant MP, 2007, RES AGING, V29, P375, DOI 10.1177/0164027507303169; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hann M, 2008, QUAL LIFE RES, V17, P413, DOI 10.1007/s11136-008-9310-0; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Kendall E, 2007, DISABIL SOC, V22, P129, DOI 10.1080/09687590601141535; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Litwin H, 1997, J Cross Cult Gerontol, V12, P45, DOI 10.1023/A:1006593025061; Litwin H, 2001, GERONTOLOGIST, V41, P516, DOI 10.1093/geront/41.4.516; McMunn A, 2009, AGEING SOC, V29, P765, DOI 10.1017/S0144686X08008350; Pahl R., 2004, CURR SOCIOL, V52, P199, DOI DOI 10.1177/0011392104041808; Parsons T., 1951, SOCIAL SYSTEM; Perry BL, 2012, AM J SOCIOL, V118, P134, DOI 10.1086/666377; Perry BL, 2011, J HEALTH SOC BEHAV, V52, P460, DOI 10.1177/0022146511408913; PESCOSOLIDO BA, 1990, SOCIOL QUART, V31, P337, DOI 10.1111/j.1533-8525.1990.tb00332.x; Pescosolido BA, 2000, AM SOCIOL REV, V65, P52, DOI 10.2307/2657289; PESCOSOLIDO BA, 1992, AM J SOCIOL, V97, P1096, DOI 10.1086/229863; Pescosolido BA, 2006, J HEALTH SOC BEHAV, V47, P189, DOI 10.1177/002214650604700301; Phillipson C., 2001, FAMILY COMMUNITY LIF; Pilgrim J, 2012, CHRONIC ILLNESS; Rogers A, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-56; Rogers A, 2009, INT J HEALTH SERV, V39, P725, DOI 10.2190/HS.39.4.h; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shaw M, 2004, BRIT J GEN PRACT, V54, P899; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Stoller EP, 2003, J AGING HEALTH, V15, P482, DOI 10.1177/0898264303253504; Taylor D, 2007, SOCIOL HEALTH ILL, V29, P27, DOI 10.1111/j.1467-9566.2007.00516.x; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; van der Meer M, 2003, COMP REPORT SOCIAL S; Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338; Webber MP, 2007, SOC SCI MED, V65, P481, DOI 10.1016/j.socscimed.2007.03.030; Wellman B, 1997, SOC NETWORKS, V19, P27, DOI 10.1016/S0378-8733(96)00289-4; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; Wellman B., 2000, COMPLEMENTARY ALTERN, P143; Wenger GC, 1997, AGING MENT HEALTH, V1, P311, DOI 10.1080/13607869757001; World Health Organisation, 2008, HLTH PROM GLOSS	51	110	111	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59723	10.1371/journal.pone.0059723	http://dx.doi.org/10.1371/journal.pone.0059723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565162	Green Published, gold, Green Accepted			2022-12-27	WOS:000317717300031
J	Inoue, S; Ikeuchi, M; Okumura, K; Nakamura, M; Kawakami, C; Ikemoto, T; Kawasaki, M; Tani, T; Ushida, T				Inoue, Shinsuke; Ikeuchi, Masahiko; Okumura, Keiko; Nakamura, Masaya; Kawakami, Chihiro; Ikemoto, Tatsunori; Kawasaki, Motohiro; Tani, Toshikazu; Ushida, Takahiro			Health Survey of Numbness/Pain and Its Associated Factors in Kotohira, Japan	PLOS ONE			English	Article							CERVICAL SPONDYLOTIC MYELOPATHY; CHRONIC PAIN; NEUROPATHIC PAIN; INJURY; PREVALENCE; BACK	We conducted a survey of adults in Kotohira, a town of about 10,000 people located in the Nakatado District of Kagawa Prefecture, Japan. The survey was distributed to 8184 individuals, and effective responses were received from 3863 persons (response rate, 47.2%) during the survey period. Results regarding numbness and pain showed numbness alone in 7.7%, pain alone in 7.2%, both numbness and pain in 6.0%, and neither numbness nor pain in 79.6%. Spine and spinal cord damage was reported present by 5.4%, and absent by 94.6%. Analysis using the Short-Form Health Survey questionnaire, with comparison between subjects reporting both numbness and pain in the extremities and subjects with either numbness or pain alone, showed lower scores for in Short-Form Health Survey subscales (physical functioning, role [ physical, emotional], bodily pain, vitality, and mental health). Subjects with numbness alone generally reported no disability in daily life. In a secondary survey, analysis of neurological findings by specialists identified 6 cases of "pain following spinal cord damage'' in which spinal cord-related pain developed in the hands or feet. This represented 0.15% of the survey population starting from the primary survey.	[Inoue, Shinsuke; Okumura, Keiko; Ikemoto, Tatsunori; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan; [Ikeuchi, Masahiko; Kawasaki, Motohiro; Tani, Toshikazu] Kochi Med Sch, Dept Orthopaed Surg, Nankoku, Kochi, Japan; [Nakamura, Masaya] Keio Univ, Dept Orthopaed Surg, Shinjyuku Ku, Tokyo, Japan; [Kawakami, Chihiro] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Ikemoto, Tatsunori; Kawasaki, Motohiro] Pain Med & Res Informat Ctr, Nankoku, Kochi, Japan	Aichi Medical University; Kochi University; Keio University; Yokohama City University	Ushida, T (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan.	ushidat-koc@umin.ac.jp	Kawasaki, Motohiro/R-3301-2019; Nakamura, Masaya/K-4111-2013; Ikemoto, Tatsunori/E-3839-2018	Kawasaki, Motohiro/0000-0002-9189-4577; Ikemoto, Tatsunori/0000-0002-4521-7639	Japanese Minitry of Health, Labour, and Welfare	Japanese Minitry of Health, Labour, and Welfare	This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Minitry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal N, 2006, HAND CLINIC, V81, P705, DOI 10.1016/S0072-9752(06)80051-5; Bigbee AJ, 2007, EXP NEUROL, V204, P273, DOI 10.1016/j.expneurol.2006.11.003; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; CHANG MH, 1992, ACTA NEUROL SCAND, V86, P622, DOI 10.1111/j.1600-0404.1992.tb05499.x; Chittleborough CR, 2006, QUAL LIFE RES, V15, P687, DOI 10.1007/s11136-005-3570-8; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; Finnerup NB, 2012, CURR PAIN HEADACHE R, P1; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hicks GE, 2008, ARTHRIT RHEUM-ARTHR, V59, P1306, DOI 10.1002/art.24006; Lian B. T., 2006, SMJ Singapore Medical Journal, V47, P1049; Lucchetta M, 2011, NEUROL SCI, V32, P423, DOI 10.1007/s10072-011-0498-3; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Robert R., 2009, Annals of Physical and Rehabilitation Medicine, V52, P194, DOI 10.1016/j.rehab.2008.12.016; SATO A, 1985, NEUROSCI LETT, V53, P15, DOI 10.1016/0304-3940(85)90090-4; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Todor D R, 2000, Neurosurg Focus, V8, pE11; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Vogt MT, 2006, SPINE, V31, P1445, DOI 10.1097/01.brs.0000219875.19688.a6; Weng HR, 2000, NEUROSCIENCE, V101, P393, DOI 10.1016/S0306-4522(00)00368-7; Wieseler J, 2010, J NEUROTRAUM, V27, P1697, DOI 10.1089/neu.2010.1311; Wollaars MM, 2007, CLIN J PAIN, V23, P383, DOI 10.1097/AJP.0b013e31804463e5; Young WF, 2000, AM FAM PHYSICIAN, V62, P1064	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60079	10.1371/journal.pone.0060079	http://dx.doi.org/10.1371/journal.pone.0060079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560069	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900044
J	Meng, HL; Wang, JF; Xiong, ZQ; Xu, F; Zhao, GP; Wang, Y				Meng, Hailin; Wang, Jianfeng; Xiong, Zhiqiang; Xu, Feng; Zhao, Guoping; Wang, Yong			Quantitative Design of Regulatory Elements Based on High-Precision Strength Prediction Using Artificial Neural Network	PLOS ONE			English	Article							RIBOSOME BINDING-SITES; ESCHERICHIA-COLI; PROMOTER STRENGTH; EXPRESSION; SEQUENCE; LIBRARY; MODEL; PARTS	Accurate and controllable regulatory elements such as promoters and ribosome binding sites (RBSs) are indispensable tools to quantitatively regulate gene expression for rational pathway engineering. Therefore, de novo designing regulatory elements is brought back to the forefront of synthetic biology research. Here we developed a quantitative design method for regulatory elements based on strength prediction using artificial neural network (ANN). One hundred mutated Trc promoter & RBS sequences, which were finely characterized with a strength distribution from 0 to 3.559 (relative to the strength of the original sequence which was defined as 1), were used for model training and test. A precise strength prediction model, NET90_19_576, was finally constructed with high regression correlation coefficients of 0.98 for both model training and test. Sixteen artificial elements were in silico designed using this model. All of them were proved to have good consistency between the measured strength and our desired strength. The functional reliability of the designed elements was validated in two different genetic contexts. The designed parts were successfully utilized to improve the expression of BmK1 peptide toxin and fine-tune deoxy-xylulose phosphate pathway in Escherichia coli. Our results demonstrate that the methodology based on ANN model can de novo and quantitatively design regulatory elements with desired strengths, which are of great importance for synthetic biology applications.	[Meng, Hailin; Wang, Jianfeng; Xiong, Zhiqiang; Xu, Feng; Zhao, Guoping; Wang, Yong] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Jianfeng] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; East China University of Science & Technology	Wang, Y (corresponding author), Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	yongwang@sibs.ac.cn		Xiong, Zhi-Qiang/0000-0002-7984-3662; Zhao, Guo-Ping/0000-0002-7621-6620	National Basic Research Program of China ("973'' Program) [2012CB721104]; National High Technology Research and Development Program ("863'' Program) [2012AA02A701]; National Natural Science Foundation of China [31170101, 31100073]; "Technology Innovation Action Plan'' Key Project of Shanghai Science and Technology Commission [10dz1910100]; major Projects of Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-J-12]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); National High Technology Research and Development Program ("863'' Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Technology Innovation Action Plan'' Key Project of Shanghai Science and Technology Commission; major Projects of Knowledge Innovation Program of Chinese Academy of Sciences	This work was supported by the National Basic Research Program of China ("973'' Program, grant no. 2012CB721104), the National High Technology Research and Development Program ("863'' Program, grant no. 2012AA02A701), the National Natural Science Foundation of China (grant no. 31170101 and 31100073), "Technology Innovation Action Plan'' Key Project of Shanghai Science and Technology Commission (grant no. 10dz1910100), and the major Projects of Knowledge Innovation Program of Chinese Academy of Sciences (grant no. KSCX2-EW-J-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Askary A, 2009, GENES GENET SYST, V84, P425, DOI 10.1266/ggs.84.425; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Bourdon J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002157; Boyle PM, 2012, METAB ENG, V14, P223, DOI 10.1016/j.ymben.2011.10.003; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Silva SDE, 2011, GENET MOL BIOL, V34, P353, DOI 10.1590/S1415-47572011000200031; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Dehli Tore, 2012, Subcell Biochem, V64, P181, DOI 10.1007/978-94-007-5055-5_9; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; ERB RJ, 1993, PHARMACEUT RES, V10, P165, DOI 10.1023/A:1018966222807; Fan SZ, 2010, CANCER LETT, V291, P158, DOI 10.1016/j.canlet.2009.10.011; Fu YJ, 2011, BIOTECHNOL LETT, V33, P1309, DOI 10.1007/s10529-011-0587-7; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HORTON PB, 1992, NUCLEIC ACIDS RES, V20, P4331, DOI 10.1093/nar/20.16.4331; Ingham AB, 2007, BIOTECHNOL APPL BIOC, V47, P1, DOI 10.1043/BA20060207; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Kakumani R, 2008, IEEE ENG MED BIO, P1355, DOI 10.1109/IEMBS.2008.4649416; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Kiryu H, 2005, BIOINFORMATICS, V21, P1062, DOI 10.1093/bioinformatics/bti094; Koessler DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S21; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; MAHADEVAN I, 1994, NUCLEIC ACIDS RES, V22, P2158, DOI 10.1093/nar/22.11.2158; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; ONEILL MC, 1992, NUCLEIC ACIDS RES, V20, P3471, DOI 10.1093/nar/20.13.3471; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Qin XL, 2011, APPL ENVIRON MICROB, V77, P3600, DOI 10.1128/AEM.02843-10; Qu W, 2011, COMPUT BIOL MED, V41, P946, DOI 10.1016/j.compbiomed.2011.08.005; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J., 2001, MOL CLONING LAB MANU; Santos K, 2007, VACCINE, V25, P1634, DOI 10.1016/j.vaccine.2006.11.004; Shao JH, 2008, BIOTECHNOL LETT, V30, P23, DOI 10.1007/s10529-007-9499-y; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; STRANEY R, 1994, J BACTERIOL, V176, P5999, DOI 10.1128/jb.176.19.5999-6006.1994; Tegel H, 2011, FEBS J, V278, P729, DOI 10.1111/j.1742-4658.2010.07991.x; Wang JW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-374; Zhu HM, 2006, PROCEEDINGS OF 2006 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P4262	42	29	37	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60288	10.1371/journal.pone.0060288	http://dx.doi.org/10.1371/journal.pone.0060288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560087	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900062
J	Wang, QW; Huang, RP; Yu, B; Cao, F; Wang, HY; Zhang, M; Wang, XH; Zhang, B; Zhou, H; Zhu, ZQ				Wang, Qiuwei; Huang, Ruiping; Yu, Bin; Cao, Fang; Wang, Huiyan; Zhang, Ming; Wang, Xinhong; Zhang, Bin; Zhou, Hong; Zhu, Ziqiang			Higher Fetal Insulin Resistance in Chinese Pregnant Women with Gestational Diabetes Mellitus and Correlation with Maternal Insulin Resistance	PLOS ONE			English	Article							BIRTH-WEIGHT; INTRAUTERINE EXPOSURE; OBESITY; GROWTH; LIPIDS; DETERMINANTS; ENVIRONMENT	Objective: The aim of this study was to determine the effect of gestational diabetes mellitus (GDM) on fetal insulin resistance or beta-cell function in Chinese pregnant women with GDM. Measurements: Maternal fasting blood and venous cord blood samples (reflecting fetal condition) were collected in 65 well-controlled Chinese GDM mothers (only given dietary intervention) and 83 control subjects. The insulin, glucose and proinsulin concentrations of both maternal and cord blood samples were measured, and the homeostasis model assessment of insulin resistance (HOMA-IR) and the proinsulin-to-insulin ratios (an indicator of fetal beta-cell function) were calculated in maternal and cord blood respectively. Results: Both maternal and fetal levels of insulin, proinsulin and HOMA-IR but not proinsulin-to-insulin ratios were significantly higher in the GDM group than in the control group (maternal insulin, 24.8 vs. 15.4 mu U/mL, P = 0.004, proinsulin, 23.3 vs. 16.2 pmol/L, P = 0.005, and HOMA-IR, 5.5 vs. 3.5, P = 0.041, respectively; fetal: insulin, 15.1 vs. 7.9 mu U/mL, P<0.001, proinsulin, 25.8 vs. 15.1 pmol/L, P = 0.015, and HOMA-IR, 2.8 vs. 1.4, P = 0.017, respectively). Fetal HOMA-IR but not proinsulin-to-insulin ratios was significantly correlated to maternal HOMA-IR (r = 0.307, P = 0.019), in the pregnant women with GDM. Conclusions: Fetal insulin resistance was higher in Chinese pregnant women with GDM than control subjects, and correlated with maternal insulin resistance.	[Wang, Qiuwei; Huang, Ruiping; Yu, Bin; Cao, Fang; Wang, Huiyan; Zhang, Ming; Wang, Xinhong; Zhang, Bin; Zhou, Hong; Zhu, Ziqiang] Nanjing Med Univ, Changzhou Women & Children Hlth Hosp, Changzhou, Jiangsu, Peoples R China	Nanjing Medical University	Zhu, ZQ (corresponding author), Nanjing Med Univ, Changzhou Women & Children Hlth Hosp, Changzhou, Jiangsu, Peoples R China.	answercn@163.com	Zhu, Ziqiang/AAT-6345-2021; yu, bin/ABG-6979-2021	Zhu, Ziqiang/0000-0001-9190-9866	Changzhou Health Bureau [ZD201013]; Changzhou Women and Children Health Hospital affiliated to Nanjing Medical University	Changzhou Health Bureau; Changzhou Women and Children Health Hospital affiliated to Nanjing Medical University	This study was supported by funding from the Changzhou Health Bureau (No. ZD201013) and Changzhou Women and Children Health Hospital affiliated to Nanjing Medical University supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Eberle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045361; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Langer O, 2005, AM J OBSTET GYNECOL, V192, P1768, DOI 10.1016/j.ajog.2004.12.049; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meas T, 2010, DIABETES METAB, V36, P11, DOI 10.1016/j.diabet.2009.09.001; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; Ortega FB, 2011, DIABETES, V60, P2295, DOI 10.2337/db10-1670; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Prasad H, 2012, POSTGRAD MED, V124, P21, DOI 10.3810/pgm.2012.01.2514; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Schaefer-Graf UM, 2011, DIABETIC MED, V28, P1053, DOI 10.1111/j.1464-5491.2011.03346.x; Schaefer-Graf UM, 2003, DIABETES CARE, V26, P193, DOI 10.2337/diacare.26.1.193; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5	25	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59845	10.1371/journal.pone.0059845	http://dx.doi.org/10.1371/journal.pone.0059845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560057	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900029
J	Jia, DW; Duan, FF; Peng, PK; Sun, LL; Liu, XJ; Wang, L; Wu, WC; Ruan, YY; Gu, JX				Jia, Dongwei; Duan, Fangfang; Peng, Peike; Sun, Linlin; Liu, Xiaojuan; Wang, Lan; Wu, Weicheng; Ruan, Yuanyuan; Gu, Jianxin			Up-Regulation of RACK1 by TGF-beta 1 Promotes Hepatic Fibrosis in Mice	PLOS ONE			English	Article							LIVER FIBROSIS; STELLATE CELLS; TGF-BETA; KAPPA-B; PROTEIN; GROWTH; ACTIVATION; EXPRESSION; RESOLUTION; CYTOKINES	Liver fibrosis represents the consequences of a sustained wound healing response to chronic liver injury, and activation of quiescent hepatic stellate cells (HSCs) into a myofibroblast-like phenotype is considered as the central event of liver fibrosis. RACK1, the receptor for activated C-kinase 1, is a classical scaffold protein implicated in numerous signaling pathways and cellular processes; however, the role of RACK1 in liver fibrosis is little defined. Herein, we report that RACK1 is up-regulated in activated HSCs in transforming growth factor beta 1 (TGF-beta 1)-dependent manner both in vitro and in vivo, and TGF-beta 1 stimulates the expression of RACK1 through NF-kappa B signaling. Moreover, RACK1 promotes TGF-beta 1 and platelet-derived growth factor (PDGF)-mediated activation of pro-fibrogenic pathways as well as the differentiation, proliferation and migration of HSCs. Depletion of RACK1 suppresses the progression of TAA-induced liver fibrosis in vivo. In addition, the expression of RACK1 in fibrogenic cells also positively correlates well with the stage of liver fibrosis in clinical cases. Our results suggest RACK1 as a downstream target gene of TGF-beta 1 involved in the modulation of liver fibrosis progression in vitro and in vivo, and propose a strategy to target RACK1 for liver fibrosis treatment.	[Jia, Dongwei; Peng, Peike; Sun, Linlin; Liu, Xiaojuan; Wu, Weicheng; Ruan, Yuanyuan; Gu, Jianxin] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Duan, Fangfang; Wang, Lan; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ruan, YY (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	yuanyuanruan@fudan.edu.cn			National Basic Research Program of China (973 Program) [2012CB822104]; State Key Project Specialized for Infectious Diseases of China [2012ZX10002-008, 2012ZX10002-012]; National High-tech R&D Program (863 Program) [2012AA020203]; Shanghai Leading Academic Discipline Project [B110]; National Natural Science Fund [31100977, 31170766, 31010103906, 31000348, 31000600, 31100586]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Project Specialized for Infectious Diseases of China; National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (2012CB822104), the State Key Project Specialized for Infectious Diseases of China (2012ZX10002-008, 2012ZX10002-012), the National High-tech R&D Program (863 Program) (2012AA020203), the Shanghai Leading Academic Discipline Project (B110), the National Natural Science Fund (31100977, 31170766, 31010103906, 31000348, 31000600, 31100586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Al-Reefy S, 2010, ONCOGENE, V29, P5651, DOI 10.1038/onc.2010.291; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bourd-Boittin K, 2008, J BIOL CHEM, V283, P26000, DOI 10.1074/jbc.M709829200; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Choi DS, 2003, MOL PHARMACOL, V64, P1541, DOI 10.1124/mol.64.6.1541; Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547; Deng L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-73; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 1999, SEMIN LIVER DIS, V19, P129, DOI 10.1055/s-2007-1007105; Geerts A, 2001, HEPATOLOGY, V33, P177, DOI 10.1053/jhep.2001.21045; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Inagaki Y, 2012, J GASTROEN HEPATOL, V27, P85, DOI 10.1111/j.1440-1746.2011.07006.x; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Marra F, 1999, HEPATOLOGY, V30, P951, DOI 10.1002/hep.510300406; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Sakata R, 2004, EUR J CLIN INVEST, V34, P129, DOI 10.1111/j.1365-2362.2004.01302.x; THOMAS P, 1992, BIOCHEM BIOPH RES CO, V188, P671, DOI 10.1016/0006-291X(92)91108-3; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Varela-Rey M, 2002, FEBS LETT, V528, P133, DOI 10.1016/S0014-5793(02)03276-3; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	36	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60115	10.1371/journal.pone.0060115	http://dx.doi.org/10.1371/journal.pone.0060115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555900	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900058
J	Pardo, D; Weimerskirch, H; Barbraud, C				Pardo, Deborah; Weimerskirch, Henri; Barbraud, Christophe			When Celibacy Matters: Incorporating Non-Breeders Improves Demographic Parameter Estimates	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; AGE-SPECIFIC SURVIVAL; REPRODUCTIVE-PERFORMANCE; UNOBSERVABLE STATES; POPULATION; SENESCENCE; UNCERTAIN; PRECISION; CLIMATE; SEABIRD	In long-lived species only a fraction of a population breeds at a given time. Non-breeders can represent more than half of adult individuals, calling in doubt the relevance of estimating demographic parameters from the sole breeders. Here we demonstrate the importance of considering observable non-breeders to estimate reliable demographic traits: survival, return, breeding, hatching and fledging probabilities. We study the long-lived quasi-biennial breeding wandering albatross (Diomedea exulans). In this species, the breeding cycle lasts almost a year and birds that succeed a given year tend to skip the next breeding occasion while birds that fail tend to breed again the following year. Most non-breeders remain unobservable at sea, but still a substantial number of observable non-breeders (ONB) was identified on breeding sites. Using multi-state capture-mark-recapture analyses, we used several measures to compare the performance of demographic estimates between models incorporating or ignoring ONB: bias (difference in mean), precision (difference is standard deviation) and accuracy (both differences in mean and standard deviation). Our results highlight that ignoring ONB leads to bias and loss of accuracy on breeding probability and survival estimates. These effects are even stronger when studied in an age-dependent framework. Biases on breeding probabilities and survival increased with age leading to overestimation of survival at old age and thus actuarial senescence and underestimation of reproductive senescence. We believe our study sheds new light on the difficulties of estimating demographic parameters in species/taxa where a significant part of the population does not breed every year. Taking into account ONB appeared important to improve demographic parameter estimates, models of population dynamics and evolutionary conclusions regarding senescence within and across taxa.	[Pardo, Deborah; Weimerskirch, Henri; Barbraud, Christophe] Ctr Etud Biol Chize, Villiers En Bois, France; [Pardo, Deborah] British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Pardo, D (corresponding author), Ctr Etud Biol Chize, Villiers En Bois, France.	deborah.pardo@gmail.com	Barbraud, Christophe/A-5870-2012; Pardo, Deborah/D-6996-2013; Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013	Barbraud, Christophe/0000-0003-0146-212X; Pardo, Deborah/0000-0001-9593-1155; Weimerskirch, Henri/0000-0002-0457-586X; 	Institut Paul Emile Victor, Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE) [109]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Institut Paul Emile Victor, Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work carried out at Possession Island was supported by Institut Paul Emile Victor (program no109), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2010, ECOLOGY, V91, P1598, DOI 10.1890/09-1633.1; Barbraud C, 2012, J ORNITHOL, V152, pS605, DOI 10.1007/s10336-011-0686-1; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; Desprez M, 2011, P ROY SOC B-BIOL SCI, V278, P3060, DOI 10.1098/rspb.2011.0189; Grosbois V, 2003, ECOLOGY, V84, P1225, DOI 10.1890/0012-9658(2003)084[1225:MDWCDD]2.0.CO;2; Hughes GR, 1982, NESTING CYCLES SEA T, P81; Hunter CM, 2009, ENVIRON ECOL STAT SE, V3, P797, DOI 10.1007/978-0-387-78151-8_37; Husting EL, 1965, COPEIA, V3, P352; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; McElligott AG, 2002, P ROY SOC B-BIOL SCI, V269, P1129, DOI 10.1098/rspb.2002.1993; Mills JA, 2008, J ANIM ECOL, V77, P1129, DOI 10.1111/j.1365-2656.2008.01383.x; Naulleau G, 1996, OECOLOGIA, V107, P301, DOI 10.1007/BF00328446; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Weimerskirch H, 1999, ROLE BODY CONDITION, P1178	22	10	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60389	10.1371/journal.pone.0060389	http://dx.doi.org/10.1371/journal.pone.0060389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555965	gold, Green Published, Green Accepted			2022-12-27	WOS:000317263900072
J	Song, C; Pedersen, NL; Reynolds, CA; Sabater-Lleal, M; Kanoni, S; Willenborg, C; Syvanen, AC; Watkins, H; Hamsten, A; Prince, JA; Ingelsson, E				Song, Ci; Pedersen, Nancy L.; Reynolds, Chandra A.; Sabater-Lleal, Maria; Kanoni, Stavroula; Willenborg, Christina; Syvanen, Ann-Christine; Watkins, Hugh; Hamsten, Anders; Prince, Jonathan A.; Ingelsson, Erik		CARDIoGRAMplusC4D Consortium	Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SWEDISH TWIN REGISTRY; ASSOCIATION; POPULATION; CHOLESTEROL; DEMENTIA; HEALTH; LOCI	Background: Circulating lipids levels, as well as several familial lipid metabolism disorders, are strongly associated with initiation and progression of atherosclerosis and incidence of myocardial infarction (MI). Objectives: We hypothesized that genetic variants associated with circulating lipid levels would also be associated with MI incidence, and have tested this in three independent samples. Setting and Subjects: Using age- and sex-adjusted additive genetic models, we analyzed 554 single nucleotide polymorphisms (SNPs) in 41 candidate gene regions proposed to be involved in lipid-related pathways potentially predisposing to incidence of MI in 2,602 participants of the Swedish Twin Register (STR; 57% women). All associations with nominal P<0.01 were further investigated in the Uppsala Longitudinal Study of Adult Men (ULSAM; N = 1,142). Results: In the present study, we report associations of lipid-related SNPs with incident MI in two community-based longitudinal studies with in silico replication in a meta-analysis of genome-wide association studies. Overall, there were 9 SNPs in STR with nominal P-value <0.01 that were successfully genotyped in ULSAM. rs4149313 located in ABCA1 was associated with MI incidence in both longitudinal study samples with nominal significance (hazard ratio, 1.36 and 1.40; P-value, 0.004 and 0.015 in STR and ULSAM, respectively). In silico replication supported the association of rs4149313 with coronary artery disease in an independent meta-analysis including 173,975 individuals of European descent from the CARDIoGRAMplusC4D consortium (odds ratio, 1.03; P-value, 0.048). Conclusions: rs4149313 is one of the few amino acid changing variants in ABCA1 known to associate with reduced cholesterol efflux. Our results are suggestive of a weak association between this variant and the development of atherosclerosis and MI.	[Song, Ci; Pedersen, Nancy L.; Prince, Jonathan A.; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Reynolds, Chandra A.] Univ Calif Riverside, Riverside, CA 92521 USA; [Sabater-Lleal, Maria; Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Kanoni, Stavroula] Wellcome Trust Sanger Inst, Hinxton, England; [Willenborg, Christina] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Willenborg, Christina] Deutsch Zentrum Herz Kreislauf Forsch DZHK, Lubeck, Germany; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Watkins, Hugh] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Hamsten, Anders] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden	Karolinska Institutet; University of California System; University of California Riverside; Karolinska Institutet; Wellcome Trust Sanger Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; German Centre for Cardiovascular Research; Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Ingelsson, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	erik.ingelsson@medsci.uu.se	Lleal, Maria Sabater/I-5832-2013; Willenborg, Christina/D-2668-2012; Meitinger, Thomas/O-1318-2015; Reynolds, Chandra/AAH-2886-2020; Kanoni, Stavroula/AAN-7161-2021	Lleal, Maria Sabater/0000-0002-0128-379X; Willenborg, Christina/0000-0001-5217-6882; Kanoni, Stavroula/0000-0002-1691-9615; Song, Ci/0000-0002-0947-9068; Watkins, Hugh/0000-0002-5287-9016	Swedish Foundation for Strategic Research [ICA08-0047]; Swedish Research Council [2009-2298]; National Institute on Aging [AG 04563, AG10175, AG08861, AG08724, AG028555]; Royal Swedish Academy of Science; Karolinska Institutet Foundation; European Community [LSHM-CT-2007-037273]; AstraZeneca; British Heart Foundation; Wellcome Trust [075491/Z/04]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular Program of Karolinska Institutet; Stockholm County Council; Foundation for Strategic Research; Stockholm County Council [560283]; NATIONAL INSTITUTE ON AGING [R01AG010175, R01AG008724, R01AG004563, R01AG028555, R37AG008861, R01AG008861] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Royal Swedish Academy of Science; Karolinska Institutet Foundation(Karolinska Institutet); European Community(European Commission); AstraZeneca(AstraZeneca); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular Program of Karolinska Institutet; Stockholm County Council(Stockholm County Council); Foundation for Strategic Research; Stockholm County Council(Stockholm County Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	STR and ULSAM were supported by the Swedish Foundation for Strategic Research (ICA08-0047), the Swedish Research Council (2009-2298), National Institute on Aging (AG 04563, AG10175, AG08861, AG08724, AG028555), the Royal Swedish Academy of Science, and Karolinska Institutet Foundation. PROCARDIS was supported by the European Community Sixth Framework Program (LSHM-CT-2007-037273), AstraZeneca, the British Heart Foundation, the Wellcome Trust (075491/Z/04), the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, the Strategic Cardiovascular Program of Karolinska Institutet and Stockholm County Council, the Foundation for Strategic Research and the Stockholm County Council (560283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikovics H, 2006, CEREBROVASC DIS, V21, P254, DOI 10.1159/000091223; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Daniels TF, 2009, INT J BIOL SCI, V5, P474; Deloukas P., 2012, NAT GENET, V45, P25, DOI [10.1038/ng.2480, DOI 10.1038/NG.2480]; Frikke-Schmidt R, 2008, ARTERIOSCL THROM VAS, V28, P180, DOI 10.1161/ATVBAHA.107.153858; Gatz M, 2005, NEUROBIOL AGING, V26, P439, DOI 10.1016/j.neurobiolaging.2004.04.004; Gold CH, 2002, J GERONTOL B-PSYCHOL, V57, pS168, DOI 10.1093/geronb/57.3.S168; Gotto AM, 2012, EXPERT REV CARDIOVAS, V10, P955, DOI [10.1586/ERC.12.82, 10.1586/erc.12.82]; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; PEDERSEN NL, 1984, ACTA GENET MED GEMEL, V33, P243, DOI 10.1017/S0001566000007285; Reynolds CA, 2009, HUM MUTAT, V30, P1348, DOI 10.1002/humu.21076; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	25	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60454	10.1371/journal.pone.0060454	http://dx.doi.org/10.1371/journal.pone.0060454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555974	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900073
J	Sun, BF; Xiao, JH; He, SM; Liu, L; Murphy, RW; Huang, DW				Sun, Bao-Fa; Xiao, Jin-Hua; He, Shunmin; Liu, Li; Murphy, Robert W.; Huang, Da-Wei			Multiple Interkingdom Horizontal Gene Transfers in Pyrenophora and Closely Related Species and Their Contributions to Phytopathogenic Lifestyles	PLOS ONE			English	Article							PLANT PARASITISM; EVOLUTION; PATHWAY; DISEASE; CHROMOSOMES; ACQUISITION; MECHANISMS; EMERGENCE; SELECTION; PROTEINS	Many studies have reported horizontal gene transfer (HGT) events from eukaryotes, especially fungi. However, only a few investigations summarized multiple interkingdom HGTs involving important phytopathogenic species of Pyrenophora and few have investigated the genetic contributions of HGTs to fungi. We investigated HGT events in P. teres and P. tritici-repentis and discovered that both species harbored 14 HGT genes derived from bacteria and plants, including 12 HGT genes that occurred in both species. One gene coding a leucine-rich repeat protein was present in both species of Pyrenophora and it may have been transferred from a host plant. The transfer of genes from a host plant to pathogenic fungi has been reported rarely and we discovered the first evidence for this transfer in phytopathogenic Pyrenophora. Two HGTs in Pyrenophora underwent subsequent duplications. Some HGT genes had homologs in a few other fungi, indicating relatively ancient transfer events. Functional analyses indicated that half of the HGT genes encoded extracellular proteins and these may have facilitated the infection of plants by Pyrenophora via interference with plant defense-response and the degradation of plant cell walls. Some other HGT genes appeared to participate in carbohydrate metabolism. Together, these functions implied that HGTs may have led to highly efficient mechanisms of infection as well as the utilization of host carbohydrates. Evolutionary analyses indicated that HGT genes experienced amelioration, purifying selection, and accelerated evolution. These appeared to constitute adaptations to the background genome of the recipient. The discovery of multiple interkingdom HGTs in Pyrenophora, their significance to infection, and their adaptive evolution, provided valuable insights into the evolutionary significance of interkingdom HGTs from multiple donors.	[Sun, Bao-Fa; Xiao, Jin-Hua; He, Shunmin; Liu, Li; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Sun, Bao-Fa] Univ Chinese Acad Sci, Beijing, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada; [Huang, Da-Wei] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum; Shandong Agricultural University	Huang, DW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw619@gmail.com	He, Shunmin/B-8037-2011	He, Shunmin/0000-0002-7294-0865; Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [31090253, 31210103912, 30900137]; Major Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-2]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]; Natural Sciences and Engineering Research Council (Canada) Discovery Grant [3148]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Innovation Program of Chinese Academy of Sciences; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research; Natural Sciences and Engineering Research Council (Canada) Discovery Grant	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 31090253, 31210103912, 30900137), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2), a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences, National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy, NSFC-J0930004), and the Natural Sciences and Engineering Research Council (Canada) Discovery Grant 3148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Campbell MA, 2012, GENOME BIOL EVOL, V4, P289, DOI 10.1093/gbe/evs011; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; Ellwood SR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r109; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Leisova-Svobodova L, 2010, J PLANT PATHOL, V92, P729; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Mitreva Makedonka, 2009, V532, P517, DOI [10.1007/978-1-60327-853-9_30, 10.1007/978-1-60327-853-9-30]; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Pavlidis P, 2012, MOL BIOL EVOL, V29, P3237, DOI 10.1093/molbev/mss136; Richards TA, 2011, P NATL ACAD SCI USA, V108, P15258, DOI 10.1073/pnas.1105100108; Richards Thomas A., 2011, Fungal Biology Reviews, V25, P98, DOI 10.1016/j.fbr.2011.04.003; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Sanders IR, 2006, TRENDS ECOL EVOL, V21, P656, DOI 10.1016/j.tree.2006.10.006; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Selman M, 2011, CURR BIOL, V21, pR576, DOI 10.1016/j.cub.2011.06.017; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sun GL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-195; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiburcio RA, 2010, J MOL EVOL, V70, P85, DOI 10.1007/s00239-009-9311-9; van der Does HC, 2012, METHODS MOL BIOL, V835, P427, DOI 10.1007/978-1-61779-501-5_26; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wu DD, 2011, GENOMICS, V98, P367, DOI 10.1016/j.ygeno.2011.08.006; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	54	31	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60029	10.1371/journal.pone.0060029	http://dx.doi.org/10.1371/journal.pone.0060029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555871	gold, Green Submitted, Green Published			2022-12-27	WOS:000317263900053
J	Davies, B; Davies, G; Preece, C; Puliyadi, R; Szumska, D; Bhattacharya, S				Davies, Benjamin; Davies, Graham; Preece, Christopher; Puliyadi, Rathi; Szumska, Dorota; Bhattacharya, Shoumo			Site Specific Mutation of the Zic2 Locus by Microinjection of TALEN mRNA in Mouse CD1, C3H and C57BL/6J Oocytes	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; RESTRICTION ENZYMES; GENE; GENOME; EFFICIENT; CELLS; NUCLEASE; KNOCKOUT; RECOGNITION; RESOURCE	Transcription Activator-Like Effector Nucleases (TALENs) consist of a nuclease domain fused to a DNA binding domain which is engineered to bind to any genomic sequence. These chimeric enzymes can be used to introduce a double strand break at a specific genomic site which then can become the substrate for error-prone non-homologous end joining (NHEJ), generating mutations at the site of cleavage. In this report we investigate the feasibility of achieving targeted mutagenesis by microinjection of TALEN mRNA within the mouse oocyte. We achieved high rates of mutagenesis of the mouse Zic2 gene in all backgrounds examined including outbred CD1 and inbred C3H and C57BL/6J. Founder mutant Zic2 mice (eight independent alleles, with frameshift and deletion mutations) were created in C3H and C57BL/6J backgrounds. These mice transmitted the mutant alleles to the progeny with 100% efficiency, allowing the creation of inbred lines. Mutant mice display a curly tail phenotype consistent with Zic2 loss-of-function. The efficiency of site-specific germline mutation in the mouse confirm TALEN mediated mutagenesis in the oocyte to be a viable alternative to conventional gene targeting in embryonic stem cells where simple loss-of-function alleles are required. This technology enables allelic series of mutations to be generated quickly and efficiently in diverse genetic backgrounds and will be a valuable approach to rapidly create mutations in mice already bearing one or more mutant alleles at other genetic loci without the need for lengthy backcrossing.	[Davies, Benjamin; Davies, Graham; Preece, Christopher; Puliyadi, Rathi; Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Davies, Graham; Puliyadi, Rathi; Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Dept Cardiovasc Med, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Davies, B (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	ben.davies@well.ox.ac.uk	Davies, Ben/GYD-9163-2022; Bhattacharya, Shoumo/F-4127-2010	Davies, Ben/0000-0003-3405-507X; Bhattacharya, Shoumo/0000-0002-5571-0478; Szumska, Dorota/0000-0001-7764-9551; Davies, Benjamin/0000-0003-3623-600X	Wellcome Trust [090532/Z/09/Z]; British Heart Foundation [CH/09/003, RG/10/17/28553]; British Heart Foundation [PG/07/045/22690] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust [090532/Z/09/Z] and the British Heart Foundation [CH/09/003 and RG/10/17/28553]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogani D, 2004, GENESIS, V40, P109, DOI 10.1002/gene.20071; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle A, 2012, TRANSGENIC RES, V21, P327, DOI 10.1007/s11248-011-9537-3; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2012, NAT REV MOL CELL BIO; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Meyer M, 2012, P NATL ACAD SCI USA, V109, P9354, DOI 10.1073/pnas.1121203109; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nagai T, 2000, P NATL ACAD SCI USA, V97, P1618, DOI 10.1073/pnas.97.4.1618; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Roessler E, 2009, HUM MUTAT, V30, pE541, DOI 10.1002/humu.20982; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Sun N, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200038; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2012, J GENET GENOMICS, V39, P275, DOI 10.1016/j.jgg.2012.04.004; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259	42	48	57	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60216	10.1371/journal.pone.0060216	http://dx.doi.org/10.1371/journal.pone.0060216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555929	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200098
J	Gu, LL; Li, ZC; Krendelchtchikov, A; Krendelchtchikova, V; Wu, HJ; Matthews, QL				Gu, Linlin; Li, Zan C.; Krendelchtchikov, Alexandre; Krendelchtchikova, Valentina; Wu, Hongju; Matthews, Qiana L.			Using Multivalent Adenoviral Vectors for HIV Vaccination	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELLULAR IMMUNE-RESPONSES; HUMAN-COMPLEMENT INHIBITOR; HUMAN MONOCLONAL-ANTIBODY; PROXIMAL EXTERNAL REGION; PREEXISTING IMMUNITY; GLYCOPROTEIN GP41; RHESUS-MONKEYS; EPITOPE; HEXON	Adenoviral vectors have been used for a variety of vaccine applications including cancer and infectious diseases. Traditionally, Ad-based vaccines are designed to express antigens through transgene expression of a given antigen. For effective vaccine development it is often necessary to express or present multiple antigens to the immune system to elicit an optimal vaccine as observed preclinically with mosaic/polyvalent HIV vaccines or malaria vaccines. Due to the wide flexibility of Ad vectors they are an ideal platform for expressing large amounts of antigen and/or polyvalent mosaic antigens. Ad vectors that display antigens on their capsid surface can elicit a robust humoral immune response, the "antigen capsid-incorporation" strategy. The adenoviral hexon protein has been utilized to display peptides in the majority of vaccine strategies involving capsid incorporation. Based on our abilities to manipulate hexon HVR2 and HVR5, we sought to manipulate HVR1 in the context of HIV antigen display for the first time ever. More importantly, peptide incorporation within HVR1 was utilized in combination with other HVRs, thus creating multivalent vectors. To date this is the first report where dual antigens are displayed within one Ad hexon particle. These vectors utilize HVR1 as an incorporation site for a seven amino acid region of the HIV glycoprotein 41, in combination with six Histidine incorporation within HVR2 or HVR5. Our study illustrates that these multivalent antigen vectors are viable and can present HIV antigen as well as His(6) within one Ad virion particle. Furthermore, mouse immunizations with these vectors demonstrate that these vectors can elicit a HIV and His(6) epitope-specific humoral immune response.	[Gu, Linlin; Li, Zan C.; Krendelchtchikov, Alexandre; Krendelchtchikova, Valentina] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Wu, Hongju] Tulane Univ, Dept Med, Endocrinol Sect, New Orleans, LA 70118 USA; [Wu, Hongju; Matthews, Qiana L.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Tulane University; University of Alabama System; University of Alabama Birmingham	Matthews, QL (corresponding author), Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA.	qlm@uab.edu	Matthews, Qiana/P-9624-2019		National Institutes of Health [5R01AI089337-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant #5R01AI089337-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bayer W, 2010, J VIROL, V84, P1967, DOI 10.1128/JVI.01840-09; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; CROMPTON J, 1994, J GEN VIROL, V75, P133, DOI 10.1099/0022-1317-75-1-133; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kaufman DR, 2012, VACCINE, V30, P506, DOI 10.1016/j.vaccine.2011.11.079; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Matthews QL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-98; McConnell MJ, 2006, J VIROL, V80, P5361, DOI 10.1128/JVI.00256-06; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Palma C, 2011, VACCINE, V29, P1683, DOI 10.1016/j.vaccine.2010.12.040; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Seregin SS, 2010, J INNATE IMMUN, V2, P353, DOI 10.1159/000284368; Shiratsuchi T, 2010, J CLIN INVEST, V120, P3688, DOI 10.1172/JCI39812; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tang YZ, 2008, VIROLOGY, V377, P391, DOI 10.1016/j.virol.2008.04.023; Vigne E, 1999, J VIROL, V73, P5156, DOI 10.1128/JVI.73.6.5156-5161.1999; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Worgall S, 2004, J VIROL, V78, P2572, DOI 10.1128/JVI.78.5.2572-2580.2004; Worgall S, 2007, J VIROL, V81, P13801, DOI 10.1128/JVI.01246-07; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Zhong TH, 2012, ARCH VIROL, V157, P1709, DOI 10.1007/s00705-012-1364-1; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60347	10.1371/journal.pone.0060347	http://dx.doi.org/10.1371/journal.pone.0060347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555957	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200108
J	Voss, B; Bolhuis, H; Fewer, DP; Kopf, M; Moke, F; Haas, F; El-Shehawy, R; Hayes, P; Bergman, B; Sivonen, K; Dittmann, E; Scanlan, DJ; Hagemann, M; Stal, LJ; Hess, WR				Voss, Bjoern; Bolhuis, Henk; Fewer, David P.; Kopf, Matthias; Moeke, Fred; Haas, Fabian; El-Shehawy, Rehab; Hayes, Paul; Bergman, Birgitta; Sivonen, Kaarina; Dittmann, Elke; Scanlan, Dave J.; Hagemann, Martin; Stal, Lucas J.; Hess, Wolfgang R.			Insights into the Physiology and Ecology of the Brackish-Water-Adapted Cyanobacterium Nodularia spumigena CCY9414 Based on a Genome-Transcriptome Analysis	PLOS ONE			English	Article							STRAIN PCC 7120; HETEROCYST-FORMING CYANOBACTERIUM; BALTIC SEA; NITROGEN-FIXATION; SYNECHOCOCCUS-SP; GENE-PRODUCT; PHOSPHONATE UTILIZATION; PSEUDOMONAS-STUTZERI; TREHALOSE METABOLISM; CELL-DIFFERENTIATION	Nodularia spumigena is a filamentous diazotrophic cyanobacterium that dominates the annual late summer cyanobacterial blooms in the Baltic Sea. But N. spumigena also is common in brackish water bodies worldwide, suggesting special adaptation allowing it to thrive at moderate salinities. A draft genome analysis of N. spumigena sp. CCY9414 yielded a single scaffold of 5,462,271 nucleotides in length on which genes for 5,294 proteins were annotated. A subsequent strand-specific transcriptome analysis identified more than 6,000 putative transcriptional start sites (TSS). Orphan TSSs located in intergenic regions led us to predict 764 non-coding RNAs, among them 70 copies of a possible retrotransposon and several potential RNA regulators, some of which are also present in other N2-fixing cyanobacteria. Approximately 4% of the total coding capacity is devoted to the production of secondary metabolites, among them the potent hepatotoxin nodularin, the linear spumigin and the cyclic nodulapeptin. The transcriptional complexity associated with genes involved in nitrogen fixation and heterocyst differentiation is considerably smaller compared to other Nostocales. In contrast, sophisticated systems exist for the uptake and assimilation of iron and phosphorus compounds, for the synthesis of compatible solutes, and for the formation of gas vesicles, required for the active control of buoyancy. Hence, the annotation and interpretation of this sequence provides a vast array of clues into the genomic underpinnings of the physiology of this cyanobacterium and indicates in particular a competitive edge of N. spumigena in nutrient-limited brackish water ecosystems.	[Voss, Bjoern; Kopf, Matthias; Haas, Fabian; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Genet & Expt Bioinformat Grp, D-79106 Freiburg, Germany; [Bolhuis, Henk; Stal, Lucas J.] Royal Netherlands Inst Sea Res, Dept Marine Microbiol, Yerseke, Netherlands; [Fewer, David P.; Sivonen, Kaarina] Univ Helsinki, Viikki Bioctr, Div Microbiol, Helsinki, Finland; [Moeke, Fred; Hagemann, Martin] Univ Rostock, Inst Biosci, D-18055 Rostock, Germany; [El-Shehawy, Rehab] IMDEA Agua, Madrid, Spain; [Hayes, Paul] Univ Portsmouth, Fac Sci, Portsmouth, Hants, England; [Bergman, Birgitta] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Dittmann, Elke] Univ Potsdam, Inst Biochem & Biol, Golm, Germany; [Scanlan, Dave J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Stal, Lucas J.] Univ Amsterdam, Dept Aquat Microbiol, Amsterdam, Netherlands	University of Freiburg; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Helsinki; University of Rostock; University of Portsmouth; Stockholm University; University of Potsdam; University of Warwick; University of Amsterdam	Hess, WR (corresponding author), Univ Freiburg, Fac Biol, Genet & Expt Bioinformat Grp, Hugstetter Str 55, D-79106 Freiburg, Germany.	wolfgang.hess@biologie.uni-freiburg.de	Voß, Björn/C-2275-2009; Scanlan, David J/G-4080-2016; Haas, Fabian/AAP-8976-2020; Dittmann, Elke/B-4742-2018; Bolhuis, Henk/M-6677-2019; Bolhuis, Henk/S-2986-2019; Fewer, David P/A-8704-2008; Bolhuis, Henk/H-8535-2014	Voß, Björn/0000-0002-5377-2800; Scanlan, David J/0000-0003-3093-4245; Haas, Fabian/0000-0002-7711-5282; Dittmann, Elke/0000-0002-7549-7918; Bolhuis, Henk/0000-0002-4772-1898; Fewer, David P/0000-0003-3978-4845; Bolhuis, Henk/0000-0002-4772-1898; El Shehawy, Rehab/0000-0003-4091-0810; Sivonen, Kaarina/0000-0002-2904-0458; Hess, Wolfgang/0000-0002-5340-3423	Gordon and Betty Moore Foundation; EU [311975]; INF (Interdisziplinare Fakultat, Maritime Systeme); DFG (Deutsche Forschungsgemeinschaft); BalticSea2020 Foundation; Baltic Ecosystem Adaptive Management Program; Academy of Finland [118637]; German Research Foundation (DFG); Albert Ludwigs University Freiburg; Natural Environment Research Council [NE/I00985X/1] Funding Source: researchfish; NERC [NE/I00985X/1] Funding Source: UKRI	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); EU(European Commission); INF (Interdisziplinare Fakultat, Maritime Systeme); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); BalticSea2020 Foundation; Baltic Ecosystem Adaptive Management Program; Academy of Finland(Academy of Finland); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the Gordon and Betty Moore Foundation for launching and supporting the Marine Microbiology initiative aiming at a substantial increase in the number of genome sequences of ecologically-relevant marine microorganisms and the EU-project MaCuMBA (Marine Microorganisms: Cultivation Methods for Improving their Biotechnological Applications) (Grant agreement no: 311975) for supporting the final project phase. Work on N. spumigena CCY9414 at Rostock University was supported by a research stipendium for F.M. from the INF (Interdisziplinare Fakultat, Maritime Systeme) and DFG (Deutsche Forschungsgemeinschaft) grant to M.H. Financial support from the BalticSea2020 Foundation and the Baltic Ecosystem Adaptive Management Program (to BB) is acknowledged. The research at the University of Helsinki was funded by the Academy of Finland grant no. 118637 to K.S. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2008, J BACTERIOL, V190, P8171, DOI 10.1128/JB.01011-08; AIBA H, 1994, MOL MICROBIOL, V13, P25, DOI 10.1111/j.1365-2958.1994.tb00399.x; Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, 10.1029/2003EO180001]; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Axmann IM, 2007, GENE, V406, P69, DOI 10.1016/j.gene.2007.06.011; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Balskus EP, 2011, FEMS MICROBIOL ECOL, V77, P322, DOI 10.1111/j.1574-6941.2011.01113.x; Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; Balskus EP, 2008, J AM CHEM SOC, V130, P15260, DOI 10.1021/ja807192u; Bench SR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00261; BINISZKIEWICZ D, 1994, EMBO J, V13, P4629, DOI 10.1002/j.1460-2075.1994.tb06785.x; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Cai YP, 1997, J BACTERIOL, V179, P267, DOI 10.1128/jb.179.1.267-271.1997; Carrasco CD, 2005, J BACTERIOL, V187, P6031, DOI 10.1128/JB.187.17.6031-6038.2005; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cumino AC, 2007, PLANT PHYSIOL, V143, P1385, DOI 10.1104/pp.106.091736; Curatti L, 2002, FEBS LETT, V513, P175, DOI 10.1016/S0014-5793(02)02283-4; Cutter GA, 2001, DEEP-SEA RES PT II, V48, P2895, DOI 10.1016/S0967-0645(01)00023-6; Degerholm J, 2008, MAR ECOL PROG SER, V360, P73, DOI 10.3354/meps07379; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Du Y, 2012, J BACTERIOL, V194, P2297, DOI 10.1128/JB.00119-12; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P1452, DOI 10.1128/AEM.72.2.1452-1458.2006; EDLER L, 1985, OPHELIA, V24, P103, DOI 10.1080/00785236.1985.10426623; Eisenhut M, 2012, J BIOL CHEM, V287, P33153, DOI 10.1074/jbc.M112.391755; Fewer DP, 2009, MOL MICROBIOL, V73, P924, DOI 10.1111/j.1365-2958.2009.06816.x; Fewer DP, 2009, ENVIRON MICROBIOL, V11, P855, DOI 10.1111/j.1462-2920.2008.01806.x; Finsinger K, 2008, ENVIRON MICROBIOL, V10, P460, DOI 10.1111/j.1462-2920.2007.01467.x; Francis G., 1878, NATURE, V18, P11, DOI [10.1038/018011d0, DOI 10.1038/018011D0]; FRIAS JE, 1994, MOL MICROBIOL, V14, P823, DOI 10.1111/j.1365-2958.1994.tb01318.x; Fujii K, 1997, TETRAHEDRON LETT, V38, P5529, DOI 10.1016/S0040-4039(97)01193-3; Fujii K, 1997, TETRAHEDRON LETT, V38, P5525, DOI 10.1016/S0040-4039(97)01192-1; Galmozzi CV, 2010, J BACTERIOL, V192, P4701, DOI 10.1128/JB.00222-10; Gao QJ, 2011, J BACTERIOL, V193, P5923, DOI 10.1128/JB.05730-11; Gaudin C, 2002, NUCLEIC ACIDS RES, V30, P2018, DOI 10.1093/nar/30.9.2018; Geiss U, 2001, FEMS MICROBIOL LETT, V197, P123, DOI 10.1016/S0378-1097(01)00098-2; Gierga G, 2009, RNA BIOL, V6, P222, DOI 10.4161/rna.6.3.8921; Gladyshev EA, 2011, P NATL ACAD SCI USA, V108, P20311, DOI 10.1073/pnas.1100266108; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; GOLDEN JW, 1985, NATURE, V314, P419, DOI 10.1038/314419a0; Gomez-Garcia MR, 2011, ISME J, V5, P141, DOI 10.1038/ismej.2010.96; Guo HT, 2008, MOL CELL, V31, P813, DOI 10.1016/j.molcel.2008.07.022; Hagemann M, 1999, J PLANT PHYSIOL, V155, P424, DOI 10.1016/S0176-1617(99)80126-6; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Hayes PK, 1997, J PHYCOL, V33, P919, DOI 10.1111/j.0022-3646.1997.00919.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Henson BJ, 2005, CURR MICROBIOL, V50, P129, DOI 10.1007/s00284-004-4338-z; Henson BJ, 2011, INT J SYST EVOL MICR, V61, P2938, DOI 10.1099/ijs.0.028340-0; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Higa KC, 2010, MOL MICROBIOL, V77, P562, DOI 10.1111/j.1365-2958.2010.07257.x; Higo A, 2006, MICROBIOL-SGM, V152, P979, DOI 10.1099/mic.0.28583-0; Higo A, 2007, MICROBIOL-SGM, V153, P3685, DOI 10.1099/mic.0.2007/009233-0; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; HUBER AL, 1985, APPL ENVIRON MICROB, V49, P73, DOI 10.1128/AEM.49.1.73-78.1985; HUBER AL, 1984, APPL ENVIRON MICROB, V47, P234, DOI 10.1128/AEM.47.2.234-238.1984; Ionescu D, 2010, J MOL BIOL, V398, P177, DOI 10.1016/j.jmb.2010.03.010; Ishida K, 2007, CHEM BIOL, V14, P565, DOI 10.1016/j.chembiol.2007.04.006; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jonasson S, 2008, FEMS MICROBIOL ECOL, V65, P31, DOI 10.1111/j.1574-6941.2008.00499.x; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Jones KM, 2003, J BACTERIOL, V185, P2306, DOI 10.1128/JB.185.7.2306-2314.2003; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kappes RM, 1999, MOL MICROBIOL, V32, P203, DOI 10.1046/j.1365-2958.1999.01354.x; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kaulmann U, 2002, ANGEW CHEM INT EDIT, V41, P1866, DOI 10.1002/1521-3773(20020603)41:11<1866::AID-ANIE1866>3.0.CO;2-3; Khudyakov I, 1996, J BACTERIOL, V178, P3572, DOI 10.1128/jb.178.12.3572-3577.1996; Kim Y, 2011, P NATL ACAD SCI USA, V108, P10109, DOI 10.1073/pnas.1106840108; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Laamanen MJ, 2001, APPL ENVIRON MICROB, V67, P4638, DOI 10.1128/AEM.67.10.4638-4647.2001; Larsson U, 2001, LIMNOL OCEANOGR, V46, P811, DOI 10.4319/lo.2001.46.4.0811; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Lechno-Yossef S, 2011, J BACTERIOL, V193, P3482, DOI 10.1128/JB.05010-11; Lehtimaki J, 2000, INT J SYST EVOL MICR, V50, P1043, DOI 10.1099/00207713-50-3-1043; Leng XY, 2011, MICROBIOL-SGM, V157, P1886, DOI 10.1099/mic.0.047134-0; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; LIANG J, 1992, P NATL ACAD SCI USA, V89, P5655, DOI 10.1073/pnas.89.12.5655; LIANG JH, 1993, J BACTERIOL, V175, P1697, DOI 10.1128/JB.175.6.1697-1704.1993; Lindberg P, 2000, ARCH MICROBIOL, V174, P129, DOI 10.1007/s002030000186; Liu DA, 2002, J BACTERIOL, V184, P6873, DOI 10.1128/JB.184.24.6873-6881.2002; LUCHT JM, 1994, FEMS MICROBIOL REV, V14, P3, DOI 10.1016/0168-6445(94)90008-6; Lyra C, 2005, INT J SYST EVOL MICR, V55, P555, DOI 10.1099/ijs.0.63288-0; MANN NH, 1994, MOL MICROBIOL, V14, P595, DOI 10.1111/j.1365-2958.1994.tb02192.x; Mao CH, 2009, RNA BIOL, V6, P355, DOI 10.4161/rna.6.4.9172; Martinez A, 2012, ENVIRON MICROBIOL, V14, P1363, DOI 10.1111/j.1462-2920.2011.02612.x; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Metcalf WW, 1998, J BACTERIOL, V180, P5547, DOI 10.1128/JB.180.21.5547-5558.1998; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004; Muro-Pastor AM, 2012, TRENDS MICROBIOL, V20, P548, DOI 10.1016/j.tim.2012.07.005; Muro-Pastor AM, 2002, MOL MICROBIOL, V44, P1377, DOI 10.1046/j.1365-2958.2002.02970.x; NAGARAJA R, 1994, BIOCHIMIE, V76, P1082, DOI 10.1016/0300-9084(94)90034-5; Nausch M, 2008, J MARINE SYST, V71, P99, DOI 10.1016/j.jmarsys.2007.06.004; Nicolaisen K, 2008, J BACTERIOL, V190, P7500, DOI 10.1128/JB.01062-08; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; NIERZWICKIBAUER SA, 1984, P NATL ACAD SCI-BIOL, V81, P5961, DOI 10.1073/pnas.81.19.5961; Orchard ED, 2009, ENVIRON MICROBIOL, V11, P2400, DOI 10.1111/j.1462-2920.2009.01968.x; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; PAERL HW, 1991, APPL ENVIRON MICROB, V57, P3086, DOI 10.1128/AEM.57.11.3086-3092.1991; Philmus B, 2008, CHEMBIOCHEM, V9, P3066, DOI 10.1002/cbic.200800560; Pitt FD, 2010, J BACTERIOL, V192, P3512, DOI 10.1128/JB.00258-10; Pop M, 2004, GENOME RES, V14, P149; Porchia AC, 1996, P NATL ACAD SCI USA, V93, P13600, DOI 10.1073/pnas.93.24.13600; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Rajagopalan R, 2010, J BACTERIOL, V192, P1088, DOI 10.1128/JB.01297-09; RAMASUBRAMANIAN TS, 1994, J BACTERIOL, V176, P1214, DOI 10.1128/jb.176.5.1214-1223.1994; Ramasubramanian TS, 1996, J BACTERIOL, V178, P922, DOI 10.1128/jb.178.3.922-926.1996; RAY JM, 1991, J BACTERIOL, V173, P4297, DOI 10.1128/JB.173.14.4297-4309.1991; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Risser DD, 2008, J BACTERIOL, V190, P7645, DOI 10.1128/JB.01110-08; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Rouhiainen L, 2010, CHEM BIOL, V17, P265, DOI 10.1016/j.chembiol.2010.01.017; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SCHNEIDER GJ, 1991, GENE, V105, P51, DOI 10.1016/0378-1119(91)90513-B; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Sellner KG, 1997, LIMNOL OCEANOGR, V42, P1089, DOI 10.4319/lo.1997.42.5_part_2.1089; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Siguier P, 2012, Methods Mol Biol, V859, P91, DOI 10.1007/978-1-61779-603-6_5; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Simola O, 2012, VET PATHOL, V49, P755, DOI 10.1177/0300985811415703; SIVONEN K, 1989, APPL ENVIRON MICROB, V55, P1990, DOI 10.1128/AEM.55.8.1990-1995.1989; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Stal LJ, 1999, AQUAT MICROB ECOL, V18, P165, DOI 10.3354/ame018165; Stal LJ, 2003, CONT SHELF RES, V23, P1695, DOI 10.1016/j.csr.2003.06.001; Stal LJ, 2009, ENVIRON MICROBIOL, V11, P1632, DOI 10.1111/j.1758-2229.2009.00016.x; Stanley DN, 2013, PLANT PHYSIOL, V161, P824, DOI 10.1104/pp.112.210542; Stevanovic M, 2012, ENVIRON MICROBIOL, V14, P1655, DOI 10.1111/j.1462-2920.2011.02619.x; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Su ZC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-156; Suikkanen S, 2010, DEEP-SEA RES PT II, V57, P199, DOI 10.1016/j.dsr2.2009.09.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; TUMER NE, 1983, NATURE, V306, P337, DOI 10.1038/306337a0; Vahtera E, 2010, AQUAT MICROB ECOL, V60, P43, DOI 10.3354/ame01408; Valladares A, 2004, J BACTERIOL, V186, P7337, DOI 10.1128/JB.186.21.7337-7343.2004; Vintila S, 2007, MICROBIOL-SGM, V153, P3704, DOI 10.1099/mic.0.2007/007849-0; Vintila S, 2011, FEMS MICROBIOL ECOL, V77, P449, DOI 10.1111/j.1574-6941.2011.01127.x; Vintila S, 2010, J ENVIRON MONITOR, V12, P1885, DOI 10.1039/c002863k; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022384; Wang HM, 2012, ASIAN PAC J CANCER P, V13, P613, DOI 10.7314/APJCP.2012.13.2.613; Wang Y, 2005, J BACTERIOL, V187, P8489, DOI 10.1128/JB.187.24.8489-8493.2005; Wanner Barry L., 1994, Biodegradation, V5, P175, DOI 10.1007/BF00696458; White AK, 2004, J BACTERIOL, V186, P4730, DOI 10.1128/JB.186.14.4730-4739.2004; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Wong FCY, 2001, J BACTERIOL, V183, P2654, DOI 10.1128/JB.183.8.2654-2661.2001; XU MQ, 1990, SCIENCE, V250, P1566, DOI 10.1126/science.2125747; Xu XD, 2001, J BACTERIOL, V183, P393, DOI 10.1128/JB.183.1.393-396.2001; Zhang W, 2007, MOL MICROBIOL, V66, P1429, DOI 10.1111/j.1365-2958.2007.05997.x; Zhao MX, 2010, P NATL ACAD SCI USA, V107, P12487, DOI 10.1073/pnas.1001556107; Ziemert N, 2008, ANGEW CHEM INT EDIT, V47, P7756, DOI 10.1002/anie.200802730	163	61	61	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60224	10.1371/journal.pone.0060224	http://dx.doi.org/10.1371/journal.pone.0060224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555932	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200100
J	Worku, AG; Yalew, AW; Afework, MF				Worku, Abebaw Gebeyehu; Yalew, Alemayehu Worku; Afework, Mesganaw Fantahun			Maternal Complications and Women's Behavior in Seeking Care from Skilled Providers in North Gondar, Ethiopia	PLOS ONE			English	Article							HEALTH; SURVIVAL; CONSEQUENCES; MORBIDITY; COUNTRIES; DELIVERY; DEATH	Background: Maternal complications are morbidities suffered during pregnancy through the postpartum period of 42 days. In Ethiopia, little is known about women's experience of complications and their care-seeking behavior. This study attempted to assess experiences related to obstetric complication and seeking assistance from a skilled provider among women who gave birth in the last 12 months preceding the study. Methods: This study was a cross-sectional survey of women who gave birth within one year preceding the study regardless of their delivery place. The study was carried out in six selected districts in North Gondar Zone, Amhara Region. Data was collected house-to-house in 12 selected clusters (kebeles) using a pretested Amharic questionnaire. During the survey, 1,668 women were interviewed. Data entry was done using Epi Info version 3.5.3 and was exported to SPSS for analysis. Logistic regression was applied to control confounders. Results: Out of the total sample, 476 women (28.5%, 95% CI: 26.4%, 30.7%) reported some kind of complication. The most common complications reported were; excessive bleeding and prolonged labor that occurred mostly at the time of delivery and postpartum period. Out of the total women who faced complications, 248 (52.1%, 95% CI: 47.6%, 56.6%) sought assistance from a skilled provider. Inability to judge the severity of morbidities, distance/transport problems, lack of money/cost considerations and use of traditional options at home were the major reasons for not seeking care from skilled providers. Belonging to a wealthier quintile, getting antenatal care from a skilled provider and agreement of a woman in planning for possible complications were significantly associated with seeking assistance from a skilled provider. Conclusion: Nearly half of the women who faced complications did not use skilled providers at the time of obstetric complications. Cognitive, geographic, economic and cultural barriers were involved in not using skilled maternal care.	[Worku, Abebaw Gebeyehu] Univ Gondar, Dept Reprod Hlth, Inst Publ Hlth, Gondar, Ethiopia; [Yalew, Alemayehu Worku] Univ Addis Ababa, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Afework, Mesganaw Fantahun] Univ Addis Ababa, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia	University of Gondar; Addis Ababa University; Addis Ababa University	Worku, AG (corresponding author), Univ Gondar, Dept Reprod Hlth, Inst Publ Hlth, Gondar, Ethiopia.	abebawgebeyehu@yahoo.com		Worku, Abebaw Gebeyehu/0000-0002-1146-3399	Addis Ababa University	Addis Ababa University	This is one part of a PhD study project funded by Addis Ababa University. The university is following whether findings are presented and published. The preliminary findings of this study were presented at school of public health (AAU University). After incorporating important comments, the authors have prepared this part for publication at PLOS ONE. Therefore all the presentation and publication process is the responsibility of the investigators. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ann C, 2009, REV GLOBAL LIT MATER; [Anonymous], 2011, MILL DEV GOALS REP; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell OMR, 1991, MEASURING DETERMINAN; Carlough M, 2005, INT J GYNECOL OBSTET, V89, P200, DOI 10.1016/j.ijgo.2004.12.044; Chowdhury RI, 2007, HEALTH SOC CARE COMM, V15, P254, DOI 10.1111/j.1365-2524.2006.00681.x; CSAEthiopia ICFinternational, 2012, ETH DEM HLTH SURV 20; Deribe K, 2010, ETHIOP J HEALTH SCI, V20, P71; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Hiluf M, 2007, ETHIOP J HEALTH DEV, V22, P14; Iyengar K, 2012, J HEALTH POPUL NUTR, V30, P226; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Mahabub-Ul-Anwar Md, 2006, Int Q Community Health Educ, V27, P281, DOI 10.2190/IQ.27.4.b; Nigussie M, 2004, ETHIOP J HEATH DEV, V18, P145; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Roost M, 2010, ACTA OBSTET GYN SCAN, V89, P335, DOI 10.3109/00016340903511050; Rossi AC, 2012, ARCH GYNECOL OBSTET, V285, P1499, DOI 10.1007/s00404-012-2301-y; UNICEF, 1997, GUID MON AV US OBST, P103; Warren C, 2010, ETHIOP J HEALTH DEV, V24, P100; White Kari, 2006, Health Care Women Int, V27, P822, DOI 10.1080/07399330600880384; WHO, 2006, STAND MAT NEON CAR B; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	29	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60171	10.1371/journal.pone.0060171	http://dx.doi.org/10.1371/journal.pone.0060171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555915	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200092
J	Christensen, J; Bentz, S; Sengstag, T; Shastri, VP; Anderle, P				Christensen, Jon; Bentz, Susanne; Sengstag, Thierry; Shastri, V. Prasad; Anderle, Pascale			FOXQ1, a Novel Target of the Wnt Pathway and a New Marker for Activation of Wnt Signaling in Solid Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; GENE-EXPRESSION; SELF-RENEWAL; CELLS; TRANSCRIPTION; COLON; DIFFERENTIATION; ADENOCARCINOMA; METASTASIS	Background: The forkhead box transcription factor FOXQ1 has been shown to be upregulated in colorectal cancer (CRC) and metastatic breast cancer and involved in tumor development, epithelial-mesenchymal transition and chemoresistance. Yet, its transcriptional regulation is still unknown. Methods: FOXQ1 mRNA and protein expression were analysed in a panel of CRC cell lines, and laser micro-dissected human biopsy samples by qRT-PCR, microarray GeneChip (R) U133 Plus 2.0 and western blots. FOXQ1 regulation was assayed by chromatin immunoprecipitation and luciferase reporter assays. Results: FOXQ1 was robustly induced in CRC compared to other tumors, but had no predictive value with regards to grade, metastasis and survival in CRC. Prototype-based gene coexpression and gene set enrichment analysis showed a significant association between FOXQ1 and the Wnt pathway in tumors and cancer cell lines from different tissues. In vitro experiments confirmed, on a molecular level, FOXQ1 as a direct Wnt target. Analysis of known Wnt targets identified FOXQ1 as the most suitable marker for canonical Wnt activation across a wide panel of cell lines derived from different tissues. Conclusions: Our data show that FOXQ1 is one of the most over-expressed genes in CRC and a direct target of the canonical Wnt pathway. It is a potential new marker for detection of early CRC and Wnt activation in tumors of different origins.	[Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, Inst Macro Mol Chem, D-79106 Freiburg, Germany; [Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Bentz, Susanne; Anderle, Pascale] Univ Bern, Inst Biochem & Mol Med, Swiss Natl Ctr Competence Res TransCure, Bern, Switzerland; [Sengstag, Thierry; Anderle, Pascale] RIKEN Yokohama Inst, OSC Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Anderle, Pascale] Swiss Natl Ctr Competence Res Mol Oncol, Lausanne, Switzerland; [Anderle, Pascale] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, Lausanne, Switzerland; [Anderle, Pascale] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Freiburg; University of Freiburg; University of Bern; RIKEN; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Christensen, J (corresponding author), Univ Freiburg, Inst Macro Mol Chem, Hugstetter Str 55, D-79106 Freiburg, Germany.	jon.christensen@makro.uni-freiburg.de; pascale.anderle@ibmm.unibe.ch		Sengstag, Thierry/0000-0002-7516-6246	project Liintop [LSH-2005-1.2.3-4, 037499]; Swiss National Science Foundation (SNSF) through the National Center of Competence in Research (NCCR) TransCure and Fondazione San Salvatore; German Federal and State Governments [EXC 294]	project Liintop; Swiss National Science Foundation (SNSF) through the National Center of Competence in Research (NCCR) TransCure and Fondazione San Salvatore; German Federal and State Governments	This research was supported by the 6th Framework programme, LSH-2005-1.2.3-4 through project Liintop (037499), the Swiss National Science Foundation (SNSF) through the National Center of Competence in Research (NCCR) TransCure and Fondazione San Salvatore, the excellence initiative of the German Federal and State Governments grant EXC 294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Candidus S, 1996, CANCER RES, V56, P49; Christensen J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-274; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Frank S, 1998, DNA CELL BIOL, V17, P679, DOI 10.1089/dna.1998.17.679; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Goering W, 2008, CYTOGENET GENOME RES, V121, P88, DOI 10.1159/000125833; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heiser PW, 2008, GASTROENTEROLOGY, V135, P1288, DOI 10.1053/j.gastro.2008.06.089; Hong HK, 2001, GENESIS, V29, P163, DOI 10.1002/gene.1020; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Polakis P, 2000, GENE DEV, V14, P1837; Qiao Y, 2011, CANC RES; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Schug J., 2008, CURR PROTOC BIOINFOR, V21, DOI DOI 10.1002/0471250953.BI0206S21; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Wetering M, 2001, CANCER RES, V61, P278; Verzi MP, 2008, GASTROENTEROLOGY, V135, P591, DOI 10.1053/j.gastro.2008.04.019; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	40	47	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60051	10.1371/journal.pone.0060051	http://dx.doi.org/10.1371/journal.pone.0060051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555880	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500114
J	Field, DJ; D'Alba, L; Vinther, J; Webb, SM; Gearty, W; Shawkey, MD				Field, Daniel J.; D'Alba, Liliana; Vinther, Jakob; Webb, Samuel M.; Gearty, William; Shawkey, Matthew D.			Melanin Concentration Gradients in Modern and Fossil Feathers	PLOS ONE			English	Article							EUMELANIN PIGMENT; PLUMAGE; COLOR; TESTOSTERONE; EVOLUTION; GROWTH; METALS; FEMALE; TRAIT; SEX	In birds and feathered non-avian dinosaurs, within-feather pigmentation patterns range from discrete spots and stripes to more subtle patterns, but the latter remain largely unstudied. A,55 million year old fossil contour feather with a dark distal tip grading into a lighter base was recovered from the Fur Formation in Denmark. SEM and synchrotron-based trace metal mapping confirmed that this gradient was caused by differential concentration of melanin. To assess the potential ecological and phylogenetic prevalence of this pattern, we evaluated 321 modern samples from 18 orders within Aves. We observed that the pattern was found most frequently in distantly related groups that share aquatic ecologies (e. g. waterfowl Anseriformes, penguins Sphenisciformes), suggesting a potential adaptive function with ancient origins.	[Field, Daniel J.; Vinther, Jakob; Gearty, William] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Vinther, Jakob] Univ Bristol, Dept Earth, Bristol, Avon, England; [Vinther, Jakob] Univ Bristol, Dept Biol Sci, Bristol, Avon, England; [Webb, Samuel M.] Stanford Linear Accelerator Ctr, Menlo Pk, CA USA	Yale University; University System of Ohio; University of Akron; University System of Ohio; University of Akron; University of Bristol; University of Bristol; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Field, DJ (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	daniel.field@yale.edu	Gearty, William/L-4418-2019; D'Alba, Liliana/AAC-4969-2022; Vinther, Jakob/GZG-4679-2022; Webb, Samuel M/D-4778-2009	Gearty, William/0000-0003-0076-3262; D'Alba, Liliana/0000-0002-2478-3455; Webb, Samuel M/0000-0003-1188-0464; Vinther, Jakob/0000-0002-3584-9616; Field, Daniel/0000-0002-1786-0352; Shawkey, Matthew/0000-0002-5131-8209	NSERC CGS; Sir James Lougheed Award of Distinction; AFOSR [FA9550-09-1-0159]; HFSP [RGY0083]	NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sir James Lougheed Award of Distinction; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); HFSP(Human Frontier Science Program)	This work was funded by a NSERC CGS, and a Sir James Lougheed Award of Distinction (both to D.J.F.), and AFOSR grant FA9550-09-1-0159 and HFSP grant RGY0083 (both to M.D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONSER RHC, 1995, CONDOR, V97, P590, DOI 10.2307/1369048; Bortolotti GR, 2006, ANIM BEHAV, V72, P423, DOI 10.1016/j.anbehav.2006.01.016; Carney RM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1642; Church JS, 2010, VIB SPECTROSC, V53, P107, DOI 10.1016/j.vibspec.2010.02.011; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; Dawson C, 1999, J THEOR BIOL, V199, P291, DOI 10.1006/jtbi.1999.0959; Fargallo JA, 2007, J ANIM ECOL, V76, P201, DOI 10.1111/j.1365-2656.2006.01193.x; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Glass K, 2012, P NATL ACAD SCI USA, V109, P10218, DOI 10.1073/pnas.1118448109; GROOTHUIS T, 1992, ANIM BEHAV, V43, P189, DOI 10.1016/S0003-3472(05)80215-5; Gunderson AR, 2008, J AVIAN BIOL, V39, P539, DOI 10.1111/j.0908-8857.2008.04413.x; Haywood RM, 2008, PHOTOCHEM PHOTOBIOL, V84, P572, DOI 10.1111/j.1751-1097.2008.00343.x; Hill G.E., 2010, NATL GEOGRAPHIC BIRD; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lloyd-Jones O, 1915, J EXP ZOOL, V18, P453, DOI 10.1002/jez.1400180304; Lucas A., 1972, AVIAN ANATOMY INTEGU; Mayaud N, 1950, TRAITE ZOOLOGIE OISE, P4; McGhee GR, 2011, VIENNA SER THEOR BIO, P1; McGraw KJ, 2003, OIKOS, V102, P402; McGraw KJ, 2006, BIRD COLORATION, V1, P295; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Muza MM, 2000, WILSON BULL, V112, P432, DOI 10.1676/0043-5643(2000)112[0432:DOBOFO]2.0.CO;2; PEDERSEN G K, 1983, Bulletin of the Geological Society of Denmark, V32, P43; Piault R, 2012, NATURWISSENSCHAFTEN, V99, P391, DOI 10.1007/s00114-012-0914-4; Premovic PI, 1999, J SERB CHEM SOC, V64, P349; Prum RO, 2003, J EXP ZOOL PART B, V298B, P73, DOI 10.1002/jez.b.00027; Prum RO, 2002, P ROY SOC B-BIOL SCI, V269, P781, DOI 10.1098/rspb.2001.1896; Py I, 2006, EVOL ECOL RES, V8, P483; Ros AFH, 1999, IBIS, V141, P451, DOI 10.1111/j.1474-919X.1999.tb04414.x; Roulin A, 1998, EVOLUTION, V52, P1451, DOI 10.1111/j.1558-5646.1998.tb02026.x; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748	33	30	30	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59451	10.1371/journal.pone.0059451	http://dx.doi.org/10.1371/journal.pone.0059451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555675	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500041
J	Sakamoto, T; Endo, S				Sakamoto, Toshiro; Endo, Shogo			Deep Cerebellar Nuclei Play an Important Role in Two-Tone Discrimination on Delay Eyeblink Conditioning in C57BL/6 Mice	PLOS ONE			English	Article							PURKINJE-CELL DEGENERATION; POSITRON-EMISSION-TOMOGRAPHY; MOUSE MODEL SYSTEM; PCD MUTANT MICE; EYELID RESPONSES; BRAIN ACTIVITY; CORTEX; MOTOR; EXPLORATION; ACQUISITION	Previous studies have shown that deep cerebellar nuclei (DCN)-lesioned mice develop conditioned responses (CR) on delay eyeblink conditioning when a salient tone conditioned stimulus (CS) is used, which suggests that the cerebellum potentially plays a role in more complicated cognitive functions. In the present study, we examined the role of DCN in tone frequency discrimination in the delay eyeblink-conditioning paradigm. In the first experiment, DCN-lesioned and sham-operated mice were subjected to standard simple eyeblink conditioning under low-frequency tone CS (LCS: 1 kHz, 80 dB) or highfrequency tone CS (HCS: 10 kHz, 70 dB) conditions. DCN-lesioned mice developed CR in both CS conditions as well as shamoperated mice. In the second experiment, DCN-lesioned and sham-operated mice were subjected to two-tone discrimination tasks, with LCS+ (or HCS+) paired with unconditioned stimulus (US), and HCS- (or LCS-) without US. CR% in sham-operated mice increased in LCS+ (or HCS+) trials, regardless of tone frequency of CS, but not in HCS- (or LCS-) trials. The results indicate that sham-operated mice can discriminate between LCS+ and HCS- (or HCS+ and LCS-). In contrast, DCN-lesioned mice showed high CR% in not only LCS+ (or HCS+) trials but also HCS- (or LCS-) trials. The results indicate that DCN lesions impair the discrimination between tone frequency in eyeblink conditioning. Our results suggest that the cerebellum plays a pivotal role in the discrimination of tone frequency.	[Sakamoto, Toshiro] Univ Tsukuba, Lab Behav Neuroendocrinol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Sakamoto, Toshiro] Kyoto Tachibana Univ, Dept Psychol, Fac Hlth Sci, Yamashina Ku, Kyoto, Japan; [Endo, Shogo] Tokyo Metropolitan Inst Gerontol, Aging Regulat Res Team, Itabashi Ku, Tokyo, Japan	University of Tsukuba; Kyoto Tachibana University; Tokyo Metropolitan Institute of Gerontology	Sakamoto, T (corresponding author), Univ Tsukuba, Lab Behav Neuroendocrinol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.	sakamoto-t@tachibana-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21530781]; Niato Foundation; Japan Foundation for Aging and Health	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Niato Foundation; Japan Foundation for Aging and Health	This work was supported, in part, by a Grant-in-Aid for Scientific Research (Scientific Research C: No, 21530781) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Niato Foundation, and Japan Foundation for Aging and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; BERGER TW, 1983, BEHAV BRAIN RES, V8, P49, DOI 10.1016/0166-4328(83)90171-7; Boele HJ, 2010, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.019.2009; Callu D, 2009, NEUROBIOL LEARN MEM, V91, P250, DOI 10.1016/j.nlm.2008.12.002; Chen L, 1996, J NEUROSCI, V16, P2829; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Fischer H, 2000, BEHAV NEUROSCI, V114, P671, DOI 10.1037//0735-7044.114.4.671; Fortier CB, 2008, NEUROPSYCHOLOGY, V22, P196, DOI 10.1037/0894-4105.22.2.196; Freeman JH, 2005, J NEUROSCI, V25, P889, DOI 10.1523/JNEUROSCI.4534-04.2005; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; GOODLETT CR, 1992, BEHAV BRAIN RES, V47, P129, DOI 10.1016/S0166-4328(05)80119-6; GOULD TJ, 1994, BRAIN RES, V652, P98, DOI 10.1016/0006-8993(94)90322-0; Green JT, 2000, PSYCHOL BULL, V126, P138, DOI 10.1037/0033-2909.126.1.138; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Ito M., 2011, CEREBELLUM BRAIN IMP; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koay G, 2002, HEARING RES, V171, P111, DOI 10.1016/S0378-5955(02)00492-6; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Lalonde R, 2003, CEREBELLUM, V2, P300, DOI 10.1080/14734220310017456; Lalonde R, 2003, BEHAV GENET, V33, P59, DOI 10.1023/A:1021003600900; LALONDE R, 1987, J NEUROGENET, V4, P285, DOI 10.3109/01677068709102349; Martin LA, 2004, GENES BRAIN BEHAV, V3, P158, DOI 10.1111/j.1601-183x.2004.00067.x; Martin LA, 2003, EUR J NEUROSCI, V18, P2002, DOI 10.1046/j.1460-9568.2003.02921.x; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Miller DP, 1997, BEHAV NEUROSCI, V111, P70; Molinari M, 1997, EUR J NEUROSCI, V9, P1986, DOI 10.1111/j.1460-9568.1997.tb00766.x; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; Ono K, 2006, EUR J NEUROSCI, V23, P1623, DOI 10.1111/j.1460-9568.2006.04695.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Petacchi A, 2011, HEARING RES, V282, P35, DOI 10.1016/j.heares.2011.09.008; Petrosini L, 1996, EUR J NEUROSCI, V8, P1882, DOI 10.1111/j.1460-9568.1996.tb01332.x; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Sakamoto T, 2008, BRAIN RES, V1230, P125, DOI 10.1016/j.brainres.2008.06.079; Sakamoto T, 2010, EUR J NEUROSCI, V32, P1537, DOI 10.1111/j.1460-9568.2010.07406.x; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Voogd J., 2004, RAT NERVOUS SYSTEM, V3rd, P205; Wada N, 2007, P NATL ACAD SCI USA, V104, P16690, DOI 10.1073/pnas.0708165104; Warr W.B., 1992, Springer Handbook of Auditory Research, V1, P410	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59880	10.1371/journal.pone.0059880	http://dx.doi.org/10.1371/journal.pone.0059880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555821	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500101
J	Wei, X; Chen, X; Wang, X; Zheng, WW; Zhang, D; Tian, DJ; Jiang, SH; Ong, CN; He, GS; Qu, WD				Wei, Xiao; Chen, Xin; Wang, Xia; Zheng, Weiwei; Zhang, Dong; Tian, Dajun; Jiang, Songhui; Ong, Choon Nam; He, Gengsheng; Qu, Weidong			Occurrence of Regulated and Emerging Iodinated DBPs in the Shanghai Drinking Water	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; MAMMALIAN-CELL CYTOTOXICITY; HALOACETIC ACIDS; HYPOIODOUS ACID; CHLORINATION; IODIDE; TRIHALOMETHANES; GENOTOXICITY; OXIDATION; TOXICITY	Drinking water chlorination plays a pivotal role in preventing pathogen contamination against water-borne disease. However, chemical disinfection leads to the formation of halogenated disinfection by products (DBPs). Many DBPs are highly toxic and are of health concern. In this study, we conducted a comprehensive measurements of DBPs, including iodoacetic acid (IAA), iodoform (IF), nine haloacetic acids and four trihalomethanes in drinking waters from 13 water plants in Shanghai, China. The results suggested that IAA and IF were found in all the water treatment plants, with maximum levels of 1.66 mu g/L and 1.25 mu g/L for IAA and IF, respectively. Owing to deterioration of water quality, the Huangpu River has higher IAA and IF than the Yangtze River. Our results also demonstrated that low pH, high natural organic matter, ammonia nitrogen, and iodide in source waters increased IAA and IF formation. Compared to chlorine, chloramines resulted in higher concentration of iodinated DBP, but reduced the levels of trihalomethanes. This is the first study to reveal the widespread occurrence of IAA and IF in drinking water in China. The data provide a better understanding on the formation of iodinated disinfection byproducts and the findings should be useful for treatment process improvement and disinfection byproducts controls.	[Wei, Xiao; Chen, Xin; Wang, Xia; Zheng, Weiwei; Tian, Dajun; Jiang, Songhui; Qu, Weidong] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Minist Educ,Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Wei, Xiao] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Nanning, Guangxi, Peoples R China; [Zhang, Dong] Natl Engn Res Ctr Urban Water Resource South, Shanghai, Peoples R China; [Ong, Choon Nam] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore; [He, Gengsheng] Fudan Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Minist Educ,Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China	Fudan University; Guangxi Medical University; National University of Singapore; Fudan University	He, GS (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Minist Educ,Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	gshe@shmu.edu.cn; wdqu@fudan.edu.cn		Tian, Dajun/0000-0001-8147-8564; Ong, Choon Nam/0000-0002-4002-1725	National Science Foundation [30972438]; National Key Technology R&D Program in the 11th Five-Year Plan [2006BAI19B02]; National High-Technology RD Program [2008AA062501-2, 2008ZX07421-004, 2013AA061804]; Shanghai Municipal Health Bureau Leading Academic Discipline Project [08GWD14]; Non-Profit Foundation of National Health Ministry in the 12th Five Year Plan [2012BAJ25B05]; Dawn Scholarship Project [07SG01]	National Science Foundation(National Science Foundation (NSF)); National Key Technology R&D Program in the 11th Five-Year Plan(National Key Technology R&D Program); National High-Technology RD Program; Shanghai Municipal Health Bureau Leading Academic Discipline Project; Non-Profit Foundation of National Health Ministry in the 12th Five Year Plan; Dawn Scholarship Project	This research was supported by grants from National Science Foundation (30972438), National Key Technology R&D Program in the 11th Five-Year Plan (2006BAI19B02), National High-Technology R&D Program (2008AA062501-2, 2008ZX07421-004, and 2013AA061804), Shanghai Municipal Health Bureau Leading Academic Discipline Project (08GWD14), Non-Profit Foundation of National Health Ministry in the 12th Five Year Plan (2012BAJ25B05), and Dawn Scholarship Project (07SG01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2012, WATER RES, DOI org/10.1016/j.watres.2012.12.002; Attene-Ramos MS, 2010, ENVIRON SCI TECHNOL, V44, P7206, DOI 10.1021/es1000193; Badawy MI, 2012, CHEMOSPHERE, V89, P235, DOI 10.1016/j.chemosphere.2012.04.025; Bai XH, 2006, J ENVIRON SCI HEAL A, V41, P1271, DOI 10.1080/10934520600656711; Bichsel Y, 1999, ENVIRON SCI TECHNOL, V33, P4040, DOI 10.1021/es990336c; Bichsel Y, 2000, WATER RES, V34, P3197, DOI 10.1016/S0043-1354(00)00077-4; Bichsel Y, 2000, ENVIRON SCI TECHNOL, V34, P2784, DOI 10.1021/es9914590; Bougeard CMM, 2010, WATER RES, V44, P729, DOI 10.1016/j.watres.2009.10.008; Bove GE, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-18; Chang CN, 2002, CHEMOSPHERE, V46, P21, DOI 10.1016/S0045-6535(01)00195-3; Chen GG, 2012, WATER WASTEWATER ENG, V48, P20; Chen Li, 2008, Wei Sheng Yan Jiu, V37, P137; Clark RM, 2001, J ENVIRON ENG-ASCE, V127, P493, DOI 10.1061/(ASCE)0733-9372(2001)127:6(493); Domino M. M., 2003, 5523 US EPA; Gallagher MD, 1998, EPIDEMIOLOGY, V9, P484, DOI 10.1097/00001648-199809000-00003; Goslan EH, 2009, WATER RES, V43, P4698, DOI 10.1016/j.watres.2009.07.029; Hautman D.P., 1997, 3001 US EPA; Hodgeson J.W., 1995, DETERMINATION CHLORI, V0; Huang L, 2008, ENVIRON SCI TECHNOL, V42, P8070, DOI 10.1021/es8008216; Hwang BF, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-23; Jeong CH, 2012, ENVIRON SCI TECHNOL, V46, P12120, DOI 10.1021/es3024226; Kallen BAJ, 2000, REPROD TOXICOL, V14, P303, DOI 10.1016/S0890-6238(00)00086-1; King WD, 2000, CANCER EPIDEM BIOMAR, V9, P813; Krasner SW, 2006, ENVIRON SCI TECHNOL, V40, P7175, DOI 10.1021/es060353j; Liu HB, 2011, WATER PURIFICATION T, V30, P6; MAROS L, 1989, ANAL CHEM, V61, P733, DOI 10.1021/ac00182a018; Muller B, 2008, SCI TOTAL ENVIRON, V402, P232, DOI 10.1016/j.scitotenv.2008.04.049; Muellner MG, 2007, ENVIRON SCI TECHNOL, V41, P645, DOI 10.1021/es0617441; Nieuwenhuijsen MJ, 2008, ENVIRON HEALTH PERSP, V116, P216, DOI 10.1289/ehp.10636; Plewa M.J., 2009, MAMMALIAN CELL CYTOT; Plewa MJ, 2008, ENVIRON SCI TECHNOL, V42, P955, DOI 10.1021/es071754h; Plewa MJ, 2010, ENVIRON MOL MUTAGEN, V51, P871, DOI 10.1002/em.20585; Plewa MJ, 2008, ACS SYM SER, V995, P36; Plewa MJ, 2004, ENVIRON SCI TECHNOL, V38, P4713, DOI 10.1021/es049971v; Richardson S.D., 1998, ENCY ENV ANAL REMEDI, V3, P1398; Richardson SD, 2008, ENVIRON SCI TECHNOL, V42, P8330, DOI 10.1021/es801169k; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Sadiq R, 2004, SCI TOTAL ENVIRON, V321, P21, DOI 10.1016/j.scitotenv.2003.05.001; Savitz DA, 2006, AM J EPIDEMIOL, V164, P1043, DOI 10.1093/aje/kwj300; Serodes JB, 2003, CHEMOSPHERE, V51, P253, DOI 10.1016/S0045-6535(02)00840-8; Toledano MB, 2005, ENVIRON HEALTH PERSP, V113, P225, DOI 10.1289/ehp.7111; U.S. EPA, 2009, 816F09004 US EPA; Villanueva CM, 2007, AM J EPIDEMIOL, V165, P148, DOI 10.1093/aje/kwj364; von Gunten U, 2003, WATER RES, V37, P1469, DOI 10.1016/S0043-1354(02)00458-X; Waller K, 1998, EPIDEMIOLOGY, V9, P134, DOI 10.1097/00001648-199803000-00006; WHO, 2011, GUID DRINK WAT QUAL; Yang CY, 2004, TOXICOLOGY, V198, P249, DOI 10.1016/j.tox.2004.01.032; Yang X, 2012, J HAZARD MATER, V239, P348, DOI 10.1016/j.jhazmat.2012.09.006; Ye T, 2012, J HAZARD MATER, V241, P348, DOI 10.1016/j.jhazmat.2012.09.046; Zhang H, 2007, ENVIRON MONIT ASSESS, V127, P429, DOI 10.1007/s10661-006-9292-8; Zhao YL, 2010, ANAL CHEM, V82, P4599, DOI 10.1021/ac100708u	51	36	36	3	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59677	10.1371/journal.pone.0059677	http://dx.doi.org/10.1371/journal.pone.0059677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555742	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500073
J	Hayashi, S; Houssaye, A; Nakajima, Y; Chiba, K; Ando, T; Sawamura, H; Inuzuka, N; Kaneko, N; Osaki, T				Hayashi, Shoji; Houssaye, Alexandra; Nakajima, Yasuhisa; Chiba, Kentaro; Ando, Tatsuro; Sawamura, Hiroshi; Inuzuka, Norihisa; Kaneko, Naotomo; Osaki, Tomohiro			Bone Inner Structure Suggests Increasing Aquatic Adaptations in Desmostylia (Mammalia, Afrotheria)	PLOS ONE			English	Article							LIFE-STYLE; MICROANATOMY; EVOLUTION; AMNIOTES; GROWTH; MITOCHONDRIAL; HISTOLOGY; POSTURE	Background: The paleoecology of desmostylians has been discussed controversially with a general consensus that desmostylians were aquatic or semi-aquatic to some extent. Bone microanatomy can be used as a powerful tool to infer habitat preference of extinct animals. However, bone microanatomical studies of desmostylians are extremely scarce. Methodology/Principal Findings: We analyzed the histology and microanatomy of several desmostylians using thin-sections and CT scans of ribs, humeri, femora and vertebrae. Comparisons with extant mammals allowed us to better understand the mode of life and evolutionary history of these taxa. Desmostylian ribs and long bones generally lack a medullary cavity. This trait has been interpreted as an aquatic adaptation among amniotes. Behemotops and Paleoparadoxia show osteosclerosis (i.e. increase in bone compactness), and Ashoroa pachyosteosclerosis (i.e. combined increase in bone volume and compactness). Conversely, Desmostylus differs from these desmostylians in displaying an osteoporotic-like pattern. Conclusions/Significance: In living taxa, bone mass increase provides hydrostatic buoyancy and body trim control suitable for poorly efficient swimmers, while wholly spongy bones are associated with hydrodynamic buoyancy control in active swimmers. Our study suggests that all desmostylians had achieved an essentially, if not exclusively, aquatic lifestyle. Behemotops, Paleoparadoxia and Ashoroa are interpreted as shallow water swimmers, either hovering slowly at a preferred depth, or walking on the bottom, and Desmostylus as a more active swimmer with a peculiar habitat and feeding strategy within Desmostylia. Therefore, desmostylians are, with cetaceans, the second mammal group showing a shift from bone mass increase to a spongy inner organization of bones in their evolutionary history.	[Hayashi, Shoji; Houssaye, Alexandra; Nakajima, Yasuhisa] Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany; [Hayashi, Shoji] Osaka Museum Nat Hist, Higashi Sumiyoshi Ku, Osaka, Japan; [Nakajima, Yasuhisa] Univ Tokyo, Univ Museum, Lab Dead Body Sci, Tokyo, Japan; [Chiba, Kentaro] Hokkaido Univ, Grad Sch Sci, Div Earth & Planetary Sci, Sapporo, Hokkaido, Japan; [Ando, Tatsuro; Sawamura, Hiroshi] Ashoro Museum Paleontol, Ashoro, Japan; [Inuzuka, Norihisa] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo, Japan; [Kaneko, Naotomo] AIST, Geol Survey Japan, Geol Museum, Ibaraki, Japan; [Osaki, Tomohiro] Tottori Univ, Sch Vet Med, Fac Agr, Tottori 680, Japan	University of Bonn; University of Tokyo; Hokkaido University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tottori University	Hayashi, S (corresponding author), Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany.	hayashi@uni-bonn.de	Houssaye, Alexandra/J-5631-2015	Nakajima, Yasuhisa/0000-0001-9162-4860; Chiba, Kentaro/0000-0003-2613-6187	Japan Society for the Promotion of Science; Deutsche Akademische Austauschdienst; Alexander von Humboldt	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Akademische Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt(Alexander von Humboldt Foundation)	The Japan Society for the Promotion of Science (http://www.jsps.go.jp/) provided funding to SH and YN. The Deutsche Akademische Austauschdienst (http://www.daad.de/) provided funding to SH. The Alexander von Humboldt (http://www.humboldt-foundation.de/) provided funding to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; Barnes Lawrence G., 2001, Bulletin of Ashoro Museum of Paleontology, V2, P7; Barnes LG, 2006, PAL WORKSH PRES STAT, P17; Beatty B, 2004, ICVM 7, P276; Beatty B.L., 2006, PalArch Series Vertebrate Palaeontology, V1, P1; Beatty BL, 2009, J VERTEBR PALEONTOL, V29, P894, DOI 10.1671/039.029.0320; Camp C. L., 1952, EARTH SONG PROLOGUE; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinzei K., 1984, MONOGR ASS GEOL COLL, V28, P13; Clementz MT, 2003, PALEOBIOLOGY, V29, P506, DOI 10.1666/0094-8373(2003)029<0506:APPTHA>2.0.CO;2; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; de Buffrenil V, 2010, J MAMM EVOL, V17, P101, DOI 10.1007/s10914-010-9130-1; de Ricqles Armand, 2001, P289; Demere A, 2006, B AM MUS NAT HIST, V279, P32; Domning DP, 2002, SM C PALEOB, P99; Domning DP., 1986, SMITHSON CONTRIB PAL, DOI [10.5479/si.00810266.59.1, DOI 10.5479/SI.00810266.59.1]; Fish FE, 1997, J EXP BIOL, V200, P2647; Fujiwara S, 2009, J MORPHOL, V270, P1107, DOI 10.1002/jmor.10748; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Gingerich Philip D., 2005, Journal of Mammalian Evolution, V12, P183, DOI 10.1007/s10914-005-5719-1; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Halstead L, 1978, EVOLUTION MAMMALS; Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619; Houssaye A, 2008, P 2 MOSASAUR M FORT, P81; Houssaye A, 2012, LETHAIA, V45, P200, DOI 10.1111/j.1502-3931.2011.00273.x; Houssaye A, 2010, J ANAT, V217, P715, DOI 10.1111/j.1469-7580.2010.01307.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Ijiri S, 1938, P IMP ACAD JPN, V14, P225; INUZUKA N, 1984, Memoirs of the Faculty of Science Kyoto University Series of Biology, V9, P157; Inuzuka N., 2005, B ASHORO MUSEUM PALE, V3, P3; Inuzuka N., 2011, B ASHORO MUSEUM PALE, V6, P3; Inuzuka N., 2006, B ASHORO MUSEUM PALE, V4, P3; Inuzuka Norihisa, 1994, Island Arc, V3, P522, DOI 10.1111/j.1440-1738.1994.tb00131.x; Inuzuka Norihisa, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P91; Inuzuka Norihisa, 2009, Bulletin of the Geological Survey of Japan, V60, P257; Inuzuka Norihisa, 2000, Historical Biology, V14, P97; Inuzuka Norihisa, 2000, Oryctos, V3, P71; Inuzuka Norihisa, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P9; Jacobs Louis L., 2007, Bulletin of Carnegie Museum of Natural History, V39, P189, DOI 10.2992/0145-9058(2007)39[189:DRFUIA]2.0.CO;2; Kaiser H. E., 1960, Palaeontographica, V114, P113; Klevezal G., 1996, RECORDING STRUCTURES; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kriloff A, 2008, J EVOLUTIONARY BIOL, V21, P1; Kunz Thomas H., 1996, P279; KURTEN B, 1971, AGE MAMMALS; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; Madar SI, 1998, ADV VERT PALEOBIOL, P353; Maddison W.P., 2008, MESQUITE MODULAR SYS; Marsh O. C., 1888, AM J SCI, V35, P94, DOI 10.2475/ajs.s3-35.205.94; Marshall CD, 1998, MAR MAMMAL SCI, V14, P274, DOI 10.1111/j.1748-7692.1998.tb00716.x; Matsui K, 2012, 161 ANN M PAL SOC JP, P56; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mitchell E. D., 1964, Geological Society of America Special Paper, V76, P214; MITCHELL EDW. D., 1963, BULL S CALIF ACAD SCT, V62, P192; Nagao T., 1935, Journal of the Geological Society of Japan, V42, P822; REINHART R, 1953, J GEOL, V61, P187, DOI 10.1086/626067; Reinhart R. H., 1959, Bulletin Department Geology University California, V36, P1; Repenning C.A., 1990, P199; Repenning CA, 1965, GEOTIMES, V9, P1; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; SAVAGE RJG, 1986, MAMMAL EVOLUTION ILL; Shikama T., 1966, PALEONTOL SOC JPN SP, V12, P1; Shikama T, 1974, LOST JAPANESE ANIMAL; Stirling I, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P888; Taylor Michael A., 2000, Historical Biology, V14, P15; Thomas HW, 2006, PAL WORKSH PRES STAT, P12; Uno H, 2008, 5 C SEC AD TETR LIF, P77; Uno Hikaru, 2004, Paleontological Research, V8, P1, DOI 10.2517/prpsj.8.1; Vanderhoof V. L., 1937, University of California Publications in Geology, V24, P169; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9	74	50	51	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59146	10.1371/journal.pone.0059146	http://dx.doi.org/10.1371/journal.pone.0059146			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565143	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300010
J	Xie, ZJ; Chen, G; Zhang, XC; Li, DF; Huang, J; Yang, CQ; Zhang, PY; Qin, YX; Duan, YF; Gong, B; Li, ZJ				Xie, Zijun; Chen, Gang; Zhang, Xuchao; Li, Dongfeng; Huang, Jian; Yang, Cuiqin; Zhang, Pingyong; Qin, Yuxuan; Duan, Yifan; Gong, Bo; Li, Zijun			Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; SOLUBLE C-ERBB-2; GENE-EXPRESSION; SERUM; AREAS; SIGNATURES; DIAGNOSIS; PROFILES; EXOSOMES; CHAOSHAN	Background and Purpose: Tissue microRNAs (miRNAs) can detect cancers and predict prognosis. Several recent studies reported that tissue, plasma, and saliva miRNAs share similar expression profiles. In this study, we investigated the discriminatory power of salivary miRNAs (including whole saliva and saliva supernatant) for detection of esophageal cancer. Materials and Methods: By Agilent microarray, six deregulated miRNAs from whole saliva samples from seven patients with esophageal cancer and three healthy controls were selected. The six selected miRNAs were subjected to validation of their expression levels by RT-qPCR using both whole saliva and saliva supernatant samples from an independent set of 39 patients with esophageal cancer and 19 healthy controls. Results: Six miRNAs (miR-10b*, miR-144, miR-21, miR-451, miR-486-5p, and miR-634) were identified as targets by Agilent microarray. After validation by RT-qPCR, miR-10b*, miR-144, and miR-451 in whole saliva and miR-10b*, miR-144, miR-21, and miR-451 in saliva supernatant were significantly upregulated in patients, with sensitivities of 89.7, 92.3, 84.6, 79.5, 43.6, 89.7, and 51.3% and specificities of 57.9, 47.4, 57.9%, 57.9, 89.5, 47.4, and 84.2%, respectively. Conclusions: We found distinctive miRNAs for esophageal cancer in both whole saliva and saliva supernatant. These miRNAs possess discriminatory power for detection of esophageal cancer. Because saliva collection is noninvasive and convenient, salivary miRNAs show great promise as biomarkers for detection of esophageal cancer in areas at high risk.	[Xie, Zijun; Qin, Yuxuan; Duan, Yifan; Gong, Bo; Li, Zijun] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Xie, Zijun] Southern Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Chen, Gang; Yang, Cuiqin] Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China; [Zhang, Xuchao] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Li, Dongfeng] Res Ctr Med Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Jian; Zhang, Pingyong] Phys Examinat Ctr East Ward, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Li, ZJ (corresponding author), Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	zijunli2005@yahoo.com.cn						Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Biagioni F, 2012, EMBO MOL MED, V4, P1214, DOI 10.1002/emmm.201201483; Bonci Desiree, 2010, Recent Pat Cardiovasc Drug Discov, V5, P156, DOI 10.2174/157489010793351962; Brenner B, 2011, WORLD J GASTROENTERO, V17, P3976, DOI 10.3748/wjg.v17.i35.3976; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Croce C, 2012, CANCER J, V18, P213, DOI 10.1097/PPO.0b013e31825efb41; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim T, 2011, J SURG ONCOL, V103, P179, DOI 10.1002/jso.21784; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lambert R, 2007, ENDOSCOPY, V39, P550, DOI 10.1055/s-2007-966530; Lee YH, 2009, AM J DENT, V22, P241; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li XY, 2011, MITOCHONDRION, V11, P27, DOI 10.1016/j.mito.2010.06.005; Li Y, 2006, J CLIN ONCOL, V24, P1754, DOI 10.1200/JCO.2005.03.7598; Li Y, 2011, ACTA BIOCH BIOPH SIN, V43, P69, DOI 10.1093/abbs/gmq114; Lin J, 2011, ASIAN PAC J CANCER P, V12, P2189; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Mbulaiteye SM, 2006, J INFECT DIS, V193, P422, DOI 10.1086/499277; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Patel RS, 2011, ARCH ORAL BIOL, V56, P1506, DOI 10.1016/j.archoralbio.2011.05.015; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rasmussen KD, 2011, BLOOD, V118, P2988, DOI 10.1182/blood-2011-04-350728; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Rossing M, 2012, J MOL ENDOCRINOL, V48, P11, DOI 10.1530/JME-11-0039; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Smith CM, 2010, WORLD J GASTROENTERO, V16, P531, DOI 10.3748/wjg.v16.i5.531; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Streckfus C, 1999, Clin Oral Investig, V3, P138, DOI 10.1007/s007840050092; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Streckfus C, 2001, ORAL SURG ORAL MED O, V91, P174, DOI 10.1067/moe.2001.111758; Sureban SM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-40; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Wang DL, 2012, CANCER EPIDEMIOL, V36, P276, DOI 10.1016/j.canep.2011.10.008; Wang T, 2012, DIG DIS SCI; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wiklund ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027840; Xu Xiao-chun, 2009, V471, P335, DOI 10.1007/978-1-59745-416-2_17; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	58	103	113	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e57502	10.1371/journal.pone.0057502	http://dx.doi.org/10.1371/journal.pone.0057502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560033	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900001
J	Kim, JS; Kim, WS; Lee, K; Won, CJ; Kim, JM; Eum, SY; Koh, WJ; Shin, SJ				Kim, Jong-Seok; Kim, Woo Sik; Lee, Keehoon; Won, Choul-Jae; Kim, Jin Man; Eum, Seok-Yong; Koh, Won-Jung; Shin, Sung Jae			Differential Immune Responses to Segniliparus rotundus and Segniliparus rugosus Infection and Analysis of Their Comparative Virulence Profiles	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INNATE IMMUNITY; TNF-ALPHA; TLR2; ABSCESSUS; PATHOGENESIS; RECOGNITION; CYTOKINES; DEFENSES; AGONIST	Two closely related bacterial species, Segniliparus rotundus and Segniliparus rugosus, have emerged as important human pathogens, but little is known about the immune responses they elicit or their comparative pathophysiologies. To determine the virulence and immune responses of the two species, we compared their abilities to grow in phagocytic and non-phagocytic cells. Both species maintained non-replicating states within A549 epithelial cells. S. rugosus persisted longer and multiplied more rapidly inside murine bone marrow-derived macrophages (BMDMs), induced more pro-inflammatory cytokines, and induced higher levels of macrophage necrosis. Activation of BMDMs by both species was mediated by toll-like receptor 2 (TLR2), followed by mitogen-activated protein kinases (MAPK) and nuclear factor kappa B (NF-kappa B) signaling pathways, indicating a critical role for TLR2 in Segniliparus-induced macrophage activation. S. rugosus triggered faster and stronger activation of MAPK signaling and I kappa B degradation, indicating that S. rugosus induces more pro-inflammatory cytokines than S. rotundus. Multifocal granulomatous inflammations in the liver and lung were observed in mice infected with S. rugosus, but S. rotundus was rapidly cleared from all organs tested within 15 days post-infection. Furthermore, S. rugosus induced faster infiltration of innate immune cells such as neutrophils and macrophages to the lung than S. rotundus. Our results suggest that S. rugosus is more virulent and induces a stronger immune response than S. rotundus.	[Kim, Jong-Seok; Kim, Woo Sik; Lee, Keehoon; Won, Choul-Jae; Shin, Sung Jae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Kim, Jong-Seok; Kim, Woo Sik; Lee, Keehoon; Won, Choul-Jae; Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Kim, Jin Man] Chungnam Natl Univ, Coll Med, Dept Pathol, Taejon, South Korea; [Eum, Seok-Yong] Int TB Res Ctr, Div Immunopathol & Cellular Immunol, Chang Won, South Korea; [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med,Samsung Med Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea.	sjshin@yuhs.ac	Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011; Lee, Keehoon/GSO-0002-2022	Koh, Won-Jung/0000-0002-4756-3527; Shin, Sung Jae/0000-0003-0854-4582; KIM, JIN MAN/0000-0003-0905-9730	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2011-0010170]; Yonsei University College of Medicine [6-2012-0045]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Yonsei University College of Medicine(General Electric)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (2011-0010170) and a faculty research grant of Yonsei University College of Medicine for 2012 (6-2012-0045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/678570; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Boyton RJ, 2002, BRIT MED BULL, V61, P1, DOI 10.1093/bmb/61.1.1; Butler WR, 2007, J CLIN MICROBIOL, V45, P3449, DOI 10.1128/JCM.00765-07; Butler WR, 2005, INT J SYST EVOL MICR, V55, P1615, DOI 10.1099/ijs.0.63465-0; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Danelishvili L, 2003, CELL MICROBIOL, V5, P649, DOI 10.1046/j.1462-5822.2003.00312.x; Davidson LB, 2012, PLOS ONE, V6; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Earl AM, 2011, STAND GENOMIC SCI, V5, P389, DOI 10.4056/sigs.2255041; Evans RH, 2011, EMERG INFECT DIS, V17, P311, DOI 10.3201/eid1702.101511; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hansen T, 2009, EMERG INFECT DIS, V15, P611, DOI 10.3201/eid1504.081479; HernandezPando R, 1997, INFECT IMMUN, V65, P3317, DOI 10.1128/IAI.65.8.3317-3327.1997; Hong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039017; Jeon BY, 2009, J MICROBIOL, V47, P633, DOI 10.1007/s12275-009-0139-1; Koh WJ, 2011, J CLIN MICROBIOL, V49, P3403, DOI 10.1128/JCM.01023-11; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Manjula S, 2002, Indian J Med Microbiol, V20, P61; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Seral C, 2003, ANTIMICROB AGENTS CH, V47, P2283, DOI 10.1128/AAC.47.7.2283-2292.2003; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin DM, 2008, CELL MICROBIOL, V10, P1893, DOI 10.1111/j.1462-5822.2008.01179.x; Shin DM, 2008, CELL MICROBIOL, V10, P1608, DOI 10.1111/j.1462-5822.2008.01151.x; Sikorski J, 2011, STAND GENOMIC SCI, V2, P203; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sohn H, 2009, MICROB PATHOGENESIS, V47, P321, DOI 10.1016/j.micpath.2009.09.010; Takabatake N, 1999, AM J RESP CRIT CARE, V159, P1215, DOI 10.1164/ajrccm.159.4.9806134; Tayabali AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037024; Theus SA, 2006, INFECT IMMUN, V74, P6865, DOI 10.1128/IAI.00561-06; Tuominen-Gustafsson H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-92; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; WALLIS RS, 1994, J LEUKOCYTE BIOL, V55, P676, DOI 10.1002/jlb.55.5.676; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216; Winter C, 2007, J IMMUNOL, V179, P3099, DOI 10.4049/jimmunol.179.5.3099; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	50	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59646	10.1371/journal.pone.0059646	http://dx.doi.org/10.1371/journal.pone.0059646			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555735	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900021
J	Matak, P; Zumerle, S; Mastrogiannaki, M; El Balkhi, S; Delga, S; Mathieu, JRR; Canonne-Hergaux, F; Poupon, J; Sharp, PA; Vaulont, S; Peyssonnaux, C				Matak, Pavle; Zumerle, Sara; Mastrogiannaki, Maria; El Balkhi, Souleiman; Delga, Stephanie; Mathieu, Jacques R. R.; Canonne-Hergaux, Francois; Poupon, Joel; Sharp, Paul A.; Vaulont, Sophie; Peyssonnaux, Carole			Copper Deficiency Leads to Anemia, Duodenal Hypoxia, Upregulation of HIF-2 alpha and Altered Expression of Iron Absorption Genes in Mice	PLOS ONE			English	Article							WILSON-DISEASE; DIETARY IRON; BRAIN IRON; IN-VITRO; METABOLISM; HEPHAESTIN; PROTEINS; RATS; CERULOPLASMIN; FERROPORTIN	Iron and copper are essential trace metals, actively absorbed from the proximal gut in a regulated fashion. Depletion of either metal can lead to anemia. In the gut, copper deficiency can affect iron absorption through modulating the activity of hephaestin - a multi-copper oxidase required for optimal iron export from enterocytes. How systemic copper status regulates iron absorption is unknown. Mice were subjected to a nutritional copper deficiency-induced anemia regime from birth and injected with copper sulphate intraperitoneally to correct the anemia. Copper deficiency resulted in anemia, increased duodenal hypoxia and Hypoxia inducible factor 2 alpha (HIF-2 alpha) levels, a regulator of iron absorption. HIF-2 alpha upregulation in copper deficiency appeared to be independent of duodenal iron or copper levels and correlated with the expression of iron transporters (Ferroportin - Fpn, Divalent Metal transporter - Dmt1) and ferric reductase - Dcytb. Alleviation of copper-dependent anemia with intraperitoneal copper injection resulted in down regulation of HIF-2 alpha-regulated iron absorption genes in the gut. Our work identifies HIF-2 alpha as an important regulator of iron transport machinery in copper deficiency.	[Matak, Pavle; Zumerle, Sara; Mastrogiannaki, Maria; Delga, Stephanie; Mathieu, Jacques R. R.; Vaulont, Sophie; Peyssonnaux, Carole] INSERM, U1016, Inst Cochin, Paris, France; [Matak, Pavle; Zumerle, Sara; Mastrogiannaki, Maria; Delga, Stephanie; Mathieu, Jacques R. R.; Vaulont, Sophie; Peyssonnaux, Carole] CNRS, UMR8104, Paris, France; [Matak, Pavle; Zumerle, Sara; Mastrogiannaki, Maria; Delga, Stephanie; Mathieu, Jacques R. R.; Vaulont, Sophie; Peyssonnaux, Carole] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [El Balkhi, Souleiman; Poupon, Joel] Hop Lariboisiere, Lab Toxicol Biol, F-75475 Paris, France; [Canonne-Hergaux, Francois] Fac Med Toulouse, INSERM, CPTP U1043, F-31073 Toulouse, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse, UPS, Ctr Phys Pathol Toulouse Purpan, Toulouse, France; [Sharp, Paul A.] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Matak, Pavle] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of London; King's College London; Duke University	Peyssonnaux, C (corresponding author), INSERM, U1016, Inst Cochin, Paris, France.	carole.peyssonnaux@inserm.fr	Vaulont, Sophie/O-6732-2017; Canonne-Hergaux, Francois/L-5363-2016; Balkhi, Souleiman El/ABB-7385-2020; CANONNE-HERGAUX, François/AAC-2073-2020; Peyssonnaux, Carole/L-4057-2017; /A-2002-2017; Peyssonnaux, Carole/GLU-5786-2022; Zumerle, Sara/AAD-2797-2020	Canonne-Hergaux, Francois/0000-0002-0621-2157; CANONNE-HERGAUX, François/0000-0002-0621-2157; /0000-0002-9743-5603; Peyssonnaux, Carole/0000-0002-1392-8225; Sharp, Paul Anthony/0000-0003-3400-6702; Zumerle, Sara/0000-0001-6980-0629	Agence Nationale pour la Recherche [ANR-08-JCJC-0123]; European Research Council Under the European Community [261296]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Research Council Under the European Community(European Research Council (ERC))	This study was supported with funding from the Agence Nationale pour la Recherche (ANR-08-JCJC-0123) and the European Research Council Under the European Community's Seventh Framework Program (FP7/2011-2015 grant agreement number 261296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ER, 2011, J BIOL CHEM, V286, P19533, DOI 10.1074/jbc.M111.238667; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Auclair S, 2006, BLOOD CELL MOL DIS, V36, P15, DOI 10.1016/j.bcmd.2005.11.003; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2003, BLOOD, V102, P1893, DOI 10.1182/blood-2003-02-0347; Cherukuri S, 2005, CELL METAB, V2, P309, DOI 10.1016/j.cmet.2005.10.003; Chung B, 2009, J NUTR, V139, P1457, DOI 10.3945/jn.108.102905; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Hait-Darshan R, 2009, J ENVIRON PATHOL TOX, V28, P209, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i3.20; Hansen SL, 2010, J ANIM SCI, V88, P275, DOI 10.2527/jas.2009-1846; Harada M, 2011, INTERNAL MED, V50, P1461, DOI 10.2169/internalmedicine.50.5209; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Jiang YC, 2007, J EXP MED, V204, P657, DOI 10.1084/jem.20061943; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Latunde-Dada GO, 2011, EUR J NUTR; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Merle U, 2010, J GASTROEN HEPATOL, V25, P1144, DOI 10.1111/j.1440-1746.2009.06173.x; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Nittis T, 2002, SEMIN HEMATOL, V39, P282, DOI 10.1053/shem.2002.35633; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; OWEN CA, 1973, AM J PHYSIOL, V224, P514; Prella M, 2001, BRIT J HAEMATOL, V114, P230, DOI 10.1046/j.1365-2141.2001.02899.x; Prohaska JR, 2012, BIOMETALS, V25, P633, DOI 10.1007/s10534-012-9521-2; Pyatskowit JW, 2008, J NUTR, V138, P1880, DOI 10.1093/jn/138.10.1880; Pyatskowit JW, 2008, COMP BIOCHEM PHYS C, V147, P316, DOI 10.1016/j.cbpc.2007.11.008; Ranganathan PN, 2012, P NATL ACAD SCI USA, V109, P3564, DOI 10.1073/pnas.1120833109; Reeves PG, 2005, EXP BIOL MED, V230, P320, DOI 10.1177/153537020523000505; Reeves PG, 2004, J NUTR, V134, P1953, DOI 10.1093/jn/134.8.1953; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Sharp P, 2004, P NUTR SOC, V63, P563, DOI 10.1079/PNS2004386; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; WILLIAMS DM, 1976, BLOOD, V48, P77; Wyman S, 2008, FEBS LETT, V582, P1901, DOI 10.1016/j.febslet.2008.05.010	48	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59538	10.1371/journal.pone.0059538	http://dx.doi.org/10.1371/journal.pone.0059538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555700	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200026
J	Aljunaibi, A; Abdulle, A; Nagelkerke, N				Aljunaibi, Abdulla; Abdulle, Abdishakur; Nagelkerke, Nico			Parental Weight Perceptions: A Cause for Concern in the Prevention and Management of Childhood Obesity in the United Arab Emirates	PLOS ONE			English	Article							CHILDREN; OVERWEIGHT; ADOLESCENTS; HEALTH	Parental participation is a key factor in the prevention and management of childhood obesity, thus parental recognition of weight problems is essential. We estimated parental perceptions and their determinants in the Emirati population. We invited 1541 students (grade 1-12; 50% boys) and their parents, but only 1440 (6-19 years) and their parents consented. Of these, 945 Emirati nationals provided data for analysis. Anthropometric and demographic variables were measured by standard methods. CDC BMI percentile charts for age and sex were used to classify children's weight. Parental perception of their children's weight status (underweight, normal, and overweight/obese) was recorded. Logistic regression analyses were used to identify independent predictors of parental perceptions of children's weight status. Of all parents, 33.8% misclassified their children's' weight status; underestimating (27.4%) or overestimating (6.3%). Misclassification was highest among parents of overweight/obese children (63.5%) and underweight (55.1%) children. More importantly, parental perceptions of their children being overweight or obese, among truly overweight/obese children, i.e. correct identification of an overweight/obese child as such, were associated with the true child's BMI percentile (CDC) with an OR of 1.313 (95% CI: 1.209-1.425; p<0.001) per percentile point, but not age, parental education, household income, and child's sex. We conclude that the majority of parents of overweight/obese children either overestimated or, more commonly, underestimated children's weight status. Predictors of accurate parental perception, in this population, include the true children's BMI, but not age, household income, and sex. Thus, parents having an incorrect perception of their child's weight status may ignore otherwise appropriate health messages.	[Aljunaibi, Abdulla] Zayed Mil Hosp, Dept Pediat, Abu Dhabi, U Arab Emirates; [Abdulle, Abdishakur] United Arab Emirates Univ, Dept Internal Med, Coll Med, Al Ain, U Arab Emirates; [Nagelkerke, Nico] United Arab Emirates Univ, Dept Community Med, Coll Med, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Abdulle, A (corresponding author), United Arab Emirates Univ, Dept Internal Med, Coll Med, Al Ain, U Arab Emirates.	shakur.a@uaeu.ac.ae	Swaibu, Ramadhani A/H-3164-2011		Medical Services Corps, United Arab Emirates Armed Forces	Medical Services Corps, United Arab Emirates Armed Forces	This research was funded by the Medical Services Corps, United Arab Emirates Armed Forces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Junaibi A, 2013, INT J OBESITY, V37, P68, DOI 10.1038/ijo.2012.131; Bayles B, 2010, PUBLIC HEALTH NURS, V27, P320, DOI 10.1111/j.1525-1446.2010.00861.x; Birch LL, 1998, PEDIATRICS, V101, P539; Boutelle KN, 2012, OBESITY, V20, P1539, DOI 10.1038/oby.2012.48; Chaimovitz R, 2008, J PEDIATR GASTR NUTR, V47, P76, DOI 10.1097/MPG.0b013e31815a34; Doak CM, 2006, OBES REV, V7, P111, DOI 10.1111/j.1467-789X.2006.00234.x; Farnesi BC, 2012, PEDIATR OBES, V7, P175, DOI 10.1111/j.2047-6310.2012.00029.x; GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X; Golan M, 2006, INT J PEDIATR OBES, V1, P66, DOI 10.1080/17477160600644272; He M, 2007, CAN FAM PHYSICIAN, V53, P1493; Hudson E, 2012, MATERN CHILD HLTH J, V16, P1801, DOI 10.1007/s10995-011-0927-1; JOHNSON AL, 1975, AM J CARDIOL, V35, P523, DOI 10.1016/0002-9149(75)90835-8; Jones AR, 2011, INT J OBESITY, V35, P953, DOI 10.1038/ijo.2011.106; Koplan JP, 2005, J AM DIET ASSOC, V105, P131, DOI 10.1016/j.jada.2004.11.023; Kuczmarski R J, 2000, Adv Data, P1; Lampard AM, 2008, INT J PEDIATR OBES, V3, P84, DOI 10.1080/17477160701832552; Lobstein T, 2005, EUR J PUBLIC HEALTH, V15, P576, DOI 10.1093/eurpub/cki068; Mathieu ME, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/306703; MITCHELL BD, 1994, DIABETES CARE, V17, P567, DOI 10.2337/diacare.17.6.567; Nathan BM, 2008, CURR OPIN ENDOCRINOL, V15, P21, DOI 10.1097/MED.0b013e3282f43d19; Parry LL, 2008, J AMBUL CARE MANAG, V31, P253, DOI 10.1097/01.JAC.0000324671.29272.04; Puhl RM, 2011, PEDIATRICS, V128, pE786, DOI 10.1542/peds.2010-3841; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Towns Nichole, 2009, J Pediatr Nurs, V24, P115, DOI 10.1016/j.pedn.2008.02.032; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Williams KJ, 2008, RURAL REMOTE HEALTH, V8	28	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59923	10.1371/journal.pone.0059923	http://dx.doi.org/10.1371/journal.pone.0059923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555833	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500105
J	Ammar, ED; Hall, DG; Shatters, RG				Ammar, El-Desouky; Hall, David G.; Shatters, Robert G., Jr.			Stylet Morphometrics and Citrus Leaf Vein Structure in Relation to Feeding Behavior of the Asian Citrus Psyllid Diaphorina citri, Vector of Citrus Huanglongbing Bacterium	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; TRANSMISSION PARAMETERS; DISEASE; BIOLOGY	The Asian citrus psyllid (ACP), Diaphorina citri (Hemiptera: Psyllidae), is the primary vector of the phloem-limited bacterium Candidatus Liberibacter asiaticus (LAS) associated with huanglongbing (HLB, citrus greening), considered the world's most serious disease of citrus. Stylet morphometrics of ACP nymphs and adults were studied in relation to citrus vein structure and to their putative (histologically verified) feeding sites on Valencia orange leaves. ACP nymphs preferred to settle and feed on the lower (abaxial) side of young leaves either on secondary veins or on the sides of the midrib, whereas adults preferred to settle and feed on the upper (adaxial) or lower secondary veins of young or old leaves. Early instar nymphs can reach and probe the phloem probably because the distance to the phloem is considerably shorter in younger than in mature leaves, and is shorter from the sides of the midrib compared to that from the center. Additionally, the thick-walled 'fibrous ring' (sclerenchyma) around the phloem, which may act as a barrier to ACP stylet penetration into the phloem, is more prominent in older than in younger leaves and in the center than on the sides of the midrib. The majority (80-90%) of the salivary sheath termini produced by ACP nymphs and adults that reached a vascular bundle were associated with the phloem, whereas only 10-20% were associated with xylem vessels. Ultrastructural studies on ACP stylets and LAS-infected leaves suggested that the width of the maxillary food canal in first instar nymphs is wide enough for LAS bacteria to traverse during food ingestion (and LAS acquisition). However, the width of the maxillary salivary canal in these nymphs may not be wide enough to accommodate LAS bacteria during salivation (and LAS inoculation) into host plants. This may explain the inability of early instar nymphs to transmit LAS/HLB in earlier reports.	[Ammar, El-Desouky; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA.	Eldesouky.ammar@ars.usda.gov		Shatters, Robert/0000-0002-3903-772X	Florida Citrus Research and Development Foundation	Florida Citrus Research and Development Foundation	Funds for this research were provided by the Florida Citrus Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2004, ARCH MICROBIOL, V181, P97, DOI 10.1007/s00203-003-0630-8; Ammar E-D, 2013, J ECON ENTOMOL, V106, P25; Ammar ED, 2012, ANN ENTOMOL SOC AM, V105, P731, DOI 10.1603/AN12056; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, FLA ENTOMOL, V94, P340, DOI 10.1653/024.094.0229; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Ammar El-Desouky, 2006, P97; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; Backus EA, 2009, ANN ENTOMOL SOC AM, V102, P847, DOI 10.1603/008.102.0512; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bonani JP, 2008, P INT RES C HUANGL O, P219; Bove JM, 2006, J PLANT PATHOL, V88, P7; Capoor S. P., 1974, Proceedings of the Sixth Conference of the International Organization of Citrus Virologists., P43; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Daugherty MP, 2009, ENTOMOL EXP APPL, V132, P84, DOI 10.1111/j.1570-7458.2009.00868.x; Duarte MR, 2005, FITOTERAPIA, V76, P41, DOI 10.1016/j.fitote.2004.10.003; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Garzo E, 2012, ARTHROPOD STRUCT DEV, V41, P79, DOI 10.1016/j.asd.2011.07.005; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hartung JS, 2010, PHYTOPATHOLOGY, V100, P756, DOI 10.1094/PHYTO-100-8-0756; Huang CH, 1985, J AGR RES CHINA, V33, P65; Hung TH, 2004, PLANT PATHOL, V53, P96, DOI 10.1111/j.1365-3059.2004.00948.x; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Moore R., 1998, BOTANY, V3; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Rangasamy M, 2009, J ECON ENTOMOL, V102, P432, DOI 10.1603/029.102.0156; Richter S, 2011, PLANTA, V233, P763, DOI 10.1007/s00425-010-1338-z; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; Xu C.F., 1988, P 10 C INT ORG CITRU, P243; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256	36	34	34	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59914	10.1371/journal.pone.0059914	http://dx.doi.org/10.1371/journal.pone.0059914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555830	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500104
J	De, D; Chakraborty, PD; Mitra, J; Sharma, K; Mandal, S; Das, A; Chakrabarti, S; Bhattacharyya, D				De, Debashree; Chakraborty, Piyali Datta; Mitra, Jyotirmoy; Sharma, Kanika; Mandal, Somnath; Das, Aneesha; Chakrabarti, Saikat; Bhattacharyya, Debasish			Ubiquitin-Like Protein from Human Placental Extract Exhibits Collagenase Activity	PLOS ONE			English	Article							INTRINSIC PROTEOLYTIC ACTIVITY; MULTIPLE SEQUENCE ALIGNMENT; HISTONE-LIKE PROTEIN; MATRIX METALLOPROTEINASES; PROTEASOME SYSTEM; AQUEOUS EXTRACT; NITRIC-OXIDE; KAPPA-B; ZYMOGRAPHY; ORGANIZATION	An aqueous extract of human placenta exhibits strong gelatinase/collagenase activity in zymography. 2-D gel electrophoresis of the extract with gelatin zymography in the second dimension displayed a single spot, identified as ubiquitin-like component upon MALDI/TOF MS/MS analysis. Immunoblot indicated presence of ubiquitin and absence of collagenase in the extract. Collagenase activity of the ubiquitin-like component was confirmed from the change in solubility of collagen in aqueous buffer, degradation of collagen by size-exclusion HPLC and atomic force microscopy. Quantification with DQ-gelatin showed that the extract contains 0.04 U/ml of collagenase activity that was inhibited up to 95% by ubiquitin antibody. Ubiquitin from bovine erythrocytes demonstrated mild collagenase activity. Bioinformatics studies suggest that placental ubiquitin and collagenase follow structurally divergent evolution. This thermostable intrinsic collagenase activity of placental extract might have wide physiological relevance in degrading and remodeling collagen as it is used as a drug for wound healing and pelvic inflammatory diseases.	[De, Debashree; Mitra, Jyotirmoy; Sharma, Kanika; Mandal, Somnath; Das, Aneesha; Chakrabarti, Saikat; Bhattacharyya, Debasish] Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, Kolkata 700032, W Bengal, India; [Chakraborty, Piyali Datta] Albert David Ltd, Res & Dev, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharyya, D (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, 4 Raja Sc Mullick Rd, Kolkata 700032, W Bengal, India.	debasish@iicb.res.in	SHARMA-MITTRA, KANIKA/AAW-4521-2020	De, Debashree/0000-0002-1422-8554; Mandal, Somnath/0000-0001-9071-8371; , KANIKA/0000-0002-7512-4185	Albert David Ltd. Calcutta; Council of Scientific and Industrial Research, New Delhi; DBT; Albert David Ltd., Kolkata, India	Albert David Ltd. Calcutta; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India); Albert David Ltd., Kolkata, India	The work was supported by a grant from Albert David Ltd. Calcutta awarded to DB. DD, JM, KS, SM and AD were supported by fellowships from Council of Scientific and Industrial Research, New Delhi. SC acknowledges DBT for Ramalingaswami Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was funded by Albert David Ltd., Kolkata, India. However, the drug house had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, they had no role in terms of employment, consultancy, patents and products in development or marketed products. Council of Scientific and Industrial Research - Indian Institute of Chemical Biology provided all infrastructural support. This therefore does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Chakraborty P D, 2009, J Wound Care, V18, P464; Chakraborty PD, 2006, INT IMMUNOPHARMACOL, V6, P100, DOI 10.1016/j.intimp.2005.07.018; Chakraborty PD, 2005, J CHROMATOGR B, V818, P67, DOI 10.1016/j.jchromb.2004.09.059; Chakraborty PD, 2005, CURR SCI INDIA, V88, P782; Chakraborty PD, 2012, RECENT ADV RES HUM P; Chan YH, 2007, NUCLEIC ACIDS RES, V35, P2573, DOI 10.1093/nar/gkm165; Datta P, 2004, J PHARMACEUT BIOMED, V36, P211, DOI 10.1016/j.jpba.2004.05.006; Daulny A, 2009, DNA REPAIR, V8, P444, DOI 10.1016/j.dnarep.2009.01.017; De D, 2011, J CELL PHYSIOL, V226, P2033, DOI 10.1002/jcp.22535; De D, 2009, J CHROMATOGR B, V877, P2435, DOI 10.1016/j.jchromb.2009.05.018; Debret G, 2009, NUCLEIC ACIDS RES, V37, pW459, DOI 10.1093/nar/gkp304; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dutta A, 2009, J ONCOL, V2009, DOI 10.1155/2009/627840; FERNANDEZRESA P, 1995, ANAL BIOCHEM, V224, P434, DOI 10.1006/abio.1995.1063; FRIED VA, 1987, P NATL ACAD SCI USA, V84, P3685, DOI 10.1073/pnas.84.11.3685; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hermann K, 1999, PRINCIPLES IMMUNOPHA; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Johansson N, 2000, ANN MED, V31, P34; Joo CK, 2008, CELL ADHES MIGR, V2, P252, DOI 10.4161/cam.2.4.6772; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Meli M, 2008, BIOPHYS J, V94, P4414, DOI 10.1529/biophysj.107.121061; Metzmacher I, 2007, WOUND REPAIR REGEN, V15, P549, DOI 10.1111/j.1524-475X.2007.00263.x; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Nath S, 2007, INDIAN J EXP BIOL, V45, P732; Ohashi N, 1998, J CLIN MICROBIOL, V36, P2671, DOI 10.1128/JCM.36.9.2671-2680.1998; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PARAKH KA, 1992, INDIAN J BIOCHEM BIO, V29, P303; Ram EVSR, 2008, NUCLEIC ACIDS RES, V36, P5061, DOI 10.1093/nar/gkn483; Ramundo J, 2009, J WOUND OSTOMY CONT, V36, pS4, DOI 10.1097/WON.0b013e3181bfdf83; Ratnikov BI, 2002, LAB INVEST, V82, P1583, DOI 10.1097/01.LAB.0000038555.67772.DB; Sakai N, 2004, INT J BIOCHEM CELL B, V36, P776, DOI 10.1016/S1357-2725(03)00263-2; Seifert U, 2008, BIOCHEM SOC T, V36, P879, DOI 10.1042/BST0360879; SEIFTER S, 1970, METHOD ENZYMOL, V19, P613; Sen T, 2010, ANTI-CANCER DRUG, V21, P632, DOI 10.1097/CAD.0b013e32833a4385; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sinclair R D, 1994, Australas J Dermatol, V35, P35, DOI 10.1111/j.1440-0960.1994.tb01799.x; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Steed DL, 1996, J AM COLL SURGEONS, V183, P61; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Taatjes DJ, 1999, MICROSC RES TECHNIQ, V44, P347, DOI 10.1002/(SICI)1097-0029(19990301)44:5<347::AID-JEMT5>3.0.CO;2-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; VIJAYKUMAR S, 1985, P NATL ACAD SCI USA, V82, P3582, DOI 10.1073/pnas.82.11.3582; Von den Hoff JW, 2003, J PERIODONTAL RES, V38, P449, DOI 10.1034/j.1600-0765.2003.00404.x; Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; WOOLLEY DE, 1975, EUR J BIOCHEM, V50, P437, DOI 10.1111/j.1432-1033.1975.tb09821.x; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Xavier LP, 2005, EUR J ENTOMOL, V102, P147, DOI 10.14411/eje.2005.023; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev; Zhang D, 2003, HORM METAB RES, V35, P802	63	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59585	10.1371/journal.pone.0059585	http://dx.doi.org/10.1371/journal.pone.0059585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555718	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500058
J	Matzkin, LM; Johnson, S; Paight, C; Markow, TA				Matzkin, Luciano M.; Johnson, Sarah; Paight, Christopher; Markow, Therese A.			Preadult Parental Diet Affects Offspring Development and Metabolism in Drosophila melanogaster	PLOS ONE			English	Article							PRENATAL EXPOSURE; EPIGENETIC MODIFICATION; PROTEIN RESTRICTION; NUTRITION; FRUCTOSE; MODELS; RATS; EXPRESSION; LACTATION; PHENOTYPE	When Drosophila melanogaster larvae are reared on isocaloric diets differing in their amounts of protein relative to sugar, emerging adults exhibit significantly different development times and metabolic pools of protein, glycogen and trigylcerides. In the current study, we show that the influence of larval diet experienced during just one generation extends into the next generation, even when that subsequent generation had been shifted to a standard diet during development. Offspring of flies that were reared on high protein relative to sugar underwent metamorphosis significantly faster, had higher reproductive outputs, and different metabolic pool contents compared to the offspring of adults from low protein relative to sugar diets. In addition, isofemale lines differed in the degree to which parental effects were observed, suggesting a genetic component to the observed transgenerational influences.	[Matzkin, Luciano M.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Johnson, Sarah; Paight, Christopher; Markow, Therese A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Markow, Therese A.] Ctr Invest & Estudios Avancados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	University of Alabama System; University of Alabama Huntsville; University of California System; University of California San Diego	Markow, TA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	tmarkow@ucsd.edu	Matzkin, Luciano/AAI-2913-2020	Matzkin, Luciano/0000-0002-3580-9171	University of California San Diego; Amylin Endowment; National Science Foundation [DEB-1219387]	University of California San Diego(University of California System); Amylin Endowment; National Science Foundation(National Science Foundation (NSF))	This project was funded by University of California San Diego and the Amylin Endowment to TAM and a National Science Foundation award (DEB-1219387) to LMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatch SA, 2010, FLY, V4, P312, DOI 10.4161/fly.4.4.13258; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Bonduriansky R, 2007, J EVOLUTION BIOL, V20, P2379, DOI 10.1111/j.1420-9101.2007.01419.x; BOURNE AR, 1975, P NUTR SOC, V34, pA80; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Chen KF, 2012, BRIEF FUNCT GENOMICS, V11, P405, DOI 10.1093/bfgp/els038; Daenzer M, 2002, J NUTR, V132, P142, DOI 10.1093/jn/132.2.142; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Fleming TP, 2012, REPROD FERT DEVELOP, V24, P35, DOI 10.1071/RD11905; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; JEN KLC, 1991, J NUTR, V121, P1999, DOI 10.1093/jn/121.12.1999; Langley-Evans SC, 2005, MATERN CHILD NUTR, V1, P142, DOI 10.1111/j.1740-8709.2005.00015.x; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; LUCAS A, 1991, CIBA F SYMP, V156, P38; Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6; Martin-Gronert MS, 2008, AM J PHYSIOL-REG I, V294, pR494, DOI 10.1152/ajpregu.00530.2007; Matzkin LM, 2011, J NUTR, V141, P1127, DOI 10.3945/jn.111.138438; Mehta A, 2009, BIOCHIMIE, V91, P1331, DOI 10.1016/j.biochi.2009.05.003; Mortensen OH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S38; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Prasad NG, 2003, EVOL ECOL RES, V5, P903; RAWANA S, 1993, J NUTR, V123, P2158; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; ROBERTSON FW, 1962, P NUTR SOC, V21, P169, DOI 10.1079/PNS19620028; ROSEWELL J, 1987, BIOL J LINN SOC, V32, P373, DOI 10.1111/j.1095-8312.1987.tb00438.x; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; Valtonen TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031611; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745	34	46	48	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59530	10.1371/journal.pone.0059530	http://dx.doi.org/10.1371/journal.pone.0059530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555695	Green Published, gold			2022-12-27	WOS:000317418500047
J	Meinel, FG; Schwab, F; Schleede, S; Bech, M; Herzen, J; Achterhold, K; Auweter, S; Bamberg, F; Yildirim, AO; Bohla, A; Eickelberg, O; Loewen, R; Gifford, M; Ruth, R; Reiser, MF; Pfeiffer, F; Nikolaou, K				Meinel, Felix G.; Schwab, Felix; Schleede, Simone; Bech, Martin; Herzen, Julia; Achterhold, Klaus; Auweter, Sigrid; Bamberg, Fabian; Yildirim, Ali Oe.; Bohla, Alexander; Eickelberg, Oliver; Loewen, Rod; Gifford, Martin; Ruth, Ronald; Reiser, Maximilian F.; Pfeiffer, Franz; Nikolaou, Konstantin			Diagnosing and Mapping Pulmonary Emphysema on X-Ray Projection Images: Incremental Value of Grating-Based X-Ray Dark-Field Imaging	PLOS ONE			English	Article							PHASE-CONTRAST TOMOGRAPHY; VOLUME REDUCTION SURGERY; LUNG DENSITOMETRY; AUGMENTATION THERAPY; CT DENSITOMETRY; CHEST	Purpose: To assess whether grating-based X-ray dark-field imaging can increase the sensitivity of X-ray projection images in the diagnosis of pulmonary emphysema and allow for a more accurate assessment of emphysema distribution. Materials and Methods: Lungs from three mice with pulmonary emphysema and three healthy mice were imaged ex vivo using a laser-driven compact synchrotron X-ray source. Median signal intensities of transmission (T), dark-field (V) and a combined parameter (normalized scatter) were compared between emphysema and control group. To determine the diagnostic value of each parameter in differentiating between healthy and emphysematous lung tissue, a receiver-operating-characteristic (ROC) curve analysis was performed both on a per-pixel and a per-individual basis. Parametric maps of emphysema distribution were generated using transmission, dark-field and normalized scatter signal and correlated with histopathology. Results: Transmission values relative to water were higher for emphysematous lungs than for control lungs (1.11 vs. 1.06, p<0.001). There was no difference in median dark-field signal intensities between both groups (0.66 vs. 0.66). Median normalized scatter was significantly lower in the emphysematous lungs compared to controls (4.9 vs. 10.8, p<0.001), and was the best parameter for differentiation of healthy vs. emphysematous lung tissue. In a per-pixel analysis, the area under the ROC curve (AUC) for the normalized scatter value was significantly higher than for transmission (0.86 vs. 0.78, p<0.001) and dark-field value (0.86 vs. 0.52, p<0.001) alone. Normalized scatter showed very high sensitivity for a wide range of specificity values (94% sensitivity at 75% specificity). Using the normalized scatter signal to display the regional distribution of emphysema provides color-coded parametric maps, which show the best correlation with histopathology. Conclusion: In a murine model, the complementary information provided by X-ray transmission and dark-field images adds incremental diagnostic value in detecting pulmonary emphysema and visualizing its regional distribution as compared to conventional X-ray projections.	[Meinel, Felix G.; Schwab, Felix; Auweter, Sigrid; Bamberg, Fabian; Reiser, Maximilian F.; Nikolaou, Konstantin] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany; [Schleede, Simone; Bech, Martin; Herzen, Julia; Achterhold, Klaus; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Garching, Germany; [Schleede, Simone; Bech, Martin; Herzen, Julia; Achterhold, Klaus; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Bech, Martin] Lund Univ, Lund, Sweden; [Yildirim, Ali Oe.; Bohla, Alexander; Eickelberg, Oliver] Helmholtz Zentrum Munich, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Neuherberg, Germany; [Loewen, Rod; Gifford, Martin] Lyncean Technol Inc, Palo Alto, CA USA; [Ruth, Ronald] SLAC Natl Accelerator Lab, Menlo Pk, CA USA; [Herzen, Julia] Helmholtz Zentrum Geesthacht, Inst Mat Res, Geesthacht, Germany	University of Munich; Technical University of Munich; Technical University of Munich; Lund University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Meinel, FG (corresponding author), Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany.	felix.meinel@med.uni-muenchen.de	Eickelberg, Oliver/A-5461-2013; Bech, Martin/K-4331-2012; Herzen, Julia/B-2368-2015	Eickelberg, Oliver/0000-0001-7170-0360; Bech, Martin/0000-0001-9109-7175; Herzen, Julia/0000-0002-9456-1591; Nikolaou, Konstantin/0000-0003-2668-7325; Meinel, Felix/0000-0002-3201-1033; Achterhold, Klaus/0000-0002-8724-1637; Yildirim, Ali Onder/0000-0003-1969-480X	DFG cluster of excellence Munich Centre for Advanced Photonics (MAP); DFG Cluster of Excellence Munich-Centre for Advanced Photonics; TUM Graduate School; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT); European Research Council [240142]; NIGMS [R44-GM074437]; NCRR [R43-RR025730]	DFG cluster of excellence Munich Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Cluster of Excellence Munich-Centre for Advanced Photonics(German Research Foundation (DFG)); TUM Graduate School; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT); European Research Council(European Research Council (ERC)European Commission); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by a research grant from the DFG cluster of excellence Munich Centre for Advanced Photonics (MAP). The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics and the European Research Council (FP7, Starting grant \#240142). S. S. acknowledges the TUM Graduate School for the support of her studies. This work was partly carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT, www.kit.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Compact Light Source experiment was supported in part by grants R44-GM074437 from NIGMS and R43-RR025730 from NCRR. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the United States National Institutes of Health. R. J. L. and M. G. are employed by Lyncean Technologies Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Bech M., 2012, PHOTONICS LASERS MED, V1, P47, DOI [10.1515/plm-2011-0012, DOI 10.1515/PLM-2011-0012]; Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Cavigli E, 2009, EUR RADIOL, V19, P1686, DOI 10.1007/s00330-009-1320-y; Chong D, 2012, EUR RADIOL, V22, P287, DOI 10.1007/s00330-011-2277-1; Criner GJ, 2010, SEMIN RESP CRIT CARE, V31, P348, DOI 10.1055/s-0030-1254075; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diemoz PC, 2012, OPT EXPRESS, V20, P2789, DOI 10.1364/OE.20.002789; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Goldin JG, 2009, J THORAC IMAG, V24, P163, DOI 10.1097/RTI.0b013e3181b41b53; Gray JE, 2005, RADIOLOGY, V235, P354, DOI 10.1148/radiol.2352020016; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Miniati M, 2008, EUR RESPIR J, V31, P509, DOI 10.1183/09031936.00095607; Muller NL, 2002, THORAX, V57, P982, DOI 10.1136/thorax.57.11.982; Parr DG, 2006, THORAX, V61, P485, DOI 10.1136/thx.2005.054890; Parr DG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-75; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Schleede S, 2012, P NATL ACAD SCI US; Schleede S, PNAS; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Stoel BC, 2004, INVEST RADIOL, V39, P681, DOI 10.1097/00004424-200411000-00006; Stoel Berend C, 2008, Proc Am Thorac Soc, V5, P919, DOI 10.1513/pats.200804-040QC; THURLBECK WM, 1978, AM J ROENTGENOL, V130, P429, DOI 10.2214/ajr.130.3.429; Washko GR, 2010, SEMIN RESP CRIT CARE, V31, P276, DOI 10.1055/s-0030-1254068; Washko George R, 2008, Proc Am Thorac Soc, V5, P421, DOI 10.1513/pats.200802-017ET; Yildirim AO, 2010, AM J RESP CRIT CARE, V181, P705, DOI 10.1164/rccm.200804-573OC	31	36	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59526	10.1371/journal.pone.0059526	http://dx.doi.org/10.1371/journal.pone.0059526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555692	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500045
J	Seenivasan, R; Sausen, N; Medlin, LK; Melkonian, M				Seenivasan, Ramkumar; Sausen, Nicole; Medlin, Linda K.; Melkonian, Michael			Picomonas judraskeda Gen. Et Sp Nov.: The First Identified Member of the Picozoa Phylum Nov., a Widespread Group of Picoeukaryotes, Formerly Known as 'Picobiliphytes'	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SINGLE-CELL GENOMICS; EUKARYOTIC PICOPLANKTON; OLIGONUCLEOTIDE PROBES; MARINE; DIVERSITY; ECOLOGY; OCEAN; RDNA; FLAGELLATE	In 2007, a novel, putatively photosynthetic picoeukaryotic lineage, the 'picobiliphytes', with no known close eukaryotic relatives, was reported from 18S environmental clone library sequences and fluorescence in situ hybridization. Although single cell genomics later showed these organisms to be heterotrophic rather than photosynthetic, until now this apparently widespread group of pico-(or nano-)eukaryotes has remained uncultured and the organisms could not be formally recognized. Here, we describe Picomonas judraskeda gen. et sp. nov., from marine coastal surface waters, which has a 'picobiliphyte' 18S rDNA signature. Using vital mitochondrial staining and cell sorting by flow cytometry, a single cell-derived culture was established. The cells are biflagellate, 2.5-3.8x2-2.5 mu m in size, lack plastids and display a novel stereotypic cycle of cell motility (described as the "jump, drag, and skedaddle"-cycle). They consist of two hemispherical parts separated by a deep cleft, an anterior part that contains all major cell organelles including the flagellar apparatus, and a posterior part housing vacuoles/vesicles and the feeding apparatus, both parts separated by a large vacuolar cisterna. From serial section analyses of cells, fixed at putative stages of the feeding cycle, it is concluded that cells are not bacterivorous, but feed on small marine colloids of less than 150 nm diameter by fluid-phase, bulk flow endocytosis. Based on the novel features of cell motility, ultrastructure and feeding, and their isolated phylogenetic position, we establish a new phylum, Picozoa, for Picomonas judraskeda, representing an apparently widespread and ecologically important group of heterotrophic picoeukaryotes, formerly known as 'picobiliphytes'.	[Seenivasan, Ramkumar; Sausen, Nicole; Melkonian, Michael] Univ Cologne, Dept Bot, Cologne Bioctr, D-50931 Cologne, Germany; [Medlin, Linda K.] The Citadel, Marine Biol Assoc UK, Lab, Plymouth, Devon, England	University of Cologne; Marine Biological Association United Kingdom	Seenivasan, R (corresponding author), Univ Cologne, Dept Bot, Cologne Bioctr, D-50931 Cologne, Germany.	rseeniva@uni-koeln.de			German Research Foundation (DFG) [ME 658/27-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This project was supported by German Research Foundation (DFG) grant no. ME 658/27-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Biegala IC, 2003, APPL ENVIRON MICROB, V69, P5519, DOI 10.1128/AEM.69.9.5519-5529.2003; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; CRAIG SR, 1986, FEMS MICROBIOL ECOL, V38, P171, DOI 10.1111/j.1574-6968.1986.tb01726.x; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Erken M, 2012, PROTIST, V163, P632, DOI 10.1016/j.protis.2011.10.008; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; Kim DY, 2011, MICROB ECOL, V62, P383, DOI 10.1007/s00248-011-9816-9; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Le Gall F, 2008, BIOGEOSCIENCES, V5, P203, DOI 10.5194/bg-5-203-2008; Li LY, 2008, SCI CHINA SER C, V51, P1121, DOI 10.1007/s11427-008-0140-7; LI WKW, 1990, CAN J FISH AQUAT SCI, V47, P1258, DOI 10.1139/f90-144; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; Mangot JF, 2009, APPL ENVIRON MICROB, V75, P6373, DOI 10.1128/AEM.00607-09; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Martin-Cereceda M, 2010, J EUKARYOT MICROBIOL, V57, P159, DOI 10.1111/j.1550-7408.2009.00449.x; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; Matz C, 2002, AQUAT MICROB ECOL, V27, P137, DOI 10.3354/ame027137; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; Medlin LK, 2006, MICROB ECOL, V52, P53, DOI 10.1007/s00248-005-0062-x; Moestrup O, 2000, SYST ASSOC SPEC VOL, V59, P69; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SENSEN CW, 1993, EUR J PHYCOL, V28, P93, DOI 10.1080/09670269300650151; Shalchian-Tabrizi K, 2006, P ROY SOC B-BIOL SCI, V273, P1833, DOI 10.1098/rspb.2006.3515; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; SIEBURTH JM, 1978, LIMNOL OCEANOGR, V23, P1256, DOI 10.4319/lo.1978.23.6.1256; Sieracki M., 2005, ALGAL CULTURING TECH, P101, DOI DOI 10.1016/B978-012088426-1/50008-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; STOCKNER JG, 1986, CAN J FISH AQUAT SCI, V43, P2472, DOI 10.1139/f86-307; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Wakeham SG, 2003, ORG GEOCHEM, V34, P857, DOI 10.1016/S0146-6380(02)00189-4; Weber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041970; WELLS ML, 1991, NATURE, V353, P342, DOI 10.1038/353342a0; Worden A Z, 2008, MICROECOL OCEANS, V2, P159, DOI [10.1002/9780470281840.ch6, DOI 10.1002/9780470281840.CH6]; Worden AZ, 2006, AQUAT MICROB ECOL, V43, P165, DOI 10.3354/ame043165; Worden AZ, 2012, CURR BIOL, V22, pR675, DOI 10.1016/j.cub.2012.07.054; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Yabuki A, 2010, PROTIST, V161, P523, DOI 10.1016/j.protis.2010.03.001; Yilmaz S, 2012, CURR OPIN BIOTECH, V23, P437, DOI 10.1016/j.copbio.2011.11.018; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	65	66	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59565	10.1371/journal.pone.0059565	http://dx.doi.org/10.1371/journal.pone.0059565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555709	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500054
J	Sewall, KB; Caro, SP; Sockman, KW				Sewall, Kendra B.; Caro, Samuel P.; Sockman, Keith W.			Song Competition Affects Monoamine Levels in Sensory and Motor Forebrain Regions of Male Lincoln's Sparrows (Melospiza lincolnii)	PLOS ONE			English	Article							MALE ZEBRA FINCHES; MATE-CHOICE CUES; LOCUS-COERULEUS; CATECHOLAMINERGIC INNERVATION; NORADRENERGIC MODULATION; TERRITORIAL BEHAVIOR; TYROSINE-HYDROXYLASE; DOPAMINERGIC SYSTEM; NEURONAL ACTIVATION; AUDITORY RESPONSES	Male animals often change their behavior in response to the level of competition for mates. Male Lincoln's sparrows (Melospiza lincolnii) modulate their competitive singing over the period of a week as a function of the level of challenge associated with competitors' songs. Differences in song challenge and associated shifts in competitive state should be accompanied by neural changes, potentially in regions that regulate perception and song production. The monoamines mediate neural plasticity in response to environmental cues to achieve shifts in behavioral state. Therefore, using high pressure liquid chromatography with electrochemical detection, we compared levels of monoamines and their metabolites from male Lincoln's sparrows exposed to songs categorized as more or less challenging. We compared levels of norepinephrine and its principal metabolite in two perceptual regions of the auditory telencephalon, the caudomedial nidopallium and the caudomedial mesopallium (CMM), because this chemical is implicated in modulating auditory sensitivity to song. We also measured the levels of dopamine and its principal metabolite in two song control nuclei, area X and the robust nucleus of the arcopallium (RA), because dopamine is implicated in regulating song output. We measured the levels of serotonin and its principal metabolite in all four brain regions because this monoamine is implicated in perception and behavioral output and is found throughout the avian forebrain. After controlling for recent singing, we found that males exposed to more challenging song had higher levels of norepinephrine metabolite in the CMM and lower levels of serotonin in the RA. Collectively, these findings are consistent with norepinephrine in perceptual brain regions and serotonin in song control regions contributing to neuroplasticity that underlies socially-induced changes in behavioral state.	[Sewall, Kendra B.; Caro, Samuel P.; Sockman, Keith W.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Sockman, Keith W.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sewall, KB (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	ksewall@vt.edu; kws@unc.edu	P, Samuel/A-5750-2008	P, Samuel/0000-0002-5405-7753; Sewall, Kendra/0000-0002-9347-5878	National Institutes of Health [NS055125, HD056981]; UNC Award from the RJ Reynolds fund; Leon Speeckaert Fund from the King of Baudouin Foundation; Belgian American Educational Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD056981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Award from the RJ Reynolds fund; Leon Speeckaert Fund from the King of Baudouin Foundation; Belgian American Educational Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH R01 grant number NS055125 to KWS, NIH IRACDA funding and F32 grant number HD056981 to KBS, http://www.nih.gov), a UNC Award from the RJ Reynolds fund (http://www.zsr.org/history.htm) to KWS, and a Leon Speeckaert Fund from the King of Baudouin Foundation and the Belgian American Educational Foundation (http://www.kbfus.org/index.html?current=9&page=6&page2=9&lang=en) to SPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2009, ANIM BEHAV, V78, P97, DOI 10.1016/j.anbehav.2009.03.023; Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; Appeltants D, 2002, NEUROREPORT, V13, P649, DOI 10.1097/00001756-200204160-00023; Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; Appeltants D, 2001, CELL TISSUE RES, V304, P237, DOI 10.1007/s004410100360; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Ball GF, 2010, J CHEM NEUROANAT, V39, P82, DOI 10.1016/j.jchemneu.2009.08.005; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BOTTJER SW, 1993, J NEUROBIOL, V24, P51, DOI 10.1002/neu.480240105; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Castelino CB, 2010, J CHEM NEUROANAT, V39, P96, DOI 10.1016/j.jchemneu.2009.08.003; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; Catchpole CK, 1990, BIRD SONG BIOL THEME; Challet E, 1996, ANAT EMBRYOL, V193, P209; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Collins S., 2004, NATURES MUSIC SCI BI; DATLA KP, 1990, INDIAN J EXP BIOL, V28, P742; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; Duffy DL, 2002, P ROY SOC B-BIOL SCI, V269, P847, DOI 10.1098/rspb.2002.1956; Eda-Fujiwara H, 2003, EUR J NEUROSCI, V17, P149, DOI 10.1046/j.1460-9568.2003.02414.x; Ferrari PF, 2005, EUR J PHARMACOL, V526, P259, DOI 10.1016/j.ejphar.2005.10.002; FLORVALL L, 1978, J MED CHEM, V21, P56, DOI 10.1021/jm00199a010; Gale SD, 2008, J COMP NEUROL, V508, P824, DOI 10.1002/cne.21700; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; GODARD R, 1993, BEHAV ECOL SOCIOBIOL, V33, P45, DOI 10.1007/BF00164345; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Harding CF, 1998, J NEUROBIOL, V34, P329, DOI 10.1002/(SICI)1097-4695(199803)34:4<329::AID-NEU4>3.0.CO;2-8; Harvey JA, 2003, LEARN MEMORY, V10, P355, DOI 10.1101/lm.60803; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Heimovics SA, 2008, PHYSIOL BEHAV, V95, P258, DOI 10.1016/j.physbeh.2008.06.009; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Huang YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003281; Hurd PL, 2005, ANIM BEHAV, V70, P1155, DOI 10.1016/j.anbehav.2005.02.014; Hurley LM, 1999, J NEUROSCI, V19, P8071; Hurley LM, 2002, HEARING RES, V168, P1, DOI 10.1016/S0378-5955(02)00365-9; Hurley LM, 2005, J NEUROSCI, V25, P7876, DOI 10.1523/JNEUROSCI.1178-05.2005; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Hurley LM, 2001, J NEUROPHYSIOL, V85, P828, DOI 10.1152/jn.2001.85.2.828; Hyman J, 2004, BEHAVIOUR, V141, P15, DOI 10.1163/156853904772746574; Hyman J, 2006, ANIM BEHAV, V72, P209, DOI 10.1016/j.anbehav.2006.01.007; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; KROODSMA DE, 1990, ANIM BEHAV, V40, P1138, DOI 10.1016/S0003-3472(05)80180-0; Kruse AA, 2004, NEUROBIOL LEARN MEM, V82, P99, DOI 10.1016/j.nlm.2004.05.001; Kubikova L, 2010, J CHEM NEUROANAT, V39, P112, DOI 10.1016/j.jchemneu.2009.10.004; Leitner S, 2005, J NEUROBIOL, V64, P275, DOI 10.1002/neu.20135; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Maney DL, 2003, J NEUROBIOL, V56, P163, DOI 10.1002/neu.10227; Maney DL, 2008, J COMP NEUROL, V511, P173, DOI 10.1002/cne.21830; Manunta Y, 2004, J NEUROPHYSIOL, V92, P1445, DOI 10.1152/jn.00079.2004; Mello CV, 1998, J COMP NEUROL, V400, P207; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MOORE KE, 1986, ANN NY ACAD SCI, V473, P303, DOI 10.1111/j.1749-6632.1986.tb23625.x; MOUNTJOY DJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P97; Naguib M, 2008, ETHOLOGY, V114, P255, DOI 10.1111/j.1439-0310.2007.01466.x; NEWMAN JD, 1991, BRAIN RES, V538, P24, DOI 10.1016/0006-8993(91)90371-2; NICHOLLS TJ, 1988, PHYSIOL REV, V68, P133, DOI 10.1152/physrev.1988.68.1.133; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P1033, DOI 10.1098/rspb.2004.2687; Pinheiro J, 2012, LINEAR NONLINEAR MIX; R Core Team, 2018, R LANG ENV STAT COMP; Rauceo S, 2008, BEHAV BRAIN RES, V187, P133, DOI 10.1016/j.bbr.2007.09.003; Ribeiro S, 1998, NEURON, V21, P359, DOI 10.1016/S0896-6273(00)80545-0; Riters LV, 2007, BRAIN RES, V1149, P127, DOI 10.1016/j.brainres.2007.02.059; Riters LV, 2004, BEHAV BRAIN RES, V155, P307, DOI 10.1016/j.bbr.2004.05.002; Salvante KG, 2010, DEV NEUROBIOL, V70, P41, DOI 10.1002/dneu.20752; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Schroeder MB, 2006, PHYSIOL BEHAV, V88, P575, DOI 10.1016/j.physbeh.2006.05.011; Sewall KB, 2010, HORM BEHAV, V58, P544, DOI 10.1016/j.yhbeh.2010.04.002; Sockman KW, 2008, DEV NEUROBIOL, V68, P656, DOI 10.1002/dneu.20611; Sockman KW, 2009, J EXP BIOL, V212, P2411, DOI 10.1242/jeb.028456; Sockman KW, 2005, J NEUROBIOL, V62, P72, DOI 10.1002/neu.20068; Sockman KW, 2002, P ROY SOC B-BIOL SCI, V269, P2479, DOI 10.1098/rspb.2002.2180; Soha JA, 1996, J NEUROBIOL, V29, P473, DOI 10.1002/(SICI)1097-4695(199604)29:4<473::AID-NEU5>3.0.CO;2-5; Stripling R, 1997, J NEUROSCI, V17, P3883; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Tchernichovski O, 2001, SOUND ANAL PRO USER; Ten Eyck GR, 2008, BEHAV BRAIN RES, V193, P144, DOI 10.1016/j.bbr.2008.05.001; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Theunissen FE, 2006, CURR OPIN NEUROBIOL, V16, P400, DOI 10.1016/j.conb.2006.07.003; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; van der Vegt BJ, 2003, HORM BEHAV, V44, P199, DOI 10.1016/S0018-506X(03)00132-6; vanFurth WR, 1995, BRAIN RES REV, V21, P162, DOI 10.1016/0165-0173(96)82985-7; Velho TAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036276; WASSERMAN FE, 1991, BEHAV ECOL SOCIOBIOL, V29, P55, DOI 10.1007/BF00164295; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; WINSLOW JT, 1990, NEUROPSYCHOPHARMACOL, V3, P51; Wood WE, 2011, J NEUROSCI, V31, P13808, DOI 10.1523/JNEUROSCI.2281-11.2011; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x	110	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59857	10.1371/journal.pone.0059857	http://dx.doi.org/10.1371/journal.pone.0059857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555809	Green Published, gold			2022-12-27	WOS:000317418500100
J	Wilcox, TM; McKelvey, KS; Young, MK; Jane, SF; Lowe, WH; Whiteley, AR; Schwartz, MK				Wilcox, Taylor M.; McKelvey, Kevin S.; Young, Michael K.; Jane, Stephen F.; Lowe, Winsor H.; Whiteley, Andrew R.; Schwartz, Michael K.			Robust Detection of Rare Species Using Environmental DNA: The Importance of Primer Specificity	PLOS ONE			English	Article							BULL TROUT; HYBRIDIZATION; ABUNDANCE; INVASION	Environmental DNA (eDNA) is being rapidly adopted as a tool to detect rare animals. Quantitative PCR (qPCR) using probe-based chemistries may represent a particularly powerful tool because of the method's sensitivity, specificity, and potential to quantify target DNA. However, there has been little work understanding the performance of these assays in the presence of closely related, sympatric taxa. If related species cause any cross-amplification or interference, false positives and negatives may be generated. These errors can be disastrous if false positives lead to overestimate the abundance of an endangered species or if false negatives prevent detection of an invasive species. In this study we test factors that influence the specificity and sensitivity of TaqMan MGB assays using co-occurring, closely related brook trout (Salvelinus fontinalis) and bull trout (S. confluentus) as a case study. We found qPCR to be substantially more sensitive than traditional PCR, with a high probability of detection at concentrations as low as 0.5 target copies/ml. We also found that number and placement of base pair mismatches between the Taqman MGB assay and non-target templates was important to target specificity, and that specificity was most influenced by base pair mismatches in the primers, rather than in the probe. We found that insufficient specificity can result in both false positive and false negative results, particularly in the presence of abundant related species. Our results highlight the utility of qPCR as a highly sensitive eDNA tool, and underscore the importance of careful assay design.	[Wilcox, Taylor M.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] US Forest Serv, USDA, Rocky Mt Res Stn, Missoula, MT USA; [Jane, Stephen F.; Whiteley, Andrew R.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Lowe, Winsor H.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Massachusetts System; University of Massachusetts Amherst; University of Montana System; University of Montana	Wilcox, TM (corresponding author), US Forest Serv, USDA, Rocky Mt Res Stn, Missoula, MT USA.	taylor.wilcox@umontana.edu	Schwartz, Michael K/C-3184-2014; Wilcox, Taylor/P-7064-2019	Schwartz, Michael K/0000-0003-3521-3367; Wilcox, Taylor/0000-0003-3341-7374; Whiteley, Andrew/0000-0002-8159-6381				Anderson GB, 2012, T AM FISH SOC, V141, P34, DOI 10.1080/00028487.2011.644193; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; DeHaan PW, 2010, CONSERV GENET, V11, P935, DOI 10.1007/s10592-009-9937-6; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Environmental DNA Calibration Study, 2012, ENV DNA CAL STUD INT; Fausch KD, 2009, CONSERV BIOL, V23, P859, DOI 10.1111/j.1523-1739.2008.01159.x; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herrero B, 2010, J AGR FOOD CHEM, V58, P4794, DOI 10.1021/jf904018h; Jerde CL, 2012, CONSERV LETT, V5, P241, DOI 10.1111/j.1755-263X.2012.00231.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kanda N, 2002, T AM FISH SOC, V131, P772, DOI 10.1577/1548-8659(2002)131&lt;0772:EOIHBB&gt;2.0.CO;2; Kinziger AP, 2003, COPEIA, P624; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Lovell S. J., 2006, Agricultural and Resource Economics Review, V35, P195; Mills L. Scott, 2000, Conservation Genetics, V1, P285, DOI 10.1023/A:1011574209558; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Peterson JT, 2004, T AM FISH SOC, V133, P462, DOI 10.1577/03-044; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Rieman BE, 2006, CAN J FISH AQUAT SCI, V63, P63, DOI 10.1139/F05-206; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; SCHMIDT TR, 1993, COPEIA, P880; Schwartz MK, 2004, CONSERV GENET, V5, P349, DOI 10.1023/B:COGE.0000031141.47148.8b; Shepard BB, 2004, N AM J FISH MANAGE, V24, P1088, DOI 10.1577/M03-105.1; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; U.S. Fish and Wildlife Service, 1999, FED REG, V64, P58910; Verspoor E, 2010, HYDROBIOLOGIA, V650, P117, DOI 10.1007/s10750-010-0106-1; Whiley DA, 2005, J CLIN VIROL, V34, P104, DOI 10.1016/j.jcv.2005.02.010; Yao Y, 2006, MOL CELL PROBE, V20, P311, DOI 10.1016/j.mcp.2006.03.003	40	273	288	4	285	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59520	10.1371/journal.pone.0059520	http://dx.doi.org/10.1371/journal.pone.0059520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555689	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500042
J	Asplund, L; Bergkvist, G; Leino, MW; Westerbergh, A; Weih, M				Asplund, Linnea; Bergkvist, Goran; Leino, Matti W.; Westerbergh, Anna; Weih, Martin			Swedish Spring Wheat Varieties with the Rare High Grain Protein Allele of NAM-B1 Differ in Leaf Senescence and Grain Mineral Content	PLOS ONE			English	Article							L. VAR. DICOCCOIDES; CONTENT GENE GPC-B1; TRITICUM-AESTIVUM; CONTENT LOCUS; DURUM-WHEAT; DRY-MATTER; YIELD; NITROGEN; BREAD; QUALITY	Some Swedish spring wheat varieties have recently been shown to carry a rare wildtype (wt) allele of the gene NAM-B1, known to affect leaf senescence and nutrient retranslocation to the grain. The wt allele is believed to increase grain protein concentration and has attracted interest from breeders since it could contribute to higher grain quality and more nitrogen-efficient varieties. This study investigated whether Swedish varieties with the wt allele differ from varieties with one of the more common, non-functional alleles in order to examine the effect of the gene in a wide genetic background, and possibly explain why the allele has been retained in Swedish varieties. Forty varieties of spring wheat differing in NAM-B1 allele type were cultivated under controlled conditions. Senescence was monitored and grains were harvested and analyzed for mineral nutrient concentration. Varieties with the wt allele reached anthesis earlier and completed senescence faster than varieties with the non-functional allele. The wt varieties also had more ears, lighter grains and higher yields of P and K. Contrary to previous information on effects of the wt allele, our wt varieties did not have increased grain N concentration or grain N yield. In addition, temporal studies showed that straw length has decreased but grain N yield has remained unaffected over a century of Swedish spring wheat breeding. The faster development of wt varieties supports the hypothesis of NAM-B1 being preserved in Fennoscandia, with its short growing season, because of accelerated development conferred by the NAM-B1 wt allele. Although the possible effects of other gene actions were impossible to distinguish, the genetic resource of Fennoscandian spring wheats with the wt NAM-B1 allele is interesting to investigate further for breeding purposes.	[Asplund, Linnea; Bergkvist, Goran; Weih, Martin] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Leino, Matti W.] Swedish Museum Cultural Hist, Julita, Sweden; [Leino, Matti W.] Linkoping Univ, IFM Biol, Linkoping, Sweden; [Westerbergh, Anna] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, BioCtr, Uppsala, Sweden	Swedish University of Agricultural Sciences; Linkoping University; Swedish University of Agricultural Sciences	Asplund, L (corresponding author), Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden.	linnea.asplund@slu.se	Weih, Martin/H-5093-2011	Weih, Martin/0000-0003-3823-9183; Bergkvist, Goran/0000-0001-9287-0510	Swedish University of Agricultural Sciences	Swedish University of Agricultural Sciences	This study was supported by the Swedish University of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman A, 1951, SVENSK VAXTFORADLING; [Anonymous], SAS SOFTW VERS 9 2 9; Asplund L, 2010, J ARCHAEOL SCI, V37, P2303, DOI 10.1016/j.jas.2010.04.003; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Brevis JC, 2010, J CEREAL SCI, V51, P357, DOI 10.1016/j.jcs.2010.02.004; Brevis JC, 2010, CROP SCI, V50, P93, DOI 10.2135/cropsci2009.02.0057; CALDERINI DF, 1995, ANN BOT-LONDON, V76, P315, DOI 10.1006/anbo.1995.1101; CANTRELL RG, 1991, CROP SCI, V31, P645, DOI 10.2135/cropsci1991.0011183X003100030020x; Cantu D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-492; Chardon F, 2012, J EXP BOT, V63, P3401, DOI 10.1093/jxb/err353; Chee PW, 2001, CROP SCI, V41, P295, DOI 10.2135/cropsci2001.412295x; Dahlin AS, 2012, EUR J AGRON, V43, P33, DOI 10.1016/j.eja.2012.04.007; Distelfeld A, 2006, NEW PHYTOL, V169, P753, DOI 10.1111/j.1469-8137.2005.01627.x; Distelfeld A, 2008, MOL BREEDING, V22, P25, DOI 10.1007/s11032-007-9153-3; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Guarda G, 2004, EUR J AGRON, V21, P181, DOI 10.1016/j.eja.2003.08.001; Hagenblad J, 2012, THEOR APPL GENET, V125, P1677, DOI 10.1007/s00122-012-1943-2; Heidlebaugh NM, 2008, FUNCT PLANT BIOL, V35, P619, DOI 10.1071/FP07247; Joppa LR, 1997, CROP SCI, V37, P1586, DOI 10.2135/cropsci1997.0011183X003700050030x; Kade M, 2005, PLANT BREEDING, V124, P343, DOI 10.1111/j.1439-0523.2005.01110.x; KIBITE S, 1984, EUPHYTICA, V33, P801, DOI 10.1007/BF00021906; Kumar J, 2011, FIELD CROP RES, V123, P226, DOI 10.1016/j.fcr.2011.05.013; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Mesfin A, 1999, CROP SCI, V39, P508, DOI 10.2135/cropsci1999.0011183X003900020035x; Mosier A.R., 2004, AGR NITROGEN CYCLE A; Olsson G., 1997, SVENSKA VAXTFORADLIN; Ortiz R, 1998, ACTA AGR SCAND B-S P, V48, P229, DOI 10.1080/09064719809362503; Parrott DL, 2012, J EXP BOT, V63, P1329, DOI 10.1093/jxb/err360; Peltonen-Sainio P, 2007, FIELD CROP RES, V100, P179, DOI 10.1016/j.fcr.2006.07.002; Peltonen-Sainio P, 2012, EUR J AGRON, V39, P1, DOI 10.1016/j.eja.2012.01.002; Piegorsch WW, 2005, ANALYZING ENVIRONMENTAL DATA, P1, DOI 10.1002/0470012234; R Development Core Team, 2012, R LANG ENV STAT COMP; Semenov MA, 2007, AGR FOREST METEOROL, V144, P127, DOI 10.1016/j.agrformet.2007.02.003; SLAFER GA, 1991, EUPHYTICA, V58, P37, DOI 10.1007/BF00035338; SLAFER GA, 1990, EUPHYTICA, V50, P63, DOI 10.1007/BF00023162; Steiger DK, 1996, CROP SCI, V36, P223, DOI 10.2135/cropsci1996.0011183X003600020001x; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Weih M, 2011, PLANT SOIL, V339, P513, DOI 10.1007/s11104-010-0599-4	43	21	24	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59704	10.1371/journal.pone.0059704	http://dx.doi.org/10.1371/journal.pone.0059704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555754	gold, Green Published, Green Accepted			2022-12-27	WOS:000316546400054
J	Chen, S; Entakli, J; Bonnard, M; Berton, E; De Graaf, JB				Chen, Sophie; Entakli, Jonathan; Bonnard, Mireille; Berton, Eric; De Graaf, Jozina B.			Functional Corticospinal Projections from Human Supplementary Motor Area Revealed by Corticomuscular Coherence during Precise Grip Force Control	PLOS ONE			English	Article							FRONTAL-LOBE; HAND MUSCLE; OSCILLATORY ACTIVITY; MEDIAL WALL; CORTEX; TASK; SYNCHRONIZATION; COORDINATION; CONTRACTION; NEURONS	The purpose of the present study was to investigate whether corticospinal projections from human supplementary motor area (SMA) are functional during precise force control with the precision grip (thumb-index opposition). Since beta band corticomuscular coherence (CMC) is well-accepted to reflect efferent corticospinal transmission, we analyzed the beta band CMC obtained with simultaneous recording of electroencephalographic (EEG) and electromyographic (EMG) signals. Subjects performed a bimanual precise visuomotor force tracking task by applying isometric low grip forces with their right hand precision grip on a custom device with strain gauges. Concurrently, they held the device with their left hand precision grip, producing similar grip forces but without any precision constraints, to relieve the right hand. Some subjects also participated in a unimanual control condition in which they performed the task with only the right hand precision grip while the device was held by a mechanical grip. We analyzed whole scalp topographies of beta band CMC between 64 EEG channels and 4 EMG intrinsic hand muscles, 2 for each hand. To compare the different topographies, we performed non-parametric statistical tests based on spatio-spectral clustering. For the right hand, we obtained significant beta band CMC over the contralateral M1 region as well as over the SMA region during static force contraction periods. For the left hand, however, beta band CMC was only found over the contralateral M1. By comparing unimanual and bimanual conditions for right hand muscles, no significant difference was found on beta band CMC over M1 and SMA. We conclude that the beta band CMC found over SMA for right hand muscles results from the precision constraints and not from the bimanual aspect of the task. The result of the present study strongly suggests that the corticospinal projections from human SMA become functional when high precision force control is required.	[Chen, Sophie; Entakli, Jonathan; Berton, Eric; De Graaf, Jozina B.] Aix Marseille Univ, CNRS, ISM UMR 7287, F-13288 Marseille, France; [Chen, Sophie; Bonnard, Mireille] Aix Marseille Univ, INSERM, INS UMR S 1106, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	De Graaf, JB (corresponding author), Aix Marseille Univ, CNRS, ISM UMR 7287, F-13288 Marseille, France.	jozina.de-graaf@univ-amu.fr	De Graaf, Jozina/AAJ-7475-2020		National Center for Scientific Research; Aix-Marseille universite	National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille universite	This work was supported in part by funds from the National Center for Scientific Research (http://www.cnrs.fr/) and the Aix-Marseille universite. This work was also supported by a PhD fellowship of the National Center for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrykiewicz A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-101; Armand J, 1997, J NEUROSCI, V17, P251, DOI 10.1523/JNEUROSCI.17-01-00251.1997; Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bonnard M, 2007, EUR J NEUROSCI, V25, P872, DOI 10.1111/j.1460-9568.2007.05320.x; Boudrias MH, 2006, CEREB CORTEX, V16, P632, DOI 10.1093/cercor/bhj009; Chakarov V, 2009, J NEUROPHYSIOL, V102, P1115, DOI 10.1152/jn.91095.2008; CHALLIS RE, 1991, MED BIOL ENG COMPUT, V29, P225, DOI 10.1007/BF02446704; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 1996, J NEUROSCI, V16, P6513; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; Gallea C, 2005, NEUROREPORT, V16, P1271, DOI 10.1097/01.wnr.0000176514.17561.94; Gerloff C, 2006, HUM BRAIN MAPP, V27, P789, DOI 10.1002/hbm.20220; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; Haller S, 2009, EUR J NEUROSCI, V30, P2401, DOI 10.1111/j.1460-9568.2009.07003.x; Halliday DM, 2010, J NEUROPHYSIOL, V103, P3547, DOI 10.1152/jn.00222.2010; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; HE SQ, 1995, J NEUROSCI, V15, P3284; HUTCHINS KD, 1988, EXP BRAIN RES, V71, P667, DOI 10.1007/BF00248761; Johnson AN, 2011, CLIN NEUROPHYSIOL, V122, P356, DOI 10.1016/j.clinph.2010.06.021; Kilner JM, 2003, NEUROIMAGE, V18, P67, DOI 10.1006/nimg.2002.1322; Kilner JM, 1999, J PHYSIOL-LONDON, V516, P559, DOI 10.1111/j.1469-7793.1999.0559v.x; Kilner JM, 2000, J NEUROSCI, V20, P8838; Koeneke S, 2004, NEUROIMAGE, V22, P1336, DOI 10.1016/j.neuroimage.2004.03.012; Krainik A, 2001, NEUROLOGY, V57, P871, DOI 10.1212/WNL.57.5.871; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Kristeva-Feige R, 2002, CLIN NEUROPHYSIOL, V113, P124, DOI 10.1016/S1388-2457(01)00722-2; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; Lattari E, 2010, REV NEUROLOGIA, V51, P610, DOI 10.33588/rn.5110.2010311; LEMON RN, 1995, J NEUROSCI, V15, P6145; LEMON RN, 1989, J PHYSIOL-LONDON, V413, P351, DOI 10.1113/jphysiol.1989.sp017658; Lemon RN, 1998, NOVART FDN SYMP, V218, P202; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Mendez-Balbuena I, 2011, CEREB CORTEX; Meng F, 2008, J NEURAL ENG, V5, P324, DOI 10.1088/1741-2560/5/3/005; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Naranjo JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-157; Ohara S, 2000, CLIN NEUROPHYSIOL, V111, P2014, DOI 10.1016/S1388-2457(00)00448-X; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PALMER C, 1981, BRAIN RES, V209, P305, DOI 10.1016/0006-8993(81)90155-4; Patino L, 2008, J NEUROPHYSIOL, V99, P1906, DOI 10.1152/jn.00390.2007; Riddle CN, 2005, J PHYSIOL-LONDON, V566, P625, DOI 10.1113/jphysiol.2005.089607; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Rouiller EM, 1996, EUR J NEUROSCI, V8, P1055, DOI 10.1111/j.1460-9568.1996.tb01592.x; Sadato N, 1997, J NEUROSCI, V17, P9667; Safri NM, 2006, INT J PSYCHOPHYSIOL, V61, P288, DOI 10.1016/j.ijpsycho.2006.03.003; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; SIRIN AV, 1987, EUR J APPL PHYSIOL O, V56, P238, DOI 10.1007/BF00640651; SMITH AM, 1979, BRAIN RES, V172, P315, DOI 10.1016/0006-8993(79)90541-9; Teitti S, 2008, NEUROIMAGE, V40, P1243, DOI 10.1016/j.neuroimage.2007.12.065; Toyokura M, 1999, BRAIN RES BULL, V48, P211, DOI 10.1016/S0361-9230(98)00165-8; Vaalto S, 2011, HUM BRAIN MAPP, V32, P1692, DOI 10.1002/hbm.21137; Wiesendanger M, 1996, ADV NEUROL, V70, P85; Witham CL, 2011, J PHYSIOL-LONDON, V589, P3789, DOI 10.1113/jphysiol.2011.211045; Witte M, 2007, EUR J NEUROSCI, V26, P3564, DOI 10.1111/j.1460-9568.2007.05942.x	63	13	13	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60291	10.1371/journal.pone.0060291	http://dx.doi.org/10.1371/journal.pone.0060291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555945	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400088
J	Tuominen, I; Al-Rabadi, L; Stavrakis, D; Karagiannides, I; Pothoulakis, C; Bugni, JM				Tuominen, Iina; Al-Rabadi, Leina; Stavrakis, Dimitris; Karagiannides, Iordanis; Pothoulakis, Charalabos; Bugni, James M.			Diet-Induced Obesity Promotes Colon Tumor Development in Azoxymethane-Treated Mice	PLOS ONE			English	Article							BODY-MASS INDEX; ABERRANT CRYPT FOCI; COLORECTAL CARCINOGENESIS; KK-A(Y) MICE; CANCER; TUMORIGENESIS; FAT; INFLAMMATION; RATS; SUSCEPTIBILITY	Obesity is an important risk factor for colon cancer in humans, and numerous studies have shown that a high fat diet enhances colon cancer development. As both increased adiposity and high fat diet can promote tumorigenesis, we examined the effect of diet-induced obesity, without ongoing high fat diet, on colon tumor development. C57BL/6J male mice were fed regular chow or high fat diet for 8 weeks. Diets were either maintained or switched resulting in four experimental groups: regular chow (R), high fat diet (H), regular chow switched to high fat diet (RH), and high fat diet switched to regular chow (HR). Mice were then administered azoxymethane to induce colon tumors. Tumor incidence and multiplicity were dramatically smaller in the R group relative to all groups that received high fat diet at any point. The effect of obesity on colon tumors could not be explained by differences in aberrant crypt foci number. Moreover, diet did not alter colonic expression of pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-6, interleukin-1 beta, and interferon-gamma, which were measured immediately after azoxymethane treatment. Crypt apoptosis and proliferation, which were measured at the same time, were increased in the HR relative to all other groups. Our results suggest that factors associated with obesity - independently of ongoing high fat diet and obesity - promote tumor development because HR group animals had significantly more tumors than R group, and these mice were fed the same regular chow throughout the entire carcinogenic period. Moreover, there was no difference in the number of aberrant crypt foci between these groups, and thus the effect of obesity appears to be on subsequent stages of tumor development when early preneoplastic lesions transition into adenomas.	[Tuominen, Iina; Al-Rabadi, Leina; Stavrakis, Dimitris; Karagiannides, Iordanis; Pothoulakis, Charalabos; Bugni, James M.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bugni, JM (corresponding author), Ferring Pharmaceut Inc, Parsippany, NJ USA.	james.bugni@ferring.com		Alrabadi, Leina/0000-0002-4507-2476	National Institutes of Health [RO-1 DK60729]; CURE (New Investigator Award: Digestive Diseases Research Center) [41301]; Martin Blinder Fund for IBD Research; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CURE (New Investigator Award: Digestive Diseases Research Center); Martin Blinder Fund for IBD Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was financially supported by the National Institutes of Health (RO-1 DK60729, CP), CURE (New Investigator Award: Digestive Diseases Research Center 41301, JMB), the Martin Blinder Fund for IBD Research (CP), and the Sigrid Juselius Foundation (Postdoctoral Fellowship, IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bousserouel S, 2011, PATHOL INT, V61, P80, DOI 10.1111/j.1440-1827.2010.02621.x; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Ealey KN, 2008, MOL CARCINOGEN, V47, P667, DOI 10.1002/mc.20419; Ealey KN, 2009, INT J CANCER, V124, P2226, DOI 10.1002/ijc.24187; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flores MB, 2012, GASTROENTEROLOGY; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Fujise T, 2007, AM J PHYSIOL-GASTR L, V292, pG1150, DOI 10.1152/ajpgi.00269.2006; Guda K, 2007, INT J ONCOL, V31, P837; Hata K, 2012, CARCINOGENESIS, V33, P702, DOI 10.1093/carcin/bgr323; Hirose Y, 2004, CARCINOGENESIS, V25, P821, DOI 10.1093/carcin/bgh059; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Ikeda K, 2011, CANCER SCI, V102, P79, DOI 10.1111/j.1349-7006.2010.01754.x; Koch TCL, 2008, EUR J NUTR, V47, P161, DOI 10.1007/s00394-008-0711-1; Levi Zohar, 2011, Cancer Epidemiol Biomarkers Prev, V20, P2524, DOI 10.1158/1055-9965.EPI-11-0531; Liu Z, 2011, J NUTR BIOCH; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Mentor-Marcel RA, 2009, CANCER PREV RES, V2, P60, DOI 10.1158/1940-6207.CAPR-08-0086; Nambiar PR, 2003, INT J ONCOL, V22, P145; Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Nunez NP, 2006, CANCER RES, V66, P5469, DOI 10.1158/0008-5472.CAN-05-4102; Padidar S, 2012, DIGEST DIS SCI, V57, P1866, DOI 10.1007/s10620-012-2092-9; REDDY BS, 1992, LIPIDS, V27, P807, DOI 10.1007/BF02535855; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Singh J, 1997, CANCER RES, V57, P253; Stattin P, 2004, INT J CANCER, V109, P149, DOI 10.1002/ijc.11668; Suto J, 1998, EUR J ENDOCRINOL, V139, P654, DOI 10.1530/eje.0.1390654; Teraoka N, 2011, INT J CANCER, V129, P528, DOI 10.1002/ijc.25711; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540	35	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60939	10.1371/journal.pone.0060939	http://dx.doi.org/10.1371/journal.pone.0060939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560112	Green Published, gold			2022-12-27	WOS:000318840100109
J	Choi, J; Kim, TH; Choi, TY; Lee, MS				Choi, Jiae; Kim, Tae-Hun; Choi, Tae-Young; Lee, Myeong Soo			Ginseng for Health Care: A Systematic Review of Randomized Controlled Trials in Korean Literature	PLOS ONE			English	Review							RED GINSENG; DOUBLE-BLIND; EFFICACY; SUPPLEMENTATION; STIFFNESS; DISEASE	Objective: This systematic review was performed to summarise randomised clinical trials (RCTs) assessing the efficacy and safety of ginseng in the Korean literature. Method: The study involved systematic searches conducted in eight Korean Medical databases. The methodological quality of all of the included studies was assessed using the Cochrane Risk of Bias tool. We included all RCTs on any type of ginseng compared to placebo, active treatment or no treatment in healthy individuals or patients regardless of conditions. Results: In total, 1415 potentially relevant studies were identified, and 30 randomised clinical trials were included. Nine RCTs assessed the effects of ginseng on exercise capacity, cognitive performance, somatic symptoms, quality of life, and sleeping in healthy persons. Six RCTs tested ginseng compared with placebo for erectile dysfunction, while another four studies evaluated the effects of ginseng against no treatment for gastric and colon cancer. Two RCTs compared the effect of red ginseng on diabetes mellitus with no treatment or placebo, and the other nine RCTs assessed the effects of ginseng compared with placebo or no treatment on various conditions. The methodological caveats of the included trials make their contribution to the current clinical evidence of ginseng somewhat limited. However, the 20 newly added trials (66.7% of the 30 trials) may provide useful information for future trials. Ginseng appears to be generally safe, and no serious adverse effects have been reported. Conclusions: The clinical effects of ginseng have been tested in a wide range of conditions in Korea. Although the quality of RCTs published in the Korean literature was generally poor, this review is useful for researchers to access studies that were originally published in languages that they would otherwise be unable to read and due to the paucity of evidence on this subject.	[Choi, Jiae; Choi, Tae-Young; Lee, Myeong Soo] Korea Inst Oriental Med, Div Med Res, Taejon, South Korea; [Kim, Tae-Hun] Mokhuri Neck & Back Hosp, Dept Spine Ctr, Seoul, South Korea	Korea Institute of Oriental Medicine (KIOM)	Lee, MS (corresponding author), Korea Inst Oriental Med, Div Med Res, Taejon, South Korea.	drmslee@gmail.com	Lee, Myeong Soo/C-8147-2013; Kim, Tae-Hun/G-8728-2014	Lee, Myeong Soo/0000-0001-6651-7641; Kim, Tae-Hun/0000-0002-8448-3219	KIOM [K13400, C12080]	KIOM	JC, TYC and MSL were supported by KIOM (K13400 and C12080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; 김덕기, 2007, [The Korean Journal of Medicine, 대한내과학회지], V72, P20; 권동현, 2011, [Journal of Korean Medicine for Obesity Research, 한방비만학회지], V11, P1; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cherdrungsi P, 1995, J GINSENG RES, V19, P93; Cho GH., 2005, J GINSENG RES, V29, P27; Choi HK., 1999, J GINSENG RES, V23, P247; Choi HK., 2001, J GINSENG RES, V25, P112; Choi K.M., 1997, KOREAN J GINSENG SCI, V21, P153; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Chung IM, 2010, J GINSENG RES, V34, P212, DOI 10.5142/jgr.2010.34.3.212; Ernst E, 2010, J GINSENG RES, V34, P259, DOI 10.5142/jgr.2010.34.4.259; 김홍식, 2006, The World Journal of Men's Health, V24, P84; Ham Won Sik, 2009, Investigative and Clinical Urology, V50, P159; Helms Steve, 2004, Altern Med Rev, V9, P259; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hong BS., 2001, THESIS U ULSAN ULSAN; Hur MH, 2010, J GINSENG RES, V34, P342, DOI 10.5142/jgr.2010.34.4.342; Hwang MK, 2006, THESIS KYUNG HEE U; Jang DJ, 2008, BRIT J CLIN PHARMACO, V66, P444, DOI 10.1111/j.1365-2125.2008.03236.x; Jeong D-W, 2006, J KOREAN ORIENT MED, V27, P38; Jia YL, 2012, COMPLEMENT THER MED, V20, P155, DOI 10.1016/j.ctim.2011.12.002; Jung, 1998, J GINSENG RES, V22, P32; Kim HO, 2011, THESIS PUSAN NATL U; 서성옥, 2004, Journal of Ginseng Research, V28, P104; Kim NR, 2010, J GINSENG RES, V34, P237, DOI 10.5142/jgr.2010.34.3.237; Kim S, 2011, CHIN J INTEGR MED, V17, P937, DOI 10.1007/s11655-011-0937-2; Kim SK, 2007, J GINSENG RES, V31, P93; Kim SW., 1999, KOREAN J ANDROL, V17, P23; Kulaputana Onanong, 2007, Journal of the Medical Association of Thailand, V90, P1172; Kwon DH, 2012, J GINSENG RES, V36, P176, DOI 10.5142/jgr.2012.36.2.176; Lee MS, 2009, J ALZHEIMERS DIS, V18, P339, DOI 10.3233/JAD-2009-1149; Lee NH, 2011, J ACUPUNCT MERIDIAN, V4, P85, DOI 10.1016/S2005-2901(11)60013-7; Lee NH, 2011, THESIS DAEJEON U; Lee S.A., 2010, SLEEP MED PSYCHOPHYS, V17, P85; Lee S. T., 2007, J GINSENG RES, V31, P51; Lee SJ, 2010, J GINSENG RES, V34, P122, DOI 10.5142/jgr.2010.34.2.122; Lee YH, 2009, THESIS EWHA WOMANS U; O. Kennedy D., 2007, Journal of Ginseng Research, V31, P34; Park BJ, 2012, KOREAN J FAM MED, V33, P190, DOI 10.4082/kjfm.2012.33.4.190; Park JW, 2010, J GINSENG RES, V34, P183, DOI 10.5142/jgr.2010.34.3.183; Rhee MY, 2011, J ALTERN COMPLEM MED, V17, P45, DOI 10.1089/acm.2010.0065; Seely D, 2008, J POPUL THER CLIN PH, V15, pE87; Seida JK, 2011, EVID-BASED COMPL ALT, V2001; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin Kyeong Seob, 2007, Journal of Ginseng Research, V31, P109; Suh Sung Ock, 2007, Journal of Ginseng Research, V31, P54; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Yeo HB, 2012, J GINSENG RES, V36, P190, DOI 10.5142/jgr.2012.36.2.190; 이선구, 2007, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V21, P1185; Yoo HY, 1995, J KOREAN SURG SOC, V54, P854; Yoon SJ, 2008, J GINSENG RES, V32; 김재환, 2009, Journal of Ginseng Research, V33, P223; 강은호, 2009, Journal of Ginseng Research, V33, P219; 김동일, 2009, Journal of Ginseng Research, V33, P115; 서정철, 2004, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V18, P606	56	68	71	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59978	10.1371/journal.pone.0059978	http://dx.doi.org/10.1371/journal.pone.0059978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560064	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900039
J	Harada, J; Mizoguchi, T; Satoh, S; Tsukatani, Y; Yokono, M; Noguchi, M; Tanaka, A; Tamiaki, H				Harada, Jiro; Mizoguchi, Tadashi; Satoh, Souichirou; Tsukatani, Yusuke; Yokono, Makio; Noguchi, Masato; Tanaka, Ayumi; Tamiaki, Hitoshi			Specific Gene bciD for C7-Methyl Oxidation in Bacteriochlorophyll e Biosynthesis of Brown-Colored Green Sulfur Bacteria	PLOS ONE			English	Article							CHLOROBIUM-TEPIDUM; CHLOROPHYLL B; IDENTIFICATION; INACTIVATION; EXPRESSION; OXYGENASE; REQUIRES; LIGHT; CAO	The gene named bciD, which encodes the enzyme involved in C7-formylation in bacteriochlorophyll e biosynthesis, was found and investigated by insertional inactivation in the brown-colored green sulfur bacterium Chlorobaculum limnaeum (previously called Chlorobium phaeobacteroides). The bciD mutant cells were green in color, and accumulated bacteriochlorophyll c homologs bearing the 7-methyl group, compared to C7-formylated BChl e homologs in the wild type. BChl-c homolog compositions in the mutant were further different from those in Chlorobaculum tepidum which originally produced BChl c: (3(1)S)-8-isobutyl-12-ethyl-BChl c was unusually predominant.	[Harada, Jiro; Noguchi, Masato] Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 830, Japan; [Mizoguchi, Tadashi; Tsukatani, Yusuke; Tamiaki, Hitoshi] Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga, Japan; [Satoh, Souichirou; Yokono, Makio; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Tsukatani, Yusuke] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan; [Tanaka, Ayumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Sapporo, Hokkaido, Japan	Kurume University; Ritsumeikan University; Hokkaido University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Harada, J (corresponding author), Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 830, Japan.	jiro_harada@med.kurume-u.ac.jp; tamiaki@fc.ritsumei.ac.jp	Yokono, Makio/N-8425-2015; Tanaka, Ayumi/D-9003-2012; Tsukatani, Yusuke/A-6448-2014	Tsukatani, Yusuke/0000-0003-2831-8996; Yokono, Makio/0000-0002-4813-2120; Satoh, Soichirou/0000-0002-7622-1868	Japan Society for the Promotion of Science [22245030, 24590366, 24550065, 24750169]; Ministry of Education, Culture, Sports, Science and Technology in Japan [24107002]; Grants-in-Aid for Scientific Research [24107002, 25650092, 24550201] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Grants-in-Aid for Scientific Research (A) (No. 22245030 to HT) and (C) (No. 24590366 to MN, and 24550065 to TM) as well as for Young Scientists (B) (No. 24750169 to JH) from the Japan Society for the Promotion of Science, as well as for Scientific Research on Innovative Areas ("Artificial Photosynthesis'', No. 24107002 to HT) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenship R.E., 2003, LIGHT HARVESTING ANT, P195; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Chew AGM, 2004, PHOTOSYNTHESIS FUNDA, P875; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; Eggink Laura L., 2004, BMC Plant Biology, V4, P5, DOI 10.1186/1471-2229-4-5; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; GLOE A, 1975, ARCH MICROBIOL, V102, P103, DOI 10.1007/BF00428353; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; Harada J, 2012, 2 INT S BIOS TETR BS; Harada J, 2012, Japan Patent: No, Patent No. [JP2012/260321, 2012260321]; Harada J, 2012, [Japan Patent: No, PCT Patent Application: No], Patent No. [JP2012/028919, 2012028919]; Harada J, 2008, PHOTOCH PHOTOBIO SCI, V7, P1179, DOI 10.1039/b802435a; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Imhoff JF, 2003, INT J SYST EVOL MICR, V53, P941, DOI 10.1099/ijs.0.02403-0; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Li YQ, 2012, BBA-BIOENERGETICS, V1817, P1292, DOI 10.1016/j.bbabio.2012.02.026; Liu ZF, 2011, J BIOL CHEM, V286, P22393, DOI 10.1074/jbc.M111.249433; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Masuda S, 2011, PLANT CELL, V23, P2644, DOI 10.1105/tpc.111.085357; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Oster U, 1997, J BIOL CHEM, V272, P9671; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Tamiaki H, 2007, PHOTOCHEM PHOTOBIOL, V83, P152, DOI 10.1562/2006-02-27-IR-819; Tamiaki H, 2011, PHOTOSYNTH RES, V107, P133, DOI 10.1007/s11120-010-9603-3; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Vogl K, 2012, 1 INT S BIOF CHEM IS; Vogl K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00298; WAHLUND TM, 1995, J BACTERIOL, V177, P2583, DOI 10.1128/jb.177.9.2583-2588.1995	34	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60026	10.1371/journal.pone.0060026	http://dx.doi.org/10.1371/journal.pone.0060026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560066	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900042
J	Molenaar, R; van den Borne, JJGC; Hazejager, E; Kristensen, NB; Heetkamp, MJW; Meijerhof, R; Kemp, B; van den Brand, H				Molenaar, Roos; van den Borne, Joost J. G. C.; Hazejager, Ewoud; Kristensen, Niels B.; Heetkamp, Marcel J. W.; Meijerhof, Ron; Kemp, Bas; van den Brand, Henry			High Environmental Temperature Increases Glucose Requirement in the Developing Chicken Embryo	PLOS ONE			English	Article							EGGSHELL TEMPERATURE; OXYGEN CONCENTRATION; CARBOHYDRATE-METABOLISM; BROILER EMBRYOS; LATE INCUBATION; TURKEY EMBRYOS; GLYCOGEN; ENERGY; LIVER; LACTATE	Environmental conditions during the perinatal period influence metabolic and developmental processes in mammals and avian species, which could impact pre- and postnatal survival and development. The current study investigated the effect of eggshell temperature (EST) on glucose metabolism in broiler chicken embryos. Broiler eggs were incubated at a high (38.9 degrees C) or normal (37.8 degrees C) EST from day 10.5 of incubation onward and were injected with a bolus of [U-C-13] glucose in the chorio-allantoic fluid at day 17.5 of incubation. After [U-C-13]glucose administration, C-13 enrichment was determined in intermediate pools and end-products of glucose metabolism. Oxidation of labeled glucose occurred for approximately 3 days after injection. Glucose oxidation was higher in the high than in the normal EST treatment from day 17.6 until 17.8 of incubation. The overall recovery of (CO2)-C-13 tended to be 4.7% higher in the high than in the normal EST treatment. An increase in EST (38.9 degrees C vs 37.8 degrees C) increased C-13 enrichment in plasma lactate at day 17.8 of incubation and C-13 in hepatic glycogen at day 18.8 of incubation. Furthermore, high compared to normal EST resulted in a lower yolk-free body mass at day 20.9 (-2.74 g) and 21.7 (-3.81 g) of incubation, a lower hepatic glycogen concentration at day 18.2 (-4.37 mg/g) and 18.8 (-4.59 mg/g) of incubation, and a higher plasma uric acid concentration (+2.8 mg/mL/+43%) at day 21.6 of incubation. These results indicate that the glucose oxidation pattern is relatively slow, but the intensity increased consistently with an increase in developmental stage of the embryo. High environmental temperatures in the perinatal period of chicken embryos increased glucose oxidation and decreased hepatic glycogen prior to the hatching process. This may limit glucose availability for successful hatching and could impact body development, probably by increased gluconeogenesis from glucogenic amino acids to allow anaerobic glycolysis.	[Molenaar, Roos] HatchTech BV, Veenendaal, Netherlands; [van den Borne, Joost J. G. C.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands; [Hazejager, Ewoud; Heetkamp, Marcel J. W.; Kemp, Bas; van den Brand, Henry] Wageningen Univ, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Kristensen, Niels B.] Knowledge Ctr Agr, Aarhus N, Denmark; [Meijerhof, Ron] Poultry Performance Plus, Voorst, Netherlands	Wageningen University & Research; Wageningen University & Research	Molenaar, R (corresponding author), HatchTech BV, Veenendaal, Netherlands.	mail@roosmolenaar.com		Kristensen, Niels Bastian/0000-0003-0214-2929	HatchTech B.V.; HatchTech	HatchTech B.V.; HatchTech	The work was supported by HatchTech B.V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HatchTech supported this study. Roos Molenaar is employed as a senior scientist at the research department of HatchTech B. V. Ron Meijerhof is the owner of the company Poultry Performance Plus and does consultancy work in the poultry industry worldwide. Hatchery Lagerwey B. V. (Lunteren, the Netherlands) donated eggs and provided assistance. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for	Alferink SJJ, 2003, EAAP PUBLIC, P465; BAGGOTT GK, 2001, PERSPECTIVES FERTILI, P23; BALLARD FJ, 1963, BIOCHIM BIOPHYS ACTA, V71, P578, DOI 10.1016/0006-3002(63)91130-2; BEATTIE J, 1964, BR POULT SCI, V5, P285; Bruininx E, 2011, J NUTR, V141, P1657, DOI 10.3945/jn.111.142562; Christensen V. L., 2007, International Journal of Poultry Science, V6, P406; CHRISTENSEN VL, 1993, POULTRY SCI, V72, P829, DOI 10.3382/ps.0720829; Christensen VL, 2011, POULTRY SCI, V80, P1729; Christian MT, 2002, J PEDIATR GASTR NUTR, V34, P158, DOI 10.1097/00005176-200202000-00010; CLAWSON RC, 1975, COMP BIOCHEM PHYS A, V51, P769, DOI 10.1016/0300-9629(75)90054-7; De Oliveira JE, 2008, WORLD POULTRY SCI J, V64, P488, DOI 10.1017/S0043933908000160; DELPHIA JM, 1965, J EMBRYOL EXP MORPH, V14, P273; Foye OT, 2007, AVIAN POULT BIOL REV, V18, P93, DOI 10.3184/147020607X296033; FREEMAN BM, 1969, COMP BIOCHEM PHYSIOL, V28, P1169, DOI 10.1016/0010-406X(69)90557-X; FREEMAN BM, 1965, COMP BIOCHEM PHYSIOL, V14, P217, DOI 10.1016/0010-406X(65)90197-0; GARCIA FJ, 1986, COMP BIOCHEM PHYS B, V85, P727, DOI 10.1016/0305-0491(86)90168-9; HAZELWOOD RL, 1959, AM J PHYSIOL, V197, P47, DOI 10.1152/ajplegacy.1959.197.1.47; Ishihara K, 2002, BIOSCI BIOTECH BIOCH, V66, P426, DOI 10.1271/bbb.66.426; JOHN TM, 1988, POULTRY SCI, V67, P463, DOI 10.3382/ps.0670463; JOHN TM, 1987, CYTOBIOS, V49, P197; Junghans P, 1997, Z ERNAHRUNGSWISS, V36, P268, DOI 10.1007/BF01617796; KILSHEIMER GS, 1960, P SOC EXP BIOL MED, V104, P515; Leksrisompong N, 2007, POULTRY SCI, V86, P2685, DOI 10.3382/ps.2007-00170; Lourens A, 2007, POULTRY SCI, V86, P2194, DOI 10.1093/ps/86.10.2194; Lourens A, 2006, POULTRY SCI, V85, P770, DOI 10.1093/ps/85.4.770; Lourens A, 2005, POULTRY SCI, V84, P914, DOI 10.1093/ps/84.6.914; Luengo C, 2009, J CHROMATOGR B, V877, P3638, DOI 10.1016/j.jchromb.2009.09.005; MCARDLE WD, 1981, EXERCISE PHYSL ENERG; Molenaar R, 2011, POULTRY SCI, V90, P1257, DOI 10.3382/ps.2010-00684; Molenaar R, 2011, POULTRY SCI, V90, P624, DOI 10.3382/ps.2010-00970; Molenaar R, 2010, POULTRY SCI, V89, P2010, DOI 10.3382/ps.2010-00787; Moran ET, 2007, POULTRY SCI, V86, P1043, DOI 10.1093/ps/86.5.1043; Mota-Rojas D, 2011, VET MED-CZECH, V56, P215, DOI 10.17221/1565-VETMED; NELSON P, 1966, ARCH BIOCHEM BIOPHYS, V114, P543, DOI 10.1016/0003-9861(66)90378-X; PEARCE J, 1971, P NUTR SOC, V30, P254, DOI 10.1079/PNS19710049; Peronnet F, 2010, DEUT Z SPORTMED, V61, P112; RAHN H, 1979, SCI AM, V240, P46, DOI 10.1038/scientificamerican0279-46; RINAUDO MT, 1962, ENZYMOLOGIA, V24, P230; Robertson MD, 2002, BRIT J NUTR, V87, P569, DOI 10.1079/BJN2002586; Romanoff A. L., 1949, AVIAN EGG; Romanoff A.L., 1967, BIOCH AVIAN EMBRYO Q; ROMANOFF ALEXIS L., 1936, POULTRY SCI, V15, P311, DOI 10.3382/ps.0150311; SAS Institute Inc, 2004, SAS STAT US GUID VER; Seymour RS, 1984, RESPIRATION METABOLI, P299, DOI 10.1007/978-94-009-6536-2_21; Sunny NE, 2010, J ANIM SCI, V88, P912, DOI 10.2527/jas.2009-2479; Swennen Q, 2007, POULTRY SCI, V86, P1960, DOI 10.1093/ps/86.9.1960; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; TAZAWA H, 1983, RESP PHYSIOL, V53, P173, DOI 10.1016/0034-5687(83)90065-8; TETENS V, 1995, ANAL CHEM, V67, P858, DOI 10.1021/ac00101a011; van den Borne JJGC, 2007, J NUTR, V137, P2234; van der Lende T, 2001, J REP FER S, P247; Vonk RJ, 2000, AM J CLIN NUTR, V72, P432; WHITTOW GC, 1991, PHYSIOL ZOOL, V64, P1371, DOI 10.1086/physzool.64.6.30158220; Willemsen H, 2011, POULTRY SCI, V90, P1302, DOI 10.3382/ps.2011-01390; Willemsen H, 2010, POULTRY SCI, V89, P2678, DOI 10.3382/ps.2010-00853; WITTMANN J, 1981, COMP BIOCHEM PHYS C, V69, P1, DOI 10.1016/0306-4492(81)90093-9; Wolanski NJ, 2004, AVIAN POULT BIOL REV, V15, P233, DOI 10.3184/147020604783637877; Yadgary L, 2012, POULTRY SCI, V91, P444, DOI 10.3382/ps.2011-01669; Yildirim I, 2004, S AFR J ANIM SCI, V34, P211	59	23	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59637	10.1371/journal.pone.0059637	http://dx.doi.org/10.1371/journal.pone.0059637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560054	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900022
J	Berman, TS; Ayali, A; Gefen, E				Berman, Tali S.; Ayali, Amir; Gefen, Eran			Neural Control of Gas Exchange Patterns in Insects: Locust Density-Dependent Phases as a Test Case	PLOS ONE			English	Article							HYPOTHESES; VENTILATION; ORIGINS; OXYGEN; PUPAE	The adaptive significance of discontinuous gas exchange cycles (DGC) in insects is contentious. Based on observations of DGC occurrence in insects of typically large brain size and often socially-complex life history, and spontaneous DGC in decapitated insects, the neural hypothesis for the evolution of DGC was recently proposed. It posits that DGC is a non-adaptive consequence of adaptive down-regulation of brain activity at rest, reverting ventilatory control to pattern-generating circuits in the thoracic ganglia. In line with the predictions of this new hypothesis, we expected a higher likelihood of DGC in the gregarious phase of the desert locust (Schistocerca gregaria, Orthoptera), which is characterized by a larger brain size and increased sensory sensitivity compared with the solitary phase. Furthermore, surgical severing of the neural connections between head and thoracic ganglia was expected to increase DGC prevalence in both phases, and to eliminate phase-dependent variation in gas exchange patterns. Using flow-through respirometry, we measured metabolic rates and gas exchange patterns in locusts at 30 degrees C. In contrast to the predictions of the neural hypothesis, we found no phase-dependent differences in DGC expression. Likewise, surgically severing the descending regulation of thoracic ventilatory control did not increase DGC prevalence in either phase. Moreover, connective-cut solitary locusts abandoned DGC altogether, and employed a typical continuous gas exchange pattern despite maintaining metabolic rate levels of controls. These results are not consistent with the predictions of the neural hypothesis for the evolution of DGC in insects, and instead suggest neural plasticity of ventilatory control.	[Berman, Tali S.; Gefen, Eran] Univ Haifa, Dept Biol & Environm, Tivon, Israel; [Ayali, Amir] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	University of Haifa; Tel Aviv University	Gefen, E (corresponding author), Univ Haifa, Dept Biol & Environm, Tivon, Israel.	gefene@research.haifa.ac.il	Ayali, Amir/B-1050-2008; Berman, Tali/K-7010-2019	Ayali, Amir/0000-0001-6152-2927; Berman, Tali/0000-0003-4006-794X	Israel Science Foundation [792/12]; Oranim, Academic College for Education	Israel Science Foundation(Israel Science Foundation); Oranim, Academic College for Education	This study was supported by an Israel Science Foundation (http://www.isf.org.il/english/) award (# 792/12 to AA and EG) and by the research fund at Oranim, Academic College for Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chown SL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P333, DOI 10.1086/499992; Chown SL, 2002, COMP BIOCHEM PHYS A, V133, P791, DOI 10.1016/S1095-6433(02)00200-3; Chown SL, 2000, J EXP BIOL, V203, P397; Chown SL, 2011, FUNCT ECOL, V25, P1163, DOI 10.1111/j.1365-2435.2011.01879.x; Contreras HL, 2010, J INSECT PHYSIOL, V56, P522, DOI 10.1016/j.jinsphys.2009.05.018; Contreras HL, 2009, J EXP BIOL, V212, P424, DOI 10.1242/jeb.024091; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Forster TD, 2010, J INSECT PHYSIOL, V56, P492, DOI 10.1016/j.jinsphys.2009.06.003; Fuchs E, 2003, J NEUROBIOL, V57, P152, DOI 10.1002/neu.10261; Gulinson SL, 1996, J EXP BIOL, V199, P379; HADLEY NF, 1993, J EXP BIOL, V177, P169; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Kirkman T. W., 1996, STAT USE; LEVY RI, 1966, J INSECT PHYSIOL, V12, P83, DOI 10.1016/0022-1910(66)90068-0; LIGHTON JRB, 1995, J EXP BIOL, V198, P521; LIGHTON JRB, 1995, J EXP BIOL, V198, P1613; Marais E, 2005, J EXP BIOL, V208, P4495, DOI 10.1242/jeb.01928; Matthews PGD, 2011, J EXP BIOL, V214, P3062, DOI 10.1242/jeb.053991; Matthews PGD, 2011, AM NAT, V177, P130, DOI 10.1086/657619; Nation J. L., 2008, INSECT PHYSL BIOCH; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Quinlan MC, 2006, RESP PHYSIOL NEUROBI, V154, P18, DOI 10.1016/j.resp.2006.04.004	23	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59967	10.1371/journal.pone.0059967	http://dx.doi.org/10.1371/journal.pone.0059967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555850	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900046
J	Freitas, AR; Novais, C; Tedim, AP; Francia, MV; Baquero, F; Peixe, L; Coque, TM				Freitas, Ana R.; Novais, Carla; Tedim, Ana P.; Victoria Francia, Maria; Baquero, Fernando; Peixe, Luisa; Coque, Teresa M.			Microevolutionary Events Involving Narrow Host Plasmids Influences Local Fixation of Vancomycin-Resistance in Enterococcus Populations	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEM; MOLECULAR CHARACTERIZATION; GLYCOPEPTIDE RESISTANCE; MULTIDRUG-RESISTANT; ANTIMICROBIAL RESISTANCE; STAPHYLOCOCCUS-AUREUS; TN1546-LIKE ELEMENTS; CLONAL COMPLEXES; AXE-TXE; FAECIUM	Vancomycin-resistance in enterococci (VRE) is associated with isolates within ST18, ST17, ST78 Enterococcus faecium (Efm) and ST6 Enterococcus faecalis (Efs) human adapted lineages. Despite of its global spread, vancomycin resistance rates in enterococcal populations greatly vary temporally and geographically. Portugal is one of the European countries where Tn1546 (vanA) is consistently found in a variety of environments. A comprehensive multi-hierarchical analysis of VRE isolates (75 Efm and 29 Efs) from Portuguese hospitals and aquatic surroundings (1996-2008) was performed to clarify the local dynamics of VRE. Clonal relatedness was established by PFGE and MLST while plasmid characterization comprised the analysis of known relaxases, rep initiator proteins and toxin-antitoxin systems (TA) by PCR-based typing schemes, RFLP comparison, hybridization and sequencing. Tn1546 variants were characterized by PCR overlapping/sequencing. Intra- and inter-hospital dissemination of Efm ST18, ST132 and ST280 and Efs ST6 clones, carrying rolling-circle (pEFNP1/pRI1) and theta-replicating (pCIZ2-like, Inc18, pHT beta-like, two pRUM-variants, pLG1-like, and pheromone-responsive) plasmids was documented. Tn1546 variants, mostly containing ISEf1 or IS1216, were located on plasmids (30-150 kb) with a high degree of mosaicism and heterogeneous RFLP patterns that seem to have resulted from the interplay between broad host Inc18 plasmids (pIP501, pRE25, pEF1), and narrow host RepA_N plasmids (pRUM, pAD1-like). TAs of Inc18 (omega-epsilon-zeta) and pRUM (Axe-Txe) plasmids were infrequently detected. Some plasmid chimeras were persistently recovered over years from different clonal lineages. This work represents the first multi-hierarchical analysis of VRE, revealing a frequent recombinatorial diversification of a limited number of interacting clonal backgrounds, plasmids and transposons at local scale. These interactions provide a continuous process of parapatric clonalization driving a full exploration of the local adaptive landscape, which might assure long-term maintenance of resistant clones and eventually fixation of Tn1546 in particular geographic areas.	[Freitas, Ana R.; Novais, Carla; Peixe, Luisa] Univ Porto, Fac Farm, Microbiol Lab, REQUIMTE, P-4100 Oporto, Portugal; [Freitas, Ana R.; Tedim, Ana P.; Baquero, Fernando; Coque, Teresa M.] IRYCIS, Madrid, Spain; [Tedim, Ana P.; Baquero, Fernando; Coque, Teresa M.] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Tedim, Ana P.; Baquero, Fernando; Coque, Teresa M.] CSIC, Unidad Resistencia Antibiot & Virulencia Bacteria, Madrid, Spain; [Victoria Francia, Maria] Hosp Univ Marques de Valdecilla, Microbiol Serv, Santander, Spain; [Victoria Francia, Maria] Inst Formac & Invest Marques de Valdecilla IFIMAV, Santander, Spain	Universidade do Porto; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Coque, TM (corresponding author), IRYCIS, Madrid, Spain.	mariateresa.coque@salud.madrid.org	Coque, Teresa M./F-5013-2015; Novais, Carla/E-6094-2010; Tedim, Ana P./F-6608-2015; Tedim, Ana P./R-1209-2018; Peixe, Luisa V/H-7347-2016; Freitas, Ana R./D-6158-2013; Peixe, Luísa/D-8715-2013	Coque, Teresa M./0000-0002-8228-3491; Tedim, Ana P./0000-0003-1016-7173; Tedim, Ana P./0000-0003-1016-7173; Peixe, Luisa V/0000-0001-5810-8215; Freitas, Ana R./0000-0002-7326-4133; Peixe, Luísa/0000-0001-5810-8215; Novais, Carla/0000-0002-3826-6731	Fundacao para a Ciencia e Tecnologia [SFRH/BD/24604/2005]; European Union [LSHE-CT-2007-037410, 6FPEU-LSHE-CT-2007-037410_ACE, 7FPEU-HEALTH-F3-2011-282004_EvoTAR]; Ministry of Economy and Competitiveness of Spain-Instituto de Salud Carlos III [PS09/02381, PI10/01081, PI12/01581, CES08/008]; Fundacao para a Ciencia e Tecnologia of Portugal [PTDC/AAC-AMB/103386/2008, PEst-C/EQB/LA0006/2011]; Spanish Network for the Research in Infectious Diseases [REIPIRD06/0008/0031]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission); Ministry of Economy and Competitiveness of Spain-Instituto de Salud Carlos III; Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Spanish Network for the Research in Infectious Diseases	Ana Freitas was supported by a fellowship from Fundacao para a Ciencia e Tecnologia (SFRH/BD/24604/2005) and from the European Union (LSHE-CT-2007-037410). This work was funded by grants from the European Union (6FPEU-LSHE-CT-2007-037410_ACE and 7FPEU-HEALTH-F3-2011-282004_EvoTAR), the Ministry of Economy and Competitiveness of Spain-Instituto de Salud Carlos III (PS09/02381, PI10/01081, PI12/01581), and Fundacao para a Ciencia e Tecnologia of Portugal (PTDC/AAC-AMB/103386/2008 and PEst-C/EQB/LA0006/2011). Work in MVFs lab is funded by the the Ministry of Economy and Competitiveness of Spain-Instituto de Salud Carlos III (PI10/01081 and CES08/008) and the Spanish Network for the Research in Infectious Diseases (REIPIRD06/0008/0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilee R, 2009, THEOR POPUL BIOL, V76, P105, DOI 10.1016/j.tpb.2009.05.003; Araujo C, 2011, MICROB DRUG RESIST, V17, P357, DOI 10.1089/mdr.2010.0171; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Baquero F, 2013, FRONTIERS A IN PRESS; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clewell DB, 2013, ENTEROCOCCI IN PRESS; Coque TM, 2012, SERIES ADV FOOD SAFE; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P113, DOI 10.1089/mdr.1999.5.113; de Regt MJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030319; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Freitas AR, 2011, J CLIN MICROBIOL, V49, P925, DOI 10.1128/JCM.01750-10; Freitas AR, 2010, ANTIMICROB AGENTS CH, V54, P2660, DOI 10.1128/AAC.00134-10; Freitas AR, 2009, APPL ENVIRON MICROB, V75, P4904, DOI 10.1128/AEM.02945-08; Freitas AR, 2009, J ANTIMICROB CHEMOTH, V63, P1104, DOI 10.1093/jac/dkp103; Galloway-Pena JR, 2009, J INFECT DIS, V200, P1566, DOI 10.1086/644790; Garcia-Migura L, 2009, CURR MICROBIOL, V58, P95, DOI 10.1007/s00284-008-9266-x; Garcia-Migura L, 2008, J ANTIMICROB CHEMOTH, V62, P681, DOI 10.1093/jac/dkn265; Garcia-Migura L, 2011, FOODBORNE PATHOG DIS, V8, P1191, DOI 10.1089/fpd.2011.0897; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gomez JAL, 2011, INT J MED MICROBIOL, V301, P165, DOI 10.1016/j.ijmm.2010.08.015; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Halvorsen EM, 2011, MICROBIOL-SGM, V157, P387, DOI 10.1099/mic.0.045492-0; HANDWERGER S, 1995, ANTIMICROB AGENTS CH, V39, P2446, DOI 10.1128/AAC.39.11.2446; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Jensen LB, 2010, J MICROBIOL METH, V80, P25, DOI 10.1016/j.mimet.2009.10.012; Johnsen PJ, 2009, LANCET INFECT DIS, V9, P357, DOI 10.1016/S1473-3099(09)70105-7; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kaufmann ME, 1998, METH MOLEC MED, V15, P33, DOI 10.1385/0-89603-498-4:33; Kawalec M, 2000, J CLIN MICROBIOL, V38, P3317, DOI 10.1128/JCM.38.9.3317-3322.2000; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Martone WJ, 1998, INFECT CONT HOSP EP, V19, P539; Mato R, 2009, EUR J CLIN MICROBIOL, V28, P855, DOI 10.1007/s10096-009-0704-x; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; Moritz EM, 2007, P NATL ACAD SCI USA, V104, P311, DOI 10.1073/pnas.0601168104; Morrison D, 1999, J CLIN MICROBIOL, V37, P1084, DOI 10.1128/JCM.37.4.1084-1091.1999; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Novais C, 2005, APPL ENVIRON MICROB, V71, P3364, DOI 10.1128/AEM.71.6.3364-3368.2005; Novais C, 2005, ANTIMICROB AGENTS CH, V49, P3073, DOI 10.1128/AAC.49.7.3073-3079.2005; Novais C, 2008, ANTIMICROB AGENTS CH, V52, P1001, DOI 10.1128/AAC.00999-07; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Qu TT, 2012, MICROB DRUG RESIST, V18, P183, DOI 10.1089/mdr.2011.0140; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rosvoll TCS, 2010, FEMS IMMUNOL MED MIC, V58, P254, DOI 10.1111/j.1574-695X.2009.00633.x; Ruiz-Barba JL, 2007, PLASMID, V57, P175, DOI 10.1016/j.plasmid.2006.06.003; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schouten MA, 2001, ANTIMICROB AGENTS CH, V45, P986, DOI 10.1128/AAC.45.3.986-989.2001; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Sletvold H, 2007, ANTIMICROB AGENTS CH, V51, P736, DOI 10.1128/AAC.00557-06; Sletvold H, 2010, J ANTIMICROB CHEMOTH, V65, P1894, DOI 10.1093/jac/dkq219; Sorum M, 2006, APPL ENVIRON MICROB, V72, P516, DOI 10.1128/AEM.72.1.516-521.2006; Stampone L, 2005, J CLIN MICROBIOL, V43, P1575, DOI 10.1128/JCM.43.4.1575-1580.2005; Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thal L, 1998, J CLIN MICROBIOL, V36, P3303, DOI 10.1128/JCM.36.11.3303-3308.1998; Tomita H, 2002, J CLIN MICROBIOL, V40, P3326, DOI 10.1128/JCM.40.9.3326-3333.2002; Valdezate S, 2012, J ANTIMICROB CHEMOTH, V67, P832, DOI 10.1093/jac/dkr545; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Weaver KE, 2009, PLASMID, V61, P94, DOI 10.1016/j.plasmid.2008.11.004; Werner G, 2008, Euro Surveill, V13; Willems RJL, 1999, ANTIMICROB AGENTS CH, V43, P483, DOI 10.1128/AAC.43.3.483; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Woodford N, 1998, ANTIMICROB AGENTS CH, V42, P502, DOI 10.1128/AAC.42.3.502; Wyllie D, 2011, J ANTIMICROB CHEMOTH, V66, P2685, DOI 10.1093/jac/dkr392; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747; Zheng B, 2007, J CLIN MICROBIOL, V45, P2813, DOI 10.1128/JCM.00457-07; Zhu WM, 2010, ANTIMICROB AGENTS CH, V54, P4314, DOI 10.1128/AAC.00185-10	77	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60589	10.1371/journal.pone.0060589	http://dx.doi.org/10.1371/journal.pone.0060589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555993	Green Published, gold, Green Accepted			2022-12-27	WOS:000317263900078
J	Kahler, DJ; Ahmad, FS; Ritz, A; Hua, HQ; Moroziewicz, DN; Sproul, AA; Dusenberry, CR; Shang, LS; Paull, D; Zimmer, M; Weiss, KA; Egli, D; Noggle, SA				Kahler, David J.; Ahmad, Faizzan S.; Ritz, Anita; Hua, Haiqing; Moroziewicz, Dorota N.; Sproul, Andrew A.; Dusenberry, Carmen R.; Shang, Linshan; Paull, Daniel; Zimmer, Matthew; Weiss, Keren A.; Egli, Dieter; Noggle, Scott A.			Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ADHESION MOLECULE; SOMATIC-CELLS; MARKER; EXPRESSION; PLATFORM	Current methods to derive induced pluripotent stem cell (iPSC) lines from human dermal fibroblasts by viral infection rely on expensive and lengthy protocols. One major factor contributing to the time required to derive lines is the ability of researchers to identify fully reprogrammed unique candidate clones from a mixed cell population containing transformed or partially reprogrammed cells and fibroblasts at an early time point post infection. Failure to select high quality colonies early in the derivation process results in cell lines that require increased maintenance and unreliable experimental outcomes. Here, we describe an improved method for the derivation of iPSC lines using fluorescence activated cell sorting (FACS) to isolate single cells expressing the cell surface marker signature CD13(NEG)SSEA4(POS)Tra-1-60(POS) on day 7-10 after infection. This technique prospectively isolates fully reprogrammed iPSCs, and depletes both parental and "contaminating" partially reprogrammed fibroblasts, thereby substantially reducing the time and reagents required to generate iPSC lines without the use of defined small molecule cocktails. FACS derived iPSC lines express common markers of pluripotency, and possess spontaneous differentiation potential in vitro and in vivo. To demonstrate the suitability of FACS for high-throughput iPSC generation, we derived 228 individual iPSC lines using either integrating (retroviral) or non-integrating (Sendai virus) reprogramming vectors and performed extensive characterization on a subset of those lines. The iPSC lines used in this study were derived from 76 unique samples from a variety of tissue sources, including fresh or frozen fibroblasts generated from biopsies harvested from healthy or disease patients.	[Kahler, David J.; Ahmad, Faizzan S.; Ritz, Anita; Hua, Haiqing; Moroziewicz, Dorota N.; Sproul, Andrew A.; Dusenberry, Carmen R.; Shang, Linshan; Paull, Daniel; Zimmer, Matthew; Weiss, Keren A.; Egli, Dieter; Noggle, Scott A.] New York Stem Cell Fdn, New York, NY USA; [Ahmad, Faizzan S.] Weill Cornell Med Coll Qatar, Doha, Qatar; [Hua, Haiqing] Columbia Univ, Dept Pediat, Div Mol Genet, New York, NY 10027 USA; [Hua, Haiqing] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA	The New York Stem Cell Foundation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University; Columbia University	Kahler, DJ (corresponding author), New York Stem Cell Fdn, New York, NY USA.	dkahler@nyscf.org	Kahler, David J/I-9275-2019	Kahler, David J/0000-0002-7144-2215; Noggle, Scott/0000-0002-0374-2240; Sproul, Andrew/0000-0001-6972-1592	NYSTEM [C024179]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	NYSTEM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NYSTEM contract C024179 (http://stemcell.ny.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sorrell JM, 2003, EXP DERMATOL, V12, P315, DOI 10.1034/j.1600-0625.2003.120312.x; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	19	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59867	10.1371/journal.pone.0059867	http://dx.doi.org/10.1371/journal.pone.0059867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555815	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900037
J	Su, YX; Benedek, GA; Sieg, P; Liao, GQ; Dendorfer, A; Meller, B; Rades, D; Klinger, M; Hakim, SG				Su, Yu-xiong; Benedek, Geza A.; Sieg, Peter; Liao, Gui-qing; Dendorfer, Andreas; Meller, Birgit; Rades, Dirk; Klinger, Matthias; Hakim, Samer G.			Radioprotective Effect of Lidocaine on Neurotransmitter Agonist-Induced Secretion in Irradiated Salivary Glands	PLOS ONE			English	Article							PROPHYLACTIC PILOCARPINE TREATMENT; PAROTID-GLAND; MYOEPITHELIAL CELLS; CANCER-PATIENTS; RADIATION; RADIOTHERAPY; ACINAR; ULTRASTRUCTURE; AMELIORATION; AMIFOSTINE	Background: Previously we verified the radioprotective effect of lidocaine on the function and ultrastructure of salivary glands in rabbits. However, the underlying mechanism of lidocaine's radioprotective effect is unknown. We hypothesized that lidocaine, as a membrane stabilization agent, has a protective effect on intracellular neuroreceptor-mediated signaling and hence can help preserve the secretory function of salivary glands during radiotherapy. Methods and Materials: Rabbits were irradiated with or without pretreatment with lidocaine before receiving fractionated radiation to a total dose of 35 Gy. Sialoscintigraphy and saliva total protein assay were performed before radiation and 1 week after the last radiation fraction. Isolated salivary gland acini were stimulated with either carbachol or adrenaline. Ca2+ influx in response to the stimulation with these agonists was measured using laser scanning confocal microscopy. Results: The uptake of activity and the excretion fraction of the parotid glands were significantly reduced after radiation, but lidocaine had a protective effect. Saliva total protein concentration was not altered after radiation. For isolated acini, Ca2+ influx in response to stimulation with carbachol, but not adrenaline, was impaired after irradiation; lidocaine pretreatment attenuated this effect. Conclusions: Lidocaine has a radioprotective effect on the capacity of muscarinic agonist-induced water secretion in irradiated salivary glands.	[Su, Yu-xiong; Benedek, Geza A.; Sieg, Peter; Hakim, Samer G.] Med Univ Lubeck, Dept Oral & Maxillofacial Surg, D-23538 Lubeck, Germany; [Su, Yu-xiong; Liao, Gui-qing] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou 510275, Guangdong, Peoples R China; [Dendorfer, Andreas] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Meller, Birgit] Med Univ Lubeck, Dept Radiol & Nucl Med, D-23538 Lubeck, Germany; [Rades, Dirk] Med Univ Lubeck, Dept Radiat Oncol, D-23538 Lubeck, Germany; [Klinger, Matthias] Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany	University of Lubeck; Sun Yat Sen University; University of Munich; University of Lubeck; University of Lubeck; University of Lubeck	Su, YX (corresponding author), Med Univ Lubeck, Dept Oral & Maxillofacial Surg, D-23538 Lubeck, Germany.	suyuxiong@hotmail.com		Su, Yu-xiong/0000-0001-7143-3370	National Natural Science Foundation of China [30901682]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171120105]; Fundamental Research Funds for the Central Universities [10ykpy18]; Natural Science Foundation of Guangdong Province [9451008901001993]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by grants from National Natural Science Foundation of China (30901682, URL: http://www.nsfc.gov.cn/), Specialized Research Fund for the Doctoral Program of Higher Education of China (20090171120105, URL:http://www.cutech.edu.cn/cn/kyjj/A0103index_1.htm), the Fundamental Research Funds for the Central Universities (10ykpy18), and Natural Science Foundation of Guangdong Province (9451008901001993, URL: http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MW, 1981, ORAL SURG ORAL MED O, V52, P495, DOI 10.1016/0030-4220(81)90361-3; Baum B, 1999, RECEPTORS SALIVARY G; Baum BJ, 2010, ORAL ONCOL, V46, P4, DOI 10.1016/j.oraloncology.2009.09.004; Burlage FR, 2001, RADIOTHER ONCOL, V61, P271, DOI 10.1016/S0167-8140(01)00427-3; Burlage FR, 2009, RADIOTHER ONCOL, V90, P253, DOI 10.1016/j.radonc.2008.11.011; Burlage FR, 2008, RADIOTHER ONCOL, V86, P347, DOI 10.1016/j.radonc.2007.10.011; Coppes RP, 2005, BRIT J CANCER, V92, P539, DOI 10.1038/sj.bjc.6602365; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; Coppes RP, 2000, RADIAT RES, V153, P339, DOI 10.1667/0033-7587(2000)153[0339:EREOMR]2.0.CO;2; Eisbruch A, 2001, SEMIN RADIAT ONCOL, V11, P234, DOI 10.1053/srao.2001.23484; Feng JL, 2009, RADIOTHER ONCOL, V92, P466, DOI 10.1016/j.radonc.2009.06.023; Gao R, 2011, GENE THER, V18, P38, DOI 10.1038/gt.2010.128; Hakim S G, 2004, Clin Oral Investig, V8, P30, DOI 10.1007/s00784-003-0249-9; Hakim SG, 2012, INT J RADIAT ONCOL, V82, pE623, DOI 10.1016/j.ijrobp.2011.09.017; Hakim SG, 2005, CANCER RES, V65, P10486, DOI 10.1158/0008-5472.CAN-05-0023; Hannig M, 2006, CLIN ORAL INVEST, V10, P61, DOI 10.1007/s00784-005-0026-z; HELMAN J, 1987, J CLIN INVEST, V79, P1310, DOI 10.1172/JCI112954; Houweling AC, 2010, INT J RADIAT ONCOL, V76, P1259, DOI 10.1016/j.ijrobp.2009.07.1685; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Paardekooper GMRM, 1998, INT J RADIAT BIOL, V73, P641, DOI 10.1080/095530098141898; Rudat V, 2008, RADIOTHER ONCOL, V89, P71, DOI 10.1016/j.radonc.2008.07.016; Satoh Y, 1997, CELL TISSUE RES, V289, P473, DOI 10.1007/s004410050893; SATOH Y, 1993, CELL TISSUE RES, V274, P1, DOI 10.1007/BF00327979; STEPHENS LC, 1989, RADIAT RES, V120, P140, DOI 10.2307/3577641; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008	26	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60256	10.1371/journal.pone.0060256	http://dx.doi.org/10.1371/journal.pone.0060256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555936	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900064
J	Wang, L; Li, K; Zhang, QE; Zeng, YW; Jin, Z; Dai, WJ; Su, YA; Wang, G; Tan, YL; Yu, X; Si, TM				Wang, Li; Li, Ke; Zhang, Qing-E; Zeng, Ya-Wei; Jin, Zhen; Dai, Wen-Ji; Su, Yun-Ai; Wang, Gang; Tan, Yun-Long; Yu, Xin; Si, Tian-Mei			Interhemispheric Functional Connectivity and Its Relationships with Clinical Characteristics in Major Depressive Disorder: A Resting State fMRI Study	PLOS ONE			English	Article							DEFAULT MODE NETWORK; CORPUS-CALLOSUM; COGNITIVE CONTROL; TREATMENT-RESISTANT; PREFRONTAL CORTEX; NEURAL ACTIVITY; WHOLE-BRAIN; ARCHITECTURE; 1ST-EPISODE; ABSENCE	Background: Abnormalities in large-scale, structural and functional brain connectivity have been increasingly reported inpatients with major depressive disorder (MDD). However, MDD-related alterations in functional interaction between the cerebral hemispheres are still not well understood. Resting state fMRI, which reveals spontaneous neural fluctuations in blood oxygen level dependent signals, provides a means to detect interhemispheric functional coherence. We examined the resting state functional connectivity (RSFC) between the two hemispheres and its relationships with clinical characteristics in MDD patients using a recently proposed measurement named "voxel-mirrored homotopic connectivity (VMHC)''. Methodology/Principal Findings: We compared the interhemispheric RSFC, computed using the VMHC approach, of seventeen first-episode drug-naive patients with MDD and seventeen healthy controls. Compared to the controls, MDD patients showed significant VMHC decreases in the medial orbitofrontal gyrus, parahippocampal gyrus, fusiform gyrus, and occipital regions including the middle occipital gyrus and cuneus. In MDD patients, a negative correlation was found between VMHC of the fusiform gyrus and illness duration. Moreover, there were several regions whose VMHC showed significant negative correlations with the severity of cognitive disturbance, including the prefrontal regions, such as middle and inferior frontal gyri, and two regions in the cereballar crus. Conclusions/Significance: These findings suggest that the functional coordination between homotopic brain regions is impaired in MDD patients, thereby providing new evidence supporting the interhemispheric connectivity deficits of MDD. The significant correlations between the VMHC and clinical characteristics in MDD patients suggest potential clinical implication of VMHC measures for MDD. Interhemispheric RSFC may serve as a useful screening method for evaluating MDD where neural connectivity is implicated in the pathophysiology.	[Wang, Li; Dai, Wen-Ji; Su, Yun-Ai; Yu, Xin; Si, Tian-Mei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Wang, Li; Dai, Wen-Ji; Su, Yun-Ai; Yu, Xin; Si, Tian-Mei] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Li, Ke; Zeng, Ya-Wei; Jin, Zhen] 306 Hosp Peoples Liberat Army, Dept Radiol, Beijing, Peoples R China; [Zhang, Qing-E; Wang, Gang] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Tan, Yun-Long] Beijing Huilongguan Hosp, Ctr Psychiat Res, Beijing, Peoples R China	Peking University; Capital Medical University	Si, TM (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	si.tian-mei@163.com		SU, YUNAI/0000-0001-8445-9633	Capital Foundation of Medicine Research and Development [2009-2026]	Capital Foundation of Medicine Research and Development	This study was supported by a grant from the Capital Foundation of Medicine Research and Development (No. 2009-2026; http://www.bjhbkj.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Key Basic Research Program of China (973 Program) (2012CB720704) for subject collection and National Key Basic Research Program of China (973 Program) (2013CB531305) for MRI scans.	Alexopoulos GS, 2012, J AFFECT DISORDERS, V139, P56, DOI 10.1016/j.jad.2011.12.002; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; ARMITAGE R, 1992, BIOL PSYCHIAT, V31, P52, DOI 10.1016/0006-3223(92)90006-L; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BANICH MT, 1992, J EXP PSYCHOL HUMAN, V18, P763, DOI 10.1037/0096-1523.18.3.763; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; BELGER A, 1992, NEUROPSYCHOLOGIA, V30, P923, DOI 10.1016/0028-3932(92)90036-L; Chantiluke K, 2012, BIOL PSYCHIAT, V71, P59, DOI 10.1016/j.biopsych.2011.09.005; Compton RJ, 2005, COGNITIVE BRAIN RES, V24, P66, DOI 10.1016/j.cogbrainres.2004.12.002; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; DIMOND SJ, 1979, CORTEX, V15, P43, DOI 10.1016/S0010-9452(79)80005-2; DIMOND SJ, 1979, J NEUROL NEUROSUR PS, V42, P70, DOI 10.1136/jnnp.42.1.70; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Dobromyslin VI, 2012, NEUROIMAGE, V60, P2073, DOI 10.1016/j.neuroimage.2012.01.139; Egner T, 2009, NAT NEUROSCI, V12, P821, DOI 10.1038/nn0709-821; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fulton MK, 2000, BIOL PSYCHIAT, V47, P618, DOI 10.1016/S0006-3223(99)00163-8; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Garrett A, 2011, AM J PSYCHIAT, V168, P173, DOI 10.1176/appi.ajp.2010.09121718; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; GILES DE, 1993, PSYCHIAT RES, V46, P269, DOI 10.1016/0165-1781(93)90095-X; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Guo WB, 2012, J PSYCHIATR RES, V46, P1366, DOI 10.1016/j.jpsychires.2012.07.003; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Haldane M, 2008, J PSYCHOPHARMACOL, V22, P138, DOI 10.1177/0269881107082955; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Liao Y, 2012, J PSYCHIATR NEUROSCI, V37; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sauerwein H C, 1997, J Neurosurg Sci, V41, P59; SAUERWEIN HC, 1994, BEHAV BRAIN RES, V64, P229, DOI 10.1016/0166-4328(94)90135-X; Schlosser RGM, 2008, NEUROIMAGE, V43, P645, DOI 10.1016/j.neuroimage.2008.08.002; SIDTIS JJ, 1981, SCIENCE, V212, P344, DOI 10.1126/science.6782673; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10; Sun J, 2009, ACTA PSYCHIAT SCAND, V120, P265, DOI 10.1111/j.1600-0447.2009.01389.x; Tamietto M, 2007, NEUROPSYCHOLOGIA, V45, P836, DOI 10.1016/j.neuropsychologia.2006.08.012; Tao H, 2011, MOL PSYCHIA IN PRESS; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Uddin LQ, 2008, NEUROREPORT, V19, P703, DOI 10.1097/WNR.0b013e3282fb8203; van Wingen GA, 2011, PSYCHOL MED, V41, P1397, DOI 10.1017/S0033291710002084; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Walterfang M, 2009, J AFFECT DISORDERS, V115, P411, DOI 10.1016/j.jad.2008.10.010; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Weissman DH, 2000, NEUROPSYCHOLOGY, V14, P41, DOI 10.1037/0894-4105.14.1.41; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Xu K, 2012, J PSYCHIATR NEUROSCI, V37; Yan CG, 2010, FRONTIERS SYSTEMS NE, V14, P13, DOI [10.3389/fnsys.2010.00013, DOI 10.3389/FNSYS.2010.00013]; Young K. D., 2011, PSYCHOL MED, V29, P1; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	72	84	93	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60191	10.1371/journal.pone.0060191	http://dx.doi.org/10.1371/journal.pone.0060191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555920	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900062
J	Higuma, M; Sanjo, N; Satoh, K; Shiga, Y; Sakai, K; Nozaki, I; Hamaguchi, T; Nakamura, Y; Kitamoto, T; Shirabe, S; Murayama, S; Yamada, M; Tateishi, J; Mizusawa, H				Higuma, Maya; Sanjo, Nobuo; Satoh, Katsuya; Shiga, Yusei; Sakai, Kenji; Nozaki, Ichiro; Hamaguchi, Tsuyoshi; Nakamura, Yosikazu; Kitamoto, Tetsuyuki; Shirabe, Susumu; Murayama, Shigeo; Yamada, Masahito; Tateishi, Jun; Mizusawa, Hidehiro			Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PROTEIN; MUTATION; PHENOTYPES	A national system for surveillance of prion diseases (PrDs) was established in Japan in April 1999. Here, we analyzed the relationships among prion protein gene (PRNP) mutations and the clinical features, cerebrospinal fluid (CSF) markers, and pathological characteristics of the major genotypes of genetic PrDs (gPrDs). We retrospectively analyzed age at onset and disease duration; the concentrations and incidences of 14-3-3 protein, tau protein, and abnormal prion protein (PrPSc) in the CSF of 309 gPrD patients with P102L, P105L, E200K, V180I, or M232R mutations; and brain pathology in 32 autopsied patients. Three clinical phenotypes were seen: rapidly progressive Creutzfeldt-Jakob disease (CJD), which included 100% of E200K cases, 70% of M232R, and 21% of P102L; slowly progressive CJD, which included 100% of V180I and 30% of M232R; and Gerstmann-Straussler-Scheinker disease, which included 100% of P105L and 79% of P102L. PrPSc was detected in the CSF of more than 80% of patients with E200K, M232R, or P102L mutations but in only 39% of patients with V180I. V180I was accompanied by weak PrP immunoreactivity in the brain. Patients negative for PrPSc in the CSF were older at disease onset than positive patients. Patients with mutations associated with high 14-3-3 protein levels in the CSF typically had synaptic deposition of PrP in the brain and a rapid course of disease. The presence of small PrP protein fragments in brain homogenates was not correlated with other clinicopathological features. Positivity for PrPSc in the CSF may reflect the pathological process before or at disease onset, or abnormality in the secretion or metabolism of PrPSc. The amount of 14-33 protein in the CSF likely indicates the severity of the pathological process and accompanying neuronal damage. These characteristic features of the CSF in cases of gPrD will likely facilitate accurate diagnosis and clinicopathological study of the various disease subtypes.	[Higuma, Maya; Sanjo, Nobuo; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, Tokyo, Japan; [Satoh, Katsuya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Shiga, Yusei] Aoba Neurosurg Hosp, Dept Neurol, Sendai, Miyagi, Japan; [Sakai, Kenji; Nozaki, Ichiro; Hamaguchi, Tsuyoshi; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Nakamura, Yosikazu] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi, Japan; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Prion Prot Res, Div CJD Sci & Technol, Sendai, Miyagi 980, Japan; [Shirabe, Susumu] Nagasaki Univ Hosp, Ctr Community Hlth Med, Nagasaki, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan; [Tateishi, Jun] Harukaze Healthcare Serv Inst, Fukuoka, Japan	Tokyo Medical & Dental University (TMDU); Nagasaki University; Kanazawa University; Jichi Medical University; Tohoku University; Nagasaki University; Tokyo Metropolitan Institute of Gerontology	Sanjo, N (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, Tokyo, Japan.	n-sanjo.nuro@tmd.ac.jp		Sanjo, Nobuo/0000-0002-1226-2425	Health and Labor Sciences Research Grant for Research on Measures for Intractable Diseases (Surveillance and Infectious Control of Prion Disease); Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [24650185] Funding Source: KAKEN	Health and Labor Sciences Research Grant for Research on Measures for Intractable Diseases (Surveillance and Infectious Control of Prion Disease); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health and Labor Sciences Research Grant for Research on Measures for Intractable Diseases (Surveillance and Infectious Control of Prion Disease), from the Ministry of Health, Labor and Welfare of Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Beck J, 2012, BRAIN, V135, DOI 10.1093/brain/awr294; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; Choi BY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-132; Hama T, 2009, NEUROPATHOLOGY, V29, P727, DOI 10.1111/j.1440-1789.2009.01016.x; Iwasaki Y, 2011, NEUROPATHOLOGY, V31, P540, DOI 10.1111/j.1440-1789.2010.01192.x; Iwasaki Y, 2009, CLIN NEUROL NEUROSUR, V111, P606, DOI 10.1016/j.clineuro.2009.03.008; Jin K, 2004, NEUROLOGY, V62, P502, DOI 10.1212/01.WNL.0000106954.54011.80; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Ladogana A, 2009, J NEUROL, V256, P1620, DOI 10.1007/s00415-009-5163-x; Majtenyi C, 2000, NEUROLOGY, V54, P2133, DOI 10.1212/WNL.54.11.2133; McGuire LI, 2012, ANN NEUROLO IN PRESS; Meiner Z, 2011, J NEUROL, V258, P255, DOI 10.1007/s00415-010-5738-6; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Popova SN, 2012, ACTA NEUROL SCAND, V126, P315, DOI 10.1111/j.1600-0404.2011.01628.x; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Satoh K, 2006, CELL MOL NEUROBIOL, V26, P45, DOI 10.1007/s10571-006-9370-z; Satoh K, 2010, LAB INVEST, V90, P1637, DOI 10.1038/labinvest.2009.68; Shiga Y, 2007, J NEUROL, V254, P1509, DOI 10.1007/s00415-007-0540-9; Shimizu H, 2009, NEUROPATHOLOGY, V29, P735, DOI 10.1111/j.1440-1789.2009.01019.x; Shimizu S, 1999, ARCH NEUROL-CHICAGO, V56, P357, DOI 10.1001/archneur.56.3.357; Shiraishi A, 2002, J NEUROL, V249, P1740, DOI 10.1007/s00415-002-0907-x; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Webb TEF, 2008, BRAIN, V131, P2632, DOI 10.1093/brain/awn202; Yamada M, 1999, NEUROLOGY, V53, P181, DOI 10.1212/WNL.53.1.181; Yang TI, 2010, J KOREAN MED SCI, V25, P1097, DOI 10.3346/jkms.2010.25.7.1097; Zheng L, 2008, AM J MED GENET B, V147B, P938, DOI 10.1002/ajmg.b.30761	33	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60003	10.1371/journal.pone.0060003	http://dx.doi.org/10.1371/journal.pone.0060003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555862	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200067
J	Pan, F; Chi, LF; Schlatt, S				Pan, Fei; Chi, Lifeng; Schlatt, Stefan			Effects of Nanostructures and Mouse Embryonic Stem Cells on In Vitro Morphogenesis of Rat Testicular Cords	PLOS ONE			English	Article							SERTOLI-CELLS; TOPOGRAPHY; CULTURE	Morphogenesis of tubular structures is a common event during embryonic development. The signals providing cells with topographical cues to define a cord axis and to form new compartments surrounded by a basement membrane are poorly understood. Male gonadal differentiation is a late event during organogenesis and continues into postnatal life. The cellular changes resemble the mechanisms during embryonic life leading to tubular structures in other organs. Testicular cord formation is dependent on and first recognized by SRY-dependent aggregation of Sertoli cells leading to the appearance of testis-specific cord-like structures. Here we explored whether testicular cells use topographical cues in the form of nanostructures to direct or stimulate cord formation and whether embryonic stem cells (ES) or soluble factors released from those cells have an impact on this process. Using primary cell cultures of immature rats we first revealed that variable nanogratings exerted effects on peritubular cells and on Sertoli cells (at less than,1000 cells/mm(2)) by aligning the cell bodies towards the direction of the nanogratings. After two weeks of culture testicular cells assembled into a network of cord-like structures. We revealed that Sertoli cells actively migrate towards existing clusters. Contractions of peritubular cells lead to the transformation of isolated clusters into cord-like structures. The addition of mouse ES cells or conditioned medium from ES cells accelerated this process. Our studies show that epithelial (Sertoli cell) and mesenchymal (peritubular cells) cells crosstalk and orchestrate the formation of cords in response to physical features of the underlying matrix as well as secretory factors from ES cells. We consider these data on testicular morphogenesis relevant for the better understanding of mechanisms in cord formation also in other organs which may help to create optimized in vitro tools for artificial organogenesis.	[Pan, Fei; Chi, Lifeng] Univ Munster, Inst Phys, D-48149 Munster, Germany; [Schlatt, Stefan] Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, D-48149 Munster, Germany	University of Munster; University of Munster	Chi, LF (corresponding author), Univ Munster, Inst Phys, D-48149 Munster, Germany.	chi@uni-muenster.de; Stefan.schlatt@ukmuenster.de	Chi, Lifeng/A-1419-2015; Pan, Fei/J-9727-2013	Schlatt, Stefan/0000-0002-7571-5313	DFG [TRR61, SCHL 394/11-1]	DFG(German Research Foundation (DFG))	The DFG is acknowledged for the co-financial support in frame of a German-Chinese collaboration project (TRR61) and support through a grant (SCHL 394/11-1). The authors express their thanks to Reinhild Sandhowe and Jutta Salzig for technical support during cell culture and immunostaining. We are thankful to Prof. Michael Meisterernst for providing us with the OG2 cell line. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Gassei K, 2006, J ANDROL, V27, P611, DOI 10.2164/jandrol.05207; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; RUSSELL LD, 1989, BIOL REPROD, V41, P571, DOI 10.1095/biolreprod41.4.571; Schlatt S, 1996, BIOL REPROD, V55, P227, DOI 10.1095/biolreprod55.2.227; Shen CJ, 2008, CELL MOL BIOENG, V1, P15, DOI 10.1007/s12195-008-0005-y; TUNG PS, 1990, BIOL REPROD, V42, P351, DOI 10.1095/biolreprod42.2.351; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	14	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60054	10.1371/journal.pone.0060054	http://dx.doi.org/10.1371/journal.pone.0060054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555881	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200074
J	Burza, MA; Romeo, S; Kotronen, A; Svensson, PA; Sjoholm, K; Torgerson, JS; Lindroos, AK; Sjostrom, L; Carlsson, LMS; Peltonen, M				Burza, Maria Antonella; Romeo, Stefano; Kotronen, Anna; Svensson, Per-Arne; Sjoholm, Kajsa; Torgerson, Jarl S.; Lindroos, Anna-Karin; Sjostrom, Lars; Carlsson, Lena M. S.; Peltonen, Markku			Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study	PLOS ONE			English	Article							RISK-FACTORS; WEIGHT-LOSS; METABOLIC SYNDROME; GASTRIC BYPASS; MORBID-OBESITY; DISEASE; AMINOTRANSFERASE; STEATOHEPATITIS	Background and Aim: Obesity is associated with elevated serum transaminase levels and non-alcoholic fatty liver disease and weight loss is a recommended therapeutic strategy. Bariatric surgery is effective in obtaining and maintaining weight loss. Aim of the present study was to examine the long-term effects of bariatric surgery on transaminase levels in obese individuals. Methods: The Swedish Obese Subjects (SOS) study is a prospective controlled intervention study designed to compare the long-term effects of bariatric surgery and usual care in obese subjects. A total of 3,570 obese participants with no excess of alcohol consumption at baseline (1,795 and 1,775 in the control and surgery group, respectively) were included in the analyses. Changes in transaminase levels during follow-up were compared in the surgery and control groups. Results: Compared to usual care, bariatric surgery was associated with lower serum ALT and AST levels at 2- and 10-year follow up. The reduction in ALT levels was proportional to the degree of weight loss. Both the incidence of and the remission from high transaminase levels were more favorable in the surgery group compared to the control group. Similarly, the prevalence of ALT/AST ratio<1 was lower in the surgery compared to the control group at both 2- and 10-year follow up. Conclusions: Bariatric surgery results in a sustained reduction in transaminase levels and a long-term benefit in obese individuals.	[Burza, Maria Antonella; Romeo, Stefano; Svensson, Per-Arne; Sjoholm, Kajsa; Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Burza, Maria Antonella; Romeo, Stefano; Svensson, Per-Arne; Sjoholm, Kajsa; Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Romeo, Stefano] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Clin Nutr Unit, Catanzaro, Italy; [Kotronen, Anna; Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Torgerson, Jarl S.] Reg Secretariat, Dept Hlth Care, Gothenburg, Sweden; [Lindroos, Anna-Karin] Natl Food Adm Toxicol Lab, Dept Nutr, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Magna Graecia University of Catanzaro; Finland National Institute for Health & Welfare	Peltonen, M (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	markku.peltonen@thl.fi	Romeo, Stefano/L-6861-2015; Carlsson, Lena/F-7570-2018; Svensson, Per-Arne/R-4626-2019; Peltonen, Markku/F-3037-2015	Romeo, Stefano/0000-0001-9168-4898; Carlsson, Lena/0000-0003-4145-6242; Peltonen, Markku/0000-0002-3767-4223; Svensson, Per-Arne/0000-0002-6731-806X; Sjoholm, Kajsa/0000-0003-0146-8193	Swedish Research Council [K2012-55X-22082-01-3, K2010-55X-11285-13, K2008-65x-20753-01-4]; Swedish Foundation for Strategic Research; Swedish federal government under the LUA/ALF agreement	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF agreement	This study was supported by grants from the Swedish Research Council (K2012-55X-22082-01-3, K2010-55X-11285-13, K2008-65x-20753-01-4), the Swedish Foundation for Strategic Research to Sahlgrenska Centre for Cardiovascular and Metabolic Research, the Swedish federal government under the LUA/ALF agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; [Anonymous], 2005, STAT STAT SOFTW REL; Chavaez-Tapia NC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007340.pub2; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; del Genio F, 2009, OBES SURG, V19, P1664, DOI 10.1007/s11695-009-9891-x; Dixon JB, 2006, OBES SURG, V16, P1278, DOI 10.1381/096089206778663805; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Hans-Erik J, 2009, OBES SURG, V19, P601, DOI 10.1007/s11695-009-9806-x; Kotronen A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-237; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Mathurin P, 2006, GASTROENTEROLOGY, V130, P1617, DOI 10.1053/j.gastro.2006.02.024; Mathurin P, 2009, GASTROENTEROLOGY, V137, P532, DOI 10.1053/j.gastro.2009.04.052; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; SIEST G, 1975, CLIN CHEM, V21, P1077; Silvestre V, 2004, OBES SURG, V14, P1227, DOI 10.1381/0960892042387048; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stratopoulos C, 2005, OBES SURG, V15, P1154, DOI 10.1381/0960892055002239; Torgerson JS, 1997, OBES RES, V5, P105, DOI 10.1002/j.1550-8528.1997.tb00650.x; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Wolf AM, 2007, OBES SURG, V17, P910, DOI 10.1007/s11695-007-9169-0	23	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60495	10.1371/journal.pone.0060495	http://dx.doi.org/10.1371/journal.pone.0060495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555982	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500138
J	Tang, HP; Tian, EB; Liu, CG; Wang, QT; Deng, HT				Tang, Haiping; Tian, Enbing; Liu, Chongdong; Wang, Qingtao; Deng, Haiteng			Oxidative Stress Induces Monocyte Necrosis with Enrichment of Cell-Bound Albumin and Overexpression of Endoplasmic Reticulum and Mitochondrial Chaperones	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PERIPHERAL-BLOOD MONOCYTES; NECROTIC DEATH; MYELODYSPLASTIC SYNDROME; DENDRITIC CELLS; CANCER; AZACITIDINE; CATHEPSIN; APOPTOSIS; GOSSYPOL	In the present study, monocytes were treated with 5-azacytidine (azacytidine), gossypol or hydrogen peroxide to induce cell death through oxidative stress. A shift from apoptotic to necrotic cell death occurred when monocytes were treated with 100 mM azacytidine for more than 12 hours. Necrotic monocytes exhibited characteristics, including enrichment of cell-bound albumin and up-regulation of endoplasmic reticulum (ER)- and mitochondrial-specific chaperones to protect mitochondrial integrity, which were not observed in other necrotic cells, including HUH-7, A2780, A549 and HOC1a. Our results show that the cell-bound albumin originates in the culture medium rather than from monocyte-derived hepatocytes, and that HSP60 is a potential binding partner of the cell-bound albumin. Proteomic analysis shows that HSP60 and protein disulfide isomerase are the most abundant up-regulated mitochondrial and ER-chaperones, and that both HSP60 and calreticulin are ubiquitinated in necrotic monocytes. In contrast, expression levels of the cytosolic chaperones HSP90 and HSP71 were down-regulated in the azacytidine-treated monocytes, concomitant with an increase in the levels of these chaperones in the cell culture medium. Collectively, our results demonstrates that chaperones from different organelles behave differently in necrotic monocytes, ER- and mitochondrial chaperones being retained and cytosolic and nuclear chaperones being released into the cell culture medium through the ruptured cell membrane. HSP60 may serve as a new target for development of myeloid leukemia treatment.	[Tang, Haiping; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Tian, Enbing; Liu, Chongdong; Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China	Tsinghua University; Capital Medical University	Deng, HT (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	dengh@biomed.tsinghua.edu.cn		Deng, Haiteng/0000-0001-9496-1280	Center for Life Sciences (Tsinghua University); National Natural Science Foundation of China [30872391]	Center for Life Sciences (Tsinghua University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Center for Life Sciences (Tsinghua University), the National Natural Science Foundation of China (No. 30872391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Asea A, 2007, J BIOSCIENCES, V32, P579, DOI 10.1007/s12038-007-0057-5; Asea Alexzander A. A., 2007, V1, P3; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO;2; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Calabrese V, 2007, J NEUROCHEM, V101, P709, DOI 10.1111/j.1471-4159.2006.04367.x; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; DZIARSKI R, 1994, J BIOL CHEM, V269, P20431; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Follo MY, 2009, P NATL ACAD SCI USA, V106, P16811, DOI 10.1073/pnas.0907109106; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Gao S, 2008, LEUKEMIA RES, V32, P771, DOI 10.1016/j.leukres.2007.09.007; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Goldstein MG, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-5; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hagemann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017388; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Huong TTT, 2011, J KOREAN MED SCI, V26, P207, DOI 10.3346/jkms.2011.26.2.207; Imre G, 2007, BBA-MOL CELL RES, V1773, P1546, DOI 10.1016/j.bbamcr.2007.07.003; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Kappler M, 2007, BBA-MOL CELL RES, V1773, P945, DOI 10.1016/j.bbamcr.2007.04.001; KOLL H, 1992, CELL, V68, P1163, DOI 10.1016/0092-8674(92)90086-R; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Mazars A, 2001, J BIOL CHEM, V276, P36797, DOI 10.1074/jbc.M101672200; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Morinaga Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-158; Nadasi E, 2009, ANTICANCER RES, V29, P2295; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rossi MR, 2002, ENVIRON HEALTH PERSP, V110, P1225, DOI 10.1289/ehp.021101225; Ruhnke M, 2005, GASTROENTEROLOGY, V128, P1774, DOI 10.1053/j.gastro.2005.03.029; Silverman LR, 2006, J CLIN ONCOL, V24, P3895, DOI 10.1200/JCO.2005.05.4346; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; STEIN RC, 1992, CANCER CHEMOTH PHARM, V30, P480, DOI 10.1007/BF00685601; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Varol U., 2009, Experimental Oncology, V31, P220; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Yan L, 2007, AM J HEMATOL, V82, P949, DOI 10.1002/ajh.21030; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	55	17	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59610	10.1371/journal.pone.0059610	http://dx.doi.org/10.1371/journal.pone.0059610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555724	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500063
J	Kuo, SM; Merhige, PM; Hagey, LR				Kuo, Shiu-Ming; Merhige, Patricia M.; Hagey, Lee R.			The Effect of Dietary Prebiotics and Probiotics on Body Weight, Large Intestine Indices, and Fecal Bile Acid Profile in Wild Type and IL10-/- Mice	PLOS ONE			English	Article							BIFIDOBACTERIUM-LACTIS; INTERLEUKIN-10-DEFICIENT MICE; LACTOBACILLUS-RHAMNOSUS; CHOLESTEROL SULFATE; SATIATING POWER; GUT MICROBIOTA; ORAL GAVAGE; INULIN; OLIGOFRUCTOSE; COLON	Previous studies have suggested roles of probiotics and prebiotics on body weight management and intestinal function. Here, the effects of a dietary prebiotic, inulin (50 mg/g diet), and probiotic, Bfidobacterium animalis subsp. lactis (Bb12) (final dose verified at 10(5) colony forming unit (cfu)/g diet, comparable to human consumption), were determined separately and in combination in mice using cellulose-based AIN-93G diets under conditions allowed for the growth of commensal bacteria. Continuous consumption of Bb12 and/or inulin did not affect food intake or body, liver, and spleen weights of young and adult mice. Fecal bile acid profiles were determined by nanoESI-MS/MS tandem mass spectrometry. In the presence of inulin, more bacterial deconjugation of taurine from primary bile acids was observed along with an increased cecal weight. Consumption of inulin in the absence or presence of Bb12 also increased the villus cell height in the proximal colon along with a trend of higher bile acid sulfation by intestinal cells. Feeding Bb12 alone at the physiological dose did not affect bile acid deconjugation and had little effect on other intestinal indices. Although interleukin (IL)10-null mice are susceptible to enterocolitis, they maintained the same body weight as the wild type mice under our specific pathogen-free housing condition and showed no signs of inflammation. Nevertheless, they had smaller cecum suggesting a mildly compromised intestinal development even before the disease manifestation. Our results are consistent with the notion that dietary factors such as prebiotics play important roles in the growth of intestinal microbiota and may impact on the intestinal health. In addition, fecal bile acid profiling could potentially be a non-invasive tool in monitoring the intestinal environment.	[Kuo, Shiu-Ming; Merhige, Patricia M.] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Hagey, Lee R.] Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 92103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California San Diego	Kuo, SM (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	smkuo@buffalo.edu			Bell Institute of Health and Nutrition	Bell Institute of Health and Nutrition	This project has been funded in part by a grant from Bell Institute of Health and Nutrition (to SMK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Araki Y, 2000, SCAND J GASTROENTERO, V35, P1060, DOI 10.1080/003655200451180; Arantes-Rodrigues R, 2012, LAB ANIMAL, V41, P129, DOI 10.1038/laban0512-129; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bosscher D, 2009, J PHYSIOL PHARMACOL, V60, P5; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Chen QX, 2011, J NUTR, V141, P790, DOI 10.3945/jn.110.133421; Collins MD, 1999, AM J CLIN NUTR, V69, p1052S, DOI 10.1093/ajcn/69.5.1052s; COLONY PC, 1989, GASTROENTEROLOGY, V97, P338, DOI 10.1016/0016-5085(89)90069-3; Cui YX, 1997, LIPIDS, V32, P599, DOI 10.1007/s11745-997-0076-2; Dianawati D, 2011, J FOOD SCI, V76, pM592, DOI 10.1111/j.1750-3841.2011.02422.x; Farmer B, 2011, J AM DIET ASSOC, V111, P819, DOI 10.1016/j.jada.2011.03.012; Femia AP, 2002, CARCINOGENESIS, V23, P1953, DOI 10.1093/carcin/23.11.1953; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Grand R J, 1979, Ciba Found Symp, P293; Hagey LR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-133; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 2008, J PEDIATR GASTR NUTR, V47, P598, DOI 10.1097/MPG.0b013e31816920a6; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iwamori M, 2000, BBA-MOL CELL BIOL L, V1487, P268, DOI 10.1016/S1388-1981(00)00102-5; Jin XL, 2010, GUT, V59, P186, DOI 10.1136/gut.2008.151175; Johnston Ian, 2011, Curr Gastroenterol Rep, V13, P418, DOI 10.1007/s11894-011-0219-3; Kevresan S, 2006, EUR J DRUG METAB PH, V31, P145, DOI 10.1007/BF03190711; Klaassen CD, 2012, PLOS ONE, V10; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langlands SJ, 2004, GUT, V53, P1610, DOI 10.1136/gut.2003.037580; Le Leu RK, 2010, CARCINOGENESIS, V31, P246, DOI 10.1093/carcin/bgp197; Lesniewska V, 2006, APPL ENVIRON MICROB, V72, P6533, DOI 10.1128/AEM.00915-06; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Mair C, 2010, ARCH ANIM NUTR, V64, P304, DOI 10.1080/1745039X.2010.492137; MARTEAU P, 1990, AM J CLIN NUTR, V52, P685, DOI 10.1093/ajcn/52.4.685; Martin NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027191; Masso-Welch PA, 2012, IMMUNOL INVEST, V41, P521, DOI 10.3109/08820139.2012.684193; Meyer D, 2009, EUR J CLIN NUTR, V63, P1277, DOI 10.1038/ejcn.2009.64; Monsivais P, 2011, APPETITE, V56, P9, DOI 10.1016/j.appet.2010.10.010; MYERS DD, 1980, LAB ANIM SCI, V30, P330; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; Nyman M, 2002, BRIT J NUTR, V87, pS163, DOI [10.1079/BJN/2002533, 10.1079/BJN2001504]; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Patterson JK, 2010, J NUTR, V140, P2158, DOI 10.3945/jn.110.130302; Perrigue MM, 2009, J AM DIET ASSOC, V109, P1862, DOI 10.1016/j.jada.2009.08.018; Quigley EMM, 2010, PHARMACOL RES, V61, P213, DOI 10.1016/j.phrs.2010.01.004; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Roller M, 2004, J NUTR, V134, P153, DOI 10.1093/jn/134.1.153; Rosenblatt J., 2002, BASIC STAT METHODS M; SAEGUSA Y, 1990, J CELL PHYSIOL, V142, P488, DOI 10.1002/jcp.1041420307; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shay CM, 2012, AM J CLIN NUTR, V96, P483, DOI 10.3945/ajcn.111.025056; Sheil B, 2006, CLIN EXP IMMUNOL, V144, P273, DOI 10.1111/j.1365-2249.2006.03051.x; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Solano-Aguilar G, 2008, APPL ENVIRON MICROB, V74, P6338, DOI 10.1128/AEM.00309-08; Swanson KS, 2001, J ANIM SCI, V79, P919; van Meer H, 2008, AM J PHYSIOL-GASTR L, V294, pG540, DOI 10.1152/ajpgi.00396.2007; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vernazza CL, 2006, J APPL MICROBIOL, V100, P846, DOI 10.1111/j.1365-2672.2006.02832.x; Vinderola CG, 2003, FOOD RES INT, V36, P895, DOI 10.1016/S0963-9969(03)00098-X; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wang Y, 2010, NUTRITION, V26, P305, DOI 10.1016/j.nut.2009.04.014; Yasuda K, 2007, J NUTR, V137, P2399, DOI 10.1093/jn/137.11.2399	65	37	39	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60270	10.1371/journal.pone.0060270	http://dx.doi.org/10.1371/journal.pone.0060270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555939	Green Published, gold			2022-12-27	WOS:000316546400085
J	Mignardot, JB; Olivier, I; Promayon, E; Nougier, V				Mignardot, Jean-Baptiste; Olivier, Isabelle; Promayon, Emmanuel; Nougier, Vincent			Origins of Balance Disorders during a Daily Living Movement in Obese: Can Biomechanical Factors Explain Everything?	PLOS ONE			English	Article							BODY-MASS INDEX; TO-STAND MOVEMENT; PHYSICAL-ACTIVITY; POSTURAL STABILITY; OVERWEIGHT; WEIGHT; EQUILIBRIUM; FRACTURES; STRENGTH; EXERCISE	Obese people suffer from postural deficits and are more subject to falls than their lean counterpart. To improve prevention and post-fall rehabilitation programs, it seems important to better understand the posturo-kinetic disorders in daily life situations by determining the contribution of some key factors, mainly morphological characteristics and physical activity level, in the apparition of these disorders. Twelve severe android obese and eight healthy non obese adults performed a reaching task mobilizing the whole body. To further determine the origin of the postural and motor behavior differences, non obese individuals also performed an experimental session with additional constraints which simulated some of the obese morphological characteristics. Impact of the sedentary lifestyle was also studied by dissociation of the obese in two subgroups: physically "active" and physically "inactive". Movement kinetics and kinematics were characterized with an optoelectronic system synchronized to a force platform. The mechanical equilibrium pattern was evaluated through the displacements of the Centre of Mass (CoM) and the centre of foot pressure within the Base of Support (BoS). Results showed that obesity decreased movement speed (approximate to -23%, p<0.01), strongly increased CoM displacement (approximate to+30%, p<0.05) and induced an important spatio-temporal desynchronization (approximate to+40%, p<0.05) of the focal and postural components of the movement during the transition between the descending and ascending movements. The role of some morphological characteristics and of physical activity on obese patients' postural control disorder is discussed and set back in the more general context of overall factors contributing to postural deficits with obesity.	[Mignardot, Jean-Baptiste; Olivier, Isabelle; Promayon, Emmanuel; Nougier, Vincent] UJF Grenoble 1, CNRS, TIMC IMAG UMR 5525, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Mignardot, JB (corresponding author), UJF Grenoble 1, CNRS, TIMC IMAG UMR 5525, Grenoble, France.	mignardot.jb@gmail.com	Olivier, Isabelle/M-6054-2014; Nougier, Vincent/AAG-5794-2021; Nougier, Vincent M/B-4993-2013; Promayon, Emmanuel/M-6872-2014	Nougier, Vincent M/0000-0002-9917-0004; Promayon, Emmanuel/0000-0001-8934-6793				BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Basdevant A, 2008, JOINT BONE SPINE, V75, P665, DOI 10.1016/j.jbspin.2008.06.007; Berarducci A, 2009, APPL NURS RES, V22, P35, DOI 10.1016/j.apnr.2007.03.004; Bergkvist D, 2009, SURG OBES RELAT DIS, V5, P670, DOI 10.1016/j.soard.2009.05.014; Bernard P. L., 2003, Annales de Readaptation et de Medecine Physique, V46, P184, DOI 10.1016/S0168-6054(03)00059-X; Berrigan F, 2006, INT J OBESITY, V30, P1750, DOI 10.1038/sj.ijo.0803342; BLIMKIE CJR, 1990, EUR J APPL PHYSIOL, V61, P313, DOI 10.1007/BF00357619; Buschbacher RM, 1998, MUSCLE NERVE, V21, P1398, DOI 10.1002/(SICI)1097-4598(199811)21:11<1398::AID-MUS6>3.0.CO;2-4; Butler EE, 2006, AM J OBSTET GYNECOL, V195, P1104, DOI 10.1016/j.ajog.2006.06.015; CHOWDHURY B, 1993, INT J OBESITY, V17, P685; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; CLEMENT G, 1988, EXP BRAIN RES, V73, P569, DOI 10.1007/BF00406615; Cliff DP, 2011, MED SCI SPORT EXER, V43, P90, DOI 10.1249/MSS.0b013e3181e741e8; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Deforche BI, 2009, INT J PEDIATR OBES, V4, P175, DOI 10.1080/17477160802468470; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Ducher G, 2009, AM J CLIN NUTR, V90, P1104, DOI 10.3945/ajcn.2009.28025; Fjeldstad Cecilie, 2008, Dyn Med, V7, P4, DOI 10.1186/1476-5918-7-4; Galli M, 2000, INT J OBESITY, V24, P1488, DOI 10.1038/sj.ijo.0801409; Goulding A, 2001, J PEDIATR-US, V139, P509, DOI 10.1067/mpd.2001.116297; Greve J, 2007, CLINICS, V62, P717, DOI 10.1590/S1807-59322007000600010; Grossniklaus DA, 2010, RES NURS HEALTH, V33, P539, DOI 10.1002/nur.20411; HILLS AP, 1992, CHILD CARE HLTH DEV, V18, P29, DOI 10.1111/j.1365-2214.1992.tb00338.x; HILLS AP, 1991, ARCH PHYS MED REHAB, V72, P403; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Janssen I, 2004, J ADOLESCENT HEALTH, V35, P360, DOI [10.1016/j.jadohealth.2003.11.095, 10.1016/S1054-139X(04)00058-8]; Jones Peter H, 2010, Methodist Debakey Cardiovasc J, V6, P33; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; KOTANI K, 1994, INT J OBESITY, V18, P207; LEE TD, 1991, PHYS THER, V71, P150, DOI 10.1093/ptj/71.2.150; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; McGraw B, 2000, ARCH PHYS MED REHAB, V81, P484, DOI 10.1053/mr.2000.3782; Menegoni F, 2009, OBESITY, V17, P1951, DOI 10.1038/oby.2009.82; Mignardot JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014387; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; Morrison SC, 2008, GAIT POSTURE, V27, P719, DOI 10.1016/j.gaitpost.2007.09.003; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Must A, 2007, OBESITY, V15, P1774, DOI 10.1038/oby.2007.211; Nantel J, 2006, OBESITY, V14, P1789, DOI 10.1038/oby.2006.206; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Petti S, 1997, ENDOD DENT TRAUMATOL, V13, P285; Poirier Paul, 2001, Cardiology Clinics, V19, P459, DOI 10.1016/S0733-8651(05)70229-0; Pozzo T, 2001, BIOL CYBERN, V85, P39, DOI 10.1007/PL00007995; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; Sibella F, 2003, CLIN BIOMECH, V18, P745, DOI 10.1016/S0268-0033(03)00144-X; Spaine LA, 1996, INJURY, V27, P687, DOI 10.1016/S0020-1383(96)00136-2; Spanier PA, 2006, CAN J PUBLIC HEALTH, V97, P255, DOI 10.1007/BF03405599; Stapley P, 2000, BIOL CYBERN, V82, P161, DOI 10.1007/s004220050016; Tagliabue M, 2008, MED BIOL ENG COMPUT, V46, P11, DOI 10.1007/s11517-007-0252-4; TAYLOR CB, 1985, PUBLIC HEALTH REP, V100, P195; Teasdale N, 2007, INT J OBESITY, V31, P153, DOI 10.1038/sj.ijo.0803360; Wang L, 2008, MED SCI MONITOR, V14, pCR129; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	57	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60491	10.1371/journal.pone.0060491	http://dx.doi.org/10.1371/journal.pone.0060491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560097	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100079
J	Townsend, AK; Sillett, TS; Lany, NK; Kaiser, SA; Rodenhouse, NL; Webster, MS; Holmes, RT				Townsend, Andrea K.; Sillett, T. Scott; Lany, Nina K.; Kaiser, Sara A.; Rodenhouse, Nicholas L.; Webster, Michael S.; Holmes, Richard T.			Warm Springs, Early Lay Dates, and Double Brooding in a North American Migratory Songbird, the Black-Throated Blue Warbler	PLOS ONE			English	Article							CLIMATE-CHANGE AFFECTS; NEOTROPICAL MIGRANT; DENDROICA-CAERULESCENS; POPULATION-DYNAMICS; AVIAN POPULATION; BIRD POPULATION; GREAT TITS; LONG-TERM; PHENOLOGY; FOREST	Numerous studies have correlated the advancement of lay date in birds with warming climate trends, yet the fitness effects associated with this phenological response have been examined in only a small number of species. Most of these species-primarily insectivorous cavity nesters in Europe-exhibit fitness declines associated with increasing asynchrony with prey. Here, we use 25 years of demographic data, collected from 1986 to 2010, to examine the effects of spring temperature on breeding initiation date, double brooding, and annual fecundity in a Nearctic - Neotropical migratory songbird, the black-throated blue warbler (Setophaga caerulescens). Data were collected from birds breeding at the Hubbard Brook Experimental Forest, New Hampshire, USA, where long-term trends toward warmer springs have been recorded. We found that black-throated blue warblers initiated breeding earlier in warmer springs, that early breeders were more likely to attempt a second brood than those starting later in the season, and that double brooding and lay date were linked to higher annual fecundity. Accordingly, we found selection favored earlier breeding in most years. However, in contrast to studies of several other long-distance migratory species in Europe, this selection pressure was not stronger in warmer springs, indicating that these warblers were able to adjust mean lay date appropriately to substantial inter-annual variation in spring temperature. Our results suggest that this North American migratory songbird might not experience the same fecundity declines as songbirds that are unable to adjust their timing of breeding in pace with spring temperatures.	[Townsend, Andrea K.; Kaiser, Sara A.; Webster, Michael S.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Townsend, Andrea K.; Kaiser, Sara A.; Webster, Michael S.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Townsend, Andrea K.; Sillett, T. Scott] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Migratory Bird Ctr, Washington, DC 20008 USA; [Lany, Nina K.; Holmes, Richard T.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Rodenhouse, Nicholas L.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	Cornell University; Cornell University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Dartmouth College; Wellesley College	Townsend, AK (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	aktownsend@ucdavis.edu	Webster, Michael/AAB-7151-2020; Sillett, Scott/N-2240-2017	Webster, Michael/0000-0001-7585-4578; Sillett, Scott/0000-0002-7486-0076; Lany, Nina/0000-0003-0868-266X; Kaiser, Sara/0000-0002-6464-3238	United States National Science Foundation; Dartmouth College; Wellesley College; Smithsonian Institution; Cornell University; United States National Science Foundation [DEB 01-08488]; Direct For Biological Sciences [1242566] Funding Source: National Science Foundation; Division Of Environmental Biology [1010223, 1242563] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Dartmouth College; Wellesley College; Smithsonian Institution(Smithsonian Institution); Cornell University; United States National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the United States National Science Foundation and by Dartmouth College, Wellesley College, the Smithsonian Institution, and Cornell University. The authors thank the many students and field assistants who have worked with them over the past 25 years. This manuscript is a contribution of the Hubbard Brook Ecosystem Study. Hubbard Brook is part of the Long-Term Ecological Research network, which is supported by the United States National Science Foundation (DEB 01-08488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Both Christiaan, 2010, P129; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Chase MK, 2005, AUK, V122, P571, DOI 10.1642/0004-8038(2005)122[0571:EOWAPD]2.0.CO;2; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Dunn PO, 2011, ECOLOGY, V92, P450, DOI 10.1890/10-0478.1; Dunn Peter O., 2010, P113; Fielding CA, 1999, FUNCT ECOL, V13, P65, DOI 10.1046/j.1365-2435.1999.00009.x; Gibbs H, 2007, EMU, V107, P284, DOI 10.1071/MU07022; Goodbred CO, 1996, WILSON BULL, V108, P467; Goodenough AE, 2010, CLIMATIC CHANGE, V102, P687, DOI 10.1007/s10584-010-9932-4; Halupka L, 2008, J AVIAN BIOL, V39, P95, DOI 10.1111/j.0908-8857.2008.04047.x; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Holmes RT, 2007, IBIS, V149, P2, DOI 10.1111/j.1474-919X.2007.00685.x; Holmes RT, 2011, FOREST ECOL MANAG, V262, P20, DOI 10.1016/j.foreco.2010.06.021; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; HOLMES RT, 1992, AUK, V109, P321, DOI 10.2307/4088201; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Holmes RT, 2005, BIRDS N AM ONLINE; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Husby A, 2009, P ROY SOC B-BIOL SCI, V276, P1845, DOI 10.1098/rspb.2008.1937; Jenkins D, 2010, BIRD STUDY, V57, P407, DOI 10.1080/00063657.2010.505946; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Miller-Rushing AJ, 2008, GLOBAL CHANGE BIOL, V14, P1959, DOI 10.1111/j.1365-2486.2008.01619.x; Moller AP, 2010, J ANIM ECOL, V79, P777, DOI 10.1111/j.1365-2656.2010.01677.x; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2007, BEHAV ECOL, V18, P62, DOI 10.1093/beheco/arl051; Morse D. H., 2013, AM WARBLERS; Nagy LR, 2005, AUK, V122, P902, DOI 10.1642/0004-8038(2005)122[0902:TDONIV]2.0.CO;2; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Nagy LR, 2004, J AVIAN BIOL, V35, P487, DOI 10.1111/j.0908-8857.2004.03429.x; Newton I., 1998, POPULATION LIMITATIO; Ogden LJE, 1996, CONDOR, V98, P736, DOI 10.2307/1369855; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; Reynolds LV, 2007, CAN J FOREST RES, V37, P481, DOI 10.1139/X06-211; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Rodenhouse NL, 2008, MITIG ADAPT STRAT GL, V13, P517, DOI 10.1007/s11027-007-9126-1; RODENHOUSE NL, 1992, CONSERV BIOL, V6, P263, DOI 10.1046/j.1523-1739.1992.620263.x; Rodenhouse NL, 2003, P ROY SOC B-BIOL SCI, V270, P2105, DOI 10.1098/rspb.2003.2438; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Sauer J.R., 2008, N AM BREEDING BIRD S; Sillett T. Scott, 2005, P426; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2004, ECOLOGY, V85, P2467, DOI 10.1890/03-0272; Strode PK, 2003, GLOBAL CHANGE BIOL, V9, P1137, DOI 10.1046/j.1365-2486.2003.00664.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilson S, 2003, P NATL ACAD SCI USA, V100, P11139, DOI 10.1073/pnas.1931407100; Wilson S, 2006, AUK, V123, P784, DOI 10.1642/0004-8038(2006)123[784:NDBPAR]2.0.CO;2; Zuur Alain F., 2009, P1	61	58	58	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59467	10.1371/journal.pone.0059467	http://dx.doi.org/10.1371/journal.pone.0059467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565154	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300022
J	Mu, B; Zhang, H; Cai, XM; Yang, JB; Shen, YW; Chen, BF; Liang, SH				Mu, Bo; Zhang, Huan; Cai, Xiaoming; Yang, Junbao; Shen, Yuewu; Chen, Baofeng; Liang, Suhua			Screening of Multiple Myeloma by Polyclonal Rabbit Anti-Human Plasmacytoma Cell Immunoglobulin	PLOS ONE			English	Article							SHOCK-PROTEIN 90; PROTEOMICS-BASED IDENTIFICATION; PHOSPHOGLYCERATE KINASE 1; TUMOR-ASSOCIATED ANTIGEN; FATTY-ACID SYNTHASE; HEAT-SHOCK-PROTEIN-90 INHIBITION; LIPID-ACCUMULATION; CANCER; HSP90; ADIPOPHILIN	Antibody-based immunotherapy has been effectively used for tumor treatment. However, to date, only a few tumor-associated antigens (TAAs) or therapeutic targets have been identified. Identification of more immunogenic antigens is essential for improvements in multiple myeloma (MM) diagnosis and therapy. In this study, we synthesized a polyclonal antibody (PAb) by immunizing rabbits with whole human plasmacytoma ARH-77 cells and identified MM-associated antigens, including enlonase, adipophilin, and HSP90s, among others, via proteomic technologies. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that 200 mu g/mL PAb inhibits the proliferation of ARH-77 cells by over 50% within 48 h. Flow cytometric assay indicated that PAb treatment significantly increases the number of apoptotic cells compared with other treatments (52.1% vs. NS, 7.3% or control rabbit IgG, 9.9%). In vivo, PAb delayed tumor growth and prolonged the lifespan of mice. Terminal deoxynucleotidyl transferase dUTP nick end labeling assay showed that PAb also induces statistically significant changes in apoptosis compared with other treatments (P<0.05). We therefore conclude that PAb could be used for the effective screening and identification of TAA. PAb may have certain anti-tumor functions in vitro and in vivo. As such, its combination with proteomic technologies could be a promising approach for sieving TAA for the diagnosis and therapy of MM.	[Mu, Bo; Zhang, Huan; Cai, Xiaoming; Yang, Junbao; Shen, Yuewu; Chen, Baofeng; Liang, Suhua] North Sichuan Med Coll, Nanchong, Sichuan, Peoples R China; [Mu, Bo] North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China	North Sichuan Medical University; North Sichuan Medical University	Mu, B (corresponding author), North Sichuan Med Coll, Med Biol Staff Room, Nanchong, Sichuan, Peoples R China.	ppnu2@yahoo.com.cn			National Natural Science Foundation of China [81101733]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China, number 81101733 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ambrosio MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044315; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Charoenfuprasert S, 2011, ONCOGENE, V30, P3570, DOI 10.1038/onc.2011.77; Chen FL, 2010, MOL CELL BIOCHEM, V337, P193, DOI 10.1007/s11010-009-0299-7; Chiosis G, 2013, NAT STRUCT MOL BIOL, V20, P1, DOI 10.1038/nsmb.2481; Chong BM, 2011, TRENDS ENDOCRIN MET, V22, P211, DOI 10.1016/j.tem.2011.04.003; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Devitt G, 2006, INT J CANCER, V118, P2210, DOI 10.1002/ijc.21626; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Duan Z, 2002, ANTICANCER RES, V22, P1933; El Hamidieh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042722; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Ferrarini M, 2006, INT J CANCER, V51, P613; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Fu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049194; Grebe SK, 2010, MAYO CLIN PROC, V85, P410, DOI 10.4065/mcp.2010.0165; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Ho MY, 2010, CANCER SCI, V101, P2411, DOI 10.1111/j.1349-7006.2010.01691.x; Kiessling Andrea, 2012, Cancers (Basel), V4, P193, DOI 10.3390/cancers4010193; Lewandrowski P, 2011, EP Patent, Patent No. [2,111,867, 2111867]; Liggins AP, 2005, METH MOLEC MED, V115, P109; Liu K.-J., 2007, J CANC MOL, V3, P45; Liu WL, 2008, BIOCHEM BIOPH RES CO, V375, P440, DOI 10.1016/j.bbrc.2008.08.039; Liu XG, 2011, ONCOL REP, V25, P1343, DOI 10.3892/or.2011.1202; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P2195, DOI 10.1158/1055-9965.EPI-11-0400; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; Miekus K, 2012, ONCOL REP, V28, P1903, DOI 10.3892/or.2012.1996; Mollapour M, 2010, CELL CYCLE, V9, P2310, DOI 10.4161/cc.9.12.12054; Ohno H, 2010, LEUKEMIA LYMPHOMA, V51, P2144, DOI 10.3109/10428194.2010.513750; Pandey PR, 2012, RECENT PAT ANTI-CANC, V7, P185; Qian F, 2005, INT J MOL MED, V15, P137; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Rajkumar SV, 2002, MAYO CLIN PROC, V77, P813, DOI 10.4065/77.8.813; Roos R, 2012, NED TIJDSCHR KLIN CH, V37, P38; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Russell TD, 2011, J CELL SCI, V124, P3247, DOI 10.1242/jcs.082974; Sapozhnikov A, 2007, CELL PROLIFERAT, V32, P363; Shimamura T, 2008, J THORAC ONCOL, V3, pS152, DOI 10.1097/JTO.0b013e318174ea3a; Shipp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037475; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Tai YT, 2011, BONE MARROW RES, V2011, P1; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsunemi S, 2010, ONCOL REP, V23, P949, DOI 10.3892/or_00000719; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; Tureci Z, 2005, METH MOLEC MED, V109, P137; Vaughan Hilary A, 2004, Cancer Immun, V4, P5; Wang YS, 2009, CLIN CANCER RES, V15, P6901, DOI 10.1158/1078-0432.CCR-09-0484; Wei YQ, 2000, NAT MED, V6, P1160, DOI 10.1038/80506; Wright Simon K., 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P320; Zagouri F, 2012, PHARMACEUTICALS, V5, P1008, DOI 10.3390/ph5091008; Zhang F, 2012, BLOOD, V119, P6080, DOI 10.1182/blood-2011-12-399519; Zieker D, 2010, INT J CANCER, V126, P1513, DOI 10.1002/ijc.24835	64	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59117	10.1371/journal.pone.0059117	http://dx.doi.org/10.1371/journal.pone.0059117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560043	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900011
J	Karlgren, A; Gyllenstrand, N; Kallman, T; Lagercrantz, U				Karlgren, Anna; Gyllenstrand, Niclas; Kallman, Thomas; Lagercrantz, Ulf			Conserved Function of Core Clock Proteins in the Gymnosperm Norway Spruce (Picea abies L. Karst)	PLOS ONE			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; PSEUDO-RESPONSE REGULATORS; ARABIDOPSIS-THALIANA; TARGETED DEGRADATION; CONTROLLED GENE; FLOWERING TIME; DISTINCT ROLES; SCFZTL COMPLEX; EXPRESSION; ZEITLUPE	From studies of the circadian clock in the plant model species Arabidopsis (Arabidopsis thaliana), a number of important properties and components have emerged. These include the genes CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), GIGANTEA (GI), ZEITLUPE (ZTL) and TIMING OF CAB EXPRESSION 1 (TOC1 also known as PSEUDO-RESPONSE REGULATOR 1 (PRR1)) that via gene expression feedback loops participate in the circadian clock. Here, we present results from ectopic expression of four Norway spruce (Picea abies) putative homologs (PaCCA1, PaGI, PaZTL and PaPRR1) in Arabidopsis, their flowering time, circadian period length, red light response phenotypes and their effect on endogenous clock genes were assessed. For PaCCA1-ox and PaZTL-ox the results were consistent with Arabidopsis lines overexpressing the corresponding Arabidopsis genes. For PaGI consistent results were obtained when expressed in the gi2 mutant, while PaGI and PaPRR1 expressed in wild type did not display the expected phenotypes. These results suggest that protein function of PaCCA1, PaGI and PaZTL are at least partly conserved compared to Arabidopsis homologs, however further studies are needed to reveal the protein function of PaPRR1. Our data suggest that components of the three-loop network typical of the circadian clock in angiosperms were present before the split of gymnosperms and angiosperms.	[Karlgren, Anna; Kallman, Thomas; Lagercrantz, Ulf] Uppsala Univ, Dept Plant Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden; [Gyllenstrand, Niclas] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala Bioctr, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Lagercrantz, U (corresponding author), Uppsala Univ, Dept Plant Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden.	ulf.lagercrantz@ebc.uu.se		Kallman, Thomas/0000-0003-0498-2665	Royal Swedish Academy of Agriculture and Forestry; Carl Trygger Foundation; Swedish Research Council; Swedish Research Council FORMAS	Royal Swedish Academy of Agriculture and Forestry; Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	AK has received financial support from the Royal Swedish Academy of Agriculture and Forestry and NG was supported by the Carl Trygger Foundation. Financial support to UL was provided by the Swedish Research Council and the Swedish Research Council FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Edwards Kieron D, 2007, Methods Mol Biol, V362, P103; Ekberg I., 1979, HOLARCTIC ECOL, V2, P255, DOI [10.1111/j.1600-0587.1979.tb01297.x, DOI 10.1111/J.1600-0587.1979.TB01297.X]; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gyllenstrand N, 2007, PLANT PHYSIOL, V144, P248, DOI 10.1104/pp.107.095802; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Holm K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-109; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Ibanez C, 2010, PLANT PHYSIOL, V153, P1823, DOI 10.1104/pp.110.158220; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Kawamura M, 2008, BIOSCI BIOTECH BIOCH, V72, P1307, DOI 10.1271/bbb.70804; Kevei E, 2006, PLANT PHYSIOL, V140, P933, DOI 10.1104/pp.105.074864; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kim WY, 2005, PLANT PHYSIOL, V139, P1557, DOI 10.1104/pp.105.067173; Liew LC, 2009, PLANT CELL, V21, P3198, DOI 10.1105/tpc.109.067223; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Lou P, 2012, PLANT CELL, V24, P2415, DOI 10.1105/tpc.112.099499; Lumsden P. J., 1998, BIOL RHYTHMS PHOTOPE; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Miwa K, 2006, PLANT CELL PHYSIOL, V47, P601, DOI 10.1093/pcp/pcj027; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; R Core Team, 2012, R LANG ENV STAT COMP; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Satbhai SB, 2011, BIOSCI BIOTECH BIOCH, V75, P786, DOI 10.1271/bbb.100859; Sato E, 2002, PLANT CELL PHYSIOL, V43, P1374, DOI 10.1093/pcp/pcf166; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng TS, 2004, PLANT CELL, V16, P1550, DOI 10.1105/tpc.019224; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Xue ZG, 2012, MOL BIOL REP, V39, P1411, DOI 10.1007/s11033-011-0875-2; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x	71	16	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60110	10.1371/journal.pone.0060110	http://dx.doi.org/10.1371/journal.pone.0060110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555899	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200084
J	Li, ML; Xu, WW; Gao, YD; Guo, Y; Wang, WJ; Wang, C; Jiang, SY; Willden, A; Huang, JF; Zhang, HT				Li, Ming-Li; Xu, Wen-Wen; Gao, Yue-Dong; Guo, Yan; Wang, Wen-Ju; Wang, Chao; Jiang, Shi-You; Willden, Andrew; Huang, Jing-Fei; Zhang, Hua-Tang			Interferon-Lambda3 (IFN-lambda 3) and Its Cognate Receptor Subunits in Tree Shrews (Tupaia belangeri): Genomic Sequence Retrieval, Molecular Identification and Expression Analysis	PLOS ONE			English	Article							LAMBDA-S; EXPERIMENTAL-INFECTION; GENETIC-VARIATION; ADULT TUPAIA; HEPATITIS; IL28B; IL-29; ANTITUMOR; PRIMATES; CLONING	Type III IFNs (IFN-lambda s) constitute a new subfamily with antiviral activities by signaling through a unique receptor complex composed of IFN-lambda s receptor 1 (IFN lambda R1) and interleukin-10 receptor 2 (IL10R2). As tree shrews (Tupaia belangeri) have shown susceptiblility to several human viruses, they are a potentially important model for analyzing viral infection. However, little is known about their IFN-lambda s system. We used the tree shrew genome to retrieve IFN-lambda s and their receptor contig sequences by BLASTN and BLASTZ algorithms, and GenScan was used to scan transcripts from the putative contig sequences. RT-PCR and bioinformatic methods were then used to clone and characterize the IFN-lambda s system. Due to its highest identity with human IFN-lambda 3, we opted to define one intact IFN-lambda gene, tsIFN-lambda 3, as well as its two receptor subunits, tsIFN lambda R1 and tsIL10R2. Additionally, our results showed that tsIFN-lambda 3 contained many features conserved in IFN-lambda 3 genes from other mammals, including conserved signal peptide cleavage and glycosylation sites, and several residues responsible for binding to the type III IFNR. We also found six transcript variants in the receptors: three in tsIFN lambda R1, wherein different extracellular regions exist in three transmembrane proteins, resulting in different affinities with IFN-lambda s; and three more variants in tsIL10R2, encoding one transmembrane and two soluble proteins. Based on tissue distribution in the liver, heart, brain, lung, intestine, kidney, spleen, and stomach, we found that IFN-lambda s receptor complex was expressed in a variety of organs although the expression level differed markedly between them. As the first study to find transcript variants in IL-10R2, our study offers novel insights that may have important implications for the role of IFN-lambda s in tree shrews' susceptibility with a variety of human viruses, bolstering the arguments for using tree shrews as an animal model in the study of human viral infections.	[Li, Ming-Li; Xu, Wen-Wen; Guo, Yan; Wang, Wen-Ju; Wang, Chao; Zhang, Hua-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Li, Ming-Li; Xu, Wen-Wen; Guo, Yan; Wang, Wen-Ju; Wang, Chao; Zhang, Hua-Tang] Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China; [Zhang, Hua-Tang] Chongqing Acad Sci & Technol, Chongqing Ctr Biomed Res & Equipment Dev, Chongqing, Peoples R China; [Li, Ming-Li; Xu, Wen-Wen; Jiang, Shi-You] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Yue-Dong; Jiang, Shi-You; Huang, Jing-Fei] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Willden, Andrew] Chinese Acad Sci, Editorial Dept, Kunming Inst Zool, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, HT (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	zhanght@mail.kiz.ac.cn	Xu, Wenwen/AAD-9116-2019	Li, Mingli/0000-0001-6921-3651; Jiang, Shi-You/0000-0001-9406-4934	Chinese Academy of Sciences [KSCX2-EW-J-23, KSCX2-EW-R-12]; National Key Basic Research and Development Program (973 programme) [2007CB512807]; Talents Program of the Chinese Academy of Sciences [A0820]; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program (973 programme); Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences	This work was supported by grants from the Chinese Academy of Sciences (KSCX2-EW-J-23 and KSCX2-EW-R-12), the National Key Basic Research and Development Program (973 programme, 2007CB512807), the Talents Program of the Chinese Academy of Sciences (No. A0820) and the Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; BARKER LF, 1973, J INFECT DIS, V127, P648, DOI 10.1093/infdis/127.6.648; Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Cao J, 2003, J MED PRIMATOL, V32, P123, DOI 10.1034/j.1600-0684.2003.00022.x; Dandri M, 2005, J CLIN VIROL, V34, pS54, DOI 10.1016/S1386-6532(05)80011-3; DARAI G, 1980, ARCH VIROL, V65, P311, DOI 10.1007/BF01314546; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2003, BIOCHEM J, V370, P391, DOI 10.1042/BJ20021935; Eder G, 1994, S ROL CHIMP RES VIEN, p[1, i]; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Karpala AJ, 2008, J INTERF CYTOK RES, V28, P341, DOI 10.1089/jir.2007.0117; Knapp B, 2008, PROTEIN SCI, V17, P977, DOI 10.1110/ps.073402508; Kotenko SV, 2004, INT IMMUNOPHARMACOL, V4, P593, DOI 10.1016/j.intimp.2004.01.003; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lanford RE, 2000, J VIROL, V74, P2955, DOI 10.1128/JVI.74.6.2955-2959.2000; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lasfar A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349575; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Li Ming-Li, 2012, Zoological Research, V33, P67, DOI 10.3724/SP.J.1141.2012.01067; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; PANG QF, 1983, CHINESE MED J-PEKING, V96, P85; PILLOT J, 1990, PATHOL BIOL, V38, P177; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang YM, 2010, J INTERF CYTOK RES, V30, P801, DOI 10.1089/jir.2010.0016; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shi X, 2012, PLOS ONE, V7; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Takahashi K, 2000, VIROLOGY, V267, P58, DOI 10.1006/viro.1999.0102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tian JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-370; Tong YM, 2011, J VIROL, V85, P2793, DOI 10.1128/JVI.01818-10; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Waddell P J, 2001, Genome Inform, V12, P141; Wang D, 2011, DEV COMP IMMUNOL, V35, P378, DOI 10.1016/j.dci.2010.11.003; Wang X B, 1982, Zhonghua Yi Xue Za Zhi, V62, P461; Warren KS, 1999, J VIROL, V73, P7860, DOI 10.1128/JVI.73.9.7860-7865.1999; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Xu XP, 2007, J GEN VIROL, V88, P2504, DOI 10.1099/vir.0.82878-0; Yan R Q, 1989, Zhonghua Bing Li Xue Za Zhi, V18, P19; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003; Zhou P, 2011, PLOS ONE, V6; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	60	6	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60048	10.1371/journal.pone.0060048	http://dx.doi.org/10.1371/journal.pone.0060048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555878	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200073
J	Miranda-CasoLuengo, AA; Miranda-CasoLuengo, R; Lieggi, NT; Luo, HX; Simpson, JC; Meijer, WG				Miranda-CasoLuengo, Aleksandra A.; Miranda-CasoLuengo, Raul; Lieggi, Nora T.; Luo, Haixia; Simpson, Jeremy C.; Meijer, Wim G.			A Real-Time Impedance Based Method to Assess Rhodococcus equi Virulence	PLOS ONE			English	Article							ISOCITRATE LYASE; PROTEIN-A; MACROPHAGES; SURVIVAL; PLASMID; SYSTEM; CELLS	Rhodococcus equi is a facultative intracellular pathogen of macrophages and the causative agent of foal pneumonia. R. equi virulence is usually assessed by analyzing intracellular growth in macrophages by enumeration of bacteria following cell lysis, which is time consuming and does not allow for a high throughput analysis. This paper describes the use of an impedance based real-time method to characterize proliferation of R. equi in macrophages, using virulent and attenuated strains lacking the vapA gene or virulence plasmid. Image analysis suggested that the time-dependent cell response profile (TCRP) is governed by cell size and roundness as well as cytoxicity of infecting R. equi strains. The amplitude and inflection point of the resulting TCRP were dependent on the multiplicity of infection as well as virulence of the infecting strain, thus distinguishing between virulent and attenuated strains.	[Miranda-CasoLuengo, Aleksandra A.; Miranda-CasoLuengo, Raul; Luo, Haixia; Meijer, Wim G.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Miranda-CasoLuengo, Aleksandra A.; Miranda-CasoLuengo, Raul; Lieggi, Nora T.; Luo, Haixia; Simpson, Jeremy C.; Meijer, Wim G.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Lieggi, Nora T.; Simpson, Jeremy C.] Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin; University College Dublin; University College Dublin	Meijer, WG (corresponding author), Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland.	wim.meijer@ucd.ie	Miranda-CasoLuengo, Raul/H-3438-2019	Miranda-CasoLuengo, Raul/0000-0002-9294-6578; Meijer, Wim/0000-0003-1302-4338; Simpson, Jeremy/0000-0002-7956-7805; Miranda-CasoLuengo, Aleksandra/0000-0001-7794-7698	Department of Agriculture, Fisheries and Food [RSF 06-379]; Science Foundation Ireland [09/IN.1/B2604]; UCD College of Science	Department of Agriculture, Fisheries and Food; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); UCD College of Science	This work was supported by a grant from the Research Stimulus Fund of the Department of Agriculture, Fisheries and Food (RSF 06-379). The JCS lab is supported by a Principal Investigator award (09/IN.1/B2604) from Science Foundation Ireland, and by a Strategic Funding Initiative grant from the UCD College of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour J, 2003, J BACTERIOL, V185, P2644, DOI 10.1128/JB.185.8.2644-2652.2003; Bast A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00277; DELAPENAMOCTEZUMA A, 1995, VET MICROBIOL, V46, P383, DOI 10.1016/0378-1135(95)00034-8; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 1998, INFECT IMMUN, V66, P1848; HONDALUS MK, 1994, INFECT IMMUN, V62, P4167, DOI 10.1128/IAI.62.10.4167-4175.1994; HONDALUS MK, 1992, VET IMMUNOL IMMUNOP, V32, P339, DOI 10.1016/0165-2427(92)90055-U; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kelly BG, 2002, MICROBIOL-SGM, V148, P793, DOI 10.1099/00221287-148-3-793; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Luhrmann A, 2004, INFECT IMMUN, V72, P853, DOI 10.1128/IAI.72.2.853-862.2004; Lundemo AG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-190; Mangan MW, 2001, FEMS MICROBIOL LETT, V205, P243, DOI 10.1111/j.1574-6968.2001.tb10955.x; Miranda-CasoLuengo R, 2005, J BACTERIOL, V187, P3438, DOI 10.1128/JB.187.10.3438-3444.2005; Miranda-CasoLuengo R, 2012, INFECT IMMUN, V80, P4106, DOI 10.1128/IAI.00678-12; Miranda-CasoLuengo R, 2011, MICROBIOL-SGM, V157, P2357, DOI 10.1099/mic.0.049759-0; Mou XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026544; NAGY I, 1995, J BACTERIOL, V177, P676, DOI 10.1128/jb.177.3.676-687.1995; Ozturk F, 2011, AM J ORTHOD DENTOFAC, V140, pE243, DOI 10.1016/j.ajodo.2011.05.019; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Prescott J. F., 2010, PATHOGENESIS BACTERI, P149; Rahim S, 2011, JOVE-J VIS EXP, DOI 10.3791/2792; Sambrook J., 2001, MOL CLONING LAB MANU; Sianina H, 2011, J MICROBIOL METH, V84, P101, DOI 10.1016/j.mimet.2010.11.004; Toyooka K, 2005, J MED MICROBIOL, V54, P1007, DOI 10.1099/jmm.0.46086-0; van der Geize R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn811; von Bargen K, 2009, INFECT IMMUN, V77, P5676, DOI 10.1128/IAI.00856-09; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005	30	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60612	10.1371/journal.pone.0060612	http://dx.doi.org/10.1371/journal.pone.0060612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555995	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200126
J	Nettelblad, C				Nettelblad, Carl			Breakdown of Methods for Phasing and Imputation in the Presence of Double Genotype Sharing	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON	In genome-wide association studies, results have been improved through imputation of a denser marker set based on reference haplotypes and phasing of the genotype data. To better handle very large sets of reference haplotypes, pre-phasing with only study individuals has been suggested. We present a possible problem which is aggravated when pre-phasing strategies are used, and suggest a modification avoiding the resulting issues with application to the MaCH tool, although the underlying problem is not specific to that tool. We evaluate the effectiveness of our remedy to a subset of Hapmap data, comparing the original version of MaCH and our modified approach. Improvements are demonstrated on the original data (phase switch error rate decreasing by 10%), but the differences are more pronounced in cases where the data is augmented to represent the presence of closely related individuals, especially when siblings are present (30% reduction in switch error rate in the presence of children, 47% reduction in the presence of siblings). The main conclusion of this investigation is that existing statistical methods for phasing and imputation of unrelated individuals might give results of sub-par quality if a subset of study individuals nonetheless are related. As the populations collected for general genome-wide association studies grow in size, including relatives might become more common. If a general GWAS framework for unrelated individuals would be employed on datasets with some related individuals, such as including familial data or material from domesticated animals, caution should also be taken regarding the quality of haplotypes. Our modification to MaCH is available on request and straightforward to implement. We hope that this mode, if found to be of use, could be integrated as an option in future standard distributions of MaCH.	[Nettelblad, Carl] Uppsala Univ, Dept Informat Technol, Div Comp Sci, Uppsala, Sweden; [Nettelblad, Carl] Uppsala Univ, Lab Mol Biophys, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Nettelblad, C (corresponding author), Uppsala Univ, Dept Informat Technol, Div Comp Sci, Uppsala, Sweden.	carl.nettelblad@icm.uu.se	Nettelblad, Carl/C-5138-2013	Nettelblad, Carl/0000-0003-0458-6902	Graduate School in Mathematics and Computing (FMB), Sweden	Graduate School in Mathematics and Computing (FMB), Sweden	This work has been funded by The Graduate School in Mathematics and Computing (FMB), Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis G, 2012, MINIMAC; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Druet T, 2010, J DAIRY SCI, V93, P5443, DOI 10.3168/jds.2010-3255; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	14	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60354	10.1371/journal.pone.0060354	http://dx.doi.org/10.1371/journal.pone.0060354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555958	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200109
J	Ringquist, S; Bellone, G; Lu, Y; Roeder, K; Trucco, M				Ringquist, Steven; Bellone, Gaia; Lu, Ying; Roeder, Kathryn; Trucco, Massimo			Clustering and Alignment of Polymorphic Sequences for HLA-DRB1 Genotyping	PLOS ONE			English	Article							HIGH-RESOLUTION; HIGH-THROUGHPUT; HLA; FRAMEWORK; SOFTWARE; HLA-DQB1; LOCI	Located on Chromosome 6p21, classical human leukocyte antigen genes are highly polymorphic. HLA alleles associate with a variety of phenotypes, such as narcolepsy, autoimmunity, as well as immunologic response to infectious disease. Moreover, high resolution genotyping of these loci is critical to achieving long-term survival of allogeneic transplants. Development of methods to obtain high resolution analysis of HLA genotypes will lead to improved understanding of how select alleles contribute to human health and disease risk. Genomic DNAs were obtained from a cohort of n = 383 subjects recruited as part of an Ulcerative Colitis study and analyzed for HLA-DRB1. HLA genotypes were determined using sequence specific oligonucleotide probes and by next-generation sequencing using the Roche/454 GSFLX instrument. The Clustering and Alignment of Polymorphic Sequences (CAPSeq) software application was developed to analyze next-generation sequencing data. The application generates HLA sequence specific 6-digit genotype information from next-generation sequencing data using MUMmer to align sequences and the R package diffusionMap to classify sequences into their respective allelic groups. The incorporation of Bootstrap Aggregating, Bagging to aid in sorting of sequences into allele classes resulted in improved genotyping accuracy. Using Bagging iterations equal to 60, the genotyping results obtained using CAPSeq when compared with sequence specific oligonucleotide probe characterized 4-digit genotypes exhibited high rates of concordance, matching at 759 out of 766 (99.1%) alleles.	[Ringquist, Steven; Lu, Ying; Trucco, Massimo] Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet,Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15261 USA; [Bellone, Gaia; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Ringquist, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet,Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15261 USA.	smr73@pitt.edu		Roeder, Kathryn/0000-0002-8869-6254	Department of Defense [W81XWH-07-1-0619]; National Institutes of Health [MH057881]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, R01MH057881] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant W81XWH-07-1-0619 from the Department of Defense (MT), MH057881 (KR) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JP, 2012, GENES IMMUN, V13, P245, DOI 10.1038/gene.2011.79; Ballen KK, 2011, BONE MARROW TRANSPL, V46, P323, DOI 10.1038/bmt.2010.260; Becquemont L, 2010, PHARMACOGENOMICS, V11, P277, DOI [10.2217/pgs.10.38, 10.2217/PGS.10.38]; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Gabriel C, 2009, HUM IMMUNOL, V70, P960, DOI 10.1016/j.humimm.2009.08.009; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Karanes C, 2008, BIOL BLOOD MARROW TR, V14, P8, DOI 10.1016/j.bbmt.2008.06.006; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lank SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-378; Lank SM, 2010, HUM IMMUNOL, V71, P1011, DOI 10.1016/j.humimm.2010.07.012; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; NG J, 1993, TISSUE ANTIGENS, V42, P473, DOI 10.1111/j.1399-0039.1993.tb02191.x; Richards JW, 2009, ASTROPHYS J, V691, P32, DOI 10.1088/0004-637X/691/1/32; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Rossini AA, 1999, PHYSIOL REV, V79, P99, DOI 10.1152/physrev.1999.79.1.99; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Shiina T, 2012, TISSUE ANTIGENS, V80, P305, DOI 10.1111/j.1399-0039.2012.01941.x; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; van Dijk A, 2007, TISSUE ANTIGENS, V69, P64, DOI 10.1111/j.1399-0039.2006.760_5.x; Voorter CEM, 1998, TISSUE ANTIGENS, V51, P80, DOI 10.1111/j.1399-0039.1998.tb02950.x; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109	30	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59835	10.1371/journal.pone.0059835	http://dx.doi.org/10.1371/journal.pone.0059835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555798	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200043
J	Yang, HC; Liu, CM; Liu, YL; Chen, CW; Chang, CC; Fann, CSJ; Chiou, JJ; Yang, UC; Chen, CH; Faraone, SV; Tsuang, MT; Hwu, HG				Yang, Hsin-Chou; Liu, Chih-Min; Liu, Yu-Li; Chen, Chia-Wei; Chang, Chien Ching; Fann, Cathy S. J.; Chiou, Jen-Jie; Yang, Ueng-Cheng; Chen, Chun-Houh; Faraone, Stephen V.; Tsuang, Ming T.; Hwu, Hai-Gwo			The DAO Gene Is Associated with Schizophrenia and Interacts with Other Genes in the Taiwan Han Chinese Population	PLOS ONE			English	Article							AMINO-ACID OXIDASE; MULTIFACTOR-DIMENSIONALITY REDUCTION; GENOME-WIDE ASSOCIATION; D-ASPARTATE RECEPTOR; SUSTAINED ATTENTION DEFICITS; D-SERINE; NONPSYCHOTIC RELATIVES; SUSCEPTIBILITY LOCUS; MULTICENTER LINKAGE; CANDIDATE REGIONS	Background: Schizophrenia is a highly heritable disease with a polygenic mode of inheritance. Many studies have contributed to our understanding of the genetic underpinnings of schizophrenia, but little is known about how interactions among genes affect the risk of schizophrenia. This study aimed to assess the associations and interactions among genes that confer vulnerability to schizophrenia and to examine the moderating effect of neuropsychological impairment. Methods: We analyzed 99 SNPs from 10 candidate genes in 1,512 subject samples. The permutation-based single-locus, multi-locus association tests, and a gene-based multifactorial dimension reduction procedure were used to examine genetic associations and interactions to schizophrenia. Results: We found that no single SNP was significantly associated with schizophrenia. However, a risk haplotype, namely A-T-C of the SNP triplet rsDAO7-rsDAO8-rsDAO13 of the DAO gene, was strongly associated with schizophrenia. Interaction analyses identified multiple between-gene and within-gene interactions. Between-gene interactions including DAO*DISC1, DAO*NRG1 and DAO*RASD2 and a within-gene interaction for CACNG2 were found among schizophrenia subjects with severe sustained attention deficits, suggesting a modifying effect of impaired neuropsychological functioning. Other interactions such as the within-gene interaction of DAO and the between-gene interaction of DAO and PTK2B were consistently identified regardless of stratification by neuropsychological dysfunction. Importantly, except for the within-gene interaction of CACNG2, all of the identified risk haplotypes and interactions involved SNPs from DAO. Conclusions: These results suggest that DAO, which is involved in the N-methyl-D-aspartate receptor regulation, signaling and glutamate metabolism, is the master gene of the genetic associations and interactions underlying schizophrenia. Besides, the interaction between DAO and RASD2 has provided an insight in integrating the glutamate and dopamine hypotheses of schizophrenia.	[Yang, Hsin-Chou; Chen, Chia-Wei; Chen, Chun-Houh] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Liu, Yu-Li] Natl Hlth Res Inst, Div Mental Hlth & Subst Abuse Res, Taipei, Taiwan; [Chang, Chien Ching; Fann, Cathy S. J.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chiou, Jen-Jie; Yang, Ueng-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Faraone, Stephen V.] SUNY Upstate Med Univ, Med Genet Res Ctr, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Tsuang, Ming T.] Harvard Univ, Harvard Inst Psychiat Epidemiol & Genet, Boston, MA 02115 USA; [Tsuang, Ming T.] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Tsuang, Ming T.] Harvard Univ, Dept Psychiat, Boston, MA 02115 USA; [Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Hwu, Hai-Gwo] Natl Taiwan Univ, Dept Psychol, Coll Sci, Taipei 10764, Taiwan; [Hwu, Hai-Gwo] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Tsuang, Ming T.] Univ Calif San Diego, Inst Behav Genom, La Jolla, CA 92093 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard University; National Taiwan University; National Taiwan University; National Taiwan University; University of California System; University of California San Diego	Hwu, HG (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.	haigohwu@ntu.edu.tw	Liu, Yu-Li/E-3829-2010; Fann, Cathy SJ/F-9410-2010; Faraone, Stephen V/O-7239-2018; Chen, Chun-houh/AAP-2640-2021; Yang, Hsin-Chou/AAP-2547-2021; Faraone, Stephen/AAE-7334-2019	Fann, Cathy SJ/0000-0001-9025-2276; Faraone, Stephen V/0000-0002-9217-3982; Chen, Chun-houh/0000-0003-0899-7477; Yang, Hsin-Chou/0000-0001-6853-7881; Faraone, Stephen/0000-0002-9217-3982; LIU, CHIH-MIN/0000-0001-7016-8990; HWU, HAI-GWO/0000-0002-2582-2807	National Research Program for Genomic Medicine, National Science Council, Taiwan [NSC91-2314-B-002-216, NSC91-3112-B-002-011, NSC92-3112-B-002-019, NSC93-3112-B-002-012, NSC94-3112-B-002-020, NSC95-3112-B002-011, NSC 97-3112-B-002-046-, NSC 97-2321-B-002-041-, NSC 98-2321-B-002-008-, NSC 100-2314-B-001-005-MY3, NSC 100-2319-B-010-002]; Career Development Award of Academia Sinica [AS-100-CDA-M03]; National Health Research Institute, Taiwan [NHRI-EX-91-9113PP, NHRI-EX-92-9113PP, NHRI-EX-93-9113PP]; National Institutes of Health, U.S.A. [IR01 MH 59624-01]; National Taiwan University [97HM00271similar to7]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059624] Funding Source: NIH RePORTER	National Research Program for Genomic Medicine, National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Career Development Award of Academia Sinica; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Taiwan University(National Taiwan University); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from the National Research Program for Genomic Medicine, National Science Council, Taiwan (NSC91-2314-B-002-216; NSC91-3112-B-002-011; NSC92-3112-B-002-019; NSC93-3112-B-002-012; NSC94-3112-B-002-020; NSC95-3112-B002-011; NSC 97-3112-B-002-046-; NSC 97-2321-B-002-041-; NSC 98-2321-B-002-008-; NSC 100-2314-B-001-005-MY3; NSC 100-2319-B-010-002), the Career Development Award of Academia Sinica (AS-100-CDA-M03), the National Health Research Institute, Taiwan (NHRI-EX-91,92,93-9113PP), the National Institutes of Health, U.S.A. (IR01 MH 59624-01), and National Taiwan University (97HM00271 similar to 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Andreasen NC, 2011, MOL PSYCHIAT, DOI http://dx.dolorg/10.1038/mp.2011.108; Bang S, 2012, NEUROSCI LETT, V521, P142, DOI 10.1016/j.neulet.2012.05.073; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Bartos JA, 2010, J NEUROSCI, V30, P449, DOI 10.1523/JNEUROSCI.4992-08.2010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Boks MPM, 2007, EUR NEUROPSYCHOPHARM, V17, P567, DOI 10.1016/j.euroneuro.2006.12.003; Brunelin J, 2012, CURRENT MED CHEM; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Carroll LS, 2010, MOL PSYCHIATR, V15, P1101, DOI 10.1038/mp.2009.96; Chen CH, 1999, AM J PSYCHIAT, V156, P1273; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen QY, 2007, J PSYCHIATR RES, V41, P428, DOI 10.1016/j.jpsychires.2006.01.001; Chen WJ, 2000, AM J MED GENET, V97, P52, DOI 10.1002/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6; Chen WJ, 2004, BIOL PSYCHIAT, V55, P995, DOI 10.1016/j.biopsych.2004.01.010; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Cosway R, 2000, PSYCHOL MED, V30, P1111, DOI 10.1017/S0033291799002585; Ducharme G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029754; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Faraone SV, 1999, J ABNORM PSYCHOL, V108, P176, DOI 10.1037/0021-843X.108.1.176; Faraone SV, 2000, BIOL PSYCHIAT, V48, P120, DOI 10.1016/S0006-3223(99)00263-2; FARAONE SV, 1995, AM J PSYCHIAT, V152, P1286; Flint J, 2011, MOL PSYCHIATR, V16, P1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Gong XQ, 2007, CAN J PHYSIOL PHARM, V85, P546, DOI 10.1139/Y07-040; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Harrison LM, 2006, NEUROSCIENCE, V137, P483, DOI 10.1016/j.neuroscience.2005.08.017; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hwu H. G., 1999, PSYCHIAT DIAGNOSTIC; Hwu H-G, 2008, WORLD C PSYCH GEN OS; Hwu HG, 2000, AM J MED GENET, V96, P74, DOI 10.1002/(SICI)1096-8628(20000207)96:1<74::AID-AJMG15>3.0.CO;2-G; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Kawazoe T, 2006, PROTEIN SCI, V15, P2708, DOI 10.1110/ps.062421606; Kifle L, 2009, J ALZHEIMERS DIS, V16, P533, DOI 10.3233/JAD-2009-1006; Lalonde JP, 2004, J BIOL CHEM, V279, P8181, DOI 10.1074/jbc.M306751200; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin C-L, 2012, LMBRD1 IS ASS UNPUB; Liu CM, 2005, AM J MED GENET B, V134B, P79, DOI 10.1002/ajmg.b.20161; Liu CM, 2001, AM J MED GENET, V105, P658, DOI 10.1002/ajmg.1547; Liu Y, 2012, AM J PSYCHIAT; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Liu YL, 2006, SCHIZOPHR RES, V87, P15, DOI 10.1016/j.schres.2006.06.020; Liu YL, 2006, BIOL PSYCHIAT, V60, P554, DOI 10.1016/j.biopsych.2006.04.024; Ma T.M., 2012, MOL PSYCHIAT; Martins-de-Souza D, 2010, J PSYCHIAT RES; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Morita Y, 2007, BIOL PSYCHIAT, V61, P1200, DOI 10.1016/j.biopsych.2006.07.025; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mowry BJ, 2004, MOL PSYCHIATR, V9, P784, DOI 10.1038/sj.mp.4001481; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Nicodemus KK, 2009, MOL PSYCHIATR, V14, P741, DOI 10.1038/mp.2008.150; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; Opgen-Rhein C, 2008, SCHIZOPHR RES, V103, P169, DOI 10.1016/j.schres.2008.04.020; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; RISCH N, 1984, AM J HUM GENET, V36, P1039; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rutsch F, 2010, J INHERIT METAB DIS; SAS Publishing, 2008, SAS GENETICS 9 2 USE; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Tan HY, 2012, BRAIN, V135, P1436, DOI 10.1093/brain/aws068; Thaker GK, 1999, PSYCHIAT RES, V88, P209, DOI 10.1016/S0165-1781(99)00084-0; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Tselnicker I, 2010, J BIOL CHEM, V285, P20462, DOI 10.1074/jbc.M110.121277; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wood LS, 2007, BIOL PSYCHIAT, V61, P1195, DOI 10.1016/j.biopsych.2006.07.005; Xu J, 2012, J BIOL CHEM, V287, P20942, DOI 10.1074/jbc.M112.368654; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Yang HC, 2009, GENET EPIDEMIOL, V33, P771; Young-Pearse TL, 2010, J NEUROSCI, V30, P10431, DOI 10.1523/JNEUROSCI.1445-10.2010; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang X, 2005, SCHIZOPHR RES, V79, P175, DOI 10.1016/j.schres.2005.05.023; Zhang Z, 2009, CELL MOL LIFE SCI, V66, P526, DOI 10.1007/s00018-008-8362-1; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	109	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60099	10.1371/journal.pone.0060099	http://dx.doi.org/10.1371/journal.pone.0060099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555897	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200083
J	Benavides, R; Rabasa, SG; Granda, E; Escudero, A; Hodar, JA; Martinez-Vilalta, J; Rincon, AM; Zamora, R; Valladares, F				Benavides, Raquel; Rabasa, Sonia G.; Granda, Elena; Escudero, Adrian; Hodar, Jose A.; Martinez-Vilalta, Jordi; Rincon, Ana M.; Zamora, Regino; Valladares, Fernando			Direct and Indirect Effects of Climate on Demography and Early Growth of Pinus sylvestris at the Rear Edge: Changing Roles of Biotic and Abiotic Factors	PLOS ONE			English	Article							PLANT-PLANT INTERACTIONS; ZERO-INFLATED POISSON; SCOTS PINE; MEDITERRANEAN MOUNTAIN; NATURAL REGENERATION; MONTSENY MOUNTAINS; TREE; RECRUITMENT; FOREST; ESTABLISHMENT	Global change triggers shifts in forest composition, with warming and aridification being particularly threatening for the populations located at the rear edge of the species distributions. This is the case of Scots pine (Pinus sylvestris) in the Mediterranean Basin where uncertainties in relation to its dynamics under these changing scenarios are still high. We analysed the relative effect of climate on the recruitment patterns of Scots pine and its interactions with local biotic and abiotic variables at different spatial scales. Number of seedlings and saplings was surveyed, and their annual shoot growth measured in 96 plots located across altitudinal gradients in three different regions in the Iberian Peninsula. We found a significant influence of climate on demography and performance of recruits, with a non-linear effect of temperature on the presence of juveniles, and a positive effect of precipitation on their survival. Abundance of juveniles of P. sylvestris that underwent their first summer drought was skewed towards higher altitudes than the altitudinal mean range of the conspecific adults and the optimum elevation for seedlings' emergence. At local level, light availability did not influence juveniles' density, but it enhanced their growth. Biotic interactions were found between juveniles and the herb cover (competition) and between the number of newly emerged seedlings and shrubs (facilitation). Results also highlighted the indirect effect that climate exerts over the local factors, modulating the interactions with the pre-existing vegetation that were more evident at more stressful sites. This multiscale approach improves our understanding of the dynamics of these marginal populations and some management criteria can be inferred to boost their conservation under the current global warming.	[Benavides, Raquel; Rabasa, Sonia G.; Granda, Elena; Valladares, Fernando] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, E-28006 Madrid, Spain; [Escudero, Adrian; Zamora, Regino] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Hodar, Jose A.] Univ Granada, Dept Ecol, Granada, Spain; [Martinez-Vilalta, Jordi] CREAF, Barcelona, Spain; [Martinez-Vilalta, Jordi] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Rincon, Ana M.] CSIC, Inst Ciencias Agr, Dept Protecc Vegetal, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad Rey Juan Carlos; University of Granada; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA)	Benavides, R (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, E-28006 Madrid, Spain.	rbenavidescalvo@gmail.com	Martínez-Vilalta, Jordi/D-3385-2014; Zamora, Regino/B-3179-2010; Hódar, José A/G-3447-2018; Rincon, Ana M/H-1295-2015; Camarero, J. Julio/A-8602-2013; Granda, Elena/AAH-2801-2019; Escudero, Adrián/H-5046-2015; Valladares, Fernando/K-9406-2014; Benavides, Raquel/AAQ-5427-2020	Martínez-Vilalta, Jordi/0000-0002-2332-7298; Zamora, Regino/0000-0002-5049-9968; Hódar, José A/0000-0003-3475-4997; Rincon, Ana M/0000-0001-6754-4609; Camarero, J. Julio/0000-0003-2436-2922; Granda, Elena/0000-0002-9559-4213; Escudero, Adrián/0000-0002-1427-5465; Valladares, Fernando/0000-0002-5374-4682; Benavides, Raquel/0000-0003-2328-5371	Spanish Ministry for Innovation and Science [CSD2008_00040]; European Union [FP7-226299]; FunDivEUROPE [FP7-ENV-2010. 265171]	Spanish Ministry for Innovation and Science(Spanish Government); European Union(European Commission); FunDivEUROPE	Funding was provided by the Spanish Ministry for Innovation and Science with the grant Consolider-Montes (CSD2008_00040), and the European Union with the projects BACCARA (CE: FP7-226299, 7FP) and FunDivEUROPE (CE: FP7-ENV-2010. 265171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck DLR, 2006, CAN J FOREST RES, V36, P2994, DOI 10.1139/X06-189; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; Barbeito I, 2011, CAN J FOREST RES, V41, P341, DOI 10.1139/X10-214; Barbeito I, 2009, APPL VEG SCI, V12, P488, DOI 10.1111/j.1654-109X.2009.01043.x; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Beland M, 2000, SCAND J FOREST RES, V15, P247, DOI 10.1080/028275800750015064; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Castro J, 2005, PLANT ECOL, V181, P191, DOI 10.1007/s11258-005-6626-5; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; Castro J, 2002, RESTOR ECOL, V10, P297, DOI 10.1046/j.1526-100X.2002.01022.x; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Davis MA, 1999, PLANT ECOL, V145, P341, DOI 10.1023/A:1009802211896; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Fortin M, 2007, FOREST SCI, V53, P529; Galiano L, 2010, ECOSYSTEMS, V13, P978, DOI 10.1007/s10021-010-9368-8; Gimeno TE, 2012, TREE PHYSIOL, V32, P326, DOI 10.1093/treephys/tps011; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2008, J ECOL, V96, P1128, DOI 10.1111/j.1365-2745.2008.01431.x; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Gonzalez-Rodriguez V, 2011, ANN FOREST SCI, V68, P1217, DOI 10.1007/s13595-011-0069-z; Granda E, 2012, J VEG SCI, V23, P164, DOI 10.1111/j.1654-1103.2011.01343.x; Gworek JR, 2007, FOREST ECOL MANAG, V239, P57, DOI 10.1016/j.foreco.2006.11.010; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; Herrero A, 2012, THESIS U GRANADA SPA; Holmgren M, 2000, PLANT ECOL, V147, P49, DOI 10.1023/A:1009804726307; Horsak M, 2010, J BIOGEOGR, V37, P1450, DOI 10.1111/j.1365-2699.2010.02280.x; JORDANO P, 1995, ECOSCIENCE, V2, P230, DOI 10.1080/11956860.1995.11682288; Jump AS, 2007, ECOSCIENCE, V14, P507, DOI 10.2980/1195-6860(2007)14[507:CROGAE]2.0.CO;2; Jurado E, 2011, SOUTHWEST NAT, V56, P154, DOI 10.1894/F03-MLK-18.1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lenoir J, 2009, ECOGRAPHY, V32, P765, DOI 10.1111/j.1600-0587.2009.05791.x; Lloret F, 2009, PERSPECT PLANT ECOL, V11, P53, DOI 10.1016/j.ppees.2008.09.001; Lloyd AH, 2003, ECOSCIENCE, V10, P176, DOI 10.1080/11956860.2003.11682765; Lo YH, 2010, FOREST CHRON, V86, p[316, 312]; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Matias L, 2012, OECOLOGIA, V169, P833, DOI 10.1007/s00442-011-2234-3; Matias L, 2011, PERSPECT PLANT ECOL, V13, P277, DOI 10.1016/j.ppees.2011.04.005; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Pardos M, 2008, FOREST SCI, V54, P260; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Penuelas J, 2007, ECOGRAPHY, V30, P829, DOI 10.1111/j.2007.0906-7590.05247.x; Quero JL, 2011, BASIC APPL ECOL, V12, P161, DOI 10.1016/j.baae.2010.11.007; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Rodriguez-Garcia E, 2011, FOREST ECOL MANAG, V262, P244, DOI 10.1016/j.foreco.2011.03.029; Ryyppo A, 1998, PHYSIOL PLANTARUM, V102, P503, DOI 10.1034/j.1399-3054.1998.1020404.x; Valladares F, 2006, ANN FOREST SCI, V63, P749, DOI 10.1051/forest:2006056; Vila-Cabrera A, 2011, ECOL APPL, V21, P1162, DOI 10.1890/10-0647.1; Wang T, 2006, GLOBAL ECOL BIOGEOGR, V15, P406, DOI 10.1111/j.1466-822x.2006.00233.x; WARDLE P, 1992, NEW ZEAL J BOT, V30, P303, DOI 10.1080/0028825X.1992.10412909; Zamora R, 2001, FOREST ECOL MANAG, V144, P33, DOI 10.1016/S0378-1127(00)00362-5	59	36	36	0	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59824	10.1371/journal.pone.0059824	http://dx.doi.org/10.1371/journal.pone.0059824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555794	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500096
J	Bertels, J; Demoulin, C; Franco, A; Destrebecqz, A				Bertels, Julie; Demoulin, Catherine; Franco, Ana; Destrebecqz, Arnaud			Side Effects of Being Blue: Influence of Sad Mood on Visual Statistical Learning	PLOS ONE			English	Article							IMPLICIT; MEMORY; JUDGMENT; DISCRIMINATION; CONFIDENCE; MODULATION; EMOTION; AROUSAL; WORDS	It is well established that mood influences many cognitive processes, such as learning and executive functions. Although statistical learning is assumed to be part of our daily life, as mood does, the influence of mood on statistical learning has never been investigated before. In the present study, a sad vs. neutral mood was induced to the participants through the listening of stories while they were exposed to a stream of visual shapes made up of the repeated presentation of four triplets, namely sequences of three shapes presented in a fixed order. Given that the inter-stimulus interval was held constant within and between triplets, the only cues available for triplet segmentation were the transitional probabilities between shapes. Direct and indirect measures of learning taken either immediately or 20 minutes after the exposure/mood induction phase revealed that participants learned the statistical regularities between shapes. Interestingly, although participants from the sad and neutral groups performed similarly in these tasks, subjective measures (confidence judgments taken after each trial) revealed that participants who experienced the sad mood induction showed increased conscious access to their statistical knowledge. These effects were not modulated by the time delay between the exposure/mood induction and the test phases. These results are discussed within the scope of the robustness principle and the influence of negative affects on processing style.	[Bertels, Julie; Demoulin, Catherine; Franco, Ana; Destrebecqz, Arnaud] Univ Libre Bruxelles, CRCN, Brussels, Belgium; [Franco, Ana] Fonds Natl Rech Luxembourg FNR, Luxembourg, Luxembourg	Universite Libre de Bruxelles; Luxembourg National Research Fund	Bertels, J (corresponding author), Univ Libre Bruxelles, CRCN, Brussels, Belgium.	jbertels@ulb.ac.be			Fonds de la Recherche Scientifique - FNRS [MIS F4524.10 4.121]	Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS)	Funding was provided by the Fonds de la Recherche Scientifique - FNRS (http://www2.frs-fnrs.be/), grant number: MIS F4524.10 4.121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloy LB, 1979, CLIN PSYCHOL REV, V11, P565; Arciuli J, 2012, NEUROSCI LETT, V517, P133, DOI 10.1016/j.neulet.2012.04.045; Bauchau Henry, 2008, BOULEVARD PERIPHERIQ; Bertels J, 2012, J EXP PSYCHOL LEARN, V38, P1425, DOI 10.1037/a0027210; Bertels J, 2011, J COGN PSYCHOL, V23, P435, DOI 10.1080/20445911.2011.535513; Bless H., 2006, AFFECT SOCIAL THINKI, P65; BODENHAUSEN GV, 1994, EUR J SOC PSYCHOL, V24, P45, DOI 10.1002/ejsp.2420240104; Brand S, 2007, LEARN INSTR, V17, P1, DOI 10.1016/j.learninstruc.2006.11.002; Braverman J, 2005, PERS SOC PSYCHOL B, V31, P1487, DOI 10.1177/0146167205276152; Buchanan TW, 2006, INT J PSYCHOPHYSIOL, V61, P26, DOI 10.1016/j.ijpsycho.2005.10.022; Casper K, 2001, THEORIES MOOD COGNIT, P27; Chan C, 1992, THESIS U OXFORD; CHEESMAN J, 1984, PERCEPT PSYCHOPHYS, V36, P387, DOI 10.3758/BF03202793; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Clore GL, 2009, COGN SYST RES, V10, P21, DOI 10.1016/j.cogsys.2008.03.002; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Dienes Z, 2010, CONSCIOUS COGN, V19, P674, DOI 10.1016/j.concog.2009.09.009; Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102; ERBER R, 1991, J EXP SOC PSYCHOL, V27, P480, DOI 10.1016/0022-1031(91)90005-Q; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Fu T, 2005, J PSYCHOPATHOL BEHAV, V27, P243, DOI 10.1007/s10862-005-2404-x; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Jallais C, 2010, BEHAV RES METHODS, V42, P318, DOI 10.3758/BRM.42.1.318; Jimenez L, 1996, J EXP PSYCHOL LEARN, V22, P948, DOI 10.1037/0278-7393.22.4.948; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kim R, 2009, NEUROSCI LETT, V461, P145, DOI 10.1016/j.neulet.2009.06.030; Kolinsky R, 2010, MUSIQUE LANGAGE EMOT, P89; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Luminet O., 2002, PSYCHOL EMOTIONS CON; MAYER JD, 1988, J PERS SOC PSYCHOL, V55, P102, DOI 10.1037/0022-3514.55.1.102; Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030; Niedenthal PM, 2001, EUR J SOC PSYCHOL, V31, P737, DOI 10.1002/ejsp.66; Okon-Singer H, 2007, EMOTION, V7, P147, DOI 10.1037/1528-3542.7.1.147; PERRUCHET P, 1990, J EXP PSYCHOL GEN, V119, P264, DOI 10.1037/0096-3445.119.3.264; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Pham MT, 2007, REV GEN PSYCHOL, V11, P155, DOI 10.1037/1089-2680.11.2.155; Phillips LH, 2002, EMOTION, V2, P12, DOI 10.1037/1528-3542.2.1.12; Pretz JE, 2010, LEARN INDIVID DIFFER, V20, P215, DOI 10.1016/j.lindif.2009.12.003; RATHUS JH, 1994, PERCEPT MOTOR SKILL, V79, P163, DOI 10.2466/pms.1994.79.1.163; REBER AS, 1992, CONSCIOUS COGN, V1, P93, DOI 10.1016/1053-8100(92)90051-B; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; Smyth AC, 2008, MEM COGNITION, V36, P403, DOI 10.3758/MC.36.2.403; Song SB, 2007, LEARN MEMORY, V14, P167, DOI 10.1101/lm.437407; Storbeck J, 2012, COGNITION EMOTION; Tunney RJ, 2003, CONSCIOUS COGN, V12, P201, DOI 10.1016/S1053-8100(02)00068-5; van Gorp WG, 1999, BIOL PSYCHIAT, V46, P525, DOI 10.1016/S0006-3223(98)00336-9; van Wouwe NC, 2011, J COGNITIVE NEUROSCI, V23, P524, DOI 10.1162/jocn.2009.21380	53	14	14	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59832	10.1371/journal.pone.0059832	http://dx.doi.org/10.1371/journal.pone.0059832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555797	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500098
J	Kim, HR; Na, BR; Kwon, MS; Ko, YS; Han, WC; Jun, CD				Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Ko, Yoo-Seung; Han, Weon-Cheol; Jun, Chang-Duk			Dynamic Motile T Cells Highly Respond to the T Cell Stimulation via PI3K-Akt and NF-kappa B Pathways	PLOS ONE			English	Article							PERIPHERAL LYMPH-NODES; PHOSPHATIDYLINOSITOL 3-KINASE; CYTOPLASMIC DOMAIN; CD28; KINASE; ACTIVATION; MIGRATION; COSTIMULATION; LYMPHOCYTES; ASSOCIATION	T lymphocytes (T cells) circulate from the blood into secondary lymphoid organs for immune surveillance. In this study, we hypothesized that circulating T cells are heterogeneous and can be grouped according to their differential migratory capacity in response to chemoattractants, rather than expressions of certain receptors or cytokines. We further hypothesized that, at least in part, this intrinsic difference in motility may be related to the T cell function. We established motile (m-T) and non-motile T (nm-T) cell lines based on their response to the chemokine SDF-1 alpha. m-T cells showed more irregular and polarized morphologies than nm-T cells did. Interestingly, m-T cells produced higher levels of IL-2, a marker for T cell activation, than nm-T cells did after stimulation; however, no differences were observed in terms of surface expression of T cell receptors (TCR), adhesion molecules LFA-1 and ICAM-1, and chemokine receptor CXCR4. Both cell lines also showed similar membrane events (i.e., T cell-APC conjugation, LFA-1 accumulation at the immunological synapse, and TCR internalization). In contrast, PKC-theta, a downstream of PI3K-Akt pathway was constitutively activated in m-T cells and the activation was more prominent during T cell stimulation. Consequently, NF-kappa B activity was selectively upregulated in m-T cells. This study is the first, to our knowledge, to demonstrate that T cells can be subcategorized on the basis of their intrinsic migratory capacity in relation to T cell activation.	[Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Ko, Yoo-Seung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Sch Life Sci, Kwangju, South Korea; [Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Ko, Yoo-Seung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju, South Korea; [Han, Weon-Cheol] Wonkwang Univ, Sch Med, Dept Pathol, Iksan, Chonbuk, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Wonkwang University	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Sch Life Sci, Kwangju, South Korea.	cdjun@gist.ac.kr			Cell Dynamics Research Center [2012-0000766]; Bio & Medical Technology Development Program [2011-0030157]; National Research Foundation (NRF) [2012R1A2A1A03002115]; Gwangju Institute of Science and Technology (GIST)	Cell Dynamics Research Center(Ministry of Science & Technology (MOST), Republic of Korea); Bio & Medical Technology Development Program; National Research Foundation (NRF); Gwangju Institute of Science and Technology (GIST)	This work was supported by the Cell Dynamics Research Center (2012-0000766), Bio & Medical Technology Development Program (2011-0030157), and Basic Science Research Program (2012R1A2A1A03002115) through the National Research Foundation (NRF), and a grant from Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 2002, J BIOCHEM, V132, P841, DOI 10.1093/oxfordjournals.jbchem.a003295; Bastian P, 2006, MOL CANCER RES, V4, P411, DOI 10.1158/1541-7786.MCR-06-0030; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CAHILL RNP, 1977, J EXP MED, V145, P420, DOI 10.1084/jem.145.2.420; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chodniewicz D, 2003, BLOOD, V102, P2251, DOI 10.1182/blood-2002-09-2936; Cockerill PN BA, 1999, P NATL ACAD SCI; Dennehy KM, 2003, INT IMMUNOL, V15, P655, DOI 10.1093/intimm/dxg063; Ding ZQ, 2000, J LEUKOCYTE BIOL, V67, P825, DOI 10.1002/jlb.67.6.825; Friedl P, 2001, TRENDS IMMUNOL, V22, P187, DOI 10.1016/S1471-4906(01)01869-5; GOWANS JL, 1959, J PHYSIOL-LONDON, V146, P54, DOI 10.1113/jphysiol.1959.sp006177; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; MACKAY CR, 1988, J EXP MED, V167, P1755, DOI 10.1084/jem.167.6.1755; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Parry R, 1997, BIOCHEM SOC T, V25, pS589, DOI 10.1042/bst025s589; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; SHIMIZU Y, 1992, J EXP MED, V175, P577, DOI 10.1084/jem.175.2.577; SOUTHERN C, 1995, IMMUNOLOGY, V84, P326; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Torgersen K. M., 2008, V186, P327, DOI 10.1007/978-3-540-72843-6_14; TURCOVSKICORRALES SM, 1995, EUR J IMMUNOL, V25, P3087, DOI 10.1002/eji.1830251115; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108; Zhelev DV, 2004, BIOPHYS J, V87, P688, DOI 10.1529/biophysj.103.036699	34	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59793	10.1371/journal.pone.0059793	http://dx.doi.org/10.1371/journal.pone.0059793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555783	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500091
J	Zhao, HM; Yi, X; Hu, Z; Hu, MY; Chen, SH; Muhammad, RUH; Dong, XL; Gong, L				Zhao, Haiming; Yi, Xin; Hu, Zhen; Hu, Meiying; Chen, Shaohua; Muhammad, Rizwan-ul-Haq; Dong, Xiaolin; Gong, Liang			RNAi-Mediated Knockdown of Catalase Causes Cell Cycle Arrest in SL-1 Cells and Results in Low Survival Rate of Spodoptera litura (Fabricius)	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ANOPHELES-GAMBIAE; NADPH BINDING; INSECT PESTS; LIFE-SPAN; OXYGEN; APOPTOSIS; HEPATOCYTES; GLUTATHIONE; RESISTANCE	Deregulated reactive oxygen species (ROS) production can lead to the disruption of structural and functional integrity of cells as a consequence of reactive interaction between ROS and various biological components. Catalase (CAT) is a common enzyme existing in nearly all organisms exposed to oxygen, which decomposes harmful hydrogen peroxide, into water and oxygen. In this study, the full length sequence that encodes CAT-like protein from Spodoptera litura named siltCAT (GenBank accession number: JQ_663444) was cloned and characterized. Amino acid sequence alignment showed siltCAT shared relatively high conservation with other insect, especially the conserved residues which defined heme and NADPH orientation. Expression pattern analysis showed that siltCAT mRNA was mainly expressed in the fat body, midgut, cuticle and malpighian tube, and as well as over last instar larvae, pupa and adult stages. RNA interference was used to silence CAT gene in SL-1 cells and the fourth-instar stage of S. litura larvae respectively. Our results provided evidence that CAT knockdown induced ROS generation, cell cycle arrest and apoptosis in SL-1 cells. It also confirmed the decrease in survival rate because of increased ROS production in experimental groups injected with double-stranded RNA of CAT (dsCAT). This study implied that ROS scavenging by CAT is important for S. litura survival.	[Zhao, Haiming; Yi, Xin; Hu, Zhen; Hu, Meiying; Chen, Shaohua; Muhammad, Rizwan-ul-Haq; Dong, Xiaolin; Gong, Liang] South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, MY (corresponding author), South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Nature Science Foundation, People's Republic of China [31171870]	National Nature Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation, People's Republic of China under grant No. 31171870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; AHMAD S, 1990, FREE RADICAL BIO MED, V8, P401, DOI 10.1016/0891-5849(90)90107-T; ALLEN RG, 1983, BIOCHEM J, V216, P503, DOI 10.1042/bj2160503; Asokan R, 2008, CURR SCI INDIA, V94, P1119; Barros MP, 2001, INSECT BIOCHEM MOLEC, V31, P393, DOI 10.1016/S0965-1748(00)00132-6; Baud O, 2004, J NEUROSCI, V24, P1531, DOI 10.1523/JNEUROSCI.3989-03.2004; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Cao Zhenbo, 2007, V44, P295; Cohn CA, 2005, GEOCHEM T, V6, P47, DOI [10.1063/1.1935449, 10.1186/1467-4866-6-47]; de Olliveira Vagner Tadeu Paes, 2003, Biociencias (Porto Alegre), V11, P195; Diaz A, 2012, ARCH BIOCHEM BIOPHYS, V525, P102, DOI 10.1016/j.abb.2011.12.011; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Essers J, 2006, CURR OPIN CELL BIOL, V18, P240, DOI 10.1016/j.ceb.2006.03.004; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; FITA I, 1985, P NATL ACAD SCI USA, V82, P1604, DOI 10.1073/pnas.82.6.1604; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Grubor-Lajsic G., 1997, Acta Entomologica Serbica, V2, P137; Grubor-Lajsic G, 2000, ARCH BIOL SCI, V52, P185; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Huang JF, 2011, PESTIC BIOCHEM PHYS, V100, P256, DOI 10.1016/j.pestbp.2011.04.010; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Jovanovic-Galovic A, 2004, ARCH INSECT BIOCHEM, V55, P79, DOI 10.1002/arch.10126; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Kumar R, 2011, TOXICOL SCI, V122, P557, DOI 10.1093/toxsci/kfr143; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Li LJ, 2005, ENVIRON TOXICOL PHAR, V20, P412, DOI 10.1016/j.etap.2005.04.001; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKAY WJ, 1989, GENETICS, V122, P643; Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200; Mittapalli O, 2006, INSECT BIOCHEM MOLEC, V36, P154, DOI 10.1016/j.ibmb.2005.11.004; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Rahimizadeh M., 2007, Helia, V30, P167, DOI 10.2298/HEL0747167R; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; SANCHEZ A, 1995, J CELL PHYSIOL, V165, P398, DOI 10.1002/jcp.1041650221; Sanchez A, 1997, HEPATOLOGY, V26, P935, DOI 10.1002/hep.510260420; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x; Van Wielendaele P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031425; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wang TS, 2001, FREE RADICAL BIO MED, V31, P321, DOI 10.1016/S0891-5849(01)00581-0; [夏阳 XIA Yang], 2009, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V34, P1661; Yamamoto K, 2005, INSECT BIOCHEM MOLEC, V35, P277, DOI 10.1016/j.ibmb.2005.01.001; Yuan ZQ, 2003, AM J RESP CELL MOL, V28, P705, DOI 10.1165/rcmb.2002-0112OC; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	63	27	32	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59527	10.1371/journal.pone.0059527	http://dx.doi.org/10.1371/journal.pone.0059527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555693	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500046
J	Im, W; Ban, J; Lim, J; Lee, M; Lee, ST; Chu, K; Kim, M				Im, Wooseok; Ban, Jaejun; Lim, Jiyeon; Lee, Mijung; Lee, Soon-Tae; Chu, Kon; Kim, Manho			Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease	PLOS ONE			English	Article							STROMAL CELLS; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; PARACRINE MECHANISMS; MUTANT HUNTINGTIN; TRANSGENIC MOUSE; THERAPY; TISSUE; ADULT; NEURODEGENERATION	Stem cell therapy is a promising treatment for incurable disorders including Huntington's disease (HD). Adipose-derived stem cell (ASC) is an easily available source of stem cells. Since ASCs can be differentiated into nervous stem cells, it has clinically feasible potential for neurodegenerative disease. In addition, ASCs secrete various anti-apoptotic growth factors, which improve the symptoms of disease from transplanted ASCs. Thus, cell-free extracts of ASCs (ASCs-E) could be a potential candidate for treatment of HD. Here, we investigated effects of ASCs-E on R6/2 HD mouse model and neuronal cells. In R6/2 HD model, injection of ASCs-E improved the performance in Rotarod test. ASCs-E also ameliorated striatal atrophy and mutant huntingtin aggregation in the striatum. In Western blot increased expressions of p-Akt, p-CREB and PGC1 alpha were noted by injection of ASCs-E, when comparing to the R6/2 HD model. Neuro2A neuroblastoma cells treated with ASCs-E showed increased expression of p-CREB and PGC1 alpha. In conclusion, ASCs-E delayed disease progression in animal model of HD by restoring of CREB-PGC1 alpha pathway and could be a potential resource for treatment of HD.	[Im, Wooseok; Ban, Jaejun; Lim, Jiyeon; Lee, Mijung; Lee, Soon-Tae; Chu, Kon; Kim, Manho] Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, M (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul 110744, South Korea.	kimmanho@snu.ac.kr		Chu, Kon/0000-0001-5863-0302; Lee, Soon-Tae/0000-0003-4767-7564	Korea Health 21 R& D Project, Ministry of Health Welfare [A092058]; WCU-Neurocytomics program; National Research Foundation of Korea (NRF) [2011-0012728]	Korea Health 21 R& D Project, Ministry of Health Welfare; WCU-Neurocytomics program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by grants from the Korea Health 21 R& D Project, Ministry of Health & Welfare (A092058), WCU-Neurocytomics program and National Research Foundation of Korea (NRF) (2011-0012728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Atsma DE, 2007, CURR OPIN LIPIDOL, V18, P645, DOI 10.1097/MOL.0b013e3282f0dd1f; Bonelli RM, 2004, INT CLIN PSYCHOPHARM, V19, P51, DOI 10.1097/00004850-200403000-00001; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dai Y, 2009, J NEUROSCI, V29, P11550, DOI 10.1523/JNEUROSCI.3307-09.2009; Frank S, 2010, DRUGS, V70, P561, DOI 10.2165/11534430-000000000-00000; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Heo SC, 2011, J INVEST DERMATOL, V131, P1559, DOI 10.1038/jid.2011.64; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jeon D, 2013, NEUROBIOL DIS; Jeon D, 2011, EPILEPSIA, V52, P1617, DOI 10.1111/j.1528-1167.2011.03182.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Leeper NJ, 2010, CIRCULATION, V122, P517, DOI 10.1161/CIRCULATIONAHA.109.881441; Li F, 2012, BIOCH BIOPHYS RES CO; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Mizuno H, 2010, CURR OPIN MOL THER, V12, P442; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	34	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59438	10.1371/journal.pone.0059438	http://dx.doi.org/10.1371/journal.pone.0059438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565152	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300019
J	Rondy, M; Puig-Barbera, J; Launay, O; Duval, X; Castilla, J; Guevara, M; Costanzo, S; Donati, KD; Moren, A				Rondy, Marc; Puig-Barbera, Joan; Launay, Odile; Duval, Xavier; Castilla, Jesus; Guevara, Marcela; Costanzo, Simona; de Gaetano Donati, Katleen; Moren, Alain			2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study	PLOS ONE			English	Article							PREVENTING INFLUENZA; VACCINATION; INFECTIONS; EFFICACY; ENGLAND; COHORT; VIRUS	Background: Influenza vaccination strategies aim at protecting high-risk population from severe outcomes. Estimating the effectiveness of seasonal vaccines against influenza related hospitalisation is important to guide these strategies. Large sample size is needed to have precise estimate of influenza vaccine effectiveness (IVE) against severe outcomes. We assessed the feasibility of measuring seasonal IVE against hospitalisation with laboratory confirmed influenza through a network of 21 hospitals in the European Union. Methods: We conducted a multicentre study in France (seven hospitals), Italy (one hospital), and Navarra (four hospitals) and Valencia (nine hospitals) regions in Spain. All >= 18 years hospitalised patients presenting an influenza-like illness within seven days were swabbed. Cases were patients RT-PCR positive for influenza A (H3N2); controls were patients negative for any influenza virus. Using logistic regression with study site as a fixed effect we calculated IVE adjusted for potential confounders. We restricted the analyses to those swabbed within four days. Results: We included, 375 A(H3N2) cases and 770 controls. The overall adjusted IVE was 24.9% (95% CI-1.8; 44.6). Among the target group for vaccination (N = 1058) the adjusted IVE was 28.8% (95% CI: 2.8; 47.9); it was respectively 36.8% (95% CI: 248.8; 73.1), 42.6% (95% CI: 216.5; 71.7), 17.8%(95% CI: 240.8; 52.1) and 37.5% (95% CI: 222.8;68.2) in the age groups 18-64, 65-74, 75-84 and more than 84 years. Discussion: Estimation of IVE based on the pooling of data obtained through a European network of hospitals was feasible. Our results suggest a low IVE against hospitalised confirmed influenza in 2011-12. The low IVE may be explained by a poor immune response in the high-risk population, imperfect match between vaccine and circulating strain or waning immunity due to a late season. Increased sample size within this network would allow more precise estimates and stratification of the IVE by time since vaccination and vaccine types or brands.	[Rondy, Marc; Moren, Alain] EpiConcept, Paris, France; [Puig-Barbera, Joan] CSISP, Valencia, Spain; [Puig-Barbera, Joan] Ctr Salud Publ Castellon, Castellon de La Plana, Spain; [Launay, Odile; Duval, Xavier] INSERM, Reseau Natl Invest Clin Vaccinol REIVAC, Paris, France; [Launay, Odile] Univ Paris 05, Paris, France; [Launay, Odile] INSERM, Ctr Invest Clin CIC Vaccinol Cochin Pasteur BT505, Paris, France; [Launay, Odile] Hop Cochin, AP HP, F-75674 Paris, France; [Duval, Xavier] Hop Bichat Claude Bernard, AP HP, INSERM, CIC 007, F-75877 Paris 18, France; [Castilla, Jesus; Guevara, Marcela] Inst Salud Publ Navarra, Pamplona, Spain; [Castilla, Jesus; Guevara, Marcela] Ctr Invest Biomed Red CIBER, Barcelona, Spain; [Castilla, Jesus; Guevara, Marcela] Ctr Epidemiol, Barcelona, Spain; [Castilla, Jesus; Guevara, Marcela] Ctr Salud Publ, Barcelona, Spain; [Costanzo, Simona] Fdn Ric & Cura Giovanni Paolo II, Res Labs, Lab Genet & Environm Epidemiol, Campobasso, Italy; [de Gaetano Donati, Katleen] Catholic Univ, Dept Infect Dis, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; IRCCS Istituto Tumori Bari Giovanni Paolo II; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Rondy, M (corresponding author), EpiConcept, Paris, France.	m.rondy@epiconcept.fr	Puig-Barberà, Joan/F-1563-2015; Guevara, Marcela/B-4473-2015; Castilla, Jesus/B-9048-2008; Costanzo, Simona/K-5076-2016	Puig-Barberà, Joan/0000-0001-5783-0409; Guevara, Marcela/0000-0001-9242-6364; Castilla, Jesus/0000-0002-6396-7265; Costanzo, Simona/0000-0003-4569-1186	Sanofi Pasteur; Inserm (Institut national de la sante et de la recherche medicale); GlaxoSmithKline; Sanofi Pasteur MSD; Navarra Health Service; European Centre for Disease Prevention and Control (I-MOVE programme); Carlos III Institute of Health [PS09/01179]; Spanish Ministry of Health [EC11-302]; EpiConcept	Sanofi Pasteur; Inserm (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur MSD; Navarra Health Service; European Centre for Disease Prevention and Control (I-MOVE programme); Carlos III Institute of Health(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); EpiConcept	The French study site was funded by Sanofi Pasteur and Inserm (Institut national de la sante et de la recherche medicale). The Italian study was partially supported by GlaxoSmithKline. The Valencia study site was funded by grants from Sanofi Pasteur and Sanofi Pasteur MSD. The study of Navarre was supported by the Navarra Health Service, by the European Centre for Disease Prevention and Control (I-MOVE programme), by the Carlos III Institute of Health (PS09/01179), and by the Spanish Ministry of Health (EC11-302). The pooled analysis was co-funded by the Sanofi Pasteur, Sanofi Pasteur MSD, GlaxoSmithKline and EpiConcept. Vaccine producers had no role in the pooled study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO INFL SEAS; [BEH Haut Conseil de la Sante Publique (HCPS)], 2011, CAL VACC REC VACC 20; Buxton JA, 2001, J INFECT DIS, V184, P188, DOI 10.1086/322013; Castilla J, 2012, EURO SURVEILL, V17; Castilla J, 2013, EURO SURVEILL, V18; Castilla J, 2012, VACCINE, V30, P195, DOI 10.1016/j.vaccine.2011.11.024; Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe, NEWS INFL CHAR SUMM; Conselleria de sanitat Generalitat valenciana, 2012, RED CENT SAN COM VAL; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; European Centre for Disease Prevention and Control (ECDC), 2012, MAIN SURV DEV WEEK 7; Hardelid P, 2012, VACCINE, V30, P1371, DOI 10.1016/j.vaccine.2011.12.038; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Institut de veille sanitaire, 2012, B HEBD GRIPP POINT 2; Istituto superiore di sanita, 2012, RAPP EP INFLUNET RET; Jimenez-Jorge S, 2012, EURO SURVEILL, V17; Jimenez-Jorge S, 2012, EURSURVEILLANCE, V17; Kissling E, 2013, EURO SURVEILL, V18; Kissling E, 2009, EURO SURVEILL, V14; Kissling E, 2012, EUROSURVEILLANCE, V17; Kissling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027622; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Madrid: Ministry of Health and Social Policy, PREV GRIP VAC ANT; MAHONEY F I, 1965, Md State Med J, V14, P61; Muller-Pebody B, 2006, EPIDEMIOL INFECT, V134, P1150, DOI 10.1017/S0950268806006376; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pebody R., 2013, EURO SURVEILL, V18; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Roma: Ministero della Salute, 2012, PREV CONTR INFL RACC; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Valenciano M, 2012, PROTOCOL HOSP BASED; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010; Van Lier A, 2007, EURO SURVEILL, V12; WHO, 2012, REC COMP INFL VIR VA; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	37	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59681	10.1371/journal.pone.0059681	http://dx.doi.org/10.1371/journal.pone.0059681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565159	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300028
J	Dubovskiy, IM; Whitten, MMA; Yaroslavtseva, ON; Greig, C; Kryukov, VY; Grizanova, EV; Mukherjee, K; Vilcinskas, A; Glupov, VV; Butt, TM				Dubovskiy, Ivan M.; Whitten, Miranda M. A.; Yaroslavtseva, Olga N.; Greig, Carolyn; Kryukov, Vadim Y.; Grizanova, Ekaterina V.; Mukherjee, Krishnendu; Vilcinskas, Andreas; Glupov, Viktor V.; Butt, Tariq M.			Can Insects Develop Resistance to Insect Pathogenic Fungi?	PLOS ONE			English	Article							DENSITY-DEPENDENT PROPHYLAXIS; METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; IMMUNE FUNCTION; DROSOPHILA-MELANOGASTER; DESTRUXIN PRODUCTION; DISEASE RESISTANCE; BEAUVERIA-BASSIANA; POTATO LEAFHOPPER; MEALWORM BEETLE	Microevolutionary adaptations and mechanisms of fungal pathogen resistance were explored in a melanic population of the Greater wax moth, Galleria mellonella. Under constant selective pressure from the insect pathogenic fungus Beauveria bassiana, 25th generation larvae exhibited significantly enhanced resistance, which was specific to this pathogen and not to another insect pathogenic fungus, Metarhizium anisopliae. Defense and stress management strategies of selected (resistant) and non-selected (susceptible) insect lines were compared to uncover mechanisms underpinning resistance, and the possible cost of those survival strategies. We hypothesize that the insects developed a transgenerationally primed resistance to the fungus B. bassiana, a costly trait that was achieved not by compromising life-history traits but rather by prioritizing and re-allocating pathogen-species-specific augmentations to integumental front-line defenses that are most likely to be encountered by invading fungi. Specifically during B. bassiana infection, systemic immune defenses are suppressed in favour of a more limited but targeted repertoire of enhanced responses in the cuticle and epidermis of the integument (e. g. expression of the fungal enzyme inhibitor IMPI, and cuticular phenoloxidase activity). A range of putative stress-management factors (e. g. antioxidants) is also activated during the specific response of selected insects to B. bassiana but not M. anisopliae. This too occurs primarily in the integument, and probably contributes to antifungal defense and/or helps ameliorate the damage inflicted by the fungus or the host's own immune responses.	[Dubovskiy, Ivan M.; Yaroslavtseva, Olga N.; Kryukov, Vadim Y.; Grizanova, Ekaterina V.; Glupov, Viktor V.] Russian Acad Sci, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Whitten, Miranda M. A.] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales; [Greig, Carolyn; Butt, Tariq M.] Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales; [Mukherjee, Krishnendu; Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Angew Zool, Abt Angew Entomol, Giessen, Germany	Russian Academy of Sciences; Swansea University; Swansea University; Justus Liebig University Giessen	Butt, TM (corresponding author), Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales.	t.butt@swansea.ac.uk	Kryukov, Vadim Yu/S-3441-2017; Mukherjee, Krishnendu/A-8186-2011; Dubovskiy, Ivan/B-8252-2008; Mukherjee, Krishnendu/U-7159-2017; yaroslavtseva, olga/O-2381-2016; Grizanova, Ekaterina V/N-6482-2016; Glupov, Viktor/N-7706-2014; Whitten, Miranda/P-8259-2015	Kryukov, Vadim Yu/0000-0001-9762-903X; Dubovskiy, Ivan/0000-0001-9691-3960; Mukherjee, Krishnendu/0000-0003-3470-9117; Grizanova, Ekaterina V/0000-0003-4103-1375; Whitten, Miranda/0000-0003-1930-5042; Butt, Tariq/0000-0002-8789-9543	Royal Society; Russian Academy of Sciences; presidium SBRAS; DFG [1399, VI 219/3-1]	Royal Society(Royal Society of London); Russian Academy of Sciences(Russian Academy of Sciences); presidium SBRAS; DFG(German Research Foundation (DFG))	Funding from both the Royal Society International Joint Project and the Russian Academy of Sciences(awarded to TB, MW, ID), presidium SBRAS (VG, ID, VK) and the DFG Priority Program 1399 "Host-Parasite-Coevolution - rapid reciprocal adaptation and its genetic basis'' to AV (VI 219/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; Amiri-Besheli B, 2000, MYCOL RES, V104, P447, DOI 10.1017/S095375629900146X; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016108; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Arnaud L, 2002, EVOLUTION, V56, P2435, DOI 10.1111/j.0014-3820.2002.tb00169.x; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Bukhari T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-23; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; BUTT TM, 1988, J INVERTEBR PATHOL, V52, P49, DOI 10.1016/0022-2011(88)90101-2; Butt TM, 2002, MYCOTA, V11, P111; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chakrabarti S, 2012, CELL HOST MICROBE, V12, P60, DOI 10.1016/j.chom.2012.06.001; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; Cotter SC, 2004, J ANIM ECOL, V73, P283, DOI 10.1111/j.0021-8790.2004.00806.x; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Destoumieux-Garzon D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006795; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Gendrin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000694; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; JOSHI L, 1995, FEMS MICROBIOL LETT, V125, P211, DOI 10.1111/j.1574-6968.1995.tb07360.x; Kraaijeveld AR, 2008, HEREDITY, V100, P400, DOI 10.1038/sj.hdy.6801092; Kraaijeveld AR, 2011, DEV COMP IMMUNOL, V35, P857, DOI 10.1016/j.dci.2011.03.019; Leemon DM, 2008, J INVERTEBR PATHOL, V97, P40, DOI 10.1016/j.jip.2007.07.006; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Qazi SS, 2007, J INVERTEBR PATHOL, V95, P48, DOI 10.1016/j.jip.2006.12.002; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sadd Ben M., 2009, P225; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Semighini CP, 2009, P NATL ACAD SCI USA, V106, P2971, DOI 10.1073/pnas.0900801106; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Skrobek A, 2008, BIOCONTROL, V53, P361, DOI 10.1007/s10526-007-9077-1; Srygley RB, 2012, J INSECT PHYSIOL, V58, P342, DOI 10.1016/j.jinsphys.2011.12.005; STLEGER RJ, 1988, J INVERTEBR PATHOL, V52, P459, DOI 10.1016/0022-2011(88)90059-6; Tinsley MC, 2006, PARASITOLOGY, V132, P767, DOI 10.1017/S0031182006009929; Trienens M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-206; Vey A, 2002, J INVERTEBR PATHOL, V80, P177, DOI 10.1016/S0022-2011(02)00104-0; Vilcinskas A, 1997, EUR J ENTOMOL, V94, P461; Vilcinskas A, 1997, J INSECT PHYSIOL, V43, P1149, DOI 10.1016/S0022-1910(97)00066-8; Vilcinskas A, 2010, VIRULENCE, V1, P206, DOI 10.4161/viru.1.3.12072; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; Whitten MMA, 2007, INSECT BIOCHEM MOLEC, V37, P440, DOI 10.1016/j.ibmb.2007.02.001; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; WRAIGHT SP, 1990, J INVERTEBR PATHOL, V56, P157, DOI 10.1016/0022-2011(90)90098-Q; Xu XX, 2012, DEV COMP IMMUNOL, V38, P275, DOI 10.1016/j.dci.2012.06.012; Yan XD, 2005, J LIPOSOME RES, V15, P109, DOI 10.1081/LPR-200064971	51	106	112	3	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60248	10.1371/journal.pone.0060248	http://dx.doi.org/10.1371/journal.pone.0060248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560083	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900058
J	Kyte, DG; Draper, H; Ives, J; Liles, C; Gheorghe, A; Calvert, M				Kyte, Derek G.; Draper, Heather; Ives, Jonathan; Liles, Clive; Gheorghe, Adrian; Calvert, Melanie			Patient Reported Outcomes (PROs) in Clinical Trials: Is 'In-Trial' Guidance Lacking? A Systematic Review	PLOS ONE			English	Review							QUALITY-OF-LIFE; PRESCRIBING RESEARCH; RANDOMIZED-TRIALS; CANCER; RECOMMENDATIONS	Background: Patient reported outcomes (PROs) are increasingly assessed in clinical trials, and guidelines are available to inform the design and reporting of such trials. However, researchers involved in PRO data collection report that specific guidance on 'in-trial' activity (recruitment, data collection and data inputting) and the management of 'concerning' PRO data (i.e., data which raises concern for the well-being of the trial participant) appears to be lacking. The purpose of this review was to determine the extent and nature of published guidelines addressing these areas. Methods and Findings: Systematic review of 1,362 articles identified 18 eligible papers containing 'in-trial' guidelines. Two independent authors undertook a qualitative content analysis of the selected papers. Guidelines presented in each of the articles were coded according to an a priori defined coding frame, which demonstrated reliability (pooled Kappa 0.86-0.97), and validity (<2% residual category coding). The majority of guidelines present were concerned with 'pre-trial' activities (72%), for example, outcome measure selection and study design issues, or 'post-trial' activities (16%) such as data analysis, reporting and interpretation. 'In-trial' guidelines represented 9.2% of all guidance across the papers reviewed, with content primarily focused on compliance, quality control, proxy assessment and reporting of data collection. There were no guidelines surrounding the management of concerning PRO data. Conclusions: The findings highlight there are minimal in-trial guidelines in publication regarding PRO data collection and management in clinical trials. No guidance appears to exist for researchers involved with the handling of concerning PRO data. Guidelines are needed, which support researchers to manage all PRO data appropriately and which facilitate unbiased data collection.	[Kyte, Derek G.; Draper, Heather; Ives, Jonathan; Liles, Clive; Gheorghe, Adrian; Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England; [Calvert, Melanie] MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England	University of Birmingham	Kyte, DG (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	kytedg@bham.ac.uk	Calvert, Melanie/F-7055-2011; Ives, Jonathan/ABE-4437-2020	Calvert, Melanie/0000-0002-1856-837X; Ives, Jonathan/0000-0002-5233-5000; Draper, Heather/0000-0002-0020-4252; kyte, Derek/0000-0002-7679-6741	National Institute for Health Research (NIHR); School of Primary Care Research (SCPR) PhD studentship; Medical Research Council [G0800808]; Medical Research Council [UD99999939] Funding Source: researchfish; National Institute for Health Research [SPCR-017] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); School of Primary Care Research (SCPR) PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DK is supported by a National Institute for Health Research (NIHR), www.nihr.ac.uk, School of Primary Care Research (SCPR) PhD studentship. MC is a member of the MRC Midland Hub for Trials Methodology Research, University of Birmingham, UK (Medical Research Council Grant ID G0800808). No other funding sources reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiardini I, 2010, ALLERGY, V65, P290, DOI 10.1111/j.1398-9995.2009.02263.x; Basch EM, 2011, VALUE HEALTH, V14, pA10, DOI 10.1016/j.jval.2011.02.060; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Calvert MJ, 2004, J CLIN PHARM THER, V29, P85, DOI 10.1046/j.0269-4727.2003.00520.x; Calvert MJ, 2003, J CLIN PHARM THER, V28, P513, DOI 10.1046/j.0269-4727.2003.00521.x; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chassany O, 2002, DRUG INF J, V36, P209, DOI 10.1177/009286150203600127; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; De Vries H, 2008, FIELD METHOD, V20, P272, DOI 10.1177/1525822X08317166; Edwards Marie, 2002, Can J Nurs Res, V34, P131; FAYERS P, 1995, QUAL LIFE RES, V4, P343, DOI 10.1007/BF01593887; Fayers PM, 1997, EUR J CANCER, V33, P20, DOI 10.1016/S0959-8049(96)00412-1; FDA, 2009, GUID IND PAT REP OUT; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; FLETCHER A, 1995, BRIT J CLIN PHARMACO, V39, P217, DOI 10.1111/j.1365-2125.1995.tb04439.x; Fletcher Astrid, 1992, British Medical Journal, V305, P1145; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; HOLLOWAY I, 1995, NURS ETHICS, V2, P223, DOI 10.1177/096973309500200305; Hopwood P, 1998, EUR J CANCER, V34, P49, DOI 10.1016/S0959-8049(97)00347-X; Houghton Catherine E, 2010, Nurse Res, V18, P15; Kiebert GM, 1998, STAT MED, V17, P561, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<561::AID-SIM803>3.3.CO;2-J; Kyte D, INCONSISTEN IN PRESS; Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x; Lemieux J, 2011, JNCI-J NATL CANCER I, V103, P178, DOI 10.1093/jnci/djq508; LUO XM, 2008, CLIN RES REGUL AFF, V25, P197, DOI DOI 10.1080/10601330802471162; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MOINPOUR CM, 1989, J NATL CANCER I, V81, P485, DOI 10.1093/jnci/81.7.485; Movsas B, 2003, SEMIN RADIAT ONCOL, V13, P235, DOI 10.1016/S1053-4296(03)00029-8; NSW Nurses & Midwives' Association, 2019, CULT SAF GAP EXP NSW; Oxford University Press, 2012, OXFORD DICT ONLINE; Poulter K, 1997, GOOD CLIN PRACTICE J, V4, P22; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Sajid MS, 2008, INT J HEALTH CARE Q, V21, P365, DOI 10.1108/09526860810880162; Schreier, 2012, QUALITATIVE CONTENT	34	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60684	10.1371/journal.pone.0060684	http://dx.doi.org/10.1371/journal.pone.0060684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117CY	23560103	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000316930900073
J	Chiuccariello, L; Boileau, I; Guranda, M; Rusjan, PM; Wilson, AA; Zawertailo, L; Houle, S; Busto, U; Le Foll, B				Chiuccariello, Lina; Boileau, Isabelle; Guranda, Mihail; Rusjan, Pablo M.; Wilson, Alan A.; Zawertailo, Laurie; Houle, Sylvain; Busto, Usoa; Le Foll, Bernard			Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [C-11]-(+)-PHNO PET Study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INDUCED BRAIN ACTIVITY; HIGH-AFFINITY STATE; NUCLEUS-ACCUMBENS; IN-VIVO; NICOTINE DEPENDENCE; COCAINE CUES; EXTRACELLULAR DOPAMINE; INDIVIDUAL-DIFFERENCES; SEEKING BEHAVIOR	The presentation of drug-associated cues has been shown to elicit craving and dopamine release in the striatum of drug-dependent individuals. Similarly, exposure to tobacco-associated cues induces craving and increases the propensity to relapse in tobacco- dependent smokers. However, whether exposure to tobacco-associated cues elicits dopamine release in the striatum of smokers remains to be investigated. We hypothesized that presentation of smoking-related cues compared to neutral cues would induce craving and elevation of intrasynaptic dopamine levels in subregions of the striatum and that the magnitude of dopamine release would be correlated with subjective levels of craving in briefly abstinent tobacco smokers. Eighteen participants underwent two [C-11]-(+)-PHNO positron emission tomography (PET) scans after one-hour abstinence period: one during presentation of smoking-associated images and one during presentation of neutral images. Smoking cues significantly increased craving compared to neutral cues on one, but not all, craving measures; however, this increase in craving was not associated with overall significant differences in [C-11]-(+)-PHNO binding potential (BPND) (an indirect measure of dopamine release) between the two experimental conditions in any of the brain regions of interest sampled. Our findings suggest that presentation of smoking cues does not elicit detectable (by PET) overall increases in dopamine in humans after one-hour nicotine abstinence. Future research should consider studying smoking cue-induced dopamine release at a longer abstinence period, since recent findings suggest the ability of smoking-related cues to induce craving is associated with a longer duration of smoking abstinence.	[Chiuccariello, Lina; Guranda, Mihail; Le Foll, Bernard] CAMH, Translat Addict Res Lab, Toronto, ON, Canada; [Chiuccariello, Lina; Boileau, Isabelle; Rusjan, Pablo M.; Wilson, Alan A.; Zawertailo, Laurie; Houle, Sylvain] CAMH, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Boileau, Isabelle] CAMH, Addict Imaging Res Grp, Toronto, ON, Canada; [Chiuccariello, Lina; Boileau, Isabelle; Rusjan, Pablo M.; Wilson, Alan A.; Houle, Sylvain] CAMH, Res Imaging Ctr, Toronto, ON, Canada; [Chiuccariello, Lina; Zawertailo, Laurie; Busto, Usoa; Le Foll, Bernard] CAMH, Clin Neurosci Program, Toronto, ON, Canada; [Le Foll, Bernard] CAMH, Alcohol Res & Treatment Clin, Toronto, ON, Canada; [Boileau, Isabelle; Wilson, Alan A.; Le Foll, Bernard] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Chiuccariello, Lina; Zawertailo, Laurie; Busto, Usoa; Le Foll, Bernard] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Le Foll, Bernard] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Busto, Usoa] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Boileau, Isabelle; Le Foll, Bernard] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Le Foll, B (corresponding author), CAMH, Translat Addict Res Lab, Toronto, ON, Canada.	bernard.lefoll@camh.ca	Le Foll, Bernard/K-2952-2014; Zawertailo, Laurie/L-2809-2019; Wilson, Alan A/A-1788-2011	Le Foll, Bernard/0000-0002-6406-4973; Rusjan, Pablo/0000-0003-0075-2918; Houle, Sylvain/0000-0002-4231-6316	Canadian Tobacco Control Research Initiative (CTCRI) [018035]; Pfizer GRAND Award [WS508591]; Pfizer; Eli Lilly; Lundbeck; SK Life Science; Canadian Institutes of Health Research (CIHR)	Canadian Tobacco Control Research Initiative (CTCRI); Pfizer GRAND Award; Pfizer(Pfizer); Eli Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); SK Life Science; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research received project support from the Canadian Tobacco Control Research Initiative (CTCRI) (http://ctcri.ca/en/, grant number 018035), the Pfizer GRAND Award (http://www.grand2012.org/, grant number WS508591) and salary support from and the Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html) Tobacco Use in Special Populations (TUSP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Le Foll has received operating grant funding for other studies from Pfizer and is a consultant for Richter Pharmaceuticals, Lundbeck, Mylan, Ethypharm and Pfizer. Drs. Wilson and Houle have received operating grant funding for other studies from Eli Lilly, Lundbeck, and SK Life Science in the past 12 months. None of these companies participated in the design or execution of this study or writing the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ABRAMS DB, 1988, BEHAV RES THER, V26, P225, DOI 10.1016/0005-7967(88)90003-4; Bedi G, 2011, BIOL PSYCHIAT, V69, P708, DOI 10.1016/j.biopsych.2010.07.014; Boileau I, 2007, J NEUROSCI, V27, P3998, DOI 10.1523/JNEUROSCI.4370-06.2007; Bradberry CW, 2000, J NEUROSCI, V20, P3874, DOI 10.1523/JNEUROSCI.20-10-03874.2000; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; de Jonge LV, 2005, ADDICT BEHAV, V30, P1587, DOI 10.1016/j.addbeh.2005.03.006; Dols M, 2002, ADDICTION, V97, P87, DOI 10.1046/j.1360-0443.2002.00010.x; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Erblich J, 2004, EXP CLIN PSYCHOPHARM, V12, P208, DOI 10.1037/1064-1297.12.3.208; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Ginovart N, 2006, J NEUROCHEM, V97, P1089, DOI 10.1111/j.1471-4159.2006.03840.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heishman SJ, 2003, NICOTINE TOB RES, V5, P645, DOI 10.1080/1462220031000158681; Hendricks PS, 2006, PSYCHOPHARMACOLOGY, V187, P385, DOI 10.1007/s00213-006-0429-9; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUGHES JR, 1992, J CONSULT CLIN PSYCH, V60, P689, DOI 10.1037/0022-006X.60.5.689; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Hussain S, 2010, ADDICT BEHAV, V35, P164, DOI 10.1016/j.addbeh.2009.09.004; Ito R, 2000, J NEUROSCI, V20, P7489; Janes AC, 2010, BIOL PSYCHIAT, V67, P722, DOI 10.1016/j.biopsych.2009.12.034; Katner SN, 1996, BEHAV PHARMACOL, V7, P669; Katner SN, 1999, ALCOHOL CLIN EXP RES, V23, P1751, DOI 10.1111/j.1530-0277.1999.tb04070.x; Kosten TR, 2006, NEUROPSYCHOPHARMACOL, V31, P644, DOI 10.1038/sj.npp.1300851; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lang P. J., 1997, ATTENTION; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Lindstrom M, 2001, TOB CONTROL, V10, P396, DOI 10.1136/tc.10.4.396; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McBride D, 2006, NEUROPSYCHOPHARMACOL, V31, P2728, DOI 10.1038/sj.npp.1301075; McClernon FJ, 2009, PSYCHOPHARMACOLOGY, V204, P25, DOI 10.1007/s00213-008-1436-9; McClernon FJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1940, DOI 10.1038/sj.npp.1300780; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Melendez RI, 2002, ALCOHOL CLIN EXP RES, V26, P318; Mizrahi R, 2010, J NUCL MED, V51, P496, DOI 10.2967/jnumed.109.072314; NIAURA R, 1989, ADDICT BEHAV, V14, P419, DOI 10.1016/0306-4603(89)90029-4; Niaura R, 1998, ADDICT BEHAV, V23, P209, DOI 10.1016/S0306-4603(97)00043-9; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Rusjan PM, 2008, NEUROIMAGE, V41, pT137, DOI 10.1016/j.neuroimage.2008.04.105; Schiffer WK, 2009, J NEUROSCI, V29, P6176, DOI 10.1523/JNEUROSCI.5221-08.2009; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Searle GE, 2013, NEUROIMAGE, V68, P119, DOI 10.1016/j.neuroimage.2012.11.033; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shotbolt P, 2012, J CEREBR BLOOD F MET, V32, P127, DOI 10.1038/jcbfm.2011.115; Sinha R, 2007, DRUG ALCOHOL REV, V26, P25, DOI 10.1080/09595230601036960; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; TIFFANY ST, 1991, BRIT J ADDICT, V86, P1467, DOI 10.1111/j.1360-0443.1991.tb01732.x; Tiffany ST, 2000, J CONSULT CLIN PSYCH, V68, P233, DOI 10.1037//0022-006X.68.2.233; Tziortzi AC, 2010, NEUROIMAGE, V52, pS23, DOI 10.1016/j.neuroimage.2010.04.207; Volkow ND, 2003, J NEUROSCI, V23, P11461; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Vollstadt-Klein S, 2011, ADDICT BIOL, V16, P166, DOI 10.1111/j.1369-1600.2010.00207.x; Willeit M, 2008, NEUROPSYCHOPHARMACOL, V33, P279, DOI 10.1038/sj.npp.1301400; Wilson AA, 2005, J MED CHEM, V48, P4153, DOI 10.1021/jm050155n; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Zijistra F, 2008, EUR NEUROPSYCHOPHARM, V18, P262, DOI 10.1016/j.euroneuro.2007.11.002	58	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60382	10.1371/journal.pone.0060382	http://dx.doi.org/10.1371/journal.pone.0060382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555962	Green Submitted, gold, Green Published			2022-12-27	WOS:000317263900071
J	den Heijer, CDJ; Penders, J; Donker, GA; Bruggeman, CA; Stobberingh, EE				den Heijer, Casper D. J.; Penders, John; Donker, Ge A.; Bruggeman, Cathrien A.; Stobberingh, Ellen E.			The Importance of Gender-Stratified Antibiotic Resistance Surveillance of Unselected Uropathogens: A Dutch Nationwide Extramural Surveillance Study	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; PROSTATITIS; MANAGEMENT; DIAGNOSIS; CYSTITIS; THERAPY; UPDATE; MEN	Few studies have been performed on urinary tract infections (UTIs) in men. In the present study, general practitioners (n = 42) from the Dutch Sentinel General Practice Network collected urinary samples from 560 male patients (>= 18 years) suspected of UTI and recorded prescribed antibiotic treatment. In this way, the antibiotic susceptibility of Gram-negative uropathogens, including extended-spectrum beta-lactamase (ESBL-) producing Escherichia coli could be determined. In addition, E. coli susceptibility and antibiotic prescriptions were compared with data from a similar UTI study among women and with data collected 7 years earlier. Of 367 uropathogens (66%) identified (>= 10(3) cfu/mL), most were Gram-negative (83%) and E. coli being isolated most frequently (51%). Antibiotic susceptibility to ciprofloxacin, norfloxacin and nitrofurantoin was 94%, 92% and 88%, respectively, whereas co-amoxiclav (76%) and co-trimoxazole (80%) showed lower susceptibilities. One ESBL (0.5%) was found. A significantly higher proportion of female UTIs was caused by E. coli compared with men (72% versus 51%, P<0.05). E. coli susceptibility tended to be lower in men compared with women, although not reaching statistical significance. No changes in E. coli susceptibility were observed over time (all P>0.05). Co-amoxiclav and nitrofurantoin prescriptions increased over time (11% versus 28% and 16% versus 23% respectively, both P<0.05), whereas co-trimoxazole prescriptions decreased (24% versus 14%, P<0.05). In conclusion, given the observed gender differences in uropathogen distribution and (tendency in) E. coli antibiotic susceptibility, empirical male UTI treatment options should be based on surveillance studies including men only. When awaiting the culture result is clinically not possible, fluoroquinolones are advised as first-choice antibiotics for male UTIs in Dutch general practices based on current antibiotic susceptibility data. The prevalence of ESBL-producers was low and no differences were observed in antibiotic susceptibility over a 7-year period. In addition, antibiotic prescriptions changed in accordance with national guidelines during this time period.	[den Heijer, Casper D. J.; Penders, John; Bruggeman, Cathrien A.; Stobberingh, Ellen E.] Maastricht Univ Med Ctr, Care & Publ Hlth Res Inst, Dept Med Microbiol, Maastricht, Netherlands; [Donker, Ge A.] NIVEL, Utrecht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Netherlands Institute for Health Services Research	Stobberingh, EE (corresponding author), Maastricht Univ Med Ctr, Care & Publ Hlth Res Inst, Dept Med Microbiol, Maastricht, Netherlands.	e.stobberingh@mumc.nl	Penders, John/A-1280-2011; Donker, Gé/AAX-8564-2021	Penders, John/0000-0001-9146-5919; Donker, Ge/0000-0001-6314-9249	Dutch Foundation of the Working Party on Antibiotic Policy (SWAB); Ministry of Health, Welfare and Sports (the Netherlands)	Dutch Foundation of the Working Party on Antibiotic Policy (SWAB); Ministry of Health, Welfare and Sports (the Netherlands)	This work was supported by the Dutch Foundation of the Working Party on Antibiotic Policy (SWAB). The Dutch Sentinel GP network is supported by a grant from the Ministry of Health, Welfare and Sports (the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean David C, 2008, Ann Clin Microbiol Antimicrob, V7, P13, DOI 10.1186/1476-0711-7-13; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Charalabopoulos K, 2003, CHEMOTHERAPY, V49, P269, DOI 10.1159/000074526; Critchley IA, 2004, CLIN MICROBIOL INFEC, V10, P502, DOI 10.1111/j.1469-0691.2004.00911.x; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; Donker GA, ANN REPORT 2010 NIVE; Donker GA, 2010, CONTINUOUS MORBIDITY; Etienne M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-12; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; Falagas ME, 2010, J ANTIMICROB CHEMOTH, V65, P1862, DOI 10.1093/jac/dkq237; Guay DR, 2001, DRUGS, V61, P353, DOI 10.2165/00003495-200161030-00004; Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hummers-Pradier E, 2004, INT J CLIN PHARM TH, V42, P360; Isenberg HD, 1998, ESSENTIAL PROCEDURES, Vxv; Koeijers JJ, 2010, UROLOGY, V76, P336, DOI 10.1016/j.urology.2010.02.052; Koeijers JJ, 2007, CLIN INFECT DIS, V45, P894, DOI 10.1086/521254; Kouri T., 2000, SCAND J CLIN LAB I S, V231, P1, DOI DOI 10.1080/00365513.2000.12056993; Lipsky BA, 1999, AM J MED, V106, P327, DOI 10.1016/S0002-9343(99)00017-0; LIPSKY BA, 1987, J INFECT DIS, V155, P847, DOI 10.1093/infdis/155.5.847; Rocha JL, 2012, BRAZ J INFECT DIS, V16, P115, DOI 10.1016/S1413-8670(12)70291-X; van Pinxteren B, 2006, Ned Tijdschr Geneeskd, V150, P718; Wagenlehner FME, 2007, EXPERT OPIN PHARMACO, V8, P1667, DOI 10.1517/14656566.8.11.1667; Wagenlehner FME, 2006, CLIN MICROBIOL INFEC, V12, P67, DOI 10.1111/j.1469-0691.2006.01398.x; Yilmaz N, 2009, MED SCI MONITOR, V15, pPI61; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	26	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60497	10.1371/journal.pone.0060497	http://dx.doi.org/10.1371/journal.pone.0060497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555983	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900075
J	Walker, AK; Park, WM; Chuang, JC; Perello, M; Sakata, I; Osborne-Lawrence, S; Zigman, JM				Walker, Angela K.; Park, Won-Mee; Chuang, Jen-Chieh; Perello, Mario; Sakata, Ichiro; Osborne-Lawrence, Sherri; Zigman, Jeffrey M.			Characterization of Gastric and Neuronal Histaminergic Populations Using a Transgenic Mouse Model	PLOS ONE			English	Article							ENTEROCHROMAFFIN-LIKE CELLS; L-HISTIDINE DECARBOXYLASE; DUODENAL-ULCER PATIENTS; MAST-CELL; PARIETAL-CELLS; TRYPTOPHAN-HYDROXYLASE; ACID-SECRETION; PEPTIC-ULCER; RAT STOMACH; ECL CELLS	Histamine is a potent biogenic amine that mediates numerous physiological processes throughout the body, including digestion, sleep, and immunity. It is synthesized by gastric enterochromaffin-like cells, a specific set of hypothalamic neurons, as well as a subset of white blood cells, including mast cells. Much remains to be learned about these varied histamine-producing cell populations. Here, we report the validation of a transgenic mouse line in which Cre recombinase expression has been targeted to cells expressing histidine decarboxylase (HDC), which catalyzes the rate-limiting step in the synthesis of histamine. This was achieved by crossing the HDC-Cre mouse line with Rosa26-tdTomato reporter mice, thus resulting in the expression of the fluorescent Tomato (Tmt) signal in cells containing Cre recombinase activity. As expected, the Tmt signal co-localized with HDC-immunoreactivity within the gastric mucosa and gastric submucosa and also within the tuberomamillary nucleus of the brain. HDC expression within Tmt-positive gastric cells was further confirmed by quantitative PCR analysis of mRNA isolated from highly purified populations of Tmt-positive cells obtained by fluorescent activated cell sorting (FACS). HDC expression within these FACS-separated cells was found to coincide with other markers of both ECL cells and mast cells. Gastrin expression was co-localized with HDC expression in a subset of histaminergic gastric mucosal cells. We suggest that these transgenic mice will facilitate future studies aimed at investigating the function of histamine-producing cells.	[Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zigman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	Jeffrey.Zigman@UTSouthwestern.edu	Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Perello, Mario/0000-0003-2114-6765; Zigman, Jeffrey/0000-0003-3477-1295	NIH [T32DA7290]; International Research Alliance; Novo Nordisk Foundation Center for Basic Metabolic Research; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Alliance; Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funding from the NIH [T32DA7290 (to A.K.W.)] and an International Research Alliance with the Novo Nordisk Foundation Center for Basic Metabolic Research (to J.M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON K, 1992, CELL TISSUE RES, V270, P7, DOI 10.1007/BF00381874; BARTH H, 1977, AGENTS ACTIONS, V7, P75, DOI 10.1007/BF01964884; Blandina P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00033; Caruso RA, 2007, ANTICANCER RES, V27, P391; Chen DA, 1998, YALE J BIOL MED, V71, P217; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Date Y, 1999, ENDOCRINOLOGY, V140, P2398, DOI 10.1210/en.140.5.2398; DEVAULT KR, 1994, MAYO CLIN PROC, V69, P867, DOI 10.1016/S0025-6196(12)61790-X; ERICSON H, 1987, J COMP NEUROL, V263, P1, DOI 10.1002/cne.902630102; GARBARG M, 1985, NEW ENGL REG ALLERGY, V6, P195; GREEN JP, 1987, AGENTS ACTIONS, V22, P1, DOI 10.1007/BF01968810; GROSSMAN MI, 1974, GASTROENTEROLOGY, V66, P517; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; HAKANSON R, 1991, SCAND J GASTROENTERO, V26, P88, DOI 10.3109/00365529109093183; Hampton DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023669; Hata S, 2006, J BIOL CHEM, V281, P11214, DOI 10.1074/jbc.M509244200; Hocker M, 1996, YALE J BIOL MED, V69, P21; Hodges Kyle, 2012, Transl Gastrointest Cancer, V1, P138; Hunyady B, 1998, ENDOCRINOLOGY, V139, P4404, DOI 10.1210/en.139.10.4404; INAGAKI N, 1990, J COMP NEUROL, V297, P132, DOI 10.1002/cne.902970110; Johnson PL, 2005, EXP NEUROL, V193, P228, DOI 10.1016/j.expneurol.2004.11.022; Kamoshida S, 1999, J GASTROENTEROL, V34, P315, DOI 10.1007/s005350050267; Karlstedt K, 2001, DEV DYNAM, V221, P81, DOI 10.1002/dvdy.1127; Kojima M, 2000, J BIOCHEM-TOKYO, V127, P121, DOI 10.1093/oxfordjournals.jbchem.a022572; Kurbel S, 1995, MED HYPOTHESES, V45, P539, DOI 10.1016/0306-9877(95)90236-8; Lambrecht NWG, 2006, PHYSIOL GENOMICS, V25, P153, DOI 10.1152/physiolgenomics.00271.2005; Lindstrom E, 2001, COMP BIOCHEM PHYS A, V128, P505, DOI 10.1016/S1095-6433(00)00331-7; MATHIAU P, 1994, NEUROSCI LETT, V182, P133, DOI 10.1016/0304-3940(94)90781-1; MATTER SE, 1990, DIGEST DIS SCI, V35, P1358, DOI 10.1007/BF01536741; Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miklos IH, 2003, EUR J NEUROSCI, V18, P3069, DOI 10.1111/j.1460-9568.2003.03033.x; Mills JC, 2003, J BIOL CHEM, V278, P46138, DOI 10.1074/jbc.M308385200; Mysore V, 2010, INDIAN J DERMATOL VE, V76, P239, DOI 10.4103/0378-6323.62962; Oh DS, 2005, J MOL NEUROSCI, V26, P85, DOI 10.1385/JMN:26:1:085; Rackoff A, 2005, DIS ESOPHAGUS, V18, P370, DOI 10.1111/j.1442-2050.2005.00518.x; RANGACHARI PK, 1992, AM J PHYSIOL, V262, pG1, DOI 10.1152/ajpgi.1992.262.1.G1; RIOUX KP, 1994, AM J PHYSIOL, V266, pG863, DOI 10.1152/ajpgi.1994.266.5.G863; ROSENTHALER J, 1965, P NATL ACAD SCI USA, V54, P152, DOI 10.1073/pnas.54.1.152; Sakata I, 2006, J ENDOCRINOL, V190, P749, DOI 10.1677/joe.1.06808; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Schubert ML, 2004, CURR OPIN GASTROEN, V20, P519, DOI 10.1097/00001574-200411000-00003; Shao JS, 1998, AM J PHYSIOL-GASTR L, V274, pG62, DOI 10.1152/ajpgi.1998.274.1.G62; Sommerhoff CP, 2007, CURR PHARM DESIGN, V13, P313, DOI 10.2174/138161207779313579; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; TAKEDA N, 1984, BRAIN RES, V323, P55, DOI 10.1016/0006-8993(84)90264-6; TROIDL H, 1976, KLIN WOCHENSCHR, V54, P947, DOI 10.1007/BF01469008; WADA H, 1991, BRAIN RES BULL, V27, P367, DOI 10.1016/0361-9230(91)90126-5; WATANABE T, 1983, Tokai Journal of Experimental and Clinical Medicine, V8, P307; Yanovsky Y, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00023; Zeng NX, 1999, J CLIN INVEST, V104, P1383, DOI 10.1172/JCI7537; Zeng NX, 1998, YALE J BIOL MED, V71, P233; Zhao CM, 2012, CURR MED CHEM, V19, P98	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60276	10.1371/journal.pone.0060276	http://dx.doi.org/10.1371/journal.pone.0060276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555941	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900065
J	Arrambide, G; Espejo, C; Yarden, J; Fire, E; Spector, L; Dotan, N; Dukler, A; Rovira, A; Montalban, X; Tintore, M				Arrambide, Georgina; Espejo, Carmen; Yarden, Jennifer; Fire, Ella; Spector, Larissa; Dotan, Nir; Dukler, Avinoam; Rovira, Alex; Montalban, Xavier; Tintore, Mar			Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis	PLOS ONE			English	Article							GLYCAN IGM ANTIBODIES; REFERENCE DISTRIBUTIONS; RELAPSE ACTIVITY; OPTIC NEURITIS; CROHNS-DISEASE; LARGE COHORT; MRI; IMMUNOGLOBULINS; DISABILITY; RESPONSES	Background: Anti-glycan antibodies can be found in autoimmune diseases. IgM against glycan P63 was identified in clinically isolated syndromes (CIS) and included in gMS-Classifier2, an algorithm designed with the aim of identifying patients at risk of a second demyelinating attack. Objective: To determine the value of gMS-Classifier2 as an early and independent predictor of conversion to clinically definite multiple sclerosis (CDMS). Methods: Data were prospectively acquired from a CIS cohort. gMS-Classifier2 was determined in patients first seen between 1995 and 2007 with >= two 200 mu L serum aliquots (N = 249). The primary endpoint was time to conversion to CDMS at two years, the factor tested was gMS-Classifier2 status (positive/negative) or units; other exploratory time points were 5 years and total time of follow-up. Results: Seventy-five patients (30.1%) were gMS-Classifier2 positive. Conversion to CDMS occurred in 31/75 (41.3%) of positive and 45/174 (25.9%) of negative patients (p = 0.017) at two years. Median time to CDMS was 37.8 months (95% CI 10.4-65.3) for positive and 83.9 months (95% CI 57.5-110.5) for negative patients. gMS-Classifier2 status predicted conversion to CDMS within two years of follow-up (HR = 1.8, 95% CI 1.1-2.8; p = 0.014). gMS-Classifier2 units were also independent predictors when tested with either Barkhof criteria and OCB (HR = 1.2, CI 1.0-1.5, p = 0.020) or with T2 lesions and OCB (HR = 1.3, CI 1.1-1.5, p = 0.008). Similar results were obtained at 5 years of follow-up. Discrimination measures showed a significant change in the area under the curve (Delta AUC) when adding gMS-Classifier2 to a model with either Barkhof criteria (Delta AUC 0.0415, p = 0.012) or number of T2 lesions (Delta AUC 0.0467, p = 0.009), but not when OCB were added to these models. Conclusions: gMS-Classifier2 is an independent predictor of early conversion to CDMS and could be of clinical relevance, particularly in cases in which OCB are not available.	[Arrambide, Georgina; Espejo, Carmen; Montalban, Xavier; Tintore, Mar] Univ Autonoma Barcelona, Vall dHebron Univ Hosp & Res Inst, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, E-08193 Barcelona, Spain; [Yarden, Jennifer; Fire, Ella; Spector, Larissa; Dotan, Nir] Glycominds, Dept Res & Dev, Modiin, Israel; [Dukler, Avinoam] Glycominds, Dept Res & Dev, Simi Valley, CA USA; [Rovira, Alex] Vall dHebron Univ Hosp, Magnet Resonance Unit IDI, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Tintore, M (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp & Res Inst, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, E-08193 Barcelona, Spain.	mtintore@vhebron.net	Rovira, Alex/AAX-3973-2020; Montalban, Xavier/J-5938-2016; Espejo, Carmen/E-5989-2018	Montalban, Xavier/0000-0002-0098-9918; Espejo, Carmen/0000-0001-9949-5901; Tintore, Mar/0000-0001-9999-5359; Arrambide, Georgina/0000-0002-2657-5510	Fondo de Investigacion Sanitaria (FIS) [RD07/0060, CP07/00146]; Ministry of Economy and Competitively, Spain; Ajuts per donar Suport als Grups de Recerca de Catalunya [2009 SGR 0793]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya, Spain; Ministry of Science and Innovation, Spain; Bayer Schering Pharma; McDonald Fellowship; Multiple Sclerosis International Federation;  [PI08/0788]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Ministry of Economy and Competitively, Spain; Ajuts per donar Suport als Grups de Recerca de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya, Spain(Generalitat de Catalunya); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bayer Schering Pharma(Bayer AG); McDonald Fellowship; Multiple Sclerosis International Federation; 	The `"Red Espanola de Esclerosis Multiple (REEM, www.reem.es)'' (RD07/0060) sponsored by the Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competitively, Spain; the "Ajuts per donar Suport als Grups de Recerca de Catalunya'' (2009 SGR 0793, http://www10.gencat.cat/agaur_web/AppJava/catala/a_beca.jsp?categoria = recerca& id_ beca = 13601), sponsored by the "Agencia de Gestio d'Ajuts Universitaris i de Recerca'' (AGAUR, www.gencat.cat/agaur/), Generalitat de Catalunya, Spain. The biomarker study was funded by the Fondo de Investigacion Sanitaria (FIS, www.isciii.es); grant number PI08/0788; Ministry of Science and Innovation, Spain. Georgina Arrambide's research is made possible by the McDonald Fellowship, awarded by the Multiple Sclerosis International Federation (www.msif.org). Carmen Espejo is partially supported by the "Miguel Servet'' program (CP07/00146) from the FIS, Ministry of Economy and Competitively, Spain (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials; Georgina Arrambide has received travel expenses for the 2011 CMSC (Consortium of Multiple Sclerosis Centers) meeting from Glycominds. Carmen Espejo has received speaking honoraria from Merck Serono and Almirall. Jennifer Yarden, Ella Fire, Larissa Spector, and Nir Dotan are employees and stock holders of Glycominds. Avinoam Dukler is an employee and share and stock holder of Glycominds. Alex Rovira serves on scientific advisory boards for NeuroTEC and on the editorial board of the American Journal of Neuroradiology and Neuroradiology, has received speaker honoraria from Bayer Schering Pharma, Sanofi-Aventis, Bracco, Merck Serono, Teva Pharmaceutical Industries Ltd. and Biogen Idec, receives research support from Bayer Schering Pharma, and serves as a consultant for Novartis. Xavier Montalban has received speaking honoraria and travel expenses for scientific meetings, has been a steering committee member of clinical trials or participated in advisory boards of clinical trials in the past with Bayer Schering Pharma, Biogen Idec, EMD Merck Serono, Genentech, Genzyme, Novartis, Sanofi-Aventis, Teva Pharmaceuticals and Almirall. Mar Tintore has received compensation for consulting services and speaking honoraria from Bayer-Schering, Merck-Serono, Biogen-Idec, Teva, Sanofi-Aventis, and Novartis. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Brettschneider J, 2009, J NEUROIMMUNOL, V217, P95, DOI 10.1016/j.jneuroim.2009.07.017; CHIBA A, 1992, ANN NEUROL, V31, P677, DOI 10.1002/ana.410310619; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Fazekas F, 2010, EUR J NEUROL, V17, P852, DOI 10.1111/j.1468-1331.2009.02943.x; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; FREDERIKSEN JL, 1992, ACTA NEUROL SCAND, V86, P317, DOI 10.1111/j.1600-0404.1992.tb05093.x; Freedman M, 2009, MULT SCLER, V15, pS71; Freedman MS, 2012, MULT SCLER J, V18, P966, DOI 10.1177/1352458511432327; Freedman MS, 2009, MULT SCLER, V15, P422, DOI 10.1177/1352458508101944; Frohman EM, 2006, ARCH NEUROL-CHICAGO, V63, P614, DOI 10.1001/archneur.63.4.614; Lolli F, 2005, J NEUROIMMUNOL, V167, P131, DOI 10.1016/j.jneuroim.2005.05.016; Lolli F, 2005, P NATL ACAD SCI USA, V102, P10273, DOI 10.1073/pnas.0503178102; Menge T, 2005, J ALLERGY CLIN IMMUN, V116, P453, DOI 10.1016/j.jaci.2005.03.023; Nimrichter L, 2004, GLYCOBIOLOGY, V14, P197, DOI 10.1093/glycob/cwh022; Pepe MS, 2013, STAT MED, V7; PETTENKOFER H. J., 1960, ZENTRALBL BAKT PARASITENK INFEKTIONSKRANKH U HYG, V179, P433; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Rio J, 2011, CURR OPIN NEUROL, V24, P230, DOI 10.1097/WCO.0b013e328346bf66; Ritchie RF, 1998, J CLIN LAB ANAL, V12, P371, DOI 10.1002/(SICI)1098-2825(1998)12:6<371::AID-JCLA7>3.3.CO;2-K; Ritchie RF, 1998, J CLIN LAB ANAL, V12, P363, DOI 10.1002/(SICI)1098-2825(1998)12:6<363::AID-JCLA6>3.0.CO;2-X; Schwarz M, 2003, GLYCOBIOLOGY, V13, P749, DOI 10.1093/glycob/cwg091; Schwarz M, 2006, J NEUROL SCI, V244, P59, DOI 10.1016/j.jns.2005.12.006; Sendid B, 1996, CLIN DIAGN LAB IMMUN, V3, P219, DOI 10.1128/CDLI.3.2.219-226.1996; SHARIEF MK, 1991, ANN NEUROL, V29, P147, DOI 10.1002/ana.410290206; SIMEL DL, 1993, J CLIN EPIDEMIOL, V46, P85, DOI 10.1016/0895-4356(93)90012-P; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Tumani H, 2009, NEUROBIOL DIS, V35, P117, DOI 10.1016/j.nbd.2009.04.010; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Yarden J, 2010, MULT SCLER S10, V16, pS187	36	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59953	10.1371/journal.pone.0059953	http://dx.doi.org/10.1371/journal.pone.0059953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555846	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200062
J	Gallagher, T; Bjorness, T; Greene, R; You, YJ; Avery, L				Gallagher, Thomas; Bjorness, Theresa; Greene, Robert; You, Young-Jai; Avery, Leon			The Geometry of Locomotive Behavioral States in C. elegans	PLOS ONE			English	Article							QUIESCENCE; SYSTEM; MODEL; CGMP	We develop a new hidden Markov model-based method to analyze C elegans locomotive behavior and use this method to quantitatively characterize behavioral states. In agreement with previous work, we find states corresponding to roaming, dwelling, and quiescence. However, we also find evidence for a continuum of intermediate states. We suggest that roaming, dwelling, and quiescence may best be thought of as extremes which, mixed in any proportion, define the locomotive repertoire of C elegans foraging and feeding behavior.	[Gallagher, Thomas; You, Young-Jai] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Bjorness, Theresa; Greene, Robert] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Avery, Leon] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA	Virginia Commonwealth University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University	Avery, L (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	lavery3@vcu.edu		you, young/0000-0002-5716-5418; Gallagher, Thomas/0000-0001-6381-6902	National Institutes of Health (NIH) grant [5R01DK083593]; Department of Veterans Affairs; NIH [MH067777]; NIH-Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067777] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) grant 5R01DK083593 (LA), and the Department of Veterans Affairs and NIH grant MH067777 (RG and TB). The CGC is supported by the NIH-Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi Kaveh, 2007, WormBook, P1; AVERY L, 1993, GENETICS, V133, P897; Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Ben Arous J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007584; BLATTBERG RC, 1974, J BUS, V47, P244, DOI 10.1086/295634; Caprio MA, 2005, COMPUT PHYS COMMUN, V171, P107, DOI 10.1016/j.cpc.2005.04.010; Carola V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014753; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gottman JM, 1990, SEQUENTIAL ANAL GUID, pix; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; JOHNSON NL, 1949, BIOMETRIKA, V36, P149, DOI 10.1093/biomet/36.1-2.149; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Press WH, 2007, NUMERICAL RECIPES AR, pxxi; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shoval O, 2012, SCIENCE; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Yamato J., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P379, DOI 10.1109/CVPR.1992.223161; You YJ, 2012, ANIMAL CELLS SYSTEMS, P1; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zheng MH, 2012, J NEUROSCI METH, V206, P78, DOI 10.1016/j.jneumeth.2012.01.002	27	53	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59865	10.1371/journal.pone.0059865	http://dx.doi.org/10.1371/journal.pone.0059865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555813	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200050
J	Barosi, G; Poletto, V; Massa, M; Campanelli, R; Villani, L; Bonetti, E; Viarengo, G; Catarsi, P; Klersy, C; Rosti, V				Barosi, Giovanni; Poletto, Valentina; Massa, Margherita; Campanelli, Rita; Villani, Laura; Bonetti, Elisa; Viarengo, Gianluca; Catarsi, Paolo; Klersy, Catherine; Rosti, Vittorio			JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis	PLOS ONE			English	Article							INTERNATIONAL WORKING GROUP; TYROSINE KINASE MUTATION; MYELOPROLIFERATIVE-DISORDERS; LEUKEMIC TRANSFORMATION; ESSENTIAL THROMBOCYTHEMIA; DISEASE TRANSFORMATION; POLYCYTHEMIA-VERA; ALLELE BURDEN; SURVIVAL; IDENTIFICATION	Purpose: The influence of JAK2 V617F mutation on blast transformation (BT) and overall survival (OS) in primary myelofibrosis (PMF) is controversial. In a large cohort of patients we applied competing risks analysis for studying the influence of JAK2V617F mutation on BT in PMF. Patients and Methods: In 462 PMF-fibrotic type patients (bone marrow [BM] fibrosis grade >0) we computed the incidence of BT and death in the framework of Cox regression analysis and of Fine and Gray competing risks analysis for BT. Results: At the Cox regression analysis, having either a wild-type (wt) or a homozygous JAK2V617F genotype were factors for BT (HR, 1.98 and 2.04, respectively, with respect to the heterozygous genotype), but not for OS. At the competing risks regression analysis, the risk for BT in wt and homozygous V617F patients increased with respect to Cox analysis, giving a sHR of 2.17 and 2.12, respectively. Correcting the results for the variables that could have influence on BT, JAK2V617F wt and homozygous genotypes remained independently associated with BT. In a validation cohort of 133 independent cases with PMF-prefibrotic type (BM fibrosis grade = 0), the BT predictive model including JAK2V617F genotype and older age retained high discriminant capacity (C statistics, 0.70; 95% CI, 0.47 to 0.92). Conclusion: The accumulation of mutated alleles in the JAK2V617F clone or the selective acquisition of a proliferative advantage in the wt clone are two relevant routes to BT in PMF. The influence of these results on treatment decisions with anti-JAK2 agents should be tested.	[Barosi, Giovanni; Poletto, Valentina; Campanelli, Rita; Villani, Laura; Bonetti, Elisa; Catarsi, Paolo; Rosti, Vittorio] IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy; [Barosi, Giovanni; Poletto, Valentina; Campanelli, Rita; Villani, Laura; Bonetti, Elisa; Catarsi, Paolo; Rosti, Vittorio] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy; [Massa, Margherita] IRCCS Policlin S Matteo Fdn, Biotechnol Res Area, Pavia, Italy; [Viarengo, Gianluca] IRCCS Policlin S Matteo Fdn, Unit Clin Immunol Immunohematol & Transfus Serv, Pavia, Italy; [Klersy, Catherine] IRCCS Policlin S Matteo Fdn, Serv Biometry & Stat, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Barosi, G (corresponding author), IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy.	barosig@smatteo.pv.it	Villani, Laura/K-1794-2018; Catarsi, Paolo/J-4463-2016; Bonetti, Elisa/D-4478-2016; Campanelli, Rita/K-4686-2016; Massa, Margherita/K-4682-2016; Barosi, Giovanni/AAI-1714-2019; Rosti, Vittorio/K-1743-2018; klersy, catherine/AAA-3003-2019	Villani, Laura/0000-0003-4199-5633; Catarsi, Paolo/0000-0002-1862-8168; Bonetti, Elisa/0000-0002-8406-5252; Campanelli, Rita/0000-0003-4923-2761; Massa, Margherita/0000-0001-8037-0439; Rosti, Vittorio/0000-0003-4195-2289; klersy, catherine/0000-0003-0314-8548	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5x1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, BLOOD, V118, P177, DOI 10.1182/blood-2010-12-327593; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Barosi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035631; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; Guglielmelli P, 2009, BLOOD, V114, P1477, DOI 10.1182/blood-2009-04-216044; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Lopes da Silva Rodrigo, 2011, Lab Hematol, V17, P12, DOI 10.1532/LH96.10018; Mesa RA, 2007, LEUKEMIA RES, V31, P737, DOI 10.1016/j.leukres.2006.12.002; Mesa RA, 2006, LEUKEMIA RES, V30, P1457, DOI 10.1016/j.leukres.2006.01.008; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Pardanani A, 2011, LEUKEMIA, V25, P1834, DOI 10.1038/leu.2011.161; Pardanani A, 2010, LEUKEMIA, V24, P1713, DOI 10.1038/leu.2010.163; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Ricci C, 2012, BRIT J HAEMATOL, V156, P404, DOI 10.1111/j.1365-2141.2011.08865.x; Rumi E, 2011, AM J HEMATOL, V86, P974, DOI 10.1002/ajh.22166; Schnittger S, 2012, HAEMATOL-HEMATOL J, V97, P1890, DOI 10.3324/haematol.2012.065375; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tam CS, 2008, BLOOD, V112, P1628, DOI 10.1182/blood-2008-02-138230; Tefferi A, 2008, LEUKEMIA, V22, P756, DOI 10.1038/sj.leu.2405097; Tefferi A, 2005, BRIT J HAEMATOL, V131, P320, DOI 10.1111/j.1365-2141.2005.05776.x; Tefferi A, 2012, LEUKEMIA, V26, P1439, DOI 10.1038/leu.2011.374; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Tefferi A, 2012, MAYO CLIN PROC, V87, P25, DOI 10.1016/j.mayocp.2011.11.001; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Thoennissen NH, 2010, BLOOD, V115, P2882, DOI 10.1182/blood-2009-07-235119; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59791	10.1371/journal.pone.0059791	http://dx.doi.org/10.1371/journal.pone.0059791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555782	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500090
J	Kuwajima, M; Mendenhall, JM; Lindsey, LF; Harris, KM				Kuwajima, Masaaki; Mendenhall, John M.; Lindsey, Laurence F.; Harris, Kristen M.			Automated Transmission-Mode Scanning Electron Microscopy (tSEM) for Large Volume Analysis at Nanoscale Resolution	PLOS ONE			English	Article							IN-VIVO; 3-DIMENSIONAL ORGANIZATION; CIRCUIT RECONSTRUCTION; 3D RECONSTRUCTION; IMAGE-ANALYSIS; SECTION; ULTRASTRUCTURE; CELLS; COMPLEXITY; SYNAPSES	Transmission-mode scanning electron microscopy (tSEM) on a field emission SEM platform was developed for efficient and cost-effective imaging of circuit-scale volumes from brain at nanoscale resolution. Image area was maximized while optimizing the resolution and dynamic range necessary for discriminating key subcellular structures, such as small axonal, dendritic and glial processes, synapses, smooth endoplasmic reticulum, vesicles, microtubules, polyribosomes, and endosomes which are critical for neuronal function. Individual image fields from the tSEM system were up to 4,295 mm(2) (65.54 mu m per side) at 2 nm pixel size, contrasting with image fields from a modern transmission electron microscope (TEM) system, which were only 66.59 mu m(2) (8.160 mu m per side) at the same pixel size. The tSEM produced outstanding images and had reduced distortion and drift relative to TEM. Automated stage and scan control in tSEM easily provided unattended serial section imaging and montaging. Lens and scan properties on both TEM and SEM platforms revealed no significant nonlinear distortions within a central field of similar to 100 mu m(2) and produced near-perfect image registration across serial sections using the computational elastic alignment tool in Fiji/TrakEM2 software, and reliable geometric measurements from RECONSTRUCT (TM) or Fiji/TrakEM2 software. Axial resolution limits the analysis of small structures contained within a section (similar to 45 nm). Since this new tSEM is non-destructive, objects within a section can be explored at finer axial resolution in TEM tomography with current methods. Future development of tSEM tomography promises thinner axial resolution producing nearly isotropic voxels and should provide within-section analyses of structures without changing platforms. Brain was the test system given our interest in synaptic connectivity and plasticity; however, the new tSEM system is readily applicable to other biological systems.	[Kuwajima, Masaaki; Mendenhall, John M.; Lindsey, Laurence F.; Harris, Kristen M.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Harris, Kristen M.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Harris, KM (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	kmh2249@gmail.com		Kuwajima, Masaaki/0000-0002-1478-3726; Harris, Kristen/0000-0002-1943-4744	United States National Institutes of Health [NS021184, NS074644, MH095980]; Texas Emerging Technologies Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021184, R37NS021184, R23NS021184, R01NS074644] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Emerging Technologies Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by United States National Institutes of Health (http://www.nih.gov; grant numbers NS021184, NS074644, and MH095980 to KMH) and Texas Emerging Technologies Fund (http://governor.state.tx.us/ecodev/etf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bogner A, 2007, MICRON, V38, P390, DOI 10.1016/j.micron.2006.06.008; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BUNDGAARD M, 1984, J ULTRA MOL STRUCT R, V88, P1, DOI 10.1016/S0022-5320(84)90177-1; Cantoni M., 2010, MICROSC ANAL, V24, P13; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CHIANG RG, 1986, J NEUROCYTOL, V15, P63, DOI 10.1007/BF02057905; Chitwood RA, 2012, NEUR M PLANN; COOK WR, 1986, J BACTERIOL, V168, P1430, DOI 10.1128/jb.168.3.1430-1438.1986; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Fiala JC, 2003, J COMP NEUROL, V465, P90, DOI 10.1002/cne.10825; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fiala JC, 2007, BRAIN STRUCT FUNCT, V212, P195, DOI 10.1007/s00429-007-0153-1; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Guise O, 2011, POLYMER, V52, P1278, DOI 10.1016/j.polymer.2011.01.030; Hara Y, 2011, J NEUROSCI, V31, P7737, DOI 10.1523/JNEUROSCI.0822-11.2011; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Horstmann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035172; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; KEDDIE FM, 1969, J ULTRA MOL STRUCT R, V29, P260, DOI 10.1016/S0022-5320(69)90105-1; Knott G, 2011, J VIS EXP, V6, pe2588, DOI DOI 10.3791/2588; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kuwajima Masaaki, 2013, Methods Mol Biol, V950, P253, DOI 10.1007/978-1-62703-137-0_15; Marc RE, 2012, CURR OPIN NEUROBIOL, V22, P568, DOI 10.1016/j.conb.2012.03.011; Mendenhall JM, 2009, NEUR M PLANN; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; NOVIKOFF PM, 1971, J CELL BIOL, V50, P859, DOI 10.1083/jcb.50.3.859; Nuntagij P, 2009, J ALZHEIMERS DIS, V16, P315, DOI 10.3233/JAD-2009-0962; Osafune T, 2010, METHODS MOL BIOL, V657, P259, DOI 10.1007/978-1-60761-783-9_21; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Popov VI, 2011, J COMP NEUROL, V519, P1338, DOI 10.1002/cne.22573; POSTEK MT, 1989, IEEE T ELECTRON DEV, V36, P2452, DOI 10.1109/16.43666; Potter CS, 2004, J STRUCT BIOL, V146, P431, DOI 10.1016/j.jsb.2004.02.002; Reichelt M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002740; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ring EA, 2011, J MICROSC-OXFORD, V243, P273, DOI 10.1111/j.1365-2818.2011.03501.x; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Saalfeld S, 2010, BIOINFORMATICS, V26, pi57, DOI 10.1093/bioinformatics/btq219; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SPACEK J, 1974, J ANAT, V117, P487; SPACEK J, 1987, ACTA NEUROPATHOL, V73, P77; Starborg T, 2009, SCAND J MED SCI SPOR, V19, P547, DOI 10.1111/j.1600-0838.2009.00907.x; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Szule JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033333; Tapia JC, 2012, NAT PROTOC, V7, P193, DOI 10.1038/nprot.2011.439; THAEMERT JC, 1966, J CELL BIOL, V28, P37, DOI 10.1083/jcb.28.1.37; Veeraraghavan A, 2010, PROC CVPR IEEE, P1767, DOI 10.1109/CVPR.2010.5539846; Villalba RM, 2011, J COMP NEUROL, V519, P989, DOI 10.1002/cne.22563; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946	58	39	40	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59573	10.1371/journal.pone.0059573	http://dx.doi.org/10.1371/journal.pone.0059573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555711	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500056
J	Hagen, WR				Hagen, Wilfred R.			Broadband Transmission EPR Spectroscopy	PLOS ONE			English	Article							RAPID-SCAN EPR; SPECTRA	EPR spectroscopy employs a resonator operating at a single microwave frequency and phase-sensitive detection using modulation of the magnetic field. The X-band spectrometer is the general standard with a frequency in the 9-10 GHz range. Most (bio)molecular EPR spectra are determined by a combination of the frequency-dependent electronic Zeeman interaction and a number of frequency-independent interactions, notably, electron spin - nuclear spin interactions and electron spin - electron spin interactions, and unambiguous analysis requires data collection at different frequencies. Extant and long-standing practice is to use a different spectrometer for each frequency. We explore the alternative of replacing the narrow-band source plus single-mode resonator with a continuously tunable microwave source plus a non-resonant coaxial transmission cell in an unmodulated external field. Our source is an arbitrary wave digital signal generator producing an amplitude-modulated sinusoidal microwave in combination with a broadband amplifier for 0.8-2.7 GHz. Theory is developed for coaxial transmission with EPR detection as a function of cell dimensions and materials. We explore examples of a doublet system, a high-spin system, and an integer-spin system. Long, straigth, helical, and helico-toroidal cells are developed and tested with dilute aqueous solutions of spin label hydroxy-tempo. A detection limit of circa 5 mM HO-tempo in water at 800 MHz is obtained for the present setup, and possibilities for future improvement are discussed.	Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Delft University of Technology	Hagen, WR (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Hagen, Wilfred R./H-8918-2017	Hagen, Wilfred R./0000-0002-1609-6671	Dutch National Research School Combination-Catalysis Controlled by Chemical Design	Dutch National Research School Combination-Catalysis Controlled by Chemical Design	This work was supported by a research grant from the Dutch National Research School Combination-Catalysis Controlled by Chemical Design (www.nrsc-catalysis.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1970, ELECT PARAMAGNETIC R; BRAMLEY R, 1983, CHEM REV, V83, P49, DOI 10.1021/cr00053a002; CUMMEROW RL, 1946, PHYS REV, V70, P433, DOI 10.1103/PhysRev.70.433; Delfs CD, 1997, J CHEM PHYS, V107, P8840, DOI 10.1063/1.475315; Ernst RR, 1966, ADV MAGN RESON, V2, P1; GONZALEZCALBET JM, 1994, J MATER RES, V9, P176, DOI 10.1557/JMR.1994.0176; GRIFFITHS JHE, 1946, NATURE, V158, P670, DOI 10.1038/158670a0; Hagen W. R., 2009, BIOMOLECULAR EPR SPE; HAGEN WR, 1982, BIOCHIM BIOPHYS ACTA, V708, P82, DOI 10.1016/0167-4838(82)90206-0; Hagen WR, 1999, COORDIN CHEM REV, V190, P209, DOI 10.1016/S0010-8545(99)00079-X; ISOBE T, 1995, J NON-CRYST SOLIDS, V189, P173, DOI 10.1016/0022-3093(95)00230-8; Kittell AW, 2011, J MAGN RESON, V211, P228, DOI 10.1016/j.jmr.2011.06.004; Kochelaev B. I., 1995, BEGINNING PARAMAGNET; MISRA SK, 1983, PHYS REV B, V28, P5300, DOI 10.1103/PhysRevB.28.5300; Mitchell DG, 2012, J MAGN RESON, V214, P221, DOI 10.1016/j.jmr.2011.11.007; Morin G, 1999, J MAGN RESON, V136, P176, DOI 10.1006/jmre.1998.1615; Natterer B, 1961, HELV PHYS ACTA, V34, P710; Pozar DM, 2012, MICROWAVE ENG; Rizzi P. A, 1988, MICROWAVE ENG PASSIV; Rubinson KA, 1998, J MAGN RESON, V132, P255, DOI 10.1006/jmre.1998.1409; RUBINSON KA, 1995, J MAGN RESON SER A, V117, P91, DOI 10.1006/jmra.1995.9966; RUBINSON KA, 1989, REV SCI INSTRUM, V60, P392, DOI 10.1063/1.1140388; Schlegel C, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3469783; Stoner JW, 2004, J MAGN RESON, V170, P127, DOI 10.1016/j.jmr.2004.06.008; Tseitlin M, 2011, J MAGN RESON, V211, P156, DOI 10.1016/j.jmr.2011.05.006; VONHIPPEL AR, 1954, DIELECTRICS WAVES; Weil JA, 2007, ELECT PARAMAGNETIC R, V2nd; WEIR WB, 1974, P IEEE, V62, P33, DOI 10.1109/PROC.1974.9382; Wells FH, 1959, MILLIMICROSECOND PUL; Wyder P, 2000, REV SCI INSTRUM, V69, P1817	31	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59874	10.1371/journal.pone.0059874	http://dx.doi.org/10.1371/journal.pone.0059874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555819	Green Published, gold			2022-12-27	WOS:000316546400067
J	Purushothuman, S; Marotte, L; Stowe, S; Johnstone, DM; Stone, J				Purushothuman, Sivaraman; Marotte, Lauren; Stowe, Sally; Johnstone, Daniel M.; Stone, Jonathan			The Response of Cerebral Cortex to Haemorrhagic Damage: Experimental Evidence from a Penetrating Injury Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; BETA-OLIGOMER FORMATION; ALZHEIMERS-DISEASE; SENILE PLAQUES; HEAD-INJURY; RISK-FACTORS; MOUSE MODEL; CELL-DEATH; HYPOTHESIS	Understanding the response of the brain to haemorrhagic damage is important in haemorrhagic stroke and increasingly in the understanding the cerebral degeneration and dementia that follow head trauma and head-impact sports. In addition, there is growing evidence that haemorrhage from small cerebral vessels is important in the pathogenesis of age-related dementia (Alzheimer's disease). In a penetration injury model of rat cerebral cortex, we have examined the neuropathology induced by a needlestick injury, with emphasis on features prominent in the ageing and dementing human brain, particularly plaque-like depositions and the expression of related proteins. Needlestick lesions were made in neo- and hippocampal cortex in Sprague Dawley rats aged 3-5 months. Brains were examined after 1-30 d survival, for haemorrhage, for the expression of hyperphosphorylated tau, Ab, amyloid precursor protein (APP), for gliosis and for neuronal death. Temporal cortex from humans diagnosed with Alzheimer's disease was examined with the same techniques. Needlestick injury induced long-lasting changes-haem deposition, cell death, plaque-like deposits and glial invasion-along the needle track. Around the track, the lesion induced more transient changes, particularly upregulation of A beta, APP and hyperphosporylated tau in neurons and astrocytes. Reactions were similar in hippocampus and neocortex, except that neuronal death was more widespread in the hippocampus. In summary, experimental haemorrhagic injury to rat cerebral cortex induced both permanent and transient changes. The more permanent changes reproduced features of human senile plaques, including the formation of extracellular deposits in which haem and Ab-related proteins co-localised, neuronal loss and gliosis. The transient changes, observed in tissue around the direct lesion, included the upregulation of A beta, APP and hyperphosphorylated tau, not associated with cell death. The findings support the possibility that haemorrhagic damage to the brain can lead to plaque-like pathology.	[Purushothuman, Sivaraman; Stowe, Sally; Johnstone, Daniel M.; Stone, Jonathan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Purushothuman, Sivaraman; Stowe, Sally; Johnstone, Daniel M.; Stone, Jonathan] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Marotte, Lauren; Stowe, Sally] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia	University of Sydney; University of Sydney; Australian National University	Stone, J (corresponding author), Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.	jonstone@eye.usyd.edu.au	Johnstone, Daniel/E-9929-2013; Stone, Jonathan/GQA-9990-2022	Johnstone, Daniel/0000-0003-2876-3299; Purushothuman, Sivaraman/0000-0002-0880-5060	Sir Zelman Cowen Universities Fund; Bluesand Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Sir Zelman Cowen Universities Fund; Bluesand Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Sir Zelman Cowen Universities Fund, and by the Bluesand Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Braak H, 2004, NEUROBIOL AGING, V25, P713, DOI 10.1016/j.neurobiolaging.2003.12.015; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Chuang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033120; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; delaTorre JC, 1997, ANN NY ACAD SCI, V826, P75; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; DOWSON JH, 1992, NEUROBIOL AGING, V13, P493, DOI 10.1016/0197-4580(92)90077-B; DOWSON JH, 1981, HISTOPATHOLOGY, V5, P305, DOI 10.1111/j.1365-2559.1981.tb01789.x; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1986, NEUROBIOL AGING, V7, P489, DOI 10.1016/0197-4580(86)90086-2; Hossmann KA, 2009, TXB STROKE MED, P1; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jolkkonen J, 2007, NEUROSCI LETT, V428, P99, DOI 10.1016/j.neulet.2007.09.043; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kumar-Singh S, 2002, AM J PATHOL, V161, P507, DOI 10.1016/S0002-9440(10)64207-1; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; LASSMANN H, 1995, ACTA NEUROPATHOL, V89, P35, DOI 10.1007/BF00294257; Lee JS, 2011, NEUROSCI LETT, V489, P84, DOI 10.1016/j.neulet.2010.11.071; MacKenzie JM, 1996, J CLIN PATHOL, V49, P360, DOI 10.1136/jcp.49.5.360; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; Meadowcroft MD, 2009, J MAGN RESON IMAGING, V29, P997, DOI 10.1002/jmri.21731; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Miyakawa T, 2000, ANN NY ACAD SCI, V903, P46, DOI 10.1111/j.1749-6632.2000.tb06349.x; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Park A, 2010, TIME MAGAZINE, P30; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Quintana C, 2007, J ALZHEIMERS DIS, V12, P157; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith MA, 2002, FREE RADICAL BIO MED, V33, P1194, DOI 10.1016/S0891-5849(02)01021-3; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Thal DR, 2002, CLIN NEUROPATHOL, V21, P35; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WEN R, 1995, J NEUROSCI, V15, P7377; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Yates PA, 2011, NEUROLOGY, V77, P48, DOI 10.1212/WNL.0b013e318221ad36	74	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59740	10.1371/journal.pone.0059740	http://dx.doi.org/10.1371/journal.pone.0059740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555765	Green Published, gold			2022-12-27	WOS:000316546400060
J	Bruewer, AR; Mowat, FM; Bartoe, JT; Boye, SL; Hauswirth, WW; Petersen-Jones, SM				Bruewer, Ashlee R.; Mowat, Freya M.; Bartoe, Joshua T.; Boye, Sanford L.; Hauswirth, William W.; Petersen-Jones, Simon M.			Evaluation of Lateral Spread of Transgene Expression following Subretinal AAV-Mediated Gene Delivery in Dogs	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; HIGH-EFFICIENCY TRANSDUCTION; LINKED RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; LARGE ANIMAL-MODEL; CANINE MODEL; MOUSE RETINA; VECTORS; THERAPY; DEGENERATION	Dog models with spontaneously occurring mutations in retinal dystrophy genes are an invaluable resource for preclinical development of retinal gene therapy. Adeno-associated virus (AAV) vectors have been most successful; to target the outer retina and RPE they are delivered by subretinal injection, causing a temporary retinal detachment with some potential for retinal morbidity. A recent reporter gene study using an AAV2/8 vector in dogs reported transgene expression beyond the boundary of the subretinal bleb. This could be a desirable feature which increases the area of retina treated while minimizing the retinal detachment and any associated morbidity. We performed a detailed study of the lateral spread of transgene expression beyond the subretinal injection site following subretinally delivered AAV vectors in normal dogs. Vectors expressed green fluorescent protein (GFP) using a small chicken beta-actin promoter. AAV2/2 (quadruple tyrosine to phenylalanine (Y-F) capsid mutant), self-complementary (sc) AAV2/8 (single Y-F capsid mutant) and a scAAV2/5 were used. We found that in all eyes GFP expression involved retina beyond the initial post-injection subretinal bleb boundary. In all eyes there was post-injection spread of the retinal detachment within the first 3 days post procedure and prior to retinal reattachment. In 11/16 eyes this accounted for the entire "lateral spread" of GFP expression while in 5/16 eyes a very slight extension of GFP expression beyond the final boundary of the subretinal bleb could be detected. All 3 AAV constructs induced GFP expression in the nerve fiber layer with spread to the optic nerve. Patients treated by subretinal injection should be monitored for possible expansion of the subretinal injection bleb prior to reattachment. Injections in the parafoveal region may expand to lead to a foveal detachment that may be undesirable. Cell-specific promoters may be required to limit spread of expressed transgene to the brain with these AAV serotypes.	[Bruewer, Ashlee R.; Mowat, Freya M.; Bartoe, Joshua T.; Petersen-Jones, Simon M.] Michigan State Univ, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	Michigan State University; State University System of Florida; University of Florida	Petersen-Jones, SM (corresponding author), Michigan State Univ, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	peter315@cvm.msu.edu	Petersen-Jones, Simon/B-3822-2018; MOWAT, FREYA/AAD-5102-2021	Petersen-Jones, Simon/0000-0002-7410-2304; hauswirth, william/0000-0002-3244-4947; Mowat, Freya/0000-0002-8726-8768; Glassen, Ronald/0000-0003-3195-5718	CVM Endowed Research Funds; Myers-Dunlap Endowment for Canine Health; Hal and Jean Glassen Memorial Foundation; Foundation Fighting Blindness; Macula Vision Research Foundation; Research to Prevent Blindness; National Eye Institute [EY021721]; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER	CVM Endowed Research Funds; Myers-Dunlap Endowment for Canine Health; Hal and Jean Glassen Memorial Foundation; Foundation Fighting Blindness(European Commission); Macula Vision Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by the CVM Endowed Research Funds and the Myers-Dunlap Endowment for Canine Health, Hal and Jean Glassen Memorial Foundation, Foundation Fighting Blindness, Macula Vision Research Foundation, Research to Prevent Blindness and the National Eye Institute (EY021721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Auricchio A, 2005, CURR GENE THER, V5, P339, DOI 10.2174/1566523054065020; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bartoe JT, 2011, ARVO M, V52, P1420; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Beltran WA, 2009, VET OPHTHALMOL, V12, P192, DOI 10.1111/j.1463-5224.2009.00694.x; Berson EL, 2008, ADV EXP MED BIOL, V613, P21, DOI 10.1007/978-0-387-74904-4_2; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mowat FM, 2012, ARVO M, V53, P1928; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Petersen-Jones SM, 2009, MOL VIS, V15, P1835; Petit L, 2012, MOL THER, V20, P2019, DOI 10.1038/mt.2012.134; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Tuntivanich N, 2009, INVEST OPHTH VIS SCI, V50, P801, DOI 10.1167/iovs.08-2562; Verdugo ME, 2001, CELL TRANSPLANT, V10, P317, DOI 10.3727/000000001783986710; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	31	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60218	10.1371/journal.pone.0060218	http://dx.doi.org/10.1371/journal.pone.0060218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560080	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100055
J	Elbanna, AE; Carlson, JM				Elbanna, Ahmed E.; Carlson, Jean M.			Dynamics of Polymer Molecules with Sacrificial Bond and Hidden Length Systems: Towards a Physically-Based Mesoscopic Constitutive Law	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; HUMAN CORTICAL BONE; NANOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; STRETCHING DNA; LIVING DIATOMS; LIVE DIATOM; TOUGHNESS; FRACTURE; FAULT	We investigate the entropic force-elongation behavior of a polymer chain in the presence of the sacrificial bond and hidden length (SBHL) system observed experimentally in many biomaterials. We show that in most cases the SBHL system leads to a significant increase in toughness. However, the presence of a large number of bonds or relatively strong bonds in the SBHL system can reduce the net gain in toughness. We also incorporate the polymer model into a network of polymers with random properties (e. g., contour length, number and strength of sacrificial bonds, length of hidden loops). This allows us to derive a physically-based mesoscopic force-displacement law that governs the collective behavior.	[Elbanna, Ahmed E.; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Elbanna, Ahmed E.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL USA	University of California System; University of California Santa Barbara; University of Illinois System; University of Illinois Urbana-Champaign	Elbanna, AE (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	elbanna2@uiuc.edu	El-Baz, Ayman/AAC-6689-2019; Elbanna, Ahmed/K-3941-2015	El-Baz, Ayman/0000-0001-7264-1323; 	David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies through U.S. Army Research Office [W911NF-09-0001]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies through U.S. Army Research Office	This work was supported by the David and Lucile Packard Foundation and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384008; Barenblatt GI, 1962, ADV APPL MECH, V7, P55, DOI DOI 10.1016/S0065-2156(08)70121-2; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bouchbinder E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031133; Bouchbinder E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031132; Bouchbinder E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031131; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; CARLSON JM, 1989, PHYS REV A, V40, P6470, DOI 10.1103/PhysRevA.40.6470; CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050; Daub EG, 2010, ANNU REV CONDEN MA P, V1, P397, DOI 10.1146/annurev-conmatphys-070909-104025; Dugdale TM, 2005, BIOPHYS J, V89, P4252, DOI 10.1529/biophysj.105.062489; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Fantner GE, 2006, BIOPHYS J, V90, P1411, DOI 10.1529/biophysj.105.069344; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Fantner GE, 2006, COMPOS SCI TECHNOL, V66, P1205, DOI 10.1016/j.compscitech.2005.10.005; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; Gebeshuber IC, 2003, J MICROSC-OXFORD, V212, P292, DOI 10.1111/j.1365-2818.2003.01275.x; Hansma P. K., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P313; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Higgins MJ, 2003, J PHYCOL, V39, P1181, DOI 10.1111/j.0022-3646.2003.03-027.x; Higgins MJ, 2003, J PHYCOL, V39, P722, DOI 10.1046/j.1529-8817.2003.02163.x; Higgins MJ, 2002, PROTIST, V153, P25, DOI 10.1078/1434-4610-00080; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; KOLMOGOROV AN, 1991, P ROY SOC LOND A MAT, V434, P9, DOI 10.1098/rspa.1991.0075; Lapusta N, 2009, NAT GEOSCI, V2, P676, DOI 10.1038/ngeo645; Lemaitre A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061611; Lieou CKC, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061308; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Nalla RK, 2004, BONE, V35, P1240, DOI 10.1016/j.bone.2004.07.016; RICE JR, 1983, PURE APPL GEOPHYS, V121, P443, DOI 10.1007/BF02590151; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332; Rubenstein MC, 2003, POLYM PHYS; Sarkar A, 2007, BIOPHYS J, V92, pL36, DOI 10.1529/biophysj.106.097741; Sbrana F, 2011, J BIOMECH, V44, P2118, DOI 10.1016/j.jbiomech.2011.05.028; Scholz C, 2002, EARTHQUAKES FAULTING; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Xia K, 2006, EXP MECH, V46, P163, DOI 10.1007/s11340-006-6423-7; XU XP, 1993, MODEL SIMUL MATER SC, V1, P111, DOI 10.1088/0965-0393/1/2/001; Yang HTY, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/105011	45	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e56118	10.1371/journal.pone.0056118	http://dx.doi.org/10.1371/journal.pone.0056118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565135	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300002
J	Miyashita, A; Koike, A; Jun, G; Wang, LS; Takahashi, S; Matsubara, E; Kawarabayashi, T; Shoji, M; Tomita, N; Arai, H; Asada, T; Harigaya, Y; Ikeda, M; Amari, M; Hanyu, H; Higuchi, S; Ikeuchi, T; Nishizawa, M; Suga, M; Kawase, Y; Akatsu, H; Kosaka, K; Yamamoto, T; Imagawa, M; Hamaguchi, T; Yamada, M; Moriaha, T; Takeda, M; Takao, T; Nakata, K; Fujisawa, Y; Sasaki, K; Watanabe, K; Nakashima, K; Urakami, K; Ooya, T; Takahashi, M; Yuzuriha, T; Serikawa, K; Yoshimoto, S; Nakagawa, R; Kim, JW; Ki, CS; Won, HH; Na, DL; Seo, SW; Mook-Jung, I; St George-Hyslop, P; Mayeux, R; Haines, JL; Pericak-Vance, MA; Yoshida, M; Nishida, N; Tokunaga, K; Yamamoto, K; Tsuji, S; Kanazawa, I; Ihara, Y; Schellenberg, GD; Farrer, LA; Kuwano, R				Miyashita, Akinori; Koike, Asako; Jun, Gyungah; Wang, Li-San; Takahashi, Satoshi; Matsubara, Etsuro; Kawarabayashi, Takeshi; Shoji, Mikio; Tomita, Naoki; Arai, Hiroyuki; Asada, Takashi; Harigaya, Yasuo; Ikeda, Masaki; Amari, Masakuni; Hanyu, Haruo; Higuchi, Susumu; Ikeuchi, Takeshi; Nishizawa, Masatoyo; Suga, Masaichi; Kawase, Yasuhiro; Akatsu, Hiroyasu; Kosaka, Kenji; Yamamoto, Takayuki; Imagawa, Masaki; Hamaguchi, Tsuyoshi; Yamada, Masahito; Moriaha, Takashi; Takeda, Masatoshi; Takao, Takeo; Nakata, Kenji; Fujisawa, Yoshikatsu; Sasaki, Ken; Watanabe, Ken; Nakashima, Kenji; Urakami, Katsuya; Ooya, Terumi; Takahashi, Mitsuo; Yuzuriha, Takefumi; Serikawa, Kayoko; Yoshimoto, Seishi; Nakagawa, Ryuji; Kim, Jong-Won; Ki, Chang-Seok; Won, Hong-Hee; Na, Duk L.; Seo, Sang Won; Mook-Jung, Inhee; St George-Hyslop, Peter; Mayeux, Richard; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Yoshida, Makiko; Nishida, Nao; Tokunaga, Katsushi; Yamamoto, Ken; Tsuji, Shoji; Kanazawa, Ichiro; Ihara, Yasuo; Schellenberg, Gerard D.; Farrer, Lindsay A.; Kuwano, Ryozo		Alzheimer Dis Genetics Consortium	SORL1 Is Genetically Associated with Late-Onset Alzheimer's Disease in Japanese, Koreans and Caucasians	PLOS ONE			English	Article							VARIANTS; METAANALYSIS; EFFICIENT; PICALM; GENE; APOE	To discover susceptibility genes of late-onset Alzheimer's disease (LOAD), we conducted a 3-stage genome-wide association study (GWAS) using three populations: Japanese from the Japanese Genetic Consortium for Alzheimer Disease (JGSCAD), Koreans, and Caucasians from the Alzheimer Disease Genetic Consortium (ADGC). In Stage 1, we evaluated data for 5,877,918 genotyped and imputed SNPs in Japanese cases (n = 1,008) and controls (n = 1,016). Genome-wide significance was observed with 12 SNPs in the APOE region. Seven SNPs from other distinct regions with p-values,2x10(-5) were genotyped in a second Japanese sample (885 cases, 985 controls), and evidence of association was confirmed for one SORL1 SNP (rs3781834, P = 7.33x10(-7) in the combined sample). Subsequent analysis combining results for several SORL1 SNPs in the Japanese, Korean (339 cases, 1,129 controls) and Caucasians (11,840 AD cases, 10,931 controls) revealed genome wide significance with rs11218343 (P = 1.77x10(-9)) and rs3781834 (P = 1.04x10(-8)). SNPs in previously established AD loci in Caucasians showed strong evidence of association in Japanese including rs3851179 near PICALM (P = 1.71x10(-5)) and rs744373 near BIN1 (P = 1.39x10(-4)). The associated allele for each of these SNPs was the same as in Caucasians. These data demonstrate for the first time genome-wide significance of LOAD with SORL1 and confirm the role of other known loci for LOAD in Japanese. Our study highlights the importance of examining associations in multiple ethnic populations.	[Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata, Japan; [Koike, Asako; Yoshida, Makiko] Hitachi Ltd, Cent Res Lab, Tokyo, Japan; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med Biomed Genet, Boston, MA USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Wang, Li-San; Schellenberg, Gerard D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Takahashi, Satoshi] Iwate Med Univ, Dept Neurol, Morioka, Iwate 020, Japan; [Matsubara, Etsuro; Kawarabayashi, Takeshi; Shoji, Mikio] Hirosaki Univ, Dept Neurol, Grad Sch Med, Hirosaki, Aomori, Japan; [Tomita, Naoki; Arai, Hiroyuki] Tohoku Univ, Grad Sch Med, Dept Geriatr & Complementary Med, Sendai, Miyagi 980, Japan; [Asada, Takashi] Univ Tsukuba, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Harigaya, Yasuo] Maebashi Red Cross Hosp, Dept Neurol, Maebashi, Gunma, Japan; [Ikeda, Masaki; Amari, Masakuni] Gunma Univ, Grad Sch Med, Dept Neurol, Maebashi, Gunma 371, Japan; [Hanyu, Haruo] Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan; [Higuchi, Susumu] Kurihama Alcoholism Ctr, Div Clin Res, Yokosuka, Kanagawa, Japan; [Ikeuchi, Takeshi; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Suga, Masaichi] Higashi Niigata Hosp, Niigata, Japan; [Kawase, Yasuhiro] Kawase Neurol Clin, Sanjo, Japan; [Akatsu, Hiroyasu; Kosaka, Kenji; Yamamoto, Takayuki] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi, Japan; [Imagawa, Masaki] Imagawa Clin, Osaka, Japan; [Hamaguchi, Tsuyoshi; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Moriaha, Takashi; Takeda, Masatoshi] Osaka Univ, Dept Psychiat, Grad Sch Med, Osaka, Japan; [Takao, Takeo] Kurashiki Heisei Hosp, Kurashiki, Okayama, Japan; [Nakata, Kenji; Fujisawa, Yoshikatsu; Sasaki, Ken] Kinoko Espoir Hosp, Kasaoka, Japan; [Watanabe, Ken] Watanabe Hosp, Tottori, Japan; [Nakashima, Kenji] Tottori Univ, Dept Neurol, Yonago, Tottori, Japan; [Urakami, Katsuya] Tottori Univ, Sect Environm & Hlth Sci, Dept Regulat Biol, Yonago, Tottori, Japan; [Ooya, Terumi] Town Off, Onan, Japan; [Takahashi, Mitsuo] Fukuoka Univ, Dept Clin Pharmacol, Fukuoka 81401, Japan; [Yuzuriha, Takefumi] Hizen Psychiat Ctr, Natl Hosp Org, Dept Psychiat, Saga, Japan; [Serikawa, Kayoko; Yoshimoto, Seishi; Nakagawa, Ryuji] Ureshino Onsen Hosp, Saga, Japan; [Kim, Jong-Won; Ki, Chang-Seok; Won, Hong-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; [Na, Duk L.; Seo, Sang Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [St George-Hyslop, Peter] Cambridge Inst Med Res, Dept Clin Neurosci, Cambridge, England; [Mayeux, Richard] Columbia Univ, Dept Neurol, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Haines, Jonathan L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Tokyo, Japan; [Yamamoto, Ken] Kyushu Univ, Dept Mol Genet, Med Inst Bioregulat, Fukuoka 812, Japan; [Tsuji, Shoji] Univ Tokyo, Dept Neurol, Tokyo, Japan; [Kanazawa, Ichiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Ihara, Yasuo] Doshisha Univ, Dept Neuropathol, Kyoto 602, Japan; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Genet & Genom, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Niigata University; Hitachi Limited; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; University of Pennsylvania; Iwate Medical University; Hirosaki University; Tohoku University; University of Tsukuba; Maebashi Red Cross Hospital; Gunma University; Tokyo Medical University; Niigata University; Kanazawa University; Osaka University; Tottori University; Tottori University; Fukuoka University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); University of Toronto; University of Cambridge; Columbia University; Vanderbilt University; University of Miami; University of Tokyo; Kyushu University; University of Tokyo; National Center for Neurology & Psychiatry - Japan; Doshisha University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	Farrer, LA (corresponding author), Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA.	farrer@bu.edu; ryosun@bri.niigata-u.ac.jp	Hardy, John/C-2451-2009; Farrer, Lindsay/AAS-1035-2020; Na, Duk Lyul/C-9598-2011; Haines, Jonathan/C-3374-2012; Mayeux, Richard/E-9788-2013; Won, Hong-Hee/D-2672-2011; ki, cs/O-5931-2014; Ki, Chang-Seok/G-7559-2014; Myers, Amanda J/B-1796-2010; Tsuang, Debby/L-7234-2016	Hardy, John/0000-0002-3122-0423; Haines, Jonathan/0000-0002-4351-4728; Mayeux, Richard/0000-0001-6519-9696; Won, Hong-Hee/0000-0001-5719-0552; Ki, Chang-Seok/0000-0001-7679-8731; Myers, Amanda J/0000-0002-3100-9396; Tsuang, Debby/0000-0002-4716-1894; Leverenz, James/0000-0002-0896-0749; Buxbaum, Joseph/0000-0001-8898-8313; Ferris, Steven/0000-0001-8641-6223; Farrer, Lindsay/0000-0001-5533-4225; Jun, Gyungah/0000-0002-3230-8697; St George-Hyslop, Peter/0000-0003-0796-7209; Shoji, Mikio/0000-0003-1027-1712; DeKosky, Steven/0000-0003-3743-2758; Reisberg, Barry/0000-0002-9104-7423	Ministry of Education, Culture, Sports, Science and Technology of Japan, 'Japanese Alzheimer's Disease Neuroimaging Initiative' by New Energy and Industrial Technology Development Organization (NEDO) in Japan; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120030]; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through ADGC [U01 AG032984, RC2 AG036528]; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through NACC [U01 AG016976]; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through NCRAD [U24 AG021886]; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through NIA LOAD [U24 AG026395, U24 AG026390]; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) [MIRAGE R01 AG025259, BU ADC P30]; Banner Sun Health Research Institute [P30 AG019610]; Boston University [P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01AG33193]; Columbia University [P50 AG008702, R37 AG015473]; Duke University [P30 AG028377, AG05128]; Emory University [AG025688]; Group Health Research Institute [UO1 AG06781, UO1 HG004610]; Indiana University [P30 AG10133]; Johns Hopkins University [P50 AG005146, R01 AG020688]; Massachusetts General Hospital [P50 AG005134]; Mayo Clinic [P50 AG016574]; Mount Sinai School of Medicine [P50 AG005138, P01 AG002219]; New York University [P30 AG08051, MO1RR00096, UL1 RR029893]; Northwestern University [P30 AG013854]; Oregon Health & Science University [P30 AG008017, R01 AG026916]; Rush University [P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146, TGen, R01 NS059873]; University of Alabama at Birmingham [P50 AG016582, UL1RR02777]; University of Arizona [R01 AG031581]; University of California, Davis [P30 AG010129]; University of California, Irvine [P50 AG016573, P50, P50 AG016575, P50 AG016576, P50 AG016577]; University of California, Los Angeles [P50 AG016570]; University of California, San Diego [P50 AG005131]; University of California, San Francisco [P50 AG023501, P01 AG019724]; University of Kentucky [P30 AG028383]; University of Michigan [P50 AG008671]; University of Pennsylvania [P30 AG010124]; University of Pittsburgh [P50 AG005133, AG030653]; University of Southern California [P50 AG005142]; University of Texas Southwestern [P30 AG012300]; University of Miami [R01 AG027944, AG010491, AG027944, AG021547, AG019757]; University of Washington [P50 AG005136]; Vanderbilt University [R01 AG019085]; Washington University [P50 AG005681, P01 AG03991]; NINDS [NS39764]; NIMH [MH60451]; Glaxo Smith Kline; NIA [AG034504]; Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Institute; Medical Research Council; state of Arizona; local NHS trusts; Newcastle University; Higher Education Funding Council for England (HEFCE); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; Northern California Institute for Research and Education by Abbott; Northern California Institute for Research and Education by AstraZeneca AB; Northern California Institute for Research and Education by Bayer Schering Pharma AG; Northern California Institute for Research and Education by Bristol-Myers Squibb; Northern California Institute for Research and Education by Eisai Global Clinical Development; Northern California Institute for Research and Education by Elan Corporation; Northern California Institute for Research and Education by Genentech; Northern California Institute for Research and Education by GE Healthcare; Northern California Institute for Research and Education by GlaxoSmithKline; Northern California Institute for Research and Education by Innogenetics; Northern California Institute for Research and Education by Johnson and Johnson; Northern California Institute for Research and Education by Eli Lilly and Co.; Northern California Institute for Research and Education by Medpace, Inc.; Northern California Institute for Research and Education by Merck and Co., Inc.; Northern California Institute for Research and Education by Novartis AG; Northern California Institute for Research and Education by Pfizer Inc; Northern California Institute for Research and Education by F. Hoffman-La Roche; Northern California Institute for Research and Education by Schering-Plough; Northern California Institute for Research and Education by Synarc, Inc.; Northern California Institute for Research and Education by Alzheimer's Association; Northern California Institute for Research and Education by Alzheimer's Drug Discovery Foundation; Northern California Institute for Research and Education by Dana Foundation; Northern California Institute for Research and Education by National Institute of Biomedical Imaging and Bioengineering; Northern California Institute for Research and Education by NIA [U01 AG024904, RC2 AG036535, K01 AG030514]; Alzheimer's Association (LAF) [IIRG-08-89720]; Alzheimer's Association (MP-V) [IIRG-05-14147]; US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health Research; Grants-in-Aid for Scientific Research [25670415, 23591231, 24510275, 24591246] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA129769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893, M01RR000096] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451, R01MH080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059873, P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016582, P01AG003991, R01AG015819, R01AG030146, RC2AG036535, P50AG008702, P01AG002219, R01AG026390, R01AG017917, R01AG033193, R01AG026916, R01AG019757, R01AG021547, U01AG010483, P50AG005138, P50AG005142, P50AG005146, K01AG030514, P30AG008017, P50AG005136, U01AG016976, P50AG005134, U01AG006781, P50AG016573, P50AG005681, P30AG028383, P50AG016570, U24AG021886, P30AG010129, U01AG032984, U24AG026395, U01AG024904, P30AG013846, R01AG040770, P01AG010491, P30AG028377, R01AG019085, R01AG017173, RC2AG036528, P01AG019724, P30AG019610, R01AG020688, P50AG025688, P30AG010133, R37AG015473, P30AG008051, P30AG010161, P30AG013854, P30AG010124, R01AG031581, P50AG023501, P50AG005133, P50AG005131, P50AG008671, P30AG012300, R01AG025259, R01AG034504, P50AG016574, R01AG027944, R01AG030653] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan, 'Japanese Alzheimer's Disease Neuroimaging Initiative' by New Energy and Industrial Technology Development Organization (NEDO) in Japan; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through ADGC; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through NACC; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through NCRAD; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) through NIA LOAD; United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA); Banner Sun Health Research Institute; Boston University; Columbia University; Duke University; Emory University; Group Health Research Institute; Indiana University; Johns Hopkins University(Johns Hopkins University); Massachusetts General Hospital(General Electric); Mayo Clinic; Mount Sinai School of Medicine; New York University; Northwestern University; Oregon Health & Science University; Rush University; University of Alabama at Birmingham; University of Arizona; University of California, Davis(University of California System); University of California, Irvine(University of California System); University of California, Los Angeles(University of California System); University of California, San Diego(University of California System); University of California, San Francisco(University of California System); University of Kentucky; University of Michigan(University of Michigan System); University of Pennsylvania; University of Pittsburgh(University of Pittsburgh); University of Southern California; University of Texas Southwestern; University of Miami; University of Washington(University of Washington); Vanderbilt University; Washington University; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Glaxo Smith Kline(GlaxoSmithKline); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); state of Arizona; local NHS trusts; Newcastle University; Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; Northern California Institute for Research and Education by Abbott; Northern California Institute for Research and Education by AstraZeneca AB; Northern California Institute for Research and Education by Bayer Schering Pharma AG; Northern California Institute for Research and Education by Bristol-Myers Squibb; Northern California Institute for Research and Education by Eisai Global Clinical Development; Northern California Institute for Research and Education by Elan Corporation; Northern California Institute for Research and Education by Genentech; Northern California Institute for Research and Education by GE Healthcare(General Electric); Northern California Institute for Research and Education by GlaxoSmithKline; Northern California Institute for Research and Education by Innogenetics; Northern California Institute for Research and Education by Johnson and Johnson; Northern California Institute for Research and Education by Eli Lilly and Co.; Northern California Institute for Research and Education by Medpace, Inc.; Northern California Institute for Research and Education by Merck and Co., Inc.; Northern California Institute for Research and Education by Novartis AG; Northern California Institute for Research and Education by Pfizer Inc; Northern California Institute for Research and Education by F. Hoffman-La Roche; Northern California Institute for Research and Education by Schering-Plough; Northern California Institute for Research and Education by Synarc, Inc.; Northern California Institute for Research and Education by Alzheimer's Association; Northern California Institute for Research and Education by Alzheimer's Drug Discovery Foundation; Northern California Institute for Research and Education by Dana Foundation; Northern California Institute for Research and Education by National Institute of Biomedical Imaging and Bioengineering; Northern California Institute for Research and Education by NIA; Alzheimer's Association (LAF)(Alzheimer's Association); Alzheimer's Association (MP-V)(Alzheimer's Association); US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a Grants-in-Aid for Scientific Research on Priority Areas, 'Advanced Brain Science Project' (Y.I.), 'Comprehensive Genomics' (R. K., K. T. and K.Y.), and 'Applied Genomics' (S. T.) and 'Integrated Database Project' (A. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 'Japanese Alzheimer's Disease Neuroimaging Initiative' (R. K.) by New Energy and Industrial Technology Development Organization (NEDO) in Japan, and by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120030). The United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01 AG032984, RC2 AG036528; NACC, U01 AG016976; NCRAD, U24 AG021886; NIA LOAD, U24 AG026395, U24 AG026390; BU ADC P30; MIRAGE R01 AG025259; Banner Sun Health Research Institute P30 AG019610; Boston University, P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01AG33193; Columbia University, P50 AG008702, R37 AG015473; Duke University, P30 AG028377, AG05128; Emory University, AG025688; Group Health Research Institute, UO1 AG06781, UO1 HG004610; Indiana University, P30 AG10133; Johns Hopkins University, P50 AG005146, R01 AG020688; Massachusetts General Hospital, P50 AG005134; Mayo Clinic, P50 AG016574; Mount Sinai School of Medicine, P50 AG005138, P01 AG002219; New York University, P30 AG08051, MO1RR00096, and UL1 RR029893; Northwestern University, P30 AG013854; Oregon Health & Science University, P30 AG008017, R01 AG026916; Rush University, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146; TGen, R01 NS059873; University of Alabama at Birmingham, P50 AG016582, UL1RR02777; University of Arizona, R01 AG031581; University of California, Davis, P30 AG010129; University of California, Irvine, P50 AG016573, P50, P50 AG016575, P50 AG016576, P50 AG016577; University of California, Los Angeles, P50 AG016570; University of California, San Diego, P50 AG005131; University of California, San Francisco, P50 AG023501, P01 AG019724; University of Kentucky, P30 AG028383; University of Michigan, P50 AG008671; University of Pennsylvania, P30 AG010124; University of Pittsburgh, P50 AG005133, AG030653; University of Southern California, P50 AG005142; University of Texas Southwestern, P30 AG012300; University of Miami, R01 AG027944, AG010491, AG027944, AG021547, AG019757; University of Washington, P50 AG005136; Vanderbilt University, R01 AG019085; and Washington University, P50 AG005681, P01 AG03991. The Kathleen Price Bryan Brain Bank at Duke University Medical Center is funded by NINDS grant #NS39764, NIMH MH60451 and by Glaxo Smith Kline. Genotyping of the TGEN2 cohort was supported by Kronos Science. The TGen series was also funded by NIA grant AG034504 to AJM, The Banner Alzheimer's Foundation, The Johnnie B. Byrd Sr.; Alzheimer's Institute, the Medical Research Council, and the state of Arizona and also includes samples from the following sites: Newcastle Brain Tissue Resource (funding via the Medical Research Council, local NHS trusts and Newcastle University), MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council), South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimer's Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and DeNDRoN), The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. Marcelle Morrison-Bogorad, PhD, Tony Phelps, PhD, and Walter Kukull, PhD, are thanked for helping to co-ordinate this collection. ADNI Funding for ADNI is through the Northern California Institute for Research and Education by grants from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., Alzheimer's Association, Alzheimer's Drug Discovery Foundation, the Dana Foundation, and by the National Institute of Biomedical Imaging and Bioengineering and NIA grants U01 AG024904, RC2 AG036535, K01 AG030514. The authors thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-officio ADGC members. Support was also from the Alzheimer's Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. P. S. G.-H. is supported by the Wellcome Trust, Howard Hughes Medical Institute, and Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Chen LH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.016; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Cuenco KT, 2008, ARCH NEUROL-CHICAGO, V65, P1640, DOI 10.1001/archneur.65.12.1640; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Donnelly P, 2009, PLOS GENET, V5; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gordon D, 2005, BIOINFORMATICS, V21, P3935, DOI 10.1093/bioinformatics/bti643; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kolsch H, 2008, NEUROSCI LETT, V440, P68, DOI 10.1016/j.neulet.2008.05.049; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; Li HL, 2011, J ALZHEIMERS DIS, V25, P111, DOI 10.3233/JAD-2011-101917; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Vardarajan BN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.020; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yu JT, 2011, J NEUROL SCI, V300, P78, DOI 10.1016/j.jns.2010.09.027	32	137	144	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e58618	10.1371/journal.pone.0058618	http://dx.doi.org/10.1371/journal.pone.0058618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565137	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300004
J	Rajan, MR; Fagerholm, S; Jonsson, C; Kjolhede, P; Turkina, MV; Stralfors, P				Rajan, Meenu Rohini; Fagerholm, Siri; Jonsson, Cecilia; Kjolhede, Preben; Turkina, Maria V.; Stralfors, Peter			Phosphorylation of IRS1 at Serine 307 in Response to Insulin in Human Adipocytes Is Not Likely to be Catalyzed by p70 Ribosomal S6 Kinase	PLOS ONE			English	Article							RECEPTOR SUBSTRATE-1 IRS-1; SERINE/THREONINE PHOSPHORYLATION; RESISTANCE; MODULATION; RAPTOR; INSULIN-RECEPTOR-SUBSTRATE-1; IDENTIFICATION; INHIBITOR; SER(307); OBESITY	The insulin receptor substrate-1 (IRS1) is phosphorylated on serine 307 (human sequence, corresponding to murine serine 302) in response to insulin as part of a feedback loop that controls IRS1 phosphorylation on tyrosine residues by the insulin receptor. This in turn directly affects downstream signaling and is in human adipocytes implicated in the pathogenesis of insulin resistance and type 2 diabetes. The phosphorylation is inhibited by rapamycin, a specific inhibitor of mammalian target of rapamycin (mTOR) in complex with raptor (mTORC1). The mTORC1-downstream p70 ribosomal protein S6 kinase (S6K1), which is activated by insulin, can phosphorylate IRS1 at serine 307 in vitro and is considered the physiological protein kinase. Because the IRS1 serine 307-kinase catalyzes a critical step in the control of insulin signaling and constitutes a potential target for treatment of insulin resistance, it is important to know whether S6K1 is the physiological serine 307-kinase or not. We report that, by several criteria, S6K1 does not phosphorylate IRS1 at serine 307 in response to insulin in intact human primary adipocytes: (i) The time-courses for phosphorylation of S6K1 and its phosphorylation of S6 are not compatible with the phosphorylation of IRS1 at serine 307; (ii) A dominant-negative construct of S6K1 inhibits the phosphorylation of S6, without effect on the phosphorylation of IRS1 at serine 307; (iii) The specific inhibitor of S6K1 PF-4708671 inhibits the phosphorylation of S6, without effect on phosphorylation of IRS1 at serine 307. mTOR-immunoprecipitates from insulin-stimulated adipocytes contains an unidentified protein kinase specific for phosphorylation of IRS1 at serine 307, but it is not mTOR or S6K1.	[Rajan, Meenu Rohini; Fagerholm, Siri; Jonsson, Cecilia; Kjolhede, Preben; Turkina, Maria V.; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	peter.stralfors@.liu.se		Stralfors, Peter/0000-0002-1196-1806	Swedish Diabetes Fund; Novo Nordic Foundation; University of Linkoping; Swedish Research Council	Swedish Diabetes Fund; Novo Nordic Foundation(Novo Nordisk Foundation); University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Diabetes Fund, Novo Nordic Foundation, University of Linkoping, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Ge YJ, 2011, J BIOL CHEM, V286, P35675, DOI 10.1074/jbc.M111.262881; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Giraud J, 2007, MOL ENDOCRINOL, V21, P2294, DOI 10.1210/me.2007-0159; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Kadowaki T, 2012, CELL, V148, P624, DOI 10.1016/j.cell.2012.01.034; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; Luo ML, 2007, ENDOCRINOLOGY, V148, P4895, DOI 10.1210/en.2007-0049; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Tzatsos A, 2009, J BIOL CHEM, V284, P22525, DOI 10.1074/jbc.M109.027748; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Waraich RS, 2008, J BIOL CHEM, V283, P11226, DOI 10.1074/jbc.M708588200; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	42	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59725	10.1371/journal.pone.0059725	http://dx.doi.org/10.1371/journal.pone.0059725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565163	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300032
J	Hibert, F; Taberlet, P; Chave, J; Scotti-Saintagne, C; Sabatier, D; Richard-Hansen, C				Hibert, Fabrice; Taberlet, Pierre; Chave, Jerome; Scotti-Saintagne, Caroline; Sabatier, Daniel; Richard-Hansen, Cecile			Unveiling the Diet of Elusive Rainforest Herbivores in Next Generation Sequencing Era? The Tapir as a Case Study	PLOS ONE			English	Article							SEED-DISPERSAL; DNA; RECRUITMENT; DIVERSITY; BARCODES; POACHERS; MAMMALS	Characterizing the trophic relationships between large herbivores and the outstanding plant diversity in rainforest is a major challenge because of their elusiveness. This is crucial to understand the role of these herbivores in the functioning of the rainforest ecosystems. We tested a non-invasive approach based on the high-throughput sequencing of environmental samples using small plant plastid sequences (the trnL P6 loop) and ribosomal ITS1 primers, referred to as DNA metabarcoding, to investigate the diet of the largest neotropical herbivore, the lowland tapir. Sequencing was performed on plant DNA extracted from tapir faeces collected at the Nouragues station, a protected area of French Guiana. In spite of a limited sampling, our approach reliably provided information about the lowland tapir's diet at this site. Indeed, 95.1% and 74.4% of the plant families and genera identified thanks to the trnL P6 loop, respectively, matched with taxa already known to be consumed by tapirs. With this approach we were able to show that two families and eight new genera are also consumed by the lowland tapir. The taxonomic resolution of this method is limited to the plant family and genera. Complementary barcodes, such as a small portion of ITS1, can be used to efficiently narrow identifications down to the species in some problematic families. We will discuss the remaining limitations of this approach and how useful it is at this stage to unravel the diet of elusive rainforest herbivores and better understand their role as engineers of the ecosystem.	[Hibert, Fabrice; Richard-Hansen, Cecile] Off Natl Chasse & Faune Sauvage, Direct Etud & Rech, Kourou, French Guiana; [Taberlet, Pierre] Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine, Grenoble, France; [Chave, Jerome] Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Diversite Biol, F-31062 Toulouse, France; [Scotti-Saintagne, Caroline] INRA, UMR 0745, EcoFoG, Kourou, French Guiana; [Sabatier, Daniel] IRD, UMR AMAP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); AgroParisTech; INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Hibert, F (corresponding author), Off Natl Chasse & Faune Sauvage, Direct Etud & Rech, Kourou, French Guiana.	fabricenz@gmail.com	Scotti-Saintagne, Caroline/AAC-1938-2020; Scotti-Saintagne, Caroline/C-3119-2009; Taberlet, Pierre/D-1178-2010	Taberlet, Pierre/0000-0002-3554-5954; Scotti-Saintagne, Caroline/0000-0001-6891-7315; Richard-Hansen, Cecile/0000-0002-9353-791X; Sabatier, Daniel/0000-0003-0883-1530				Alcover JA, 1999, BIOL J LINN SOC, V66, P57, DOI 10.1006/bijl.1998.0260; Baamrane MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035643; BODMER RE, 1991, OECOLOGIA, V85, P361, DOI 10.1007/BF00320611; BONGERS F, 2001, NOURAGUES DYNAMICS P; Bradford MG, 2008, BIOTROPICA, V40, P338, DOI 10.1111/j.1744-7429.2007.00372.x; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DeSantis LG, 2011, BIOTROPICA, V43, P746, DOI 10.1111/j.1744-7429.2011.00761.x; DIRZO R, 1990, CONSERV BIOL, V4, P444, DOI 10.1111/j.1523-1739.1990.tb00320.x; DOLEDEC S, 1987, ACTA OECOL-OEC GEN, V8, P403; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fragoso JMV, 2000, J TROP ECOL, V16, P369, DOI 10.1017/S0266467400001462; Funk V.A., 2007, CONTRIB U S NATL HER, V55, P1; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Henry O, 2000, BIOTROPICA, V32, P364, DOI 10.1646/0006-3606(2000)032[0364:DOTLTT]2.0.CO;2; Hibert F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025850; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lim J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S8; Moran C, 2009, BIOL CONSERV, V142, P541, DOI 10.1016/j.biocon.2008.11.006; MORI SA, 2002, GUIDE VASCULAR PLA 2; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Norden N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001079; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Poncy O, 2001, MONOG BIOL, V80, P31; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; SABATIER D, 1985, REV ECOL-TERRE VIE, V40, P289; Salas LA, 1996, CAN J ZOOL, V74, P1444, DOI 10.1139/z96-159; Shehzad W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032104; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Steinheim G, 2005, J ZOOL, V265, P377, DOI 10.1017/S0952836905006448; Steinmetz R, 2008, BIOTROPICA, V40, P344, DOI 10.1111/j.1744-7429.2007.00367.x; Stoner KE, 2007, BIOTROPICA, V39, P316, DOI 10.1111/j.1744-7429.2007.00292.x; Taber A, 2008, DESTINO ARQUITECTOS; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Tobler M, 2008, THESIS TEXAS A M U; Tobler MW, 2010, BIOTROPICA, V42, P215, DOI 10.1111/j.1744-7429.2009.00549.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Yoccoz NG, 2012, MOL ECOL, V21, DOI [10.1111/j.1365-1294X.2012.05545.x., DOI 10.1111/J.1365-1294X.2012.05545.X]; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	61	44	46	1	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60799	10.1371/journal.pone.0060799	http://dx.doi.org/10.1371/journal.pone.0060799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560107	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900077
J	Zhu, L; You, ZH; Huang, DS; Wang, B				Zhu, Lin; You, Zhu-Hong; Huang, De-Shuang; Wang, Bing			LSE: A Novel Robust Geometric Approach for Modeling Protein-Protein Interaction Networks	PLOS ONE			English	Article							GENERALIZED THERMOSTATISTICS; RELIABILITY; COMPLEXES	Protein-protein interaction (PPI) networks provide insights into understanding of biological processes, function and the underlying complex evolutionary mechanisms of the cell. Modeling PPI network is an important and fundamental problem in system biology, where it is still of major concern to find a better fitting model that requires less structural assumptions and is more robust against the large fraction of noisy PPIs. In this paper, we propose a new approach called t-logistic semantic embedding (t-LSE) to model PPI networks. t-LSE tries to adaptively learn a metric embedding under the simple geometric assumption of PPI networks, and a non-convex cost function was adopted to deal with the noise in PPI networks. The experimental results show the superiority of the fit of t-LSE over other network models to PPI data. Furthermore, the robust loss function adopted here leads to big improvements for dealing with the noise in PPI network. The proposed model could thus facilitate further graph-based studies of PPIs and may help infer the hidden underlying biological knowledge. The Matlab code implementing the proposed method is freely available from the web site: http://home.ustc.edu.cn/similar to yzh33108/PPIModel.htm.	[Zhu, Lin] Chinese Acad Sci, Inst Intelligent Machines, Intelligent Comp Lab, Hefei, Anhui, Peoples R China; [Zhu, Lin] Univ Sci & Technol China, Dept Automat, Hefei 230026, Anhui, Peoples R China; [You, Zhu-Hong] Shenzhen Univ, Coll Comp Sci & Software Engn, Shenzhen, Guangdong, Peoples R China; [Huang, De-Shuang; Wang, Bing] Tongji Univ, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Shenzhen University; Tongji University	Huang, DS (corresponding author), Tongji Univ, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China.	dshuang@tongji.edu.cn	You, Zhu-Hong/A-4056-2011; You, Zhu-Hong/AAI-6862-2020; Wang, Bing/J-7812-2012; WANG, BING/AAF-2747-2020	You, Zhu-Hong/0000-0003-1266-2696; WANG, BING/0000-0003-4945-7725	National Science Foundation of China [61133010, 31071168]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant of the National Science Foundation of China, Nos. 61133010 & 31071168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Brun C, 2003, GENOME BIOL, V5, P6; Cayton L., 2006, P 23 INT C MACH LEAR, P169; Chua HN, 2008, DRUG DISCOV TODAY, V13, P652, DOI 10.1016/j.drudis.2008.05.004; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Ding N, 2011, ADV NEURAL INFORM PR; Ding N, 2010, ADV NEURAL INFORM PR; Fang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019349; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Golub G.H., 1996, MATRIX COMPUTATIONS; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Higham DJ, 2008, BIOINFORMATICS, V24, P1093, DOI 10.1093/bioinformatics/btn079; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Kuchaiev O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P39; Lappe M, 2004, NAT BIOTECHNOL, V22, P98, DOI 10.1038/nbt921; Long PM, 2010, MACH LEARN, V78, P287, DOI 10.1007/s10994-009-5165-z; Mehlhorn K., 1999, LEDA PLATFORM COMBIN; Memisevic V, 2010, J INTEGR BIOINFORM, V7, P120; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milenkovic T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005967; Morrison JL, 2006, BIOINFORMATICS, V22, P2012, DOI 10.1093/bioinformatics/btl338; Naudts J, 2004, PHYSICA A, V340, P32, DOI 10.1016/j.physa.2004.03.074; Naudts J, 2004, PHYSICA A, V332, P279, DOI 10.1016/j.physa.2003.10.013; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Przulj N, 2006, J R SOC INTERFACE, V3, P711, DOI 10.1098/rsif.2006.0147; Przulj N, 2010, BIOCOMPUT-PAC SYM, P178; Reid MD, 2010, J MACH LEARN RES, V11, P2387; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rito T, 2010, BIOINFORMATICS, V26, pi611, DOI 10.1093/bioinformatics/btq386; Saito R, 2003, BIOINFORMATICS, V19, P756, DOI 10.1093/bioinformatics/btg070; Saito R, 2002, NUCLEIC ACIDS RES, V30, P1163, DOI 10.1093/nar/30.5.1163; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu YC, 2007, J AM STAT ASSOC, V102, P974, DOI 10.1198/016214507000000617; You ZH, 2010, BIOINFORMATICS, V26, P2744, DOI 10.1093/bioinformatics/btq510	51	60	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58368	10.1371/journal.pone.0058368	http://dx.doi.org/10.1371/journal.pone.0058368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560036	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900004
J	Sertic, S; Evolvi, C; Tumini, E; Plevani, P; Muzi-Falconi, M; Rotondo, G				Sertic, Sarah; Evolvi, Claudio; Tumini, Emanuela; Plevani, Paolo; Muzi-Falconi, Marco; Rotondo, Giuseppe			Non-Canonical CRL4A/4B(CDT2) Interacts with RAD18 to Modulate Post Replication Repair and Cell Survival	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; DNA-DAMAGE; S-PHASE; COP9 SIGNALOSOME; POSTREPLICATION REPAIR; CDT1 PROTEOLYSIS; PCNA; EXPRESSION; UBIQUITYLATION; OVEREXPRESSION	The Cullin-4(CDT2) E3 ubiquitin ligase plays an essential role in DNA replication origin licensing directing degradation of several licensing factors at the G1/S transition in order to prevent DNA re-replication. Recently a RAD18-independent role of Cullin-4(CDT2) in PCNA monoubiquitylation has been proposed. In an effort to better understand the function of Cullin-4(CDT2) E3 ubiquitin ligase in mammalian Post-Replication Repair during an unperturbed S-phase, we show that down-regulation of Cullin-4(CDT2) leads to two distinguishable independent phenotypes in human cells that unveil at least two independent roles of Cullin-4(CDT2) in S-phase. Apart from the re-replication preventing activity, we identified a non-canonical Cullin-4(CDT2) complex, containing both CUL4A and CUL4B, associated to the COP9 signalosome, that controls a RAD18-dependent damage avoidance pathway essential during an unperturbed S-phase. Indeed, we show that the non-canonical Cullin-4A/4B(CDT2) complex binds to RAD18 and it is required to modulate RAD18 protein levels onto chromatin and the consequent dynamics of PCNA monoubiquitylation during a normal S-phase. This function prevents replication stress, ATR hyper-signaling and, ultimately, apoptosis. A very similar PRR regulatory mechanism has been recently described for Spartan. Our findings uncover a finely regulated process in mammalian cells involving Post-Replication Repair factors, COP9 signalosome and a non-canonical Cullin4-based E3 ligase which is essential to tolerate spontaneous damage and for cell survival during physiological DNA replication.	[Sertic, Sarah; Evolvi, Claudio; Tumini, Emanuela; Plevani, Paolo; Muzi-Falconi, Marco; Rotondo, Giuseppe] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milan	Muzi-Falconi, M (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	marco.muzifalconi@unimi.it; giuseppe.rotondo@unimi.it	Tumini, Emanuela/C-2163-2017; Muzi-Falconi, Marco/A-6035-2012; Sertic, Sarah/AAD-8972-2021	Tumini, Emanuela/0000-0001-9412-9355; Muzi-Falconi, Marco/0000-0001-7046-6090; SERTIC, SARAH/0000-0003-1458-410X; PLEVANI, PAOLO/0000-0003-1869-2626; Rotondo, Giuseppe/0000-0001-7811-1753	AIRC; MIUR; Regione Lombardia and Fondazione Cariplo; Telethon-Italy [GGP11003]	AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia and Fondazione Cariplo; Telethon-Italy(Fondazione Telethon)	This work was supported by grants from AIRC (http://www.airc.it), MIUR, Regione Lombardia and Fondazione Cariplo to P.P. and M.M.-F. The financial support of Telethon-Italy (http://www.telethon.it, grant number GGP11003) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Dohmann EMN, 2008, DEVELOPMENT, V135, P2013, DOI 10.1242/dev.020743; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harari-Steinberg O, 2004, CURR PROTEIN PEPT SC, V5, P185, DOI 10.2174/1389203043379792; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin J, 2012, FRONTIERS ONCOLOGY, V2; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Lee KY, 2008, MOL CELLS, V26, P5; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schmaler T, 2010, SUBCELL BIOCHEM, V54, P57, DOI 10.1007/978-1-4419-6676-6_5; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Truong LN, 2011, J MOL CELL BIOL, V3, P13, DOI 10.1093/jmcb/mjq052; Tumini E, 2011, DNA REPAIR, V10, P149, DOI 10.1016/j.dnarep.2010.10.006; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60000	10.1371/journal.pone.0060000	http://dx.doi.org/10.1371/journal.pone.0060000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555860	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900049
J	Hong, JJ; Amancha, PK; Rogers, K; Ansari, AA; Villinger, F				Hong, Jung Joo; Amancha, Praveen K.; Rogers, Kenneth; Ansari, Aftab A.; Villinger, Francois			Re-Evaluation of PD-1 Expression by T Cells as a Marker for Immune Exhaustion during SIV Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; RHESUS MACAQUE; ACTIVATION; AIDS; HOMEOSTASIS; ANTIGEN; CD4; CYTOKINES; ANTIBODY; LIGANDS	PD-1 expression is generally associated with exhaustion of T cells during chronic viral infections based on the finding that PD-1 expressing cells respond poorly to antigen activation and blockade of PD-1/PD-ligand interaction restores such antigen specific responses in vitro. We tested this hypothesis by examining PD-1 expression on virus-specific CD8 T cells and total T cells in vivo to determine whether PD-1 expression constitutes a reliable marker of immune exhaustion during SIV infection. The expression of PD-1 and Ki67 was monitored longitudinally on T cell subsets in peripheral blood, bone marrow, lymph node and rectal biopsy specimens from rhesus macaques prior to and post infection with pathogenic SIVmac239. During the course of infection, a progressive negative correlation was noted between PD-1 density and Ki67 expression in p11CM(+) CD8(+) T cells, as seen in other studies. However, for total and memory CD4 and CD8 T cells, a positive correlation was observed between PD-1 and Ki67 expression. Thus, while the levels of non-proliferating PD-1(+) p11CM(+) CD8 T cells were markedly elevated with progressing infection, such an increase was not seen on total T cells. In addition, total memory PD1(+) T cells exhibited higher levels of CCR5 than PD-1 2 T cells. Interestingly, few PD-1(+) CD8(+) T cells expressed CCR7 compared to PD-1(+) CD4 T cells and PD-1 2 T cells. In conclusion, overall PD1(+) T cells likely represent a particular differentiation stage or trafficking ability rather than exhaustion and in the context of chronic SIV infection, the level of PD-1 expression by T cells does not by itself serve as a reliable marker for immune exhaustion.	[Ansari, Aftab A.; Villinger, Francois] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Hong, Jung Joo; Amancha, Praveen K.; Rogers, Kenneth; Villinger, Francois] Yerkes Natl Primate Res Ctr, Div Pathol, Atlanta, GA USA	Emory University	Villinger, F (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	fvillin@emory.edu	amancha, praveen kumar/K-3445-2014	amancha, praveen kumar/0000-0001-6466-8112	National Institutes of Health [R01 AI078775, 8R24 OD010947, OD P51 OD11132]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078775] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010947, P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01 AI078775 and 8R24 OD010947 to FV, and OD P51 OD11132 grant to Yerkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berhanu D, 2003, J IMMUNOL METHODS, V279, P199, DOI 10.1016/S0022-1759(03)00186-8; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Centlivre M, 2007, AIDS, V21, P1, DOI 10.1097/QAD.0b013e3280117f7f; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doms RW, 2001, AIDS, V15, pS34, DOI 10.1097/00002030-200102001-00051; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Hokey DA, 2008, EUR J IMMUNOL, V38, P1435, DOI 10.1002/eji.200737857; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Onlamoon N, 2008, IMMUNOLOGY, V124, P277, DOI 10.1111/j.1365-2567.2007.02766.x; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Shedlock DJ, 2010, CYTOM PART A, V77A, P275, DOI 10.1002/cyto.a.20857; Shetty RD, 2012, J CLIN INVEST, V122, P1712, DOI 10.1172/JCI60612; Sina ST, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S7; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Ssewanyana I, 2009, AIDS RES HUM RETROV, V25, P65, DOI 10.1089/aid.2008.0138; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; Tendeiro R, 2012, AIDS, V26, P1065, DOI 10.1097/QAD.0b013e32835374db; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vollbrecht T, 2010, J MED VIROL, V82, P358, DOI 10.1002/jmv.21723; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Yao ZQ, 2007, VIRAL IMMUNOL, V20, P276, DOI 10.1089/vim.2006.0096	41	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60186	10.1371/journal.pone.0060186	http://dx.doi.org/10.1371/journal.pone.0060186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555918	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200094
J	Hussain, AR; Uddin, S; Ahmed, M; Al-Dayel, F; Bavi, PP; Al-Kuraya, KS				Hussain, Azhar R.; Uddin, Shahab; Ahmed, Maqbool; Al-Dayel, Fouad; Bavi, Prashant P.; Al-Kuraya, Khawla S.			Phosphorylated I kappa B alpha Predicts Poor Prognosis in Activated B-Cell Lymphoma and Its Inhibition with Thymoquinone Induces Apoptosis via ROS Release	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; THERAPEUTIC TARGET; GENE-EXPRESSION; DOWN-REGULATION; UP-REGULATION; INDUCTION; CANCER; KINASE; DEATH; CHEMOTHERAPY	Activated B-cell lymphoma (ABC), one of the three subtypes of Diffuse Large B-cell Lymphoma (DLBCL) has the worst survival rate after upfront chemotherapy and is characterized by constitutively activated NF kappa B. We therefore studied the role of NF kappa B In a cohort of clinical DLBCL samples and ABC cell lines. In our clinical tissue microarray cohort of DLBCL samples, p-I kappa B alpha was detected in 38.3% of ABC DLBCL and was an independent prognostic marker for poor survival. In vitro, we found that Thymoquinone (TQ), a natural compound isolated from Nigella sativa caused release of ROS in ABC cells. TQ-mediated release of ROS in turn inhibited NF kappa B activity by dephosphorylating I kappa B alpha and decreased translocation of p65 subunit of NF kappa B in the nuclear compartment in ABC cell lines. This led to inhibition of cell viability and induction of mitochondrial dependent apoptosis in ABC-DLBCL cell lines. Additionally, TQ treatment also caused up-regulation of death receptor 5 (DR5), however, up-regulation of DR5 did not play a role in TQ-induced apoptosis. Finally, combination of suboptimal doses of TQ and TRAIL induced efficient apoptosis in ABC-DLBCL cell lines. These data show that p-I kappa B alpha can be used as a prognostic marker and target for therapy in this aggressive sub-type of DLBCL and TQ may play an important role in the management of DLBCL in the future.	[Hussain, Azhar R.; Uddin, Shahab; Ahmed, Maqbool; Bavi, Prashant P.; Al-Kuraya, Khawla S.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia; [Al-Dayel, Fouad] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia; [Al-Kuraya, Khawla S.] Al Faisal Univ, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University	Al-Kuraya, KS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia.	Kkuraya@kfshrc.edu.sa	Bavi, Prashant/B-2123-2009	Bavi, Prashant/0000-0002-7711-2911; Uddin, Shahab/0000-0003-1886-6710				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; Bavi P, 2008, HUM PATHOL, V39, P885, DOI 10.1016/j.humpath.2007.10.014; Bavi P, 2006, CANCER EPIDEM BIOMAR, V15, P1708, DOI 10.1158/1055-9965.EPI-05-0972; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; Bentink S, 2008, LEUKEMIA, V22, P1746, DOI 10.1038/leu.2008.166; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chou TC, 1984, ADV ENZYME REGUL, V22, P22; Cui Ying, 1999, Zhonghua Zhongliu Zazhi, V21, P217; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; Escalon MP, 2008, EXPERT OPIN PHARMACO, V9, P2247, DOI 10.1517/14656566.9.13.2247 ; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gali-Muhtasib H, 2006, INT J BIOCHEM CELL B, V38, P1249, DOI 10.1016/j.biocel.2005.10.009; Horie S, 2012, KOREAN J UROL, V53, P665, DOI 10.4111/kju.2012.53.10.665; Hussain AR, 2010, CELL PROLIFERAT, V43, P170, DOI 10.1111/j.1365-2184.2009.00662.x; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Hussain AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024703; Hussain AR, 2011, FREE RADICAL BIO MED, V50, P978, DOI 10.1016/j.freeradbiomed.2010.12.034; Hussain AR, 2009, LEUKEMIA LYMPHOMA, V50, P1204, DOI 10.1080/10428190902951799; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Kwon D, 2008, BIOCHEM BIOPH RES CO, V372, P870, DOI 10.1016/j.bbrc.2008.05.148; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Mukhtar E, 2012, CURR DRUG TARGETS; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Patterson BH, 1997, CANCER EPIDEM BIOMAR, V6, P63; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Prasad S, 2010, J BIOL CHEM; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Schiller V, 2013, COMP BIOCHEM PHYS C, V157, P41, DOI 10.1016/j.cbpc.2012.09.005; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Uddin S, 2012, HAEMATOL-HEMATOL J, V97, P1092, DOI 10.3324/haematol.2011.053421; Uddin S, 2009, AM J GASTROENTEROL, V104, P1790, DOI 10.1038/ajg.2009.230; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Wilson-Simpson F, 2007, BIOMED SCI INSTRUM, V43, P378	46	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60540	10.1371/journal.pone.0060540	http://dx.doi.org/10.1371/journal.pone.0060540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555990	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200125
J	Pan, DF; Zhang, SL; Jiang, JC; Jiang, L; Zhang, Q; Liu, JF				Pan, Dunfei; Zhang, Shengli; Jiang, Jicai; Jiang, Li; Zhang, Qin; Liu, JianFeng			Genome-Wide Detection of Selective Signature in Chinese Holstein	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; ARTIFICIAL SELECTION; NATURAL-SELECTION; CATTLE BREEDS; DAIRY-CATTLE; BOS-INDICUS; POLYMORPHISM; TRAITS; TAURUS	Selective signatures in whole genome can help us understand the mechanisms of selection and target causal variants for breeding program. In present study, we performed Extended Haplotype Homozygosity (EHH) tests to identify significant core regions harboring such signals in Chinese Holstein, and then verified the biological significance of these identified regions based on commonly-used bioinformatics analyses. Results showed a total of 125 significant regions in entire genome containing some of important functional genes such as LEP, ABCG2, CSN1S1, CSN3 and TNF based on the Gene Ontology database. Some of these annotated genes involved in the core regions overlapped with those identified in our previous GWAS as well as those involved in a recently constructed candidate gene database for cattle, further indicating these genes under positive selection maybe underlie milk production traits and other important traits in Chinese Holstein. Furthermore, in the enrichment analyses for the second level GO terms and pathways, we observed some significant terms over represented in these identified regions as compared to the entire bovine genome. This indicates that some functional genes associated with milk production traits, as reflected by GO terms, could be clustered in core regions, which provided promising evidence for the exploitability of the core regions identified by EHH tests. Findings in our study could help detect functional candidate genes under positive selection for further genetic and breeding research in Chinese Holstein.	[Pan, Dunfei; Zhang, Shengli; Jiang, Jicai; Jiang, Li; Zhang, Qin; Liu, JianFeng] China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, JF (corresponding author), China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn		Jiang, Li/0000-0002-0648-2173; Liu, Jian-Feng/0000-0002-5766-7864; Jiang, Jicai/0000-0001-6890-7539	National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Natural Science Foundations of China [31272419, 30972092]; Natural Science Foundations of Beijing [6102016]; New-Century Training Program Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Beijing; New-Century Training Program Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors appreciate the financial support provided by the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Natural Science Foundations of China (31272419, 30972092), the Natural Science Foundations of Beijing (6102016), New-Century Training Program Foundation for the Talents by the State Education Commission of China (NETC-10-0783), Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hanni S, 2009, BMC GENOMICS, P10; Harder B, 2006, J ANIM BREED GENET, V123, P89, DOI 10.1111/j.1439-0388.2006.00577.x; HUNTER RA, 1985, BRIT J NUTR, V53, P637, DOI 10.1079/BJN19850073; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kaupe B, 2004, J DAIRY RES, V71, P182, DOI 10.1017/S0022029904000032; LEWONTIN RC, 1973, GENETICS, V74, P175; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Xie HQ, 2002, GENOME RES, V12, P785, DOI 10.1101/gr.86902	26	52	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60440	10.1371/journal.pone.0060440	http://dx.doi.org/10.1371/journal.pone.0060440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555972	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200116
J	Pujol, C; Bratic-Hench, I; Sumakovic, M; Hench, J; Mourier, A; Baumann, L; Pavlenko, V; Trifunovic, A				Pujol, Claire; Bratic-Hench, Ivana; Sumakovic, Marija; Hench, Juergen; Mourier, Arnaud; Baumann, Linda; Pavlenko, Victor; Trifunovic, Aleksandra			Succinate Dehydrogenase Upregulation Destabilize Complex I and Limits the Lifespan of gas-1 Mutant	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ELECTRON-TRANSPORT; MITOCHONDRIAL; SUBUNIT; EXPRESSION; METABOLISM; INHIBITION; MUTATIONS; STRESS; GENES	Many Caenorhabditis elegans mutants with dysfunctional mitochondrial electron transport chain are surprisingly long lived. Both short-lived (gas-1(fc21)) and long-lived (nuo-6(qm200)) mutants of mitochondrial complex I have been identified. However, it is not clear what are the pathways determining the difference in longevity. We show that even in a short-lived gas-1(fc21) mutant, many longevity assurance pathways, shown to be important for lifespan prolongation in long-lived mutants, are active. Beside similar dependence on alternative metabolic pathways, short-lived gas-1(fc21) mutants and long-lived nuo-6(qm200) mutants also activate hypoxia-inducible factor -1 alpha (HIF-1 alpha) stress pathway and mitochondrial unfolded protein response (UPRmt). The major difference that we detected between mutants of different longevity, is in the massive loss of complex I accompanied by upregulation of complex II levels, only in short-lived, gas-1(fc21) mutant. We show that high levels of complex II negatively regulate longevity in gas-1(fc21) mutant by decreasing the stability of complex I. Furthermore, our results demonstrate that increase in complex I stability, improves mitochondrial function and decreases mitochondrial stress, putting it inside a "window'' of mitochondrial dysfunction that allows lifespan prolongation.	[Pujol, Claire; Bratic-Hench, Ivana; Sumakovic, Marija; Baumann, Linda; Pavlenko, Victor; Trifunovic, Aleksandra] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bratic-Hench, Ivana; Trifunovic, Aleksandra] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Hench, Juergen] Univ Basel Hosp, Dept Neuropathol, Inst Pathol, CH-4031 Basel, Switzerland; [Mourier, Arnaud] Max Planck Inst Biol Aging, Cologne, Germany; [Trifunovic, Aleksandra] Ctr Mol Med Cologne, Cologne, Germany	University of Cologne; Karolinska Institutet; University of Basel; Max Planck Society; University of Cologne	Trifunovic, A (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.	aleksandra.trifunovic@uk-koeln.de	MOURIER, Arnaud/F-9657-2019; MOURIER, Arnaud/I-8117-2012	MOURIER, Arnaud/0000-0002-5413-611X; MOURIER, Arnaud/0000-0002-5413-611X	Swedish Research Council [K2006-03P-20237-01-4]; Cluster of Excellence: Cellular Stress Responses in Ageing-Associated Diseases (CECAD) via the DFG within the Excellence Initiative; German federal government; state government	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cluster of Excellence: Cellular Stress Responses in Ageing-Associated Diseases (CECAD) via the DFG within the Excellence Initiative; German federal government; state government	This work was supported by a grant from Swedish Research Council (K2006-03P-20237-01-4) and funding under the Cluster of Excellence: Cellular Stress Responses in Ageing-Associated Diseases (CECAD) via the DFG within the Excellence Initiative by the German federal and state governments to promote top-level research at German Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bianchi Laura, 2006, WormBook, P1; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Genova ML, 2005, BIOFACTORS, V25, P5, DOI 10.1002/biof.5520250103; GOLDBERG GS, 1993, GENE, V133, P233, DOI 10.1016/0378-1119(93)90644-I; Grad LI, 2006, BBA-BIOENERGETICS, V1757, P115, DOI 10.1016/j.bbabio.2005.11.009; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Hench J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028417; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kondo M, 2005, MECH AGEING DEV, V126, P637, DOI 10.1016/j.mad.2004.11.011; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; KURAMOCHI T, 1994, MOL BIOCHEM PARASIT, V68, P177, DOI 10.1016/0166-6851(94)90163-5; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Steinberg TH, 2009, METHOD ENZYMOL, V463, P541, DOI 10.1016/S0076-6879(09)63031-7; Stiernagle Theresa, 2006, WormBook, P1; Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232; van den Ecker D, 2010, ANAL BIOCHEM, V407, P287, DOI 10.1016/j.ab.2010.08.009; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	47	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59493	10.1371/journal.pone.0059493	http://dx.doi.org/10.1371/journal.pone.0059493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555681	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200022
J	Xiao, CL; Zhang, L				Xiao, Chengli; Zhang, Lei			Egocentric Representation Acquired from Offline Map Learning	PLOS ONE			English	Article							SPATIAL REPRESENTATIONS; TO-OBJECT; KNOWLEDGE; MEMORY; ENVIRONMENT; NAVIGATION; SYSTEMS; ERRORS; FRAMES	It is widely accepted that people establish allocentric spatial representation after learning a map. However, it is unknown whether people can directly acquire egocentric representation after map learning. In two experiments, the participants learned a distal environment through a map and then performed the egocentric pointing tasks in that environment under three conditions: with the heading aligned with the learning perspective (baseline), after 240 degrees rotation from the baseline (updating), and after disorientation (disorientation). Disorientation disrupted the internal consistency of pointing among objects when the participants learned the sequentially displayed map, on which only one object name was displayed at a time while the location of "self'' remained on the screen all the time. However, disorientation did not affect the internal consistency of pointing among objects when the participants learned the simultaneously displayed map. These results suggest that the egocentric representation can be acquired from a sequentially presented map.	[Xiao, Chengli; Zhang, Lei] Nanjing Univ, Dept Psychol, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Lei] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	Nanjing University; University of Alberta	Xiao, CL (corresponding author), Nanjing Univ, Dept Psychol, Nanjing 210008, Jiangsu, Peoples R China.	xiaocl@nju.edu.cn		Xiao, Chengli/0000-0002-5195-6446	National Natural Science Foundation of China [31000457]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Preparation of this article and the research reported in it were supported by grant 31000457 from the National Natural Science Foundation of China to CX (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraamides MN, 2008, COGN PROCESS, V9, P93, DOI 10.1007/s10339-007-0188-5; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Coluccia E, 2008, APPL COGNITIVE PSYCH, V22, P217, DOI 10.1002/acp.1357; Holmes MC, 2005, J EXP PSYCHOL LEARN, V31, P1069, DOI 10.1037/0278-7393.31.5.1069; Howell D, 2002, STAT METHODS PSYCHOL; Kelly JW, 2007, J EXP PSYCHOL LEARN, V33, P1092, DOI 10.1037/0278-7393.33.6.1092; Lafon M, 2009, EXP BRAIN RES, V194, P541, DOI 10.1007/s00221-009-1728-2; MAY M, 1995, ECOL PSYCHOL, V7, P21, DOI 10.1207/s15326969eco0701_2; May M, 2007, PSYCHOL RES-PSYCH FO, V71, P277, DOI 10.1007/s00426-006-0083-1; Mou WM, 2006, J EXP PSYCHOL LEARN, V32, P1274, DOI 10.1037/0278-7393.32.6.1274; Mou WM, 2008, COGNITION, V106, P750, DOI 10.1016/j.cognition.2007.04.009; Nori R, 2003, PERCEPTION, V32, P307, DOI 10.1068/p3380; POMERANTZ JR, 1989, J EXP PSYCHOL HUMAN, V15, P635, DOI 10.1037/0096-1523.15.4.635; PRESSON CC, 1984, J EXP PSYCHOL LEARN, V10, P716, DOI 10.1037/0278-7393.10.4.716; Rao JS., 2001, TOPICS CIRCULAR STAT; Richardson AE, 1999, MEM COGNITION, V27, P741, DOI 10.3758/BF03211566; Sargent J, 2010, J EXP PSYCHOL LEARN, V36, P576, DOI 10.1037/a0017528; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Shelton AL, 2010, J EXP PSYCHOL LEARN, V36, P686, DOI 10.1037/a0018713; Sholl M. J., 1999, SPAT COGN COMPUT, V1, P475, DOI DOI 10.1023/A:1010047911951; Taylor HA, 1999, MEM COGNITION, V27, P309, DOI 10.3758/BF03211414; THORNDYKE PW, 1982, COGNITIVE PSYCHOL, V14, P560, DOI 10.1016/0010-0285(82)90019-6; Waller D, 2006, J EXP PSYCHOL LEARN, V32, P867, DOI 10.1037/0278-7393.32.4.867; Wang RF, 2012, PSYCHON B REV, V19, P575, DOI 10.3758/s13423-012-0258-2; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Wang RXF, 2003, J EXP PSYCHOL LEARN, V29, P398, DOI 10.1037/0278-7393.29.3.398; Xiao CL, 2009, J EXP PSYCHOL LEARN, V35, P1137, DOI 10.1037/a0016273	27	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60194	10.1371/journal.pone.0060194	http://dx.doi.org/10.1371/journal.pone.0060194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555922	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200095
J	Dornieden, S; Muller-Schiffmann, A; Sticht, H; Jiang, N; Cinar, Y; Wordehoff, M; Korth, C; Funke, SA; Willbold, D				Dornieden, Silke; Mueller-Schiffmann, Andreas; Sticht, Heinrich; Jiang, Nan; Cinar, Yeliz; Woerdehoff, Michael; Korth, Carsten; Funke, Susanne Aileen; Willbold, Dieter			Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Ab: A Biotechnical Tool for Studies on Alzheimer's Disease?	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; PRECURSOR PROTEIN; FV ANTIBODY; OLIGOMERS; AGGREGATION; STRATEGIES; IMMUNOTHERAPY; PATHOLOGY	Alzheimer's disease (AD) is a progressive neurodegenerative disorder with devastating effects. Currently, therapeutic options are limited to symptomatic treatment. For more than a decade, research focused on immunotherapy for the causal treatment of AD. However, clinical trials with active immunization using A beta encountered severe complications, for example meningoencephalitis. Consequently, attention focused on passive immunization using antibodies. As an alternative to large immunoglobulins (IgGs), A beta binding single-chain variable fragments (scFvs) were used for diagnostic and therapeutic research approaches. scFvs can be expressed in E. coli and may provide improved pharmacokinetic properties like increased blood-brain barrier permeability or reduced side-effects in vivo. In this study, we constructed an scFv from an A beta binding IgG, designated IC16, which binds the N-terminal region of A beta (A beta(1-8)). scFv-IC16 was expressed in E. coli, purified and characterized with respect to its interaction with different A beta species and its influence on A beta fibril formation. We were able to show that scFv-IC16 strongly influenced the aggregation behavior of A beta and could be applied as an A beta detection probe for plaque staining in the brains of transgenic AD model mice. The results indicate potential for therapy and diagnosis of AD.	[Dornieden, Silke; Jiang, Nan; Cinar, Yeliz; Funke, Susanne Aileen; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Mueller-Schiffmann, Andreas; Korth, Carsten] Univ Dusseldorf, Inst Neuropathol, D-40225 Dusseldorf, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Funke, Susanne Aileen] Hsch Angew Wissensch, Coburg, Germany; [Woerdehoff, Michael; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Woerdehoff, Michael; Willbold, Dieter] Univ Dusseldorf, BMFZ, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; University of Erlangen Nuremberg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Funke, SA (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany.	a.funke@fz-juelich.de	Willbold, Dieter/A-6280-2013; JIANG, NAN/AHB-1945-2022; Wördehoff, Michael MW/N-7271-2016; Funke, Susanne/A-1460-2015	Willbold, Dieter/0000-0002-0065-7366; Wördehoff, Michael MW/0000-0002-1591-0168; Sticht, Heinrich/0000-0001-5644-045X	International Helmholtz Research School on Biophysics and Soft Matter (BioSoft); EU-FP7 grant PRIORITY; KNDD/rpAD [BMBF 01ED1201B]	International Helmholtz Research School on Biophysics and Soft Matter (BioSoft); EU-FP7 grant PRIORITY; KNDD/rpAD	SD was supported by a fellowship of the International Helmholtz Research School on Biophysics and Soft Matter (BioSoft) granted to DW. CK was supported by EU-FP7 grant PRIORITY. SAF, CK and DW were supported by a grant from the KNDD/rpAD (BMBF 01ED1201B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cai J, 2003, NEUROREPORT, V14, P265, DOI 10.1097/00001756-200302100-00022; Callaway E, 2012, NATURE, V489, P13, DOI 10.1038/489013a; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Gardberg A, 2009, BIOCHEMISTRY-US, V48, P5210, DOI 10.1021/bi9001216; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Haas C, 2012, J ALZHEIMERS DIS, V28, P241, DOI 10.3233/JAD-2011-110986; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HSU E, 1992, CURR OPIN STRUC BIOL, V2, P422; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim S, 2007, APPL MICROBIOL BIOT, V77, P99, DOI 10.1007/s00253-007-1133-3; Klaver AC, 2010, J NEUROSCI METH, V187, P263, DOI 10.1016/j.jneumeth.2010.01.018; Klaver AC, 2010, INT IMMUNOPHARMACOL, V10, P115, DOI 10.1016/j.intimp.2009.10.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Leliveld SR, 2008, BIOCHEMISTRY-US, V47, P6267, DOI 10.1021/bi800253c; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lichtlen P, 2008, J NEUROCHEM, V104, P859, DOI 10.1111/j.1471-4159.2007.05064.x; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Muller-Schiffmann A, 2010, ANGEW CHEM INT EDIT, V49, P8743, DOI 10.1002/anie.201004437; Mueller-Schiffmann A, 2009, MOL IMMUNOL, V46, P532, DOI 10.1016/j.molimm.2008.07.023; Nordberg A, 2008, NEUROPSYCHOLOGIA, V46, P1636, DOI 10.1016/j.neuropsychologia.2008.03.020; Nordberg A, 2007, CURR OPIN NEUROL, V20, P398, DOI 10.1097/WCO.0b013e3281a47744; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puzzo D, 2012, J ALZHEIMERS DIS; Robert R, 2009, PROTEIN ENG DES SEL, V22, P199, DOI 10.1093/protein/gzn052; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sohn JH, 2007, BIOCHEM BIOPH RES CO, V361, P800, DOI 10.1016/j.bbrc.2007.07.107; Solorzano-Vargas RS, 2008, MOL IMMUNOL, V45, P881, DOI 10.1016/j.molimm.2007.08.008; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Valadon P, 2006, P NATL ACAD SCI USA, V103, P407, DOI 10.1073/pnas.0506938103; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang YJ, 2010, J ALZHEIMERS DIS, V21, P1065, DOI 10.3233/JAD-2010-100195; Wang YJ, 2010, BRAIN BEHAV IMMUN, V24, P1281, DOI 10.1016/j.bbi.2010.05.010; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004	55	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59820	10.1371/journal.pone.0059820	http://dx.doi.org/10.1371/journal.pone.0059820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555792	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500095
J	Dyment, NA; Liu, CF; Kazemi, N; Aschbacher-Smith, LE; Kenter, K; Breidenbach, AP; Shearn, JT; Wylie, C; Rowe, DW; Butler, DL				Dyment, Nathaniel A.; Liu, Chia-Feng; Kazemi, Namdar; Aschbacher-Smith, Lindsey E.; Kenter, Keith; Breidenbach, Andrew P.; Shearn, Jason T.; Wylie, Christopher; Rowe, David W.; Butler, David L.			The Paratenon Contributes to Scleraxis-Expressing Cells during Patellar Tendon Healing	PLOS ONE			English	Article							GENE-EXPRESSION; REPAIR; INJURY; DIFFERENTIATION; TENDINOPATHY; STIMULATION; REPORTERS; EGR-1	The origin of cells that contribute to tendon healing, specifically extrinsic epitenon/paratenon cells vs. internal tendon fibroblasts, is still debated. The purpose of this study is to determine the location and phenotype of cells that contribute to healing of a central patellar tendon defect injury in the mouse. Normal adult patellar tendon consists of scleraxis-expressing (Scx) tendon fibroblasts situated among aligned collagen fibrils. The tendon body is surrounded by paratenon, which consists of a thin layer of cells that do not express Scx and collagen fibers oriented circumferentially around the tendon. At 3 days following injury, the paratenon thickens as cells within the paratenon proliferate and begin producing tenascin-C and fibromodulin. These cells migrate toward the defect site and express scleraxis and smooth muscle actin alpha by day 7. The thickened paratenon tissue eventually bridges the tendon defect by day 14. Similarly, cells within the periphery of the adjacent tendon struts express these markers and become disorganized. Cells within the defect region show increased expression of fibrillar collagens (Col1a1 and Col3a1) but decreased expression of tenogenic transcription factors (scleraxis and mohawk homeobox) and collagen assembly genes (fibromodulin and decorin). By contrast, early growth response 1 and 2 are upregulated in these tissues along with tenascin-C. These results suggest that paratenon cells, which normally do not express Scx, respond to injury by turning on Scx and assembling matrix to bridge the defect. Future studies are needed to determine the signaling pathways that drive these cells and whether they are capable of producing a functional tendon matrix. Understanding this process may guide tissue engineering strategies in the future by stimulating these cells to improve tendon repair.	[Dyment, Nathaniel A.; Rowe, David W.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Coll Dent Med, Farmington, CT 06032 USA; [Liu, Chia-Feng; Aschbacher-Smith, Lindsey E.; Wylie, Christopher] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Kazemi, Namdar; Kenter, Keith] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Breidenbach, Andrew P.; Shearn, Jason T.; Butler, David L.] Univ Cincinnati, Biomed Engn Program, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA	University of Connecticut; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Dyment, NA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Coll Dent Med, Farmington, CT 06032 USA.	dyment@uchc.edu	Dyment, Nathaniel/AAD-6747-2021	Dyment, Nathaniel/0000-0001-8708-112X	National Institutes of Health [AR56943-03, AR46574-10]; NIAMS [AR054713-05]; NIDCR [5T90DE021989-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046574, R01AR056943, R01AR054713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by National Institutes of Health grants AR56943-03, AR46574-10, and AR054713-05 from NIAMS and 5T90DE021989-01 from NIDCR (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge HL, 2011, ANN BIOMED ENG, V39, P1904, DOI 10.1007/s10439-011-0299-0; Bhattacharyya S, 2011, MATRIX BIOL, V30, P235, DOI 10.1016/j.matbio.2011.03.005; Braddock M, 2001, ANN MED, V33, P313, DOI 10.3109/07853890109002083; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chokalingam K, 2009, TISSUE ENG PT A, V15, P2561, DOI [10.1089/ten.tea.2008.0451, 10.1089/ten.TEA.2008.0451]; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Gott M, 2011, DISCOV MED, V11, P75; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kimura W, 2011, GENESIS, V49, P2, DOI 10.1002/dvg.20688; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Liu CF, 2012, TISSUE ENG PT A, V18, P598, DOI [10.1089/ten.tea.2011.0338, 10.1089/ten.TEA.2011.0338]; Liu CF, 2011, TISSUE ENG PART B-RE, V17, P165, DOI 10.1089/ten.teb.2010.0662; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.tea.2012.0182, 10.1089/ten.TEA.2012.0182]; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Praemer A., 1992, MUSCULOSKELETAL COND, P143; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; Tan Q, 2012, TISSUE ENG PT A, V18, P840, DOI [10.1089/ten.tea.2011.0362, 10.1089/ten.TEA.2011.0362]; Ushiku C, 2010, J ORTHOP RES, V28, P1338, DOI 10.1002/jor.21105; Webborn ADJ, 2008, DISABIL REHABIL, V30, P1572, DOI 10.1080/09638280701786377	32	82	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59944	10.1371/journal.pone.0059944	http://dx.doi.org/10.1371/journal.pone.0059944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555841	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500106
J	Chen, PK; Chang, HH; Lin, GL; Wang, TP; Lai, YL; Lin, TK; Hsieh, MC; Kau, JH; Huang, HH; Hsu, HL; Liao, CY; Sun, DS				Chen, Po-Kong; Chang, Hsin-Hou; Lin, Guan-Ling; Wang, Tsung-Pao; Lai, Yi-Ling; Lin, Ting-Kai; Hsieh, Ming-Chun; Kau, Jyh-Hwa; Huang, Hsin-Hsien; Hsu, Hui-Ling; Liao, Chi-Yuan; Sun, Der-Shan			Suppressive Effects of Anthrax Lethal Toxin on Megakaryopoiesis	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; THROMBOCYTOPENIC PURPURA; MEGAKARYOCYTE GROWTH; PLATELET ACTIVATION; MPL-LIGAND; THROMBOPOIETIN; APOPTOSIS; MODEL; P38; DIFFERENTIATION	Anthrax lethal toxin (LT) is a major virulence factor of Bacillus anthracis. LT challenge suppresses platelet counts and platelet function in mice, however, the mechanism responsible for thrombocytopenia remains unclear. LT inhibits cellular mitogen-activated protein kinases (MAPKs), which are vital pathways responsible for cell survival, differentiation, and maturation. One of the MAPKs, the MEK1/2-extracellular signal-regulated kinase pathway, is particularly important in megakaryopoiesis. This study evaluates the hypothesis that LT may suppress the progenitor cells of platelets, thereby inducing thrombocytopenic responses. Using cord blood-derived CD34(+) cells and mouse bone marrow mononuclear cells to perform in vitro differentiation, this work shows that LT suppresses megakaryopoiesis by reducing the survival of megakaryocytes. Thrombopoietin treatments can reduce thrombocytopenia, megakaryocytic suppression, and the quick onset of lethality in LT-challenged mice. These results suggest that megakaryocytic suppression is one of the mechanisms by which LT induces thrombocytopenia. These findings may provide new insights for developing feasible approaches against anthrax.	[Chang, Hsin-Hou; Wang, Tsung-Pao; Lai, Yi-Ling; Lin, Ting-Kai; Hsieh, Ming-Chun; Sun, Der-Shan] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chen, Po-Kong; Chang, Hsin-Hou; Lin, Guan-Ling; Sun, Der-Shan] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Kau, Jyh-Hwa] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Huang, Hsin-Hsien; Hsu, Hui-Ling] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Liao, Chi-Yuan] Mennonite Christian Hosp, Dept Obstet & Gynecol, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Defense Medical Center; National Defense Medical Center	Sun, DS (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	dssun@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	Tzu-Chi University [TCMRC911002, TCIRP98001, TCRPP100003]; National Science Council, Taiwan [NSC 95-2311-B-320-006, NSC 96-2311-B-320-005-MY3, NSC 99-2311-B-320-003-MY3]	Tzu-Chi University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Tzu-Chi University (http://www.tcu.edu.tw/) (TCMRC911002, TCIRP98001, TCRPP100003) and National Science Council, Taiwan (http://web1.nsc.gov.tw/mp.aspx) (NSC 95-2311-B-320-006, NSC 96-2311-B-320-005-MY3, and NSC 99-2311-B-320-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abushullaih BA, 2001, EXP HEMATOL, V29, P1425, DOI 10.1016/S0301-472X(01)00748-2; Apostolidis PA, 2012, EXP HEMATOL, V40, P131, DOI 10.1016/j.exphem.2011.10.006; Baker GR, 1997, AM J HEMATOL, V56, P17; Bakhshi T, 2008, TRANSFUSION, V48, P2638, DOI 10.1111/j.1537-2995.2008.01926.x; Banks David J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010714; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Chauncey KM, 2012, J INFECT DIS, V205, P453, DOI 10.1093/infdis/jir763; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chung MC, 2008, FEMS IMMUNOL MED MIC, V54, P309, DOI 10.1111/j.1574-695X.2008.00480.x; Cortin Valerie, 2009, V482, P109, DOI 10.1007/978-1-59745-060-7_7; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619; DEBILI N, 1995, BLOOD, V86, P2516; Dominguez V, 2003, HAEMATOLOGICA, V88, P679; EBBE S, 1965, BLOOD-J HEMATOL, V26, P20, DOI 10.1182/blood.V26.1.20.20; Freedman A, 2002, JAMA-J AM MED ASSOC, V287, P869, DOI 10.1001/jama.287.7.869; Fuhrken PG, 2008, J BIOL CHEM, V283, P15589, DOI 10.1074/jbc.M801923200; Geddis AE, 2011, PEDIATR BLOOD CANCER, V57, P199, DOI 10.1002/pbc.22927; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; HARKER LA, 1969, J CLIN INVEST, V48, P963, DOI 10.1172/JCI106077; Herodin F, 2003, BLOOD, V101, P2609, DOI 10.1182/blood-2002-06-1634; Huang HS, 2010, BLOOD, V116, P5002, DOI 10.1182/blood-2010-03-275123; Inagaki K, 2004, BLOOD, V104, P58, DOI 10.1182/blood-2003-10-3623; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-98; Kau JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014289; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Kuter DJ, 2009, ANNU REV MED, V60, P193, DOI 10.1146/annurev.med.60.042307.181154; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Mantysaari M, 2011, AVIAT SPACE ENVIR MD, V82, P699, DOI 10.3357/ASEM.3012.2011; Mina B, 2002, JAMA-J AM MED ASSOC, V287, P858, DOI 10.1001/jama.287.7.858; Miyazaki R, 2001, ANN HEMATOL, V80, P284, DOI 10.1007/s002770000285; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; PINTADO CO, 1995, VET IMMUNOL IMMUNOP, V44, P359, DOI 10.1016/0165-2427(94)05310-O; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Rameshwar P, 2012, CYTOKINE, V57, P143, DOI 10.1016/j.cyto.2011.10.013; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Rebuck JW, 1961, BLOOD PLATELETS, P595; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x; Shcherbina A, 1999, BLOOD, V93, P4222, DOI 10.1182/blood.V93.12.4222.412k34_4222_4231; Shibuya K, 2002, EXP HEMATOL, V30, P1185, DOI 10.1016/S0301-472X(02)00898-6; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Sun DS, 2003, CELL BIOL INT, V27, P769, DOI 10.1016/S1065-6995(03)00165-3; ten Cate H, 2003, PATHOPHYSIOL HAEMO T, V33, P413, DOI 10.1159/000083838; TOMER A, 1987, BLOOD, V70, P1735; von Kanel R, 2003, CHEST, V124, P1956, DOI 10.1378/chest.124.5.1956; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Yao CL, 2003, ENZYME MICROB TECH, V33, P343, DOI 10.1016/S0141-0229(03)00144-3; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Yu M, 2012, METHODS MOL BIOL, V788, P291, DOI 10.1007/978-1-61779-307-3_20; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	69	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59512	10.1371/journal.pone.0059512	http://dx.doi.org/10.1371/journal.pone.0059512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555687	Green Submitted, gold, Green Published			2022-12-27	WOS:000316546400046
J	Munshi, T; Gupta, A; Evangelopoulos, D; Guzman, JD; Gibbons, S; Keep, NH; Bhakta, S				Munshi, Tulika; Gupta, Antima; Evangelopoulos, Dimitrios; Guzman, Juan David; Gibbons, Simon; Keep, Nicholas H.; Bhakta, Sanjib			Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis	PLOS ONE			English	Article							DIPHOSPHATE-N-ACETYLMURAMATE; SER/THR PROTEIN-KINASES; L-ALANINE LIGASE; D-GLUTAMATE; SERINE/THREONINE KINASE; PSEUDOMONAS-AERUGINOSA; OVER-PRODUCTION; DIVISION GENE; PURIFICATION; ENZYME	ATP-dependent Mur ligases (Mur synthetases) play essential roles in the biosynthesis of cell wall peptidoglycan (PG) as they catalyze the ligation of key amino acid residues to the stem peptide at the expense of ATP hydrolysis, thus representing potential targets for antibacterial drug discovery. In this study we characterized the division/cell wall (dcw) operon and identified a promoter driving the co-transcription of mur synthetases along with key cell division genes such as ftsQ and ftsW. Furthermore, we have extended our previous investigations of MurE to MurC, MurD and MurF synthetases from Mycobacterium tuberculosis. Functional analyses of the pure recombinant enzymes revealed that the presence of divalent cations is an absolute requirement for their activities. We also observed that higher concentrations of ATP and UDP-sugar substrates were inhibitory for the activities of all Mur synthetases suggesting stringent control of the cytoplasmic steps of the peptidoglycan biosynthetic pathway. In line with the previous findings on the regulation of mycobacterial MurD and corynebacterial MurC synthetases via phosphorylation, we found that all of the Mur synthetases interacted with the Ser/Thr protein kinases, PknA and PknB. In addition, we critically analyzed the interaction network of all of the Mur synthetases with proteins involved in cell division and cell wall PG biosynthesis to re-evaluate the importance of these key enzymes as novel therapeutic targets in anti-tubercular drug discovery.	[Munshi, Tulika; Gupta, Antima; Evangelopoulos, Dimitrios; Guzman, Juan David; Keep, Nicholas H.; Bhakta, Sanjib] Univ London, Dept Biol Sci, Inst Struct & Mol Biol, London, England; [Guzman, Juan David; Gibbons, Simon] UCL Sch Pharm, Dept Pharmaceut & Biol Chem, London, England	University of London; Birkbeck University London; University of London; University College London	Bhakta, S (corresponding author), Univ London, Dept Biol Sci, Inst Struct & Mol Biol, London, England.	s.bhakta@bbk.ac.uk	Keep, Nicholas/R-3493-2019; Evangelopoulos, Dimitrios/F-8251-2013; Guzman, Juan/B-1585-2013; Keep, N/C-2759-2008	Keep, Nicholas/0000-0002-5042-1837; Evangelopoulos, Dimitrios/0000-0003-0472-7576; Guzman, Juan/0000-0003-4120-9065; Keep, N/0000-0002-5042-1837; Gibbons, Simon/0000-0003-1587-6809	Medical Research Council, UK [G0801956]; Biotechnology and Biological Sciences Research Council [BB/F011148/1] Funding Source: researchfish; Medical Research Council [G0802079, G0801956] Funding Source: researchfish; BBSRC [BB/F011148/1] Funding Source: UKRI; MRC [G0801956, G0802079] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the Medical Research Council, UK (www.mrc.ac.uk) for a New Investigators Research Grant award to SB (Grant Code: G0801956). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Azzolina BA, 2001, PROTEIN EXPRES PURIF, V21, P393, DOI 10.1006/prep.2001.1390; Bannantine JP, 1997, MICROBIOL-UK, V143, P921, DOI 10.1099/00221287-143-3-921; Barreteau H, 2012, BIOCHEM PHARMACOL, V84, P625, DOI 10.1016/j.bcp.2012.06.006; Basavannacharya C, 2010, PROTEIN CELL, V1, P1011, DOI 10.1007/s13238-010-0132-9; Basavannacharya C, 2010, TUBERCULOSIS, V90, P16, DOI 10.1016/j.tube.2009.10.007; Bertrand JA, 1999, J MOL BIOL, V289, P579, DOI 10.1006/jmbi.1999.2800; Boniface A, 2006, J BIOL CHEM, V281, P15680, DOI 10.1074/jbc.M506311200; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; DUNCAN K, 1990, BIOCHEMISTRY-US, V29, P2379, DOI 10.1021/bi00461a023; Emanuele JJ, 1996, PROTEIN SCI, V5, P2566, DOI 10.1002/pro.5560051219; Feng ZY, 2003, ANTIMICROB AGENTS CH, V47, P283, DOI 10.1128/AAC.47.1.283-291.2003; Fiuza M, 2008, J BIOL CHEM, V283, P36553, DOI 10.1074/jbc.M807175200; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Gupta A, 2009, J ANTIMICROB CHEMOTH, V64, P774, DOI 10.1093/jac/dkp279; Guzman JD, 2010, J ANTIMICROB CHEMOTH, V65, P2101, DOI 10.1093/jac/dkq313; Guzman JD, 2011, J ANTIMICROB CHEMOTH, V66, P1766, DOI 10.1093/jac/dkr203; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Hesse L, 2003, J BACTERIOL, V185, P6507, DOI 10.1128/JB.185.22.6507-6512.2003; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; LIGER D, 1995, EUR J BIOCHEM, V230, P80, DOI 10.1111/j.1432-1033.1995.0080i.x; Mahapatra S, 2005, J BACTERIOL, V187, P2747, DOI 10.1128/JB.187.8.2747-2757.2005; Mahapatra S, 2000, J BACTERIOL, V182, P6827, DOI 10.1128/JB.182.23.6827-6830.2000; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; MIZUNO Y, 1968, J BIOL CHEM, V243, P2665; MIZUNO Y, 1973, J BIOCHEM-TOKYO, V74, P525, DOI 10.1093/oxfordjournals.jbchem.a130273; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Mulder MA, 1997, TUBERCLE LUNG DIS, V78, P211, DOI 10.1016/S0962-8479(97)90001-0; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Osman K, 2012, INT J ANTIMICROB AG, V39, P124, DOI 10.1016/j.ijantimicag.2011.09.018; Paradis-Bleau C, 2009, BIOCHEM J, V421, P263, DOI 10.1042/BJ20081395; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Patin D, 2010, BIOCHIMIE, V92, P1793, DOI 10.1016/j.biochi.2010.07.009; PRATVIELSOSA F, 1991, EUR J BIOCHEM, V202, P1169, DOI 10.1111/j.1432-1033.1991.tb16486.x; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Raymond JB, 2005, J BIOL CHEM, V280, P326, DOI 10.1074/jbc.M411006200; Roy S, 2005, J BACTERIOL, V187, P2540, DOI 10.1128/JB.187.7.2540-2550.2005; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Sengupta S, 2008, MICROBIOL-SGM, V154, P2796, DOI 10.1099/mic.0.2008/020933-0; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Smith CA, 2006, J MOL BIOL, V362, P640, DOI 10.1016/j.jmb.2006.07.066; Tamames J, 2004, BACTERIAL DCW GENE C; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Usha V, 2006, FEMS MICROBIOL LETT, V262, P39, DOI 10.1111/j.1574-6968.2006.00356.x; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Walsh AW, 1999, J BACTERIOL, V181, P5395, DOI 10.1128/JB.181.17.5395-5401.1999; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; WHO, 2012, GLOB TUB CONTR	66	56	57	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60143	10.1371/journal.pone.0060143	http://dx.doi.org/10.1371/journal.pone.0060143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555903	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400081
J	Billot, C; Ramu, P; Bouchet, S; Chantereau, J; Deu, M; Gardes, L; Noyer, JL; Rami, JF; Rivallan, R; Li, Y; Lu, P; Wang, TY; Folkertsma, RT; Arnaud, E; Upadhyaya, HD; Glaszmann, JC; Hash, CT				Billot, Claire; Ramu, Punna; Bouchet, Sophie; Chantereau, Jacques; Deu, Monique; Gardes, Laetitia; Noyer, Jean-Louis; Rami, Jean-Francois; Rivallan, Ronan; Li, Yu; Lu, Ping; Wang, Tianyu; Folkertsma, Rolf T.; Arnaud, Elizabeth; Upadhyaya, Hari D.; Glaszmann, Jean-Christophe; Hash, C. Thomas			Massive Sorghum Collection Genotyped with SSR Markers to Enhance Use of Global Genetic Resources	PLOS ONE			English	Article							RFLP LINKAGE MAP; POPULATION-STRUCTURE; CORE COLLECTION; DIVERSITY; WILD; CONSTRUCTION; GENOME; CLASSIFICATION; LANDRACES; GERMPLASM	Large ex situ collections require approaches for sampling manageable amounts of germplasm for in-depth characterization and use. We present here a large diversity survey in sorghum with 3367 accessions and 41 reference nuclear SSR markers. Of 19 alleles on average per locus, the largest numbers of alleles were concentrated in central and eastern Africa. Cultivated sorghum appeared structured according to geographic regions and race within region. A total of 13 groups of variable size were distinguished. The peripheral groups in western Africa, southern Africa and eastern Asia were the most homogeneous and clearly differentiated. Except for Kafir, there was little correspondence between races and marker-based groups. Bicolor, Caudatum, Durra and Guinea types were each dispersed in three groups or more. Races should therefore better be referred to as morphotypes. Wild and weedy accessions were very diverse and scattered among cultivated samples, reinforcing the idea that large gene-flow exists between the different compartments. Our study provides an entry to global sorghum germplasm collections. Our reference marker kit can serve to aggregate additional studies and enhance international collaboration. We propose a core reference set in order to facilitate integrated phenotyping experiments towards refined functional understanding of sorghum diversity.	[Billot, Claire; Bouchet, Sophie; Chantereau, Jacques; Deu, Monique; Gardes, Laetitia; Noyer, Jean-Louis; Rami, Jean-Francois; Rivallan, Ronan; Glaszmann, Jean-Christophe] Cirad, UMR AGAP, Montpellier, France; [Ramu, Punna; Folkertsma, Rolf T.; Upadhyaya, Hari D.; Hash, C. Thomas] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Li, Yu; Lu, Ping; Wang, Tianyu] Chinese Acad Agr Sci CAAS, Inst Crop Sci, Beijing, Peoples R China; [Arnaud, Elizabeth] Biovers Int, Montpellier, France	CIRAD; Universite de Montpellier; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Alliance; Bioversity International	Billot, C (corresponding author), Cirad, UMR AGAP, Montpellier, France.	claire.billot@cirad.fr	Updhayaya, Hari/C-4858-2014	Updhayaya, Hari/0000-0002-5166-6844; Noyer, Jean-Louis/0000-0002-7389-5621; Arnaud, Elizabeth/0000-0002-6020-5919	Generation Challenge Programme (GCP); Council of Scientific and Industrial Research (CSIR), New Delhi, India; Microsoft Corporation	Generation Challenge Programme (GCP); Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Microsoft Corporation(Microsoft)	The authors thank the Generation Challenge Programme (GCP) for their financial support to this project. The research fellowship provided to PR by the Council of Scientific and Industrial Research (CSIR), New Delhi, India, is gratefully acknowledged. Part of this work was carried out by using the resources of the Computational Biology Service Unit from Cornell University partially funded by Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama H. A., 2003, African Journal of Biotechnology, V2, P334; ALDRICH PR, 1992, THEOR APPL GENET, V85, P293, DOI 10.1007/BF00222873; Ali ML, 2008, MOL BREEDING, V21, P497, DOI 10.1007/s11032-007-9149-z; Anas, 2004, PLANT PROD SCI, V7, P217, DOI 10.1626/pps.7.217; Barnaud A, 2007, THEOR APPL GENET, V114, P237, DOI 10.1007/s00122-006-0426-8; Billot C, 2012, AM J BOT, V99, pE245, DOI 10.3732/ajb.1100548; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Brown PJ, 2011, CROP SCI, V51, P224, DOI 10.2135/cropsci2010.03.0179; Burow GB, 2009, THEOR APPL GENET, V118, P423, DOI 10.1007/s00122-008-0908-y; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Casa AM, 2005, THEOR APPL GENET, V111, P23, DOI 10.1007/s00122-005-1952-5; Deu M, 2008, THEOR APPL GENET, V116, P903, DOI 10.1007/s00122-008-0721-7; Deu M, 2006, GENOME, V49, P168, DOI 10.1139/G05-092; DEU M, 1995, GENOME, V38, P635, DOI 10.1139/g95-081; Deu M, 2010, THEOR APPL GENET, V120, P1301, DOI 10.1007/s00122-009-1257-1; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Doggett H, 1988, SORGHUM LONGMAN SCI; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folkertsma RT, 2005, THEOR APPL GENET, V111, P399, DOI 10.1007/s00122-005-1949-0; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Ghebru B, 2002, THEOR APPL GENET, V105, P229, DOI 10.1007/s00122-002-0929-x; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grenier C, 2000, THEOR APPL GENET, V101, P197, DOI 10.1007/s001220051469; Grenier C, 2001, CROP SCI, V41, P234, DOI 10.2135/cropsci2001.411234x; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; HULBERT SH, 1990, P NATL ACAD SCI USA, V87, P4251, DOI 10.1073/pnas.87.11.4251; Idury RM, 1997, GENOME RES, V7, P1104, DOI 10.1101/gr.7.11.1104; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Mace ES, 2003, PLANT MOL BIOL REP, V21, p459a, DOI DOI 10.1007/BF02772596; Mann J.A., 1983, BULLETIN, V1454; Mutegi E, 2011, THEOR APPL GENET, V122, P989, DOI 10.1007/s00122-010-1504-5; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Ollitrault P, 1987, EVALUATION GENETIQUE; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paterson Andrew H, 2008, Int J Plant Genomics, V2008, P362451, DOI 10.1155/2008/362451; PEREIRA MG, 1994, GENOME, V37, P236, DOI 10.1139/g94-033; Perrier X., 2006, DARWIN SOFTWARE; Pritchard J, 2002, AM J HUM GENET, V71, P177; RAGAB RA, 1994, GENOME, V37, P590, DOI 10.1139/g94-084; Rami JF, 1998, THEOR APPL GENET, V97, P605, DOI 10.1007/s001220050936; Sagnard F, 2011, THEOR APPL GENET, V123, P1231, DOI 10.1007/s00122-011-1662-0; Shehzad T, 2009, GENET RESOUR CROP EV, V56, P809, DOI 10.1007/s10722-008-9403-1; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tao YZ, 1998, AUST J AGR RES, V49, P729, DOI 10.1071/A97112; Tesso T, 2008, CROP SCI, V48, P1425, DOI 10.2135/cropsci2007.08.0441; Upadhyaya HD, 2009, CROP SCI, V49, P1769, DOI 10.2135/cropsci2009.01.0014; Ventelon M, 2001, THEOR APPL GENET, V102, P379, DOI 10.1007/s001220051657; Wang M. L., 2005, Plant Genetic Resources Characterization and Utilization, V3, P45, DOI 10.1079/PGR200461; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wang ML, 2006, EUPHYTICA, V148, P319, DOI 10.1007/s10681-005-9040-0; WHITKUS R, 1992, GENETICS, V132, P1119; Xin ZG, 2009, BIOENERG RES, V2, P10, DOI 10.1007/s12155-008-9029-3; XU GW, 1994, THEOR APPL GENET, V89, P139, DOI 10.1007/BF00225133; Yonemaru J, 2009, DNA RES, V16, P187, DOI 10.1093/dnares/dsp005	59	47	50	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59714	10.1371/journal.pone.0059714	http://dx.doi.org/10.1371/journal.pone.0059714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565161	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300030
J	Megaw, J; Busetti, A; Gilmore, BF				Megaw, Julianne; Busetti, Alessandro; Gilmore, Brendan F.			Isolation and Characterisation of 1-Alkyl-3-Methylimidazolium Chloride Ionic Liquid-Tolerant and Biodegrading Marine Bacteria	PLOS ONE			English	Article							ACUTE TOXICITY; DEGRADATION; BIOREMEDIATION; IMIDAZOLIUM; RHODOCOCCUS; IDENTIFICATION; GROUNDWATER; NAPHTHALENE; SOIL; TRANSFORMATION	The aim of this study was to isolate and identify marine-derived bacteria which exhibited high tolerance to, and an ability to biodegrade, 1-alkyl-3-methylimidazolium chloride ionic liquids. The salinity and hydrocarbon load of some marine environments may induce selective pressures which enhance the ability of microbes to grow in the presence of these liquid salts. The isolates obtained in this study generally showed a greater ability to grow in the presence of the selected ionic liquids compared to microorganisms described previously, with two marine-derived bacteria, Rhodococcus erythropolis and Brevibacterium sanguinis growing in concentrations exceeding 1 M 1-ethyl-3-methylimidazolium chloride. The ability of these bacteria to degrade the selected ionic liquids was assessed using High Performance Liquid Chromatography (HPLC), and three were shown to degrade the selected ionic liquids by up to 59% over a 63-day test period. These bacterial isolates represent excellent candidates for further potential applications in the bioremediation of ionic liquid-containing waste or following accidental environmental exposure.	[Megaw, Julianne; Busetti, Alessandro; Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland	Queens University Belfast	Gilmore, BF (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	b.gilmore@qub.ac.uk		Megaw, Julianne/0000-0003-4554-9892	Irish Marine Institute under the Beaufort Marine Biodiscovery Research; Irish Government under the National Development Plan (2007-2013)	Irish Marine Institute under the Beaufort Marine Biodiscovery Research; Irish Government under the National Development Plan (2007-2013)	This research was supported the Irish Marine Institute under the Beaufort Marine Biodiscovery Research award funded by the Irish Government under the National Development Plan (2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci C, 2011, GREEN CHEM, V13, P709, DOI 10.1039/c0gc00766h; Al-Saleh E, 2009, INT BIODETER BIODEGR, V63, P400, DOI 10.1016/j.ibiod.2008.11.004; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Atefi F, 2009, GREEN CHEM, V11, P1595, DOI 10.1039/b913057h; Bailey MM, 2008, GREEN CHEM, V10, P1213, DOI 10.1039/b807019a; Bica K, 2010, PHYS CHEM CHEM PHYS, V12, P2011, DOI 10.1039/b923855g; Blasco R, 2001, ARCH MICROBIOL, V175, P435, DOI 10.1007/s002030100285; Boethling RS, 2007, CHEM REV, V107, P2207, DOI 10.1021/cr050952t; Boopathy R, 2000, BIORESOURCE TECHNOL, V74, P63, DOI 10.1016/S0960-8524(99)00144-3; Carson L, 2009, GREEN CHEM, V11, P492, DOI 10.1039/b821842k; Chaillan F, 2004, RES MICROBIOL, V155, P587, DOI 10.1016/j.resmic.2004.04.006; Coleman D, 2012, GREEN CHEM, V14, P1350, DOI 10.1039/c2gc16090k; Coleman D, 2010, CHEM SOC REV, V39, P600, DOI 10.1039/b817717c; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; de Carvalho CCCR, 2005, APPL MICROBIOL BIOT, V67, P715, DOI 10.1007/s00253-005-1932-3; de Souza RF, 2003, ELECTROCHEM COMMUN, V5, P728, DOI 10.1016/S1388-2481(03)00173-5; Deive FJ, 2011, GREEN CHEM, V13, P687, DOI 10.1039/c0gc00369g; Docherty KM, 2005, GREEN CHEM, V7, P185, DOI 10.1039/b419172b; European Chemicals Agency, REG EV AUTH RESTR CH; Farhadian M, 2008, BIORESOURCE TECHNOL, V99, P5296, DOI 10.1016/j.biortech.2007.10.025; Ford L, 2010, GREEN CHEM, V12, P1783, DOI 10.1039/c0gc00082e; Gallego JLR, 2001, BIODEGRADATION, V12, P325, DOI 10.1023/A:1014397732435; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; Garcia MT, 2005, GREEN CHEM, V7, P9, DOI 10.1039/b411922c; Gathergood N, 2002, AUST J CHEM, V55, P557, DOI 10.1071/CH02148; Gathergood N, 2004, GREEN CHEM, V6, P166, DOI 10.1039/b315270g; Geiselbrecht AD, 1998, APPL ENVIRON MICROB, V64, P4703; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Harjani JR, 2009, GREEN CHEM, V11, P821, DOI 10.1039/b900787c; Hedlund BP, 1999, APPL ENVIRON MICROB, V65, P251; HOPKINS GD, 1993, ENVIRON SCI TECHNOL, V27, P2542, DOI 10.1021/es00048a035; Huddleston JG, 1998, CHEM COMMUN, P1765, DOI 10.1039/a803999b; Innovotech Incorporated, MAN INSTR MBEC PHYS; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Liu CW, 2009, BIOCHEM ENG J, V45, P69, DOI 10.1016/j.bej.2009.02.009; Loh KC, 1997, BIODEGRADATION, V8, P329, DOI 10.1023/A:1008267607634; Luczak J, 2010, GREEN CHEM, V12, P593, DOI 10.1039/b921805j; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Manahan S. E., 2006, GREEN CHEM 10 COMMAN; Mariano AP, 2007, BRAZ J MICROBIOL, V38, P346, DOI 10.1590/S1517-83822007000200030; Matzke M, 2007, GREEN CHEM, V9, P1198, DOI 10.1039/b705795d; MIHELCIC JR, 1988, APPL ENVIRON MICROB, V54, P1188, DOI 10.1128/AEM.54.5.1188-1198.1988; Modelli A, 2008, CHEMOSPHERE, V73, P1322, DOI 10.1016/j.chemosphere.2008.07.012; Moscoso F, 2012, IND ENG CHEM RES, V51, P15895, DOI 10.1021/ie3021736; Neumann J, 2010, GREEN CHEM, V12, P620, DOI 10.1039/b918453h; Palomar J, 2009, CARBON, V47, P1846, DOI 10.1016/j.carbon.2009.03.028; PIRNIK MP, 1974, J BACTERIOL, V119, P868, DOI 10.1128/JB.119.3.868-878.1974; Pretti C, 2006, GREEN CHEM, V8, P238, DOI 10.1039/b511554j; Radwan S, 2010, MICROB ECOL, V60, P354, DOI 10.1007/s00248-010-9702-x; Rahman KSM, 2003, BIORESOURCE TECHNOL, V90, P159, DOI 10.1016/S0960-8524(03)00114-7; Ranke J., 2006, Toxicological and Environmental Chemistry, V88, P273, DOI 10.1080/02772240600589505; Ranke J, 2004, ECOTOX ENVIRON SAFE, V58, P396, DOI 10.1016/S0147-6513(03)00105-2; Rockne KJ, 1998, ENVIRON SCI TECHNOL, V32, P3962, DOI 10.1021/es980368k; Romero A, 2008, J HAZARD MATER, V151, P268, DOI 10.1016/j.jhazmat.2007.10.079; Samanta SK, 1999, APPL MICROBIOL BIOT, V53, P98, DOI 10.1007/s002530051621; Samori C, 2007, ENVIRON TOXICOL CHEM, V26, P2379, DOI 10.1897/07-066R2.1; Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f; Siedlecka EM, 2011, IONIC LIQUIDS: THEORY, PROPERTIES, NEW APPROACHES, P701; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stepnowski P, 2005, ENVIRON SCI POLLUT R, V12, P199, DOI 10.1065/espr2005.05.255; Stepnowski P, 2005, J PHOTOCH PHOTOBIO A, V170, P45, DOI 10.1016/j.jphotochem.2004.07.019; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stolte S, 2008, GREEN CHEM, V10, P214, DOI 10.1039/b713095c; Swatloski RP, 2004, CHEM COMMUN, P668, DOI 10.1039/b316491h; Tang SK, 2008, INT J SYST EVOL MICR, V58, P574, DOI 10.1099/ijs.0.65183-0; TRENZ SP, 1994, J BACTERIOL, V176, P789, DOI 10.1128/jb.176.3.789-795.1994; Visser AE, 2000, GREEN CHEM, V2, P1, DOI 10.1039/a908888a; Wang WP, 2012, FEMS MICROBIOL ECOL, V80, P523, DOI 10.1111/j.1574-6941.2012.01322.x; Watson WJW, 2012, GREEN CHEM, V14, P251, DOI 10.1039/c1gc15904f; Wauters G, 2004, J CLIN MICROBIOL, V42, P2829, DOI 10.1128/JCM.42.6.2829-2832.2004; Wells AS, 2006, ORG PROCESS RES DEV, V10, P794, DOI 10.1021/op060048i; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Whyte LG, 1997, APPL ENVIRON MICROB, V63, P3719, DOI 10.1128/AEM.63.9.3719-3723.1997; Zhao H, 2005, J MOL CATAL B-ENZYM, V37, P16, DOI 10.1016/j.molcatb.2005.08.007	76	28	28	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60806	10.1371/journal.pone.0060806	http://dx.doi.org/10.1371/journal.pone.0060806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560109	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900079
J	Stenfors, CUD; Hanson, LM; Oxenstierna, G; Theorell, T; Nilsson, LG				Stenfors, Cecilia U. D.; Hanson, Linda Magnusson; Oxenstierna, Gabriel; Theorell, Tores; Nilsson, Lars-Goran			Psychosocial Working Conditions and Cognitive Complaints among Swedish Employees	PLOS ONE			English	Article							SUBJECTIVE MEMORY COMPLAINTS; POPULATION-BASED SAMPLE; JOB DEMAND-CONTROL; SELF-RATED HEALTH; INTRAGROUP CONFLICT; MENTAL-HEALTH; OLDER-PEOPLE; STRESS; PERFORMANCE; SYMPTOMS	Background: Cognitive complaints involving problems with concentration, memory, decision-making and thinking are relatively common in the work force. The sensitivity of both subjective and objective cognitive functioning to common psychiatric conditions, stress levels and to cognitive load makes it plausible that psychosocial working conditions play a role in cognitive complaints. Thus, this study aimed to test the associations between psychosocial work factors and cognitive complaints in nationally representative samples of the Swedish work force. Cross-sectional (n = 9751) and prospective (n = 3644; two time points two years apart) sequential multiple regression analyses were run, adjusting for general confounders, depressive-and sleeping problems. Additional prospective analyses were run adjusting for baseline cognitive complaints. Cross-sectional results: High quantitative demands, information and communication technology (ICT) demands, underqualification and conflicts were positively associated with cognitive complaints, while social support, good resources at work and overqualification were negatively associated with cognitive complaints in all models. Skill discretion and decision authority were weakly associated with cognitive complaints. Conflicts were more strongly associated with cognitive complaints in women than in men, after adjustment for general confounders. Prospective results: Quantitative job demands, ICT demands and underqualification were positively associated with future cognitive complaints in all models, including when adjusted for baseline cognitive complaints. Decision authority was weakly positively associated with future cognitive complaints, only after adjustment for depressive-and sleeping problems respectively. Social support was negatively associated with future cognitive complaints after adjustment for general confounders and baseline cognitive complaints. Skill discretion and resources were negatively associated with future cognitive complaints after adjustment for general confounders. The associations between quantitative demands and future cognitive complaints were stronger in women. Discussion/Conclusions: The findings indicate that psychosocial working conditions should be taken into account when considering cognitive complaints among employees.	[Stenfors, Cecilia U. D.; Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Stenfors, Cecilia U. D.; Hanson, Linda Magnusson; Oxenstierna, Gabriel; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Theorell, Tores] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Oxenstierna, Gabriel] Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden	Stockholm University; Stockholm University; Karolinska Institutet; Royal Institute of Technology	Stenfors, CUD (corresponding author), Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.	cecilia.stenfors@psychology.su.se	Hanson, Linda L Magnusson/D-2435-2017	Hanson, Linda L Magnusson/0000-0002-2908-1903; Stenfors, Cecilia/0000-0002-8411-0666; Theorell, Tores/0000-0003-1956-7931	Swedish Council for Working Life and Social Research [2009-0764]; Afa Insurance [090283]; Swedish Research Council; Swedish Council for Working Life and Social Research; Afa Insurance	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Afa Insurance; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Afa Insurance	The work was supported by research grants from the Swedish Council for Working Life and Social Research (Dnr 2009-0764), http://www.fas.se/en/; and Afa Insurance (Dnr 090283), http://www.afaforsakring.se/Andra-sprak/Engelska/. The data collection for SLOSH was supported by the Swedish Research Council and the Swedish Council for Working Life and Social Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partially funded by Afa Insurance. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Akerstedt T, 2008, CHRONOBIOL INT, V25, P333, DOI 10.1080/07420520802113922; Akerstedt T, 2007, PHYSIOL BEHAV, V90, P209, DOI 10.1016/j.physbeh.2006.09.007; Albertsen K, 2001, WORK STRESS, V15, P241, DOI 10.1080/02678370110066562; Albertsen K, 2010, SCAND J PUBLIC HEALT, V38, P81, DOI 10.1177/1403494809352104; Arnetz BB, 1997, J PSYCHOSOM RES, V43, P35, DOI 10.1016/S0022-3999(97)00083-4; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker AB, 2007, J EDUC PSYCHOL, V99, P274, DOI 10.1037/0022-0663.99.2.274; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Bech P, 2009, ACTA PSYCHIAT SCAND, V119, P298, DOI 10.1111/j.1600-0447.2008.01289.x; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179; Carnevale PJ, 1998, J PERS SOC PSYCHOL, V74, P1300, DOI 10.1037/0022-3514.74.5.1300; Comijs HC, 2002, J AFFECT DISORDERS, V72, P157, DOI 10.1016/S0165-0327(01)00453-0; de Braek DMJMSI, 2011, J ATTEN DISORD, V15, P46, DOI 10.1177/1087054709347260; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; de Jonge J, 2008, INT J NURS STUD, V45, P1460, DOI 10.1016/j.ijnurstu.2007.11.002; De Lange AH, 2009, J SLEEP RES, V18, P374, DOI 10.1111/j.1365-2869.2009.00735.x; de Wit FRC, 2012, J APPL PSYCHOL, V97, P360, DOI 10.1037/a0024844; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; Ekstedt M, 2005, J ADV NURS, V49, P59, DOI 10.1111/j.1365-2648.2004.03264.x; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; Elovainio M, 2009, OCCUP ENVIRON MED, V66, P32, DOI 10.1136/oem.2008.039305; Eppler MJ, 2004, INFORM SOC, V20, P325, DOI 10.1080/01972240490507974; Garrett DD, 2010, PSYCHOL AGING, V25, P74, DOI 10.1037/a0017726; Gronlund A, 2007, GENDER WORK ORGAN, V14, P476, DOI 10.1111/j.1468-0432.2007.00361.x; Hausser JA, 2010, WORK STRESS, V24, P1, DOI 10.1080/02678371003683747; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; Hanson LLM, 2011, SLEEP, V34, P1403, DOI 10.5665/SLEEP.1288; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hogh A, 2005, SCAND J PSYCHOL, V46, P429, DOI 10.1111/j.1467-9450.2005.00474.x; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Holman David J, 2002, J Occup Health Psychol, V7, P283; Jacobs N, 2007, BIOL PSYCHOL, V74, P60, DOI 10.1016/j.biopsycho.2006.07.002; Jehn KA, 2001, ACAD MANAGE J, V44, P238, DOI 10.2307/3069453; Johansson-Hiden B, 2003, HUMANIT 2003; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Jorm AF, 2004, PSYCHOL MED, V34, P1495, DOI 10.1017/S0033291704003162; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Karasek B, 1990, HLTH WORK STRESS PRO; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; KECKLUND G, 1992, J SLEEP RES, V1, P30, DOI 10.1111/j.1365-2869.1992.tb00005.x; Kompier MAJ, 2006, SCAND J WORK ENV HEA, V32, P421, DOI 10.5271/sjweh.1048; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kristiansen J, 2009, INT ARCH OCC ENV HEA, V82, P631, DOI 10.1007/s00420-008-0367-4; Lazarus R.S., 1984, EMOTION ADAPTATION; Lipman R.S., 1986, ASSESSMENT DEPRESSIO, P232, DOI [DOI 10.1007/978-3-642-70486-4_22, 10.1007/978-3-642-70486-4_22]; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Luethi M, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.005.2008; MacEachen E, 2008, SOC SCI MED, V66, P1019, DOI 10.1016/j.socscimed.2007.11.013; Magnusson Hanson L, 2009, INT ARCH OCCUP ENV H; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Mellner C, 2006, INT J BEHAV MED, V13, P1, DOI 10.1207/s15327558ijbm1301_1; Moss-Racusin CA, 2012, P NATL ACAD SCI US; Murrough JW, 2011, NEUROBIOL LEARN MEM, V96, P553, DOI 10.1016/j.nlm.2011.06.006; Naswall K, 2007, INDIVIDUAL IN THE CHANGING WORKING LIFE, P1; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Ohman L, 2007, SCAND J WORK ENV HEA, V33, P223; Osterberg K, 2009, STRESS, V12, P70, DOI 10.1080/10253890802049699; Osterberg K, 2012, STRESS; Oxenstierna G WM, 2008, PSYKOSOCIALA FACTORE; Persson J, 2007, NEUROPSYCHOLOGIA, V45, P1571, DOI 10.1016/j.neuropsychologia.2006.12.007; Podewils LJ, 2003, PSYCHOSOMATICS, V44, P461, DOI 10.1176/appi.psy.44.6.461; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; RABBITT P, 1990, BRIT J PSYCHOL, V81, P1, DOI 10.1111/j.2044-8295.1990.tb02342.x; RABBITT P, 1991, BRIT J PSYCHOL, V82, P137, DOI 10.1111/j.2044-8295.1991.tb02389.x; Rau R, 2010, WORK STRESS, V24, P88, DOI 10.1080/02678371003661164; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reid M, 2012, J CLIN EPIDEMIOL, V65, P199, DOI 10.1016/j.jclinepi.2011.06.006; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Ronnlund M, 2011, J GENET PSYCHOL, V172, P266, DOI 10.1080/00221325.2010.538450; de Leon JMRS, 2010, REV NEUROLOGIA, V51, P650, DOI 10.33588/rn.5111.2010270; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63, DOI 10.1177/070674370605100202; Sandmark H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-210; Sandstrom A, 2005, BIOL PSYCHOL, V69, P271, DOI 10.1016/j.biopsycho.2004.08.003; Sandstrom A, 2012, STRESS; Sandstrom A, 2011, SCAND J PSYCHOL, V52, P71, DOI 10.1111/j.1467-9450.2010.00844.x; Schmidt KH, 2007, WORK STRESS, V21, P142, DOI 10.1080/02678370701431680; SETTERLIND S, 1995, STRESS MEDICINE, V11, P85, DOI 10.1002/smi.2460110116; Socialstyrelsen [The National Board of Health and Welfare Sweden], 2003, 200312318 SOC; Staland-Nyman C, 2008, SCAND J PUBLIC HEALT, V36, P21, DOI 10.1177/1403494807085307; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Statistics Sweden, 2010, X10BR1001ENG STAT SW; Swedish Social Insurance Agency, 2012, SOC INS FIG 2012; The Swedish Social Insurance Agency, 2011, SOC INS FIG; Theorell T, 2004, R OCC ST W, V3, P323; Van der Linden D, 2005, WORK STRESS, V19, P23, DOI 10.1080/02678370500065275; Vestergren P, 2011, APPL COGNITIVE PSYCH, V25, P641, DOI 10.1002/acp.1734; Walumbwa FO, 2008, PERS PSYCHOL, V61, P793, DOI 10.1111/j.1744-6570.2008.00131.x; Walumbwa FO, 2011, J OCCUP ORGAN PSYCH, V84, P153, DOI 10.1348/096317910X485818; Walumbwa FO, 2011, ORGAN BEHAV HUM DEC, V115, P204, DOI 10.1016/j.obhdp.2010.11.002; Wang YL, 2011, EUR J APPL PHYSIOL, V111, P2791, DOI 10.1007/s00421-011-1908-1; Westerlund H, 2008, COMMUNICATION; Witt ST, 2012, NEUROIMAGE, V62, P2055, DOI 10.1016/j.neuroimage.2012.05.007; Zapf D, 2001, PSYCHOL HEALTH, V16, P527, DOI 10.1080/08870440108405525	100	38	39	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60637	10.1371/journal.pone.0060637	http://dx.doi.org/10.1371/journal.pone.0060637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117CY	23560101	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900072
J	Zhou, YJ; Yuan, ML; Li, R; Zhu, LP; Chen, ZH				Zhou, Yi-Jie; Yuan, Man-Li; Li, Rui; Zhu, Li-Ping; Chen, Zhao-Hui			Real-Time Placental Perfusion on Contrast-Enhanced Ultrasound and Parametric Imaging Analysis in Rats at Different Gestation Time and Different Portions of Placenta	PLOS ONE			English	Article							INTERVILLOUS BLOOD-FLOW; INTRAUTERINE GROWTH-RETARDATION; FETAL; PREGNANCY; ANGIOGENESIS; PERMEABILITY; CIRCULATION	Objectives: To quantitatively analyze placental perfusion in a rat model at different gestation time and different portions of placenta by real-time contrast-enhanced ultrasound (CEUS) and parametric imaging analysis. Materials and Methods: Sixty pregnant rats at different gestation time (15 dys, 17 days and 20 days) were injected intravenously with microbubbles (5x10(5) microbubbles /ml, 1.0 ml/kg), and cadence contrast pulse sequencing (transmission frequency of 7 MHz, mechanical index 0.18) was performed. Dynamic enhancement changes in placenta at different gestation time and different portions of placenta were measured and enhancement parameters analyzed with software. Correlation between enhancement parameters and average area densities of placenta vascular compartment was compared. Results: The pattern and real-time sequence of enhancement in uterus and placenta were clearly depicted by CEUS. The time-to-peak enhancement was earlier in central portion than that in peripheral portion (12.30 +/- 6.33s vs 36.26 +/- 10.65 s, p = 0.005), and peak intensity of enhancement is much higher in central portion than that in peripheral portion (30.20 +/- 2.85 dB vs 20.95 +/- 6.25 dB, p = 0.000). The peak intensity of enhancement at day 15 (27.70 +/- 4.47 dB) was lower than that at day 17 (30.20 +/- 2.85 dB, p = 0.042) and at day 20 (31.85 +/- 4.41 dB, p = 0.015) of gestation. Significant correlation between average area densities of vascular compartment and the peak intensity of enhancement was identified in placenta at different gestation time (p<0.05). The average area densities of vascular compartment was higher in central portion than that in peripheral portion and has significant correlation with peak intensity of enhancement of the two potions (p<0.01). Conclusion: CEUS is feasible to depict real-time sequence and quantitative parameters of perfusion in different portion of placenta at different gestational time in a rat model.	[Zhou, Yi-Jie; Yuan, Man-Li; Li, Rui; Zhu, Li-Ping; Chen, Zhao-Hui] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China	Army Medical University	Li, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China.	raylee_7991@yahoo.com.cn	Zhu, Li/GXH-9801-2022					Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Alison M, 2013, INVEST RADIOL, V48, P17, DOI 10.1097/RLI.0b013e318271a5f8; Barth WH, 2006, PLACENTA, V27, P719, DOI 10.1016/j.placenta.2005.07.007; BROSENS I, 1977, BRIT J OBSTET GYNAEC, V84, P656; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Carr Chad L, 2008, Curr Cardiol Rep, V10, P233, DOI 10.1007/s11886-008-0039-8; Chien PFW, 2000, BRIT J OBSTET GYNAEC, V107, P196, DOI 10.1111/j.1471-0528.2000.tb11690.x; Chung SM, 2002, J NEURO-OPHTHALMOL, V22, P35, DOI 10.1097/00041327-200203000-00009; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Crussner S, 2004, ROFO FORTSCHR RONTG, V176, P91; CUSICK W, 1995, AM J REPROD IMMUNOL, V34, P141, DOI 10.1111/j.1600-0897.1995.tb00930.x; David R, 1996, AUST NZ J OBSTET GYN, V36, P267, DOI 10.1111/j.1479-828X.1996.tb02708.x; Deloison B, 2012, BJOG-INT J OBSTET GY, V119, P626, DOI 10.1111/j.1471-0528.2011.03251.x; Eisenbrey JR, 2012, ACAD RADIOL, V19, P732, DOI 10.1016/j.acra.2012.02.015; Feingold S, 2010, INVEST RADIOL, V45, P669, DOI 10.1097/RLI.0b013e3181ef0a78; FORSBERG F, 1994, J ULTRAS MED, V13, P357; Greis, 2004, EUROPEAN RADIOLOGY, V14, P11; Hua X, 2009, PLACENTA, V30, P780, DOI 10.1016/j.placenta.2009.06.009; JOUPPILA P, 1991, CURR OPIN OBSTET GYN, V3, P248; KAAR K, 1980, ACTA OBSTET GYN SCAN, V59, P7; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; KAUL S, 1989, J AM COLL CARDIOL, V13, P468, DOI 10.1016/0735-1097(89)90528-7; KELLER MW, 1990, J AM COLL CARDIOL, V16, P1267, DOI 10.1016/0735-1097(90)90565-7; LOW JA, 1991, AM J OBSTET GYNECOL, V164, P1049, DOI 10.1016/0002-9378(91)90585-F; Merz M, 2012, INVEST RADIOL, V47, P422, DOI 10.1097/RLI.0b013e31824f635a; Orden MR, 2000, FETAL DIAGN THER, V15, P139, DOI 10.1159/000020993; Panigel M, 1975, Eur J Obstet Gynecol Reprod Biol, V5, P251, DOI 10.1016/0028-2243(75)90034-9; PANIGEL M, 1988, TROPH RES, V3, P271; Quaia E, 2011, EUR RADIOL, V21, P604, DOI 10.1007/s00330-010-1965-6; Quaia E, 2009, ULTRASOUND MED BIOL, V35, P616, DOI 10.1016/j.ultrasmedbio.2008.10.003; Ragavendra N, 2001, PLACENTA, V22, P200, DOI 10.1053/plac.2000.0605; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Rim SJ, 2001, CIRCULATION, V104, P2582, DOI 10.1161/hc4601.099400; Salomon LJ, 2005, RADIOLOGY, V235, P73, DOI 10.1148/radiol.2351040192; Schmiedl UP, 1998, J ULTRAS MED, V17, P75; Simpson NAB, 1998, ULTRASOUND OBST GYN, V11, P204, DOI 10.1046/j.1469-0705.1998.11030204.x; Smoljanovic L, 1993, DEV STAT METHODOLO A, V9; Stieger SM, 2008, CONTRAST MEDIA MOL I, V3, P9, DOI 10.1002/cmmi.224; Sugimoto K, 2007, HEPATOL RES, V37, P464, DOI 10.1111/j.1872-034X.2007.00060.x; Taillieu F, 2006, RADIOLOGY, V241, P737, DOI 10.1148/radiol.2413051168; Tomlinson TM, 2010, AM J PHYSIOL-REG I, V298, pR312, DOI 10.1152/ajpregu.00425.2009; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5	42	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58986	10.1371/journal.pone.0058986	http://dx.doi.org/10.1371/journal.pone.0058986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560042	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900010
J	Chen, HF; Mai, JR; Wan, JX; Gao, YF; Lin, LN; Wang, SZ; Chen, YX; Zhang, CZ; Zhang, YJ; Xia, B; Liao, K; Lin, YC; Lin, ZN				Chen, Hui-Feng; Mai, Jian-Rong; Wan, Jian-Xin; Gao, Yan-fang; Lin, Li-Na; Wang, Song-Zi; Chen, Yu-Xi; Zhang, Chen-Zi; Zhang, Yu-Jing; Xia, Bin; Liao, Kun; Lin, Yu-Chun; Lin, Zhong-Ning			Role of a Novel Functional Variant in the PPP2R1A Promoter on the Regulation of PP2A-Aalpha and the Risk of Hepatocellular Carcinoma	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; NF-KAPPA-B; VIRUS-X-PROTEIN; ALPHA ER EXPRESSION; BREAST-CANCER; CELL-TRANSFORMATION; TUMOR-SUPPRESSOR; DNA METHYLATION; JNK ACTIVATION; PP2A COMPLEXES	Previously, we identified the genetic variant -241 (-/G) (rs11453459) in the PP2A-A alpha gene (PPP2R1A) promoter and demonstrated that this variant influences the DNA-binding affinity of nuclear factor-kappa B (NF-kappa B). In this study, we further confirmed that the transcriptional activity of PPP2R1A may be regulated by NF-kappa B through the functional genetic variant -241 (-/G). Moreover, we also demonstrated that the methylation status of CpG islands in the promoter of PPP2R1A influences the activity of this gene promoter. Few studies have examined the role of this -241 (-/G) variant in genetic or epigenetic regulation in hepatocellular carcinoma (HCC). To investigate whether this functional variant in the PPP2R1A promoter is associated with the risk of HCC and confirm the function of the -241 (-/G) variant in the HCC population, we conducted a case-control study involving 251 HCC cases and 252 cancer-free controls from a Han population in southern China. Compared with the -241 (--) homozygote, the heterozygous -241 (-G) genotype (adjusted OR = 0.32, 95% confidence interval (CI) = 0.17-0.58, P<0.001) and the -241 (-G)/(GG) genotypes (adjusted OR = 0.38, 95% CI = 0.22-0.67, P = 0.001) were both significantly associated with a reduced risk of HCC. Stratification analysis indicated that the protective role of -241 (-G) was more pronounced in individuals who were <= 40 years of age, female and HBV-negative. Our data suggest that the transcriptional activity of PPP2R1A is regulated by NF-kappa B through the -241 (-/G) variant and by the methylation of the promoter region. Moreover, the functional -241 (-/G) variant in the PPP2R1A promoter contributes to the decreased risk of HCC. These findings contribute novel information regarding the gene transcription of PPP2R1A regulated by the polymorphism and methylation in the promoter region through genetic and epigenetic mechanisms in hepatocarcinogenesis.	[Lin, Yu-Chun; Lin, Zhong-Ning] Xiamen Univ, Sch Publ Hlth, Xiamen, Fujian, Peoples R China; [Chen, Hui-Feng; Mai, Jian-Rong; Gao, Yan-fang; Lin, Li-Na; Chen, Yu-Xi; Zhang, Chen-Zi; Zhang, Yu-Jing; Xia, Bin; Liao, Kun; Lin, Yu-Chun; Lin, Zhong-Ning] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Jian-Xin; Wang, Song-Zi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Hui-Feng] Guangdong Prevent & Treatment Ctr Occupat Dis, Guangzhou, Guangdong, Peoples R China	Xiamen University; Sun Yat Sen University; Sun Yat Sen University	Lin, YC (corresponding author), Xiamen Univ, Sch Publ Hlth, Xiamen, Fujian, Peoples R China.	linych@mail.sysu.edu.cn; linzhn@mail.sysu.edu.cn			National Natural Science Foundation of China [NSFC 81172705, 81072334]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171110052]; Natural Science Foundation of Guangdong Province [S2011020002769]; Key Program of NSFC [81130052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key Program of NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 81172705, 81072334), Key Program (81130052) of NSFC, the Specialized Research Fund for the Doctoral Program of Higher Education of China (20090171110052) and the Key Project of Natural Science Foundation of Guangdong Province (S2011020002769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsura M, 2005, CANCER LETT, V229, P157, DOI 10.1016/j.canlet.2005.07.008; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007019; Chen HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035524; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Chen KF, 2010, J HEPATOL, V52, P88, DOI 10.1016/j.jhep.2009.10.011; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Duong FHT, 2010, HEPATOLOGY, V51, P741, DOI 10.1002/hep.23388; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esplin ED, 2006, GENE CHROMOSOME CANC, V45, P182, DOI 10.1002/gcc.20284; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ezzikouri S, 2009, INFECT GENET EVOL, V9, P877, DOI 10.1016/j.meegid.2009.05.012; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; Huang W, 2005, J CELL PHYSIOL, V205, P37, DOI 10.1002/jcp.20372; Hudson TJ, 2003, NAT GENET, V33, P439, DOI 10.1038/ng0403-439; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kane MA, 2003, CANCER EPIDEM BIOMAR, V12, P2; Keen JC, 2005, J BIOL CHEM, V280, P29519, DOI 10.1074/jbc.M505317200; Keen JC, 2004, CANCER BIOL THER, V3, P1304, DOI 10.4161/cbt.3.12.1458; Kloth M, 2012, INT J CANCER, V131, pE897, DOI 10.1002/ijc.27628; Lin YC, 2011, MUTAT RES-FUND MOL M, V716, P66, DOI 10.1016/j.mrfmmm.2011.08.004; Lin ZN, 2008, HUM MUTAT, V29, P113, DOI 10.1002/humu.20610; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Nijhara R, 2001, FEBS LETT, V504, P59, DOI 10.1016/S0014-5793(01)02773-9; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Park JY, 2006, HUM MOL GENET, V15, P1963, DOI 10.1093/hmg/ddl119; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Stepanova M, 2006, MOL CELL PROBE, V20, P348, DOI 10.1016/j.mcp.2006.03.007; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Suzuki K, 2006, BIOCHEM BIOPH RES CO, V349, P255, DOI 10.1016/j.bbrc.2006.08.037; Takagi Y, 2000, GUT, V47, P268, DOI 10.1136/gut.47.2.268; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Dung TD, 2012, INT J MOL MED, V29, P1045, DOI 10.3892/ijmm.2012.938; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Xiong XD, 2008, MUTAT RES-FUND MOL M, V643, P70, DOI 10.1016/j.mrfmmm.2008.06.006; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	61	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59574	10.1371/journal.pone.0059574	http://dx.doi.org/10.1371/journal.pone.0059574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555712	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900017
J	Nye, V; Copley, JT; Tyler, PA				Nye, Verity; Copley, Jonathan T.; Tyler, Paul A.			Spatial Variation in the Population Structure and Reproductive Biology of Rimicaris hybisae (Caridea: Alvinocarididae) at Hydrothermal Vents on the Mid-Cayman Spreading Centre	PLOS ONE			English	Article							DEEP-SEA VENT; BATHYMODIOLUS-AZORICUS; DECAPOD CRUSTACEANS; DECADAL-SCALE; COLD SEEPS; SHRIMP; DISPERSAL; BRESILIIDAE; EXOCULATA; ECOLOGY	The dynamics and microdistribution of faunal assemblages at hydrothermal vents often reflect the fine-scale spatial and temporal heterogeneity of the vent environment. This study examined the reproductive development and population structure of the caridean shrimp Rimicaris hybisae at the Beebe and Von Damm Vent Fields (Mid-Cayman Spreading Centre, Caribbean) using spatially discrete samples collected in January 2012. Rimicaris hybisae is gonochoric and exhibits iteroparous reproduction. Oocyte size-frequency distributions (21-823 mm feret diameters) varied significantly among samples. Embryo development was asynchronous among females, which may result in asynchronous larval release for the populations. Specimens of R. hybisae from the Von Damm Vent Field (2294 m) were significantly larger than specimens from the Beebe Vent Field. Brooding females at Von Damm exhibited greater size-specific fecundity, possibly as a consequence of a non-linear relationship between fecundity and body size that was consistent across both vent fields. Samples collected from several locations at the Beebe Vent Field (4944-4972 m) revealed spatial variability in the sex ratios, population structure, size, and development of oocytes and embryos of this mobile species. Samples from the Von Damm Vent Field and sample J2-613-24 from Beebe Woods exhibited the highest frequencies of ovigerous females and significantly female-biased sex ratios. Environmental variables within shrimp aggregations may influence the distribution of ovigerous females, resulting in a spatially heterogeneous pattern of reproductive development in R. hybisae, as found in other vent taxa.	[Nye, Verity; Copley, Jonathan T.; Tyler, Paul A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Nye, V (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	vn205@noc.soton.ac.uk	Nye, Verity/I-9200-2012; Copley, Jon/I-7076-2012	Nye, Verity/0000-0002-1331-6448; Copley, Jon/0000-0003-3333-4325	UK Natural Environmental Research Council (NERC) [NE/F017774/1]; National Science Foundation (NSF) [OCE-1031050]; NASA ASTEP through WHOI [NNX09AB75G]; NERC [NE/F017774/1] Funding Source: UKRI; Natural Environment Research Council [NE/F017774/1] Funding Source: researchfish	UK Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation (NSF)(National Science Foundation (NSF)); NASA ASTEP through WHOI; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	VN was supported by a UK Natural Environmental Research Council (NERC) award (NE/F017774/1) to J. Copley and P. Tyler, which is gratefully acknowledged. The biological component of the 'Atlantis' Cayman cruise was supported by a National Science Foundation (NSF) award (OCE-1031050) and NASA ASTEP subcontract through WHOI (NNX09AB75G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 1998, THESIS U SOUTHAMPTON; Anger K, 1998, J CRUSTACEAN BIOL, V18, P823, DOI 10.2307/1549156; Bauer RT., 2004, REMARKABLE SHRIMPS A; Christoffersen M.L., 1989, Boletim de Zoologia, V10, P273; CLARKE A, 1993, FUNCT ECOL, V7, P411, DOI 10.2307/2390028; Colaco A, 2006, J EXP MAR BIOL ECOL, V333, P166, DOI 10.1016/j.jembe.2005.12.005; Company JB, 2000, MAR BIOL, V136, P79, DOI 10.1007/s002270050011; Connelly DP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1636; Copley CEA, 1998, CAH BIOL MAR, V39, P229; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P859, DOI 10.1017/S0025315407056512; Copley JTP, 2006, MAR ECOL PROG SER, V315, P199, DOI 10.3354/meps315199; Copley JTP, 2003, MAR ECOL PROG SER, V255, P171, DOI 10.3354/meps255171; COREY S, 1991, CRUSTACEANA, V60, P270, DOI 10.1163/156854091X00056; Creasey S, 1996, MAR BIOL, V125, P473; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; Dixon DR, 2006, J MAR BIOL ASSOC UK, V86, P1363, DOI 10.1017/S0025315406014391; Gebruk A, 2010, CAH BIOL MAR, V51, P383; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Herring PJ, 1998, CAH BIOL MAR, V39, P387; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Hilario A, 2009, MAR ECOL PROG SER, V378, P153, DOI 10.3354/meps07858; Koyama S, 2005, MAR BIOTECHNOL, V7, P272, DOI 10.1007/s10126-004-3050-0; Llodra ER, 2002, ADV MAR BIOL, V43, P87; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Nye V, 2013, J MAR BIOL ASSOC UK, V93, P1017, DOI 10.1017/S0025315412000823; Nye V, 2013, J MAR BIOL ASSOC UK, V93, P741, DOI 10.1017/S0025315412000884; Nye V, 2012, J MAR BIOL ASSOC UK, V92, P1057, DOI 10.1017/S0025315411002001; Perovich GM, 2003, MAR ECOL PROG SER, V251, P211, DOI 10.3354/meps251211; Pond D, 1997, MAR ECOL PROG SER, V146, P289, DOI 10.3354/meps146289; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Pond DW, 2000, MAR ECOL PROG SER, V198, P171, DOI 10.3354/meps198171; Pond DW, 1997, MAR ECOL PROG SER, V157, P221, DOI 10.3354/meps157221; Pradillon F, 2007, J MAR SCI TECH-TAIW, V15, P37; Ramirez-Llodra E, 2006, J MAR BIOL ASSOC UK, V86, P1347, DOI 10.1017/S0025315406014378; Ramirez-Llodra R, 2000, J MAR BIOL ASSOC UK, V80, P473, DOI [10.1017/S0025315400002174, DOI 10.1017/S0025315400002174]; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Sheader M, 2007, MAR ECOL PROG SER, V331, P181, DOI 10.3354/meps331181; Stevens CJ, 2008, MAR ECOL PROG SER, V356, P225, DOI 10.3354/meps07270; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Van Dover C.L., 1995, BULL BIOL SOC WASH, V6, P223; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; WILLIAMS AB, 1988, FISH B-NOAA, V86, P263; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0; Young CM, 2003, ECOSY WORLD, V28, P381	50	24	24	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60319	10.1371/journal.pone.0060319	http://dx.doi.org/10.1371/journal.pone.0060319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555955	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000317263900069
J	Yu, LS; Jiang, Y; Wang, L; Sheng, R; Hu, YZ; Zeng, S				Yu, Lushan; Jiang, Yan; Wang, Lu; Sheng, Rong; Hu, Yongzhou; Zeng, Su			Metabolism of BYZX in Human Liver Microsomes and Cytosol: Identification of the Metabolites and Metabolic Pathways of BYZX	PLOS ONE			English	Article							DRUG-DRUG INTERACTION; DOUBLE-BOND REDUCTASE; IN-VITRO; RAT-LIVER; ALPHA,BETA-UNSATURATED KETONE; HUMAN CYTOCHROME-P450; KINETICS; 1-AMINOBENZOTRIAZOLE; PURIFICATION; PERSPECTIVE	BYZX, [(E)-2-(4-((diethylamino) methyl) benzylidene)-5,6-dimethoxy-2,3-dihydroinden-one], belongs to a series of novel acetylcholinesterase inhibitors and has been synthesized as a new chemical entity for the treatment of Alzheimer's disease symptoms. When incubated with human liver microsomes (HLMs), BYZX was rapidly transformed into its metabolites M1, M2, and M3. The chemical structures of these metabolites were identified using liquid chromatography tandem mass spectrometry and nuclear magnetic resonance, which indicated that M1 was an N-desethylated and C = C hydrogenation metabolite of BYZX. M2 and M3 were 2 precursor metabolites, which resulted from the hydrogenation and desethylation of BYZX, respectively. Further studies with chemical inhibitors and human recombinant cytochrome P450s (CYPs), and correlation studies were performed. The results indicated that the N-desethylation of BYZX and M2 was mediated by CYP3A4 and CYP2C8. The reduced form of beta-nicotinamide adenine dinucleotide 2'-phosphate was involved in the hydrogenation of BYZX and M3, and this reaction occurred in the HLMs and in the human liver cytosol. The hydrogenation reaction was not inhibited by any chemical inhibitors of CYPs, but it was significantly inhibited by some substrates of a, alpha,beta-ketoalkene C = C reductases and their inhibitors such as benzylideneacetone, dicoumarol, and indomethacin. Our results suggest that alpha,beta-ketoalkene C = C reductases may play a role in the hydrogenation reaction, but this issue requires further clarification.	[Yu, Lushan; Jiang, Yan; Wang, Lu; Zeng, Su] Zhejiang Univ, Lab Pharmaceut Anal & Drug Metab, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Rong; Hu, Yongzhou] Zhejiang Univ, Zhejiang Univ Ecole Normole Super Joint Lab Med C, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zeng, S (corresponding author), Zhejiang Univ, Lab Pharmaceut Anal & Drug Metab, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zengsu@zju.edu.cn			National Major Special Project for Science and Technology Development of Ministry of Science and Technology of China [2012ZX09506001-004]; Natural Scientific Foundation of China [81230080]	National Major Special Project for Science and Technology Development of Ministry of Science and Technology of China; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Major Special Project for Science and Technology Development of Ministry of Science and Technology of China (2012ZX09506001-004) (http://www.cncbd.org.cn/web/default.aspx) and the Natural Scientific Foundation of China (81230080) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins WM, 2004, DRUG DISCOV TODAY, V9, P478, DOI 10.1016/S1359-6446(04)03072-7; Bjornsson TD, 2003, DRUG METAB DISPOS, V31, P815, DOI 10.1124/dmd.31.7.815; Chen W, 1996, DERMATOLOGY, V193, P177, DOI 10.1159/000246242; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038495; Clarke SE, 1998, XENOBIOTICA, V28, P1167, DOI 10.1080/004982598238877; DEMONTELLANO PRO, 1984, TETRAHEDRON, V40, P511; DEMONTELLANO PRO, 1981, BIOCHEM J, V195, P761, DOI 10.1042/bj1950761; Ekins S, 1998, INT J CLIN PHARM TH, V36, P642; Galetin A, 2003, DRUG METAB DISPOS, V31, P1108, DOI 10.1124/dmd.31.9.1108; GILLETTE JR, 1974, ANNU REV PHARMACOL, V14, P271, DOI 10.1146/annurev.pa.14.040174.001415; Hellriegel ET, 1996, CLIN PHARMACOL THER, V60, P601, DOI 10.1016/S0009-9236(96)90208-8; Ishida M, 1996, BIOCHEM MOL BIOL INT, V39, P1157; Itoh K, 2008, XENOBIOTICA, V38, P249, DOI 10.1080/00498250701767667 ; KITAMURA S, 1990, ARCH BIOCHEM BIOPHYS, V282, P183, DOI 10.1016/0003-9861(90)90102-5; Kitamura S, 2002, DRUG METAB DISPOS, V30, P414, DOI 10.1124/dmd.30.4.414; Knowles SR, 2000, LANCET, V356, P1587, DOI 10.1016/S0140-6736(00)03137-8; Kobayashi K, 1999, DRUG METAB DISPOS, V27, P763; Kohno Y, 2005, DRUG METAB DISPOS, V33, P1115, DOI 10.1124/dmd.104.002634; Kokate TG, 1999, J PHARMACOL EXP THER, V288, P679; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Lee MS, 2011, MASS SPECTROMETRY DR; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; LINDSTROM TD, 1984, XENOBIOTICA, V14, P503, DOI 10.3109/00498258409151438; Obach RS, 2005, DRUG METAB DISPOS, V33, P262, DOI 10.1124/dmd.104.002428; Sheng R, 2005, BIOORG MED CHEM LETT, V15, P3834, DOI 10.1016/j.bmcl.2005.05.132; Sheng R, 2009, EUR J MED CHEM, V44, P7, DOI 10.1016/j.ejmech.2008.03.003; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Tomalik-Scharte D, 2011, DRUG METAB DISPOS, V39, P927, DOI 10.1124/dmd.110.036921; Tracy TS, 2003, CURR DRUG METAB, V4, P341, DOI 10.2174/1389200033489280; Wang RW, 2000, DRUG METAB DISPOS, V28, P360; Wang Xiao-Wen, 2009, Zhongguo Yaolixue Yu Dulixue Zazhi, V23, P456, DOI 10.3867/j.issn.1000-3002.2009.06.007; Xia ZL, 2007, J CHROMATOGR B, V857, P266, DOI 10.1016/j.jchromb.2007.07.029; Yu LS, 2007, BIOCHEM PHARMACOL, V73, P1842, DOI 10.1016/j.bcp.2007.02.004; Zhang J, 2009, EUR J PHARMACOL, V613, P1, DOI 10.1016/j.ejphar.2009.03.054	35	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59882	10.1371/journal.pone.0059882	http://dx.doi.org/10.1371/journal.pone.0059882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555822	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900039
J	Kim, K; Jeong, JH; Lim, D; Hong, Y; Yun, M; Min, JJ; Kwak, SJ; Choy, HE				Kim, Kwangsoo; Jeong, Jae Ho; Lim, Daejin; Hong, Yeongjin; Yun, Misun; Min, Jung-Joon; Kwak, Sahng-June; Choy, Hyon E.			A Novel Balanced-Lethal Host-Vector System Based on glmS	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; STATIONARY-PHASE INDUCTION; SALMONELLA-TYPHIMURIUM; PEPTIDOGLYCAN SYNTHESIS; COORDINATED REGULATION; N-ACETYLGLUCOSAMINE; PPGPP; GENE; STRAINS; OPERON	During the last decade, an increasing number of papers have described the use of various genera of bacteria, including E. coli and S. typhimurium, in the treatment of cancer. This is primarily due to the facts that not only are these bacteria capable of accumulating in the tumor mass, but they can also be engineered to deliver specific therapeutic proteins directly to the tumor site. However, a major obstacle exists in that bacteria because the plasmid carrying the therapeutic gene is not needed for bacterial survival, these plasmids are often lost from the bacteria. Here, we report the development of a balanced-lethal host-vector system based on deletion of the glmS gene in E. coli and S. typhimurium. This system takes advantage of the phenotype of the GlmS(-) mutant, which undergoes lysis in animal systems that lack the nutrients required for proliferation of the mutant bacteria, D-glucosamine (GlcN) or N-acetyl-D-glucosamine (GlcNAc), components necessary for peptidoglycan synthesis. We demonstrate that plasmids carrying a glmS gene (GlmS(+) p) complemented the phenotype of the GlmS(-) mutant, and that GlmS(+) p was maintained faithfully both in vitro and in an animal system in the absence of selection pressure. This was further verified by bioluminescent signals from GlmS(+) pLux carried in bacteria that accumulated in grafted tumor tissue in a mouse model. The signal was up to several hundred-fold stronger than that from the control plasmid, pLux, due to faithful maintenance of the plasmid. We believe this system will allow to package a therapeutic gene onto an expression plasmid for bacterial delivery to the tumor site without subsequent loss of plasmid expression as well as to quantify bioluminescent bacteria using in vivo imaging by providing a direct correlation between photon flux and bacterial number.	[Kim, Kwangsoo; Jeong, Jae Ho; Lim, Daejin; Hong, Yeongjin; Choy, Hyon E.] Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea; [Yun, Misun; Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Kwangju, South Korea; [Kwak, Sahng-June] Dankook Univ, Coll Med, Dept Biochem, Cheonan, Anseo, South Korea	Chonnam National University; Chonnam National University; Dankook University	Choy, HE (corresponding author), Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea.	hyonchoy@jnu.ac.kr	Yun, Misun/AAI-4681-2021	Jeong, Jae-Ho/0000-0002-5544-9572	Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science, and Technology (MEST) [2011- 0031958, 2012- 0001031]; National Research Foundation of Korea (NRF) [2012-0006072]; Pioneer Research Center Program "Bacteriobot" through NFR	Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Pioneer Research Center Program "Bacteriobot" through NFR	This work was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project funded by the Ministry of Education, Science, and Technology (MEST) (2011- 0031958). JJM was supported by the National Research Foundation of Korea (NRF) (No. 2012-0006072). YH was supported by the Pioneer Research Center Program "Bacteriobot" through NFR funded by the Ministry of Education, Science, and Technology (MEST) (2012- 0001031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN BJ, 1983, MICROBIOL REV, V47, P454; Chen JK, 2010, MAR DRUGS, V8, P2493, DOI 10.3390/md8092493; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; El Ashry ESH, 2007, PURE APPL CHEM, V79, P2229, DOI 10.1351/pac200779122229; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GARRETT S, 1985, J BACTERIOL, V162, P840, DOI 10.1128/JB.162.2.840-844.1985; HOLMES RP, 1972, J BACTERIOL, V11, P290, DOI 10.1128/JB.111.1.290-291.1972; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Jiang SN, 2010, MOL THER, V18, P635, DOI 10.1038/mt.2009.295; JONESMORTIMER MC, 1980, J GEN MICROBIOL, V117, P369; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; Kim EY, 2004, J MICROBIOL, V42, P103; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Na HS, 2006, VACCINE, V24, P2027, DOI 10.1016/j.vaccine.2005.11.031; Nguyen VH, 2010, CANCER RES, V70, P18, DOI 10.1158/0008-5472.CAN-09-3453; Persiani S, 2007, OSTEOARTHR CARTILAGE, V15, P764, DOI 10.1016/j.joca.2007.01.019; PLUMBRIDGE J, 1995, EMBO J, V14, P3958, DOI 10.1002/j.1460-2075.1995.tb00067.x; PLUMBRIDGE JA, 1989, MOL MICROBIOL, V3, P505, DOI 10.1111/j.1365-2958.1989.tb00197.x; PLUMBRIDGE JA, 1993, J BACTERIOL, V175, P4951, DOI 10.1128/JB.175.16.4951-4956.1993; PUTNAM SL, 1975, ANAL BIOCHEM, V63, P350, DOI 10.1016/0003-2697(75)90357-7; SARVAS M, 1971, J BACTERIOL, V105, P467, DOI 10.1128/JB.105.2.467-471.1971; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; Song M, 2010, J MICROBIOL, V48, P89, DOI 10.1007/s12275-009-0179-6; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; WITTMANN HG, 1975, MOL GEN GENET, V141, P331, DOI 10.1007/BF00331454; Wu GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017082; WU HC, 1971, J BACTERIOL, V105, P455, DOI 10.1128/JB.105.2.455-466.1971; ZUBAY G, 1972, P NATL ACAD SCI USA, V69, P1100, DOI 10.1073/pnas.69.5.1100	36	15	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60511	10.1371/journal.pone.0060511	http://dx.doi.org/10.1371/journal.pone.0060511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555984	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200121
J	Li, L; Stahlman, M; Rutberg, M; Haversen, L; Fogelstrand, P; Andersson, L; Levin, M; Boren, J				Li, Lu; Stahlman, Marcus; Rutberg, Mikael; Haversen, Liliana; Fogelstrand, Per; Andersson, Linda; Levin, Malin; Boren, Jan			ARF6 Regulates Neuron Differentiation through Glucosylceramide Synthase	PLOS ONE			English	Article							NEURITE OUTGROWTH; GLYCOSPHINGOLIPID SYNTHESIS; INHIBITOR; CELLS; ACTIVATION; TRANSPORT; ENDOSOME; GROWTH; ARNO	The small GTPase ADP ribosylation factor 6 (ARF6) mediates endocytosis and has in addition been shown to regulate neuron differentiation. Here we investigated whether ARF6 promotes differentiation of Neuro-2a neuronal cells by modifying the cellular lipid composition. We showed that knockdown of ARF6 by siRNA in Neuro-2a cells increased neuronal outgrowth as expected. ARF6 knockdown also resulted in increased glucosylceramide levels and decreased sphingomyelin levels, but did not affect the levels of ceramide or phospholipids. We speculated that the ARF6 knockdown-induced increase in glucosylceramide was caused by an effect on glucosylceramide synthase and, in agreement, showed that ARF6 knockdown increased the mRNA levels and activity of glucosylceramide synthase. Finally, we showed that incubation of Neuro-2a cells with the glucosylceramide synthase inhibitor D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) normalized the increased neuronal outgrowth induced by ARF6 knockdown. Our results thus show that ARF6 regulates neuronal differentiation through an effect on glucosylceramide synthase and glucosylceramide levels.	[Li, Lu; Stahlman, Marcus; Rutberg, Mikael; Haversen, Liliana; Fogelstrand, Per; Andersson, Linda; Levin, Malin; Boren, Jan] Sahlgrens Univ Hosp, Wallenberg Lab, Gothenburg, Sweden; [Li, Lu; Stahlman, Marcus; Rutberg, Mikael; Haversen, Liliana; Fogelstrand, Per; Andersson, Linda; Levin, Malin; Boren, Jan] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Boren, J (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab, Gothenburg, Sweden.	jan.boren@wlab.gu.se	StÃhlman, Marcus/M-4597-2019	Levin, Malin/0000-0003-1069-5275; Andersson, Linda/0000-0003-3230-5397; Henricsson, Marcus/0000-0002-4202-0339	Swedish Research Council; Swedish Heart and Lung Foundation; Torsten Foundation; Ragnar Soderbergs Foundation; Swedish Diabetes Foundation; Novo Nordic Foundation; Swedish Foundation for Strategic Research; EU program LipidomicNet; Novo Nordisk Fonden [NNF13OC0004973] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Torsten Foundation; Ragnar Soderbergs Foundation; Swedish Diabetes Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EU program LipidomicNet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Swedish Research Council, the Swedish Heart and Lung Foundation, Torsten and Ragnar Soderbergs Foundations, the Swedish Diabetes Foundation, Novo Nordic Foundation, the Swedish Foundation for Strategic Research, and the EU program LipidomicNet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hernandez-Deviez D, 2007, TRAFFIC, V8, P1750, DOI 10.1111/j.1600-0854.2007.00649.x; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Ledeen R, 2011, J NEUROCHEM, V116, P714, DOI 10.1111/j.1471-4159.2010.07115.x; Lee Jae-Hyuk, 2011, Chonnam Med J, V47, P27, DOI 10.4068/cmj.2011.47.1.27; Miyazaki H, 2005, FEBS LETT, V579, P6834, DOI 10.1016/j.febslet.2005.11.022; Mutoh T, 1998, J BIOL CHEM, V273, P26001, DOI 10.1074/jbc.273.40.26001; Schweitzer JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005193; UEMURA K, 1991, J BIOCHEM-TOKYO, V110, P96, DOI 10.1093/oxfordjournals.jbchem.a123549; UEMURA K, 1995, J BIOCHEM, V118, P371, DOI 10.1093/oxfordjournals.jbchem.a124916; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; VANTHOF W, 1992, BIOCHEM J, V283, P913, DOI 10.1042/bj2830913; WU GS, 1994, MOL CHEM NEUROPATHOL, V21, P259, DOI 10.1007/BF02815354; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60118	10.1371/journal.pone.0060118	http://dx.doi.org/10.1371/journal.pone.0060118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555901	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200085
J	Li, X; Zhuo, R; Tiong, S; Di Cara, F; King-Jones, K; Hughes, SC; Campbell, SD; Wevrick, R				Li, Xiao; Zhuo, Ran; Tiong, Stanley; Di Cara, Francesca; King-Jones, Kirst; Hughes, Sarah C.; Campbell, Shelagh D.; Wevrick, Rachel			The Smc5/Smc6/MAGE Complex Confers Resistance to Caffeine and Genotoxic Stress in Drosophila melanogaster	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; SYNDROME PROTEIN NECDIN; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; SMC5-SMC6 COMPLEX; REPLICATION FORKS; SMC5/6 COMPLEX; SUMO LIGASE; POSTEMBRYONIC NEUROGENESIS; CHECKPOINT	The SMC5/6 protein complex consists of the Smc5, Smc6 and Non-Smc-Element (Nse) proteins and is important for genome stability in many species. To identify novel components in the DNA repair pathway, we carried out a genetic screen to identify mutations that confer reduced resistance to the genotoxic effects of caffeine, which inhibits the ATM and ATR DNA damage response proteins. This approach identified inactivating mutations in CG5524 and MAGE, homologs of genes encoding Smc6 and Nse3 in yeasts. The fact that Smc5 mutants are also caffeine-sensitive and that Mage physically interacts with Drosophila homologs of Nse proteins suggests that the structure of the Smc5/6 complex is conserved in Drosophila. Although Smc5/6 proteins are required for viability in S. cerevisiae, they are not essential under normal circumstances in Drosophila. However, flies carrying mutations in Smc5, Smc6 and MAGE are hypersensitive to genotoxic agents such as ionizing radiation, camptothecin, hydroxyurea and MMS, consistent with the Smc5/6 complex serving a conserved role in genome stability. We also show that mutant flies are not compromised for pre-mitotic cell cycle checkpoint responses. Rather, caffeine-induced apoptosis in these mutants is exacerbated by inhibition of ATM or ATR checkpoint kinases but suppressed by Rad51 depletion, suggesting a functional interaction involving homologous DNA repair pathways that deserves further scrutiny. Our insights into the SMC5/6 complex provide new challenges for understanding the role of this enigmatic chromatin factor in multi-cellular organisms.	[Li, Xiao; Hughes, Sarah C.; Wevrick, Rachel] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Zhuo, Ran; Tiong, Stanley; Di Cara, Francesca; King-Jones, Kirst; Campbell, Shelagh D.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Wevrick, R (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	rwevrick@ualberta.ca	Campbell, Shelagh/A-2623-2014; Zhuo, Ran/AAA-5998-2022	Campbell, Shelagh/0000-0001-6433-9757; Zhuo, Ran/0000-0002-0455-3281; Di cara, Francesca/0000-0002-6973-3232; Wevrick, Rachel/0000-0002-3343-5794	Cancer Research Society (Canada); Canadian Institutes of Health Research Operating Grant [MOP 93761]; NSERC Discovery Grant [G121210462]	Cancer Research Society (Canada); Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by an operating grant from the Cancer Research Society (Canada) to RW and SCH, a Canadian Institutes of Health Research Operating Grant to KK-J (MOP 93761), and an NSERC Discovery Grant (G121210462) to SDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Bermudez-Lopez M, 2010, NUCLEIC ACIDS RES, V38, P6502, DOI 10.1093/nar/gkq546; Bertrand MJM, 2008, CELL DEATH DIFFER, V15, P1921, DOI 10.1038/cdd.2008.127; Bickel JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001028; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; BOYD JB, 1976, GENETICS, V84, P485; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Brodsky MH, 2000, GENE DEV, V14, P666; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cuylen S, 2011, TRENDS CELL BIOL, V21, P552, DOI 10.1016/j.tcb.2011.06.003; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guerineau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035813; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Han WN, 2011, J BIOL CHEM, V286, P22825, DOI 10.1074/jbc.M111.222349; Harvey SH, 2004, MOL CELL BIOL, V24, P662, DOI 10.1128/MCB.24.2.662-674.2004; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hudson JJR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017270; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Johansson F, 2006, DNA REPAIR, V5, P1449, DOI 10.1016/j.dnarep.2006.07.005; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurencon A, 2003, GENETICS, V164, P589; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Maggert Keith A., 2008, V420, P155, DOI 10.1007/978-1-59745-583-1_9; Miranda EI, 2010, LEUKEMIA RES, V34, P1121, DOI 10.1016/j.leukres.2010.03.045; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nishimura I, 2008, NEUROSCIENCE, V154, P572, DOI 10.1016/j.neuroscience.2008.03.075; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pold M, 2000, DEV COMP IMMUNOL, V24, P719, DOI 10.1016/S0145-305X(00)00027-6; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Rai R, 2011, J BIOL CHEM, V286, P14516, DOI 10.1074/jbc.M110.157149; Sang MX, 2011, CANCER LETT, V302, P85, DOI 10.1016/j.canlet.2010.10.021; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Silva E, 2004, CURR BIOL, V14, P1341, DOI 10.1016/j.cub.2004.06.056; Silva EA, 2006, GENOME, V49, P1416, DOI 10.1139/G06-098; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Stephan AK, 2011, FEBS LETT, V585, P2907, DOI 10.1016/j.febslet.2011.04.067; Stephan AK, 2011, MOL CELL BIOL, V31, P1369, DOI 10.1128/MCB.00786-10; Stowers RS, 1999, GENETICS, V152, P1631; Sullivan W., 2000, Drosophila protocols; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Thomas Barbara J., 1994, Trends in Cell Biology, V4, P389, DOI 10.1016/0962-8924(94)90051-5; Toba G, 1999, GENETICS, V151, P725; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Watanabe K, 2009, PLANT CELL, V21, P2688, DOI 10.1105/tpc.108.060525; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	70	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59866	10.1371/journal.pone.0059866	http://dx.doi.org/10.1371/journal.pone.0059866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555814	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200051
J	Nguyen, NP; Ceizyk, M; Vos, P; Betz, M; Chi, A; Almeida, F; Davis, R; Slane, B; Gelumbauskas, S; Smith-Raymond, L; Abraham, D; Stevie, M; Jang, SY; Vinh-Hung, V				Nguyen, Nam P.; Ceizyk, Misty; Vos, Paul; Betz, Michael; Chi, Alexander; Almeida, Fabio; Davis, Rick; Slane, Benjamin; Gelumbauskas, Steven; Smith-Raymond, Lexie; Abraham, Dave; Stevie, Michelle; Jang, Siyoung; Vinh-Hung, Vincent			Feasibility of Tomotherapy-Based Image-Guided Radiotherapy for Locally Advanced Oropharyngeal Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; NECK-CANCER; HELICAL TOMOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY; HEAD; CHEMORADIATION; AMIFOSTINE	Purpose: The study aims to assess the feasibility of tomotherapy-based image-guided (IGRT) radiotherapy for locally advanced oropharyngeal cancer. A retrospective review of 33 patients undergoing concurrent chemoradiation for locally advanced oropharyngeal cancers was conducted. Radiotherapy planning, treatment toxicity and loco-regional control were assessed. Results: At a median follow-up of 32 months (6-47 months), no patient developed loco-regional recurrence. Two patients (6%) developed distant metastases. Grade 3-4 acute toxicity was respectively 72% and 25% for mucositis and gastrointestinal toxicity. Two patients (6%) had long-term dependence on tube feedings. Dose-volume histogram demonstrated excellent target volume coverage and low radiation dose to the organs at risk for complications. Conclusions and clinical relevance: IGRT provides excellent loco-regional control but acute toxicity remains significant and needs to be addressed in future prospective trials. The feasibility of Tomotherapy to decrease radiation dose to the normal tissues merits further investigations.	[Nguyen, Nam P.; Ceizyk, Misty; Davis, Rick; Slane, Benjamin; Gelumbauskas, Steven; Smith-Raymond, Lexie; Abraham, Dave; Stevie, Michelle; Jang, Siyoung] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA; [Vos, Paul] E Carolina Univ, Dept Biostat, Greenville, NC USA; [Betz, Michael] Hirslanden Radiat Oncol Inst, Lausanne, Switzerland; [Chi, Alexander] W Virginia Univ, Dept Radiat Oncol, Morgantown, WV 26506 USA; [Almeida, Fabio] Southwest PET CT Inst, Tucson, AZ USA; [Vinh-Hung, Vincent] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland	University of Arizona; University of North Carolina; East Carolina University; West Virginia University; University of Geneva	Nguyen, NP (corresponding author), Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA.	NamPhong.Nguyen@yahoo.com	Vinh-Hung, Vincent/A-5762-2008	Vinh-Hung, Vincent/0000-0002-6403-6120				Buntzel J, 2007, ANTICANCER RES, V27, P1953; Buntzel J, 1998, ANN ONCOL, V9, P505, DOI 10.1023/A:1008282412670; Cannon DM, 2008, INT J RADIAT ONCOL, V70, P660, DOI 10.1016/j.ijrobp.2007.09.018; Chen AM, 2010, TECHNOL CANCER RES T, V9, P291, DOI 10.1177/153303461000900308; Daly ME, 2010, INT J RADIAT ONCOL, V76, P1339, DOI 10.1016/j.ijrobp.2009.04.006; de Arruda FF, 2006, INT J RADIAT ONCOL, V64, P363, DOI 10.1016/j.ijrobp.2005.03.006; Feng FY, 2010, J CLIN ONCOL, V28, P2732, DOI 10.1200/JCO.2009.24.6199; Jacob V, 2010, STRAHLENTHER ONKOL, V186, P502, DOI 10.1007/s00066-010-2124-3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kuntz AL, 1999, LARYNGOSCOPE, V109, P1334, DOI 10.1097/00005537-199908000-00030; LAUCIELLO FR, 1980, J PROSTHET DENT, V43, P204, DOI 10.1016/0022-3913(80)90188-2; Lee TF, 2008, RADIOTHER ONCOL, V89, P89, DOI 10.1016/j.radonc.2008.05.010; Malone JP, 2009, ARCH OTOLARYNGOL, V135, P1119, DOI 10.1001/archoto.2009.152; Murthy V, 2010, J CANCER RES THER, V6, P194, DOI 10.4103/0973-1482.65245; Nguyen NP, 2010, QJM-INT J MED, V103, P229, DOI 10.1093/qjmed/hcp176; Nguyen NP, 2009, BRIT J RADIOL, V82, P675, DOI 10.1259/bjr/72852974; Nguyen NP, 2007, AM J OTOLARYNG, V28, P3, DOI 10.1016/j.amjoto.2006.03.007; Nguyen NP, 2011, ORAL ONCOL, V47, P414, DOI 10.1016/j.oraloncology.2011.03.011; Nguyen NP, 2010, ORAL ONCOL, V46, P283, DOI 10.1016/j.oraloncology.2010.01.010; Ong SC, 2008, J NUCL MED, V49, P532, DOI 10.2967/jnumed.107.044792; Parsons JT, 2002, CANCER-AM CANCER SOC, V94, P2967, DOI 10.1002/cncr.10567; Pauloski BR, 2004, HEAD NECK-J SCI SPEC, V26, P625, DOI 10.1002/hed.20013; Salaun PY, 2007, HEAD NECK-J SCI SPEC, V29, P1125; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Soo KC, 2005, BRIT J CANCER, V93, P279, DOI 10.1038/sj.bjc.6602696; Ulrich S, 2009, MED PHYS, V36, P4702, DOI 10.1118/1.3223633; Yao M, 2005, INT J RADIAT ONCOL, V63, P991, DOI 10.1016/j.ijrobp.2005.03.066	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60268	10.1371/journal.pone.0060268	http://dx.doi.org/10.1371/journal.pone.0060268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555938	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200103
J	Garcia-Olivares, J; Torres-Salazar, D; Owens, WA; Baust, T; Siderovski, DP; Amara, SG; Zhu, J; Daws, LC; Torres, GE				Garcia-Olivares, Jennie; Torres-Salazar, Delany; Owens, William A.; Baust, Tracy; Siderovski, David P.; Amara, Susan G.; Zhu, Jun; Daws, Lynette C.; Torres, Gonzalo E.			Inhibition of Dopamine Transporter Activity by G Protein beta gamma Subunits	PLOS ONE			English	Article							SYNTAXIN 1A; DISSOCIATION; MODULATION; RECEPTORS; BINDING; DOMAIN	Uptake through the Dopamine Transporter (DAT) is the primary mechanism of terminating dopamine signaling within the brain, thus playing an essential role in neuronal homeostasis. Deregulation of DAT function has been linked to several neurological and psychiatric disorders including ADHD, schizophrenia, Parkinson's disease, and drug addiction. Over the last 15 years, several studies have revealed a plethora of mechanisms influencing the activity and cellular distribution of DAT; suggesting that fine-tuning of dopamine homeostasis occurs via an elaborate interplay of multiple pathways. Here, we show for the first time that the beta gamma subunits of G proteins regulate DAT activity. In heterologous cells and brain tissue, a physical association between G beta gamma subunits and DAT was demonstrated by co-immunoprecipitation. Furthermore, in vitro pull-down assays using purified proteins established that this association occurs via a direct interaction between the intracellular carboxy-terminus of DAT and G beta gamma. Functional assays performed in the presence of the non-hydrolyzable GTP analog GTP-gamma-S, G beta gamma subunit overexpression, or the G beta gamma activator mSIRK all resulted in rapid inhibition of DAT activity in heterologous systems. G beta gamma activation by mSIRK also inhibited dopamine uptake in brain synaptosomes and dopamine clearance from mouse striatum as measured by high-speed chronoamperometry in vivo. G beta gamma subunits are intracellular signaling molecules that regulate a multitude of physiological processes through interactions with enzymes and ion channels. Our findings add neurotransmitter transporters to the growing list of molecules regulated by G-proteins and suggest a novel role for G beta gamma signaling in the control of dopamine homeostasis.	[Garcia-Olivares, Jennie; Torres-Salazar, Delany; Baust, Tracy; Amara, Susan G.; Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Amara, Susan G.; Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Owens, William A.; Daws, Lynette C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Siderovski, David P.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC USA; [Zhu, Jun] Univ S Carolina, Dept Pharmaceut & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Torres, GE (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA.	gtorres@pitt.edu	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Amara, Susan/0000-0001-8914-1106; Torres-Salazar, Delany/0000-0002-6789-9810	National Institute on Drug Abuse, National Institutes of Health [DA 016710-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA016710] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse, National Institutes of Health (DA 016710-02 to G. E. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 1998, EMBO J, V17, P406, DOI 10.1093/emboj/17.2.406; AHNERTHILGER G, 1994, EUR J CELL BIOL, V65, P26; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Callaghan PD, 2005, NEUROCHEM INT, V47, P350, DOI 10.1016/j.neuint.2005.04.026; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; CASS WA, 1994, NEUROSCI LETT, V176, P259, DOI 10.1016/0304-3940(94)90096-5; Cervinski MA, 2010, NEUROSCIENCE, V170, P408, DOI 10.1016/j.neuroscience.2010.07.025; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lin ZC, 2011, PROG MOL BIOL TRANSL, V98, P1, DOI 10.1016/B978-0-12-385506-0.00001-6; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Smrcka AV, 2008, COMB CHEM HIGH T SCR, V11, P382, DOI 10.2174/138620708784534761; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Zahniser NR, 1999, J PHARMACOL EXP THER, V289, P266; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; Zhao Y, 2010, J PHYSIOL-LONDON, V588, P3485, DOI 10.1113/jphysiol.2010.190090; Zhu J, 2009, J PHARMACOL EXP THER, V329, P1071, DOI 10.1124/jpet.108.150144	35	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59788	10.1371/journal.pone.0059788	http://dx.doi.org/10.1371/journal.pone.0059788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555781	Green Published, gold, Green Accepted			2022-12-27	WOS:000317418500089
J	Kim, SE; Patapoutian, A; Grandl, J				Kim, Sung Eun; Patapoutian, Ardem; Grandl, Joerg			Single Residues in the Outer Pore of TRPV1 and TRPV3 Have Temperature-Dependent Conformations	PLOS ONE			English	Article							CAPSAICIN RECEPTOR; ION-CHANNEL; DICTATE SENSITIVITY; HEAT ACTIVATION; STIMULI; TURRET; COLD; CYSTEINE; MENTHOL; PATHWAY	Thermosensation is mediated by ion channels that are highly temperature-sensitive. Several members of the family of transient receptor potential (TRP) ion channels are activated by cold or hot temperatures and have been shown to function as temperature sensors in vivo. The molecular mechanism of temperature-sensitivity of these ion channels is not understood. A number of domains or even single amino acids that regulate temperature-sensitivity have been identified in several TRP channels. However, it is unclear what precise conformational changes occur upon temperature activation. Here, we used the cysteine accessibility method to probe temperature-dependent conformations of single amino acids in TRP channels. We screened over 50 amino acids in the predicted outer pore domains of the heat-activated ion channels TRPV1 and TRPV3. In both ion channels we found residues that have temperature-dependent accessibilities to the extracellular solvent. The identified residues are located within the second predicted extracellular pore loop. These residues are identical or proximal to residues that were shown to be specifically required for temperature-activation, but not chemical activation. Our data precisely locate conformational changes upon temperature-activation within the outer pore domain. Collectively, this suggests that these specific residues and the second predicted pore loop in general are crucial for the temperature activation mechanism of these heat-activated thermoTRPs.	[Kim, Sung Eun; Patapoutian, Ardem; Grandl, Joerg] Scripps Res Inst TSRI, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Patapoutian, Ardem] Novartis Res Fdn GNF, Genom Inst, San Diego, CA USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst TSRI, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	ardem@scripps.edu		Grandl, Jorg/0000-0001-7179-7609	Skaggs Institute; NRSA fellowship; National Institutes of Health [R01-NS046303]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303, F32NS062515] Funding Source: NIH RePORTER	Skaggs Institute; NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S.E.K. is supported by the Skaggs Institute and J.G. was supported by an NRSA fellowship. Research was support by the National Institutes of Health (R01-NS046303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian S, 2003, J BIOL CHEM, V278, P1067, DOI 10.1074/jbc.M206099200; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Baez-Nieto D, 2011, ADV EXP MED BIOL, V704, P469, DOI 10.1007/978-94-007-0265-3_26; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung Y, 2006, J AM CHEM SOC, V128, P15332, DOI 10.1021/ja065827t; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Nelson SW, 2000, BIOCHEMISTRY-US, V39, P11100, DOI 10.1021/bi000609c; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang H, 2013, J PHYSIOL-LONDON, V591, P185, DOI 10.1113/jphysiol.2012.242842; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, P NATL ACAD SCI USA, V107, pE125, DOI 10.1073/pnas.1008272107; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	32	18	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59593	10.1371/journal.pone.0059593	http://dx.doi.org/10.1371/journal.pone.0059593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555720	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500060
J	Mao, SC; Chang, CH; Wu, CC; Orejanera, MJ; Manzoni, OJ; Gean, PW				Mao, Sheng-Chun; Chang, Chih-Hua; Wu, Chia-Chen; Orejanera, Maria Juliana; Manzoni, Olivier J.; Gean, Po-Wu			Inhibition of Spontaneous Recovery of Fear by mGluR5 after Prolonged Extinction Training	PLOS ONE			English	Article							LONG-TERM DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; METABOTROPIC GLUTAMATE RECEPTORS; SURFACE AMPA RECEPTORS; X MENTAL-RETARDATION; FRAGILE-X; IN-VIVO; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION	Fear behavior is vital for survival and involves learning contingent associations of non-threatening cues with aversive stimuli. In contrast, excessive levels of fear can be maladaptive and lead to anxiety disorders. Generally, extensive sessions of extinction training correlates with reduced spontaneous recovery. The molecular mechanisms underlying the long-term inhibition of fear recovery following repeated extinction training are not fully understood. Here we show that in rats, prolonged extinction training causes greater reduction in both fear-potentiated startle and spontaneous recovery. This effect was specifically blocked by metabotropic glutamate receptor 5 (mGluR5), but not by mGluR1 antagonists and by a protein synthesis inhibitor. Similar inhibition of memory recovery following prolonged extinction training was also observed in mice. In agreement with the instrumental role of mGluR5 in the prolonged inhibition of fear recovery, we found that FMR1-/- mice which exhibit enhanced mGluR5-mediated signaling exhibit lower spontaneous recovery of fear after extinction training than wild-type littermates. At the molecular level, we discovered that prolonged extinction training reversed the fear conditioning-induced increase in surface expression of GluR1, AMPA/NMDA ratio, postsynaptic density-95 (PSD-95) and synapse-associated protein-97 (SAP97). Accordingly, delivery of Tat-GluR2(3Y), a synthetic peptide that blocks AMPA receptor endocytosis, inhibited prolonged extinction training-induced inhibition of fear recovery. Together, our results demonstrate that prolonged extinction training results in the mGluR5-dependent long-term inhibition of fear recovery. This effect may involve the degradation of original memory and may explain the beneficial effects of prolonged exposure therapy for the treatment of phobias.	[Mao, Sheng-Chun; Chang, Chih-Hua; Wu, Chia-Chen; Gean, Po-Wu] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Mao, Sheng-Chun; Chang, Chih-Hua; Wu, Chia-Chen; Gean, Po-Wu] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Orejanera, Maria Juliana; Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France	National Cheng Kung University; National Cheng Kung University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Manzoni, OJ (corresponding author), INSERM, U901, F-13258 Marseille, France.	olivier.manzoni@inserm.fr; powu@mail.ncku.edu.tw	Chang, Chih-Hua/AGY-5609-2022; Manzoni, Olivier/M-7899-2016	Manzoni, Olivier/0000-0002-5579-6208	National Science Council [NSC99-2923-B-006-001-MY3]; National Health Research Institute [NHRI-EX101-10117NI]; Aim for the Top University Project of the National Cheng-Kung University of Taiwan; INSERM; ANR-Blanc France-Taiwan RescueMemo; FRAXA research foundation; NARSAD	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Aim for the Top University Project of the National Cheng-Kung University of Taiwan; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR-Blanc France-Taiwan RescueMemo(French National Research Agency (ANR)); FRAXA research foundation; NARSAD(NARSAD)	This study was supported by grants NSC99-2923-B-006-001-MY3 from the National Science Council, NHRI-EX101-10117NI from the National Health Research Institute and Aim for the Top University Project of the National Cheng-Kung University of Taiwan. INSERM (O.J.M.), ANR-Blanc France-Taiwan RescueMemo (O.J.M. and P. W. G.), FRAXA research foundation (O.J.M.), a NARSAD 2010 Independent Investigator Grant given by the Brain & Behavior Research Foundation (O.J.M.), and Fondation pour la Recherche Medicale (M.J.O.) also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Anderson JJ, 2003, EUR J PHARMACOL, V473, P35, DOI 10.1016/S0014-2999(03)01935-6; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; BOUTON ME, 1992, ANIM LEARN BEHAV, V20, P313, DOI 10.3758/BF03197954; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; Cain CK, 2003, J EXP PSYCHOL ANIM B, V29, P323, DOI 10.1037/0097-7403.29.4.323; Catania MV, 2001, J NEUROSCI, V21, P7664, DOI 10.1523/JNEUROSCI.21-19-07664.2001; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Devenport LD, 1998, ANIM LEARN BEHAV, V26, P172, DOI 10.3758/BF03199210; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Godfraind JM, 1996, AM J MED GENET, V64, P246; Gravius A, 2006, NEUROPHARMACOLOGY, V51, P1146, DOI 10.1016/j.neuropharm.2006.07.008; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim J, 2007, BIOCHEM BIOPH RES CO, V355, P188, DOI 10.1016/j.bbrc.2007.01.125; Litschig S, 1999, MOL PHARMACOL, V55, P453; Lu YM, 1997, J NEUROSCI, V17, P5196; Mao SC, 2006, J NEUROSCI, V26, P8892, DOI 10.1523/JNEUROSCI.0365-06.2006; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Pavlov I., 1927, CONDITIONED REFLEX I; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rudy JW, 2009, LEARN MEMORY, V16, P421, DOI 10.1101/lm.1444909; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yeh SH, 2006, MOL PHARMACOL, V69, P299, DOI 10.1124/mol.105.017194; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	62	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59580	10.1371/journal.pone.0059580	http://dx.doi.org/10.1371/journal.pone.0059580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555716	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400051
J	Watanabe, N; Morimoto, S; Fujiwara, T; Suzuki, T; Taniguchi, K; Ando, T; Kimura, T; Sago, H; Ichihara, A				Watanabe, Noriyoshi; Morimoto, Satoshi; Fujiwara, Takeo; Suzuki, Tomo; Taniguchi, Kosuke; Ando, Takashi; Kimura, Tadashi; Sago, Haruhiko; Ichihara, Atsuhiro			Association between Soluble (Pro)Renin Receptor Concentration in Cord Blood and Small for Gestational Age Birth: A Cross-Sectional Study	PLOS ONE			English	Article							CHILDREN BORN SMALL; METABOLIC SYNDROME; PRORENIN RECEPTOR; RENIN; WEIGHT	Objective: The (pro)renin receptor [(P)RR] has been recognized as a multifunctional receptor. The purpose of this study was to assess the association between plasma soluble (P) RR [s(P)RR] concentration in human cord blood (i.e., neonatal blood at birth) and small for gestational age (SGA) birth. Methods: Participants were women with a singleton pregnancy who delivered at the National Center for Child Health and Development between January 2010 and December 2011. Inclusion criteria were availability of maternal pre-pregnancy and paternal body mass index, and the absence of structural anomalies in neonates. s(P) RR concentration in cord blood was measured in 621 neonates. The 621 pairs of mothers and neonates were categorized into four groups based on quartiles of s(P) RR concentrations in cord blood. SGA was defined as a birth weight below the 10th percentile for gestational age. Logistic regression analysis was performed to assess the association between cord plasma s(P) RR concentration (quartiles) and incidence of SGA births. Results: Among 621 neonates, 55 (8.9%) were diagnosed as SGA (SGA group) and 566 (91.1%) were not (non-SGA group). Average s(P) RR concentration in cord blood was 66.1 +/- 12.6 ng/ml (mean +/- standard deviation). There were 155 pairs in the first plasma s(P) RR concentration quartile (Q1: <58.2 ng/ml), 153 pairs in the second quartile (Q2: 58.2-65.1 ng/ml), 157 pairs in the third quartile (Q3: 65.1-73.1 ng/ml) and 156 pairs in the fourth quartile (Q4: >73.1 ng/ml). The distribution of SGA births was 18 (11.6%) in Q1, 14 (9.2%) in Q2, 16 (10.2%) in Q3 and 7 (4.5%) in Q4, respectively. The odds ratio of SGA births was 0.24 (95% confidence interval: 0.08-0.71) for the fourth quartile compared to the first quartile in multivariate models. The P-value for trend was also significant (P = 0.020). Conclusion: High s(P)RR concentration is associated with a lower SGA birth likelihood.	[Watanabe, Noriyoshi; Morimoto, Satoshi; Ando, Takashi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Shinjuku Ku, Tokyo, Japan; [Watanabe, Noriyoshi; Suzuki, Tomo; Taniguchi, Kosuke; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal & Neonatal Med, Setagaya Ku, Tokyo, Japan; [Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan; [Kimura, Tadashi] Osaka Univ, Dept Obstet & Gynecol, Suita, Osaka, Japan	Tokyo Women's Medical University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Osaka University	Ichihara, A (corresponding author), Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Shinjuku Ku, Tokyo, Japan.	atzichi@endm.twmu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390171]; Ministry of Health, Labor, and Welfare of Japan [10103222]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was approved by the Ethics Committee of our institution, and supported by a Grant for Scientific Research (No. 22390171) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Grant from the Ministry of Health, Labor, and Welfare of Japan (No. 10103222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; Bartels DB, 2005, ARCH DIS CHILD-FETAL, V90, pF53, DOI 10.1136/adc.2004.053892; Biosca M, 2011, NUTR HOSP, V26, P971, DOI [10.3305/nh.2011.26.5.5162, 10.1590/S0212-16112011000500008]; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Chan PYL, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/280402; Chiavaroli V, 2009, PEDIATRICS, V124, P695, DOI 10.1542/peds.2008-3056; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; de Bie HMA, 2010, HORM RES PAEDIAT, V73, P6, DOI 10.1159/000271911; Gardosi J, 2009, AM J OBSTET GYNECOL, V201, pe21, DOI DOI 10.1016/J.AJ0G.2009.04.035; Gardosi J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.034; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Ichihara A, 2012, FRONT BIOSC IN PRESS; Ichihara A, 2011, J RENIN-ANGIO-ALDO S, V12, P638, DOI 10.1177/1470320311429227; Itabashi K, 2011, J JPN PEDIAT SOC, V114, P1271; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; McCowan LME, 2005, BJOG-INT J OBSTET GY, V112, P1026, DOI 10.1111/j.1471-0528.2005.00656.x; Muller DN, 2012, ANN MED, V44, pS43, DOI 10.3109/07853890.2012.660496; Nguyen G, 2011, CLIN SCI, V120, P169, DOI 10.1042/CS20100432; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; PACIFICI GM, 1995, CLIN PHARMACOKINET, V28, P235, DOI 10.2165/00003088-199528030-00005; Rafiq Kazi, 2011, Front Biosci (Schol Ed), V3, P1478; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reinehr T, 2009, EUR J ENDOCRINOL, V160, P579, DOI 10.1530/EJE-08-0914; Sharma Puneet, 2004, BMC Pediatr, V4, P9, DOI 10.1186/1471-2431-4-9; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60036	10.1371/journal.pone.0060036	http://dx.doi.org/10.1371/journal.pone.0060036			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555874	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400076
J	Yan, ER; Yang, XD; Chang, SX; Wang, XH				Yan, En-Rong; Yang, Xiao-Dong; Chang, Scott X.; Wang, Xi-Hua			Plant Trait-Species Abundance Relationships Vary with Environmental Properties in Subtropical Forests in Eastern China	PLOS ONE			English	Article							RELATIVE ABUNDANCE; FUNCTIONAL TRAITS; COMMUNITIES; DISTRIBUTIONS; STRATEGIES; ECONOMICS; SHIFTS; COMPETITION; MECHANISMS; DIVERSITY	Understanding how plant trait-species abundance relationships change with a range of single and multivariate environmental properties is crucial for explaining species abundance and rarity. In this study, the abundance of 94 woody plant species was examined and related to 15 plant leaf and wood traits at both local and landscape scales involving 31 plots in subtropical forests in eastern China. Further, plant trait-species abundance relationships were related to a range of single and multivariate (PCA axes) environmental properties such as air humidity, soil moisture content, soil temperature, soil pH, and soil organic matter, nitrogen (N) and phosphorus (P) contents. At the landscape scale, plant maximum height, and twig and stem wood densities were positively correlated, whereas mean leaf area (MLA), leaf N concentration (LN), and total leaf area per twig size (TLA) were negatively correlated with species abundance. At the plot scale, plant maximum height, leaf and twig dry matter contents, twig and stem wood densities were positively correlated, but MLA, specific leaf area, LN, leaf P concentration and TLA were negatively correlated with species abundance. Plant trait-species abundance relationships shifted over the range of seven single environmental properties and along multivariate environmental axes in a similar way. In conclusion, strong relationships between plant traits and species abundance existed among and within communities. Significant shifts in plant trait-species abundance relationships in a range of environmental properties suggest strong environmental filtering processes that influence species abundance and rarity in the studied subtropical forests.	[Yan, En-Rong; Yang, Xiao-Dong; Wang, Xi-Hua] E China Normal Univ, Dept Environm Sci, Shanghai 200062, Peoples R China; [Yan, En-Rong; Yang, Xiao-Dong; Wang, Xi-Hua] Chinese Natl Ecosyst Observat & Res Network, Tiantong Natl Stn Forest Ecosyst, Ningbo, Peoples R China; [Chang, Scott X.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	East China Normal University; University of Alberta	Yan, ER (corresponding author), E China Normal Univ, Dept Environm Sci, Shanghai 200062, Peoples R China.	eryan@des.ecnu.edu.cn	Chang, Scott X/G-2029-2011	Chang, Scott/0000-0002-7624-439X	National Natural Science Foundation of China [31070383, 31270475]; '211' Project for Ecology in East China Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '211' Project for Ecology in East China Normal University	This study was supported by the National Natural Science Foundation of China (Grant No. 31070383 and 31270475), and '211' Project for Ecology in East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Aerts R, 1999, J EXP BOT, V50, P29, DOI 10.1093/jexbot/50.330.29; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Berendse F, 1987, FUNCT ECOL, V1, P293; Brady N.C., 2004, ELEMENTS NATURE PROP, Vsecond; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cingolani AM, 2007, J VEG SCI, V18, P911, DOI 10.1111/j.1654-1103.2007.tb02607.x; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Dornelas M, 2008, ECOL LETT, V11, P1008, DOI 10.1111/j.1461-0248.2008.01208.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gleason SM, 2009, FUNCT ECOL, V23, P1157, DOI 10.1111/j.1365-2435.2009.01575.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Hubbell Stephen P., 2001, V32, pi; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Marby C, 2000, J VEG SCI, V11, P213, DOI 10.2307/3236801; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mokany K, 2010, OIKOS, V119, P1504, DOI 10.1111/j.1600-0706.2010.18411.x; Morlon H, 2009, ECOL LETT, V12, P488, DOI 10.1111/j.1461-0248.2009.01318.x; Mouillot D, 2007, OECOLOGIA, V152, P729, DOI 10.1007/s00442-007-0688-0; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Reader RJ, 1998, PLANT ECOL, V134, P43, DOI 10.1023/A:1009700100343; Rothstein DE, 2010, SOIL BIOL BIOCHEM, V42, P1743, DOI 10.1016/j.soilbio.2010.06.011; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Song Y., 1995, VEGETATION FLORA TIA; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Suding KN, 2003, ECOLOGY, V84, P1; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; TILMAN D, 1991, AM NAT, V138, P1269, DOI 10.1086/285283; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Yan ER, 2006, PLANT SOIL, V289, P187, DOI 10.1007/s11104-006-9128-x; Yan ER, 2009, PLANT SOIL, V320, P181, DOI 10.1007/s11104-008-9883-y	51	25	27	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61113	10.1371/journal.pone.0061113	http://dx.doi.org/10.1371/journal.pone.0061113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560114	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100116
J	Parmentier, I; Duminil, J; Kuzmina, M; Philippe, M; Thomas, DW; Kenfack, D; Chuyong, GB; Cruaud, C; Hardy, OJ				Parmentier, Ingrid; Duminil, Jerome; Kuzmina, Maria; Philippe, Morgane; Thomas, Duncan W.; Kenfack, David; Chuyong, George B.; Cruaud, Corinne; Hardy, Olivier J.			How Effective Are DNA Barcodes in the Identification of African Rainforest Trees?	PLOS ONE			English	Article							SPECIES DELIMITATION; TROPICAL TREE; PHYLOGENY; DIVERSITY; TAXONOMY; RATES	Background: DNA barcoding of rain forest trees could potentially help biologists identify species and discover new ones. However, DNA barcodes cannot always distinguish between closely related species, and the size and completeness of barcode databases are key parameters for their successful application. We test the ability of rbcL, matK and trnH-psbA plastid DNA markers to identify rain forest trees at two sites in Atlantic central Africa under the assumption that a database is exhaustive in terms of species content, but not necessarily in terms of haplotype diversity within species. Methodology/Principal Findings: We assess the accuracy of identification to species or genus using a genetic distance matrix between samples either based on a global multiple sequence alignment (GD) or on a basic local alignment search tool (BLAST). Where a local database is available (within a 50 ha plot), barcoding was generally reliable for genus identification (95-100% success), but less for species identification (71-88%). Using a single marker, best results for species identification were obtained with trnH-psbA. There was a significant decrease of barcoding success in species-rich clades. When the local database was used to identify the genus of trees from another region and did include all genera from the query individuals but not all species, genus identification success decreased to 84-90%. The GD method performed best but a global multiple sequence alignment is not applicable on trnH-psbA. Conclusions/Significance: Barcoding is a useful tool to assign unidentified African rain forest trees to a genus, but identification to a species is less reliable, especially in species-rich clades, even using an exhaustive local database. Combining two markers improves the accuracy of species identification but it would only marginally improve genus identification. Finally, we highlight some limitations of the BLAST algorithm as currently implemented and suggest possible improvements for barcoding applications.	[Parmentier, Ingrid; Duminil, Jerome; Philippe, Morgane; Hardy, Olivier J.] Univ Libre Bruxelles, Fac Sci, Brussels, Belgium; [Duminil, Jerome] Biovers Int, Subreg Off Cent Africa, Yaounde, Cameroon; [Kuzmina, Maria] Univ Guelph, Biodivers Inst Ontario, Canadian Ctr DNA Barcoding, Guelph, ON N1G 2W1, Canada; [Thomas, Duncan W.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Kenfack, David] Smithsonian Inst, Dept Bot, Washington, DC 20560 USA; [Chuyong, George B.] Univ Buea, Dept Plant & Anim Sci, Buea, Cameroon; [Cruaud, Corinne] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom Genoscope, Evry, France	Universite Libre de Bruxelles; Alliance; Bioversity International; University of Guelph; Oregon State University; Smithsonian Institution; Smithsonian National Museum of Natural History; CEA; UDICE-French Research Universities; Universite Paris Saclay	Hardy, OJ (corresponding author), Univ Libre Bruxelles, Fac Sci, Brussels, Belgium.	ohardy@ulb.ac.be	Hardy, Olivier/R-6531-2018; Duminil, Jérôme/I-2024-2017	Hardy, Olivier/0000-0003-2052-1527; Cruaud, Corinne/0000-0002-4752-7278; Kuzmina, Maria/0000-0003-2725-9146; Duminil, Jerome/0000-0002-2500-824X; Kenfack, David/0000-0001-8208-3388	Centre National de Sequencage (Genoscope, France); Government of Canada through Genome Canada; Ontario Genomics Institute [2008-OGI-ICI-03]; Belgian Fund for Scientific Research (Fonds de la Recherche Scientifique-FNRS) [MIS 4.519.10]; FRS-FNRS	Centre National de Sequencage (Genoscope, France); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Belgian Fund for Scientific Research (Fonds de la Recherche Scientifique-FNRS)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	DNA extraction and sequencing were financed by the Centre National de Sequencage (Genoscope, France, http://www.genoscope.cns.fr/spip/), the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03), and by the Belgian Fund for Scientific Research (Fonds de la Recherche Scientifique-FNRS, http://www1.frs-fnrs.be/) through grant MIS 4.519.10. IP and JD (postdoctoral researchers), and OJH (research associate) are financed by the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2011, BIOL CONSERV, V144, P131, DOI 10.1016/j.biocon.2010.08.008; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chuyong GB, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P506; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Dainou K, 2010, MOL ECOL, V19, P4462, DOI 10.1111/j.1365-294X.2010.04831.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Duminil J, 2012, MOL PHYLOGENET EVOL, V62, P275, DOI 10.1016/j.ympev.2011.09.020; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koffi KG, 2011, AM J BOT, V98, P254, DOI 10.3732/ajb.1000220; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Ley AC, 2010, MOL PHYLOGENET EVOL, V57, P859, DOI 10.1016/j.ympev.2010.08.027; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Parmentier I, 2011, J BIOGEOGR, V38, P1164, DOI 10.1111/j.1365-2699.2010.02467.x; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Samyn Y, 2002, SCIENCE, V295, P276, DOI 10.1126/science.295.5553.276; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Sunderland T., 2004, PRELIMINARY VEGETATI, DOI DOI 10.13140/2.1.2193.6321; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	44	71	78	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e54921	10.1371/journal.pone.0054921	http://dx.doi.org/10.1371/journal.pone.0054921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565134	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300001
J	Facey, PD; Hitchings, MD; Williams, JS; Skibinski, DOF; Dyson, PJ; Del Sol, R				Facey, Paul D.; Hitchings, Matthew D.; Williams, Jason S.; Skibinski, David O. F.; Dyson, Paul J.; Del Sol, Ricardo			The Evolution of an Osmotically Inducible dps in the Genus Streptomyces	PLOS ONE			English	Article							DNA-BINDING PROTEIN; MYCOBACTERIUM-SMEGMATIS DPS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; IRON; FERRITIN; IDENTIFICATION; DETOXIFICATION; PROTECTION; RESISTANCE	Dps proteins are found almost ubiquitously in bacterial genomes and there is now an appreciation of their multifaceted roles in various stress responses. Previous studies have shown that this family of proteins assemble into dodecamers and their quaternary structure is entirely critical to their function. Moreover, the numbers of dps genes per bacterial genome is variable; even amongst closely related species - however, for many genera this enigma is yet to be satisfactorily explained. We reconstruct the most probable evolutionary history of Dps in Streptomyces genomes. Typically, these bacteria encode for more than one Dps protein. We offer the explanation that variation in the number of dps per genome among closely related Streptomyces can be explained by gene duplication or lateral acquisition, and the former preceded a subsequent shift in expression patterns for one of the resultant paralogs. We show that the genome of S. coelicolor encodes for three Dps proteins including a tailless Dps. Our in vivo observations show that the tailless protein, unlike the other two Dps in S. coelicolor, does not readily oligomerise. Phylogenetic and bioinformatic analyses combined with expression studies indicate that in several Streptomyces species at least one Dps is significantly over-expressed during osmotic shock, but the identity of the ortholog varies. In silico analysis of dps promoter regions coupled with gene expression studies of duplicated dps genes shows that paralogous gene pairs are expressed differentially and this correlates with the presence of a sigB promoter. Lastly, we identify a rare novel clade of Dps and show that a representative of these proteins in S. coelicolor possesses a dodecameric quaternary structure of high stability.	[Facey, Paul D.; Hitchings, Matthew D.; Williams, Jason S.; Skibinski, David O. F.; Dyson, Paul J.; Del Sol, Ricardo] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales	Swansea University	Facey, PD (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales.	P.Facey@swansea.ac.uk	Del Sol, Ricardo/L-3171-2015; Facey, Paul/AAK-3265-2021; Dyson, Paul/S-7312-2019	Del Sol, Ricardo/0000-0003-0015-3843; Dyson, Paul/0000-0002-0558-2666; Hitchings, Matthew/0000-0002-5527-4709; Facey, Paul/0000-0002-3229-0255; SKIBINSKI, David/0000-0003-4077-6236	BBSRC [BB/E019242/1]; Biotechnology and Biological Sciences Research Council [BB/E019242/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research has been supported by a grant from the BBSRC (BB/E019242/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Athane A, 2008, J APPL MICROBIOL, V105, P1866, DOI 10.1111/j.1365-2672.2008.03967.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bhattacharyya G, 2007, J BIOL CHEM, V282, P11921, DOI 10.1074/jbc.M611255200; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; Choulet F, 2006, MOL BIOL EVOL, V23, P2361, DOI 10.1093/molbev/msl108; Chowdhury RP, 2007, J BACTERIOL, V189, P8973, DOI 10.1128/JB.01222-07; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Facey PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025593; Fan RL, 2009, BIOCHEMISTRY-US, V48, P5623, DOI 10.1021/bi900387t; Fischer G, 1997, J BACTERIOL, V179, P4553, DOI 10.1128/jb.179.14.4553-4558.1997; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Hopwood DA, 2006, ANNU REV GENET, V40, P1, DOI 10.1146/annurev.genet.40.110405.090639; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SG, 2006, J MOL BIOL, V361, P105, DOI 10.1016/j.jmb.2006.06.010; Maccari G, 2010, BIOINFORMATICS, V26, P1777, DOI 10.1093/bioinformatics/btq258; MATIN A, 1991, MOL MICROBIOL, V5, P3, DOI 10.1111/j.1365-2958.1991.tb01819.x; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nicodeme M, 2004, CURR MICROBIOL, V48, P51, DOI 10.1007/s00284-003-4116-3; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; Pesek J, 2011, J BIOL CHEM, V286, P34872, DOI 10.1074/jbc.M111.246108; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reon BJ, 2012, BIOCH J; Roy S, 2003, ACTA CRYSTALLOGR D, V59, P2254, DOI 10.1107/S0907444903018742; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Roy S, 2007, J MOL BIOL, V370, P752, DOI 10.1016/j.jmb.2007.05.004; Saraswathi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008017; Schwartz JK, BIOCHEMISTRY, V49, P10516; Smulczyk-Krawczyszyn A, 2006, J BACTERIOL, V188, P6184, DOI 10.1128/JB.00528-06; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Takatsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020985; Tamura K, 2011, MOL BIOL EVOLUTION; Thieme D, 2010, MICROBIOL RES, V165, P108, DOI 10.1016/j.micres.2008.12.003; Zhang Y, 2011, INT J MOL SCI, V12, P5406, DOI 10.3390/ijms12085406	46	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60772	10.1371/journal.pone.0060772	http://dx.doi.org/10.1371/journal.pone.0060772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560105	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900075
J	Grubbs, N; Leach, M; Su, X; Petrisko, T; Rosario, JB; Mahaffey, JW				Grubbs, Nathaniel; Leach, Megan; Su, Xin; Petrisko, Tiffany; Rosario, Juan B.; Mahaffey, James W.			New Components of Drosophila Leg Development Identified through Genome Wide Association Studies	PLOS ONE			English	Article							PROXIMAL-DISTAL AXIS; PROXIMODISTAL AXIS; LIMB DEVELOPMENT; GENE-EXPRESSION; COP9 SIGNALOSOME; PS INTEGRINS; HEDGEHOG; PROTEIN; PATHWAY; COMPLEX	The adult Drosophila melanogaster body develops from imaginal discs, groups of cells set-aside during embryogenesis and expanded in number during larval stages. Specification and development of Drosophila imaginal discs have been studied for many years as models of morphogenesis. These studies are often based on mutations with large developmental effects, mutations that are often lethal in embryos when homozygous. Such forward genetic screens can be limited by factors such as early lethality and genetic redundancy. To identify additional genes and genetic pathways involved in leg imaginal disc development, we employed a Genome Wide Association Study utilizing the natural genetic variation in leg proportionality found in the Drosophila Genetic Reference Panel fly lines. In addition to identifying genes already known to be involved in leg development, we identified several genes involved in pathways that had not previously been linked with leg development. Several of the genes appear to be involved in signaling activities, while others have no known roles at this time. Many of these uncharacterized genes are conserved in mammals, so we can now begin to place these genes into developmental contexts. Interestingly, we identified five genes which, when their function is reduced by RNAi, cause an antenna-to-leg transformation. Our results demonstrate the utility of this approach, integrating the tools of quantitative and molecular genetics to study developmental processes, and provide new insights into the pathways and networks involved in Drosophila leg development.	[Grubbs, Nathaniel; Rosario, Juan B.; Mahaffey, James W.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Leach, Megan] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Su, Xin] Howard Hughes Med Inst, Transgen Dept, Ashburn, VA USA; [Petrisko, Tiffany] Emory Univ, Atlanta, GA 30322 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Howard Hughes Medical Institute; Emory University	Mahaffey, JW (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	jim_mahaffey@ncsu.edu	Grubbs, Nathaniel/I-1721-2016	Grubbs, Nathaniel/0000-0002-3631-7427	Developmental Mechanisms Program of the National Science Foundation [IOS-0842201]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	Developmental Mechanisms Program of the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a grant (IOS-0842201) from the Developmental Mechanisms Program of the National Science Foundation (www.nsf.gov) to J.W.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Briscoe J, 2005, DEV CELL, V8, P143, DOI 10.1016/j.devcel.2005.01.008; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Camp D, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-28; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Chen HW, 2002, MOL CELL BIOL, V22, P1792, DOI 10.1128/MCB.22.6.1792-1803.2002; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dong PDS, 2002, DEVELOPMENT, V129, P1967; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Estella C, 2012, CURR TOP DEV BIOL, V98, P173, DOI 10.1016/B978-0-12-386499-4.00007-0; Giorgianni MW, 2011, DEV CELL, V20, P455, DOI 10.1016/j.devcel.2011.03.017; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; Goto S, 1997, DEVELOPMENT, V124, P125; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kojima T, 2004, DEV GROWTH DIFFER, V46, P115; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Mahaffey JW, 2001, GENETICS, V157, P225; MARDON G, 1994, DEVELOPMENT, V120, P3473; Mckay DJ, 2009, DEVELOPMENT, V136, P61, DOI 10.1242/dev.029975; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Morata G, 2001, NAT REV MOL CELL BIO, V2, P89, DOI 10.1038/35052047; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; Patel M, 2007, DEV BIOL, V309, P56, DOI 10.1016/j.ydbio.2007.06.017; PHILLIPS MD, 1990, GENETICS, V125, P91; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Popov VM, 2010, TRENDS ENDOCRIN MET, V21, P41, DOI 10.1016/j.tem.2009.08.002; Pueyo JI, 2005, CURR OPIN GENET DEV, V15, P439, DOI 10.1016/j.gde.2005.06.007; RAUSKOLB C, 1995, DEVELOPMENT, V121, P3663; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; SHEARN A, 1978, GENETICS, V89, P355; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Snodgrass RE, 1958, EVOLUTION ARTHROPOD; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; SUNKEL CE, 1987, ROUX ARCH DEV BIOL, V196, P124, DOI 10.1007/BF00402034; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; WILCOX M, 1989, DEVELOPMENT, V107, P891; Wu J, 2000, MECH DEVELOP, V94, P47, DOI 10.1016/S0925-4773(00)00311-7; Wu J, 1999, DEVELOPMENT, V126, P109; Wu JT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1185; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299; Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310; ZUSMAN S, 1990, DEVELOPMENT, V108, P391	76	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60261	10.1371/journal.pone.0060261	http://dx.doi.org/10.1371/journal.pone.0060261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560084	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900059
J	Lilleri, D; Kabanova, A; Revello, MG; Percivalle, E; Sarasini, A; Genini, E; Sallusto, F; Lanzavecchia, A; Corti, D; Gerna, G				Lilleri, Daniele; Kabanova, Anna; Revello, Maria Grazia; Percivalle, Elena; Sarasini, Antonella; Genini, Emilia; Sallusto, Federica; Lanzavecchia, Antonio; Corti, Davide; Gerna, Giuseppe			Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; UL131-128 GENES; CMV; VIRUS; HCMV; FIBROBLASTS; PREGNANCY; RESPONSES	Primary human cytomegalovirus (HCMV) infections during pregnancy are associated with a high risk of virus transmission to the fetus. To identify correlates of intrauterine HCMV transmission, serial serum samples from HCMV transmitter and non-transmitter pregnant women with primary HCMV infection were analyzed for the presence of neutralizing antibodies against different glycoproteins and glycoprotein complexes, which are known to mediate entry into distinct types of host cells. Neutralizing activity was detected in the sera early after primary infection; absorption with a soluble pentameric complex formed by gH/gL/pUL128-131, but not with gH/gL dimer or with gB, abolished the capacity of sera to neutralize infection of epithelial cells. Importantly, an early, high antibody response to pentamer antigenic sites was associated with a significantly reduced risk of HCMV transmission to the fetus. This association is consistent with the high in vitro inhibition of HCMV infection of epithelial/endothelial cells as well as cell-to-cell spreading and virus transfer to leukocytes by anti-pentamer antibodies. Taken together, these findings indicate that the HCMV pentamer complex is a major target of the antibody-mediated maternal immunity.	[Lilleri, Daniele; Gerna, Giuseppe] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Lab Sperimentali Ric, Area Trapiantol, I-27100 Pavia, Italy; [Lilleri, Daniele; Kabanova, Anna; Sallusto, Federica; Lanzavecchia, Antonio; Corti, Davide] Inst Res Biomed, Bellinzona, Switzerland; [Revello, Maria Grazia] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, SC Ostetricia & Ginecol, I-27100 Pavia, Italy; [Percivalle, Elena; Sarasini, Antonella; Genini, Emilia] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, SS Virol Mol, SC Virol & Microbiol, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; Universita della Svizzera Italiana; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Gerna, G (corresponding author), Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Lab Sperimentali Ric, Area Trapiantol, I-27100 Pavia, Italy.	g.gerna@smatteo.pv.it	Kabanova, Anna/I-2562-2018; percivalle, elena/K-7994-2016; Lilleri, Daniele/K-7776-2016	Kabanova, Anna/0000-0002-2077-472X; percivalle, elena/0000-0002-3355-1410; Lilleri, Daniele/0000-0001-7747-7622; Gerna, Giuseppe/0000-0001-5956-2786; Genini, Emilia/0000-0002-6884-0028	Fondazione CARIPLO, Milan, Italy [93043/A]; Ministero della Salute, Ricerca Corrente Fondazione IRCCS Policlinico San Matteo [80206, 80513]; Fondazione Carlo Denegri (FCD), Torino, Italy; Helmut Horten Foundation	Fondazione CARIPLO, Milan, Italy(Fondazione Cariplo); Ministero della Salute, Ricerca Corrente Fondazione IRCCS Policlinico San Matteo(Ministry of Health, Italy); Fondazione Carlo Denegri (FCD), Torino, Italy; Helmut Horten Foundation	This work was partially supported by the Fondazione CARIPLO, Milan, Italy, grant 93043/A (to G. Gerna), by the Ministero della Salute, Ricerca Corrente Fondazione IRCCS Policlinico San Matteo grants 80206 (to E. Percivalle) and 80513 (to MG. Revello), and by the Fondazione Carlo Denegri (FCD), Torino, Italy (to G. Gerna). A.Lanzavecchia is supported by the Helmut Horten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodeus M, 1999, OBSTET GYNECOL, V93, P658, DOI 10.1016/S0029-7844(98)00538-9; Carlson C, 1997, VIROLOGY, V239, P198, DOI 10.1006/viro.1997.8892; Compton T, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P231; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cui XH, 2008, VACCINE, V26, P5760, DOI 10.1016/j.vaccine.2008.07.092; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Fornara C, 2011, J CLIN IMMUNOL, V31, P1054, DOI 10.1007/s10875-011-9577-8; Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Furione M, 2012, J CLIN VIROL, V55, P317, DOI 10.1016/j.jcv.2012.08.017; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Genini E, 2011, J CLIN VIROL, V52, P113, DOI 10.1016/j.jcv.2011.06.018; Gerna G, 2000, J VIROL, V74, P5629, DOI 10.1128/JVI.74.12.5629-5638.2000; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Gerna G, 2006, J MED VIROL, V78, P408, DOI 10.1002/jmv.20555; Gerna G, 2003, J CLIN MICROBIOL, V41, P4494, DOI 10.1128/JCM.41.9.4494-4495.2003; GERNA G, 1992, J CLIN MICROBIOL, V30, P1232, DOI 10.1128/JCM.30.5.1232-1237.1992; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Huber MT, 1998, J VIROL, V72, P8191, DOI 10.1128/JVI.72.10.8191-8197.1998; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Lilleri D., 2012, J CLIN IMMUNOL; Lilleri D, 2008, J INFECT DIS, V198, P536, DOI 10.1086/590118; Lilleri D, 2007, J INFECT DIS, V195, P1062, DOI 10.1086/512245; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718; Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015; Potzsch S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002172; Revello MG, 2011, J CLIN VIROL, V50, P303, DOI 10.1016/j.jcv.2010.12.012; Revello MG, 2010, J CLIN VIROL, V48, P255, DOI 10.1016/j.jcv.2010.05.004; Revello MG, 2006, J INFECT DIS, V193, P269, DOI 10.1086/498872; Revello MG, 2001, J GEN VIROL, V82, P1429, DOI 10.1099/0022-1317-82-6-1429; REVELLO MG, 1991, J VIROL METHODS, V35, P315, DOI 10.1016/0166-0934(91)90073-9; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Ryckman BJ, 2010, J VIROL, V84, P2597, DOI 10.1128/JVI.02256-09; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wille PT, 2010, J VIROL, V84, P2585, DOI 10.1128/JVI.02249-09	42	146	149	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59863	10.1371/journal.pone.0059863	http://dx.doi.org/10.1371/journal.pone.0059863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555812	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900036
J	Wang, CT; Yin, XL; Kong, XX; Li, WS; Ma, L; Sun, XD; Guan, YL; Todd, CD; Yang, YP; Hu, XY				Wang, Chuntao; Yin, Xianlun; Kong, Xiangxiang; Li, Wansha; Ma, Lan; Sun, Xudong; Guan, Yanlong; Todd, Christopher D.; Yang, Yongping; Hu, Xiangyang			A Series of TA-Based and Zero-Background Vectors for Plant Functional Genomics	PLOS ONE			English	Article							PROTEIN-KINASE; VERSATILE; CLONING; EXPRESSION; SYSTEM; TOLERANCE; ENCODES; GENES; SET	With the sequencing of genomes from many organisms now complete and the development of high-throughput sequencing, life science research has entered the functional post-genome era. Therefore, deciphering the function of genes and how they interact is in greater demand. To study an unknown gene, the basic methods are either overexpression or gene knockout by creating transgenic plants, and gene construction is usually the first step. Although traditional cloning techniques using restriction enzymes or a site-specific recombination system (Gateway or Clontech cloning technology) are highly useful for efficiently transferring DNA fragments into destination plasmids, the process is time consuming and expensive. To facilitate the procedure of gene construction, we designed a TA-based cloning system in which only one step was needed to subclone a DNA fragment into vectors. Such a cloning system was developed from the pGreen binary vector, which has a minimal size and facilitates construction manipulation, combined with the negative selection marker gene ccdB, which has the advantages of eliminating the self-ligation background and directly enabling high-efficiency TA cloning technology. We previously developed a set of transient and stable transformation vectors for constitutive gene expression, gene silencing, protein tagging, subcellular localization analysis and promoter activity detection. Our results show that such a system is highly efficient and serves as a high-throughput platform for transient or stable transformation in plants for functional genome research.	[Wang, Chuntao; Yin, Xianlun; Kong, Xiangxiang; Li, Wansha; Ma, Lan; Sun, Xudong; Guan, Yanlong; Yang, Yongping; Hu, Xiangyang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunna, Peoples R China; [Wang, Chuntao; Yin, Xianlun; Li, Wansha; Sun, Xudong; Yang, Yongping; Hu, Xiangyang] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunna, Peoples R China; [Kong, Xiangxiang; Ma, Lan; Guan, Yanlong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Todd, Christopher D.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Saskatchewan	Hu, XY (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunna, Peoples R China.	huxiangyang@mail.kib.ac.cn	Hu, Xiangyang/AAQ-3313-2021; Sun, Xudong/HHN-3905-2022	Todd, Christopher/0000-0003-1393-5211	National Sciences Foundation of China [30971452, 31170256]; Major Sciences and Technology Program [110201101003-TS-03]; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2012HB041]; State Education Ministry; Grants-in-Aid for Scientific Research [25505001, 23500465, 24390278, 15K09761] Funding Source: KAKEN	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Major Sciences and Technology Program; Young Academic and Technical Leader Raising Foundation of Yunnan Province; State Education Ministry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Sciences Foundation of China (grants 30971452 and 31170256), the Major Sciences and Technology Program (grant 110201101003-TS-03), State Education Ministry and the Young Academic and Technical Leader Raising Foundation of Yunnan Province (2012HB041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Chen QJ, 2006, ANAL BIOCHEM, V358, P120, DOI 10.1016/j.ab.2006.08.015; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cheong YH, 2010, MOL CELLS, V29, P159, DOI 10.1007/s10059-010-0025-z; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Liang G, 2012, PLANTA, P1; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Sambrook J., 2001, MOL CLONING LAB MANU; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhou MY, 2000, CURR ISSUES MOL BIOL, V2, P2000; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x; Zuo JR, 2000, CURR OPIN BIOTECH, V11, P146, DOI 10.1016/S0958-1669(00)00073-2	31	14	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59576	10.1371/journal.pone.0059576	http://dx.doi.org/10.1371/journal.pone.0059576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555713	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900018
J	Higuchi, S; Hida, A; Tsujimura, S; Mishima, K; Yasukouchi, A; Lee, S; Kinjyo, Y; Miyahira, M				Higuchi, Shigekazu; Hida, Akiko; Tsujimura, Sei-ichi; Mishima, Kazuo; Yasukouchi, Akira; Lee, Sang-il; Kinjyo, Youhei; Miyahira, Manabu			Melanopsin Gene Polymorphism I394T Is Associated with Pupillary Light Responses in a Dose-Dependent Manner	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; JAPANESE VERSION; SUPPRESSION; MELATONIN; SLEEP; CONE; SIZE; ROD; PHOTORECEPTORS; WAVELENGTH	Background: Melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) play an important role in non-image forming responses to light, such as circadian photoentrainment, light-induced melatonin suppression, and pupillary light response. Although it is known that there are some single nucleotide polymorphisms (SNPs) in the melanopsin (OPN4) gene in humans, the associations of the SNPs with non-image forming responses to light remains unclear. In the present study, we examined the associations of melanopsin gene polymorphisms with pupillary light response. Methods: Japanese university students (mean age: 21.0 +/- 1.7 years) with the genotypes of TT (n = 38), TC (n = 28) and CC (n = 7) at rs1079610 (I394T) located in the coding region participated in the present study. They were matched by age and sex ratio. Dark-adapted pupil size (<1 lx) was first measured. Then steady-state pupil size was measured during exposure to five lighting conditions (10 lx, 100 lx, 1000 lx, 3000 lx, 6000 lx in the vertical direction at eye level). Results: Significant interaction between the genotype of I394T (TT versus TC+CC) and luminance levels was found in pupil size. Under high illuminance levels (1000 lx, 3000 lx and 6000 lx), pupil sizes in subjects with the C allele were significantly smaller than those in subjects with the TT genotype. On the other hand, pupil size in subjects with the C allele under low illuminance (<1 lx) was significantly larger than that in subjects with the TT genotype. Percentages of pupil constriction under high illuminance levels were significantly greater in subjects with the C allele than in subjects with the TT genotype. Conclusions: Human melanopsin gene polymorphism I394T interacted with irradiance in association with pupil size. This is the first evidence suggesting a functional connection between melanopsin gene polymorphism and pupillary light response as an index of non-image forming response to light.	[Higuchi, Shigekazu; Yasukouchi, Akira; Lee, Sang-il; Kinjyo, Youhei; Miyahira, Manabu] Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan; [Hida, Akiko; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan; [Tsujimura, Sei-ichi] Kagoshima Univ, Dept Informat Sci & Biomed Engn, Kagoshima 890, Japan	Kyushu University; National Center for Neurology & Psychiatry - Japan; Kagoshima University	Higuchi, S (corresponding author), Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan.	higu-s@design.kyushu-u.ac.jp	Tsujimura, Sei-ichi/E-5340-2012; HIGUCHI, Shigekazu/AAM-5800-2020	higuchi, shigekazu/0000-0001-7131-0792; MISHIMA, KAZUO/0000-0003-1182-1181; Tsujimura, Sei-ichi/0000-0002-4619-1469; Lee, Sangil/0000-0001-8998-5827	JSPS KAKENHI [22657063, 24370102]; Ministry of Education, Culture, Sports, Science and Technology of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by JSPS KAKENHI (22657063, 24370102) and a Grant-in-Aid for the Strategic Research Program for Brain Sciences (Understanding of molecular and environmental bases for brain health) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOUMA H, 1962, NATURE, V193, P690, DOI 10.1038/193690a0; Brainard GC, 2005, J BIOL RHYTHM, V20, P314, DOI 10.1177/0748730405278951; Brown TM, 2012, CURR BIOL, V22, P1134, DOI 10.1016/j.cub.2012.04.039; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Fukuda Y, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-20; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goel N, 2002, DEPRESS ANXIETY, V15, P34, DOI 10.1002/da.1083; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Higuchi S, 2008, NEUROSCI LETT, V440, P23, DOI 10.1016/j.neulet.2008.05.037; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; ISHIHARA K, 1984, PERCEPT MOTOR SKILL, V59, P863, DOI 10.2466/pms.1984.59.3.863; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Lockley SW, 2006, CURR BIOL, V16, pR795, DOI 10.1016/j.cub.2006.08.039; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Nischler C, 2012, GRAEFES ARC IN PRESS; Okawa M, 1996, ACTA PSYCHIAT SCAND, V94, P211, DOI 10.1111/j.1600-0447.1996.tb09851.x; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Roecklein KA, 2012, CHRONOBIOL INT, V29, P1036, DOI 10.3109/07420528.2012.706766; Roecklein KA, 2009, J AFFECT DISORDERS, V114, P279, DOI 10.1016/j.jad.2008.08.005; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Ruger M, 2005, J SLEEP RES, V14, P221, DOI 10.1111/j.1365-2869.2005.00452.x; Santhi N, 2012, J PINEAL RES, V53, P47, DOI 10.1111/j.1600-079X.2011.00970.x; Tsujimura S, 2011, OPHTHAL PHYSL OPT, V31, P469, DOI 10.1111/j.1475-1313.2011.00846.x; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Yu MZ, 2007, OPHTHAL PHYSL OPT, V27, P130, DOI 10.1111/j.1475-1313.2006.00450.x; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	40	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60310	10.1371/journal.pone.0060310	http://dx.doi.org/10.1371/journal.pone.0060310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555953	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200107
J	Hines, DJ; Choi, HB; Hines, RM; Phillips, AG; MacVicar, BA				Hines, Dustin J.; Choi, Hyun B.; Hines, Rochelle M.; Phillips, Anthony G.; MacVicar, Brian A.			Prevention of LPS-Induced Microglia Activation, Cytokine Production and Sickness Behavior with TLR4 Receptor Interfering Peptides	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; SYSTEMIC INFLAMMATION; INNATE IMMUNITY; IN-VIVO; BRAIN; CELLS; LIPOPOLYSACCHARIDE; MECHANISMS; NEURODEGENERATION; DIMERIZATION	The innate immune receptor Toll-like 4 (TLR4) is the receptor activated by lipopolysaccharide (LPS), and TLR4-LPS interaction is well known to induce an innate immune response, triggering sickness behavior. Within the brain, TLR4 is highly expressed in brain microglia, and excessive inflammation resulting from activation of this pathway in the brain has been implicated in depressive disorders and neurodegenerative pathologies. We hypothesized that blocking LPS-induced activation of TLR4 would prevent downstream immune signaling in the brain and suppress the induction of sickness behavior. We used interfering peptides to block TLR4 activation and confirmed their efficacy in preventing second messenger activation and cytokine production normally induced by LPS treatment. Further, these peptides blocked morphological changes in microglia that are typically induced by LPS. We also demonstrated that intraperitoneal (i.p.) injection of Tat-TLR4 interfering peptides prevented LPS-induced sickness behavior, as assessed in home cage behavior and with the intracranial self-stimulation paradigm. These newly synthesised peptides inhibit TLR4 signaling thereby preventing changes in behavior and motivation caused by inflammatory stimuli. These peptides highlight the roll of TLR4 and microglia morphology changes in sickness behavior, and thus may be of therapeutic value in limiting the deleterious impact of excessive inflammation in specific CNS pathologies.	[MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	bmacvicar@brain.ubc.ca	Hines, Rochelle/AAE-3784-2020; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015; Hines, Dustin/AAC-6394-2021	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Hines, Rochelle/0000-0002-0459-7911; Hines, Dustin/0000-0003-2952-9824	Canadian Institutes of Health Research; Fondation Leducq; Heart and Stroke Foundation of Canada; Arthur and June Willms Fellowship; Michael Smith Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leducq(Leducq Foundation); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Arthur and June Willms Fellowship; Michael Smith Foundation(Michael Smith Foundation for Health Research)	Supported by operating Grants from the Canadian Institutes of Health Research and by the Fondation Leducq to BAM. BAM is a Canada Research Chair. DJH was supported by a Heart and Stroke Foundation of Canada Ph.D. award. HBC was supported by postdoctoral fellowships from the Arthur and June Willms Fellowship and the Heart and Stroke Foundation of Canada. RMH was supported by CIHR and Michael Smith Foundation for Health Research PhD awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Barr AM, 2003, INT J NEUROPSYCHOPH, V6, P23, DOI 10.1017/S146114570200319X; Borowski T, 1998, NEUROREPORT, V9, P3797, DOI 10.1097/00001756-199812010-00006; Brown SDM, 2005, NAT GENET, V37, P1155, DOI 10.1038/ng1105-1155; Brown SDM, 2006, PLOS GENET, V2, P1131, DOI 10.1371/journal.pgen.0020118; Buttini M, 1996, NEUROCHEM INT, V29, P25, DOI 10.1016/0197-0186(95)00141-7; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Cunningham Colm, 2002, Trends in Neurosciences, V25, P546, DOI 10.1016/S0166-2236(02)02265-8; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davies M, 2006, MOL VIS, V12, P467; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hines D, 2009, GLIA; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelley KW, 2003, BRAIN BEHAV IMMUN, V17, pS112; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111/j.1460-9568.2008.06549.x; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; PHILLIPS AG, 1984, BRAIN RES BULL, V12, P195, DOI 10.1016/0361-9230(84)90189-8; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J	33	95	107	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60388	10.1371/journal.pone.0060388	http://dx.doi.org/10.1371/journal.pone.0060388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555964	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200113
J	Stiles, JM; Amaya, C; Rains, S; Diaz, D; Pham, R; Battiste, J; Modiano, JF; Kokta, V; Boucheron, LE; Mitchell, DC; Bryan, BA				Stiles, Jessica M.; Amaya, Clarissa; Rains, Steven; Diaz, Dolores; Pham, Robert; Battiste, James; Modiano, Jaime F.; Kokta, Victor; Boucheron, Laura E.; Mitchell, Dianne C.; Bryan, Brad A.			Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma	PLOS ONE			English	Article							BREAST-CANCER; EPITHELIOID HEMANGIOENDOTHELIOMA; PROPRANOLOL TREATMENT; KAPOSIFORM HEMANGIOENDOTHELIOMA; PHASE-II; TUMOR; CELLS; MICE; CHEMOTHERAPY; METASTASIS	Therapeutic targeting of the beta-adrenergic receptors has recently shown remarkable efficacy in the treatment of benign vascular tumors such as infantile hemangiomas. As infantile hemangiomas are reported to express high levels of beta adrenergic receptors, we examined the expression of these receptors on more aggressive vascular tumors such as hemangioendotheliomas and angiosarcomas, revealing beta 1, 2, and 3 receptors were indeed present and therefore aggressive vascular tumors may similarly show increased susceptibility to the inhibitory effects of beta blockade. Using a panel of hemangioendothelioma and angiosarcoma cell lines, we demonstrate that beta adrenergic inhibition blocks cell proliferation and induces apoptosis in a dose dependent manner. Beta blockade is selective for vascular tumor cells over normal endothelial cells and synergistically effective when combined with standard chemotherapeutic or cytotoxic agents. We demonstrate that inhibition of beta adrenergic signaling induces large scale changes in the global gene expression patterns of vascular tumors, including alterations in the expression of established cell cycle and apoptotic regulators. Using in vivo tumor models we demonstrate that beta blockade shows remarkable efficacy as a single agent in reducing the growth of angiosarcoma tumors. In summary, these experiments demonstrate the selective cytotoxicity and tumor suppressive ability of beta adrenergic inhibition on malignant vascular tumors and have laid the groundwork for a promising treatment of angiosarcomas in humans.	[Stiles, Jessica M.; Amaya, Clarissa; Rains, Steven; Diaz, Dolores; Mitchell, Dianne C.; Bryan, Brad A.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, El Paso, TX 79905 USA; [Pham, Robert; Boucheron, Laura E.] New Mexico State Univ, Klipsch Sch Elect & Comp Engn, Las Cruces, NM 88003 USA; [Battiste, James] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Dept Vet Clin Sci, Minneapolis, MN USA; [Boucheron, Laura E.] Univ Montreal, Dept Pathol, CHU St Justine, Montreal, PQ H3C 3J7, Canada	Texas Tech University System; Texas Tech University; New Mexico State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Bryan, BA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, El Paso, TX 79905 USA.	brad.bryan@ttuhsc.edu	Boucheron, Laura E./O-3955-2014; MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	National Heart, Lung, and Blood Institute [HL098931]; TTUHSC startup funds; Liddy Shriver Sarcoma Inititive grant; NASA EPSCoR award; NMSU; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL098931] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); TTUHSC startup funds; Liddy Shriver Sarcoma Inititive grant; NASA EPSCoR award; NMSU; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support of this study was provided by a National Heart, Lung, and Blood Institute grant HL098931, TTUHSC startup funds, and a Liddy Shriver Sarcoma Inititive grant to BAB, and a NASA EPSCoR award to NMSU and internal support from NMSU to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2002, MOL MED, V8, P551, DOI 10.1007/BF03402165; Avagyan S, 2013, J PEDIAT GA IN PRESS; Budd G Thomas, 2002, Curr Oncol Rep, V4, P515, DOI 10.1007/s11912-002-0066-3; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Chisholm KM, 2012, MODERN PATHOL, V25, P1446, DOI 10.1038/modpathol.2012.108; Chiu YE, 2012, PEDIATR BLOOD CANCER, V59, P934, DOI 10.1002/pbc.24103; De Giorgi Vincenzo, 2012, Recenti Progressi in Medicina, V103, P11, DOI 10.1701/1022.11152; Fury MG, 2005, CANCER J, V11, P241, DOI 10.1097/00130404-200505000-00011; George S, 2009, J CLIN ONCOL, V27, P3154, DOI 10.1200/JCO.2008.20.9890; Glasner A, 2010, J IMMUNOL, V184, P2449, DOI 10.4049/jimmunol.0903301; Hasegawa H, 2002, JPN J CANCER RES, V93, P729, DOI 10.1111/j.1349-7006.2002.tb01313.x; Hermans DJJ, 2011, J PEDIAT HEMATOL ONC, V33, pE171, DOI 10.1097/MPH.0b013e3182152e4e; Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819; Lichtenstein N, 2003, CYTOM PART A, V54A, P8, DOI 10.1002/cyto.a.10053; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Mentzel T, 1997, AM J SURG PATHOL, V21, P363, DOI 10.1097/00000478-199704000-00001; Morais P, 2011, CUTAN OCUL TOXICOL, V30, P245, DOI 10.3109/15569527.2011.554483; Mosoia L, 2008, J SURG ONCOL, V98, P432, DOI 10.1002/jso.21132; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Park MS, 2010, CURR OPIN ONCOL, V22, P351, DOI 10.1097/CCO.0b013e32833aaad4; Pasquier E, 2011, ONCOTARGET, V2, P797; Pinero CP, 2012, BRIT J PHARMACOL, V166, P721, DOI 10.1111/j.1476-5381.2011.01791.x; Powe DG, 2011, BREAST CANCER RES TR, V130, P457, DOI 10.1007/s10549-011-1371-z; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Sarialioglu F, 2010, PEDIATR BLOOD CANCER, V55, P1433, DOI 10.1002/pbc.22691; Singh H, 2011, BIOCHEM SOC T, V39, P1592, DOI 10.1042/BST20110699; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Stiles J, 2012, EXP THER MED, V4, P594, DOI 10.3892/etm.2012.654; Street CA, 2010, INT J ONCOL, V37, P1297, DOI 10.3892/ijo_00000781; Szewczyk M, 2012, ANTICANCER RES, V32, P2133; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; VEKSLER IG, 1984, EKSP ONKOL, V6, P50	33	60	62	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60021	10.1371/journal.pone.0060021	http://dx.doi.org/10.1371/journal.pone.0060021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555867	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200070
J	Gavrilov, AA; Golov, AK; Razin, SV				Gavrilov, Alexey A.; Golov, Arkadiy K.; Razin, Sergey V.			Actual Ligation Frequencies in the Chromosome Conformation Capture Procedure	PLOS ONE			English	Article							CHROMATIN; ORGANIZATION; TRANSCRIPTION; CELLS; 5C; 3C	Chromosome conformation capture (3C) and derivative experimental procedures are used to estimate the spatial proximity between different genomic elements, thus providing information about the 3D organization of genomic domains and whole genomes within the nucleus. All C-methods are based on the proximity ligation-the preferential ligation of joined DNA fragments obtained upon restriction enzyme digestion of in vivo cross-linked chromatin. Here, using the mouse beta-globin genes in erythroid cells as a model, we estimated the actual frequencies of ligation between the fragments bearing the promoter of the major beta-globin gene and its distant enhancers and showed that the number of ligation products produced does not exceed 1% of all fragments subjected to the ligation. Although this low yield of 3C ligation products may be explained entirely by technical issues, it may as well reflect a low frequency of interaction between DNA regulatory elements in vivo.	[Gavrilov, Alexey A.; Golov, Arkadiy K.; Razin, Sergey V.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Golov, Arkadiy K.; Razin, Sergey V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Gavrilov, Alexey A.] Univ Oslo, Ctr Med Studies Russia, Moscow, Russia; [Razin, Sergey V.] LIA 1066 French Russian Joint Canc Res Lab, Villejuif, France; [Razin, Sergey V.] LIA 1066 French Russian Joint Canc Res Lab, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University	Gavrilov, AA (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.	aleksey.a.gavrilov@gmail.com	Razin, Sergey V/M-6701-2015; Golov, Arkadiy/AAD-8380-2020; Gavrilov, Alexey/N-2978-2016; Gavrilov, Alexey A./K-3396-2013	Razin, Sergey V/0000-0003-1976-8661; Golov, Arkadiy/0000-0001-7802-3163; Gavrilov, Alexey/0000-0001-8444-1994	Ministry of Science and Education of the Russian Federation [14.740.12.1344, 16.740.11.0483, 8052, 16.552.11.7067]; Russian Foundation for Support of Basic Research [11-04-00361-a, 11-04-91334-NNIO_a, 12-04-93109-CNRS_a, 12-04-00036-a]; Presidium of the Russian Academy of Sciences from the Program on Molecular and Cellular Biology; President of the Russian Federation for young scientists [MK-3813.2012.4]; Dmitri Zimin's "Dynasty" foundation	Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Support of Basic Research; Presidium of the Russian Academy of Sciences from the Program on Molecular and Cellular Biology; President of the Russian Federation for young scientists; Dmitri Zimin's "Dynasty" foundation	This work was supported by the Ministry of Science and Education of the Russian Federation (contracts 14.740.12.1344, 16.740.11.0483 and grant 8052), by the Russian Foundation for Support of Basic Research (grants 11-04-00361-a, 11-04-91334-NNIO_a, 12-04-93109-CNRS_a and 12-04-00036-a by the Presidium of the Russian Academy of Sciences (grants from the Program on Molecular and Cellular Biology), by a grant from the President of the Russian Federation for young scientists (MK-3813.2012.4) and by Dmitri Zimin's "Dynasty" foundation. Experiments were performed using the equipment of the IGB RAS facilities, which are supported by the Ministry of Science and Education of the Russian Federation (contract 16.552.11.7067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comet I, 2011, P NATL ACAD SCI USA, V108, P2294, DOI 10.1073/pnas.1002059108; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ferraiuolo MA, 2012, METHODS, V58, P255, DOI 10.1016/j.ymeth.2012.10.011; Gavrilov A, 2009, METHODS MOL BIOL, V567, P171, DOI 10.1007/978-1-60327-414-2_12; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Naumova N, 2012, METHODS, V58, P192, DOI 10.1016/j.ymeth.2012.07.022; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	18	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60403	10.1371/journal.pone.0060403	http://dx.doi.org/10.1371/journal.pone.0060403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555968	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500132
J	Hamamoto, I; Takaku, H; Tashiro, M; Yamamoto, N				Hamamoto, Itsuki; Takaku, Hiroshi; Tashiro, Masato; Yamamoto, Norio			High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; A-VIRUS; NS1 PROTEIN; ANTIVIRAL RESPONSES; BETA-INTERFERON; RIG-I; INDUCTION; VACCINE; ACTIVATION; GENE	Influenza is a serious public health problem that causes a contagious respiratory disease. Vaccination is the most effective strategy to reduce transmission and prevent influenza. In recent years, cell-based vaccines have been developed with continuous cell lines such as Madin-Darby canine kidney (MDCK) and Vero. However, wild-type influenza and egg-based vaccine seed viruses will not grow efficiently in these cell lines. Therefore, improvement of virus growth is strongly required for development of vaccine seed viruses and cell-based influenza vaccine production. The aim of our research is to develop novel MDCK cells supporting highly efficient propagation of influenza virus in order to expand the capacity of vaccine production. In this study, we screened a human siRNA library that involves 78 target molecules relating to three major type I interferon (IFN) pathways to identify genes that when knocked down by siRNA lead to enhanced production of influenza virus A/Puerto Rico/8/1934 in A549 cells. The siRNAs targeting 23 candidate genes were selected to undergo a second screening pass in MDCK cells. We examined the effects of knockdown of target genes on the viral production using newly designed siRNAs based on sequence analyses. Knockdown of the expression of a canine gene corresponding to human IRF7 by siRNA increased the efficiency of viral production in MDCK cells through an unknown process that includes the mechanisms other than inhibition of IFN-alpha/beta induction. Furthermore, the viral yield greatly increased in MDCK cells stably transduced with the lentiviral vector for expression of short hairpin RNA against IRF7 compared with that in control MDCK cells. Therefore, we propose that modified MDCK cells with lower expression level of IRF7 could be useful not only for increasing the capacity of vaccine production but also facilitating the process of seed virus isolation from clinical specimens for manufacturing of vaccines.	[Hamamoto, Itsuki; Tashiro, Masato; Yamamoto, Norio] Natl Inst Infect Dis, Lab Cell Based Vaccine Dev, Influenza Virus Res Ctr, Musashimurayama, Tokyo, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Yamamoto, Norio] Juntendo Univ, Sch Med, Dept Gen Med, Bunkyo Ku, Tokyo 113, Japan	National Institute of Infectious Diseases (NIID); Chiba Institute of Technology; Juntendo University	Yamamoto, N (corresponding author), Natl Inst Infect Dis, Lab Cell Based Vaccine Dev, Influenza Virus Res Ctr, Musashimurayama, Tokyo, Japan.	n-yama-5@nih.go.jp			Ministry of Health, Labour and Welfare of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan; MEXT (Ministry of Education, Culture, Sports, Science and Technology) [S1201013]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan; MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Health Sciences Research Grant-in-Aid for Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare of Japan, and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan. This study was also supported in part by a Grant-in-Aid (S1201013) from MEXT (Ministry of Education, Culture, Sports, Science and Technology) - Supported Program for the Strategic Research Foundation at Private Universities, 2012-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de Vries W, 2008, GENE THER, V15, P545, DOI 10.1038/gt.2008.12; Donelan NR, 2004, J VIROL, V78, P11574, DOI 10.1128/JVI.78.21.11574-11582.2004; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Halperin SA, 2002, VACCINE, V20, P1240, DOI 10.1016/S0264-410X(01)00428-5; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kistner O, 1999, WIEN KLIN WOCHENSCHR, V111, P207; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sherwood V, 2007, J GEN VIROL, V88, P71, DOI 10.1099/vir.0.82445-0; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wood JM, 2007, INFLUENZA OTHER RESP, V1, P5, DOI 10.1111/j.1750-2659.2006.00003.x; Young DF, 2003, J VIROL, V77, P2174, DOI 10.1128/JVI.77.3.2174-2181.2003	32	33	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59892	10.1371/journal.pone.0059892	http://dx.doi.org/10.1371/journal.pone.0059892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555825	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500102
J	Jager, W; Moskalev, I; Janssen, C; Hayashi, T; Awrey, S; Gust, KM; So, AI; Zhang, KX; Fazli, L; Li, E; Thuroff, JW; Lange, D; Black, PC				Jaeger, Wolfgang; Moskalev, Igor; Janssen, Claudia; Hayashi, Tetsutaro; Awrey, Shannon; Gust, Kilian M.; So, Alan I.; Zhang, Kaixin; Fazli, Ladan; Li, Estelle; Thueroff, Joachim W.; Lange, Dirk; Black, Peter C.			Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach	PLOS ONE			English	Article							TRANSITIONAL-CELL-CARCINOMA; GENE-THERAPY; MOUSE MODEL; UROTHELIAL CARCINOMA; IN-VIVO; BIOLUMINESCENCE; GROWTH	Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected between the muscle wall and the mucosa to separate these layers, and tumor cells were subsequently injected into this space. Bioluminescence and ultrasound were used to monitor tumor growth. Contrast-enhanced ultrasound was used to study changes in tumor perfusion after systemic gemcitabine/cisplatin treatment. To demonstrate proof of principle that therapeutic agents can be injected into established xenografts under ultrasound guidance, oncolytic virus (VSV) was injected into UM-UC3 tumors. Xenograft tissue was harvested for immunohistochemistry after 23-37 days. Percutaneous injection of tumor cells into the bladder wall was performed efficiently (mean time: 5.7 min) and without complications in all 50 animals. Ultrasound and bioluminescence confirmed presence of tumor in the anterior bladder wall in all animals 3 days later. The average tumor volumes increased steadily over the study period. UM-UC13 tumors showed a marked decrease in volume and perfusion after chemotherapy. Immunohistochemical staining for VSV-G demonstrated virus uptake in all UM-UC3 tumors after intratumoral injection. We have developed a novel method for creating orthotopic bladder cancer xenograft in a minimally invasive fashion. In our hands this has replaced the traditional model requiring laparotomy, because this model is more time efficient, more precise and associated with less morbidity for the mice.	[Jaeger, Wolfgang; Moskalev, Igor; Janssen, Claudia; Hayashi, Tetsutaro; Awrey, Shannon; Gust, Kilian M.; So, Alan I.; Zhang, Kaixin; Fazli, Ladan; Li, Estelle; Lange, Dirk; Black, Peter C.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Jaeger, Wolfgang; Moskalev, Igor; Janssen, Claudia; Hayashi, Tetsutaro; Awrey, Shannon; Gust, Kilian M.; So, Alan I.; Zhang, Kaixin; Fazli, Ladan; Li, Estelle; Lange, Dirk; Black, Peter C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Jaeger, Wolfgang; Janssen, Claudia; Thueroff, Joachim W.] Johannes Gutenberg Univ Mainz, Dept Urol, D-55122 Mainz, Germany; [Gust, Kilian M.] Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany	University of British Columbia; University of British Columbia; Johannes Gutenberg University of Mainz; Goethe University Frankfurt	Black, PC (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada.	pblack@mail.ubc.ca	Lange, Dirk/K-9401-2019; Black, Peter/AAE-8424-2020; Thueroff, Joachim/AAF-7652-2020	Black, Peter/0000-0002-2919-7068; Thueroff, Joachim/0000-0002-9189-2387; Moskalev, Igor/0000-0001-9383-8985	DFG [JA 2117/1-1:1]; Canadian Cancer Society Research Institute [2010-700527]; Mentored Physician Scientist Award from Vancouver Coastal Health Research Institute [F08-04967]; Canadian Foundation for Innovation [27255]	DFG(German Research Foundation (DFG)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Mentored Physician Scientist Award from Vancouver Coastal Health Research Institute; Canadian Foundation for Innovation(Canada Foundation for Innovation)	Grant funding was provided through DFG (WJ; www.dfg.de/en; JA 2117/1-1:1), the Canadian Cancer Society Research Institute (PCB; www.cancer.ca/Research.aspx; 2010-700527) and a Mentored Physician Scientist Award from Vancouver Coastal Health Research Institute (PCB; http://www.vch.ca/about_us/awards_&_recognition; F08-04967). The ultrasound imaging platform was funded by the Canadian Foundation for Innovation (PCB; www.innovation.ca; 27255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2007, J UROLOGY, V177, P1900, DOI 10.1016/j.juro.2007.01.003; American Joint Committee on Cancer, 2010, AJCC CANC STAGING MA; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Black PC, 2010, BJU INT, V106, P1799, DOI 10.1111/j.1464-410X.2010.09424.x; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Cheon J, 2002, INT J UROL, V9, P261, DOI 10.1046/j.1442-2042.2002.00464.x; Cho EJ, 2011, INVEST RADIOL, V46, P441, DOI 10.1097/RLI.0b013e3182174fad; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; GROSSMAN HB, 1984, J UROLOGY, V132, P834, DOI 10.1016/S0022-5347(17)49883-1; GROSSMAN HB, 1986, J UROLOGY, V136, P953, DOI 10.1016/S0022-5347(17)45139-1; Hadaschik BA, 2007, BJU INT, V100, P1377, DOI 10.1111/j.1464-410X.2007.07165.x; Hanna N, 2012, CANCER GENE THER, V19, P374, DOI 10.1038/cgt.2012.10; Horiguchi Y, 2000, GENE THER, V7, P844, DOI 10.1038/sj.gt.3301157; IINUMA S, 1995, J UROLOGY, V153, P802, DOI 10.1016/S0022-5347(01)67726-7; Jager W, 2013, J UROL IN PRESS; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; Olson P, 2011, P NATL ACAD SCI USA, V108, pE1275, DOI 10.1073/pnas.1111079108; Patel AR, 2010, UROLOGY, V75, P799, DOI 10.1016/j.urology.2009.06.047; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Rychak JJ, 2007, MOL IMAGING, V6, P289, DOI 10.2310/7290.2007.00024; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SUMMERHAYES IC, 1979, J NATL CANCER I, V62, P1017; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Xiao Z, 1999, BRIT J CANCER, V81, P638, DOI 10.1038/sj.bjc.6690741; Zhang ZT, 1999, CANCER RES, V59, P3512	30	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59536	10.1371/journal.pone.0059536	http://dx.doi.org/10.1371/journal.pone.0059536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555699	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500048
J	Andre, T; Meuleman, N; Stamatopoulos, B; De Bruyn, C; Pieters, K; Bron, D; Lagneaux, L				Andre, Thibaud; Meuleman, Nathalie; Stamatopoulos, Basile; De Bruyn, Cecile; Pieters, Karlien; Bron, Dominique; Lagneaux, Laurence			Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LARGE GENE LISTS; GROWTH-FACTOR; UNDETERMINED SIGNIFICANCE; REPLICATIVE SENESCENCE; MONOCLONAL GAMMOPATHY; SECRETORY PHENOTYPE; TUMOR SUPPRESSION; CANCER; PROLIFERATION	Background: In multiple myeloma, bone marrow mesenchymal stromal cells support myeloma cell growth. Previous studies have suggested that direct and indirect interactions between malignant cells and bone marrow mesenchymal stromal cells result in constitutive abnormalities in the bone marrow mesenchymal stromal cells. Design and Methods: The aims of this study were to investigate the constitutive abnormalities in myeloma bone marrow mesenchymal stromal cells and to evaluate the impact of new treatments. Results: We demonstrated that myeloma bone marrow mesenchymal stromal cells have an increased expression of senescence-associated beta-galactosidase, increased cell size, reduced proliferation capacity and characteristic expression of senescence-associated secretory profile members. We also observed a reduction in osteoblastogenic capacity and immunomodulatory activity and an increase in hematopoietic support capacity. Finally, we determined that current treatments were able to partially reduce some abnormalities in secreted factors, proliferation and osteoblastogenesis. Conclusions: We showed that myeloma bone marrow mesenchymal stromal cells have an early senescent profile with profound alterations in their characteristics. This senescent state most likely participates in disease progression and relapse by altering the tumor microenvironment.	[Andre, Thibaud; Stamatopoulos, Basile; Pieters, Karlien; Lagneaux, Laurence] Univ Libre Bruxelles, Inst Jules Bordet, Lab Clin Cell Therapy, Brussels, Belgium; [Meuleman, Nathalie; De Bruyn, Cecile; Bron, Dominique] Inst Jules Bordet, Dept Hematol, B-1000 Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet	Andre, T (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Lab Clin Cell Therapy, Brussels, Belgium.	thibaud.andre@bordet.be			FRS-FNRS (Fonds National de la Recherche Scientifique) of Belgium [Televie FC79946]	FRS-FNRS (Fonds National de la Recherche Scientifique) of Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported by a grant provided by the FRS-FNRS (Fonds National de la Recherche Scientifique) of Belgium (Grant- Televie FC79946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Barille-Nion Sophie, 2003, Hematology Am Soc Hematol Educ Program, P248; Basak GW, 2009, CURR PHARM BIOTECHNO, V10, P335, DOI 10.2174/138920109787847493; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Blade J, 2008, LEUKEMIA, V22, P1651, DOI 10.1038/leu.2008.203; Brody H, 2011, NATURE, V480, pS33, DOI 10.1038/480S33a; Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Ciavarella S, 2012, BRIT J HAEMATOL, V157, P586, DOI 10.1111/j.1365-2141.2012.09082.x; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; De Bruyn C, 2011, STEM CELLS DEV, V20, P547, DOI 10.1089/scd.2010.0260; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Feng YD, 2010, STEM CELLS DEV, V19, P1289, DOI 10.1089/scd.2010.0010; Fong CY, 2012, J CELL BIOCHEM, V113, P658, DOI 10.1002/jcb.23395; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Giuliani N, 2010, LEUKEMIA, V24, P1368, DOI 10.1038/leu.2010.96; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295; Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257; Hasskarl J, 2011, LEUKEMIA LYMPHOMA, V52, P247, DOI 10.3109/10428194.2010.529207; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Li BZ, 2007, STEM CELLS DEV, V16, P921, DOI 10.1089/scd.2007.0074; Li X, 2009, CANCER LETT, V284, P175, DOI 10.1016/j.canlet.2009.04.022; Lisanti MP, 2011, CELL CYCLE, V10, P2059, DOI 10.4161/cc.10.13.16233; Mailankody S, 2011, BLOOD, V118, P4086, DOI 10.1182/blood-2011-05-355743; Martinez-Jaramillo G, 2011, LEUKEMIA RES, V35, P250, DOI 10.1016/j.leukres.2010.06.014; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pasqualetti P, 1997, BIOMED PHARMACOTHER, V51, P74, DOI 10.1016/S0753-3322(97)87730-X; PATCHEN ML, 1991, BLOOD, V77, P472; Podar K, 2007, BEST PRACT RES CL HA, V20, P597, DOI 10.1016/j.beha.2007.08.002; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Raicevic G, 2012, TISSUE ENG PT A, V18, P1410, DOI [10.1089/ten.tea.2011.0434, 10.1089/ten.TEA.2011.0434]; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Takeda K, 1998, J IMMUNOL, V161, P4652; Terpos E, 2006, BRIT J HAEMATOL, V135, P688, DOI 10.1111/j.1365-2141.2006.06356.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Todoerti K, 2010, EXP HEMATOL, V38, P141, DOI 10.1016/j.exphem.2009.11.009; Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943; UCHIYAMA H, 1993, BLOOD, V82, P3712; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wallace SR, 2001, CANCER-AM CANCER SOC, V91, P1219, DOI 10.1002/1097-0142(20010401)91:7<1219::AID-CNCR1122>3.0.CO;2-1; Xu XM, 2011, J CANCER RES CLIN, V137, P495, DOI 10.1007/s00432-010-0908-6; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; Zdzisinska B, 2008, ARCH IMMUNOL THER EX, V56, P207, DOI 10.1007/s00005-008-0022-5; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016	66	70	71	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59756	10.1371/journal.pone.0059756	http://dx.doi.org/10.1371/journal.pone.0059756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555770	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400063
J	Herman, JP; Cloud, CP; Wallman, J				Herman, James P.; Cloud, C. Phillip; Wallman, Josh			End-Point Variability Is Not Noise in Saccade Adaptation	PLOS ONE			English	Article							ADAPTIVE-CONTROL; ERROR; SIGNALS; PLASTICITY; MEMORY; SIZE	When each of many saccades is made to overshoot its target, amplitude gradually decreases in a form of motor learning called saccade adaptation. Overshoot is induced experimentally by a secondary, backwards intrasaccadic target step (ISS) triggered by the primary saccade. Surprisingly, however, no study has compared the effectiveness of different sizes of ISS in driving adaptation by systematically varying ISS amplitude across different sessions. Additionally, very few studies have examined the feasibility of adaptation with relatively small ISSs. In order to best understand saccade adaptation at a fundamental level, we addressed these two points in an experiment using a range of small, fixed ISS values (from 0 degrees to 1 degrees after a 10 degrees primary target step). We found that significant adaptation occurred across subjects with an ISS as small as 0.25 degrees. Interestingly, though only adaptation in response to 0.25 degrees ISSs appeared to be complete (the magnitude of change in saccade amplitude was comparable to size of the ISS), further analysis revealed that a comparable proportion of the ISS was compensated for across conditions. Finally, we found that ISS size alone was sufficient to explain the magnitude of adaptation we observed; additional factors did not significantly improve explanatory power. Overall, our findings suggest that current assumptions regarding the computation of saccadic error may need to be revisited.	[Herman, James P.; Cloud, C. Phillip; Wallman, Josh] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Herman, James P.; Wallman, Josh] CUNY, Grad Ctr, PhD Program Biol, New York, NY USA; [Cloud, C. Phillip] CUNY, Grad Ctr, PhD Program Psychol, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Herman, JP (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	james.herman@nih.gov		Herman, James/0000-0001-6916-2807	National Science Foundation [BCS-0842464]; National Institute of Health [1R01EY019508, RR-03060]; Direct For Social, Behav & Economic Scie [0842464] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019508] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was funded by grant BCS-0842464 from the National Science Foundation (www.nsf.gov), and grants 1R01EY019508 and RR-03060 from the National Institute of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABEL LA, 1978, ANN NEUROL, V4, P313, DOI 10.1002/ana.410040405; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; BOCK O, 1995, EXP BRAIN RES, V104, P349; Collins T, 2012, J NEUROPHYSIOL, V107, P3342, DOI 10.1152/jn.00746.2011; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; Deubel H., 1987, EYE MOVEMENTS PHYSL, P181, DOI [DOI 10.1016/B978-0-444-70113-8.50030-8, 10.1016/B978-0-444-70113-8.50030-8]; Ditterich J, 1998, BEHAV BRAIN RES, V95, P205, DOI 10.1016/S0166-4328(97)00160-5; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Ethier V, 2008, J NEUROSCI, V28, P13929, DOI 10.1523/JNEUROSCI.3470-08.2008; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; Hernandez TD, 2008, J VISION, V8, DOI 10.1167/8.8.3; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; KOMMERELL G, 1976, INVEST OPHTH VISUAL, V15, P657; Kroller J, 1999, EXP BRAIN RES, V124, P351, DOI 10.1007/s002210050632; Marko MK, 2012, J NEUROPHYSIOL; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; OPTICAN LM, 1985, J NEUROPHYSIOL, V54, P940, DOI 10.1152/jn.1985.54.4.940; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; SNOW R, 1985, INVEST OPHTH VIS SCI, V26, P924; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; WARABI T, 1984, ANN NEUROL, V16, P449, DOI 10.1002/ana.410160405; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Wurtz RH, 2010, J VIS, V10, P221; Zee DS, 1986, SHORT TERM SACCADIC; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59731	10.1371/journal.pone.0059731	http://dx.doi.org/10.1371/journal.pone.0059731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555763	gold, Green Submitted, Green Published			2022-12-27	WOS:000316546400058
J	Kishore, R; Verma, SK; Mackie, AR; Vaughan, EE; Abramova, TV; Aiko, I; Krishnamurthy, P				Kishore, Raj; Verma, Suresh K.; Mackie, Alexander R.; Vaughan, Erin E.; Abramova, Tatiana V.; Aiko, Ito; Krishnamurthy, Prasanna			Bone Marrow Progenitor Cell Therapy-Mediated Paracrine Regulation of Cardiac miRNA-155 Modulates Fibrotic Response in Diabetic Hearts	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; ACUTE MYOCARDIAL-INFARCTION; MESENCHYMAL TRANSITION; STEM-CELLS; MICRORNAS; FIBROSIS; INJURY; TRANSPLANTATION; DYSFUNCTION; GENE	Diabetes is associated with a higher incidence of myocardial infarction (MI) and increased risk for adverse vascular and fibrogenic events post-MI. Bone marrow-derived progenitor cell (BMPC) therapy has been shown to promote neovascularization, decrease infarct area and attenuate left ventricular (LV) dysfunction after MI. Unlike vascular effects, the anti-fibrosis mechanisms of BMPC, specifically under diabetic conditions, are poorly understood. We demonstrated that intramyocardial delivery of BMPCs in infarcted diabetic db/db mice significantly down-regulates profibrotic miRNA-155 in the myocardium and improves LV remodeling and function. Furthermore, inhibition of paracrine factor hepatocyte growth factor (HGF) signaling in vivo suppressed the BMPC-mediated inhibition of miR-155 expression and the associated protective effect on cardiac fibrosis and function. In vitro studies confirmed that the conditioned media of BMPC inhibited miR-155 expression and profibrotic signaling in mouse cardiac fibroblasts under diabetic conditions. However, neutralizing antibodies directed against HGF blocked these effects. Furthermore, miR-155 over-expression in mouse cardiac fibroblasts inhibited antifibrotic Sloan-Kettering Institute proto-oncogene (Ski) and Ski-related novel gene, non-Alu-containing (SnoN) signaling and abrogated antifibrogenic response of HGF. Together, our data demonstrates that paracrine regulation of cardiac miRNAs by transplanted BMPCs contributes to the antifibrotic effects of BMPC therapy. BMPCs release HGF, which inhibits miR-155-mediated profibrosis signaling, thereby preventing cardiac fibrosis. These data suggest that targeting miR-155 might serve as a potential therapy against cardiac fibrosis in the diabetic heart.	[Kishore, Raj; Verma, Suresh K.; Mackie, Alexander R.; Vaughan, Erin E.; Abramova, Tatiana V.; Aiko, Ito; Krishnamurthy, Prasanna] Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University	Krishnamurthy, P (corresponding author), Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	p-krishnamurthy@northwestern.edu	Verma, Suresh/AAU-9979-2020	Verma, Suresh Kumar/0000-0002-0739-1302	American Heart Association National-The Davee Foundation SDG Grant [0530350N]; National Institutes of Health (NIH) [HL091983, HL105597, HL095874, HL053354, HL108795]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105597, R01HL091983, R01HL095874, R37HL053354, R01HL053354, P01HL108795] Funding Source: NIH RePORTER	American Heart Association National-The Davee Foundation SDG Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by American Heart Association National-The Davee Foundation SDG Grant 0530350N (to PK) and National Institutes of Health (NIH) grants HL091983, HL105597, HL095874, HL053354 and HL108795 (to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Bauersachs J, 2010, J CARDIOVASC PHARM, V56, P454, DOI 10.1097/FJC.0b013e3181ee81df; Blanco RR, 2012, J CARD FAIL, V18, P717, DOI 10.1016/j.cardfail.2012.06.531; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Chang CC, 2012, AM J PHYSIOL-LUNG C, V302, pL755, DOI 10.1152/ajplung.00350.2011; Chen XH, 2007, J CARD FAIL, V13, P874, DOI 10.1016/j.cardfail.2007.07.004; Corsten MF, 2012, CIRC RES, V111, P415, DOI 10.1161/CIRCRESAHA.112.267443; Cunnington RH, 2011, AM J PHYSIOL-CELL PH, V300, pC176, DOI 10.1152/ajpcell.00050.2010; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eguchi M, 2012, J CELL MOL MED, V16, P2925, DOI 10.1111/j.1582-4934.2012.01613.x; Eguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030450; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Golden HB, 2012, METHODS MOL BIOL, V843, P245, DOI 10.1007/978-1-61779-523-7_23; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lamblin N, 2012, J CARDIOVASC MED, V13, P353, DOI 10.2459/JCM.0b013e328353694b; Lee YJ, 2012, EUR RESPIR J, V40, P424, DOI 10.1183/09031936.00096711; Levati L, 2011, PIGM CELL MELANOMA R, V24, P538, DOI 10.1111/j.1755-148X.2011.00857.x; Li CJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-73; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Matsumoto S, 2012, BIOCHEM BIOPH RES CO, V427, P280, DOI 10.1016/j.bbrc.2012.09.039; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Okayama K, 2012, HYPERTENSION, V59, P958, DOI 10.1161/HYPERTENSIONAHA.111.183905; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sessa WC, 2011, ARTERIOSCL THROM VAS, V31, P2369, DOI 10.1161/ATVBAHA.111.238311; Song MB, 2009, VASC PHARMACOL, V51, P205, DOI 10.1016/j.vph.2009.06.009; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taniyama Y, 2000, CIRCULATION, V102, P246, DOI 10.1161/01.CIR.102.2.246; Thal MA, 2012, CIRC RES, V111, P180, DOI 10.1161/CIRCRESAHA.112.270462; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2012, CARDIOVASC RES, V93, P573, DOI 10.1093/cvr/cvr344; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Verma SK, 2011, CARDIOVASC RES, V90, P88, DOI 10.1093/cvr/cvq385; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou YJ, 2009, LIFE SCI, V85, P670, DOI 10.1016/j.lfs.2009.09.006	52	55	62	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60161	10.1371/journal.pone.0060161	http://dx.doi.org/10.1371/journal.pone.0060161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560074	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900051
J	Weitzel, LB; Ambardekar, AV; Brieke, A; Cleveland, JC; Serkova, NJ; Wischmeyer, PE; Lowes, BD				Weitzel, Lindsay B.; Ambardekar, Amrut V.; Brieke, Andreas; Cleveland, Joseph C.; Serkova, Natalie J.; Wischmeyer, Paul E.; Lowes, Brian D.			Left Ventricular Assist Device Effects on Metabolic Substrates in the Failing Heart	PLOS ONE			English	Article							CONTRACTILE FUNCTION; HISTOLOGIC-CHANGES; GLUTAMINE; SUPPORT; IMPROVEMENT; SIGNATURES; RECOVERY; DISEASE; LINKING; INJURY	Background: Heart failure patients have inadequate nutritional intake and alterations in metabolism contributing to an overall energy depleted state. Left ventricular assist device (LVAD) support is a common and successful intervention in patients with end-stage heart failure. LVAD support leads to alterations in cardiac output, functional status, neurohormonal activity and transcriptional profiles but the effects of LVADs on myocardial metabolism are unknown. This study set out to measure cardiac metabolites in non-failing hearts, failing hearts, and hearts post-LVAD support. Methods: The study population consisted of 8 non-ischemic failing (at LVAD implant) and 8 post-LVAD hearts, plus 8 non-failing hearts obtained from the tissue bank at the University of Colorado. NMR spectroscopy was utilized to evaluate differences in myocardial energy substrates. Paired and non-paired t-tests were used to determine differences between the appropriate groups. Results: Glucose and lactate values both decreased from non-failing to failing hearts and increased again significantly in the (paired) post-LVAD hearts. Glutamine, alanine, and aromatic amino acids decreased from non-failing to failing hearts and did not change significantly post-LVAD. Total creatine and succinate decreased from non-failing to failing hearts and did not change significantly post-LVAD. Discussion: Measured metabolites related to glucose metabolism are diminished in failing hearts, but recovered their values post-LVAD. This differed from the amino acid levels, which decreased in heart failure but did not recover following LVAD. Creatine and the citric acid cycle intermediate succinate followed a similar pattern as the amino acid levels.	[Weitzel, Lindsay B.; Serkova, Natalie J.; Wischmeyer, Paul E.] Univ Colorado, Dept Anesthesiol, Aurora, CO 80045 USA; [Ambardekar, Amrut V.; Brieke, Andreas] Univ Colorado, Dept Cardiol, Aurora, CO USA; [Cleveland, Joseph C.] Univ Colorado, Dept Surg, Aurora, CO USA; [Lowes, Brian D.] Univ Nebraska Med Ctr, Dept Cardiol, Omaha, NE USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Nebraska System; University of Nebraska Medical Center	Weitzel, LB (corresponding author), Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO 80045 USA.	Lindsay.Weitzel@ucdenver.edu	Lowes, Brian/M-9020-2017	Lowes, Brian/0000-0002-5919-2540	NIH [P20 HL101435, R01 GM078312]; NIH/NCRR Colorado CTSI [UL1 RR025780]; Thoratec; HeartWare; Fresenius; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoratec; HeartWare; Fresenius; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH P20 HL101435 (Lowes, Brian: PI) (National Institutes of Health). Amrut Ambardekar is supported by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. Paul Wischmeyer, MD and Lindsay Weitzel PhD received support from the NIH (R01 GM078312) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Andreas Brieke, MD is sub-PI for LVAD studies supported by Thoratec and HeartWare. LVADs are marketed by Thoratec and HeartWare. The remaining authors have no conflicts of interest to disclose. Joe Cleveland, MD was a surgical PI for the HeartMate II destination therapy trial and the Endurance therapy trial. Paul Wischmeyer, MD has received funding from Fresenius for trials related to glutamine therapy and has patents pending for glutamine's use to enhance heat shock protein expression. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ambardekar AV, 2011, CIRC-HEART FAIL, V4, P425, DOI 10.1161/CIRCHEARTFAILURE.111.961326; Anker SD, 2011, CLIN PHARMACOL THER, V90, P188, DOI 10.1038/clpt.2011.72; Aquilani R, 2003, J AM COLL CARDIOL, V42, P1218, DOI 10.1016/S0735-1097(03)00946-X; Arcand J, 2009, J AM DIET ASSOC, V109, P1909, DOI 10.1016/j.jada.2009.08.011; Burkhoff D, 2006, J CARD FAIL, V12, P227, DOI 10.1016/j.cardfail.2005.10.012; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Katz AM, 1998, CARDILOGY CLIN, V16; Khogali SEO, 1998, J MOL CELL CARDIOL, V30, P819, DOI 10.1006/jmcc.1998.0647; Klotz S, 2005, CIRCULATION, V112, P364, DOI 10.1161/CIRCULATIONAHA.104.515106; Lomivorotov VV, 2011, HEART SURG FORUM, V14, pE384, DOI 10.1532/HSF98.20111074; Maybaum S, 2007, CIRCULATION, V115, P2497, DOI 10.1161/CIRCULATIONAHA.106.633180; MCCARTHY PM, 1995, ANN THORAC SURG, V59, P609, DOI 10.1016/0003-4975(94)00953-8; Nakatani S, 1996, J AM COLL CARDIOL, V27, P894, DOI 10.1016/0735-1097(95)00555-2; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Qanud K, 2008, AM J PHYSIOL-HEART C, V295, pH2098, DOI 10.1152/ajpheart.00471.2008; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Rosiers CD, 2011, CARDIOVASC RES, V90, P210, DOI 10.1093/cvr/cvr055; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Sheeran FL, 2006, BBA-BIOENERGETICS, V1757, P543, DOI 10.1016/j.bbabio.2006.03.008; Stringer KA, 2011, AM J PHYSIOL-LUNG C, V300, pL4, DOI 10.1152/ajplung.00231.2010; Sufit A, 2012, J PARENTERA IN PRESS; Wischmeyer PE, 2003, JPEN-PARENTER ENTER, V27, P396, DOI 10.1177/0148607103027006396; Wischmeyer PE, 2003, JPEN-PARENTER ENTER, V27, P116, DOI 10.1177/0148607103027002116	28	17	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60292	10.1371/journal.pone.0060292	http://dx.doi.org/10.1371/journal.pone.0060292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560088	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900063
J	de Graaf, TA; Gross, J; Paterson, G; Rusch, T; Sack, AT; Thut, G				de Graaf, Tom A.; Gross, Joachim; Paterson, Gavin; Rusch, Tessa; Sack, Alexander T.; Thut, Gregor			Alpha-Band Rhythms in Visual Task Performance: Phase-Locking by Rhythmic Sensory Stimulation	PLOS ONE			English	Article							EEG ALPHA; SPATIAL ATTENTION; OCCIPITAL CORTEX; OSCILLATIONS; PERCEPTION; FLUCTUATIONS; MODULATION; EXPECTATIONS; ENTRAINMENT; INHIBITION	Oscillations are an important aspect of neuronal activity. Interestingly, oscillatory patterns are also observed in behaviour, such as in visual performance measures after the presentation of a brief sensory event in the visual or another modality. These oscillations in visual performance cycle at the typical frequencies of brain rhythms, suggesting that perception may be closely linked to brain oscillations. We here investigated this link for a prominent rhythm of the visual system (the alpha-rhythm, 8-12 Hz) by applying rhythmic visual stimulation at alpha-frequency (10.6 Hz), known to lead to a resonance response in visual areas, and testing its effects on subsequent visual target discrimination. Our data show that rhythmic visual stimulation at 10.6 Hz: 1) has specific behavioral consequences, relative to stimulation at control frequencies (3.9 Hz, 7.1 Hz, 14.2 Hz), and 2) leads to alpha-band oscillations in visual performance measures, that 3) correlate in precise frequency across individuals with resting alpha-rhythms recorded over parieto-occipital areas. The most parsimonious explanation for these three findings is entrainment (phase-locking) of ongoing perceptually relevant alpha-band brain oscillations by rhythmic sensory events. These findings are in line with occipital alpha-oscillations underlying periodicity in visual performance, and suggest that rhythmic stimulation at frequencies of intrinsic brain-rhythms can be used to reveal influences of these rhythms on task performance to study their functional roles.	[de Graaf, Tom A.; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [de Graaf, Tom A.; Sack, Alexander T.] Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Gross, Joachim; Paterson, Gavin; Rusch, Tessa; Thut, Gregor] Univ Glasgow, Ctr Cognit NeuroImaging, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Rusch, Tessa] Univ Munich, Dept Psychol, Munich, Germany	Maastricht University; Maastricht University; University of Glasgow; University of Munich	de Graaf, TA (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	tom.degraaf@maastrichtuniversity.nl	Thut, Gregor/A-4374-2009; Gross, Joachim/C-5886-2009	Gross, Joachim/0000-0002-3994-1006; Sack, Alexander/0000-0002-1471-0885; Thut, Gregor/0000-0003-1313-4262	Wellcome Trust [084067, 091928]; NWO [021-002-087]; European Research Council under the European Union's Seventh Framework Programme [263472]	Wellcome Trust(Wellcome TrustEuropean Commission); NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC))	This work was supported by the Wellcome Trust [084067, 091928] (http://www.wellcome.ac.uk/) and NWO [021-002-087] (http://www.nwo.nl/), as well as the European Research Council (http://erc.europa.eu/) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no [263472]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga A, 2008, PSYCHOL RES-PSYCH FO, V72, P192, DOI 10.1007/s00426-006-0100-4; Bonnefond M, 2012, CURR BIOL, V22, P1969, DOI 10.1016/j.cub.2012.08.029; Breitmeyer B., 2006, VISUAL MASKING; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buzsaki G., 2006, RHYTHMS BRAIN; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Drewes J, 2011, J NEUROSCI, V31, P4698, DOI 10.1523/JNEUROSCI.4795-10.2011; Ekroll V, 2008, J VISION, V8, DOI 10.1167/8.4.31; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Mathewson KE, 2012, J COGNITIVE NEUROSCI, V24, P2321, DOI 10.1162/jocn_a_00288; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Shang CF, 2011, J PHYSIOL-LONDON, V589, P3125, DOI 10.1113/jphysiol.2011.205245; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Snyder AC, 2010, J NEUROSCI, V30, P4024, DOI 10.1523/JNEUROSCI.5684-09.2010; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; VanRullen R, 2012, CURR BIOL, V22, P995, DOI 10.1016/j.cub.2012.03.050; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00203; Worden MS, 2000, J NEUROSCI, V20	49	116	119	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60035	10.1371/journal.pone.0060035	http://dx.doi.org/10.1371/journal.pone.0060035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555873	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900054
J	He, GL; Xu, WM; Chen, Y; Liu, XH; Xi, MR				He, Guolin; Xu, Wenming; Chen, Yan; Liu, Xinghui; Xi, Mingrong			Abnormal Apoptosis of Trophoblastic Cells Is Related to the Up- Regulation of CYP11A Gene in Placenta of Preeclampsia Patients	PLOS ONE			English	Article							MICROARRAY ANALYSIS; UP-REGULATION; EXPRESSION; TISSUE	Abnormal placenta trophoblast proliferation and apoptosis is related to the pathogenesis of preeclampsia. Emerging evidence has also indicated that key pregnancy-associated hormones, such as hCG, progesterone, are found in high concentration at the maternal-fetal interface. The purpose of this study was to investigate the expression of CYP11A, a key enzyme in steroid hormone synthesis and metabolism, in normal pregnancy and severe preeclampsia placenta and to explore the underlying mechanism of the relationship between the altered CYP11A expression and onset of preeclampsia. Immunohistochemistry method was used to study the localization of CYP11A-encoded protein P450scc in the placenta; reverse transcription polymerase chain reaction (RT-PCR) and Western blotting were used to examine CYP11A expression at mRNA and protein levels in patients with severe preeclampsia and normal placental tissue. CYP11A overexpression in trophoblastic cells was used to evaluate the effect on viability. TUNEL staining was used to determine whether overexpression of CYP11A could affect trophoblastic cell apoptosis. The results showed that CYP11A was selectively expressed in the cytoplasm of the placental trophoblastic cells. CYP11A expression were significantly increased in severe preeclampsia compared with normal pregnancy in both mRNA and protein levels. Multiple regression analysis indicated that CYP11A gene expression was positively correlated to ALT level and Plt, while negatively correlated to INR. Overexpression of CYP11A reduced trophoblastic cell proliferation and induced HTR8/SVneo cells apoptosis through activation of activated caspase-3 expression. These results suggest that abnormally high expression of CYP11A inhibits trophoblastic proliferation and increases apoptosis and therefore could be involved in the pathogenesis of preeclampsia.	[He, Guolin; Liu, Xinghui; Xi, Mingrong] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [He, Guolin; Xu, Wenming; Chen, Yan] Sichuan Univ, Joint Lab Reprod Med, Sichuan Univ Chinese Univ Hong Kong SCU CUHK, West China Univ Hosp 2, Chengdu 610064, Peoples R China; [Xu, Wenming; Chen, Yan] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, West China Univ Hosp 2, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Liu, XH (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China.	Xinghuiliu@163.com; qmrjzz@126.com			National Basic Research Program of China [2012CB944903]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2012CB944903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Cecil RL, 2004, TXB MED, P129; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cnaltingius S, 2004, AM J MED GENET, V130, P365; Gack S, 2005, J MOL MED, V83, P887, DOI 10.1007/s00109-005-0714-9; Goddard KAB, 2007, HUM HERED, V63, P1, DOI 10.1159/000097926; Han JY, 2006, MOL CELLS, V22, P168; Hansson SR, 2006, MOL HUM REPROD, V12, P169, DOI 10.1093/molehr/gal011; Heikkila A, 2005, ACTA OBSTET GYN SCAN, V84, P679; Herse F, 2007, HYPERTENSION, V49, P604, DOI 10.1161/01.HYP.0000257797.49289.71; Matsuo K, 2007, AM J PERINAT, V24, P257, DOI 10.1055/s-2007-976548; Mutter WP, 2007, MICROVASC RES, V12, P129; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Pang Zhan-Jun, 2004, Archives of Gynecology and Obstetrics, V269, P91, DOI 10.1007/s00404-002-0413-5; Pang ZJ, 2003, BRIT J BIOMED SCI, V60, P97, DOI 10.1080/09674845.2003.11783682; Pang ZJ, 2003, J PERINAT MED, V31, P153, DOI 10.1515/JPM.2003.021; Reimer T, 2002, MOL HUM REPROD, V8, P674, DOI 10.1093/molehr/8.7.674; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Tsoi SM, 2003, J SOC GYNECOL INVEST, V10, P496, DOI 10.1016/S1071-5576(03)00154-0; WINKEL CA, 1980, ENDOCRINOLOGY, V106, P1054, DOI 10.1210/endo-106-4-1054; Zhou RR, 2006, GYNECOL OBSTET INVES, V62, P108, DOI 10.1159/000092857	21	34	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59609	10.1371/journal.pone.0059609	http://dx.doi.org/10.1371/journal.pone.0059609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555723	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900019
J	Kawakatsu, M; Urata, Y; Imai, R; Goto, S; Ono, Y; Nishida, N; Li, TS				Kawakatsu, Miho; Urata, Yoshishige; Imai, Ryo; Goto, Shinji; Ono, Yusuke; Nishida, Noriyuki; Li, Tao-Sheng			Nicaraven Attenuates Radiation-Induced Injury in Hematopoietic Stem/Progenitor Cells in Mice	PLOS ONE			English	Article							HYDROXYL RADICAL SCAVENGER; PERSISTENT OXIDATIVE STRESS; NORMAL TISSUE-INJURY; SUBARACHNOID HEMORRHAGE; IRRADIATION; EXPOSURE; DYSFUNCTION; SURVIVAL; TRIAL; AVS	Nicaraven, a chemically synthesized hydroxyl radical-specific scavenger, has been demonstrated to protect against ischemia-reperfusion injury in various organs. We investigated whether nicaraven can attenuate radiation-induced injury in hematopoietic stem/progenitor cells, which is the conmen complication of radiotherapy and one of the major causes of death in sub-acute phase after accidental exposure to high dose radiation. C57BL/6 mice were exposed to 1 Gy gamma-ray radiation daily for 5 days in succession (a total of 5 Gy), and given nicaraven or a placebo after each exposure. The mice were sacrificed 2 days after the last radiation treatment, and the protective effects and relevant mechanisms of nicaraven in hematopoietic stem/progenitor cells with radiation-induced damage were investigated by ex vivo examination. We found that post-radiation administration of nicaraven significantly increased the number, improved the colony-forming capacity, and decreased the DNA damage of hematopoietic stem/progenitor cells. The urinary levels of 8-oxo-2'-deoxyguanosine, a marker of DNA oxidation, were significantly lower in mice that were given nicaraven compared with those that received a placebo treatment, although the levels of intracellular and mitochondrial reactive oxygen species in the bone marrow cells did not differ significantly between the two groups. Interestingly, compared with the placebo treatment, the administration of nicaraven significantly decreased the levels of the inflammatory cytokines IL-6 and TNF-alpha in the plasma of mice. Our data suggest that nicaraven effectively diminished the effects of radiation-induced injury in hematopoietic stem/progenitor cells, which is likely associated with the anti-oxidative and anti-inflammatory properties of this compound.	[Kawakatsu, Miho; Urata, Yoshishige; Imai, Ryo; Goto, Shinji; Ono, Yusuke; Li, Tao-Sheng] Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Li, TS (corresponding author), Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	litaoshe@nagasaki-u.ac.jp		Ono, Yusuke/0000-0002-4802-7507; Li, Tao-Sheng/0000-0002-7653-8873	Ministry of Education, Science, Sports, Culture and Technology, Japan	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for the Global Centers of Excellence Program from the Ministry of Education, Science, Sports, Culture and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2000, CHEM PHARM BULL, V48, P467; Alam MS, 1998, MOL CELL BIOCHEM, V178, P237; Asano T, 1984, Neurol Res, V6, P163; Asano T, 1996, J NEUROSURG, V84, P792, DOI 10.3171/jns.1996.84.5.0792; ASANO T, 1984, Neurological Research, V6, P49; Bairati I, 2005, J CLIN ONCOL, V23, P5805, DOI 10.1200/JCO.2005.05.514; Bourhis J, 2011, J CLIN ONCOL, V29, P2590, DOI 10.1200/JCO.2010.33.1454; Cachaco AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008980; Delanian S, 2003, J CLIN ONCOL, V21, P2545, DOI 10.1200/JCO.2003.06.064; Gallet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029399; Huang L, 2003, ONCOGENE, V22, P5848, DOI 10.1038/sj.onc.1206697; Imperatore C, 2000, LIFE SCI, V66, P779, DOI 10.1016/S0024-3205(99)00651-7; Li HL, 2011, FREE RADICAL BIO MED, V51, P30, DOI 10.1016/j.freeradbiomed.2011.04.016; Li TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025543; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Masaki Y, 1998, TRANSPLANT P, V30, P3758, DOI 10.1016/S0041-1345(98)01223-8; MASANA Y, 1995, NEUROSCI RES, V23, P217, DOI 10.1016/0168-0102(95)00936-N; Merchant AA, 2011, BLOOD, V118, P6572, DOI 10.1182/blood-2011-05-355362; Mori Yasutane, 1993, Okayama Igakkai Zasshi, V105, P673; Mori Yasutane, 1993, Nippon Acta Radiologica, V53, P704; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Rastogi S, 2012, RADIAT RES, V177, P244, DOI 10.1667/RR2805.1; Rhodes LE, 2003, CARCINOGENESIS, V24, P919, DOI 10.1093/carcin/bgg038; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Takemoto Y, 2011, SURGERY, V149, P792, DOI 10.1016/j.surg.2011.02.005; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Watanabe M, 2006, ANTICANCER RES, V26, P3421; Yamamoto S, 2000, J NEUROSURG, V92, P1009, DOI 10.3171/jns.2000.92.6.1009; Yokota R, 2000, SURGERY, V127, P661, DOI 10.1067/msy.2000.105864; Yoshida T, 2012, FREE RADICAL RES, V46, P147, DOI 10.3109/10715762.2011.645207; Zhang M, 2012, CYTOKINE, V58, P169, DOI 10.1016/j.cyto.2011.12.023; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790; Zingarelli B, 2000, SHOCK, V13, P126, DOI 10.1097/00024382-200013020-00006	34	14	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60023	10.1371/journal.pone.0060023	http://dx.doi.org/10.1371/journal.pone.0060023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555869	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900052
J	Pezzolesi, MG; Jeong, J; Smiles, AM; Skupien, J; Mychaleckyj, JC; Rich, SS; Warram, JH; Krolewski, AS				Pezzolesi, Marcus G.; Jeong, Jackson; Smiles, Adam M.; Skupien, Jan; Mychaleckyj, Josyf C.; Rich, Stephen S.; Warram, James H.; Krolewski, Andrzej S.			Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; STAGE RENAL-DISEASE; KIDNEY-DISEASE; GENE; VARIANTS; TYPE-1; HERITABILITY; SCAN; PVT1	A genome-wide association scan of type 1 diabetic patients from the GoKinD collections previously identified four novel diabetic nephropathy susceptibility loci that have subsequently been shown to be associated with diabetic nephropathy in unrelated patients with type 2 diabetes. To expand these findings, we examined whether single nucleotide polymorphisms (SNPs) at these susceptibility loci were associated with diabetic nephropathy in patients from the Joslin Study of Genetics of Nephropathy in Type 2 Diabetes Family Collection. Six SNPs across the four loci identified in the GoKinD collections and 7 haplotype tagging SNPs, were genotyped in 66 extended families of European ancestry. Pedigrees from this collection contained an average of 18.5 members, including 2 to 14 members with type 2 diabetes. Among diabetic family members, the 9q21.32 locus approached statistical significance with advanced diabetic nephropathy (P=0.037 [adjusted P=0.222]). When we expanded our definition of diabetic nephropathy to include individuals with high microalbuminuria, the strength of this association improved significantly (P=1.42x10(-3) [adjusted P=0.009]). This same locus also trended toward statistical significance with variation in urinary albumin excretion in family members with type 2 diabetes (P=0.032 [adjusted P=0.192]) and in analyses expanded to include all relatives (P=0.019 [adjusted P=0.114]). These data increase support that SNPs identified in the GoKinD collections on chromosome 9q21.32 are true diabetic nephropathy susceptibility loci.	[Pezzolesi, Marcus G.; Jeong, Jackson; Smiles, Adam M.; Skupien, Jan; Warram, James H.; Krolewski, Andrzej S.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Pezzolesi, Marcus G.; Skupien, Jan; Krolewski, Andrzej S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Mychaleckyj, Josyf C.; Rich, Stephen S.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Virginia	Pezzolesi, MG (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	marcus.pezzolesi@joslin.harvard.edu		Rich, Stephen/0000-0003-3872-7793	National Institutes of Health (NIH) [DK090125, DK096628, DK58549, DK77532, DK36836]; Juvenile Diabetes Research Foundation (JDRF) [3-2009-397]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058549, R01DK077532, K01DK090125, P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge grant support from the National Institutes of Health (NIH) (DK090125 and DK096628 to M.G.P., DK58549 and DK77532 to A.S.K., and DK36836 to the Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center). The authors also acknowledge support from the Juvenile Diabetes Research Foundation (JDRF) (3-2009-397 to J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Canani LH, 1999, DIABETES, V48, P909, DOI 10.2337/diabetes.48.4.909; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dolan V, 2003, PEDIATR NEPHROL, V18, P75, DOI 10.1007/s00467-002-0988-x; Faronato PP, 1997, DIABETOLOGIA, V40, P816, DOI 10.1007/s001250050754; Fogarty DG, 2000, KIDNEY INT, V57, P250, DOI 10.1046/j.1523-1755.2000.00833.x; Fogarty DG, 2000, DIABETES, V49, P1057, DOI 10.2337/diabetes.49.6.1057; Forsblom CM, 1999, DIABETOLOGIA, V42, P1359, DOI 10.1007/s001250051450; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hanson RL, 2010, MOL GENET METAB, V101, P383, DOI 10.1016/j.ymgme.2010.08.014; Klupa T, 2002, DIABETES CARE, V25, P2292, DOI 10.2337/diacare.25.12.2292; Krolewski AS, 2006, KIDNEY INT, V69, P129, DOI 10.1038/sj.ki.5000023; Krolewski AS, 1997, TXB DIABETES, P5351; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; Leak TS, 2009, ANN HUM GENET, V73, P152, DOI 10.1111/j.1469-1809.2008.00498.x; Maeda S, 2010, DIABETES IN PRESS; Martini S, 2013, DIABETES IN PRESS; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; Parving H., 2004, BRENNER RECTORS KIDN, P1777; Pezzolesi MG, 2011, KIDNEY INT, V80, P105, DOI 10.1038/ki.2011.64; Pezzolesi MG, 2009, DIABETES, V58, P2698, DOI 10.2337/db09-0641; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Placha G, 2005, ADV CHRONIC KIDNEY D, V12, P155, DOI 10.1053/j.ackd.2005.02.002; Quinn M, 1996, DIABETOLOGIA, V39, P940; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Sheehan S, 2007, AM J PHYSIOL-RENAL, V293, pF1649, DOI 10.1152/ajprenal.00233.2007; Shimazaki A, 2005, DIABETES, V54, P1171, DOI 10.2337/diabetes.54.4.1171; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Williams WW, 2012, DIABETES, V61, P2187, DOI 10.2337/db11-0751	31	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60301	10.1371/journal.pone.0060301	http://dx.doi.org/10.1371/journal.pone.0060301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555951	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900067
J	Rygg, AD; Cox, JPL; Abel, R; Webb, AG; Smith, NB; Craven, BA				Rygg, Alex D.; Cox, Jonathan P. L.; Abel, Richard; Webb, Andrew G.; Smith, Nadine B.; Craven, Brent A.			A Computational Study of the Hydrodynamics in the Nasal Region of a Hammerhead Shark (Sphyrna tudes): Implications for Olfaction	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; AIR-FLOW; ELASMOBRANCHS; CARCHARHINID; TRANSPORT; MUCUS; ORGAN; FISH	The hammerhead shark possesses a unique head morphology that is thought to facilitate enhanced olfactory performance. The olfactory chambers, located at the distal ends of the cephalofoil, contain numerous lamellae that increase the surface area for olfaction. Functionally, for the shark to detect chemical stimuli, water-borne odors must reach the olfactory sensory epithelium that lines these lamellae. Thus, odorant transport from the aquatic environment to the sensory epithelium is the first critical step in olfaction. Here we investigate the hydrodynamics of olfaction in Sphyrna tudes based on an anatomically-accurate reconstruction of the head and olfactory chamber from high-resolution micro-CT and MRI scans of a cadaver specimen. Computational fluid dynamics simulations of water flow in the reconstructed model reveal the external and internal hydrodynamics of olfaction during swimming. Computed external flow patterns elucidate the occurrence of flow phenomena that result in high and low pressures at the incurrent and excurrent nostrils, respectively, which induces flow through the olfactory chamber. The major (prenarial) nasal groove along the cephalofoil is shown to facilitate sampling of a large spatial extent (i.e., an extended hydrodynamic "reach'') by directing oncoming flow towards the incurrent nostril. Further, both the major and minor nasal grooves redirect some flow away from the incurrent nostril, thereby limiting the amount of fluid that enters the olfactory chamber. Internal hydrodynamic flow patterns are also revealed, where we show that flow rates within the sensory channels between olfactory lamellae are passively regulated by the apical gap, which functions as a partial bypass for flow in the olfactory chamber. Consequently, the hammerhead shark appears to utilize external (major and minor nasal grooves) and internal (apical gap) flow regulation mechanisms to limit water flow between the olfactory lamellae, thus protecting these delicate structures from otherwise high flow rates incurred by sampling a larger area.	[Rygg, Alex D.; Craven, Brent A.] Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; [Rygg, Alex D.; Craven, Brent A.] Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA; [Cox, Jonathan P. L.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [Abel, Richard] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Webb, Andrew G.; Smith, Nadine B.] Leiden Univ, Med Ctr, Dept Radiol, CJ Gorter Ctr High Field MRI, Leiden, Netherlands; [Craven, Brent A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bath; Natural History Museum London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rygg, AD (corresponding author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.	adr5023@psu.edu; craven@psu.edu	Webb, Andrew/G-9642-2016	Webb, Andrew/0000-0003-4045-9732	Pennsylvania State University Applied Research Laboratory	Pennsylvania State University Applied Research Laboratory	This work was supported by the Pennsylvania State University Applied Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2010, COMP BIOCHEM PHYS A, V155, P464, DOI 10.1016/j.cbpa.2009.10.029; BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Bertmar G, 1972, CELL TISSUE RES, V128, P336; BLAIR A M J N, 1969, British Journal of Pharmacology, V35, p379P; BRONSHTEIN AA, 1964, DOKL AKAD NAUK SSSR+, V156, P715; Cimbala J.M., 2008, ESSENTIALS FLUID MEC; Cox JPL, 2008, J R SOC INTERFACE, V5, P575, DOI 10.1098/rsif.2007.1281; Cox JPL, 2013, FISH FISH, V14, P364, DOI 10.1111/j.1467-2979.2012.00476.x; Craven BA, 2007, ANAT REC, V290, P1325, DOI 10.1002/ar.20592; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; Craven BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148202; DOVING KB, 1977, ACTA ZOOL-STOCKHOLM, V58, P245, DOI 10.1111/j.1463-6395.1977.tb00260.x; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; GILBERT PW, 1962, SCI AM, V207, P60, DOI 10.1038/scientificamerican0762-60; HARA T J, 1975, Progress in Neurobiology (Oxford), V5, P271, DOI 10.1016/0301-0082(75)90014-3; Holl A., 1965, Zeitschrift fuer Morphologie und Oekologie der Tiere, V54, P707, DOI 10.1007/BF00429940; Holmes WM, 2011, ANAT REC, V294, P1045, DOI 10.1002/ar.21382; JOHNSEN PB, 1985, MAR BEHAV PHYSIOL, V11, P283, DOI 10.1080/10236248509387053; Kajiura SM, 2005, J MORPHOL, V264, P253, DOI 10.1002/jmor.10208; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Lowe CG, 1996, J EXP BIOL, V199, P2605; McElwain A, 2010, J PARASITOL, V96, P887, DOI 10.1645/GE-2361.1; Meredith TL, 2010, J EXP BIOL, V213, P3449, DOI 10.1242/jeb.045849; Nadeau JL, 2009, AQUAT CONSERV, V19, P428, DOI 10.1002/aqc.1002; PROCTOR DF, 1982, NOSE UPPER AIRWAY PH, P245; Quraishi MS, 1998, CLIN OTOLARYNGOL, V23, P403, DOI 10.1046/j.1365-2273.1998.00172.x; Schluessel V, 2008, J MORPHOL, V269, P1365, DOI 10.1002/jmor.10661; SELLERS LA, 1988, CARBOHYD RES, V178, P93, DOI 10.1016/0008-6215(88)80104-6; Tester A, 1963, SHARKS SURVIVAL, V8, P255; THEISEN B, 1986, ACTA ZOOL-STOCKHOLM, V67, P73, DOI 10.1111/j.1463-6395.1986.tb00851.x; TUCKER D, 1983, FISH NEUROBIOLOGY, V1, P311; White FM., 1994, FLUID MECH-SOV RES, V3; ZEISKE E, 1987, CAN J ZOOL, V65, P2406, DOI 10.1139/z87-362; ZEISKE E, 1986, P 2 INT C IND FISH, P381	35	16	16	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59783	10.1371/journal.pone.0059783	http://dx.doi.org/10.1371/journal.pone.0059783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555780	Green Submitted, gold, Green Published			2022-12-27	WOS:000317263900029
J	Chen, ZC; Jones, JA; Liu, P; Li, WF; Huang, DF; Liu, HJ				Chen, Zhaocong; Jones, Jeffery A.; Liu, Peng; Li, Weifeng; Huang, Dongfeng; Liu, Hanjun			Dynamics of Vocalization-Induced Modulation of Auditory Cortical Activity at Mid-utterance	PLOS ONE			English	Article							VOICE FUNDAMENTAL-FREQUENCY; INDUCED SUPPRESSION; SPEECH PRODUCTION; FEEDBACK-CONTROL; PITCH FEEDBACK; RESPONSES; CORTEX; MODEL; PERTURBATIONS; LANGUAGE	Background: Recent research has addressed the suppression of cortical sensory responses to altered auditory feedback that occurs at utterance onset regarding speech. However, there is reason to assume that the mechanisms underlying sensorimotor processing at mid-utterance are different than those involved in sensorimotor control at utterance onset. The present study attempted to examine the dynamics of event-related potentials (ERPs) to different acoustic versions of auditory feedback at mid-utterance. Methodology/Principal findings: Subjects produced a vowel sound while hearing their pitch-shifted voice (100 cents), a sum of their vocalization and pure tones, or a sum of their vocalization and white noise at mid-utterance via headphones. Subjects also passively listened to playback of what they heard during active vocalization. Cortical ERPs were recorded in response to different acoustic versions of feedback changes during both active vocalization and passive listening. The results showed that, relative to passive listening, active vocalization yielded enhanced P2 responses to the 100 cents pitch shifts, whereas suppression effects of P2 responses were observed when voice auditory feedback was distorted by pure tones or white noise. Conclusion/Significance: The present findings, for the first time, demonstrate a dynamic modulation of cortical activity as a function of the quality of acoustic feedback at mid-utterance, suggesting that auditory cortical responses can be enhanced or suppressed to distinguish self-produced speech from externally-produced sounds.	[Chen, Zhaocong; Liu, Peng; Li, Weifeng; Huang, Dongfeng; Liu, Hanjun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China; [Jones, Jeffery A.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; [Jones, Jeffery A.] Wilfrid Laurier Univ, Laurier Ctr Cognit Neurosci, Waterloo, ON N2L 3C5, Canada	Sun Yat Sen University; Wilfrid Laurier University; Wilfrid Laurier University	Liu, HJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China.	lhanjun@mail.sysu.edu.cn		Chen, Zhaocong/0000-0002-0144-2754; Liu, Hanjun/0000-0003-1466-4193	National Natural Science Foundation of China [30970965, 31070990]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from National Natural Science Foundation of China (Nos. 30970965 and 31070990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Baess P, 2011, PSYCHOPHYSIOLOGY, V48, P1276, DOI 10.1111/j.1469-8986.2011.01196.x; Bass P, 2008, INT J PSYCHOPHYSIOL, V70, P137, DOI 10.1016/j.ijpsycho.2008.06.005; Bauer JJ, 2006, J ACOUST SOC AM, V119, P2363, DOI 10.1121/1.2173513; Behroozmand R, 2011, CLIN NEUROPHYSIOL, V122, P2408, DOI 10.1016/j.clinph.2011.04.019; Behroozmand R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-54; Behroozmand R, 2011, J COGNITIVE NEUROSCI, V23, P1205, DOI 10.1162/jocn.2010.21447; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Boersma Paul, 2002, GLOT INT, V5, P341; Chang EF, 2013, P NATL ACAD SCI USA, V110, P2653, DOI 10.1073/pnas.1216827110; Chen SH, 2007, J ACOUST SOC AM, V121, P1157, DOI 10.1121/1.2404624; Chen ZC, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-55; Chen ZC, 2012, BRAIN LANG, V121, P25, DOI 10.1016/j.bandl.2012.02.004; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Christoffels IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018307; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Flinker A, 2010, J NEUROSCI, V30, P16643, DOI 10.1523/JNEUROSCI.1809-10.2010; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Hawco CS, 2009, BRAIN RES, V1276, P131, DOI 10.1016/j.brainres.2009.04.033; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Heinks-Maldonado TH, 2006, NEUROREPORT, V17, P1375, DOI 10.1097/01.wnr.0000233102.43526.e9; Hesse MD, 2010, CEREB CORTEX, V20, P425, DOI 10.1093/cercor/bhp110; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Jacobs O.L.R., 1993, INTRO CONTROL THEORY, V2nd; Lange K, 2011, PSYCHOPHYSIOLOGY, V48, P1088, DOI 10.1111/j.1469-8986.2010.01174.x; Liu HJ, 2007, J ACOUST SOC AM, V122, P3671, DOI 10.1121/1.2800254; Liu HJ, 2010, J ACOUST SOC AM, V128, P3739, DOI 10.1121/1.3500675; Liu HJ, 2010, NEUROREPORT, V21, P527, DOI 10.1097/WNR.0b013e3283393a44; Liu P, 2010, J ACOUST SOC AM, V128, P1306, DOI 10.1121/1.3467773; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; MULLERPREUSS P, 1980, BRAIN RES, V202, P307, DOI 10.1016/0006-8993(80)90143-2; Numminen J, 1999, NEUROSCI LETT, V272, P29, DOI 10.1016/S0304-3940(99)00573-X; Price CJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00237; Ventura MI, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-58; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	44	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60039	10.1371/journal.pone.0060039	http://dx.doi.org/10.1371/journal.pone.0060039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555876	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200071
J	Mallela, J				Mallela, Jennie			Calcification by Reef-Building Sclerobionts	PLOS ONE			English	Article							LAGOONS FRENCH-POLYNESIA; CRUSTOSE CORALLINE ALGAE; CARBONATE PRODUCTION; ST-CROIX; GROWTH-RATES; HIGH ISLANDS; COMMUNITIES; RECRUITMENT; ENVIRONMENT; SUCCESSION	It is widely accepted that deteriorating water quality associated with increased sediment stress has reduced calcification rates on coral reefs. However, there is limited information regarding the growth and development of reef building organisms, aside from the corals themselves. This study investigated encruster calcification on five fore-reefs in Tobago subjected to a range of sedimentation rates (1.2 to 15.9 mg cm(-2) d(-1)). Experimental substrates were used to assess rates of calcification in sclerobionts (e. g. crustose coralline algae, bryozoans and barnacles) across key reef microhabitats: cryptic (low-light), exposed (open-horizontal) and vertical topographic settings. Sedimentation negatively impacted calcification by photosynthesising crustose coralline algae in exposed microhabitats and encrusting foram cover (%) in exposed and cryptic substrates. Heterotrophs were not affected by sedimentation. Fore-reef, turbid water encruster assemblages calcified at a mean rate of 757 (SD +/- 317) g m(-2) y(-1). Different microhabitats were characterised by distinct calcareous encruster assemblages with different rates of calcification. Taxa with rapid lateral growth dominated areal cover but were not responsible for the majority of CaCO3 production. Cryptobiont assemblages were composed of a suite of calcifying taxa which included sciaphilic cheilostome bryozoans and suspension feeding barnacles. These calcified at mean rates of 20.1 (SD +/- 27) and 4.0 (SD +/- 3.6) g m 22 y 21 respectively. Encruster cover (%) on exposed and vertical substrates was dominated by crustose coralline algae which calcified at rates of 105.3 (SD +/- 67.7) g m(-2) y(-1) and 56.3 (SD +/- 8.3) g m(-2) y(-1) respectively. Globally, encrusting organisms contribute significant amounts of carbonate to the reef framework. These results provide experimental evidence that calcification rates, and the importance of different encrusting organisms, vary significantly according to topography and sediment impacts. These findings also highlight the need for caution when modelling reef framework accretion and interpreting results which extrapolate information from limited data.	[Mallela, Jennie] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Mallela, Jennie] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Mallela, Jennie] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago	Australian National University; Australian National University; University West Indies Mona Jamaica; University West Indies Saint Augustine	Mallela, J (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	j.a.mallela93@members.leeds.ac.uk		Mallela, Jennie/0000-0002-7811-6850	University of the West Indies (UWI, Trinidad and Tobago); Buccoo Reef Trust; GEF funded Integrating Watershed and Coastal Area Management (IWCAM) Tobago Program; Government Research Fund of Trinidad and Tobago	University of the West Indies (UWI, Trinidad and Tobago); Buccoo Reef Trust; GEF funded Integrating Watershed and Coastal Area Management (IWCAM) Tobago Program; Government Research Fund of Trinidad and Tobago	The University of the West Indies (UWI, Trinidad and Tobago), The Buccoo Reef Trust and The GEF funded Integrating Watershed and Coastal Area Management (IWCAM) Tobago Program, Government Research Fund of Trinidad and Tobago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2012, LETHAIA, V45, P14, DOI 10.1111/j.1502-3931.2011.00268.x; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; AGARD J. B. R., 2000, SEAS MILLENNIUM ENV, V1, P627; Anderson MJ, 2008, PERMANOVA A PRIMER G; Bak R.P.M., 1976, Netherlands J Sea Res, V10, P285, DOI 10.1016/0077-7579(76)90009-0; BOSENCE DWJ, 1984, PALAEONTOLOGY, V27, P549; Bouchon, 2008, STATUS CORAL REEFS W, V2008, P265; Brett CE, 2011, PALAEOGEOGR PALAEOCL, V312, P278, DOI 10.1016/j.palaeo.2011.05.019; Burke L., 2011, REEFS RISK REVISITED, P114; Burke L., 2008, COASTAL CAPITAL EC V; CHAVE KE, 1972, MAR GEOL, V12, P123, DOI 10.1016/0025-3227(72)90024-2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Davies P.J., 1983, Coral Reefs, V2, P27, DOI 10.1007/BF00304729; Dong Ryong Choi, 1983, Coral Reefs, V2, P165; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Eakin CM, 1996, CORAL REEFS, V15, P109; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FAGERSTROM JA, 1991, CORAL REEFS, V10, P47, DOI 10.1007/BF00301908; Ginsburg R.N., 1983, Australian Institute of Marine Science Contribution, P148; Gorley C.K., 2006, GETTING STARTED PRIM; Harney JN, 2003, J SEDIMENT RES, V73, P856, DOI 10.1306/051503730856; Hart DE, 2007, CORAL REEFS, V26, P53, DOI 10.1007/s00338-006-0168-8; Hibino K, 2000, J EXP MAR BIOL ECOL, V252, P1, DOI 10.1016/S0022-0981(00)00214-8; HUBBARD DK, 1986, J SEDIMENT PETROL, V56, P848; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; IWCAM, 2011, GEF IWCAM DAT; JACKSON JBC, 1982, J EXP MAR BIOL ECOL, V57, P135, DOI 10.1016/0022-0981(82)90188-5; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kumarsingh K, 1998, MAR POLLUT BULL, V36, P1012, DOI 10.1016/S0025-326X(98)00086-1; Land L. S, 1974, P 2 INT COR REEF S, V2, P409; Lapointe BE, 2010, MAR POLLUT BULL, V60, P334, DOI 10.1016/j.marpolbul.2009.10.020; LAUBIER L, 1966, ANN I OCEANOGR PARIS, V43, P137; Mallela J, 2008, CORAL REEFS, V27, P787, DOI 10.1007/s00338-008-0401-8; Mallela J, 2007, CORAL REEFS, V26, P775, DOI 10.1007/s00338-007-0260-8; Mallela J, 2009, MAR ENVIRON RES, V68, P158, DOI 10.1016/j.marenvres.2009.06.001; Mallela J, 2007, CORAL REEFS, V26, P53, DOI DOI 10.1007/S00338-006-0168-8; Mallela J, 2008, MAR ECOL PROG SER, V368, P41, DOI 10.3354/meps07589; Mallela J, 2010, CARIBB J SCI, V46, P83; MARTINDALE W, 1992, CORAL REEFS, V11, P167, DOI 10.1007/BF00255472; MATSUDA S, 1989, CORAL REEFS, V7, P185, DOI 10.1007/BF00301597; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Pari N, 2002, J EXP MAR BIOL ECOL, V276, P109, DOI 10.1016/S0022-0981(02)00243-5; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; Payri CE, 1997, HYDROLITHON REINBOLD; RASMUSSEN KA, 1985, GEOLOGY, V13, P551, DOI 10.1130/0091-7613(1985)13<551:TOHCBF>2.0.CO;2; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; Risk M., 1992, P 7 INT COR REEF S, P156; Scoffin TP, 1974, P 2 INT COR REEF S B, V2, P429; STEARN CW, 1977, B MAR SCI, V27, P479; Stearn CW, 1977, P 3 INT COR REEF S, V2, P471; STENECK RS, 1976, BOT MAR, V19, P197, DOI 10.1515/botm.1976.19.4.197; Taylor P.D., 1990, P346; Taylor PD, 2002, PALAIOS, V17, P522, DOI 10.1669/0883-1351(2002)017<0522:ANTFMO>2.0.CO;2; Vecsei A, 2004, GLOBAL PLANET CHANGE, V43, P1, DOI 10.1016/j.gloplacha.2003.12.002; Vecsei A, 2001, PALAEOGEOGR PALAEOCL, V2739, P1; Walker SE, 2011, PALAEOGEOGR PALAEOCL, V312, P325, DOI 10.1016/j.palaeo.2011.04.028	61	27	27	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60010	10.1371/journal.pone.0060010	http://dx.doi.org/10.1371/journal.pone.0060010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555864	gold, Green Published			2022-12-27	WOS:000317262200068
J	Westerweel, PE; Teraa, M; Rafii, S; Jaspers, JE; White, IA; Hooper, AT; Doevendans, PA; Verhaar, MC				Westerweel, Peter E.; Teraa, Martin; Rafii, Shahin; Jaspers, Janneke E.; White, Ian A.; Hooper, Andrea T.; Doevendans, Pieter A.; Verhaar, Marianne C.			Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NITRIC-OXIDE-SYNTHASE; STEM-CELLS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; VASCULAR REPAIR; CD34(+) CELLS; GROWTH-FACTOR	Background: Circulating Endothelial Progenitor Cell (EPC) levels are reduced in diabetes mellitus. This may be a consequence of impaired mobilization of EPC from the bone marrow. We hypothesized that under diabetic conditions, mobilization of EPC from the bone marrow to the circulation is impaired -at least partly- due to dysfunction of the bone marrow stromal compartment. Methods: Diabetes was induced in mice by streptozotocin injection. Circulating Sca-1(+)Flk-1(+) EPC were characterized and quantified by flow cytometry at baseline and after mobilization with G-CSF/SCF injections. In vivo hemangiogenic recovery was tested by 5-FU challenge. Interaction within the bone marrow environment between CD34(+) hematopoietic progenitor cells (HPC) and supporting stroma was assessed by co-cultures. To study progenitor cell-endothelial cell interaction under normoglycemic and hyperglycemic conditions, a co-culture model using E4Orf1-transfected human endothelial cells was employed. Results: In diabetic mice, bone marrow EPC levels were unaffected. However, circulating EPC levels in blood were lower at baseline and mobilization was attenuated. Diabetic mice failed to recover and repopulate from 5-FU injection. In vitro, primary cultured bone marrow stroma from diabetic mice was impaired in its capacity to support human CFU-forming HPC. Finally, hyperglycemia hampered the HPC supportive function of endothelial cells in vitro. Conclusion: EPC mobilization is impaired under experimental diabetic conditions and our data suggest that diabetes induces alterations in the progenitor cell supportive capacity of the bone marrow stroma, which could be partially responsible for the attenuated EPC mobilization and reduced EPC levels observed in diabetic patients.	[Westerweel, Peter E.; Teraa, Martin; Jaspers, Janneke E.; Verhaar, Marianne C.] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Westerweel, Peter E.; Rafii, Shahin; White, Ian A.; Hooper, Andrea T.] Weill Cornell Med Coll, Ansary Stem Cell Ctr Regenerat Med, Howard Hughes Med Inst, New York, NY USA; [Westerweel, Peter E.] Univ Med Ctr Utrecht, Dept Haematol, Utrecht, Netherlands; [Teraa, Martin] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Doevendans, Pieter A.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Cornell University; Howard Hughes Medical Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Verhaar, MC (corresponding author), Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands.	M.C.Verhaar@umcutrecht.nl	Verhaar, Marianne/AAM-6788-2020; Teraa, Martin/A-2508-2012	Verhaar, Marianne/0000-0002-3276-6428; Teraa, Martin/0000-0002-6751-6752; Hooper, Andrea/0000-0003-1131-1229	Dutch Heart Foundation, The Netherlands [2004T022, 2006R024]; ZonMw, The Netherlands [2007/12579, 016.096.359]	Dutch Heart Foundation, The Netherlands(Netherlands Heart FoundationNetherlands Government); ZonMw, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	The reported work was supported by the Dutch Heart Foundation (Dr. E. Dekker Grant 2004T022 and travel grant 2006R024, The Netherlands, www.hartstichting.nl) and ZonMw (AGIKO grant 2007/12579 and Vidi grant 016.096.359, The Netherlands, www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Carral A, 2002, BONE MARROW TRANSPL, V29, P825, DOI 10.1038/sj.bmt.1703566; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0313-1; Fadini GP, 2012, EXP DIABETES RES, DOI 10.1155/2012/742976; Fadini GP, 2012, DIABETES CARE; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hazra S, 2013, DIABETOLOGIA, V56, P644, DOI 10.1007/s00125-012-2781-0; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kang LN, 2009, CLIN EXP PHARMACOL P, V36, pe47, DOI 10.1111/j.1440-1681.2009.05219.x; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Leone AM, 2006, INT J CARDIOL, V111, P202, DOI 10.1016/j.ijcard.2005.06.043; Li HW, 2012, NAT REV IMMUNOL, V12, P403, DOI 10.1038/nri3226; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Michejda M, 2004, FETAL DIAGN THER, V19, P2, DOI 10.1159/000074252; MOLINEUX G, 1991, BLOOD, V78, P961; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Oikawa A, 2010, ARTERIOSCL THROM VAS, V30, P498, DOI 10.1161/ATVBAHA.109.200154; Onodera R, 2011, BONE MARROW TRANSPL, V46, P278, DOI 10.1038/bmt.2010.110; Orlandi A, 2010, BASIC RES CARDIOL, V105, P703, DOI 10.1007/s00395-010-0109-0; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; RAFII S, 1994, BLOOD, V84, P10; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Stokman G, 2008, NEPHROL DIAL TRANSPL, V23, P483, DOI 10.1093/ndt/gfm607; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Verhaar MC, 1998, CARDIOVASC DRUG THER, V12, P125, DOI 10.1023/A:1007737412395; Voo S, 2009, J INTERN MED, V265, P238, DOI 10.1111/j.1365-2796.2008.02011.x; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Wang XL, 2010, HAEMATOL-HEMATOL J, V95, P884, DOI 10.3324/haematol.2009.013151; Weisel KC, 2009, STEM CELLS DEV, V18, P229, DOI 10.1089/scd.2008.0069; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Westerweel PE, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-55; Wu AG, 1999, PEDIATR RES, V46, P163, DOI 10.1203/00006450-199908000-00006; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568	56	52	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60357	10.1371/journal.pone.0060357	http://dx.doi.org/10.1371/journal.pone.0060357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555959	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200110
J	Baton, LA; Pacidonio, EC; Goncalves, DD; Moreira, LA				Baton, Luke Anthony; Pacidonio, Etiene Casagrande; Goncalves, Daniela da Silva; Moreira, Luciano Andrade			wFlu: Characterization and Evaluation of a Native Wolbachia from the Mosquito Aedes fluviatilis as a Potential Vector Control Agent	PLOS ONE			English	Article							UNIDIRECTIONAL CYTOPLASMIC INCOMPATIBILITY; RICKETTSIA-LIKE MICROORGANISMS; LIFE-SHORTENING WOLBACHIA; CULEX-QUINQUEFASCIATUS; DROSOPHILA-SIMULANS; ALBOPICTUS DIPTERA; BACTERIAL DENSITY; INDUCED MORTALITY; BLOCKS DENGUE; INFECTION	There is currently considerable interest and practical progress in using the endosymbiotic bacteria Wolbachia as a vector control agent for human vector-borne diseases. Such vector control strategies may require the introduction of multiple, different Wolbachia strains into target vector populations, necessitating the identification and characterization of appropriate endosymbiont variants. Here, we report preliminary characterization of wFlu, a native Wolbachia from the neotropical mosquito Aedes fluviatilis, and evaluate its potential as a vector control agent by confirming its ability to cause cytoplasmic incompatibility, and measuring its effect on three parameters determining host fitness (survival, fecundity and fertility), as well as vector competence (susceptibility) for pathogen infection. Using an aposymbiotic strain of Ae. fluviatilis cured of its native Wolbachia by antibiotic treatment, we show that in its natural host wFlu causes incomplete, but high levels of, unidirectional cytoplasmic incompatibility, has high rates of maternal transmission, and no detectable fitness costs, indicating a high capacity to rapidly spread through host populations. However, wFlu does not inhibit, and even enhances, oocyst infection with the avian malaria parasite Plasmodium gallinaceum. The stage-and sex-specific density of wFlu was relatively low, and with limited tissue distribution, consistent with the lack of virulence and pathogen interference/ symbiont-mediated protection observed. Unexpectedly, the density of wFlu was also shown to be specifically-reduced in the ovaries after bloodfeeding Ae. fluviatilis. Overall, our observations indicate that the Wolbachia strain wFlu has the potential to be used as a vector control agent, and suggests that appreciable mutualistic coevolution has occurred between this endosymbiont and its natural host. Future work will be needed to determine whether wFlu has virulent host effects and/or exhibits pathogen interference when artificially-transfected to the novel mosquito hosts that are the vectors of human pathogens.	[Baton, Luke Anthony; Pacidonio, Etiene Casagrande; Goncalves, Daniela da Silva; Moreira, Luciano Andrade] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Moreira, LA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	luciano@cpqrr.fiocruz.br		da Silva Goncalves, Daniela/0000-0002-3191-9509; Baton, Luke/0000-0003-4515-8867	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); FAPEMIG; CNPq; INCT-EM; CPqRR/Fiocruz	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-EM; CPqRR/Fiocruz	LAB was supported by a Post-doctoral Fellowship from the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG). ECP was supported by a scholarship from FAPEMIG. DSG was supported by CNPq. LAM is a CNPq research fellow. Financial support was provided by FAPEMIG and CNPq. This work was partially supported by CNPq, FAPEMIG, INCT-EM and CPqRR/Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2007, TRENDS ECOL EVOL, V22, P506, DOI 10.1016/j.tree.2007.08.007; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Barr A R, 1966, Proc Pap Annu Conf Calif Mosq Control Assoc, V34, P32; BECKETT EB, 1978, ANN TROP MED PARASIT, V72, P277, DOI 10.1080/00034983.1978.11719316; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; BINNINGTON KC, 1989, J INVERTEBR PATHOL, V54, P344, DOI 10.1016/0022-2011(89)90118-3; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BREEUWER JAJ, 1993, GENETICS, V135, P565; Brelsfoard CL, 2011, J MED ENTOMOL, V48, P1008, DOI 10.1603/ME10202; Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Brumpt E, 1935, CR HEBD ACAD SCI, V200, P783; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Calvitti M, 2009, MED VET ENTOMOL, V23, P132, DOI 10.1111/j.1365-2915.2008.00791.x; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Consoli R. A. G B., 1976, THESIS U FEDERAL MIN; CONSOLI RAGB, 1978, B ENTOMOL RES, V68, P123, DOI 10.1017/S0007485300007203; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Cook PE, 2010, TRENDS PARASITOL, V26, P373, DOI 10.1016/j.pt.2010.05.006; Curtis CF, 1998, PARASITOLOGY, V116, pS111, DOI 10.1017/S0031182000084997; CURTIS CF, 1983, J INVERTEBR PATHOL, V41, P214, DOI 10.1016/0022-2011(83)90221-5; CURTIS CF, 1992, NATURE, V357, P450, DOI 10.1038/357450b0; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; de Almeida F, 2011, INFECT GENET EVOL, V11, P2138, DOI 10.1016/j.meegid.2011.08.022; DECAMARGO MT, 1978, J PARASITOL, V64, P924, DOI 10.2307/3279533; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2003, TRENDS PARASITOL, V19, P128, DOI 10.1016/S1471-4922(03)00002-3; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Dutton TJ, 2005, MED VET ENTOMOL, V19, P60, DOI 10.1111/j.0269-283X.2005.00557.x; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Echaubard P, 2010, HEREDITY, V104, P15, DOI 10.1038/hdy.2009.100; Ewald PW, 1994, EVOLUTION INFECT DIS; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7; Forattini O P, 2002, CULICIDOLOGICA MED; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Fu YQ, 2010, APPL ENVIRON MICROB, V76, P5887, DOI 10.1128/AEM.00218-10; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HERTIG M., 1936, Parasitology, V28, P453, DOI 10.1017/S0031182000022666; Hertig M, 1924, J MED RES, V44, P329; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Irving-Bell R. J., 1977, Advances in Invertebrate Reproduction, Volume I, P36; IRVINGBELL RJ, 1974, LIFE SCI, V14, P1149, DOI 10.1016/0024-3205(74)90239-2; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jamnongluk W, 2000, J MED ENTOMOL, V37, P53, DOI 10.1603/0022-2585-37.1.53; KAMBHAMPATI S, 1993, EVOLUTION, V47, P673, DOI [10.2307/2410079, 10.1111/j.1558-5646.1993.tb02121.x]; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; Kittayapong P, 2002, AM J TROP MED HYG, V66, P103, DOI 10.4269/ajtmh.2002.66.103; KRISHNAMURTHY BS, 1977, J GENET, V63, P31, DOI 10.1007/BF02984223; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.2307/2410731, 10.1111/j.1558-5646.1996.tb03560.x]; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; Mazurkiewicz-Kania M, 2012, ARTHROPOD STRUCT DEV, V41, P65, DOI 10.1016/j.asd.2011.07.004; McCall K, 2004, DEV BIOL, V274, P3, DOI 10.1016/j.ydbio.2004.07.017; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McGraw EA, 1999, TRENDS MICROBIOL, V7, P297, DOI 10.1016/S0966-842X(99)01531-0; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Mercot H, 1998, NATURE, V391, P853, DOI 10.1038/36021; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Rasgon JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030381; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Rasgon JL, 2003, GENETICS, V165, P2029; Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x; Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103; SINGH KRP, 1976, ANN TROP MED PARASIT, V70, P463, DOI 10.1080/00034983.1976.11687148; Sinkins SP, 1997, INFLUENTIAL PASSENGERS, P155; Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Soper FL, 1933, AM J HYG, V18, P555, DOI 10.1093/oxfordjournals.aje.a117967; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Subbarao S.K., 1982, P313; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Tason de Camargo M.V., 1983, Memorias do Instituto Oswaldo Cruz, V78, P83; Thomas P, 2011, DEV COMP IMMUNOL, V35, P360, DOI 10.1016/j.dci.2010.11.007; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; TRPIS M, 1981, J HERED, V72, P313, DOI 10.1093/oxfordjournals.jhered.a109513; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x; TURELLI M, 1995, GENETICS, V140, P1319; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Walker T, 2011, MEM I OSWALDO CRUZ, V106, P212, DOI 10.1590/S0074-02762011000900026; Weeks AR, 2002, TRENDS ECOL EVOL, V17, P257, DOI 10.1016/S0169-5347(02)02480-1; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wiwatanaratanabutr S, 2006, MED VET ENTOMOL, V20, P300, DOI 10.1111/j.1365-2915.2006.00640.x; World Health Organization, 1964, WHO SCI GROUP M HELD; WRIGHT JD, 1978, J ULTRA MOL STRUCT R, V63, P79, DOI 10.1016/S0022-5320(78)80046-X; WRIGHT JD, 1980, J INVERTEBR PATHOL, V35, P200, DOI 10.1016/0022-2011(80)90185-8; WRIGHT JD, 1980, J ULTRA MOL STRUCT R, V72, P52, DOI 10.1016/S0022-5320(80)90135-5; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Yen J.H., 1974, P97; YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; YEN JH, 1975, ANN NY ACAD SCI, V266, P152, DOI 10.1111/j.1749-6632.1975.tb35096.x; Zele F, 2012, J EVOLUTION BIOL, V25, P1243, DOI 10.1111/j.1420-9101.2012.02519.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	130	58	59	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59619	10.1371/journal.pone.0059619	http://dx.doi.org/10.1371/journal.pone.0059619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555728	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500066
J	Chicaybam, L; Sodre, AL; Curzio, BA; Bonamino, MH				Chicaybam, Leonardo; Sodre, Andressa Laino; Curzio, Bianca Azevedo; Bonamino, Martin Hernan			An Efficient Low Cost Method for Gene Transfer to T Lymphocytes	PLOS ONE			English	Article							MESSENGER-RNA ELECTROPORATION; SLEEPING-BEAUTY; ADOPTIVE IMMUNOTHERAPY; LENTIVIRAL VECTOR; CELLS; TRANSPOSON; RECEPTORS; TRANSDUCTION; CYTOTOXICITY; EXPRESSION	Gene transfer to T lymphocytes has historically relied on retro and lentivirus, but recently transposon-based gene transfer is rising as a simpler and straight forward approach to achieve stable transgene expression. Transfer of expression cassettes to T lymphocytes remains challenging, being based mainly on commercial kits. Aims: We herein report a convenient and affordable method based on in house made buffers, generic cuvettes and utilization of the widely available Lonza nucleofector II device to promote efficient gene transfer to T lymphocytes. Results: This approach renders high transgene expression levels in primary human T lymphocytes (mean 45%, 41-59%), the hard to transfect murine T cells (mean 38%, 36-42% for C57/BL6 strain) and human Jurkat T cell line. Cell viability levels after electroporation allowed further manipulations such as in vitro expansion and Chimeric Antigen Receptor (CAR) mediated gain of function for target cell lysis. Conclusions: We describe here an efficient general protocol for electroporation based modification of T lymphocytes. By opening access to this protocol, we expect that efficient gene transfer to T lymphocytes, for transient or stable expression, may be achieved by an increased number of laboratories at lower and affordable costs.	[Chicaybam, Leonardo; Sodre, Andressa Laino; Curzio, Bianca Azevedo; Bonamino, Martin Hernan] Inst Nacl Canc INCA, Coordenacao Pesquisa CPQ, Programa Carcinogenese Mol, Rio De Janeiro, Brazil; [Chicaybam, Leonardo] Fundacao Inst Oswaldo Cruz FIOCRUZ, Inst Pesquisa Clin Evandro Chagas IPEC, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Fundacao Oswaldo Cruz	Bonamino, MH (corresponding author), Inst Nacl Canc INCA, Coordenacao Pesquisa CPQ, Programa Carcinogenese Mol, Rio De Janeiro, Brazil.	mbonamino@inca.gov.br	; Bonamino, Martin/A-9623-2014	Chicaybam Peixoto, Leonardo/0000-0002-1541-9029; Bonamino, Martin/0000-0002-4416-5822	CNPq; Instituto do MIlenio de Terapia Genica; CAPES; Fundacao do Cancer; INCa; Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto do MIlenio de Terapia Genica; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao do Cancer; INCa(Institut National du Cancer (INCA) France); Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho	This work was supported by grants of CNPq, Instituto do MIlenio de Terapia Genica, CAPES, Fundacao do Cancer, INCa and Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio F., 2012, Proceedings of the 2012 6th European Conference on Antennas and Propagation (EuCAP), P356, DOI 10.1109/EuCAP.2012.6206719; Bell MP, 2001, NAT MED, V7, P1155, DOI 10.1038/nm1001-1155; Bonamino M, 2004, GENE THER, V11, P85, DOI 10.1038/sj.gt.3302141; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brenner MK, 2012, CANC GENE THERAPY; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chicaybam L, 2011, INT REV IMMUNOL, V30, P294, DOI 10.3109/08830185.2011.595855; D'Amico G, 2006, LEUKEMIA, V20, P2015, DOI 10.1038/sj.leu.2404390; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Ebert O, 1997, GENE THER, V4, P296, DOI 10.1038/sj.gt.3300394; Flanagan M, 2011, CANCER GENE THER, V18, P579, DOI 10.1038/cgt.2011.27; Galla M, 2011, NUCLEIC ACIDS RES, V39, P7147, DOI 10.1093/nar/gkr384; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Grund EM, 2005, J IMMUNOL METHODS, V296, P31, DOI 10.1016/j.jim.2004.10.008; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Huls MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50070; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kebriaei P, 2012, HUM GENE THER, V23, P444, DOI 10.1089/hum.2011.167; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; Lehner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031210; Mitchell DA, 2008, HUM GENE THER, V19, P511, DOI 10.1089/hum.2007.115; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Murakami T, 2011, CURRENT GENE THERAPY, P11; Newrzela S, 2008, BLOOD, V112, P2278, DOI 10.1182/blood-2007-12-128751; Peng PD, 2009, GENE THER, V16, P1042, DOI 10.1038/gt.2009.54; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rabinovich PM, 2009, HUM GENE THER, V20, P51, DOI 10.1089/hum.2008.068; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Salmon P, 2000, BLOOD, V96, P3392; Schaft N, 2006, CANCER IMMUNOL IMMUN, V55, P1132, DOI 10.1007/s00262-005-0098-2; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Serafini M, 2004, HAEMATOLOGICA, V89, P86; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Sutlu T, 2012, HUM GENE THER, V23, P1090, DOI 10.1089/hum.2012.080; Tran J, 2007, MOL THER, V15, P1331, DOI 10.1038/sj.mt.6300184; Van Driessche A, 2005, FOLIA HISTOCHEM CYTO, V43, P213; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Westwood JA, 2008, GENE THER, V15, P1056, DOI 10.1038/gt.2008.47; Zhao YB, 2006, MOL THER, V13, P151, DOI 10.1016/j.ymthe.2005.07.688	48	81	93	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60298	10.1371/journal.pone.0060298	http://dx.doi.org/10.1371/journal.pone.0060298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555950	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500128
J	Fedick, A; Su, J; Jalas, C; Northrop, L; Devkota, B; Ekstein, J; Treff, NR				Fedick, Anastasia; Su, Jing; Jalas, Chaim; Northrop, Lesley; Devkota, Batsal; Ekstein, Josef; Treff, Nathan R.			High-Throughput Carrier Screening Using TaqMan Allelic Discrimination	PLOS ONE			English	Article							ASHKENAZI JEWISH POPULATION; GAUCHER-DISEASE; CYSTIC-FIBROSIS; IDENTIFICATION; MUTATION; STRATEGY; GENES	Members of the Ashkenazi Jewish community are at an increased risk for inheritance of numerous genetic diseases such that carrier screening is medically recommended. This paper describes the development and evaluation of 30 TaqMan allelic discrimination qPCR assays for 29 mutations on 2 different high-throughput platforms. Four of these mutations are in the GBA gene and are successfully examined using short amplicons due to the qualitative nature of TaqMan allelic discrimination. Two systems were tested for their reliability (call rate) and consistency with previous diagnoses (diagnostic accuracy) indicating a call rate of 99.04% and a diagnostic accuracy of 100% (+/- 20.00%) from one platform, and a call rate of 94.66% and a diagnostic accuracy of 93.35% (+/- 20.29%) from a second for 9,216 genotypes. Results for mutations tested at the expected carrier frequency indicated a call rate of 97.87% and a diagnostic accuracy of 99.96% (+/- 20.05%). This study demonstrated the ability of a high throughput qPCR methodology to accurately and reliably genotype 29 mutations in parallel. The universally applicable nature of this technology provides an opportunity to increase the number of mutations that can be screened simultaneously, and reduce the cost and turnaround time for accommodating newly identified and clinically relevant mutations.	[Fedick, Anastasia; Treff, Nathan R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol & Mol Genet, Piscataway, NJ 08854 USA; [Fedick, Anastasia; Su, Jing; Northrop, Lesley; Devkota, Batsal; Treff, Nathan R.] Reprod Med Associates New Jersey, Basking Ridge, NJ USA; [Jalas, Chaim] Bonei Olam, Ctr Rare Jewish Genet Disorders, Brooklyn, NY USA; [Ekstein, Josef] Dor Yeshorim, Brooklyn, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Reproductive Medicine Associates of New Jersey	Fedick, A (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol & Mol Genet, Piscataway, NJ 08854 USA.	afedick@rmanj.com			Dor Yeshorim, The Committee for Prevention of Jewish Diseases, 429 Wythe Ave., Brooklyn, NY, USA	Dor Yeshorim, The Committee for Prevention of Jewish Diseases, 429 Wythe Ave., Brooklyn, NY, USA	Funding for this project was provided by Dor Yeshorim, The Committee for Prevention of Jewish Diseases, 429 Wythe Ave., Brooklyn, NY, 11211, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Brown JT, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-69; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Fares F, 2008, PRENATAL DIAG, V28, P236, DOI 10.1002/pd.1943; Farkas DH, 2010, J MOL DIAGN, V12, P611, DOI 10.2353/jmoldx.2010.090233; Fedick Anastasia, 2012, BMC Res Notes, V5, P573, DOI 10.1186/1756-0500-5-573; Fedick A, 2012, GENOMICS, V99, P127, DOI 10.1016/j.ygeno.2012.01.003; Gomez-Fernandez N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-57; HOROWITZ M, 1993, AM J HUM GENET, V53, P921; Hui Lester, 2008, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0210s56; Jeong SY, 2011, J HUM GENET, V56, P469, DOI 10.1038/jhg.2011.37; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Pletcher BA, 2008, GENET MED, V10, P33, DOI [10.1097/GIM.0b013e31815f6eac, 10.1097/GIM.0b013e31815f247c]; Reish O, 2009, GENET MED, V11, P101, DOI 10.1097/GIM.0b013e31818efd59; Robledo R, 2003, GENOMICS, V82, P580, DOI 10.1016/S0888-7543(03)00172-1; Rohlfs EM, 2011, CLIN CHEM, V57, P841, DOI 10.1373/clinchem.2010.159285; Schleinitz D, 2011, METHODS MOL BIOL, V700, P77, DOI 10.1007/978-1-61737-954-3_6; Schrijver I, 2007, J MOL DIAGN, V9, P228, DOI 10.2353/jmoldx.2007.060100; Scott SA, 2010, HUM MUTAT, V31, P1240, DOI 10.1002/humu.21327; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Shi MM, 2001, CLIN CHEM, V47, P164; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Tzvetkov MV, 2010, PHARMACOGENOMICS, V11, P449, DOI [10.2217/pgs.10.14, 10.2217/PGS.10.14]; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Winfield SL, 1997, GENOME RES, V7, P1020, DOI 10.1101/gr.7.10.1020; Zuckerman S, 2007, JAMA-J AM MED ASSOC, V298, P1281, DOI 10.1001/jama.298.11.1281	31	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59722	10.1371/journal.pone.0059722	http://dx.doi.org/10.1371/journal.pone.0059722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555759	Green Published, gold			2022-12-27	WOS:000317418500085
J	Putty, K; Marcus, SA; Mittl, PRE; Bogadi, LE; Hunter, AM; Arur, S; Berg, DE; Sethu, P; Kalia, A				Putty, Kalyani; Marcus, Sarah A.; Mittl, Peer R. E.; Bogadi, Lindsey E.; Hunter, Allison M.; Arur, Swathi; Berg, Douglas E.; Sethu, Palaniappan; Kalia, Awdhesh			Robustness of Helicobacter pylori Infection Conferred by Context-Variable Redundancy among Cysteine-Rich Paralogs	PLOS ONE			English	Article							PROTEIN-A; CRYSTAL-STRUCTURE; GENE DUPLICATION; EVOLUTION; HEAT-SHOCK-PROTEIN-60; SEQUENCE; DIFFERENTIATION; MODEL; SHAPE	Deletion of single genes from expanded gene families in bacterial genomes often does not elicit a phenotype thus implying redundancy or functional non-essentiality of paralogous genes. The molecular mechanisms that facilitate evolutionary maintenance of such paralogs despite selective pressures against redundancy remain mostly unexplored. Here, we investigate the evolutionary, genetic, and functional interaction between the Helicobacter pylori cysteine-rich paralogs hcpG and hcpC in the context of H. pylori infection of cultured mammalian cells. We find that in natural H. pylori populations both hcpG and hcpC are maintained by positive selection in a dual genetic relationship that switches from complete redundancy during early infection, whereby Delta hcpC or Delta hcpG mutants themselves show no growth defect but a significant growth defect is seen in the Delta hcpC, Delta hcpG double mutant, to quantitative redundancy during late infection wherein the growth defect of the Delta hcpC mutant is exacerbated in the Delta hcpC, Delta hcpG double mutant although the Delta hcpG mutant itself shows no defect. Moreover, during early infection both hcpG and hcpC are essential for optimal translocation of the H. pylori HspB/GroEL chaperone, but during middle-to-late infection hcpC alone is necessary and sufficient for HspB/GroEL translocation thereby revealing the lack of functional compensation among paralogs. We propose that evolution of context-dependent differences in the nature of genetic redundancy, and function, between hcpG and hcpC may facilitate their maintenance in H. pylori genomes, and confer robustness to H. pylori growth during infection of cultured mammalian cells.	[Putty, Kalyani; Marcus, Sarah A.; Bogadi, Lindsey E.; Hunter, Allison M.; Kalia, Awdhesh] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Sethu, Palaniappan] Univ Louisville, Dept Biomed Engn, Louisville, KY 40292 USA; [Mittl, Peer R. E.] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Berg, Douglas E.] Washington Univ Sch Med, Dept Mol Microbiol, St Louis, MO USA; [Arur, Swathi] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Kalia, Awdhesh] Univ Texas MD Anderson Canc Ctr, Mol Genet Technol Program, Houston, TX 77030 USA	University of Louisville; University of Louisville; University of Zurich; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kalia, A (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	akalia@mdanderson.org	Mittl, Peer/E-5352-2017	Marcus, Sarah/0000-0002-3795-0806; Kalia, Awdhesh/0000-0001-5365-1702	university of Louisville undergraduate summer research fellowship	university of Louisville undergraduate summer research fellowship	S.A.M. and L.E.B. were supported by the university of Louisville undergraduate summer research fellowship. This study was not funded by any dedicated grants received from federal, state or private sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Brookfield John, 1992, Current Biology, V2, P553, DOI 10.1016/0960-9822(92)90036-A; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Vries N, 2003, FEMS IMMUNOL MED MIC, V38, P45, DOI 10.1016/S0928-8244(03)00105-6; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Deml L, 2005, INFECT IMMUN, V73, P4732, DOI 10.1128/IAI.73.8.4732-4742.2005; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Fay JC, 2001, CURR OPIN GENET DEV, V11, P642, DOI 10.1016/S0959-437X(00)00247-1; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Gobert AP, 2004, J BIOL CHEM, V279, P245, DOI 10.1074/jbc.M307858200; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Habyarimana F, 2008, ENVIRON MICROBIOL, V10, P1460, DOI 10.1111/j.1462-2920.2007.01560.x; Huesca M, 1996, INFECT IMMUN, V64, P2643, DOI 10.1128/IAI.64.7.2643-2648.1996; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kafri R, 2010, EVOLUTION AFTER GENE DUPLICATION, P229; Kitsos CM, 1998, CURR MICROBIOL, V37, P88, DOI 10.1007/s002849900344; Klein AM, 2010, CELL, V143, P867, DOI 10.1016/j.cell.2010.11.046; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CS, 2010, BIOCHEM BIOPH RES CO, V397, P283, DOI 10.1016/j.bbrc.2010.05.101; Lin CS, 2010, BIOCHEM BIOPH RES CO, V392, P183, DOI 10.1016/j.bbrc.2010.01.010; Luthy L, 2004, J MOL BIOL, V340, P829, DOI 10.1016/j.jmb.2004.04.055; Luthy L, 2002, J BIOL CHEM, V277, P10187, DOI 10.1074/jbc.M108993200; Luthy L, 2003, STRUCTURAL FUNCTIONA; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2007, ORIGINS GENOME ARCHI; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mittl PRE, 2003, CLIN DIAGN LAB IMMUN, V10, P542, DOI 10.1128/CDLI.10.4.542-545.2003; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Ohno S., 1970, EVOLUTION GENE DUPLI; Owen RJ, 1997, ISOLATION H PYLORI G; Phadnis SH, 1996, INFECT IMMUN, V64, P905, DOI 10.1128/IAI.64.3.905-912.1996; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Roschitzki B, 2011, CURRENT MICROBIOLOGY, P1; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Serres MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46; Shen FF, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-210; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Tamura K, 2011, MOL BIOL EVOLUTION; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vanet A, 1998, INFECT IMMUN, V66, P1023, DOI 10.1128/IAI.66.3.1023-1027.1998; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59560	10.1371/journal.pone.0059560	http://dx.doi.org/10.1371/journal.pone.0059560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555707	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000317418500053
J	Skinner, C; McMahon, S; Rasooly, R; Carter, JM; He, XH				Skinner, Craig; McMahon, Stephanie; Rasooly, Reuven; Carter, John Mark; He, Xiaohua			Purification and Characterization of Shiga Toxin 2f, an Immunologically Unrelated Subtype of Shiga Toxin 2	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; RELATIVE TOXICITIES; VARIANTS; HUMANS; CELLS; ASSAY; MICE; IDENTIFICATION; PATHOGENESIS; SPECIFICITY	Background: Shiga-like toxin 2 (Stx2) is one of the most important virulence factors in enterohaemorrhagic Escherichia coli (E. coli) strains such as O157H7. Subtypes of Stx2 are diverse with respect to their sequence, toxicity, and distribution. The most diverse Stx2 subtype, Stx2f, is difficult to detect immunologically, but is becoming more frequently associated with human illness. Methods and Findings: A purification regimen was developed for the purification of Stx2f involving cation exchange, hydrophobic interaction, anion exchange, and gel filtration. The molecular weight of Stx2f B-subunit was approximately 5 kDa, which appeared significantly smaller than that of Stx2a (6 kDa) on a SDS-PAGE gel, although the size of the A subunit was similar to Stx2a (30 kDa). Stx2f was shown to be active in both cell-free and cell-based assays. The 50% cytotoxic dose in Vero cells was 3.4 or 1.7 pg (depending on the assay conditions), about 3-5 times higher than the archetypical Stx2a, while the activity of Stx2f and Stx2a in a cell-free rabbit reticulocyte system was similar. Stx2f bound to both globotriose-lipopolysaccharide (Gb3-LPS) and globotetraose-LPS (Gb4-LPS, mimics for globotriaosylceramide and globotetraosylceramide, respectively), but its ability to bind Gb4-LPS was much stronger than Stx2a. Stx2f was also much more stable at low pH and high temperature compared to Stx2a, suggesting the toxin itself may survive harsher food preparation practices. Conclusions: Here, we detail the purification, biochemical properties, and toxicity of Stx2f, from an E. coli strain isolated from a feral pigeon. Information obtained in this study will be valuable for characterizing Stx2f and explaining the differences of Stx2a and Stx2f in host specificity and cytotoxicity.	[Skinner, Craig; McMahon, Stephanie; Rasooly, Reuven; Carter, John Mark; He, Xiaohua] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	xiaohua.he@ars.usda.gov	Carter, John Mark/P-9919-2019; Carter, John Mark/K-2485-2015	Carter, John Mark/0000-0001-8251-4168; Carter, John Mark/0000-0001-8251-4168	United States Department of Agriculture-Agricultural Research Service National Program NP108; Current Research Information System project [5325-42000-048-00D]	United States Department of Agriculture-Agricultural Research Service National Program NP108; Current Research Information System project	This research was supported by United States Department of Agriculture-Agricultural Research Service National Program NP108, Current Research Information System project 5325-42000-048-00D. The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Beutin L, 2008, APPL ENVIRON MICROB, V74, P4806, DOI 10.1128/AEM.00623-08; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bonyadian M, 2010, INDIAN J MED RES, V132, P328; CANTEY JR, 1985, J INFECT DIS, V151, P766, DOI 10.1093/infdis/151.5.766; Coombes BK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00090; Di R, 2011, TOXICON, V57, P525, DOI 10.1016/j.toxicon.2010.12.006; DOWNES FP, 1988, INFECT IMMUN, V56, P1926, DOI 10.1128/IAI.56.8.1926-1933.1988; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gamage SD, 2003, INFECT IMMUN, V71, P3107, DOI 10.1128/IAI.71.6.3107-3115.2003; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; He XH, 2009, J AGR FOOD CHEM, V57, P5084, DOI 10.1021/jf9002285; Hertig A, 2010, NEPHROL THER, V6, P258, DOI 10.1016/j.nephro.2010.03.002; LAW D, 1992, J MED MICROBIOL, V36, P198, DOI 10.1099/00222615-36-3-198; Lentz EK, 2011, INFECT IMMUN, V79, P3527, DOI 10.1128/IAI.05139-11; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; MACLEOD DL, 1990, INFECT IMMUN, V58, P1232, DOI 10.1128/IAI.58.5.1232-1239.1990; Marcato P, 2001, J INFECT DIS, V183, P435, DOI 10.1086/318080; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175, DOI 10.1016/S0749-0720(15)30142-0; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; PAI CH, 1986, INFECT IMMUN, V51, P16, DOI 10.1128/IAI.51.1.16-23.1986; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton AW, 2001, INFECT IMMUN, V69, P1967, DOI 10.1128/IAI.69.3.1967-1970.2001; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Prager R, 2009, INT J MED MICROBIOL, V299, P343, DOI 10.1016/j.ijmm.2008.10.008; Quinones B, 2011, METHODS MOL BIOL, V739, P61, DOI 10.1007/978-1-61779-102-4_6; Rasooly R, 2010, J AGR FOOD CHEM, V58, P9281, DOI 10.1021/jf101744z; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Schuller S, 2011, TOXINS, V3, P626, DOI 10.3390/toxins3060626; Shimizu T, 2009, INFECT IMMUN, V77, P2813, DOI 10.1128/IAI.00060-09; Sonntag AK, 2005, APPL ENVIRON MICROB, V71, P8855, DOI 10.1128/AEM.71.12.8855-8863.2005; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	43	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59760	10.1371/journal.pone.0059760	http://dx.doi.org/10.1371/journal.pone.0059760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555772	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500087
J	Mizrahy, O; Bar-Dolev, M; Guy, S; Braslavsky, I				Mizrahy, Ortal; Bar-Dolev, Maya; Guy, Shlomit; Braslavsky, Ido			Inhibition of Ice Growth and Recrystallization by Zirconium Acetate and Zirconium Acetate Hydroxide	PLOS ONE			English	Article							ANTIFREEZE PROTEIN; BINDING FACE; CRYSTALS; MECHANISM; CRYSTALLIZATION; XYLOMANNAN; ADSORPTION; MUTANTS; CELLS; WATER	The control over ice crystal growth, melting, and shaping is important in a variety of fields, including cell and food preservation and ice templating for the production of composite materials. Control over ice growth remains a challenge in industry, and the demand for new cryoprotectants is high. Naturally occurring cryoprotectants, such as antifreeze proteins (AFPs), present one solution for modulating ice crystal growth; however, the production of AFPs is expensive and inefficient. These obstacles can be overcome by identifying synthetic substitutes with similar AFP properties. Zirconium acetate (ZRA) was recently found to induce the formation of hexagonal cavities in materials prepared by ice templating. Here, we continue this line of study and examine the effects of ZRA and a related compound, zirconium acetate hydroxide (ZRAH), on ice growth, shaping, and recrystallization. We found that the growth rate of ice crystals was significantly reduced in the presence of ZRA and ZRAH, and that solutions containing these compounds display a small degree of thermal hysteresis, depending on the solution pH. The compounds were found to inhibit recrystallization in a manner similar to that observed in the presence of AFPs. The favorable properties of ZRA and ZRAH suggest tremendous potential utility in industrial applications.	[Mizrahy, Ortal; Bar-Dolev, Maya; Guy, Shlomit; Braslavsky, Ido] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Bar-Dolev, M (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	mayabar00@gmail.com	Braslavsky, Ido/O-1859-2013; Dolev, Maya Bar/AAG-7771-2020	Braslavsky, Ido/0000-0001-8985-8211; Bar Dolev, Maya/0000-0001-8619-8481; Rewald, Ortal/0000-0003-1909-0459	Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Israel Science Foundation (ISF) [1279/10, 1281/10]; European Research Council (ERC) [281595]; Marie Curie International Reintegration grant [256364]	Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Israel Science Foundation (ISF)(Israel Science Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); Marie Curie International Reintegration grant(European Commission)	This work was supported in part by grants from The Lady Davis Fellowship Trust and The Valazzi-Pikovsky Fellowship Fund (to MBD), the Israel Science Foundation (ISF) grants #1279/10 and #1281/10, the European Research Council (ERC) grant #281595, and the Marie Curie International Reintegration grant #256364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; Baardsnes J, 1999, FEBS LETT, V463, P87, DOI 10.1016/S0014-5793(99)01588-4; Bar M, 2008, CRYST GROWTH DES, V8, P2954, DOI 10.1021/cg800066g; Bar-Dolev M, 2012, J R SOC INTERFACE, V9, P3249, DOI 10.1098/rsif.2012.0388; Baruch E, 2007, MACROMOL RAPID COMM, V28, P2256, DOI 10.1002/marc.200700501; BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1; Braslavsky I, 2013, JOVE-J VIS EXP, DOI 10.3791/4189; Budke C, 2006, CHEMPHYSCHEM, V7, P2601, DOI 10.1002/cphc.200600533; CARPENTER JF, 1992, P NATL ACAD SCI USA, V89, P8953, DOI 10.1073/pnas.89.19.8953; Celik Y, 2013, P NATL ACAD SCI USA, V110, P1309, DOI 10.1073/pnas.1213603110; Celik Y, 2010, P NATL ACAD SCI USA, V107, P5423, DOI 10.1073/pnas.0909456107; CHAO H, 1993, PROTEIN SCI, V2, P1411, DOI 10.1002/pro.5560020906; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; CLEARFIELD A, 1990, J MATER RES, V5, P161, DOI 10.1557/JMR.1990.0161; DeLuca CI, 1996, BIOPHYS J, V71, P2346, DOI 10.1016/S0006-3495(96)79476-6; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026474; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Ebbinghaus S, 2010, J AM CHEM SOC, V132, P12210, DOI 10.1021/ja1051632; FAHY GM, 1986, CRYOBIOLOGY, V23, P1, DOI 10.1016/0011-2240(86)90013-1; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Geiculescu AC, 1999, J SOL-GEL SCI TECHN, V16, P243, DOI 10.1023/A:1008769204022; Geiculescu AC, 2002, J NON-CRYST SOLIDS, V306, P30, DOI 10.1016/S0022-3093(02)01056-6; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Guizard C, 2012, LANGMUIR; HANNANE S, 1994, B SOC CHIM FR, V131, P262; Hobbs P. V, 1974, ICE PHYS; Hui YH, 2008, PRINCIPLES FOOD PROC, P1; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; Ishiwata A, 2011, J AM CHEM SOC, V133, P19524, DOI 10.1021/ja208528c; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; JUTSON JA, 1990, MATER RES SOC SYMP P, V180, P123, DOI 10.1557/PROC-180-123; Kirshenbaum K, 2012, P NATL ACAD SCI; KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9; Knight CA, 2001, CRYST GROWTH DES, V1, P439, DOI 10.1021/cg0155321; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Kuang C, 1969, RUSS J INORG CHEM, V14, P1084; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Marshall CB, 2002, FEBS LETT, V529, P261, DOI 10.1016/S0014-5793(02)03355-0; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Moles PJ, 2002, USE ZIRCONIUM SURFAC; MUHA GM, 1960, J CHEM PHYS, V33, P194, DOI 10.1063/1.1731077; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Peltier R, 2010, CRYST GROWTH DES, V10, P5066, DOI 10.1021/cg1005083; Pertaya N, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/412101; Pertaya N, 2008, BIOPHYS J, V95, P333, DOI 10.1529/biophysj.107.125328; Pertaya N, 2007, BIOPHYS J, V92, P3663, DOI 10.1529/biophysj.106.096297; RUBINSKY B, 1992, CRYOBIOLOGY, V29, P69, DOI 10.1016/0011-2240(92)90006-N; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scotter AJ, 2006, CRYOBIOLOGY, V53, P229, DOI 10.1016/j.cryobiol.2006.06.006; Singhal A, 1996, J AM CHEM SOC, V118, P11529, DOI 10.1021/ja9602399; SONNICHSEN FD, 1993, SCIENCE, V259, P1154, DOI 10.1126/science.8438165; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; Tam RY, 2009, J AM CHEM SOC, V131, P15745, DOI 10.1021/ja904169a; Towell JD, 2006, FROZEN CONFECTIONERY; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Walters KR, 2009, P NATL ACAD SCI USA, V106, P20210, DOI 10.1073/pnas.0909872106; Wierzbicki A, 2000, BIOMACROMOLECULES, V1, P268, DOI 10.1021/bm000004w; Wierzbicki A, 1996, BIOPHYS J, V71, P8, DOI 10.1016/S0006-3495(96)79204-4; Yu SO, 2010, CRYOBIOLOGY, V61, P327, DOI 10.1016/j.cryobiol.2010.10.158	61	37	37	6	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59540	10.1371/journal.pone.0059540	http://dx.doi.org/10.1371/journal.pone.0059540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555701	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400050
J	Van Zaen, J; Murray, MM; Meuli, RA; Vesin, JM				Van Zaen, Jerome; Murray, Micah M.; Meuli, Reto A.; Vesin, Jean-Marc			Adaptive Filtering Methods for Identifying Cross-Frequency Couplings in Human EEG	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; PHASE SYNCHRONIZATION; GAMMA-OSCILLATIONS; BRAIN DYNAMICS; TIME-SERIES; INTEGRATION; NETWORKS; SCHIZOPHRENIA; COMPLETION; PERCEPTION	Oscillations have been increasingly recognized as a core property of neural responses that contribute to spontaneous, induced, and evoked activities within and between individual neurons and neural ensembles. They are considered as a prominent mechanism for information processing within and communication between brain areas. More recently, it has been proposed that interactions between periodic components at different frequencies, known as cross-frequency couplings, may support the integration of neuronal oscillations at different temporal and spatial scales. The present study details methods based on an adaptive frequency tracking approach that improve the quantification and statistical analysis of oscillatory components and cross-frequency couplings. This approach allows for time-varying instantaneous frequency, which is particularly important when measuring phase interactions between components. We compared this adaptive approach to traditional band-pass filters in their measurement of phase-amplitude and phase-phase cross-frequency couplings. Evaluations were performed with synthetic signals and EEG data recorded from healthy humans performing an illusory contour discrimination task. First, the synthetic signals in conjunction with Monte Carlo simulations highlighted two desirable features of the proposed algorithm vs. classical filter-bank approaches: resilience to broad-band noise and oscillatory interference. Second, the analyses with real EEG signals revealed statistically more robust effects (i.e. improved sensitivity) when using an adaptive frequency tracking framework, particularly when identifying phase-amplitude couplings. This was further confirmed after generating surrogate signals from the real EEG data. Adaptive frequency tracking appears to improve the measurements of cross-frequency couplings through precise extraction of neuronal oscillations.	[Van Zaen, Jerome; Vesin, Jean-Marc] Swiss Fed Inst Technol, Appl Signal Proc Grp, CH-1015 Lausanne, Switzerland; [Murray, Micah M.] Ctr Biomed Imaging Lausanne & Geneva, EEG Brain Mapping Core, Lausanne, Switzerland; [Murray, Micah M.] Univ Hosp Ctr, Neuropsychol & Neurorehabil Serv, Lausanne, Switzerland; [Murray, Micah M.; Meuli, Reto A.] Univ Lausanne, Lausanne, Switzerland; [Murray, Micah M.; Meuli, Reto A.] Univ Hosp Ctr, Serv Radiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Van Zaen, J (corresponding author), Swiss Fed Inst Technol, Appl Signal Proc Grp, CH-1015 Lausanne, Switzerland.	jerome.vanzaen@epfl.ch	Murray, Micah/A-8851-2008; McLean, Laurence JA/C-7367-2014	Murray, Micah/0000-0002-7821-117X; 	Swiss National Science Foundation [320030_120579]; National Institutes of Health [R37MH49334, MH63434, MH01439]; Center for Biomedical Imaging (CIBM) of Geneva; Center for Biomedical Imaging (CIBM) of Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049334, R01MH049334, R03MH063434] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomedical Imaging (CIBM) of Geneva; Center for Biomedical Imaging (CIBM) of Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant 320030_120579 from the Swiss National Science Foundation (http://www.snf.ch/) and grants R37MH49334, MH63434, and MH01439 from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jean-Francois Knebel for many helpful comments regarding statistical analysis. The Cartool software (http://sites.google.com/site/fbmlab/cartool/) has been programmed by Denis Brunet, from the Functional Brain Mapping Laboratory, Geneva, Switzerland, and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne.	Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Billingsley P., 1995, PROBABILITY MEASURE; Borgnat P, 2010, IEEE T SIGNAL PROCES, V58, P3459, DOI 10.1109/TSP.2010.2043971; Bosman CA, 2010, BRAIN RES, V1319, P92, DOI 10.1016/j.brainres.2010.01.004; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Celka P, 2007, IEEE SIGNAL PROC LET, V14, P577, DOI 10.1109/LSP.2007.896142; Chavez M, 2006, J NEUROSCI METH, V154, P149, DOI 10.1016/j.jneumeth.2005.12.009; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; de Lange FP, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.007.2008; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fallani FD, 2011, BRAIN TOPOGR, V23, P344, DOI 10.1007/s10548-010-0152-z; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fiebelkorn IC, 2013, NEUROIMAGE, V69, P126, DOI 10.1016/j.neuroimage.2012.11.021; Foster BL, 2012, NEUROIMAGE, V60, P384, DOI 10.1016/j.neuroimage.2011.12.019; Foxe JJ, 2005, CEREB CORTEX, V15, P1914, DOI 10.1093/cercor/bhi069; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Knebel JF, 2012, NEUROIMAGE, V59, P2808, DOI 10.1016/j.neuroimage.2011.09.031; Knebel JF, 2011, PSYCHIAT RES-NEUROIM, V193, P168, DOI 10.1016/j.pscychresns.2011.02.006; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Marple SL, 1999, IEEE T SIGNAL PROCES, V47, P2600, DOI 10.1109/78.782222; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Murray MM, 2004, J NEUROSCI, V24, P6898, DOI 10.1523/JNEUROSCI.1996-04.2004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oppenheim A. V., 2010, DISCRETE TIME SIGNAL; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schyns PG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001064; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Shpaner M, 2009, EUR J NEUROSCI, V30, P2018, DOI 10.1111/j.1460-9568.2009.06981.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Uldry L, 2009, ADVANCED BIOSIGNAL PROCESSING, P123, DOI 10.1007/978-3-540-89506-0_6; Van Zaen J, 2010, J NEUROSCI METH, V186, P97, DOI 10.1016/j.jneumeth.2009.10.018; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068	61	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60513	10.1371/journal.pone.0060513	http://dx.doi.org/10.1371/journal.pone.0060513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560098	Green Published, gold			2022-12-27	WOS:000318840100081
J	Hatanaka, Y; Shimizu, N; Nishikawa, S; Tokoro, M; Shin, SW; Nishihara, T; Amano, T; Anzai, M; Kato, H; Mitani, T; Hosoi, Y; Kishigami, S; Matsumoto, K				Hatanaka, Yuki; Shimizu, Natsumi; Nishikawa, Satoshi; Tokoro, Mikiko; Shin, Seung-Wook; Nishihara, Takuji; Amano, Tomoko; Anzai, Masayuki; Kato, Hiromi; Mitani, Tasuku; Hosoi, Yoshihiko; Kishigami, Satoshi; Matsumoto, Kazuya			GSE Is a Maternal Factor Involved in Active DNA Demethylation in Zygotes	PLOS ONE			English	Article							PATERNAL GENOME; STEM-CELLS; MOUSE; METHYLATION; EXPRESSION; FERTILIZATION; OOCYTES; PROTEIN; REGION; REPAIR	After fertilization, the sperm and oocyte genomes undergo extensive epigenetic reprogramming to form a totipotent zygote. The dynamic epigenetic changes during early embryo development primarily involve DNA methylation and demethylation. We have previously identified Gse (gonad-specific expression gene) to be expressed specifically in germ cells and early embryos. Its encoded protein GSE is predominantly localized in the nuclei of cells from the zygote to blastocyst stages, suggesting possible roles in the epigenetic changes occurring during early embryo development. Here, we report the involvement of GSE in epigenetic reprogramming of the paternal genome during mouse zygote development. Preferential binding of GSE to the paternal chromatin was observed from pronuclear stage 2 (PN2) onward. A knockdown of GSE by antisense RNA in oocytes produced no apparent effect on the first and second cell cycles in preimplantation embryos, but caused a significant reduction in the loss of 5-methylcytosine (5 mC) and the accumulation of 5-hydroxymethylcytosine (5 hmC) in the paternal pronucleus. Furthermore, DNA methylation levels in CpG sites of LINE1 transposable elements, Lemd1, Nanog and the upstream regulatory region of the Oct4 (also known as Pou5f1) gene were clearly increased in GSE-knockdown zygotes at mid-pronuclear stages (PN3-4), but the imprinted H19-differential methylated region was not affected. Importantly, DNA immunoprecipitation of 5 mC and 5 hmC also indicates that knockdown of GSE in zygotes resulted in a significant reduction of the conversion of 5 mC to 5 hmC on LINE1. Therefore, our results suggest an important role of maternal GSE for mediating active DNA demethylation in the zygote.	[Hatanaka, Yuki; Shimizu, Natsumi; Nishikawa, Satoshi; Tokoro, Mikiko; Shin, Seung-Wook; Nishihara, Takuji; Amano, Tomoko; Hosoi, Yoshihiko; Kishigami, Satoshi; Matsumoto, Kazuya] Kinki Univ, Div Biol Sci, Grad Sch Biol Oriented Sci & Technol, Wakayama, Japan; [Anzai, Masayuki; Kato, Hiromi; Mitani, Tasuku] Kinki Univ, Inst Adv Technol, Wakayama, Japan	Kindai University (Kinki University); Kindai University (Kinki University)	Matsumoto, K (corresponding author), Kinki Univ, Div Biol Sci, Grad Sch Biol Oriented Sci & Technol, Wakayama, Japan.	kazum@waka.kindai.ac.jp		Hatanaka, Yuki/0000-0003-1339-8612; Kishigami, Satoshi/0000-0001-9447-5100; Tokoro, Mikiko/0000-0003-1589-0889	Japan MEXT; Japan Society for the Promotion of Science [23658292, 23380164]; INAMORI Foundation	Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); INAMORI Foundation	This study was supported in part by a Grant-in-Aid for the 21st Century COE Program of the Japan MEXT to MT SWS SN, a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 23658292 and 23380164 to KM, and a grant from the INAMORI Foundation to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; Anzai M, 2006, J REPROD DEVELOP, V52, P601, DOI 10.1262/jrd.18040; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Kang J, 2013, CELL RES, V23, P6, DOI 10.1038/cr.2012.117; Kawasumi M, 2009, MOL REPROD DEV, V76, P342, DOI 10.1002/mrd.20966; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Matsuoka T, 2008, J REPROD DEVELOP, V54, P192, DOI 10.1262/jrd.20008; Mizuno S, 2006, J REPROD DEVELOP, V52, P429, DOI 10.1262/jrd.18005; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Satoh M, 2009, J REPROD DEVELOP, V55, P316, DOI 10.1262/jrd.20217; Shin SW, 2010, J REPROD DEVELOP, V56, P655, DOI 10.1262/jrd.10-104M; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Surani A, 2012, NATURE, V487, P43, DOI 10.1038/487043a; Tokoro M, 2010, J REPROD DEVELOP, V56, P607, DOI 10.1262/jrd.10-088M; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tsunemoto K, 2008, MOL REPROD DEV, V75, P1104, DOI 10.1002/mrd.20863; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80	34	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60205	10.1371/journal.pone.0060205	http://dx.doi.org/10.1371/journal.pone.0060205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560077	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900054
J	Gundisch, S; Schott, C; Wolff, C; Tran, K; Beese, C; Viertler, C; Zatloukal, K; Becker, KF				Guendisch, Sibylle; Schott, Christina; Wolff, Claudia; Tran, Kai; Beese, Christian; Viertler, Christian; Zatloukal, Kurt; Becker, Karl-Friedrich			The PAXgene (R) Tissue System Preserves Phosphoproteins in Human Tissue Specimens and Enables Comprehensive Protein Biomarker Research	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; PROTEOMIC ANALYSIS; HIGH-THROUGHPUT; FIXED TISSUES; FORMALIN; RNA; OPPORTUNITIES; OPTIMIZATION; FIXATIVES	Precise quantitation of protein biomarkers in clinical tissue specimens is a prerequisite for accurate and effective diagnosis, prognosis, and personalized medicine. Although progress is being made, protein analysis from formalin-fixed and paraffin-embedded tissues is still challenging. In previous reports, we showed that the novel formalin-free tissue preservation technology, the PAXgene Tissue System, allows the extraction of intact and immunoreactive proteins from PAXgene-fixed and paraffin-embedded (PFPE) tissues. In the current study, we focused on the analysis of phosphoproteins and the applicability of two-dimensional gel electrophoresis (2D-PAGE) and enzyme-linked immunosorbent assay (ELISA) to the analysis of a variety of malignant and non-malignant human tissues. Using western blot analysis, we found that phosphoproteins are quantitatively preserved in PFPE tissues, and signal intensities are comparable to that in paired, frozen tissues. Furthermore, proteins extracted from PFPE samples are suitable for 2D-PAGE and can be quantified by ELISA specific for denatured proteins. In summary, the PAXgene Tissue System reliably preserves phosphoproteins in human tissue samples, even after prolonged fixation or stabilization times, and is compatible with methods for protein analysis such as 2D-PAGE and ELISA. We conclude that the PAXgene Tissue System has the potential to serve as a versatile tissue fixative for modern pathology.	[Guendisch, Sibylle; Schott, Christina; Wolff, Claudia; Tran, Kai; Beese, Christian; Becker, Karl-Friedrich] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany; [Viertler, Christian; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Guendisch, Sibylle; Schott, Christina; Viertler, Christian; Zatloukal, Kurt; Becker, Karl-Friedrich] SPIDIA Consortium, Qiagen Res & Dev, Hilden, Germany	Technical University of Munich; Medical University of Graz; QIAGEN GmbH	Becker, KF (corresponding author), Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany.	kf.becker@lrz.tum.de	Becker, Karl-Friedrich/D-3636-2015	Becker, Karl-Friedrich/0000-0002-6801-4498	European Union [222916]	European Union(European Commission)	This work was performed within the European consortium SPIDIA (Standardisation and improvement of generic Pre-analytical tools and procedures for In vitro DIAgnostics, www.spidia.eu), which is funded by the European Union within the Seventh Framework Programme (FP7/2007-2013) under grant agreement no222916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P4329, DOI 10.1002/pmic.200900010; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Braun M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-511; Broxterman HJ, 2004, DRUG RESIST UPDATE, V7, P79, DOI 10.1016/j.drup.2004.02.004; Bussolati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021043; Campos PF, 2012, METHODS MOL BIOL, V840, P81, DOI 10.1007/978-1-61779-516-9_11; Dotti I, 2010, DIAGN MOL PATHOL, V19, P112, DOI 10.1097/PDM.0b013e3181b520f8; Ergin B, 2010, J PROTEOME RES, V9, P5188, DOI 10.1021/pr100664e; Evers DL, 2011, J MOL DIAGN, V13, P282, DOI 10.1016/j.jmoldx.2011.01.010; Jin HJ, 2010, CANCER BIOMARK, V6, P281, DOI 10.3233/CBM-2009-0140; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Lassalle S, 2009, THYROID, V19, P1239, DOI 10.1089/thy.2009.0095; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Minden JS, 2009, ELECTROPHORESIS, V30, pS156, DOI 10.1002/elps.200900098; Mueller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023780; National Toxicology Program, 2010, I512 NAT TOX PROGR, pi; Nirmalan NJ, 2008, MOL BIOSYST, V4, P712, DOI 10.1039/b800098k; Ostasiewicz P, 2010, J PROTEOME RES, V9, P3688, DOI 10.1021/pr100234w; Ralton LD, 2011, J CLIN PATHOL, V64, P297, DOI 10.1136/jcp.2010.086835; Stanta G, 2006, DIAGN MOL PATHOL, V15, P115, DOI 10.1097/00019606-200606000-00009; Tanca A, 2012, PROTEOM CLIN APPL, V6, P7, DOI 10.1002/prca.201100044; Tanca A, 2011, PROTEOMICS, V11, P1005, DOI 10.1002/pmic.201000353; Van den Bergh Gert, 2009, V519, P439, DOI 10.1007/978-1-59745-281-6_29; Viertler C, 2012, J MOL DIAGN; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Xie R, 2011, J HISTOCHEM CYTOCHEM, V59, P356, DOI 10.1369/0022155411398488; Zangar RC, 2006, EXPERT REV PROTEOMIC, V3, P37, DOI 10.1586/14789450.3.1.37	27	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60638	10.1371/journal.pone.0060638	http://dx.doi.org/10.1371/journal.pone.0060638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555997	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900080
J	Ciucci, A; De Stefano, I; Vellone, VG; Lisi, L; Bottoni, C; Scambia, G; Zannoni, GF; Gallo, D				Ciucci, Alessandra; De Stefano, Ilaria; Vellone, Valerio Gaetano; Lisi, Lucia; Bottoni, Carolina; Scambia, Giovanni; Zannoni, Gian Franco; Gallo, Daniela			Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; STEM-CELL; IN-VITRO; GROWTH; INHIBITION; SUPPRESSION; ACTIVATION	Recent evidence links aberrant activation of Hedgehog (Hh) signaling with the pathogenesis of several cancers including medulloblastoma, glioblastoma, melanoma as well as pancreas, colorectal, and prostate carcinomas. Here we investigated the role of the transcription factor Gli1 in ovarian cancer. To this end, the expression profile of Gli1 was examined in normal ovaries, ovarian tumors, and ovarian cancer cell lines, and the in vitro effects of a specific Hh-pathway blocker, KAAD-cyclopamine, or a specific Gli1 inhibitor (GANT58) on cell proliferation and on Hh target gene expression were also assessed. Results obtained showed that epithelial cells in ovarian cancer tissue express significantly higher levels of nuclear Gli1 than in normal ovarian tissue, where the protein was almost undetectable. In addition, multivariate analysis showed that nuclear Gli1 was independently associated to poor survival in advanced serous ovarian cancer patients (HR = 2.2, 95% CI 1.0-5.1, p = 0.04). In vitro experiments demonstrated Gli1 expression in the three ovarian carcinoma cell lines tested, A2780, SKOV-3 and OVCAR-3. Remarkably, although KAAD-cyclopamine led to decreased cell proliferation, this treatment did not inhibit hedgehog target gene expression in any of the three ovarian cancer cell lines, suggesting that the inhibition of cell proliferation was a nonspecific or toxic effect. In line with these data, no differences on cell proliferation were observed when cell lines were treated with GANT58. Overall, our clinical data support the role of Gli1 as a prognostic marker in advanced serous ovarian cancer and as a possible therapeutic target in this disease. However, our in vitro findings draw attention to the need for selection of appropriate experimental models that accurately represent human tumor for testing future therapies involving Hh pathway inhibitors.	[Ciucci, Alessandra; De Stefano, Ilaria; Vellone, Valerio Gaetano; Bottoni, Carolina; Scambia, Giovanni; Gallo, Daniela] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy; [Vellone, Valerio Gaetano; Zannoni, Gian Franco] Univ Cattolica Sacro Cuore, Dept Histopathol, I-00168 Rome, Italy; [Lisi, Lucia] Univ Cattolica Sacro Cuore, Inst Pharmacol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gallo, D (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Largo A Gemelli 8, I-00168 Rome, Italy.	d.gallo@rm.unicatt.it	Zannoni, Gian Franco/AAC-4754-2020; Lisi, Lucia/AAL-1063-2020; Vellone, Valerio Gaetano/M-6139-2019; Gallo, Daniela/K-2518-2018; Vellone, Valerio Gaetano/A-4342-2018; Bottoni, Carolina/AAC-2876-2019; Vellone, Valerio Gaetano/E-3600-2016	Zannoni, Gian Franco/0000-0002-4473-7560; Vellone, Valerio Gaetano/0000-0002-5107-1584; Gallo, Daniela/0000-0002-1918-1054; Vellone, Valerio Gaetano/0000-0002-5107-1584; Bottoni, Carolina/0000-0003-2084-8263; Vellone, Valerio Gaetano/0000-0002-5107-1584; Lisi, Lucia/0000-0003-1397-2426				Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; De Stefano I, 2011, GYNECOL ONCOL, V122, P573, DOI 10.1016/j.ygyno.2011.05.025; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; DUBOIS A, 2009, CANCER, V115, P1234, DOI DOI 10.1002/CNCR.24149; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Gallo D, 2010, CURR DRUG TARGETS, V11, P474, DOI 10.2174/138945010790980385; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kandala PK, 2012, J BIOL CHEM, V287, P28745, DOI 10.1074/jbc.M112.351379; Kar S, 2012, EXP CELL RES, V318, P1959, DOI 10.1016/j.yexcr.2012.05.015; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Kudo K, 2012, ONCOGENE, V31, P4718, DOI 10.1038/onc.2011.610; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; McMillan R, 2012, CLIN CANCER RES, V18, P4883, DOI 10.1158/1078-0432.CCR-11-2509; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Mozzetti S, 2012, BIOCHEM PHARMACOL; Onishi H, 2011, CANCER SCI, V102, P1756, DOI 10.1111/j.1349-7006.2011.02010.x; Pizem J, 2011, J NEURO-ONCOL, V103, P459, DOI 10.1007/s11060-010-0431-2; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Rustin GJ, 2003, J CLIN ONCOL, V21, P187; Rustin GJS, 2004, JNCI-J NATL CANCER I, V96, P487, DOI 10.1093/jnci/djh081; Schmid S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e15515; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; SIEUWERTS AM, 1995, EUR J CLIN CHEM CLIN, V33, P813; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Steg AD, 2012, MOL CANCER THER, V11, P1587, DOI 10.1158/1535-7163.MCT-11-1058; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Yang L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-112; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	39	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60145	10.1371/journal.pone.0060145	http://dx.doi.org/10.1371/journal.pone.0060145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555905	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200086
J	Hou, YJ; Zhao, YY; Xiong, B; Cui, XS; Kim, NH; Xu, YX; Sun, SC				Hou, Yan-Jun; Zhao, Yong-Yan; Xiong, Bo; Cui, Xiang-Shun; Kim, Nam-Hyung; Xu, Yin-Xue; Sun, Shao-Chen			Mycotoxin-Containing Diet Causes Oxidative Stress in the Mouse	PLOS ONE			English	Article							BLOOD PHAGOCYTIC-ACTIVITY; DEOXYNIVALENOL VOMITOXIN; SUPEROXIDE-DISMUTASE; BALB/C MICE; ZEARALENONE; ANTIOXIDANTS; RATS; CHICKENS; TOXICITY; BROILERS	Mycotoxins which mainly consist of Aflatoxin (AF), Zearalenone (ZEN) and Deoxynivalenol (DON) are commonly found in many food commodities. Although each component has been shown to cause liver toxicity and oxidative stress in several species, there is no evidence regarding the effect of naturally contained multiple mycotoxins on tissue toxicity and oxidative stress in vivo. In the present study, mycotoxins-contaminated maize (AF 597 mu g/kg, ZEN 729 mu g/kg, DON 3.1 mg/kg maize) was incorporated into the diet at three different doses (0, 5 and 20%) to feed the mice, and blood and tissue samples were collected to examine the oxidative stress related indexes. The results showed that the indexes of liver, kidney and spleen were all increased and the liver and kidney morphologies changed in the mycotoxin-treated mice. Also, the treatment resulted in the elevated glutathione peroxidase (GPx) activity and malondialdehyde (MDA) level in the serum and liver, indicating the presence of the oxidative stress. Moreover, the decrease of catalase (CAT) activity in the serum, liver and kidney as well as superoxide dismutase (SOD) activity in the liver and kidney tissue further confirmed the occurrence of oxidative stress. In conclusion, our data indicate that the naturally contained mycotoxins are toxic in vivo and able to induce the oxidant stress in the mouse.	[Hou, Yan-Jun; Zhao, Yong-Yan; Xu, Yin-Xue; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Xiong, Bo] NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea	Nanjing Agricultural University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Chungbuk National University	Xu, YX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xuyinxue@njau.edu.cn; sunsc@njau.edu.cn			Fundamental Research Funds for the Central Universities [KYRC201202]; Biogreen 21 Program, RDA, Republic of Korea [PJ0090802013, PJ0090982013]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Fundamental Research Funds for the Central Universities (KYRC201202); and the Biogreen 21 Program (PJ0090802013, PJ0090982013), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbes S, 2006, TOXICON, V47, P567, DOI 10.1016/j.toxicon.2006.01.016; Abbes S, 2006, INT IMMUNOPHARMACOL, V6, P1251, DOI 10.1016/j.intimp.2006.03.012; Abdel-Wahhab MA, 2005, J APPL TOXICOL, V25, P218, DOI 10.1002/jat.1057; Abdel-Wahhab MA, 2003, J AGR FOOD CHEM, V51, P2409, DOI 10.1021/jf0209185; ABOUZIED MM, 1991, APPL ENVIRON MICROB, V57, P672, DOI 10.1128/AEM.57.3.672-677.1991; Ben Salah-Abbes J, 2009, TOXICON, V53, P525, DOI 10.1016/j.toxicon.2009.01.013; Borutova R, 2008, ARCH ANIM NUTR, V62, P303, DOI 10.1080/17450390802190292; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K; Doll S, 2003, ARCH ANIM NUTR, V57, P311, DOI 10.1080/00039420310001607680; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Faixova Z, 2010, ACTA VET HUNG, V58, P275, DOI 10.1556/AVet.58.2010.3.1; Ferrer E, 2009, TOXICOL IN VITRO, V23, P1504, DOI 10.1016/j.tiv.2009.07.009; Gajecki M., 2002, Polish Journal of Veterinary Sciences, V5, P117; Gresakova L, 2012, ACTA VET HUNG, V60, P103, DOI 10.1556/AVet.2012.009; Gui D, 2010, ANIM FEED SCI TECH, V156, P112, DOI 10.1016/j.anifeedsci.2010.01.012; KENSLER TW, 1985, CARCINOGENESIS, V6, P759, DOI 10.1093/carcin/6.5.759; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; LARSEN C, 1985, POULTRY SCI, V64, P2287, DOI 10.3382/ps.0642287; Lu RZ, 2009, NEUROCHEM INT, V55, P552, DOI 10.1016/j.neuint.2009.05.009; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Placha I, 2009, J ANIM PHYSIOL AN N, V93, P695, DOI 10.1111/j.1439-0396.2008.00857.x; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Tiemann U, 2007, FOOD ADDIT CONTAM A, V24, P306, DOI 10.1080/02652030601053626; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Yuan H, 2010, TOXICOL MECH METHOD, V20, P153, DOI 10.3109/15376511003660185	28	85	96	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60374	10.1371/journal.pone.0060374	http://dx.doi.org/10.1371/journal.pone.0060374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555961	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200111
J	Morris, AR; Visick, KL				Morris, Andrew R.; Visick, Karen L.			Inhibition of SypG-Induced Biofilms and Host Colonization by the Negative Regulator SypE in Vibrio fischeri	PLOS ONE			English	Article							EUPRYMNA-SCOLOPES; SYMBIOTIC COLONIZATION; RESPONSE REGULATOR; BACTERIAL BIOFILMS; LOCUS; ENVIRONMENT; EXPRESSION; INFECTION; CHOLERAE; MOTILITY	Vibrio fischeri produces a specific biofilm to promote colonization of its eukaryotic host, the squid Euprymna scolopes. Formation of this biofilm is induced by the sensor kinase RscS, which functions upstream of the response regulator SypG to regulate transcription of the symbiosis polysaccharide (syp) locus. Biofilm formation is also controlled by SypE, a multidomain response regulator that consists of a central regulatory receiver (REC) domain flanked by an N-terminal serine kinase domain and a C-terminal serine phosphatase domain. SypE permits biofilm formation under rscS overexpression conditions, but inhibits biofilms induced by overexpression of sypG. We previously investigated the function of SypE in controlling biofilm formation induced by RscS. Here, we examined the molecular mechanism by which SypE naturally inhibits SypG-induced biofilms. We found that SypE's N-terminal kinase domain was both required and sufficient to inhibit SypG-induced biofilms. This effect did not occur at the level of syp transcription. Instead, under sypG-overexpressing conditions, SypE inhibited biofilms by promoting the phosphorylation of another syp regulator, SypA, a putative anti-sigma factor antagonist. Inhibition by SypE of SypG-induced biofilm formation could be overcome by the expression of a non-phosphorylatable SypA mutant, indicating that SypE functions primarily if not exclusively to control SypA activity via phosphorylation. Finally, the presence of SypE was detrimental to colonization under sypG-overexpressing conditions, as cells deleted for sypE outcompeted wild-type cells for colonization when both strains overexpressed sypG. These results provide further evidence that biofilm formation is critical to symbiotic colonization, and support a model in which SypE naturally functions to restrict biofilm formation, and thus host colonization, to the appropriate environmental conditions.	[Morris, Andrew R.; Visick, Karen L.] Loyola Univ, Med Ctr, Dept Microbiol & Immunol, Maywood, IL 60153 USA	Loyola University Chicago	Visick, KL (corresponding author), Loyola Univ, Med Ctr, Dept Microbiol & Immunol, 2160 S 1st Ave, Maywood, IL 60153 USA.	kvisick@lumc.edu		Visick, Karen/0000-0002-2400-2591	National Institutes of Health (NIH) [GM59690]; Conservation Medicine Center of Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059690] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conservation Medicine Center of Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM59690 award to KLV and a grant from the Conservation Medicine Center of Chicago awarded to ARM. www.nih.gov/. http://www.luhs.org/depts/cmcc/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; Davis R., 1980, ADV BACTERIAL GENETI; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; GRAF J, 1994, J BACTERIOL, V176, P6986, DOI 10.1128/JB.176.22.6986-6991.1994; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; Hussa EA, 2008, J BACTERIOL, V190, P4576, DOI 10.1128/JB.00130-08; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kozak NA, 2005, J BACTERIOL, V187, P5665, DOI 10.1128/JB.187.16.5665-5676.2005; Kuchma SL, 2000, CURR OPIN BIOTECH, V11, P429, DOI 10.1016/S0958-1669(00)00123-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCann J, 2003, APPL ENVIRON MICROB, V69, P5928, DOI 10.1128/AEM.69.10.5928-5934.2003; Miller J.H., 1972, EXPT MOL GENETICS; Morris AR, 2013, MOL MICROBIOL, V87, P509, DOI 10.1111/mmi.12109; Morris AR, 2011, MOL MICROBIOL, V82, P114, DOI 10.1111/j.1365-2958.2011.07800.x; Morris AR, 2010, ENVIRON MICROBIOL, V12, P2051, DOI 10.1111/j.1462-2920.2010.02269.x; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Ray VA, 2012, MOL MICROBIOL, V86, P954, DOI 10.1111/mmi.12035; Ray VA, 2012, JOVE-J VIS EXP, DOI 10.3791/4035; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Shibata S, 2012, J BACTERIOL; Shikuma NJ, 2009, J BACTERIOL, V191, P5147, DOI 10.1128/JB.00401-09; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Visick KL, 2001, J BACTERIOL, V183, P835, DOI 10.1128/JB.183.3.835-842.2001; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Yip ES, 2005, MOL MICROBIOL, V57, P1485, DOI 10.1111/j.1365-2958.2005.04784.x	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60076	10.1371/journal.pone.0060076	http://dx.doi.org/10.1371/journal.pone.0060076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555890	Green Published, gold			2022-12-27	WOS:000317262200080
J	Souza, DG; Bellaver, B; Souza, DO; Quincozes-Santos, A				Souza, Debora Guerini; Bellaver, Bruna; Souza, Diogo Onofre; Quincozes-Santos, Andre			Characterization of Adult Rat Astrocyte Cultures	PLOS ONE			English	Article							GLUTAMATE-GLUTAMINE CYCLE; IMPROVES NEURONAL SURVIVAL; OXIDATIVE STRESS; FREE-RADICALS; IN-VITRO; ACTIN CYTOSKELETON; S100B SECRETION; CEREBRAL-CORTEX; UP-REGULATION; JANUS FACE	Astrocytes, a major class of glial cells, regulate neurotransmitter systems, synaptic processing, ion homeostasis, antioxidant defenses and energy metabolism. Astrocyte cultures derived from rodent brains have been extensively used to characterize astrocytes' biochemical, pharmacological and morphological properties. The aims of this study were to develop a protocol for routine preparation and to characterize a primary astrocyte culture from the brains of adult (90 days old) Wistar rats. For this we used enzymatic digestion (trypsin and papain) and mechanical dissociation. Medium exchange occurred from 24 h after obtaining a culture and after, twice a week up to reach the confluence (around the 4(th) to 5(th) week). Under basal conditions, adult astrocytes presented a polygonal to fusiform and flat morphology. Furthermore, approximately 95% the cells were positive for the main glial markers, including GFAP, glutamate transporters, glutamine synthetase and S100B. Moreover, the astrocytes were able to take up glucose and glutamate. Adult astrocytes were also able to respond to acute H2O2 exposure, which led to an increase in reactive oxygen species (ROS) levels and a decrease in glutamate uptake. The antioxidant compound resveratrol was able to protect adult astrocytes from oxidative damage. A response of adult astrocytes to an inflammatory stimulus with LPS was also observed. Changes in the actin cytoskeleton were induced in stimulated astrocytes, most likely by a mechanism dependent on MAPK and Rho A signaling pathways. Taken together, these findings indicate that the culture model described in this study exhibits the biochemical and physiological properties of astrocytes and may be useful for elucidating the mechanisms related to the adult brain, exploring changes between neonatal and adult astrocytes, as well as investigating compounds involved in cytotoxicity and cytoprotection.	[Souza, Debora Guerini; Bellaver, Bruna; Souza, Diogo Onofre; Quincozes-Santos, Andre] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Quincozes-Santos, A (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, Porto Alegre, RS, Brazil.	andrequincozes@yahoo.com.br	Souza, Diogo O/J-8894-2014; Quincozes-Santos, André/AAO-2714-2020	Souza, Diogo O/0000-0002-4322-0404; Quincozes-Santos, Andre/0000-0001-8611-4890; Bellaver, Bruna/0000-0002-2212-3373	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Financiadora de Estudos e Projetos (FINEP) -IBN Net (Instituto Brasileiro de Neurociencias); Instituto Nacional de Ciencias e Tecnologia para Excitotoxicidade e Neuroprotecao (INCTEN)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Financiadora de Estudos e Projetos (FINEP) -IBN Net (Instituto Brasileiro de Neurociencias); Instituto Nacional de Ciencias e Tecnologia para Excitotoxicidade e Neuroprotecao (INCTEN)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Financiadora de Estudos e Projetos (FINEP) -IBN Net (Instituto Brasileiro de Neurociencias) 01.06.0842-00 and Instituto Nacional de Ciencias e Tecnologia para Excitotoxicidade e Neuroprotecao (INCTEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Anderson CM, 2000, GLIA, V32, P1; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bastianetto S, 2010, EXP NEUROL, V225, P237, DOI 10.1016/j.expneurol.2010.06.019; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Bobermin LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052164; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Browne R W, 1998, Methods Mol Biol, V108, P347; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Desclaux M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006227; DIAMOND MC, 1975, BEHAV BIOL, V14, P163, DOI 10.1016/S0091-6773(75)90161-3; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duan SM, 1999, J NEUROSCI, V19, P10193; Frizzo JK, 2004, NEUROCHEM RES, V29, P735, DOI 10.1023/B:NERE.0000018844.51009.40; Funchal C, 2004, GLIA, V48, P230, DOI 10.1002/glia.20072; Gottfried C, 2002, MECH AGEING DEV, V123, P1333, DOI 10.1016/S0047-6374(02)00069-6; Guasch RM, 2003, J NEUROSCI RES, V72, P487, DOI 10.1002/jnr.10594; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hyzinski-Garcia MC, 2011, J NEUROCHEM, V118, P140, DOI 10.1111/j.1471-4159.2011.07289.x; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Klamt F, 2002, NEUROREPORT, V13, P1515, DOI 10.1097/00001756-200208270-00005; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Lewis DK, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.007; Lin DT, 2007, NEUROBIOL AGING, V28, P99, DOI 10.1016/j.neurobiolaging.2005.11.004; LINDSAY RM, 1982, BRAIN RES, V243, P329, DOI 10.1016/0006-8993(82)90257-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; Matos M, 2012, GLIA, V60, P702, DOI 10.1002/glia.22290; Menet V, 2001, J NEUROSCI, V21, P6147; Mongin AA, 2012, ANTIOXID REDOX SIGN, V17, P992, DOI 10.1089/ars.2012.4559; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Quincozes-Santos A, 2009, NEUROTOX RES, V16, P30, DOI 10.1007/s12640-009-9042-0; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schousboe A, 2011, J NEUROSCI RES, V89, P1926, DOI 10.1002/jnr.22746; Segovia G, 2001, MECH AGEING DEV, V122, P1, DOI 10.1016/S0047-6374(00)00225-6; Segovia G, 2001, NEUROCHEM RES, V26, P37, DOI 10.1023/A:1007624531077; Seib TM, 2011, GLIA, V59, P1387, DOI 10.1002/glia.21176; Sergeeva M, 2000, NEUROSCIENCE, V97, P765, DOI 10.1016/S0306-4522(00)00062-2; Skytt DM, 2010, NEUROCHEM RES, V35, P2043, DOI 10.1007/s11064-010-0329-6; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; SWANSON RA, 1992, GLIA, V6, P198, DOI 10.1002/glia.440060307; Swanson RA, 1997, J NEUROSCI, V17, P932; Tanabe K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-16; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Uwechue NM, 2012, J PHYSIOL-LONDON, V590, P2317, DOI 10.1113/jphysiol.2011.226605; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Verbich D, 2012, GLIA, V60, P1067, DOI 10.1002/glia.22335; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; Won SJ, 2010, J NEUROSCI, V30, P15409, DOI 10.1523/JNEUROSCI.2084-10.2010; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Yoshiura T, 2005, ACAD RADIOL, V12, P268, DOI 10.1016/j.acra.2004.12.015; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	80	57	59	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60282	10.1371/journal.pone.0060282	http://dx.doi.org/10.1371/journal.pone.0060282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555943	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200104
J	Gupta, S; Garg, NJ				Gupta, Shivali; Garg, Nisha Jain			TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; CHAGAS-DISEASE; PROTECTIVE IMMUNITY; RECOMBINANT VIRUSES; DELIVERY-SYSTEM; CELL ACTIVATION; T-CELLS; DNA; VACCINATION; IMMUNOGENICITY	We characterized the immune responses elicited by a DNA-prime/MVA-boost vaccine (TcVac3) constituted of antigenic candidates (TcG2 and TcG4), shown to be recognized by B and T cell responses in Trypanosoma cruzi (Tc) infected multiple hosts. C57BL/6 mice immunized with TcVac3 elicited a strong antigen-specific, high-avidity, trypanolytic antibody response (IgG2b>IgG1); and a robust antigen-and Tc-specific CD8(+)T cell response with type-1 cytokine (IFN-gamma+TNF-alpha>IL-4(+)IL-10) and cytolytic effector (CD8(+)CD107a(+)IFN-gamma(+)Perforin(+)) phenotype. The vaccine-induced effector T cells significantly expanded upon challenge infection and provided >92% control of T. cruzi. Co-delivery of IL-12 and GMCSF cytokine adjuvants didn't enhance the TcVac3-induced resistance to T. cruzi. In chronic phase, vaccinated/infected mice exhibited a significant decline (up to 70%) in IFN-gamma(+)CD8(+) T cells, a predominance of immunoregulatory IL-10(+)/CD4(+)T and IL10(+)/CD8(+)T cells, and presented undetectable tissue parasitism, inflammatory infiltrate, and fibrosis in vaccinated/infected mice. In comparison, control mice responded to challenge infection by a low antibody response, mixed cytokine profile, and consistent activation of pro-inflammatory CD8(+)T cells associated with parasite persistence and pathologic damage in the heart. We conclude that TcVac3 elicited type-1 effector T cell immunity that effectively controlled T. cruzi infection, and subsequently, predominance of anti-inflammatory responses prevented chronic inflammation and myocarditis in chagasic mice.	[Gupta, Shivali; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Ctr Trop Dis, Fac Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Garg, NJ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	nigarg@utmb.edu			National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI072538, 2AI054578]; American Heart Association [0855059F]; Sealy Center for Vaccine Development post-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); Sealy Center for Vaccine Development post-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases/National Institutes of Health (AI072538, 2AI054578) and from American Heart Association (0855059F) to NJG. SG is a recipient of Sealy Center for Vaccine Development post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Burgos JE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001050; Araujo FF, 2007, FRONT BIOSCI-LANDMRK, V12, P2797, DOI 10.2741/2273; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; Bhatia V, 2008, CLIN VACCINE IMMUNOL, V15, P1158, DOI 10.1128/CVI.00144-08; Bhatia V, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P1423, DOI 10.1016/B978-0-12-369408-9.00069-X; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Cordeiro FD, 2001, CLIN DIAGN LAB IMMUN, V8, P112, DOI 10.1128/CDLI.8.1.112-118.2001; Costa RP, 2000, SCAND J IMMUNOL, V51, P511, DOI 10.1046/j.1365-3083.2000.00706.x; Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Drigo SA, 2006, MICROBES INFECT, V8, P598, DOI 10.1016/j.micinf.2005.08.009; Earl PL, 2007, VIROLOGY, V366, P84, DOI 10.1016/j.virol.2007.02.041; GALVAO LMC, 1993, T ROY SOC TROP MED H, V87, P220, DOI 10.1016/0035-9203(93)90501-G; Garg N, 2004, BIOCHEM J, V381, P743, DOI 10.1042/BJ20040356; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Gupta S, 2012, VACCINE, V30, P7179, DOI 10.1016/j.vaccine.2012.10.018; Gupta S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000797; Marcipar IS, 2001, CLIN DIAGN LAB IMMUN, V8, P802, DOI 10.1128/CDLI.8.4.802-805.2001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; MCCABE R, 1991, INFECT IMMUN, V59, P1633, DOI 10.1128/IAI.59.5.1633-1638.1991; Meseda CA, 2002, J INFECT DIS, V186, P1065, DOI 10.1086/344234; Miyahira Y, 2005, INFECT IMMUN, V73, P7356, DOI 10.1128/IAI.73.11.7356-7365.2005; Montes CL, 2007, J LEUKOCYTE BIOL, V82, P1027, DOI 10.1189/jlb.0407214; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Namujju PB, 1916, BMC RES NOTES, V4, P170; Narita M, 1998, CLIN DIAGN LAB IMMUN, V5, P799, DOI 10.1128/CDLI.5.6.799-803.1998; NOGUEIRA N, 1981, EXP PARASITOL, V51, P325, DOI 10.1016/0014-4894(81)90120-X; Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001; REED SG, 1988, J IMMUNOL, V140, P4342; Rocha CD, 2004, INT MICROBIOL, V7, P83; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Souza APD, 2005, BRAZ J MED BIOL RES, V38, P509, DOI 10.1590/S0100-879X2005000400004; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878; Vasconcelos JRC, 2003, IMMUNOL CELL BIOL, V81, P121, DOI 10.1046/j.0818-9641.2002.01136.x; Vazquez-Chagoyan JC, 2011, ADV PARASIT, V75, P121, DOI 10.1016/B978-0-12-385863-4.00006-X; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; World Health Organization, 2010, CHAG DIS CONTR EL	48	38	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59434	10.1371/journal.pone.0059434	http://dx.doi.org/10.1371/journal.pone.0059434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555672	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500039
J	Wang, LY; Chen, DD; Yang, XF; Olson, JJ; Gopinath, K; Fan, TN; Mao, H				Wang, Liya; Chen, Dandan; Yang, Xiaofeng; Olson, Jeffrey J.; Gopinath, Kaundinya; Fan, Tianning; Mao, Hui			Group Independent Component Analysis and Functional MRI Examination of Changes in Language Areas Associated with Brain Tumors at Different Locations	PLOS ONE			English	Article							EVENT-RELATED FMRI; LOW-GRADE GLIOMAS; IMAGING ACTIVATION; BROCAS AREA; INSIGHTS; REORGANIZATION; PLASTICITY; RETRIEVAL	Object: This study investigates the effect of tumor location on alterations of language network by brain tumors at different locations using blood oxygenation level dependent (BOLD) fMRI and group independent component analysis (ICA). Subjects and Methods: BOLD fMRI data were obtained from 43 right handed brain tumor patients. Presurgical mapping of language areas was performed on all 43 patients with a picture naming task. All data were retrospectively analyzed using group ICA. Patents were divided into three groups based on tumor locations, i.e., left frontal region, left temporal region or right hemisphere. Laterality index (LI) was used to assess language lateralization in each group. Results: The results from BOLD fMRI and ICA revealed the different language activation patterns in patients with brain tumors located in different brain regions. Language areas, such as Broca's and Wernicke's areas, were intact in patients with tumors in the right hemisphere. Significant functional changes were observed in patients with tumor in the left frontal and temporal areas. More specifically, the tumors in the left frontal region affect both Broca's and Wernicke's areas, while tumors in the left temporal lobe affect mainly Wernicke's area. The compensated activation increase was observed in the right frontal areas in patients with left hemisphere tumors. Conclusion: Group ICA provides a model free alternative approach for mapping functional networks in brain tumor patients. Altered language activation by different tumor locations suggested reorganization of language functions in brain tumor patients and may help better understanding of the language plasticity.	[Wang, Liya; Yang, Xiaofeng; Gopinath, Kaundinya; Mao, Hui] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Wang, Liya; Yang, Xiaofeng; Gopinath, Kaundinya; Fan, Tianning; Mao, Hui] Emory Univ, Sch Med, Ctr Syst Imaging, Atlanta, GA USA; [Wang, Liya] Baoan Hosp, Dept Radiol, Shenzhen, Guangdong, Peoples R China; [Chen, Dandan] Emory Univ, Sch Med, Dept Phys, Atlanta, GA USA; [Olson, Jeffrey J.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University	Mao, H (corresponding author), Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA.	hmao@emory.edu	Chen, Dan/GRY-2691-2022; Yang, Xiaofeng/G-9479-2012; Yang, Xiaofeng/AAN-9258-2020	Chen, Dan/0000-0002-1570-9034; Yang, Xiaofeng/0000-0001-9023-5855	Emory University Research Council; Brain Tumor Program of Emory Winship Cancer Institute	Emory University Research Council; Brain Tumor Program of Emory Winship Cancer Institute	This study is supported in part by a grant from Emory University Research Council (H.M.) and Brain Tumor Program of Emory Winship Cancer Institute (H.M.). No additional external funding received for this study.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Beckmann CF, 2006, HUM BRAIN MAPP, V27, P380, DOI 10.1002/hbm.20246; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Bogomolny Dmitry L, 2004, Top Magn Reson Imaging, V15, P325, DOI 10.1097/00002142-200410000-00005; Bookheimer S, 2007, NEUROPSYCHOL REV, V17, P145, DOI 10.1007/s11065-007-9026-x; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cousin Emilie, 2008, Neuropsychiatr Dis Treat, V4, P235; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gaillard WD, 2007, NEUROLOGY, V69, P1761, DOI 10.1212/01.wnl.0000289650.48830.1a; Grabowski TJ, 2003, NEUROIMAGE, V20, P940, DOI 10.1016/S1053-8119(03)00284-2; Grier JT, 2006, ONCOLOGIST, V11, P681, DOI 10.1634/theoncologist.11-6-681; Harrington GS, 2006, AM J NEURORADIOL, V27, P938; Henry RG, 2009, J NEUROL SCI, V282, P61, DOI 10.1016/j.jns.2009.02.379; Holodny AI, 2000, AM J NEURORADIOL, V21, P1415; Hopfinger JB, 2000, NEUROIMAGE, V11, P326, DOI 10.1006/nimg.2000.0549; Hou BL, 2006, NEUROIMAGE, V32, P489, DOI 10.1016/j.neuroimage.2006.04.188; HOWARD D, 1985, BRAIN, V108, P817; Inoue T, 1999, NEUROIMAGE, V10, P738, DOI 10.1006/nimg.1999.0501; Lidzba K, 2006, NEUROREPORT, V17, P929, DOI 10.1097/01.wnr.0000221841.12632.d6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mbwana J, 2009, BRAIN, V132, P347, DOI 10.1093/brain/awn329; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.3.CO;2-5; Partovi S, 2012, AJNR AM J NEURORADIO; Pillai JJ, 2010, AM J NEURORADIOL, V31, P990, DOI 10.3174/ajnr.A1896; Plaza M, 2009, NEUROCASE, V15, P294, DOI 10.1080/13554790902729473; Rodionov R, 2007, NEUROIMAGE, V38, P488, DOI 10.1016/j.neuroimage.2007.08.003; Rosenberg K, 2008, NEUROCASE, V14, P465, DOI 10.1080/13554790802459486; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Ruff IM, 2008, AM J NEURORADIOL, V29, P528, DOI 10.3174/ajnr.A0841; Saccuman MC, 2006, NEUROIMAGE, V32, P1865, DOI 10.1016/j.neuroimage.2006.04.179; Schreiber A, 2000, AM J NEURORADIOL, V21, P1055; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Sunaert S, 2006, J MAGN RESON IMAGING, V23, P887, DOI 10.1002/jmri.20582; Talairach, 1988, COPLANAR STEREOTAXIC; Thevenaz P, 2000, IEEE T IMAGE PROCESS, V9, P2083, DOI 10.1109/83.887976; Tie YM, 2008, NEUROIMAGE, V42, P1214, DOI 10.1016/j.neuroimage.2008.05.028; Tie Y, 2009, NEUROIMAGE, V47, pT107, DOI 10.1016/j.neuroimage.2008.11.020; Voets NL, 2006, BRAIN, V129, P754, DOI 10.1093/brain/awh679; Wang LY, 2012, ACTA RADIOL, V53, P802, DOI 10.1258/ar.2012.120118; Wu CX, 2008, CHINESE MED J-PEKING, V121, P2026; Wu X, 2007, MAGN RESON IMAGING, V25, P703, DOI 10.1016/j.mri.2006.09.038	47	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59657	10.1371/journal.pone.0059657	http://dx.doi.org/10.1371/journal.pone.0059657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555736	Green Published, gold			2022-12-27	WOS:000317418500068
J	Anzai, M; Iijima, N; Higo, S; Takumi, K; Matsuo, I; Mori, K; Ohe, Y; Kadota, K; Akimoto, T; Sakamoto, A; Ozawa, H				Anzai, Megumi; Iijima, Norio; Higo, Shimpei; Takumi, Ken; Matsuo, Izumi; Mori, Keisuke; Ohe, Yumiko; Kadota, Kana; Akimoto, Toshio; Sakamoto, Atsuhiro; Ozawa, Hitoshi			Direct and Specific Effect of Sevoflurane Anesthesia on rat Per2 Expression in the Suprachiasmatic Nucleus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MESSENGER-RNA; CLOCK GENES; CIRCADIAN OSCILLATIONS; INHALATION ANESTHESIA; RAT; GABA(A); RHYTHMS; NEURONS; SYSTEM	Background: Our previous studies revealed that application of the inhalation anesthetic, sevoflurane, reversibly repressed the expression of Per2 in the mouse suprachiasmatic nucleus (SCN). We aimed to examine whether sevoflurane directly affects the SCN. Methods: We performed in vivo and in vitro experiments to investigate rat Per2 expression under sevoflurane-treatment. The in vivo effects of sevoflurane on rPer2 expression were examined by quantitative in situ hybridization with a radioactively-labeled cRNA probe. Additionally, we examined the effect of sevoflurane anesthesia on rest/activity rhythms in the rat. In the in vitro experiments, we applied sevoflurane to SCN explant cultures from Per2-dLuc transgenic rats, and monitored luciferase bioluminescence, representing Per2 promoter activity. Bioluminescence from two peripheral organs, the kidney cortex and the anterior pituitary gland, were also analyzed. Results: Application of sevoflurane in rats significantly suppressed Per2 expression in the SCN compared with untreated animals. We observed no sevoflurane-induced phase-shift in the rest/activity rhythms. In the in vitro experiments, the intermittent application of sevoflurane repressed the increase of Per2-dLuc luminescence and led to a phase delay in the Per2-dLuc luminescence rhythm. Sevoflurane treatment did not suppress bioluminescence in the kidney cortex or the anterior pituitary gland. Conclusion: The suppression of Per2-dLuc luminescence by sevoflurane in in vitro SCN cultures isolated from peripheral inputs and other nuclei suggest a direct action of sevoflurane on the SCN itself. That sevoflurane has no such effect on peripheral organs suggests that this action might be mediated through a neuron-specific cellular mechanism or a regulation of the signal transduction between neurons.	[Anzai, Megumi; Iijima, Norio; Higo, Shimpei; Takumi, Ken; Matsuo, Izumi; Mori, Keisuke; Ozawa, Hitoshi] Nippon Med Sch, Grad Sch Med, Dept Anat & Neurobiol, Bunkyo Ku, Tokyo 113, Japan; [Anzai, Megumi; Matsuo, Izumi; Mori, Keisuke; Ohe, Yumiko; Kadota, Kana; Sakamoto, Atsuhiro] Nippon Med Sch, Dept Anesthesiol, Grad Sch Med, Bunkyo Ku, Tokyo 113, Japan; [Akimoto, Toshio] Nippon Med Sch, Div Lab Anim Sci, Bunkyo Ku, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School; Nippon Medical School	Iijima, N (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Anat & Neurobiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	niijima@nms.ac.jp	Ozawa, Hitoshi/AAB-1348-2020		Ministry of Education, Culture, Sports, Science and Technology; MEXT [S0801035];  [20591820];  [22590230];  [23659125];  [24790241]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; 	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/), the MEXT-Supported Program for Strategic Research Foundation at Private Universities (S0801035 to HO) and the Grant-in-Aid for Scientific Researches (20591820 to AS), (22590230 to HO), (23659125 to NI), (24790241 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2006, P NATL ACAD SCI USA, V103, P19188, DOI 10.1073/pnas.0607466103; BROWN BR, 1993, ANESTHESIOLOGY, V79, P201, DOI 10.1097/00000542-199307000-00051; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Chu GY, 2011, CHRONOBIOL INT, V28, P477, DOI 10.3109/07420528.2011.589933; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Ehlen JC, 2008, J BIOL RHYTHM, V23, P16, DOI 10.1177/0748730407310785; Ehlen JC, 2006, EUR J NEUROSCI, V23, P3328, DOI 10.1111/j.1460-9568.2006.04857.x; FORREST JB, 1990, ANESTHESIOLOGY, V72, P252, DOI 10.1097/00000542-199002000-00008; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Fukuda H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023568; Gauer F, 1998, MOL BRAIN RES, V60, P193, DOI 10.1016/S0169-328X(98)00177-6; He PJ, 2007, J ENDOCRINOL, V193, P413, DOI 10.1677/JOE-07-0044; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Ibata Y, 1999, FRONT NEUROENDOCRIN, V20, P241, DOI 10.1006/frne.1999.0180; Kadota K, 2012, NEUROSCI LETT, V528, P153, DOI 10.1016/j.neulet.2012.07.061; Kennaway DJ, 2010, J PSYCHOPHARMACOL, V24, P5, DOI 10.1177/1359786810372980; Kubo Y, 2012, J PHARMACOL EXP THER, V340, P698, DOI 10.1124/jpet.111.188615; Lamont EW, 2010, ISR J PSYCHIATR REL, V47, P27; LEVY WJ, 1984, BRIT J ANAESTH, V56, pS101; Maywood ES, 2011, EXP NEUROL; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; OHARA BF, 1995, MOL BRAIN RES, V28, P239, DOI 10.1016/0169-328X(94)00212-W; Ohe Y, 2011, NEUROSCI LETT, V490, P231, DOI 10.1016/j.neulet.2010.12.059; OKAMURA H, 1989, NEUROSCI LETT, V102, P131, DOI 10.1016/0304-3940(89)90067-0; Sakamoto A, 2005, GENE, V356, P39, DOI 10.1016/j.gene.2005.03.022; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shinohara K, 2000, NEUROSCI RES, V38, P43, DOI 10.1016/S0168-0102(00)00141-3; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; Sugden D, 1999, MOL BRAIN RES, V72, P176, DOI 10.1016/S0169-328X(99)00222-3; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tanaka M, 1997, J HISTOCHEM CYTOCHEM, V45, P1231, DOI 10.1177/002215549704500906; Touitou Y., 2008, ANNALES PHARMACEUTIQUES FRANCAISES, V66, P146, DOI 10.1016/j.pharma.2008.05.001; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	45	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59454	10.1371/journal.pone.0059454	http://dx.doi.org/10.1371/journal.pone.0059454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555676	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400041
J	Meehan, AC; Mifsud, NA; Nguyen, THO; Levvey, BJ; Snell, GI; Kotsimbos, TC; Westall, GP				Meehan, Aislin C.; Mifsud, Nicole A.; Nguyen, Thi H. O.; Levvey, Bronwyn J.; Snell, Greg I.; Kotsimbos, Tom C.; Westall, Glen P.			Impact of Commonly Used Transplant Immunosuppressive Drugs on Human NK Cell Function Is Dependent upon Stimulation Condition	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SOLID-ORGAN TRANSPLANTATION; LUNG TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; PERIPHERAL-BLOOD; IN-VITRO; CYCLOSPORINE; CYTOTOXICITY; INHIBITION; ACTIVATION	Lung transplantation is a recognised treatment for patients with end stage pulmonary disease. Transplant recipients receive life-long administration of immunosuppressive drugs that target T cell mediated graft rejection. However little is known of the impact on NK cells, which have the potential to be alloreactive in response to HLA-mismatched ligands on the lung allograft and in doing so, may impact negatively on allograft survival. NK cells from 20 healthy controls were assessed in response to Cyclosporine A, Mycophenolic acid (MPA; active form of Mycophenolate mofetil) and Prednisolone at a range of concentrations. The impact of these clinically used immunosuppressive drugs on cytotoxicity (measured by CD107a expression), IFN-gamma production and CFSE proliferation was assessed in response to various stimuli including MHC class-I negative cell lines, IL-2/IL-12 cytokines and PMA/Ionomycin. Treatment with MPA and Prednisolone revealed significantly reduced CD107a expression in response to cell line stimulation. In comparison, addition of MPA and Cyclosporine A displayed reduced CD107a expression and IFN-gamma production following PMA/Ionomycin stimulation. Diminished proliferation was observed in response to treatment with each drug. Additional functional inhibitors (LY294002, PD98059, Rottlerin, Rapamycin) were used to elucidate intracellular pathways of NK cell activation in response to stimulation with K562 or PMAI. CD107a expression was significantly decreased with the addition of PD98059 following K562 stimulation. Similarly, CD107a expression significantly decreased following PMA-I stimulation with the addition of LY294002, PD98059 and Rottlerin. Ten lung transplant patients, not receiving immunosuppressive drugs pre-transplant, were assessed for longitudinal changes post-transplant in relation to the administration of immunosuppressive drugs. Individual patient dynamics revealed different longitudinal patterns of NK cell function post-transplantation. These results provide mechanistic insights into pathways of NK cell activation and show commonly administered transplant immunosuppression agents and clinical rejection/infection events have differential effects on NK cell function that may impact the immune response following lung transplantation.	[Meehan, Aislin C.; Mifsud, Nicole A.; Nguyen, Thi H. O.; Kotsimbos, Tom C.; Westall, Glen P.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Meehan, Aislin C.; Mifsud, Nicole A.; Nguyen, Thi H. O.; Levvey, Bronwyn J.; Snell, Greg I.; Kotsimbos, Tom C.; Westall, Glen P.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Westall, GP (corresponding author), Monash Univ, Dept Med, Melbourne, Vic 3004, Australia.	G.Westall@alfred.org.au	Nguyen, Thi Hoang Oanh/AAM-6827-2021	Nguyen, Thi Hoang Oanh/0000-0002-9294-7693; Mifsud, Nicole/0000-0001-8647-2102; Westall, Glen/0000-0002-3711-068X; Levvey, Bronwyn/0000-0002-1954-4249	National Health and Medical Research Council (NHMRC); Margaret Pratt Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Margaret Pratt Foundation	This work has been supported by the National Health and Medical Research Council (NHMRC) with the provision of the Dora Lush Postgraduate Research Scholarship and the Margaret Pratt Foundation (http://www.mprattfoundation.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan James S, 2004, Semin Thorac Cardiovasc Surg, V16, P333, DOI 10.1053/j.semtcvs.2004.09.010; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arns W, 2006, TRANSPLANTATION, V82, P1004, DOI 10.1097/01.tp.0000232697.38021.9a; Baran J, 2001, CLIN DIAGN LAB IMMUN, V8, P303, DOI 10.1128/CDLI.8.2.303-313.2001; Barten MJ, 2003, J IMMUNOL METHODS, V283, P99, DOI 10.1016/j.jim.2003.08.015; CHEN SH, 1983, TRANSPLANTATION, V35, P127, DOI 10.1097/00007890-198302000-00004; Chiossone L, 2007, BLOOD, V109, P3767, DOI 10.1182/blood-2006-07-037846; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Eissens DN, 2010, AM J TRANSPLANT, V10, P1981, DOI 10.1111/j.1600-6143.2010.03242.x; Engstrand M, 2003, CLIN EXP IMMUNOL, V132, P96, DOI 10.1046/j.1365-2249.2003.02098.x; Fildes JE, 2008, TRANSPL IMMUNOL, V19, P1, DOI 10.1016/j.trim.2008.01.004; Fildes JE, 2008, J HEART LUNG TRANSPL, V27, P203, DOI 10.1016/j.healun.2007.11.571; Gummert JF, 1999, J AM SOC NEPHROL, V10, P1366; Gummert JF, 1999, J PHARMACOL EXP THER, V291, P1100; Hoogduijn MJ, 2011, HUM GENE THER, V22, P1587, DOI 10.1089/hum.2011.039; INTRONA M, 1981, TRANSPLANTATION, V31, P113, DOI 10.1097/00007890-198102000-00004; Kwakkel-van Erp JM, 2008, J HEART LUNG TRANSPL, V27, P995, DOI 10.1016/j.healun.2008.06.006; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Meehan AC, 2010, TRANSPLANTATION, V89, P756, DOI 10.1097/TP.0b013e3181cab17f; Morteau O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013294; Morton JM, 2006, J HEART LUNG TRANSPL, V25, P557, DOI 10.1016/j.healun.2005.11.460; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oellerich M, 1998, CLIN BIOCHEM, V31, P309, DOI 10.1016/S0009-9120(98)00049-6; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Petersson E, 1997, TRANSPLANTATION, V63, P1138, DOI 10.1097/00007890-199704270-00014; Pillet AH, 2009, J IMMUNOL, V182, P6267, DOI 10.4049/jimmunol.0801933; Pratschke J, 2009, TRANSPL INT, V22, P859, DOI 10.1111/j.1432-2277.2009.00884.x; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Srinivas TR, 2003, EXPERT OPIN PHARMACO, V4, P2325, DOI 10.1517/14656566.4.12.2325; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Thum MY, 2008, AM J REPROD IMMUNOL, V59, P259, DOI 10.1111/j.1600-0897.2007.00574.x; van der Touw W, 2010, AM J TRANSPLANT, V10, P1354, DOI 10.1111/j.1600-6143.2010.03086.x; Vitale C, 2004, EUR J IMMUNOL, V34, P3028, DOI 10.1002/eji.200425418; Wai LE, 2008, TRANSPLANTATION, V85, P145, DOI 10.1097/01.tp.0000296817.28053.7b; Wang H, 2007, BLOOD, V110, P1530, DOI 10.1182/blood-2006-10-048173; Warren HS, 2011, J IMMUNOL METHODS, V370, P86, DOI 10.1016/j.jim.2011.06.002; WASIK M, 1991, TRANSPLANTATION, V51, P268, DOI 10.1097/00007890-199101000-00045; Yokoyama WM, 2005, ADV EXP MED BIOL, V560, P57	38	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60144	10.1371/journal.pone.0060144	http://dx.doi.org/10.1371/journal.pone.0060144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555904	Green Published, gold			2022-12-27	WOS:000316546400082
J	Jap, T; Tiatri, S; Jaya, ES; Suteja, MS				Jap, Tjibeng; Tiatri, Sri; Jaya, Edo Sebastian; Suteja, Mekar Sari			The Development of Indonesian Online Game Addiction Questionnaire	PLOS ONE			English	Article							COMPUTER GAMES; AGGRESSION	Online game is an increasingly popular source of entertainment for all ages, with relatively prevalent negative consequences. Addiction is a problem that has received much attention. This research aims to develop a measure of online game addiction for Indonesian children and adolescents. The Indonesian Online Game Addiction Questionnaire draws from earlier theories and research on the internet and game addiction. Its construction is further enriched by including findings from qualitative interviews and field observation to ensure appropriate expression of the items. The measure consists of 7 items with a 5-point Likert Scale. It is validated by testing 1,477 Indonesian junior and senior high school students from several schools in Manado, Medan, Pontianak, and Yogyakarta. The validation evidence is shown by item-total correlation and criterion validity. The Indonesian Online Game Addiction Questionnaire has good item-total correlation (ranging from 0.29 to 0.55) and acceptable reliability (alpha = 0.73). It is also moderately correlated with the participant's longest time record to play online games (r = 0.39; p<0.01), average days per week in playing online games (rho = 0.43; p<0.01), average hours per days in playing online games (rho = 0.41; p<0.01), and monthly expenditure for online games (rho = 0.30; p<0.01). Furthermore, we created a clinical cut-off estimate by combining criteria and population norm. The clinical cut-off estimate showed that the score of 14 to 21 may indicate mild online game addiction, and the score of 22 and above may indicate online game addiction. Overall, the result shows that Indonesian Online Game Addiction Questionnaire has sufficient psychometric property for research use, as well as limited clinical application.	[Jap, Tjibeng; Tiatri, Sri; Jaya, Edo Sebastian; Suteja, Mekar Sari] Tarumanagara Univ, Sci Technol & Soc STS Res Grp, Jakarta, Indonesia; [Jap, Tjibeng] Tarumanagara Univ, Fac Informat Technol, Jakarta, Indonesia; [Tiatri, Sri] Tarumanagara Univ, Fac Psychol, Jakarta, Indonesia	Tarumanagara University; Tarumanagara University; Tarumanagara University	Jap, T (corresponding author), Tarumanagara Univ, Sci Technol & Soc STS Res Grp, Jakarta, Indonesia.	t.jap@untar.ac.id; sri.tiatri@untar.ac.id; edojaya@hotmail.com	Jaya, Edo S./K-8961-2016; Beng, Jap Tji/AAD-6501-2021; Tiatri, Sri/AAD-7262-2021	Jaya, Edo S./0000-0002-7232-6312; Beng, Jap Tji/0000-0002-0932-690X; Tiatri, Sri/0000-0003-2047-1603	Indonesian Higher Education Department, Jakarta, Indonesia; Tarumanagara University, Jakarta, Indonesia	Indonesian Higher Education Department, Jakarta, Indonesia; Tarumanagara University, Jakarta, Indonesia	This research is funded by the Indonesian Higher Education Department, Jakarta and Tarumanagara University, Jakarta, Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D.H., 2007, P INT S COUNS TREAT, P49; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Demetrovics Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036417; Faiola Anthony, 2006, WASHINGTON POST; Fauzi A, 2011, RATUSAN GAMERS COBA; Firdaus F, 2010, PESAN MENKES ENDANG; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Griffiths M, 2008, INT J MENTAL HLTH AD, V6, P182, DOI DOI 10.1007/S11469-007-9128-Y; Griffiths M., 1996, J WORKPLACE LEARN, V8, P19, DOI [10.1108/13665629610116872, DOI 10.1108/13665629610116872]; Griffiths MD, 1998, PSYCHOL REP, V82, P475, DOI 10.2466/PR0.82.2.475-480; Ismail M, 2011, DUH KECANDUAN GAME O; Joewono BN, 2010, WARNET TEMPAT FAVORI; Johansson A, 2004, PSYCHOL REP, V95, P641, DOI 10.2466/pr0.95.2.641-650; Ju Y., 2007, 2007 INT S COUNS TRE, P243; Kendari B, 2011, KECANDUAN GAME ONLIN; Kim EJ, 2008, EUR PSYCHIAT, V23, P212, DOI 10.1016/j.eurpsy.2007.10.010; Kompas, 2010, AN GEN INT HIB WARN; Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458; Naeem F, 2011, BEHAV COGN PSYCHOTH, V39, P165, DOI 10.1017/S1352465810000822; Pomerantz AM, 2011, CLIN PSYCHOL SCI PRA; Sherry JL, 2001, HUM COMMUN RES, V27, P409, DOI 10.1093/hcr/27.3.409; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Xing W., 2007, CHINA DAILY; Young K.S., 1999, INNOVATIONS CLIN PRA, V17, P351	25	19	19	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61098	10.1371/journal.pone.0061098	http://dx.doi.org/10.1371/journal.pone.0061098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23560113	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100115
J	Yadav, R; Hillman, BG; Gupta, SC; Suryavanshi, P; Bhatt, JM; Pavuluri, R; Stairs, DJ; Dravid, SM				Yadav, Roopali; Hillman, Brandon G.; Gupta, Subhash C.; Suryavanshi, Pratyush; Bhatt, Jay M.; Pavuluri, Ratnamala; Stairs, Dustin J.; Dravid, Shashank M.			Deletion of Glutamate Delta-1 Receptor in Mouse Leads to Enhanced Working Memory and Deficit in Fear Conditioning	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; INHIBITORY PRESYNAPTIC DIFFERENTIATION; MEDIAL TEMPORAL-LOBE; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; CANDIDATE GENES; KAINATE RECEPTORS; NMDA RECEPTORS; MESSENGER-RNAS; SPATIAL MEMORY	Glutamate delta-1 (GluD1) receptors are expressed throughout the forebrain during development with high levels in the hippocampus during adulthood. We have recently shown that deletion of GluD1 receptor results in aberrant emotional and social behaviors such as hyperaggression and depression-like behaviors and social interaction deficits. Additionally, abnormal expression of synaptic proteins was observed in amygdala and prefrontal cortex of GluD1 knockout mice ( GluD1 KO). However the role of GluD1 in learning and memory paradigms remains unknown. In the present study we evaluated GluD1 KO in learning and memory tests. In the eight-arm radial maze GluD1 KO mice committed fewer working memory errors compared to wildtype mice but had normal reference memory. Enhanced working memory in GluD1 KO was also evident by greater percent alternation in the spontaneous Y-maze test. No difference was observed in object recognition memory in the GluD1 KO mice. In the Morris water maze test GluD1 KO mice showed no difference in acquisition but had longer latency to find the platform in the reversal learning task. GluD1 KO mice showed a deficit in contextual and cue fear conditioning but had normal latent inhibition. The deficit in contextual fear conditioning was reversed by D-Cycloserine (DCS) treatment. GluD1 KO mice were also found to be more sensitive to foot-shock compared to wildtype. We further studied molecular changes in the hippocampus, where we found lower levels of GluA1, GluA2 and GluK2 subunits while a contrasting higher level of GluN2B in GluD1 KO. Additionally, we found higher postsynaptic density protein 95 (PSD95) and lower glutamate decarboxylase 67 (GAD67) expression in GluD1 KO. We propose that GluD1 is crucial for normal functioning of synapses and absence of GluD1 leads to specific abnormalities in learning and memory. These findings provide novel insights into the role of GluD1 receptors in the central nervous system.	[Yadav, Roopali; Hillman, Brandon G.; Gupta, Subhash C.; Suryavanshi, Pratyush; Bhatt, Jay M.; Pavuluri, Ratnamala; Dravid, Shashank M.] Creighton Univ, Dept Pharmacol, Omaha, NE 68178 USA; [Stairs, Dustin J.] Creighton Univ, Dept Psychol, Omaha, NE 68178 USA	Creighton University; Creighton University	Dravid, SM (corresponding author), Creighton Univ, Dept Pharmacol, Omaha, NE 68178 USA.	ShashankDravid@creighton.edu	Suryavanshi, Pratyush/ABE-6107-2021		Health Future Foundation; National Alliance for Research on Schizophrenia and Depression; National Center for Research Resources [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER	Health Future Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Health Future Foundation (SMD) and the National Alliance for Research on Schizophrenia and Depression (SMD). The project was also supported by G20RR024001 from National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Balciuniene J, 2007, AM J HUM GENET, V80, P938, DOI 10.1086/513607; Bannerman DM, 2009, BIOCHEM SOC T, V37, P1323, DOI 10.1042/BST0371323; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bennett E, 2012, J AUTISM DEV DISORD, V42, P2739, DOI 10.1007/s10803-012-1533-9; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brielmaier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040914; Brigman JL, 2006, BEHAV NEUROSCI, V120, P984, DOI 10.1037/0735-7044.120.4.984; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Curley AA, 2013, NEUROBIOL DIS, V50, P179, DOI 10.1016/j.nbd.2012.10.018; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Duffy S, 2008, NEUROPSYCHOPHARMACOL, V33, P1004, DOI 10.1038/sj.npp.1301486; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Eastwood SL, 1997, MOL BRAIN RES, V44, P92, DOI 10.1016/S0169-328X(96)00195-7; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Floresco SB, 2009, BEHAV BRAIN RES, V204, P396, DOI 10.1016/j.bbr.2008.12.001; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Gaigg SB, 2008, NEUROPSYCHOLOGIA, V46, P983, DOI 10.1016/j.neuropsychologia.2007.11.011; Gao JG, 2007, MOL CELL BIOL, V27, P4500, DOI 10.1128/MCB.02051-06; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Guo SZ, 2007, SCHIZOPHR RES, V93, P385, DOI 10.1016/j.schres.2007.03.007; Hagerman R, 2012, RESULTS PROBL CELL D, V54, P297, DOI 10.1007/978-3-642-21649-7_17; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; HARRISON PJ, 1991, LANCET, V337, P450, DOI 10.1016/0140-6736(91)93392-M; Hartley CA, 2012, BIOL PSYCHIAT, V72, P113, DOI 10.1016/j.biopsych.2011.12.027; Hillman BG, 2011, NEUROBIOL LEARN MEM, V95, P404, DOI 10.1016/j.nlm.2011.01.008; Holt DJ, 2012, ARCH GEN PSYCHIAT, V69, P893, DOI 10.1001/archgenpsychiatry.2011.2310; Huettner JE, 2002, NEUROSCIENTIST, V8, P89, DOI 10.1177/107385840200800204; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Ko S, 2005, J NEUROSCI, V25, P977, DOI 10.1523/JNEUROSCI.4059-04.2005; Kochlamazashvili G, 2012, J NEUROSCI, V32, P2263, DOI 10.1523/JNEUROSCI.5103-11.2012; Kooy RF, 1996, AM J MED GENET, V64, P241, DOI 10.1002/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MacPherson P, 2008, BRAIN RES, V1210, P179, DOI 10.1016/j.brainres.2008.03.008; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Nanda U, 2012, HERD-HEALTH ENV RES, V5, P40, DOI 10.1177/193758671200500404; Ng WXD, 2009, NEUROSCI BIOBEHAV R, V33, P336, DOI 10.1016/j.neubiorev.2008.10.001; Noland JS, 2010, DEVELOPMENTAL SCI, V13, P244, DOI 10.1111/j.1467-7687.2009.00882.x; Nord AS, 2011, EUR J HUM GENET, V19, P727, DOI 10.1038/ejhg.2011.24; Olmos-Serrano JL, 2011, DEV NEUROSCI-BASEL, V33, P395, DOI 10.1159/000332884; OLTON DS, 1981, EXP BRAIN RES, V41, P380; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Pietersen CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001360; Porter RHP, 1997, BRAIN RES, V751, P217, DOI 10.1016/S0006-8993(96)01404-7; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Provenzano G, 2012, DIS MARKERS, V33, P225, DOI [10.1155/2012/916082, 10.3233/DMA-2012-0917]; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Raineki C, 2010, HIPPOCAMPUS, V20, P1037, DOI 10.1002/hipo.20702; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Ryu K, 2012, BIOCHEM BIOPH RES CO, V417, P157, DOI 10.1016/j.bbrc.2011.11.075; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Scarr E, 2003, BIPOLAR DISORD, V5, P257, DOI 10.1034/j.1399-5618.2003.00024.x; Schmid SM, 2008, MOL NEUROBIOL, V37, P126, DOI 10.1007/s12035-008-8025-0; Schmitz N, 2008, BRIT J PSYCHIAT, V192, P19, DOI 10.1192/bjp.bp.107.036921; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Smith M, 2009, ANN NY ACAD SCI, V1151, P102, DOI 10.1111/j.1749-6632.2008.03571.x; South M, 2012, AUTISM RES, V5, P398, DOI 10.1002/aur.1255; South M, 2011, AUTISM RES, V4, P412, DOI 10.1002/aur.221; Sullivan P, 2012, ARCH GEN PSYCHIAT, V2, P1; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011; van Bon BWM, 2011, EUR J HUM GENET, V19, P400, DOI 10.1038/ejhg.2010.211; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wallace GL, 2009, PHILOS T R SOC B, V364, P1425, DOI 10.1098/rstb.2008.0330; White TL, 2004, BRAIN RES, V1021, P1, DOI 10.1016/j.brainres.2004.05.114; Yadav R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032969; Yamada D, 2011, NEUROSCI LETT, V488, P242, DOI 10.1016/j.neulet.2010.11.038; Yang M, 2012, PHYSIOL BEHAV, V107, P649, DOI 10.1016/j.physbeh.2011.12.025; Yasumura M, 2012, J NEUROCHEM, V121, P705, DOI 10.1111/j.1471-4159.2011.07631.x; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang XH, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-9	99	177	178	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60785	10.1371/journal.pone.0060785	http://dx.doi.org/10.1371/journal.pone.0060785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560106	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100103
J	Trzaskowski, M; Eley, TC; Davis, OSP; Doherty, SJ; Hanscombe, KB; Meaburn, EL; Haworth, CMA; Price, T; Plomin, R				Trzaskowski, Maciej; Eley, Thalia C.; Davis, Oliver S. P.; Doherty, Sophia J.; Hanscombe, Ken B.; Meaburn, Emma L.; Haworth, Claire M. A.; Price, Thomas; Plomin, Robert			First Genome-Wide Association Study on Anxiety-Related Behaviours in Childhood	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; CANDIDATE-GENE; DEPRESSION; SYMPTOMS; DISORDERS; HERITABILITY; INTELLIGENCE; NEUROTICISM; CHILDREN; ABILITY	Background: Twin studies have shown that anxiety in a general population sample of children involves both domain-general and trait-specific genetic effects. For this reason, in an attempt to identify genes responsible for these effects, we investigated domain-general and trait-specific genetic associations in the first genome-wide association (GWA) study on anxiety-related behaviours (ARBs) in childhood. Methods: The sample included 2810 7-year-olds drawn from the Twins Early Development Study (TEDS) with data available for parent-rated anxiety and genome-wide DNA markers. The measure was the Anxiety-Related Behaviours Questionnaire (ARBQ), which assesses four anxiety traits and also yields a general anxiety composite. Affymetrix GeneChip 6.0 DNA arrays were used to genotype nearly 700,000 single-nucleotide polymorphisms (SNPs), and IMPUTE v2 was used to impute more than 1 million SNPs. Several GWA associations from this discovery sample were followed up in another TEDS sample of 4804 children. In addition, Genome-wide Complex Trait Analysis (GCTA) was used on the discovery sample, to estimate the total amount of variance in ARBs that can be accounted for by SNPs on the array. Results: No SNP associations met the demanding criterion of genome-wide significance that corrects for multiple testing across the genome (p < 5x10(-8)). Attempts to replicate the top associations did not yield significant results. In contrast to the substantial twin study estimates of heritability which ranged from 0.50 (0.03) to 0.61 (0.01), the GCTA estimates of phenotypic variance accounted for by the SNPs were much lower 0.01 (0.11) to 0.19 (0.12). Conclusions: Taken together, these GWAS and GCTA results suggest that anxiety - similar to height, weight and intelligence - is affected by many genetic variants of small effect, but unlike these other prototypical polygenic traits, genetic influence on anxiety is not well tagged by common SNPs.	[Trzaskowski, Maciej; Eley, Thalia C.; Davis, Oliver S. P.; Doherty, Sophia J.; Hanscombe, Ken B.; Haworth, Claire M. A.; Price, Thomas; Plomin, Robert] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Meaburn, Emma L.] Univ London, Dept Psychol Sci, Birkbeck, London, England	University of London; King's College London; University of London	Trzaskowski, M (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, De Crespigny Pk, London WC2R 2LS, England.	maciej.trzaskowski@kcl.ac.uk	Price, Thomas S./B-7372-2008; Davis, Oliver SP/B-9653-2008; Meaburn, Emma/D-5433-2011; Haworth, Claire M.A./C-7073-2009	Price, Thomas S./0000-0001-7356-2109; Davis, Oliver SP/0000-0002-6448-3684; Haworth, Claire M.A./0000-0002-8608-289X; Trzaskowski, Maciej/0000-0001-8559-6525; Meaburn, Emma/0000-0001-8096-9089; Plomin, Robert/0000-0002-0756-3629	U.K. Medical Research Council (MRC) [G0500079]; US National Institutes of Health [HD044454, HD046167]; Wellcome Trust Case Control Consortium 2 project [085475/B/08/Z, 085475/Z/08/Z]; Medical Research Council Research Professorship award [G19/2]; European Advanced Investigator award [295366]; Sir Henry Wellcome Fellowship from the Wellcome Trust [WT088984]; British Academy; Medical Research Council [G19/2, G0500079, G9817803B] Funding Source: researchfish; MRC [G0500079, G19/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044454] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046167] Funding Source: NIH RePORTER	U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Case Control Consortium 2 project; Medical Research Council Research Professorship award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Advanced Investigator award; Sir Henry Wellcome Fellowship from the Wellcome Trust; British Academy; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	TEDS is supported by a program grant (G0500079) from the U.K. Medical Research Council (MRC), with additional support from the US National Institutes of Health (HD044454; HD046167). Genome-wide genotyping was made possible by grants from the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z; 085475/Z/08/Z). RP is supported by a Medical Research Council Research Professorship award (G19/2) and a European Advanced Investigator award (295366); O.S.P.D. is supported by a Sir Henry Wellcome Fellowship from the Wellcome Trust (WT088984); C. M. A. H. is supported by a research fellowship from the British Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calboli FCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011504; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Docherty SJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-61; Eley TC, 2003, J CHILD PSYCHOL PSYC, V44, P945, DOI 10.1111/1469-7610.00179; Eley TC, 2004, BEHAV GENETICS ANXIE; Ferdinand RF, 2007, J ABNORM CHILD PSYCH, V35, P325, DOI 10.1007/s10802-006-9093-0; Franic S, 2010, J AM ACAD CHILD PSY, V49, P820, DOI 10.1016/j.jaac.2010.05.013; Gladstone GL, 2005, DEPRESS ANXIETY, V22, P103, DOI 10.1002/da.20082; Goldsmith HH, 2000, BIOL PSYCHIAT, V48, P1199, DOI 10.1016/S0006-3223(00)01003-9; Hallett V, 2009, DEPRESS ANXIETY, V26, P316, DOI 10.1002/da.20539; Hindorff L, 2012, CATALOG PUBLISHED GE; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kendler KS, 2008, PSYCHOL MED, V38, P1567, DOI 10.1017/S003329170800384X; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; LAST CG, 1992, J AM ACAD CHILD PSY, V31, P1070, DOI 10.1097/00004583-199211000-00012; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marciniak MD, 2005, DEPRESS ANXIETY, V21, P178, DOI 10.1002/da.20074; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meaburn EL, 2008, MOL PSYCHIATR, V13, P729, DOI 10.1038/sj.mp.4002063; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Plomin R, PSYCHOL SCI IN PRESS; Plomin R, 2012, BEHAV GENETICS; Plomin R., 2012, CHILD DEV, V30, P1467; Plomin R, 2012, NATURE, V482, P165, DOI 10.1038/482165a; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; Silberg J, 1999, ARCH GEN PSYCHIAT, V56, P225, DOI 10.1001/archpsyc.56.3.225; Silberg JL, 2001, BIOL PSYCHIAT, V49, P1040, DOI 10.1016/S0006-3223(01)01161-1; Spence SH, 1997, J ABNORM PSYCHOL, V106, P280, DOI 10.1037/0021-843X.106.2.280; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Trzaskowski M, 2012, J ABNORM CHILD PSYCH, V40, P85, DOI 10.1007/s10802-011-9545-z; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	45	42	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e58676	10.1371/journal.pone.0058676	http://dx.doi.org/10.1371/journal.pone.0058676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565138	Green Published, Green Accepted, gold			2022-12-27	WOS:000317717300005
J	Zhao, GH; Ren, WX; Gao, M; Bian, QQ; Hu, B; Cong, MM; Lin, Q; Wang, RJ; Qi, M; Qi, MZ; Zhu, XQ; Zhang, LX				Zhao, Guang-Hui; Ren, Wan-Xin; Gao, Man; Bian, Qing-Qing; Hu, Bing; Cong, Mei-Mei; Lin, Qing; Wang, Rong-Jun; Qi, Meng; Qi, Mao-Zhen; Zhu, Xing-Quan; Zhang, Long-Xian			Genotyping Cryptosporidium andersoni in Cattle in Shaanxi Province, Northwestern China	PLOS ONE			English	Article							DAIRY-CATTLE; PREVALENCE; CALVES; GENE; IDENTIFICATION; INFECTION; CHILDREN; PARVUM; MURIS; HERD	The present study examined the prevalence and genotypes of Cryptosporidium andersoni in cattle in Shaanxi province, China. A total of 2071 fecal samples (847 from Qinchuan cattle and 1224 from dairy cattle) were examined for the presence of Cryptosporidium oocysts, and 70 samples (3.4%) were C. andersoni-positive and those positive samples were identified by PCR amplification of the small subunit ribosomal RNA (SSU rRNA) and the Cryptosporidium oocyst wall protein (COWP) genes. C. andersoni was the only species found in the examined cattle in this province. Fifty-seven C. andersoni isolates were characterized into 5 MLST subtypes using multilocus sequence typing analysis, including a new subtype in the native beef breed Qinchuan cattle. All of these C. andersoni isolates presented a clonal genetic structure. These findings provide new insights into the genetic structure of C. andersoni isolates in Shaanxi province and basic data of Cryptosporidium prevalence status, which in turn have implications for controlling cryptosporidiosis in this province.	[Zhao, Guang-Hui; Ren, Wan-Xin; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zhao, Guang-Hui; Ren, Wan-Xin; Bian, Qing-Qing; Hu, Bing; Cong, Mei-Mei; Lin, Qing; Qi, Mao-Zhen] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Man] Pulike Biol Engn Inc, Luoyang, Henan Province, Peoples R China; [Wang, Rong-Jun; Qi, Meng; Zhang, Long-Xian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Northwest A&F University - China; Henan Agricultural University	Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	xingquanzhu1@hotmail.com; zhanglx8999@yahoo.com.cn	Zhang, Longxian/I-9223-2019; Zhang, Longxian/R-7799-2019; qi, maozhen/HIA-0257-2022; Zhang, Longxian/HGE-1918-2022	Zhang, Longxian/0000-0002-5706-131X; 	National Natural Science Foundation of China [31101805, 31110103901]; Fund for Basic Scientific Research [ZD2012010, QN2012018]; Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2011KFKT011]; National Key Project of Scientific and Technical Supporting Program [2012BAD12B07]; Special Funds for Talents in Northwest AF University [Z109021107, 2010BSJJ015]; National University Student Innovation Program in Northwest AF University [1210712040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Basic Scientific Research; Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; National Key Project of Scientific and Technical Supporting Program; Special Funds for Talents in Northwest AF University; National University Student Innovation Program in Northwest AF University	This work was supported, in part, by the National Natural Science Foundation of China (Grant No. 31101805, 31110103901), the Fund for Basic Scientific Research (Grant No. ZD2012010 and QN2012018), the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVEB2011KFKT011), National Key Project of Scientific and Technical Supporting Program (2012BAD12B07), the Special Funds for Talents in Northwest A&F University (Grant Nos. Z109021107 and 2010BSJJ015), and National University Student Innovation Program in Northwest A&F University (Grant No. 1210712040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer S, 2010, VET PARASITOL, V169, P382, DOI 10.1016/j.vetpar.2010.01.017; Anderson BC, 1998, J DAIRY SCI, V81, P3036, DOI 10.3168/jds.S0022-0302(98)75868-0; Burenbaatar B, 2008, PARASITOL RES, V102, P901, DOI 10.1007/s00436-007-0847-6; Diaz P, 2012, VET PARASITOL, V186, P188, DOI 10.1016/j.vetpar.2011.11.039; Enemark HL, 2002, VET PARASITOL, V107, P37, DOI 10.1016/S0304-4017(02)00083-3; ESTEBAN E, 1995, J DAIRY SCI, V78, P1068, DOI 10.3168/jds.S0022-0302(95)76723-6; Fall A, 2003, J PARASITOL, V89, P399, DOI 10.1645/0022-3395(2003)089[0399:MINART]2.0.CO;2; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2008, VET PARASITOL, V156, P191, DOI 10.1016/j.vetpar.2008.05.024; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Gatei W, 2006, J EUKARYOT MICROBIOL, V53, pS43, DOI 10.1111/j.1550-7408.2006.00169.x; Imre K, 2011, VET PARASITOL, V181, P321, DOI 10.1016/j.vetpar.2011.04.042; Kar S, 2011, VET PARASITOL, V177, P366, DOI 10.1016/j.vetpar.2010.12.005; Kato S, 2003, VET PARASITOL, V111, P153, DOI 10.1016/S0304-4017(02)00353-9; Kvac M, 2006, VET PARASITOL, V137, P202, DOI 10.1016/j.vetpar.2006.01.027; Kvac M, 2003, J VET MED B, V50, P451, DOI 10.1046/j.0931-1793.2003.00701.x; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Li PY, 2003, ANIM HUSB VET MED, V35, P13; Lin Q, 2012, AFR J MICROBIOL RES, V6, P6252, DOI 10.5897/AJMR12.558; Lu QingBin, 2008, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V38, P261; Masuno K, 2006, VET PATHOL, V43, P202, DOI 10.1354/vp.43-2-202; MCNABB SJN, 1985, J CLIN MICROBIOL, V22, P587, DOI 10.1128/JCM.22.4.587-589.1985; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2008, VET PARASITOL, V155, P15, DOI 10.1016/j.vetpar.2008.04.018; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Tanriverdi S, 2006, INFECT GENET EVOL, V6, P113, DOI 10.1016/j.meegid.2005.02.002; Tao Li, 2012, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V42, P742; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043782; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5499, DOI 10.1128/AEM.66.12.5499-5502.2000; Xiao Lihua, 2007, P119; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xu WL, 2007, J ANHUI SCI TECHNOL, V21, P9; [杨晓野 Yang Xiaoye], 2004, [内蒙古农业大学学报. 自然科学版, Journal of Inner Mongolia Agicultural University], V25, P40; Yu Jae-Ran, 2004, Korean Journal of Parasitology, V42, P1, DOI 10.3347/kjp.2004.42.1.1; ZHANG J, 2006, CHIN QINGHAI J ANIM, V36, P16	46	47	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60112	10.1371/journal.pone.0060112	http://dx.doi.org/10.1371/journal.pone.0060112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560072	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900047
J	Bechini, A				Bechini, Alessio			On the Characterization and Software Implementation of General Protein Lattice Models	PLOS ONE			English	Article							MONTE-CARLO; FOLDING SIMULATION; HP; ALGORITHM; SEARCH; PREDICTION	The Abstract models of proteins have been widely used as a practical means to computationally investigate general properties of the system. In lattice models any sterically feasible conformation is represented as a self-avoiding walk on a lattice, and residue types are limited in number. So far, only two- or three-dimensional lattices have been used. The inspection of the neighborhood of alpha carbons in the core of real proteins reveals that also lattices with higher coordination numbers, possibly in higher dimensional spaces, can be adopted. In this paper, a new general parametric lattice model for simplified protein conformations is proposed and investigated. It is shown how the supporting software can be consistently designed to let algorithms that operate on protein structures be implemented in a lattice-agnostic way. The necessary theoretical foundations are developed and organically presented, pinpointing the role of the concept of main directions in lattice-agnostic model handling. Subsequently, the model features across dimensions and lattice types are explored in tests performed on benchmark protein sequences, using a Python implementation. Simulations give insights on the use of square and triangular lattices in a range of dimensions. The trend of potential minimum for sequences of different lengths, varying the lattice dimension, is uncovered. Moreover, an extensive quantitative characterization of the usage of the so-called "move types'' is reported for the first time. The proposed general framework for the development of lattice models is simple yet complete, and an object-oriented architecture can be proficiently employed for the supporting software, by designing ad-hoc classes. The proposed framework represents a new general viewpoint that potentially subsumes a number of solutions previously studied. The adoption of the described model pushes to look at protein structure issues from a more general and essential perspective, making computational investigations over simplified models more straightforward as well.	Univ Pisa, Dept Informat Engn, Pisa, Italy	University of Pisa	Bechini, A (corresponding author), Univ Pisa, Dept Informat Engn, Pisa, Italy.	a.bechini@ing.unipi.it	Bechini, Alessio/AGD-7668-2022; Bechini, Alessio/B-9356-2012; Bechini, Alessio/ABD-1212-2020	Bechini, Alessio/0000-0002-5951-1265; Bechini, Alessio/0000-0002-5951-1265; Bechini, Alessio/0000-0002-5951-1265	University of Pisa	University of Pisa	The work was supported by the individual institutional funds received from the University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 1997, RECOMB 97, P1, DOI [10.1145/267521.267522, DOI 10.1145/267521.267522]; Albrecht AA, 2008, COMPUT BIOL CHEM, V32, P248, DOI 10.1016/j.compbiolchem.2008.03.004; Backofen R, 2006, CONSTRAINTS, V11, P5, DOI 10.1007/s10601-006-6848-8; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Bornberg-Bauer E., 1997, RECOMB 97, P47, DOI DOI 10.1145/267521.267528; BROWER RC, 1993, BIOPOLYMERS, V33, P329, DOI 10.1002/bip.360330302; Chan HS, 1996, PROTEINS, V24, P345; Chen Mao, 2005, Genomics Proteomics & Bioinformatics, V3, P225; Chou CI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066704; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conway JH, 1999, SPHERE PACKINGS LATT; DILL KA, 1995, PROTEIN SCI, V4, P561; Dotu I, 2011, IEEE ACM T COMPUT BI, V8, P1620, DOI 10.1109/TCBB.2011.41; Gamma E., 1994, DESIGN PATTERNS; Gillespie J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-369; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; GURLER MT, 1983, MACROMOLECULES, V16, P398, DOI 10.1021/ma00237a012; Heun V, 2003, DISCRETE APPL MATH, V127, P163, DOI 10.1016/S0166-218X(02)00382-7; HILHORST HJ, 1975, J CHEM PHYS, V63, P5153, DOI 10.1063/1.431297; HINDS DA, 1994, J MOL BIOL, V243, P668, DOI 10.1016/0022-2836(94)90040-X; Hoque MT, 2007, IEEE C EVOL COMPUTAT, P4138, DOI 10.1109/CEC.2007.4425011; Hsieh SY, 2011, IEEE T NANOBIOSCI, V10, P69, DOI 10.1109/TNB.2011.2145388; Hsu HP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021113; Jacob E, 2007, BIOINFORMATICS, V23, pI240, DOI 10.1093/bioinformatics/btm180; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jiang Minghui, 2005, Journal of Bioinformatics and Computational Biology, V3, P19, DOI 10.1142/S0219720005000850; Jiang MH, 2007, LECT N BIOINFORMAT, V4463, P518; Kapsokalivas L, 2008, COMM COM INF SC, V13, P167; Kennedy T, 2002, J STAT PHYS, V106, P407, DOI 10.1023/A:1013750203191; Klimov DK, 2001, PROTEINS, V43, P465, DOI 10.1002/prot.1058; Koehl P, 1998, J CHEM PHYS, V108, P9540, DOI 10.1063/1.476402; Kolinski A, 2004, POLYMER, V45, P511, DOI 10.1016/j.polymer.2003.10.064; LANDAU DP, 2005, GUIDE MONTE CARLO SI; LAU KF, 1989, MACROMOLECULES, V22, P3986, DOI 10.1021/ma00200a030; Lesh N., 2003, RECOMB, P188, DOI DOI 10.1145/640075.640099; Li XM, 2007, LECT NOTES COMPUT SC, V4488, P397; Li Zhenping, 2005, Appl Bioinformatics, V4, P105, DOI 10.2165/00822942-200504020-00004; Liang FM, 2001, J CHEM PHYS, V115, P3374, DOI 10.1063/1.1387478; Mann M., 2012, ADV BIOINFORM, V2012, P6; Mann M, 2009, BIOINFORMATICS, V25, P676, DOI 10.1093/bioinformatics/btp034; Melin R, 1999, J CHEM PHYS, V110, P1252, DOI 10.1063/1.478168; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Moreno-Hernandez S, 2012, PROTEINS, V80, P1683, DOI 10.1002/prot.24067; Mortari D, 2001, J ASTRONAUTICAL SCI, V49; Nardelli M, 2013, P 28 ACM S APPL COMP, P1323; Noivirt-Brik O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000592; Noivirt-Brik O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-4; Oakley MT, 2008, CURR PROTEIN PEPT SC, V9, P260, DOI 10.2174/138920308784534032; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pande VS, 1999, P NATL ACAD SCI USA, V96, P1273, DOI 10.1073/pnas.96.4.1273; Perdomo-Ortiz A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00571; Ramakrishnan R, 1997, J CHEM PHYS, V106, P2418, DOI 10.1063/1.473791; Schiemann R, 2005, COMPUT PHYS COMMUN, V166, P8, DOI 10.1016/j.cpc.2004.09.011; Shell MS, 2006, PROTEINS, V62, P232, DOI 10.1002/prot.20714; Shmygelska A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-30; Shmygelska A., 2003, LECT NOTES COMPUTER, V2671, P993, DOI [10.1007/3-540-44886-1 30, DOI 10.1007/3-540-44886-130]; Thachuk C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-342; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; VERDIER PH, 1962, J CHEM PHYS, V36, P227, DOI 10.1063/1.1732301; YUE K, 1995, P NATL ACAD SCI USA, V92, P325, DOI 10.1073/pnas.92.1.325; YUE K, 1995, P NATL ACAD SCI USA, V92, P146, DOI 10.1073/pnas.92.1.146	61	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59504	10.1371/journal.pone.0059504	http://dx.doi.org/10.1371/journal.pone.0059504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555684	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900015
J	Lecuroux, C; Girault, I; Cheret, A; Versmisse, P; Nembot, G; Meyer, L; Rouzioux, C; Pancino, G; Venet, A; Saez-Cirion, A				Lecuroux, Camille; Girault, Isabelle; Cheret, Antoine; Versmisse, Pierre; Nembot, Georges; Meyer, Laurence; Rouzioux, Christine; Pancino, Gianfranco; Venet, Alain; Saez-Cirion, Asier		ANRS 147 OPTIPRIM Clinical Trial	CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; RESPONSES; NONPROGRESSORS; HETEROGENEITY; ASSOCIATION; LYMPHOCYTES; VIREMIA	The strong CD8+ T-cell-mediated HIV-1-suppressive capacity found in a minority of HIV-infected patients in chronic infection is associated with spontaneous control of viremia. However, it is still unclear whether such capacities were also present earlier in the CD8+ T cells from non controller patients and then lost as a consequence of uncontrolled viral replication. We studied 50 patients with primary HIV-1-infection to determine whether strong CD8+ T-cell-mediated HIV suppression is more often observed at that time. Despite high frequencies of polyfunctional HIV-specific CD8+ T-cells and a strong CD4+ T-helper response, CD8+ T-cells from 48 patients lacked strong HIV-suppressive capacities ex vivo. This indicates that the superior HIV-suppressive capacity of CD8+ T-cells from HIV controllers is not a general characteristic of the HIV-specific CD8+ T cell response in primary HIV infection.	[Lecuroux, Camille; Girault, Isabelle; Venet, Alain] INSERM, U1012, F-94275 Le Kremlin Bicetre, France; [Cheret, Antoine] Hop Gustave Dron, Serv Malad Infect & Voyageur, Tourcoing, France; [Cheret, Antoine; Rouzioux, Christine] Univ Paris 05, EA 3620, Sorbonne Paris Cite, Paris, France; [Versmisse, Pierre; Pancino, Gianfranco; Saez-Cirion, Asier] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Nembot, Georges; Meyer, Laurence] Univ Paris 11, INSERM, U1018, Le Kremlin Bicetre, France; [Nembot, Georges; Meyer, Laurence] Hop Bicetre, AP HP, Dept Epidemiol, Le Kremlin Bicetre, France; [Rouzioux, Christine] CHU Necker Enfants Malad, AP HP, Virol Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Saez-Cirion, A (corresponding author), Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France.	asier.saez-cirion@pasteur.fr	treluyer, Jean-Marc/F-8036-2010; Cuzin, Lise/AAF-8812-2020; Saez-Cirion, Asier/A-8640-2008	Cuzin, Lise/0000-0002-6345-497X; Saez-Cirion, Asier/0000-0003-2406-7536; Girault, Isabelle/0000-0002-9587-5197; ABEL, Sylvie/0000-0002-3351-0547	ANRS (French National Agency for Research on AIDS and Viral Hepatitis); MSD; Janssen; ViiV Healthcare; Gilead	ANRS (French National Agency for Research on AIDS and Viral Hepatitis)(ANRSFrench National Research Agency (ANR)); MSD; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV Healthcare; Gilead(Gilead Sciences)	The OPTIPRIM clinical trial was funded by the ANRS (French National Agency for Research on AIDS and Viral Hepatitis). However, ANRS received financial support from MSD, Janssen, ViiV Healthcare and Gilead to complement funding concerning this trial. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; D'Souza MP, 2008, J INFECT DIS, V197, P337, DOI 10.1086/525288; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2012, J VIROLOGY; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Youngblood B, 2012, CURR OPIN HIV AIDS, V7, P50, DOI 10.1097/COH.0b013e32834ddcf2	21	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59767	10.1371/journal.pone.0059767	http://dx.doi.org/10.1371/journal.pone.0059767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555774	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900026
J	Dahl, HHM; Ching, TYC; Hutchison, W; Hou, S; Seeto, M; Sjahalam-King, J				Dahl, Hans-Henrik M.; Ching, Teresa Y. C.; Hutchison, Wendy; Hou, Sanna; Seeto, Mark; Sjahalam-King, Jessica			Etiology and Audiological Outcomes at 3 Years for 364 Children in Australia	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; HEARING-LOSS; VESTIBULAR AQUEDUCT; PENDRED-SYNDROME; GJB2 MUTATIONS; SLC26A4 GENE; CYTOMEGALOVIRUS; CONNEXIN-26; DEAFNESS; ENLARGEMENT	Hearing loss is an etiologically heterogeneous trait with differences in the age of onset, severity and site of lesion. It is caused by a combination of genetic and/or environmental factors. A longitudinal study to examine the efficacy of early intervention for improving child outcomes is ongoing in Australia. To determine the cause of hearing loss in these children we undertook molecular testing of perinatal "Guthrie'' blood spots of children whose hearing loss was either detected via newborn hearing screening or detected later in infancy. We analyzed the GJB2 and SLC26A4 genes for the presence of mutations, screened for the mitochondrial DNA (mtDNA) A1555G mutation, and screened for congenital CMV infection in DNA isolated from dried newborn blood spots. Results were obtained from 364 children. We established etiology for 60% of children. One or two known GJB2 mutations were present in 82 children. Twenty-four children had one or two known SLC26A4 mutations. GJB2 or SLC26A4 changes with unknown consequences on hearing were found in 32 children. The A1555G mutation was found in one child, and CMV infection was detected in 28 children. Auditory neuropathy spectrum disorder was confirmed in 26 children whose DNA evaluations were negative. A secondary objective was to investigate the relationship between etiology and audiological outcomes over the first 3 years of life. Regression analysis was used to investigate the relationship between hearing levels and etiology. Data analysis does not support the existence of differential effects of etiology on degree of hearing loss or on progressiveness of hearing loss.	[Dahl, Hans-Henrik M.; Hutchison, Wendy] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Ching, Teresa Y. C.; Hou, Sanna; Seeto, Mark; Sjahalam-King, Jessica] Natl Acoust Labs, Sydney, NSW, Australia; [Ching, Teresa Y. C.; Hou, Sanna; Seeto, Mark; Sjahalam-King, Jessica] HEARing Cooperat Res Ctr, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; National Acoustic Laboratories	Ching, TYC (corresponding author), Natl Acoust Labs, Sydney, NSW, Australia.	Teresa.Ching@nal.gov.au	Ching, Teresa/AAR-6239-2021	Ching, Teresa/0000-0002-1588-5599	National Institute on Deafness and Other Communication Disorders [R01DC008080]; Commonwealth of Australia; Cooperative Research Centres Program; Victorian Government's Operational Infrastructure Support Program in Australia; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008080] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Commonwealth of Australia(Australian Government); Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian Government's Operational Infrastructure Support Program in Australia; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The project described was partly supported by Award Number R01DC008080 from the National Institute on Deafness and Other Communication Disorders. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Deafness and Other Communication Disorders or the National Institutes of Health. The authors acknowledge the financial support of the Commonwealth of Australia through the establishment of the HEARing CRC and the Cooperative Research Centres Program. The authors also acknowledge the financial support of the Victorian Government's Operational Infrastructure Support Program in Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; [Anonymous], 2012, DEAFN GEN MUT DAT; Australian Hearing, 2012, AUSTR HEARING WEBSIT; Azaiez H, 2007, HUM GENET, V122, P451, DOI 10.1007/s00439-007-0415-2; Ballana E, CONNEXIN DEAFNESS; Barbi M, 2000, J CLIN VIROL, V17, P159, DOI 10.1016/S1386-6532(00)00089-5; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Chang E, PENDRED BOR; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Cucci RA, 2000, GENET TEST, V4, P335, DOI 10.1089/109065700750065063; Dahl HHM, 2006, J MED GENET, V43, P850, DOI 10.1136/jmg.2006.042051; Dahl HHM, 2001, MED J AUSTRALIA, V175, P191, DOI 10.5694/j.1326-5377.2001.tb143093.x; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Davis A, 2011, COMPREHENSIVE HDB PE, P85; Declau F, 2008, PEDIATRICS, V121, P1119, DOI 10.1542/peds.2007-1479; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; Deloitte Access Economics, 2011, ECIMP INC AUSTR; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Fugazzola L, 2002, PEDIATR RES, V51, P479, DOI 10.1203/00006450-200204000-00013; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Houseman MJ, 2001, J MED GENET, V38, P20, DOI 10.1136/jmg.38.1.20; Kenna MA, 2010, ARCH OTOLARYNGOL, V136, P81, DOI 10.1001/archoto.2009.202; Kim HJ, 2010, CLIN EXP OTORHINOLAR, V3, P65, DOI 10.3342/ceo.2010.3.2.65; King AC, 2011, EUR J PUBLIC HEALTH, V21, P424, DOI 10.1093/eurpub/ckq104; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Mese G, 2004, HUM GENET, V115, P191, DOI 10.1007/s00439-004-1142-6; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Murgia A, 1999, J MED GENET, V36, P829; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Pinheiro J., NLME LINEAR NONLINEA; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Sanchez JL, 2002, J CLIN MICROBIOL, V40, P2381, DOI 10.1128/JCM.40.7.2381-2386.2002; Scanga L, 2006, J MOL DIAGN, V8, P240, DOI 10.2353/jmoldx.2006.050075; Siemering K, 2006, J MOL DIAGN, V8, P483, DOI 10.2353/jmoldx.2006.050147; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Stehel EK, 2008, PEDIATRICS, V121, P970, DOI 10.1542/peds.2006-3441; Teek R, 2010, INT J PEDIATR OTORHI, V74, P1007, DOI 10.1016/j.ijporl.2010.05.026; Tekin M, 2010, ANN HUM GENET, V74, P155, DOI 10.1111/j.1469-1809.2010.00564.x; The R Project for Statistical Computing, LANG ENV STAT COMP V; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; Thonnissen E, 2002, HUM GENET, V111, P190, DOI 10.1007/s00439-002-0750-2; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Wang QJ, 2011, INT J PEDIATR OTORHI, V75, P535, DOI 10.1016/j.ijporl.2011.01.016; Werff KRV, 2009, EAR HEARING, V30, P350, DOI 10.1097/AUD.0b013e31819f3145; Wickham H., GGPLOT2 IMPLEMENTATI; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314	53	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59624	10.1371/journal.pone.0059624	http://dx.doi.org/10.1371/journal.pone.0059624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555729	Green Published, gold			2022-12-27	WOS:000317262200032
J	Davidson, DC; Schifitto, G; Maggirwar, SB				Davidson, Donna C.; Schifitto, Giovanni; Maggirwar, Sanjay B.			Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CENTRAL-NERVOUS-SYSTEM; HIV-INFECTION; HIV-1-INFECTED PATIENTS; PLATELET REACTIVITY; P-SELECTIN; DEMENTIA; LIGAND; ENCEPHALITIS; BRAIN	Despite the use of highly active antiretroviral therapies (HAART), a majority of Human Immunodeficiency Virus Type 1 (HIV) infected individuals continually develop HIV - Associated Neurocognitive Disorders (HAND), indicating that host inflammatory mediators, in addition to viral proteins, may be contributing to these disorders. Consistent with this notion, we have previously shown that levels of the inflammatory mediator soluble CD40 ligand (sCD40L) are elevated in the plasma and cerebrospinal fluid (CSF) of HIV infected, cognitively impaired individuals, and that excess sCD40L can contribute to blood brain barrier (BBB) permeability in vivo, thereby signifying the importance of this inflammatory mediator in the pathogenesis of HAND. Here we demonstrate that the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (EFV) induces the release of circulating sCD40L in both HIV infected individuals and in an in vitro suspension of washed human platelets, which are the main source of circulating sCD40L. Additionally, EFV was found to activate glycogen synthase kinase 3 beta (GSK3 beta) in platelets, and we now show that valproic acid (VPA), a known GSK3 beta inhibitor, was able to attenuate the release of sCD40L in HIV infected individuals receiving EFV, and in isolated human platelets. Collectively these results have important implications in determining the pro-inflammatory role that some antiretroviral regimens may have. The use of antiretrovirals remains the best strategy to prevent HIV-associated illnesses, including HAND, however these drugs have clear limitations to this end, and thus, these results underscore the need to develop adjunctive therapies for HAND that can also minimize the undesired negative effects of the antiretrovirals.	[Davidson, Donna C.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Schifitto, Giovanni] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Maggirwar, SB (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu			National Institutes of Health [RO1NS054578, RO1NS066801]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants: RO1NS054578 and RO1NS066801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2008, J THROMB HAEMOST, V6, P2007, DOI 10.1111/j.1538-7836.2008.03169.x; Adam F, 2010, BLOOD, V115, P4083, DOI 10.1182/blood-2009-07-233932; Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Ances BM, 2006, J NEUROVIROL, V12, P403, DOI 10.1080/13550280600981695; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Bossi P, 1998, CLIN INFECT DIS, V26, P1072, DOI 10.1086/520301; Bugaud F, 1999, BLOOD, V94, P3800, DOI 10.1182/blood.V94.11.3800.423k25_3800_3805; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Chini M, 2012, INT J IMMUNOPATH PH, V25, P247, DOI 10.1177/039463201202500127; Corrales-Medina VF, 2010, JAIDS-J ACQ IMM DEF, V54, P217, DOI 10.1097/QAI.0b013e3181c8f4c9; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; DiCenzo R, 2004, ANTIMICROB AGENTS CH, V48, P4328, DOI 10.1128/AAC.48.11.4328-4331.2004; Dou HY, 2003, J NEUROSCI, V23, P9162; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Minagar A, 2008, MOL DIAGN THER, V12, P25, DOI 10.1007/BF03256266; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; O'Brien JJ, 2008, BLOOD, V112, P4051, DOI 10.1182/blood-2008-05-158535; Ragin AB, 2011, J NEUROVIROL, V17, P487, DOI 10.1007/s13365-011-0053-2; Ramirez SH, 2010, J NEUROSCI, V30, P9454, DOI 10.1523/JNEUROSCI.5796-09.2010; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Rom S, 2012, AM J PATHOL, V181, P1414, DOI 10.1016/j.ajpath.2012.06.018; Romano MF, 2006, VIRAL IMMUNOL, V19, P363, DOI 10.1089/vim.2006.19.363; Satchell CS, 2011, J INFECT DIS, V204, P1202, DOI 10.1093/infdis/jir509; Schifitto G, 2006, NEUROLOGY, V66, P919, DOI 10.1212/01.wnl.0000204294.28189.03; Sipsas NV, 2002, CLIN DIAGN LAB IMMUN, V9, P558, DOI 10.1128/CDLI.9.3.558-561.2002; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Tong N, 2001, EUR J NEUROSCI, V13, P1913, DOI 10.1046/j.0953-816x.2001.01572.x; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wolf K, 2002, J INFECT DIS, V185, P456, DOI 10.1086/338572; Yacoub D, 2010, ARTERIOSCL THROM VAS, V30, P2424, DOI 10.1161/ATVBAHA.110.216143	47	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59950	10.1371/journal.pone.0059950	http://dx.doi.org/10.1371/journal.pone.0059950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555843	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200060
J	Salmon, RC; Cliff, MJ; Rafferty, JB; Kelly, DJ				Salmon, Robert C.; Cliff, Matthew J.; Rafferty, John B.; Kelly, David J.			The CouPSTU and TarPQM Transporters in Rhodopseudomonas palustris: Redundant, Promiscuous Uptake Systems for Lignin-Derived Aromatic Substrates	PLOS ONE			English	Article							ANAEROBIC DEGRADATION; TRAP TRANSPORTERS; BENZOATE-COENZYME; FERULIC ACID; P-COUMARATE; PROTEIN; GENES; SEQUENCE; PATHWAY; LIGASE	The biodegradation of lignin, one of the most abundant carbon compounds on Earth, has important biotechnological applications in the derivation of useful products from lignocellulosic wastes. The purple photosynthetic bacterium Rhodopseudomonas palustris is able to grow photoheterotrophically under anaerobic conditions on a range of phenylpropeneoid lignin monomers, including coumarate, ferulate, caffeate, and cinnamate. RPA1789 (CouP) is the periplasmic binding-protein component of an ABC system (CouPSTU; RPA1789, RPA1791-1793), which has previously been implicated in the active transport of this class of aromatic substrate. Here, we show using both intrinsic tryptophan fluorescence and isothermal titration calorimetry that CouP binds a range of phenylpropeneoid ligands with K-d values in the nanomolar range. The crystal structure of CouP with ferulate as the bound ligand shows H-bond interactions between the 4-OH group of the aromatic ring with His309 and Gln305. H-bonds are also made between the carboxyl group on the ferulate side chain and Arg197, Ser222, and Thr102. An additional transport system (TarPQM; RPA1782-1784), a member of the tripartite ATP-independent periplasmic (TRAP) transporter family, is encoded at the same locus as rpa1789 and several other genes involved in coumarate metabolism. We show that the periplasmic binding-protein of this system (TarP; RPA1782) also binds coumarate, ferulate, caffeate, and cinnamate with nanomolar Kd values. Thus, we conclude that R. palustris uses two redundant but energetically distinct primary and secondary transporters that both employ high-affinity periplasmic binding-proteins to maximise the uptake of lignin-derived aromatic substrates from the environment. Our data provide a detailed thermodynamic and structural basis for understanding the interaction of lignin-derived aromatic substrates with proteins and will be of use in the further exploitation of the flexible metabolism of R. palustris for anaerobic aromatic biotransformations.	[Salmon, Robert C.; Rafferty, John B.; Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Cliff, Matthew J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Sheffield; University of Manchester	Rafferty, JB (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	j.rafferty@sheffield.ac.uk; d.kelly@sheffield.ac.uk		Rafferty, John/0000-0003-1183-7474; Cliff, Matthew/0000-0002-7482-0234	UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/D524975/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [974895, BB/D524975/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a postgraduate studentship to Robert Salmon from the UK Biotechnology and Biological Sciences Research Council (BBSRC). The BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; EGLAND PG, 1995, J BACTERIOL, V177, P6545, DOI 10.1128/jb.177.22.6545-6551.1995; ELDER DJE, 1992, ARCH MICROBIOL, V157, P148, DOI 10.1007/BF00245283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; GEISSLER JF, 1988, J BACTERIOL, V170, P1709, DOI 10.1128/jb.170.4.1709-1714.1988; Giuliani SE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S8; GOLD MH, 1993, MICROBIOL REV, V57, P605, DOI 10.1128/MMBR.57.3.605-622.1993; Gunsior M, 2004, BIOCHEMISTRY-US, V43, P663, DOI 10.1021/bi035762w; Hara H, 2003, J BACTERIOL, V185, P41, DOI 10.1128/JB.185.1.41-50.2003; HARWOOD CS, 1988, APPL ENVIRON MICROB, V54, P712, DOI 10.1128/AEM.54.3.712-717.1988; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; MASAI E, 1993, FEBS LETT, V323, P135, DOI 10.1016/0014-5793(93)81465-C; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; Phattarasukol S, 2012, APPL ENVIRON MICROB, V78, P6812, DOI 10.1128/AEM.01418-12; Pietri R, 2012, J BIOL CHEM, V287, P23748, DOI 10.1074/jbc.M112.352385; Plaggenborg R, 2001, FEMS MICROBIOL LETT, V205, P9, DOI 10.1111/j.1574-6968.2001.tb10918.x; Smart JP, 2009, MOL MICROBIOL, V74, P742, DOI 10.1111/j.1365-2958.2009.06902.x; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; TOMS A, 1970, BIOCHEMISTRY-US, V9, P337, DOI 10.1021/bi00804a021; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59844	10.1371/journal.pone.0059844	http://dx.doi.org/10.1371/journal.pone.0059844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555803	Green Accepted, Green Published, gold			2022-12-27	WOS:000317262200046
J	Spadaro, F; Cecchetti, S; Purificato, C; Sabbatucci, M; Podo, F; Ramoni, C; Gessani, S; Fantuzzi, L				Spadaro, Francesca; Cecchetti, Serena; Purificato, Cristina; Sabbatucci, Michela; Podo, Franca; Ramoni, Carlo; Gessani, Sandra; Fantuzzi, Laura			Nuclear Phosphoinositide-Specific Phospholipase C beta 1 Controls Cytoplasmic CCL2 mRNA Levels in HIV-1 gp120-Stimulated Primary Human Macrophages	PLOS ONE			English	Article							PROTEIN-KINASE-C; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIPHERAL-BLOOD MONOCYTES; HUMAN SYNOVIAL FIBROBLASTS; NATURAL-KILLER-CELLS; KAPPA-B PATHWAY; AIDS PATHOGENESIS; VIRAL REPLICATION; PRIMARY CULTURES; SMALL-MOLECULE	HIV-1 envelope glycoprotein gp120 induces, independently of infection, the release of CCL2 from macrophages. In turn, this chemokine acts as an autocrine factor enhancing viral replication. In this study, we show for the first time that phosphoinositide-specific phospholipase C (PI-PLC) is required for the production of CCL2 triggered by gp120 in macrophages. Using a combination of confocal laser-scanner microscopy, pharmacologic inhibition, western blotting and fluorescence-activated cell sorter analysis, we demonstrate that gp120 interaction with CCR5 leads to nuclear localization of the PI-PLC beta 1 isozyme mediated by mitogen-activated protein kinase ERK-1/2. Notably, phosphatidylcholine-specific phospholipase C (PC-PLC), previously reported to be required for NF-kB-mediated CCL2 production induced by gp120 in macrophages, drives both ERK1/2 activation and PI-PLC beta 1 nuclear localization induced by gp120. PI-PLC beta 1 activation through CCR5 is also triggered by the natural chemokine ligand CCL4, but independently of ERK1/2. Finally, PI-PLC inhibition neither blocks gp120-mediated NF-kB activation nor overall accumulation of CCL2 mRNA, whereas it decreases CCL2 transcript level in the cytoplasm. These results identify nuclear PI-PLC beta 1 as a new intermediate in the gp120-triggered PC-PLC-driven signal transduction pathway leading to CCL2 secretion in macrophages. The finding that a concerted gp120-mediated signaling involving both PC-and PI-specific PLCs is required for the expression of CCL2 in macrophages suggests that this signal transduction pathway may also be relevant for the modulation of viral replication in these cells. Thus, this study may contribute to identify novel targets for therapeutic intervention in HIV-1 infection.	[Spadaro, Francesca; Purificato, Cristina; Sabbatucci, Michela; Podo, Franca; Gessani, Sandra; Fantuzzi, Laura] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Cecchetti, Serena; Podo, Franca; Ramoni, Carlo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Fantuzzi, L (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	laura.fantuzzi@iss.it	Gessani, Sandra/K-5151-2016; Spadaro, Francesca/M-7512-2017; Purificato, Cristina/ABA-9404-2021; Fantuzzi, Laura/K-9724-2018; Cecchetti, Serena/N-1061-2015; Sabbatucci, Michela/M-9642-2017	Gessani, Sandra/0000-0002-8451-0758; Spadaro, Francesca/0000-0002-6610-350X; Purificato, Cristina/0000-0001-8394-2893; Fantuzzi, Laura/0000-0002-0869-2596; Cecchetti, Serena/0000-0002-3601-176X; Sabbatucci, Michela/0000-0001-5889-1780	Italian Ministry of Health, Bando Nazionale AIDS [3H/31, 3H/14]	Italian Ministry of Health, Bando Nazionale AIDS	This work was supported by grants from the Italian Ministry of Health, Bando Nazionale AIDS 2009-2010, 3H/31 to SG and 3H/14 to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Ansari AW, 2011, EUR J IMMUNOL, V41, P3412, DOI 10.1002/eji.201141676; Avazeri N, 2003, CELL SIGNAL, V15, P1003, DOI 10.1016/S0898-6568(03)00071-8; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barbin G, 2001, NEUROCHEM RES, V26, P107, DOI 10.1023/A:1011086426652; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Cecchetti S, 2007, EUR J IMMUNOL, V37, P2912, DOI 10.1002/eji.200737266; Chihara T, 2012, J IMMUNOL, V188, P3620, DOI 10.4049/jimmunol.1101593; Chiu YC, 2008, MOL IMMUNOL, V45, P1587, DOI 10.1016/j.molimm.2007.10.004; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; Cobos-Jimenez V, 2011, CURR OPIN HIV AIDS, V6, P385, DOI 10.1097/COH.0b013e3283497203; Cocco L, 2011, ADV ENZYME REGUL, V51, P2, DOI 10.1016/j.advenzreg.2010.09.015; Conti L, 2004, IMMUNOBIOLOGY, V209, P99, DOI 10.1016/j.imbio.2004.02.008; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Ehrlich Lorna S, 2012, Mol Biol Int, V2012, P851670, DOI 10.1155/2012/851670; Ehrlich LS, 2010, J VIROL, V84, P6438, DOI 10.1128/JVI.01588-09; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Faenza I, 2004, J CELL PHYSIOL, V200, P291, DOI 10.1002/jcp.20001; Faenza I, 2003, J CELL PHYSIOL, V195, P446, DOI 10.1002/jcp.10264; Faenza I, 2008, FRONT BIOSCI-LANDMRK, V13, P2452, DOI 10.2741/2858; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Fantuzzi L, 2003, BLOOD, V102, P2334, DOI 10.1182/blood-2002-10-3275; Fantuzzi L, 2003, J LEUKOCYTE BIOL, V74, P719, DOI 10.1189/jlb.0403175; Fantuzzi L, 2001, EUR CYTOKINE NETW, V12, P597; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Fantuzzi L, 2008, BLOOD, V111, P3355, DOI 10.1182/blood-2007-08-104901; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Harmon B, 2008, J VIROL, V82, P9191, DOI 10.1128/JVI.00424-08; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Hong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033659; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Juno JA, 2010, AIDS REV, V12, P164; Kennedy A, 2010, J LIPID RES, V51, P1906, DOI 10.1194/jlr.M005447; Keune WJ, 2011, ADV ENZYME REGUL, V51, P91, DOI 10.1016/j.advenzreg.2010.09.009; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kohler JJ, 2003, J LEUKOCYTE BIOL, V73, P407, DOI 10.1189/jlb.0702358; Lee C, 2005, J LEUKOCYTE BIOL, V78, P1016, DOI 10.1189/jlb.0105056; Lee CH, 2008, MOL IMMUNOL, V45, P3693, DOI 10.1016/j.molimm.2008.06.007; Litosch I, 2003, BIOCHEMISTRY-US, V42, P1618, DOI 10.1021/bi026414h; Liu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.140; Lucas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013121; Manzoli L, 1997, CANCER RES, V57, P2137; Mendez-Samperio P, 2007, CELL IMMUNOL, V245, P111, DOI 10.1016/j.cellimm.2007.04.005; Mir KD, 2012, CYTOKINE GROWTH F R, V23, P223, DOI 10.1016/j.cytogfr.2012.05.009; Nozawa Y, 2002, J BIOCHEM, V131, P283, DOI 10.1093/oxfordjournals.jbchem.a003100; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Okada M, 2008, P NATL ACAD SCI USA, V105, P8649, DOI 10.1073/pnas.0802533105; Okada M, 2009, RNA BIOL, V6, P12, DOI 10.4161/rna.6.1.7439; Park SY, 2011, ARCH PHARM RES, V34, P1759, DOI 10.1007/s12272-011-1020-4; Podo F, 1996, ANTICANCER RES, V16, P1399; POWIS G, 1992, CANCER RES, V52, P2835; Premasekharan G, 2011, FREE RADICAL BIO MED, V51, P1184, DOI 10.1016/j.freeradbiomed.2011.06.018; Ramoni C, 2004, EXP CELL RES, V299, P370, DOI 10.1016/j.yexcr.2004.05.037; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Spadaro F, 2006, EUR J IMMUNOL, V36, P3277, DOI 10.1002/eji.200635927; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63; Vicenzi E, 2000, J LEUKOCYTE BIOL, V68, P405; Visnjic D, 2007, PFLUG ARCH EUR J PHY, V455, P19, DOI 10.1007/s00424-007-0288-1; Vitale M, 2001, FASEB J, V15, P1789, DOI 10.1096/fj.01-0008fje; Weiss L, 1997, J INFECT DIS, V176, P1621, DOI 10.1086/517341; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; ZAULI G, 1995, EUR J IMMUNOL, V25, P2695, DOI 10.1002/eji.1830250944; Zhang L, 2011, J CELL PHYSIOL, V226, P1694, DOI 10.1002/jcp.22500; Zhao J, 1998, J CELL BIOCHEM, V71, P36, DOI 10.1002/(SICI)1097-4644(19981001)71:1<36::AID-JCB4>3.0.CO;2-2; ZINI N, 1994, EUR J CELL BIOL, V65, P206	78	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59705	10.1371/journal.pone.0059705	http://dx.doi.org/10.1371/journal.pone.0059705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555755	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200035
J	Zhao, YY; Feng, YL; Bai, X; Tan, XJ; Lin, RC; Mei, QB				Zhao, Ying-Yong; Feng, Ya-Long; Bai, Xu; Tan, Xiao-Jie; Lin, Rui-Chao; Mei, Qibing			Ultra Performance Liquid Chromatography-Based Metabonomic Study of Therapeutic Effect of the Surface Layer of Poria cocos on Adenine-Induced Chronic Kidney Disease Provides New Insight into Anti-Fibrosis Mechanism	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; SENSITIVITY MASS-SPECTROMETRY; INDUCED OXIDATIVE STRESS; LANOSTANE TRITERPENOIDS; URINARY METABONOMICS; EXPERIMENTAL-MODEL; FREE CHOLINE; SERUM; RATS; ERGOSTA-4,6,8(14),22-TETRAEN-3-ONE	The surface layer of Poria cocos (Fu-Ling-Pi, FLP) is commonly used in traditional Chinese medicine and its diuretic effect was confirmed in rat. Ultra performance liquid chromatography/quadrupole time-of-flight high-sensitivity mass spectrometry and a novel mass spectrometry(Elevated Energy) data collection technique was employed to investigate metabonomic characteristics of chronic kidney disease (CKD) induced from adenine excess and the protective effects of FLP. Multiple metabolites are detected in the CKD and are correlated with progressive renal injury. Among these biomarkers, lysoPC(18:0), tetracosahexaenoic acid, lysoPC(18:2), creatinine, lysoPC (16:0) and lysoPE(22:0/0:0) in the FLP-treated group were completely reversed to levels in the control group which lacked CKD. Combined with biochemistry and histopathology results, the changes in serum metabolites indicate that the perturbations of phospholipids metabolism, energy metabolism and amino acid metabolism are related to adenine-induced CKD and to the interventions of FLP on all the three metabolic pathways. FLP may regulate the metabolism of these biomarkers, especially their efficient utilization within the context of CKD. Furthermore, these biomarkers might serve as characteristics to explain the mechanisms of FLP.	[Zhao, Ying-Yong; Feng, Ya-Long] Northwest Univ, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China; [Bai, Xu; Tan, Xiao-Jie; Mei, Qibing] Waters Technol Shanghai Ltd, Solut Ctr, Shanghai, Peoples R China; [Lin, Rui-Chao] Natl Inst Food & Drug Control, State Food & Drug Adm, Res & Inspect Ctr Tradit Chinese Med & Ethnomed, Beijing, Peoples R China; Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China	Northwest University Xi'an; National Institute of Food & Drug Control - China; Air Force Military Medical University	Zhao, YY (corresponding author), Northwest Univ, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China.	zyy@nwu.edu.cn; qbmei@fmmu.edu.cn	Zhao, Ying-Yong/I-9326-2014; tan, xiao/GZL-0264-2022; Zhao, Ying-Yong/I-3590-2019	Zhao, Ying-Yong/0000-0002-0239-7342; Zhao, Ying-Yong/0000-0002-0239-7342; Feng, Ya-long/0000-0001-5207-5010	National Scientific Foundation of China [81001622, 81073029]; China Postdoctoral Science Foundation [2012M521831]; Innovative Research Team in University of Ministry of Education of China [IRT1174]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovative Research Team in University of Ministry of Education of China(Ministry of Education, China)	This study was supported in part by grants from the National Scientific Foundation of China (Nos. 81001622, 81073029) and China Postdoctoral Science Foundation (2012M521831) and Innovative Research Team in University of Ministry of Education of China (No. IRT1174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihisa T, 2007, J NAT PROD, V70, P948, DOI 10.1021/np0780001; [Anonymous], 2010, PHARMACOPOEIA PEOPLE, P224; Bassa BV, 2007, BBA-MOL CELL BIOL L, V1771, P1364, DOI 10.1016/j.bbalip.2007.09.004; Chen YY, 2004, FOOD CHEM TOXICOL, V42, P759, DOI 10.1016/j.fct.2004.01.018; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Ilcol YO, 2002, CLIN BIOCHEM, V35, P233, DOI 10.1016/S0009-9120(02)00298-9; Ilcol YO, 2002, CLIN BIOCHEM, V35, P307, DOI 10.1016/S0009-9120(02)00319-3; Lao YM, 2009, BRIT J PHARMACOL, V157, P1128, DOI 10.1111/j.1476-5381.2009.00257.x; Lee KY, 2003, INT IMMUNOPHARMACOL, V3, P1353, DOI 10.1016/S1567-5769(03)00113-9; Maldonado PD, 2003, LIFE SCI, V73, P2543, DOI 10.1016/S0024-3205(03)00609-X; Maldonado PD, 2003, FREE RADICAL BIO MED, V35, P317, DOI 10.1016/S0891-5849(03)00312-5; Miyata T, 2000, KIDNEY INT, V58, pS120, DOI 10.1046/j.1523-1755.2000.07615.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; OTVOS JD, 1991, CLIN CHEM, V37, P377; Rahman A, 2003, ARCH BIOCHEM BIOPHYS, V418, P71, DOI 10.1016/S0003-9861(03)00365-5; Rios JL, 2011, PLANTA MED, V77, P681, DOI 10.1055/s-0030-1270823; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Sekiya N, 2003, PHYTOTHER RES, V17, P160, DOI 10.1002/ptr.1097; Shidfar F, 2008, East Mediterr Health J, V14, P305; TAI T, 1995, PHYTOCHEMISTRY, V39, P1165, DOI 10.1016/0031-9422(95)00110-S; TAI T, 1993, PHYTOCHEMISTRY, V32, P1239, DOI 10.1016/S0031-9422(00)95099-4; van Wietmarschen H, 2009, JCR-J CLIN RHEUMATOL, V15, P330, DOI 10.1097/RHU.0b013e3181ba3926; Wang YF, 2004, CARBOHYD RES, V339, P327, DOI 10.1016/j.carres.2003.10.006; Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r; Wrona M, 2005, RAPID COMMUN MASS SP, V19, P2597, DOI 10.1002/rcm.2101; WYNGAARDEN JB, 1957, ARCH BIOCHEM BIOPHYS, V70, P150, DOI 10.1016/0003-9861(57)90088-7; Xiang Z, 2011, PHYTOCHEM ANALYSIS, V22, P411, DOI 10.1002/pca.1296; Yang B, 2012, J PHARMACEUT BIOMED, V58, P113, DOI 10.1016/j.jpba.2011.09.033; Yang CH, 2009, HELV CHIM ACTA, V92, P660, DOI 10.1002/hlca.200800360; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Zhao YY, 2013, CHEM-BIOL INTERACT, V201, P31, DOI 10.1016/j.cbi.2012.12.002; Zhao YY, 2013, J PROTEOME RES, V12, P692, DOI 10.1021/pr3007792; Zhao YY, 2012, PROCESS BIOCHEM, V47, P1980, DOI 10.1016/j.procbio.2012.07.008; Zhao YY, 2012, J ETHNOPHARMACOL, V144, P775, DOI 10.1016/j.jep.2012.09.033; Zhao YY, 2012, BIOMARKERS, V17, P721, DOI 10.3109/1354750X.2012.724450; Zhao YY, 2012, CLIN CHIM ACTA, V413, P1438, DOI 10.1016/j.cca.2012.06.005; Zhao YY, 2012, BIOMARKERS, V17, P48, DOI 10.3109/1354750X.2011.637180; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014; Zheng Y, 2008, J ASIAN NAT PROD RES, V10, P640, DOI 10.1080/10286020802133597; Zheng Y, 2008, J ASIAN NAT PROD RES, V10, P289, DOI 10.1080/10286020701782742	40	99	111	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59617	10.1371/journal.pone.0059617	http://dx.doi.org/10.1371/journal.pone.0059617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555727	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500065
J	Guareschi, S; Coccia, C; Sanchez-Fernandez, D; Carbonell, JA; Velasco, J; Boyero, L; Green, AJ; Millan, A				Guareschi, Simone; Coccia, Cristina; Sanchez-Fernandez, David; Antonio Carbonell, Jose; Velasco, Josefa; Boyero, Luz; Green, Andy J.; Millan, Andres			How Far Could the Alien Boatman Trichocorixa verticalis verticalis Spread? Worldwide Estimation of Its Current and Future Potential Distribution	PLOS ONE			English	Article							CLIMATE-CHANGE; BIOLOGICAL INVASIONS; SPECIES DISTRIBUTION; AQUATIC INVERTEBRATES; GLOBAL CLIMATE; DISTRIBUTION MODELS; BIODIVERSITY; HETEROPTERA; DISPERSAL; RISK	Invasions of alien species are considered among the least reversible human impacts, with diversified effects on aquatic ecosystems. Since prevention is the most cost-effective way to avoid biodiversity loss and ecosystem problems, one challenge in ecological research is to understand the limits of the fundamental niche of the species in order to estimate how far invasive species could spread. Trichocorixa verticalis verticalis (Tvv) is a corixid (Hemiptera) originally distributed in North America, but cited as an alien species in three continents. Its impact on native communities is under study, but it is already the dominant species in several saline wetlands and represents a rare example of an aquatic alien insect. This study aims: i) to estimate areas with suitable environmental conditions for Tvv at a global scale, thus identifying potential new zones of invasion; and ii) to test possible changes in this global potential distribution under a climate change scenario. Potential distributions were estimated by applying a multidimensional envelope procedure based on both climatic data, obtained from observed occurrences, and thermal physiological data. Our results suggest Tvv may expand well beyond its current range and find inhabitable conditions in temperate areas along a wide range of latitudes, with an emphasis on coastal areas of Europe, Northern Africa, Argentina, Uruguay, Australia, New Zealand, Myanmar, India, the western boundary between USA and Canada, and areas of the Arabian Peninsula. When considering a future climatic scenario, the suitability area of Tvv showed only limited changes compared with the current potential distribution. These results allow detection of potential contact zones among currently colonized areas and potential areas of invasion. We also identified zones with a high level of suitability that overlap with areas recognized as global hotspots of biodiversity. Finally, we present hypotheses about possible means of spread, focusing on different geographical scales.	[Guareschi, Simone; Sanchez-Fernandez, David; Antonio Carbonell, Jose; Velasco, Josefa; Millan, Andres] Univ Murcia, Dept Ecol & Hydrol, Murcia, Spain; [Coccia, Cristina; Boyero, Luz; Green, Andy J.] Donana Biol Stn EBD CSIC, Wetland Ecol Dept, Seville, Spain; [Sanchez-Fernandez, David] CSIC Univ Pompeu Fabra, Inst Evolutionary Biol, Barcelona, Spain; [Boyero, Luz] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; James Cook University	Guareschi, S (corresponding author), Univ Murcia, Dept Ecol & Hydrol, Murcia, Spain.	simone.guareschi@um.es	Millan, Andres/D-3655-2009; Sánchez-Fernández, David/J-2658-2012; Coccia, Cristina/C-6105-2015; Green, Andy J/A-5189-2008; Boyero, Luz/N-1719-2019; Guareschi, Simone/O-5047-2019; Boyero, Luz/L-5822-2014	Millan, Andres/0000-0003-0036-363X; Coccia, Cristina/0000-0002-0832-2050; Green, Andy J/0000-0002-1268-4951; Boyero, Luz/0000-0001-7366-9299; Guareschi, Simone/0000-0003-2962-0863; Boyero, Luz/0000-0001-7366-9299; Sanchez-Fernandez, David/0000-0003-1766-0761	Spanish Ministry of Economy and Competitiveness; FPU grant (Spanish Ministry of Education, Culture and Sport); JAE grant (CSIC); Atlas y libro rojo de los coleopteros acuaticos de Espana peninsular; Spanish Ministry of the Environment (MIMAN); Estructura y dinamica de meta-comunidades de macroinvertebrados en humedales temporales y el papel de la especie invasora Trichocorixa verticalis [P10- RNM-6262]; Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia)	Spanish Ministry of Economy and Competitiveness(Spanish Government); FPU grant (Spanish Ministry of Education, Culture and Sport); JAE grant (CSIC); Atlas y libro rojo de los coleopteros acuaticos de Espana peninsular; Spanish Ministry of the Environment (MIMAN); Estructura y dinamica de meta-comunidades de macroinvertebrados en humedales temporales y el papel de la especie invasora Trichocorixa verticalis; Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia)(Junta de Andalucia)	DSF and LB were supported by the "Juan de la Cierva" and "Ramon y Cajal" programs respectively from the Spanish Ministry of Economy and Competitiveness. JAC and CC were supported by an FPU grant (Spanish Ministry of Education, Culture and Sport) and a JAE grant (CSIC) respectively. The study was partially supported by the projects "Atlas y libro rojo de los coleopteros acuaticos de Espana peninsular" financed by the Spanish Ministry of the Environment (MIMAN) and "Estructura y dinamica de meta-comunidades de macroinvertebrados en humedales temporales y el papel de la especie invasora Trichocorixa verticalis (P10- RNM-6262)" financed by the Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi R, 2011, INT J ENVIRON RES, V5, P1047; AIKEN RB, 1995, CAN J ZOOL, V73, P552, DOI 10.1139/z95-063; Aragon P, 2010, J APPL ECOL, V47, P1026, DOI 10.1111/j.1365-2664.2010.01847.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Arribas P, 2012, GLOBAL CHANGE BIOL, V18, P2135, DOI 10.1111/j.1365-2486.2012.02691.x; Bacon SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047689; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Briski E, 2012, BIOL INVASIONS, V14, P1843, DOI 10.1007/s10530-012-0194-0; Briski E, 2011, LIMNOL OCEANOGR, V56, P1929, DOI 10.4319/lo.2011.56.5.1929; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; BWM Convention (Ballast Water Management Convention), 2004, INT CONV CONTR MAN S; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Calenge C, 2008, J THEOR BIOL, V252, P674, DOI 10.1016/j.jtbi.2008.02.036; Capinha C, 2012, BIOL INVASIONS, V14, P1737, DOI 10.1007/s10530-012-0187-z; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Dai A, 2001, GEOPHYS RES LETT, V28, P4511, DOI 10.1029/2001GL013359; Devin S, 2005, HYDROBIOLOGIA, V551, P137, DOI 10.1007/s10750-005-4456-z; Devin S, 2008, AQUAT SCI, V70, P100, DOI 10.1007/s00027-008-8009-1; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Domisch S, 2011, FRESHWATER BIOL, V56, P2009, DOI 10.1111/j.1365-2427.2011.02631.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Etherington TR, 2009, J BIOGEOGR, V36, P845, DOI 10.1111/j.1365-2699.2008.02041.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; GBIF-Global Biodiversity Information Facility [online], 2007, FREE OP ACC BIOD DAT; Govindasamy B, 2003, CLIM DYNAM, V21, P391, DOI 10.1007/s00382-003-0340-6; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Green AJ, 2006, BIOL LETT-UK, V2, P55, DOI 10.1098/rsbl.2005.0413; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; GUNTER G, 1959, ECOLOGY, V40, P724, DOI 10.2307/1929829; Gunther H., 2004, MITTEILUNGEN INT ENT, V29, P45; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Hutchinson GE, 1993, ZOOBENTHOS; International Maritime Organization (IMO), 2012, SHIPP WORLD TRAD; JANSSON A, 1982, PAC INSECTS, V24, P95; Jansson A, 1999, AFR ENTOMOL, V7, P295; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A., 2011, ENCY BIOL INVASIONS, P661; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Junk WJ, 2013, AQUAT SCI, V75, P151, DOI 10.1007/s00027-012-0278-z; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Karatayev AY, 2009, BIOL INVASIONS, V11, P2009, DOI 10.1007/s10530-009-9498-0; KELTS LJ, 1979, HYDROBIOLOGIA, V64, P37, DOI 10.1007/BF00015451; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kenner R. D., 2004, Journal of the Entomological Society of British Columbia, V101, P147; Klein G, 2010, BIOL INVASIONS, V12, P1031, DOI 10.1007/s10530-009-9520-6; L'Mohdi Ouassima, 2010, Boletin de la SEA, V46, P395; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Lockwood JL, 2007, INVASION ECOLOGY; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Machler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045400; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Millan Andres, 2005, Boletin de la SEA, V36, P157; Munoz J, 2010, CRUSTACEANA, V83, P465, DOI 10.1163/001121610X489449; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naranjo C, 2010, REV BIOL TROP, V58, P897; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Pluess T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048157; Rabitsch W., 2010, BIORISK - Biodiversity and Ecosystem Risk Assessment, P407; Rabitsch W, 2008, ZOOTAXA, P1; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; Rodriguez-Perez H, 2009, HYDROBIOLOGIA, V634, P209, DOI 10.1007/s10750-009-9901-y; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sailer RI, 1948, U KANSAS SCI B, V32, P289; Sala J., 2005, Graellsia, V61, P31; Sanchez MI, 2012, FRESHWATER BIOL, V57, P1896, DOI 10.1111/j.1365-2427.2012.02852.x; Sanchez-Fernandez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048163; Sanchez-Fernandez D, 2011, DIVERS DISTRIB, V17, P163, DOI 10.1111/j.1472-4642.2010.00716.x; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simon KS, 2003, FRESHWATER BIOL, V48, P982, DOI 10.1046/j.1365-2427.2003.01069.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; StatSoft, 2008, STATISTICA DAT AN SO; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Tamelander J, 2010, GLOBALLAST MONOGRAPH, V18; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; USHER MB, 1988, BIOL CONSERV, V44, P119, DOI 10.1016/0006-3207(88)90007-9; Van De Meutter F, 2010, HYDROBIOLOGIA, V649, P231, DOI 10.1007/s10750-010-0250-7; Van de Meutter F, 2010, FUND APPL LIMNOL, V177, P283, DOI 10.1127/1863-9135/2010/0177-0283; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Webb BW, 2003, HYDROL PROCESS, V17, P3069, DOI 10.1002/hyp.1280; WURTSBAUGH WA, 1992, OECOLOGIA, V89, P168, DOI 10.1007/BF00317215; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745	100	28	33	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59757	10.1371/journal.pone.0059757	http://dx.doi.org/10.1371/journal.pone.0059757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555771	Green Published, gold, Green Accepted			2022-12-27	WOS:000316546400064
J	Shamaei, K; Sawicki, GS; Dollar, AM				Shamaei, Kamran; Sawicki, Gregory S.; Dollar, Aaron M.			Estimation of Quasi-Stiffness and Propulsive Work of the Human Ankle in the Stance Phase of Walking	PLOS ONE			English	Article							JOINT STIFFNESS; TRANSTIBIAL PROSTHESIS; POSITION DEPENDENCE; HUMAN LOCOMOTION; FOOT PROSTHESIS; LIMB JOINTS; DYNAMICS; DESIGN; SPEED; KNEE	Characterizing the quasi-stiffness and work of lower extremity joints is critical for evaluating human locomotion and designing assistive devices such as prostheses and orthoses intended to emulate the biological behavior of human legs. This work aims to establish statistical models that allow us to predict the ankle quasi-stiffness and net mechanical work for adults walking on level ground. During the stance phase of walking, the ankle joint propels the body through three distinctive phases of nearly constant stiffness known as the quasi-stiffness of each phase. Using a generic equation for the ankle moment obtained through an inverse dynamics analysis, we identify key independent parameters needed to predict ankle quasi-stiffness and propulsive work and also the functional form of each correlation. These parameters include gait speed, ankle excursion, and subject height and weight. Based on the identified form of the correlation and key variables, we applied linear regression on experimental walking data for 216 gait trials across 26 subjects (speeds from 0.75-2.63 m/s) to obtain statistical models of varying complexity. The most general forms of the statistical models include all the key parameters and have an R 2 of 75% to 81% in the prediction of the ankle quasi-stiffnesses and propulsive work. The most specific models include only subject height and weight and could predict the ankle quasi-stiffnesses and work for optimal walking speed with average error of 13% to 30%. We discuss how these models provide a useful framework and foundation for designing subject-and gait-specific prosthetic and exoskeletal devices designed to emulate biological ankle function during level ground walking.	[Shamaei, Kamran; Dollar, Aaron M.] Yale Univ, Dept Mech Engn & Mat Sci, Sch Engn & Appl Sci, New Haven, CT 06520 USA; [Sawicki, Gregory S.] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Sawicki, Gregory S.] Univ N Carolina Chapel Hill, Raleigh, NC USA	Yale University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Shamaei, K (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, Sch Engn & Appl Sci, New Haven, CT 06520 USA.	kamran.shamaei@yale.edu		Dollar, Aaron/0000-0002-2409-4668	US Defense Medical Research Development Program [W81XWH-11-2-0054]; US Army Natick Soldier Research Development and Engineering Center [W911NF-07-D-0001]	US Defense Medical Research Development Program; US Army Natick Soldier Research Development and Engineering Center	1) US Defense Medical Research Development Program, contract #W81XWH-11-2-0054. 2) US Army Natick Soldier Research Development and Engineering Center, contract #W911NF-07-D-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1992, PHILOS T ROY SOC B, V338, P189, DOI 10.1098/rstb.1992.0138; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; CAVAGNA GA, 1983, J PHYSIOL-LONDON, V343, P323, DOI 10.1113/jphysiol.1983.sp014895; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Crenna P, 2011, HUM MOVEMENT SCI, V30, P1185, DOI 10.1016/j.humov.2011.02.009; Davis RB, 1996, GAIT POSTURE, V4, P224, DOI 10.1016/0966-6362(95)01045-9; Dean JC, 2009, J R SOC INTERFACE, V6, P561, DOI 10.1098/rsif.2008.0415; DEVITA P, 1994, J BIOMECH, V27, P501, DOI 10.1016/0021-9290(94)90025-6; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Dubbeldam R, 2010, CLIN BIOMECH, V25, P796, DOI 10.1016/j.clinbiomech.2010.06.007; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Endo K, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4935, DOI 10.1109/IROS.2006.282454; Endo K, 2009, IEEE INT CONF ROBOT, P2790; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; FERRIGNO G, 1985, IEEE T BIO-MED ENG, V32, P943, DOI 10.1109/TBME.1985.325627; Ferris DP, 2009, IEEE ENG MED BIO, P2119, DOI 10.1109/IEMBS.2009.5333984; Frigo C, 1998, MED BIOL ENG COMPUT, V36, P179, DOI 10.1007/BF02510740; Frigo C, 1996, J ELECTROMYOGR KINES, V6, P177, DOI 10.1016/1050-6411(96)00030-2; Frigo C, 1998, GAIT POSTURE, V8, P91, DOI 10.1016/S0966-6362(98)00031-9; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Gunther M, 2002, J BIOMECH, V35, P1459, DOI 10.1016/S0021-9290(02)00183-5; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hansen AH, 2004, J BIOMECH, V37, P1467, DOI 10.1016/j.jbiomech.2004.01.017; Hitt J, 2009, IND ROBOT, V36, P441, DOI 10.1108/01439910910980169; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; Hortobagyi T, 2011, J APPL PHYSIOL, V111, P1391, DOI 10.1152/japplphysiol.00291.2011; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Lark SD, 2003, CLIN BIOMECH, V18, P848, DOI 10.1016/S0268-0033(03)00150-5; Leurs F, 2011, J EXP BIOL, V214, P2276, DOI 10.1242/jeb.054452; Markowitz J, 2011, PHILOS T R SOC B, V366, P1621, DOI 10.1098/rstb.2010.0347; McGeer T., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P1640, DOI 10.1109/ROBOT.1990.126245; Minetti AE, 2001, ACTA ASTRONAUT, V49, P191, DOI 10.1016/S0094-5765(01)00098-4; MINETTI AE, 1994, EUR J APPL PHYSIOL O, V68, P285, DOI 10.1007/BF00571444; Minetti AE, 2000, EUR J ENDOCRINOL, V142, P35, DOI 10.1530/eje.0.1420035; MOCHON S, 1980, MATH BIOSCI, V52, P241, DOI 10.1016/0025-5564(80)90070-X; Pedotti A., 1992, FUNCT NEUROL, V7, P47; Perry J., 1992, GAIT ANAL NORMAL PAT; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Rose J., 2006, HUMAN WALKING, V3rd ed.; Salsich GB, 2000, GAIT POSTURE, V11, P207, DOI 10.1016/S0966-6362(00)00047-3; Sawicki GS, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-3; Sawicki GS, 2009, EXERC SPORT SCI REV, V37, P130, DOI 10.1097/JES.0b013e31819c2df6; Shamaei Kamran, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975478, DOI 10.1109/ICORR.2011.5975478; Shamaei K, 2011, IEEE ENG MED BIO, P8135, DOI 10.1109/IEMBS.2011.6092007; Silder A, 2008, J BIOMECH, V41, P1520, DOI 10.1016/j.jbiomech.2008.02.016; SINGER E, 1995, ANN BIOMED ENG, V23, P691, DOI 10.1007/BF02584466; SKINNER SR, 1985, ORTHOPEDICS, V8, P355; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Stefanyshyn DJ, 1998, J APPL BIOMECH, V14, P292, DOI 10.1123/jab.14.3.292; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Sup F, 2008, P IEEE RAS-EMBS INT, P523, DOI 10.1109/BIOROB.2008.4762811; TAGA G, 1995, BIOL CYBERN, V73, P97, DOI 10.1007/BF00204048; Walsh CJ, 2006, IEEE INT CONF ROBOT, P3485, DOI 10.1109/ROBOT.2006.1642234; WEISS PL, 1986, J BIOMECH, V19, P737, DOI 10.1016/0021-9290(86)90197-1; WEISS PL, 1986, J BIOMECH, V19, P727, DOI 10.1016/0021-9290(86)90196-X; Wiggin M., 2011, 2011 IEEE INT C REH, P1, DOI [10.1109/ICORR.2011.5975342, 10.1109/icorr.2011.5975342, DOI 10.1109/ICORR.2011.5975342]; Winter D, 2005, BIOMECHANICS MOTOR C; WINTER DA, 1978, BIOL CYBERN, V29, P137, DOI 10.1007/BF00337349; Winter DA., 1987, BIOMECHANICS MOTOR C; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	69	80	81	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59935	10.1371/journal.pone.0059935	http://dx.doi.org/10.1371/journal.pone.0059935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555839	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400069
J	Singhal, K; Vreede, J; Mashaghi, A; Tans, SJ; Bolhuis, PG				Singhal, Kushagra; Vreede, Jocelyne; Mashaghi, Alireza; Tans, Sander J.; Bolhuis, Peter G.			Hydrophobic Collapse of Trigger Factor Monomer in Solution	PLOS ONE			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI; NASCENT CHAIN; FUNCTIONAL DISSECTION; MOLECULAR CHAPERONES; FORCE-FIELD; PROTEINS; RECOGNITION; RIBOSOME; BINDING	Trigger factor (TF) is a chaperone, found in bacterial cells and chloroplasts, that interacts with nascent polypeptide chains to suppress aggregation. While its crystal structure has been resolved, the solution structure and dynamics are largely unknown. We performed multiple molecular dynamics simulations on Trigger factor in solution, and show that its tertiary domains display collective motions hinged about inter-domain linkers with minimal or no loss in secondary structure. Moreover, we find that isolated TF typically adopts a collapsed state, with the formation of domain pairs. This collapse of TF in solution is induced by hydrophobic interactions and stabilised by hydrophilic contacts. To determine the nature of the domain interactions, we analysed the hydrophobicity of the domain surfaces by using the hydrophobic probe method of Acharya et al. [1,2], as the standard hydrophobicity scales predictions are limited due to the complex environment. We find that the formation of domain pairs changes the hydrophobic map of TF, making the N-terminal and arm2 domain pair more hydrophilic and the head and arm1 domain pair more hydrophobic. These insights into the dynamics and interactions of the TF domains are important to eventually understand chaperone-substrate interactions and chaperone function.	[Singhal, Kushagra; Vreede, Jocelyne; Bolhuis, Peter G.] Univ Amsterdam, vant Hoff Inst Mol Sci, Amsterdam, Netherlands; [Mashaghi, Alireza; Tans, Sander J.] FOM Inst AMOLF, Dept Syst Biophys, Amsterdam, Netherlands	University of Amsterdam; AMOLF	Bolhuis, PG (corresponding author), Univ Amsterdam, vant Hoff Inst Mol Sci, Amsterdam, Netherlands.	p.g.bolhuis@uva.nl	Tans, Sander/AAS-2901-2020; Mashaghi, Alireza/Q-8218-2017; Bolhuis, Peter/K-6115-2015	Mashaghi, Alireza/0000-0002-2157-1211; Bolhuis, Peter/0000-0002-3698-9258	Netherlands Organisation for Scientific Research (NWO) [VICI 700.58.442]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is financially supported through the research programme VICI 700.58.442, which is financed by the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya H, 2010, FARADAY DISCUSS, V146, P353, DOI 10.1039/b927019a; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Betts M. J, 2007, BIOINFORMATICS GENET, P311, DOI [10.1002/9780470059180.ch13, DOI 10.1002/9780470059180.CH13]; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Fenton WA, 1997, PROTEIN SCI, V6, P743; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huang GC, 2000, BBA-PROTEIN STRUCT M, V1480, P77, DOI 10.1016/S0167-4838(00)00094-7; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jamadagni SN, 2011, ANNU REV CHEM BIOMOL, V2, P147, DOI 10.1146/annurev-chembioeng-061010-114156; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kristensen O, 2003, STRUCTURE, V11, P1547, DOI 10.1016/j.str.2003.11.003; Liu CP, 2005, J BIOL CHEM, V280, P13315, DOI 10.1074/jbc.M414151200; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Schaffitzel E, 2001, BIOL CHEM, V382, P1235, DOI 10.1515/BC.2001.154; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Yao Y, 2008, J BIOMOL NMR, V40, P23, DOI 10.1007/s10858-007-9207-1; Zarnt T, 1997, J MOL BIOL, V271, P827, DOI 10.1006/jmbi.1997.1206	48	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59683	10.1371/journal.pone.0059683	http://dx.doi.org/10.1371/journal.pone.0059683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565160	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300029
J	Wei, SJ; Shi, BC; Gong, YJ; Jin, GH; Chen, XX; Meng, XF				Wei, Shu-Jun; Shi, Bao-Cai; Gong, Ya-Jun; Jin, Gui-Hua; Chen, Xue-Xin; Meng, Xiang-Feng			Genetic Structure and Demographic History Reveal Migration of the Diamondback Moth Plutella xylostella (Lepidoptera: Plutellidae) from the Southern to Northern Regions of China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; LONG-DISTANCE MIGRATION; RADAR OBSERVATIONS; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; NILAPARVATA-LUGENS; SPRING MIGRATION; ANIMAL MIGRATION; SITOBION-AVENAE; GRAIN APHID	The diamondback moth Plutella xylostella (Linnaeus) (Lepidoptera: Plutellidae) is one of the most destructive insect pests of cruciferous plants worldwide. Biological, ecological and genetic studies have indicated that this moth is migratory in many regions around the world. Although outbreaks of this pest occur annually in China and cause heavy damage, little is known concerning its migration. To better understand its migration pattern, we investigated the population genetic structure and demographic history of the diamondback moth by analyzing 27 geographical populations across China using four mitochondrial genes and nine microsatellite loci. The results showed that high haplotype diversity and low nucleotide diversity occurred in the diamondback moth populations, a finding that is typical for migratory species. No genetic differentiation among all populations and no correlation between genetic and geographical distance were found. However, pairwise analysis of the mitochondrial genes has indicated that populations from the southern region were more differentiated than those from the northern region. Gene flow analysis revealed that the effective number of migrants per generation into populations of the northern region is very high, whereas that into populations of the southern region is quite low. Neutrality testing, mismatch distribution and Bayesian Skyline Plot analyses based on mitochondrial genes all revealed that deviation from Hardy-Weinberg equilibrium and sudden expansion of the effective population size were present in populations from the northern region but not in those from the southern region. In conclusion, all our analyses strongly demonstrated that the diamondback moth migrates within China from the southern to northern regions with rare effective migration in the reverse direction. Our research provides a successful example of using population genetic approaches to resolve the seasonal migration of insects.	[Wei, Shu-Jun; Shi, Bao-Cai; Gong, Ya-Jun; Jin, Gui-Hua] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Chen, Xue-Xin] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Xue-Xin] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China; [Meng, Xiang-Feng] Zhumadian Acad Agr Sci, Zhumadian, Peoples R China	Beijing Academy of Agriculture & Forestry; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Wei, SJ (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	shujun268@163.com	Chen, Xue-xin/D-1592-2010; Wei, Shu-Jun/C-1109-2011	Chen, Xue-xin/0000-0002-9109-8853; Wei, Shu-Jun/0000-0001-7398-0968	National Basic Research Program of China [2013CB127600]; National Science Foundation of China [31101661]; Beijing New Star Program on Science and Technology [2010B027]; Special Fund for the Promotion and Innovation of Beijing Academy of Agriculture and Forestry Sciences [KJCX201104009]; Beijing Excellent Talents Program [2010D002020000010]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing New Star Program on Science and Technology; Special Fund for the Promotion and Innovation of Beijing Academy of Agriculture and Forestry Sciences; Beijing Excellent Talents Program	The research was funded jointly by the National Basic Research Program of China (no. 2013CB127600) to XXC and SJW, the National Science Foundation of China (no. 31101661), Beijing New Star Program on Science and Technology (no. 2010B027), Special Fund for the Promotion and Innovation of Beijing Academy of Agriculture and Forestry Sciences (no. KJCX201104009) and Beijing Excellent Talents Program (no. 2010D002020000010) to SJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Capinera JL, 2000, DIAMONDBACK MOTH PLU, V119, P1; CAPRIO MA, 1992, ENVIRON ENTOMOL, V21, P808, DOI 10.1093/ee/21.4.808; Carde RT, 2008, CURR BIOL, V18, pR1007, DOI 10.1016/j.cub.2008.09.013; Chang WXZ, 1997, ANN ENTOMOL SOC AM, V90, P590, DOI 10.1093/aesa/90.5.590; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chen Feizhou, 2004, Yingyong Shengtai Xuebao, V15, P99; CHEN RL, 1989, ECOL ENTOMOL, V14, P149, DOI 10.1111/j.1365-2311.1989.tb00765.x; Dallimer M, 2003, MOL ECOL, V12, P345, DOI 10.1046/j.1365-294X.2003.01733.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; DINGLE H, 1972, SCIENCE, V175, P1327, DOI 10.1126/science.175.4028.1327; Dosdall LM, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P95; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; Endersby NM, 2005, MOL ECOL NOTES, V5, P51, DOI 10.1111/j.1471-8286.2004.00827.x; Esselink GD, 2006, MOL ECOL NOTES, V6, P1246, DOI 10.1111/j.1471-8286.2006.01504.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Feng Xia, 2011, Chinese Journal of Applied Entomology, V48, P247; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Franklin MT, 2011, EVOL APPL, V4, P89, DOI 10.1111/j.1752-4571.2010.00135.x; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; FRENCH R. A., 1967, BIOMETEOROLOGY, V2, P565; Fricke HC, 2011, NATURE, V480, P513, DOI 10.1038/nature10570; Fu YX, 1997, GENETICS, V147, P915; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gatehouse AG, 1997, ANNU REV ENTOMOL, V42, P475, DOI 10.1146/annurev.ento.42.1.475; GRAY R. A. H., 1915, Journal of the Board of Agriculture and Fisheries, V22, P222; Grzywacz D, 2010, CROP PROT, V29, P68, DOI 10.1016/j.cropro.2009.08.009; Gu HN, 2009, ENVIRON ENTOMOL, V38, P524, DOI 10.1603/022.038.0303; HARCOURT D. G., 1963, Proc. eat. Soc. Ont., 1962, V93, P61; Hardy J.E., 1938, Bulletin of Entomological Research London, V29, P343, DOI 10.1017/S0007485300026274; HECKEL DG, 1995, ANN ENTOMOL SOC AM, V88, P531, DOI 10.1093/aesa/88.4.531; Herrero S, 2001, APPL ENVIRON MICROB, V67, P979, DOI 10.1128/AEM.67.2.979-981.2001; Hofinger BJ, 2011, MOL ECOL, V20, P3653, DOI 10.1111/j.1365-294X.2011.05201.x; HONDA K, 1992, DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P43; Hori K, 1910, SPECIAL REPORT FORMO, P228; Kfir R, 1998, ANN ENTOMOL SOC AM, V91, P164, DOI 10.1093/aesa/91.2.164; Kim I, 2003, KOREAN J GENETIC, V25, P155; Kim Yonggyun, 1999, Journal of Asia-Pacific Entomology, V2, P1; Kraus RHS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-99; Laude R.P., 1992, Philippine Entomologist, V8, P1265; Li JH, 2006, EUR J ENTOMOL, V103, P605, DOI 10.14411/eje.2006.081; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; LOKKI J, 1978, Notulae Entomologicae, V58, P121; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Ma ChunSen, 1995, Journal of Jilin Agricultural University, V17, P27; [马春森 Ma Chunsen], 2010, [生态学报, Acta Ecologica Sinica], V21, P3628; MA CS, 1993, J JILIN AGR SCI, P44; Ma CS, 1991, P 1 NAT PLANT PROT C, P294; Ma Q, 2009, J ZHEJIANG AGR SCI, P956; MANTEL N, 1967, CANCER RES, V27, P209; Marsh HO, 1917, J AGRIC RES, V10, P1; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Mun JH, 1999, B ENTOMOL RES, V89, P245, DOI 10.1017/S000748539900036X; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saito O, 1998, RES B HOKKAIDO NATL, V167; Saw Jesslyn, 2006, Insect Science, V13, P365, DOI 10.1111/j.1744-7917.2006.00105.x; SCHNEIDER F, 1962, ANNU REV ENTOMOL, V7, P223, DOI 10.1146/annurev.en.07.010162.001255; Schneider S, 1999, GENETICS, V152, P1079; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Sivapragasam A, 1996, P 3 INT WORKSH MAL A, P3; SLATKIN M, 1991, GENETICS, V129, P555; SMITH DB, 1982, P ENTOMOL SOC ONT, V113, P21; STINNER RE, 1983, ANNU REV ENTOMOL, V28, P319, DOI 10.1146/annurev.en.28.010183.001535; TAJIMA F, 1989, GENETICS, V123, P585; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Theobald F, 1926, J KENT FARMERS UNION, V20, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Uthicke S, 2003, MOL ECOL, V12, P2635, DOI 10.1046/j.1365-294X.2003.01954.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang SL, 2005, Proceedings of the 13th International Congress on Genes, Gene Families and Isozymes, P29; Wink M, 2006, J ORNITHOL, V147, P234, DOI 10.1007/s10336-006-0065-5; Wu YP, 2012, DNA CELL BIOL, V31, P1508, DOI 10.1089/dna.2012.1642; Xu ZH, 2011, AGR SCI CHINA, V10, P1041, DOI 10.1016/S1671-2927(11)60092-8; Zalucki MP, 2008, MANAGEMENT DIAMONDBA, P122; Zhao JZ, 2006, J ECON ENTOMOL, V99, P176, DOI 10.1603/0022-0493(2006)099[0176:MODMLP]2.0.CO;2; Zhou XM, 2010, INSECT SCI, V17, P353, DOI 10.1111/j.1744-7917.2009.01307.x	101	75	83	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59654	10.1371/journal.pone.0059654	http://dx.doi.org/10.1371/journal.pone.0059654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565158	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300027
J	Di Virgilio, G; Laffan, SW; Ebach, MC				Di Virgilio, Giovanni; Laffan, Shawn W.; Ebach, Malte C.			Quantifying High Resolution Transitional Breaks in Plant and Mammal Distributions at Regional Extent and Their Association with Climate, Topography and Geology	PLOS ONE			English	Article							TREE SPECIES RICHNESS; NEW-SOUTH-WALES; SPATIAL-PATTERNS; BETA-DIVERSITY; BIODIVERSITY HOTSPOTS; RESERVE NETWORKS; ZONES; GRADIENTS; REPRESENTATION; PROBABILITIES	Objectives: We quantify spatial turnover in communities of 1939 plant and 59 mammal species at 2.5 km resolution across a topographically heterogeneous region in south-eastern Australia to identify distributional breaks and low turnover zones where multiple species distributions overlap. Environmental turnover is measured to determine how climate, topography and geology influence biotic turnover differently across a variety of biogeographic breaks and overlaps. We identify the genera driving turnover and confirm the versatility of this approach across spatial scales and locations. Methods: Directional moving window analyses, rotated through 360 degrees, were used to measure spatial turnover variation in different directions between gridded cells containing georeferenced plant and mammal occurrences and environmental variables. Generalised linear models were used to compare taxic turnover results with equivalent analyses for geology, regolith weathering, elevation, slope, solar radiation, annual precipitation and annual mean temperature, both uniformly across the entire study area and by stratifying it into zones of high and low turnover. Identified breaks and transitions were compared to a conservation bioregionalisation framework widely used in Australia. Results/Significance: Detailed delineations of plant and mammal turnover zones with gradational boundaries denoted subtle variation in species assemblages. Turnover patterns often diverged from bioregion boundaries, though plant turnover adhered most closely. A prominent break zone contained either comparable or greater numbers of unique genera than adjacent overlaps, but these were concentrated in a small subsection relatively under-protected by conservation reserves. The environmental correlates of biotic turnover varied for different turnover zones in different subsections of the study area. Topography and temperature showed much stronger relationships with plant turnover in a topographically complex overlap, relative to a lowland overlap where weathering was most predictive. This method can quantify transitional turnover patterns from small to broad extents, at different resolutions for any location, and complements broad-scale bioregionalisation schemes in conservation planning.	[Di Virgilio, Giovanni; Laffan, Shawn W.; Ebach, Malte C.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Ebach, Malte C.] Australian Museum, Dept Palaeontol, Sydney, NSW 2000, Australia	University of New South Wales Sydney; Australian Museum	Di Virgilio, G (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	giovanni@unsw.edu.au	Laffan, Shawn W/A-3761-2008; Ebach, Malte/D-8274-2016	Laffan, Shawn W/0000-0002-5996-0570; Ebach, Malte/0000-0002-9594-9010; Di Virgilio, Giovanni/0000-0001-7014-8412	Australian Research Council [FT0992002]; University of New South Wales [RG114989]	Australian Research Council(Australian Research Council); University of New South Wales	This research was supported by the Australian Research Council's "Future Fellow" funding scheme (project number FT0992002, awarded to MCE) and a University of New South Wales Goldstar grant (RG114989 to SWL and MCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, FOR NAT PARK EST ACT; Araujo MB, 2002, CONSERV BIOL, V16, P1662, DOI 10.1046/j.1523-1739.2002.02068.x; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Austin MP, 2009, J ECOL, V97, P496, DOI 10.1111/j.1365-2745.2009.01494.x; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Austin MP, 1996, AUST J ECOL, V21, P154, DOI 10.1111/j.1442-9993.1996.tb00596.x; AUSTIN MP, 1990, ECOL MONOGR, V60, P161, DOI 10.2307/1943043; Burley HM, 2012, INT J GEOGR INF SCI, V26, P2065, DOI 10.1080/13658816.2012.692371; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Cabeza M, 2004, J APPL ECOL, V41, P252, DOI 10.1111/j.0021-8901.2004.00905.x; Camarero JJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P182, DOI 10.1111/j.1466-822x.2006.00211.x; Davidar P, 2007, GLOBAL ECOL BIOGEOGR, V16, P510, DOI 10.1111/j.1466-8238.2007.00307.x; Department of Sustainability Environment Water Population and Communities, 2004, INT BIOG REG AUSTR I; Di Virgilio G, 2012, J BIOGEOGR, V39, P1862, DOI 10.1111/j.1365-2699.2012.02739.x; Garcillan PP, 2003, J VEG SCI, V14, P475, DOI 10.1111/j.1654-1103.2003.tb02174.x; Gaston KJ, 2001, ECOL LETT, V4, P4, DOI 10.1046/j.1461-0248.2001.00196.x; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huston M. A., 1994, BIOL DIVERSITY; Jarvis A, 2008, HOLE FILLED SRTM GLO; Jenkins DG, 2011, PHILOS T R SOC B, V366, P2331, DOI 10.1098/rstb.2011.0064; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; MAC ARTHUR ROBERT H., 1967; McDonald R, 2005, BIOL CONSERV, V126, P24, DOI 10.1016/j.biocon.2005.05.008; Morrone Juan J., 2004, Acta Entomologica Chilena, V28, P41; National Reserve System Task Group, 2009, AUSTR STRAT NAT RES, P67; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; O'Brien EM, 2000, OIKOS, V89, P588, DOI 10.1034/j.1600-0706.2000.890319.x; OEH, 2010, ATL NSW WILDL; Pepper M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-152; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rodrigues ASL, 2000, P ROY SOC B-BIOL SCI, V267, P49, DOI 10.1098/rspb.2000.0965; Rouget M, 2003, BIOL CONSERV, V112, P217, DOI 10.1016/S0006-3207(02)00415-9; Ruggiero A, 1998, J BIOGEOGR, V25, P1093, DOI 10.1046/j.1365-2699.1998.00253.x; Shriner SA, 2006, ECOL APPL, V16, P1660, DOI 10.1890/1051-0761(2006)016[1660:RNBORH]2.0.CO;2; Smith TB, 2001, TRENDS ECOL EVOL, V16, P431, DOI 10.1016/S0169-5347(01)02201-7; Thackway R, 1997, NAT AREA J, V17, P241; Thiel-Egenter C, 2011, J BIOGEOGR, V38, P772, DOI 10.1111/j.1365-2699.2010.02441.x; Torras O, 2008, BIODIVERS CONSERV, V17, P1227, DOI 10.1007/s10531-007-9277-0; Van Teeffelen AJA, 2006, BIODIVERS CONSERV, V15, P899, DOI 10.1007/s10531-004-2933-8; White AB, 2005, REMOTE SENS ENVIRON, V98, P1, DOI 10.1016/j.rse.2005.05.017; Wilford J, 2012, GEODERMA, V183, P124, DOI 10.1016/j.geoderma.2010.12.022; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Williams PH, 1999, J BIOGEOGR, V26, P459, DOI 10.1046/j.1365-2699.1999.00294.x; WILSON MV, 1984, J ECOL, V72, P1055, DOI 10.2307/2259551	52	10	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59227	10.1371/journal.pone.0059227	http://dx.doi.org/10.1371/journal.pone.0059227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560044	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900012
J	Liu, X; Chen, B; Chen, LL; Ren, WT; Liu, J; Wang, GX; Fan, W; Wang, X; Wang, Y				Liu, Xu; Chen, Ben; Chen, Lulan; Ren, Wan-Ting; Liu, Juan; Wang, Guoxiang; Fan, Wei; Wang, Xin; Wang, Yun			U-Shape Suppressive Effect of Phenol Red on the Epileptiform Burst Activity via Activation of Estrogen Receptors in Primary Hippocampal Culture	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMIC NEURONS; HUMAN MCF-7 CELLS; SPINE DENSITY; FEMALE RATS; ADULT-RAT; ESTRADIOL; CYCLOTHIAZIDE; EXCITABILITY; INDUCTION; EPILEPSY	Phenol red is widely used in cell culture as a pH indicator. Recently, it also has been reported to have estrogen-like bioactivity and be capable of promoting cell proliferation in different cell lines. However, the effect of phenol red on primary neuronal culture has never been investigated. By using patch clamp technique, we demonstrated that hippocampal pyramidal neurons cultured in neurobasal medium containing no phenol red had large depolarization-associated epileptiform bursting activities, which were rarely seen in neurons cultured in phenol red-containing medium. Further experiment data indicate that the suppressive effect of the phenol red on the abnormal epileptiform burst neuronal activities was U-shape dose related, with the most effective concentration at 28 mu M. In addition, this concentration related inhibitory effect of phenol red on the epileptiform neuronal discharges was mimicked by 17-beta-estradiol, an estrogen receptor agonist, and inhibited by ICI-182,780, an estrogen receptor antagonist. Our results suggest that estrogen receptor activation by phenol red in the culture medium prevents formation of abnormal, epileptiform burst activity. These studies highlight the importance of phenol red as estrogen receptor stimulator and cautions of careful use of phenol red in cell culture media.	[Wang, Xin] Fudan Univ, Dept Neurol, Zhongshan Hosp, Inst Brain Sci, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Dept Neurol, Zhongshan Hosp, Inst Brain Sci, Shanghai 200433, Peoples R China.	wang.xin@zs-hospital.sh.cn; yunwang@fudan.edu.cn			Nature Science Foundation of China [31129003, 81171224, 31273356]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Nature Science Foundation of China (31129003, 81171224) to YW and (31273356) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Berdichevsky Y, 2009, J NEUROSCI METH, V178, P59, DOI 10.1016/j.jneumeth.2008.11.016; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Blurton-Jones M, 2002, J COMP NEUROL, V452, P276, DOI 10.1002/cne.10393; Calizo LH, 2000, J NEUROSCI, V20, P1589; Chen B, 2012, BRAIN RES, V1486, P1, DOI 10.1016/j.brainres.2012.08.054; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; ERNST M, 1989, J STEROID BIOCHEM, V33, P907, DOI 10.1016/0022-4731(89)90239-2; FRANKFURT M, 1990, NEUROENDOCRINOLOGY, V51, P530, DOI 10.1159/000125387; Grassi S, 2010, NEUROSCIENCE, V165, P1100, DOI 10.1016/j.neuroscience.2009.11.039; Herzog AG, 2008, SEIZURE-EUR J EPILEP, V17, P151, DOI 10.1016/j.seizure.2007.11.014; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; JORDAN VC, 1985, ENDOCRINOLOGY, V116, P1845, DOI 10.1210/endo-116-5-1845; Moreno-Cuevas JE, 2000, IN VITRO CELL DEV-AN, V36, P447, DOI 10.1290/1071-2690(2000)036<0447:EMAIIP>2.0.CO;2; Qi JS, 2006, J PHYSIOL-LONDON, V571, P605, DOI 10.1113/jphysiol.2005.103812; Rao ML, 2003, PSYCHONEUROENDOCRINO, V28, P83, DOI 10.1016/S0306-4530(02)00126-9; Ronnekleiv OK, 2012, J NEUROENDOCRINOL, V24, P122, DOI 10.1111/j.1365-2826.2011.02160.x; Saleh TM, 2003, BRAIN RES, V990, P58, DOI 10.1016/S0006-8993(03)03387-0; Still K, 2003, CALCIFIED TISSUE INT, V73, P173, DOI 10.1007/s00223-002-2076-4; Veliskova J, 2006, NEUROSCIENCE, V138, P837, DOI 10.1016/j.neuroscience.2005.07.005; Veliskova J, 2007, J NEUROSCI, V27, P6054, DOI 10.1523/JNEUROSCI.0366-07.2007; Wang Y, 2009, NEUROPHARMACOLOGY, V57, P49, DOI 10.1016/j.neuropharm.2009.04.007; WELSHONS WV, 1988, ENDOCRINOLOGY, V122, P2379, DOI 10.1210/endo-122-6-2379; Wesierska-Gadek J, 2007, CELL MOL BIOL LETT, V12, P280, DOI 10.2478/s11658-007-0002-5; Wesierska-Gadek J, 2006, J CELL BIOCHEM, V98, P1367, DOI 10.1002/jcb.20960; Wong JK, 2003, J NEUROSCI, V23, P4984; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Zadran S, 2009, P NATL ACAD SCI USA, V106, P21936, DOI 10.1073/pnas.0912558106; Zhao R, 2011, EPILEPSY BEHAV, V20, P267, DOI 10.1016/j.yebeh.2010.12.006; Zhou J, 2005, P NATL ACAD SCI USA, V102, P14907, DOI 10.1073/pnas.0507440102	31	19	20	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60189	10.1371/journal.pone.0060189	http://dx.doi.org/10.1371/journal.pone.0060189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560076	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900053
J	Personne, Y; Brown, AC; Schuessler, DL; Parish, T				Personne, Yoann; Brown, Amanda C.; Schuessler, Dorothee L.; Parish, Tanya			Mycobacterium tuberculosis ClpP Proteases Are Co-transcribed but Exhibit Different Substrate Specificities	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL-ACTIVATOR; BACILLUS-SUBTILIS; STRESS-RESPONSE; DEGRADATION; CLGR; REGULATOR; INSIGHTS; VARIANTS; PATHWAYS	Caseinolytic (Clp) proteases are widespread energy-dependent proteases; the functional ATP-dependent protease is comprised of multimers of proteolytic and regulatory subunits. Mycobacterium tuberculosis has two ClpP proteolytic subunits (ClpP1 and ClpP2), with both being essential for growth in vitro. ClpP1 and clpP2 are arranged in an apparent operon; we demonstrated that the two genes are co-expressed under normal growth conditions. We identified a single promoter region for the clpP1P2 operon; no promoter was detected upstream of clpP2 demonstrating that independent expression of clpP1 and clpP2 was highly unlikely. Promoter activity was not induced by heat shock or oxidative stress. We identified a regulatory region upstream of the promoter with a consensus sequence matching the ClgR regulator motif; we determined the limits of the region by mutagenesis and confirmed that positive regulation of the promoter occurs in M. tuberculosis. We developed a reporter system to monitor ClpP1 and ClpP2 enzymatic activities based on LacZ incorporating ssrAtag sequences. We showed that whilst both ClpP1 and ClpP2 degrade SsrA-tagged LacZ, ClpP2 (but not ClpP1) degrades untagged proteins. Our data suggest that the two proteolytic subunits display different substrate specificities and therefore have different, but overlapping roles in M. tuberculosis.	[Personne, Yoann; Brown, Amanda C.; Schuessler, Dorothee L.; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AT, England	University of London; Queen Mary University London	Parish, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AT, England.	t.parish@qmul.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC); Barts; London charity	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Barts; London charity	This project was funded by a studentship to YP from the Biotechnology and Biological Sciences Research Council (BBSRC) and Barts and the London charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat S, 2009, J BACTERIOL, V191, P2894, DOI 10.1128/JB.01715-08; Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; [Anonymous], 2011, GLOB TUB CONTR; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Blokpoel MCJ, 2003, J MICROBIOL METH, V54, P203, DOI 10.1016/S0167-7012(03)00044-7; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Braman J, 1996, Methods Mol Biol, V57, P31; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Carroll Paul, 2008, V465, P265, DOI 10.1007/978-1-59745-207-6_18; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Novoa PG, 2004, NUCLEIC ACIDS RES, V32, pD104, DOI 10.1093/nar/gkh102; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gomez M, 1998, MOL MICROBIOL, V29, P617, DOI 10.1046/j.1365-2958.1998.00960.x; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Kim JH, 2011, NUCLEIC ACIDS RES, V39, P2210, DOI 10.1093/nar/gkq1149; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kruger E, 2000, J BACTERIOL, V182, P3259, DOI 10.1128/JB.182.11.3259-3265.2000; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Pashley CA, 2006, MICROBIOL-SGM, V152, P2727, DOI 10.1099/mic.0.28942-0; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; Schuessler DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034471; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Socha AM, 2010, BIOORGAN MED CHEM, V18, P7193, DOI 10.1016/j.bmc.2010.08.032; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Thomsen LE, 2002, MICROBIOL-SGM, V148, P2727, DOI 10.1099/00221287-148-9-2727; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, MYCOBACTERIUM TUBERC; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003	48	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60228	10.1371/journal.pone.0060228	http://dx.doi.org/10.1371/journal.pone.0060228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560081	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900056
J	Tang, JLW; Nicolle, AD; Klettner, CA; Pantelic, J; Wang, LD; Bin Suhaimi, A; Tan, AYL; Ong, GWX; Su, RK; Sekhar, C; Cheong, DDW; Tham, KW				Tang, Julian W.; Nicolle, Andre D.; Klettner, Christian A.; Pantelic, Jovan; Wang, Liangde; Bin Suhaimi, Amin; Tan, Ashlynn Y. L.; Ong, Garrett W. X.; Su, Ruikun; Sekhar, Chandra; Cheong, David D. W.; Tham, Kwok Wai			Airflow Dynamics of Human Jets: Sneezing and Breathing - Potential Sources of Infectious Aerosols	PLOS ONE			English	Article							OXYGEN DELIVERY; DROPLETS; MASKS; TRANSPORT	Natural human exhalation flows such as coughing, sneezing and breathing can be considered as 'jet-like' airflows in the sense that they are produced from a single source in a single exhalation effort, with a relatively symmetrical, conical geometry. Although coughing and sneezing have garnered much attention as potential, explosive sources of infectious aerosols, these are relatively rare events during daily life, whereas breathing is necessary for life and is performed continuously. Real-time shadowgraph imaging was used to visualise and capture high-speed images of healthy volunteers sneezing and breathing (through the nose - nasally, and through the mouth - orally). Six volunteers, who were able to respond to the pepper sneeze stimulus, were recruited for the sneezing experiments (2 women: 27.5 +/- 6.36 years; 4 men: 29.25 +/- 10.53 years). The maximum visible distance over which the sneeze plumes (or puffs) travelled was 0.6 m, the maximum sneeze velocity derived from these measured distances was 4.5 m/s. The maximum 2-dimensional (2-D) area of dissemination of these sneezes was 0.2 m(2). The corresponding derived parameter, the maximum 2-D area expansion rate of these sneezes was 2 m(2)/s. For nasal breathing, the maximum propagation distance and derived velocity were 0.6 m and 1.4 m/s, respectively. The maximum 2-D area of dissemination and derived expansion rate were 0.11 m(2) and 0.16 m(2)/s, respectively. Similarly, for mouth breathing, the maximum propagation distance and derived velocity were 0.8 m and 1.3 m/s, respectively. The maximum 2-D area of dissemination and derived expansion rate were 0.18 m(2) and 0.17 m(2)/s, respectively. Surprisingly, a comparison of the maximum exit velocities of sneezing reported here with those obtained from coughing (published previously) demonstrated that they are relatively similar, and not extremely high. This is in contrast with some earlier estimates of sneeze velocities, and some reasons for this difference are discussed.	[Tang, Julian W.] Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada; [Tang, Julian W.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Nicolle, Andre D.; Klettner, Christian A.; Wang, Liangde; Bin Suhaimi, Amin; Tan, Ashlynn Y. L.; Ong, Garrett W. X.; Su, Ruikun] Natl Univ Singapore Hosp, Dept Lab Med, Singapore 117548, Singapore; [Pantelic, Jovan; Sekhar, Chandra; Cheong, David D. W.; Tham, Kwok Wai] Natl Univ Singapore, Dept Bldg, Sch Design & Environm, Singapore 117548, Singapore	University of Alberta; University of Alberta; National University of Singapore; National University of Singapore	Tang, JLW (corresponding author), Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Sekhar, Chandra/0000-0002-0814-8662; Pantelic, Jovan/0000-0001-7541-8274; Tang, Julian/0000-0002-4963-1028; Cheong, David/0000-0001-7680-4281	National Medical Research Council (NMRC) of Singapore [NMRC/1208/2009]	National Medical Research Council (NMRC) of Singapore(National Medical Research Council, Singapore)	This study was funded by the National Medical Research Council (NMRC) of Singapore by a grant awarded to JW Tang (the Principal Investigator) Ref: NMRC/1208/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Granville-Chapman J, 2007, BMJ-BRIT MED J, V335, P1293, DOI 10.1136/bmj.39422.578970.DE; Gupta JK, 2011, INDOOR AIR, V21, P341, DOI 10.1111/j.1600-0668.2011.00709.x; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Gupta JK, 2011, INDOOR AIR, V21, P3, DOI 10.1111/j.1600-0668.2010.00676.x; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Hui DS, 2007, CHEST, V132, P540, DOI 10.1378/chest.07-0636; Hui DS, 2006, CHEST, V130, P822, DOI 10.1378/chest.130.3.822; Inouye S, 2006, JPN J INFECT DIS, V59, P179; Ip M, 2007, AM J INFECT CONTROL, V35, P684, DOI 10.1016/j.ajic.2007.05.007; JAVORKA K, 1982, EUR J RESPIR DIS, V63, P442; Jennison MW, 1940, P SOC EXP BIOL MED, V43, P455; Jennison MW, 1942, AEROBIOLOGY, V17, P106, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1]; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; MAHAJAN RP, 1994, BRIT J ANAESTH, V72, P298, DOI 10.1093/bja/72.3.298; Somogyi R, 2004, CHEST, V125, P1155, DOI 10.1378/chest.125.3.1155; Songu Murat, 2009, Ther Adv Respir Dis, V3, P131, DOI 10.1177/1753465809340571; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034818; Tang JLW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021392; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; VanSciver M, 2011, AEROSOL SCI TECH, V45, P415, DOI 10.1080/02786826.2010.542785; Veiga J, 2009, CLINICS, V64, P649, DOI 10.1590/S1807-59322009000700008; Wells WF, 1955, AIR HYG ECOL STUDY D; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	27	158	162	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59970	10.1371/journal.pone.0059970	http://dx.doi.org/10.1371/journal.pone.0059970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560060	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900036
J	Jia, YP; Wood, F; Buehler, PW; Alayash, AI				Jia, Yiping; Wood, Francine; Buehler, Paul W.; Alayash, Abdu I.			Haptoglobin Preferentially Binds beta but Not alpha Subunits Cross-Linked Hemoglobin Tetramers with Minimal Effects on Ligand and Redox Reactions	PLOS ONE			English	Article							OXYGEN-BINDING; AUTOCATALYTIC OXIDATION; CHAINS; NITRITE; COMPLEX; MECHANISM; PEROXIDE; OXYHEMOGLOBIN; INTERMEDIATE; DECREASES	Human hemoglobin (Hb) and haptoglobin (Hp) exhibit an extremely high affinity for each other, and the dissociation of Hb tetramers into dimers is generally believed to be a prerequisite for complex formation. We have investigated Hp interactions with native Hb, alpha alpha, and beta beta cross-linked Hb (alpha alpha XLHb and beta beta XLHb, respectively), and rapid kinetics of Hb ligand binding as well as the redox reactivity in the presence of and absence of Hp. The quaternary conformation of beta beta subunit cross-linking results in a higher binding affinity than that of alpha alpha subunit cross-linked Hb. However, beta beta cross-linked Hb exhibits a four fold slower association rate constant than the reaction rate of unmodified Hb with Hp. The Hp contact regions in the Hb dimer interfaces appear to be more readily exposed in beta beta XLHb than alpha alpha XLHb. In addition, apart from the functional changes caused by chemical modifications, Hp binding does not induce appreciable effects on the ligand binding and redox reactions of beta beta XLHb. Our findings may therefore be relevant to the design of safer Hb-based oxygen therapeutics by utilizing this preferential binding of beta beta XLHb to Hp. This may ultimately provide a safe oxidative inactivation and clearance pathway for chemically modified Hbs in circulation.	[Jia, Yiping; Wood, Francine; Buehler, Paul W.; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Jia, YP (corresponding author), US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	yiping.jia@fda.hhs.gov			National Institutes of Health (NIH) [HL 110900]; U.S. Food and Drug Administration (MODSCI); H.H.S. Medical Counter Measures Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Food and Drug Administration (MODSCI); H.H.S. Medical Counter Measures Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grant HL 110900 (AIA), the U.S. Food and Drug Administration (MODSCI 2011) (AIA), and H.H.S. Medical Counter Measures Grant (PWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayash AI, 2011, CLIN CHIM ACTA, V412, P493, DOI 10.1016/j.cca.2010.12.011; Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Banerjee S, 2012, FREE RADICAL BIO MED, V53, P1317, DOI 10.1016/j.freeradbiomed.2012.07.023; BENESCH RE, 1976, J BIOL CHEM, V251, P465; BONAVENTURA C, 1991, J BIOL CHEM, V266, P23033; Bonaventura C, 2010, BBA-PROTEINS PROTEOM, V1804, P1988, DOI 10.1016/j.bbapap.2010.06.016; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; BUCCI E, 1989, J BIOL CHEM, V264, P6191; Buehler PW, 2008, ANTIOXID REDOX SIGN, V10, P1449, DOI 10.1089/ars.2008.2028; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; CARRICO RJ, 1978, J BIOL CHEM, V253, P2386; CHATTERJEE R, 1982, BIOCHEMISTRY-US, V21, P5901, DOI 10.1021/bi00266a027; CHIANCONE E, 1968, J MOL BIOL, V34, P347, DOI 10.1016/0022-2836(68)90258-1; COHENDIX P, 1973, BIOCHEMISTRY-US, V12, P3744, DOI 10.1021/bi00743a025; Cooper C. E., 2012, ANTIOXID REDOX SIGNA; Dalton J, 2009, Patent, Patent No. [US2009/0281282, 20090281282]; Highsmith FA, 1997, BIOLOGICALS, V25, P257, DOI 10.1006/biol.1997.0096; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Jia YP, 2004, BBA-GEN SUBJECTS, V1672, P164, DOI 10.1016/j.bbagen.2004.03.009; KOSAKA H, 1982, BIOCHIM BIOPHYS ACTA, V709, P187, DOI 10.1016/0167-4838(82)90460-5; KOSAKA H, 1982, BIOCHIM BIOPHYS ACTA, V702, P237; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Levy AP, 2010, ANTIOXID REDOX SIGN, V12, P293, DOI 10.1089/ars.2009.2793; Lissi E, 1998, FREE RADICAL BIO MED, V24, P1535, DOI 10.1016/S0891-5849(98)00004-5; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; NAGEL RL, 1971, J BIOL CHEM, V246, P69; Nielsen MJ, 2007, J BIOL CHEM, V282, P1072, DOI 10.1074/jbc.M605684200; Polticelli F, 2008, FEBS J, V275, P5648, DOI 10.1111/j.1742-4658.2008.06690.x; Roche CJ, 2012, NITRIC OXIDE-BIOL CH, V27, P32, DOI 10.1016/j.niox.2012.04.002; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; SNYDER SR, 1987, P NATL ACAD SCI USA, V84, P7280, DOI 10.1073/pnas.84.20.7280; VALETTE I, 1981, J BIOL CHEM, V256, P672; VANDEGRIFF KD, 1989, J BIOL CHEM, V264, P17824; VANDEGRIFF KD, 1991, J BIOL CHEM, V266, P17049; WALDER JA, 1979, BIOCHEMISTRY-US, V18, P4265, DOI 10.1021/bi00587a001	38	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59841	10.1371/journal.pone.0059841	http://dx.doi.org/10.1371/journal.pone.0059841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555800	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900032
J	Zhou, SC; Yan, JJ; Da, H; Yang, Y; Wang, N; Wang, WY; Ding, Y; Sun, SY				Zhou, Shuncheng; Yan, Juanjuan; Da, Hu; Yang, Yang; Wang, Na; Wang, Wenyong; Ding, Yin; Sun, Shiyao			A Correlational Study of Scoliosis and Trunk Balance in Adult Patients with Mandibular Deviation	PLOS ONE			English	Article							CRANIOFACIAL MORPHOLOGY; ORTHOGNATHIC SURGERY; MULTIPLE-REGRESSION; HEAD POSTURE; ASYMMETRY; MALOCCLUSION; CURVATURE; IMPLANTS; GROWTH	Previous studies have confirmed that patients with mandibular deviation often have abnormal morphology of their cervical vertebrae. However, the relationship between mandibular deviation, scoliosis, and trunk balance has not been studied. Currently, mandibular deviation is usually treated as a single pathology, which leads to poor clinical efficiency. We investigated the relationship of spine coronal morphology and trunk balance in adult patients with mandibular deviation, and compared the finding to those in healthy volunteers. 35 adult patients with skeletal mandibular deviation and 10 healthy volunteers underwent anterior X-ray films of the head and posteroanterior X-ray films of the spine. Landmarks and lines were drawn and measured on these films. The axis distance method was used to measure the degree of scoliosis and the balance angle method was used to measure trunk balance. The relationship of mandibular deviation, spine coronal morphology and trunk balance was evaluated with the Pearson correlation method. The spine coronal morphology of patients with mandibular deviation demonstrated an "S'' type curve, while a straight line parallel with the gravity line was found in the control group (significant difference, p < 0.01). The trunk balance of patients with mandibular deviation was disturbed (imbalance angle > 1 degrees), while the control group had a normal trunk balance (imbalance angle < 1 degrees). There was a significant difference between the two groups (p < 0.01). The degree of scoliosis and shoulder imbalance correlated with the degree of mandibular deviation, and presented a linear trend. The direction of mandibular deviation was the same as that of the lateral bending of thoracolumbar vertebrae, which was opposite to the direction of lateral bending of cervical vertebrae. Our study shows the degree of mandibular deviation has a high correlation with the degree of scoliosis and trunk imbalance, all the three deformities should be clinically evaluated in the management of mandibular deviation.	[Zhou, Shuncheng; Sun, Shiyao] 161th Hosp PLA, Dept Orthodont, Wuhan, Peoples R China; [Zhou, Shuncheng; Ding, Yin] Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Peoples R China; [Yan, Juanjuan; Wang, Na] Fourth Mil Med Univ, Dept Prosthet, Sch Stomatol, Xian 710032, Peoples R China; [Da, Hu] 82nd Hosp PLA, Dept Orthoped, Huaian, Peoples R China; [Yang, Yang] Fourth Mil Med Univ, Dept Cardiovasc Surg, Xijing Hosp, Xian 710032, Peoples R China; [Wang, Wenyong] Fourth Mil Med Univ, Dept Physiol & Pathophysiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Ding, Y (corresponding author), Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Peoples R China.	yang200214@163.com; yanwuliu210@126.com			National Natural Science Foundation of China [81102687]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (NO. 81102687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2005, AM J ORTHOD DENTOFAC, V128, P583, DOI 10.1016/j.ajodo.2004.06.038; Ben-Bassat Y, 2006, AM J ORTHOD DENTOFAC, V130, P629, DOI 10.1016/j.ajodo.2005.01.032; Cheong You-Wei, 2011, Chang Gung Med J, V34, P341; Chung KR, 2010, AM J ORTHOD DENTOFAC, V137, P135, DOI 10.1016/j.ajodo.2007.06.023; COOKE MS, 1990, AM J ORTHOD DENTOFAC, V97, P489, DOI 10.1016/S0889-5406(05)80029-0; Ferro F, 2011, AM J ORTHOD DENTOFAC, V140, P828, DOI 10.1016/j.ajodo.2011.08.003; Fudalej P, 2007, AM J ORTHOD DENTOFAC, V131, pS59, DOI 10.1016/j.ajodo.2006.07.022; Hashimoto T, 2009, AM J ORTHOD DENTOFAC, V136, P868, DOI 10.1016/j.ajodo.2007.06.022; He JW, 2009, SPINE, V34, pE323, DOI 10.1097/BRS.0b013e31819b2504; HUGGARE J, 1991, European Journal of Orthodontics, V13, P435; Hwang HS, 2009, AM J ORTHOD DENTOFAC, V136, P564, DOI 10.1016/j.ajodo.2007.10.060; Hwang HS, 2007, AM J ORTHOD DENTOFAC, V132, DOI 10.1016/j.ajodo.2007.01.017; Ito G, 1995, J AM DENT ASSOC, V48, P15; Kau CH, 2011, AM J ORTHOD DENTOFAC, V139, pE285, DOI 10.1016/j.ajodo.2009.03.054; Kokich VG, 2006, AM J ORTHOD DENTOFAC, V130, P437, DOI 10.1016/j.ajodo.2006.05.025; Kondo Etsuko, 2004, World J Orthod, V5, P9; Lippold Carsten, 2003, J Orofac Orthop, V64, P330, DOI 10.1007/s00056-003-0236-4; Lippold C, 2010, EUR SPINE J, V19, P427, DOI 10.1007/s00586-009-1218-z; LONSTEIN JE, 1982, J BONE JOINT SURG AM, V64, P481, DOI 10.2106/00004623-198264040-00002; MAKOFSKY HW, 1991, CRANIO, V9, P316, DOI 10.1080/08869634.1991.11678378; Oguri Y, 2003, J ORAL REHABIL, V30, P392, DOI 10.1046/j.1365-2842.2003.01040.x; Olsen TM, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.08.024; OZBEK MM, 1993, AM J ORTHOD DENTOFAC, V104, P584, DOI 10.1016/S0889-5406(05)80442-1; Perinetti G, 2010, CLINICS, V65, P689, DOI 10.1590/S1807-59322010000700007; PIRTTINIEMI P, 1990, EUR J ORTHODONT, V12, P408, DOI 10.1093/ejo/12.4.408; Saga AY, 2009, AM J ORTHOD DENTOFAC, V135, pS103, DOI 10.1016/j.ajodo.2008.08.019; Slota GP, 2008, CLIN BIOMECH, V23, P381, DOI 10.1016/j.clinbiomech.2007.11.006; Tecco S, 2007, EUR J ORTHODONT, V29, P204, DOI 10.1093/ejo/cjl061; Wakano S, 2011, J PROSTHODONT RES, V55, P228, DOI 10.1016/j.jpor.2011.03.001; You KH, 2010, AM J ORTHOD DENTOFAC, V138, DOI 10.1016/j.ajodo.2010.06.008	30	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59929	10.1371/journal.pone.0059929	http://dx.doi.org/10.1371/journal.pone.0059929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555836	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900044
J	Brazdova, M; Navratilova, L; Tichy, V; Nemcova, K; Lexa, M; Hrstka, R; Pecinka, P; Adamik, M; Vojtesek, B; Palecek, E; Deppert, W; Fojta, M				Brazdova, Marie; Navratilova, Lucie; Tichy, Vlastimil; Nemcova, Katerina; Lexa, Matej; Hrstka, Roman; Pecinka, Petr; Adamik, Matej; Vojtesek, Borivoj; Palecek, Emil; Deppert, Wolfgang; Fojta, Miroslav			Preferential Binding of Hot Spot Mutant p53 Proteins to Supercoiled DNA In Vitro and in Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; C-TERMINAL DOMAIN; OF-FUNCTION MUTATIONS; HUMAN TOPOISOMERASE-I; WILD-TYPE P53; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITIES; BAX PROMOTER; CORE DOMAIN; GAIN	Hot spot mutant p53 (mutp53) proteins exert oncogenic gain-of-function activities. Binding of mutp53 to DNA is assumed to be involved in mutp53-mediated repression or activation of several mutp53 target genes. To investigate the importance of DNA topology on mutp53-DNA recognition in vitro and in cells, we analyzed the interaction of seven hot spot mutp53 proteins with topologically different DNA substrates (supercoiled, linear and relaxed) containing and/or lacking mutp53 binding sites (mutp53BS) using a variety of electrophoresis and immunoprecipitation based techniques. All seven hot spot mutp53 proteins (R175H, G245S, R248W, R249S, R273C, R273H and R282W) were found to have retained the ability of wildtype p53 to preferentially bind circular DNA at native negative superhelix density, while linear or relaxed circular DNA was a poor substrate. The preference of mutp53 proteins for supercoiled DNA (supercoil-selective binding) was further substantiated by competition experiments with linear DNA or relaxed DNA in vitro and ex vivo. Using chromatin immunoprecipitation, the preferential binding of mutp53 to a sc mutp53BS was detected also in cells. Furthermore, we have shown by luciferase reporter assay that the DNA topology influences p53 regulation of BAX and MSP/MST1 promoters. Possible modes of mutp53 binding to topologically constrained DNA substrates and their biological consequences are discussed.	[Brazdova, Marie; Navratilova, Lucie; Tichy, Vlastimil; Nemcova, Katerina; Pecinka, Petr; Adamik, Matej; Palecek, Emil; Fojta, Miroslav] Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Vvi, CS-61265 Brno, Czech Republic; [Deppert, Wolfgang] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Tumor Virol, Hamburg, Germany; [Hrstka, Roman; Vojtesek, Borivoj] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno, Czech Republic; [Lexa, Matej] Masaryk Univ, Fac Informat, Brno, Czech Republic; [Pecinka, Petr] Univ Ostrava, Fac Sci, Ctr Environm, CZ-70103 Ostrava, Czech Republic; [Fojta, Miroslav] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Heinrich Pette Institute; Masaryk Memorial Cancer Institute; Masaryk University Brno; University of Ostrava; Masaryk University Brno	Brazdova, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic.	maruska@ibp.cz	Fojta, Miroslav/D-6971-2012; Lexa, Matej/A-1772-2011; Lexa, Matej/S-7256-2019; Tichy, Vlastimil/H-1913-2014; Brazdova, Marie/H-1924-2014; Palecek, Emil/C-1075-2013; Hrstka, Roman/AAM-4430-2020; Pečinka, Petr/H-8493-2014	Fojta, Miroslav/0000-0003-1854-6506; Lexa, Matej/0000-0002-4213-5259; Palecek, Emil/0000-0003-2561-8336; Hrstka, Roman/0000-0002-6139-2664; Pecinka, Petr/0000-0003-1270-3646; Adamik, Matej/0000-0003-0683-5853	Czech Science Foundation [P301/10/2370, 13-36108S, 204/06/P369, 204/08/1560, P301/11/1678, P301/11/2055]; Internal Grant Agency of the Ministry of Health of the CR [NT/13794-4/2012, RECAMO CZ. 1.05/2.1.00/03.0101]; Ministry of Education of the CR [1K04119]; Academy of Sciences of the CR [AV0Z50040702]; European commission [QLGA-CT-2001-52001, MERG-6-CT-2005-014875, EU - 502983]; Institute of Environmental Technologies [CZ.1.05/2.1.00/03.0100]; Jung Foundation for Science, Hamburg	Czech Science Foundation(Grant Agency of the Czech Republic); Internal Grant Agency of the Ministry of Health of the CR; Ministry of Education of the CR(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the CR(Czech Academy of Sciences); European commission(European CommissionEuropean Commission Joint Research Centre); Institute of Environmental Technologies; Jung Foundation for Science, Hamburg	This work was supported by the Czech Science Foundation (P301/10/2370, 13-36108S, 204/06/P369 and 204/08/1560, to MB; P301/11/1678 to BV; P301/11/2055 to EP), by the Internal Grant Agency of the Ministry of Health of the CR (NT/13794-4/2012 and RECAMO CZ. 1.05/2.1.00/03.0101 to BV), by the Ministry of Education of the CR (1K04119 to MB), by the Academy of Sciences of the CR (AV0Z50040702) and by the European commission (QLGA-CT-2001-52001 and MERG-6-CT-2005-014875 to MB, EU - 502983 to EP and to WD) and is a part of the project: Institute of Environmental Technologies, reg. no. CZ.1.05/2.1.00/03.0100. The senior professorship of WD is financially supported by the Jung Foundation for Science, Hamburg. The publication reflects only the authors' views and the Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albor A, 1998, CANCER RES, V58, P2091; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bi CP, 2004, BIOINFORMATICS, V20, P1477, DOI 10.1093/bioinformatics/bth304; Blandino G, 2012, CELL DEATH DIFFER, V19, P180, DOI 10.1038/cdd.2011.148; BOWATER R, 1992, METHOD ENZYMOL, V212, P105; Brazdova M, 2002, BIOELECTROCHEMISTRY, V55, P115, DOI 10.1016/S1567-5394(01)00137-2; Brazdova M, 2002, NUCLEIC ACIDS RES, V30, P4966, DOI 10.1093/nar/gkf616; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Cherny DI, 2005, BIOPHYS CHEM, V114, P261, DOI 10.1016/j.bpc.2004.12.042; Choe CY, 2011, GENE, V487, P52, DOI 10.1016/j.gene.2011.07.026; Deppert W, 1996, J CELL BIOCHEM, V62, P172, DOI 10.1002/(SICI)1097-4644(199608)62:2<172::AID-JCB5>3.0.CO;2-P; Deppert W, 2000, J CELL BIOCHEM, P115; El-Hizawi S, 2002, CANCER RES, V62, P3264; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fojta M, 2004, EUR J BIOCHEM, V271, P3865, DOI 10.1111/j.1432-1033.2004.04323.x; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; FOORD OS, 1991, NUCLEIC ACIDS RES, V19, P5191, DOI 10.1093/nar/19.19.5191; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Gobert C, 1999, P NATL ACAD SCI USA, V96, P10355, DOI 10.1073/pnas.96.18.10355; Gohler T, 2005, NUCLEIC ACIDS RES, V33, P1087, DOI 10.1093/nar/gki252; Grochova D, 2008, ONCOGENE, V27, P1243, DOI 10.1038/sj.onc.1210748; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; Jagelska EB, 2010, BIOCHEM BIOPH RES CO, V391, P1409, DOI 10.1016/j.bbrc.2009.12.076; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Kaku S, 2001, BIOCHEM BIOPH RES CO, V280, P204, DOI 10.1006/bbrc.2000.4060; Kim E, 2007, ONCOGENE, V26, P2185, DOI 10.1038/sj.onc.1210312; Kim E, 1999, ONCOGENE, V18, P7310, DOI 10.1038/sj.onc.1203139; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kim E, 2003, BIOCHEM CELL BIOL, V81, P141, DOI 10.1139/o03-046; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Koga H, 2000, ONCOGENE, V19, P4178, DOI 10.1038/sj.onc.1203745; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Lexa M, 2011, BIOINFORMATICS, V27, P2510, DOI 10.1093/bioinformatics/btr439; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mazur SJ, 1999, J MOL BIOL, V292, P241, DOI 10.1006/jmbi.1999.3064; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; MIDGLEY CA, 1992, J CELL SCI, V101, P183; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nemcova K, 2010, ANAL CHIM ACTA, V668, P166, DOI 10.1016/j.aca.2010.04.018; Nili EL, 2010, GENOME RES, V20, P1361, DOI 10.1101/gr.103945.109; O'Farrell TJ, 2004, CANCER RES, V64, P8199, DOI 10.1158/0008-5472.CAN-03-3639; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Palecek E, 2004, ONCOGENE, V23, P2119, DOI 10.1038/sj.onc.1207324; PALECEK E, 1991, CRIT REV BIOCHEM MOL, V26, P151, DOI 10.3109/10409239109081126; Palecek E, 1997, ONCOGENE, V15, P2201, DOI 10.1038/sj.onc.1201398; Palecek E, 1999, ONCOGENE, V18, P3617, DOI 10.1038/sj.onc.1202710; Palecek E, 2001, EUR J BIOCHEM, V268, P573, DOI 10.1046/j.1432-1327.2001.01898.x; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pivonkova H, 2006, BIOCHEM BIOPH RES CO, V339, P477, DOI 10.1016/j.bbrc.2005.11.038; Pivonkova H, 2010, BIOCH BIOPHYS RES CO; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Quante T, 2012, CELL CYCLE, V11, P3290, DOI 10.4161/cc.21646; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Scian MJ, 2004, ONCOGENE, V23, P4430, DOI 10.1038/sj.onc.1207553; Shi XB, 2002, PROSTATE, V51, P59, DOI 10.1002/pros.10072; SIF S, 1994, J VIROL, V68, P7131, DOI 10.1128/JVI.68.11.7131-7138.1994; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Soe K, 2003, NUCLEIC ACIDS RES, V31, P6585, DOI 10.1093/nar/gkg846; Solomon H, 2012, J CELL SCI, V125, P3144, DOI 10.1242/jcs.099663; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Vikhanskaya F, 2005, CLIN CANCER RES, V11, P4348, DOI 10.1158/1078-0432.CCR-04-1547; Vikhanskaya F, 2007, NUCLEIC ACIDS RES, V35, P2093, DOI 10.1093/nar/gkm099; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Walter K, 2005, J BIOL CHEM, V280, P42497, DOI 10.1074/jbc.M507038200; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Will K, 1998, P NATL ACAD SCI USA, V95, P13681, DOI 10.1073/pnas.95.23.13681; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yoshihara Y, 2012, BIOCHEM BIOPH RES CO, V421, P57, DOI 10.1016/j.bbrc.2012.03.108; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zotchev SB, 2000, NUCLEIC ACIDS RES, V28, P4005, DOI 10.1093/nar/28.20.4005	88	33	36	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59567	10.1371/journal.pone.0059567	http://dx.doi.org/10.1371/journal.pone.0059567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555710	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500055
J	Mirza, IA; Burk, DL; Xiong, B; Iwaki, H; Hasegawa, Y; Grosse, S; Lau, PCK; Berghuis, AM				Mirza, I. Ahmad; Burk, David L.; Xiong, Bing; Iwaki, Hiroaki; Hasegawa, Yoshie; Grosse, Stephan; Lau, Peter C. K.; Berghuis, Albert M.			Structural Analysis of a Novel Cyclohexylamine Oxidase from Brevibacterium oxydans IH-35A	PLOS ONE			English	Article							EMPIRICAL FORCE-FIELD; MONOAMINE-OXIDASE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; OXIDATION; SUBSTRATE; INSIGHTS; TARGET	Cyclohexylamine oxidase (CHAO) is a flavoprotein first described in Brevibacterium oxydans strain IH-35A that carries out the initial step of the degradation of the industrial chemical cyclohexylamine to cyclohexanone. We have cloned and expressed in Escherichia coli the CHAO-encoding gene (chaA) from B. oxydans, purified CHAO and determined the structures of both the holoenzyme form of the enzyme and a product complex with cyclohexanone. CHAO is a 50 kDa monomer with a PHBH fold topology. It belongs to the flavin monooxygenase family of enzymes and exhibits high substrate specificity for alicyclic amines and sec-alkylamines. The overall structure is similar to that of other members of the flavin monooxygenase family, but lacks either of the C- or N-terminal extensions observed in these enzymes. Active site features of the flavin monooxygenase family are conserved in CHAO, including the characteristic aromatic cage. Differences in the orientations of residues of the CHAO aromatic cage result in a substrate-binding site that is more open than those of its structural relatives. Since CHAO has a buried hydrophobic active site with no obvious route for substrates and products, a random acceleration molecular dynamics simulation has been used to identify a potential egress route. The path identified includes an intermediate cavity and requires transient conformation changes in a shielding loop and a residue at the border of the substrate-binding cavity. These results provide a foundation for further studies with CHAO aimed at identifying features determining substrate specificity and for developing the biocatalytic potential of this enzyme.	[Mirza, I. Ahmad; Burk, David L.; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Mirza, I. Ahmad; Burk, David L.; Berghuis, Albert M.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ, Canada; [Xiong, Bing] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Iwaki, Hiroaki; Hasegawa, Yoshie] Kansai Univ, Dept Life Sci & Biotechnol, Suita, Osaka, Japan; [Iwaki, Hiroaki; Hasegawa, Yoshie] Kansai Univ, ORDIST, Suita, Osaka, Japan; [Grosse, Stephan; Lau, Peter C. K.] Natl Res Council Canada, Montreal, PQ, Canada; [Lau, Peter C. K.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Lau, Peter C. K.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Lau, Peter C. K.] FQRNT Ctr Green Chem & Catalysis, Montreal, PQ, Canada	McGill University; McGill University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Kansai University; Kansai University; National Research Council Canada; McGill University; McGill University	Lau, PCK (corresponding author), Natl Res Council Canada, Montreal, PQ, Canada.	peter.lau@cnrc-nrc.gc.ca; albert.berghuis@mcgill.ca	Xiong, Bing/B-8849-2008; Berghuis, Albert M/A-6495-2008; Xiong, Bin/L-7560-2019	Xiong, Bing/0000-0001-9776-8136; Xiong, Bin/0000-0001-9776-8136; Berghuis, Albert/0000-0002-2663-025X	Natural Sciences and Engineering Research Council of Canada [RGPIN-183867]; Canadian Institutes of Health Research [MOP-48370]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The research was made possible throughout grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca)(RGPIN-183867) and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) (MOP-48370) awarded to AMB. AMB holds a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva M, 2002, ANGEW CHEM INT EDIT, V41, P3177, DOI 10.1002/1521-3773(20020902)41:17<3177::AID-ANIE3177>3.0.CO;2-P; Atkin KE, 2008, J MOL BIOL, V384, P1218, DOI 10.1016/j.jmb.2008.09.090; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carr R, 2005, CHEMBIOCHEM, V6, P637, DOI 10.1002/cbic.200400329; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Eve TSC, 2007, CHEM COMMUN, P1530, DOI 10.1039/b617537f; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Hartmann C, 1997, METHOD ENZYMOL, V280, P98; Iwaki H, 1999, APPL ENVIRON MICROB, V65, P2232; Iwaki H, 1999, J BIOSCI BIOENG, V88, P264, DOI 10.1016/S1389-1723(00)80007-9; Kohler V, 2010, ANGEW CHEM INT EDIT, V49, P2182, DOI 10.1002/anie.200906655; Leisch H, 2012, CAN J CHEM, V90, P39, DOI 10.1139/V11-086; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Li M, 2006, BIOCHEMISTRY-US, V45, P4775, DOI 10.1021/bi051847g; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Ma JC, 2004, J MOL BIOL, V338, P103, DOI 10.1016/j.jmb.2004.02.032; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sablin SO, 1998, EUR J BIOCHEM, V253, P270, DOI 10.1046/j.1432-1327.1998.2530270.x; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Stahl SM, 2008, CNS SPECTRUMS, V13, P855, DOI 10.1017/S1092852900016965; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Hellemond EW, 2008, APPL MICROBIOL BIOT, V78, P455, DOI 10.1007/s00253-007-1310-4; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; WIERENGA RK, 1979, J MOL BIOL, V131, P55, DOI 10.1016/0022-2836(79)90301-2; Yachnin BJ, 2012, J AM CHEM SOC, V134, P7788, DOI 10.1021/ja211876p	37	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60072	10.1371/journal.pone.0060072	http://dx.doi.org/10.1371/journal.pone.0060072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555888	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500116
J	Pang, CC; Scharaschkin, T; Su, YCF; Saunders, RMK				Pang, Chun-Chiu; Scharaschkin, Tanya; Su, Yvonne C. F.; Saunders, Richard M. K.			Functional Monoecy Due to Delayed Anther Dehiscence: A Novel Mechanism in Pseuduvaria mulgraveana (Annonaceae)	PLOS ONE			English	Article							BEETLE POLLINATION; ECOLOGICAL ASPECTS; FLOWER EVOLUTION; GENERIC STATUS; GENUS; PHYLOGENY; BIOLOGY	Unlike most genera in the early-divergent angiosperm family Annonaceae, Pseuduvaria exhibits a diversity of floral sex expression. Most species are structurally andromonoecious (or possibly androdioecious), although the hermaphroditic flowers have been inferred to be functionally pistillate, with sterile staminodes. Pseuduvaria presents an ideal model for investigating the evolution of floral sex in early-divergent angiosperms, although detailed empirical studies are currently lacking. The phenology and pollination ecology of the Australian endemic species Pseuduvaria mulgraveana are studied in detail, including evaluations of floral scent chemistry, pollen viability, and floral visitors. Results showed that the flowers are pollinated by small diurnal nitidulid beetles and are protogynous. Pollen from both hermaphroditic and staminate flowers are shown to be equally viable. The structurally hermaphroditic flowers are nevertheless functionally pistillate as anther dehiscence is delayed until after petal abscission and hence after the departure of pollinators. This mechanism to achieve functional unisexuality of flowers has not previously been reported in angiosperms. It is known that protogyny is widespread amongst early-divergent angiosperms, including the Annonaceae, and is effective in preventing autogamy. Delayed anther dehiscence represents a further elaboration of this, and is effective in preventing geitonogamy since very few sexually mature flowers occur simultaneously in an individual. We highlight the necessity for field-based empirical interpretations of functional floral sex expression prior to evaluations of evolutionary processes.	[Pang, Chun-Chiu; Su, Yvonne C. F.; Saunders, Richard M. K.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Scharaschkin, Tanya] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Su, Yvonne C. F.] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Hong Kong; Queensland University of Technology (QUT); National University of Singapore	Saunders, RMK (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	saunders@hku.hk	Saunders, Richard M. K./A-7436-2008	Saunders, Richard M. K./0000-0002-8104-7761	University of Hong Kong Research Committee	University of Hong Kong Research Committee(University of Hong Kong)	This research was funded by a grant from the University of Hong Kong Research Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanayake AMAS, 2010, THESIS U HONG KONG C; Azuma H, 2001, J PLANT RES, V114, P411, DOI 10.1007/PL00014006; Bakker, 2000, ANNONACEAE GENERA WO; Chatrou L. W, 1998, CHANGING GENERA SYST, P105; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; Dafni A., 1992, POLLINATION ECOLOGY; ELSAYED AM, 2006, PHEROBASE DATABASE I; Endress PK, 2010, PHILOS T R SOC B, V365, P411, DOI 10.1098/rstb.2009.0228; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P165, DOI 10.1007/BF00936404; Gottsberger G, 2011, FLORA, V206, P498, DOI 10.1016/j.flora.2010.08.005; Jurgens A, 2000, PHYTOCHEMISTRY, V55, P551, DOI 10.1016/S0031-9422(00)00241-7; Kenfack D, 2003, NOVON, V13, P443, DOI 10.2307/3393377; Kovats E, 1965, ADV CHROMATOGR, V1, P229; LLOYD DG, 1980, EVOLUTION, V34, P123, DOI 10.1111/j.1558-5646.1980.tb04795.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; MAAS P J M, 1984, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V105, P73; MAAS P J M, 1985, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V105, P145; MORAWETZ W, 1988, PLANT SYST EVOL, V159, P49, DOI 10.1007/BF00937425; Oliveira Jorge, 1999, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V15, P117; Pang CC, 2011, THESIS U HONG KONG C; Ratnayake RMCS, 2007, INT J PLANT SCI, V168, P1255, DOI 10.1086/521689; Ratnayake RMCS, 2006, INT J PLANT SCI, V167, P483, DOI 10.1086/502715; Richards A.J, 1997, PLANT BREEDING SYSTE; Sakai S, 2002, J PLANT RES, V115, P161, DOI 10.1007/s102650200021; Saunders RMK, 2012, BOT J LINN SOC, V169, P222, DOI 10.1111/j.1095-8339.2011.01208.x; Saunders RMK, 2010, BIOL REV, V85, P571, DOI 10.1111/j.1469-185X.2009.00116.x; Saunders RMK, 2004, SYST BOT, V29, P42, DOI 10.1600/036364404772974202; Schatz G.E., 1990, Man and the Biosphere Series, V7, P69; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Silberbauer-Gottsberger I, 1997, ANNONACEAE NEWSL, V11, P55; Su Y.C.F., 2006, SYSTEMATIC BOT MONOG, V79, P1; Su YCF, 2005, SYST BOT, V30, P494, DOI 10.1600/0363644054782189; Su YCF, 2008, MOL PHYLOGENET EVOL, V48, P188, DOI 10.1016/j.ympev.2008.03.028; Su YCF, 2010, SYST BOT, V35, P30, DOI 10.1600/036364410790862533; Takahashi M, 2008, INT J PLANT SCI, V169, P908, DOI 10.1086/589693; Tucker NIJ, 1997, FOREST ECOL MANAG, V99, P133, DOI 10.1016/S0378-1127(97)00200-4; Turner I. M., 2010, Malayan Nature Journal, V62, P359; VANDERPIJL L, 1960, EVOLUTION, V14, P403, DOI 10.2307/2405990; VANDERPIJL L, 1961, EVOLUTION, V15, P44, DOI 10.2307/2405842; VANHEUSDEN ECH, 1995, BLUMEA, V40, P429; VERDCOURT B, 1969, Adansonia, V9, P87; Webber AC, 1993, ANNONACEAE NEWSLETTE, V9, P25; Weerasooriya AD., 2010, SYSTEMATIC BOT MONOG; Westra L. Y. T., 1995, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V117, P273	46	10	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59951	10.1371/journal.pone.0059951	http://dx.doi.org/10.1371/journal.pone.0059951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555844	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500108
J	Weber, NS; Fisher, JA; Cowan, DN; Postolache, TT; Larsen, RA; Niebuhr, DW				Weber, Natalya S.; Fisher, Jared A.; Cowan, David N.; Postolache, Teodor T.; Larsen, Rakel A.; Niebuhr, David W.			Descriptive Epidemiology and Underlying Psychiatric Disorders among Hospitalizations with Self-Directed Violence	PLOS ONE			English	Article							ATTEMPTED-SUICIDE; UNITED-STATES; HARM; LETHALITY; INJURY; ADULTS; INTENT; RATES; RISK	Background: Suicide claims over one million lives worldwide each year. In the United States, 1 per 10,000 persons dies from suicide every year, and these rates have remained relatively constant over the last 20 years. There are nearly 25 suicide attempts for each suicide, and previous self-directed violence is a strong predictor of death from suicide. While many studies have focused on suicides, the epidemiology of non-fatal self-directed violence is not well-defined. Objective: We used a nationally representative survey to examine demographics and underlying psychiatric disorders in United States (US) hospitalizations with non-fatal self-directed violence (SDV). Method: International Classification of Disease, 9th Revision (ICD-9) discharge diagnosis data from the National Hospital Discharge Survey (NHDS) were examined from 1997 to 2006 using frequency measures and adjusted logistic regression. Results: The rate of discharges with SDV remained relatively stable over the study time period with 4.5 to 5.7 hospitalizations per 10,000 persons per year. Excess SDV was documented for females, adolescents, whites, and those from the Midwest or West. While females had a higher likelihood of self-poisoning, both genders had comparable proportions of hospitalizations with SDV resulting in injury. Over 86% of the records listing SDV also included psychiatric disorders, with the most frequent being affective (57.8%) and substance abuse (37.1%) disorders. The association between psychiatric disorders and self-injury was strongest for personality disorders for both males (OR = 2.1; 95% CI = 1.3-3.4) and females (OR = 3.8; 95% CI = 2.7-5.3). Conclusion: The NHDS provides new insights into the demographics and psychiatric morbidity of those hospitalized with SDV. Classification of SDV as self-injury or self-poisoning provides an additional parameter useful to epidemiologic studies.	[Weber, Natalya S.; Fisher, Jared A.; Cowan, David N.; Larsen, Rakel A.; Niebuhr, David W.] Walter Reed Army Inst Res, Prevent Med Program, Silver Spring, MD USA; [Fisher, Jared A.; Cowan, David N.; Larsen, Rakel A.] Allied Technol Grp Inc, Rockville, MD USA; [Postolache, Teodor T.] Univ Maryland, Sch Med, Dept Psychiat, Mood & Anxiety Program, Baltimore, MD 21201 USA; [Niebuhr, David W.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA	Weber, NS (corresponding author), Walter Reed Army Inst Res, Prevent Med Program, Silver Spring, MD USA.	Natalya.Weber@us.army.mil		Postolache, Teodor/0000-0001-6056-4244	Stanley Medical Research Institute, Bethesda, MD, (CRADA) [DAMD17-04-0041]; Department of the Army; Walter Reed Army Institute of Research (WRAIR)	Stanley Medical Research Institute, Bethesda, MD, (CRADA); Department of the Army; Walter Reed Army Institute of Research (WRAIR)	The effort is funded by the Stanley Medical Research Institute, Bethesda, MD, (CRADA# DAMD17-04-0041, http://www.stanleyresearch.org/dnn/ResearchGrants/Overview/tabid/156/Default.aspx) and the Department of the Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ATG has had a service support contract with the Walter Reed Army Institute of Research (WRAIR) for over 15 years. ATG personnel include epidemiologists and statisticians who support and collaborate with the WRAIR researchers. ATG staff are all at the master's or doctoral level of training, and they assist in the design, analysis, interpretation and presentation of studies, and in writing and publishing of manuscripts for peer-reviewed journals. There is no financial or other conflict of interest between ATG staff and any of the research with which they participate. ATG and its staff members are contractors with no vested interests in the results, conclusions, and recommendations resulting from any research and have no interests related to employment, consultancy, patents, products in development or marketed products, or any other aspect of this research. Even though Natalya S. Weber, M. D., M. P. H., is a PLOS One Editorial board member, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2012, NAT HOSP DISCH SURV; [Anonymous], 2000, DIAGN STAT MAN MENT, P385; Bailey RK, 2011, J NATL MED ASSOC, V103, P614, DOI 10.1016/S0027-9684(15)30388-6; Bergen H, 2012, J AFFECT DISORDERS, V136, P526, DOI 10.1016/j.jad.2011.10.036; Bertolote Jose Manoel, 2004, Crisis, V25, P147, DOI 10.1027/0227-5910.25.4.147; Bolton JM, 2010, AM J PUBLIC HEALTH, V100, P2473, DOI 10.2105/AJPH.2010.192252; Caine ED, 2001, INT CLIN PSYCHOPHARM, V16, pS25, DOI 10.1097/00004850-200103002-00005; Center for Disease Control & Prevention (CDC), 2012, WEB BAS INJ STAT QUE; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Crosby A., 2011, SELF DIRECTED VIOLEN; Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Leo D, 2001, INT J GERIATR PSYCH, V16, P300, DOI 10.1002/gps.337.abs; Dennison C, 2000, Vital Health Stat 1, P1; Dombrovski AY, 2008, AM J GERIAT PSYCHIAT, V16, P905, DOI 10.1097/JGP.0b013e3181860034; Doshi A, 2005, ANN EMERG MED, V46, P369, DOI 10.1016/j.annemergmed.2005.04.018; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; Gabbard G O, 2000, J Psychother Pract Res, V9, P1; Goodman M, 2000, Curr Psychiatry Rep, V2, P56, DOI 10.1007/s11920-000-0043-1; Harriss L, 2005, BRIT J PSYCHIAT, V186, P60, DOI 10.1192/bjp.186.1.60; Haw C, 2003, SUICIDE LIFE-THREAT, V33, P353, DOI 10.1521/suli.33.4.353.25232; Houston K, 2001, J AFFECT DISORDERS, V63, P159, DOI 10.1016/S0165-0327(00)00175-0; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Kausch O, 2003, J CLIN PSYCHIAT, V64, P1031, DOI 10.4088/JCP.v64n0908; Lubin G, 2010, SUICIDE LIFE-THREAT, V40, P421, DOI 10.1521/suli.2010.40.5.421; Lundin A, 2011, ACTA PSYCHIAT SCAND, V124, P454, DOI 10.1111/j.1600-0447.2011.01752.x; Mann JJ, 2002, ANN INTERN MED, V136, P302, DOI 10.7326/0003-4819-136-4-200202190-00010; MEEHAN PJ, 1992, AM J PSYCHIAT, V149, P41; Miller M, 2002, EPIDEMIOLOGY, V13, P517, DOI 10.1097/00001648-200209000-00006; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; National Center for Health Statistics, 1999, HOSP PAY INT CLASS D; NIMEUS A., 2002, ARCH SUICIDE RES, V6, P211, DOI DOI 10.1080/13811110214142; Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x; Patrick AR, 2010, PHARMACOEPIDEM DR S, V19, P1263, DOI 10.1002/pds.2037; Rhodes Anne E, 2002, Chronic Dis Can, V23, P139; RICH CL, 1988, ARCH GEN PSYCHIAT, V45, P589, DOI 10.1001/archpsyc.1988.01800300087012; RUNESON B, 1989, ACTA PSYCHIAT SCAND, V79, P490, DOI 10.1111/j.1600-0447.1989.tb10292.x; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; U.S. Department of Health and HumanServices (HHS), 2012, 2012 NAT STRAT SUIC; Wilkinson P, 2011, EUR CHILD ADOLES PSY, V20, P103, DOI 10.1007/s00787-010-0156-y; Zanni Guido R, 2010, Consult Pharm, V25, P93, DOI 10.4140/TCP.n.2010.93	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59818	10.1371/journal.pone.0059818	http://dx.doi.org/10.1371/journal.pone.0059818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555791	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500094
J	Longo, AV; Rodriguez, D; Leite, DD; Toledo, LF; Almeralla, CM; Burrowes, PA; Zamudio, KR				Longo, Ana V.; Rodriguez, David; Leite, Domingos da Silva; Toledo, Luis Felipe; Mendoza Almeralla, Cinthya; Burrowes, Patricia A.; Zamudio, Kelly R.			ITS1 Copy Number Varies among Batrachochytrium dendrobatidis Strains: Implications for qPCR Estimates of Infection Intensity from Field-Collected Amphibian Skin Swabs	PLOS ONE			English	Article							QUANTITATIVE PCR; FUNGAL PATHOGEN; CHYTRIDIOMYCOSIS; DYNAMICS; DNA	Genomic studies of the amphibian-killing fungus (Batrachochytrium dendrobatidis, [Bd]) identified three highly divergent genetic lineages, only one of which has a global distribution. Bd strains within these linages show variable genomic content due to differential loss of heterozygosity and recombination. The current quantitative polymerase chain reaction (qPCR) protocol to detect the fungus from amphibian skin swabs targets the intergenic transcribed spacer 1 (ITS1) region using a TaqMan fluorescent probe specific to Bd. We investigated the consequences of genomic differences in the quantification of ITS1 from eight distinct Bd strains, including representatives from North America, South America, the Caribbean, and Australia. To test for potential differences in amplification, we compared qPCR standards made from Bd zoospore counts for each strain, and showed that they differ significantly in amplification rates. To test potential mechanisms leading to strain differences in qPCR reaction parameters (slope and y-intercept), we: a) compared standard curves from the same strains made from extracted Bd genomic DNA in equimolar solutions, b) quantified the number of ITS1 copies per zoospore using a standard curve made from PCR-amplicons of the ITS1 region, and c) cloned and sequenced PCR-amplified ITS1 regions from these same strains to verify the presence of the probe site in all haplotypes. We found high strain variability in ITS1 copy number, ranging from 10 to 144 copies per single zoospore. Our results indicate that genome size might explain strain differences in ITS1 copy number, but not ITS1 sequence variation because the probe-binding site and primers were conserved across all haplotypes. For standards constructed from uncharacterized Bd strains, we recommend the use of single ITS1 PCR-amplicons as the absolute standard in conjunction with current quantitative assays to inform on copy number variation and provide universal estimates of pathogen zoospore loads from field-caught amphibians.	[Longo, Ana V.; Rodriguez, David; Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Leite, Domingos da Silva] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Antigenos Bacterianos 2, Campinas, SP, Brazil; [Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Museu Zool Prof Adao Jose Cardoso, Campinas, SP, Brazil; [Mendoza Almeralla, Cinthya] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Burrowes, Patricia A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	Cornell University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidad Nacional Autonoma de Mexico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Longo, AV (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	avl7@cornell.edu	Toledo, Luís Felipe/I-4017-2012; Leite, Domingos/L-4531-2013; Longo, Ana V./AAH-1522-2020; Zamudio, Kelly/R-3533-2016; Leite, Domingos S/D-4365-2012	Toledo, Luís Felipe/0000-0002-4929-9598; Leite, Domingos/0000-0002-0946-4165; Longo, Ana V./0000-0002-5112-1246; Zamudio, Kelly/0000-0001-5107-6206; Da Silva Leite, Domingos/0000-0003-4737-7852	National Science Foundation [DEB-0815315, DEB-1120249, DBI-0905810]; SUNY/Sage Diversity Fellowships; Ford Foundation's Pre-Doctoral Fellowship; Cornell Open Access Publication Fund; Cornell University Office of the University Provost; Cornell University Library; Direct For Biological Sciences [1120249] Funding Source: National Science Foundation; Office Of The Director [1159513] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); SUNY/Sage Diversity Fellowships; Ford Foundation's Pre-Doctoral Fellowship; Cornell Open Access Publication Fund; Cornell University Office of the University Provost; Cornell University Library; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was funded by National Science Foundation grants DEB-0815315, DEB-1120249, and DBI-0905810 (to DR). SUNY/Sage Diversity Fellowships and Ford Foundation's Pre-Doctoral Fellowship supported of the authors (AVL). A percentage of the funding for the author publication charges came from the Cornell Open Access Publication Fund (http://compact.library.cornell.edu), which is funded jointly by the Cornell University Office of the University Provost and Cornell University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Dorak M.T., 2006, REAL TIME PCR, P89; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Rosenblum EB, 2010, DIS AQUAT ORGAN, V92, P131, DOI 10.3354/dao02179; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Whiley DA, 2005, J CLIN VIROL, V34, P104, DOI 10.1016/j.jcv.2005.02.010	20	76	78	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59499	10.1371/journal.pone.0059499	http://dx.doi.org/10.1371/journal.pone.0059499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555682	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400045
J	Vaportzis, E; Georgiou-Karistianis, N; Stout, JC				Vaportzis, Eleftheria; Georgiou-Karistianis, Nellie; Stout, Julie C.			Dual Task Performance in Normal Aging: A Comparison of Choice Reaction Time Tasks	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DIVIDED-ATTENTION; WORKING-MEMORY; BRAIN ACTIVATION; POSTURAL CONTROL; SPEED; ADULTS; YOUNG; OLDER; GENERATION	This study examined dual task performance in 28 younger (18-30 years) and 28 older (>60 years) adults using two sets of choice reaction time (RT) tasks paired with digit tasks. Set one paired simple choice RT with digit forward; set two paired complex choice RT with digit backward. Each task within each set had easy and hard conditions. For the simple choice RT, participants viewed single letters and pressed a specified keyboard key if the letter was X or Z or a different key for other letters (easy). For the hard condition, there were 4 target letters (X, Z, O, Y). Digit forward consisted of 4 (easy) or 5 (hard) digits. For the complex choice RT, participants viewed 4 x 4 matrices of Xs and Os, and indicated whether four Xs (easy) or four Xs or four Os (hard) appeared in a row. Digit backward consisted of 3 (easy) or 4 (hard) digits. Within each set, participants performed every possible combination of tasks. We found that in the simple choice RT tasks older adults were significantly slower than, but as accurate as younger adults. In the complex choice RT tasks, older adults were significantly less accurate, but as fast as younger adults. For both age groups and both dual task sets, RT decreased and error rates increased with greater task difficulty. Older adults had greater dual task costs for error rates in the simple choice RT, whereas in the complex choice RT, it was the younger group that had greater dual task costs. Findings suggest that younger and older adults may adopt differential behavioral strategies depending on complexity and difficulty of dual tasks.	[Vaportzis, Eleftheria; Georgiou-Karistianis, Nellie; Stout, Julie C.] Monash Univ, Sch Psychol & Psychiat, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia	Monash University	Stout, JC (corresponding author), Monash Univ, Sch Psychol & Psychiat, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia.	julie.stout@monash.edu	Georgiou-Karistianis, Nellie/ABC-5623-2020; Georgiou-Karistianis, Nellie/H-9727-2014; Vaportzis, Eleftheria/A-5531-2016	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Stout, Julie/0000-0001-9637-8590; Vaportzis, Eleftheria/0000-0002-0522-5095	School of Psychology and Psychiatry, Monash University	School of Psychology and Psychiatry, Monash University(Monash University)	Financial support for this study was obtained from the School of Psychology and Psychiatry, Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BABCOCK RL, 1990, PSYCHOL AGING, V5, P421, DOI 10.1037/0882-7974.5.3.421; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BENTON A, 1986, CORTEX, V22, P129, DOI 10.1016/S0010-9452(86)80037-5; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; BORS DA, 1995, INTELLIGENCE, V20, P229, DOI 10.1016/0160-2896(95)90009-8; Brebion G, 2003, EXP AGING RES, V29, P269, DOI 10.1080/03610730303725; Cho CY, 2008, GERONTOLOGY, V54, P120, DOI 10.1159/000118603; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Ribaupierre A, 2003, EXP AGING RES, V29, P79, DOI 10.1080/03610730303705; Deary IJ, 2010, PSYCHOL AGING, V25, P219, DOI 10.1037/a0017750; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Goble DJ, 2010, HUM BRAIN MAPP, V31, P1281, DOI 10.1002/hbm.20943; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; HAWKINS HL, 1992, PSYCHOL AGING, V7, P643, DOI 10.1037/0882-7974.7.4.643; Hein G, 2004, PSYCHOL AGING, V19, P416, DOI 10.1037/0882-7974.19.3.416; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Ivanoff J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002635; Kemper S, 2003, PSYCHOL AGING, V18, P181, DOI 10.1037/0882-7974.18.2.181; Kemper S, 2011, AGING NEUROPSYCHOL C, V18, P257, DOI 10.1080/13825585.2010.527317; Kemper S, 2009, AGING NEUROPSYCHOL C, V16, P241, DOI 10.1080/13825580802438868; Kolev V, 2006, NEUROBIOL AGING, V27, P1719, DOI 10.1016/j.neurobiolaging.2005.09.027; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; Loose R, 2006, BRAIN RES, V1090, P146, DOI 10.1016/j.brainres.2006.03.039; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Matthews A, 2006, NEUROSCI LETT, V400, P172, DOI 10.1016/j.neulet.2006.02.043; MCDOWD JM, 1988, J EXP PSYCHOL HUMAN, V14, P267, DOI 10.1037/0096-1523.14.2.267; McPhee LC, 2004, HUM FACTORS, V46, P674, DOI 10.1518/hfes.46.4.674.56817; Mendelson DN, 2010, AGING NEUROPSYCHOL C, V17, P1, DOI 10.1080/13825580902914040; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; MOORE H, 1992, NEUROBIOL AGING, V13, P759, DOI 10.1016/0197-4580(92)90100-C; Muller SV, 2002, J CLIN EXP NEUROPSYC, V24, P517, DOI 10.1076/jcen.24.4.517.1043; Murray LL, 1998, J SPEECH LANG HEAR R, V41, P213, DOI 10.1044/jslhr.4101.213; Mutter SA, 1997, J GERONTOL B-PSYCHOL, V52, pP319, DOI 10.1093/geronb/52B.6.P319; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rush AJ, 2006, INT J METH PSYCH RES, V9, P45, DOI DOI 10.1002/MPR.79]; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Swanenburg J, 2010, OPEN REHABIL J, V3, P169, DOI DOI 10.2174/1874943701003010169; UNESCO, 2006, INT STANDARD CLASSIF; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Wechsler D., 2001, WECHSLER TEST ADULT; Williams BR, 2005, NEUROPSYCHOLOGY, V19, P88, DOI 10.1037/0894-4105.19.1.88; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042	55	35	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60265	10.1371/journal.pone.0060265	http://dx.doi.org/10.1371/journal.pone.0060265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555937	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400084
J	Castillo-Rojas, G; Mazari-Hiriart, M; de Leon, SP; Amieva-Fernandez, RI; Agis-Juarez, RA; Huebner, J; Lopez-Vidal, Y				Castillo-Rojas, Gonzalo; Mazari-Hiriart, Marisa; Ponce de Leon, Sergio; Amieva-Fernandez, Rosa I.; Agis-Juarez, Raul A.; Huebner, Johannes; Lopez-Vidal, Yolanda			Comparison of Enterococcus faecium and Enterococcus faecalis Strains Isolated from Water and Clinical Samples: Antimicrobial Susceptibility and Genetic Relationships	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; GENOTYPIC CHARACTERIZATION; IDENTIFICATION; RESISTANCE; PCR; MICROSCAN; DIVERSITY; SPP.; PFGE	Enterococci are part of the normal intestinal flora in a large number of mammals, and these microbes are currently used as indicators of fecal contamination in water and food for human consumption. These organisms are considered one of the primary causes of nosocomial and environmental infections due to their ability to survive in the environment and to their intrinsic resistance to antimicrobials. The aims of this study were to determine the biochemical patterns and antimicrobial susceptibilities of Enterococcus faecalis and E. faecium isolates from clinical samples and from water (groundwater, water from the Xochimilco wetland, and treated water from the Mexico City Metropolitan Area) and to determine the genetic relationships among these isolates. A total of 121 enterococcus strains were studied; 31 and 90 strains were isolated from clinical samples and water (groundwater, water from the Xochimilco wetland, and water for agricultural irrigation), respectively. Identification to the species level was performed using a multiplex PCR assay, and antimicrobial profiles were obtained using a commercial kit. Twenty-eight strains were analyzed by pulsed-field gel electrophoresis (PFGE). E. faecium strains isolated from water showed an atypical biochemical pattern. The clinical isolates showed higher resistance to antibiotics than those from water. Both the enterococci isolated from humans, and those isolated from water showed high genetic diversity according to the PFGE analysis, although some strains seemed to be closely related. In conclusion, enterococci isolated from humans and water are genetically different. However, water represents a potential route of transmission to the community and a source of antimicrobial resistance genes that may be readily transmitted to other, different bacterial species.	[Castillo-Rojas, Gonzalo; Amieva-Fernandez, Rosa I.; Agis-Juarez, Raul A.; Lopez-Vidal, Yolanda] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico; [Mazari-Hiriart, Marisa] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Ecol Quim, Mexico City 04510, DF, Mexico; [Ponce de Leon, Sergio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Serv Paramed, Mexico City, DF, Mexico; [Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Freiburg	Lopez-Vidal, Y (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico.	lvidal@unam.mx	López-Vidal, Yolanda/ABE-9501-2021	López-Vidal, Yolanda/0000-0001-7111-8813; Huebner, Johannes/0000-0003-1232-4646	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [78787M]; operative budget of the Facultad de Medicina, Universidad Nacional Autonoma de Mexico;  [Salud-2009-C01-112588]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); operative budget of the Facultad de Medicina, Universidad Nacional Autonoma de Mexico; 	This research was funded by grant Consejo Nacional de Ciencia y Tecnologia (CONACyT) 78787M, and Salud-2009-C01-112588 and the operative budget of the Facultad de Medicina, Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, STANDARD METHODS EXA; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Arias CA, 2003, J ANTIMICROB CHEMOTH, V51, P59, DOI 10.1093/jac/dkg002; Clinical and Laboratory Standards Institute (CLSI), 2008, AUSTRALIA; d'Azevedo PA, 2001, DIAGN MICR INFEC DIS, V40, P157, DOI 10.1016/S0732-8893(01)00272-3; Delgado S, 2004, INT J FOOD MICROBIOL, V90, P309, DOI 10.1016/S0168-1605(03)00323-4; DEVRIESE LA, 1995, INT J FOOD MICROBIOL, V26, P187, DOI 10.1016/0168-1605(94)00119-Q; DEVRIESE LA, 1987, INT J SYST BACTERIOL, V37, P257, DOI 10.1099/00207713-37-3-257; Dicuonzo G, 2001, FEMS MICROBIOL LETT, V201, P205, DOI 10.1111/j.1574-6968.2001.tb10758.x; Domig KJ, 2003, INT J FOOD MICROBIOL, V88, P165, DOI 10.1016/S0168-1605(03)00178-8; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Franzetti L, 2004, CURR MICROBIOL, V49, P255, DOI 10.1007/s00284-004-4242-6; Free Laurie, 1996, P150; Grammenou Panagiota, 2006, Journal of Water and Health, V4, P263, DOI 10.2166/wh.2006.0022; Graves AK, 2010, J APPL MICROBIOL, V108, P1226, DOI 10.1111/j.1365-2672.2009.04516.x; Iversen A, 2004, ENVIRON MICROBIOL, V6, P55, DOI 10.1046/j.1462-2920.2003.00534.x; Iwen PC, 1996, J CLIN MICROBIOL, V34, P1779, DOI 10.1128/JCM.34.7.1779-1783.1996; Iwen PC, 1999, J CLIN MICROBIOL, V37, P3756, DOI 10.1128/JCM.37.11.3756-3758.1999; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Ke DB, 1999, J CLIN MICROBIOL, V37, P3497, DOI 10.1128/JCM.37.11.3497-3503.1999; Knijff E, 2001, J MICROBIOL METH, V47, P35, DOI 10.1016/S0167-7012(01)00297-4; Layton BA, 2010, J APPL MICROBIOL, V109, P539, DOI 10.1111/j.1365-2672.2010.04675.x; Mannu L, 2002, J APPL MICROBIOL, V92, P55, DOI 10.1046/j.1365-2672.2002.01489.x; Marino M, 2003, FEMS MICROBIOL LETT, V229, P133, DOI 10.1016/S0378-1097(03)00816-4; Mazari-Hiriart M, 2002, CANC QUINT ROO MEX 2; Monstein HJ, 1998, MICROBIOL-UK, V144, P1171, DOI 10.1099/00221287-144-5-1171; Saeedi B, 2002, APMIS, V110, P869, DOI 10.1034/j.1600-0463.2002.1101205.x; Silva J, 2005, REV MED CHILE, V133, P1201; Teixeira LM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P430; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TRITZ DM, 1990, J CLIN MICROBIOL, V28, P1477, DOI 10.1128/JCM.28.6.1477-1478.1990; Willey BM, 1999, DIAGN MICR INFEC DIS, V34, P165, DOI 10.1016/S0732-8893(99)00032-2	32	39	41	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59491	10.1371/journal.pone.0059491	http://dx.doi.org/10.1371/journal.pone.0059491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560050	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900018
J	Chacon, JA; Wu, RC; Sukhumalchandra, P; Molldrem, JJ; Sarnaik, A; Pilon-Thomas, S; Weber, J; Hwu, P; Radvanyi, L				Chacon, Jessica Ann; Wu, Richard C.; Sukhumalchandra, Pariya; Molldrem, Jeffrey J.; Sarnaik, Amod; Pilon-Thomas, Shari; Weber, Jeffrey; Hwu, Patrick; Radvanyi, Laszlo			Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8(+) Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; 4-1BB; PERSISTENCE; REGRESSION; IMMUNOTHERAPY; COSTIMULATION; CHEMOTHERAPY; EXPRESSION; GENERATION; RESPONSES	Adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can induce tumor regression in up to 50% or more of patients with unresectable metastatic melanoma. However, current methods to expand melanoma TIL, especially the "rapid expansion protocol'' (REP) were not designed to enhance the generation of optimal effector-memory CD8(+) T cells for infusion. One approach to this problem is to manipulate specific co-stimulatory signaling pathways to enhance CD8(+) effector-memory T-cell expansion. In this study, we determined the effects of activating the TNF-R family member 4-1BB/CD137, specifically induced in activated CD8(+) T cells, on the yield, phenotype, and functional activity of expanded CD8(+) T cells during the REP. We found that CD8(+) TIL up-regulate 4-1BB expression early during the REP after initial TCR stimulation, but neither the PBMC feeder cells in the REP or the activated TIL expressed 4-1BB ligand. However, addition of an exogenous agonistic anti-4-1BB IgG(4) (BMS 663513) to the REP significantly enhanced the frequency and total yield of CD8(+) T cells as well as their maintenance of CD28 and increased their anti-tumor CTL activity. Gene expression analysis found an increase in bcl-2 and survivin expression induced by 4-1BB that was associated with an enhanced survival capability of CD8(+) post-REP TIL when re-cultured in the absence or presence of cytokines. Our findings suggest that adding an agonistic anti-4-1BB antibody during the time of TIL REP initiation produces a CD8(+) T cell population capable of improved effector function and survival. This may greatly improve TIL persistence and anti-tumor activity in vivo after adoptive transfer into patients.	[Chacon, Jessica Ann; Wu, Richard C.; Hwu, Patrick; Radvanyi, Laszlo] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Chacon, Jessica Ann; Wu, Richard C.; Molldrem, Jeffrey J.; Hwu, Patrick; Radvanyi, Laszlo] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Univ Texas Hlth Sci Ctr, Program Immunol, Houston, TX 77030 USA; [Sukhumalchandra, Pariya; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Sarnaik, Amod; Pilon-Thomas, Shari; Weber, Jeffrey] Univ S Florida, H Lee Moffitt Canc Ctr, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33682 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Radvanyi, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.	lradvanyi@mdanderson.org	Sarnaik, Amod/W-5536-2019		Developmental Research Program of the Melanoma SPORE [5 P50 CA093459-05-DRP21]; Melanoma Research Alliance (MRA); Miriam and Sheldon Adelson Medical Research Foundation (AMRF); TIL-DC grant [5R01CA11999]; NATIONAL CANCER INSTITUTE [P50CA093459, P50CA100632, P30CA016672, P30CA076292] Funding Source: NIH RePORTER	Developmental Research Program of the Melanoma SPORE; Melanoma Research Alliance (MRA); Miriam and Sheldon Adelson Medical Research Foundation (AMRF); TIL-DC grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Developmental Research Program of the Melanoma SPORE (5 P50 CA093459-05-DRP21), Team Science Award from the Melanoma Research Alliance (MRA), TIL-DC grant (5R01CA11999), and the Postdoctoral Fellow/Research Assistant Award from Dr. Miriam and Sheldon Adelson Medical Research Foundation (AMRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Besser MJ, 2009, J IMMUNOTHER, V32, P415, DOI 10.1097/CJI.0b013e31819c8bda; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Ferrer IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040559; Flaherty KT, 2012, ANNU REV MED, V63, P171, DOI 10.1146/annurev-med-050410-105655; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hernandez-Chacon JA, 2011, J IMMUNOTHER, V34, P236, DOI 10.1097/CJI.0b013e318209e7ec; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; Li YF, 2010, J IMMUNOL, V184, P452, DOI 10.4049/jimmunol.0901101; Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20; Parish ST, 2010, J CLIN IMMUNOL, V30, P798, DOI 10.1007/s10875-010-9449-7; Peperzak V, 2010, J CLIN INVEST, V120, P168, DOI 10.1172/JCI40178; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Pulle G, 2006, J IMMUNOL, V176, P2739, DOI 10.4049/jimmunol.176.5.2739; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Sluijter BJR, 2010, CLIN IMMUNOL, V137, P221, DOI 10.1016/j.clim.2010.07.009; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465; Ye QR, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-131; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007	34	96	113	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60031	10.1371/journal.pone.0060031	http://dx.doi.org/10.1371/journal.pone.0060031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560068	Green Submitted, gold, Green Published			2022-12-27	WOS:000316930900043
J	Isono, T; Chano, T; Okabe, H; Suzaki, M				Isono, Takahiro; Chano, Tokuhiro; Okabe, Hidetoshi; Suzaki, Masafumi			Study of Global Transcriptional Changes of N-GlcNAc(2) Proteins-Producing T24 Bladder Carcinoma Cells under Glucose Deprivation	PLOS ONE			English	Article							N-GLYCOSYLATION; O-GLCNAC; CANCER; GRP78; OVEREXPRESSION; ISOMERASE; KINASES; FOXM1	Increased levels of N-linked (beta-N-acetylglucosamine)(2) [N-GlcNAc(2)]-modified proteins have been recognized to be an effective response to glucose deprivation. In the first step of this study, using a next generation sequencer, we investigated the global transcriptional changes induced by glucose deprivation in a T24 bladder carcinoma cell line, producing N-GlcNAc(2)-modified proteins under glucose deprivation. Our transcriptome analysis revealed significant up-regulation of the UDP-GlcNAc biosynthesis pathway and unfolded protein response genes, and down-regulation of G2/M transition-related genes containing mitotic kinases. Our biological analysis confirmed that N-GlcNAc(2)-modified proteins were localized with BiP proteins in the ER. G2/M arrest was caused by glucose deprivation in T24 cells. Moreover, the knockdown of unfolded protein response genes induced the expressional recovery of mitotic kinases under glucose deprivation. Taken together, our results suggest N-GlcNAc(2)-modified proteins produced under glucose deprivation caused unfolded protein response in the ER, and that this response induced G2/M arrest.	[Isono, Takahiro; Suzaki, Masafumi] Shiga Univ Med Sci, Cent Reseach Lab, Otsu, Shiga 52021, Japan; [Chano, Tokuhiro; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Isono, T (corresponding author), Shiga Univ Med Sci, Cent Reseach Lab, Otsu, Shiga 52021, Japan.	isono@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A part of the study was supported by KAKENHI (Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (for T. C.). The funding sources had no influence on the design of the study or in the collection, analysis, or interpretation of the data. No additional external funding was received for this study.	Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cueva R, 1998, YEAST, V14, P773, DOI 10.1002/(SICI)1097-0061(19980615)14:8<773::AID-YEA284>3.3.CO;2-J; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Menniti M, 2005, AM J PHYSIOL-CELL PH, V288, pC148, DOI 10.1152/ajpcell.00284.2004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakaishi Y, 2009, FEBS LETT, V583, P163, DOI 10.1016/j.febslet.2008.11.041; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	34	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60397	10.1371/journal.pone.0060397	http://dx.doi.org/10.1371/journal.pone.0060397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560094	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900069
J	Martyanov, V; Gross, RH				Martyanov, Viktor; Gross, Robert H.			Computational Discovery of Transcriptional Regulatory Modules in Fungal Ribosome Biogenesis Genes Reveals Novel Sequence and Function Patterns	PLOS ONE			English	Article							RRB REGULON; RNA; IDENTIFICATION; EXPRESSION; EVOLUTION; NETWORKS; GROWTH; MOTIFS; TOOL	Genes involved in ribosome biogenesis and assembly (RBA) are responsible for ribosome formation. In Saccharomyces cerevisiae, their transcription is regulated by two dissimilar DNA motifs. We were interested in analyzing conservation and divergence of RBA transcription regulation machinery throughout fungal evolution. We have identified orthologs of S. cerevisiae RBA genes in 39 species across fungal phylogeny and searched upstream regions of these gene sets for DNA sequences significantly similar to S. cerevisiae RBA regulatory motifs. In addition to confirming known motif arrangements comprising two different motifs in a set of S. cerevisiae close relatives or two instances of the same motif (that we refer to as modules), we have also discovered novel modules in a group of fungi closely related to Neurospora crassa. Despite a single nucleotide difference between consensus sequences of RBA motifs, modules associated with S, cerevisiae group and N. crassa group displayed consistently different characteristics with respect to preferred module organization and several other module properties. For a given species, we have found a correlation between the configuration of the RBA module and significant enrichment in a set of specific Gene Ontology biological processes. We have identified several likely new candidates for a role in ribosome biogenesis in S. cerevisiae based on the combined evidence of RBA module presence in the upstream regions, functional annotation information and microarray expression profiles. We believe that this approach will be useful in terms of generating hypotheses about functional roles of genes for which only fragmentary data from a single source are available.	[Martyanov, Viktor] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA; [Gross, Robert H.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Gross, RH (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	robert.h.gross@dartmouth.edu			National Science Foundation [DBI-0445967]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant to RHG from the National Science Foundation, DBI-0445967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Chakravarty A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-249; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cipollina C, 2008, MICROBIOL-SGM, V154, P337, DOI 10.1099/mic.0.2007/011767-0; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Freckleton G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000449; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Lavoie H, 2009, CURR OPIN MICROBIOL, V12, P655, DOI 10.1016/j.mib.2009.09.015; Liko D, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704762200; Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; Wade CH, 2006, YEAST, V23, P293, DOI 10.1002/yea.1353; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	27	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59851	10.1371/journal.pone.0059851	http://dx.doi.org/10.1371/journal.pone.0059851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555806	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900033
J	Patterson-Lomba, O; Althouse, BM; Goerg, GM; Hebert-Dufresne, L				Patterson-Lomba, Oscar; Althouse, Benjamin M.; Goerg, Georg M.; Hebert-Dufresne, Laurent			Optimizing Treatment Regimes to Hinder Antiviral Resistance in Influenza across Time Scales	PLOS ONE			English	Article							DRUG-RESISTANCE; PANDEMIC INFLUENZA; EVOLUTION; POPULATION; EMERGENCE; VIRUS; DISEASE; TRANSMISSION; OSELTAMIVIR; STRATEGIES	The large-scale use of antivirals during influenza pandemics poses a significant selection pressure for drug-resistant pathogens to emerge and spread in a population. This requires treatment strategies to minimize total infections as well as the emergence of resistance. Here we propose a mathematical model in which individuals infected with wild-type influenza, if treated, can develop de novo resistance and further spread the resistant pathogen. Our main purpose is to explore the impact of two important factors influencing treatment effectiveness: i) the relative transmissibility of the drug-resistant strain to wild-type, and ii) the frequency of de novo resistance. For the endemic scenario, we find a condition between these two parameters that indicates whether treatment regimes will be most beneficial at intermediate or more extreme values (e.g., the fraction of infected that are treated). Moreover, we present analytical expressions for effective treatment regimes and provide evidence of its applicability across a range of modeling scenarios: endemic behavior with deterministic homogeneous mixing, and single-epidemic behavior with deterministic homogeneous mixing and stochastic heterogeneous mixing. Therefore, our results provide insights for the control of drug-resistance in influenza across time scales.	[Patterson-Lomba, Oscar] Arizona State Univ, Sch Human Evolut & Social Change, Math Computat & Modeling Sci Ctr, Tempe, AZ 85069 USA; [Althouse, Benjamin M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Goerg, Georg M.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Hebert-Dufresne, Laurent] Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ, Canada	Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Carnegie Mellon University; Laval University	Patterson-Lomba, O (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Math Computat & Modeling Sci Ctr, Tempe, AZ 85069 USA.	opatters@asu.edu			WAESOBD LSAMPBD NSF [HRD-1025879]; Natural Sciences and Engineering Research Council of Canada; INET [IN01100005]; NSF Graduate Research Fellowship [DGE-0707427]	WAESOBD LSAMPBD NSF; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); INET; NSF Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by WAESOBD LSAMPBD NSF Cooperative Agreement HRD-1025879 (OPL); The Natural Sciences and Engineering Research Council of Canada (LHD); INET grant (no. IN01100005) (GMG); NSF Graduate Research Fellowship (grant no. DGE-0707427) (BMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Althouse BM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002912; Althouse BM, 2010, P NATL ACAD SCI USA, V107, P1696, DOI 10.1073/pnas.0906078107; Anderson R, 1992, INFECT DIS HUMANS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hansen E, 2011, P ROY SOC B-BIOL SCI, V278, P1082, DOI 10.1098/rspb.2010.1469; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jaberi-Douraki M, 2012, DIFF EQUAT, P1; Keeling, 2008, MODELING INFECT DIS; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lipsitch M, 2001, TRENDS MICROBIOL, V9, P438, DOI 10.1016/S0966-842X(01)02130-8; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Lipsitch M, 2012, SCIENCE, V336, P1529, DOI 10.1126/science.1223204; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Newman M., 2018, NETWORKS, DOI [10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Qiu Z, 2010, B MATH BIOL, V72, P1, DOI 10.1007/s11538-009-9435-5; Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schwartz B, 1997, JAMA-J AM MED ASSOC, V278, P944, DOI 10.1001/jama.278.11.944; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; WHO, 2006, WHO CHILD GROWTH STA; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	42	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59529	10.1371/journal.pone.0059529	http://dx.doi.org/10.1371/journal.pone.0059529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555694	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900016
J	Su, DM; Yang, ZF; Li, Q; Guan, LN; Zhang, HL; E, DD; Zhang, L; Zhu, SQ; Ma, X				Su, Dongmei; Yang, Zhenfei; Li, Qian; Guan, Lina; Zhang, Huiling; E, Dandan; Zhang, Lei; Zhu, Siquan; Ma, Xu			Identification and Functional Analysis of GJA8 Mutation in a Chinese Family with Autosomal Dominant Perinuclear Cataracts	PLOS ONE			English	Article							CONGENITAL CATARACT; INHERITED CATARACT; TRANSGENIC MICE; LENS; HEMICHANNEL; CONNEXIN50; EXPRESSION; GENETICS; PROTEIN; GENOME	Congenital cataract is a clinically and genetically heterogeneous group of eye disorders that causes visual impairment and childhood blindness. The purpose of this study was to identify the genetic defect associated with autosomal dominant congenital perinuclear cataract in a Chinese family. A detailed family history and clinical data of the family were recorded, and candidate gene sequencing was performed to screen for mutation-causing disease in our study. Direct sequencing revealed a c.601G > A (p.E201K) transversion in exon 2 of GJA8. This mutation co-segregated with all affected individuals in the family and was not found in unaffected family members or 100 unrelated controls. The function and mechanism of novel GJA8 point mutation E201K in Chinese patients were then investigated in this study. We found E201K aberrantly located in cytoplasm and prevented its location in the plasma membrane. Induction of E201K expression led to a decrease in cell growth and viability by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Our study provides important evidence that GJA8 is a disease-causing gene for congenital cataract and that mutation of GJA8 has a potential causative effect.	[Su, Dongmei; Li, Qian; Guan, Lina; Zhang, Huiling; E, Dandan; Zhang, Lei; Ma, Xu] Natl Res Inst Family Planning, Dept Genet, Beiing, Peoples R China; [Yang, Zhenfei; Zhu, Siquan] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	Capital Medical University	Zhu, SQ (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	siquanzhu@sina.com; .jswkysgc@126.com	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		Central Public-interest Scientific Institution Basal Research Fund [2010GJSSJKA07]	Central Public-interest Scientific Institution Basal Research Fund	This research was supported by grants from the Central Public-interest Scientific Institution Basal Research Fund (Grant No. 2010GJSSJKA07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Bennett TM, 2011, MOL VIS, V17, P2255; Boyadjiev SA, 2003, HUM GENET, V113, P1, DOI 10.1007/s00439-003-0932-6; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Buch K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-1; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; de Figueiredo ES, 2011, MOL VIS, V17, P2207; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; Francis Peter J, 2004, Curr Opin Ophthalmol, V15, P10, DOI 10.1097/00055735-200402000-00003; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Holmes JM, 2003, OPHTHAL EPIDEMIOL, V10, P67, DOI 10.1076/opep.10.2.67.13894; Hu SS, 2010, MOL VIS, V16, P1585; Klein BEK, 2012, OPHTHALMOLOGY, V119, P1628, DOI 10.1016/j.ophtha.2012.01.050; LANDEL CP, 1988, GENE DEV, V2, P1168, DOI 10.1101/gad.2.9.1168; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; PRICE P, 1990, CANCER RES, V50, P1392; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Vanita V, 2006, MOL VIS, V12, P1217; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zhang LY, 2009, MOL VIS, V15, P1127; Zhang QJ, 2004, MOL VIS, V10, P890; Zhu YA, 2010, MOL VIS, V16, P2347	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59926	10.1371/journal.pone.0059926	http://dx.doi.org/10.1371/journal.pone.0059926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555834	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900042
J	Xu, M; Tao, GQ; Kang, MY; Gao, Y; Zhu, HX; Gong, WD; Wang, ML; Wu, DM; Zhang, ZD; Zhao, QH				Xu, Ming; Tao, Guoquan; Kang, Meiyun; Gao, Yan; Zhu, Haixia; Gong, Weida; Wang, Meilin; Wu, Dongmei; Zhang, Zhengdong; Zhao, Qinghong			A Polymorphism (rs2295080) in mTOR Promoter Region and Its Association with Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; GENETIC-VARIATIONS; PI3K/PTEN/AKT/MTOR PATHWAY; PI3K/AKT/MTOR PATHWAY; THERAPEUTIC TARGET; PROSTATE-CANCER; LUNG-CANCER; INHIBITOR; RISK; PROGRESSION	Background: As an imperative part of PI3K/Akt/mTOR pathway, mammalian target of rapamycin (mTOR) has been demonstrated to increase in gastric cancer cells and tumors. Our research explored the relationship between single nucleotide polymorphism (SNP) rs2295080 in mTOR promoter region and the risk of gastric cancer (GC). Methods: Seven hundred and fifty-three (753) gastric adenocarcinoma patients and 854 matched healthy subjects were recruited in the cancer association study and 60 tissues were used to test the expression of mTOR. Unconditional logistic regression was selected to evaluate the association between the rs2295080 T. G polymorphism and GC risk. We then examined the functionality of this promoter genetic variant by luciferase assay and EMSA. Results: Individuals with G allele had a 23% decreased risk of GC, comparing with those carrying T allele (adjusted OR = 0.77, 95% CI = 0.65-0.92). This protective effect of G allele stood out better in male group. Meanwhile, GC patients carrying TG/GG genotype also displayed a decreased mRNA level of mTOR (P = 0.004). In luciferase assay, T allele tended to enhance the transcriptional activity of mTOR with an approximate 0.5-fold over G allele. Furthermore, EMSA tests explained that different alleles of rs2295080 displayed different affinities to some transcriptional factor. Conclusion: The mTOR promoter polymorphism rs2295080 was significantly associated with GC risk. This SNP, which effectively influenced the expression of mTOR, may be a new biomarker of early diagnosis of gastric cancer and a suitable indicator of utilizing mTOR inhibitor for treatment of GC.	[Xu, Ming; Kang, Meiyun; Gao, Yan; Zhu, Haixia; Wang, Meilin; Wu, Dongmei; Zhang, Zhengdong] Nanjing Med Univ, Ctr Canc, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Xu, Ming; Kang, Meiyun; Gao, Yan; Wang, Meilin; Wu, Dongmei; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Dept Genet Toxicol,Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Tao, Guoquan] Nanjing Med Univ, Huai An Peoples Hosp 1, Dept Gen Surg, Huaian, Peoples R China; [Zhu, Haixia] Nantong Tumor Hosp, Core Lab, Nantong, Peoples R China; [Gong, Weida] Yixing Canc Hosp, Dept Gen Surg, Yixing, Peoples R China; [Zhao, Qinghong] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, ZD (corresponding author), Nanjing Med Univ, Ctr Canc, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China.	drzdzhang@gmail.com; njzhqh@sina.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81230068, 30972444, 81001274, 81102089]; Key Program of Natural Science Foundation of Jiangsu Province [BK2010080]; Natural Science Foundation of Jiangsu Province [BK2011773, BK2012842]; Key Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002, 12KJA330002]; Qing-Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Qing-Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by National Natural Science Foundation of China (81230068, 30972444, 81001274, and 81102089), the Key Program of Natural Science Foundation of Jiangsu Province (BK2010080), Natural Science Foundation of Jiangsu Province (BK2011773 and BK2012842), the Key Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002 and 12KJA330002), the Qing-Lan Project of Jiangsu Provincial Department of Education, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). We would also like to thank Luo Y (Nanjing Red Cross Blood Center) for her assistance with functional experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batran SE, 2012, INT J CANCER, V130, P491, DOI 10.1002/ijc.26396; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302; Chen JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040817; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; Ferlay J, 2010, IARC CANCERBASE, V10; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Galoian KA, 2011, TUMOR BIOL, V32, P745, DOI 10.1007/s13277-011-0176-3; Greene FL, 2002, AJCC CANC STAGING MA, DOI [10.1007/978-1-4757-3656-4, DOI 10.1007/978-1-4757-3656-4]; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Huang LZ, 2012, LEUKEMIA LYMPHOMA, V53, P947, DOI 10.3109/10428194.2011.628062; Hudes GR, 2009, CANCER, V115, P2313, DOI 10.1002/cncr.24239; Kudo M, 2011, DIGEST DIS, V29, P310, DOI 10.1159/000327565; Le Tourneau C, 2008, BRIT J CANCER, V99, P1197, DOI 10.1038/sj.bjc.6604636; Li J, 2011, AM J PHYSIOL-CELL PH, V301, pC213, DOI 10.1152/ajpcell.00067.2011; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Patel PH, 2006, CLIN CANCER RES, V12, P7215, DOI 10.1158/1078-0432.CCR-06-2254; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Sanghera KP, 2011, MOL CELL NEUROSCI, V47, P145, DOI 10.1016/j.mcn.2011.03.010; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schatz JH, 2011, CURR ONCOL REP, V13, P398, DOI 10.1007/s11912-011-0187-7; Schiewer MJ, 2012, ENDOCR-RELAT CANCER, V19, P1, DOI 10.1530/ERC-11-0072; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Smrz D, 2011, BLOOD, V118, P6803, DOI 10.1182/blood-2011-06-359984; Wang ML, 2011, INT J CANCER, V129, P1207, DOI 10.1002/ijc.25740; Wysocki PJ, 2009, EXPERT REV MOL DIAGN, V9, P231, DOI [10.1586/erm.09.8, 10.1586/ERM.09.8]; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zitzmann K, 2007, NEUROENDOCRINOLOGY, V85, P54, DOI 10.1159/000100057	34	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60080	10.1371/journal.pone.0060080	http://dx.doi.org/10.1371/journal.pone.0060080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555892	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900057
J	Cheng, KH; Huang, SP; Huang, CN; Lee, YC; Chu, CS; Chang, CF; Lai, WT; Liu, CC				Cheng, Kai-Hung; Huang, Shu-Pin; Huang, Chun-Nung; Lee, Yung-Chin; Chu, Chih-Sheng; Chang, Chu-Fen; Lai, Wen-Ter; Liu, Chia-Chu			The Impact of Estradiol and 1,25(OH)2D3 on Metabolic Syndrome in Middle-Aged Taiwanese Males	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; ESTROGEN-RECEPTOR; RISK-FACTORS; ERECTILE DYSFUNCTION; PARATHYROID-HORMONE; INSULIN-RESISTANCE; ADIPONECTIN; DISEASE; SUPPLEMENTATION; ASSOCIATION	In addition to adipocytokines, estradiol (E2) and vitamin D have been reported to affect insulin sensitivity, glucose homeostasis and body weight. However, studies about the impact of E2 and vitamin D on metabolic syndrome (MetS) are still limited. The aim of this study is to clarify the roles of circulating E2 and vitamin D on the risk of MetS in middle-aged Taiwanese males. A total of 655 male volunteers, including 243 subjects with MetS (mean age: 56.7 +/- 5.8 years) and 412 normal controls (mean age: 55.1 +/- 3.6 years), were evaluated. Subjects with MetS had significantly lower circulating E2, 1,25(OH)(2)D3, and adiponectin, and higher leptin than those without MetS (P<0.001 for all comparisons). E2 and 1,25(OH)(2)D3 were significantly associated with 4 individual components of MetS; more than adiponectin and leptin that were only associated with 3 individual components. In multivariate regression analysis, E2 (beta = -0.216, P<0.001) and 1,25(OH)(2)D3 (beta = 0.067, P = 0.045) were still significant predictors of MetS independent of adiponectin and leptin. Further large studies are needed to confirm our preliminary results and elucidate the possible mechanism.	[Cheng, Kai-Hung; Chu, Chih-Sheng; Lai, Wen-Ter] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Cheng, Kai-Hung; Chu, Chih-Sheng; Lai, Wen-Ter] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Cheng, Kai-Hung; Lee, Yung-Chin; Chu, Chih-Sheng; Lai, Wen-Ter; Liu, Chia-Chu] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Pin; Huang, Chun-Nung; Lee, Yung-Chin; Liu, Chia-Chu] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Huang, Chun-Nung; Lee, Yung-Chin; Liu, Chia-Chu] Kaohsiung Med Univ, Dept Urol, Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Chu-Fen] Tzu Chi Univ, Dept Phys Therapy, Hualien, Taiwan; [Liu, Chia-Chu] Pingtung Hosp, Dept Hlth, Executive Yuan, Pingtung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tzu Chi University	Lai, WT (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	wtlai@cc.kmu.edu.tw; ccliu0204@gmail.com	LIU, CHIA CHU/T-2880-2019	Cheng, Kai-Hung/0000-0003-1066-9499	Taiwan National Science Council [NSC98-2314-B-037-030-MY3, NSC99-2314-B-037-022-MY3]; Kaohsiung Medical University Hospital [KMUH100-0R45, KMUH101-1M43]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This study was financially supported by grants from the Taiwan National Science Council (NSC98-2314-B-037-030-MY3; NSC99-2314-B-037-022-MY3) and Kaohsiung Medical University Hospital (KMUH100-0R45; KMUH101-1M43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkharfy KM, 2013, BASIC CLIN PHARMACOL, V112, P42, DOI 10.1111/j.1742-7843.2012.00936.x; Amato MC, 2011, GYNECOL ENDOCRINOL, V27, P579, DOI 10.3109/09513590.2010.495797; Arnal JF, 2009, CLIMACTERIC, V12, P12, DOI 10.1080/13697130902820006; Assmann G, 2008, INT J OBESITY, V32, pS11, DOI 10.1038/ijo.2008.29; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; Ballantyne CM, 2008, INT J OBESITY, V32, pS21, DOI 10.1038/ijo.2008.31; Barseghian A, 2011, J AM COLL CARDIOL, V57, P761, DOI 10.1016/j.jacc.2010.11.011; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Chabrolle C, 2009, FERTIL STERIL, V92, P1988, DOI 10.1016/j.fertnstert.2008.09.008; Chang-Quan H, 2008, ARCH MED RES, V39, P380, DOI 10.1016/j.arcmed.2007.12.008; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Clapauch R, 2009, ARQ BRAS ENDOCRINOL, V53, P1020, DOI 10.1590/S0004-27302009000800017; Conde J, 2010, EXPERT REV CLIN IMMU, V6, P801, DOI [10.1586/eci.10.48, 10.1586/ECI.10.48]; Deng JY, 2008, DIABETES, V57, P1814, DOI 10.2337/db07-1750; Denti Licia, 2010, Acta Biomed, V81 Suppl 1, P73; Fichna M, 2010, INT J IMMUNOGENET, V37, P367, DOI 10.1111/j.1744-313X.2010.00935.x; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Frankel DS, 2009, J AM COLL CARDIOL, V53, P754, DOI 10.1016/j.jacc.2008.07.073; Gannage-Yared MH, 2009, EUR J ENDOCRINOL, V160, P965, DOI 10.1530/EJE-08-0952; Gilliver SC, 2010, J STEROID BIOCHEM, V120, P105, DOI 10.1016/j.jsbmb.2009.12.015; Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x; Hsu HF, 2010, TOXICOL APPL PHARM, V245, P370, DOI 10.1016/j.taap.2010.04.008; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Javed F, 2012, J NUTR HEALTH AGING, V16, P445, DOI 10.1007/s12603-011-0353-5; Jones G, 2007, SEMIN DIALYSIS, V20, P316, DOI 10.1111/j.1525-139X.2007.00302.x; Judd SE, 2009, AM J MED SCI, V338, P40, DOI 10.1097/MAJ.0b013e3181aaee91; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Lee CH, 2007, INT J CANCER, V120, P1755, DOI 10.1002/ijc.22324; Lee DM, 2009, EUR J ENDOCRINOL, V161, P947, DOI 10.1530/EJE-09-0496; Lee YC, 2010, J SEX MED, V7, P3127, DOI 10.1111/j.1743-6109.2010.01852.x; Liu CC, 2009, J SEX MED, V6, P936, DOI 10.1111/j.1743-6109.2008.01171.x; Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Maffei L, 2007, CLIN ENDOCRINOL, V67, P218, DOI 10.1111/j.1365-2265.2007.02864.x; Maggio M, 2010, J ANDROL, V31, P155, DOI 10.2164/jandrol.108.006098; Malik Shaista, 2009, Expert Rev Cardiovasc Ther, V7, P273, DOI 10.1586/14779072.7.3.273; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; Matyskova R, 2010, HORM METAB RES, V42, P182, DOI 10.1055/s-0029-1243250; Nemerovski CW, 2009, PHARMACOTHERAPY, V29, P691, DOI 10.1592/phco.29.6.691; Nimitphong H, 2009, ENDOCRINE, V36, P205, DOI 10.1007/s12020-009-9216-9; Nishimura Satoshi, 2009, Discov Med, V8, P55; Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057; Peterlik M, 2009, EUR J CLIN NUTR, V63, P1377, DOI 10.1038/ejcn.2009.105; Ponholzer A, 2006, INT J IMPOT RES, V18, P489, DOI 10.1038/sj.ijir.3901468; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Rahal OM, 2011, ENDOCRINOLOGY, V152, P3409, DOI 10.1210/en.2011-1085; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Rinaldi S, 2002, CANCER EPIDEM BIOMAR, V11, P1065; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Salehpour A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-78; Saltiki K, 2010, ENDOCRINE, V37, P329, DOI 10.1007/s12020-010-9307-7; Sattar N, 2009, J AM COLL CARDIOL, V53, P167, DOI 10.1016/j.jacc.2008.09.035; Saunier EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028333; Scarpellini E, 2012, DIGEST DIS, V30, P148, DOI 10.1159/000336664; Shufelt CL, 2009, J AM COLL CARDIOL, V53, P221, DOI 10.1016/j.jacc.2008.09.042; Soderberg S, 2009, INT J OBESITY, V33, P123, DOI 10.1038/ijo.2008.224; Song QM, 2012, NUTR RES REV, V25, P130, DOI 10.1017/S0954422412000029; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301; Tsai WC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-162; Valkenburg O, 2008, J CLIN ENDOCR METAB, V93, P470, DOI 10.1210/jc.2007-1756; van Dam EWCM, 2004, AM J PHYSIOL-ENDOC M, V286, pE615, DOI 10.1152/ajpendo.00377.2003; Van Linthout S, 2010, ATHEROSCLEROSIS, V210, P438, DOI 10.1016/j.atherosclerosis.2010.01.001; Wang QP, 2012, BONE, V51, P515, DOI 10.1016/j.bone.2012.05.011; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Zhu W, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-8; Zhuo Q, 2010, BIOMED ENVIRON SCI, V23, P53, DOI 10.1016/S0895-3988(10)60032-3; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	70	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60295	10.1371/journal.pone.0060295	http://dx.doi.org/10.1371/journal.pone.0060295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555948	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200105
J	Dyszy, F; Pinto, APA; Araujo, APU; Costa, AJ				Dyszy, Fabio; Pinto, Andressa P. A.; Araujo, Ana P. U.; Costa-Filho, Antonio J.			Probing the Interaction of Brain Fatty Acid Binding Protein (B-FABP) with Model Membranes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; ANIONIC PHOSPHOLIPID-VESICLES; COLLISION-MEDIATED TRANSFER; CANCER GROWTH INHIBITOR; ELECTRON-SPIN-RESONANCE; SURFACE LYSINE RESIDUES; ALPHA-HELICAL DOMAIN; LIPID-BINDING; DIFFERENT MECHANISMS; MAGNETIC-RESONANCE	Brain fatty acid-binding protein (B-FABP) interacts with biological membranes and delivers polyunsaturated fatty acids (FAs) via a collisional mechanism. The binding of FAs in the protein and the interaction with membranes involve a motif called "portal region'', formed by two small alpha-helices, A1 and A2, connected by a loop. We used a combination of site-directed mutagenesis and electron spin resonance to probe the changes in the protein and in the membrane model induced by their interaction. Spin labeled B-FABP mutants and lipidic spin probes incorporated into a membrane model confirmed that BFABP interacts with micelles through the portal region and led to structural changes in the protein as well in the micelles. These changes were greater in the presence of LPG when compared to the LPC models. ESR spectra of B-FABP labeled mutants showed the presence of two groups of residues that responded to the presence of micelles in opposite ways. In the presence of lysophospholipids, group I of residues, whose side chains point outwards from the contact region between the helices, had their mobility decreased in an environment of lower polarity when compared to the same residues in solution. The second group, composed by residues with side chains situated at the interface between the a-helices, experienced an increase in mobility in the presence of the model membranes. These modifications in the ESR spectra of B-FABP mutants are compatible with a less ordered structure of the portal region inner residues (group II) that is likely to facilitate the delivery of FAs to target membranes. On the other hand, residues in group I and micelle components have their mobilities decreased probably as a result of the formation of a collisional complex. Our results bring new insights for the understanding of the gating and delivery mechanisms of FABPs.	[Dyszy, Fabio; Pinto, Andressa P. A.; Araujo, Ana P. U.; Costa-Filho, Antonio J.] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, Sao Paulo, Brazil; [Costa-Filho, Antonio J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Fac Filosofia, Lab Biofis Mol,Dept Fis, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Costa, AJ (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, Sao Paulo, Brazil.	ajcosta@ffclrp.usp.br	Costa-Filho, Antonio J/D-3153-2012; Araujo, Ana Paula U/I-6664-2012; Costa-Filho, Antonio José/AAZ-1808-2020	Costa-Filho, Antonio J/0000-0001-6730-8737; Araujo, Ana Paula U/0000-0001-5455-084X; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17662-8, 2009/15810-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [150549/2009-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The funding was provided by the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grant no. 2010/17662-8) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). AJCF thanks a research fellowship from CNPq and FHD thanks a post-doctoral fellowship from CNPq (150549/2009-1) and FAPESP (2009/15810-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona GH, 1997, BBA-BIOMEMBRANES, V1329, P74, DOI 10.1016/S0005-2736(97)00089-8; Alvarez C, 2003, CHEM PHYS LIPIDS, V122, P97, DOI 10.1016/S0009-3084(02)00181-0; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Bustad HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049671; Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906; CONNOR WE, 1984, T ASSOC AM PHYSICIAN, V97, P1; Corsico B, 2005, J LIPID RES, V46, P1765, DOI 10.1194/jlr.M500140-JLR200; Corsico B, 2004, BIOCHEMISTRY-US, V43, P3600, DOI 10.1021/bi0357356; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Costa AJ, 2003, BIOPHYS J, V84, P3364, DOI 10.1016/S0006-3495(03)70060-5; Couto SG, 2011, BIOCH BIOPHYS RES CO; Couto SG, 2008, BIOPHYS J, V94, P1746, DOI 10.1529/biophysj.107.120055; Davies JK, 1999, BIOCHEMISTRY-US, V38, P16932, DOI 10.1021/bi991926q; Davies JK, 2002, J BIOL CHEM, V277, P48395, DOI 10.1074/jbc.M208141200; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Franchini GR, 2008, BBA-MOL CELL BIOL L, V1781, P192, DOI 10.1016/j.bbalip.2008.01.005; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Hagan RM, 2008, BIOCHEM J, V410, P123, DOI 10.1042/BJ20071109; Herr FM, 1996, BIOCHEMISTRY-US, V35, P1296, DOI 10.1021/bi952204b; HERR FM, 1995, BIOCHEMISTRY-US, V34, P11840, DOI 10.1021/bi00037a023; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Hohoff C, 1998, CANCER RES, V58, P4015; Hohoff C, 1998, FETT-LIPID, V100, P252; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; HUBBELL WL, 1971, J AM CHEM SOC, V93, P314; Inbaraj JJ, 2004, J MAGN RESON, V171, P71, DOI 10.1016/j.jmr.2004.08.002; Innis SM, 1999, LIPIDS, V34, P139, DOI 10.1007/s11745-999-0348-x; Janes RR, 2009, MUS MEAN, P1; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; JOST PC, 1973, P NATL ACAD SCI USA, V70, P480, DOI 10.1073/pnas.70.2.480; KANG SY, 1979, BIOCHEMISTRY-US, V18, P3257, DOI 10.1021/bi00582a010; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KIM HK, 1992, J BIOL CHEM, V267, P20051; Kleinschmidt JH, 1997, BIOPHYS J, V72, P767, DOI 10.1016/S0006-3495(97)78711-3; Klug CS, 1997, BIOCHEMISTRY-US, V36, P13027, DOI 10.1021/bi971232m; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Lin Y, 1998, SCIENCE, V279, P1925, DOI 10.1126/science.279.5358.1925; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mihajlovic M, 2007, PROTEIN SCI, V16, P2042, DOI 10.1110/ps.072875307; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Motojima K, 2000, INT J BIOCHEM CELL B, V32, P1085, DOI 10.1016/S1357-2725(00)00046-7; Oeemig JS, 2009, BIOMOL NMR ASSIGN, V3, P89, DOI 10.1007/s12104-009-9148-6; Oh KJ, 1996, SCIENCE, V273, P810, DOI 10.1126/science.273.5276.810; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Rademacher M, 2002, MOL CELL BIOCHEM, V239, P61, DOI 10.1023/A:1020566909213; Retrosi G, 2011, J PEDIATR SURG, V46, P1197, DOI 10.1016/j.jpedsurg.2011.03.053; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez-Font MF, 2003, NUCLEIC ACIDS RES, V31, P2769, DOI 10.1093/nar/gkg396; Schachtrup C, 2004, BIOCHEM J, V382, P239, DOI 10.1042/BJ20031340; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P375; SCHREIER S, 1984, BIOCHIM BIOPHYS ACTA, V769, P231, DOI 10.1016/0005-2736(84)90027-0; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shi YE, 1997, CANCER RES, V57, P3084; Shimizu F, 1997, BBA-GENE STRUCT EXPR, V1354, P24, DOI 10.1016/S0167-4781(97)00115-2; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Takaoka N, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-31; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Teixeira CV, 2001, BBA-BIOMEMBRANES, V1510, P93, DOI 10.1016/S0005-2736(00)00338-2; Thumser AEA, 2000, J LIPID RES, V41, P647; Thumser AEA, 2001, J MOL NEUROSCI, V16, P143, DOI 10.1385/JMN:16:2-3:143; Toelle A, 2011, ONCOL REP, V25, P1307, DOI 10.3892/or.2011.1209; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; XU ZH, 1992, BIOCHEMISTRY-US, V31, P3484, DOI 10.1021/bi00128a024; YAMAMOTO N, 1987, J LIPID RES, V28, P144; Zamarreno F, 2012, BBA-BIOMEMBRANES, V1818, P1691, DOI 10.1016/j.bbamem.2012.03.003; Zimmerman AW, 1999, BIOCHEM J, V344, P495, DOI 10.1042/0264-6021:3440495; [No title captured]	81	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60198	10.1371/journal.pone.0060198	http://dx.doi.org/10.1371/journal.pone.0060198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555925	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200096
J	Kim, KZ; Shin, A; Kim, J; Park, JW; Park, SC; Choi, HS; Chang, HJ; Kim, DY; Oh, JH				Kim, Kyee-Zu; Shin, Aesun; Kim, Jeongseon; Park, Ji Won; Park, Sung Chan; Choi, Hyo Seong; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan			Association between CASR Polymorphisms, Calcium Intake, and Colorectal Cancer Risk	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; EPITHELIAL-CELL PROLIFERATION; SENSING RECEPTOR; DIETARY CALCIUM; COLON-CANCER; EXTRACELLULAR CALCIUM; GENE POLYMORPHISMS; EXPRESSION; FOLATE	Aim: The current study aimed to assess the effect of dietary calcium intake and possible interactions with calcium-sensing receptor (CASR) gene polymorphisms on colorectal cancer risk. Methods: A total of 420 colorectal cancer cases and 815 controls were included in the analysis. Calcium intake was investigated using a 103 item semi-quantitative food frequency questionnaire, and four single nucleotide polymorphisms (SNPs) within the CASR, rs10934578, rs12485716, rs2270916, and rs4678174, were evaluated. Results: No SNPs were associated with colorectal cancer risk after adjusting for covariates. Overall, no significant effect modification by CASR polymorphisms on the association between calcium intake and colorectal cancer risk were detected. However, all 4 of the polymorphisms within the CASR showed significantly higher odds ratios for association with colorectal cancer risk in the low-calcium-intake group compared to the high-calcium-intake group. In the case of rs2270916, individuals with the CC genotype and low calcium intake showed an increased colorectal cancer risk compared to their counterparts with the TT genotype and high calcium intake (OR = 2.11, 95% CI = 1.27-3.51). Conclusions: Subjects with lower calcium intake exhibited a higher colorectal cancer risk compared with subjects with the same genotype who had higher calcium intake. Our results suggest that individuals who have low dietary calcium intake should be aware of their increased colorectal cancer risk and prevention strategies.	[Kim, Kyee-Zu; Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Res Inst, Mol Epidemiol Branch, Goyang Si, South Korea; [Park, Ji Won; Park, Sung Chan; Choi, Hyo Seong; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan] Natl Canc Ctr Hosp, Ctr Colorectal Canc, Natl Canc Ctr, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Shin, A (corresponding author), Natl Canc Ctr, Res Inst, Mol Epidemiol Branch, Goyang Si, South Korea.	shina@ncc.re.kr	Kim, Kyeezu/AGB-4685-2022; Shin, Aesun/E-9145-2014; KIM, JEONGSEON/AAA-4643-2022	Shin, Aesun/0000-0002-6426-1969; Kim, Kyeezu/0000-0002-9094-9011	Basic Science Research Program of the National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0010276]	Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2010-0010276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Bacsi K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-317; BUSET M, 1986, CANCER RES, V46, P5426; Byers T, 2000, NEW ENGL J MED, V342, P1206, DOI 10.1056/NEJM200004203421609; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Chakrabarty S, 2003, CANCER RES, V63, P67; Chattopadhyay N, 1998, AM J PHYSIOL-GASTR L, V274, pG122, DOI 10.1152/ajpgi.1998.274.1.G122; Cheng SX, 2002, AM J PHYSIOL-GASTR L, V283, pG240, DOI 10.1152/ajpgi.00500.2001; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Dai Q, 2007, AM J CLIN NUTR, V86, P743, DOI 10.1093/ajcn/86.3.743; Dong LM, 2008, CANCER EPIDEM BIOMAR, V17, P2755, DOI 10.1158/1055-9965.EPI-08-0388; Health Canada, 2010, DIETARY REFERENCE IN; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Huncharek M, 2009, NUTR CANCER, V61, P47, DOI 10.1080/01635580802395733; Jacobs ET, 2010, CARCINOGENESIS, V31, P1412, DOI 10.1093/carcin/bgq127; Jenab M, 2009, CANCER EPIDEM BIOMAR, V18, P2485, DOI 10.1158/1055-9965.EPI-09-0319; Jokic M, 2011, DNA CELL BIOL, V30, P771, DOI 10.1089/dna.2010.1189; Kallay E, 1997, BIOCHEM BIOPH RES CO, V232, P80, DOI 10.1006/bbrc.1997.6225; Kallay E, 2000, CANCER DETECT PREV, V24, P127; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; LAPRE JA, 1993, CANCER RES, V53, P784; Larsson SC, 2006, AM J CLIN NUTR, V83, P667, DOI 10.1093/ajcn.83.3.667; Lee JE, 2012, CANCER CAUSE CONTROL, V23, P537, DOI 10.1007/s10552-012-9911-3; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P1812, DOI 10.1158/1055-9965.EPI-10-0151; LIPKIN M, 1985, NEW ENGL J MED, V313, P1381, DOI 10.1056/NEJM198511283132203; NEWMARK HL, 1984, J NATL CANCER I, V72, P1323; Park K, 2006, CANCER LETT, V237, P199, DOI 10.1016/j.canlet.2005.05.048; Park SY, 2007, AM J EPIDEMIOL, V165, P784, DOI 10.1093/aje/kwk069; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Shin A, 2006, INT J CANCER, V119, P2938, DOI 10.1002/ijc.22196; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P2752, DOI 10.1158/1055-9965.EPI-07-2611; Slattery ML, 2007, NUTR REV, V65, pS102, DOI 10.1111/j.1753-4887.2007.tb00332.x; Slattery ML, 2006, INT J CANCER, V118, P3140, DOI 10.1002/ijc.21791; Slattery ML, 2004, INT J CANCER, V111, P750, DOI 10.1002/ijc.20330; Speer G, 2002, INT J COLORECTAL DIS, V17, P20, DOI 10.1007/s003840100359; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Taioli E, 2009, AM J EPIDEMIOL, V170, P1207, DOI 10.1093/aje/kwp275; VANDERMEER R, 1991, EUROPEAN JOURNAL OF CANCER PREVENTION, VOL 1, SUPPLEMENT 2, OCTOBER 1991, P55, DOI 10.1097/00008469-199110002-00010; WARGOVICH MJ, 1984, CANCER LETT, V23, P253, DOI 10.1016/0304-3835(84)90091-0; Wong HL, 2003, CARCINOGENESIS, V24, P1091, DOI 10.1093/carcin/bgg059; Wu K, 2002, JNCI-J NATL CANCER I, V94, P437, DOI 10.1093/jnci/94.6.437	41	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59628	10.1371/journal.pone.0059628	http://dx.doi.org/10.1371/journal.pone.0059628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555732	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200034
J	Podgaiski, LR; Joner, F; Lavorel, S; Moretti, M; Ibanez, S; Mendonca, MD; Pillar, VD				Podgaiski, Luciana R.; Joner, Fernando; Lavorel, Sandra; Moretti, Marco; Ibanez, Sebastien; Mendonca, Milton de S., Jr.; Pillar, Valerio D.			Spider Trait Assembly Patterns and Resilience under Fire-Induced Vegetation Change in South Brazilian Grasslands	PLOS ONE			English	Article							COMPLEX-STRUCTURED HABITATS; CO-INERTIA ANALYSIS; FUNCTIONAL DIVERSITY; COMMUNITY ORGANIZATION; PLANT DIVERSITY; SPECIES-DIVERSITY; ANT ASSEMBLAGES; SITE SELECTION; CONVERGENCE; RESPONSES	Disturbances induce changes on habitat proprieties that may filter organism's functional traits thereby shaping the structure and interactions of many trophic levels. We tested if communities of predators with foraging traits dependent on habitat structure respond to environmental change through cascades affecting the functional traits of plants. We monitored the response of spider and plant communities to fire in South Brazilian Grasslands using pairs of burned and unburned plots. Spiders were determined to the family level and described in feeding behavioral and morphological traits measured on each individual. Life form and morphological traits were recorded for plant species. One month after fire the abundance of vegetation hunters and the mean size of the chelicera increased due to the presence of suitable feeding sites in the regrowing vegetation, but irregular web builders decreased due to the absence of microhabitats and dense foliage into which they build their webs. Six months after fire rosette-form plants with broader leaves increased, creating a favourable habitat for orb web builders which became more abundant, while graminoids and tall plants were reduced, resulting in a decrease of proper shelters and microclimate in soil surface to ground hunters which became less abundant. Hence, fire triggered changes in vegetation structure that lead both to trait-convergence and trait-divergence assembly patterns of spiders along gradients of plant biomass and functional diversity. Spider individuals occurring in more functionally diverse plant communities were more diverse in their traits probably because increased possibility of resource exploitation, following the habitat heterogeneity hypothesis. Finally, as an indication of resilience, after twelve months spider communities did not differ from those of unburned plots. Our findings show that functional traits provide a mechanistic understanding of the response of communities to environmental change, especially when more than one trophic level is considered.	[Podgaiski, Luciana R.; Joner, Fernando; Mendonca, Milton de S., Jr.; Pillar, Valerio D.] Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil; [Lavorel, Sandra] Univ Grenoble 1, CNRS, Lab Ecol Alpine, Grenoble, France; [Moretti, Marco; Ibanez, Sebastien] Swiss Fed Res Inst WSL, Community Ecol Unite, Bellinzona, Switzerland; [Joner, Fernando] Univ Fed Fronteira Sul, Curso Agron, Chapeco, Santa Catarina, Brazil	Universidade Federal do Rio Grande do Sul; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universidade Federal da Fronteira Sul	Podgaiski, LR (corresponding author), Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil.	podgaiski@gmail.com	Mendonça, Milton/AIE-5944-2022; de Souza Mendonca, Milton/J-6479-2012; Pillar, Valerio/B-9872-2008; Podgaiski, Luciana Regina/D-4241-2013	de Souza Mendonca, Milton/0000-0001-5272-5124; Pillar, Valerio/0000-0001-6408-2891; Podgaiski, Luciana Regina/0000-0001-8020-2312; Moretti, Marco/0000-0002-5845-3198	CNPq, Brazil [479083/2008-8, 306573/2009-1]; CAPES, Brazil; Dimensions of Biodiversity Distributed Graduate Seminar (NSF, USA) [1050680]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Dimensions of Biodiversity Distributed Graduate Seminar (NSF, USA)	The project was supported by grants from CNPq, Brazil, to Valerio Pillar (479083/2008-8 and 306573/2009-1). Luciana Podgaiski and Fernando Joner received PhD Scholarships from CAPES, Brazil. The project benefitted from travel funding provided to Luciana Podgaiski and Valerio Pillar by the Dimensions of Biodiversity Distributed Graduate Seminar (NSF, USA, grant 1050680 coordinated by Sandy Andelman and Julia Parrish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE TM, 1993, ECOLOGY, V74, P455, DOI 10.2307/1939307; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], 1961, CLIMA RIO GRANDE SUL; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Behling H., 2008, GRASSLANDS ECOLOGY M, P99; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Bengtsson J, 2002, EUR J SOIL BIOL, V38, P119, DOI 10.1016/S1164-5563(02)01133-0; Blaum N, 2011, BIODIVERS CONSERV, V20, P2333, DOI 10.1007/s10531-011-9995-1; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bonte D, 2003, P ROY SOC B-BIOL SCI, V270, P1601, DOI 10.1098/rspb.2003.2432; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brennan KEC, 2006, FOREST ECOL MANAG, V231, P138, DOI 10.1016/j.foreco.2006.05.035; Buckup EH, 2010, IHERINGIA SER ZOOL, V100, P483, DOI 10.1590/S0073-47212010000400021; Cardoso P, 2004, BIOL CONSERV, V117, P453, DOI 10.1016/j.biocon.2003.08.013; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Carlucci MB, 2012, J VEG SCI, V23, P176, DOI 10.1111/j.1654-1103.2011.01339.x; Coddington JA, 1996, J ARACHNOL, V24, P111; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; Cunha ER, 2012, WETLANDS, V32, P369, DOI 10.1007/s13157-012-0272-1; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dacke M, 2001, J EXP BIOL, V204, P2481; de Bello F, 2009, J VEG SCI, V20, P475, DOI 10.1111/j.1654-1103.2009.01042.x; De Souza ALT, 2004, AUSTRAL ECOL, V29, P342, DOI 10.1111/j.1442-9993.2004.01371.x; Diamond J.M., 1975, P342; Dias SC, 2010, J NAT HIST, V44, P219, DOI 10.1080/00222930903383503; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Entling W, 2010, J BIOGEOGR, V37, P477, DOI 10.1111/j.1365-2699.2009.02216.x; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fidelis A., 2011, BIODIVERS BRAS, V2, P12; Fidelis A, 2008, PLANT ECOL, V195, P55, DOI 10.1007/s11258-007-9298-5; Fidelis A, 2012, J VEG SCI, V23, P552, DOI 10.1111/j.1654-1103.2011.01364.x; Fidelis A, 2010, INTERCIENCIA, V35, P739; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Foelix R., 2011, BIOL SPIDERS, V3; Foellmer MW, 2005, OECOLOGIA, V142, P653, DOI 10.1007/s00442-004-1756-3; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Gerisch M, 2012, OIKOS, V121, P508, DOI 10.1111/j.1600-0706.2011.19749.x; GIBSON CWD, 1992, J APPL ECOL, V29, P132, DOI 10.2307/2404356; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Halaj J, 1998, J ARACHNOL, V26, P203; Hassall M, 2007, INVERTEBR BIOL, V126, P46, DOI 10.1111/j.1744-7410.2007.00075.x; HATLEY CL, 1980, ENVIRON ENTOMOL, V9, P632, DOI 10.1093/ee/9.5.632; Hibbert AC, 2008, J ARACHNOL, V36, P195, DOI 10.1636/T07-14SC.1; IRGANG B E, 1974, Boletim Instituto Central de Biociencias Serie Botanica, V32, P1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Langellotto GA, 2006, ECOL ENTOMOL, V31, P575, DOI 10.1111/j.1365-2311.2006.00816.x; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; Leps J, 2006, PRESLIA, V78, P481; Lopes CT, 2011, BIOTROPICA, V43, P612, DOI 10.1111/j.1744-7429.2011.00757.x; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Makkonen M, 2011, SOIL BIOL BIOCHEM, V43, P377, DOI 10.1016/j.soilbio.2010.11.004; Malumbres-Olarte J, 2013, INSECT CONSERV DIVER, V6, P124, DOI 10.1111/j.1752-4598.2012.00195.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Melbourne BA, 1999, AUST J ECOL, V24, P228, DOI 10.1046/j.1442-9993.1999.00967.x; Moretti M, 2002, J APPL ECOL, V39, P321, DOI 10.1046/j.1365-2664.2002.00701.x; Moretti M, 2009, J ANIM ECOL, V78, P98, DOI 10.1111/j.1365-2656.2008.01462.x; Moretti M, 2010, ECOGRAPHY, V33, P760, DOI 10.1111/j.1600-0587.2009.06172.x; Moretti M, 2009, ECOGRAPHY, V32, P299, DOI 10.1111/j.1600-0587.2008.05524.x; Nipperess DA, 2004, ECOLOGY, V85, P2728, DOI 10.1890/03-0741; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Overbeck GE, 2007, FLORA, V202, P27, DOI 10.1016/j.flora.2005.11.004; Overbeck GF, 2005, J VEG SCI, V16, P655, DOI 10.1111/j.1654-1103.2005.tb02408.x; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Persons MH, 1997, ECOSCIENCE, V4, P1; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pillar VD, 2009, J VEG SCI, V20, P334, DOI 10.1111/j.1654-1103.2009.05666.x; Pillar VD, 2003, J VEG SCI, V14, P323, DOI 10.1658/1100-9233(2003)014[0323:AIMFSP]2.0.CO;2; PILLAR VD, 1991, COMPUTER ASSISTED VE, P87; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Podani J, 1999, TAXON, V48, P331, DOI 10.2307/1224438; Pyke DA, 2010, RESTOR ECOL, V18, P274, DOI 10.1111/j.1526-100X.2010.00658.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rypstra AL, 1999, J ARACHNOL, V27, P371; Rypstra AL, 2007, OIKOS, V116, P853, DOI [10.1111/j.2007.0030-1299.15622.x, 10.1111/j.0030-1299.2007.15622.x]; Safford HD, 2004, ECOLOGY, V85, P539, DOI 10.1890/03-0039; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Souza ALT., 2007, ECOLOGIA COMPORTAMEN, P25; STEVENSON BG, 1982, J ARACHNOL, V10, P165; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Sunderland K, 2000, ENTOMOL EXP APPL, V95, P1, DOI 10.1023/A:1003986225443; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Uetz G.W., 1979, Psyche (Cambridge), V86, P79, DOI 10.1155/1979/76206; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Viera Carmen, 2003, Anales de Biologia (Murcia), V25, P13; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Wagner JD, 2003, J ARACHNOL, V31, P28, DOI 10.1636/0161-8202(2003)031[0028:SSILDB]2.0.CO;2; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Weiher E, 1999, ECOLOGICAL ASSEMBLY, P130, DOI DOI 10.1017/CBO9780511542237.006; Weiher Evan, 1999, P251, DOI 10.1017/CBO9780511542237.010; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	101	65	67	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60207	10.1371/journal.pone.0060207	http://dx.doi.org/10.1371/journal.pone.0060207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555927	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200097
J	Ayres-Sander, CE; Lauridsen, H; Maier, CL; Sava, P; Pober, JS; Gonzalez, AL				Ayres-Sander, Chantal E.; Lauridsen, Holly; Maier, Cheryl L.; Sava, Parid; Pober, Jordan S.; Gonzalez, Anjelica L.			Transendothelial Migration Enables Subsequent Transmigration of Neutrophils through Underlying Pericytes	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; LEUKOCYTE DIAPEDESIS; TIGHT JUNCTIONS; VENULAR WALLS; IN-VIVO; ADHESION; GROWTH; IDENTIFICATION; CHEMOTAXIS; CAPILLARY	During acute inflammation, neutrophil recruitment into extravascular tissue requires neutrophil tethering and rolling on cytokine-activated endothelial cells (ECs), tight adhesion, crawling towards EC junctions and transendothelial migration (TEM). Following TEM, neutrophils must still traverse the subendothelial basement membrane and network of pericytes (PCs). Until recently, the contribution of the PC layer to neutrophil recruitment was largely ignored. Here we analyze human neutrophil interactions with interleukin (IL)-1 beta-activated human EC monolayers, PC monolayers and EC/PC bilayers in vitro. Compared to EC, PC support much lower levels of neutrophil binding (54.6% vs. 7.1%, respectively) and transmigration (63.7 vs. 8.8%, respectively) despite comparable levels of IL-8 (CXCL8) synthesis and display. Remarkably, EC/PC bilayers support intermediate levels of transmigration (37.7%). Neutrophil adhesion to both cell types is Mac-1-dependent and while ICAM-1 transduction of PCs increases neutrophil adhesion to (41.4%), it does not increase transmigration through PC monolayers. TEM, which increases neutrophil Mac-1 surface expression, concomitantly increases the ability of neutrophils to traverse PCs (19.2%). These data indicate that contributions from both PCs and ECs must be considered in evaluation of microvasculature function in acute inflammation.	[Ayres-Sander, Chantal E.; Lauridsen, Holly; Sava, Parid; Gonzalez, Anjelica L.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Maier, Cheryl L.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Yale University	Gonzalez, AL (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	anjelica.gonzalez@yale.edu	Sava, Paul/ABE-3668-2020	Sava, Paul/0000-0002-7813-598X	National Institutes of Health [R01 HL051014]; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health R01 HL051014 and The Hartwell Foundation (http://www.thehartwellfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allt G, 2001, CELLS TISSUES ORGANS, V169, P1, DOI 10.1159/000047855; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Bixel MG, 2010, BLOOD, V116, P1172, DOI 10.1182/blood-2009-12-256388; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Burns AR, 2000, J CELL SCI, V113, P45; Burns AR, 1997, J IMMUNOL, V159, P2893; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Clark PR, 2007, J INVEST DERMATOL, V127, P762, DOI 10.1038/sj.jid.5700670; Ding ZM, 1999, J IMMUNOL, V163, P5029; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Gonzalez AL, 2007, J LEUKOCYTE BIOL, V81, P686, DOI 10.1189/jlb.0906553; Gopalan PK, 2000, J LEUKOCYTE BIOL, V68, P47; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; Helmbold P, 2001, J CUTAN PATHOL, V28, P206, DOI 10.1034/j.1600-0560.2001.028004206.x; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; HUANG AJ, 1988, J CELL PHYSIOL, V135, P355, DOI 10.1002/jcp.1041350302; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maier CL, 2011, ARTERIOSCL THROM VAS, V31, P183, DOI 10.1161/ATVBAHA.110.217117; Maier CL, 2010, MICROCIRCULATION, V17, P367, DOI 10.1111/j.1549-8719.2010.00038.x; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; ROT A, 1993, ADV EXP MED BIOL, V351, P77; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930; Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375; Zheng L, 2000, J IMMUNOL, V164, P4665, DOI 10.4049/jimmunol.164.9.4665	38	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60025	10.1371/journal.pone.0060025	http://dx.doi.org/10.1371/journal.pone.0060025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555870	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500113
J	Byler, KA; Carmi-Veal, M; Fine, M; Goulet, TL				Byler, Kristen A.; Carmi-Veal, Maya; Fine, Maoz; Goulet, Tamar L.			Multiple Symbiont Acquisition Strategies as an Adaptive Mechanism in the Coral Stylophora pistillata	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ALGAL SYMBIOSIS; SYMBIODINIUM; SPECIFICITY; DIVERSITY; ONSET; ENDOSYMBIONTS; TRANSMISSION; STABILITY; BIOGEOGRAPHY	In obligate symbioses, the host's survival relies on the successful acquisition and maintenance of symbionts. Symbionts can either be transferred from parent to offspring via direct inheritance (vertical transmission) or acquired anew each generation from the environment (horizontal transmission). With vertical symbiont transmission, progeny benefit by not having to search for their obligate symbionts, and, with symbiont inheritance, a mechanism exists for perpetuating advantageous symbionts. But, if the progeny encounter an environment that differs from that of their parent, they may be disadvantaged if the inherited symbionts prove suboptimal. Conversely, while in horizontal symbiont acquisition host survival hinges on an unpredictable symbiont source, an individual host may acquire genetically diverse symbionts well suited to any given environment. In horizontal acquisition, however, a potentially advantageous symbiont will not be transmitted to subsequent generations. Adaptation in obligate symbioses may require mechanisms for both novel symbiont acquisition and symbiont inheritance. Using denaturing-gradient gel electrophoresis and real-time PCR, we identified the dinoflagellate symbionts (genus Symbiodinium) hosted by the Red Sea coral Stylophora pistillata throughout its ontogenesis and over depth. We present evidence that S. pistillata juvenile colonies may utilize both vertical and horizontal symbiont acquisition strategies. By releasing progeny with maternally derived symbionts, that are also capable of subsequent horizontal symbiont acquisition, coral colonies may acquire physiologically advantageous novel symbionts that are then perpetuated via vertical transmission to subsequent generations. With symbiont inheritance, natural selection can act upon the symbiotic variability, providing a mechanism for coral adaptation.	[Byler, Kristen A.; Goulet, Tamar L.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Carmi-Veal, Maya; Fine, Maoz] Interuniv Inst Marine Sci, Elat, Israel; [Fine, Maoz] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	University of Mississippi; Bar Ilan University	Goulet, TL (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	tlgoulet@olemiss.edu	Fine, Maoz/S-5582-2019	Fine, Maoz/0000-0003-4911-4562	Sigma Xi; Lerner Gray Memorial Fund of the American Museum of Natural History; University of Mississippi Graduate School Council; Israel Science Foundation; University of Mississippi College of Liberal Arts; Office of Research and Sponsored Programs; National Science Foundation [IOS-0747205]	Sigma Xi; Lerner Gray Memorial Fund of the American Museum of Natural History; University of Mississippi Graduate School Council; Israel Science Foundation(Israel Science Foundation); University of Mississippi College of Liberal Arts; Office of Research and Sponsored Programs; National Science Foundation(National Science Foundation (NSF))	Funding was provided by Sigma Xi Grants-In-Aid of Research, the Lerner Gray Memorial Fund of the American Museum of Natural History, the University of Mississippi Graduate School Council (KAB); an Israel Science Foundation grant (MF); and by the University of Mississippi College of Liberal Arts, the Office of Research and Sponsored Programs, and the National Science Foundation (IOS-0747205) (TLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Abrego D, 2009, MOL ECOL, V18, P3518, DOI 10.1111/j.1365-294X.2009.04275.x; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Baillie BK, 2000, MAR BIOL, V136, P829, DOI 10.1007/s002270000290; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Benayahu Y, 1998, MAR BIOL, V131, P433, DOI 10.1007/s002270050336; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Buddemeier R.W., 2004, CORAL REEFS GLOBAL C, P1; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Douglas A.E., 1995, Advances in Ecological Research, V26, P69, DOI 10.1016/S0065-2504(08)60064-1; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Goulet TL, 2005, LIMNOL OCEANOGR, V50, P1490, DOI 10.4319/lo.2005.50.5.1490; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Harii S, 2009, MAR BIOL, V156, P1203, DOI 10.1007/s00227-009-1162-9; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lampert-Karako S, 2008, AQUAT CONSERV, V18, P1039, DOI 10.1002/aqc.927; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Muscatine L., 1990, P75; Padilla-Gamino JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038440; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Rodriguez-Lanetty M, 2004, MAR ECOL PROG SER, V275, P97, DOI 10.3354/meps275097; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Stewart FJ, 2008, MOL BIOL EVOL, V25, P673, DOI 10.1093/molbev/msn010; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; Veron J.E.N., 2000, CORALS WORLD, V1-3; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; Winters G, 2009, MAR ECOL PROG SER, V384, P107, DOI 10.3354/meps08036; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Yang JK, 2011, AQUAT MICROB ECOL, V62, P231, DOI 10.3354/ame01473; Zakai D, 2006, MAR ECOL PROG SER, V311, P93, DOI 10.3354/meps311093	60	74	75	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59596	10.1371/journal.pone.0059596	http://dx.doi.org/10.1371/journal.pone.0059596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555721	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500061
J	Chavda, AP; Prole, DL; Taylor, CW				Chavda, Alap P.; Prole, David L.; Taylor, Colin W.			A Bead Aggregation Assay for Detection of Low-Affinity Protein-Protein Interactions Reveals Interactions between N-Terminal Domains of Inositol 1,4,5-Trisphosphate Receptors	PLOS ONE			English	Article							CISTERNAL STACKS; TRANSIENT; INSP(3)	Interactions between proteins are a hallmark of all cellular activities. Such interactions often occur with low affinity, a feature that allows them to be rapidly reversible, but it makes them difficult to detect using conventional methods such as yeast 2-hybrid analyses, co-immunoprecipitation or analytical ultracentrifugation. We developed a simple and economical bead aggregation assay to study low-affinity interactions between proteins. By coating beads with interacting proteins, the weak interactions between many proteins are sufficient to allow stable aggregation of beads, an avidity effect. The aggregation is easily measured to allow quantification of protein-protein interactions under a variety of controlled conditions. We use this assay to demonstrate low-affinity interactions between the N-terminal domains of an intracellular Ca2+ channel, the type 1 inositol 1,4,5-trisphosphate receptor. This simple bead aggregation assay may have widespread application in the study of low-affinity interactions between macromolecules.	[Chavda, Alap P.; Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	cwt1000@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665	Wellcome Trust [085295]; Meres research associateship from St. John's College, Cambridge	Wellcome Trust(Wellcome TrustEuropean Commission); Meres research associateship from St. John's College, Cambridge	This work was supported by the Wellcome Trust (grant number 085295 to CWT) and by a Meres research associateship from St. John's College, Cambridge (to DLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; Ding Z, 2010, MOL PHARMACOL, V77, P995, DOI 10.1124/mol.109.062596; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Leunissen ME, 2009, SOFT MATTER, V5, P2422, DOI 10.1039/b817679e; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Rahman T. U., 2009, NATURE, V458, P655; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; RUSAKOV DA, 1993, J NEUROCYTOL, V22, P273, DOI 10.1007/BF01187126; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Szlufcik K, 2006, CELL CALCIUM, V39, P325, DOI 10.1016/j.ceca.2005.11.007; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Van Criekinge Wim, 1999, Biological Procedures Online, V2, P1, DOI 10.1251/bpo16	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60609	10.1371/journal.pone.0060609	http://dx.doi.org/10.1371/journal.pone.0060609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555994	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500141
J	Byun, YH; Ha, M; Kwon, HJ; Hong, YC; Leem, JH; Sakong, J; Kim, SY; Lee, CG; Kang, D; Choi, HD; Kim, N				Byun, Yoon-Hwan; Ha, Mina; Kwon, Ho-Jang; Hong, Yun-Chul; Leem, Jong-Han; Sakong, Joon; Kim, Su Young; Lee, Chul Gab; Kang, Dongmug; Choi, Hyung-Do; Kim, Nam			Mobile Phone Use, Blood Lead Levels, and Attention Deficit Hyperactivity Symptoms in Children: A Longitudinal Study	PLOS ONE			English	Article							RADIOFREQUENCY-RADIATION-EXPOSURE; BRAIN-BARRIER PERMEABILITY; NERVE-CELL DAMAGE; ELECTROMAGNETIC-FIELDS; FLOW; NEURODEVELOPMENT; METAANALYSIS; SENSITIVITY; IMPAIRMENT; MICROWAVES	Background: Concerns have developed for the possible negative health effects of radiofrequency electromagnetic field (RF-EMF) exposure to children's brains. The purpose of this longitudinal study was to investigate the association between mobile phone use and symptoms of Attention Deficit Hyperactivity Disorder (ADHD) considering the modifying effect of lead exposure. Methods: A total of 2,422 children at 27 elementary schools in 10 Korean cities were examined and followed up 2 years later. Parents or guardians were administered a questionnaire including the Korean version of the ADHD rating scale and questions about mobile phone use, as well as socio-demographic factors. The ADHD symptom risk for mobile phone use was estimated at two time points using logistic regression and combined over 2 years using the generalized estimating equation model with repeatedly measured variables of mobile phone use, blood lead, and ADHD symptoms, adjusted for covariates. Results: The ADHD symptom risk associated with mobile phone use for voice calls but the association was limited to children exposed to relatively high lead. Conclusions: The results suggest that simultaneous exposure to lead and RF from mobile phone use was associated with increased ADHD symptom risk, although possible reverse causality could not be ruled out.	[Byun, Yoon-Hwan] Dankook Univ, Coll Med, Dept Med, Cheonan, South Korea; [Ha, Mina; Kwon, Ho-Jang] Dankook Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea; [Ha, Mina; Kwon, Ho-Jang] Dankook Univ, Med Ctr, Ctr Environm Hlth, Cheonan, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Leem, Jong-Han] Inha Univ, Coll Med, Dept Occupat & Environm Med, Inchon, South Korea; [Sakong, Joon] Yeungnam Univ, Coll Med, Dept Prevent Med, Taegu, South Korea; [Kim, Su Young] Jeju Natl Univ, Coll Med, Dept Prevent Med, Cheju, South Korea; [Lee, Chul Gab] Chosun Univ, Sch Med, Dept Occupat Med, Kwangju, South Korea; [Kang, Dongmug] Busan Natl Univ, Sch Med, Dept Occupat Med, Pusan, South Korea; [Choi, Hyung-Do] Elect & Telecommun Res Inst, Radio Technol Res Dept, Taejon 305606, South Korea; [Kim, Nam] Chungbuk Natl Univ, Coll Elect & Comp Engn, Sch Informat & Commun Engn, Chonju, South Korea	Dankook University; Dankook University; Dankook University; Seoul National University (SNU); Inha University; Yeungnam University; Jeju National University; Chosun University; Pusan National University; Pusan National University Hospital; Electronics & Telecommunications Research Institute - Korea (ETRI); Chungbuk National University	Ha, M (corresponding author), Dankook Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea.	minaha@dku.edu	Hong, Yun-Chul/J-5725-2012; Lee, Chul Gab/E-8525-2013; Sakong, Joon/AFE-2002-2022; Kim, Yoon-Ji/ABG-7898-2021	Kim, Yoon-Ji/0000-0002-8137-8915; KANG, DONGMUG/0000-0002-0657-0181	Ministry of Environment; Ministry of Knowledge and Economy	Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Ministry of Knowledge and Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This study was financially supported by the Ministry of Environment and Ministry of Knowledge and Economy. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript, but supported to collect data by sending the official paper to schools for encouraging them to participate in the survey.	Aalto S, 2006, J CEREBR BLOOD F MET, V26, P885, DOI 10.1038/sj.jcbfm.9600279; Abramson MJ, 2009, BIOELECTROMAGNETICS, V30, P678, DOI 10.1002/bem.20534; Aldad TS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00312; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Barth A, 2008, OCCUP ENVIRON MED, V65, P342, DOI 10.1136/oem.2006.031450; Barth A, 2012, BIOELECTROMAGNETICS, V33, P159, DOI 10.1002/bem.20697; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Carlberg M, 2007, BMC PUBLIC HEALTH, V11, P105; CLARKSON TW, 1987, ENVIRON HEALTH PERSP, V75, P59, DOI 10.2307/3430577; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.10179; Divan HA, 2011, SCAND J WORK ENV HEA, V37, P341, DOI 10.5271/sjweh.3157; Divan HA, 2012, J EPIDEMIOL COMMUN H, V66, P524, DOI 10.1136/jech.2010.115402; Eberhardt JL, 2008, ELECTROMAGN BIOL MED, V27, P215, DOI 10.1080/15368370802344037; Finnie JW, 2006, PATHOLOGY, V38, P63, DOI 10.1080/00313020500459607; Guzeller CO, 2012, CYBERPSYCH BEH SOC N, V15, P205, DOI 10.1089/cyber.2011.0210; Ha M, 2009, NEUROTOXICOLOGY, V30, P31, DOI 10.1016/j.neuro.2008.11.011; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hossmann KA, 2003, BIOELECTROMAGNETICS, V24, P49, DOI 10.1002/bem.10068; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; International Telecommunication Union, 2009, WORLD 2009 ICT FACTS; Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Kwon MS, 2012, BIOELECTROMAGNETICS, V33, P247, DOI 10.1002/bem.20702; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; McQuade JMS, 2009, RADIAT RES, V171, P615, DOI 10.1667/RR1507.1; Millichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332; Mizuno Y, 2009, BIOELECTROMAGNETICS, V30, P536, DOI 10.1002/bem.20508; Nigg JT, 2010, J CHILD PSYCHOL PSYC, V51, P58, DOI 10.1111/j.1469-7610.2009.02135.x; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Nittby H, 2008, ELECTROMAGN BIOL MED, V27, P103, DOI 10.1080/15368370802061995; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Nittby Henrietta, 2009, Pathophysiology, V16, P103, DOI 10.1016/j.pathophys.2009.01.001; PERSSON BRR, 1992, ANN NY ACAD SCI, V649, P356, DOI 10.1111/j.1749-6632.1992.tb49629.x; Repacholi MH, 1998, BIOELECTROMAGNETICS, V19, P1, DOI 10.1002/(SICI)1521-186X(1998)19:1<1::AID-BEM1>3.0.CO;2-5; Salford LG, 2003, ENVIRON HEALTH PERSP, V111, P881, DOI 10.1289/ehp.6039; Saunders NR, 2000, CELL MOL NEUROBIOL, V20, P29, DOI 10.1023/A:1006991809927; Stam R, 2010, BRAIN RES REV, V65, P80, DOI 10.1016/j.brainresrev.2010.06.001; Thomas S, 2010, OCCUP ENVIRON MED, V67, P861, DOI 10.1136/oem.2009.054080; Thomas S, 2010, EUR J EPIDEMIOL, V25, P135, DOI 10.1007/s10654-009-9408-x; THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6; Tokola K, 2008, BIOELECTROMAGNETICS, V29, P559, DOI 10.1002/bem.20424; Tsurita G, 2000, BIOELECTROMAGNETICS, V21, P364, DOI 10.1002/1521-186X(200007)21:5<364::AID-BEM5>3.0.CO;2-Q; Valentini E, 2010, OCCUP ENVIRON MED, V67, P708, DOI 10.1136/oem.2009.047027; Vrijheid M, 2010, EPIDEMIOLOGY, V21, P259, DOI 10.1097/EDE.0b013e3181cb41e0; Walkowiak J, 1998, NEUROTOXICOL TERATOL, V20, P511, DOI 10.1016/S0892-0362(98)00010-5; Weiss MD, 2011, ADHD-ATTEND DEFICIT, V3, P327, DOI 10.1007/s12402-011-0065-z; 소유경, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P283	47	37	39	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59742	10.1371/journal.pone.0059742	http://dx.doi.org/10.1371/journal.pone.0059742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555766	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400061
J	Matsuo, Y; Nishino, K; Mizuno, K; Akihiro, T; Toda, T; Matsuo, Y; Kaino, T; Kawamukai, M				Matsuo, Yuzy; Nishino, Kouhei; Mizuno, Kouhei; Akihiro, Takashi; Toda, Takashi; Matsuo, Yasuhiro; Kaino, Tomohiro; Kawamukai, Makoto			Polypeptone Induces Dramatic Cell Lysis in ura4 Deletion Mutants of Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; GENE; PROTEIN; BIOSYNTHESIS; DISRUPTION; PHENOTYPES; CLONING; DOMAIN	Polypeptone is widely excluded from Schizosaccharomyces pombe growth medium. However, the reasons why polypeptone should be avoided have not been documented. Polypeptone dramatically induced cell lysis in the ura4 deletion mutant when cells approached the stationary growth phase, and this phenotype was suppressed by supplementation of uracil. To determine the specificity of this cell lysis phenotype, we created deletion mutants of other genes involved in de novo biosynthesis of uridine monophosphate (ura1, ura2, ura3, and ura5). Cell lysis was not observed in these gene deletion mutants. In addition, concomitant disruption of ura1, ura2, ura3, or ura5 in the ura4 deletion mutant suppressed cell lysis, indicating that cell lysis induced by polypeptone is specific to the ura4 deletion mutant. Furthermore, cell lysis was also suppressed when the gene involved in coenzyme Q biosynthesis was deleted. This is likely because Ura3 requires coenzyme Q for its activity. The ura4 deletion mutant was sensitive to zymolyase, which mainly degrades (1,3)-beta-D glucan, when grown in the presence of polypeptone, and cell lysis was suppressed by the osmotic stabiliser, sorbitol. Finally, the induction of cell lysis in the ura4 deletion mutant was due to the accumulation of orotidine-5-monophosphate. Cell wall integrity was dramatically impaired in the ura4 deletion mutant when grown in the presence of polypeptone. Because ura4 is widely used as a selection marker in S. pombe, caution needs to be taken when evaluating phenotypes of ura4 mutants.	[Matsuo, Yuzy; Nishino, Kouhei; Mizuno, Kouhei; Matsuo, Yasuhiro; Kaino, Tomohiro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Akihiro, Takashi] Shimane Univ, Fac Life & Environm Sci, Dept Biol Sci, Matsue, Shimane, Japan; [Matsuo, Yuzy; Toda, Takashi] Canc Res UK, London Res Inst, Cell Regulat Lab, London, England	Shimane University; Shimane University; Cancer Research UK	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimane-u.ac.jp	Matsuo, Yasuhiro/AAT-6220-2021; Kawamukai, Makoto/AET-1038-2022	Matsuo, Yasuhiro/0000-0002-2858-7179; Kawamukai, Makoto/0000-0003-2929-8798	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380056]; Cancer Research UK [15670] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research UK(Cancer Research UK)	This work was supported by a grant-in-aid (#24380056) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Makoto Kawamukai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano M, 1999, J CELL SCI, V112, P3569; BACH ML, 1987, CURR GENET, V12, P527, DOI 10.1007/BF00419562; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Egel R., 2003, FISSION YEAST GEN GE; Furuya K, 2009, YEAST, V26, P221, DOI 10.1002/yea.1662; Godoy C, 1996, YEAST, V12, P983, DOI 10.1002/(SICI)1097-0061(199608)12:10<983::AID-YEA2>3.0.CO;2-D; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; LOLLIER M, 1995, CURR GENET, V28, P138, DOI 10.1007/BF00315780; Maniatis T, 1989, MOL CLONING LABLATOR; Matsuo Y, 2004, YEAST, V21, P1005, DOI 10.1002/yea.1145; Matsuo Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1489, DOI 10.1271/bbb.68.1489; Matsuo Y, 2010, BIOSCI BIOTECH BIOCH, V74, P685, DOI 10.1271/bbb.90967; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Miki R, 2008, FEBS J, V275, P5309, DOI 10.1111/j.1742-4658.2008.06661.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Paul SK, 2009, BIOSCI BIOTECH BIOCH, V73, P1339, DOI 10.1271/bbb.90005; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Saiki R, 2003, BIOFACTORS, V18, P229, DOI 10.1002/biof.5520180225; SAKAGUCHI J, 1982, P NATL ACAD SCI-BIOL, V79, P7819, DOI 10.1073/pnas.79.24.7819; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Tanae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030472; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Vos A, 2007, J BIOL CHEM, V282, P18969, DOI 10.1074/jbc.M605147200	27	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59887	10.1371/journal.pone.0059887	http://dx.doi.org/10.1371/journal.pone.0059887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555823	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400068
J	Zaepffel, M; Trachel, R; Kilavik, BE; Brochier, T				Zaepffel, Manuel; Trachel, Romain; Kilavik, Bjorg Elisabeth; Brochier, Thomas			Modulations of EEG Beta Power during Planning and Execution of Grasping Movements	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; CORTICAL OSCILLATORY ACTIVITY; REACTION-TIME; MOTOR CORTEX; SENSORIMOTOR CORTEX; SYNCHRONIZATION; RHYTHMS; STIMULATION; ALPHA; GAMMA	Although beta oscillations (approximate to 13-35 Hz) are often considered as a sensorimotor rhythm, their functional role remains debated. In particular, the modulations of beta power during preparation and execution of complex movements in different contexts were barely investigated. Here, we analysed the beta oscillations recorded with electroencephalography (EEG) in a precued grasping task in which we manipulated two critical parameters: the grip type (precision vs. side grip) and the force (high vs. low force) required to pull an object along a horizontal axis. A cue was presented 3 s before a GO signal and provided full, partial or no information about the two movement parameters. We measured beta power over the centroparietal areas during movement preparation and execution as well as during object hold. We explored the modulations of power in relation to the amount and type of prior information provided by the cue. We also investigated how beta power was affected by the grip and force parameters. We observed an increase in beta power around the cue onset followed by a decrease during movement preparation and execution. These modulations were followed by a transient power increase during object hold. This pattern of modulations did not differ between the 4 movement types (2 grips x2 forces). However, the amount and type of prior information provided by the cue had a significant effect on the beta power during the preparatory delay. We discuss how these results fit with current hypotheses on the functional role of beta oscillations.	[Zaepffel, Manuel; Trachel, Romain; Kilavik, Bjorg Elisabeth; Brochier, Thomas] Aix Marseille Univ, Inst Neurosci Timone, CNRS, UMR 7289, Marseille, France; [Trachel, Romain] INRIA, Athena Project Team, Sophia Antipolis, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Inria	Zaepffel, M (corresponding author), Aix Marseille Univ, Inst Neurosci Timone, CNRS, UMR 7289, Marseille, France.	brochier@incm.cnrs-mrs.fr		Kilavik, Bjorg/0000-0002-8235-4624	Ministere de l'enseignement superieur et de la recherche (French government); Les Treilles fondation; French ministry of defense (DGA)	Ministere de l'enseignement superieur et de la recherche (French government); Les Treilles fondation; French ministry of defense (DGA)	This work was supported by the Ministere de l'enseignement superieur et de la recherche (French government), Les Treilles fondation (to M.Z.) and the French ministry of defense (DGA) (to R. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2008, CLIN NEUROPHYSIOL, V119, P290, DOI 10.1016/j.clinph.2007.10.017; Alegre M, 2006, CLIN NEUROPHYSIOL, V117, P16, DOI 10.1016/j.clinph.2005.08.030; Alegre M, 2003, NEUROREPORT, V14, P381, DOI 10.1097/01.wnr.0000059624.96928.c0; Alegre M, 2003, EXP BRAIN RES, V148, P17, DOI 10.1007/s00221-002-1255-x; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Bauml KHT, 2011, HUM BRAIN MAPP, DOI 101002/hbm.21322; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cassim F, 2001, NEUROREPORT, V12, P3859, DOI 10.1097/00001756-200112040-00051; Cassim F, 2000, CLIN NEUROPHYSIOL, V111, P2032, DOI 10.1016/S1388-2457(00)00455-7; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Devos D, 2006, PROG BRAIN RES, V159, P331, DOI 10.1016/S0079-6123(06)59022-3; Doyle LMF, 2005, CLIN NEUROPHYSIOL, V116, P1879, DOI 10.1016/j.clinph.2005.03.017; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Engelhard B, 2013, NEURON, V77, P361, DOI 10.1016/j.neuron.2012.11.015; Erbil N, 2007, BRAIN RES, V1169, P44, DOI 10.1016/j.brainres.2007.07.014; Feige B, 1996, BRAIN RES, V734, P252, DOI 10.1016/0006-8993(96)00648-8; Fischer T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012514; Formaggio E, 2008, BRAIN TOPOGR, V21, P100, DOI 10.1007/s10548-008-0058-1; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gaetz W, 2010, NEUROIMAGE, V51, P792, DOI 10.1016/j.neuroimage.2010.01.077; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Houdayer E, 2006, CLIN NEUROPHYSIOL, V117, P628, DOI 10.1016/j.clinph.2005.12.001; Jasper H., 1949, ARCH PSYCHIAT NERVEN, V183, P163, DOI [DOI 10.1007/BF01062488, 10.1007/BF01062488]; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kilavik BE, 2010, ATTENTION TIME, P257, DOI 10.1093/acprof; Kilavik BE, 2012, CEREB CORTEX, V22, P2148, DOI 10.1093/cercor/bhr299; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Leocani L, 2006, PROG BRAIN RES, V159, P351, DOI 10.1016/S0079-6123(06)59023-5; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; Molnar M, 2008, PSYCHOPHYSIOLOGY, V45, P412, DOI 10.1111/j.1469-8986.2008.00648.x; Muller GR, 2003, NEUROSCI LETT, V340, P143, DOI 10.1016/S0304-3940(03)00019-3; Muller-Gerking J, 2000, CLIN NEUROPHYSIOL, V111, P1353, DOI 10.1016/S1388-2457(00)00345-X; Nakagawa K, 2011, NEUROREPORT, V22, P217, DOI 10.1097/WNR.0b013e328344b480; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; NEUPER C, 1999, HANDB EL CL, V6, P303; Ohara S, 2000, BRAIN, V123, P1203, DOI 10.1093/brain/123.6.1203; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 2009, CLIN NEUROPHYSIOL, V120, P24, DOI 10.1016/j.clinph.2008.09.027; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rau C, 2003, CLIN NEUROPHYSIOL, V114, P1819, DOI 10.1016/S1388-2457(03)00174-3; Reyns N, 2008, CLIN NEUROPHYSIOL, V119, P1335, DOI 10.1016/j.clinph.2008.02.020; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Rohrbaugh J.W., 1983, TUTORIALS ERP RES EN, P269, DOI 10.1016/S0166-4115(08)62044-0; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Roux SG, 2007, J NEUROSCI METH, V160, P135, DOI 10.1016/j.jneumeth.2006.09.001; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; Salmelin R, 1995, ELECTROEN CLIN NEURO, V95, P444, DOI 10.1016/0013-4694(95)00193-X; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sochurkova D, 2006, EXP BRAIN RES, V173, P637, DOI 10.1007/s00221-006-0407-9; Spinks RL, 2008, J NEUROSCI, V28, P10961, DOI 10.1523/JNEUROSCI.1956-08.2008; Stancak A, 1997, ELECTROEN CLIN NEURO, V102, P495, DOI 10.1016/S0013-4694(96)96623-0; Stancak A, 2003, CLIN NEUROPHYSIOL, V114, P1936, DOI 10.1016/S1388-2457(03)00201-3; Stancak A, 1996, COGNITIVE BRAIN RES, V4, P171, DOI 10.1016/S0926-6410(96)00031-6; Stevenson CM, 2011, HUM BRAIN MAPP, V32, P182, DOI 10.1002/hbm.21016; Szurhaj W, 2003, CLIN NEUROPHYSIOL, V114, P107, DOI 10.1016/S1388-2457(02)00333-4; Takahashi K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00040; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; van Elk M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.008.2010; van Wijk BCM, 2009, CEREB CORTEX, V19, P1294, DOI 10.1093/cercor/bhn174; Vecchiato G, 2010, J NEUROSCI METH, V191, P283, DOI 10.1016/j.jneumeth.2010.07.009; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wheaton L, 2009, CLIN NEUROPHYSIOL, V120, P980, DOI 10.1016/j.clinph.2009.02.161; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028; Zaepffel M, 2012, PSYCHOPHYSIOLOGY, V49, P17, DOI 10.1111/j.1469-8986.2011.01277.x	78	98	98	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60060	10.1371/journal.pone.0060060	http://dx.doi.org/10.1371/journal.pone.0060060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555884	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400078
J	Chang, HW; Bacallado, S; Pande, VS; Carlsson, GE				Chang, Huang-Wei; Bacallado, Sergio; Pande, Vijay S.; Carlsson, Gunnar E.			Persistent Topology and Metastable State in Conformational Dynamics	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; PROTEINS; KINETICS; DENSITY; MODELS	The large amount of molecular dynamics simulation data produced by modern computational models brings big opportunities and challenges to researchers. Clustering algorithms play an important role in understanding biomolecular kinetics from the simulation data, especially under the Markov state model framework. However, the ruggedness of the free energy landscape in a biomolecular system makes common clustering algorithms very sensitive to perturbations of the data. Here, we introduce a data-exploratory tool which provides an overview of the clustering structure under different parameters. The proposed Multi-Persistent Clustering analysis combines insights from recent studies on the dynamics of systems with dominant metastable states with the concept of multi-dimensional persistence in computational topology. We propose to explore the clustering structure of the data based on its persistence on scale and density. The analysis provides a systematic way to discover clusters that are robust to perturbations of the data. The dominant states of the system can be chosen with confidence. For the clusters on the borderline, the user can choose to do more simulation or make a decision based on their structural characteristics. Furthermore, our multi-resolution analysis gives users information about the relative potential of the clusters and their hierarchical relationship. The effectiveness of the proposed method is illustrated in three biomolecules: alanine dipeptide, Villin headpiece, and the FiP35 WW domain.	[Chang, Huang-Wei] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Bacallado, Sergio] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Carlsson, Gunnar E.] Stanford Univ, Dept Math, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Chang, HW (corresponding author), Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA.	huangwei@stanford.edu	Pande, Vijay/ABE-8145-2020		National Science Foundation [DMS-0900700]; National Institutes of Health (NIH) via NIH [R01-GM062868]; Air Force Office of Scientific Research [FA9550-09-0-1-0531, FA9550-09-1-0643]; NSF DMS [0905823]; Office of Naval Research [N00014-08-1-0931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062868] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH) via NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF DMS(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant DMS-0900700. VSP also thanks National Institutes of Health (NIH) for support via NIH R01-GM062868. GEC is supported by Air Force Office of Scientific Research grants FA9550-09-0-1-0531 and FA9550-09-1-0643, NSF DMS 0905823, and Office of Naval Research grant N00014-08-1-0931. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp KA, 2012, P NATL ACAD SCI US; Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; Bertoni A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S7; Bowman GR, 2009, METHODS, V49, P197, DOI 10.1016/j.ymeth.2009.04.013; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Carlsson G, 2009, DISCRETE COMPUT GEOM, V42, P71, DOI 10.1007/s00454-009-9176-0; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chaudhuri K, 2010, NEURAL INFORM PROCES; Chazal F, 2011, COMPUTATIONAL GEOMETRY (SCG 11), P97; Chodera JD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714538; Deuflhard P, 2000, LINEAR ALGEBRA APPL, V315, P39, DOI 10.1016/S0024-3795(00)00095-1; Deuflhard P, 2005, LINEAR ALGEBRA APPL, V398, P161, DOI 10.1016/j.laa.2004.10.026; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Evans DA, 2003, J CHEM PHYS, V118, P3891, DOI 10.1063/1.1540099; Krivov SV, 2002, J CHEM PHYS, V117, P10894, DOI 10.1063/1.1517606; Lane TJ, 2012, CURR OPIN STRUCT BIO; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Memoli F, 2009, MULTIPARAMETER HIERA; Muff S, 2008, PROTEINS, V70, P1185, DOI 10.1002/prot.21565; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Prinz J.-H, 2011, J CHEM PHYS, V134; Rinaldo A, 2010, ANN STAT, V38, P2678, DOI 10.1214/10-AOS797; Shamir O, 2009, ADV NEURAL INFORM PR; Shamir O, 2010, MACH LEARN, V80, P213, DOI 10.1007/s10994-010-5177-8; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Singhal N, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2116947; Stuetzle W, 2010, J COMPUT GRAPH STAT, V19, P397, DOI 10.1198/jcgs.2009.07049; von Luxburg U, 2011, INT C MACH LEARN ICM; Von Luxburg U, 2008, P INT C COMP LEARN T; Wales DJ, 2005, PHILOS T R SOC A, V363, P357, DOI 10.1098/rsta.2004.1497	31	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e58699	10.1371/journal.pone.0058699	http://dx.doi.org/10.1371/journal.pone.0058699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565139	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300006
J	Brugger, K; Rubel, F				Brugger, Katharina; Rubel, Franz			Bluetongue Disease Risk Assessment Based on Observed and Projected Culicoides obsoletus spp. Vector Densities	PLOS ONE			English	Article							USUTU-VIRUS DYNAMICS; SEROTYPE 8; SEASONAL ABUNDANCE; TRANSMISSION; CLIMATE; DIPTERA; CERATOPOGONIDAE; EPIDEMIOLOGY; SURVEILLANCE; PARAMETERS	Bluetongue is an arboviral disease of ruminants causing significant economic losses. Our risk assessment is based on the epidemiological key parameter, the basic reproduction number. It is defined as the number of secondary cases caused by one primary case in a fully susceptible host population, in which values greater than one indicate the possibility, i. e., the risk, for a major disease outbreak. In the course of the Bluetongue virus serotype 8 (BTV-8) outbreak in Europe in 2006 we developed such a risk assessment for the University of Veterinary Medicine Vienna, Austria. Basic reproduction numbers were calculated using a well-known formula for vector-borne diseases considering the population densities of hosts (cattle and small ruminants) and vectors (biting midges of the Culicoides obsoletus spp.) as well as temperature dependent rates. The latter comprise the biting and mortality rate of midges as well as the reciprocal of the extrinsic incubation period. Most important, but generally unknown, is the spatio-temporal distribution of the vector density. Therefore, we established a continuously operating daily monitoring to quantify the seasonal cycle of the vector population by a statistical model. We used cross-correlation maps and Poisson regression to describe vector densities by environmental temperature and precipitation. Our results comprise time series of observed and simulated Culicoides obsoletus spp. counts as well as basic reproduction numbers for the period 2009-2011. For a spatio-temporal risk assessment we projected our results from the location of Vienna to the entire region of Austria. We compiled both daily maps of vector densities and the basic reproduction numbers, respectively. Basic reproduction numbers above one were generally found between June and August except in the mountainous regions of the Alps. The highest values coincide with the locations of confirmed BTV cases.	[Brugger, Katharina; Rubel, Franz] Univ Vet Med Vienna, Inst Vet Publ Hlth, Vienna, Austria	University of Veterinary Medicine Vienna	Brugger, K (corresponding author), Univ Vet Med Vienna, Inst Vet Publ Hlth, Vienna, Austria.	katharina.brugger@vetmeduni.ac.at	Rubel, Franz/ABD-2867-2021; Brugger, Katharina/O-6031-2015; Rubel, Franz/I-7409-2012	Rubel, Franz/0000-0002-0048-7379; Brugger, Katharina/0000-0002-7327-4841; Rubel, Franz/0000-0002-0048-7379	University of Veterinary Medicine Vienna	University of Veterinary Medicine Vienna	The research was supported by the PL2 Start-up project bluetongue disease model of the University of Veterinary Medicine Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderle Franziska, 2008, Beitraege zur Entomofaunistik, V9, P67; [Anonymous], 2007, EUROPEAN PARLIAMENT, V50; Brugger K, 2009, PREV VET MED, V88, P24, DOI 10.1016/j.prevetmed.2008.06.023; Burgin LE, 2013, TRANSBOUND EMERG DIS, V60, P263, DOI 10.1111/j.1865-1682.2012.01345.x; Caporale V, 2010, REV SCI TECH OIE, V29, P573, DOI 10.20506/rst.29.3.2001; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Carpenter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027987; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Charron MVP, 2011, J THEOR BIOL, V291, P1, DOI 10.1016/j.jtbi.2011.08.041; Clausen PH, 2009, PARASITOL RES, V105, P381, DOI 10.1007/s00436-009-1417-x; Conraths FJ, 2009, EMERG INFECT DIS, V15, P433, DOI 10.3201/eid1503.081210; Curriero FC, 2005, VECTOR-BORNE ZOONOT, V5, P267, DOI 10.1089/vbz.2005.5.267; de Koeijer AA, 2007, ECOL CONT VECTOR-BOR, V1, P99; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Delecolle J. C., 1985, THESIS U L PASTEUR S; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Frei C, 1998, INT J CLIMATOL, V18, P873, DOI [10.1002/(SICI)1097-0088(19980630)18:8<873::AID-JOC255>3.0.CO;2-9, 10.1002/(SICI)1097-0088(19980630)18:8&lt;873::AID-JOC255&gt;3.0.CO;2-9]; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gethmann J, 2010, TIERAERZTL UMSCHAU, V65, P4; Goffredo M, 2004, VETER ITAL SER, V40, P260; Gubbins S, 2012, PREV VET MED, V105, P297, DOI 10.1016/j.prevetmed.2012.02.016; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Jungblut C, 2012, AUSTRIAN CONTRIBUTIO, V7; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Loitsch A, 2009, DURCHFUHRUNG BLUETON; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Mullens BA, 2004, VETER ITAL SER, V40, P160; R Development Core Team, 2012, R LANG ENV STAT COMP; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Rawlings Peter, 1996, Graellsia, V52, P57; Robinson Timothy P, 2007, Vet Ital, V43, P745; Rubel F, 2008, PREV VET MED, V85, P166, DOI 10.1016/j.prevetmed.2008.01.006; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Schorer M, 2012, BLAUZUNGENUBERWACHUN; Shone SM, 2006, J MED ENTOMOL, V43, P393, DOI 10.1603/0022-2585(2006)043[0393:CPDOAS]2.0.CO;2; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Venter GJ, 2009, VET PARASITOL, V166, P299, DOI 10.1016/j.vetpar.2009.08.020; VENTER GJ, 1994, ONDERSTEPOORT J VET, V61, P327; Walsh AS, 2008, ENVIRON ECOL STAT, V15, P279, DOI 10.1007/s10651-007-0056-6; Wang Y, 2011, Q J ROY METEOR SOC, V137, P483, DOI 10.1002/qj.751; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x	47	35	35	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60330	10.1371/journal.pone.0060330	http://dx.doi.org/10.1371/journal.pone.0060330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560090	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900065
J	Oaks, AW; Frankfurt, M; Finkelstein, DI; Sidhu, A				Oaks, Adam W.; Frankfurt, Maya; Finkelstein, David I.; Sidhu, Anita			Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function	PLOS ONE			English	Article							PARKINSONS-DISEASE; TRANSGENIC MICE; NOREPINEPHRINE TRANSPORTER; NONMOTOR SYMPTOMS; ANIMAL-MODELS; CYTOSOLIC DOPAMINE; TAU; HYPERACTIVITY; PROTEIN; MOTOR	Expression of A53T mutant human alpha-synuclein under the mouse prion promoter is among the most successful transgenic models of Parkinson's disease. Accumulation of A53T alpha-synuclein causes adult mice to develop severe motor impairment resulting in early death at 8-12 months of age. In younger, pre-symptomatic animals, altered motor activity and anxiety-like behaviors have also been reported. These behavioral changes, which precede severe neuropathology, may stem from non-pathological functions of alpha-synuclein, including modulation of monoamine neurotransmission. Our analysis over the adult life-span of motor activity, anxiety-like, and depressive-like behaviors identifies perturbations both before and after the onset of disease. Young A53T mice had increased distribution of the dopamine transporter (DAT) to the membrane that was associated with increased striatal re-uptake function. DAT function decreased with aging, and was associated with neurochemical alterations that included increased expression of beta-synuclein and gamma synuclein. Prior to normalization of dopamine uptake, transient activation of Tau kinases and hyperphosphorylation of Tau in the striatum were also observed. Aged A53T mice had reduced neuron counts in the substantia nigra pars compacta, yet striatal medium spiny neuron dendritic spine density was largely maintained. These findings highlight the involvement of the synuclein family of proteins and phosphorylation of Tau in the response to dopaminergic dysfunction of the nigrostriatal pathway.	[Oaks, Adam W.; Sidhu, Anita] Georgetown Univ, Med Ctr, Lab Mol Neurochem, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Frankfurt, Maya] Hofstra North Shore LIJ Sch Med, Dept Sci Educ, Hempstead, NY USA; [Finkelstein, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia	Georgetown University; Hofstra University; Northwell Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Sidhu, A (corresponding author), Georgetown Univ, Med Ctr, Lab Mol Neurochem, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.	sidhua@georgetown.edu	Finkelstein, David/B-9617-2009; Frankfurt, Maya/I-5812-2019	Finkelstein, David/0000-0002-8167-4917; Frankfurt, Maya/0000-0003-3737-0497	National Institutes of Health; National Institute of Mental Health [R01MH075020]; National Institute on Aging [R01AG28108]; National Institute of Neurological Disorders and Stroke [R01NS060041]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported primarily by National Institutes of Health grants to Anita Sidhu from the National Institute of Mental Health (R01MH075020), the National Institute on Aging (R01AG28108), and the National Institute of Neurological Disorders and Stroke (R01NS060041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Cabin DE, 2005, NEUROBIOL AGING, V26, P25, DOI 10.1016/j.neurobiolaging.2004.02.026; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Duka T, 2009, FASEB J; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Elhwuegi AS, 2004, PROG NEURO-PSYCHOPH, V28, P435, DOI 10.1016/j.pnpbp.2003.11.018; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; Frankfurt M, 2011, SYNAPSE, V65, P955, DOI 10.1002/syn.20918; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; George S, 2008, EXP NEUROL, V210, P788, DOI 10.1016/j.expneurol.2007.12.017; George S, 2010, J MOL NEUROSCI, V42, P243, DOI 10.1007/s12031-010-9378-1; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Graham DR, 2010, J NEUROSCI RES, V88, P1777, DOI 10.1002/jnr.22331; Haggerty T, 2011, EUR J NEUROSCI, V33, P1598, DOI 10.1111/j.1460-9568.2011.07660.x; Hung LW, 2012, J EXP MED, V209, P837, DOI 10.1084/jem.20112285; Ikeda M, 2009, BRAIN RES, V1250, P232, DOI 10.1016/j.brainres.2008.10.011; Jeannotte AM, 2007, EUR J NEUROSCI, V26, P1509, DOI 10.1111/j.1460-9568.2007.05757.x; Jeannotte AM, 2009, NEUROPSYCHOPHARMACOL, V34, P987, DOI 10.1038/npp.2008.146; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kaul T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-79; Kuhn M, 2007, NEUROGENETICS, V8, P71, DOI 10.1007/s10048-007-0079-z; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lindgren HS, 2012, EUR J NEUROSCI, V35, P1894, DOI 10.1111/j.1460-9568.2012.08162.x; Lindvall O, 1978, Adv Biochem Psychopharmacol, V19, P1; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martins-Silva C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017611; McDowell K, 2012, NEUROBIOL DIS, V46, P597, DOI 10.1016/j.nbd.2011.12.040; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Pena-Oliver Y, 2010, BEHAV BRAIN RES, V209, P234, DOI 10.1016/j.bbr.2010.01.049; Platt NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036397; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SOTIRIOU E, 2009, NEUROBIOL AGING; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Tozzi A, 2012, NEUROBIOL AGING, V33, P1792, DOI 10.1016/j.neurobiolaging.2011.05.002; Unger EL, 2006, NEUROBIOL DIS, V21, P431, DOI 10.1016/j.nbd.2005.08.005; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Villalba RM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00133; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Wersinger C, 2004, BIOCHEMISTRY-US, V43, P1242, DOI 10.1021/bi035308s; Wersinger C, 2003, MOL CELL NEUROSCI, V24, P91, DOI 10.1016/S1044-7431(03)00124-6; Wersinger C, 2006, EUR J NEUROSCI, V24, P3141, DOI 10.1111/j.1460-9568.2006.05181.x; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Yao I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017317; Yavich L, 2006, J NEUROCHEM, V99, P724, DOI 10.1111/j.1471-4159.2006.04098.x; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200	74	57	59	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60378	10.1371/journal.pone.0060378	http://dx.doi.org/10.1371/journal.pone.0060378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560093	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900068
J	Zhang, TJ; Tian, XH; Ma, FC; Yang, Y; Yu, F; Zhao, YP; Gao, MY; Ding, YY; Jiang, QW; He, N				Zhang, Tiejun; Tian, Xiuhong; Ma, Fuchang; Yang, Ying; Yu, Feng; Zhao, Yanping; Gao, Meiyang; Ding, Yingying; Jiang, Qingwu; He, Na			Community Based Promotion on VCT Acceptance among Rural Migrants in Shanghai, China	PLOS ONE			English	Article							FEMALE SEX WORKERS; TESTING PROGRAMS; HEALTH-PROMOTION; HIV-INFECTION; RISK; ATTITUDES; ACCEPTABILITY; INTERVENTION; POPULATIONS; KNOWLEDGE	Objective: Voluntary counseling and testing (VCT) plays an important integral role in response to the HIV/AIDS epidemic. However, VCT service has not been effectively utilized among rural migrants, a high risk group in China. In this study, we developed a community based intervention to examine if community mobilization with comprehensive VCT is more effective than current HIV preventions with routine VCT service in promoting VCT acceptability among rural migrants in Shanghai, China. Methods: A comprehensive intervention with community mobilization and comprehensive VCT services including community-based VCT and mobile VCT was implemented during 2007-2009. Three communities in Minhang District of Shanghai were randomly selected and were designed to receive community mobilization and comprehensive VCT, traditional VCT and none intervention, respectively. After 24 months intervention, effects were evaluated by comparing outcome indicators between the baseline (2,690 participants) and follow-up surveys (1,850 participants). Findings: A substantial increase in VCT acceptance was observed among community mobilization group (94.9% vs. 88.5%, P<0.001), whereas the reverse effect was seen in the traditional VCT group (86.1% vs. 94.6%, P<0.001) and control group (69.0% vs. 91.7%, P<0.001). Rural migrants from community mobilization group were more likely to accept VCT (OR = 2.91, 95% CI 1.69-4.97). Rural migrants from community mobilization group also showed significant increase in HIV/AIDS knowledge, positive attitude towards HIV positive individuals and condom use. Conclusion: Community mobilization with comprehensive VCT has significant impact on promotion of VCT acceptance and utilization among rural migrants in Shanghai. These findings provide evidence to support community mobilization as a suitable strategy for VCT promotion among rural migrants in Shanghai, China.	[Zhang, Tiejun; Ma, Fuchang; Gao, Meiyang; Ding, Yingying; Jiang, Qingwu; He, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhang, Tiejun; Ma, Fuchang; Gao, Meiyang; Ding, Yingying; Jiang, Qingwu; He, Na] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Tian, Xiuhong; Yang, Ying; Yu, Feng; Zhao, Yanping] Minghang Dist Ctr Dis Control & Prevent, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention	He, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	zhao, yan/GWC-9174-2022; zhang, Tiejun/HGD-6858-2022; Zhang, Tiejun/HDM-7091-2022; ding, yy/HHS-9589-2022	Jiang, Qingwu/0000-0001-8921-3317	U.S. National Institutes of Health Fogarty International Center [R01TW007298]; Shanghai Leading Academic Discipline Project [B118]; FOGARTY INTERNATIONAL CENTER [R01TW007298] Funding Source: NIH RePORTER	U.S. National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the U.S. National Institutes of Health Fogarty International Center grant (R01TW007298) and Shanghai Leading Academic Discipline Project (B118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; [Anonymous], 2002, INCR ACC HIV TEST CO; Burki TK, 2011, LANCET, V377, P286, DOI 10.1016/S0140-6736(11)60079-2; *CHIN STAT COUNC A, 2007, JOINT ASS HIV AIDS P; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Derose KP, 2010, J URBAN HEALTH, V87, P617, DOI 10.1007/s11524-010-9444-6; He N, 2009, AIDS EDUC PREV, V21, P570, DOI 10.1521/aeap.2009.21.6.570; Hesketh T, 2005, SEX TRANSM INFECT, V81, P108, DOI 10.1136/sti.2004.009704; Holtgrave D, 2007, CLIN INFECT DIS, V45, pS240, DOI 10.1086/522544; Hong Y, 2006, AIDS BEHAV, V10, P421, DOI 10.1007/s10461-005-9039-5; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; KOEPSELL TD, 1992, ANNU REV PUBL HEALTH, V13, P31, DOI 10.1146/annurev.pu.13.050192.000335; Koku EF, 2011, J COMMUN HEALTH, V36, P289, DOI 10.1007/s10900-010-9310-1; Li L, 2010, WORK, V37, P375, DOI 10.3233/WOR-2010-1091; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Li XM, 2006, AIDS EDUC PREV, V18, P406, DOI 10.1521/aeap.2006.18.5.406; Lieber E, 2006, AIDS BEHAV, V10, P463, DOI 10.1007/s10461-005-9047-5; Liu HJ, 2001, CHIN J PREV MED, V35, P30; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; Minkler M, 2006, HEALTH PROMOT INT, V21, P293, DOI 10.1093/heapro/dal025; Sopheab H, 2008, HEALTH POLICY PLANN, V23, P277, DOI 10.1093/heapol/czn014; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2009, JOINT ASS HIV AIDS P; Sweat M, 2011, LANCET INFECT DIS; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Wu ZY, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000304701.93002.00; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Wu ZY, 2005, AIDS EDUC PREV, V17, P12, DOI 10.1521/aeap.17.1.12.58686; Zhang TJ, 2012, EUR J PUBLIC HEALTH, V22, P192, DOI 10.1093/eurpub/ckr006; Zhou L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-23; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986	32	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60106	10.1371/journal.pone.0060106	http://dx.doi.org/10.1371/journal.pone.0060106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117CY	23560071	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900046
J	Zhao, HT; Liu, L; Mo, HX; Qian, LT; Cao, Y; Cui, SJ; Li, X; Ma, LG				Zhao, Hongtao; Liu, Lei; Mo, Huixian; Qian, Litao; Cao, Ying; Cui, Sujuan; Li, Xia; Ma, Ligeng			The ATP-Binding Cassette Transporter ABCB19 Regulates Postembryonic Organ Separation in Arabidopsis	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; AXILLARY MERISTEM FORMATION; COTYLEDON DEVELOPMENT; SHOOT MERISTEM; TWISTED DWARF1; BOUNDARY; GROWTH; GENE; IMMUNOPHILIN; PROTEINS	The phytohormone auxin plays a critical role in plant development, including embryogenesis, organogenesis, tropism, apical dominance and in cell growth, division, and expansion. In these processes, the concentration gradient of auxin, which is established by polar auxin transport mediated by PIN-FORMED (PIN) proteins and several ATP-binding cassette/multi-drug resistance/P-glycoprotein (ABCB/MDR/PGP) transporters, is a crucial signal. Here, we characterized the function of ABCB19 in the control of Arabidopsis organ boundary development. We identified a new abcb19 allele, abcb19-5, which showed stem-cauline leaf and stem-pedicel fusion defects. By virtue of the DII-VENUS marker, the auxin level was found to be increased at the organ boundary region in the inflorescence apex. The expression of CUP-SHAPED COTYLEDON2 (CUC2) was decreased, while no obvious change in the expression of CUC3 was observed, in abcb19. In addition, the fusion defects were greatly enhanced in cuc3 abcb19-5, which was reminiscent of cuc2 cuc3. We also found that some other organ boundary genes, such as LOF1/2 were down-regulated in abcb19. Together, these results reveal a new aspect of auxin transporter ABCB19 function, which is largely dependent on the positive regulation of organ boundary genes CUC2 and LOFs at the postembryonic organ boundary.	[Zhao, Hongtao; Liu, Lei; Mo, Huixian; Qian, Litao; Cao, Ying; Cui, Sujuan; Ma, Ligeng] Hebei Normal Univ, Mol Cell Biol Lab, Shijiazhuang, Hebei, Peoples R China; [Cao, Ying; Ma, Ligeng] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Zhao, Hongtao; Li, Xia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources, State Key Lab Plant Cell & Chromosome Engn, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Capital Normal University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Ma, LG (corresponding author), Hebei Normal Univ, Mol Cell Biol Lab, Shijiazhuang, Hebei, Peoples R China.	Ligeng.ma@mail.hebtu.edu.cn	li, xia/HHZ-7468-2022		National Basic Research Program of China (973 Program) [2012CB910900, 2012CB114200]; Hebei Province Key Laboratory Program [109960121D]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Hebei Province Key Laboratory Program	This work was supported by grants from the National Basic Research Program of China (973 Program) (2012CB910900 and 2012CB114200) and the Hebei Province Key Laboratory Program (109960121D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2006, CURR OPIN PLANT BIOL, V9, P72, DOI 10.1016/j.pbi.2005.11.011; Aida M, 2002, DEVELOPMENT, V129, P3965; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bell EM, 2012, P NATL ACAD SCI USA, V109, P21146, DOI 10.1073/pnas.1210789109; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Ha CM, 2007, PLANT CELL, V19, P1809, DOI 10.1105/tpc.107.051938; Hibara K, 2006, PLANT CELL, V18, P2946, DOI 10.1105/tpc.106.045716; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Kwiatkowska D, 2004, J EXP BOT, V55, P1021, DOI 10.1093/jxb/erh109; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Lee DK, 2009, DEVELOPMENT, V136, P2423, DOI 10.1242/dev.031971; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Lewis DR, 2009, PLANT J, V60, P91, DOI 10.1111/j.1365-313X.2009.03941.x; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Nawy T, 2012, NAT METHODS, V9, P219, DOI 10.1038/nmeth.1915; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Norberg M, 2005, DEVELOPMENT, V132, P2203, DOI 10.1242/dev.01815; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rast MI, 2008, CURR OPIN GENET DEV, V18, P287, DOI 10.1016/j.gde.2008.05.005; Reinhardt D, 2005, CURR OPIN PLANT BIOL, V8, P487, DOI 10.1016/j.pbi.2005.07.012; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Treml BS, 2005, DEVELOPMENT, V132, P4063, DOI 10.1242/dev.01969; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Wu GS, 2010, PLANT CELL, V22, P3295, DOI 10.1105/tpc.110.078360; Wu GS, 2010, PLANT J, V62, P179, DOI 10.1111/j.1365-313X.2010.04137.x	52	15	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60809	10.1371/journal.pone.0060809	http://dx.doi.org/10.1371/journal.pone.0060809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560110	Green Submitted, gold, Green Published			2022-12-27	WOS:000316930900080
J	Demir, IE; Schorn, S; Schremmer-Danninger, E; Wang, K; Kehl, T; Giese, NA; Algul, H; Friess, H; Ceyhan, GO				Demir, Ihsan Ekin; Schorn, Stephan; Schremmer-Danninger, Elisabeth; Wang, Kun; Kehl, Timo; Giese, Nathalia A.; Alguel, Hana; Friess, Helmut; Ceyhan, Gueralp O.			Perineural Mast Cells Are Specifically Enriched in Pancreatic Neuritis and Neuropathic Pain in Pancreatic Cancer and Chronic Pancreatitis	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; NERVE GROWTH-FACTOR; SUBSTANCE-P; EXPRESSION; HYPERSENSITIVITY; DEGRANULATION; INFLAMMATION; INNERVATION; PLASTICITY; CORRELATE	Background: Pancreatic neuritis is a histopathological hallmark of pancreatic neuropathy and correlates to abdominal neuropathic pain sensation in pancreatic adenocarcinoma (PCa) and chronic pancreatitis (CP). However, inflammatory cell subtypes that compose pancreatic neuritis and their correlation to the neuropathic pain syndrome in PCa and CP are yet unknown. Methods: Inflammatory cells within pancreatic neuritis lesions of patients with PCa (n = 20) and CP (n = 20) were immunolabeled and colorimetrically quantified with the pan-leukocyte marker CD45, with CD68 (macrophages), CD8 (cytotoxic T-lymphocytes), CD4 (T-helper cells), CD20 (B-lymphocytes), NCL-PC (plasma cells), neutrophil elastase, PRG2 (eosinophils), anti-mast cell (MC) tryptase and correlated to pain sensation. Perineural mast cell subtypes were analyzed by double immunolabeling with MC chymase. Expression and neural immunoreactivity of protease-activated receptor type 1 (PAR-1) and type 2 (PAR-2) were analyzed in PCa and CP and correlated to pain status of the patients. Results: In PCa and CP, nerves were predominantly infiltrated by cytotoxic T-lymphocytes (PCa: 35% of all perineural inflammatory cells, CP: 33%), macrophages (PCa: 39%, CP: 33%) and MC (PCa: 21%, CP: 27%). In both entities, neuropathic pain sensation was associated with a specific increase of perineural MC (PCa without pain: 14% vs. PCa with pain: 31%; CP without pain: 19% vs. CP with pain: 34%), not affecting the frequency of other inflammatory cell subtypes. The vast majority of these MC contained MC chymase. PAR-1 and PAR-2 expression did not correlate to the pain sensation of PCa and CP patients. Conclusion: Pancreatic neuritis in PC and CP is composed of cytotoxic T-lymphocytes, macrophages and MC. The specific enrichment of MC around intrapancreatic nerves in neuropathic pain due to PCa and CP suggests the presence of MC-induced visceral hypersensitivity in the pancreas. Therefore, pancreatic and enteric neuropathies seem to share a similar type of neuro-immune interaction in the generation of visceral pain.	[Demir, Ihsan Ekin; Schorn, Stephan; Schremmer-Danninger, Elisabeth; Kehl, Timo; Friess, Helmut; Ceyhan, Gueralp O.] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany; [Wang, Kun] Peking Univ, Beijing Canc Hosp & Inst,Minist Educ, Sch Oncol,Dept Hepat Biliary & Pancreat Surg, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Alguel, Hana] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany; [Giese, Nathalia A.] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany	Technical University of Munich; Peking University; Technical University of Munich; Ruprecht Karls University Heidelberg	Demir, IE (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany.	ekin.demir@tum.de	Schorn, Stephan/AAZ-8009-2020	Algul, Hana/0000-0002-5067-7031				Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Bauer O, 2000, NEWS PHYSIOL SCI, V15, P213, DOI 10.1152/physiologyonline.2000.15.5.213; BOCKMAN DE, 1988, GASTROENTEROLOGY, V94, P1459; BUCHLER M, 1992, PANCREAS, V7, P183; Buhner S, 2012, BBA-MOL BASIS DIS, V1822, P85, DOI 10.1016/j.bbadis.2011.06.004; Ceyhan GO, 2007, GUT, V56, P534, DOI 10.1136/gut.2006.105528; Ceyhan GO, 2010, BEST PRACT RES CL GA, V24, P311, DOI 10.1016/j.bpg.2010.03.001; Ceyhan GO, 2010, ANN SURG, V251, P923, DOI 10.1097/SLA.0b013e3181d974d4; Ceyhan GO, 2009, LAB INVEST, V89, P347, DOI 10.1038/labinvest.2008.170; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Ceyhan GO, 2008, BEST PRACT RES CL GA, V22, P31, DOI 10.1016/j.bpg.2007.10.016; Corvera CU, 1999, J PHYSIOL-LONDON, V517, P741, DOI 10.1111/j.1469-7793.1999.0741s.x; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; De Jonge F, 2004, AM J PHYSIOL-GASTR L, V287, pG178, DOI 10.1152/ajpgi.00528.2003; Demir IE, 2012, AM J PHYSIOL-GASTR L, V303, pG1017, DOI 10.1152/ajpgi.00517.2011; Demir Ihsan Ekin, 2010, Cancers (Basel), V2, P1513, DOI 10.3390/cancers2031513; Demir IE, 2011, LANGENBECK ARCH SURG, V396, P151, DOI 10.1007/s00423-010-0731-1; Di Sebastiano P, 2000, GUT, V47, P423, DOI 10.1136/gut.47.3.423; Di Sebastiano P, 1999, LANCET, V354, P461, DOI 10.1016/S0140-6736(98)10463-4; DiSebastiano P, 1997, GASTROENTEROLOGY, V112, P1648, DOI 10.1016/S0016-5085(97)70047-7; Drewes AM, 2008, GUT, V57, P1616, DOI 10.1136/gut.2007.146621; FRANZIUS D, 1994, PFLUG ARCH EUR J PHY, V428, P433, DOI 10.1007/BF00374562; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Hagiyama M, 2011, J IMMUNOL, V186, P5983, DOI 10.4049/jimmunol.1002244; Hoogerwerf WA, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-8; Hoogerwerf WA, 2004, GASTROENTEROLOGY, V127, P883, DOI 10.1053/j.gastro.2004.07.002; JIPPO T, 1994, BLOOD, V84, P2977; KEITH RG, 1985, CAN J SURG, V28, P207; Klooker TK, 2010, GUT, V59, P1213, DOI 10.1136/gut.2010.213108; KRUMINS SA, 1993, NEUROPEPTIDES, V24, P5, DOI 10.1016/0143-4179(93)90035-9; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Liddle RA, 2004, PANCREATOLOGY, V4, P551, DOI 10.1159/000082180; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; STEAD RH, 1989, GASTROENTEROLOGY, V97, P575, DOI 10.1016/0016-5085(89)90627-6; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Wood JD, 2011, CURR PHARM DESIGN, V17, P1573; Zhu YH, 2012, AM J PHYSIOL-GASTR L, V302, pG176, DOI 10.1152/ajpgi.00053.2011	40	56	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60529	10.1371/journal.pone.0060529	http://dx.doi.org/10.1371/journal.pone.0060529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555989	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200124
J	Lauria, I; van Uum, J; Mjumjunov-Crncevic, E; Walrafen, D; Spitta, L; Thiele, C; Lang, T				Lauria, Ines; van Ueuem, Jan; Mjumjunov-Crncevic, Esmina; Walrafen, David; Spitta, Luis; Thiele, Christoph; Lang, Thorsten			GLTP Mediated Non-Vesicular GM1 Transport between Native Membranes	PLOS ONE			English	Article							GLYCOLIPID TRANSFER PROTEIN; LIPID-TRANSFER PROTEINS; GLYCOSPHINGOLIPID SYNTHESIS; START DOMAIN; BOVINE BRAIN; GLUCOSYLCERAMIDE; CELLS; CHOLESTEROL; SPECIFICITY; MODULATION	Lipid transfer proteins (LTPs) are emerging as key players in lipid homeostasis by mediating non-vesicular transport steps between two membrane surfaces. Little is known about the driving force that governs the direction of transport in cells. Using the soluble LTP glycolipid transfer protein (GLTP), we examined GM1 (monosialotetrahexosyl-ganglioside) transfer to native membrane surfaces. With artificial GM1 donor liposomes, GLTP can be used to increase glycolipid levels over natural levels in either side of the membrane leaflet, i.e., external or cytosolic. In a system with native donor-and acceptor-membranes, we find that GLTP balances highly variable GM1 concentrations in a population of membranes from one cell type, and in addition, transfers lipids between membranes from different cell types. Glycolipid transport is highly efficient, independent of cofactors, solely driven by the chemical potential of GM1 and not discriminating between the extra-and intracellular membrane leaflet. We conclude that GLTP mediated non-vesicular lipid trafficking between native membranes is driven by simple thermodynamic principles and that for intracellular transport less than 1 mu M GLTP would be required in the cytosol. Furthermore, the data demonstrates the suitability of GLTP as a tool for artificially increasing glycolipid levels in cellular membranes.	[Lauria, Ines; van Ueuem, Jan; Mjumjunov-Crncevic, Esmina; Walrafen, David; Spitta, Luis; Lang, Thorsten] Univ Bonn, Dept Membrane Biochem, LIMES Life & Med Sci Inst, Bonn, Germany; [Thiele, Christoph] Univ Bonn, Dept Biochem & Cell Biol Lipids, LIMES Inst, Bonn, Germany	University of Bonn; University of Bonn	Lang, T (corresponding author), Univ Bonn, Dept Membrane Biochem, LIMES Life & Med Sci Inst, Bonn, Germany.	thorsten.lang@uni-bonn.de		Lauria, Ines/0000-0001-5813-3103	Deutsche Forschungsgemeinschaft [TRR83]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (TRR83 to TL and CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2011, ADV EXP MED BIOL, V721, P99, DOI 10.1007/978-1-4614-0650-1_7; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Bose HS, 2008, BIOCHEMISTRY-US, V47, P2277, DOI 10.1021/bi701966a; BROWN RE, 1985, CHEM PHYS LIPIDS, V38, P79, DOI 10.1016/0009-3084(85)90059-3; Carton I, 2010, BIOPHYS J, V99, P2947, DOI 10.1016/j.bpj.2010.09.016; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; GAMMON CM, 1987, BIOCHEMISTRY-US, V26, P6239, DOI 10.1021/bi00393a043; Gao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019990; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Lang T, 2003, BIOCHEM SOC T, V31, P861, DOI 10.1042/BST0310861; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Mather AR, 2011, ADV EXP MED BIOL, V721, P121, DOI 10.1007/978-1-4614-0650-1_8; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; METZ RJ, 1980, J BIOL CHEM, V255, P4463; Neumann S, 2008, BIOL CHEM, V389, P1349, DOI 10.1515/BC.2008.154; Nylund M, 2005, BBA-BIOMEMBRANES, V1669, P87, DOI 10.1016/j.bbamem.2004.12.014; Nylund M, 2007, LANGMUIR, V23, P11726, DOI 10.1021/la701927u; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Rodriguez-Agudo D, 2008, J LIPID RES, V49, P1409, DOI 10.1194/jlr.M700537-JLR200; SASAKI T, 1990, EXPERIENTIA, V46, P611, DOI 10.1007/BF01939700; Schreiber A, 2012, BIOPHYS J, V102, P1411, DOI 10.1016/j.bpj.2012.02.031; Soccio RE, 2005, J BIOL CHEM, V280, P19410, DOI 10.1074/jbc.M501778200; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; van Meer G., 2011, COLD SPRING HARB PER, V3; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; YAMADA K, 1985, J BIOL CHEM, V260, P4615; Yu RK, 2010, FEBS LETT, V584, P1694, DOI 10.1016/j.febslet.2009.08.026; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53; Zou XQ, 2011, J BIOL CHEM, V286, P1301, DOI 10.1074/jbc.M110.127837	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59871	10.1371/journal.pone.0059871	http://dx.doi.org/10.1371/journal.pone.0059871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555818	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200053
J	Nakagawa, S; Hirata, Y; Kameyama, T; Tokunaga, Y; Nishito, Y; Hirabayashi, K; Yano, J; Ochiya, T; Tateno, C; Tanaka, Y; Mizokami, M; Tsukiyama-Kohara, K; Inoue, K; Yoshiba, M; Takaoka, A; Kohara, M				Nakagawa, Shin-ichiro; Hirata, Yuichi; Kameyama, Takeshi; Tokunaga, Yuko; Nishito, Yasumasa; Hirabayashi, Kazuko; Yano, Junichi; Ochiya, Takahiro; Tateno, Chise; Tanaka, Yasuhito; Mizokami, Masashi; Tsukiyama-Kohara, Kyoko; Inoue, Kazuaki; Yoshiba, Makoto; Takaoka, Akinori; Kohara, Michinori			Targeted Induction of Interferon-lambda in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; GENOME-WIDE ASSOCIATION; INNATE IMMUNE-RESPONSE; B-VIRUS; GENETIC-VARIATION; LIPOSOME COMPLEX; ADAPTER PROTEIN; CELL-ACTIVITY; IN-VIVO	Background & Aims: The interferon (IFN) system plays a critical role in innate antiviral response. We presume that targeted induction of IFN in human liver shows robust antiviral effects on hepatitis C virus (HCV) and hepatitis B virus (HBV). Methods: This study used chimeric mice harboring humanized livers and infected with HCV or HBV. This mouse model permitted simultaneous analysis of immune responses by human and mouse hepatocytes in the same liver and exploration of the mechanism of antiviral effect against these viruses. Targeted expression of IFN was induced by treating the animals with a complex comprising a hepatotropic cationic liposome and a synthetic double-stranded RNA analog, pIC (LIC-pIC). Viral replication, IFN gene expression, IFN protein production, and IFN antiviral activity were analyzed (for type I, II and III IFNs) in the livers and sera of these humanized chimeric mice. Results: Following treatment with LIC-pIC, the humanized livers of chimeric mice exhibited increased expression (at the mRNA and protein level) of human IFN-lambda s, resulting in strong antiviral effect on HBV and HCV. Similar increases were not seen for human IFN-alpha or IFN-beta in these animals. Strong induction of IFN-lambda s by LIC-pIC occurred only in human hepatocytes, and not in mouse hepatocytes nor in human cell lines derived from other (non-hepatic) tissues. LIC-pIC-induced IFN-lambda production was mediated by the immune sensor adaptor molecules mitochondrial antiviral signaling protein (MAVS) and Toll/IL-1R domain-containing adaptor molecule-1 (TICAM-1), suggesting dual recognition of LIC-pIC by both sensor adaptor pathways. Conclusions: These findings demonstrate that the expression and function of various IFNs differ depending on the animal species and tissues under investigation. Chimeric mice harboring humanized livers demonstrate that IFN-lambda s play an important role in the defense against human hepatic virus infection.	[Nakagawa, Shin-ichiro; Hirata, Yuichi; Tokunaga, Yuko; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Nakagawa, Shin-ichiro; Hirabayashi, Kazuko; Yano, Junichi] Nippon Shinyaku Co Ltd, Discovery Res Labs, Tsukuba, Ibaraki, Japan; [Kameyama, Takeshi; Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Microarray Anal, Setagaya Ku, Tokyo 113, Japan; [Ochiya, Takahiro] Japanese Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo, Japan; [Tateno, Chise] PhoenixBio Co Ltd, Hiroshima, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Mizokami, Masashi] Japan Konodai Hosp, Res Ctr Hepatitis & Immunol, Int Med Ctr, Ichikawa, Chiba, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 890, Japan; [Hirata, Yuichi; Inoue, Kazuaki; Yoshiba, Makoto] Showa Univ, Fujigaoka Hosp, Div Gastroenterol, Yokohama, Kanagawa 227, Japan	Tokyo Metropolitan Institute of Medical Science; Nippon Shinyaku Co Ltd; Hokkaido University; Tokyo Metropolitan Institute of Medical Science; National Cancer Center - Japan; PHOENIXBIO CO. LTD.; Nagoya City University; Nagoya City University; Kagoshima University; Showa University	Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Bunkyo Ku, Tokyo 113, Japan.	kohara-mc@igakuken.or.jp	Ochiya, Takahiro/AAH-7585-2019	Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation of Japan; and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; DJEU JY, 1979, J IMMUNOL, V122, P182; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Hirabayashi K, 1999, CANCER RES, V59, P4325; Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09; Kashiwakuma T, 1996, J IMMUNOL METHODS, V190, P79, DOI 10.1016/0022-1759(95)00261-8; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tanaka T, 2004, J MED VIROL, V72, P223, DOI 10.1002/jmv.10566; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Yano J, 2004, CLIN CANCER RES, V10, P7721, DOI 10.1158/1078-0432.CCR-04-1049; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yuen MF, 2001, HEPATOLOGY, V34, P139, DOI 10.1053/jhep.2001.25273	41	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59611	10.1371/journal.pone.0059611	http://dx.doi.org/10.1371/journal.pone.0059611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555725	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200031
J	Wientjes, R; Noordmans, HJ; van der Eijk, JAJ; van den Brink, H				Wientjes, Rens; Noordmans, Herke J.; van der Eijk, Jerine A. J.; van den Brink, Henk			Automated Objective Routine Examination of Optical Quality of Rigid Endoscopes in a Clinical Setting	PLOS ONE			English	Article								Rigid endoscopes degrade during clinical use due to sterilization, ionizing radiation and mechanical forces. Despite visual checks on functionality at the department of sterilization, surgeons are still confronted with suboptimal instruments as it is difficult to assess this degradation in an objective manner. To guarantee that endoscopes have sufficient optical quality for minimal invasive surgery, an experimental opto-electronic test bench has been developed in order to be used at the department of sterilization. Transmission of illumination fibres and lens contrast values are stored in a database to enable empirical criteria to reject endoscope for further clinical usage or to accept endoscopes after repair. Results of the test bench are given for an eight month period, where a trained operator performed 1599 measurements on 46 different types. Stability of the system, trends in quality of clinical endoscopes, and effect of repair or replacement were assessed. Although the period was too short to draw firm conclusions, a slow downwards trend in quality of clinically used endoscopes could be observed. Also, endoscopes generally improve in quality after repair or replacement, while endoscope replacement seems to slightly outperform endoscope repair. To optimize the measurement process, a new system is being developed requiring less user interaction and measuring more optical parameters of an endoscope. By commercializing this system, we hope that measurements at different hospitals will give improved insight which acceptance and rejection criteria to use and which factors (usage, cleaning protocol, and brands) determine the economic lifetime of endoscopes.	[Wientjes, Rens; Noordmans, Herke J.; van der Eijk, Jerine A. J.; van den Brink, Henk] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Wientjes, R (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	r.wientjes@umcutrecht.nl	Noordmans, Herke Jan/AAN-8366-2020	Noordmans, Herke Jan/0000-0002-9913-4556	University Medical Center Utrecht	University Medical Center Utrecht	This work is funded by University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYLIFFE GAJ, 1992, J HOSP INFECT, V22, P265, DOI 10.1016/0195-6701(92)90011-A; Boer I de, 2008, KWALITEITSBORGING IN; Darzi A, 2004, ANNU REV MED, V55, P223, DOI 10.1146/annurev.med.55.091902.105248; Health Care Inspectorate, 2009, TOETS FOLL UP MIN IN; Karl Storz-Endoscope, MAN TEL HOPKINS TEL; Noordmans HJ, 2008, SPIE DESIGN QUALITY; Noordmans HJ, 2006, SPIE DESIGN QUALITY; Spry Cynthia, 2004, AORN J, V80, P103, DOI 10.1016/S0001-2092(06)60848-X	8	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59579	10.1371/journal.pone.0059579	http://dx.doi.org/10.1371/journal.pone.0059579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555715	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200029
J	Huang, YJ; Samorajski, J; Kreimer, R; Searson, PC				Huang, Yu-Ja; Samorajski, Justin; Kreimer, Rachel; Searson, Peter C.			The Influence of Electric Field and Confinement on Cell Motility	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; MIGRATION; ADHESION; CANCER; FIBROBLASTS; ORIENTATION; LOCOMOTION; SIGNALS; MOTION	The ability of cells to sense and respond to endogenous electric fields is important in processes such as wound healing, development, and nerve regeneration. In cell culture, many epithelial and endothelial cell types respond to an electric field of magnitude similar to endogenous electric fields by moving preferentially either parallel or antiparallel to the field vector, a process known as galvanotaxis. Here we report on the influence of dc electric field and confinement on the motility of fibroblast cells using a chip-based platform. From analysis of cell paths we show that the influence of electric field on motility is much more complex than simply imposing a directional bias towards the cathode or anode. The cell velocity, directedness, as well as the parallel and perpendicular components of the segments along the cell path are dependent on the magnitude of the electric field. Forces in the directions perpendicular and parallel to the electric field are in competition with one another in a voltage-dependent manner, which ultimately govern the trajectories of the cells in the presence of an electric field. To further investigate the effects of cell reorientation in the presence of a field, cells are confined within microchannels to physically prohibit the alignment seen in 2D environment. Interestingly, we found that confinement results in an increase in cell velocity both in the absence and presence of an electric field compared to migration in 2D.	[Huang, Yu-Ja; Kreimer, Rachel; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Huang, Yu-Ja; Kreimer, Rachel; Searson, Peter C.] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Huang, Yu-Ja; Kreimer, Rachel; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD USA; [Samorajski, Justin] Univ Dallas, Dept Chem, Irving, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	searson@jhu.edu	Samorajski, Justin/Z-5137-2019	Samorajski, Justin/0000-0002-0813-9993; Searson, Peter/0000-0002-5417-0828	NIH [EB008259, U54CA143868]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge support from NIH (EB008259 and U54CA143868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; DUNN GA, 1987, J CELL SCI, P81; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Hammerick KE, 2010, BIOCHEM BIOPH RES CO, V397, P12, DOI 10.1016/j.bbrc.2010.05.003; Hawkins RJ, 2009, PHYS REV LETT, V102, P58103; HOTARY KB, 1992, DEVELOPMENT, V114, P985; HOTARY KB, 1994, DEV BIOL, V166, P789, DOI 10.1006/dbio.1994.1357; Huang CW, 2009, BIOSENS BIOELECTRON, V24, P3510, DOI 10.1016/j.bios.2009.05.001; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Li J, 2011, LAB CHIP, V11, P1298, DOI 10.1039/c0lc00371a; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li XF, 2002, J VASC RES, V39, P391, DOI 10.1159/000064517; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; SHOEMAKER DP, 1967, EXPT PHYS CHEM; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; STOKES CL, 1991, J CELL SCI, V99, P419; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Walmod PS, 2001, METH MOL B, V161, P59; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	33	20	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59447	10.1371/journal.pone.0059447	http://dx.doi.org/10.1371/journal.pone.0059447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555674	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500040
J	Markovic, J; Grdovic, N; Dinic, S; Karan-Djurasevic, T; Uskokovic, A; Arambasic, J; Mihailovic, M; Pavlovic, S; Poznanovic, G; Vidakovic, M				Markovic, Jelena; Grdovic, Nevena; Dinic, Svetlana; Karan-Djurasevic, Teodora; Uskokovic, Aleksandra; Arambasic, Jelena; Mihailovic, Mirjana; Pavlovic, Sonja; Poznanovic, Goran; Vidakovic, Melita			PARP-1 and YY1 Are Important Novel Regulators of CXCL12 Gene Transcription in Rat Pancreatic Beta Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE BINDS; STRESS INDUCTION; EXPRESSION; PROMOTER; MICE; PROTEIN; ACTIVATION; REPRESSION; MOUSE; ONSET	Despite significant progress, the molecular mechanisms responsible for pancreatic beta cell depletion and development of diabetes remain poorly defined. At present, there is no preventive measure against diabetes. The positive impact of CXCL12 expression on the pancreatic beta cell prosurvival phenotype initiated this study. Our aim was to provide novel insight into the regulation of rat CXCL12 gene (Cxcl12) transcription. The roles of poly(ADP-ribose) polymerase-1 (PARP-1) and transcription factor Yin Yang 1 (YY1) in Cxcl12 transcription were studied by examining their in vitro and in vivo binding affinities for the Cxcl12 promoter in a pancreatic beta cell line by the electrophoretic mobility shift assay and chromatin immunoprecipitation. The regulatory activities of PARP-1 and YY1 were assessed in transfection experiments using a reporter vector with a Cxcl12 promoter sequence driving luciferase gene expression. Experimental evidence for PARP-1 and YY1 revealed their trans-acting potential, wherein PARP-1 displayed an inhibitory, and YY1 a strong activating effect on Cxcl12 transcription. Streptozotocin (STZ)-induced general toxicity in pancreatic beta cells was followed by changes in Cxcl12 promoter regulation. PARP-1 binding to the Cxcl12 promoter during basal and in STZ-compromised conditions led us to conclude that PARP-1 regulates constitutive Cxcl12 expression. During the early stage of oxidative stress, YY1 exhibited less affinity toward the Cxcl12 promoter while PARP-1 displayed strong binding. These interactions were accompanied by Cxcl12 downregulation. In the later stages of oxidative stress and intensive pancreatic beta cell injury, YY1 was highly expressed and firmly bound to Cxcl12 promoter in contrast to PARP-1. These interactions resulted in higher Cxcl12 expression. The observed ability of PARP-1 to downregulate, and of YY1 to upregulate Cxcl12 promoter activity anticipates corresponding effects in the natural context where the functional interplay of these proteins could finely balance Cxcl12 transcription.	[Markovic, Jelena; Grdovic, Nevena; Dinic, Svetlana; Uskokovic, Aleksandra; Arambasic, Jelena; Mihailovic, Mirjana; Poznanovic, Goran; Vidakovic, Melita] Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia; [Karan-Djurasevic, Teodora; Pavlovic, Sonja] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Hematol, Belgrade, Serbia	University of Belgrade; University of Belgrade	Vidakovic, M (corresponding author), Univ Belgrade, Inst Biol Res, Dept Mol Biol, Karnegijeva 4, Belgrade, Serbia.	melita@ibiss.bg.ac.rs	Mihailovic, Mirjana/E-6308-2015; Vidaković, Melita/G-6747-2016; Poznanovic, Goran/E-6349-2015; Dinic, Svetlana/C-8348-2017; Arambasic Jovanovic, Jelena/L-1415-2016	Mihailovic, Mirjana/0000-0002-8097-1186; Vidaković, Melita/0000-0001-8410-6264; Poznanovic, Goran/0000-0003-0839-7017; Dinic, Svetlana/0000-0002-7612-3117; Markovic Filipovic, Jelena/0000-0003-2470-2018; Arambasic Jovanovic, Jelena/0000-0002-8810-0668; Uskokovic, Aleksandra/0000-0002-9616-1102; Karan-Djurasevic, Teodora/0000-0002-6156-0584; Grdovic, Nevena/0000-0003-1504-4578	Ministry of Education, Science and Technological Development of the Republic of Serbia [173020, III 41004]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was financed by the Ministry of Education, Science and Technological Development of the Republic of Serbia, grants 173020 and III 41004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Beranger GE, 2008, J BONE MINER RES, V23, P564, DOI 10.1359/JBMR.071111; Berman MA, 1996, J IMMUNOL, V157, P4690; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Calonge E, 2010, J MOL BIOL, V396, P463, DOI 10.1016/j.jmb.2009.11.064; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Chen L, 2010, ACTA BIOCH BIOPH SIN, V42, P1, DOI 10.1093/abbs/gmp108; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Doetsch M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044125; Dubois-Laforgue D, 2001, DIABETES, V50, P1211, DOI 10.2337/diabetes.50.5.1211; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; Guo J, 2001, J BIOL CHEM, V276, P48871, DOI 10.1074/jbc.M101592200; Habener JF, 2012, ISLETS, V4, P188, DOI 10.4161/isl.20500; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Ide A, 2003, HUM IMMUNOL, V64, P973, DOI 10.1016/S0198-8859(03)00176-9; Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC; Kim K, 2007, J LEUKOCYTE BIOL, V82, P1332, DOI 10.1189/jlb.1106697; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Lagergren A, 2007, J BIOL CHEM, V282, P14454, DOI 10.1074/jbc.M610263200; Li WW, 1997, MOL CELL BIOL, V17, P61, DOI 10.1128/MCB.17.1.61; Liu Z, 2011, DIABETOLOGIA, V54, P2067, DOI 10.1007/s00125-011-2181-x; Martin SK, 2010, HAEMATOL-HEMATOL J, V95, P776, DOI 10.3324/haematol.2009.015628; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oei SL, 2000, J BIOL CHEM, V275, P23234, DOI 10.1074/jbc.M002429200; Oei SL, 2001, BIOCHEM BIOPH RES CO, V285, P27, DOI 10.1006/bbrc.2001.5115; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; Olive M, 2008, J CLIN INVEST, V118, P2050, DOI 10.1172/JCI31244; Pesole G, 2000, GENE, V261, P85, DOI 10.1016/S0378-1119(00)00471-6; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; Plaza S, 1999, ONCOGENE, V18, P1041, DOI 10.1038/sj.onc.1202406; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sakamaki J, 2009, BIOCHEM BIOPH RES CO, V382, P497, DOI 10.1016/j.bbrc.2009.03.022; Santiago B, 2011, CYTOKINE, V53, P184, DOI 10.1016/j.cyto.2010.06.006; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SimbulanRosenthal CM, 1996, BIOCHEMISTRY-US, V35, P11622, DOI 10.1021/bi953010z; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Vidakovic M, 2009, J MOL BIOL, V388, P730, DOI 10.1016/j.jmb.2009.03.032; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wu ZL, 2000, INT IMMUNOL, V12, P405, DOI 10.1093/intimm/12.4.405; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Yoon KB, 2009, TOP CATAL, V52, P1, DOI 10.1007/s11244-008-9132-x	59	18	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59679	10.1371/journal.pone.0059679	http://dx.doi.org/10.1371/journal.pone.0059679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555743	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500074
J	Akimoto, Y; Kanno, A; Kambara, T; Nozawa, T; Sugiura, M; Okumura, E; Kawashima, R				Akimoto, Yoritaka; Kanno, Akitake; Kambara, Toshimune; Nozawa, Takayuki; Sugiura, Motoaki; Okumura, Eiichi; Kawashima, Ryuta			Spatiotemporal Dynamics of High-Gamma Activities during a 3-Stimulus Visual Oddball Task	PLOS ONE			English	Article							BAND SYNCHRONIZATION; TOP-DOWN; PHASE SYNCHRONIZATION; TARGET DETECTION; HUMAN BRAIN; BOTTOM-UP; FREQUENCY; THETA; OSCILLATIONS; ATTENTION	Although many studies have investigated the neural basis of top-down and bottom-up attention, it still requires refinement in both temporal and spatial terms. We used magnetoencephalography to investigate the spatiotemporal dynamics of high-gamma (52-100 Hz) activities during top-down and bottom-up visual attentional processes, aiming to extend the findings from functional magnetic resonance imaging and event-related potential studies. Fourteen participants performed a 3-stimulus visual oddball task, in which both infrequent non-target and target stimuli were presented. We identified high-gamma event-related synchronization in the left middle frontal gyrus, the left intraparietal sulcus, the left thalamus, and the visual areas in different time windows for the target and non-target conditions. We also found elevated imaginary coherence between the left intraparietal sulcus and the right middle frontal gyrus in the high-gamma band from 300 to 400 ms in the target condition, and between the left thalamus and the left middle frontal gyrus in theta band from 150 to 450 ms. In addition, the strength of high-gamma imaginary coherence between the left middle frontal gyrus and left intraparietal sulcus, between the left middle frontal gyrus and the right middle frontal gyrus, and the high-gamma power in the left thalamus predicted inter-subject variation in target detection response time. This source-level electrophysiological evidence enriches our understanding of bi-directional attention processes: stimulus-driven bottom-up attention orientation to a salient, but irrelevant stimulus; and top-down allocation of attentional resources to stimulus evaluation.	[Akimoto, Yoritaka; Kanno, Akitake; Sugiura, Motoaki; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Kambara, Toshimune] Keio Univ, Fac Environm & Informat Studies, Kanagawa, Japan; [Nozawa, Takayuki; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Okumura, Eiichi] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Keio University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Akimoto, Y (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan.	y-akimoto@idac.tohoku.ac.jp	Nozawa, Takayuki/Y-9610-2019; Kambara, Toshimune/E-3336-2019	Nozawa, Takayuki/0000-0001-6300-4373; Kambara, Toshimune/0000-0002-6598-3365	Japan Society for Promotion of Science (JSPS) [23700305]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-In-Aid for young scientists (B) (23700305) from the Japan Society for Promotion of Science (JSPS) (JSPS HP:http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Choi JW, 2010, NEUROSCI LETT, V468, P156, DOI 10.1016/j.neulet.2009.10.088; Cohen J, 1997, INT J PSYCHOPHYSIOL, V25, P249, DOI 10.1016/S0167-8760(96)00743-X; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Darvas F, 2010, NEUROIMAGE, V49, P930, DOI 10.1016/j.neuroimage.2009.08.041; Demiralp T, 2001, BRAIN TOPOGR, V13, P251, DOI 10.1023/A:1011102628306; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Goto T, 2011, NEUROIMAGE, V54, P560, DOI 10.1016/j.neuroimage.2010.08.023; Green JJ, 2008, PLOS BIOL, V6, P730, DOI 10.1371/journal.pbio.0060081; Gurtubay IG, 2004, NEUROSCI LETT, V367, P6, DOI 10.1016/j.neulet.2004.05.104; Gurtubay IG, 2001, CLIN NEUROPHYSIOL, V112, P1219, DOI 10.1016/S1388-2457(01)00557-0; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Herdman AT, 2009, BRAIN SIGNAL ANALYSIS: ADVANCES IN NEUROELECTRIC AND NEUROMAGNETIC METHODS, P99; Hoogenboom N, 2010, NEUROIMAGE, V51, P1162, DOI 10.1016/j.neuroimage.2010.03.041; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kahlbrock N, 2012, NEUROIMAGE, V59, P673, DOI 10.1016/j.neuroimage.2011.07.017; Kaiser J, 2004, NEUROREPORT, V15, P2185, DOI 10.1097/00001756-200410050-00008; Kim KH, 2008, BRAIN RES, V1236, P105, DOI 10.1016/j.brainres.2008.07.118; Klostermann F, 2006, BRAIN, V129, P923, DOI 10.1093/brain/awl014; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Lee B, 2007, NEUROSCI LETT, V413, P210, DOI 10.1016/j.neulet.2006.11.066; Madden DJ, 2004, CEREB CORTEX, V14, P143, DOI 10.1093/cercor/bhg113; Mazzoni A, 2011, J PHYSIOL-PARIS, V105, P2, DOI 10.1016/j.jphysparis.2011.07.014; Miller E.K., 2012, CURR OPIN NEUROBIOL, V23, P1; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Missonnier P, 2006, J NEURAL TRANSM, V113, P1477, DOI 10.1007/s00702-005-0443-9; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; O'Connell RG, 2012, NEUROBIOL AGING, V33, P2448, DOI 10.1016/j.neurobiolaging.2011.12.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozaki TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020079; Ozaki TJ, 2009, NEUROREPORT, V20, P1371, DOI 10.1097/WNR.0b013e3283313ef3; Padmanabhapillai A, 2006, INT J PSYCHOPHYSIOL, V60, P15, DOI 10.1016/j.ijpsycho.2005.03.026; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prado J, 2011, NEUROIMAGE, V54, P541, DOI 10.1016/j.neuroimage.2010.08.022; Ranganathan M, 2006, INT J PSYCHOPHYSIOL, V62; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Sekihara K, 2011, IEEE T BIO-MED ENG, V58, P3121, DOI 10.1109/TBME.2011.2162514; Stefanics G, 2004, BRAIN TOPOGR, V16, P261; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Ueno S, 2012, NEUROSCI LETT, V515, P141, DOI 10.1016/j.neulet.2012.03.031; Van der Werf YD, 2001, COGNITIVE BRAIN RES, V11, P377, DOI 10.1016/S0926-6410(01)00010-6; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Walhovd KB, 2005, NEUROPSYCHOLOGIA, V43, P704, DOI 10.1016/j.neuropsychologia.2004.08.006; Wang X, 2011, CLIN NEUROPHYSIOL, V122, P916, DOI 10.1016/j.clinph.2010.09.011; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004	68	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59969	10.1371/journal.pone.0059969	http://dx.doi.org/10.1371/journal.pone.0059969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555852	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400073
J	Sierra-Valdez, FJ; Forero-Quintero, LS; Zapata-Morin, PA; Costas, M; Chavez-Reyes, A; Ruiz-Suarez, JC				Sierra-Valdez, Francisco J.; Forero-Quintero, Linda S.; Zapata-Morin, Patricio A.; Costas, Miguel; Chavez-Reyes, Arturo; Ruiz-Suarez, Jesus C.			The Influence of Non Polar and Polar Molecules in Mouse Motile Cells Membranes and Pure Lipid Bilayers	PLOS ONE			English	Article							HUMAN-SPERM MOTILITY; PHASE-BEHAVIOR; TETRACAINE; CAFFEINE; ANESTHETICS; TARGETS; NERVE	We report an experimental study of mouse sperm motility that shows chief aspects characteristic of neurons: the anesthetic (produced by tetracaine) and excitatory (produced by either caffeine or calcium) effects and their antagonic action. While tetracaine inhibits sperm motility and caffeine has an excitatory action, the combination of these two substances balance the effects, producing a motility quite similar to that of control cells. We also study the effects of these agents (anesthetic and excitatory) on the melting points of pure lipid liposomes constituted by 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and dipalmitoyl phosphatidic acid (DPPA). Tetracaine induces a large fluidization of the membrane, shifting the liposomes melting transition temperature to much lower values. The effect of caffeine is null, but its addition to tetracaine-doped liposomes greatly screen the fluidization effect. A high calcium concentration stiffens pure lipid membranes and strongly reduces the effect of tetracaine. Molecular Dynamics Simulations are performed to further understand our experimental findings at the molecular level. We find a strong correlation between the effect of antagonic molecules that could explain how the mechanical properties suitable for normal cell functioning are affected and recovered.	[Sierra-Valdez, Francisco J.; Forero-Quintero, Linda S.; Zapata-Morin, Patricio A.; Chavez-Reyes, Arturo; Ruiz-Suarez, Jesus C.] CINVESTAV Monterrey, Apodaca, Nuevo Leon, Mexico; [Costas, Miguel] Univ Nacl Autonoma Mexico, Dept Fisicoquim, Fac Quim, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico	Ruiz-Suarez, JC (corresponding author), CINVESTAV Monterrey, Apodaca, Nuevo Leon, Mexico.	jcrs.mty@gmail.com	Chavez-Reyes, Arturo/ABG-1231-2020	Sierra-Valdez, Francisco J/0000-0002-7803-9701; Costas, Miguel/0000-0001-8604-6381; Chavez-Reyes, Arturo/0000-0002-6655-815X; Forero, Linda/0000-0002-6724-5315; Zapata, Patricio/0000-0003-1851-2293	Conacyt (Mexico) [101384, 99844]	Conacyt (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The source of funding that has supported the work is Conacyt (Mexico), under Grants: 101384 and 99844. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1958, PROC R SOC SER B-BIO, V148, P149, DOI 10.1098/rspb.1958.0012; AMELAR RD, 1980, FERTIL STERIL, V34, P197; BOTTNER M, 1993, BIOPHYS J, V65, P2041, DOI 10.1016/S0006-3495(93)81254-2; Fodor AA, 1997, J GEN PHYSIOL, V109, P3, DOI 10.1085/jgp.109.1.3; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Griesbauer J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198103; HAUSER H, 1968, BIOCHEM J, V109, P909, DOI 10.1042/bj1090909; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heimburg T., 2007, THERMAL BIOPHYSICS M; Heimburg Thomas, 2007, Biophysical Reviews and Letters, V2, P57, DOI 10.1142/S179304800700043X; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; HONG CY, 1981, BRIT J CLIN PHARMACO, V12, P751, DOI 10.1111/j.1365-2125.1981.tb01301.x; HOSKINS DD, 1974, J REPROD FERTIL, V37, P131, DOI 10.1530/jrf.0.0370131; JOHNSON FH, 1950, SCIENCE, V112, P91, DOI 10.1126/science.112.2899.91-a; Kruger J, 2008, J COMPUT CHEM, V29, P2416, DOI 10.1002/jcc.20986; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Marcelli G, 1999, J CHEM PHYS, V111, P1533, DOI 10.1063/1.479412; Overton C.E., 1901, STUDIEN NARKOSE; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; RITCHIE JM, 1985, Q REV BIOPHYS, V18, P451, DOI 10.1017/S0033583500005382; Sanjeewa R, 2010, J MOL STRUC-THEOCHEM, V944, P116, DOI 10.1016/j.theochem.2009.12.027; SCHOFF PK, 1987, BIOL REPROD, V37, P1037, DOI 10.1095/biolreprod37.4.1037; Sierra-Valdez FJ, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3700248; TAMBLYN TM, 1977, ARCH BIOCHEM BIOPHYS, V181, P208, DOI 10.1016/0003-9861(77)90499-4; Urban B. W., 2008, V182, P3, DOI 10.1007/978-3-540-74806-9_1; Urban BW, 2006, PHARMACOL THERAPEUT, V111, P729, DOI 10.1016/j.pharmthera.2005.12.005; Wang LJ, 2008, BRIT J ANAESTH, V101, P883, DOI 10.1093/bja/aen307; Whitten WK, 1971, ADV BIOSCI, V6, P129, DOI DOI 10.1016/B978-0-08-017571-3.50013-9; Wood BL, 2003, CONTRACEPTION, V67, P241, DOI 10.1016/S0010-7824(02)00515-2; Wunderlich B, 2009, BIOPHYS J, V96, P4592, DOI 10.1016/j.bpj.2009.02.053; Zhang JZ, 2007, BIOPHYS J, V92, P3988, DOI 10.1529/biophysj.106.102434	33	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59364	10.1371/journal.pone.0059364	http://dx.doi.org/10.1371/journal.pone.0059364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565149	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300016
J	Igarashi, D; Bethke, G; Xu, Y; Tsuda, K; Glazebrook, J; Katagiri, F				Igarashi, Daisuke; Bethke, Gerit; Xu, Yuan; Tsuda, Kenichi; Glazebrook, Jane; Katagiri, Fumiaki			Pattern-Triggered Immunity Suppresses Programmed Cell Death Triggered by Fumonisin B1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; III SECRETION SYSTEM; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; SALICYLIC-ACID; DISEASE RESISTANCE; TRANSGENIC PLANTS; JASMONIC ACID; DEFENSE; STRESS	Programmed cell death (PCD) is a crucial process for plant innate immunity and development. In plant innate immunity, PCD is believed to prevent the spread of pathogens from the infection site. Although proper control of PCD is important for plant fitness, we have limited understanding of the molecular mechanisms regulating plant PCD. Plant innate immunity triggered by recognition of effectors (effector-triggered immunity, ETI) is often associated with PCD. However pattern-triggered immunity (PTI), which is triggered by recognition of elicitors called microbe-associated molecular patterns (MAMPs), is not. Therefore we hypothesized that PTI might suppress PCD. Here we report that PCD triggered by the mycotoxin fumonisin B1 (FB1) can be suppressed by PTI in Arabidopsis. FB1-triggered cell death was suppressed by treatment with the MAMPs flg22 (a part of bacterial flagellin) or elf18 (a part of the bacterial elongation factor EF-Tu) but not chitin (a component of fungal cell walls). Although plant hormone signaling is associated with PCD and PTI, both FB1-triggered cell death and suppression of cell death by flg22 treatment were still observed in mutants deficient in jasmonic acid (JA), ethylene (ET) and salicylic acid (SA) signaling. The MAP kinases MPK3 and MPK6 are transiently activated and inactivated within one hour during PTI. We found that FB1 activated MPK3 and MPK6 about 36-48 hours after treatment. Interestingly, this late activation was attenuated by flg22 treatment. These results suggest that PTI suppression of FB1-triggered cell death may involve suppression of MPK3/MPK6 signaling but does not require JA/ET/SA signaling.	[Igarashi, Daisuke; Bethke, Gerit; Xu, Yuan; Tsuda, Kenichi; Glazebrook, Jane; Katagiri, Fumiaki] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Igarashi, Daisuke] Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, Kawasaki, Kanagawa, Japan	University of Minnesota System; University of Minnesota Twin Cities; Ajinomoto Co Inc	Katagiri, F (corresponding author), Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA.	katagiri@umn.edu	Tsuda, Kenichi/A-2453-2009; Igarashi, Daisuke/D-7697-2013	Tsuda, Kenichi/0000-0001-7074-0731; Glazebrook, Jane/0000-0001-5167-736X; Katagiri, Fumiaki/0000-0001-6893-3788; Xu, Yuan/0000-0002-8259-2315	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-05ER15670]; Ajinomoto Co. Inc.; National Science Foundation [MCB-0918908, IOS-1121425]; Ajinomoto, Co, Inc.	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Ajinomoto Co. Inc.; National Science Foundation(National Science Foundation (NSF)); Ajinomoto, Co, Inc.	Trypan blue staining for Fig 1B was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-FG02-05ER15670 to JG. Other work was supported by a grant from Ajinomoto Co. Inc. and grants MCB-0918908 and IOS-1121425 from the National Science Foundation to FK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors R, 2004, PLANT J, V40, P512, DOI 10.1111/j.1365-313X.2004.02229.x; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; Bethke G, 2012, MOL PLANT MICROBE IN, V25, P471, DOI 10.1094/MPMI-11-11-0281; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Crabill E, 2010, PLANT PHYSIOL, V154, P233, DOI 10.1104/pp.110.159723; DESJARDINS AE, 1995, APPL ENVIRON MICROB, V61, P79, DOI 10.1128/AEM.61.1.79-86.1995; Devadas SK, 2002, PLANT J, V30, P467, DOI 10.1046/j.1365-313X.2002.01300.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Pinelli E, 1999, CARCINOGENESIS, V20, P1683, DOI 10.1093/carcin/20.9.1683; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Saucedo-Garcia M, 2011, NEW PHYTOL, V191, P943, DOI 10.1111/j.1469-8137.2011.03727.x; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Stone JM, 2000, PLANT CELL, V12, P1811, DOI 10.1105/tpc.12.10.1811; Thaler JS, 2012, TRENDS PLANT SCI, P10; Tolleson WH, 1996, CARCINOGENESIS, V17, P239, DOI 10.1093/carcin/17.2.239; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x; van Wees SCM, 2000, P NATL ACAD SCI USA, V97, P8711, DOI 10.1073/pnas.130425197; von Malek B, 2002, PLANTA, V216, P187, DOI 10.1007/s00425-002-0906-2; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Wang W, 1996, P NATL ACAD SCI USA, V93, P3461; Wattenberg EV, 1996, BIOCHEM BIOPH RES CO, V227, P622, DOI 10.1006/bbrc.1996.1555; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	50	22	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60769	10.1371/journal.pone.0060769	http://dx.doi.org/10.1371/journal.pone.0060769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560104	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900074
J	Han, L; Han, YN; Xiao, XG				Han, Lei; Han, Ya-Nan; Xiao, Xing-Guo			Truncated Cotton Subtilase Promoter Directs Guard Cell-Specific Expression of Foreign Genes in Tobacco and Arabidopsis	PLOS ONE			English	Article							STOMATAL RESPONSES; ABSCISIC-ACID; 5'-UNTRANSLATED REGION; SIGNAL-TRANSDUCTION; POTASSIUM CHANNEL; SERINE-PROTEASE; BINDING PROTEIN; CLONING; LIGHT; PHOTOSYNTHESIS	A 993-bp regulatory region upstream of the translation start codon of subtilisin-like serine protease gene was isolated from Gossypium barbadense. This (T/A)AAAG-rich region, GbSLSP, and its 5'- and 3'-truncated versions were transferred into tobacco and Arabidopsis after fusing with GUS or GFP. Histochemical and quantitative GUS analysis and confocal GFP fluorescence scanning in the transgenic plants showed that the GbSLSP-driven GUS and GFP expressed preferentially in guard cells, whereas driven by GbSLSPF2 to GbSLSPF4, the 5'-truncated GbSLSP versions with progressively reduced Dof1 elements, both GUS and GFP expressed exclusively in guard cells, and the expression strength declined with (T/A)AAAG copy decrement. Deletion of 5'-untranslated region from GbSLSP markedly weakened the activity of GUS and GFP, while deletion from the strongest guard cell-specific promoter, GbSLSPF2, not only significantly decreased the expression strength, but also completely abolished the guard cell specificity. These results suggested both guard cell specificity and expression strength of the promoters be coordinately controlled by 5'-untranslated region and a cluster of at least 3 (T/A)AAAG elements within a region of about 100 bp relative to transcription start site. Our guard cell-specific promoters will enrich tools to manipulate gene expression in guard cells for scientific research and crop improvement.	[Han, Lei; Han, Ya-Nan; Xiao, Xing-Guo] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Xiao, XG (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	xiaoxg@cau.edu.cn			Transgenic Plant RD Key Program; Ministry of Agriculture of China [2011ZX08002-001-07]; National Nature Science Foundation of China [31070268]	Transgenic Plant RD Key Program; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants for XXG from Transgenic Plant R&D Key Program, the Ministry of Agriculture of China (Grant No. 2011ZX08002-001-07) and from National Nature Science Foundation of China (Grant No. 31070268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Antunes WC, 2012, PLANT CELL ENVIRON, V35, P747, DOI 10.1111/j.1365-3040.2011.02448.x; Bate N, 1996, PLANT J, V10, P613, DOI 10.1046/j.1365-313X.1996.10040613.x; Berger D, 2000, GENE DEV, V14, P1119; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-162; Curie C, 1997, PLANT CELL, V9, P2025; Dorbe MF, 1998, PLANT SCI, V139, P71, DOI 10.1016/S0168-9452(98)00181-2; Francia P, 2008, PLANT SIGNAL BEHAV, V3, P684, DOI 10.4161/psb.3.9.5820; Galbiati M, 2008, PLANT J, V53, P750, DOI 10.1111/j.1365-313X.2007.03371.x; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Geng AQ, 2009, AFR J BIOTECHNOL, V8, P5193; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hou L, 2006, Patent, Patent No. [CN100471954C, 100471954]; Hou L, 2008, CHINESE SCI BULL, V53, P2639, DOI 10.1007/s11434-008-0290-9; Hua XJ, 2001, PLANT J, V26, P157, DOI 10.1046/j.1365-313x.2001.01020.x; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Hulzink RJM, 2002, PLANT PHYSIOL, V129, P342, DOI 10.1104/pp.001701; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang K, 2012, PLANT CELL, V24, P2031, DOI 10.1105/tpc.112.096263; Koers S, 2011, PLANT J, V68, P670, DOI 10.1111/j.1365-313X.2011.04719.x; Kopka J, 1997, PLANT J, V11, P871, DOI 10.1046/j.1365-313X.1997.11040871.x; Lawson T, 2009, NEW PHYTOL, V181, P13, DOI 10.1111/j.1469-8137.2008.02685.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lemichez E, 2001, GENE DEV, V15, P1808, DOI 10.1101/gad.900401; Li J, 2005, SCI CHINA SER C, V48, P181, DOI [10.1360/04yc0004, 10.1007/BF02879671]; Li ZX, 2012, J INTEGR PLANT BIOL, V54, P169, DOI 10.1111/j.1744-7909.2012.01100.x; Liu WX, 2010, THEOR APPL GENET, V121, P1267, DOI 10.1007/s00122-010-1386-6; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Messinger SM, 2006, PLANT PHYSIOL, V140, P771, DOI 10.1104/pp.105.073676; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; MULLERROBER B, 1994, PLANT CELL, V6, P601, DOI 10.1105/tpc.6.5.601; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; NEININGER A, 1994, PLANTA, V194, P186, DOI 10.1007/BF01101677; Nie XL, 2010, AFR J BIOTECHNOL, V9, P6826; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Peak D, 2011, PLANT CELL ENVIRON, V34, P162, DOI 10.1111/j.1365-3040.2010.02234.x; Plesch G, 2000, GENE, V249, P83, DOI 10.1016/S0378-1119(00)00150-5; Plesch G, 2001, PLANT J, V28, P455, DOI 10.1046/j.1365-313X.2001.01166.x; Powles JE, 2006, PLANT CELL ENVIRON, V29, P981, DOI 10.1111/j.1365-3040.2005.01491.x; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Ribeiro DM, 2009, PLANT CELL ENVIRON, V32, P46, DOI 10.1111/j.1365-3040.2008.01906.x; Rienmuller F, 2010, PLANT CELL PHYSIOL, V51, P1548, DOI 10.1093/pcp/pcq102; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Shope JC, 2008, PLANT CELL ENVIRON, V31, P1290, DOI 10.1111/j.1365-3040.2008.01844.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sugio T, 2008, J BIOSCI BIOENG, V105, P300, DOI 10.1263/jbb.105.300; Sze H, 2012, Patent, Patent No. [US7993926B2, 7993926]; Tanaka H, 2001, DEVELOPMENT, V128, P4681; TERRYN N, 1993, PLANT CELL, V5, P1761, DOI 10.1105/tpc.5.12.1761; Tonelli C., 2010, Patent, Patent No. [US7662947, 7662947]; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Wang Y, 2008, PLANT CELL ENVIRON, V31, P1307, DOI 10.1111/j.1365-3040.2008.01843.x; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Xiao XG, 2012, Patent, Patent No. [CN102367439A, 102367439]; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Zhu JH, 2002, PLANT CELL, V14, P3009, DOI 10.1105/tpc.006981	71	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59802	10.1371/journal.pone.0059802	http://dx.doi.org/10.1371/journal.pone.0059802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555786	gold, Green Submitted, Green Published			2022-12-27	WOS:000317263900030
J	Lee, GB; Brandt, EB; Xiao, C; Gibson, AM; Le Cras, TD; Brown, LAS; Fitzpatrick, AM; Hershey, GKK				Lee, Gerald B.; Brandt, Eric B.; Xiao, Chang; Gibson, Aaron M.; Le Cras, Timothy D.; Brown, Lou Ann S.; Fitzpatrick, Anne M.; Hershey, Gurjit K. Khurana			Diesel Exhaust Particles Induce Cysteine Oxidation and S-Glutathionylation in House Dust Mite Induced Murine Asthma	PLOS ONE			English	Article							AIR-POLLUTION; BIOLOGY; STRESS; CHILDREN; COHORT; MICE	Background: Diesel exhaust particle (DEP) exposure enhances allergic inflammation and has been linked to the incidence of asthma. Oxidative stress on the thiol molecules cysteine (Cys) and glutathione (GSH) can promote inflammatory host responses. The effect of DEP on the thiol oxidation/reduction (redox) state in the asthmatic lung is unknown. Objective: To determine if DEP exposure alters the Cys or GSH redox state in the asthmatic airway. Methods: Bronchoalveolar lavage fluid was obtained from a house dust mite (HDM) induced murine asthma model exposed to DEP. GSH, glutathione disulfide (GSSG), Cys, cystine (CySS), and s-glutathionylated cysteine (CySSG) were determined by high pressure liquid chromatography. Results: DEP co-administered with HDM, but not DEP or HDM alone, decreased total Cys, increased CySS, and increased CySSG without significantly altering GSH or GSSG. Conclusions: DEP exposure promotes oxidation and S-glutathionylation of cysteine amino acids in the asthmatic airway, suggesting a novel mechanism by which DEP may enhance allergic inflammatory responses.	[Lee, Gerald B.; Brandt, Eric B.; Xiao, Chang; Gibson, Aaron M.; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH USA; [Lee, Gerald B.; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH USA; [Le Cras, Timothy D.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Brown, Lou Ann S.; Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Emory University	Hershey, GKK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH USA.	Gurjit.Hershey@cchmc.org	Lee, Gwo-Bin Vincent/D-3032-2012	Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Fitzpatrick, Anne/0000-0002-2933-5926; Khurana Hershey, Gurjit/0000-0001-6663-977X; Brandt, Eric/0000-0003-0617-4100; Le Cras, Timothy/0000-0001-8538-2703	National Institutes of Health (NIH) [1R01HL098134-01]; National Institute of Environmental Health Sciences (NIEHS) [T32 ES010957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) 1R01HL098134-01 (GKKH and TDLC) and National Institute of Environmental Health Sciences (NIEHS) T32 ES010957 (EBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Brunekreef B, 2009, ENVIRON HEALTH PERSP, V117, P1791, DOI 10.1289/ehp.0800467; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; HEI Panel on the Health Effects of Traffic-Related Air Pollution, 2010, TRAFF REL AIR POLL C; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Likogianni V, 2006, CLIN CHIM ACTA, V372, P140, DOI 10.1016/j.cca.2006.03.035; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Pearson PJK, 2004, THORAX, V59, P652, DOI 10.1136/thx.2004.022616; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Riedl MA, 2008, CURR ALLERGY ASTHM R, V8, P139, DOI 10.1007/s11882-008-0024-8; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Ryan PH, 2009, AM J RESP CRIT CARE, V180, P1068, DOI 10.1164/rccm.200808-1307OC; Schroer KT, 2009, J PEDIATR-US, V154, P401, DOI 10.1016/j.jpeds.2008.08.040; Stevens T, 2009, TOXICOL SCI, V107, P522, DOI 10.1093/toxsci/kfn248; Whitekus MJ, 2002, J IMMUNOL, V168, P2560, DOI 10.4049/jimmunol.168.5.2560	21	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60632	10.1371/journal.pone.0060632	http://dx.doi.org/10.1371/journal.pone.0060632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555996	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900079
J	Sylvestre, G; Gandini, M; Maciel-de-Freitas, R				Sylvestre, Gabriel; Gandini, Mariana; Maciel-de-Freitas, Rafael			Age-Dependent Effects of Oral Infection with Dengue Virus on Aedes aegypti (Diptera: Culicidae) Feeding Behavior, Survival, Oviposition Success and Fecundity	PLOS ONE			English	Article							RIO-DE-JANEIRO; MOSQUITO; SUSCEPTIBILITY; TRANSMISSION; ALBOPICTUS; FEMALES; TYPE-2; LONGEVITY; PASSAGE; BIOLOGY	Background: Aedes aegypti is the main vector of dengue, a disease that is increasing its geographical range as well as incidence rates. Despite its public health importance, the effect of dengue virus (DENV) on some mosquito traits remains unknown. Here, we investigated the impact of DENV-2 infection on the feeding behavior, survival, oviposition success and fecundity of Ae. aegypti females. Methods/Principal Findings: After orally-challenging Ae. aegypti females with a DENV-2 strain using a membrane feeder, we monitored the feeding behavior, survival, oviposition success and fecundity throughout the mosquito lifespan. We observed an age-dependent cost of DENV infection on mosquito feeding behavior and fecundity. Infected individuals took more time to ingest blood from anesthetized mice in the 2nd and 3rd weeks post-infection, and also longer overall blood-feeding times in the 3rd week post-infection, when females were around 20 days old. Often, infected Ae. aegypti females did not lay eggs and when they were laid, smaller number of eggs were laid compared to uninfected controls. A reduction in the number of eggs laid per female was evident starting on the 3rd week post-infection. DENV-2 negatively affected mosquito lifespan, since overall the longevity of infected females was halved compared to that of the uninfected control group. Conclusions: The DENV-2 strain tested significantly affected Ae. aegypti traits directly correlated with vectorial capacity or mosquito population density, such as feeding behavior, survival, fecundity and oviposition success. Infected mosquitoes spent more time ingesting blood, had reduced lifespan, laid eggs less frequently, and when they did lay eggs, the clutches were smaller than uninfected mosquitoes.	[Sylvestre, Gabriel; Maciel-de-Freitas, Rafael] Inst Oswaldo Cruz Fiocruz, Lab Transmissores Hematozoarios, Rio De Janeiro, Brazil; [Gandini, Mariana] Fiocruz MS, Lab Imunologia Viral, Inst Oswaldo Cruz Fiocruz, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Maciel-de-Freitas, R (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Transmissores Hematozoarios, Rio De Janeiro, Brazil.	freitas@ioc.fiocruz.br	Gandini, Mariana/AAZ-6964-2021; Maciel-de-Freitas, Rafael/J-1997-2012; Kubelka, Claire F/C-5558-2009	Maciel-de-Freitas, Rafael/0000-0002-2198-6492; Gandini, Mariana/0000-0003-3603-6921				ANDERSON R M, 1991; Anderson RA, 1996, J VECTOR ECOL, V21, P94; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Chevillon C, 2003, TRENDS MICROBIOL, V11, P415, DOI 10.1016/S0966-842X(03)00206-3; CHRISTENSEN BM, 1981, MOSQ NEWS, V41, P78; Ciota Alexander T., 2011, BMC Ecology, V11, P23, DOI 10.1186/1472-6785-11-23; Colisson R, 2010, BLOOD, V115, P2177, DOI 10.1182/blood-2009-06-224741; de Roode JC, 2010, EVOLUTION, V64, P502, DOI 10.1111/j.1558-5646.2009.00845.x; EDMAN JD, 1992, J MED ENTOMOL, V29, P1033; ELSAWAF BM, 1994, AM J TROP MED HYG, V51, P767, DOI 10.4269/ajtmh.1994.51.767; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Halstead SB, 2003, AM J TROP MED HYG, V69, P5; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Harbach RE, 2002, TAXONOMISTS GLOSSARY; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Lambrechts L, 2007, AM J TROP MED HYG, V76, P475, DOI 10.4269/ajtmh.2007.76.475; Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022; Lambrechts L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001019; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; Massad E, 2012, MEM I OSWALDO CRUZ, V107, P564, DOI 10.1590/S0074-02762012000400022; Miagostovich Mariz P., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P149, DOI 10.1590/S0036-46651993000200006; PAHO [Pan-America Health Organization], 1994, PAHO SCI PUBL, V548; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; RENSHAW M, 1994, PARASITOLOGY, V109, P337, DOI 10.1017/S0031182000078367; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schwartz A, 2004, J EVOLUTION BIOL, V17, P834, DOI 10.1111/j.1420-9101.2004.00720.x; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005; Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x; Vazeille M, 2003, AM J TROP MED HYG, V68, P203, DOI 10.4269/ajtmh.2003.68.203; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003; WALKER ED, 1985, J MED ENTOMOL, V22, P370, DOI 10.1093/jmedent/22.4.370	49	44	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59933	10.1371/journal.pone.0059933	http://dx.doi.org/10.1371/journal.pone.0059933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555838	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900045
J	Capra, V; Busnelli, M; Perenna, A; Ambrosio, M; Accomazzo, MR; Gales, C; Chini, B; Rovati, GE				Capra, Valerie; Busnelli, Marta; Perenna, Alessandro; Ambrosio, Manuela; Accomazzo, Maria Rosa; Gales, Celine; Chini, Bice; Rovati, G. Enrico			Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation	PLOS ONE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVITY; COUPLED RECEPTOR; IONIC LOCK; BETA(1)-ADRENERGIC RECEPTOR; MOLECULAR-DYNAMICS; INTRACELLULAR LOOP; LIGAND-BINDING	The intrahelical salt bridge between E/D-3.49 and R-3.50 within the E/DRY motif on helix 3 (H3) and the interhelical hydrogen bonding between the E/DRY and residues on H6 are thought to be critical in stabilizing the class A G protein-coupled receptors in their inactive state. Removal of these interactions is expected to generate constitutively active receptors. This study examines how neutralization of E-3.49/6.30 in the thromboxane prostanoid (TP) receptor alters ligand binding, basal, and agonist-induced activity and investigates the molecular mechanisms of G protein activation. We demonstrate here that a panel of full and partial agonists showed an increase in affinity and potency for E129V and E240V mutants. Yet, even augmenting the sensitivity to detect constitutive activity (CA) with overexpression of the receptor or the G protein revealed resistance to an increase in basal activity, while retaining fully the ability to cause agonist-induced signaling. However, direct G protein activation measured through bioluminescence resonance energy transfer (BRET) indicates that these mutants more efficiently communicate and/or activate their cognate G proteins. These results suggest the existence of additional constrains governing the shift of TP receptor to its active state, together with an increase propensity of these mutants to agonist-induced signaling, corroborating their definition as superactive mutants. The particular nature of the TP receptor as somehow "resistant'' to CA should be examined in the context of its pathophysiological role in the cardiovascular system. Evolutionary forces may have favored regulation mechanisms leading to low basal activity and selected against more highly active phenotypes.	[Capra, Valerie; Perenna, Alessandro; Accomazzo, Maria Rosa; Rovati, G. Enrico] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Busnelli, Marta; Chini, Bice] CNR Inst Neurosci, Milan, Italy; [Busnelli, Marta] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Ambrosio, Manuela] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Gales, Celine] Univ Toulouse 3, Ctr Hosp Univ Toulouse, Inst Malad Metab & Cardiovasc, INSERM,U1048, F-31062 Toulouse, France	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan; University of Wurzburg; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Capra, V (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	Valerie.Capra@unimi.it	Busnelli, Marta/AAR-5513-2021; Capra, Valérie/B-6225-2008	Busnelli, Marta/0000-0003-3387-2190; Capra, Valérie/0000-0003-3956-0833; GALES, Celine/0000-0002-4938-1583; Rovati, G.Enrico/0000-0002-8788-9783; Chini, Bice/0000-0002-1686-284X	Regione Lombardia [16755-Rif. SAL-02]; Progetto TerDisMental [16983-Rif. SAL-50]; Fondazione Banca del Monte di Lombardia; Cariplo Foundation [2008.2314]	Regione Lombardia(Regione Lombardia); Progetto TerDisMental; Fondazione Banca del Monte di Lombardia; Cariplo Foundation(Fondazione Cariplo)	This work was supported in part by a grant from Regione Lombardia (Progetto Ex-ASTIL ID 16755-Rif. SAL-02 to G.E.R and Progetto TerDisMental, ID 16983-Rif. SAL-50 to B.C.), Fondazione Banca del Monte di Lombardia (Funding programme 2010 to G.E.R), and Cariplo Foundation (Grant 2008.2314 to B.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Ambrosio C, 2005, J BIOL CHEM, V280, P23464, DOI 10.1074/jbc.M502901200; Ambrosio M, 2010, CELL MOL LIFE SCI, V67, P2979, DOI 10.1007/s00018-010-0368-9; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; Capra V, 2004, MOL PHARMACOL, V66, P880, DOI 10.1124/mol.104.001487; Capra V, 2012, MED RES REV; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Fanelli F, 2011, CELL MOL LIFE SCI, V68, P3109, DOI 10.1007/s00018-010-0615-0; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Jojart B, 2010, J PHYS CHEM LETT, V1, P1008, DOI 10.1021/jz900403a; Kim JH, 2008, ARCH PHARM RES, V31, P474, DOI 10.1007/s12272-001-1181-x; Kinsella BT, 2001, BIOCHEM SOC T, V29, P641, DOI 10.1042/BST0290641; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Laroche G, 2005, CELL SIGNAL, V17, P1373, DOI 10.1016/j.cellsig.2005.02.008; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Leschner J, 2012, J PHARM EXP THER; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pathe-Neuschafer-Rube A, 2005, BIOCHEM J, V388, P317, DOI 10.1042/BJ20041321; Raimondi F, 2008, J AM CHEM SOC, V130, P4310, DOI 10.1021/ja077268b; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Rovati GE, 1998, TRENDS PHARMACOL SCI, V19, P365; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; TOH H, 1995, FEBS LETT, V361, P17, DOI 10.1016/0014-5793(95)00129-W; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Wilson SJ, 2004, J BIOL CHEM, V279, P53036, DOI 10.1074/jbc.M405002200; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; Zhang L, 2006, MOL PHARMACOL, V69, P1433, DOI 10.1124/mol.105.019703	57	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60475	10.1371/journal.pone.0060475	http://dx.doi.org/10.1371/journal.pone.0060475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555978	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200119
J	Gu, J; Zhao, Y; Wang, XG; Jiang, JJ; Tian, JH; Yang, KH				Gu, Jing; Zhao, Ye; Wang, Xiaogang; Jiang, Jianjun; Tian, Jinhui; Yang, Kehu			Registration Quality Assessment of Acupuncture Clinical Trials	PLOS ONE			English	Article							STATEMENT; INFORMATION	Background: Registration can help with transparency of acupuncture clinical trials (ACTs) by making protocol information and results available to the public. Recently, the number of registered ACTs has increased greatly, but only a few researchers have focused on the quality of ACTs registration. This review provides the first assessment of the registration quality of ACTs and the baseline information for future development. Methods: All records of ACTs registered in the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) were collected. Data was extracted and input to Excel spreadsheets. The current 20 items of the WHO Trial Registration Data Set (TRDS) and the special prepared items for acupuncture intervention details were used to assess the registration quality of ACTs. Results: A total of 740 records, found in 11 registries, were examined. The number of registered ACTs increased rapidly and involved a number of different diseases. The completeness of 20 items was not too poor due to 16 of them had a higher reported percentage (>85%). The completeness of the 20 items was different among registries. For example, the average registration percentage of 20 items in Clinicaltrials.gov, ChiCTR, ISRCTN and ANZCTR were 89.6%, 92.2%, 82.4% and 91.6% respectively. Detailed information regarding acupuncture intervention was seriously insufficient. Among the 740 registration records, 89.2% lacked information on the style of acupuncture, 80.8% did not contain details regarding the needles used, 53.5% lacked information on the treatment regimen and 76.2% did not give details of other interventions administered with acupuncture. Conclusions: The overall registration quality of ACTs is not high enough due to the serious lack of information on the specifics of acupuncture intervention. It is vital that a number of special items be set regarding acupuncture in order to develop a suitable system for the registration of ACTs.	[Gu, Jing; Zhao, Ye; Wang, Xiaogang; Tian, Jinhui; Yang, Kehu] Lanzhou Univ, Evidence Based Med Ctr, Inst Integrated Tradit Chinese & Western Med, Sch Basic Med Sci, Lanzhou 730000, Gansu, Peoples R China; [Gu, Jing] Gansu Univ Tradit Chinese Med, Inst Integrated Tradit Chinese & Western Med, Lanzhou, Gansu, Peoples R China; [Jiang, Jianjun] Lanzhou Univ, Sch Clin Med 2, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Gansu University of Chinese Medicine; Lanzhou University	Yang, KH (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Inst Integrated Tradit Chinese & Western Med, Sch Basic Med Sci, Lanzhou 730000, Gansu, Peoples R China.	yangkhebm2006@126.com						Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; De Angelis CD, 2005, CROAT MED J, V46, P499; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Geng Ling-Ling, 2008, Zhongguo Zhen Jiu, V28, P439; Ghersi Davina, 2009, J Evid Based Med, V2, P1, DOI 10.1111/j.1756-5391.2009.01014.x; International Committee of Medical Journal, 2004, CLIN TRIAL REG STAT; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Lao Li-xing, 2008, Zhen Ci Yan Jiu, V33, P53; Li Zheng-Jie, 2012, Zhen Ci Yan Jiu, V37, pcover; Liu Xuemei, 2009, J Evid Based Med, V2, P8, DOI 10.1111/j.1756-5391.2009.01007.x; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; National Health Service, 2012, AC EV ITS EFF; NIH Consensus Development Program, 1997, AC CONS DEV C STAT; Organization WH., 2003, PARKINSONISM RELAT D, pS163, DOI [10.1016/S1353-8020(11)70706-4, DOI 10.1016/S1353-8020(11)70706-4]; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Reviz L, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-30; RICHARDSON PH, 1986, PAIN, V24, P15, DOI 10.1016/0304-3959(86)90023-0; Scherer RW, 2007, COCHRANE DB SYST REV, V18; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; US National Center for Complementary and Alternative Medicine, 2006, AC; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Wang L, 2007, XIAN DAI QING BAO, V27, P221; World Medical Association, 2008, DECL HELS; Wu B, 2002, J CLIN ACUPUNCTURE M, V18, P1; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Yang DQ, 2008, INVESTIGATION REGIST; Yong S., 2011, CJCM, V3, P69	29	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59506	10.1371/journal.pone.0059506	http://dx.doi.org/10.1371/journal.pone.0059506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555686	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200024
J	Zeng, L; Choi, SC; Danko, CG; Siepel, A; Stanhope, MJ; Burne, RA				Zeng, Lin; Choi, Sang Chul; Danko, Charles G.; Siepel, Adam; Stanhope, Michael J.; Burne, Robert A.			Gene Regulation by CcpA and Catabolite Repression Explored by RNA-Seq in Streptococcus mutans	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SEQUENCE-ANALYSIS; TRANSCRIPTIONAL REGULATION; PHOSPHOTRANSFERASE SYSTEM; BACILLUS-SUBTILIS; OXIDATIVE STRESS; VIRULENCE TRAITS; PROTEIN; SUGAR; IDENTIFICATION	A bacterial transcriptome of the primary etiological agent of human dental caries, Streptococcus mutans, is described here using deep RNA sequencing. Differential expression profiles of the transcriptome in the context of carbohydrate source, and of the presence or absence of the catabolite control protein CcpA, revealed good agreement with previously-published DNA microarrays. In addition, RNA-seq considerably expanded the repertoire of DNA sequences that showed statistically-significant changes in expression as a function of the presence of CcpA and growth carbohydrate. Novel mRNAs and small RNAs were identified, some of which were differentially expressed in conditions tested in this study, suggesting that the function of the S. mutans CcpA protein and the influence of carbohydrate sources has a more substantial impact on gene regulation than previously appreciated. Likewise, the data reveal that the mechanisms underlying prioritization of carbohydrate utilization are more diverse than what is currently understood. Collectively, this study demonstrates the validity of RNA-seq as a potentially more-powerful alternative to DNA microarrays in studying gene regulation in S. mutans because of the capacity of this approach to yield a more precise landscape of transcriptomic changes in response to specific mutations and growth conditions.	[Zeng, Lin; Burne, Robert A.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Choi, Sang Chul; Stanhope, Michael J.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Choi, Sang Chul; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	State University System of Florida; University of Florida; Cornell University; Cornell University	Burne, RA (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	rburne@dental.ufl.edu	Zeng, Lin/L-5931-2019	Siepel, Adam/0000-0002-3557-7219; Danko, Charles/0000-0002-1999-7125; Zeng, Lin/0000-0002-9269-2707; Burne, Robert/0000-0002-4234-0316	National Institute of Allergy and Infectious Disease; U.S. National Institutes of Health [AI073368]; National Institute for Dental and Craniofacial Research [DE12236]; National Science Foundation [DBI-0644111]; David and Lucile Packard Fellowship for Science and Engineering; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012236] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Fellowship for Science and Engineering(The David & Lucile Packard Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by the National Institute of Allergy and Infectious Disease (http://www.niaid.nih.gov), U.S. National Institutes of Health (http://www.nih.gov), under grant number AI073368 and National Institute for Dental and Craniofacial Research (http://www.nidcr.nih.gov/) grant number DE12236. Additional support was provided by National Science Foundation (http://www.nsf.gov) Career Award DBI-0644111 and a David and Lucile Packard Fellowship for Science and Engineering (to A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; Ahn SJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-187; Ahn SJ, 2010, MICROBIOL-SGM, V156, P3136, DOI 10.1099/mic.0.039586-0; Ahn SJ, 2005, J BACTERIOL, V187, P3028, DOI 10.1128/JB.187.9.3028-3038.2005; Ajdic D, 1998, J BACTERIOL, V180, P5727; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Burne R A, 2009, Adv Dent Res, V21, P17, DOI 10.1177/0895937409335593; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; Conway T, 2003, MOL MICROBIOL, V47, P879, DOI 10.1046/j.1365-2958.2003.03338.x; Cote CK, 2000, MICROBIOL-UK, V146, P1555, DOI 10.1099/00221287-146-7-1555; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filiatrault MJ, 2011, CURR OPIN MICROBIOL, V14, P579, DOI 10.1016/j.mib.2011.07.023; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; HARRIS GS, 1992, INFECT IMMUN, V60, P3175, DOI 10.1128/IAI.60.8.3175-3185.1992; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Lemme A, 2011, J BACTERIOL; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Qi FX, 2001, APPL ENVIRON MICROB, V67, P15, DOI 10.1128/AEM.67.1.15-21.2001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SATO Y, 1989, J BACTERIOL, V171, P263, DOI 10.1128/jb.171.1.263-271.1989; Sato Y, 1997, INFECT IMMUN, V65, P668, DOI 10.1128/IAI.65.2.668-675.1997; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; SHIROZA T, 1987, J BACTERIOL, V169, P4263, DOI 10.1128/jb.169.9.4263-4270.1987; SHIROZA T, 1988, J BACTERIOL, V170, P810, DOI 10.1128/jb.170.2.810-816.1988; Simpson CL, 1998, INFECT IMMUN, V66, P2085, DOI 10.1128/IAI.66.5.2085-2092.1998; Sridhar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011970; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; UEDA S, 1988, GENE, V69, P101, DOI 10.1016/0378-1119(88)90382-4; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wen ZT, 2001, FEMS MICROBIOL LETT, V205, P337, DOI 10.1111/j.1574-6968.2001.tb10969.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x; Zeng L, 2010, J BACTERIOL, V192, P2434, DOI 10.1128/JB.01624-09; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08	59	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60465	10.1371/journal.pone.0060465	http://dx.doi.org/10.1371/journal.pone.0060465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555977	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000317262200118
J	Bertossa, RC; van Dijk, J; Diao, WW; Saunders, D; Beukeboom, LW; Beersma, DGM				Bertossa, Rinaldo C.; van Dijk, Jeroen; Diao, Wenwen; Saunders, David; Beukeboom, Leo W.; Beersma, Domien G. M.			Circadian Rhythms Differ between Sexes and Closely Related Species of Nasonia Wasps	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY RHYTHM; MATING-BEHAVIOR; TIME MEASUREMENT; GENETIC-BASIS; CLOCK GENES; TURNIP MOTH; HYMENOPTERA; INSECT; EMERGENCE; PHOTOPERIODISM	Activity rhythms in 24 h light-dark cycles, constant darkness, and constant light conditions were analyzed in four different Nasonia species for each sex separately. Besides similarities, clear differences are evident among and within Nasonia species as well as between sexes. In all species, activity in a light-dark cycle is concentrated in the photophase, typical for diurnal organisms. Contrary to most diurnal insect species so far studied, Nasonia follows Aschoff's rule by displaying long (>24 h) internal rhythms in constant darkness but short (<24 h) in constant light. In constant light, N. vitripennis males display robust circadian activity rhythms, whereas females are usually arrhythmic. In contrast to other Nasonia species, N. longicornis males display anticipatory activity, i.e. activity shortly before light-on in a light-dark cycle. As expected, N. oneida shows activity patterns similar to those of N. giraulti but with important differences in key circadian parameters. Differences in circadian activity patterns and parameters between species may reflect synchronization of specific life-history traits to environmental conditions. Scheduling mating or dispersion to a specific time of the day could be a strategy to avoid interspecific hybridization in Nasonia species that live in sympatry.	[Bertossa, Rinaldo C.; Beersma, Domien G. M.] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [van Dijk, Jeroen] Univ Sherbrooke, Dept Biol, Quebec City, PQ, Canada; [Bertossa, Rinaldo C.; Diao, Wenwen; Beukeboom, Leo W.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Saunders, David] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Groningen; University of Sherbrooke; University of Groningen; University of Edinburgh	Bertossa, RC (corresponding author), Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands.	r.c.bertossa@rug.nl		van Dijk, Jeroen/0000-0003-2802-5915	Netherlands Organization for Scientific Research (NWO) [ALW 817.02.020]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	RCB was supported by a grant (ALW 817.02.020) from the Netherlands Organization for Scientific Research (NWO) URL: http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bertossa RC, 2010, J INSECT PHYSIOL, V56, P805, DOI 10.1016/j.jinsphys.2010.02.008; Bloch Guy, 2009, P402; Bradshaw WE, 2012, HEREDITY, V108, P473, DOI 10.1038/hdy.2011.108; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; DARLING DC, 1990, ANN ENTOMOL SOC AM, V83, P352, DOI 10.1093/aesa/83.3.352; Desjardins CA, 2010, HEREDITY, V104, P270, DOI 10.1038/hdy.2009.145; Drapeau MD, 1999, EVOL ECOL RES, V1, P223; Goto SG, 2013, ENTOMOL SCI, V16, P1, DOI 10.1111/ens.12000; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; Harano T, 2010, HEREDITY, V105, P268, DOI 10.1038/hdy.2010.4; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; Hoedjes KM, 2012, GENES BRAIN BEHAV, V11, P879, DOI 10.1111/j.1601-183X.2012.00823.x; Itoh MT, 2000, J BIOL RHYTHM, V15, P241, DOI 10.1177/074873040001500305; Johnson JN, 2010, J INSECT PHYSIOL, V56, P761, DOI 10.1016/j.jinsphys.2010.01.004; Joshi DS, 1999, CAN J ZOOL, V77, P865, DOI 10.1139/cjz-77-6-865; Kostal V, 2011, J INSECT PHYSIOL, V57, P538, DOI 10.1016/j.jinsphys.2010.10.006; Leonard JE, 2006, ANIM BEHAV, V71, P641, DOI 10.1016/j.anbehav.2005.07.010; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Ndoutoume-Ndong A, 2006, CR BIOL, V329, P476, DOI 10.1016/j.crvi.2006.01.011; O'Brien C, 2011, MOL ECOL, V20, P2471, DOI 10.1111/j.1365-294X.2011.05133.x; Paolucci S, 2013, J EVOL BIOL IN PRESS; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; R Core Team, 2012, LANG ENV STAT COMP; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; Reznik SY, 2008, EUR J ENTOMOL, V105, P81, DOI 10.14411/eje.2008.011; Rivas GBS, 2008, MED VET ENTOMOL, V22, P288, DOI 10.1111/j.1365-2915.2008.00742.x; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Rosen WQ, 2003, J BIOL RHYTHM, V18, P402, DOI 10.1177/0748730403256869; Rosen WQ, 2002, ARCH INSECT BIOCHEM, V50, P21, DOI 10.1002/arch.10026; Rymer J, 2007, J BIOL RHYTHM, V22, P43, DOI 10.1177/0748730406295462; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Saunders DS, 2011, J INSECT PHYSIOL, V57, P557, DOI 10.1016/j.jinsphys.2011.01.013; Saunders DS, 2012, PHYSIOL ENTOMOL, V37, P207, DOI 10.1111/j.1365-3032.2012.00837.x; Saunders DS, 2008, EUR J ENTOMOL, V105, P585, DOI 10.14411/eje.2008.078; SAUNDERS DS, 1973, SCIENCE, V181, P358, DOI 10.1126/science.181.4097.358; SAUNDERS DS, 1968, J INSECT PHYSIOL, V14, P433, DOI 10.1016/0022-1910(68)90060-7; SAUNDERS DS, 1974, J INSECT PHYSIOL, V20, P77, DOI 10.1016/0022-1910(74)90125-5; SAUNDERS DS, 1970, SCIENCE, V168, P601, DOI 10.1126/science.168.3931.601; Saunders DS, 2002, INSECT CLOCKS; Sharma VK, 2003, CHRONOBIOL INT, V20, P901, DOI 10.1081/CBI-120026099; Shimizu T, 1997, PHYSIOL ENTOMOL, V22, P83, DOI 10.1111/j.1365-3032.1997.tb01144.x; Simunovic A, 2006, EVOL ECOL RES, V8, P803; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stelzer RJ, 2010, J BIOL RHYTHM, V25, P257, DOI 10.1177/0748730410371750; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Van den Assem J, 1999, NETH J ZOOL, V49, P125, DOI 10.1163/156854299505641; VANDENASSEM J, 1994, J INSECT BEHAV, V7, P53, DOI 10.1007/BF01989827; Vanlalhriatpuia Keny, 2007, Journal of Circadian Rhythms, V5, P1, DOI 10.1186/1740-3391-5-1; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023	52	17	17	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60167	10.1371/journal.pone.0060167	http://dx.doi.org/10.1371/journal.pone.0060167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555911	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500118
J	Buckley, M				Buckley, Michael			A Molecular Phylogeny of Plesiorycteropus Reassigns the Extinct Mammalian Order 'Bibymalagasia'	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEIN SEQUENCES; OSTEOCALCIN; REANALYSIS; NETWORKS; COLLAGEN; SPECTRA; BONE	Madagascar is well known for its diverse fauna and flora, being home to many species not found anywhere else in the world. However, its biodiversity in the recent past included a range of extinct enigmatic fauna, such as elephant birds, giant lemurs and dwarfed hippopotami. The 'Malagasy aardvark' (Plesiorycteropus) has remained one of Madagascar's least well-understood extinct species since its discovery in the 19th century. Initially considered a close relative of the aardvark (Orycteropus) within the order Tubulidentata, more recent morphological analyses challenged this placement on the grounds that the identifiably derived traits supporting this allocation were adaptations to digging rather than shared ancestry. Because the skeletal evidence showed many morphological traits diagnostic of different eutherian mammal orders, they could not be used to resolve its closest relatives. As a result, the genus was tentatively assigned its own taxonomic order 'Bibymalagasia', yet how this order relates to other eutherian mammal orders remains unclear despite numerous morphological investigations. This research presents the first known molecular sequence data for Plesiorycteropus, obtained from the bone protein collagen (I), which places the 'Malagasy aardvark' as more closely related to tenrecs than aardvarks. More specifically, Plesiorycteropus was recovered within the order Tenrecoidea (golden moles and tenrecs) within Afrotheria, suggesting that the taxonomic order 'Bibymalagasia' is obsolete. This research highlights the potential for collagen sequencing in investigating the phylogeny of extinct species as a viable alternative to ancient DNA (aDNA) sequencing, particularly in cases where aDNA cannot be recovered.	Manchester Inst Biotechnol, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Buckley, M (corresponding author), Manchester Inst Biotechnol, Fac Life Sci, Manchester, Lancs, England.	m.buckley@manchester.ac.uk		Buckley, Michael/0000-0002-4166-8213	NERC; Wellcome Trust; NERC [NE/K000799/1] Funding Source: UKRI; Natural Environment Research Council [NE/K000799/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC & Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Asher RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-108; Bern M, 2009, J PROTEOME RES, V8, P4328, DOI 10.1021/pr900349r; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; Buckley M., 2011, ANTIQUA, V1, pe1, DOI [10.4081/antiqua.2011.e1.-e1, DOI 10.4081/ANTIQUA.2011.E1.-E1, DOI 10.4081/ANTIQUA.2011.E1]; Buckley M, 2008, J ARCHAEOL SCI, V35, P1756, DOI 10.1016/j.jas.2007.11.022; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley Mike, 2008, Science, V319, P33, DOI 10.1126/science.1147046; CLARK WEL, 1926, P ZOOL SOC LOND, V30, P445; COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019; DEJONG WW, 1981, NATURE, V292, P538, DOI 10.1038/292538a0; Dobberstein RC, 2009, ARCHAEOL ANTHROP SCI, V1, P31, DOI 10.1007/s12520-009-0002-7; El-Aneed A, 2009, APPL SPECTROSC REV, V44, P210, DOI 10.1080/05704920902717872; FILHOL H, 1895, B MUS HIST NAT PARIS, V1, P12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Horovitz I., 2004, FANFARE UNCOMMON PAL, V36, P63; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUQ NL, 1990, BIOCHEM INT, V21, P491; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Lamberton C, 1946, B ACAD MALGACHE, V25; Lavocat R, 1958, TRAITE PALEONTOL, V6, P139; MACINNESS D. G., 1956, FOSSIL MAMMALS OF AFRICA BRIT MUS [NAT HIST], V10, P1; MacPhee R, 1994, B AM MUS NAT HIS, V220; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; PATTERSON B, 1975, Bulletin of the Museum of Comparative Zoology, V147, P185; Patterson B., 1978, P268; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; RAINEY WE, 1984, NATURWISSENSCHAFTEN, V71, P586, DOI 10.1007/BF01189187; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; THEWISSEN JGM, 1985, MAMMALIA, V49, P257, DOI 10.1515/mamm.1985.49.2.257; Tuross N., 1989, Applied Geochemistry, V4, P255, DOI 10.1016/0883-2927(89)90026-7; Tuross N., 1980, COLLAGEN FOSSIL BONE; Van der Geer A., 2010, EVOLUTION ISLAND MAM	41	46	46	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59614	10.1371/journal.pone.0059614	http://dx.doi.org/10.1371/journal.pone.0059614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555726	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500064
J	Ng, C; Sundararajan, J; Hogan, M; Purves, D				Ng, Cherlyn; Sundararajan, Janani; Hogan, Michael; Purves, Dale			Network Connections That Evolve to Circumvent the Inverse Optics Problem	PLOS ONE			English	Article							CONTRAST; EXPLANATION; STATISTICS; LUMINANCE	A fundamental problem in vision science is how useful perceptions and behaviors arise in the absence of information about the physical sources of retinal stimuli (the inverse optics problem). Psychophysical studies show that human observers contend with this problem by using the frequency of occurrence of stimulus patterns in cumulative experience to generate percepts. To begin to understand the neural mechanisms underlying this strategy, we examined the connectivity of simple neural networks evolved to respond according to the cumulative rank of stimulus luminance values. Evolved similarities with the connectivity of early level visual neurons suggests that biological visual circuitry uses the same mechanisms as a means of creating useful perceptions and behaviors without information about the real world.	[Ng, Cherlyn; Sundararajan, Janani; Hogan, Michael; Purves, Dale] Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore; [Purves, Dale] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Purves, Dale] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	National University of Singapore; Duke University; Duke University	Purves, D (corresponding author), Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore.	purves@neuro.duke.edu	Ng, Cherlyn/AAW-8058-2021	Ng, Cherlyn/0000-0001-5816-8744	Duke-NUS Graduate Medical School Singapore [BCS-0924181]	Duke-NUS Graduate Medical School Singapore	This work was supported by Duke-NUS Graduate Medical School Singapore (BCS-0924181; http://www.duke-nus.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bekesy GV, 1967, SENSORY INHIBITION; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brady N, 2000, PERCEPTION, V29, P1041, DOI 10.1068/p2996; Cornsweet T., 1970, VISUAL PERCEPTION; Daw N.W., 2006, VISUAL DEV; Dror R, 2004, J VISION, V4, P821, DOI 10.1167/4.9.11; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Gilchrist A., 2006, SEEING BLACK WHITE; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Graham DJ, 2006, VISION RES, V46, P2901, DOI 10.1016/j.visres.2006.03.008; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laming D, 1997, MEASUREMENT SENSATIO; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Nundy S, 2002, P NATL ACAD SCI USA, V99, P14482, DOI 10.1073/pnas.172520399; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Palmer SE, 1999, VISION SCI PHOTONS P, P31; Purves, 1985, PRINCIPLES NEURAL DE; Purves D, 2011, P NATL ACAD SCI USA, V108, P15588, DOI 10.1073/pnas.1012178108; Purves D, 2011, WHY WE SEE WHAT WE DO REDUX: A WHOLLY EMPIRICAL THEORY OF VISION, P1; SAKMANN B, 1969, PFLUG ARCH EUR J PHY, V313, P168, DOI 10.1007/BF00586245; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; STEVENS SS, 1966, J OPT SOC AM, V56, P1135, DOI 10.1364/JOSA.56.001135; Stevens SS, 1975, PSYCHOPHYSICS INTRO, pxiv; TAKASAKI H, 1966, J OPT SOC AM, V56, P504, DOI 10.1364/JOSA.56.000504; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Yang ZY, 2004, P NATL ACAD SCI USA, V101, P8745, DOI 10.1073/pnas.0402192101; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60490	10.1371/journal.pone.0060490	http://dx.doi.org/10.1371/journal.pone.0060490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555981	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500137
J	Teixeira, C; Correia, S; Victora, CG; Barros, H				Teixeira, Cristina; Correia, Sofia; Victora, Cesar G.; Barros, Henrique			The Brazilian Preference: Cesarean Delivery among Immigrants in Portugal	PLOS ONE			English	Article							ACUTE MATERNAL MORBIDITY; SECTION RATES; WOMEN; BIRTH; CARE; MORTALITY; OUTCOMES; PRIVATE; MODE; RISK	Objective: To evaluate how the country of origin affects the probability of being delivered by cesarean section when giving birth at public Portuguese hospitals. Study Design: Women delivered of a singleton birth (n = 8228), recruited from five public level III maternities (April 2005-August 2006) during the procedure of assembling a birth cohort, were classified according to the country of origin and her migration status as Portuguese (n = 7908), non-Portuguese European (n = 84), African (n = 77) and Brazilian (n = 159). A Poisson model was used to evaluate the association between country of birth and cesarean section that was measured by adjusted prevalence ratio (PR) and respective 95% confidence intervals (95% CI). Results: The cesarean section rate varied from 32.1% in non-Portuguese European to 48.4% in Brazilian women (p = 0.008). After adjustment for potential confounders and compared to Portuguese women as a reference, Brazilian women presented significantly higher prevalence of cesarean section (PR = 1.26; 95% CI: 1.08-1.47). The effect was more evident among multiparous women (PR = 1.39; 95% CI: 1.12-1.73) and it was observed when cesarean section was performed either before labor (PR = 1.43; 95% CI: 0.99-2.06) or during labor (PR = 1.30; 95% CI: 1.07-1.58). Conclusions: The rate of cesarean section was significantly higher among Brazilian women and it was independent of the presence of any known risk factors or usual clinical indications, suggesting that cultural background influences the mode of delivery overcoming the expected standard of care and outcomes in public health services.	[Teixeira, Cristina; Correia, Sofia; Barros, Henrique] Univ Porto, Dept Clin Epidemiol Predict Med & Publ Hlth, Sch Med, P-4100 Oporto, Portugal; [Teixeira, Cristina; Correia, Sofia; Barros, Henrique] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	Universidade do Porto; Universidade do Porto; Universidade Federal de Pelotas	Teixeira, C (corresponding author), Univ Porto, Dept Clin Epidemiol Predict Med & Publ Hlth, Sch Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cristina.teixeira@ipb.pt	Victora, Cesar G/D-4476-2013; Barros, Henrique/A-5488-2008; Correia, Sofia/AAD-6210-2020; Barros, Henrique/Q-8609-2019; Teixeira, Cristina/O-2296-2013; Victora, Cesar Gomes/Y-2455-2019; Teixeira, Cristina/AAC-9697-2019	Victora, Cesar G/0000-0002-2465-2180; Correia, Sofia/0000-0002-9361-1999; Barros, Henrique/0000-0003-4699-6571; Teixeira, Cristina/0000-0001-5194-5141; Victora, Cesar Gomes/0000-0002-2465-2180; 	Health Ministry of Portugal; Portuguese Foundation for Science and Technology [PIC/IC/83038/2007, SFRH/PROTEC/67591/2010]; Calouste Gulbenkian Foundation	Health Ministry of Portugal; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Calouste Gulbenkian Foundation	This study was supported by a grant from Health Ministry of Portugal (through Programa Operacional de Saude - SAUDE XXI, Quadro Comunitario de Apoio III and Administracao Regional de Saude do Norte), Portuguese Foundation for Science and Technology (institutional PIC/IC/83038/2007 and individual SFRH/PROTEC/67591/2010 grants) and Calouste Gulbenkian Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2000, EV CES DEL; Allin S, 2007, PORTUGAL HLTH SYSTEM, V9; [Anonymous], 2011, WORLD HLTH STAT; Bailit JL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.051; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BARROS FC, 1991, LANCET, V338, P167, DOI 10.1016/0140-6736(91)90149-J; Behague Dominique, 2002, BRIT MED J, V324, P324; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Bollini P, 2009, SOC SCI MED, V68, P452, DOI 10.1016/j.socscimed.2008.10.018; Bryant AS, 2009, PAEDIATR PERINAT EP, V23, P454, DOI 10.1111/j.1365-3016.2009.01059.x; Cammu H, 2011, BIRTH-ISS PERINAT C, V38, P191, DOI 10.1111/j.1523-536X.2011.00476.x; David Matthias, 2006, Archives of Gynecology and Obstetrics, V274, P271, DOI 10.1007/s00404-006-0182-7; Essen B, 2002, BJOG-INT J OBSTET GY, V109, P677, DOI 10.1016/S1470-0328(02)01077-7; *EURO PERISTAT PRO, 2008, EUR PER HLTH REP; Finger C, 2003, LANCET, V362, P628, DOI 10.1016/S0140-6736(03)14204-3; Freitas PF, 2009, INT J GYNECOL OBSTET, V107, P198, DOI 10.1016/j.ijgo.2009.08.017; Gagnon AJ, 2009, SOC SCI MED, V69, P934, DOI 10.1016/j.socscimed.2009.06.027; Gagnon AJ, 2011, PAEDIATR PERINAT EP, V25, P575, DOI 10.1111/j.1365-3016.2011.01230.x; Habiba M, 2006, BJOG-INT J OBSTET GY, V113, P647, DOI 10.1111/j.1471-0528.2006.00933.x; Hansen AK, 2007, ACTA OBSTET GYN SCAN, V86, P389, DOI 10.1080/00016340601159256; Henderson J, 2001, BRIT J OBSTET GYNAEC, V108, P149; Ismail KI, 2011, EUR J OBSTET GYN R B, V158, P214, DOI 10.1016/j.ejogrb.2011.06.009; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Malin M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-84; Malloy MH, 2009, BIRTH-ISS PERINAT C, V36, P26, DOI 10.1111/j.1523-536X.2008.00292.x; McCallum C, 2005, SOCIOL HEALTH ILL, V27, P215, DOI 10.1111/j.1467-9566.2005.00440.x; Merten S, 2007, INT J PUBLIC HEALTH, V52, P210, DOI 10.1007/s00038-007-6035-8; OECD Health Data, 2009, STAT IND 30 COUNTR; Padilla B, 2007, HLTH MIGRATION EU BU; Pallasmaa N, 2008, ACTA OBSTET GYN SCAN, V87, P662, DOI 10.1080/00016340802108763; Potter JE, 2001, BRIT MED J, V323, P1155, DOI 10.1136/bmj.323.7322.1155; Rio I, 2010, EUR J PUBLIC HEALTH, V20, P524, DOI 10.1093/eurpub/ckq067; Rizzo N, 2004, EUR J OBSTET GYN R B, V116, P170, DOI 10.1016/j.ejogrb.2004.02.018; Roberts CL, 2000, BRIT MED J, V321, P137, DOI 10.1136/bmj.321.7254.137; Robertson E, 2005, ACTA OBSTET GYN SCAN, V84, P825, DOI 10.1111/j.0001-6349.2005.00686.x; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Servico de Estrangeiros e Fronteiras, 2009, REL IM FRONT AS; Small R, 2008, BJOG-INT J OBSTET GY, V115, P1630, DOI 10.1111/j.1471-0528.2008.01942.x; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Steinberg S, 1996, SOC SCI MED, V43, P1765, DOI 10.1016/S0277-9536(96)00071-8; van Dillen J, 2010, ACTA OBSTET GYN SCAN, V89, P1460, DOI 10.3109/00016349.2010.519018; Vangen S, 2000, ACTA OBSTET GYN SCAN, V79, P553, DOI 10.1034/j.1600-0412.2000.079007553.x; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Zeitlin J, 2004, BJOG-INT J OBSTET GY, V111, P849, DOI 10.1111/j.1471-0528.2004.00184.x; Zlot AI, 2005, MATERN CHILD HLTH J, V9, P11, DOI 10.1007/s10995-005-2447-3; Zwart JJ, 2011, EUR J PUBLIC HEALTH, V21, P229, DOI 10.1093/eurpub/ckq046	47	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60168	10.1371/journal.pone.0060168	http://dx.doi.org/10.1371/journal.pone.0060168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555912	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500119
J	Tsai, CC; Chiu, CC; Hsu, JD; Hsu, HS; Tzang, BS; Hsu, TC				Tsai, Chun-Chou; Chiu, Chun-Ching; Hsu, Jeng-Dong; Hsu, Huai-Sheng; Tzang, Bor-Show; Hsu, Tsai-Ching			Human Parvovirus B19 NS1 Protein Aggravates Liver Injury in NZB/W F1 Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; NONSTRUCTURAL PROTEIN; ANTIPHOSPHOLIPID ANTIBODIES; AUTOIMMUNE-DISEASES; GENE-EXPRESSION; INFECTION; MATRIX-METALLOPROTEINASE-9; CYCLOOXYGENASE-2; MANIFESTATIONS	Human parvovirus B19 (B19) has been associated with a variety of diseases. However, the influence of B19 viral proteins on hepatic injury in SLE is still obscure. To elucidate the effects of B19 viral proteins on livers in SLE, recombinant B19 NS1, VP1u or VP2 proteins were injected subcutaneously into NZB/W F1 mice, respectively. Significant expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) were detected in NZB/W F1 mice receiving B19 NS1 as compared to those mice receiving PBS. Markedly hepatocyte disarray and lymphocyte infiltration were observed in livers from NZB/WF 1 mice receiving B19 NS1 as compared to those mice receiving PBS. Additionally, significant increases of Tumor Necrosis Factor -alpha (TNF-alpha), TNF-alpha receptor, I kappa B kinase -alpha (IKK-alpha), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (I kappa B) and nuclear factor-kappa B (NF-kappa B) were detected in livers from NZB/W F1 mice receiving B19 NS1 as compared to those mice receiving PBS. Accordingly, significant increases of matrix metalloproteinase-9 (MMP9) and U-plasminogen activator (uPA) were also detected in livers from NZB/W F1 mice receiving B19 NS1 as compared to those mice receiving PBS. Contrarily, no significant variation on livers from NZB/W F1 mice receiving B19 VP1u or VP2 was observed as compared to those mice receiving PBS. These findings firstly demonstrated the aggravated effects of B19 NS1 but not VP1u or VP2 protein on hepatic injury and provide a clue in understanding the role of B19 NS1 on hepatic injury in SLE.	[Tsai, Chun-Chou; Chiu, Chun-Ching; Hsu, Huai-Sheng; Hsu, Tsai-Ching] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Chiu, Chun-Ching] Chunghua Christian Hosp, Dept Neurol, Chunghua, Taiwan; [Chiu, Chun-Ching] Chunghua Christian Hosp, Dept Med Intens Care Unit, Chunghua, Taiwan; [Hsu, Jeng-Dong] Chung Shan Med Univ, Sch Med, Dept Pathol, Taichung, Taiwan; [Hsu, Jeng-Dong] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Tzang, BS (corresponding author), Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan.	bstzang@csmu.edu.tw; htc@csmu.edu.tw		Bor-Show, Tzang/0000-0003-0140-9943	National Science Council, Taiwan, Republic of China [NSC 97-2314-B040-009, NSC 98-2314-B-040-008-MY3, NSC 101-2314-B-040-008]; National Science Council; Ministry of Education; Chung Shan Medical University	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chung Shan Medical University	This study was supported by NSC 97-2314-B040-009, NSC 98-2314-B-040-008-MY3, and NSC 101-2314-B-040-008 from the National Science Council, Taiwan, Republic of China. Upright optical microscope, chemiluminescence imaging analyzer and gel digital imaging analyzer from the Instrument center of Chung Shan Medical University were utilized in this study, which is partly supported by National Science Council, Ministry of Education and Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2004, ANN RHEUM DIS, V63, P123, DOI 10.1136/ard.2002.001826; Ainiala H, 2004, ARTHRITIS RHEUM-US, V50, P858, DOI 10.1002/art.20045; Belmont HM, 1997, ARTHRITIS RHEUM, V40, P1810, DOI 10.1002/art.1780401013; Bock CT, 2005, J VET MED B, V52, P340, DOI 10.1111/j.1439-0450.2005.00867.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET FM, 1965, AUSTRALAS ANN MED, V14, P185; Chen DY, 2010, CLIN CHIM ACTA, V411, P1084, DOI 10.1016/j.cca.2010.04.004; DOERIG C, 1990, J VIROL, V64, P387, DOI 10.1128/JVI.64.1.387-396.1990; Faber-Elmann A, 2002, CLIN EXP IMMUNOL, V127, P393, DOI 10.1046/j.1365-2249.2002.01758.x; Fung HB, 1999, CLIN THER, V21, P1131, DOI 10.1016/S0149-2918(00)80018-1; Goetzl EJ, 1995, J IMMUNOL, V156, P1; Hahn BH, 1993, DUBOIS LUPUS ERYTHEM, P69; Hatakka A, 2011, J CLIN MICROBIOL, V49, P3422, DOI 10.1128/JCM.00575-11; KAJIGAYA S, 1991, P NATL ACAD SCI USA, V88, P4646, DOI 10.1073/pnas.88.11.4646; Kerr JR, 2001, J GEN VIROL, V82, P3011, DOI 10.1099/0022-1317-82-12-3011; Lehmann HW, 2003, AUTOIMMUN REV, V2, P218, DOI 10.1016/S1568-9972(03)00014-4; Li W, 2010, BIOL REPROD, V83, P481, DOI 10.1095/biolreprod.109.082578; Mackay IK, 1959, LANCET, V5, P65; Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996; Prince HE, 2005, BIOMARKERS, V10, pS44, DOI 10.1080/13547500500214194; Pugliese A, 2007, CELL BIOCHEM FUNCT, V25, P639, DOI 10.1002/cbf.1364; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Runyon, 1980, AM J MED, V69, P187; SATO H, 1993, J BIOL CHEM, V268, P23460; Servant-Delmas A, 2010, J VIROL, V84, P9658, DOI 10.1128/JVI.00684-10; Seve P, 2005, SEMIN ARTHRITIS RHEU, V34, P642, DOI 10.1016/j.semarthrit.2004.07.008; Shiraishi A, 2012, PEDIATR INFECT DIS J, V31, P103, DOI 10.1097/INF.0b013e31823662ee; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; Sun L, 2012, HEPATOLOGY, V55, P329, DOI 10.1002/hep.24720; Sun L, 2011, SCAND J INFECT DIS, V43, P547, DOI 10.3109/00365548.2011.554856; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tzang BS, 2007, CLIN CHIM ACTA, V378, P59, DOI 10.1016/j.cca.2006.10.016; Tzang BS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-40; Tzang BS, 2009, CLIN CHIM ACTA, V405, P76, DOI 10.1016/j.cca.2009.04.002; von Landenberg P, 2003, ARTHRITIS RHEUM-US, V48, P1939, DOI 10.1002/art.11038; Wang GD, 2010, ARTHRITIS RHEUM-US, V62, P2064, DOI 10.1002/art.27442; Wang HP, 2009, EUR J PHARMACOL, V607, P102, DOI 10.1016/j.ejphar.2009.02.039; Weinberg JB, 2000, IMMUNOL RES, V22, P319, DOI 10.1385/IR:22:2-3:319; Xu LT, 2004, NAT MED, V10, P411, DOI 10.1038/nm1005; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zhang L, 2007, ARTHRITIS RHEUM-US, V56, P4132, DOI 10.1002/art.23054	41	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59724	10.1371/journal.pone.0059724	http://dx.doi.org/10.1371/journal.pone.0059724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555760	Green Submitted, gold, Green Published			2022-12-27	WOS:000316546400056
J	Wakefield, CB; Lewis, PD; Coutts, TB; Fairclough, DV; Langlois, TJ				Wakefield, Corey B.; Lewis, Paul D.; Coutts, Teresa B.; Fairclough, David V.; Langlois, Timothy J.			Fish Assemblages Associated with Natural and Anthropogenically-Modified Habitats in a Marine Embayment: Comparison of Baited Videos and Opera-House Traps	PLOS ONE			English	Article							SNAPPER PAGRUS-AURATUS; WESTERN-AUSTRALIA; COCKBURN SOUND; CHRYSOPHRYS-UNICOLOR; GENETIC SUBDIVISION; URBAN STRUCTURES; AGE COMPOSITION; SEAGRASS; ABUNDANCE; POPULATION	Marine embayments and estuaries play an important role in the ecology and life history of many fish species. Cockburn Sound is one of a relative paucity of marine embayments on the west coast of Australia. Its sheltered waters and close proximity to a capital city have resulted in anthropogenic intrusion and extensive seascape modification. This study aimed to compare the sampling efficiencies of baited videos and fish traps in determining the relative abundance and diversity of temperate demersal fish species associated with naturally occurring (seagrass, limestone outcrops and soft sediment) and modified (rockwall and dredge channel) habitats in Cockburn Sound. Baited videos sampled a greater range of species in higher total and mean abundances than fish traps. This larger amount of data collected by baited videos allowed for greater discrimination of fish assemblages between habitats. The markedly higher diversity and abundances of fish associated with seagrass and limestone outcrops, and the fact that these habitats are very limited within Cockburn Sound, suggests they play an important role in the fish ecology of this embayment. Fish assemblages associated with modified habitats comprised a subset of species in lower abundances when compared to natural habitats with similar physical characteristics. This suggests modified habitats may not have provided the necessary resource requirements (e. g. shelter and/or diet) for some species, resulting in alterations to the natural trophic structure and interspecific interactions. Baited videos provided a more efficient and non-extractive method for comparing fish assemblages and habitat associations of smaller bodied species and juveniles in a turbid environment.	[Wakefield, Corey B.; Lewis, Paul D.; Coutts, Teresa B.; Fairclough, David V.; Langlois, Timothy J.] Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, Perth, WA, Australia; [Langlois, Timothy J.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia	Western Australian Fisheries & Marine Research Laboratories; University of Western Australia	Wakefield, CB (corresponding author), Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, Perth, WA, Australia.	corey.wakefield@fish.wa.gov.au	Fairclough, David V/F-2596-2013; Langlois, Tim/H-5241-2014	Fairclough, David V/0000-0002-9620-5064; 	Fremantle Ports; Oceanica consulting; Department of Fisheries, Government of Western Australia	Fremantle Ports; Oceanica consulting; Department of Fisheries, Government of Western Australia	This research received funding from Fremantle Ports, Oceanica consulting and the Department of Fisheries, Government of Western Australia to assist with the environmental impact assessment for the Kwinana Quays port development in Cockburn Sound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; AYVAZIAN SG, 1994, MAR BIOL, V118, P25, DOI 10.1007/BF00699216; Breheny N. B., 2012, Journal of the Royal Society of Western Australia, V95, P103; CAMBRIDGE ML, 1984, AQUAT BOT, V20, P229, DOI 10.1016/0304-3770(84)90089-5; CAMBRIDGE ML, 1986, AQUAT BOT, V24, P269, DOI 10.1016/0304-3770(86)90062-8; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2006, AUSTR SOC FISH BIOL, VVol. 1, P101, DOI DOI 10.1007/978-1-62703-724-2_1; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; de Lestang S, 2003, J CRUSTACEAN BIOL, V23, P908, DOI 10.1651/C-2376; Dybdahl RE, 1979, 4 DEP CONS ENV; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Glasby TM, 1999, AMBIO, V28, P595; Gorley C.K., 2006, GETTING STARTED PRIM; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Hayes L, 1994, UTILITY SMALL BAITED; Haywood MDE, 2012, USE BRUVS TOOL ASSES; HIGH WL, 1973, HELGOLAND WISS MEER, V24, P341, DOI 10.1007/BF01609524; Hyndes GA, 1998, FISH B-NOAA, V96, P258; JOHNSON MS, 1986, AUST J MAR FRESH RES, V37, P337; Johnston D J., 2008, DEVELOPING LONG TERM; Kendrick GA, 2002, AQUAT BOT, V73, P75, DOI 10.1016/S0304-3770(02)00005-0; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; LENANTON RC, 1974, AUST J MAR FRESH RES, V25, P281; Morrison M, 2006, FISH RES, V82, P150, DOI 10.1016/j.fishres.2006.06.024; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Penn JW, 1977, 20 DEP FISH WILDL W; POTTER IC, 1990, ENVIRON BIOL FISH, V28, P143, DOI 10.1007/BF00751033; Sadovy Y, 2003, FISH FISH, V4, P86, DOI 10.1046/j.1467-2979.2003.00104.x; SILBERSTEIN K, 1986, AQUAT BOT, V24, P355, DOI 10.1016/0304-3770(86)90102-6; Sumpton W, 1996, 93074 QDPI FRDC; Thrush SF, 2002, MAR ECOL PROG SER, V245, P273, DOI 10.3354/meps245273; Travers MJ, 2006, J FISH BIOL, V69, P987, DOI 10.1111/j.1095-8649.2006.01179.x; Vanderklift MA, 2003, MAR ECOL PROG SER, V247, P225, DOI 10.3354/meps247225; Vanderklift MA, 1996, THESIS EDITH COWAN U; Wakefield CB, 2010, J FISH BIOL, V77, P1359, DOI 10.1111/j.1095-8649.2010.02756.x; Wakefield C.B., 2006, THESIS MURDOCH U W A; Wakefield CB, 2007, FISH RES, V85, P37, DOI 10.1016/j.fishres.2006.11.037; Wakefield CB, 2011, FISH RES, V109, P243, DOI 10.1016/j.fishres.2011.02.008; Walker DI, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P551; Watts RJ, 2004, MAR FRESHWATER RES, V55, P641, DOI 10.1071/MF04051; Wood WF, 1986, DEP CONSERVATION ENV, V11; [No title captured]	49	28	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59959	10.1371/journal.pone.0059959	http://dx.doi.org/10.1371/journal.pone.0059959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555847	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400071
J	Li, Y; Zhu, CL; Nie, CJ; Li, JC; Zeng, TT; Zhou, J; Chen, JN; Chen, K; Fu, L; Liu, HB; Qin, YR; Guan, XY				Li, Yan; Zhu, Cai-Lei; Nie, Chang-Jun; Li, Jiang-Chao; Zeng, Ting-Ting; Zhou, Jie; Chen, Jinna; Chen, Kai; Fu, Li; Liu, Haibo; Qin, Yanru; Guan, Xin-Yuan			Investigation of Tumor Suppressing Function of CACNA2D3 in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROMOTER HYPERMETHYLATION; MOLECULAR-CLONING; GENE-EXPRESSION; POOR-PROGNOSIS; CHROMOSOME 3P; CANCER; PROLIFERATION; SUBUNIT; HETEROZYGOSITY	Background: Deletion of 3p is one of the most frequent genetic alterations in esophageal squamous cell carcinoma (ESCC), suggesting the existence of one or more tumor suppressor genes (TSGs) within these regions. In this study, one TSG, CACNA2D3 at 3p21.1, was characterized. Methods: Expression of CACNA2D3 in ESCCs was tested by quantitative real-time PCR and tissue microarray. The mechanism of CACNA2D3 downregulation was investigated by methylation-specific polymerase chain reaction (MS-PCR). The tumor suppressive function of CACNA2D3 was characterized by both in vitro and in vivo tumorigenic assays, cell migration and invasion assays. Results: CACNA2D3 was frequently downregulated in ESCCs (24/48, 50%), which was significantly associated with promoter methylation and allele loss (P<0.05). Tissue microarray result showed that downregulation of CACNA2D3 was detected in (127/224, 56.7%) ESCCs, which was significantly associated with lymph node metastasis (P = 0.01), TNM staging (P = 0.003) and poor outcome of ESCC patients (P<0.05). Functional studies demonstrated that CACNA2D3 could inhibit tumorigenicity, cell motility and induce apoptosis. Mechanism study found that CACNA2D3 could arrest cell cycle at G1/S checkpoint by increasing expressions of p21 and p53 and decreasing expression of CDK2. In addition, CACNA2D3 could upregulate intracellular free cytosolic Ca2+ and subsequently induce apoptosis. Conclusion: CACNA2D3 is a novel TSG responsible to the 3p21 deletion event and plays a critical suppressing role in the development and progression of ESCC.	[Li, Yan; Nie, Chang-Jun; Li, Jiang-Chao; Zeng, Ting-Ting; Zhou, Jie; Chen, Kai; Liu, Haibo; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Cai-Lei; Chen, Jinna; Fu, Li; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Qin, Yanru] Zhengzhou Univ, Dept Clin Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Li, Jiang-Chao] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; University of Hong Kong; Zhengzhou University; Guangdong Pharmaceutical University	Li, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	liy6@mail.sysu.edu.cn; xyguan@hkucc.hku.hk	Fu, Li/F-7182-2010; Chen, Jinna/AAY-9073-2020; Chen, Jinna/GXM-9165-2022; Li, Jiangchao/AAF-4515-2021; /A-3639-2009	Fu, Li/0000-0003-2643-6278; Chen, Jinna/0000-0002-6244-8009; Li, Jiangchao/0000-0002-0947-7580; /0000-0003-1874-9805	National Natural Science Foundation of China [81172338, 30971606]; Sun Yat-Sen University "Hundred Talents Program'' [85000-3171311]; Hong Kong Research Grant Council Central Allocation [HKUST 2/06C]; Sun Yat-sen University Young Talent Teachers Plan [11ykpy58]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University "Hundred Talents Program''; Hong Kong Research Grant Council Central Allocation; Sun Yat-sen University Young Talent Teachers Plan	This work was supported by grants from the National Natural Science Foundation of China (81172338, 30971606), Sun Yat-Sen University "Hundred Talents Program'' (85000-3171311), Hong Kong Research Grant Council Central Allocation (HKUST 2/06C), Sun Yat-sen University Young Talent Teachers Plan (11ykpy58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimov A, 2000, ONCOGENE, V19, P1392, DOI 10.1038/sj.onc.1203449; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Carboni GL, 2003, ONCOGENE, V22, P615, DOI 10.1038/sj.onc.1206134; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Daigo Y, 1999, CANCER RES, V59, P1966; Fang Y, 2001, GENE CHROMOSOME CANC, V30, P254, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1086>3.0.CO;2-D; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Gao BN, 2000, J BIOL CHEM, V275, P12237, DOI 10.1074/jbc.275.16.12237; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Guan XY, 2001, CANCER RES, V61, P3806; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Imamichi Y, 2007, CELLS TISSUES ORGANS, V185, P180, DOI 10.1159/000101319; Ko KS, 2001, J CELL SCI, V114, P1155; Kuroki T, 2003, CANCER RES, V63, P3724; Kwong D, 2004, HUM PATHOL, V35, P309, DOI 10.1016/j.humpath.2003.10.020; Li Y, 2011, CANCER RES, V71, P6106, DOI 10.1158/0008-5472.CAN-10-4291; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tai ALS, 2006, CANCER RES, V66, P4133, DOI 10.1158/0008-5472.CAN-05-2775; Vasavi M, 2006, TUMORI J, V92, P155, DOI 10.1177/030089160609200212; Wanajo A, 2008, GASTROENTEROLOGY, V135, P580, DOI 10.1053/j.gastro.2008.05.041; Wei Wen-qiang, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P398; Wong ML, 2006, INT J ONCOL, V28, P767; Zhu C, 2009, ONCOGENE, V28, P2821, DOI 10.1038/onc.2009.137	34	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60027	10.1371/journal.pone.0060027	http://dx.doi.org/10.1371/journal.pone.0060027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560067	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100043
J	Wright, AL; Zinn, R; Hohensinn, B; Konen, LM; Beynon, SB; Tan, RP; Clark, IA; Abdipranoto, A; Vissel, B				Wright, Amanda L.; Zinn, Raphael; Hohensinn, Barbara; Konen, Lyndsey M.; Beynon, Sarah B.; Tan, Richard P.; Clark, Ian A.; Abdipranoto, Andrea; Vissel, Bryce			Neuroinflammation and Neuronal Loss Precede Ab Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; TRANSGENIC MICE; COGNITIVE DEFICITS; NEPRILYSIN OVEREXPRESSION; ACTIVATED MICROGLIA; INTERFERON-GAMMA; DENTATE GYRUS; BETA PROTEIN; IN-VIVO	Recent human trials of treatments for Alzheimer's disease (AD) have been largely unsuccessful, raising the idea that treatment may need to be started earlier in the disease, well before cognitive symptoms appear. An early marker of AD pathology is therefore needed and it is debated as to whether amyloid-beta (A beta) plaque load may serve this purpose. We investigated this in the hAPP-J20 AD mouse model by studying disease pathology at 6, 12, 24 and 36 weeks. Using robust stereological methods, we found there is no neuron loss in the hippocampal CA3 region at any age. However loss of neurons from the hippocampal CA1 region begins as early as 12 weeks of age. The extent of neuron loss increases with age, correlating with the number of activated microglia. Gliosis was also present, but plateaued during aging. Increased hyperactivity and spatial memory deficits occurred at 16 and 24 weeks. Meanwhile, the appearance of plaques and oligomeric A beta were essentially the last pathological changes, with significant changes only observed at 36 weeks of age. This is surprising given that the hAPP-J20 AD mouse model is engineered to over-expresses A beta. Our data raises the possibility that plaque load may not be the best marker for early AD and suggests that activated microglia could be a valuable marker to track disease progression.	[Wright, Amanda L.; Zinn, Raphael; Hohensinn, Barbara; Konen, Lyndsey M.; Beynon, Sarah B.; Tan, Richard P.; Abdipranoto, Andrea; Vissel, Bryce] Garvan Inst Med Res, Dept Neurosci, Sydney, NSW, Australia; [Wright, Amanda L.; Zinn, Raphael; Hohensinn, Barbara; Vissel, Bryce] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Clark, Ian A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Australian National University	Vissel, B (corresponding author), Garvan Inst Med Res, Dept Neurosci, Sydney, NSW, Australia.	b.vissel@garvan.org.au		Zinn, Raphael/0000-0003-4278-5881; Vissel, Bryce/0000-0001-8860-8050; Wright, Amanda/0000-0001-7141-6212	Iain S. Gray Foundation; Stanley and John Roth; Patricia A. Quick foundation; David King; Doug Battersby; Tony and Vivian Howland-Rose; Walter and Edith Sheldon; Gleneagle Securities; Bill Gruy; Geoffrey Towner; Amadeus Energy Ltd.; Nick and Melanie Kell; J.O. and J. R. Wicking Trust; Mason Foundation; New South Wales Government through office for Science and Medical Research; SpinalCure Australia	Iain S. Gray Foundation; Stanley and John Roth; Patricia A. Quick foundation; David King; Doug Battersby; Tony and Vivian Howland-Rose; Walter and Edith Sheldon; Gleneagle Securities; Bill Gruy; Geoffrey Towner; Amadeus Energy Ltd.; Nick and Melanie Kell; J.O. and J. R. Wicking Trust; Mason Foundation; New South Wales Government through office for Science and Medical Research; SpinalCure Australia	Funding provided by Iain S. Gray Foundation, Stanley and John Roth, Patricia A. Quick foundation, David King, Doug Battersby, Tony and Vivian Howland-Rose, Walter and Edith Sheldon, Gleneagle Securities, Bill Gruy, Geoffrey Towner, Amadeus Energy Ltd., Nick and Melanie Kell, J.O. and J. R. Wicking Trust and the Mason Foundation, the New South Wales Government, through their office for Science and Medical Research, and SpinalCure Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto A, 2008, CNS NEUROL DISORD-DR, V7, P187, DOI 10.2174/187152708784083858; Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; AlzheimerResearchForum, 2012, NEWS FOC HUM AM IM S; AlzheimerResearchForum, 2013, HAI SPOTL TAU TRAC H; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Ballard C, 1999, Curr Psychiatry Rep, V1, P49, DOI 10.1007/s11920-999-0010-4; Bartley MG, 2012, J ALZHEIMERS DIS, V28, P855, DOI 10.3233/JAD-2011-111172; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bobinski M, 1997, J NEUROPATH EXP NEUR, V56, P414, DOI 10.1097/00005072-199704000-00010; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850; Clark IA, 2011, J ALZHEIMERS DIS, V26, P201, DOI 10.3233/JAD-2011-110266; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Combs CK, 2001, J NEUROSCI, V21, P1179; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Coultrap SJ, 2005, MOL BRAIN RES, V135, P104, DOI 10.1016/j.molbrainres.2004.12.005; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Ferretti MT, 2012, NEUROBIOL AGING, V33, P1329, DOI 10.1016/j.neurobiolaging.2011.01.007; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Galvan V, 2008, BEHAV BRAIN RES, V191, P246, DOI 10.1016/j.bbr.2008.03.035; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Hayes A, 2002, NEUROSCI LETT, V331, P171, DOI 10.1016/S0304-3940(02)00888-1; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Holtzman DM, 2011, SCI TRANSL MED, V3; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Jawhar S., 2012, NEUROBIOL AGING, V33, pe129, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.027, DOI 10.1016/j.neurobiolaging.2010.05.027]; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Karl T, 2012, BEHAV BRAIN RES, V228, P392, DOI 10.1016/j.bbr.2011.12.021; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lobello K, 2012, INT J ALZHEIMERS DIS, V2012; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Meda L, 1994, LETT NATURE, V374, P347; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mulholland PJ, 2003, NEUROSCI RES, V46, P369, DOI 10.1016/S0168-0102(03)00102-0; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Poirier R, 2006, NEUROBIOL DIS, V24, P475, DOI 10.1016/j.nbd.2006.08.003; Quigley H, 2011, INT J GERIATR PSYCH, V26, P991, DOI 10.1002/gps.2640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schmidt JC, 2008, QUELLEN STUD PHILOS, V81, P1; Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047; Shankar G, 2009, NEUROBIOLOL DIS; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Solito E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00014; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Stepanichev MY, 2004, PHYSIOL BEHAV, V80, P647, DOI 10.1016/j.physbeh.2003.11.003; Venneti S, 2009, NEUROBIOL AGING, V30, P1217, DOI 10.1016/j.neurobiolaging.2007.11.005; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; West MJ, 2000, ANN NY ACAD SCI, V908, P255; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Wiltgen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012818; Wirths O, 2010, INT J ALZHEIMERS DIS, V2010; Wirths O, 2010, NEUROBIOL AGING, V31, P747, DOI 10.1016/j.neurobiolaging.2008.06.011; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T., 2012, COLD SPRING HARBOR P, V2; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yokokura M, 2011, EUR J NUCL MED MOL I, V38, P343, DOI 10.1007/s00259-010-1612-0; Zelikowsky M, 2012, J NEUROSCI, V32, P3393, DOI 10.1523/JNEUROSCI.4339-11.2012; Zhang W, 2012, FREE RADIC IN PRESS; Zhang W, 2012, NEUROBIOLOG IN PRESS	90	197	198	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59586	10.1371/journal.pone.0059586	http://dx.doi.org/10.1371/journal.pone.0059586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560052	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900020
J	Zakharova, YR; Galachyants, YP; Kurilkina, MI; Likhoshvay, AV; Petrova, DP; Shishlyannikov, SM; Ravin, NV; Mardanov, AV; Beletsky, AV; Likhoshway, YV				Zakharova, Yulia R.; Galachyants, Yuri P.; Kurilkina, Maria I.; Likhoshvay, Alexander V.; Petrova, Darya P.; Shishlyannikov, Sergey M.; Ravin, Nikolai V.; Mardanov, Andrey V.; Beletsky, Alexey V.; Likhoshway, Yelena V.			The Structure of Microbial Community and Degradation of Diatoms in the Deep Near-Bottom Layer of Lake Baikal	PLOS ONE			English	Article							EXTRACELLULAR PRODUCTS; CLIMATE-CHANGE; SEDIMENTS; PHYTOPLANKTON; RESOLUTION; RECORD; DISSOLUTION; BACTERIA; SILICA; FRESH	Insight into the role of bacteria in degradation of diatoms is important for understanding the factors and components of silica turnover in aquatic ecosystems. Using microscopic methods, it has been shown that the degree of diatom preservation and the numbers of diatom-associated bacteria in the surface layer of bottom sediments decrease with depth; in the near-bottom water layer, the majority of bacteria are associated with diatom cells, being located either on the cell surface or within the cell. The structure of microbial community in the near-bottom water layer has been characterized by pyrosequencing of the 16S rRNA gene, which has revealed 149 208 unique sequences. According to the results of metagenomic analysis, the community is dominated by representatives of Proteobacteria (41.9%), Actinobacteria (16%); then follow Acidobacteria (6.9%), Cyanobacteria (5%), Bacteroidetes (4.7%), Firmicutes (2.8%), Nitrospira (1.6%), and Verrucomicrobia (1%); other phylotypes account for less than 1% each. For 18.7% of the sequences, taxonomic identification has been possible only to the Bacteria domain level. Many bacteria identified to the genus level have close relatives occurring in other aquatic ecosystems and soils. The metagenome of the bacterial community from the near-bottom water layer also contains 16S rRNA gene sequences found in previously isolated bacterial strains possessing hydrolytic enzyme activity. These data show that potential degraders of diatoms occur among the vast variety of microorganisms in the near-bottom water of Lake Baikal.	[Zakharova, Yulia R.; Galachyants, Yuri P.; Kurilkina, Maria I.; Likhoshvay, Alexander V.; Petrova, Darya P.; Shishlyannikov, Sergey M.; Likhoshway, Yelena V.] Russian Acad Sci, Siberian Branch, Limnol Inst, Irkutsk 664003, Russia; [Ravin, Nikolai V.; Mardanov, Andrey V.; Beletsky, Alexey V.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Research Center of Biotechnology RAS; Russian Academy of Sciences	Zakharova, YR (corresponding author), Russian Acad Sci, Siberian Branch, Limnol Inst, Irkutsk 664003, Russia.	zakharova@lin.irk.ru; yel@lin.irk.ru	Petrova, Darya/J-7615-2016; Galachyants, Yuri P/J-4633-2018; Likhoshway, Yelena V./J-4496-2018; Mardanov, Andrey/S-2294-2016; Ravin, Nikolai V/C-5907-2014; Shishlyannikov, Sergey/N-9431-2018; Beletsky, Alexey/AAA-5366-2019	Galachyants, Yuri P/0000-0002-4764-6330; Likhoshway, Yelena V./0000-0002-2432-9260; Mardanov, Andrey/0000-0002-8245-8757; Shishlyannikov, Sergey/0000-0002-6377-7445; Beletsky, Alexey/0000-0002-7611-2354; Likhoshway, Yelena/0000-0001-5745-6891; Petrova, Darya/0000-0003-3121-467X; Solodkoff, Alexander/0000-0002-2521-9303; Ravin, Nikolai/0000-0002-1456-1832	Russian Foundation for Basic Research [09-04-12231ofi-m]; Integration Project of the Siberian Branch of the Russian Academy of Sciences [137]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Integration Project of the Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	This study was supported by the Russian Foundation for Basic Research (project no. 09-04-12231ofi-m) and by the Integration Project of the Siberian Branch of the Russian Academy of Sciences, no. 137 "Development of new approaches to process data generated by Next-generation sequencing machines.'' The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva SA, 2005, APPL BIOCHEM MICRO+, V41, P185, DOI 10.1007/s10438-005-0033-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahulikar RA, 2007, EUR J PHYCOL, V42, P199, DOI 10.1080/09670260701289779; Battarbee RW, 2005, GLOBAL PLANET CHANGE, V46, P75, DOI 10.1016/j.gloplacha.2004.11.007; BEZRUKOVA E V, 1991, Doklady Akademii Nauk SSSR, V321, P1032; BHOSLE NB, 1995, BOT MAR, V38, P103, DOI 10.1515/botm.1995.38.1-6.103; BIDDANDA BA, 1988, MAR ECOL PROG SER, V42, P79, DOI 10.3354/meps042079; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2003, LIMNOL OCEANOGR, V48, P1855, DOI 10.4319/lo.2003.48.5.1855; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; Bradbury J. Platt, 1994, Journal of Paleolimnology, V10, P213, DOI 10.1007/BF00684034; BROUWER JFC, 2002, J PHYCOL, V38, P464; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edlund MB, 2000, LIMNOL OCEANOGR, V45, P948, DOI 10.4319/lo.2000.45.4.0948; Fandino LB, 2001, AQUAT MICROB ECOL, V23, P119, DOI 10.3354/ame023119; FLOWER RJ, 1993, HYDROBIOLOGIA, V269, P473, DOI 10.1007/BF00028045; FOGG GE, 1983, BOT MAR, V26, P3, DOI 10.1515/botm.1983.26.1.3; Garrity GM, 2004, BERGEYS MANUAL SYS B, V2; Gerbersdorf SU, 2009, J SOIL SEDIMENT, V9, P640, DOI 10.1007/s11368-009-0142-5; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Glantz SA, 1998, PRIMER BIOSTATISTICS; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Grachev MA, 1998, QUATERNARY SCI REV, V17, P1101, DOI 10.1016/S0277-3791(98)00048-1; Grachev MA, 1996, DOKL ROSS AKAD NAUK, V350, P1066; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Gumerov VM, 2011, MICROBIOLOGY+, V80, P244, DOI 10.1134/S002626171102007X; Holt J., 1994, BERGEYS MANUAL DETER; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Kadnikov VV, 2012, FEMS MICROBIOL ECOL, V79, P348, DOI 10.1111/j.1574-6941.2011.01221.x; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Karabanov EB, 2000, PALAEOGEOGR PALAEOCL, V156, P211, DOI 10.1016/S0031-0182(99)00141-8; Khursevich GK, 2001, GEOL GEOFIZ+, V42, P108; Kim BS, 2008, J MICROBIOL, V46, P357, DOI 10.1007/s12275-008-0071-9; Kusaikin MI, 2010, CHEM NAT COMPD+, V46, P1, DOI 10.1007/s10600-010-9510-z; Likhoshway EV, 2005, GEOL GEOFIZ, V46, P34; Likhoshway YV, 1996, J GREAT LAKES RES, V22, P5, DOI 10.1016/S0380-1330(96)70929-2; Mackay AW, 2007, EARTH-SCI REV, V82, P181, DOI 10.1016/j.earscirev.2007.03.002; Mackay AW, 2006, GLOBAL CHANGE BIOL, V12, P2297, DOI 10.1111/j.1365-2486.2006.01270.x; Mackay AW, 2000, TERRA NOSTRA, V9, P34; MAGUE TH, 1980, LIMNOL OCEANOGR, V25, P262, DOI 10.4319/lo.1980.25.2.0262; Maksimenko SYu, 2006, P 19 INT DIAT S, P96; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; Murray R. G. E., 1994, P21; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; PATRICK S, 1985, J APPL BACTERIOL, V59, P7, DOI 10.1111/j.1365-2672.1985.tb01768.x; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rioual P, 2005, GLOBAL PLANET CHANGE, V46, P199, DOI 10.1016/j.gloplacha.2004.08.002; Ryves DB, 2003, GLOBAL PLANET CHANGE, V46, P281; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmid M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033223; Shimaraev M.N., 1995, GEOL GEOFIZ, V36, p[97, 94]; SMITH DC, 1995, DEEP-SEA RES PT II, V42, P75, DOI 10.1016/0967-0645(95)00005-B; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Smith DJ, 1998, LIMNOL OCEANOGR, V43, P1578, DOI 10.4319/lo.1998.43.7.1578; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STOERMER EF, 1995, J PALEOLIMNOL, V14, P69, DOI 10.1007/BF00682594; Stover BC, 2010, BMC BIOINFORMATICS, P11; Taylor IS, 1998, ESTUAR COAST SHELF S, V46, P359, DOI 10.1006/ecss.1997.0288; Vereshchagin AL, 2008, BIOTEKHNOL RUSS, V4, P77; Volcani B. E., 1981, SILICON SILICEOUS ST; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISS RF, 1991, NATURE, V349, P665, DOI 10.1038/349665a0; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wustman BA, 1997, PLANT PHYSIOL, V113, P1059, DOI 10.1104/pp.113.4.1059; Zakharova YR, 2013, PALEONTOL J IN PRESS, V47	75	26	28	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59977	10.1371/journal.pone.0059977	http://dx.doi.org/10.1371/journal.pone.0059977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560063	Green Submitted, gold, Green Published			2022-12-27	WOS:000316930900038
J	Rendina, E; Hembree, KD; Davis, MR; Marlow, D; Clarke, SL; Halloran, BP; Lucas, EA; Smith, BJ				Rendina, Elizabeth; Hembree, Kelsey D.; Davis, McKale R.; Marlow, Denver; Clarke, Stephen L.; Halloran, Bernard P.; Lucas, Edralin A.; Smith, Brenda J.			Dried Plum's Unique Capacity to Reverse Bone Loss and Alter Bone Metabolism in Postmenopausal Osteoporosis Model	PLOS ONE			English	Article							PROSTATE-CANCER; CARDIOVASCULAR-DISEASE; GREEN TEA; RAT MODEL; PATHWAY; SUPPLEMENTATION; POLYPHENOLS; MORTALITY; CELLS; BISPHOSPHONATES	Interest in dried plum has increased over the past decade due to its promise in restoring bone and preventing bone loss in animal models of osteoporosis. This study compared the effects of dried plum on bone to other dried fruits and further explored the potential mechanisms of action through which dried plum may exert its osteoprotective effects. Adult osteopenic ovariectomized (OVX) C57BL/6 mice were fed either a control diet or a diet supplemented with 25% (w/w) dried plum, apple, apricot, grape or mango for 8 weeks. Whole body and spine bone mineral density improved in mice consuming the dried plum, apricot and grape diets compared to the OVX control mice, but dried plum was the only fruit to have an anabolic effect on trabecular bone in the vertebra and prevent bone loss in the tibia. Restoration of biomechanical properties occurred in conjunction with the changes in trabecular bone in the spine. Compared to other dried fruits in this study, dried plum was unique in its ability to down-regulate osteoclast differentiation coincident with up-regulating osteoblast and glutathione (GPx) activity. These alterations in bone metabolism and antioxidant status compared to other dried fruits provide insight into dried plum's unique effects on bone.	[Rendina, Elizabeth; Hembree, Kelsey D.; Davis, McKale R.; Clarke, Stephen L.; Lucas, Edralin A.; Smith, Brenda J.] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA; [Marlow, Denver] Kansas State Univ, Comparat Med Grp, Manhattan, KS 66506 USA; [Halloran, Bernard P.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Kansas State University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smith, BJ (corresponding author), Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA.	bjsmith@okstate.edu		, Stephen/0000-0001-8313-9638; Montgomery, McKale/0000-0001-5318-6687	National Institutes of Health/National Center for Complementary and Alternative Medicine (NIH/NCCAM) [1R21AT006580]; Oklahoma State University Business and Technology Development Program; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R21AT006580] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Complementary and Alternative Medicine (NIH/NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Oklahoma State University Business and Technology Development Program; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This project was funded in part by National Institutes of Health/National Center for Complementary and Alternative Medicine (NIH/NCCAM) (1R21AT006580) and the Oklahoma State University Business and Technology Development Program. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujazia MA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/525079; Adrian M, 2008, J HYPERTENS, V26, P44, DOI 10.1097/HJH.0b013e3282f09f68; Arjmandi BH., 2001, JANA, V4, P50; Badescu L, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/848269; BARBAGALLO M, 1989, BONE, V10, P113, DOI 10.1016/8756-3282(89)90008-2; Basu A, 2007, NUTR REV, V65, P361, DOI 10.1111/j.1753-4887.2007.tb00314.x; Bu SY, 2007, OSTEOPOROSIS INT, V18, P931, DOI 10.1007/s00198-007-0335-y; Bu SY, 2008, CALCIFIED TISSUE INT; Bu SY, 2008, J NUTR BIOCH; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y; Clerici C, 2007, J NUTR, V137, P2270, DOI 10.1093/jn/137.10.2270; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Cosman F, 2008, CURR OPIN ENDOCRINOL, V15, P495, DOI 10.1097/MED.0b013e32831a46d6; Deal Chad, 2004, Curr Rheumatol Rep, V6, P49; Devareddy L, 2008, J NUTR BIOCHEM, V19, P694, DOI 10.1016/j.jnutbio.2007.09.004; Deyhim F, 2005, MENOPAUSE, V12, P755, DOI 10.1097/01.gme.0000185486.55758.5b; Dikeman CL, 2004, J AGR FOOD CHEM, V52, P853, DOI 10.1021/jf034858u; Droke Elizabeth A, 2007, J Inflamm (Lond), V4, P17, DOI 10.1186/1476-9255-4-17; Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327; Farage MA, 2009, OBSTET GYNECOL SURV, V64, P58, DOI 10.1097/OGX.0b013e3181932a37; Franklin M, 2006, BONE, V39, P1331, DOI 10.1016/j.bone.2006.05.024; Gallagher AC, 1996, AM J PHYSIOL-ENDOC M, V270, pE407, DOI 10.1152/ajpendo.1996.270.3.E407; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Hooshmand S, 2011, BRIT J NUTR, V106, P923, DOI 10.1017/S000711451100119X; Hsu YL, 2009, MOL NUTR FOOD RES, V53, P1452, DOI 10.1002/mnfr.200800483; Hwang ES, 2005, BIOFACTORS, V23, P97, DOI 10.1002/biof.5520230205; KEYAK JH, 1990, J BIOMED ENG, V12, P389, DOI 10.1016/0141-5425(90)90022-F; Kim WK, 2011, J CELL BIOCHEM, V112, P3159, DOI 10.1002/jcb.23242; Kono R, 2011, BIOSCI BIOTECH BIOCH, V75, P1907, DOI 10.1271/bbb.110264; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lee BS, 1996, AM J PHYSIOL-CELL PH, V270, pC382, DOI 10.1152/ajpcell.1996.270.1.C382; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; NOF, 2002, AM BON HLTH STAT OST; O. of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495; Piga A, 2003, J AGR FOOD CHEM, V51, P3675, DOI 10.1021/jf021207+; Purcell PM, 2005, MED J AUSTRALIA, V182, P417, DOI 10.5694/j.1326-5377.2005.tb06762.x; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Rendina E, 2012, J NUTR BIOCHEM, V23, P60, DOI 10.1016/j.jnutbio.2010.10.010; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Rotondo S, 2001, Ital Heart J, V2, P1; Schmitzer V, 2011, J SCI FOOD AGR, V91, P860, DOI 10.1002/jsfa.4257; Stoner GD, 1999, TOXICOL SCI, V52, P95, DOI 10.1093/toxsci/52.suppl_1.95; Vrhovsek U, 2004, J AGR FOOD CHEM, V52, P6532, DOI 10.1021/jf049317z; WRONSKI TJ, 1985, CALCIFIED TISSUE INT, V37, P324, DOI 10.1007/BF02554882	50	54	57	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60569	10.1371/journal.pone.0060569	http://dx.doi.org/10.1371/journal.pone.0060569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555991	Green Submitted, gold, Green Published			2022-12-27	WOS:000317263900077
J	Chiang, SW; Tsai, PH; Chang, YC; Wang, CY; Chung, HW; Lee, HS; Chou, MC; Hsu, YC; Huang, GS				Chiang, Shih-Wei; Tsai, Ping-Huei; Chang, Yue-Cune; Wang, Chao-Ying; Chung, Hsiao-Wen; Lee, Herng-Sheng; Chou, Ming-Chung; Hsu, Yi-Chih; Huang, Guo-Shu			T2 Values of Posterior Horns of Knee Menisci in Asymptomatic Subjects	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; PROTEOGLYCAN SYNTHESIS; PATELLAR CARTILAGE; HEALTHY-SUBJECTS; OSTEOARTHRITIS; POPULATION; TEARS; AGE; FIBROCHONDROCYTES; DEGENERATION	Purpose: The magnetic resonance (MR) T2 value of cartilage is a reliable indicator of tissue properties and therefore may be used as an objective diagnostic tool in early meniscal degeneration. The purpose of this study was to investigate age, gender, location, and zonal differences in MR T2 value of the posterior horns of knee menisci in asymptomatic subjects. Methods: Sixty asymptomatic volunteers (30 men and 30 women) were enrolled and divided into three different age groups: 20-34, 35-49 and 50-70 years. The inclusion criteria were BMI < 30 kg/cm(2), normalized Western Ontario and McMaster Universities (WOMAC) pain score of zero, and no evidence of meniscal and ligamentous abnormalities on routine knee MR imaging. The T2 values were measured on images acquired with a T2-weighted fat-suppressed turbo spin-echo sequence at 3T. Results: The mean T2 values in both medial and lateral menisci for the 20-34, 35-49, and 50-70 age groups were 9.94 msec +/- 0.94, 10.73 msec +/- 1.55, and 12.36 msec +/- 2.27, respectively, for women and 9.17 msec +/- 0.74, 9.64 msec +/- 0.67, and 10.95 msec +/- 1.33, respectively, for men. The T2 values were significantly higher in the 50-70 age group than the 20-34 age group (P < 0.001) and in women than in men (P = 0.001, 0.004, and 0.049 for each respective age group). T2 values were significantly higher in medial menisci than in lateral menisci only in women age 50-70 (3.33 msec, P = 0.006) and in the white zone and red/white zone of the 50-70 and 35-49 age groups than that of the 20-34 age group (2.47, 1.02; 2.77, 1.16 msec, respectively, all P < 0.01). Conclusion: The MR T2 values of the posterior meniscal horns increase with increasing age in women and are higher in women than in men. The age-related rise of T2 values appears to be more severe in medial menisci than in lateral menisci. Differences exist in the white zone and red/white zone.	[Chiang, Shih-Wei; Chung, Hsiao-Wen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chiang, Shih-Wei; Wang, Chao-Ying; Hsu, Yi-Chih; Huang, Guo-Shu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Tsai, Ping-Huei] Taipei Med Univ, Imaging Res Ctr, Taipei, Taiwan; [Tsai, Ping-Huei] Wan Fang Hosp, Dept Radiol, Taipei, Taiwan; [Chang, Yue-Cune] Tamkang Univ, Dept Math, Taipei, Taiwan; [Wang, Chao-Ying] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Lee, Herng-Sheng] Triserv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Taipei, Taiwan; [Chou, Ming-Chung] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Tamkang University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Kaohsiung Medical University	Huang, GS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	gsh5@seed.net.tw	Chou, Mingchung/AAC-3628-2021	Chung, Hsiao-Wen/0000-0001-7127-1244	Tri-Service General Hospital, Taiwan [TSGH-C99-048]	Tri-Service General Hospital, Taiwan	This study was supported by grant TSGH-C99-048 from the Tri-Service General Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JG, 1999, CLIN RADIOL, V54, P502, DOI 10.1016/S0009-9260(99)90846-2; Asahina S, 1996, ARTHROSCOPY, V12, P541, DOI 10.1016/S0749-8063(96)90191-7; Bates DM, 1988, NONLINEAR REGRESSION, P33; Bear DM, 2010, J ORTHOP RES, V28, P546, DOI 10.1002/jor.20998; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bursac P, 2009, AM J SPORT MED, V37, P884, DOI 10.1177/0363546508330140; Bydder M, 2007, J MAGN RESON IMAGING, V25, P290, DOI 10.1002/jmri.20850; Chou MC, 2009, OSTEOARTHR CARTILAGE, V17, P441, DOI 10.1016/j.joca.2008.09.009; COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7; Englund M, 2009, RHEUM DIS CLIN N AM, V35, P579, DOI 10.1016/j.rdc.2009.08.004; Englund M, 2009, RADIOL CLIN N AM, V47, P703, DOI 10.1016/j.rcl.2009.03.003; Fukuta Shoji, 2002, J Orthop Sci, V7, P287, DOI 10.1007/s007760200049; Grotle M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-132; Hauger O, 2000, RADIOLOGY, V217, P193, DOI 10.1148/radiology.217.1.r00se36193; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P990, DOI 10.1016/j.joca.2011.05.004; Kerrigan DC, 1998, AM J PHYS MED REHAB, V77, P2, DOI 10.1097/00002060-199801000-00002; Koff MF, 2007, OSTEOARTHR CARTILAGE, V15, P198, DOI 10.1016/j.joca.2006.07.007; KORNICK J, 1990, RADIOLOGY, V177, P463, DOI 10.1148/radiology.177.2.2217786; Krishnan N, 2007, ARTHRITIS RHEUM, V56, P1507, DOI 10.1002/art.22592; Lange AK, 2007, OSTEOARTHR CARTILAGE, V15, P701, DOI 10.1016/j.joca.2006.11.004; McAlinden A, 2001, OSTEOARTHR CARTILAGE, V9, P33, DOI 10.1053/joca.2000.0347; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Nakano T, 1997, J ORTHOP RES, V15, P213, DOI 10.1002/jor.1100150209; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; PETERFY CG, 1994, AM J ROENTGENOL, V163, P149, DOI 10.2214/ajr.163.1.8010202; Rauscher I, 2008, RADIOLOGY, V249, P591, DOI 10.1148/radiol.2492071870; Setton LA, 1999, CLIN ORTHOP RELAT R, pS254, DOI 10.1097/00003086-199910001-00025; Stehling C, 2011, SKELETAL RADIOL, V40, P725, DOI 10.1007/s00256-010-1058-2; STOLLER DW, 1987, RADIOLOGY, V163, P731, DOI 10.1148/radiology.163.3.3575724; Stone KR, 2007, ARTHROSCOPY, V23, P503, DOI 10.1016/j.arthro.2006.12.025; Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697; Takahashi M, 1998, ARTHROSCOPY, V14, P366, DOI 10.1016/S0749-8063(98)70003-9; Tanaka T, 1999, KNEE SURG SPORT TR A, V7, P75, DOI 10.1007/s001670050125; Taylor C, 2009, MAGN RESON IMAGING, V27, P779, DOI 10.1016/j.mri.2009.01.016; TENUTA JJ, 1994, AM J SPORT MED, V22, P797, DOI 10.1177/036354659402200611; Tsai PH, 2009, OSTEOARTHR CARTILAGE, V17, P988, DOI 10.1016/j.joca.2009.03.009; Watrin-Pinzano A, 2005, RADIOLOGY, V234, P162, DOI 10.1148/radiol.2341030394; WEBBER RJ, 1986, ARTHRITIS RHEUM-US, V29, P1010, DOI 10.1002/art.1780290810; WEISS CB, 1989, J BONE JOINT SURG AM, V71A, P811, DOI 10.2106/00004623-198971060-00003; Yue B, 2011, KNEE SURG SPORT TR A, V19, P80, DOI 10.1007/s00167-010-1139-8; Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012	43	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59769	10.1371/journal.pone.0059769	http://dx.doi.org/10.1371/journal.pone.0059769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555775	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200037
J	Dine, J; Ionescu, IA; Stepan, J; Yen, YC; Holsboer, F; Landgraf, R; Eder, M; Schmidt, U				Dine, Julien; Ionescu, Irina A.; Stepan, Jens; Yen, Yi-Chun; Holsboer, Florian; Landgraf, Rainer; Eder, Matthias; Schmidt, Ulrike			Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; FEAR EXPRESSION; MOUSE-BRAIN; ANXIETY; NEURONS; AMYGDALA; PHARMACOLOGY; EXTINCTION; ANTAGONIST; MODULATION	Neuropeptide S (NPS) increasingly emerges as a potential novel treatment option for anxiety diseases like panic and posttraumatic stress disorder. However, the neural underpinnings of its anxiolytic action are still not clearly understood. Recently, we reported that neurons of the ventral hippocampus (VH) take up intranasally administered fluorophore-conjugated NPS and, moreover, that application of NPS to mouse brain slices affects neurotransmission and plasticity at hippocampal CA3-CA1 synapses. Although these previous findings define the VH as a novel NPS target structure, they leave open whether this brain region is directly involved in NPS-mediated anxiolysis and how NPS impacts on neuronal activity propagation in the VH. Here, we fill this knowledge gap by demonstrating, first, that microinjections of NPS into the ventral CA1 region are sufficient to reduce anxiety-like behavior of C57BL/6N mice and, second, that NPS, via the NPS receptor, rapidly weakens evoked neuronal activity flow from the dentate gyrus to area CA1 in vitro. Additionally, we show that intranasally applied NPS alters neurotransmission and plasticity at CA3-CA1 synapses in the same way as NPS administered to hippocampal slices. Thus, our study provides, for the first time, strong experimental evidence for a direct involvement of the VH in NPS-induced anxiolysis and furthermore presents a novel mechanism of NPS action.	[Dine, Julien; Stepan, Jens; Eder, Matthias] Max Planck Inst Psychiat, RG Neuronal Network Dynam, Munich, Germany; [Ionescu, Irina A.; Schmidt, Ulrike] Max Planck Inst Psychiat, RG Mol Psychotraumatol, D-80804 Munich, Germany; [Yen, Yi-Chun] Max Planck Inst Psychiat, RG Neuronal Plast, D-80804 Munich, Germany; [Holsboer, Florian] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Landgraf, Rainer] Max Planck Inst Psychiat, RG Behav Neuroendocrinol, D-80804 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society	Eder, M (corresponding author), Max Planck Inst Psychiat, RG Neuronal Network Dynam, Munich, Germany.	eder@mpipsykl.mpg.de	Yen, Yi-Chun/GYD-3634-2022	Eder, Matthias/0000-0002-2579-2628; Dine, Julien/0000-0001-6381-8916	private Horst Kubler foundation, Bad Ragaz	private Horst Kubler foundation, Bad Ragaz	Part of the study (consumables) was funded by the private Horst Kubler foundation, Bad Ragaz. The Horst Kubler foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Andersen P., 2007, HIPPOCAMPUS BOOK; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; Castro AA, 2009, PHARMACOL BIOCHEM BE, V91, P636, DOI 10.1016/j.pbb.2008.10.015; Clark SD, 2011, J COMP NEUROL, V519, P1867, DOI 10.1002/cne.22606; DEKLOET ER, 1985, EUR J PHARMACOL, V110, P113, DOI 10.1016/0014-2999(85)90036-6; Duangdao DM, 2009, BEHAV BRAIN RES, V205, P1, DOI 10.1016/j.bbr.2009.07.024; Etkin A, 2010, CURR TOP BEHAV NEURO, V2, P251, DOI 10.1007/7854_2009_5; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Franklin K., 2007, MOUSE BRAIN STEREOTA; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Ionescu IA, 2012, NEUROPSYCHOPHARMACOL, V37, P1323, DOI 10.1038/npp.2011.317; Jinno S, 2003, J COMP NEUROL, V461, P333, DOI 10.1002/cne.10700; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Lukas M, 2012, NEUROPHARMACOLOGY, V62, P398, DOI 10.1016/j.neuropharm.2011.08.016; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; Meis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018020; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Moghaddam AH, 2012, PHARMACOL REP, V64, P45, DOI 10.1016/S1734-1140(12)70729-6; Myers-Schulz B, 2012, MOL PSYCHIATR, V17, P132, DOI 10.1038/mp.2011.88; Okamura N, 2008, J PHARMACOL EXP THER, V325, P893, DOI 10.1124/jpet.107.135103; Pacheco R, 2011, PHARMACOL BIOCHEM BE, V99, P726, DOI 10.1016/j.pbb.2011.06.028; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Satpute AB, 2012, EMOTION, V12, P58, DOI 10.1037/a0026517; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Somerville LH, 2013, CEREB CORTEX, V23, P49, DOI 10.1093/cercor/bhr373; Stepan J, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00064; Trapella C, 2011, J MED CHEM, V54, P2738, DOI 10.1021/jm200138r; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; Windle RJ, 2006, ENDOCRINOLOGY, V147, P2423, DOI 10.1210/en.2005-1079; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zhu HY, 2010, PSYCHONEUROENDOCRINO, V35, P1119, DOI 10.1016/j.psyneuen.2010.01.012	49	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60219	10.1371/journal.pone.0060219	http://dx.doi.org/10.1371/journal.pone.0060219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555930	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200099
J	Hollmann, M; Garin, O; Galante, M; Ferrer, M; Dominguez, A; Alonso, J				Hollmann, Malen; Garin, Olatz; Galante, Mariana; Ferrer, Montserrat; Dominguez, Angela; Alonso, Jordi			Impact of Influenza on Health-Related Quality of Life among Confirmed (H1N1) 2009 Patients	PLOS ONE			English	Article							SPANISH VERSION; VIRUS-INFECTION; HOSPITALIZATION; INTERVENTIONS; QUESTIONNAIRE; ASSESSMENTS; CHILDREN; EUROQOL; BURDEN; EQ-5D	Background: We aimed to assess the changes in health-related quality of life (HRQL) in patients with confirmed diagnosis of influenza (H1N1) 2009, and to estimate the individual and societal loss of quality-adjusted life years (QALYs) caused by the pandemic. Methods and Results: Longitudinal study of patients recruited at major hospitals and primary care centers in Spain. Patients reported their HRQL (EQ-5D) during their influenza episode and seven days prior to it. A subsample was monitored to evaluate HRQL after recovery. HRQL loss was estimated as the difference between EQ-5D prior to the influenza episode and during it. Individual QALY loss (disutility multiplied by the duration of the influenza episode in days) for confirmed cases was calculated and used to estimate the societal loss in Spain (with the official estimations). A total of 432 inpatients and 563 outpatients were included, of whom 145 and 184, respectively, were followed up. Baseline mean HRQL loss was 0.58 (95% CI, 0.53-0.63) for inpatients and 0.43 (95% CI, 0.40-0.46) for outpatients. The majority of the 145 inpatients and 184 outpatients who were followed up regained initial HRQL levels, presenting a mean difference of 0.01 between the EQ-5D score prior to and after the influenza episode. Individual QALY losses for inpatients (0.031, 95% CI, 0.025-0.037) were higher than for outpatients (0.009, 95% CI, 0.007-0.011), while societal QALY losses were reversed: 94 years for inpatients and 6,778 years for outpatients. For fatal cases (an official number of 318), we estimated a QALY loss of 11,981. Conclusions: The influenza (H1N1) 2009 pandemic had a significant but temporary impact on the HRQL of the majority of confirmed in-and outpatients. The societal impact of the influenza pandemic in Spain was estimated to be higher than other acute conditions. These results provide useful data for future cost-utility analyses.	[Hollmann, Malen; Garin, Olatz; Galante, Mariana; Ferrer, Montserrat; Alonso, Jordi] IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Grp, Barcelona, Spain; [Hollmann, Malen; Garin, Olatz; Galante, Mariana; Alonso, Jordi] Univ Pompeu Fabra, Barcelona, Spain; [Garin, Olatz; Galante, Mariana; Ferrer, Montserrat; Dominguez, Angela; Alonso, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Ferrer, Montserrat] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona	Alonso, J (corresponding author), IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Grp, Barcelona, Spain.	jalonso@imim.es	Garin, Olatz/K-5468-2013; Ferrer, Montse/A-5510-2010; Alonso, Jordi/A-5514-2010	Garin, Olatz/0000-0001-6193-0779; Ferrer, Montse/0000-0001-9867-7391; Alonso, Jordi/0000-0001-8627-9636	Health Institute ISCIII [GR09/0026];  [AGAUR_2009 SGR 1095]	Health Institute ISCIII; 	This work was financed by the Health Institute ISCIII GR09/0026 as a commissioner Investigation; and by the AGAUR_2009 SGR 1095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Catala-Lopez F, 2010, REV ESP SALUD PUBLIC, V84, P353, DOI [10.1590/S1135-57272010000400002, 10.1590/s1135-57272010000400002]; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Cunillera O, 2010, QUAL LIFE RES, V19, P853, DOI 10.1007/s11136-010-9639-z; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Dominguez A, 2011, REV ESP SALUD PUBLIC, V85, P3, DOI 10.1590/S1135-57272011000100002; Dorman PJ, 1997, STROKE, V28, P1883, DOI 10.1161/01.STR.28.10.1883; Duncan B, 2009, EUROSURVEILLANCE, V14, P15; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Fuhrman C, 2010, EURO SURVEILL, V15; Galante M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031696; Garin O, 2011, REV ESP SALUD PUBLIC, V85, P19, DOI 10.1590/S1135-57272011000100003; Ghendon Y., 1992, World Health Statistics Quarterly, V45, P306; Graham-Rowe D, 2011, NATURE, V480, pS2, DOI 10.1038/480S2a; Grandes G, 2011, EUR PSYCHIAT; Gusi N, 2009, ATEN PRIM, V41, P19, DOI 10.1016/j.aprim.2008.04.005; Herdman M, 2001, Aten Primaria, V28, P425; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; JOHNSON JR, 1985, CANCER TREAT REP, V69, P1155; Karlawish JH, 2008, ALZHEIMERS DEMENT, V4, P203, DOI 10.1016/j.jalz.2007.11.018; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Camara AL, 2010, REV ESP SALUD PUBLIC, V84, P569, DOI [10.1590/S1135-57272010000500009, 10.1590/s1135-57272010000500009]; Lavelle TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027777; Gomez IL, 2010, REV ESP SALUD PUBLIC, V84, P589, DOI 10.1590/S1135-57272010000500010; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Matza LS, 2005, PHARMACOECONOMICS, V23, P777, DOI 10.2165/00019053-200523080-00004; Muennig PA, 2001, CLIN INFECT DIS, V33, P1879, DOI 10.1086/324491; Velasco RP, 2009, GAC SANIT, V23, P104, DOI 10.1016/j.gaceta.2008.04.001; Prosser Lisa A, 2005, Health Qual Life Outcomes, V3, P18, DOI 10.1186/1477-7525-3-18; Prosser LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022308; Rapkin Bruce D, 2004, Health Qual Life Outcomes, V2, P14, DOI 10.1186/1477-7525-2-14; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Santa-Olalla P, 2010, EURO SURVEILL, V15, P19667; SISalut - Sistema d' Informacio de Salut, 2010, LLIBR MORT AN; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Szucs T, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.suppl_2.11; The EuroQol Group, 1999, GUIA US EQ 5D VERS E; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; Woodwell David A, 2004, Adv Data, P1; World Health Organization, 2009, CDC PROT REALT RTPCR; World Health Organization, 2009, INFL SEAS FACT SHEET	47	34	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60477	10.1371/journal.pone.0060477	http://dx.doi.org/10.1371/journal.pone.0060477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121RP	23555979	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200120
J	Lin, Y; Huo, LJ; Liu, ZH; Li, JL; Liu, Y; He, QZ; Wang, XC; Liang, SP				Lin, Yong; Huo, Linju; Liu, Zhonghua; Li, Jianglin; Liu, Yi; He, Quanze; Wang, Xianchun; Liang, Songping			Sodium Laurate, a Novel Protease- and Mass Spectrometry-Compatible Detergent for Mass Spectrometry-Based Membrane Proteomics	PLOS ONE			English	Article							PLASMA-MEMBRANE; PROTEINS; SURFACTANT; DIGESTION; IDENTIFICATION; DEOXYCHOLATE; TOPOLOGY; REMOVAL; SHOTGUN; TRYPSIN	The hydrophobic nature of most membrane proteins severely complicates their extraction, proteolysis and identification. Although detergents can be used to enhance the solubility of the membrane proteins, it is often difficult for a detergent not only to have a strong ability to extract membrane proteins, but also to be compatible with the subsequent proteolysis and mass spectrometric analysis. In this study, we made evaluation on a novel application of sodium laurate (SL) to the shotgun analysis of membrane proteomes. SL was found not only to lyse the membranes and solubilize membrane proteins as efficiently as SDS, but also to be well compatible with trypsin and chymotrypsin. Furthermore, SL could be efficiently removed by phase transfer method from samples after acidification, thus ensuring not to interfere with the subsequent CapLC-MS/MS analysis of the proteolytic peptides of proteins. When SL was applied to assist the digestion and identification of a standard protein mixture containing bacteriorhodoposin and the proteins in rat liver plasma membrane-enriched fractions, it was found that, compared with other two representative enzyme-and MS-compatible detergents RapiGest SF (RGS) and sodium deoxycholate (SDC), SL exhibited obvious superiority in the identification of membrane proteins particularly those with high hydrophobicity and/or multiple transmembrane domains.	[Lin, Yong; Huo, Linju; Li, Jianglin; Liu, Yi; He, Quanze; Wang, Xianchun; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Natl Educ Comm, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Lin, Yong; Liu, Zhonghua] Hunan Agr Univ, Natl Res Ctr Engn & Technol Utilizat Bot Funct In, Changsha, Hunan, Peoples R China	Hunan Normal University; Hunan Agricultural University	Wang, XC (corresponding author), Hunan Normal Univ, Coll Life Sci, Natl Educ Comm, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	wang_xianchun@263.net; liangsp@hunnu.edu.cn			Hunan Provincial Natural Science Foundation of China [11JJ2019]; National Natural Science Foundation of China [31070700, 31100502]; Specialized Research Foundation for the doctorial Program of Higher Education of China [20094306110003, 20114320120004]; Science Research Foundation of Department of Education of Hunan Province [12B064]; National Basic Research Program or "973 Program'' of China [2010CB529800]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Foundation for the doctorial Program of Higher Education of China; Science Research Foundation of Department of Education of Hunan Province; National Basic Research Program or "973 Program'' of China(National Basic Research Program of China)	This work was supported by grants from Hunan Provincial Natural Science Foundation of China (11JJ2019), National Natural Science Foundation of China (31070700, 31100502), Specialized Research Foundation for the doctorial Program of Higher Education of China (20094306110003, 20114320120004), Science Research Foundation of Department of Education of Hunan Province (12B064) and National Basic Research Program or "973 Program'' of China (2010CB529800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Botelho D, 2010, J PROTEOME RES, V9, P2863, DOI 10.1021/pr900949p; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Jeannot MA, 1999, J AM SOC MASS SPECTR, V10, P512, DOI 10.1016/S1044-0305(99)00022-7; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin Y, 2008, ANAL BIOCHEM, V377, P259, DOI 10.1016/j.ab.2008.03.009; Lin Y, 2010, ELECTROPHORESIS, V31, P2705, DOI 10.1002/elps.201000161; LOO RRO, 1994, PROTEIN SCI, V3, P1975, DOI 10.1002/pro.5560031109; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Naldrett Mike J, 2005, J Biomol Tech, V16, P423; Ott CM, 2002, J CELL SCI, V115, P2003; Ponnusamy S, 2012, J PROTEOMICS, V75, P5762, DOI 10.1016/j.jprot.2012.07.020; Rabilloud T, 2003, NAT BIOTECHNOL, V21, P508, DOI 10.1038/nbt0503-508; RAY TK, 1970, BIOCHIM BIOPHYS ACTA, V196, P1, DOI 10.1016/0005-2736(70)90159-8; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; Shaw AR, 2003, CURR OPIN MOL THER, V5, P294; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Torres J, 2003, TRENDS BIOCHEM SCI, V28, P137, DOI 10.1016/S0968-0004(03)00026-4; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Yu YQ, 2003, ANAL CHEM, V75, P6023, DOI 10.1021/ac0346196; Zhang LJ, 2006, CELL MOL LIFE SCI, V63, P1790, DOI 10.1007/s00018-006-6126-3; Zhang N, 2007, PROTEOMICS, V7, P484, DOI 10.1002/pmic.200600518; Zhou Chunlong, 2004, Genomics Proteomics & Bioinformatics, V2, P1; Zhou J, 2006, J PROTEOME RES, V5, P2547, DOI 10.1021/pr060112a; Zischka H, 2004, PROTEOMICS, V4, P3776, DOI 10.1002/pmic.200400851	28	32	33	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59779	10.1371/journal.pone.0059779	http://dx.doi.org/10.1371/journal.pone.0059779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555778	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200038
J	Santos, G; Torres, NV				Santos, Guido; Torres, Nestor V.			New Targets for Drug Discovery against Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; INVASION; ERYTHROCYTES; OPTIMIZATION; PARASITEMIA	A mathematical model which predicts the intraerythrocytic stages of Plasmodium falciparum infection was developed using data from malaria-infected mice. Variables selected accounted for levels of healthy red blood cells, merozoite (Plasmodium asexual phase) infected red blood cells, gametocyte (Plasmodium sexual phase) infected red blood cells and a phenomenological variable which accounts for the mean activity of the immune system of the host. The model built was able to reproduce the behavior of three different scenarios of malaria. It predicts the later dynamics of malaria-infected humans well after the first peak of parasitemia, the qualitative response of malaria-infected monkeys to vaccination and the changes observed in malaria-infected mice when they are treated with antimalarial drugs. The mathematical model was used to identify new targets to be focused on drug design. Optimization methodologies were applied to identify five targets for minimizing the parasite load; four of the targets thus identified have never before been taken into account in drug design. The potential targets include: 1) increasing the death rate of the gametocytes, 2) decreasing the invasion rate of the red blood cells by the merozoites, 3) increasing the transformation of merozoites into gametocytes, 4) decreasing the activation of the immune system by the gametocytes, and finally 5) a combination of the previous target with decreasing the recycling rate of the red blood cells. The first target is already used in current therapies, whereas the remainders are proposals for potential new targets. Furthermore, the combined target (the simultaneous decrease of the activation of IS by gRBC and the decrease of the influence of IS on the recycling of hRBC) is interesting, since this combination does not affect the parasite directly. Thus, it is not expected to generate selective pressure on the parasites, which means that it would not produce resistance in Plasmodium.	[Santos, Guido; Torres, Nestor V.] Univ La Laguna, Dept Bioquim & Biol Mol, Tenerife, Spain; [Torres, Nestor V.] Univ La Laguna, Inst Univ Enfermedades Tropicales & Salud Publ Ca, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna	Torres, NV (corresponding author), Univ La Laguna, Dept Bioquim & Biol Mol, Tenerife, Spain.	ntorres@ull.edu.es	Santos, Guido/AAB-4695-2019; Torres, Nestor/K-2529-2014	Santos, Guido/0000-0002-4231-5946; Torres, Nestor/0000-0002-7594-9515	Spanish MICINN [BIO2011-29233-C02-02]; ACIISI [PIL2070901]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ACIISI	This work was co-funded by research grants from Spanish MICINN, Ref. No. BIO2011-29233-C02-02 and ACIISI Project PIL2070901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; [Anonymous], 2012, WORLD MALARIA REPORT; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; BEURIA MK, 1991, INDIAN J EXP BIOL, V29, P284; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Chimanuka B, 2002, J PHARMACEUT BIOMED, V28, P13, DOI 10.1016/S0731-7085(01)00611-2; Curto R, 1998, BIOCHEM J, V329, P777; Diebner HH, 2000, J THEOR BIOL, V202, P113, DOI 10.1006/jtbi.1999.1041; Gadsby N, 2009, INT J PARASITOL, V39, P347, DOI 10.1016/j.ijpara.2008.07.005; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Hormiga J, 2010, MOL BIOSYST, V6, P699, DOI 10.1039/b913063b; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Langer BM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-1; Makobongo MO, 2006, J INFECT DIS, V193, P731, DOI 10.1086/500150; Marin-Sanguino A, 2010, METHOD ENZYMOL, V487, P321; Mota MM, 1998, INFECT IMMUN, V66, P4080; Murambiwa P, 2011, ACTA TROP, V118, P71, DOI 10.1016/j.actatropica.2011.03.005; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Okell LC, 2008, MALARIA J, P1; Olliaro P, 2008, TROP MED INT HEALTH, V13, P83, DOI 10.1111/j.1365-3156.2007.01977.x; Parija SC, 2011, INDIAN J MED MICROBI, V29, P243, DOI 10.4103/0255-0857.83906; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Porter-Kelley Johanna M, 2010, Infect Drug Resist, V3, P87, DOI 10.2147/IDR.S7454; Qi Z, 2011, TXB SCHIZOPHRENIA SP; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Vera J, 2007, BIOINFORMATICS, V23, P2281, DOI 10.1093/bioinformatics/btm326; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2009, MATH BIOSCI, V217, P11, DOI 10.1016/j.mbs.2008.09.005; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, P1; Ward R, 2011, QUANTITATIVE SYSTEMS; Wells TNC, 2010, SCIENCE, V329, P1153, DOI 10.1126/science.1194923; Xiao LH, 1996, INFECT IMMUN, V64, P1373, DOI 10.1128/IAI.64.4.1373-1378.1996	42	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59968	10.1371/journal.pone.0059968	http://dx.doi.org/10.1371/journal.pone.0059968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555851	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200063
J	Park, DY; Ahn, YT; Park, SH; Huh, CS; Yoo, SR; Yu, R; Sung, MK; McGregor, RA; Choi, MS				Park, Do-Young; Ahn, Young-Tae; Park, Se-Hoon; Huh, Chul-Sung; Yoo, Sae-Rom; Yu, Rina; Sung, Mi-Kyung; McGregor, Robin A.; Choi, Myung-Sook			Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in Diet-Induced Obese Mice Is Associated with Gut Microbial Changes and Reduction in Obesity	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; ADIPOSE-TISSUE; LINOLEIC-ACID; ANTIOBESITY; BACTERIA; METABOLISM; MECHANISMS; RESISTANCE; PREBIOTICS; PROBIOTICS	Objective: To investigate the functional effects of probiotic treatment on the gut microbiota, as well as liver and adipose gene expression in diet-induced obese mice. Design: Male C57BL/6J mice were fed a high-fat diet (HFD) for 8 weeks to induce obesity, and then randomized to receive HFD+probiotic (Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, n = 9) or HFD+placebo (n = 9) for another 10 weeks. Normal diet (ND) fed mice (n = 9) served as non-obese controls. Results: Diet-induced obese mice treated with probiotics showed reduced body weight gain and fat accumulation as well as lowered plasma insulin, leptin, total-cholesterol and liver toxicity biomarkers. A total of 151,061 pyrosequencing reads for fecal microbiota were analyzed with a mean of 6,564, 5,274 and 4,464 reads for the ND, HFD+placebo and HFD+probiotic groups, respectively. Gut microbiota species were shared among the experimental groups despite the different diets and treatments. The diversity of the gut microbiota and its composition were significantly altered in the diet-induced obese mice and after probiotic treatment. We observed concurrent transcriptional changes in adipose tissue and the liver. In adipose tissue, pro-inflammatory genes (TNF alpha, IL6, IL1 beta and MCP1) were down-regulated in mice receiving probiotic treatment. In the liver, fatty acid oxidation-related genes (PGC1 alpha, CPT1, CPT2 and ACOX1) were up-regulated in mice receiving probiotic treatment. Conclusions: The gut microbiota of diet-induced obese mice appears to be modulated in mice receiving probiotic treatment. Probiotic treatment might reduce diet-induced obesity and modulate genes associated with metabolism and inflammation in the liver and adipose tissue.	[Park, Do-Young; Ahn, Young-Tae; Park, Se-Hoon; Huh, Chul-Sung] Korea Yakult Co Ltd, Yongin, Gyeonggi, South Korea; [Yu, Rina; Sung, Mi-Kyung; McGregor, Robin A.; Choi, Myung-Sook] Kyungpook Natl Univ, Ctr Food & Nutr Genom, Taegu, South Korea; [Yoo, Sae-Rom; Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu, South Korea; [Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan 680749, South Korea; [Sung, Mi-Kyung] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea	Kyungpook National University; Kyungpook National University; University of Ulsan; Sookmyung Women's University	Huh, CS (corresponding author), Korea Yakult Co Ltd, Yongin, Gyeonggi, South Korea.	cshuh@re.yakult.co.kr; mschoi@knu.ac.kr	Park, Se Hoon/GMX-1199-2022	Park, Se Hoon/0000-0001-5084-9326; Yu, Rina/0000-0002-1965-3891; Yoo, Sae-Rom/0000-0001-8731-2469	Korea Yakult Co., Ltd.; SRC Program of National Research Foundation (NRF) of Korea [2012-0000644]; Ministry of Education, Science and Technology	Korea Yakult Co., Ltd.; SRC Program of National Research Foundation (NRF) of Korea; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was jointly supported by Korea Yakult Co., Ltd., and the SRC Program (2012-0000644) of the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Arora T, 2012, BRIT J NUTR, V108, P1382, DOI 10.1017/S0007114511006957; Arvanitoyannis IS, 2005, CRIT REV FOOD SCI, V45, P385, DOI 10.1080/10408390590967667; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chang JH, 2010, J APPL MICROBIOL, V109, P220, DOI 10.1111/j.1365-2672.2009.04648.x; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen JJ, 2011, EXP BIOL MED, V236, P823, DOI 10.1258/ebm.2011.010399; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Felsenstein J., 2004, INFERRING PHYLOGENIE; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kondo S, 2010, BIOSCI BIOTECH BIOCH, V74, P1656, DOI 10.1271/bbb.100267; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Mestdagh R, 2012, J PROTEOME RES, V11, P620, DOI 10.1021/pr200938v; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Park DY, 2013, WORLD J GASTROENTERO, V19, P274, DOI 10.3748/wjg.v19.i2.274; Park DY, 2011, J MED FOOD, V14, P670, DOI 10.1089/jmf.2010.1355; Pereira DIA, 2002, CRIT REV BIOCHEM MOL, V37, P259, DOI 10.1080/10409230290771519; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Song SL, 2004, BBA-GENE STRUCT EXPR, V1679, P164, DOI 10.1016/j.bbaexp.2004.06.006; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Yin YN, 2010, WORLD J GASTROENTERO, V16, P3394, DOI 10.3748/wjg.v16.i27.3394; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x	58	199	209	11	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59470	10.1371/journal.pone.0059470	http://dx.doi.org/10.1371/journal.pone.0059470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555678	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400043
J	Yamato, E; Tashiro, F; Miyazaki, J				Yamato, Eiji; Tashiro, Fumi; Miyazaki, Jun-ichi			Microarray Analysis of Novel Candidate Genes Responsible for Glucose-Stimulated Insulin Secretion in Mouse Pancreatic beta Cell Line MIN6	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; DNA METHYLATION; BINDING PROTEIN; ISLETS; IDENTIFICATION; REVEALS; GROWTH; ALPHA; KCNQ1; MICE	Elucidating the regulation of glucose-stimulated insulin secretion (GSIS) in pancreatic islet beta cells is important for understanding and treating diabetes. MIN6 cells, a transformed beta-cell line derived from a mouse insulinoma, retain GSIS and are a popular in vitro model for insulin secretion. However, in long-term culture, MIN6 cells' GSIS capacity is lost. We previously isolated a subclone, MIN6 clone 4, from the parental MIN6 cells, that shows well-regulated insulin secretion in response to glucose, glybenclamide, and KCl, even after prolonged culture. To investigate the molecular mechanisms responsible for preserving GSIS in this subclone, we compared four groups of MIN6 cells: Pr-LP (parental MIN6, low passage number), Pr-HP (parental MIN6, high passage number), C4-LP (MIN6 clone 4, low passage number), and C4-HP (MIN6 clone 4, high passage number). Based on their capacity for GSIS, we designated the Pr-LP, C4-LP, and C4-HP cells as "responder cells." In a DNA microarray analysis, we identified a group of genes with high expression in responder cells ("responder genes"), but extremely low expression in the Pr-HP cells. Another group of genes ("non-responder genes") was expressed at high levels in the Pr-HP cells, but at extremely low levels in the responder cells. Some of the responder genes were involved in secretory machinery or glucose metabolism, including Chrebp, Scgn, and Syt7. Among the non-responder genes were Car2, Maf, and Gcg, which are not normally expressed in islet b cells. Interestingly, we found a disproportionate number of known imprinted genes among the responder genes. Our findings suggest that the global expression profiling of GSIS-competent and GSIS-incompetent MIN6 cells will help delineate the gene regulatory networks for insulin secretion.	[Yamato, Eiji; Tashiro, Fumi; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan	Osaka University	Yamato, E (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan.	yamato@nutri.med.osaka-u.ac.jp; jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Yamato, Eiji/0000-0002-9075-6869	Japanese Society for the Promotion of Science [23617011]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid (No. 23617011) from the Japanese Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2004, J CELL SCI, V117, P2239, DOI 10.1242/jcs.01041; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Carlsson C, 1997, ENDOCRINOLOGY, V138, P3940, DOI 10.1210/en.138.9.3940; Cheng K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040868; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Cram DS, 1999, DIFFERENTIATION, V64, P237, DOI 10.1046/j.1432-0436.1999.6440237.x; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Dowling P, 2008, ELECTROPHORESIS, V29, P4141, DOI 10.1002/elps.200800152; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Friedrichsen BN, 2003, J ENDOCRINOL, V176, P257, DOI 10.1677/joe.0.1760257; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao ZY, 2000, J BIOL CHEM, V275, P36079, DOI 10.1074/jbc.M004284200; Gartner W, 2007, AM J PHYSIOL-ENDOC M, V293, pE347, DOI 10.1152/ajpendo.00055.2007; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; GIDDINGS SJ, 1991, MOL ENDOCRINOL, V5, P549, DOI 10.1210/mend-5-4-549; Gosmain Y, 2011, DIABETES OBES METAB, V13, P31, DOI 10.1111/j.1463-1326.2011.01445.x; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hald J, 2012, DIABETOLOGIA, V55, P154, DOI 10.1007/s00125-011-2295-1; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Hoffmann A, 2012, MOL CELL BIOL, V32, P2549, DOI 10.1128/MCB.06637-11; Inada A, 2006, DEV DYNAM, V235, P1571, DOI 10.1002/dvdy.20754; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kataoka M, 2009, J NEUROCHEM, V108, P1109, DOI 10.1111/j.1471-4159.2009.05874.x; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kayo T, 1996, J BIOL CHEM, V271, P10731, DOI 10.1074/jbc.271.18.10731; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Leclerc I, 2012, J ENDOCRINOL, V213, P115, DOI 10.1530/JOE-11-0480; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Ling ZD, 1998, ENDOCRINOLOGY, V139, P491, DOI 10.1210/en.139.2.491; Ma D, 2004, J CLIN INVEST, V114, P339, DOI 10.1172/jci200419876; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Meur G, 2011, J BIOL CHEM, V286, P13647, DOI 10.1074/jbc.M110.204248; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Sawada Y, 2001, MOL CELL ENDOCRINOL, V182, P265, DOI 10.1016/S0303-7207(01)00482-8; Schmidt JV, 2000, GENE DEV, V14, P1997; Soggia A, 2012, DIABETOLOGIA, V55, P2713, DOI 10.1007/s00125-012-2623-0; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Varrault A, 2001, J BIOL CHEM, V276, P18653, DOI 10.1074/jbc.C100095200; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	60	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61211	10.1371/journal.pone.0061211	http://dx.doi.org/10.1371/journal.pone.0061211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23560115	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100118
J	Ellison, KS; Ribic, CA; Sample, DW; Fawcett, MJ; Dadisman, JD				Ellison, Kevin S.; Ribic, Christine A.; Sample, David W.; Fawcett, Megan J.; Dadisman, John D.			Impacts of Tree Rows on Grassland Birds and Potential Nest Predators: A Removal Experiment	PLOS ONE			English	Article							CONSERVATION RESERVE PROGRAM; DOLICHONYX-ORYZIVORUS; POPULATION TRENDS; HENSLOWS SPARROW; PRAIRIE; SURVIVAL; HABITAT; LANDSCAPES; NORTHERN; FIELDS	Globally, grasslands and the wildlife that inhabit them are widely imperiled. Encroachment by shrubs and trees has widely impacted grasslands in the past 150 years. In North America, most grassland birds avoid nesting near woody vegetation. Because woody vegetation fragments grasslands and potential nest predator diversity and abundance is often greater along wooded edge and grassland transitions, we measured the impacts of removing rows of trees and shrubs that intersected grasslands on potential nest predators and the three most abundant grassland bird species (Henslow's sparrow [Ammodramus henslowii], Eastern meadowlark [Sturnella magna], and bobolink [Dolichonyx oryzivorus]) at sites in Wisconsin, U. S. A. We monitored 3 control and 3 treatment sites, for 1 yr prior to and 3 yr after tree row removal at the treatment sites. Grassland bird densities increased (2-4 times for bobolink and Henslow's sparrow) and nesting densities increased (all 3 species) in the removal areas compared to control areas. After removals, Henslow's sparrows nested within <= 50 m of the treatment area, where they did not occur when tree rows were present. Most dramatically, activity by woodland-associated predators nearly ceased (nine-fold decrease for raccoon [Procyon lotor]) at the removals and grassland predators increased (up to 27 times activity for thirteen-lined ground squirrel [Ictidomys tridecemlineatus]). Nest success did not increase, likely reflecting the increase in grassland predators. However, more nests were attempted by all 3 species (175 versus 116) and the number of successful nests for bobolinks and Henslow's sparrows increased. Because of gains in habitat, increased use by birds, greater production of young, and the effective removal of woodland-associated predators, tree row removal, where appropriate based on the predator community, can be a beneficial management action for conserving grassland birds and improving fragmented and degraded grassland ecosystems.	[Ellison, Kevin S.; Fawcett, Megan J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Ribic, Christine A.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Sample, David W.; Dadisman, John D.] Bur Sci Serv, Wisconsin Dept Nat Resources, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Ellison, KS (corresponding author), Wildlife Conservat Soc, Bozeman, MT USA.	kellison@wcs.org		Ellison, Kevin/0000-0002-1021-6345	Wisconsin Department of Natural Resources (WI-DNR); Federal 1 Aid in Wildlife Restoration Project [W-160-P]; WI-DNR Pheasant Stamp Program; U.S. Fish and Wildlife Service (USFWS) Region 3 Non-game Bird Conservation Program; USFWS Wisconsin Private Lands Program; U.S. Geological Survey - Wisconsin Cooperative Wildlife Research Unit; U.S. Department of Agriculture Hatch grant through the University of Wisconsin-Madison	Wisconsin Department of Natural Resources (WI-DNR); Federal 1 Aid in Wildlife Restoration Project; WI-DNR Pheasant Stamp Program; U.S. Fish and Wildlife Service (USFWS) Region 3 Non-game Bird Conservation Program; USFWS Wisconsin Private Lands Program; U.S. Geological Survey - Wisconsin Cooperative Wildlife Research Unit(United States Geological Survey); U.S. Department of Agriculture Hatch grant through the University of Wisconsin-Madison	This project was supported with funds from the Wisconsin Department of Natural Resources (WI-DNR) with Federal 1 Aid in Wildlife Restoration Project W-160-P, the WI-DNR Pheasant Stamp Program, U.S. Fish and Wildlife Service (USFWS) Region 3 Non-game Bird Conservation Program, USFWS Wisconsin Private Lands Program, U.S. Geological Survey - Wisconsin Cooperative Wildlife Research Unit, and a U.S. Department of Agriculture Hatch grant through the University of Wisconsin-Madison. The authors thank the Department of Forest and Wildlife Ecology, University of Wisconsin, Madison, for assistance with publication expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Andren Henrik, 1995, IALE Studies in Landscape Ecology, V2, P225; [Anonymous], 2011, NATURAL RESCOURCES C; Archer S., 2001, GLOBAL BIOGEOCHEM CY, P115; Bakker Kristel K., 2003, Proceedings of the South Dakota Academy of Science, V82, P119; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Blouin-Demers G, 2001, ECOLOGY, V82, P2882, DOI 10.1890/0012-9658(2001)082[2882:HUBBRS]2.0.CO;2; Bollinger EK, 2004, AUK, V121, P767, DOI 10.1642/0004-8038(2004)121[0767:RONBDO]2.0.CO;2; Browder Sharon Freshman, 2002, Ecological Indicators, V2, P257, DOI 10.1016/S1470-160X(02)00060-2; Browning DM, 2008, ECOL APPL, V18, P928, DOI 10.1890/07-1559.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x; Ellison KS, 2012, STUD AVIAN BIOL, P149; ESRI, 2008, ARCGIS VERS 9 3; FITCH H S, 1987, P143; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Gill JL, 1978, DESIGN ANAL EXPT ANI, V1; Grant TA, 2006, J WILDLIFE MANAGE, V70, P691, DOI 10.2193/0022-541X(2006)70[691:NSOCAV]2.0.CO;2; Grant TA, 2011, WILDLIFE SOC B, V35, P368, DOI 10.1002/wsb.65; Graves BM, 2010, WILSON J ORNITHOL, V122, P646, DOI 10.1676/09-101.1; Henwood William D., 2010, Great Plains Research, V20, P121; Herkert J. R., 1996, MANAGEMENT MIDWESTER, P89; Herkert JR, 2007, J WILDLIFE MANAGE, V71, P2749, DOI 10.2193/2007-002; Herkert JR, 2007, J WILDLIFE MANAGE, V71, P1229, DOI 10.2193/2006-029; Herkert JR, 1997, BIOL CONSERV, V80, P107, DOI 10.1016/S0006-3207(96)00066-3; Herkert JR, 2003, CONSERV BIOL, V17, P587, DOI 10.1046/j.1523-1739.2003.01418.x; HERKERT JR, 1995, AM MIDL NAT, V134, P41, DOI 10.2307/2426481; Herkert JR, 1997, J FIELD ORNITHOL, V68, P235; HERKERT JR, 2002, BIRDS N AM, V672; Heske EJ, 1999, LANDSCAPE ECOL, V14, P345, DOI 10.1023/A:1008033603827; Hovick TJ, 2011, CONDOR, V113, P429, DOI 10.1525/cond.2011.100135; *IBCC, 1970, B ECOLOGICAL RES COM, V9, P49; Jensen WE, 2004, AM MIDL NAT, V151, P192, DOI 10.1674/0003-0031(2004)151[0192:EEONDS]2.0.CO;2; JOHNSON RG, 1990, J WILDLIFE MANAGE, V54, P106, DOI 10.2307/3808909; Jones S. L, 2010, SPRAGUES PIPIT ANTHU; Kelsey KW, 2006, NAT AREA J, V26, P254, DOI 10.3375/0885-8608(2006)26[254:PTIPLD]2.0.CO;2; Kershner EL, 2004, AUK, V121, P1146, DOI 10.1642/0004-8038(2004)121[1146:PMASOJ]2.0.CO;2; King RB, 2002, FUNCT ECOL, V16, P766, DOI 10.1046/j.1365-2435.2002.00678.x; Klug P, 2009, ECOGRAPHY, V32, P973, DOI 10.1111/j.1600-0587.2009.05857.x; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Lanyon WE, 1995, BIRDS N AM ONLINE; Lloyd CJ., 1999, STAT ANAL CATEGORICA; MARTIN SG, 1995, BIRDS N AM, V176; MARTIN TE, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P455; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Noble J.C., 1997, DELICATE NOXIOUS SCR; North American Bird Conservation Initiative (NABCI), 2009, STAT BIRDS; O'Leary CH, 2000, NAT AREA J, V20, P243; Pashley David, 1996, National Audubon Society Field Notes, V50, P129; PASITSCHNIAKARTS M, 1995, OIKOS, V73, P347, DOI 10.2307/3545958; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Perlut NG, 2008, BIOL CONSERV, V141, P3139, DOI 10.1016/j.biocon.2008.09.011; Pietz PJ, 2012, STUD AVIAN BIOL, P3; R Development Core Team, 2007, R LANG ENV STAT COMP; Ramankutty N, 1999, GLOBAL ECOL BIOGEOGR, V8, P381, DOI 10.1046/j.1365-2699.1999.00141.x; RAPPOLE JH, 1986, SCI TOTAL ENVIRON, V55, P91, DOI 10.1016/0048-9697(86)90169-5; Renfrew RB, 2005, AUK, V122, P618, DOI 10.1642/0004-8038(2005)122[0618:EABNGB]2.0.CO;2; Renfrew RB, 2003, AUK, V120, P371, DOI 10.1642/0004-8038(2003)120[0371:GPNPNP]2.0.CO;2; Renfrew RB, 2008, LANDSCAPE ECOL, V23, P181, DOI 10.1007/s10980-007-9179-2; Ribic CA, 2012, STUD AVIAN BIOL, P119; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; Ribic CA, 2009, AM MIDL NAT, V161, P110, DOI 10.1674/0003-0031-161.1.110; RICH TD, 2004, PARTNERS FLIGHT N AM; Richardson TW, 2009, J WILDLIFE MANAGE, V73, P287, DOI 10.2193/2007-566; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Roper JJ, 1997, J AVIAN BIOL, V28, P111, DOI 10.2307/3677304; RUGG D. J., 2003, NC232 USDA FOR SERV; Sample D.W., 1997, MANAGING HABITAT GRA; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Thompson FR, 2012, STUD AVIAN BIOL, P23; Turner B., 1990, EARTH TRANSFORMED HU; Wells KMS, 2007, CONDOR, V109, P781, DOI 10.1650/0010-5422(2007)109[781:SOPGBI]2.0.CO;2; Winter M, 2006, J WILDLIFE MANAGE, V70, P158, DOI 10.2193/0022-541X(2006)70[158:PSALEO]2.0.CO;2; Winter M, 2004, WILSON BULL, V116, P211, DOI 10.1676/03-082; Winter M, 2000, CONDOR, V102, P256, DOI 10.1650/0010-5422(2000)102[0256:EFEEOM]2.0.CO;2; Wisconsin Department of Natural Resources, 2005, WISC STRAT WILDL SPE; With KA, 2008, BIOL CONSERV, V141, P3152, DOI 10.1016/j.biocon.2008.09.025	81	42	45	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59151	10.1371/journal.pone.0059151	http://dx.doi.org/10.1371/journal.pone.0059151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565144	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300011
J	Qian, L; Xu, KF; Xu, XY; Gu, R; Liu, X; Shan, S; Yang, T				Qian, Li; Xu, Kuanfeng; Xu, Xinyu; Gu, Rong; Liu, Xuan; Shan, Shan; Yang, Tao			UCP2-866G/A, Ala55Val and UCP3-55C/T Polymorphisms in Association with Obesity Susceptibility - A Meta-Analysis Study	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 GENE; MESSENGER-RNA EXPRESSION; BODY-MASS INDEX; UCP3 GENE; PROMOTER POLYMORPHISM; MUTATIONAL ANALYSIS; INSULIN-RESISTANCE; VARIANTS; POPULATION; CHILDHOOD	Aims/hypothesis: Variants of UCP2 and UCP3 genes have been reported to be associated with obesity, but the available data on the relationship are inconsistent. A meta-analysis was performed to determine whether there are any associations between the UCP2 -866G/A, Ala55Val, and UCP3 -55C/T polymorphisms and obesity susceptibility. Methods: The PubMed, Embase, Web of Science and CNKI, CBMdisc databases were searched for all relevant case-control studies. The fixed or random effect pooled measure was determined on the bias of heterogeneity test among studies. Publication bias was examined by the modified Begg's and Egger's test. Results: Twenty-two published articles with thirty-two outcomes were included in the meta-analysis: 12 studies with a total of 7,390 cases and 9,860 controls were analyzed for UCP2 -866G/A polymorphism with obesity, 9 studies with 1,483 cases and 2,067 controls for UCP2 Ala55Val and 8 studies with 2,180 cases and 2,514 controls for UCP3 -55C/T polymorphism. Using an additive model, the UCP2 -866G/A polymorphism showed no significant association with obesity risk in Asians (REM OR = 0.81, 95% CI: 0.65-1.01). In contrast, a statistically significant association was observed in subjects of European descent (FEM OR = 1.06, 95% CI: 1.01-1.12). But neither the UCP2 Ala55Val nor the UCP3 -55C/T polymorphism showed any significant association with obesity risk in either subjects of Asian (REM OR = 0.84, 95% CI: 0.67-1.06 for Ala55Val; REM OR = 0.94, 95% CI: 0.55-1.28 for -55C/T) or of European descent (REM OR = 1.04, 95% CI: 0.80-1.36 for Ala55Val; FEM OR = 1.08, 95% CI: 0.97-1.20 for -55C/T). Conclusions and Interpretation: Our meta-analysis revealed that the UCP2 -866G/A polymorphism may be a risk factor for susceptibility to obesity in subjects of European descent, but not in individuals of Asian descent. And our results did not support the association between UCP2 Ala55Val, UCP3 -55C/T polymorphisms and obesity in the populations investigated. This conclusion warrants confirmation by further studies.	[Qian, Li; Xu, Kuanfeng; Xu, Xinyu; Gu, Rong; Liu, Xuan; Shan, Shan; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn		Qian, LI/0000-0002-6833-5080	National Natural Science Foundation of China [81270892, 30400219, 30671010, 30971405]; Natural Science Foundation of Jiangsu province [BK2012486]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province)	The study was supported by grants from the National Natural Science Foundation of China (numbers 81270892, 30400219, 30671010 and 30971405) and the Natural Science Foundation of Jiangsu province (number BK2012486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2005, ANN NUTR METAB, V49, P183, DOI 10.1159/000086883; Andersen G, 2013, INT J OBESITY, V37, P175, DOI 10.1038/ijo.2012.22; Berentzen T, 2005, INT J OBESITY, V29, P93, DOI 10.1038/sj.ijo.0802841; Borecki IB, 1998, AM J HUM GENET, V63, P831, DOI 10.1086/302006; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Dalgaard LT, 2001, J CLIN ENDOCR METAB, V86, P1398, DOI 10.1210/jc.86.3.1398; Dalgaard LT, 2003, OBES RES, V11, P1420, DOI 10.1038/oby.2003.191; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jun HS, 2009, OBESITY, V17, P355, DOI 10.1038/oby.2008.531; Kosuge K, 2008, ENDOCRINE, V34, P87, DOI 10.1007/s12020-008-9111-9; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Kubota T, 1998, J CLIN ENDOCR METAB, V83, P2800, DOI 10.1210/jc.83.8.2800; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Mancini FP, 2003, CLIN ENDOCRINOL, V59, P817, DOI 10.1046/j.1365-2265.2003.01926.x; Matsuda J, 1997, FEBS LETT, V418, P200, DOI 10.1016/S0014-5793(97)01381-1; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; Mottagui-Tabar S, 2008, HORM RES, V69, P31, DOI 10.1159/000111793; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Ochoa MC, 2007, MOL GENET METAB, V92, P351, DOI 10.1016/j.ymgme.2007.07.011; Oktavianthi S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-41; Otabe S, 1998, DIABETES, V47, P840, DOI 10.2337/diabetes.47.5.840; Rosmond R, 2003, INT J OBESITY, V27, P1141, DOI 10.1038/sj.ijo.0802397; Schauble N, 2003, EXP CLIN ENDOCR DIAB, V111, P73, DOI 10.1055/s-2003-39232; Schrauwen P, 1999, INT J OBESITY, V23, P1242, DOI 10.1038/sj.ijo.0801057; Schrauwen P, 1999, DIABETES, V48, P146, DOI 10.2337/diabetes.48.1.146; Srivastava N, 2010, MOL CELL BIOCHEM, V337, P293, DOI 10.1007/s11010-009-0311-2; Urhammer SA, 1997, DIABETOLOGIA, V40, P1227, DOI 10.1007/s001250050811; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, pE1, DOI 10.1152/ajpendo.00231.2003; Wang TN, 2007, INT J OBESITY, V31, P1746, DOI 10.1038/sj.ijo.0803648; Xiu Ling-ling, 2004, Zhonghua Yi Xue Za Zhi, V84, P375; Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y; [杨明 Yang Ming], 2004, [上海医学, Shanghai medical journal], V27, P237; Zhou H, 2011, MOL CARDIOL CHINA, V11, P158	42	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58939	10.1371/journal.pone.0058939	http://dx.doi.org/10.1371/journal.pone.0058939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23560041	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900009
J	Kalyango, JN; Rutebemberwa, E; Karamagi, C; Mworozi, E; Ssali, S; Alfven, T; Peterson, S				Kalyango, Joan N.; Rutebemberwa, Elizeus; Karamagi, Charles; Mworozi, Edison; Ssali, Sarah; Alfven, Tobias; Peterson, Stefan			High Adherence to Antimalarials and Antibiotics under Integrated Community Case Management of Illness in Children Less than Five Years in Eastern Uganda	PLOS ONE			English	Article							HOME MANAGEMENT; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; COMBINATION THERAPY; FALCIPARUM-MALARIA; CARE-SEEKING; PNEUMONIA; OVERLAP; DETERMINANTS	Background: Development of resistance to first line antimalarials led to recommendation of artemisinin based combination therapies (ACTs). High adherence to ACTs provided by community health workers (CHWs) gave reassurance that community based interventions did not increase the risk of drug resistance. Integrated community case management of illnesses (ICCM) is now recommended through which children will access both antibiotics and antimalarials from CHWs. Increased number of medicines has been shown to lower adherence. Objective: To compare adherence to antimalarials alone versus antimalarials combined with antibiotics under ICCM in children less than five years. Methods: A cohort study was nested within a cluster randomized trial that had CHWs treating children less than five years with antimalarials and antibiotics (intervention areas) and CHWs treating children with antimalarials only (control areas). Children were consecutively sampled from the CHWs' registers in the control areas (667 children); and intervention areas (323 taking antimalarials only and 266 taking antimalarials plus antibiotics). The sampled children were visited at home on day one and four of treatment seeking. Adherence was assessed using self reports and pill counts. Results: Adherence in the intervention arm to antimalarials alone and antimalarials plus antibiotics arm was similar (mean 99% in both groups) but higher than adherence in the control arm (antimalarials only) (mean 96%). Forgetfulness (38%) was the most cited reason for non-adherence. At adjusted analysis: absence of fever (OR = 3.3, 95%CI = 1.6-6.9), seeking care after two or more days (OR = 2.2, 95%CI = 1.3-3.7), not understanding instructions given (OR = 24.5, 95% CI = 2.7-224.5), vomiting (OR = 2.6, 95%CI = 1.2-5.5), and caregivers' perception that the child's illness was not severe (OR = 2.0, 95%CI = 1.1-3.8) were associated with non-adherence. Conclusions: Addition of antibiotics to antimalarials did not lower adherence. However, caregivers should be adequately counseled to understand the dosing regimens; continue with medicines even when the child seems to improve; and re-administer doses that have been vomited.	[Kalyango, Joan N.; Alfven, Tobias; Peterson, Stefan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Kalyango, Joan N.; Karamagi, Charles] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Coll Hlth Sci, Dept Pharm, Kampala, Uganda; [Rutebemberwa, Elizeus; Peterson, Stefan] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Karamagi, Charles; Mworozi, Edison] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [Ssali, Sarah] Makerere Univ, Dept Gender & Women Studies, Kampala, Uganda; [Alfven, Tobias] Karolinska Inst, Sachs Childrens Hosp, Dept Paediat, Stockholm, Sweden; [Peterson, Stefan] Uppsala Univ, Int Maternal & Child Hlth Unit, Uppsala, Sweden	Karolinska Institutet; Makerere University; Makerere University; Makerere University; Makerere University; Makerere University; Karolinska Institutet; Uppsala University	Kalyango, JN (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	nakayaga2001@yahoo.com	SSALI, SARAH/AAT-6884-2021	SSALI, SARAH/0000-0002-5678-1868; Rutebemberwa, Elizeus/0000-0001-8363-7928; Alfven, Tobias/0000-0002-2328-3512	Sida/SAREC; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases	Sida/SAREC; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases	This study received financial support from Sida/SAREC and UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2763; Adamchak S, 2000, GUIDE MONITORING EVA; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-190; [Anonymous], MAL CHILDR PROGR INT; [Anonymous], ROLL BACK MAL STRAT; [Anonymous], 2001, ANT DRUG COMB THER; Beer N, 2009, TROP MED INT HEALTH, V14, P766, DOI 10.1111/j.1365-3156.2009.02289.x; BUSH PJ, 1990, MED CARE, V28, P69, DOI 10.1097/00005650-199001000-00008; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Kabanywanyi AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-48; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kalyango JN, 2012, AM J TROP M IN PRESS; Kalyango JN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-282; Kolaczinski JH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-40; Lawford H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-281; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Minzi O M S, 2008, Tanzan J Health Res, V10, P84; Nanyunja M, 2011, MALARIA TREATMENT PO, V2011; Nsungwa-Sabiiti J, 2004, TROP MED INT HEALTH, V9, P1191, DOI 10.1111/j.1365-3156.2004.01319.x; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Simba DO, T ROYAL SOC TROPICAL, V106, P3; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; UNICEF WHO, 2006, PNEUM FORG KILL CHIL, P44; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; WHO, 2011, CHILD AD HLTH PROGR; WHO, 2012, GLOB AMDP DAT WHO AF; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2008, INT MAN CHILDH ILLN; World Health Organization, 2007, COMM HLTH WORK WHAT; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	36	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60481	10.1371/journal.pone.0060481	http://dx.doi.org/10.1371/journal.pone.0060481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555980	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900074
J	Penzvalto, Z; Tegze, B; Szasz, AM; Sztupinszki, Z; Liko, I; Szendroi, A; Schafer, R; Gyorffy, B				Penzvalto, Zsofia; Tegze, Balint; Szasz, A. Marcell; Sztupinszki, Zsofia; Liko, Istvan; Szendroi, Attila; Schaefer, Reinhold; Gyorffy, Balazs			Identifying Resistance Mechanisms against Five Tyrosine Kinase Inhibitors Targeting the ERBB/RAS Pathway in 45 Cancer Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LUNG-CANCER; KRAS MUTATIONS; ONCOGENE ADDICTION; TUMOR PROGRESSION; INTERFERON-ALPHA; SOLID TUMORS; GENE LISTS; ANNEXIN A3; EXPRESSION	Because of the low overall response rates of 10-47% to targeted cancer therapeutics, there is an increasing need for predictive biomarkers. We aimed to identify genes predicting response to five already approved tyrosine kinase inhibitors. We tested 45 cancer cell lines for sensitivity to sunitinib, erlotinib, lapatinib, sorafenib and gefitinib at the clinically administered doses. A resistance matrix was determined, and gene expression profiles of the subsets of resistant vs. sensitive cell lines were compared. Triplicate gene expression signatures were obtained from the caArray project. Significance analysis of microarrays and rank products were applied for feature selection. Ninety-five genes were also measured by RT-PCR. In case of four sunitinib resistance associated genes, the results were validated in clinical samples by immunohistochemistry. A list of 63 top genes associated with resistance against the five tyrosine kinase inhibitors was identified. Quantitative RT-PCR analysis confirmed 45 of 63 genes identified by microarray analysis. Only two genes (ANXA3 and RAB25) were related to sensitivity against more than three inhibitors. The immunohistochemical analysis of sunitinib-treated metastatic renal cell carcinomas confirmed the correlation between RAB17, LGALS8, and EPCAM and overall survival. In summary, we determined predictive biomarkers for five tyrosine kinase inhibitors, and validated sunitinib resistance biomarkers by immunohistochemistry in an independent patient cohort.	[Penzvalto, Zsofia; Tegze, Balint; Sztupinszki, Zsofia] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Szasz, A. Marcell] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Liko, Istvan] Gedeon Richter Plc, Budapest, Hungary; [Szendroi, Attila] Semmelweis Univ, Dept Urol, H-1085 Budapest, Hungary; [Gyorffy, Balazs] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary	Semmelweis University; Semmelweis University; Gedeon Richter Chemistry Works; Semmelweis University; Hungarian Academy of Sciences	Gyorffy, B (corresponding author), Charite, Lab Funct Genom & Mol Tumor Pathol, D-13353 Berlin, Germany.	gyorffy@kmplot.com	Gyorffy, Balazs/AAA-9135-2021; Schäfer, Reinhold/AAB-5110-2021	Gyorffy, Balazs/0000-0002-5772-3766; Sztupinszki, Zsofia/0000-0002-8691-4086; Liko, Istvan/0000-0001-7668-4726; Szasz, Attila Marcell/0000-0003-2739-4196	OTKA [PD 83154]; Alexander von Humboldt Stiftung; Predict project [259303];  [TAMOP-4.2.1.B-09/1/KMR-2010-0001]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Predict project; 	The study was supported by the OTKA PD 83154, by the Predict project (grant no. 259303 of the Health.2010.2.4.1.-8 call), by the TAMOP-4.2.1.B-09/1/KMR-2010-0001 and by the Alexander von Humboldt Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakanat A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-75; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Armato SG, 2007, ACAD RADIOL, V14, P1409, DOI 10.1016/j.acra.2007.07.008; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Cheng JM, 2010, INT J CANCER, V126, P2799, DOI 10.1002/ijc.24900; Choueiri TK, 2008, J CLIN ONCOL, V26, P127, DOI 10.1200/JCO.2007.13.3223; Cludts S, 2009, ANTICANCER RES, V29, P4933; Cohen Allan J, 2003, Sci Pract Perspect, V2, P15; Cohen MH, 2003, ONCOLOGIST, V8, P303, DOI 10.1634/theoncologist.8-4-303; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Dietmann S, 2010, NUCLEIC ACIDS RES, V38, pW118, DOI 10.1093/nar/gkq515; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gyorffy B, 2010, CURR CANCER DRUG TAR, V10, P858, DOI 10.2174/156800910793357916; Gyorffy B, 2005, ONCOGENE, V24, P7542, DOI 10.1038/sj.onc.1208908; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jung EJ, 2010, PROTEOM CLIN APPL, V4, P528, DOI 10.1002/prca.200900063; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; LUTCKE A, 1993, J CELL BIOL, V121, P553, DOI 10.1083/jcb.121.3.553; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Minematsu T, 2011, MOL CANCER THER, V10, P531, DOI 10.1158/1535-7163.MCT-10-0731; Miyake M, 1996, CANCER RES, V56, P1244; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nam KT, 2010, J CLIN INVEST, V120, P840, DOI 10.1172/JCI40728; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Ruan L, 2010, MED ONCOL, V27, P1407, DOI 10.1007/s12032-009-9394-6; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Widemann BC, 2012, CLIN CANCER RES, V18, P6011, DOI 10.1158/1078-0432.CCR-11-3284; Yan XD, 2010, CANCER RES, V70, P1616, DOI 10.1158/0008-5472.CAN-09-3215; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	52	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59503	10.1371/journal.pone.0059503	http://dx.doi.org/10.1371/journal.pone.0059503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555683	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900014
J	Jiang, DJ; Zheng, DW; Wang, LY; Huang, Y; Liu, HB; Xu, LT; Liao, Q; Liu, PP; Shi, XB; Wang, ZY; Sun, LB; Zhou, QY; Li, N; Xu, LM; Le, YP; Ye, M; Shao, GF; Duan, SW				Jiang, Danjie; Zheng, Dawei; Wang, Lingyan; Huang, Yi; Liu, Haibo; Xu, Leiting; Liao, Qi; Liu, Panpan; Shi, Xinbao; Wang, Zhaoyang; Sun, Lebo; Zhou, Qingyun; Li, Ni; Xu, Limin; Le, Yanping; Ye, Meng; Shao, Guofeng; Duan, Shiwei			Elevated PLA2G7 Gene Promoter Methylation as a Gender-Specific Marker of Aging Increases the Risk of Coronary Heart Disease in Females	PLOS ONE			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; CATALYTIC ACTIVITY CONCENTRATIONS; ACUTE MYOCARDIAL-INFARCTION; GLOBAL DNA METHYLATION; ARTERY-DISEASE; PHOSPHOLIPASE A(2); ATHEROSCLEROTIC PLAQUE; UNSTABLE ANGINA; ASSOCIATION; SEX	PLA2G7 gene product is a secreted enzyme whose activity is associated with coronary heart disease (CHD). The goal of our study is to investigate the contribution of PLA2G7 promoter DNA methylation to the risk of CHD. Using the bisulphite pyrosequencing technology, PLA2G7 methylation was measured among 36 CHD cases and 36 well-matched controls. Our results indicated that there was a significant association between PLA2G7 methylation and CHD (adjusted P = 0.025). Significant gender-specific correlation was observed between age and PLA2G7 methylation (males: adjusted r = -0.365, adjusted P = 0.037; females: adjusted r = 0.373, adjusted P = 0.035). A breakdown analysis by gender showed that PLA2G7 methylation was significantly associated with CHD in females (adjusted P = 0.003) but not in males. A further two-way ANOVA analysis showed there was a significant interaction between gender and status of CHD for PLA2G7 methylation (gender*CHD: P = 6.04E-7). Moreover, PLA2G7 methylation is associated with the levels of total cholesterols (TC, r = 0.462, P = 0.009), triglyceride (TG, r = 0.414, P = 0.02) and Apolipoprotein B (ApoB, r = 0.396, P = 0.028) in females but not in males (adjusted P > 0.4). Receiver operating characteristic (ROC) curves showed that PLA2G7 methylation could predict the risk of CHD in females (area under curve (AUC) = 0.912, P = 2.40E-5). Our results suggest that PLA2G7 methylation changes with aging in a gender-specific pattern. The correlation between PLA2G7 methylation and CHD risk in females is independent of other parameters including age, smoking, diabetes and hypertension. PLA2G7 methylation might exert its effects on the risk of CHD by regulating the levels of TC, TG, and ApoB in females. The gender disparities in the PLA2G7 methylation may play a role in the molecular mechanisms underlying the pathophysiology of CHD.	[Jiang, Danjie; Zheng, Dawei; Shi, Xinbao; Wang, Zhaoyang; Sun, Lebo; Zhou, Qingyun; Li, Ni; Shao, Guofeng] Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China; [Jiang, Danjie; Huang, Yi; Xu, Leiting; Liao, Qi; Liu, Panpan; Xu, Limin; Le, Yanping; Ye, Meng; Duan, Shiwei] Ningbo Univ, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Jiang, Danjie; Huang, Yi; Xu, Leiting; Liao, Qi; Liu, Panpan; Xu, Limin; Le, Yanping; Duan, Shiwei] Ningbo Univ, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Lingyan] Ningbo 2 Hosp, Bank Blood Prod, Ningbo, Zhejiang, Peoples R China; [Liu, Haibo] Ningbo Univ, Yinzhou Peoples Hosp, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University; Ningbo University; Ningbo University	Ye, M (corresponding author), Ningbo Univ, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China.	dryemeng@yahoo.com.cn; sgf1958@sina.com; duanshiwei@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022; , Liu/AAL-6898-2020; Liu, Haibo/HHN-6599-2022; Liu, Haibo/AAI-6812-2020	, Liu/0000-0002-6999-8927; Liu, Haibo/0000-0002-6999-8927; Huang, Yi/0000-0003-3598-9747; Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919]; K. C. Wong Magna Fund in Ningbo University; Advanced Key Scientific and Technological Programs of Ningbo [2011C51001]; Science and Technology Innovation team of Ningbo [2011B82015]; Ningbo natural science foundation [2011A610036, 2011A610052]; Zhejiang provincial natural science foundation [LY12H16002]; Ningbo social development research projects [2012C50032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Magna Fund in Ningbo University; Advanced Key Scientific and Technological Programs of Ningbo; Science and Technology Innovation team of Ningbo; Ningbo natural science foundation; Zhejiang provincial natural science foundation(Natural Science Foundation of Zhejiang Province); Ningbo social development research projects	The research was supported by the grants from National Natural Science Foundation of China (31100919), K. C. Wong Magna Fund in Ningbo University, Advanced Key Scientific and Technological Programs of Ningbo (2011C51001), Science and Technology Innovation team of Ningbo (2011B82015), Ningbo natural science foundation (2011A610036, 2011A610052), Zhejiang provincial natural science foundation (LY12H16002), and Ningbo social development research projects (2012C50032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmal M, 2010, MOL BIOL REP, V37, P3869, DOI 10.1007/s11033-010-0043-0; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Anderson J, 2001, Nurse Pract, V26, P21; Anderson J, 2001, NURSE PRACT, V26, P32; Anderson J, 2001, NURSE PRACT, V26, P21; Anderson J, 2001, NURSE PRACT, V26, P18; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bosner S, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-79; Bressler J, 2011, ATHEROSCLEROSIS, V219, P958, DOI 10.1016/j.atherosclerosis.2011.09.040; Casas JP, 2010, CIRCULATION, V121, P2284, DOI 10.1161/CIRCULATIONAHA.109.923383; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Chen CX, 2001, CHINESE MED J-PEKING, V114, P1095; Corti MC, 1996, AGING CLIN EXP RES, V8, P75, DOI 10.1007/BF03339560; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Docherty SJ, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-31; Doumas BT, 1997, CLIN CHIM ACTA, V258, P3, DOI 10.1016/S0009-8981(96)06446-7; Epps KC, 2011, J INTERN MED, V269, P94, DOI 10.1111/j.1365-2796.2010.02297.x; Fang CF, 2009, ACTA CARDIOL, V64, P195, DOI 10.2143/AC.64.2.2036137; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Ferguson JF, 2012, J AM COLL CARDIOL, V59, P764, DOI 10.1016/j.jacc.2011.11.019; Friso S, 2012, J MED GENET, V49, P192, DOI 10.1136/jmedgenet-2011-100195; Gan SC, 2000, NEW ENGL J MED, V343, P8, DOI 10.1056/NEJM200007063430102; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Grallert H, 2012, EUR HEART J, V33, P238, DOI 10.1093/eurheartj/ehr372; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Hyvarinen M, 2010, INT J STROKE, V5, P152, DOI 10.1111/j.1747-4949.2010.00423.x; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kerr KM, 2007, DIS MARKERS, V23, P5, DOI 10.1155/2007/985474; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Lawton JS, 2011, SEMIN THORAC CARDIOV, V23, P126, DOI 10.1053/j.semtcvs.2011.07.006; Li LY, 2011, ANN HUM GENET, V75, P605, DOI 10.1111/j.1469-1809.2011.00666.x; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Mahon NG, 2000, AM J CARDIOL, V85, P921, DOI 10.1016/S0002-9149(99)00902-9; McDonald KL, 2012, EUR J CANC; Mosher MJ, 2008, GENES NUTR, V3, P87, DOI 10.1007/s12263-008-0075-4; Nie G-n, 2011, MATERN CHILD HLTH J, V26, P3; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Sbarouni E, 2011, BIOMARKERS, V16, P457, DOI 10.3109/1354750X.2011.576431; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; Schumann G, 2010, CLIN CHEM LAB MED, V48, P615, DOI 10.1515/CCLM.2010.137; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Sertic Jadranka, 2010, Acta Med Croatica, V64, P237; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; van der Meer MG, 2012, EUR J PREV CARDIOL; Vittos O, 2012, BIOMARKERS, V17, P289, DOI 10.3109/1354750X.2012.664170; Wang QQ, 2010, THROMB RES, V126, P498, DOI 10.1016/j.thromres.2010.09.009; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; YASUDA K, 1992, ENDOCRINOLOGY, V130, P708, DOI 10.1210/en.130.2.708; Yasuda K, 1996, BIOL REPROD, V54, P224, DOI 10.1095/biolreprod54.1.224; Yoshimura T, 1999, MATURITAS, V31, P249, DOI 10.1016/S0378-5122(99)00004-3; Zhao Ying, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P423; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023	58	65	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59752	10.1371/journal.pone.0059752	http://dx.doi.org/10.1371/journal.pone.0059752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555769	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200036
J	Safeukui, I; Buffet, PA; Perrot, S; Sauvanet, A; Aussilhou, B; Dokmak, S; Couvelard, A; Hatem, DC; Mohandas, N; David, PH; Mercereau-Puijalon, O; Milon, G				Safeukui, Innocent; Buffet, Pierre A.; Perrot, Sylvie; Sauvanet, Alain; Aussilhou, Beatrice; Dokmak, Safi; Couvelard, Anne; Hatem, Dominique Cazals; Mohandas, Narla; David, Peter H.; Mercereau-Puijalon, Odile; Milon, Genevieve			Surface Area Loss and Increased Sphericity Account for the Splenic Entrapment of Subpopulations of Plasmodium falciparum Ring-Infected Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; RESA PROTEIN; DEFORMABILITY; CHOLESTEROL; SURVIVAL; PULP	Ex vivo perfusion of human spleens revealed innate retention of numerous cultured Plasmodium falciparum ring-infected red blood cells (ring-iRBCs). Ring-iRBC retention was confirmed by a microsphiltration device, a microbead-based technology that mimics the mechanical filtering function of the human spleen. However, the cellular alterations underpinning this retention remain unclear. Here, we use ImageStream technology to analyze infected RBCs' morphology and cell dimensions before and after fractionation with microsphiltration. Compared to fresh normal RBCs, the mean cell membrane surface area loss of trophozoite-iRBCs, ring-iRBCs and uninfected co-cultured RBCs (uRBCs) was 14.2% (range: 8.3-21.9%), 9.6% (7.3-12.2%) and 3.7% (0-8.4), respectively. Microsphilters retained 100%, similar to 50% and 4% of trophozoite-iRBCs, ring-iRBCs and uRBCs, respectively. Retained ring-iRBCs display reduced surface area values (estimated mean, range: 17%, 15-18%), similar to the previously shown threshold of surface-deficient RBCs retention in the human spleen (surface area loss: >18%). By contrast, ring-iRBCs that successfully traversed microsphilters had minimal surface area loss and normal sphericity, suggesting that these parameters are determinants of their retention. To confirm this hypothesis, fresh normal RBCs were exposed to lysophosphatidylcholine to induce a controlled loss of surface area. This resulted in a dose-dependent retention in microsphilters, with complete retention occurring for RBCs displaying >14% surface area loss. Taken together, these data demonstrate that surface area loss and resultant increased sphericity drive ring-iRBC retention in microsphilters, and contribute to splenic entrapment of a subpopulation of ring-iRBCs. These findings trigger more interest in malaria research fields, including modeling of infection kinetics, estimation of parasite load, and analysis of risk factors for severe clinical forms. The determination of the threshold of splenic retention of ring-iRBCs has significant implications for diagnosis (spleen functionality) and drug treatment (screening of adjuvant therapy targeting ring-iRBCs).	[Safeukui, Innocent; Perrot, Sylvie; David, Peter H.; Mercereau-Puijalon, Odile; Milon, Genevieve] Inst Pasteur, Dept Parasitol Mycol, Paris, France; [Safeukui, Innocent; Perrot, Sylvie; David, Peter H.; Mercereau-Puijalon, Odile] CNRS, URA2581, Paris, France; [Safeukui, Innocent] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Buffet, Pierre A.] Univ Paris 06, UMRs945, INSERM, Paris, France; [Buffet, Pierre A.] Hop La Pitie Salpetriere, AP HP, Dept Parasitol, Paris, France; [Sauvanet, Alain; Aussilhou, Beatrice; Dokmak, Safi] Beaujon Hosp, AP HP, Dept Surg, Clichy, France; [Couvelard, Anne; Hatem, Dominique Cazals] Beaujon Hosp, AP HP, Dept Pathol, Clichy, France; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Notre Dame; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; New York Blood Center	Safeukui, I (corresponding author), Inst Pasteur, Dept Parasitol Mycol, Paris, France.	innocent.safeukui@nd.edu	Mercereau-Puijalon, Odile/AAA-2242-2020; Buffet, Pierre A/O-6189-2017	Buffet, Pierre A/0000-0003-4010-929X; SAUVANET, alain/0000-0002-7436-5999; Anne, Couvelard/0000-0002-6316-1210	Fonds dedie Combattre les maladies parasitaires; Sanofi Aventis-Ministe re de l'Enseignement Superieur et de la Recherche-Institut Pasteur; Centre National de la Recherche Scientifique; Institut Pasteur; Dim Malinf of the Region Ile de France; European Union Seventh Framework Program [242095 (Evimalar)]; Project: Mechanisms of erythrocytic Infection & Anemia in Malaria PI Kasturi Haldar; National Institutes of Health [5P01HL078826-06, DK32094]; Conseil de la Region Ile de France [I-08-1090]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, P01DK032094] Funding Source: NIH RePORTER	Fonds dedie Combattre les maladies parasitaires; Sanofi Aventis-Ministe re de l'Enseignement Superieur et de la Recherche-Institut Pasteur; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Dim Malinf of the Region Ile de France(Region Ile-de-France); European Union Seventh Framework Program(European Commission); Project: Mechanisms of erythrocytic Infection & Anemia in Malaria PI Kasturi Haldar; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conseil de la Region Ile de France(Region Ile-de-France); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the "Fonds dedie Combattre les maladies parasitaires,'' Sanofi Aventis-Ministe re de l'Enseignement Superieur et de la Recherche-Institut Pasteur, the Centre National de la Recherche Scientifique, and the Institut Pasteur. I.S. was funded by a fellowship from the Dim Malinf of the Region Ile de France. The research leading to these results received funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement 242095 (Evimalar) and from the Project: Mechanisms of erythrocytic Infection & Anemia in Malaria PI Kasturi Haldar, and the National Institutes of Health (Award Number 5P01HL078826-06). The ImageStream apparatus (Amnis) was acquired by a grant from the Conseil de la Region Ile de France, program Sesame 2007 no I-08-1090 - Imagopole. N.M. acknowledges the "Fonds dedie Combattre les maladies parasitaires,'' Sanofi Aventis-Ministe re de l'Enseignement Superieur et de la Recherche-Institut Pasteur, which made possible his sabbatical stay at Institut Pasteur and NIH grant DK32094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANHAM PB, 1969, CIRC RES, V25, P39, DOI 10.1161/01.RES.25.1.39; CHASIS JA, 1989, BLOOD, V74, P2562; CHEN L, 1972, AM J ANAT, V134, P425, DOI 10.1002/aja.1001340404; CHEN LT, 1973, BLOOD, V41, P529, DOI 10.1182/blood.V41.4.529.529; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; COOPER RA, 1968, J CLIN INVEST, V47, P809, DOI 10.1172/JCI105775; Cortes A, 2008, TRENDS PARASITOL, V24, P517, DOI 10.1016/j.pt.2008.08.005; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Deplaine G, 2011, BLOOD, V117, pE88, DOI 10.1182/blood-2010-10-312801; Dyrda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009447; Esposito A, 2010, BIOPHYS J, V99, P953, DOI 10.1016/j.bpj.2010.04.065; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; Hardeman MR, 1999, CLIN HEMORHEOL MICRO, V21, P277; HEBBEL RP, 1991, BIOPHYS J, V60, P712, DOI 10.1016/S0006-3495(91)82100-2; Herricks T, 2012, CELL MICROBIOL, V14, P1880, DOI 10.1111/cmi.12007; Herricks T, 2009, CELL MICROBIOL, V11, P1340, DOI 10.1111/j.1462-5822.2009.01334.x; JACOB HS, 1964, J CLIN INVEST, V43, P1704, DOI 10.1172/JCI105046; LANGE Y, 1982, J LIPID RES, V23, P1121; Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104; MOHANDAS N, 1980, J CLIN INVEST, V66, P563, DOI 10.1172/JCI109888; MOHANDAS N, 1978, J SUPRAMOL STR CELL, V9, P453, DOI 10.1002/jss.400090315; Murdock RC, 2000, AM J PHYSIOL-CELL PH, V279, pC970, DOI 10.1152/ajpcell.2000.279.4.C970; Nash G, 1988, CHANGES HUMAN RED CE; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Ogembo JG, 2012, J IMMUNOL, V188, P4496, DOI 10.4049/jimmunol.1103086; PARPART AK, 1947, J CLIN INVEST, V26, P636, DOI 10.1172/JCI101847; Pouvelle B, 2000, NAT MED, V6, P1264, DOI 10.1038/81374; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Safeukui I, 2012, BLOOD, V120, P424, DOI 10.1182/blood-2012-01-404103; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; Waugh RE, 1996, AM J PHYSIOL-CELL PH, V271, pC1847, DOI 10.1152/ajpcell.1996.271.6.C1847	32	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60150	10.1371/journal.pone.0060150	http://dx.doi.org/10.1371/journal.pone.0060150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555907	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200087
J	Ding, F; Yao, J; Zhao, LQ; Mao, ZS; Chen, SH; Brinton, RD				Ding, Fan; Yao, Jia; Zhao, Liqin; Mao, Zisu; Chen, Shuhua; Brinton, Roberta Diaz			Ovariectomy Induces a Shift in Fuel Availability and Metabolism in the Hippocampus of the Female Transgenic Model of Familial Alzheimer's	PLOS ONE			English	Article							BRAIN GLUCOSE-METABOLISM; AMYLOID-BETA-PROTEIN; POSITRON-EMISSION-TOMOGRAPHY; A-BETA; HEXOKINASE-ACTIVITY; AEROBIC GLYCOLYSIS; ENERGY-METABOLISM; HORMONE-THERAPY; RAT-BRAIN; IN-VIVO	Previously, we demonstrated that reproductive senescence in female triple transgenic Alzheimer's (3xTgAD) mice was paralleled by a shift towards a ketogenic profile with a concomitant decline in mitochondrial activity in brain, suggesting a potential association between ovarian hormone loss and alteration in the bioenergetic profile of the brain. In the present study, we investigated the impact of ovariectomy and 17 beta-estradiol replacement on brain energy substrate availability and metabolism in a mouse model of familial Alzheimer's (3xTgAD). Results of these analyses indicated that ovarian hormones deprivation by ovariectomy (OVX) induced a significant decrease in brain glucose uptake indicated by decline in 2-[F-18]fluoro-2-deoxy-D-glucose uptake measured by microPET-imaging. Mechanistically, OVX induced a significant decline in blood-brain-barrier specific glucose transporter expression, hexokinase expression and activity. The decline in glucose availability was accompanied by a significant rise in glial LDH5 expression and LDH5/LDH1 ratio indicative of lactate generation and utilization. In parallel, a significant rise in ketone body concentration in serum occurred which was coupled to an increase in neuronal MCT2 expression and 3-oxoacid-CoA transferase (SCOT) required for conversion of ketone bodies to acetyl-CoA. In addition, OVX-induced decline in glucose metabolism was paralleled by a significant increase in A beta oligomer levels. 17 beta-estradiol preserved brain glucose-driven metabolic capacity and partially prevented the OVX-induced shift in bioenergetic substrate as evidenced by glucose uptake, glucose transporter expression and gene expression associated with aerobic glycolysis. 17 beta-estradiol also partially prevented the OVX-induced increase in A beta oligomer levels. Collectively, these data indicate that ovarian hormone loss in a preclinical model of Alzheimer's was paralleled by a shift towards the metabolic pathway required for metabolism of alternative fuels in brain with a concomitant decline in brain glucose transport and metabolism. These findings also indicate that estrogen plays a critical role in sustaining brain bioenergetic capacity through preservation of glucose metabolism.	[Ding, Fan; Yao, Jia; Zhao, Liqin; Mao, Zisu; Chen, Shuhua; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Brinton, Roberta Diaz] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Brinton, RD (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	rbrinton@usc.edu		Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [R01AG032236]; Kenneth T. Eileen L. Norris Foundation; NATIONAL INSTITUTE ON AGING [R01AG032236] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kenneth T. Eileen L. Norris Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute on Aging grant R01AG032236 (to RDB) and the Kenneth T. Eileen L. Norris Foundation (to RDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTUONO PG, 1995, DEMENTIA, V6, P200, DOI 10.1159/000106947; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Barros LF, 2005, TRENDS NEUROSCI, V28, P117, DOI 10.1016/j.tins.2005.01.002; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bentourkia M, 2009, AM J PHYSIOL-ENDOC M, V296, pE796, DOI 10.1152/ajpendo.90644.2008; BISHOP J, 1995, BRAIN RES BULL, V36, P315, DOI 10.1016/0361-9230(94)00208-I; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Chen KW, 2010, NEUROIMAGE, V51, P654, DOI 10.1016/j.neuroimage.2010.02.064; Deecher DC, 2007, ARCH WOMEN MENT HLTH, V10, P247, DOI 10.1007/s00737-007-0209-5; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Eberling JL, 2000, NEUROLOGY, V55, P875, DOI 10.1212/WNL.55.6.875; Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254; Gallicchio L, 2006, FERTIL STERIL, V85, P1432, DOI 10.1016/j.fertnstert.2005.10.033; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Haney AF, 2007, MENOPAUSE, V14, P592, DOI 10.1097/gme.0b013e31804154d5; HOYER S, 1991, ANN NY ACAD SCI, V640, P53, DOI 10.1111/j.1749-6632.1991.tb00190.x; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klepper J, 2004, CURR OPIN NEUROL, V17, P193, DOI 10.1097/00019052-200404000-00018; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; KOSTANYAN A, 1992, BIOCHIM BIOPHYS ACTA, V1133, P301, DOI 10.1016/0167-4889(92)90051-C; Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35; Lazic SE, 2011, NEUROBIOLOGY AGING; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Leybaert L, 2005, J CEREBR BLOOD F MET, V25, P2, DOI 10.1038/sj.jcbfm.9600001; Maki PM, 2001, NEUROIMAGE, V14, P789, DOI 10.1006/nimg.2001.0887; Marcus DL, 1997, ANN NY ACAD SCI, V826, P248, DOI 10.1111/j.1749-6632.1997.tb48476.x; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi L, 2006, J NUCL MED, V47, P1778; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Nilsen J, 2007, J NEUROSCI, V27, P14069, DOI 10.1523/JNEUROSCI.4391-07.2007; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pascual JM, 2002, ANN NEUROL, V52, P458, DOI 10.1002/ana.10311; Pauwels EKJ, 2000, J CANCER RES CLIN, V126, P549, DOI 10.1007/PL00008465; Pavlides S, 2010, AGING-US, V2, P185, DOI 10.18632/aging.100134; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Rasgon NL, 2005, NEUROBIOL AGING, V26, P229, DOI 10.1016/j.neurobiolaging.2004.03.003; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Rosario ER, 2012, BRAIN RES; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Sharma V, 2002, J MAGN RESON IMAGING, V16, P336, DOI 10.1002/jmri.10182; Silverman DHS, 2008, SEMIN NUCL MED, V38, P251, DOI 10.1053/j.semnuclmed.2008.02.006; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; SORBI S, 1990, NEUROSCI LETT, V117, P165, DOI 10.1016/0304-3940(90)90138-Y; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; VENKOV L, 1976, BRAIN RES, V109, P323, DOI 10.1016/0006-8993(76)90533-3; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Williams H, 2010, ENDOCRINOLOGY, V151, P5389, DOI 10.1210/en.2010-0630; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Yao J, 2011, NEUROBIOLOGY AGING; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; YESAVAGE JA, 1982, GERONTOLOGY, V28, P377, DOI 10.1159/000212559; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267	64	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59825	10.1371/journal.pone.0059825	http://dx.doi.org/10.1371/journal.pone.0059825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555795	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500097
J	Lepiller, Q; Abbas, W; Kumar, A; Tripathy, MK; Herbein, G				Lepiller, Quentin; Abbas, Wasim; Kumar, Amit; Tripathy, Manoj K.; Herbein, Georges			HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; HUMAN CYTOMEGALOVIRUS; CYCLIN D1; LIVER INFLAMMATION; CANCER; P53; STAT3; INTERLEUKIN-6; INHIBITION; EXPRESSION	Objectives: There has been increased interest in the possible role of human cytomegalovirus (HCMV) in carcinogenesis during the last decade. HCMV seroprevalence was enhanced in patients with hepatocellular carcinoma (HCC) but a possible relationship between HCC and HCMV infection remained to be assessed. The aim of this work was to investigate the protumor influence of HCMV on primary human hepatocytes (PHH) and HepG2 cells. Methods: Following infection of PHH and HepG2 cells by two different strains of HCMV, we measured the production of IL-6 in culture supernatants by ELISA and the protein levels of STAT3, pSTAT3, JAK, cyclin D1, survivin, p53, p21, and Mdm2 by western Blotting in infected and uninfected cells. Cell proliferation and transformation were investigated using Ki67Ag expression measurement and soft-agar colony formation assay respectively. Results: Infection of HepG2 cells and PHH by HCMV resulted in the production of IL-6 and the subsequent activation of the IL-6R-JAK-STAT3 pathway. HCMV increased the expression of cyclin D1 and survivin. Cell proliferation was enhanced in HepG2 and PHH infected with HCMV, despite a paradoxical overexpression of p53 and p21. More importantly, we observed the formation of colonies in soft agar seeded with PHH infected with HCMV and when we challenged the HepG2 cultures to form tumorspheres, we found that the HCMV-infected cultures formed 2.5-fold more tumorspheres than uninfected cultures. Conclusion: HCMV activated the IL-6-JAK-STAT3 pathway in PHH and HepG2 cells, favored cellular proliferation, induced PHH transformation and enhanced HepG2 tumorsphere formation. Our observations raise the possibility that HCMV infection might be involved in the genesis of hepatocellular carcinoma.	[Lepiller, Quentin; Abbas, Wasim; Kumar, Amit; Tripathy, Manoj K.; Herbein, Georges] Univ Franche Comte, EA Pathogens & Inflammat 4266, SFR FED4234, CHU Besancon,Dept Virol, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon	Herbein, G (corresponding author), Univ Franche Comte, EA Pathogens & Inflammat 4266, SFR FED4234, CHU Besancon,Dept Virol, F-25030 Besancon, France.	georges.herbein@univ-fcomte.fr	Lepiller, Quentin/ABE-4040-2020; Lepiller, Quentin/C-9889-2019; Tripathy, Manoj/C-1310-2009; Kumar, Amit/F-7708-2013	Lepiller, Quentin/0000-0003-2892-4216; Tripathy, Manoj/0000-0002-2839-6727; Kumar, Amit/0000-0002-7398-0498	University of Franche-Comte (UFC); Region Franche-Comte [RECH-FON12-000013, 2012C-06102]; Higher Education Commission, Pakistan	University of Franche-Comte (UFC); Region Franche-Comte(Region Bourgogne-Franche-Comte); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This work was supported by grants from the University of Franche-Comte (UFC) and the Region Franche-Comte (RECH-FON12-000013) to G.H. A.K. is a recipient of a postdoctoral grant from the Region Franche-Comte (No 2012C-06102). W.A. is a recipient of a doctoral scholarship from the Higher Education Commission, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; BOLDOGH I, 1991, ARCH VIROL, V118, P163, DOI 10.1007/BF01314027; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; Botto S, 2011, BLOOD, V117, P352, DOI 10.1182/blood-2010-06-291245; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Carlier J, 2011, BLOOD, V118, P6783, DOI 10.1182/blood-2011-02-337956; Carlquist JF, 1999, J INFECT DIS, V179, P1094, DOI 10.1086/314734; Chen KF, 2010, CLIN CANCER RES, V16, P5189, DOI 10.1158/1078-0432.CCR-09-3389; Chen ZP, 2007, J BIOL CHEM, V282, P29284, DOI 10.1074/jbc.M705349200; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Cobbs CS, 2002, CANCER RES, V62, P3347; Curtit E, 2011, J CLIN ONCOL, V29, pE330, DOI 10.1200/JCO.2010.32.6785; Driscoll B, 1997, AM J PHYSIOL-LUNG C, V273, pL941, DOI 10.1152/ajplung.1997.273.5.L941; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Gu FM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-150; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iwamoto GK, 1997, J INVEST MED, V45, P175; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Joo M, 2001, LIVER, V21, P89, DOI 10.1034/j.1600-0676.2001.021002089.x; Khan KA, 2009, J IMMUNOL, V182, P7784, DOI 10.4049/jimmunol.0803800; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kovacs A, 1996, AM J PATHOL, V149, P1531; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LANDBERG G, 1990, EXP CELL RES, V187, P111, DOI 10.1016/0014-4827(90)90124-S; Lepiller Q, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-485; Lepiller Quentin, 2011, Open Virol J, V5, P60, DOI 10.2174/1874357901105010060; Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Michaelis M, 2011, CELL MOL LIFE SCI, V68, P1079, DOI 10.1007/s00018-010-0510-8; MUGANDA P, 1994, J VIROL, V68, P8028, DOI 10.1128/JVI.68.12.8028-8034.1994; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Peroukides S, 2010, HISTOL HISTOPATHOL, V25, P299, DOI 10.14670/HH-25.299; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shiraki K, 2006, LIVER INT, V26, P1018, DOI 10.1111/j.1478-3231.2006.01320.x; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Sun XX, 2008, CANCER LETT, V262, P201, DOI 10.1016/j.canlet.2007.12.009; Takahashi Y, 2007, PATHOL INT, V57, P437, DOI 10.1111/j.1440-1827.2007.02120.x; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wagayama H, 2002, HUM PATHOL, V33, P429, DOI 10.1053/hupa.2002.124724; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Won C, 2010, ANTICANCER RES, V30, P481; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zafiropoulos A, 2003, CANCER LETT, V198, P77, DOI 10.1016/S0304-3835(03)00269-6	62	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59591	10.1371/journal.pone.0059591	http://dx.doi.org/10.1371/journal.pone.0059591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555719	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500059
J	Li, W; Chiang, YH; Coaker, G				Li, Wei; Chiang, Yi-Hsuan; Coaker, Gitta			The HopQ1 Effector's Nucleoside Hydrolase-Like Domain Is Required for Bacterial Virulence in Arabidopsis and Tomato, but Not Host Recognition in Tobacco	PLOS ONE			English	Article							SYRINGAE PV. TOMATO; PSEUDOMONAS-SYRINGAE; ESCHERICHIA-COLI; PLANT IMMUNITY; NICOTIANA-BENTHAMIANA; DISEASE RESISTANCE; NONHOST PLANTS; GENE-CLUSTER; THALIANA; PATHOGENICITY	Bacterial pathogens deliver multiple effector proteins into host cells to facilitate bacterial growth. HopQ1 is an effector from Pseudomonas syringae pv. tomato DC3000 that is conserved across multiple bacterial pathogens which infect plants. HopQ1's central region possesses some homology to nucleoside hydrolases, but possesses an alternative aspartate motif not found in characterized enzymes. A structural model was generated for HopQ1 based on the E. coli RihB nucleoside hydrolase and the role of HopQ1's potential catalytic residues for promoting bacterial virulence and recognition in Nicotiana tabacum was investigated. Transgenic Arabidopsis plants expressing HopQ1 exhibit enhanced disease susceptibility to DC3000. HopQ1 can also promote bacterial virulence on tomato when naturally delivered from DC3000. HopQ1's nucleoside hydrolase-like domain alone is sufficient to promote bacterial virulence, and putative catalytic residues are required for virulence promotion during bacterial infection of tomato and in transgenic Arabidopsis lines. HopQ1 is recognized and elicits cell death when transiently expressed in N. tabacum. Residues required to promote bacterial virulence were dispensable for HopQ1's cell death promoting activities in N. tabacum. Although HopQ1 has some homology to nucleoside hydrolases, we were unable to detect HopQ1 enzymatic activity or nucleoside binding capability using standard substrates. Thus, it is likely that HopQ1 promotes pathogen virulence by hydrolyzing alternative ribose- containing substrates in planta.	[Li, Wei; Chiang, Yi-Hsuan; Coaker, Gitta] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Coaker, G (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	glcoaker@ucdavis.edu	Chiang, Yi-Hsuan/B-2662-2014		United States Department of Agriculture National Institute of Food and Agriculture [2010-65108-20527]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work is supported by a grant from the United States Department of Agriculture National Institute of Food and Agriculture 2010-65108-20527 awarded to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bent A, 2006, METH MOL B, V343, P87; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Brychkova G, 2008, PLANT J, V54, P496, DOI 10.1111/j.1365-313X.2008.03440.x; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cui HT, 2010, CELL HOST MICROBE, V7, P164, DOI 10.1016/j.chom.2010.01.009; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ferrante P, 2009, MOL PLANT PATHOL, V10, P837, DOI 10.1111/j.1364-3703.2009.00577.x; Giabbai B, 2004, STRUCTURE, V12, P739, DOI 10.1016/S0969-2126(04)00122-4; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Jung B, 2011, PLANT J, V65, P703, DOI 10.1111/j.1365-313X.2010.04455.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kunkeaw S, 2010, MOL PLANT MICROBE IN, V23, P415, DOI 10.1094/MPMI-23-4-0415; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Li W, 2013, PLANT PHYSIOL, V161, P2062, DOI 10.1104/pp.112.211748; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; PARKIN DW, 1991, J BIOL CHEM, V266, P20658; Petersen C, 2001, J BIOL CHEM, V276, P884, DOI 10.1074/jbc.M008300200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Stuttmann J, 2011, PLANT CELL, V23, P2788, DOI 10.1105/tpc.111.087684; Tavernier V, 2007, J EXP BOT, V58, P3351, DOI 10.1093/jxb/erm182; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002; Versees W, 2001, J MOL BIOL, V307, P1363, DOI 10.1006/jmbi.2001.4548; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	38	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59684	10.1371/journal.pone.0059684	http://dx.doi.org/10.1371/journal.pone.0059684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555744	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500075
J	Luca, AC; Mersch, S; Deenen, R; Schmidt, S; Messner, I; Schafer, KL; Baldus, SE; Huckenbeck, W; Piekorz, RP; Knoefel, WT; Krieg, A; Stoecklein, NH				Luca, Anna C.; Mersch, Sabrina; Deenen, Rene; Schmidt, Stephan; Messner, Isabelle; Schaefer, Karl-Ludwig; Baldus, Stephan E.; Huckenbeck, Wolfgang; Piekorz, Roland P.; Knoefel, Wolfram T.; Krieg, Andreas; Stoecklein, Nikolas H.			Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines	PLOS ONE			English	Article							BREAST EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; MALIGNANT BREAST; CULTURE MODELS; TUMOR; GROWTH; GLYCOSYLATION; ACTIVATION; INTEGRINS; COMPLEXES	Three-dimensional (3D) tumor cell cultures grown in laminin-rich-extracellular matrix (lrECM) are considered to reflect human tumors more realistic as compared to cells grown as monolayer on plastic. Here, we systematically investigated the impact of ECM on phenotype, gene expression, EGFR signaling pathway, and on EGFR inhibition in commonly used colorectal cancer (CRC) cell lines. LrECM on-top (3D) culture assays were performed with the CRC cell lines SW-480, HT-29, DLD-1, LOVO, CACO-2, COLO-205 and COLO-206F. Morphology of lrECM cultivated CRC cell lines was determined by phase contrast and confocal laser scanning fluorescence microscopy. Proliferation of cells was examined by MTT assay, invasive capacity of the cell lines was assayed using Matrigel-coated Boyden chambers, and migratory activity was determined employing the Fence assay. Differential gene expression was analyzed at the transcriptional level by the Agilent array platform. EGFR was inhibited by using the specific small molecule inhibitor AG1478. A specific spheroid growth pattern was observed for all investigated CRC cell lines. DLD-1, HT-29 and SW-480 and CACO-2 exhibited a clear solid tumor cell formation, while LOVO, COLO-205 and COLO-206F were characterized by forming grape-like structures. Although the occurrence of a spheroid morphology did not correlate with an altered migratory, invasive, or proliferative capacity of CRC cell lines, gene expression was clearly altered in cells grown on lrECM as compared to 2D cultures. Interestingly, in KRAS wild-type cell lines, inhibition of EGFR was less effective in lrECM (3D) cultures as compared to 2D cell cultures. Thus, comparing both 2D and 3D cell culture models, our data support the influence of the ECM on cancer growth. Compared to conventional 2D cell culture, the lrECM (3D) cell culture model offers the opportunity to investigate permanent CRC cell lines under more physiological conditions, i.e. in the context of molecular therapeutic targets and their pharmacological inhibition.	[Luca, Anna C.; Mersch, Sabrina; Knoefel, Wolfram T.; Krieg, Andreas; Stoecklein, Nikolas H.] Univ Dusseldorf, Dept Surg A, D-40225 Dusseldorf, Germany; [Luca, Anna C.; Mersch, Sabrina; Schmidt, Stephan; Messner, Isabelle; Schaefer, Karl-Ludwig; Baldus, Stephan E.; Huckenbeck, Wolfgang; Piekorz, Roland P.; Knoefel, Wolfram T.; Krieg, Andreas; Stoecklein, Nikolas H.] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Deenen, Rene] Univ Dusseldorf, Biol & Med Res Ctr BMFZ, D-40225 Dusseldorf, Germany; [Schmidt, Stephan; Piekorz, Roland P.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Messner, Isabelle; Schaefer, Karl-Ludwig; Baldus, Stephan E.] Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany; [Huckenbeck, Wolfgang] Univ Dusseldorf, Inst Forens Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Krieg, A (corresponding author), Univ Dusseldorf, Dept Surg A, D-40225 Dusseldorf, Germany.	andreas.krieg@med.uni-duesseldorf.de; nikolas.stoecklein@uni-duesseldorf.de			Forschungskommission of the Medical Faculty, University Duesseldorf [41/09, 24/10]; Rudolf Bartling-Stiftung [II/98]; Deutsche Forschungsgemeinschaft [SFB 728]; NRW graduate school "BioStruct"	Forschungskommission of the Medical Faculty, University Duesseldorf; Rudolf Bartling-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NRW graduate school "BioStruct"	This work was partly supported by grants from the Forschungskommission of the Medical Faculty, University Duesseldorf (41/09 to AK and 24/10 to KLS), the Rudolf Bartling-Stiftung (II/98 to NHS) and by grants from the Deutsche Forschungsgemeinschaft (SFB 728) and the NRW graduate school "BioStruct" (both to RPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BOWERS SL, J MOL CELL CARDIOL, V48, P474; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kenny PA, 2007, BIOCHEM SOC T, V35, P665, DOI 10.1042/BST0350665; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li Q, J PHARM EXP THER, V332, P821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weigelt B, 2009, BREAST CANC RES TREA; YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119	31	222	225	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59689	10.1371/journal.pone.0059689	http://dx.doi.org/10.1371/journal.pone.0059689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555746	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500076
J	Poon, KK; Dang, BN; Davila, JA; Hartman, C; Giordano, TP				Poon, Kenneth K.; Dang, Bich N.; Davila, Jessica A.; Hartman, Christine; Giordano, Thomas P.			Treatment Outcomes in Undocumented Hispanic Immigrants with HIV Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE ACCESS; MEDICAL-CARE; UNITED-STATES; ANTIRETROVIRAL THERAPY; MEXICAN IMMIGRANTS; LATINO IMMIGRANTS; RISK-FACTORS; PUERTO-RICO; VIRAL LOAD	Objective: Little is known about the treatment outcomes of undocumented Hispanic immigrants with HIV infection. We sought to compare the treatment outcomes of undocumented and documented patients 12-months after entering HIV care. Methods: We conducted a retrospective cohort study of antiretroviral-naive patients 18 years and older attending their first visit at Thomas Street Health Center in Houston, Texas, between 1/1/2003 and 6/30/2008. The study population of 1,620 HIV-infected adults included 186 undocumented Hispanic, 278 documented Hispanic, 986 Black, and 170 White patients. The main outcome measures were retention in care (quarter years with at least one completed HIV primary care provider visit) and HIV suppression (HIV RNA,400 copies/mL), both measured 12-months after entering HIV care. Results: Undocumented Hispanic patients had lower median initial CD4 cell count (132 cells/mm(3)) than documented Hispanic patients (166 cells/mm(3); P = 0.186), Black patients (226 cells/mm(3); P<0.001), and White patients (264 cells/mm(3); P = 0.001). However, once in care, undocumented Hispanic patients did as well or better than their documented counterparts. One year after entering HIV care, undocumented Hispanics achieved similar rates of retention in care and HIV suppression as documented Hispanic and White patients. Of note, black patients were significantly less likely to have optimal retention in care (adjusted odds ratio [aOR] 0.65, CI = 0.45-0.94) or achieve HIV suppression (aOR 0.32, CI = 0.17-0.61) than undocumented Hispanics. Conclusions: Undocumented Hispanic persons with HIV infection enter care with more advanced disease than documented persons, suggesting testing and/or linkage to care efforts for this difficult-to-reach population need intensification. Once diagnosed, however, undocumented Hispanics have outcomes as good as or better than other racial/ethnic groups. Safety net providers for undocumented immigrants are vital for maintaining individual and public health.	[Poon, Kenneth K.; Dang, Bich N.; Davila, Jessica A.; Hartman, Christine; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dang, Bich N.; Davila, Jessica A.; Hartman, Christine; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, VA Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Giordano, TP (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	tpg@bcm.edu		Poon, Kenneth/0000-0001-5661-6523; Giordano, Thomas/0000-0002-9346-5530	Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]; facilities and resources of Harris Health System, Houston, Texas	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Houston VA Health Services Research and Development Center of Excellence; facilities and resources of Harris Health System, Houston, Texas	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and the Houston VA Health Services Research and Development Center of Excellence (HFP90-020). This material was also supported in part by the facilities and resources of Harris Health System, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adih W. K., 2010, Morbidity and Mortality Weekly Report, V59, P1297; Berk ML, 2000, HEALTH AFFAIR, V19, P51, DOI 10.1377/hlthaff.19.4.51; Bustamante AV, 2012, J IMMIGR MINOR HEALT, V14, P146, DOI 10.1007/s10903-010-9406-9; Centers for Disease Control and Prevention (CDC), 2012, HIV SURV REP, V22; Cohn D., 2010, US UNAUTHORIZED IMMI; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Dang BN, 2012, J IMMIGR MINOR HEALT, V14, P124, DOI 10.1007/s10903-011-9542-x; DeLuca LA, 2010, J IMMIGR MINOR HEALT, V12, P113, DOI 10.1007/s10903-008-9197-4; Dennis AM, 2011, CLIN INFECT DIS, V53, P480, DOI 10.1093/cid/cir434; Ennis SR, 2011, C2010BR04 US CENS BU; Espinoza L, 2012, JAIDS-J ACQ IMM DEF, V60, P205, DOI 10.1097/QAI.0b013e31824d9a29; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano TP, 2010, AIDS PATIENT CARE ST, V24, P287, DOI 10.1089/apc.2009.0332; HUBBELL FA, 1991, WESTERN J MED, V154, P414; Kang Ezer, 2003, J Immigr Health, V5, P49; Kelley CF, 2007, AIDS READ, V17, P73; Kullgren JT, 2003, AM J PUBLIC HEALTH, V93, P1630, DOI 10.2105/AJPH.93.10.1630; Loue Sana, 2006, J Immigr Minor Health, V8, P313, DOI 10.1007/s10903-006-9001-2; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Miller Jane E, 2002, J Immigr Health, V4, P63, DOI 10.1023/A:1014542324401; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Nandi A, 2008, AM J PUBLIC HEALTH, V98, P2011, DOI 10.2105/AJPH.2006.096222; Ortega AN, 2007, ARCH INTERN MED, V167, P2354, DOI 10.1001/archinte.167.21.2354; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1, P1; Passel Jeffrey S., 2009, PORTRAIT UNAUTHORIZE; Pivnick A, 2010, J IMMIGR MINOR HEALT, V12, P496, DOI 10.1007/s10903-009-9293-0; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rodriguez MA, 2009, J GEN INTERN MED, V24, P508, DOI 10.1007/s11606-009-1098-2; Saracino A, 2005, AIDS PATIENT CARE ST, V19, P599, DOI 10.1089/apc.2005.19.599; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Shedlin MG, 2005, J NATL MED ASSOC, V97, p32S; SHERBOURNE CD, 1990, J HEALTH SOC BEHAV, V31, P328, DOI 10.2307/2136817; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Smith KY, 2009, CLIN INFECT DIS, V49, P1579, DOI 10.1086/644773; Stone VE, 2012, CURR INFECT DIS REP, V14, P53, DOI 10.1007/s11908-011-0226-4; Swindells S, 2002, AIDS, V16, P1832, DOI 10.1097/00002030-200209060-00020; Thrasher AD, 2008, JAIDS-J ACQ IMM DEF, V49, P84, DOI 10.1097/QAI.0b013e3181845589; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Turner BJ, 2000, ARCH INTERN MED, V160, P2614, DOI 10.1001/archinte.160.17.2614; *US BUR CENS, STAT COUNT QUICKFACT; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	44	48	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e60022	10.1371/journal.pone.0060022	http://dx.doi.org/10.1371/journal.pone.0060022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555868	gold, Green Submitted, Green Published			2022-12-27	WOS:000317418500112
J	Kong, LQ; Zhu, XD; Xu, HX; Zhang, JB; Lu, L; Wang, WQ; Zhang, QB; Wu, WZ; Wang, L; Fan, J; Tang, ZY; Sun, HC				Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan			The Clinical Significance of the CD163+and CD68+Macrophages in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HEMOGLOBIN SCAVENGER RECEPTOR; SOLUBLE CD163; CURATIVE RESECTION; HUMAN MONOCYTES; BREAST-CANCER; EXPRESSION; INFILTRATION; SURVIVAL; ANTIGEN	Our previous study has found that the abundance of peritumoral CD68(+) macrophages was associated with poor prognosis in hepatocellular carcinoma (HCC) after resection. However, CD68 staining could not discriminate the protumoral or tumoricidal subpopulations from pan-macrophages. CD163 is a marker of alternatively activated macrophages. In this study, the clinical significance of CD163(+) cells in tumors and peritumoral liver tissues was evaluated in a cohort of 295 patients with HCC after curative resection. We found that the density of CD163(+) cells was well correlated with that of CD68(+) cells in both tumors and peritumoral liver tissues but was much more. Immunostaining on consecutive sections and flow cytometry assay on surgical resected specimens further supported the findings that the CD163+ cells was more abundant than CD68(+) cells. The density of peritumoral CD68(+) cells was associated with poor recurrence-free survival (RFS) and poor overall survival (OS) (P = 0.004 and P = 0.001, respectively), whereas the CD163(+) cells have no prognostic values either in tumors or in peritumoral liver tissues. In another cohort of 107 HCC patients, preoperative plasma concentration of soluble form of CD163 (sCD163) was associated with active hepatitis-related factors but not associated with the markers of tumor invasion. In conclusion, both the CD163(+) cells local infiltration and plasma sCD163 were of limited significance in HCC, and they were more likely markers related to active hepatitis rather than tumor progression.	[Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Xu, Hua-Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China	Fudan University; Ministry of Education, China; Fudan University; Ministry of Education, China; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China.	sun.huichuan@zs-hospital.sh.cn	Zhu, Xiao-Dong/A-8197-2010; Fan, Jia/C-6689-2017	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [30872504, 81020108025]; China National "211'' Project for Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "211'' Project for Higher Education	This study was jointly supported by National Natural Science Foundation of China (30872504, 81020108025), and China National "211'' Project for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; FALINI B, 1993, AM J PATHOL, V142, P1359; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Hamada I, 2002, ANTICANCER RES, V22, P4281; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hogger P, 1998, J IMMUNOL, V161, P1883; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Koide N, 2004, AM J GASTROENTEROL, V99, P1667, DOI 10.1111/j.1572-0241.2004.30733.x; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moller HJ, 2007, J HEPATOL, V47, P671, DOI 10.1016/j.jhep.2007.05.014; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Ohno S, 2004, ANTICANCER RES, V24, P3335; Qian YB, 2006, CANCER, V107, P1562, DOI 10.1002/cncr.22206; Ritter M, 1999, PATHOBIOLOGY, V67, P257, DOI 10.1159/000028105; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Sanchez C, 1999, J IMMUNOL, V162, P5230; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Tsutsui S, 2005, ONCOL REP, V14, P425; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	85	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59771	10.1371/journal.pone.0059771	http://dx.doi.org/10.1371/journal.pone.0059771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	24205176	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900027
J	Iyer, S; Killingback, T; Sundaram, B; Wang, Z				Iyer, Swami; Killingback, Timothy; Sundaram, Bala; Wang, Zhen			Attack Robustness and Centrality of Complex Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; ERROR; TOLERANCE	Many complex systems can be described by networks, in which the constituent components are represented by vertices and the connections between the components are represented by edges between the corresponding vertices. A fundamental issue concerning complex networked systems is the robustness of the overall system to the failure of its constituent parts. Since the degree to which a networked system continues to function, as its component parts are degraded, typically depends on the integrity of the underlying network, the question of system robustness can be addressed by analyzing how the network structure changes as vertices are removed. Previous work has considered how the structure of complex networks change as vertices are removed uniformly at random, in decreasing order of their degree, or in decreasing order of their betweenness centrality. Here we extend these studies by investigating the effect on network structure of targeting vertices for removal based on a wider range of non-local measures of potential importance than simply degree or betweenness. We consider the effect of such targeted vertex removal on model networks with different degree distributions, clustering coefficients and assortativity coefficients, and for a variety of empirical networks.	[Iyer, Swami] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA; [Killingback, Timothy] Univ Massachusetts, Dept Math, Boston, MA 02125 USA; [Sundaram, Bala; Wang, Zhen] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Killingback, T (corresponding author), Univ Massachusetts, Dept Math, Harbor Campus, Boston, MA 02125 USA.	timothy.killingback@umb.edu	Sundaram, Bala/A-6532-2010; Alam, Hunain/H-2984-2019	Sundaram, Bala/0000-0002-1728-704X; Alam, Hunain/0000-0002-6183-3677				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BEAUCHAMP MA, 1965, BEHAV SCI, V10, P161, DOI 10.1002/bs.3830100205; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Callaway DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041902; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Crucitti P, 2004, PHYSICA A, V340, P388, DOI 10.1016/j.physa.2004.04.031; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Dym H, 2007, LINEAR ALGEBRA ACTIO, V78; Faust K, 2000, SOCIAL NETWORK ANAL; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Newman M, 2008, MATH NETWORKS; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; STAUFFER D, 1994, INTRO PERCOLATION TH; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	37	287	296	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59613	10.1371/journal.pone.0059613	http://dx.doi.org/10.1371/journal.pone.0059613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23341946	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300025
J	Lee, BH; Gauna, AE; Perez, G; Park, YJ; Pauley, KM; Kawai, T; Cha, S				Lee, Byung Ha; Gauna, Adrienne E.; Perez, Geidys; Park, Yun-Jong; Pauley, Kaleb M.; Kawai, Toshihisa; Cha, Seunghee			Autoantibodies against Muscarinic Type 3 Receptor in Sjogren's Syndrome Inhibit Aquaporin 5 Trafficking	PLOS ONE			English	Article							APICAL PLASMA-MEMBRANE; 2ND EXTRACELLULAR LOOP; SALIVARY ACINAR-CELLS; ACETYLCHOLINE-RECEPTOR; WATER CHANNEL; ABNORMAL DISTRIBUTION; SUBMANDIBULAR-GLANDS; MOUSE MODEL; HSG CELLS; NOD MICE	Sjogren's syndrome (SjS) is a chronic autoimmune disease that mainly targets the salivary and lacrimal glands. It has been controversial whether anti-muscarinic type 3 receptor (alpha-M3R) autoantibodies in patients with SjS inhibit intracellular trafficking of aquaporin-5 (AQP5), water transport protein, leading to secretory dysfunction. To address this issue, GFP-tagged human AQP5 was overexpressed in human salivary gland cells (HSG-hAQP5) and monitored AQP5 trafficking to the plasma membrane following carbachol (CCh, M3R agonist) stimulation. AQP5 trafficking was indeed mediated by M3R stimulation, shown in partial blockage of trafficking by M3R-antagonist 4-DAMP. HSG-hAQP5 pre-incubated with SjS plasma for 24 hours significantly reduced AQP5 trafficking with CCh, compared with HSG-hAQP5 pre-incubated with healthy control (HC) plasma. This inhibition was confirmed by monoclonal a-M3R antibody and pre-absorbed plasma. Interestingly, HSG-hAQP5 pre-incubated with SjS plasma showed no change in cell volume, compared to the cells incubated with HC plasma showing shrinkage by twenty percent after CCh-stimulation. Our findings clearly indicate that binding of anti-M3R autoantibodies to the receptor, which was verified by immunoprecipitation, suppresses AQP5 trafficking to the membrane and contribute to impaired fluid secretion in SjS. Our current study urges further investigations of clinical associations between SjS symptoms, such as degree of secretory dysfunction, cognitive impairment, and/or bladder irritation, and different profiles (titers, isotypes, and/or specificity) of anti-M3R autoantibodies in individuals with SjS.	[Lee, Byung Ha; Gauna, Adrienne E.; Perez, Geidys; Park, Yun-Jong; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA; [Pauley, Kaleb M.] Cedarville Univ, Coll Arts & Sci, Dept Sci & Math, Cedarville, OH USA; [Kawai, Toshihisa] Forsyth Inst, Dept Immunol, Cambridge, MA USA	State University System of Florida; University of Florida; Cedarville University; Harvard University; Forsyth Institute	Cha, S (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA.	scha@dental.ufl.edu		Williams, Adrienne/0000-0003-0247-1175	NIH/NIDCR [DE019644, DE 016705];  [UL1 RR029890];  [TL1 RR029889];  [T90 DE021990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890, TL1RR029889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE019644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016705] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	S.CHA was supported by NIH/NIDCR grants DE019644 and DE 016705. The funders had no role in study design, data c S.CHA was supported by NIH/NIDCR grants DE019644 and DE 016705. AE.GAUNA was supported by UL1 RR029890, TL1 RR029889, and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukas T, 2001, LANCET, V358, P1875, DOI 10.1016/S0140-6736(01)06900-8; Cavill D, 2004, SCAND J IMMUNOL, V59, P261, DOI 10.1111/j.0300-9475.2004.01395.x; Cha SH, 2006, J RHEUMATOL, V33, P296; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Dawson L, 2005, ARTHRITIS RHEUM-US, V52, P2984, DOI 10.1002/art.21347; FATHERAZI S, 1994, J MEMBRANE BIOL, V142, P181; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; Ishii M, 2006, CURR PHARM DESIGN, V12, P3573, DOI 10.2174/138161206778522056; ISHIKAWA T, 1994, PFLUG ARCH EUR J PHY, V427, P203, DOI 10.1007/BF00374525; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Ishikawa Y, 2000, FEBS LETT, V477, P253, DOI 10.1016/S0014-5793(00)01763-4; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Katz J, 2008, CANCER LETT, V270, P87, DOI 10.1016/j.canlet.2008.04.051; Konttinen YT, 2005, J RHEUMATOL, V32, P1071; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Li JC, 2004, LAB INVEST, V84, P1430, DOI 10.1038/labinvest.3700173; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Marczinovits I, 2005, J AUTOIMMUN, V24, P47, DOI 10.1016/j.jaut.2004.11.005; Nagy K, 2007, ACTA PHYSIOL HUNG, V94, P301, DOI 10.1556/APhysiol.94.2007.4.2; Nguyen CQ, 2007, FRONT BIOSCI-LANDMRK, V12, P1767, DOI 10.2741/2187; Nguyen KHT, 2000, ARTHRITIS RHEUM-US, V43, P2297, DOI 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Ohashi Y, 2008, CURR EYE RES, V33, P621, DOI 10.1080/02713680802262819; Roescher N, 2011, ANN RHEUM DIS, V70, P235, DOI 10.1136/ard.2010.129049; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Smith AJ, 2005, HUM IMMUNOL, V66, P411, DOI 10.1016/j.humimm.2005.01.020; Soyfoo MS, 2007, ARTHRITIS RHEUM-US, V56, P2566, DOI 10.1002/art.22826; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Tada J, 1999, BIOCHEM BIOPH RES CO, V266, P443, DOI 10.1006/bbrc.1999.1828; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; Wellner RB, 2005, TISSUE ENG, V11, P1449, DOI 10.1089/ten.2005.11.1449; Yuan ZF, 2003, EUR J PHARMACOL, V464, P197, DOI 10.1016/S0014-2999(03)01375-X	43	59	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53113	10.1371/journal.pone.0053113	http://dx.doi.org/10.1371/journal.pone.0053113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382834	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800018
J	Vas, S; Adori, C; Konczol, K; Katai, Z; Pap, D; Papp, RS; Bagdy, G; Palkovits, M; Toth, ZE				Vas, Szilvia; Adori, Csaba; Koenczoel, Katalin; Katai, Zita; Pap, Dorottya; Papp, Rege S.; Bagdy, Gyoergy; Palkovits, Miklos; Toth, Zsuzsanna E.			Nesfatin-1/NUCB2 as a Potential New Element of Sleep Regulation in Rats	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; CORTICOTROPIN-RELEASING HORMONE; PARADOXICAL SLEEP; OREXIN NEURONS; SATIETY MOLECULE; MOTOR-ACTIVITY; REM-SLEEP; RECEPTOR; DEPRIVATION; ACTIVATION	Study Objectives: Millions suffer from sleep disorders that often accompany severe illnesses such as major depression; a leading psychiatric disorder characterized by appetite and rapid eye movement sleep (REMS) abnormalities. Melanin-concentrating hormone (MCH) and nesfatin-1/NUCB2 (nesfatin) are strongly co - expressed in the hypothalamus and are involved both in food intake regulation and depression. Since MCH was recognized earlier as a hypnogenic factor, we analyzed the potential role of nesfatin on vigilance. Design: We subjected rats to a 72 h-long REMS deprivation using the classic flower pot method, followed by a 3 h-long 'rebound sleep'. Nesfatin mRNA and protein expressions as well as neuronal activity (Fos) were measured by quantitative in situ hybridization technique, ELISA and immunohistochemistry, respectively, in 'deprived' and 'rebound' groups, relative to controls sacrificed at the same time. We also analyzed electroencephalogram of rats treated by intracerebroventricularly administered nesfatin-1, or saline. Results: REMS deprivation downregulated the expression of nesfatin (mRNA and protein), however, enhanced REMS during 'rebound' reversed this to control levels. Additionally, increased transcriptional activity (Fos) was demonstrated in nesfatin neurons during 'rebound'. Centrally administered nesfatin-1 at light on reduced REMS and intermediate stage of sleep, while increased passive wake for several hours and also caused a short-term increase in light slow wave sleep. Conclusions: The data designate nesfatin as a potential new factor in sleep regulation, which fact can also be relevant in the better understanding of the role of nesfatin in the pathomechanism of depression.	[Vas, Szilvia; Adori, Csaba; Katai, Zita; Pap, Dorottya; Bagdy, Gyoergy] Semmelweis Univ, Dept Pharmacodynam, H-1085 Budapest, Hungary; [Adori, Csaba] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Koenczoel, Katalin; Papp, Rege S.; Palkovits, Miklos; Toth, Zsuzsanna E.] Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol & Neuroendocrine Res Lab, H-1085 Budapest, Hungary; [Koenczoel, Katalin; Papp, Rege S.; Palkovits, Miklos; Toth, Zsuzsanna E.] Hungarian Acad Sci, Budapest, Hungary; [Bagdy, Gyoergy] Hungarian Acad Sci, Grp Neurochem, Budapest, Hungary; [Bagdy, Gyoergy] Hungarian Acad Sci, Grp Neuropsychopharmacol, Budapest, Hungary	Semmelweis University; Karolinska Institutet; Semmelweis University; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Toth, ZE (corresponding author), Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol & Neuroendocrine Res Lab, H-1085 Budapest, Hungary.	tothzs@ana.sote.hu	Toth, Zsuzsanna/U-2579-2019; Vas, Szilvia/H-4917-2014; Bagdy, György/O-3893-2017; Palkovits, Miklos/F-2707-2013	Vas, Szilvia/0000-0001-7236-5672; Bagdy, György/0000-0001-8141-3410; Palkovits, Miklos/0000-0003-0578-0387; Vaz, Sharmila/0000-0003-1003-9593	European Community [LSHM-CT-2004-503474]; Hungarian Research Fund Grant [T020500]; Ministry of Welfare Research Grant [460/2006, TAMOP-4.2.1. B-09/1/KMR-2010-0001, OTKA-CK-80180, ETT495/05]	European Community(European Commission); Hungarian Research Fund Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministry of Welfare Research Grant	This work was supported by the 6th Framework Program of the European Community (LSHM-CT-2004-503474), Hungarian Research Fund Grant (T020500), Ministry of Welfare Research Grant 460/2006, TAMOP-4.2.1. B-09/1/KMR-2010-0001 (http://www.tamop-palyazat.hu, G. B.), OTKA-CK-80180 (www.otka.hu, M. P.) and ETT495/05 (http://www.ett.hu, Z.E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnaou A, 2008, EUR J PHARMACOL, V579, P177, DOI 10.1016/j.ejphar.2007.10.017; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Ari M, 2011, PROG NEURO-PSYCHOPH, V35, P497, DOI 10.1016/j.pnpbp.2010.12.004; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Bloem B, 2012, NEUROPHARMACOLOGY, V62, P297, DOI 10.1016/j.neuropharm.2011.07.023; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Cheeta S, 1997, BIOL PSYCHIAT, V41, P419, DOI 10.1016/S0006-3223(96)00058-3; Cinosi E, 2011, CLIN TER, V162, pE195; de Lecea L, 2002, NEUROPEPTIDES, V36, P85, DOI 10.1054/npep.2002.0892; Fenzl T, 2011, BEHAV BRAIN RES, V222, P43, DOI 10.1016/j.bbr.2011.03.026; Filakovszky J, 1999, NEUROSCI LETT, V261, P89, DOI 10.1016/S0304-3940(99)00015-4; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; Gao XB, 2002, J PHYSIOL-LONDON, V542, P273, DOI 10.1113/jphysiol.2002.019372; Goebel-Stengel M, 2011, BRAIN RES, V1396, P20, DOI 10.1016/j.brainres.2011.04.031; Graf M, 2004, NEUROSCI LETT, V359, P45, DOI 10.1016/j.neulet.2004.01.072; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hillebrand JJG, 2002, PEPTIDES, V23, P2283, DOI 10.1016/S0196-9781(02)00269-3; Holshoe JM, 2009, PERSPECT PSYCHIATR C, V45, P191, DOI 10.1111/j.1744-6163.2009.00221.x; Jego S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052525; Kantor S, 2004, BRIT J PHARMACOL, V142, P1332, DOI 10.1038/sj.bjp.0705887; Kantor S, 2002, BRAIN RES, V943, P105, DOI 10.1016/S0006-8993(02)02698-7; Kitka T, 2011, NEUROCHEM INT, V59, P686, DOI 10.1016/j.neuint.2011.06.015; Kitka T, 2009, BEHAV BRAIN RES, V205, P482, DOI 10.1016/j.bbr.2009.08.004; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Konczol K, 2012, INT J OBES LOND; Konczol K, 2010, NEUROCHEM INT, V57, P189, DOI 10.1016/j.neuint.2010.04.012; Landolt HP, 2002, NEUROPSYCHOPHARMACOL, V27, P462, DOI 10.1016/S0893-133X(02)00322-6; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Nollet M, 2011, NEUROPHARMACOLOGY, V61, P336, DOI 10.1016/j.neuropharm.2011.04.022; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rachalski A, 2009, J NEUROSCI, V29, P15575, DOI 10.1523/JNEUROSCI.3138-09.2009; Romanowski CPN, 2010, SLEEP, V33, P427, DOI 10.1093/sleep/33.4.427; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shimazaki T, 2006, CNS DRUGS, V20, P801, DOI 10.2165/00023210-200620100-00002; Shimizu H, 2009, ENDOCR J, V56, P537, DOI 10.1507/endocrj.K09E-117; Steiger A, 2010, J PSYCHIATR RES, V44, P242, DOI 10.1016/j.jpsychires.2009.08.013; Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x; Suchecki D, 2002, J NEUROENDOCRINOL, V14, P549, DOI 10.1046/j.1365-2826.2002.00812.x; Tan BK, 2011, J CLIN ENDOCR METAB, V96, pE669, DOI 10.1210/jc.2010-1782; To CT, 1999, NEUROPHARMACOLOGY, V38, P279; Torterolo Pablo, 2011, Front Neurol, V2, P14, DOI 10.3389/fneur.2011.00014; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; VANHULZEN ZJM, 1981, PHYSIOL BEHAV, V27, P741, DOI 10.1016/0031-9384(81)90250-X; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Yoshida N, 2010, AGING-US, V2, P775, DOI 10.18632/aging.100207; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003	56	200	202	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59809	10.1371/journal.pone.0059809	http://dx.doi.org/10.1371/journal.pone.0059809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	24040139	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900027
J	Chen, L; Wang, T; Liu, L; Shen, YC; Wan, C; Wen, FQ				Chen, Lei; Wang, Tao; Liu, Lian; Shen, Yongchun; Wan, Chun; Wen, Fuqiang			Matrix Metalloproteinase-9-1562C/T Promoter Polymorphism Confers Risk for COPD: A Meta-Analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENETIC-POLYMORPHISM; MATRIX-METALLOPROTEINASE-9; POPULATION; EMPHYSEMA; ASSOCIATION	Background: The role of matrix metalloproteinase (MMP) gene polymorphisms in the development of chronic obstructive pulmonary disease (COPD) has been reported with inconsistent results. This meta-analysis was performed to assess the association of MMP-1 -1607G/GG and MMP-9 -1562C/T promoter polymorphisms with COPD susceptibility. Methods: Published case-control studies from Pubmed and China National Knowledge Infrastructure (CNKI) databases were retrieved. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. Results: A total of fourteen case-control studies were included in this meta-analysis. Pooled effect size showed an association of MMP-9 -1562 C/T with the risk of COPD (dominant model: TT+CT vs CC; OR: 1.46; 95% CI: 1.02-2.08; p = 0.04). However, no correlation with COPD was revealed in MMP-1 -1607G/GG polymorphism. When stratified by ethnicity, results indicated MMP-1 -1607G/GG (recessive model: G/G vs G/GG+GG/GG; OR: 1.20; 95% CI: 1.01-1.44; p = 0.04) and MMP-9 -1562 C/T (dominant model; OR: 1.66; 95% CI: 1.01-2.71; p = 0.04) were correlated with COPD susceptibility among Caucasians and Asians respectively. According to source of controls, signifiant association of MMP-9 -1562 C/T (additive model: T vs C; OR: 1.71, 95% CI: 1.42-2.07; p<0.00001, and dominant model; OR: 1.92; 95% CI: 1.34-2.76; p = 0.0004) with COPD susceptibility was revealed in the subgroup with smoker-based controls. However, in the aforementioned risk estimates, only the association of MMP-9 -1562 C/T (additive and dominant models) with the risk of COPD in the subgroup with smoker-based controls persisted significantly after Bonferroni correction for multiple testing. Moreover, after excluding the studies without Hardy-Weinberg equilibrium and/or with small sample size, the pooled results were robust and no publication bias was found in this study. Conclusion: This meta-analysis suggests, when using healthy smokers as controls, MMP-9 -1562 C/T, but not MMP-1 -1607 G/GG polymorphism is associated with the risk of COPD.	[Chen, Lei; Wang, Tao; Liu, Lian; Shen, Yongchun; Wan, Chun; Wen, Fuqiang] Sichuan Univ, West China Hosp, West China Sch Med, Div Pulm Dis,State Key Lab Biotherapy China, Chengdu 610064, Sichuan, Peoples R China; [Chen, Lei; Wang, Tao; Liu, Lian; Shen, Yongchun; Wan, Chun; Wen, Fuqiang] Sichuan Univ, West China Hosp, West China Sch Med, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wen, FQ (corresponding author), Sichuan Univ, West China Hosp, West China Sch Med, Div Pulm Dis,State Key Lab Biotherapy China, Chengdu 610064, Sichuan, Peoples R China.	wenfuqiang.scu@gmail.com	; YANG, Jun/E-6680-2011	Chen, Guangjie/0000-0001-8035-6565; YANG, Jun/0000-0002-7920-2777; Liu, Lemian/0000-0002-8977-6969	National Natural Science Foundation of China [31000513, 31171103, 81200031, 81230001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants 31000513, 31171103, 81200031, and 81230001 from the National Natural Science Foundation of China. The funders (grants 31000513, 31171103, 81200031, and 81230001 from the National Natural Science Foundation of China) have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Cai J., 2010, SHAN DONG YI YAO, V50, P76; Cheng SL, 2009, BIOCHEM GENET, V47, P591, DOI 10.1007/s10528-009-9252-4; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Han W., 2006, ZHONG HUA JIE HE HE, V29, P277; Haq I, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-7; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hua DM, 2010, INT J RESPI, V30, P1157; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; Korytina GF, 2008, RUSS J GENET+, V44, P202, DOI 10.1134/S1022795408020130; Lee SY, 2010, RESPIRATION, V80, P133, DOI 10.1159/000284926; Minematsu N, 2001, BIOCHEM BIOPH RES CO, V289, P116, DOI 10.1006/bbrc.2001.5936; Rutter JL, 1998, CANCER RES, V58, P5321; Sampsonas F, 2007, POSTGRAD MED J, V83, P244, DOI 10.1136/pgmj.2006.052100; Schirmer H, 2009, GENET MOL RES, V8, P1028, DOI 10.4238/vol8-3gmr596; Soler Artigas M, 2012, THORAX, V67, P271, DOI 10.1136/thoraxjnl-2011-200724; Sun P., 2005, CHIN J RESP CRIT CAR, V4, P342; Tesfaigzi Yohannes, 2006, Int J Chron Obstruct Pulmon Dis, V1, P267, DOI 10.2147/copd.2006.1.3.267; Todd JL, 2011, AM J RESP CRIT CARE, V184, P873, DOI 10.1164/rccm.201106-0971PP; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788; Zhang Rong-bao, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P907; Zhou M, 2004, CHINESE MED J-PEKING, V117, P1481	23	40	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e60523	10.1371/journal.pone.0060523	http://dx.doi.org/10.1371/journal.pone.0060523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555986	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200123
J	Ding, WN; Sun, JH; Sun, YW; Zhou, Y; Li, L; Xu, JR; Du, YS				Ding, Wei-na; Sun, Jin-hua; Sun, Ya-wen; Zhou, Yan; Li, Lei; Xu, Jian-rong; Du, Ya-song			Altered Default Network Resting-State Functional Connectivity in Adolescents with Internet Gaming Addiction	PLOS ONE			English	Article							STRIATAL DOPAMINE RELEASE; CINGULATE CORTEX; HUMAN BRAIN; RESPONSE-INHIBITION; PREFRONTAL CORTEX; WORKING-MEMORY; REWARD; ABNORMALITIES; INVOLVEMENT; DYSFUNCTION	Purpose: Excessive use of the Internet has been linked to a variety of negative psychosocial consequences. This study used resting-state functional magnetic resonance imaging (fMRI) to investigate whether functional connectivity is altered in adolescents with Internet gaming addiction (IGA). Methods: Seventeen adolescents with IGA and 24 normal control adolescents underwent a 7.3 minute resting-state fMRI scan. Posterior cingulate cortex (PCC) connectivity was determined in all subjects by investigating synchronized low-frequency fMRI signal fluctuations using a temporal correlation method. To assess the relationship between IGA symptom severity and PCC connectivity, contrast images representing areas correlated with PCC connectivity were correlated with the scores of the 17 subjects with IGA on the Chen Internet Addiction Scale (CIAS) and Barratt Impulsiveness Scale-11 (BIS-11) and their hours of Internet use per week. Results: There were no significant differences in the distributions of the age, gender, and years of education between the two groups. The subjects with IGA showed longer Internet use per week (hours) (p<0.0001) and higher CIAS (p<0.0001) and BIS-11 (p = 0.01) scores than the controls. Compared with the control group, subjects with IGA exhibited increased functional connectivity in the bilateral cerebellum posterior lobe and middle temporal gyrus. The bilateral inferior parietal lobule and right inferior temporal gyrus exhibited decreased connectivity. Connectivity with the PCC was positively correlated with CIAS scores in the right precuneus, posterior cingulate gyrus, thalamus, caudate, nucleus accumbens, supplementary motor area, and lingual gyrus. It was negatively correlated with the right cerebellum anterior lobe and left superior parietal lobule. Conclusion: Our results suggest that adolescents with IGA exhibit different resting-state patterns of brain activity. As these alterations are partially consistent with those in patients with substance addiction, they support the hypothesis that IGA as a behavioral addiction that may share similar neurobiological abnormalities with other addictive disorders.	[Ding, Wei-na; Sun, Ya-wen; Zhou, Yan; Li, Lei; Xu, Jian-rong] Shanghai Jiao Tong Univ, Dept Radiol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Sun, Jin-hua; Du, Ya-song] Shanghai Jiao Tong Univ, Dept Child & Adolescent Psychiat, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; yasongdu@yahoo.com.cn	SUN, JIN/GPX-9641-2022		National Natural Science Foundation of China [81171325]; Shanghai Science and Technology Committee Medical Guide Project [114119a0900]; Shanghai Leading Academic Discipline Project [S30203]; National Key Technology RD Program [2007BAI17B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Medical Guide Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Key Technology RD Program(National Key Technology R&D Program)	This research was supported by the National Natural Science Foundation of China (No. 81171325), Shanghai Science and Technology Committee Medical Guide Project (No. 114119a0900), Shanghai Leading Academic Discipline Project (Project No. S30203), and the National Key Technology R&D Program 2007BAI17B03. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude E, 2006, CNS SPECTRUMS, V11, P750, DOI 10.1017/S1092852900014875; Alavi SS, 2012, INT J PREVENTIVE MED, V3, P290; Alonso-Solis A, 2012, SCHIZOPHR RES, V139, P13, DOI 10.1016/j.schres.2012.05.005; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Beutel ME, 2011, Z PSYCHOSOM MED PSYC, V57, P77, DOI 10.13109/zptm.2011.57.1.77; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen SH, 2003, CHINESE J PSYCHOL, V45, P279, DOI [DOI 10.1037/T44491-000, 10.1037/t44491-000]; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; Collin Guusje, 2011, Front Psychiatry, V2, P73, DOI 10.3389/fpsyt.2011.00073; Corbit LH, 2003, EUR J NEUROSCI, V18, P1286, DOI 10.1046/j.1460-9568.2003.02833.x; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dong GH, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-41; Dong GH, 2012, J PSYCHIATR RES, V46, P1212, DOI 10.1016/j.jpsychires.2012.05.015; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Hou HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/854524; Janes AC, 2012, DRUG ALCOHOL DEPEN, V125, P252, DOI 10.1016/j.drugalcdep.2012.02.020; KEEPERS GA, 1990, J AM ACAD CHILD PSY, V29, P49, DOI 10.1097/00004583-199001000-00009; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2011, ADDICT BIOL; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kuss DJ, 2012, BRAIN SCI, V2, P347, DOI 10.3390/brainsci2030347; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Lesieur Henry R., 1993, Journal of Addictive Diseases, V12, P89, DOI 10.1300/J069v12n03_08; Lewald J, 2011, NEUROPSYCHOLOGIA, V49, P209, DOI 10.1016/j.neuropsychologia.2010.11.038; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Paradiso S, 2011, J STROKE CEREBROVASC, V20, P94, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.005; Passamonti L, 2011, BRAIN, V134, P2274, DOI 10.1093/brain/awr164; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Rogers Paul, 1998, J Gambl Stud, V14, P111, DOI 10.1023/A:1023042708217; Ruef A, 2012, J PSYCHIATR NEUROSCI, V37, P305, DOI 10.1503/jpn.110057; Schultz CC, 2010, SCHIZOPHR RES, V123, P137, DOI 10.1016/j.schres.2010.08.033; Seiferth NY, 2008, NEUROIMAGE, V40, P289, DOI 10.1016/j.neuroimage.2007.11.020; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P776, DOI 10.1100/tsw.2008.104; Shi J, 2008, EUR J PHARMACOL, V579, P160, DOI 10.1016/j.ejphar.2007.09.042; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Siomos KE, 2008, CYBERPSYCHOL BEHAV, V11, P653, DOI 10.1089/cpb.2008.0088; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Strata P, 2011, PHYSIOL RES, V60, pS39, DOI 10.33549/physiolres.932169; Sun DL, 2009, CNS SPECTRUMS, V14, P75, DOI 10.1017/S1092852900000225; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Tanabe J, 2011, PSYCHOPHARMACOLOGY, V216, P287, DOI 10.1007/s00213-011-2221-8; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Tirapu-Ustarroz J, 2011, REV NEUROLOGIA, V53, P301, DOI 10.33588/rn.5305.2010747; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K, 2010, WORLD PSYCHIATRY, V9, P91; Yu CX, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00014; Zhang Y, 2011, BRAIN RES, V1402, P46, DOI 10.1016/j.brainres.2011.05.054; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025; Zink CF, 2003, J NEUROSCI, V23, P8092; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	85	89	90	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59902	10.1371/journal.pone.0059902	http://dx.doi.org/10.1371/journal.pone.0059902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555827	gold, Green Submitted, Green Published			2022-12-27	WOS:000317418500103
J	Huang, ZG; Jin, Q; Fan, M; Cong, XL; Han, SF; Gao, H; Shan, Y				Huang, Zhi Gang; Jin, Qun; Fan, Min; Cong, Xiao Liang; Han, Shu Fang; Gao, Hai; Shan, Yi			Myocardial Remodeling in Diabetic Cardiomyopathy Associated with Cardiac Mast Cell Activation	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE ACTIVITY; HYPERTENSIVE HEART-DISEASE; NECROSIS-FACTOR-ALPHA; ANGIOTENSIN-II; MEDIATOR RELEASE; TNF-ALPHA; INFLAMMATION; INHIBITION; FIBROSIS; CHYMASE	Diabetic cardiomyopathy is a specific disease process distinct from coronary artery disease and hypertension. The disease features cardiac remodeling stimulated by hyperglycemia of the left ventricle wall and disrupts contractile functions. Cardiac mast cells may be activated by metabolic byproducts resulted from hyperglycermia and then participate in the remodeling process by releasing a multitude of cytokines and bioactive enzymes. Nedocromil, a pharmacologic stabilizer of mast cells, has been shown to normalize cytokine levels and attenuate cardiac remodeling. In this study, we describe the activation of cardiac mast cells by inducing diabetes in normal mice using streptozotocin (STZ). Next, we treated the diabetic mice with nedocromil for 12 weeks and then examined their hearts for signs of cardiac remodeling and quantified contractile function. We observed significantly impaired heart function in diabetic mice, as well as increased cardiac mast cell density and elevated mast cell secretions that correlated with gene expression and aberrant cytokine levels associated with cardiac remodeling. Nedocromil treatment halted contractile dysfunction in diabetic mice and reduced cardiac mast cell density, which correlated with reduced bioactive enzyme secretions, reduced expression of extracellular matrix remodeling factors and collagen synthesis, and normalized cytokine levels. However, the results showed nedocromil treatments did not return diabetic mice to a normal state. We concluded that manipulation of cardiac mast cell function is sufficient to attenuate cardiomyopathy stimulated by diabetes, but other cellular pathways also contribute to the disease process.	[Huang, Zhi Gang; Fan, Min; Cong, Xiao Liang] Second Mil Med Univ, Chang Zheng Hosp, Dept Cardiol, Shanghai, Peoples R China; [Jin, Qun; Han, Shu Fang] Gen Hosp Jinan Mil Reg, Dept Cardiol, Jinan, Peoples R China; [Gao, Hai] Third Peoples Hosp Haiyang, Haiyang, Shandong, Peoples R China; [Shan, Yi] Second Mil Med Univ, Chang Zheng Hosp, Dept Emergency Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Gao, H (corresponding author), Third Peoples Hosp Haiyang, Haiyang, Shandong, Peoples R China.	doctorhd@126.com; shanyikxy@126.com		Qiao, Lei/0000-0003-1626-1769				Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Andrzejczak D, 2006, PHARMACOL REP, V58, P711; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Asghar O, 2009, CLIN SCI, V116, P741, DOI 10.1042/CS20080500; Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brower GL, 2002, AM J PHYSIOL-HEART C, V283, pH518, DOI 10.1152/ajpheart.00218.2000; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; DORING HJ, 1990, PHYSIOL BOHEMOSLOV, V39, P481; DVORAK AM, 1986, NEW ENGL J MED, V315, P969; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Levick SP, 2008, J MOL CELL CARDIOL, V45, P56, DOI 10.1016/j.yjmcc.2008.04.010; Levick SP, 2009, HYPERTENSION, V53, P1041, DOI 10.1161/HYPERTENSIONAHA.108.123158; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Liu JW, 2012, BIOCHEM BIOPH RES CO, V427, P441, DOI 10.1016/j.bbrc.2012.09.058; Marshall JS, 1996, J CLIN INVEST, V97, P1122, DOI 10.1172/JCI118506; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; Matsumoto T, 2003, CIRCULATION, V107, P2555, DOI 10.1161/01.CIR.0000074041.81728.79; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miki T, 2012, HEART FAIL REV; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Murray DB, 2010, J MOL CELL CARDIOL, V49, P245, DOI 10.1016/j.yjmcc.2010.04.005; Nelson N, 1996, J IMMUNOL, V156, P3711; Oyamada S, 2011, J PHARMACOL EXP THER, V339, P143, DOI 10.1124/jpet.111.179697; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; PANIZO A, 1995, J HYPERTENS, V13, P1201, DOI 10.1097/00004872-199510000-00015; PATELLA V, 1995, INT ARCH ALLERGY IMM, V106, P386, DOI 10.1159/000236871; Patella V, 1997, INFLAMM RES, V46, pS31, DOI 10.1007/s000110050041; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Rottem M, 2005, AUTOIMMUN REV, V4, P21, DOI 10.1016/j.autrev.2004.05.001; Shiota N, 2003, J HYPERTENS, V21, P1935, DOI 10.1097/00004872-200310000-00022; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2011, TRENDS PHARMACOL SCI, V32, P534, DOI 10.1016/j.tips.2011.05.005; URATA H, 1990, CIRC RES, V66, P883, DOI 10.1161/01.RES.66.4.883; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu QL, 2006, HYPERTENSION, V48, P98, DOI 10.1161/01.HYP.0000227247.27111.B2; Zhao XY, 2008, MOL CELL BIOCHEM, V310, P159, DOI 10.1007/s11010-007-9676-2	42	75	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60827	10.1371/journal.pone.0060827	http://dx.doi.org/10.1371/journal.pone.0060827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	24058605	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900082
J	Feng, XW; Liang, N; Zhu, DX; Gao, Q; Peng, L; Dong, HM; Yue, QW; Liu, HL; Bao, LH; Zhang, J; Hao, J; Gao, YM; Yu, XJ; Sun, JH				Feng, Xiaowen; Liang, Nan; Zhu, Dexiao; Gao, Qing; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Hao, Jing; Gao, Yingmao; Yu, Xuejie; Sun, Jinhao			Resveratrol Inhibits beta-Amyloid-Induced Neuronal Apoptosis through Regulation of SIRT1-ROCK1 Signaling Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PC12 CELLS; LIFE-SPAN; CALORIE RESTRICTION; HYDROGEN-PEROXIDE; OXIDATIVE INJURY; SIRT1 ACTIVATION; TOXICITY; DEATH; PREVENTION	Alzheimer's disease (AD) is characterized by the accumulation of beta-amyloid peptide (Ab) and loss of neurons. Recently, a growing body of evidences have indicated that as a herbal compound naturally derived from grapes, resveratrol modulates the pathophysiology of AD, however, with a largely unclear mechanism. Therefore, we aimed to investigate the protection of resveratrol against the neurotoxicity of beta-amyloid peptide 25-35 (A beta(25-35)) and further explore its underlying mechanism in the present study. PC12 cells were injuried by A beta(25-35), and resveratrol at different concentrations was added into the culture medium. We observed that resveratrol increased cell viability through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase (LDH) colorimetric assays. Flow cytometry indicated the reduction of cell apoptosis by resveratrol. Moreover, resveratrol also stabilized the intercellular Ca2+ homeostasis and attenuated A beta(25-35) neurotoxicity. Additionally, A beta(25-35)-suppressed silent information regulator 1 (SIRT1) activity was significantly reversed by resveratrol, resulting in the downregulation of Rho-associated kinase 1 (ROCK1). Our results clearly revealed that resveratrol significantly protected PC12 cells and inhibited the beta-amyloid-induced cell apoptosis through the upregulation of SIRT1. Moreover, as a downstream signal molecule, ROCK1 was negatively regulated by SIRT1. Taken together, our study demonstrated that SIRT1-ROCK1 pathway played a critical role in the pathomechanism of AD.	[Feng, Xiaowen; Zhu, Dexiao; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Sun, Jinhao] Shandong Univ, Key Lab, Minist Educ Expt Teratol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Feng, Xiaowen; Zhu, Dexiao; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Sun, Jinhao] Shandong Univ, Dept Anat, Sch Med, Jinan 250100, Shandong, Peoples R China; [Liang, Nan] Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan 250100, Shandong, Peoples R China; [Gao, Qing; Hao, Jing; Gao, Yingmao] Shandong Univ, Sch Med, Dept Histol & Embryol, Jinan 250100, Shandong, Peoples R China; [Yu, Xuejie] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Sun, JH (corresponding author), Shandong Univ, Key Lab, Minist Educ Expt Teratol, Sch Med, Jinan 250100, Shandong, Peoples R China.	sunjinhao@sdu.edu.cn	SUN, JIN/GPX-9641-2022; Yu, Xuejie/AAP-9246-2021		National Natural Science Foundation of China [81071081]; Natural Science Foundation of Shandong Province [ZR2010HM051, ZR2012HM026]; Shandong Provincial Science and Technology Development Plan [2011GSF11810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Science and Technology Development Plan	This work was financially supported by grants of National Natural Science Foundation of China (No. 81071081), Natural Science Foundation of Shandong Province (ZR2010HM051 and ZR2012HM026), and a grant of Shandong Provincial Science and Technology Development Plan (2011GSF11810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 2007, NEUROSCIENCE, V147, P746, DOI 10.1016/j.neuroscience.2007.04.029; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Conte A, 2003, BRAIN RES BULL, V62, P29, DOI 10.1016/j.brainresbull.2003.08.001; Dong J, 2007, P NATL ACAD SCI USA, V104, P13313, DOI 10.1073/pnas.0702669104; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; Frankel D, 1999, EXP NEUROL, V160, P376, DOI 10.1006/exnr.1999.7214; Furuya TK, 2012, NEUROCHEM INT, V61, P973, DOI 10.1016/j.neuint.2012.07.014; Guarente L, 2000, GENE DEV, V14, P1021; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Howes MJR, 2003, PHYTOTHER RES, V17, P1, DOI 10.1002/ptr.1280; Huang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029102; Hung LW, 2012, FUTURE MED CHEM, V4, P955, DOI [10.4155/FMC.12.32, 10.4155/fmc.12.32]; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Ji ZN, 2006, J ETHNOPHARMACOL, V107, P48, DOI 10.1016/j.jep.2006.02.004; Jia LQ, 2012, J ETHNOPHARMACOL, V143, P100, DOI 10.1016/j.jep.2012.06.007; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x; Limpeanchob N, 2008, J ETHNOPHARMACOL, V120, P112, DOI 10.1016/j.jep.2008.07.039; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Olofsson Maria Haegg, 2008, BMC Chemical Biology, V8, P2, DOI 10.1186/1472-6769-8-2; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Sharma M, 2002, LIFE SCI, V71, P2489, DOI 10.1016/S0024-3205(02)02083-0; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Surh YJ, 1999, MUTAT RES-FUND MOL M, V428, P305, DOI 10.1016/S1383-5742(99)00057-5; Tang BL, 2005, BIOCHEM BIOPH RES CO, V331, P375, DOI 10.1016/j.bbrc.2005.03.074; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Xi YD, 2011, J BIOENERG BIOMEMBR, V43, P399, DOI 10.1007/s10863-011-9362-7; Xiao QA, 2010, EUR J PHARMACOL, V647, P48, DOI 10.1016/j.ejphar.2010.08.002; Xie XH, 2012, INFLAMMATION, V35, P1392, DOI 10.1007/s10753-012-9452-7; Yang SH, 2011, J ETHNOPHARMACOL, V137, P1095, DOI 10.1016/j.jep.2011.07.014	48	117	122	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59888	10.1371/journal.pone.0059888	http://dx.doi.org/10.1371/journal.pone.0059888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	24223855	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200055
J	Bauer, M; Metzler, R				Bauer, Maximilian; Metzler, Ralf			In Vivo Facilitated Diffusion Model	PLOS ONE			English	Article							REPRESSOR-OPERATOR INTERACTION; ANOMALOUS DIFFUSION; PROTEIN TRANSLOCATION; DRIVEN MECHANISMS; NUCLEIC-ACIDS; DNA; KINETICS; SEARCH; CONFINEMENT; DYNAMICS	Under dilute in vitro conditions transcription factors rapidly locate their target sequence on DNA by using the facilitated diffusion mechanism. However, whether this strategy of alternating between three-dimensional bulk diffusion and one-dimensional sliding along the DNA contour is still beneficial in the crowded interior of cells is highly disputed. Here we use a simple model for the bacterial genome inside the cell and present a semi-analytical model for the in vivo target search of transcription factors within the facilitated diffusion framework. Without having to resort to extensive simulations we determine the mean search time of a lac repressor in a living E. coli cell by including parameters deduced from experimental measurements. The results agree very well with experimental findings, and thus the facilitated diffusion picture emerges as a quantitative approach to gene regulation in living bacteria cells. Furthermore we see that the search time is not very sensitive to the parameters characterizing the DNA configuration and that the cell seems to operate very close to optimal conditions for target localization. Local searches as implied by the colocalization mechanism are only found to mildly accelerate the mean search time within our model.	[Bauer, Maximilian; Metzler, Ralf] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Bauer, Maximilian] Tech Univ Munich, Dept Phys, Garching, Germany; [Metzler, Ralf] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	University of Potsdam; Technical University of Munich; Tampere University	Metzler, R (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	rmetzler@uni-potsdam.de	Metzler, Ralf/J-9088-2013; Stefanadis, Christodoulos/ABH-2232-2020	Metzler, Ralf/0000-0002-6013-7020; Liao, Ronglih/0000-0002-9598-9020; Stefanadis, Christodoulos/0000-0001-5974-6454; Cheng, Susan/0000-0002-4977-036X	Academy of Finland (FiDiPro scheme); German Federal Ministry for Education and Research	Academy of Finland (FiDiPro scheme)(Academy of Finland); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Academy of Finland (FiDiPro scheme): www.aka.fi/eng; and German Federal Ministry for Education and Research: www.bmbf.de/en/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Bauer M, 2012, BIOPHYS J, V102, P2321, DOI 10.1016/j.bpj.2012.04.008; Benichou O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038102; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Buenemann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013806; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Foffano G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021919; Fritsche M, 2012, NUCLEIC ACIDS RES, V40, P972, DOI 10.1093/nar/gkr779; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hellmann M, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/58004; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jun S, 2010, NAT REV MICROBIOL, V8, P600, DOI 10.1038/nrmicro2391; Jung Y, 2012, SOFT MATTER, V8, P2095, DOI 10.1039/c1sm05706e; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Kolomeisky AB, 2011, PHYS CHEM CHEM PHYS, V13, P2088, DOI 10.1039/c0cp01966f; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Koslover EF, 2011, BIOPHYS J, V101, P856, DOI 10.1016/j.bpj.2011.06.066; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Lomholt MA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200603; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; MADRAS N, 1990, J STAT PHYS, V58, P159, DOI 10.1007/BF01020290; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Meyer B, 2010, PHYS REV E, V83; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Morelli MJ, 2011, BIOPHYS J, V101, P2882, DOI 10.1016/j.bpj.2011.10.053; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Reingruber J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/6/065103; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Romantsov T, 2007, BIOPHYS J, V92, P2875, DOI 10.1529/biophysj.106.095729; Sereshki LE, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/20008; Sheinman M, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/2/026601; Sheinman M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016003; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Sokolov IM, 2005, BIOPHYS J, V89, P895, DOI 10.1529/biophysj.104.057612; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; van den Broek B, 2008, P NATL ACAD SCI USA, V105, P15738, DOI 10.1073/pnas.0804248105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; von Smoluchowski M, 1916, PHYS Z, V17, P557; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Wunderlich Z, 2008, NUCLEIC ACIDS RES, V36, P3570, DOI 10.1093/nar/gkn173; Zhou HX, 2011, P NATL ACAD SCI USA, V108, P8651, DOI 10.1073/pnas.1101555108	55	80	81	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53956	10.1371/journal.pone.0053956	http://dx.doi.org/10.1371/journal.pone.0053956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349772	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800019
J	Yu, QF; Ye, W; Wang, W; Chen, HF				Yu, Qingfen; Ye, Wei; Wang, Wei; Chen, Hai-Feng			Global Conformational Selection and Local Induced Fit for the Recognition between Intrinsic Disordered p53 and CBP	PLOS ONE			English	Article							DYNAMIC ENERGY LANDSCAPE; CREB-BINDING-PROTEIN; TRANSITION-STATE; MOLECULAR-DYNAMICS; TRANSCRIPTIONAL ACTIVATION; CHYMOTRYPSIN INHIBITOR-2; TRANSACTIVATION DOMAIN; COUPLED BINDING; MECHANISM; COACTIVATOR	The transactivation domain (TAD) of tumor suppressor p53 can bind with the nuclear coactivator binding domain (NCBD) of cyclic-AMP response element binding protein (CBP) and activate transcription. NMR experiments demonstrate that both apo-NCBD and TAD are intrinsic disordered and bound NCBD/TAD undergoes a transition to well folded. The recognition mechanism between intrinsic disordered proteins is still hotly debated. Molecular dynamics (MD) simulations in explicit solvent are used to study the recognition mechanism between intrinsic disordered TAD and NCBD. The average RMSD values between bound and corresponding apo states and Kolmogorov-Smirnov P test analysis indicate that TAD and NCBD may follow an induced fit mechanism. Quantitative analysis indicates there is also a global conformational selection. In summary, the recognition of TAD and NCBD might obey a local induced fit and global conformational selection. These conclusions are further supported by high-temperature unbinding kinetics and room temperature landscape analysis. These methods can be used to study the recognition mechanism of other intrinsic disordered proteins.	[Yu, Qingfen; Ye, Wei; Wang, Wei; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Chen, HF (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020	Li, Haizhou/0000-0001-9158-9401	Ministry of Science and Technology China [2012CB721003]; National High-tech Research & Development Program of China (863 Program) [2012AA020403]; National Natural Science Foundation of China [31271403]; Shanghai Education Committee [12ZZ023]; Shanghai Pujiang Program [10PJD010]; Natural Science Foundation of Shanghai from China [10ZR1414500]; Medical Engineering Cross Fund of Shanghai Jiaotong University [YG2010MS67]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National High-tech Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Education Committee; Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai from China; Medical Engineering Cross Fund of Shanghai Jiaotong University	This work was sponsored by grants from Ministry of Science and Technology China(2012CB721003), by National High-tech Research & Development Program of China (863 Program)(2012AA020403), by National Natural Science Foundation of China (31271403), by Innovation Program of Shanghai Education Committee (Grants No. 12ZZ023), by Shanghai Pujiang Program (10PJD010), by the Natural Science Foundation of Shanghai from China (Grants No. 10ZR1414500), and by Medical Engineering Cross Fund of Shanghai Jiaotong University (YG2010MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agakishiev G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.072302; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; CAFLISCH A, 1994, P NATL ACAD SCI USA, V91, P1746, DOI 10.1073/pnas.91.5.1746; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case D.A., 2022, AMBER 2020; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Fernandez-Escamilla AM, 2004, P NATL ACAD SCI USA, V101, P2834, DOI 10.1073/pnas.0304180101; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Henkels CH, 2006, J AM CHEM SOC, V128, P7772, DOI 10.1021/ja057279+; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422; Petsko GA, 2003, CURR PROTOC BIOINFOR; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Ritort F, 2002, P NATL ACAD SCI USA, V99, P13544, DOI 10.1073/pnas.172525099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Ye W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043788; Ye W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036382	64	87	90	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59627	10.1371/journal.pone.0059627	http://dx.doi.org/10.1371/journal.pone.0059627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	24223789	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500067
J	Huang, LN; Liu, Y; Zhang, P; Kang, RT; Liu, Y; Li, XZ; Bo, LJ; Dong, ZM				Huang, Lining; Liu, Yue; Zhang, Pei; Kang, Rongtian; Liu, Ya; Li, Xuze; Bo, Lijun; Dong, Zhenming			In Vitro Dose-Dependent Inhibition of the Intracellular Spontaneous Calcium Oscillations in Developing Hippocampal Neurons by Ketamine	PLOS ONE			English	Article							REGIONAL EXPRESSION; CA2+ OSCILLATIONS; NMDA RECEPTORS; RAT; NEUROTOXICITY; INVOLVEMENT; MECHANISMS; GABA(A); CHANNEL; BRAIN	Spatial and temporal abnormalities in the frequency and amplitude of the cytosolic calcium oscillations can impact the normal physiological functions of neuronal cells. Recent studies have shown that ketamine can affect the growth and development and even induce the apoptotic death of neurons. This study used isolated developing hippocampal neurons as its study subjects to observe the effect of ketamine on the intracellular calcium oscillations in developing hippocampal neurons and to further explore its underlying mechanism using Fluo-4-loaded laser scanning confocal microscopy. Using a semi-quantitative method to analyze the spontaneous calcium oscillatory activities, a typical type of calcium oscillation was observed in developing hippocampal neurons. In addition, the administration of NMDA (N-Methyl-D-aspartate) at a concentration of 100 mu M increased the calcium oscillation amplitude. The administration of MK801 at a concentration of 40 mu M inhibited the amplitude and frequency of the calcium oscillations. Our results demonstrated that an increase in the ketamine concentration, starting from 30 mu M, gradually decreased the neuronal calcium oscillation amplitude. The inhibition of the calcium oscillation frequency by 300 mu M ketamine was statistically significant, and the neuronal calcium oscillations were completely eliminated with the administration of 3,000 mu M Ketamine. The administration of 100, 300, and 1,000 mu M NMDA to the 1 mM ketamine-pretreated hippocampal neurons restored the frequency and amplitude of the calcium oscillations in a dose-dependent manner. In fact, a concentration of 1,000 mu M NMDA completely reversed the decrease in the calcium oscillation frequency and amplitude that was induced by 1 mM ketamine. This study revealed that ketamine can inhibit the frequency and amplitude of the calcium oscillations in developing hippocampal neurons though the NMDAR (NMDA receptor) in a dose-dependent manner, which might highlight a possible underlying mechanism of ketamine toxicity on the rat hippocampal neurons during development.	[Huang, Lining; Liu, Yue; Zhang, Pei; Kang, Rongtian; Liu, Ya; Li, Xuze; Bo, Lijun; Dong, Zhenming] Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University	Dong, ZM (corresponding author), Hebei Med Univ, Hosp 2, Dept Anesthesiol, Shijiazhuang, Hebei Province, Peoples R China.	dongzhenmingmzk@yahoo.com.cn		Mo, Jinhan/0000-0002-3178-6507	Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society [CSA2010LB017]; Key Medicine Scientific Developing Program of Hebei Province [20110338]	Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society; Key Medicine Scientific Developing Program of Hebei Province	This work was supported by Libang Scientific Research Funds of Chinese Medical Association Anesthesiology Society (CSA2010LB017) and Key Medicine Scientific Developing Program of Hebei Province (No. 20110338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BRODIN L, 1991, J NEUROPHYSIOL, V66, P473, DOI 10.1152/jn.1991.66.2.473; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Dunn RJ, 1999, J EXP BIOL, V202, P1319; Gomes LMRS, 2011, PAIN PHYSICIAN, V14, P83; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; IRIFUNE M, 1992, BRAIN RES, V596, P1, DOI 10.1016/0006-8993(92)91525-J; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; JACOBSON I, 1990, EXP BRAIN RES, V80, P409; Kanemaru K, 2007, J NEUROSCI, V27, P8957, DOI 10.1523/JNEUROSCI.2276-07.2007; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LIN LH, 1992, J PHARMACOL EXP THER, V263, P569; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Orser BA, 1997, ANESTHESIOLOGY, V86, P903, DOI 10.1097/00000542-199704000-00021; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Paupard MC, 1997, NEUROSCIENCE, V79, P399, DOI 10.1016/S0306-4522(96)00677-X; Przewlocki R, 1999, J NEUROSCI, V19, P9705; Sinner B, 2005, ANESTH ANALG, V100, P1660, DOI 10.1213/01.ANE.0000150946.18875.48; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; Tang FJ, 2003, J NEUROSCI, V23, P927; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P877, DOI 10.1007/s10571-004-6927-6; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010; Zou XJ, 2009, TOXICOL SCI, V108, P149, DOI 10.1093/toxsci/kfn270	40	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59804	10.1371/journal.pone.0059804	http://dx.doi.org/10.1371/journal.pone.0059804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	24244522	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200040
J	Iyer, SV; Dange, PP; Alam, H; Sawant, SS; Ingle, AD; Borges, AM; Shirsat, NV; Dalal, SN; Vaidya, MM				Iyer, Sapna V.; Dange, Prerana P.; Alam, Hunain; Sawant, Sharada S.; Ingle, Arvind D.; Borges, Anita M.; Shirsat, Neelam V.; Dalal, Sorab N.; Vaidya, Milind M.			Understanding the Role of Keratins 8 and 18 in Neoplastic Potential of Breast Cancer Derived Cell Lines	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; EPITHELIAL-CELLS; CYTOKERATIN EXPRESSION; E-CADHERIN; DIFFERENTIATION; GENE; CARCINOMAS; VIMENTIN; INTEGRIN; INVASION	Background: Breast cancer is a complex disease which cannot be defined merely by clinical parameters like lymph node involvement and histological grade, or by routinely used biomarkers like estrogen receptor (ER), progesterone receptor (PGR) and epidermal growth factor receptor 2 (HER2) in diagnosis and prognosis. Breast cancer originates from the epithelial cells. Keratins (K) are cytoplasmic intermediate filament proteins of epithelial cells and changes in the expression pattern of keratins have been seen during malignant transformation in the breast. Expression of the K8/18 pair is seen in the luminal cells of the breast epithelium, and its role in prognostication of breast cancer is not well understood. Methodology/Principal Findings: In this study, we have modulated K8 expression to understand the role of the K8/18 pair in three different breast epithelium derived cell lines: non-transformed MCF10A, transformed but poorly invasive MDA MB 468 and highly invasive MDA MB 435. The up-regulation of K8 in the invasive MDA MB 435 cell line resulted in a significant decrease in proliferation, motility, in-vitro invasion, tumor volume and lung metastasis. The down-regulation of K8 in MDA MB 468 resulted in a significant increase in transformation potential, motility and invasion in-vitro, while MCF10A did not show any changes in cell transformation assays. Conclusions/Significance: These results indicate the role of K8/18 in modulating invasion in breast cancer - its presence correlating with less invasive phenotype and absence correlating with highly invasive, dedifferentiated phenotype. These data may have important implications for prognostication of breast cancer.	[Iyer, Sapna V.; Dange, Prerana P.; Alam, Hunain; Sawant, Sharada S.; Ingle, Arvind D.; Shirsat, Neelam V.; Dalal, Sorab N.; Vaidya, Milind M.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India; [Borges, Anita M.] SL Raheja Hosp, Asian Inst Oncol, Dept Histopathol, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Vaidya, MM (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India.	mvaidya@actrec.gov.in	Sundaram, Bala/A-6532-2010; Alam, Hunain/H-2984-2019	Sundaram, Bala/0000-0002-1728-704X; Alam, Hunain/0000-0002-6183-3677	Department of Biotechnology (DBT)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by grants from Department of Biotechnology (DBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; BAUMAN PA, 1994, P NATL ACAD SCI USA, V91, P5311, DOI 10.1073/pnas.91.12.5311; BLOBEL GA, 1984, VIRCHOWS ARCH B, V45, P407, DOI 10.1007/BF02889883; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CASANOVA L, 1995, J CELL SCI, V108, P811; CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369; Cortes Gutierrez Elva I, 2005, Ginecol Obstet Mex, V73, P111; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Galvin S, 1989, Adv Dermatol, V4, P277; Gonzalez A, 2012, APPL MICROBIOL BIOTE; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HEYDEN A, 1992, J ORAL PATHOL MED, V21, P7, DOI 10.1111/j.1600-0714.1992.tb00960.x; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; MOLL R, 1987, ACTA HISTOCHEM, P37; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; OUHAYOUN JP, 1985, DIFFERENTIATION, V30, P123; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Ramesh S, 1999, BRIT J CANCER, V81, P1392, DOI 10.1038/sj.bjc.6693437; Ranganathan K, 2006, J ORAL PATHOL MED, V35, P25, DOI 10.1111/j.1600-0714.2005.00366.x; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Sawaf M H, 1991, J Biol Buccale, V19, P187; SCHAAFSMA HE, 1993, J PATHOL, V170, P77, DOI 10.1002/path.1711700113; Schaller G, 1996, CLIN CANCER RES, V2, P1879; Schaller G, 1999, Zentralbl Gynakol, V121, P126; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Singhai R, 2011, N AM J MED SCI, V3, P227, DOI 10.4297/najms.2011.3227; SOULE HD, 1990, CANCER RES, V50, P6075; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Vaidya MM, 1998, ORAL ONCOL, V34, P261, DOI 10.1016/S1368-8375(97)00095-X; VAIDYA MM, 1989, J ORAL PATHOL MED, V18, P282, DOI 10.1111/j.1600-0714.1989.tb00398.x; VANMUIJEN GNP, 1987, EXP CELL RES, V171, P331, DOI 10.1016/0014-4827(87)90166-2; Woelfle U, 2004, CLIN CANCER RES, V10, P2670, DOI 10.1158/1078-0432.CCR-03-0114; Xiang RH, 2002, CANCER RES, V62, P2637	60	287	296	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53532	10.1371/journal.pone.0053532	http://dx.doi.org/10.1371/journal.pone.0053532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341946	gold, Green Submitted, Green Published			2022-12-27	WOS:000314707700020
J	Welch, JR; Brondizio, ES; Hetrick, SS; Coimbra, CEA				Welch, James R.; Brondizio, Eduardo S.; Hetrick, Scott S.; Coimbra, Carlos E. A., Jr.			Indigenous Burning as Conservation Practice: Neotropical Savanna Recovery amid Agribusiness Deforestation in Central Brazil	PLOS ONE			English	Article							CERRADO VEGETATION; FIRE MANAGEMENT; CLIMATE-CHANGE; MATO-GROSSO; PEOPLES; ABUNDANCE; FORESTS	International efforts to address climate change by reducing tropical deforestation increasingly rely on indigenous reserves as conservation units and indigenous peoples as strategic partners. Considered win-win situations where global conservation measures also contribute to cultural preservation, such alliances also frame indigenous peoples in diverse ecological settings with the responsibility to offset global carbon budgets through fire suppression based on the presumed positive value of non-alteration of tropical landscapes. Anthropogenic fire associated with indigenous ceremonial and collective hunting practices in the Neotropical savannas (cerrado) of Central Brazil is routinely represented in public and scientific conservation discourse as a cause of deforestation and increased CO2 emissions despite a lack of supporting evidence. We evaluate this claim for the Xavante people of Pimentel Barbosa Indigenous Reserve, Brazil. Building upon 23 years of longitudinal interdisciplinary research in the area, we used multi-temporal spatial analyses to compare land cover change under indigenous and agribusiness management over the last four decades (1973-2010) and quantify the contemporary Xavante burning regime contributing to observed patterns based on a four year sample at the end of this sequence (2007-2010). The overall proportion of deforested land remained stable inside the reserve (0.6%) but increased sharply outside (1.5% to 26.0%). Vegetation recovery occurred where reserve boundary adjustments transferred lands previously deforested by agribusiness to indigenous management. Periodic traditional burning by the Xavante had a large spatial distribution but repeated burning in consecutive years was restricted. Our results suggest a need to reassess overreaching conservation narratives about the purported destructiveness of indigenous anthropogenic fire in the cerrado. The real challenge to conservation in the fire-adapted cerrado biome is the long-term sustainability of indigenous lands and other tropical conservation islands increasingly subsumed by agribusiness expansion rather than the localized subsistence practices of indigenous and other traditional peoples.	[Welch, James R.; Coimbra, Carlos E. A., Jr.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Brondizio, Eduardo S.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Brondizio, Eduardo S.; Hetrick, Scott S.] Indiana Univ, Anthropol Ctr Training & Res Global Environm Chan, Bloomington, IN USA	Fundacao Oswaldo Cruz; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Welch, JR (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.	welch@ensp.fiocruz.br	Brondizio, Eduardo/R-7643-2019; Welch, James R/B-5042-2013	Welch, James R/0000-0002-9094-5491; Chunco, Amanda/0000-0002-8265-327X; Coimbra Jr., Carlos E. A./0000-0003-4085-1080	Brazilian National School of Public Health (INOVA-ENSP program); Fulbright Commission (Fulbright-Hays DDRAF) [P022A040016]; Brazilian Research Council (CNPq) [475674/2008-1, 403569/2008-7, 500072/2010-8]	Brazilian National School of Public Health (INOVA-ENSP program); Fulbright Commission (Fulbright-Hays DDRAF); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financing was provided by the Brazilian National School of Public Health (INOVA-ENSP program), the Fulbright Commission (Fulbright-Hays DDRAF no. P022A040016), and the Brazilian Research Council (CNPq grants 475674/2008-1, 403569/2008-7, and 500072/2010-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1987, SCIENCE, V235, P1450, DOI 10.1126/science.235.4795.1450; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; [Anonymous], BIODIVERS BRAS; [Anonymous], 2002, XAVANTE TRANSITION H; [Anonymous], 2011, BIODIVERS BRAS; [Anonymous], 2006, SAVANA DRY FORESTS L; [Anonymous], 2013, HUMAN ENV INTERACTIO; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Birrell K, 2012, J HUM RIGHTS ENVIRON, V3, P196, DOI 10.4337/jhre.2012.03.02; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Briani DC, 2004, BIODIVERS CONSERV, V13, P1023, DOI 10.1023/B:BIOC.0000014467.27138.0b; Brondizio ES, 2009, ANNU REV ENV RESOUR, V34, P253, DOI 10.1146/annurev.environ.020708.100707; Cavalcanti Roberto B., 1997, Ornitologia Neotropical, V8, P85; COUTINHO LM, 1990, ECOL STU AN, V84, P82; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; De Castro EA, 1998, J TROP ECOL, V14, P263, DOI 10.1017/S0266467498000212; de Melo MM, 2013, SOC NATUR RESOUR, V26, P478, DOI 10.1080/08941920.2012.713087; Diaz M.d.C.V., 2002, PRECO OCULTO FOGO AM; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Ferreira JuCnior L.G, 2011, REV BRASILEIRA CARTO, V63, P461; Flowers N. M., 1983, ADAPTIVE RESPONSES N, P357; FRIZZO, 2011, OECOLOGIA AUSTR RIO, V15, P365, DOI DOI 10.4257/0EC0.2011.1502.13; Garfield S, 2001, INDIGENOUS STRUGGLE; Georgescu M, 2013, GEOPHYS RES LETT, V40, P972, DOI 10.1002/grl.50206; GROSS DR, 1979, SCIENCE, V206, P1043, DOI 10.1126/science.206.4422.1043; Hecht S. B., 2009, P143, DOI 10.1007/978-1-4020-9031-8_7; Kassu Milanez F, 2010, AGUA BOA NEWS   1212; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Leach M, 2012, J PEASANT STUD, V39, P285, DOI 10.1080/03066150.2012.658042; Ledru Marie-Pierre., 2002, CERRADOS BRAZIL ECOL, P33; Leeuwenberg FJ, 2000, BIOL RESOURCE MANAGE, P375; Leite DLP, 2007, THESIS U BRASILIA BR; Leonel M., 2000, ESTUD AV-SAO PAULO, V14, P231, DOI [10.1590/S0103-40142000000300019, DOI 10.1590/S0103-40142000000300019]; McGregor S, 2010, HUM ECOL, V38, P721, DOI 10.1007/s10745-010-9362-y; Miranda H.S., 2002, CERRADOS BRAZIL ECOL, P51, DOI 10.7312/oliv12042-005; Mistry J, 1998, PROG PHYS GEOG, V22, P425, DOI 10.1177/030913339802200401; Mistry J, 2005, HUM ECOL, V33, P365, DOI 10.1007/s10745-005-4143-8; Mittermeier Russell A., 2004, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nascimento LJ, 2013, G1 MATO GROSSO  0820; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Oliveira M, 2001, DIARIO CUIABA   0814; Pereira C. A., 2004, Floresta, V34, P95; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; Pivello VR, 2011, FIRE ECOL, V7, P24, DOI 10.4996/fireecology.0701024; Prada M, 1995, BIOTROPICA, V27, P513, DOI 10.2307/2388965; Prada M, 2004, AUSTRAL ECOL, V29, P568, DOI 10.1111/j.1442-9993.2004.01391.x; Prada M, 2001, MAMMALIA, V65, P55, DOI 10.1515/mamm.2001.65.1.55; Ramos-Neto MB, 2000, ENVIRON MANAGE, V26, P675, DOI 10.1007/s002670010124; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Soares R. V., 2002, Floresta, V32, P219; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Turnhout E, 2012, NATURE, V488, P454, DOI 10.1038/488454a; United Nations, 2012, 2 SESS PLEN M DET MO; van Dam C, 2011, FORESTS, V2, P394, DOI 10.3390/f2010394; van Wilgen BW, 2010, J APPL ECOL, V47, P631, DOI 10.1111/j.1365-2664.2010.01800.x; VanWey LK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0168; Villalobos M. P., 2002, THESIS U BRASILIA BR; VITT LJ, 1993, J HERPETOL, V27, P46, DOI 10.2307/1564904; WARMING Eugenius, 1892, LAGOA SANTA BIDRAG B; WELCH J. R., 2013, PRIMEIRA MARGEM RIO; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; Whitehead PJ, 2003, INT J WILDLAND FIRE, V12, P415, DOI 10.1071/WF03027	67	82	98	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81226	10.1371/journal.pone.0081226	http://dx.doi.org/10.1371/journal.pone.0081226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349045	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300022
J	Tang, CK; Aoshi, T; Jounai, N; Ito, J; Ohata, K; Kobiyama, K; Dessailly, BH; Kuroda, E; Akira, S; Mizuguchi, K; Coban, C; Ishii, KJ				Tang, Choon Kit; Aoshi, Taiki; Jounai, Nao; Ito, Junichi; Ohata, Keiichi; Kobiyama, Kouji; Dessailly, Benoit H.; Kuroda, Etsushi; Akira, Shizuo; Mizuguchi, Kenji; Coban, Cevayir; Ishii, Ken J.			The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant	PLOS ONE			English	Article							VASCULAR DISRUPTING AGENT; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; INNATE; ACTIVATION; IMMUNOGENICITY; CARBOPLATIN; PACLITAXEL; ASA404; PLAYS; CELLS	5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent type I interferon (IFN) inducer, was evaluated as a chemotherapeutic agent in mouse cancer models and proved to be well tolerated in human cancer clinical trials. Despite its multiple biological functions, DMXAA has not been fully characterized for the potential application as a vaccine adjuvant. In this report, we show that DMXAA does act as an adjuvant due to its unique property as a soluble innate immune activator. Using OVA as a model antigen, DMXAA was demonstrated to improve on the antigen specific immune responses and induce a preferential Th2 (Type-2) response. The adjuvant effect was directly dependent on the IRF3-mediated production of type-I-interferon, but not IL-33. DMXAA could also enhance the immunogenicity of influenza split vaccine which led to significant increase in protective responses against live influenza virus challenge in mice compared to split vaccine alone. We propose that DMXAA can be used as an adjuvant that targets a specific innate immune signaling pathway via IRF3 for potential applications including vaccines against influenza which requires a high safety profile.	[Tang, Choon Kit] Agcy Sci & Technol Res, Singapore Immunol Network, Singapore, Singapore; [Tang, Choon Kit; Ohata, Keiichi; Coban, Cevayir] Osaka Univ, Immunol Frontier Res Ctr IFReC, Malaria Immunol Lab, Suita, Osaka 565, Japan; [Tang, Choon Kit; Akira, Shizuo] Osaka Univ, IFReC, Host Def Lab, Suita, Osaka 565, Japan; [Tang, Choon Kit; Aoshi, Taiki; Kobiyama, Kouji; Kuroda, Etsushi; Ishii, Ken J.] Osaka Univ, IFReC, Vaccine Sci Lab, Suita, Osaka 565, Japan; [Aoshi, Taiki; Jounai, Nao; Kobiyama, Kouji; Kuroda, Etsushi; Ishii, Ken J.] NIBIO, Lab Adjuvant Innovat, Osaka, Japan; [Ito, Junichi; Dessailly, Benoit H.; Mizuguchi, Kenji] Natl Inst Biomed Innovat NIBIO, Lab Bioinformat, Osaka, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Osaka University; Osaka University; Osaka University	Ishii, KJ (corresponding author), Osaka Univ, IFReC, Vaccine Sci Lab, Suita, Osaka 565, Japan.	kenishii@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Ishii, Ken J/B-1685-2012; Mizuguchi, Kenji/GVS-5857-2022; COBAN, Cevayir/P-1928-2019; Coban, Cevayir/B-2129-2012	Ishii, Ken J/0000-0002-6728-3872; Mizuguchi, Kenji/0000-0003-3021-7078; COBAN, Cevayir/0000-0002-4467-7799; Ohata, Keiichi/0000-0002-5635-4292	Japanese Ministry of Health, Labour and Welfare; A*STAR, Singapore	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a Health and Labour Sciences Research Grant 'Adjuvant database Project' of the Japanese Ministry of Health, Labour and Welfare. CKT was funded by A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer R, 2010, NEOPLASIA, V12, P755, DOI 10.1593/neo.10636; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; LAWS AL, 1995, BRIT J CANCER, V71, P1204, DOI 10.1038/bjc.1995.234; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Peng SW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-21; Perkins DJ, 2012, J IMMUNOL; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Tang CK, 2009, BIOMATERIALS, V30, P1389, DOI 10.1016/j.biomaterials.2008.11.010; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhao LL, 2005, INT J CANCER, V116, P322, DOI 10.1002/ijc.21005	30	124	128	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60038	10.1371/journal.pone.0060038	http://dx.doi.org/10.1371/journal.pone.0060038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	24066172	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400077
J	Zhang, XY; Sun, Q; Shan, M; Niu, M; Liu, T; Xia, BS; Liang, XS; Wei, W; Sun, SS; Zhang, YX; Liu, XS; Song, QB; Yang, YM; Ma, YY; Liu, Y; Yang, L; Ren, YL; Zhang, GQ; Pang, D				Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Liu, Xiaolong Sean; Song, Qingbin; Yang, Yanmei; Ma, Yuyan; Liu, Yang; Yang, Long; Ren, Yanlv; Zhang, Guoqiang; Pang, Da			Promoter Hypermethylation of ARID1A Gene Is Responsible for Its Low mRNA Expression in Many Invasive Breast Cancers	PLOS ONE			English	Article							CLEAR-CELL CARCINOMA; SOMATIC MUTATIONS; SWI/SNF COMPLEXES; PROTEIN P270; EPIGENETICS; COMPONENT	ARID1A (AT-rich interactive domain 1A) has recently been identified as a tumor suppressor gene. Its mRNA expression is significantly low in many breast cancers; this is often associated with more aggressive phenotypes. However, the underlying molecular mechanism for its low expression has not been fully understood. This study was undertaken to evaluate the contribution of gene copy number variation, mutations, promoter methylation and histone modification to ARID1A's low expression. 38 pairs of breast invasive ductal carcinomas and their normal breast tissue counterparts from the same patients were randomly selected for gene expression and copy number variation detection. Promoter methylation and histone modification levels were evaluated by MeDIP-qPCR and ChIP-qPCR, respectively. PCR product Sanger sequencing was carried out to detect the exon mutation rate. Twenty-two out of 38 invasive ductal carcinomas in the study (57.9%) revealed ARID1A mRNA low expression by realtime RT-PCR. The relative promoter methylation level was, significantly higher in ARID1A mRNA low expression group compared with its high expression group (p<0.001). In the low expression group, nineteen out of 22 invasive ductal carcinomas (86.4%) exhibited ARID1A promoter hypermthylation. In addition, the promoter hypermethylation was accompanied with repressive histone modification (H3K27Me3). Although five out of 38 invasive ductal carcinomas (13.2%) exhibited loss of ARID1A gene copy number by realtime PCR and nine exon novel mutations are seen from eight out of 33 invasive ductal carcinomas (24.2%), there was no statistically significant difference in both ARID1A mRNA low and high expression groups (p = 0.25, and p = 0.68, respectively). We demonstrate that promoter hypermethylation was the main culprit for ARID1A mRNA low expression in invasive ductal carcinomas. The influence of mutation and copy number variation on the expression were statistically insignificant at mRNA level, and were, therefore, not considered the main causes for ARID1A mRNA low expression in invasive breast cancer.	[Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Ren, Yanlv; Zhang, Guoqiang; Pang, Da] Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Liu, Xiaolong Sean] Harbin Med Univ, Dept Pathol, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Song, Qingbin] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Yang, Yanmei; Ma, Yuyan; Pang, Da] Heilongjiang Inst Canc Res, Key Lab, Harbin, Heilongjiang, Peoples R China; [Yang, Long] Life Technol Corp, ICFC Custom Serv, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Icahn School of Medicine at Mount Sinai; Thermo Fisher Scientific	Pang, D (corresponding author), Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China.	pangda@ems.hrbmu.edu.cn	Zhang, Guo-Qiang/AAG-6817-2019; Liu, Wei/N-4465-2017	Zhang, Guo-Qiang/0000-0001-6439-019X; Liu, Wei/0000-0001-9819-3178; Wu, Chongming/0000-0003-2898-370X; LIU, TONG/0000-0001-9234-1328	National Natural Science Foundation of China [81172498/H1622]; Harbin Science and Technology bureau [2011RFXYS056]; Postgraduate Innovation Research Fund of Heilongjiang Province [YJSCX2011-332-HLJ]; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University [JJ2010-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology bureau; Postgraduate Innovation Research Fund of Heilongjiang Province; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University	This work was supported by National Natural Science Foundation of China (81172498/H1622), Harbin Science and Technology bureau (2011RFXYS056), Postgraduate Innovation Research Fund of Heilongjiang Province (YJSCX2011-332-HLJ) and Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University (JJ2010-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornen S., 2012, ONCOGENE; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zhang XY, 2012, CANCER EPIDEMIOL, V36, P288, DOI 10.1016/j.canep.2011.07.006	21	711	732	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53931	10.1371/journal.pone.0053931	http://dx.doi.org/10.1371/journal.pone.0053931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23556003	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000021
J	Zhu, X; Silva, LCR; Doane, TA; Horwath, WR				Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.			Iron: The Forgotten Driver of Nitrous Oxide Production in Agricultural Soil	PLOS ONE			English	Article							SPECTROPHOTOMETRIC DETERMINATION; WETLAND SOILS; NO EMISSIONS; FERROUS IRON; OXIDATION; REDUCTION; N2O; NITRATE; MICROORGANISMS; HYDROXYLAMINE	In response to rising interest over the years, many experiments and several models have been devised to understand emission of nitrous oxide (N2O) from agricultural soils. Notably absent from almost all of this discussion is iron, even though its role in both chemical and biochemical reactions that generate N2O was recognized well before research on N2O emission began to accelerate. We revisited iron by exploring its importance alongside other soil properties commonly believed to control N2O production in agricultural systems. A set of soils from California's main agricultural regions was used to observe N2O emission under conditions representative of typical field scenarios. Results of multivariate analysis showed that in five of the twelve different conditions studied, iron ranked higher than any other intrinsic soil property in explaining observed emissions across soils. Upcoming studies stand to gain valuable information by considering iron among the drivers of N2O emission, expanding the current framework to include coupling between biotic and abiotic reactions.	[Zhu, Xia] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhu, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Doane, TA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	tadoane@ucdavis.edu	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	California Department of Resources Recycling and Recovery [IWM09027]; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station	California Department of Resources Recycling and Recovery; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station(University of California System)	Support was provided by the California Department of Resources Recycling and Recovery (www.calrecycle.ca.gov), Agreement IWM09027; the J. G. Boswell Endowed Chair in Soil Science; and the University of California Agricultural Experiment Station (http://caes.ucdavis.edu/research/agexpstn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; BREMNER JM, 1946, NATURE, V158, P790, DOI 10.1038/158790b0; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Burger M, 2011, ACS SYM SER, V1072, P179; Burt R, 1992, 42 USDA; CASSEL DK, 1986, AGRONOMY, V9, P901; Chalamet A, 1976, SOIL BIOL BIOCHEM, V9, P281; CHAO TT, 1966, SOIL SCI SOC AM PRO, V30, P193, DOI 10.2136/sssaj1966.03615995003000020016x; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Dominik P, 2000, TALANTA, V51, P701, DOI 10.1016/S0039-9140(99)00324-0; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P74, DOI 10.1890/100137; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; HANSEN HCB, 1994, GEOCHIM COSMOCHIM AC, V58, P2599, DOI 10.1016/0016-7037(94)90131-7; HENDRICKSON AH, 1945, PLANT PHYSIOL, V20, P517, DOI 10.1104/pp.20.4.517; Li CS, 2000, J GEOPHYS RES-ATMOS, V105, P4369, DOI 10.1029/1999JD900949; LOVELAND PJ, 1984, J SOIL SCI, V35, P243, DOI 10.1111/j.1365-2389.1984.tb00280.x; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Marcoulides GA, 2009, MIS QUART, V33, P171; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; ROBERTSON K, 1994, J ENVIRON QUAL, V23, P805, DOI 10.2134/jeq1994.00472425002300040027x; Sahrawat K. L., 1986, Advances in Soil Science, USA, V4, P103; SCHUPPLI PA, 1983, SOIL SCI SOC AM J, V47, P1026, DOI 10.2136/sssaj1983.03615995004700050037x; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; Silver WL, 2011, IRON REDOX ENGINE DR; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Veihmeyer FJ, 1931, SOIL SCI, V32, P181, DOI 10.1097/00010694-193109000-00003; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124	46	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60146	10.1371/journal.pone.0060146	http://dx.doi.org/10.1371/journal.pone.0060146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555906	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900060
J	Zhu, XY; Li, P; Yang, YB; Liu, ML				Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin			Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-CELLS; HEART-DISEASE; ERYTHROCYTES; VISCOSITY; AORTA; DEFORMABILITY; PATHOGENESIS; ACTIVATION; PATHWAY	Background: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. Methodology/Principal Findings: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD+Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. Conclusions/Significance: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.	[Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin] Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China	Peking University	Liu, ML (corresponding author), Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China.	meilinliu@yahoo.com	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	China Health & Medical Development Foundation	China Health & Medical Development Foundation	This work was supported by China Health & Medical Development Foundation (http://www.chmdf.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti MR, 2006, CLIN EXP PHARMACOL P, V33, P305, DOI 10.1111/j.1440-1681.2006.04366.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; HAHN R, 1989, ANGIOLOGY, V40, P914, DOI 10.1177/000331978904001010; Herold S, 2004, INORG CHEM, V43, P3783, DOI 10.1021/ic035340a; Heyman SN, 1999, MICROCIRCULATION, V6, P199; Horn P, 2011, FREE RADICAL RES, V45, P653, DOI 10.3109/10715762.2011.574288; Huang ZY, 2004, LIFE SCI, V75, P3103, DOI 10.1016/j.lfs.2004.04.054; JORIS I, 1983, AM J PATHOL, V113, P341; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koenig W, 1998, ARTERIOSCL THROM VAS, V18, P768, DOI 10.1161/01.ATV.18.5.768; Korbut RA, 2002, J PHYSIOL PHARMACOL, V53, P655; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee AJ, 1998, CIRCULATION, V97, P1467; Lee BK, 2008, CLIN HEMORHEOL MICRO, V39, P43, DOI 10.3233/CH-2008-1066; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; Recchia FA, 2000, AM J PHYSIOL-HEART C, V279, pH852, DOI 10.1152/ajpheart.2000.279.2.H852; Toda N, 2011, INT J ANGIOL, V20, P121, DOI 10.1055/s-0031-1283220; Tsuda K, 2000, BIOCHEM BIOPH RES CO, V275, P946, DOI 10.1006/bbrc.2000.3408; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Zorio E, 2008, CLIN HEMORHEOL MICRO, V39, P33, DOI 10.3233/CH-2008-1065	40	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62731	10.1371/journal.pone.0062731	http://dx.doi.org/10.1371/journal.pone.0062731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23555906	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400008
